<SEC-DOCUMENT>0001062993-21-002769.txt : 20210317
<SEC-HEADER>0001062993-21-002769.hdr.sgml : 20210317
<ACCEPTANCE-DATETIME>20210316211731
ACCESSION NUMBER:		0001062993-21-002769
CONFORMED SUBMISSION TYPE:	40-F
PUBLIC DOCUMENT COUNT:		123
CONFORMED PERIOD OF REPORT:	20201231
FILED AS OF DATE:		20210317
DATE AS OF CHANGE:		20210316

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			FSD Pharma Inc.
		CENTRAL INDEX KEY:			0001771885
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		40-F
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39152
		FILM NUMBER:		21748170

	BUSINESS ADDRESS:	
		STREET 1:		FIRST CANADIAN PLACE
		STREET 2:		100 KING STREET WEST, SUITE 3400
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5X 1A4
		BUSINESS PHONE:		(416) 854-8884

	MAIL ADDRESS:	
		STREET 1:		FIRST CANADIAN PLACE
		STREET 2:		100 KING STREET WEST, SUITE 3400
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5X 1A4
</SEC-HEADER>
<DOCUMENT>
<TYPE>40-F
<SEQUENCE>1
<FILENAME>form40f.htm
<DESCRIPTION>FORM 40-F
<TEXT>
<html>

<head>
    <title>FSD Pharma Inc.: Form 40-F - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt; font-family:'Times New Roman';">
    <hr width="100%" size="3" color="black" noshade="noshade"><a name="page_1"></a>
    <p style="margin-bottom: 0pt; text-align: center;"><b><font size="5">UNITED STATES</font></b></p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b><font size="5">SECURITIES AND EXCHANGE COMMISSION</font></b></p>
    <p style="margin-top: 0pt; text-align: center;"><b>Washington, D.C. 20549</b></p>
    <div style="text-align: center;">
        <hr style="width: 25%; color: #000000; background-color: #000000; text-align: center;" size="1" noshade="noshade">
    </div>
    <p style="text-align: center;"><b><font size="5">FORM 40-F</font></b></p>
    <p style="text-align: justify;">[&#160; ] REGISTRATION STATEMENT PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934</p>
    <p style="text-align: center;">OR</p>
    <p style="text-align: justify;">[X] ANNUAL REPORT PURSUANT TO SECTION 13(a) OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</p>
    <p style="text-align: center;">For the fiscal year ended<b> </b><u><b>December 31, 2020</b></u></p>
    <p style="text-align: center;">Commission File Number <u><b>001-39152</b></u></p>
    <p style="margin-bottom: 0pt; text-align: center;"><b><font size="5"><u>FSD PHARMA INC.</u></font> </b></p>
    <p style="margin-top: 0pt; text-align: center;">(Exact name of Registrant as specified in its charter)</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 33%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top;">
                <p style="margin-left: 10pt; text-indent: -10pt; text-align: center;"><u><b>Ontario, Canada</b></u><br>(Province or Other Jurisdiction of Incorporation or Organization)</p>
            </td>
            <td style="width: 33%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top;">
                <p style="margin-left: 10pt; text-indent: -10pt; text-align: center;"><u><b>2834</b></u><br>(Primary Standard Industrial Classification Code<br>Number (if applicable))</p>
            </td>
            <td style="width: 33%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top;">
                <p style="text-align: center;"><u><b>N/A</b></u><br>(I.R.S. Employer<br>identification Number (if applicable))</p>
            </td>
        </tr>
    </table>
    <p style="margin-bottom: 0pt; text-align: center;"><b>First Canadian Place</b><br><b>100 King Street West, Suite 3400 </b></p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>Toronto, Ontario M5X 1A4</b><br><b>(416) 854-8884 </b></p>
    <p style="margin-top: 0pt; text-align: center;">(Address and telephone number of Registrant's principal executive offices)</p>
    <p style="margin-bottom: 0pt; text-align: center;"><b>CT Corporation System</b></p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>28 Liberty Street</b></p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>New York, New York 10005</b></p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><u><b>(212) 894-8940</b></u></p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center;">(Name, address (including zip code) and</p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center;">telephone number (including area code) of</p>
    <p style="margin-top: 0pt; text-align: center;">agent for service in the United States)</p>
    <p style="text-align: justify;">Securities registered or to be registered pursuant to Section 12(b) of the Act:</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 33%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: bottom;">
                <p style="text-align: center; border-bottom: 0.75pt solid #000000;"><b>Title of Each Class</b></p>
            </td>
            <td style="width: 33%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: bottom;">
                <p style="text-align: center; border-bottom: 0.75pt solid #000000;"><b>Trading Symbol(s)</b></p>
            </td>
            <td style="width: 33%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: bottom;">
                <p style="text-align: center; border-bottom: 0.75pt solid #000000;"><b>Name of Each Exchange on Which Registered</b></p>
            </td>
        </tr>
        <tr>
            <td style="width: 33%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top;">
                <p style="margin-left: 10pt; text-indent: -10pt; text-align: center;"><b>Class B Subordinate Voting Shares, no par value</b></p>
            </td>
            <td style="width: 33%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top;">
                <p style="text-align: center;"><b>HUGE</b></p>
            </td>
            <td style="width: 33%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top;">
                <p style="text-align: center;"><b>The Nasdaq Stock Market LLC</b></p>
            </td>
        </tr>
    </table>
    <p style="text-align: justify;">Securities registered or to be registered pursuant to Section 12(g) of the Act: <b>None</b></p>
    <p style="text-align: justify;">Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: <b>None</b></p>
    <p style="text-align: justify;">For annual reports, indicate by check mark the information filed with this Form:</p>
    <p style="text-align: center;">&#160; &#160; [X]&#160; Annual information form&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; [X]&#160; Audited annual financial statements</p>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_2"></a>
    <p style="text-align: justify;">Indicate the number of outstanding shares of each of the issuer's classes of capital or common stock as of the close of the period covered by the annual report: 19,161,620 Class B Subordinate Voting Shares.</p>
    <p style="text-align: justify;">Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days.</p>
    <p style="text-align: right;">Yes&#160; [X]&#160; &#160; &#160; &#160; &#160; &#160; No&#160; &#9744;</p>
    <p style="text-align: justify;">Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files).</p>
    <p style="text-align: right;">Yes&#160; [X]&#160; &#160; &#160; &#160; &#160; &#160; No&#160; [&#160; ]</p>
    <p style="text-align: justify;">Indicate by check mark whether the Registrant is an emerging growth company as defined in Rule 12b-2 of the Exchange Act.</p>
    <p style="text-align: right;">Emerging growth company&#160; [X]</p>
    <p style="text-align: justify;">If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</p>
    <p style="text-align: right;">[&#160; ]</p>
    <p style="text-align: justify;">Indicate by check mark whether the Registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.</p>
    <div style="border-bottom: 4.5pt solid #000000; clear: both;">
        <p style="text-align: right;">[&#160; ]</p>
    </div>
    <p style="text-align: center;"><b>FORWARD-LOOKING STATEMENTS</b></p>
    <p style="text-indent: 36pt; text-align: justify;">This Annual Report on Form 40-F, including the exhibits hereto (collectively, the "Form 40-F"), includes certain statements that constitute "forward-looking statements" and "forward-looking information" within the meaning of Canadian securities laws and United States securities laws (collectively referred to as "forward-looking statements"). Forward-looking statements relate to future events or future performance, business prospects or opportunities of the Registrant that are based on forecasts of future results, estimates of amounts not yet determined and assumptions of management made in light of management's experience and perception of historical trends, current conditions and expected future developments. All statements other than statements of historical fact may be forward-looking statements.</p>
    <p style="text-indent: 36pt; text-align: justify;">Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance are not statements of historical fact and may be forward-looking statements. Forward-looking statements are often, but not always, identified by words or phrases such as "seek", "anticipate", "believe", "expect", "plan", "continue", "estimate", "will", "predict", "intend", "forecast", "future", "target", "project", "capacity", "could", "should", "might", "focus", "proposed", "scheduled", "outlook", "potential", "may" or similar expressions and includes suggestions of future outcomes, including, but not limited to statements about: discussions concerning the Registrant's exploration of near-term funding strategies&#894; the progress of the Phase 1 study, approved by the Ethics Committee of the Alfred Hospital in Victoria, Australia, to evaluate the safety, tolerability and pharmacokinetics of single and multiple ascending doses of ultramicronized-PEA in normal healthy volunteers&#894; the Registrant's plans to advance the research &amp; development of ultramicronized-palmitoylethanolamide ("ultramicronized-PEA" or "FSD-201") to commercialization through studies and clinical trials, including anticipated timing and associated costs&#894; the status of the Phase 2(a) clinical trial for the use of FSD-201 to treat COVID-19 (the "FSD-201 COVID-19 Trials") and the review thereof by the U.S. Food and Drug Administration (the "FDA"), including the timing, completion and outcomes of any trials or whether FSD-201 may be effective and feasible in treating COVID-19, the application and the costs associated with such planned trials, and the Registrant's ability to obtain required funding and the terms and timing thereof&#894; the expansion of the Registrant's product offering(s), the Registrant's business objectives and the expected impacts of previously announced acquisitions and developments&#894; the investigational new drug FDA application process and any review thereof and its affects on our business objectives; the sale of substantially all of the assets of the Registrant's wholly owned subsidiary, FV Pharma, Inc., including of its facility located at 520 William Street, Cobourg, Ontario, K9A 3A5 (the "Facility"); the anticipated resignation of James A. Datin from the Registrant's board of directors and audit committee; or any actions that may or may not be taken at the annual meeting of the shareholders by certain shareholders of the Registrant claiming to hold in excess of 5.1% of the Class B Subordinate Voting Shares of the Registrant (the "Class B Shares"), including Mr. Zeeshan Saeed, the former President of the Registrant and Mr. Anthony Durkacz, who is a director of the Registrant.</p>
    <p style="text-indent: 36pt; text-align: justify;">The Registrant has made certain assumptions with respect to the forward-looking statements regarding, among other things: the Registrant's ability to generate sufficient cash flow from operations and obtain financing, if needed, on acceptable terms or at all; the general economic, financial market, regulatory and political conditions in which the Registrant operates; the interest of potential purchasers in the Registrant's products; anticipated and unanticipated costs; the government regulation of the Registrant's activities and products; the timely receipt of any required regulatory approvals; the Registrant's ability to obtain qualified staff, equipment and services in a timely and cost efficient manner; the Registrant's ability to conduct operations in a safe, efficient and effective manner; and the Registrant's expansion plans and timeframe for completion of such plans.</p>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_3"></a>
    <p style="text-indent: 36pt; text-align: justify;">Although the Registrant believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements, because no assurance can be given that such statements will prove to be correct. Since forward-looking statements addressing future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially and adversely from those currently anticipated due to a number of factors and risks. These include, but are not limited to: the limited operating history and history of losses, and anticipated significant losses for the foreseeable incurred to pursue commercialization of FSD-201&#894; the Registrant's ability to continue as a going concern; the highly speculative nature of pharmaceutical development; the Registrant's ability to generate sufficient revenue to be profitable; the inability to obtain required additional financing on terms favourable to the Registrant&#894; the Registrant's dual class share structure; whether an active trading market for the Class B Shares is sustained; risks inherent in an pharmaceutical business and with development and commercialization of pharmaceutical products, including the inability to accurately predict timing or amounts of expenses, requirements of regulatory authorities, and completion of clinical studies (including the FSD-201 COVID-19 Trials) on anticipated timelines, which may encounter substantial delays or may not be able to be completed at all; the Registrant's reliance on only one pharmaceutical candidate, FSD-201; risk related to the sale of the Facility, including whether the Registrant will be able to sell the Facility on terms favourable to the Registrant, or at all; vulnerability to rising or volatile energy costs; the Registrant's reliance on management and key persons; manufacturing problems that could result in delay of the Registrant's development or commercialization programs; the Registrant's compliance with environmental, health and safety laws and regulations; the Regisrant's expected minimal environmental impacts; insurance and uninsured risks; interruptions in the supply chain for key inputs; claims from suppliers; risk of conflict related to directors and officers of the Registrant who may currently, or in the future, also serve as directors and/or officers of other public companies that may be involved in the same industry as the Registrant; demand for skilled labour, specialized knowledge, equipment, parts and components; the Registrant's ability to manage its growth effectively; the Registrant's ability to realize production targets; supply chain interruptions and the ability to maintain required supplies of skilled labour, specialized knowledge, equipment, parts and components; the Registrant's ability to successfully implement and maintain adequate internal controls over financial reporting or disclosure controls and procedures; the Registrant not having been required to certify that it maintains effective internal control over financial reporting or effective disclosure controls and procedures; increased costs as a result of operating as a public company in the United States; risks related to the Registrant's status as a foreign private issuer; the Registrant's ability to identify and execute future acquisitions or dispositions effectively, including the ability to successfully manage the impacts of such transactions on its operations; the Registrant's international business operations, including expansion to new jurisdictions, could expose it to regulatory risks or factors beyond our control such as currency exchange rates, changes in governmental policy, trade barriers, trade embargoes, investigation of sanctions relating to corruption of foreign public officials or international sanctions and delays in the development of international markets for its products; risks associated with acquisitions and partnerships, including the ability to attract and retain business partners and reliance of the Registrant on the operations of its partners, and the lack of control over such operations associated with investments the Registrant has made in strategic partners; the Registrant taking advantage of reduced disclosure requirements applicable to emerging growth companies; the Registrant's ability to successfully identify and execute future acquisitions or dispositions; expansion of international operations; reliance on the operations of the Registrant's partners; results of litigation; conflicts of interest between the Registrant and its directors and officers; lack of dividends, and reinvestment of retained earnings, if any, into the Registrant's business; the dependence of the Registrant's operations, in part, on the maintenance and protection of its information technology systems, and the information technology systems of its third-party research institution collaborators, contract research organizations or other contractors or consultants, which could face cyber-attacks; tax-related risks, including unforeseen changes to tax and accounting rules, practices or requirements that may be difficult or impossible for the Registrant to implement or comply with, and its classification as a "passive foreign investment company"; changes, whether anticipated or not, in laws, regulations and guidelines that may result in significant compliance costs for the Registrant, including in relation to restrictions on branding and advertising, regulation of provincial distribution and excise taxes; the Registrant's ability to promote and sustain its products, including any restrictions or constraints on marketing practices under the regulatory framework in which the Registrant operates; failure to execute definitive agreements with entities in which the Registrant has entered into letters of intent or memoranda of understanding; changes in government or government policy, or changes in funding for the FDA and other government agencies, which could hinder their ability to hire and retain key leadership and other personnel, prevent new products and services from being developed or commercialized in a timely manner or otherwise prevent those agencies from performing normal functions, upon which the Registrant may rely; failure of counterparties to perform contractual obligations; the Registrant's ability to successfully develop new products or find a market for their sale; the Registrant's ability to promote and sustain its brands; the shelf life of inventory, including unexpected write-downs or fair value adjustments of biological assets or recall of products; the ability to provide the capital required for research, product development, operations and marketing; the impact of any future recall of the Registrant's products; reputational risks to third parties with whom the Registrant does business; the Registrant's ability to produce and sell medical products in, and export medical products to, other jurisdictions outside of Canada, which is dependent on compliance with additional regulatory or other requirements; co-investment risks associated with investments the Registrant may make with strategic investors or other third parties through joint ventures or other entities from time to time; failure to comply with laws and regulations; the Registrant's reliance on its own market research and forecasts; competition from other technologies and pharmaceutical products, including from synthetic production, new manufacturing processes and new technologies, and expected significant competition from other companies with similar businesses, and significant competition in an environment of rapid technological and scientific change as competitors have proposed various new product candidates or existing pharmaceutical products or technologies as an effective treatment for COVID-19, which may be safer, more advanced or more effective than the proposed use of FSD-201 as an effective treatment; the Registrant's ability to safely, securely, efficiently and cost-effectively transport our products to consumers; liability arising from any fraudulent or illegal activity, or other misconduct or improper activities that the Registrant's directors, officers, employees, contractors, consultants, commercial partners or vendors may engage in, including noncompliance with regulatory standards and requirements; the Registrant's inability attain the regulatory approvals it needs to commercialize pharmaceutical products; the Registrant's product candidates being in the preclinical development stage; the Registrant's ability to obtain regulatory approval in jurisdictions for any product candidates; failure to obtain regulatory approval for FSD-201, or to achieve the degree of market acceptance and demand for our products by physicians, patients, healthcare payors, and others in the medical community which are necessary for commercial success, including, in the case of the FSD-201 COVID-19 Trials for the use of FSD-201 to treat COVID-19, due to the possibility that alternative, superior treatments for COVID-19 may be available prior to the approval and commercialization of FSD-201 for the treatment of COVID-19, should such approval be received at all; delays in clinical trials; failure of clinical trials to demonstrate substantial evidence of the safety and/or effectiveness of product candidates, which could prevent, delay or limit the scope of regulatory approval and commercialization, including from difficulties encountered in enrolling patients in clinical trials, and reliance on third parties to conduct our clinical trials and some aspects of our research and preclinical testing, or results from future clinical testing which may demonstrate opposing evidence and draw negative conclusions regarding the effectiveness of FSD-201 as a treatment for COVID-19 or other medical conditions; results of earlier studies or clinical trials not being predictive of future clinical trials and initial studies or clinical trials may not establish an adequate safety or efficacy profile for the Registrant's product candidates to justify proceeding to advanced clinical trials or an application for regulatory approval; difficulties enrolling patients in clinical trials; potential side effects, adverse events, or other properties or safety risks of the Registrant's product candidates, which could delay or halt their clinical development, prevent their regulatory approval, cause suspension or discontinuance of clinical trials, abandonment of a product candidate, limit their commercial potential, if approved, or result in other negative consequences; regulatory regimes of locations for clinical trials outside of the United States; failure to obtain approval to commercialize product candidates outside of the United States; if clinical trials are conducted for product candidates outside of the United States, the FDA and comparable regulatory authorities may not accept data from such trials, or the scope of such approvals from regulatory authorities may be limited; preliminary, interim data obtained from the Registrant's clinical trials that it may announce or publish from time to time may not be indicative of future scientific observations or conclusions as more patient data becomes available, further analyses are conducted, and as the data becomes subject to subsequent audit and verification procedures; manufacturing problems resulting in delays in development or commercialization programs; inability to successfully validate, develop and obtain regulatory approval for companion diagnostic tests for drug candidates; changes in funding for the FDA and other government agencies; unforeseen claims made against the Registrant, including product liability claims or regulatory actions if products are alleged to have caused significant loss or injury; misconduct or other improper activities by employees, independent contractors, consults, commercial partners and vendors; failure to achieve market acceptance in the medical community; inability to establish sales and marketing capabilities, or enter in to agreements with third parties, to sell and market any product candidates that the Registrant may develop; failure to comply with health and data protection laws; reliance on third parties to conduct clinical trials; reliance on single-source suppliers, including single-course suppliers for the acquisition of the drug substance and drug product for FSD-201; reliance on contract manufacturing facilities; inability to obtain or maintain sufficient intellectual property protection for the Registrant's products; uncertainty associated with insurance coverage and reimbursement status for newly-approved pharmaceutical products, which could result in product candidates becoming subject to unfavourable pricing regulations, third-party coverage and reimbursement practices, or healthcare reform initiatives, including legislative measures aimed at reducing healthcare costs; third-party claims of intellectual property infringement; patent terms being insufficient to protect competitive position on product candidates; risk factors related to the sale of the Facility; inability to obtain patent term extensions or non-patent exclusivity; inability to protect the confidentiality of trade secrets; inability to protect trademarks and trade names; filing of claims challenging the inventorship of the Registrant's patents and other intellectual property; invalidity or unenforceability of patents, including legal challenges to patents covering FSD-201; claims regarding wrongfully used or disclosed confidential information of third parties; inability to protect property rights around the world; conditions in the global economy and capital markets, including impacts to trade and public health or geopolitical risks, as a result of impacts of COVID-19 or otherwise; that additional issuances of the Registrant's shares could have a significant dilutive effect; and other factors beyond the Registrant's control.</p>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_4"></a>
    <p style="text-align: justify;"><font style="width: 36pt; display: inline-block;">&#160;</font>The Registrant cautions that the foregoing list of important risk factors and uncertainties is not exhaustive. Although the Registrant has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated, intended or projected. There is no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Readers should carefully consider the maters as further discussed under the heading "Risk Factors" in the Registrant's Annual Information Form for the year ended December 31, 2020, which is filed as Exhibit 99.1 hereto and incorporated by reference herein.</p>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_5"></a>
    <p style="text-align: justify;"><font style="width: 36pt; display: inline-block;">&#160;</font>The forward-looking statements contained in, or incorporated by reference into, this Form 40-F are made as of the date of this Form 40-F or as otherwise specified. Except as required by applicable securities law, the Registrant undertakes no obligation to update publicly or otherwise revise any forward-looking statements or the foregoing list of factors affecting those statements, whether as a result of new information, future events or otherwise or the foregoing lists of factors affecting this information. All forward-looking statements contained in this Form 40-F are expressly qualified in their entirety by this cautionary statement.</p>
    <p style="text-align: center;"><b>DIFFERENCES IN UNITED STATES AND CANADIAN REPORTING PRACTICES</b></p>
    <p style="text-align: justify;"><font style="width: 36pt; display: inline-block;">&#160;</font>The Registrant is permitted, under a multijurisdictional disclosure system adopted by the United States, to prepare this report in accordance with Canadian disclosure requirements, which are different from those of the United States. The Registrant prepares its financial statements, which are filed with this Form 40-F in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board, and the audit is subject to applicable Canadian auditing and auditor independence standards and independence in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (the "Commission") and the Public Company Accounting Oversight Board.</p>
    <p style="text-align: center;"><b>INCORPORATED DOCUMENTS</b></p>
    <p style="text-align: justify;"><i>Annual Information Form</i></p>
    <p style="text-align: justify;">The Registrant's Annual Information Form ("AIF") is filed as Exhibit 99.1 to this Form 40-F.</p>
    <p style="text-align: justify;"><i>Audited Annual Financial Statements</i></p>
    <p style="text-align: justify;">The Registrant's consolidated financial statements and auditor's report thereon is filed as Exhibit 99.2 to this Form 40-F.</p>
    <p style="text-align: justify;"><i>Management's Discussion and Analysis</i></p>
    <p style="text-align: justify;">The Registrant's management's discussion and analysis ("MD&amp;A") is filed as Exhibit 99.3 to this Form 40-F.</p>
    <p style="text-align: center;"><b>DISCLOSURE CONTROLS AND PROCEDURES </b></p>
    <p style="text-indent: 36pt; text-align: justify;">At the end of the period covered by this report, an evaluation was carried out under the supervision of and with the participation of the Registrant's management, including the Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO"), of the effectiveness of the design and operation of the Registrant's disclosure controls and procedures (as defined in Rule 13a - 15(e) and Rule 15d - 15(e) under the United States Securities Exchange Act of 1934, as amended (the "Exchange Act")). Based on that evaluation the CEO and the CFO have concluded that as of the end of the period covered by this report, the Registrant's disclosure controls and procedures were adequately designed and effective in ensuring that: (i) information required to be disclosed by the Registrant in reports that it files or submits to the Commission under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in applicable rules and forms and (ii) information required to be disclosed in the Registrant's reports filed under the Exchange Act is accumulated and communicated to management, including the CEO and CFO, as appropriate, to allow for accurate and timely decisions regarding required disclosure.</p>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_6"></a>
    <p style="text-align: center;"><b>MANAGEMENT'S ANNUAL REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING</b></p>
    <p style="text-indent: 36pt; text-align: justify;">The Registrant's management, including the CEO and the CFO, are responsible for establishing and maintaining adequate internal control over financial reporting ("ICFR") for the Registrant. The control framework used by management to evaluate the effectiveness of the Regisrant's ICFR uses the framework and criteria established in the Internal Control - Integrated Framework (2013), issued by the Committee of Sponsoring Organizations of the Treadway Commission. The Registrant's management, including the CEO and the CFO, have assessed the effectiveness of the Registrant's ICFR as of the end of the fiscal year ended December 31, 2020, and have determined that such ICFR are effective.</p>
    <p style="text-align: center;"><b>ATTESTATION REPORT OF INDEPENDENT AUDITORS</b></p>
    <p style="text-indent: 36pt; text-align: justify;">Under the Jumpstart Our Business Startups Act ("JOBS Act"), emerging growth companies (as defined in the JOBS Act) are exempt from Section 404(b) of the Sarbanes-Oxley Act, which generally requires an issuer to provide an independent auditor attestation of management's assessment of the effectiveness of its internal control over financial reporting in its annual report. The Registrant qualified as an emerging growth company as of December 31, 2020 and, as a consequence, this Form 40-F does not include an attestation report of the Registrant's independent auditor on the effectiveness of its internal control over financial reporting.</p>
    <p style="text-align: center;"><b>CHANGES IN INTERNAL CONTROLS OVER FINANCIAL REPORTING</b></p>
    <p style="text-indent: 36pt; text-align: justify;">During the year ended December 31, 2020 there were no changes to the Registrant's ICFR that have materially affected or are reasonably likely to materially affect the Registrant's ICFR.</p>
    <p style="text-align: center;"><b>NOTICES PURSUANT TO REGULATION BTR</b></p>
    <p style="text-indent: 36pt; text-align: justify;">The Registrant was not required by Rule 104 of Regulation BTR to send any notices to any of its directors or executive officers during the fiscal year ended December 31, 2020.</p>
    <p style="text-align: center;"><b>AUDIT COMMITTEE FINANCIAL EXPERT</b></p>
    <p style="text-indent: 36pt; text-align: justify;">The board of directors of the Registrant has determined that Mr. Robert J. Ciaruffoli, the chair of the Registrant's audit committee, qualifies as an audit committee financial expert for purposes of paragraph (8) of General Instruction B to Form 40-F. The board of directors has further determined that Mr. Ciaruffoli is also independent, as that term is defined in the corporate governance requirements of the NASDAQ Capital Market ("Nasdaq"). The Commission has indicated that the designation of Mr. Ciaruffoli as an audit committee financial expert does not make him an "expert" for any purpose, impose any duties, obligations or liabilities on him that are greater than those imposed on members of the audit committee and the board of directors who do not carry this designation or affect the duties, obligations or liabilities of any other member of the audit committee or the board of directors.</p>
    <p style="text-align: center;"><b>CODE OF ETHICS</b></p>
    <p style="text-indent: 36pt; text-align: justify;">The Registrant has adopted a written Code of Conduct and Ethics (the "Code") that is applicable to all employees, contractors, consultants, officers and directors of the Registrant.</p>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_7"></a>
    <p style="text-indent: 36pt; text-align: justify;">All departures from, all amendments to the Code, and all waivers of the Code with respect to any of the senior officers covered by it, which waiver may be made only by the board of directors of the Registrant in respect of senior officers, will be disclosed as required. The Code is located on the Registrant's website at www.fsdpharma.com. Information contained in or otherwise accessible through the Registrant's website does not form part of this Form 40-F, and is not incorporated into this Form 40-F by reference.</p>
    <p style="text-align: center;"><b>PRINCIPAL ACCOUNTANT FEES AND SERVICES</b></p>
    <p style="text-indent: 36pt; text-align: justify;">The fees paid to the independent auditor are included under the heading "Audit Committee Information-Auditors' Fees" in the AIF, which is filed as Exhibit 99.1 hereto and incorporated by reference herein.</p>
    <p style="text-indent: 36pt; text-align: justify;">The Registrant's audit committee has adopted a pre-approval policy. Under this policy, audit and non-audit services will be presented to the audit committee for pre-approval. The Registrant did not rely on the de minimis exemption provided by Section (c)(7) (i)(C) of Rule 2-01 of Regulation S-X.</p>
    <p style="text-align: center;"><b>OFF-BALANCE SHEET TRANSACTIONS</b></p>
    <p style="text-indent: 36pt; text-align: justify;">The Registrant does not have any off-balance sheet transactions that have or are reasonably likely to have a current or future effect on the Registrant's financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.</p>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_8"></a>
    <p style="text-align: center;"><b>TABULAR DISCLOSURE OF CONTRACTUAL OBLIGATIONS</b></p>
    <p style="text-align: justify;">At December 31, 2020, the Registrant had the following contractual obligations outstanding:</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="1" cellspacing="0" cellpadding="3">
        <tr>
            <td style="width: 22%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: justify;">&#160;</p>
            </td>
            <td style="width: 73%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;" colspan="5">
                <p style="text-align: center;"><b>Payment due by period (in United States dollars)</b></p>
            </td>
        </tr>
        <tr>
            <td style="width: 22%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: center;"><b>Contractual Obligations</b></p>
            </td>
            <td style="width: 11%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;"><b>Total</b></p>
            </td>
            <td style="width: 11%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;"><b>Less than 1 year</b></p>
            </td>
            <td style="width: 12%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;"><b>1-3 years</b></p>
            </td>
            <td style="width: 10%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;"><b>3-5 years</b></p>
            </td>
            <td style="width: 17%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: center;"><b>More than 5 years</b></p>
            </td>
        </tr>
        <tr>
            <td style="width: 22%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p>Trade Payables and Accrued Liabilities</p>
            </td>
            <td style="width: 11%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;">$3,700,103</p>
            </td>
            <td style="width: 11%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;">$3,700,103</p>
            </td>
            <td style="width: 12%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;">-</p>
            </td>
            <td style="width: 10%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;">-</p>
            </td>
            <td style="width: 17%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: center;">-</p>
            </td>
        </tr>
        <tr>
            <td style="width: 22%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: justify;">Lease Obligations</p>
            </td>
            <td style="width: 11%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;">$141,018</p>
            </td>
            <td style="width: 11%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;">$46,842</p>
            </td>
            <td style="width: 12%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;">$94,176</p>
            </td>
            <td style="width: 10%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: center;">-</p>
            </td>
        </tr>
        <tr>
            <td style="width: 22%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: justify;">Notes Payable</p>
            </td>
            <td style="width: 11%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;">$384,647</p>
            </td>
            <td style="width: 11%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;">$384,647</p>
            </td>
            <td style="width: 12%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;">-</p>
            </td>
            <td style="width: 10%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;">-</p>
            </td>
            <td style="width: 17%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: center;">-</p>
            </td>
        </tr>
        <tr>
            <td style="width: 22%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: justify;"><b>Total</b></p>
            </td>
            <td style="width: 11%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: center;">$4,225,768</p>
            </td>
            <td style="width: 11%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: center;">$4,131,592</p>
            </td>
            <td style="width: 12%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: center;">$94,176</p>
            </td>
            <td style="width: 10%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: center;">-</p>
            </td>
            <td style="width: 17%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: center;">-</p>
            </td>
        </tr>
    </table>
    <p style="text-align: center;"><b>IDENTIFICATION OF THE AUDIT COMMITTEE</b></p>
    <p style="text-indent: 36pt; text-align: justify;">The Registrant's Board of Directors has a separately designated standing Audit Committee established in accordance with Section 3(a)(58)(A) of the Exchange Act. The required disclosure is included under the heading "Audit Committee Information-Composition of the Audit Committee" in the AIF, which is filed as Exhibit 99.1 hereto and incorporated by reference herein.</p>
    <p style="text-align: center;"><b>CORPORATE GOVERNANCE PRACTICES</b></p>
    <p style="text-indent: 36pt; text-align: justify;">There are certain differences between the corporate governance practices applicable to the Registrant and those applicable to U.S. companies under the Nasdaq Corporate Governance Requirements. A summary of the significant differences can be found on the Registrant's website at www.fsdpharma.com. Information contained in or otherwise accessible through the Registrant's website does not form part of this Form 40-F, and is not incorporated into this Form 40-F by reference.</p>
    <p style="text-align: center;"><b>UNDERTAKINGS </b></p>
    <p style="text-align: justify; text-indent: 36pt;">The Registrant undertakes to make available, in person or by telephone, representatives to respond to inquiries made by the Commission staff, and to furnish promptly, when requested to do so by the Commission staff, information relating to the securities in relation to which the obligation to file an annual report on Form 40-F arises or transactions in said securities.</p>
    <p style="text-align: center;"><b>CONSENT TO SERVICE OF PROCESS</b></p>
    <p style="text-align: justify; text-indent: 36pt;">The Registrant has previously filed with the Commission a written irrevocable consent and power of attorney on Form F-X. Any change to the name or address of the Registrant's agent for service shall be communicated promptly to the Commission by amendment to the Form F-X referencing the file number of the Registrant.</p>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_9"></a>
    <p style="text-align: justify;">The following documents are being filed with the Commission as exhibits to this Form 40-F.</p>
    <p style="text-align: center;"><b>EXHIBIT INDEX</b></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 11.5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top;">
                <p style="margin-left: 10pt; text-indent: -10pt;">Exhibits</p>
            </td>
            <td style="width: 88.5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top;">
                <p style="text-align: justify;">Documents</p>
            </td>
        </tr>
        <tr>
            <td style="width: 11.5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top; background-color: #eeeeee;">
                <p style="margin-left: 10pt; text-indent: -10pt; text-align: center;"><a href="exhibit99-1.htm">99.1</a></p>
            </td>
            <td style="width: 88.5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top; background-color: #eeeeee;">
                <p style="text-align: justify;"><a href="exhibit99-1.htm">Annual Information Form for the year ended December 31, 2020</a></p>
            </td>
        </tr>
        <tr>
            <td style="width: 11.5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top;">
                <p style="margin-left: 10pt; text-indent: -10pt; text-align: center;"><a href="exhibit99-2.htm">99.2</a></p>
            </td>
            <td style="width: 88.5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top;">
                <p style="text-align: justify;"><a href="exhibit99-2.htm">Audited Consolidated Financial Statements for the years ended December 31, 2020 and 2019 and auditor's report thereon</a></p>
            </td>
        </tr>
        <tr>
            <td style="width: 11.5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top; background-color: #eeeeee;">
                <p style="margin-left: 10pt; text-indent: -10pt; text-align: center;"><a href="exhibit99-3.htm">99.3</a></p>
            </td>
            <td style="width: 88.5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top; background-color: #eeeeee;">
                <p style="text-align: justify;"><a href="exhibit99-3.htm">Management's Discussion and Analysis for the year ended December 31, 2020</a></p>
            </td>
        </tr>
        <tr>
            <td style="width: 11.5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top;">
                <p style="margin-left: 10pt; text-indent: -10pt; text-align: center;"><a href="exhibit99-4.htm">99.4</a></p>
            </td>
            <td style="width: 88.5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top;">
                <p style="text-align: justify;"><a href="exhibit99-4.htm">Certifications of Chief Executive Officer pursuant to Rule 13a-14 or 15d-14 of the Securities Exchange Act of 1934</a></p>
            </td>
        </tr>
        <tr>
            <td style="width: 11.5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top; background-color: #eeeeee;">
                <p style="margin-left: 10pt; text-indent: -10pt; text-align: center;"><a href="exhibit99-5.htm">99.5</a></p>
            </td>
            <td style="width: 88.5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top; background-color: #eeeeee;">
                <p style="text-align: justify;"><a href="exhibit99-5.htm">Certifications of Chief Financial Officer pursuant to Rule 13a-14 or 15d-14 of the Securities Exchange Act of 1934</a></p>
            </td>
        </tr>
        <tr>
            <td style="width: 11.5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top;">
                <p style="margin-left: 10pt; text-indent: -10pt; text-align: center;"><a href="exhibit99-6.htm">99.6</a></p>
            </td>
            <td style="width: 88.5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top;">
                <p style="text-align: justify;"><a href="exhibit99-6.htm">Certifications of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></p>
            </td>
        </tr>
        <tr>
            <td style="width: 11.5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top; background-color: #eeeeee;">
                <p style="margin-left: 10pt; text-indent: -10pt; text-align: center;"><a href="exhibit99-7.htm">99.7</a></p>
            </td>
            <td style="width: 88.5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top; background-color: #eeeeee;">
                <p style="text-align: justify;"><a href="exhibit99-7.htm">Certifications of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></p>
            </td>
        </tr>
        <tr>
            <td style="width: 11.5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top;">
                <p style="margin-left: 10pt; text-indent: -10pt; text-align: center;"><a href="exhibit99-8.htm">99.8</a></p>
            </td>
            <td style="width: 88.5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top;">
                <p style="text-align: justify;"><a href="exhibit99-8.htm">Consent of MNP LLP</a></p>
            </td>
        </tr>
        <tr>
            <td style="width: 11.5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top; background-color: #eeeeee;">
                <p style="margin-left: 10pt; text-indent: -10pt; text-align: center;"><a href="exhibit99-9.htm">99.9</a></p>
            </td>
            <td style="width: 88.5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top; background-color: #eeeeee;">
                <p style="text-align: justify;"><a href="exhibit99-9.htm">Consent of McGovern Hurley LLP</a></p>
            </td>
        </tr>
        <tr>
            <td style="width: 11.5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top;">
                <p style="margin-left: 10pt; text-indent: -10pt; text-align: center;">101</p>
            </td>
            <td style="width: 88.5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top;">
                <p style="text-align: justify;">Interactive Data File</p>
            </td>
        </tr>
        <tr>
            <td style="width: 11.5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top; background-color: #eeeeee;">
                <p style="margin-left: 10pt; text-indent: -10pt; text-align: center;"><a href="huge-20201231.xml">101.INS</a></p>
            </td>
            <td style="width: 88.5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top; background-color: #eeeeee;">
                <p style="text-align: justify;"><a href="huge-20201231.xml">XBRL Instance Document</a></p>
            </td>
        </tr>
        <tr>
            <td style="width: 11.5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top;">
                <p style="margin-left: 10pt; text-indent: -10pt; text-align: center;"><a href="huge-20201231.xsd">101.SCH</a></p>
            </td>
            <td style="width: 88.5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top;">
                <p style="text-align: justify;"><a href="huge-20201231.xsd">XBRL Taxonomy Extension Schema Document</a></p>
            </td>
        </tr>
        <tr>
            <td style="width: 11.5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top; background-color: #eeeeee;">
                <p style="margin-left: 10pt; text-indent: -10pt; text-align: center;"><a href="huge-20201231_cal.xml">101.CAL</a></p>
            </td>
            <td style="width: 88.5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top; background-color: #eeeeee;">
                <p style="text-align: justify;"><a href="huge-20201231_cal.xml">XBRL Taxonomy Extension Calculation Linkbase Document</a></p>
            </td>
        </tr>
        <tr>
            <td style="width: 11.5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top;">
                <p style="margin-left: 10pt; text-indent: -10pt; text-align: center;"><a href="huge-20201231_def.xml">101.DEF</a></p>
            </td>
            <td style="width: 88.5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top;">
                <p style="text-align: justify;"><a href="huge-20201231_def.xml">XBRL Taxonomy Extension Definition Linkbase Document</a></p>
            </td>
        </tr>
        <tr>
            <td style="width: 11.5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top; background-color: #eeeeee;">
                <p style="margin-left: 10pt; text-indent: -10pt; text-align: center;"><a href="huge-20201231_lab.xml">101.LAB</a></p>
            </td>
            <td style="width: 88.5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top; background-color: #eeeeee;">
                <p style="text-align: justify;"><a href="huge-20201231_lab.xml">XBRL Taxonomy Extension Label Linkbase Document</a></p>
            </td>
        </tr>
        <tr>
            <td style="width: 11.5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top;">
                <p style="margin-left: 10pt; text-indent: -10pt; text-align: center;"><a href="huge-20201231_pre.xml">101.PRE</a></p>
            </td>
            <td style="width: 88.5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top;">
                <p style="text-align: justify;"><a href="huge-20201231_pre.xml">XBRL Taxonomy Extension Presentation Linkbase Document</a></p>
            </td>
        </tr>
    </table>
    <br>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_10"></a>
    <p style="text-align: center;"><b>SIGNATURES</b></p>
    <p style="text-indent: 36pt; text-align: justify;">Pursuant to the requirements of the Exchange Act, the Registrant certifies that it meets all of the requirements for filing on Form 40-F and has duly caused this Annual Report to be signed on its behalf by the undersigned, thereunto duly authorized.</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 43.62%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top;">
                <p style="margin-left: 10pt; text-indent: -10pt;">&#160;</p>
            </td>
            <td style="padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top;" colspan="3">
                <p><b>FSD PHARMA INC.</b></p>
            </td>
        </tr>
        <tr>
            <td style="width: 43.62%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top;">
                <p style="margin-left: 10pt; text-indent: -10pt;">&#160;</p>
            </td>
            <td style="width: 4.98%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: bottom;">
                <p>By:</p>
            </td>
            <td style="padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: bottom;" colspan="2">
                <p><br><br>/s/ Raza Bokhari</p>
            </td>
        </tr>
        <tr>
            <td style="width: 43.62%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top;">
                <p style="margin-left: 10pt; text-indent: -10pt;">&#160;</p>
            </td>
            <td style="width: 4.98%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top;">
                <p>&#160;</p>
            </td>
            <td style="width: 7.8%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top; border-top: 0.75pt solid #000000;">
                <p>Name:</p>
            </td>
            <td style="width: 43.62%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: bottom; border-top: 0.75pt solid #000000;">
                <p>Raza Bokhari</p>
            </td>
        </tr>
        <tr>
            <td style="width: 43.62%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top;">
                <p style="margin-left: 10pt; text-indent: -10pt;">&#160;</p>
            </td>
            <td style="width: 4.98%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top;">
                <p>&#160;</p>
            </td>
            <td style="width: 7.8%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top;">
                <p>Title:</p>
            </td>
            <td style="width: 43.62%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: bottom;">
                <p>Executive Chairman and Chief Executive Officer</p>
            </td>
        </tr>
        <tr>
            <td style="width: 43.62%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top;">
                <p style="margin-left: 10pt; text-indent: -10pt;">Date: March 16, 2021</p>
            </td>
            <td style="padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top;" colspan="3">
                <p>&#160;</p>
            </td>
        </tr>
    </table>
    <br>
    <hr width="100%" size="5" color="black" noshade="noshade">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>

<head>
    <title>FSD Pharma Inc.: Exhibit 99.1 - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt; font-family:'Times New Roman';">
    <hr width="100%" size="3" color="black" noshade="noshade"><a name="page_1"></a>
    <p style="text-align: center;"><img src="exhibit99-1x001.jpg" style="width: 193px;" height="99"></p>
    <p style="text-align: center;"><b>FSD PHARMA INC.</b></p>
    <p style="text-align: center;"><b>Annual Information Form</b><br><b>for the year ended December 31, 2020</b></p>
    <p style="text-align: center;"><b>March 16, 2021</b></p>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_2"></a>
    <p style="text-align: center;"><b>TABLE OF CONTENTS</b></p>
    <table style="font-size: 10pt; width: 100%; border-collapse: collapse;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="text-align: left; background-color: #eeeeee;"><a href="#page_4">ANNUAL INFORMATION FORM</a></td>
            <td style="width: 10%; text-align: right; background-color: #eeeeee;"><a href="#page_4">- 4 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left;"><a href="#page_4">MARKET AND INDUSTRY DATA</a></td>
            <td style="width: 10%; text-align: right;"><a href="#page_4">- 4 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; background-color: #eeeeee;"><a href="#page_4">FORWARD-LOOKING STATEMENTS</a></td>
            <td style="width: 10%; text-align: right; background-color: #eeeeee;"><a href="#page_4">- 4 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left;"><a href="#page_8">GLOSSARY OF TERMS</a></td>
            <td style="width: 10%; text-align: right;"><a href="#page_8">- 8 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; background-color: #eeeeee;"><a href="#page_11">CORPORATE STRUCTURE</a></td>
            <td style="width: 10%; text-align: right; background-color: #eeeeee;"><a href="#page_11">- 11 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; padding-left: 12.25pt;"><a href="#page_11">Name, Address and Incorporation</a></td>
            <td style="width: 10%; text-align: right;"><a href="#page_11">- 11 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; padding-left: 12.25pt; background-color: #eeeeee;"><a href="#page_11">Intercorporate Relationships</a></td>
            <td style="width: 10%; text-align: right; background-color: #eeeeee;"><a href="#page_11">- 11 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; padding-left: 12.25pt;"><a href="#page_11">History of FV Pharma</a></td>
            <td style="width: 10%; text-align: right;"><a href="#page_11">- 11 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; padding-left: 12.25pt; background-color: #eeeeee;"><a href="#page_12">History of FSD BioSciences, Inc.</a></td>
            <td style="width: 10%; text-align: right; background-color: #eeeeee;"><a href="#page_12">- 12 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; padding-left: 12.25pt;"><a href="#page_12">History of Prismic</a></td>
            <td style="width: 10%; text-align: right;"><a href="#page_12">- 12 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; background-color: #eeeeee;"><a href="#page_12">GENERAL DEVELOPMENT OF THE BUSINESS</a></td>
            <td style="width: 10%; text-align: right; background-color: #eeeeee;"><a href="#page_12">- 12 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; padding-left: 12.25pt;"><a href="#page_12">Three Year History</a></td>
            <td style="width: 10%; text-align: right;"><a href="#page_12">- 12 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; padding-left: 12.25pt; background-color: #eeeeee;"><a href="#page_19"><i>Epitech License Agreement</i></a></td>
            <td style="width: 10%; text-align: right; background-color: #eeeeee;"><a href="#page_19">- 19 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; padding-left: 12.25pt;"><a href="#page_21"><i>June Private Placement</i></a></td>
            <td style="width: 10%; text-align: right;"><a href="#page_21">- 21 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; padding-left: 12.25pt; background-color: #eeeeee;"><a href="#page_22"><i>Approval of Issuance of Share Compensation</i></a></td>
            <td style="width: 10%; text-align: right; background-color: #eeeeee;"><a href="#page_22">- 22 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; padding-left: 12.25pt;"><a href="#page_22"><i>July Offering</i></a></td>
            <td style="width: 10%; text-align: right;"><a href="#page_22">- 22 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; padding-left: 12.25pt; background-color: #eeeeee;"><a href="#page_22"><i>Suspension of FV Pharma Activities</i></a></td>
            <td style="width: 10%; text-align: right; background-color: #eeeeee;"><a href="#page_22">- 22 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; padding-left: 12.25pt;"><a href="#page_22"><i>October Offering</i></a></td>
            <td style="width: 10%; text-align: right;"><a href="#page_22">- 22 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; padding-left: 12.25pt; background-color: #eeeeee;"><a href="#page_23"><i>Settlement of Class Action Proceeding</i></a></td>
            <td style="width: 10%; text-align: right; background-color: #eeeeee;"><a href="#page_23">- 23 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; padding-left: 12.25pt;"><a href="#page_23"><i>Matters to be Addressed at Annual Meeting</i></a></td>
            <td style="width: 10%; text-align: right;"><a href="#page_23">- 23 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; padding-left: 12.25pt; background-color: #eeeeee;"><a href="#page_23"><i>2021 Equity Distribution Agreement</i></a></td>
            <td style="width: 10%; text-align: right; background-color: #eeeeee;"><a href="#page_23">- 23 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; padding-left: 12.25pt;"><a href="#page_23"><i>Innovet License Agreement</i></a></td>
            <td style="width: 10%; text-align: right;"><a href="#page_23">- 23 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; background-color: #eeeeee;"><a href="#page_23">DESCRIPTION OF THE BUSINESS</a></td>
            <td style="width: 10%; text-align: right; background-color: #eeeeee;"><a href="#page_23">&#160;-23 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; padding-left: 12.25pt;"><a href="#page_23">Overview</a></td>
            <td style="width: 10%; text-align: right;"><a href="#page_23">&#160;-23 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; padding-left: 12.25pt; background-color: #eeeeee;"><a href="#page_24"><i>FV Pharma and the Facility</i></a></td>
            <td style="width: 10%; text-align: right; background-color: #eeeeee;"><a href="#page_24">- 24 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; padding-left: 12.25pt;"><a href="#page_24">Products and Sales</a></td>
            <td style="width: 10%; text-align: right;"><a href="#page_24">- 24 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; padding-left: 12.25pt; background-color: #eeeeee;"><a href="#page_25">Specialized Knowledge and Personnel</a></td>
            <td style="width: 10%; text-align: right; background-color: #eeeeee;"><a href="#page_25">- 25 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; padding-left: 12.25pt;"><a href="#page_25">Competitive Conditions</a></td>
            <td style="width: 10%; text-align: right;"><a href="#page_25">- 25 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; padding-left: 12.25pt; background-color: #eeeeee;"><a href="#page_25">Environmental Matters</a></td>
            <td style="width: 10%; text-align: right; background-color: #eeeeee;"><a href="#page_25">- 25 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; padding-left: 12.25pt;"><a href="#page_25">Employees</a></td>
            <td style="width: 10%; text-align: right;"><a href="#page_25">- 25 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; padding-left: 12.25pt; background-color: #eeeeee;"><a href="#page_25">FSD Biosciences Inc., &amp; Industry Overview</a></td>
            <td style="width: 10%; text-align: right; background-color: #eeeeee;"><a href="#page_25">- 25 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; padding-left: 12.25pt;"><a href="#page_25">Regulatory Environment</a></td>
            <td style="width: 10%; text-align: right;"><a href="#page_25">- 25 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; padding-left: 12.25pt; background-color: #eeeeee;"><a href="#page_27">Reorganizations</a></td>
            <td style="width: 10%; text-align: right; background-color: #eeeeee;"><a href="#page_27">- 27 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left;"><a href="#page_27">RISK FACTORS</a></td>
            <td style="width: 10%; text-align: right;"><a href="#page_27">- 27 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; padding-left: 12.25pt; background-color: #eeeeee;"><a href="#page_36">Risks Related to the Pharmaceutical Business</a></td>
            <td style="width: 10%; text-align: right; background-color: #eeeeee;"><a href="#page_36">- 36 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; padding-left: 12.25pt;"><a href="#page_51">Risks Related to our Intellectual Property</a></td>
            <td style="width: 10%; text-align: right;"><a href="#page_51">- 51 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; padding-left: 12.25pt; background-color: #eeeeee;"><a href="#page_56">General Corporate Risks</a></td>
            <td style="width: 10%; text-align: right; background-color: #eeeeee;"><a href="#page_56">- 56 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left;"><a href="#page_69">DIVIDENDS AND DISTRIBUTIONS</a></td>
            <td style="width: 10%; text-align: right;"><a href="#page_69">- 69 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; background-color: #eeeeee;"><a href="#page_69">DESCRIPTION OF CAPITAL STRUCTURE</a></td>
            <td style="width: 10%; text-align: right; background-color: #eeeeee;"><a href="#page_69">- 69 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left;"><a href="#page_71">MARKETS FOR SECURITIES</a></td>
            <td style="width: 10%; text-align: right;"><a href="#page_71">- 71 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; padding-left: 12.25pt; background-color: #eeeeee;"><a href="#page_71">Trading Price and Volume</a></td>
            <td style="width: 10%; text-align: right; background-color: #eeeeee;"><a href="#page_71">- 71 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left;"><a href="#page_73">ESCROWED SECURITIES AND SECURITIES&#160; SUBJECT TO CONTRACTUAL RESTRICTION ON TRANSFER</a></td>
            <td style="width: 10%; text-align: right;"><a href="#page_73">- 73 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; background-color: #eeeeee;"><a href="#page_73">DIRECTORS AND EXECUTIVE OFFICERS</a></td>
            <td style="width: 10%; text-align: right; background-color: #eeeeee;"><a href="#page_73">- 73 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; padding-left: 12.25pt;"><a href="#page_73">Name, Occupation and Security Holding</a></td>
            <td style="width: 10%; text-align: right;"><a href="#page_73">- 73 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; padding-left: 12.25pt; background-color: #eeeeee;"><a href="#page_75">Cease Trade Orders, Bankruptcies, Penalties or Sanctions</a></td>
            <td style="width: 10%; text-align: right; background-color: #eeeeee;"><a href="#page_75">- 75 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; padding-left: 12.25pt;"><a href="#page_76">Conflicts of Interest</a></td>
            <td style="width: 10%; text-align: right;"><a href="#page_76">- 76 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; background-color: #eeeeee;"><a href="#page_76">PROMOTERS</a></td>
            <td style="width: 10%; text-align: right; background-color: #eeeeee;"><a href="#page_76">- 76 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left;"><a href="#page_76">LEGAL PROCEEDINGS AND REGULATORY ACTIONS</a></td>
            <td style="width: 10%; text-align: right;"><a href="#page_76">- 76 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; background-color: #eeeeee;"><a href="#page_77">INTEREST OF MANAGEMENT AND OTHERS IN MATERIAL TRANSACTIONS</a></td>
            <td style="width: 10%; text-align: right; background-color: #eeeeee;"><a href="#page_77">- 77 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left;"><a href="#page_78">TRANSFER AGENT AND REGISTRAR</a></td>
            <td style="width: 10%; text-align: right;"><a href="#page_78">- 78 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; background-color: #eeeeee;"><a href="#page_78">MATERIAL CONTRACTS</a></td>
            <td style="width: 10%; text-align: right; background-color: #eeeeee;"><a href="#page_78">- 78 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left;"><a href="#page_78">AUDIT COMMITTEE INFORMATION</a></td>
            <td style="width: 10%; text-align: right;"><a href="#page_78">- 78 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; padding-left: 12.25pt; background-color: #eeeeee;"><a href="#page_78">Composition of the Audit and Risk Committee</a></td>
            <td style="width: 10%; text-align: right; background-color: #eeeeee;"><a href="#page_78">- 78 -</a></td>
        </tr>
    </table>
    <p style="margin-top: 0pt; margin-left: 12.25pt; margin-bottom: 0pt; text-align: justify;"><font style="color: #0000ff;">&#160;</font></p>
    <div id="footer_page_2">
        <p style="text-align: center;">- 2 -</p>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_3"></a>
    <p style="margin-top: 0pt; margin-left: 12.25pt; margin-bottom: 0pt; text-align: justify;"><font style="color: #0000ff;">&#160;</font></p>
    <table style="font-size: 10pt; width: 100%; border-collapse: collapse;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="text-align: left; padding-left: 12.25pt;"><a href="#page_78">Relevant Education and Experience</a></td>
            <td style="width: 10%; text-align: right;"><a href="#page_78">- 78 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; padding-left: 12.25pt; background-color: #eeeeee;"><a href="#page_80">Pre-Approval Policies and Procedures</a></td>
            <td style="width: 10%; text-align: right; background-color: #eeeeee;"><a href="#page_80">- 80 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; padding-left: 12.25pt;"><a href="#page_80">Reliance on Certain Exemptions</a></td>
            <td style="width: 10%; text-align: right;"><a href="#page_80">- 80 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; padding-left: 12.25pt; background-color: #eeeeee;"><a href="#page_80">Auditors' Fees</a></td>
            <td style="width: 10%; text-align: right; background-color: #eeeeee;"><a href="#page_80">- 80 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left;"><a href="#page_80">INTERESTS OF EXPERTS</a></td>
            <td style="width: 10%; text-align: right;"><a href="#page_80">- 80 -</a></td>
        </tr>
        <tr>
            <td style="text-align: left; background-color: #eeeeee;"><a href="#page_81">ADDITIONAL INFORMATION</a></td>
            <td style="width: 10%; text-align: right; background-color: #eeeeee;"><a href="#page_81">- 81 -</a></td>
        </tr>
    </table>
    <br>
    <div id="footer_page_3">
        <p style="text-align: center;">- 3 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_4"></a>
    <p style="text-align: center;"><b>ANNUAL INFORMATION FORM</b></p>
    <p style="text-align: justify;">In this Annual Information Form (this "<b>AIF</b>"), unless otherwise noted or the context indicates otherwise, references to "<b>FSD Pharma</b>", "<b>FSD</b>", the "<b>Corporation</b>", "<b>we</b>", "<b>us</b>" and "<b>our</b>" refer, collectively, to FSD Pharma Inc., a corporation formed under the OBCA (as defined herein) and its wholly-owned subsidiaries, including FV Pharma, FSD Biosciences Inc. and Prismic (as such terms are defined herein).</p>
    <p style="text-align: justify;">All financial information in this AIF is prepared in Canadian dollars and using International Financial Reporting Standards as issued by the International Accounting Standards Board. The information contained herein is dated as of March 16, 2021, unless otherwise stated.</p>
    <p style="text-align: center;"><b>MARKET AND INDUSTRY DATA</b></p>
    <p style="text-align: justify;">This AIF includes market and industry data that has been obtained from third party sources, including industry publications. The Corporation believes that its industry data is accurate and that its estimates and assumptions are reasonable, but there is no assurance as to the accuracy or completeness of this data. Third party sources generally state that the information contained therein has been obtained from sources believed to be reliable, but there is no assurance as to the accuracy or completeness of included information. Although the data is believed to be reliable, the Corporation has not independently verified any of the data from third party sources referred to in this AIF or ascertained the underlying economic assumptions relied upon by such sources.</p>
    <p style="text-align: center;"><b>FORWARD-LOOKING STATEMENTS</b></p>
    <p style="text-align: justify;">The information provided in this AIF, including information incorporated by reference, contains certain "forward&#8208;looking information" or "forward-looking statements" within the meaning of Canadian securities laws and United States securities laws (collectively, "<b>Forward&#8208;Looking Statements</b>"). Forward-Looking Statements relate to future events or future performance, business prospects or opportunities of the Corporation that are based on forecasts of future results, estimates of amounts not yet determined and assumptions of management made in light of management's experience and perception of historical trends, current conditions and expected future developments. All statements other than statements of historical fact may be Forward-Looking Statements.</p>
    <p style="text-align: justify;">Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance are not statements of historical fact and may be Forward-Looking Statements. Forward-Looking Statements are often, but not always, identified by words or phrases such as "seek", "anticipate", "believe", "expect", "plan", "continue", "estimate", "will", "predict", "intend", "forecast", "future", "target", "project", "capacity", "could", "should", "might", "focus", "proposed", "scheduled", "outlook", "potential", "may" or similar expressions and includes suggestions of future outcomes, including, but not limited to statements about: discussions concerning the Corporation's exploration of near-term funding strategies; the progress of the Alfred Hospital Phase 1 Trials (as defined below); the Corporation's plans to advance the research &amp; development of FSD-201 (as defined below) to commercialization through studies and clinical trials, including anticipated timing and associated costs; the status of the FSD-201 COVID-19 Trials (as defined below) for the use of FSD-201 to treat COVID-19 (as defined below) and the review thereof by the FDA (as defined below, including the timing, completion and outcomes of any trials or whether FSD-201 may be effective and feasible in treating COVID-19, the application and the costs associated with such planned trials, and the Corporation's ability to obtain required funding and the terms and timing thereof; the expansion of our product offering(s), our business objectives and the expected impacts of previously announced acquisitions and developments; disposition of other non-core assets in transactions similar to the Pharmadrug Share Sale (as defined below); the investigational new drug&#160; FDA application process and any review thereof and its affects on our business objectives; the sale of substantially all of the assets of FV Pharma (as defined below), including the Facility (as defined below); the anticipated resignation of James A. Datin from the Board and the Audit Committee; or any actions that may or may not be taken at the annual meeting of the shareholders by the Requisitioning Shareholders (as defined below). Readers are cautioned not to place undue reliance on Forward-Looking Statements as the Corporation's actual results may differ materially and adversely from those expressed or implied.</p>
    <p style="text-align: justify;">The Corporation has made certain assumptions with respect to the Forward-Looking Statements regarding, among other things: the Corporation's ability to generate sufficient cash flow from operations and obtain financing, if needed, on acceptable terms or at all; the general economic, financial market, regulatory and political conditions in which the Corporation operates; the interest of potential purchasers in the Corporation's products; anticipated and unanticipated costs; the government regulation of the Corporation's activities and products; the timely receipt of any required regulatory approvals; the Corporation's ability to obtain qualified staff, equipment and services in a timely and cost efficient manner; the Corporation's ability to conduct operations in a safe, efficient and effective manner; and the Corporation's expansion plans and timeframe for completion of such plans.</p>
    <div id="footer_page_4">
        <p style="text-align: center;">- 4 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_5"></a>
    <p style="text-align: justify;">Although the Corporation believes that the expectations and assumptions on which the Forward-Looking Statements are based are reasonable, undue reliance should not be placed on the Forward-Looking Statements, because no assurance can be given that such statements will prove to be correct. Since Forward-Looking Statements addressing future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially and adversely from those currently anticipated due to a number of factors and risks. These include, but are not limited to: the limited operating history of the Corporation and history of losses, and anticipated significant losses for the foreseeable incurred to pursue commercialization of FSD-201; the Corporation's ability to continue as a going concern; the highly speculative nature of pharmaceutical development; the Corporation's ability to generate sufficient revenue to be profitable; the inability to obtain required additional financing on terms favourable to the Corporation; the Corporation's dual class share structure; whether an active trading market for the Corporation's Class B Shares is sustained; risks inherent in an pharmaceutical business and the development and commercialization of pharmaceutical products, including the inability to accurately predict timing or amounts of expenses, requirements of regulatory authorities, and completion of clinical studies (including the FSD-201 COVID-19 Trials) on anticipated timelines, which may encounter substantial delays or may not be able to be completed at all; the Corporation's reliance on only one pharmaceutical candidate, FSD-201; risk related to the sale of the Facility, including whether the Corporation will be able to sell the Facility on terms favourable to the Corporation, or at all; vulnerability to rising or volatile energy costs; the Corporation's reliance on management and key persons; manufacturing problems that could result in delay of the Corporation's development or commercialization programs; the Corporation's compliance with environmental, health and safety laws and regulations; the Corporation's expected minimal environmental impacts; insurance and uninsured risks; interruptions in the supply chain for key inputs; claims from suppliers;&#160; risk of conflict related to directors and officers of FSD Pharma who may currently, or in the future, also serve as directors and/or officers of other public companies that may be involved in the same industry as FSD Pharma; demand for skilled labour, specialized knowledge, equipment, parts and components; the Corporation's ability to manage its growth effectively; the Corporation's ability to realize production targets; supply chain interruptions and the ability to maintain required supplies of skilled labour, specialized knowledge, equipment, parts and components; the Corporation's ability to successfully implement and maintain adequate internal controls over financial reporting or disclosure controls and procedures; the Corporation not having been required to certify that it maintains effective internal control over financial reporting or effective disclosure controls and procedures; increased costs as a result of operating as a public company in the United States; risks related to the Corporation's status as a foreign private issuer; the Corporation's ability to identify and execute future acquisitions or dispositions effectively, including the ability to successfully manage the impacts of such transactions on its operations; the Corporation's international business operations, including expansion to new jurisdictions, could expose it to regulatory risks or factors beyond our control such as currency exchange rates, changes in governmental policy, trade barriers, trade embargoes, investigation of sanctions relating to corruption of foreign public officials or international sanctions and delays in the development of international markets for its products; risks associated with acquisitions and partnerships, including the ability to attract and retain business partners and reliance of the Corporation on the operations of its partners, and the lack of control over such operations associated with investments the Corporation has made in strategic partners; the Corporation taking advantage of reduced disclosure requirements applicable to emerging growth companies; the Corporation's ability to successfully identify and execute future acquisitions or dispositions; expansion of international operations; reliance on the operations of the Corporation's partners; results of litigation; conflicts of interest between the Corporation and its directors and officers; lack of dividends, and reinvestment of retained earnings, if any, into the Corporation's business; the dependence of the Corporation's operations, in part, on the maintenance and protection of its information technology systems, and the information technology systems of its third-party research institution collaborators, contract research organizations or other contractors or consultants, which could face cyber-attacks; tax-related risks, including unforeseen changes to tax and accounting rules, practices or requirements that may be difficult or impossible for the Corporation to implement or comply with, and its classification as a "passive foreign investment company"; changes, whether anticipated or not, in laws, regulations and guidelines that may result in significant compliance costs for the Corporation, including in relation to restrictions on branding and advertising, regulation of provincial distribution and excise taxes; the Corporation's ability to promote and sustain its products, including any restrictions or constraints on marketing practices under the regulatory framework in which the Corporation operates; failure to execute definitive agreements with entities in which the Corporation has entered into letters of intent or memoranda of understanding; changes in government or government policy, or changes in funding for the FDA and other government agencies, which could hinder their ability to hire and retain key leadership and other personnel, prevent new products and services from being developed or commercialized in a timely manner or otherwise prevent those agencies from performing normal functions, upon which the Corporation may rely; failure of counterparties to perform contractual obligations; the Corporation's ability to successfully develop new products or find a market for their sale; the Corporation's ability to promote and sustain its brands; the shelf life of inventory, including unexpected write-downs or fair value adjustments of biological assets or recall of products; the ability to provide the capital required for research, product development, operations and marketing; the impact of any future recall of the Corporation's products; reputational risks to third parties with whom the Corporation does business; the Corporation's ability to produce and sell medical products in, and export medical products to, other jurisdictions outside of Canada, which is dependent on compliance with additional regulatory or other requirements; co-investment risks associated with investments the Corporation may make with strategic investors or other third parties through joint ventures or other entities from time to time; failure to comply with laws and regulations; the Corporation's reliance on its own market research and forecasts; competition from other technologies and pharmaceutical products, including from synthetic production, new manufacturing processes and new technologies, and expected significant competition from other companies with similar businesses, and significant competition in an environment of rapid technological and scientific change as competitors have proposed various new product candidates or existing pharmaceutical products or technologies as an effective treatment for&#160;</p>
    <div id="footer_page_5">
        <p style="text-align: center;">- 5 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_6"></a>
    <p style="text-align: justify;">COVID-19, which may be safer, more advanced or more effective than the proposed use of FSD-201 as an effective treatment; the Corporation's ability to safely, securely, efficiently and cost-effectively transport our products to consumers; liability arising from any fraudulent or illegal activity, or other misconduct or improper activities that the Corporation's directors, officers, employees, contractors, consultants, commercial partners or vendors may engage in, including noncompliance with regulatory standards and requirements; the Corporation's inability attain the regulatory approvals it needs to commercialize pharmaceutical products; the Corporation's product candidates being in the preclinical development stage; the Corporation's ability to obtain regulatory approval in jurisdictions for any product candidates; failure to obtain regulatory approval for FSD-201, or to achieve the degree of market acceptance and demand for our products by physicians, patients, healthcare payors, and others in the medical community which are necessary for commercial success, including, in the case of the FSD-201 COVID-19 Trials for the use of FSD-201 to treat COVID-19, due to the possibility that alternative, superior treatments for COVID-19 may be available prior to the approval and commercialization of FSD-201 for the treatment of COVID-19, should such approval be received at all; delays in clinical trials; failure of clinical trials to demonstrate substantial evidence of the safety and/or effectiveness of product candidates, which could prevent, delay or limit the scope of regulatory approval and commercialization, including from difficulties encountered in enrolling patients in clinical trials, and reliance on third parties to conduct our clinical trials and some aspects of our research and preclinical testing, or results from future clinical testing which may demonstrate opposing evidence and draw negative conclusions regarding the effectiveness of FSD-201 as a treatment for COVID-19 or other medical conditions; results of earlier studies or clinical trials not being predictive of future clinical trials and initial studies or clinical trials may not establish an adequate safety or efficacy profile for the Corporation's product candidates to justify proceeding to advanced clinical trials or an application for regulatory approval; difficulties enrolling patients in clinical trials; potential side effects, adverse events, or other properties or safety risks of the Corporation's product candidates, which could delay or halt their clinical development, prevent their regulatory approval, cause suspension or discontinuance of clinical trials, abandonment of a product candidate, limit their commercial potential, if approved, or result in other negative consequences; regulatory regimes of locations for clinical trials outside of the United States; failure to obtain approval to commercialize product candidates outside of the United States; if clinical trials are conducted for product candidates outside of the United States, the FDA and comparable regulatory authorities may not accept data from such trials, or the scope of such approvals from regulatory authorities may be limited; preliminary, interim data obtained from the Corporation's clinical trials that it may announce or publish from time to time may not be indicative of future scientific observations or conclusions as more patient data becomes available, further analyses are conducted, and as the data becomes subject to subsequent audit and verification procedures; manufacturing problems resulting in delays in development or commercialization programs;&#160;</p>
    <div id="footer_page_6">
        <p style="text-align: center;">- 6 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_7"></a><font style="font-size: 13.3333px; text-align: justify;"><br></font>
    <p style="text-align: justify;"><font style="font-size: 13.3333px;">inability to successfully validate, develop and obtain regulatory approval for companion diagnostic tests for drug candidates; changes in funding for the FDA and other government agencies; unforeseen claims made against the Corporation, including product liability claims or regulatory actions if products are alleged to have caused significant loss or injury; misconduct or other improper activities by employees, independent contractors, consults, commercial partners and vendors; failure to achieve market acceptance in the medical community; inability to establish sales and marketing capabilities, or enter in to agreements with third parties, to sell and market any product candidates that the Corporation may develop; failure to comply with health and data protection laws; reliance on third parties to conduct clinical trials; reliance on single-source suppliers, including single-course suppliers for the acquisition of the drug substance and drug product for FSD-201; reliance on contract manufacturing facilities; inability to obtain or maintain sufficient intellectual property protection for the Corporation's products; uncertainty associated with insurance coverage and reimbursement status for newly-approved pharmaceutical products, which could result in product candidates becoming subject to unfavourable pricing regulations, third-party coverage and reimbursement practices, or healthcare reform initiatives, including legislative measures aimed at reducing healthcare costs; third-party claims of intellectual property infringement; patent terms being insufficient to protect competitive position on product candidates; risk factors related to the sale of the Facility; inability to obtain patent term extensions or non-patent exclusivity; inability to protect the confidentiality of trade secrets; inability to protect trademarks and trade names; filing of claims challenging the inventorship of the Corporation's patents and other intellectual property; invalidity or unenforceability of patents, including legal challenges to patents covering FSD-201; claims regarding wrongfully used or disclosed confidential information of third parties; inability to protect property rights around the world; conditions in the global economy and capital markets, including impacts to trade and public health or geopolitical risks, as a result of impacts of COVID-19 or otherwise; that additional issuances of the Corporation's shares could have a significant dilutive effect; and other factors beyond the Corporation's control.</font></p>
    <p style="text-align: justify;">The Corporation cautions that the foregoing list of important risk factors and uncertainties is not exhaustive. Although the Corporation has attempted to identify important factors that could cause actual results to differ materially from those contained in Forward-Looking Statements, there may be other factors that cause results not to be as anticipated, estimated, intended or projected. There is no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on Forward-Looking Statements. You should carefully consider the matters as further discussed under "<i>Risk Factors</i>".</p>
    <p style="text-align: justify;">The Forward-Looking Statements contained or incorporated by reference in this AIF are made as of the date of this AIF or as otherwise specified. Except as required by applicable securities law, we undertake no obligation to update publicly or otherwise revise any Forward-Looking Statements or the foregoing list of factors affecting those statements, whether as a result of new information, future events or otherwise or the foregoing lists of factors affecting this information.</p>
    <div id="footer_page_7">
        <p style="text-align: center;">- 7 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_8"></a>
    <p style="text-align: center;"><b>GLOSSARY OF TERMS</b></p>
    <p style="text-align: justify;">In addition to terms defined elsewhere in this AIF, the following terms, when used in this AIF, have the following meanings (unless otherwise indicated):</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>ACA</b>" means, collectively, the U.S. <i>Patient Protection and Affordable Care Act</i>, as amended by the U.S.<i> Health Care and Education Reconciliation Act of 2010</i>.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>Acquireco</b>" means 2620756 Ontario Inc., a wholly-owned subsidiary of the Corporation incorporated under the OBCA for the purpose of carrying out the Amalgamation.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>AIF</b>" has the meaning ascribed to herein under "<i>Annual Information Form</i>".</p>
    <p style="text-align: justify;">"<b>Amalco</b>" means the amalgamated entity following the Amalgamation of Acquireco and FV Pharma, which continued under the name "FV Pharma Inc.".</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>Amalgamation</b>" means the amalgamation of Acquireco and FV Pharma pursuant to the terms of the Amalgamation Agreement.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>Amalgamation Agreement</b>" means the business combination agreement dated March 9, 2018, entered into among the Corporation, Acquireco and FV Pharma in respect of the Amalgamation.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>Articles</b>" means the articles of amalgamation of the Corpoation.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>Articles of Amendment</b>" means the amendment to the Articles providing for the change of name of the Corporation from "Century Financial Capital Group Inc." to "FSD Pharma Inc.", and the concurrent reorganization of the Corporation's share capital, as further described herein.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>Audit Committee</b>" means the Audit Committee of the Board.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>Aura</b>" means Aura Health Inc.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>Auxly</b>" means Auxly Cannabis Group Inc.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>Board</b>" means the board of directors of the Corporation.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>BPCIA</b>" means the U.S. <i>Biologics Price Competition and Innovation Act of 2009</i>.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>Business Combination</b>" means the reverse takeover of the Corporation by the shareholders of FV Pharma.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>Canada House</b>" means Canada House Wellness Group Inc.</p>
    <p style="text-align: justify;">"<b>Cannabis Act</b>" means the <i>Cannabis Act</i>, S.C. 2018, c.16,.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>Cannabis Licenses</b>" means the three licenses received from Health Canada under (or as migrated to, as applicable) the Cannabis Act: (i) a Cultivation License; (ii) a Standard Processing License; and (iii) a Sale for Medical Purposes License, each of which have been forfeited by the Corporation.</p>
    <p style="text-align: justify;">"<b>Cannara</b>" means Cannara Biotech Inc.</p>
    <p style="text-align: justify;">"<b>Canntab</b>" means Canntab Therapeutics Limited.</p>
    <p style="text-align: justify;">"<b>CBD"</b> means Cannabidiol.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>Century Shares</b>" means common shares in the capital of the Corporation prior to the reorganization of the Corporation's share capital as described in the Articles of Amalgamation.</p>
    <div id="footer_page_8">
        <p style="text-align: center;">- 8 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_9"></a>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>Class A Shares</b>"<b> </b>means the Class A multiple voting shares in the capital of the Corporation.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>Class B Shares</b>"<b> </b>means the Class B subordinate voting shares in the capital of the Corporation.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>Clover</b>" means Clover Cannastrip Thin Film Technologies Inc.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>CMO</b>" means contract manufacturing organization.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>CMS</b>" means Centers for Medicare &amp; Medicaid Services.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>Coattail Agreement</b>" means the coattail agreement dated May 24, 2018 among the Corporation, Computershare and certain of the Shareholders holding at least 80% of the Class A Shares.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>Computershare</b>" means Computershare Trust Company of Canada, the registrar and transfer agent of the Corporation.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>Corporation</b>" means FSD Pharma Inc. (formerly Century Financial Capital Group Inc.), a corporation formed under the OBCA.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>COVID-19</b>" means the 2019 novel coronavirus (SARS-CoV-2).</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>CRO</b>" means contract research organization<b>. </b></p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>CSA Notice</b>" means the CSA Staff Notice 51-352 <i>Issuers with U.S. Marijuana Related Activities.</i></p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>CSE</b>" means the Canadian Securities Exchange.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>EMA</b>" means European Medicines Agency.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>Epitech</b>" means Epitech Group SpA.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>Facility</b>" means the facility located at 520 William Street, Cobourg, Ontario, K9A 3A5.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>FDA</b>" means the U.S. Food and Drug Administration.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>FDC Act</b>" means the U.S. <i>Federal Food, Drug, and Cosmetic Act</i>.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>First Republic</b>" means First Republic Capital Corporation, a company controlled by Anthony Durkacz.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>FSD Biosciences</b>" means FSD Biosciences, Inc., a corporation incorporated under the laws of Delaware<b> </b>and a wholly-owned subsidiary.&#160;</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>FV Pharma</b>" means FV Pharma Inc., a corporation incorporated under the OBCA and a wholly-owned subsidiary of the Corporation.</p>
    <div id="footer_page_9">
        <p style="text-align: center;">- 9 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_10"></a>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>High Tide</b>" means High Tide Ventures Inc.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>HIPAA</b>" means the U.S. <i>Health Insurance Portability and Accountability Act </i>of 1996.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>JOBS Act</b>" means the U.S. <i>Jumpstart Our Business Startups Act</i>.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>MCTO</b>" means management cease trade order.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>MNP</b>" means MNP LLP, auditors of the Corporation since November 29, 2019.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>Nasdaq</b>" means The Nasdaq Stock Market LLC.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>NI 52-109</b>" means National Instrument 52-109 Certification of Disclosure in Issuers' Annual and Interim Filings.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>NP 46-201</b>" means National Policy 46-201 - <i>Escrow for Initial Public Offerings</i>.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>OBCA</b>" means the <i>Business Corporations Act</i> (Ontario).</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>OTCQB</b>" means the OTCQB Venture Market.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>PEA</b>" means palmitoylethanolamide.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>Pharmadrug DE</b>" means Pharmadrug Production GmbH.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>Pharmastrip</b>" means Pharmastrip Corp.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>Prismic</b>" means Prismic Pharmaceuticals, Inc., a corporation incorporated under the laws of Arizona and a wholly-owned subsidiary of the Corporation.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>SAB</b>" means the Scientific Advisory Board of the Corporation.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>Sales Agent</b>" means A.G.P./Alliance Global Partners.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>SciCann</b>" means SciCann Therapeutics Inc.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>SEDAR</b>" means System for Electronic Document Analysis and Retrieval.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>Shareholders</b>" means shareholders of the Corporation.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>Solarvest</b>" means Solarvest BioEnergy Inc.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>Stock Options</b>" means incentive stock options of the Corporation.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>THC</b>" means tetrahydrocannabinol.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>USPTO</b>" means the United States Patent and Trademark Office.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>U.S. Exchange Act</b>" means the United States Securities Exchange Act of 1934, as amended.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>Warrants</b>"<b> </b>means warrants of the Corporation to purchase Class B Shares.</p>
    <p style="text-align: justify; margin-left: 0.5pt; text-indent: -0.5pt;">"<b>World Class</b>" means World Class Extractions Inc.</p>
    <div id="footer_page_10">
        <p style="text-align: center;">- 10 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_11"></a>
    <p style="text-align: center;"><b>CORPORATE STRUCTURE</b></p>
    <p style="text-align: justify; margin-left: 54pt; text-indent: -54pt;"><b>Name, Address and Incorporation</b></p>
    <p style="text-align: justify;">The Corporation was formed under the OBCA on November 1, 1998 pursuant to the amalgamation of Olympic ROM World Inc., 1305206 Ontario Corporation, 1305207 Ontario Inc., Century Financial Capital Group Inc. and Dunberry Graphic Associates Ltd.</p>
    <p style="text-align: justify;">On March 15, 2018, the Shareholders approved the amendments contemplated by the Articles of Amendment at the 2018 annual and special meeting of the Shareholders, pursuant to which, among other things, the Shareholders approved the redesignation of the Century Shares to Class B Shares, the creation of the new class of Class A Shares, and the elimination of the Corporation's existing non-voting Class A Preferred Shares and non-voting Class B Preferred Shares.</p>
    <p style="text-align: justify;">On May 24, 2018, FV Pharma completed a reverse takeover of the Corporation by way of a three-cornered amalgamation among the Corporation, FV Pharma and Acquireco, a wholly-owned subsidiary of the Corporation formed solely for the purposes of completing the Amalgamation. In connection with the completion of the Amalgamation, the Corporation: (i) changed its name from "Century Financial Capital Group Inc." to "FSD Pharma Inc."; and (ii) reorganized the capital structure of the Corporation to create a new class of Class A Shares, amended the terms of and re-designated the existing common shares as Class B Shares, and eliminated the existing non-voting Class A Preferred Shares and non-voting Class B Preferred Shares, pursuant to the Articles of Amendment.</p>
    <p style="text-align: justify;">On May 29, 2018, the Class B Shares commenced trading on the CSE under the trading symbol "HUGE".</p>
    <p style="text-align: justify;">The Corporation's head office is located at First Canadian Place, 100 King Street West, Suite 3400, Toronto, Ontario, Canada M5X 1A4. The Corporation's registered office is located at 1 Rossland Road West, Suite 202, Ajax, Ontario, Canada L1Z 1Z2. As at the date of this AIF, the Corporation is a reporting issuer in each of the provinces of Canada (other than Qu&#233;bec).</p>
    <p style="text-align: justify;">On October 16, 2019, the Corporation amended its articles of incorporation to complete a consolidation of all of its issued and outstanding share capital. Pursuant to the amendment, all of the issued and outstanding Class A Shares and Class B Shares were consolidated on the basis of one post-consolidation share for every 201 pre-consolidation shares of the Corporation (the "<b>Consolidation</b>"). Unless otherwise noted, presentation in this AIF of the number of Class A Shares, Class B Shares, options, warrants and the issue or exercise prices and any other data related to the foregoing securities are all presented on a post-Consolidation basis.</p>
    <p style="text-align: justify;">On January 9, 2020, the Class B Shares commenced trading on the Nasdaq under the trading symbol "HUGE". The Corporation's principal business activity is a clinical-stage biotechnology company that is focused on bioscience, including research and development and clinical development of its lead compound, FSD 201, ultra-micronized Palmitoyl ethylamine (PEA). FSD 201 is known to stabilize mast cells of the human body and down-regulate the pro-inflammatory cytokines to effectuate an anti-inflammatory response.</p>
    <p style="text-align: justify; margin-left: 54pt; text-indent: -54pt;"><b>Intercorporate Relationships</b></p>
    <p style="text-align: justify;">As at the date of this AIF, the Corporation has two material subsidiaries, FV Pharma and Prismic, which are both wholly-owned by the Corporation.</p>
    <p style="text-align: justify; margin-left: 54pt; text-indent: -54pt;"><b>History of FV Pharma</b></p>
    <p style="text-align: justify;">FV Pharma was incorporated under the OBCA on September 12, 2011 under the name "2298519 Ontario Corp." and changed to its present name, "FV Pharma Inc.", on September 17, 2013. The registered and head office of FV Pharma is located at 1 Rossland Road West, Suite 202, Ajax, Ontario, L1Z 1Z2. FV Pharma's plant and operations are located at 520 William Street, Area 4, Bldg. #3, Cobourg, Ontario, Canada, K9A 3A5.</p>
    <p style="text-align: justify;">In March 2020, substantially all of the assets of FV Pharma were classified as being held for sale, and the Corporation is actively exploring a sale of the Facility and/or the Facility Property.</p>
    <div id="footer_page_11">
        <p style="text-align: center;">- 11 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_12"></a>
    <p style="text-align: justify; margin-left: 54pt; text-indent: -54pt;"><b>History of FSD BioSciences, Inc.</b></p>
    <p style="text-align: justify;">FSD BioSciences, Inc., a wholly-owned subsidiary, is a specialty biotech pharmaceutical R&amp;D company focused on developing over time multiple applications of its lead compound, FSD-201 ultra-micronized palmitoylethanolamide (Ultra-Micro PEA). Ultra-Micro PEA stabilizes mast cells and down-regulates the pro-inflammatory cytokines to effectuate an anti-inflammatory response.</p>
    <p style="text-align: justify; margin-left: 54pt; text-indent: -54pt;"><b>History of Prismic</b></p>
    <p style="text-align: justify;">Prismic is incorporated under the laws of the State of Arizona. The registered and head office of Prismic is located at 474 Grove Street, Suite 740, Worcester, Massachusetts, United States, 06105.</p>
    <p style="text-align: justify;">Prismic is a U.S.-based specialty pharmaceutical company dedicated to addressing the opioid crisis by developing novel non-addictive prescription drugs for the treatment of pain, inflammation, and neurological disorders, based on formulations utilizing the Corporation's micro-PEA development platform (palmitoylethanolamide with particle sizes of 0.6 - 10 microns).</p>
    <p style="text-align: center;"><b>GENERAL DEVELOPMENT OF THE BUSINESS</b></p>
    <p style="text-align: justify; margin-left: 54pt; text-indent: -54pt;"><b>Three Year History</b></p>
    <p style="text-align: justify; margin-left: 1.4pt; text-indent: -0.7pt;"><i><b>Business Combination with FV Pharma and Concurrent Financing</b></i></p>
    <p style="text-align: justify;">Prior to the closing of the Business Combination, the Corporation was engaged in the leasing of operating and manufacturing equipment such as industrial and construction machinery. As of August 31, 2016, all of the Corporation's former leases had been written off and the Corporation was inactive until the completion of the Amalgamation.</p>
    <p style="text-align: justify;">On March 9, 2018, the Corporation entered into a definitive Business Combination agreement with FV Pharma, which provided for the reverse takeover of the Corporation by the shareholders of FV Pharma. The Business Combination was carried out by way of a "three-cornered amalgamation" pursuant to the provisions of the OBCA. The three-cornered amalgamation included the following steps:</p>
    <p style="text-align: justify; margin-left: 54pt; text-indent: -18pt;">(i)<font style="width: 9.12pt; text-indent: 0pt; display: inline-block;">&#160;</font>the Corporation filed Articles of Amendment, providing for the change of name of the Corporation from "Century Financial Capital Group Inc." to "FSD Pharma Inc." and the amendment and re-designation of the Corporation's share capitalization pursuant to which the existing Century Shares were re-designated as "Class B Shares", a new class of "Class A Shares" was created, and the existing classes of non-voting Class A Preferred Shares and non-voting Class B Preferred Shares were eliminated;</p>
    <p style="text-align: justify; margin-left: 54pt; text-indent: -18pt;">(ii)<font style="width: 6.06pt; text-indent: 0pt; display: inline-block;">&#160;</font>Acquireco and FV Pharma amalgamated;</p>
    <p style="text-align: justify; margin-left: 54pt; text-indent: -18pt;">(iii)<font style="width: 3.01pt; text-indent: 0pt; display: inline-block;">&#160;</font>each holder of FV Pharma Class A voting common shares transferred such shares to the Corporation in exchange for an aggregate of 15,000 fully paid and non-assessable Class A Shares on a one-for-one basis, and each holder of FV Pharma Class B non-voting common shares transferred such shares to the Corporation in exchange for an aggregate of 1,305,770,018 fully paid and non-assessable Class B Shares on a one-for-one basis (1,305,770,018 total, on a pre-Consolidation basis);</p>
    <p style="text-align: justify; margin-left: 54pt; text-indent: -18pt;">(iv)<font style="width: 4.12pt; text-indent: 0pt; display: inline-block;">&#160;</font>the Corporation received one fully paid and non-assessable common share of Amalco for each common share of Acquireco held by the Corporation, following which all such common shares of Acquireco were cancelled;</p>
    <p style="text-align: justify; margin-left: 54pt; text-indent: -18pt;">(v)<font style="width: 6.67pt; text-indent: 0pt; display: inline-block;">&#160;</font>all FV Pharma shares held by the Corporation as a result of the exchanges described above were cancelled and the Corporation received, for each FV Pharma share, one common share of Amalco and Amalco became a wholly-owned subsidiary of the Corporation; and</p>
    <div id="footer_page_12">
        <p style="text-align: center;">- 12 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_13"></a>
    <p style="text-align: justify; margin-left: 54pt; text-indent: -18pt;">(vi)<font style="width: 4.12pt; text-indent: 0pt; display: inline-block;">&#160;</font>Stock Options and Warrants were issued to the holders of the FV Pharma stock options and warrants, respectively, in exchange and replacement for, on an equivalent basis, such FV Pharma stock options and warrants, which were cancelled.</p>
    <p style="text-align: justify;">The Amalgamation resulted in Amalco becoming a wholly-owned subsidiary of the Corporation. Concurrently with the completion of the Amalgamation, the Corporation changed its name to "FSD Pharma Inc." and Amalco continued under the name "FV Pharma Inc.". The Corporation continued the medical cannabis business of FV Pharma.</p>
    <p style="text-align: justify;">The valuation ascribed to FV Pharma in the Amalgamation was determined by arm's length negotiations between the Corporation and FV Pharma, and based in part upon FV Pharma's pre-Amalgamation financings. A formal third party valuation was not determined to be necessary.</p>
    <p style="text-align: justify;">The Amalgamation was approved by a special resolution of the holders of FV Pharma shares at a shareholder meeting held on May 15, 2018, and by the Corporation, in its capacity as sole shareholder of Acquireco. The Amalgamation was approved, pursuant to the policies of the CSE, by a majority (50% plus one vote) of the votes cast at the meeting of shareholders of FV Pharma.</p>
    <p style="text-align: justify;">Concurrently with the completion of the Business Combination, FV Pharma completed a multi-tranche private placement of subscription receipts of FV Pharma (each, a "<b>Subscription Receipt</b>") pursuant to the terms of an agency agreement (the "<b>Agency Agreement</b>") dated March 9, 2018 between FV Pharma and First Republic, as exclusive agent (the "<b>Concurrent Financing</b>"), and each Subscription Receipt converted into one Class B Share in connection with the closing of the Amalgamation. Under the Concurrent Financing, FV Pharma issued an aggregate of 371,159,913 Subscription Receipts at a price of $0.09 per Subscription Receipt (the "<b>Subscription Price</b>") for aggregate gross proceeds of $33,404,392.</p>
    <p style="text-align: justify;">On the closing of the Business Combination and the satisfaction of certain other escrow release conditions contained in the Agency Agreement and the subscription receipt agreement dated March 9, 2018 among FV Pharma, First Republic and Garfinkle Biderman LLP, as subscription agent, the Subscription Receipts converted into Class B Shares and the net proceeds from the Concurrent Financing ($29,862,645) were released to the Corporation.</p>
    <p style="text-align: justify; margin-left: 1.4pt; text-indent: -0.7pt;"><i><b>Investment in SciCann </b></i></p>
    <p style="text-align: justify;">On June 6, 2018, the Corporation announced that FV Pharma made an investment into SciCann by executing a term sheet (the "<b>Term Sheet</b>") pursuant to which the Corporation invested approximately $2 million and received shares of SciCann representing approximately 10.52% of SciCann's equity. On February 28, 2020, the Term Sheet was amended and certain of FV Pharma's rights thereunder were assigned to the Corporation.</p>
    <p style="text-align: justify; margin-left: 1.4pt; text-indent: -0.7pt;"><i><b>Partnership Agreement with Cannara </b></i></p>
    <p style="text-align: justify;">On June 19, 2018, the Corporation announced the signing of a partnership agreement between FV Pharma and Cannara (the "<b>Cannara Agreement</b>"), effective May 31, 2018 concerning the development of Cannara's proposed cannabis cultivation facility outside of Montreal, Qu&#233;bec.&#160; In connection with the Cannara Agreement, the Corporation (via FV Pharma) received approximately 75 million shares of Cannara (each, a "<b>Cannara Share</b>"). On July 24, 2018, the Corporation announced that Cannara completed a $17.66 million common share equity financing, during which the Corporation made an additional investment of $1 million.</p>
    <p style="text-align: justify;">On February 20, 2020, the Corporation announced that it sold all of its direct and indirect equity interests in Cannara to a consortium of buyers for cash proceeds of approximately $7.7 million. The terms of the sale were negotiated at arm's length with a group of buyers that included entities controlled by members of the Cannara board and senior management. A substantial portion of the Corporation's shareholdings in Cannara were subject to a statutory escrow period set to expire in December 2021. Under the terms of the transaction, the buyers agreed to acquire all of the Cannara Shares owned by the Corporation subject to escrow and, as such, assumed all of the associated market risk. The sale represents a 670% return on the Corporation's investment in Cannara.</p>
    <div id="footer_page_13">
        <p style="text-align: center;">- 13 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_14"></a>
    <p style="text-align: justify; margin-left: 1.4pt; text-indent: -0.7pt;"><i><b>Collaboration Agreement with Canntab</b></i></p>
    <p style="text-align: justify;">On September 18, 2018, the Corporation announced that it had signed a definitive collaboration agreement dated effective September 17, 2018&#160; with Canntab. Under the terms of the agreement, the Corporation assisted Canntab in obtaining a license to process and sell cannabis products and provided Canntab with up to 10,000 square feet of space at the Facility in exchange for certain royalty and profit-sharing rights in connection with the sale of Canntab-manufactured cannabis-based products. The collaboration agreement with Canntab was terminated in connection with the forfeiture of the Cannabis Licenses.</p>
    <p style="text-align: justify; margin-left: 1.4pt; text-indent: -0.7pt;"><i><b>Investment in High Tide</b></i></p>
    <p style="text-align: justify;">In April 2018 and October 2019, the Corporation completed two investments in High Tide for an aggregate purchase price of $2.2 million. High Tide operates 19 licensed cannabis stores across Canada and holds provincial e-commerce licenses in Saskatchewan and Manitoba. On November 22, 2019, the Corporation sold all of the securities of High Tide it previously acquired to a third party for aggregate cash proceeds of $614,520.</p>
    <p style="text-align: justify; margin-left: 1.4pt; text-indent: -0.7pt;"><i><b>International Securities Listings</b></i></p>
    <p style="text-align: justify;">On August 14, 2018, the Corporation listed its Class B Shares on the Frankfurt exchange and trading under "WKN: A2JM6M" and the ticker symbol "0K9".</p>
    <p style="text-align: justify;">On September 19, 2018, the Corporation announced that the Class B Shares were upgraded to a listing on the OTCQB, trading under the ticker symbol "FSDDF".</p>
    <p style="text-align: justify;">On January 9, 2020, the Class B Shares commenced trading on the Nasdaq under the symbol "HUGE".</p>
    <p style="text-align: justify; margin-left: 1.4pt; text-indent: -0.7pt;"><i><b>Migration of Licenses to the Cannabis Act</b></i></p>
    <p style="text-align: justify;">On November 13, 2018, the Corporation announced that its Cultivation License, which was originally granted under the <i>Access to Cannabis for Medical Purposes Regulations</i> (Canada), had been migrated to the Cannabis Act, effective November 8, 2018. As of November 7, 2018, FV Pharma also received license amendments approving all of the remaining 30,000 square feet currently built out for additional grow and operations. On June 21, 2019, the Cannabis Licenses were amended to allow the Corporation to sell or provide fresh or dried cannabis or cannabis oil to such other persons who are permitted to purchase medical cannabis products under the Cannabis Act. On July 30, 2020, the Corporation announced that it had notified Health Canada of the Corporation's decision to forfeit all of the Cannabis Licenses, and suspend all activities by FV Pharma.</p>
    <p style="text-align: justify; margin-left: 1.4pt; text-indent: -0.7pt;"><i><b>Collaboration with World Class Extractions</b></i></p>
    <p style="text-align: justify;">On December 6, 2018, the Corporation announced that it had entered into a definitive collaboration and license Agreement with World Class, a company that has developed a unique extraction process designed to produce large-scale, quality, potent cannabis extracts. Under the terms of the agreement and a related lease, the Corporation agreed to (i) provide World Class with 5,000 square feet of space at the Facility, (ii) assist World Class in obtaining an extraction license from Health Canada, and (iii) provide World Class with raw cannabis needed to produce cannabis extracts. The collaboration and license agreement with World Class was terminated in connection with the forfeiture of the Cannabis Licenses.</p>
    <p style="text-align: justify; margin-left: 1.4pt; text-indent: -0.7pt;"><i><b>Investment in Huge Shops</b></i></p>
    <p style="text-align: justify;">Huge Shops operates as a cannabis retailer and offers cannabis products to consumers. Huge Shops has a strategic alliance with Chairman's Brands Corporation, parent company of Coffee Time, a well-established operator of retail coffee shops with more than 75 locations in Canada and other locations worldwide.</p>
    <div id="footer_page_14">
        <p style="text-align: center;">- 14 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_15"></a>
    <p style="text-align: justify;">On December 20, 2018, the Corporation announced that it had completed the purchase of 17,333,333 shares of Huge Shops (each, a "<b>Huge Shop Share</b>") based on the December 2018 subscription price of $0.075 per Huge Shop Share, for a total investment of approximately $1.3 million to acquire approximately 9.9% of the issued and outstanding shares of Huge Shops.</p>
    <p style="text-align: justify; margin-left: 1.4pt; text-indent: -0.7pt;"><i><b>Solarvest Transactions</b></i></p>
    <p style="text-align: justify;">On May 7, 2019, the Corporation announced that it signed a definitive Collaboration and Research Development Agreement with Solarvest (the "<b>Solarvest Agreement</b>") to conduct research using its algal expression technology to develop pharma-grade cannabinoids (the "<b>Solarvest Research Project</b>"). The Corporation and Solarvest allocated an initial budget of $1 million for the Solarvest Research Project, over a two-year period, and created a joint scientific review committee to assess progress of the project against budgets and timelines.</p>
    <p style="text-align: justify;">In connection with the Solarvest Agreement, (i) the Corporation issued 49,751 Class B Shares to Solarvest, at a deemed price of $60.30 per Class B Share, (ii) Solarvest issued 3,000,000 units to the Corporation, at a deemed price of $0.25 per unit (each, a "<b>Solarvest Unit</b>"), with each Solarvest Unit being comprised of one common share in the capital of Solarvest (each, a "<b>Solarvest Share</b>") and one common share purchase warrant with an exercise price of $0.25 per Solarvest Share and a term of two years, and (iii) Solarvest issued a convertible debenture to the Corporation in the principal amount of $2.4 million (the debenture has a five-year term, bears interest of 3% per annum, and is convertible into Solarvest Shares at a conversion price of $1.00 per Solarvest Share, provided that the Corporation will be required to convert the debenture if Solarvest Shares close at a price of at least $1.20 for a period of 20 consecutive trading days).</p>
    <p style="text-align: justify;">On February 4, 2020, the Corporation announced that it agreed to certain amendments to the Solarvest Agreement whereby the Corporation agreed to issue an additional 225,371 Class B Shares to Solarvest in settlement of derivative liability under the Solarvest Agreement. In addition, Solarvest appointed Dr. Edward J. Brennan Jr., the President of the Corporation's BioSciences Division, to the board of directors of Solarvest. The Solarvest Agreement and related agreements were terminated in connection with the forfeiture of the Cannabis Licenses.</p>
    <p style="text-align: justify;"><i><b>Auxly Joint Venture</b></i></p>
    <p style="text-align: justify;">On March 3, 2018, the Corporation entered into a Definitive Strategic Alliance and Streaming Agreement (the "<b>Auxly Agreement</b>") with Auxly. On February 6, 2019, the Corporation sent Auxly a Notice of Default, thereby terminating the Agreement effective immediately. Later that same day, Auxly sent a Notice of Default to the Corporation in response. To date, neither party has taken further legal steps.</p>
    <p style="text-align: justify;">To fund the development, Auxly purchased 37,313 Class B Shares for the aggregate of $7,500,000 from the treasury by way of private placement, which funds were placed in trust to be spent on construction and development costs in respect of the Facility. The funds were placed in a trust account to be administered by Auxly. Due to the termination of the Auxly Agreement and subsequent negotiations, it is indeterminable at this point as to the amount, if any, of these funds will be released to the Corporation. As a result, the Corporation entered a provision for loss against the funds, which loss has been recognized in the Corporation's consolidated financial statements. Should any funds be released to the Corporation, those amounts will be recognized in future periods as gains on recovery. No other provision has been recorded for this matter as at December 31, 2020.</p>
    <p style="text-align: justify; margin-left: 1.4pt; text-indent: -0.7pt;"><i><b>Investment in Pharmastrip</b></i></p>
    <p style="text-align: justify;">On September 6, 2018, the Corporation invested $1.5 million in Clover. The investment included units comprising 7,500,000 shares and 3,750,000 warrants. In connection with the investment, the Corporation entered into a definitive collaboration and profit sharing agreement with Pharmastrip (the "<b>Pharmastrip Agreement</b>"), an entity represented to be an affiliate of Clover, effective January 23, 2019.</p>
    <p style="text-align: justify;">FSD was subsequently informed that certain principals of Clover were the subject of Federal Trade Commission proceedings in the U.S., and that the U.S.-based owner of the licensed technology had been placed into receivership. As a result of the foregoing, it may be difficult or impossible for us to realize a return on the investment in Clover and to commercialize the licensed Pharmastrip technology. The Corporation has written down the equity investment to $0 in light of the circumstances.</p>
    <div id="footer_page_15">
        <p style="text-align: center;">- 15 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_16"></a>
    <p style="text-align: justify; margin-left: 1.4pt; text-indent: -0.7pt;"><i><b>Supply Agreement with Canntab and World Class</b></i></p>
    <p style="text-align: justify;">On February 12, 2019, the Corporation announced that it had entered into a supply agreement with Canntab and World Class (together, the "<b>Purchasers</b>") to purchase hemp flower from a supplier (the "<b>Supplier</b>"). Pursuant to this agreement, the Purchasers agreed to buy approximately 1,000 kg of the Supplier's 2018 organic hemp crop, for which the Corporation purchased a quantity with a value of $100,000 prior to September 30, 2019. Approximately $500,000 was paid by the Purchasers for the 2019 organic hemp crop as a loan to the Supplier in the form of equipment, and paid back in the form of hemp pursuant to a supply and loan agreement (the "<b>Supply and Loan Agreement</b>"). Pursuant to the Supply and Loan Agreement, the Supplier granted the Purchasers the right and option to purchase up to $5.0 million of the Supplier's hemp crop for a period of five years commencing in 2019 at a purchase price of $100 per kg per 1% of CBD extracted from the flower. The Supply and Loan Agreement has been terminated in connection with the forfeiture of the Cannabis Licenses.</p>
    <p style="text-align: justify; margin-left: 1.4pt; text-indent: -0.7pt;"><i><b>Acquisition of Prismic</b></i></p>
    <p style="text-align: justify;">On April 23, 2019, the Corporation announced that it entered into a definitive securities exchange agreement with Prismic (the "<b>Prismic Exchange Agreement</b>"). Prismic is a U.S.-based specialty research and development pharmaceutical company, developing novel non-addictive prescription drugs with unique safety profiles with the goal of addressing the opioid crisis based on formulations utilizing micro-palmitoylethanolamide's "entourage" effect on certain drugs impacting the endocannabinoid system.</p>
    <p style="text-align: justify;">The acquisition of Prismic was completed on June 28, 2019. Pursuant to the terms of the Prismic Exchange Agreement, the Corporation acquired all outstanding securities of Prismic for an aggregate purchase price of US$15,713,448 million (C$20,887,086 million based on an exchange rate of US$1 to CAD$1.3349 calculated based on the average daily exchange rate between April 5, 2019 and April 18, 2019), satisfied by the issuance of an aggregate of 510,940 Class B Shares at a deemed price of $45.7275 (US$34.2504) per Class B Share. The Class B Shares issued to the former Prismic shareholders are subject to an 18-month staggered escrow release pursuant to the terms of the Prismic Exchange Agreement. Additionally, the Corporation assumed approximately US$2.90 million of outstanding Prismic liabilities on closing, some of which may be settled by the issuance of additional Class B Shares.</p>
    <p style="text-align: justify;">In accordance with the terms of the Prismic Exchange Agreement, all of the outstanding Prismic stock options and warrants were converted into options and warrants to purchase Class B Shares, with the number and exercise price of such securities having been adjusted in accordance with the exchange ratio under the Prismic Exchange Agreement. The Class B Shares underlying the replacement warrants and options issued to former Prismic securityholders are also subject to an 18-month staggered escrow release pursuant to the terms of the Prismic Exchange Agreement.</p>
    <p style="text-align: justify; margin-left: 1.4pt; text-indent: -0.7pt;"><i><b>Agreement with Aura Health</b></i></p>
    <p style="text-align: justify;">On April 16, 2019, the Corporation entered into a share exchange agreement (the "<b>Aura Exchange Agreement</b>") with Aura. Pursuant to the Aura Exchange Agreement, the Corporation acquired common shares in the capital of Aura (each, an "<b>Aura Share</b>") valued at approximately $3 million issued from treasury (13,562,386 Aura Shares at a deemed price of $0.221 per Aura Share) in exchange for Class B Shares having an aggregate value of $3 million (being 65,577 Class B Shares at a deemed price of $45.7476 per Class B Share). Subsequent to September 30, 2019, Aura announced a name change to Pharmadrug Inc.</p>
    <p style="text-align: justify;">In addition to the Aura Exchange Agreement, Aura, through Pharmadrug DE, a company in which Aura holds an 80% equity interest, and the Corporation entered into a consulting agreement and a supply agreement, each of which is no longer in effect following the forfeiture of the Cannabis Licenses.</p>
    <p style="text-align: justify;">In October 2019, FSD issued an additional 61,892 Class B Shares to Aura pursuant to a make whole provision under the Aura Exchange Agreement.</p>
    <div id="footer_page_16">
        <p style="text-align: center;">- 16 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_17"></a>
    <p style="text-align: justify; margin-left: 1.4pt; text-indent: -0.7pt;"><i><b>Changes to Management, Board of Directors and Advisors</b></i></p>
    <p style="text-align: justify;">On July 23, 2018, the Corporation announced the appointment of Mr. Donal Carroll to the role of interim Chief Financial Officer. Mr. Carroll is a finance executive with 20 years of corporate finance leadership and public company experience, as well as deep expertise in syndicate investing, both in equity and debt securities. Mr. Carroll has successfully guided companies for expansion and growth, and has worked with major companies such as Danaher and Unilever (NYSE:UL), where he was instrumental in major restructuring activities, mergers and acquisitions, and the implementations of new internal controls and enterprise resource planning systems resulting in significant efficiencies through periods of substantial change and strong company growth. Mr. Carroll has been an independent director of Bird River Resources Inc. and holds a CPA-CMA designation, as well as a Bachelor of Commerce degree, from University College Dublin.</p>
    <p style="text-align: justify;">On August 2, 2018, the Corporation announced the appointment of Dr. Raza Bokhari to its Board. Dr. Bokhari served as the Chairman &amp; Chief Executive Officer of PCL, Inc., a global diagnostic provider of addiction screening and opioid prescription medication monitoring, including designer drugs and synthetic cannabinoids. He is also the managing partner of RBx Capital, LP and a recipient of Philadelphia Business Journal's "40 under 40" award. A physician-turned-entrepreneur, Dr. Bokhari has, over the past several years, developed expertise in aggregating and accelerating life sciences and healthcare services companies. He has a vast knowledge base of developing creative concepts, implementing programs and forming strategic alliances. An effective "change agent" with several years of experience and expertise in start-up and turn-around businesses, he is adept at turning around struggling companies. Dr. Bokhari recognizes the special role of public offerings, private equity funds, venture capital money, and leveraged debt partners in executing accelerated growth trends in healthcare services and cancer diagnostics and therapeutics.</p>
    <p style="text-align: justify;">On October 29, 2018, Dr. Bokhari was appointed as Executive Co-Chairman of the Board and interim Chief Executive Officer of the Corporation. Further, the Corporation announced the appointment of Mr. Zeeshan Saeed as President of the Corporation and Mr. Anthony Durkacz as Executive Co-Chairman of the Board.</p>
    <p style="text-align: justify;">On November 14, 2018, the Corporation announced the appointment of Mr. David Urban to the Board. Mr. Urban is an accomplished business and government relations executive. He and his company advise organizations ranging in size from start-ups to the Fortune 100 companies on interactions with government in order to maximize stakeholder and shareholder value. In the field of politics, Mr. Urban has achieved success serving as an advisor to campaigns at the highest levels, including the President of the United States, the United States Senate and United States House of Representatives. In addition to his role as a business consultant and political advisor, Mr. Urban is a frequent contributor to CNN as a political commentator.</p>
    <p style="text-align: justify;">On November 26, 2018, the Corporation announced the appointment of Mr. Rupert Haynes as Chief Executive Officer of the Corporation. Mr. Haynes was subsequently terminated as Chief Executive Officer on February 6 2019, and Dr. Raza Bokhari was appointed interim (and subsequently permanent) Chief Executive Officer.</p>
    <p style="text-align: justify;">On March 13, 2019, the Corporation announced the departure of Mr. Thomas Fairfull as President of FV Pharma and the subsequent appointment of Dr. Sara May as President of FV Pharma. Additionally, the Corporation announced the departure of Mr. Vladimir Klacar, a former Board nominee of Auxly, from the Board.</p>
    <p style="text-align: justify;">On May 28, 2019, the Corporation announced the appointment of pharmaceutical industry leader, Dr. Edward J. Brennan, Jr., M.D., FACS, as President of its Biosciences division. Dr. Brennan has more than 25 years' experience in leadership roles at major pharmaceutical companies and clinical research organizations. Dr. Brennan has extensive experience in all phases of clinical development across multiple therapeutic areas. As a Medical Director with Wyeth-Ayerst Research and GlaxoSmithKline, he led teams through ten investigational new drug applications and advanced multiple compounds from pre-candidate selection (proof of concept) through clinical trial management and approval. At GlaxoSmithKline, he was also responsible for coordinating all clinical activities for external partners within its Center of Excellence in External Drug Discovery. He next founded IndiPharm, a full-service global CRO that was eventually acquired by a private equity company, Velocity Fund Partners. Dr. Brennan received his undergraduate Bachelor of Science Degree in Pharmacy from the Philadelphia College of Pharmacy and Science. He went on to study medicine at the Royal College of Surgeons in Ireland before receiving his medical degree from the Temple University School of Medicine.</p>
    <div id="footer_page_17">
        <p style="text-align: center;">- 17 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_18"></a>
    <p style="text-align: justify;">On June 3, 2019, the Corporation announced that Dr. Raza Bokhari had been appointed as (permanent) Chief Executive Officer of the Corporation.</p>
    <p style="text-align: justify;">On June 12, 2019, the Corporation announced the appointment of Mr. James A. Datin and Mr. Robert J. Ciaruffoli to the Board. Mr. Datin is the current President and Chief Executive Officer of BioAgilytix Labs, LLC, a leading global bioanalytical CRO that supports the development of novel therapeutic biologics. Mr. Datin also has considerable experience managing growing companies throughout the U.S., Europe and Asia, and has completed various corporate transactions including venture investments, buyouts, acquisitions, mergers, initial public offerings, licensing and partnership agreements.</p>
    <p style="text-align: justify;">Mr. Ciaruffoli is a CPA and served as the Chairman and CEO of the ParenteBeard/Baker Tilly accounting and advisory firm. During his tenure as Chairman and Chief Executive Officer, he and his team transitioned the firm from a Pennsylvania practice to a multi-state super-regional firm. In 2014, he orchestrated a merger of the ParenteBeard and Baker Tilly Virchow Krause firms to create the 12th largest U.S. accounting and advisory firm. Throughout his career, Mr. Ciaruffoli has served on numerous for-profit and not-for-profit boards.</p>
    <p style="text-align: justify;">On October 11, 2019, Mr. Stephen Buyer, a former member of the U.S. House of Representatives, was appointed as a director of the Corporation. Mr. Buyer was a member of the United States House of Representatives, serving nine consecutive terms from January 1993 to January 2011. During Congressman Buyer's long tenure in Congress, he served on the Veterans Affairs, Armed Services, Judiciary, Energy and Commerce Committees, and also served on the Military Compensation and Retirement Modernization Commission. He is presently the Managing Partner of the 10-Square Solution, LLC, focusing on business development, mergers and acquisitions, and representation before the U.S. federal government.</p>
    <p style="text-align: justify;">On January 2, 2020, the Corporation announced further changes to its management team. The Corporation appointed Mr. Donal Carroll as the Chief Financial Officer on a permanent basis, Ms. Sandra Lottes as Vice President &amp; Head of Clinical Research for the Corporation's BioSciences Division and Mr. Shahzad Shah as Chief Operating Officer of FV Pharma.</p>
    <p style="text-align: justify;">On January 22, 2020, the Corporation appointed Dr. Larry Kaiser to the Board. Dr. Kaiser was formerly the Dean, Lewis Katz School of Medicine at Temple University, President &amp; CEO of Temple Health System and Senior Executive Vice President for Health Affairs at Temple University in Philadelphia, and was named one of the "50 Most Influential Clinical Executives" for 2019 by Modern Healthcare.</p>
    <p style="text-align: justify;">On July 29, 2020, the Scientific Advisory Board was dissolved.</p>
    <p style="text-align: justify;">On October 20, 2020, Mr. David Urban resigned from the Board due to external contractual obligations.</p>
    <p style="text-align: justify;">On January 26, 2021, the Corporation terminated of its former president, Mr. Zeeshan Saeed, for cause. As a result of his termination, in accordance with the terms of his employment agreement, Mr. Saeed resigned from all other positions held with the Corporation and its subsidiaries, including from the Board.</p>
    <div id="footer_page_18">
        <p style="text-align: center;">- 18 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_19"></a>
    <p style="text-align: justify;">Effective April 30, 2021, Mr. James A. Datin will be resigning from the Board.</p>
    <p style="text-align: justify;">Effective March 1, 2021, Randell Mack was appointed as President of FSD BioSciences and Dr. Ed Brennan was named Chief Medical Officer of the Corporation.</p>
    <p style="text-align: justify; margin-left: 1.4pt; text-indent: -0.7pt;"><i><b>Q4 2019 Private Placement</b></i></p>
    <p style="text-align: justify;">The Corporation completed a private placement of Class B Shares in two tranches closed on September 30, 2019 and November 4, 2019 (the "<b>2019</b> <b>Private Placement</b>"). Under the 2019 Private Placement, the Corporation issued an aggregate of 228,670 Class B Shares to the purchasers under the private placement at a price of $20.10 per Class B Share, for aggregate gross proceeds of $4,593,777. Certain of the purchasers of Class B Shares in the 2019 Private Placement included members of senior management and the Board. The Corporation's leadership team, representing founders, directors and members of senior management collectively invested more than $500,000. The net proceeds from the 2019 Private Placement will be used for the expansion of the Corporation's biosciences division, including the research and development of PP-101 micro-PEA plus pregabalin - the Corporation's pre-clinical drug candidate for the treatment of symptoms related to fibromyalgia - and for general corporate purposes, including working capital, potential investments and acquisitions.</p>
    <p style="text-align: justify; margin-left: 1.4pt; text-indent: -0.7pt;"><i><b>Nasdaq Listing</b></i></p>
    <p style="text-align: justify;">On December 16, 2019, the Corporation announced that its Class B shares were approved to be listed on the Nasdaq. The Class B Shares commenced trading on the Nasdaq on January 9, 2020 under the symbol "HUGE".</p>
    <p style="text-align: justify;"><i><b>Epitech License Agreement</b></i></p>
    <p style="text-align: justify;">On January 8, 2020, the Corporation entered into an amended and restated license agreement with Epitech, as further amended in June 2020 (the "<b>License Agreement</b>"), which amended and restated the license agreement between Prismic and Epitech through which Prismic secured certain intellectual property rights to PEA from Epitech. The License Agreement grants the Corporation an exclusive, worldwide license (excluding Italy and Spain where the Corporation is not licensed and Epitech remains entitled to commercialize the Licensed Products (as defined herein), directly or indirectly) (the "<b>Epitech License</b>") to research, manufacture and commercialize products (the "<b>Licensed Products</b>") that are developed using certain proprietary formulations of PEA owned by Epitech and that are to be used to treat chronic kidney disease in humans or, if a prescription drug, any other human condition that is related to pain and chronic pain. The Epitech License also gives the Corporation the right to use the Licensed IP (as defined in the Epitech License) in the development of a prescription drug for the treatment of the cytokine storm associated with COVID-19. In addition, under the terms of the Epitech License, as further amended on July 29, 2020, if Epitech develops or commercializes a prescription drug for the treatment of any other human condition unrelated to pain and chronic pain (a "<b>Different Prescription Drug</b>") in its territory, the Corporation has a first refusal right to use Epitech's patents to develop and commercialize this Different Prescription Drug in its territory (i.e. worldwide excluding Italy and Spain). Should the Corporation exercise this right, but then fail to demonstrate commercially reasonable efforts to develop the Different Prescription Drug in the two years following, Epitech would be free to exploit and/or license to third parties the use of the patents for the Different Prescription Drug. The FSD-201 COVID-19 Trials are subject to such requirements. Finally, the Epitech License provides the Corporation with a non-exclusive license to use Epitech's scientific and technical know-how with respect to ultramicronized-PEA in connection with the development or commercialization of the Licensed Products discussed above. See also "<i>Risk Factors - Risk Relating to the Development of FSD-201.</i>"</p>
    <p style="text-align: justify;">Under the terms of the License Agreement, the Corporation is required to make payments to Epitech upon the achievement of specified milestones. Upon first notification by the FDA of approval of a New Drug Application, the non-refundable sum of US$700,000 is due and payable to Epitech. Within ten business days of the first notification of approval of a Supplemental New Drug Application by the FDA, the Corporation is required to pay the non-refundable sum of US$1,000,000 to Epitech.</p>
    <div id="footer_page_19">
        <p style="text-align: center;">- 19 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_20"></a>
    <p style="text-align: justify;">The License Agreement also specifies certain royalty payments. Pursuant to the License Agreement, the Corporation must pay Epitech 25% (in the case of non-prescription drug rights) and 5% (in the case of prescription drug rights) of any one-off lump sum payments it receives as consideration for granting a sub-license to a third-party with respect to a Licensed Product. In addition, the Corporation is required to pay either: (a) 7% of net sales of the Licensed Products in a product regulatory category other than prescription drugs placed on the market by the Corporation; (b) 25% of the royalties received by the Corporation from sub-licensees (such royalties, the "<b>Net Receipts</b>") where Licensed Products in a product regulatory category other than prescription drugs are placed on the market by such sub-licensees; or (c) 5% of net sales or Net Receipts of the Licensed Products that are prescription drugs.</p>
    <p style="text-align: justify;">Unless otherwise terminated in accordance with its terms, the Epitech License will remain in force until the Corporation is no longer obligated to pay royalties under the License Agreement, which obligation will expire on a country-by-country basis when the last valid claim of the Licensed Patents covering the Licensed Products in a given country expires. The approval of a therapeutically equivalent, generic version of the Licensed Product(s) in a country will conclusively demonstrate that a valid claim does not cover the Licensed Products in that country. If there are no patents covering the Licensed Products in a country, royalties are payable for the license of the scientific and technical know-how under the Epitech License until expiration of the last-to expire Epitech patent that relates to PEA.</p>
    <p style="text-align: justify;"><i><b>Phase 1 (Australia) Trials</b></i></p>
    <p style="text-align: justify;">The Corporation announced on March 9, 2020, that it received approval from the Ethics Committee of the Alfred Hospital, part of the Alfred Health group of hospitals serving the state of Victoria, Australia, to initiate a Phase 1, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability and pharmacokinetics of single and multiple ascending doses of ultramicronized-PEA in normal healthy volunteers (the "<b>Alfred Hospital Phase 1 Trials</b>"). The principal researcher of this first-in-human safety and tolerability study is the Chief Medical Officer of Nucleus Network, one of Australia's largest and most experienced Phase 1 clinical research organizations.</p>
    <p style="text-align: justify;">The Corporation has completed Phase 1 clinical trials accordance with FDA-approved guidelines.</p>
    <p style="text-align: justify;">On June 22, 2020, the Corporation announced favourable top-line results from the Alfred Hospital Phase 1 Trials, with no significant safety concerns found up to the highest dose tested of 2400 mg/day. The Alfred Hospital Phase 1 Trials were a single-site study and were conducted at the Alfred Hospital with 48 healthy adult men and women enrolled. The trial sequentially tested single ascending doses ranging from 600 mg to 2400 mg tablets and multiple ascending doses ranging from 600 mg to 1200 mg tablets administered twice daily for 7 consecutive days. The single ascending dose subjects also were tested for food effect.</p>
    <p style="text-align: justify;">The study found FSD-201 to be safe and well-tolerated. Mild and self-limiting side effects were reported and were deemed unlikely to be related to the drug being studied. There were no abnormal laboratory findings or electrocardiograms observed during the study and no serious adverse events were reported. No subjects withdrew due to an adverse event and all eligible subjects completed all doses. The pharmacokinetic profile of FSD-201 utilized in the Alfred Hospital Phase 1 Trials is still being analyzed.&#160; The results of the Alfred Hospital Phase 1 Trials are subject to additional audit and verification procedures. See "<i>Risk Factors - Risks Relating to the Development of FSD-201 - Interim, "top-line," and preliminary data from our clinical trials that we announce or publish from time to time may change as more patient data becomes available or as additional analyses are conducted, and as the data are subject to audit and verification procedures that could result in material changes in the final data.</i>"</p>
    <p style="text-align: justify;"><i><b>FSD-201 COVID-19 Trials</b></i></p>
    <p style="text-align: justify;">On June 3, 2020, the Corporation announced that the FDA has given the Corporation permission to submit an investigational new drug application to design a Phase 2(a) clinical trial for the use of FSD-201 to treat suspected or confirmed cases of COVID-19, the disease caused by the SARS-CoV-2 virus (the "<b>FSD-201 COVID-19 Trials</b>" and, together with the Alfred Hospital Phase 1 Trials, the "<b>FSD-201 Trials</b>").</p>
    <p style="text-align: justify;">On August 31, 2020, the Corporation announced that it had submitted an investigational new drug application to the FDA in respect of the FSD-201 COVID-19 Trials.</p>
    <div id="footer_page_20">
        <p style="text-align: center;">- 20 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_21"></a>
    <p style="text-align: justify;">On September 28, 2020, the Corporation announced that the FDA had authorized the initiation of the FSD-201 COVID-19 Trials on 352 patients.</p>
    <p style="text-align: justify;">Severe COVID-19 is characterized by an over-exuberant inflammatory response that may lead to a cytokine storm and ultimately death. The Corporation is focused on developing FSD-201 for its anti-inflammatory properties to down-regulate the over-expressed immune response and mitigate the cytokine storm associated with acute lung injury in hospitalized COVID-19 patients.</p>
    <p style="text-align: justify;">The FSD-201 COVID-19 Trials consist of randomized, controlled, double-blind, U.S.-multicenter study on 352 patients to assess the efficacy and safety of FSD-201 dosed at 600mg or 1200mg twice-daily, as well as potentially higher dosage levels, together with standard of care compared to standard of care alone in hospitalized patients with COVID-19. Eligible patients will present with symptoms consistent with influenza/coronavirus signs (fever, dry cough, malaise, difficulty breathing) and newly documented positive COVID-19 disease.</p>
    <p style="text-align: justify;">The primary objective of the FSD-201 COVID-19 Trials is to determine whether FSD-201 plus standard of care provides a significant improvement in the clinical status of patients (e.g., shorter time to symptom relief). Secondary objectives of the FSD-201 COVID-19 Trials include determining whether FSD-201 plus standard of care demonstrates additional benefit in terms of safety, objective assessments such as length of time to normalization of fever, length of time to improvement of oxygen saturation and length of time to clinical progression, including time to mechanical ventilation or hospitalization, and length of hospital stay. The exploratory endpoint is cytokine clearance as measured by Enzyme Linked Immunosorbent Assay (ELISA). The treatment period of patients in the FSD-201 COVID-19 Trials is expected to be at least 14 days and the primary end point is determined at 28 days. All patients who experience clinical benefit are expected to continue to receive their assigned treatment until study completion.</p>
    <p style="text-align: justify;">The duration and cost of clinical trials can vary significantly depending on multiple factors, including the enrollment rate of volunteers, country in which trials are conducted, and specific trial protocols required.&#160; The process of developing pharmaceutical products and receiving the necessary regulatory approvals for commercialization typically takes several years. Accordingly, no near-term revenues from product sales or services are expected from our ultramicronized-PEA candidate(s). The milestones described above represent customary inflection points for financing by clinical-stage biotech companies. However, there is no assurance that the Corporation will be able to achieve these clinical milestones, nor, if successful in doing so, that the Corporation will be able to access additional financing on terms or timing acceptable to the Corporation.&#160;</p>
    <p style="text-align: justify;">The Corporation's current Phase 2(a) clinical trial is being conducted on hospitalized COVID-19 infected patients.&#160; Additional trials, targeting different medical conditions&#160; may be undertaken depending on FDA approval and available capital, subject to the requirements of the Epitech License and regulatory approvals as required. See also "<i>Risk Factors &#8211; Risks Relating to the Development of FSD-201</i>."</p>
    <p style="text-align: justify;"><i><b>Pharmadrug Share Sale</b></i></p>
    <p style="text-align: justify;">On May 21, 2020, the Corporation announced the sale of 5,000,000 common shares ("<b>Pharmadrug Shares</b>") of Pharmadrug Inc. (formerly Aura Health) ("<b>Pharmadrug</b>") in a privately negotiated transaction at a price of $0.08 per Pharmadrug Share for cash proceeds of $400,000 (the "<b>Pharmadrug Share Sale</b>"). Upon completion of the Pharmadrug Share Sale, the Corporation held 8,562,387 Pharmadrug Shares. The Corporation has since sold all of its Pharmadrug Shares.</p>
    <p style="text-align: justify;"><i><b>June Private Placement</b></i></p>
    <p style="text-align: justify;">On June 4, 2020, the Corporation announced that it entered into definitive agreements with certain institutional investors pertaining to the private placement (the "<b>June Private Placement</b>") by certain placement agents led by the Sales Agent (collectively, the "<b>Placement Agents</b>") of an aggregate of 1,500,000 Class B Shares at a price of $6.75 per Class B Share and warrants (the "<b>June Warrants</b>") to purchase an additional 1,500,000 Class B Shares (the "<b>June Warrant Shares</b>")<b> </b>for aggregate proceeds to the Corporation of approximately $10,125,000 (before deducting fees payable to the Placement Agents and other estimated offering expenses). The June Warrants have a five-year term and an exercise price of $9.65 per June Warrant Share. The June Private Placement was completed on June 8, 2020, generating net proceeds to the Corporation of $9,185,159. In addition, the Corporation granted the Placement Agents an option to arrange for purchases of up to an additional 1,500,000 Class B Shares and June Warrants to purchase an additional 1,500,000 June Warrant Shares on the same terms as the June Private Placement for a period of 30 days following the initial closing of the June Private Placement.</p>
    <div id="footer_page_21">
        <p style="text-align: center;">- 21 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_22"></a>
    <p style="text-align: justify;"><i><b>2020 Equity Distribution Agreement</b></i></p>
    <p style="text-align: justify;">On July 10, 2020, the Corporation entered into an equity distribution agreement with the Sales Agent (the "<b>2020 Distribution Agreement</b>") pursuant to which the Corporation was permitted, at its discretion and from time-to-time during the term of the 2020 Distribution Agreement, sell, through the Sales Agent, Class B Shares of the Corporation for aggregate gross proceeds to the Corporation of up to US$20.0 million. The Corporation has completed all sales under the 2020 Distribution Agreement, and entered into new equity distribution agreement. See "<i>General Development of the Business - Three Year History - 2021 Equity Distribution Agreement</i>"</p>
    <p style="text-align: justify;"><i><b>Approval of Issuance of Share Compensation</b></i></p>
    <p style="text-align: justify;">On July 24, 2020, the Board authorized the issuance of 1,322,927 Class B Shares in the aggregate as compensation to its directors, officers and certain of its employees.</p>
    <p style="text-align: justify;">On January 21, 2021 and February 10, 2021, the Board authorized the issuance of an aggregate of 1,349,765 Class B Shares as annual share-based awards to certain directors, officers and employees of the Corporation.</p>
    <p style="text-align: justify;"><i><b>July Offering</b></i></p>
    <p style="text-align: justify;">On July 31, 2020, the Corporation announced that it entered into definitive agreements with investors pertaining to the public offering (the "<b>July Offering</b>") by the Sales Agent, as sole placement agent, of an aggregate of 2,762,430 Class B Shares (the "<b>July Shares</b>") at a price of US$3.62 per Class B Share and warrants (the "<b>July Warrants</b>" and together with the July Shares, the "<b>July Securities</b>") to purchase an additional 1,381,215 Class B Shares (the "<b>July Warrant Shares</b>")<b> </b>for aggregate proceeds to the Corporation of approximately US$10 million (before deducting fees payable to the A.G.P. and other offering expenses). The July Warrants have a five-year term and an exercise price of US$4.26 per July Warrant Share. The July Offering was completed on August 6, 2020, generating net proceeds to the Corporation of US$9,086,648. In addition, the Corporation granted A.G.P. an option to arrange for purchases of up to an additional US$10 million of July Securities on the same terms as the July Offering for a period of 30 days following the initial closing of the July Offering.</p>
    <p style="text-align: justify;"><i><b>Suspension of FV Pharma Activities</b></i></p>
    <p style="text-align: justify;">On July 30, 2020, the Corporation announced that it has notified Health Canada of the Corporation's decision to forfeit the Cannabis Licenses of its wholly owned subsidiary, FV Pharma, and suspend all activities by FV Pharma within 30 days of the notification date. The Corporation is actively exploring the sale all of FV Pharma's assets, including the sale of the its cannabis production facility in Cobourg, Ontario and/or the adjacent real estate.</p>
    <p style="text-align: justify;"><i><b>October Offering</b></i></p>
    <p style="text-align: justify;">On October 16, 2020, the Corporation announced that it entered into definitive agreements with investors pertaining to the public offering (the "<b>October Offering</b>") by the Sales Agent, as sole placement agent, of an aggregate of 4,318,179 Class B Shares (the "<b>October Shares</b>") at a price of US$2.20 per Class B Share and warrants (the "<b>October Warrants</b>" and together with the October Shares, the "<b>October Securities</b>") to purchase an additional 3,454,543 Class B Shares (the "<b>October Warrant Shares</b>")<b> </b>for aggregate proceeds to the Corporation of approximately US$9.5 million (before deducting fees payable to the A.G.P. and other offering expenses). The October Warrants have a five-year term and an exercise price of US$2.60 per October Warrant Share. The October Offering was completed on October 20, 2020. In addition, the Corporation granted A.G.P. an option to arrange for purchases of up to an additional US$10 million of October Securities on the same terms as the October Offering for a period of 30 days following the initial closing of the October Offering.</p>
    <div id="footer_page_22">
        <p style="text-align: center;">- 22 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_23"></a>
    <p style="text-align: justify;"><i><b>Settlement of Class Action Proceeding</b></i></p>
    <p style="text-align: justify;">On October 29, 2020, the Corporation announced that it has entered into a definitive settlement agreement (the "<b>Settlement Agreement</b>") with respect to the class action litigation commenced by a plaintiff shareholder in the Ontario Superior Court of Justice in February 2019 relating to the build-out of its facility in Cobourg, Ontario (the "<b>Settled Action</b>"). The Settlement Agreement was approved by the Ontario Superior Court of Justice on February 4, 2021. In entering into the Settlement Agreement, the Corporation made no admissions of liability whatsoever. The Settlement Agreement provides for a full and final release of the Corporation, its officers, directors and various other related parties from any and all claims that arose or could have arisen from the claim issued by the plaintiff within the Settled Action. The Settlement Agreement provides for a settlement amount of $5,500,000, of which $4,571,459 has been funded with the proceeds of insurance and the remaining $928,541 has been funded by the Corporation.</p>
    <p style="text-align: justify;"><i><b>Matters to be Addressed at Annual Meeting</b></i></p>
    <p style="text-align: justify;">On March 16, 2021, the Corporation announced that it will hold its annual meeting of shareholders and special meeting of the shareholders on May 14, 2021, at which, in addition to normal course matters, it will address matters contained in a requisition for a special meeting submitted to the Corporation by certain shareholders of the Corporation (the "<b>Requisitioning Shareholders</b>") claiming to hold in excess of 5.1% of the Class B Shares, including Mr. Zeeshan Saeed, the former President of the Corporation and Mr. Anthony Durkacz, who is a director of the Corporation. In addition to the Class B Shares controlled by this group, Mr. Saeed and Mr. Durkacz each hold 24 Class A Shares, with each Class A Share being entitled to 276,660 votes. Dr. Raza Bokhari, the Corporation's Executive Chairman and Chief Executive Officer, holds the remaining 24 Class A Shares. As of the date hereof, the Corporation has 72 Class A Shares and approximately 19,161,602 Class B Shares issued and outstanding. The Requisitioning Shareholders are seeking to reduce the size of the Board to five, and to replace six of the incumbent directors, including Dr. Raza Bokhari, with three directors selected by such shareholders. This annual and special shareholder meeting is in lieu of the June 29, 2021 meeting announced by the corporation on January 22, 2021.</p>
    <p style="text-align: justify;"><i><b>2021 Equity Distribution Agreement</b></i></p>
    <p style="text-align: justify;">The Corporation entered into an Equity Distribution Agreement dated February 11, 2021 (the "<b>2021 Equity Distribution Agreement</b>") with the Sales Agent. Under the 2021 Equity Distribution Agreement the Corporation may, at its discretion and from time-to-time during the term of the 2021 Equity Distribution Agreement, sell, through the Sales Agent, Class B Shares. Sales of Class B Shares will be made through "at-the-market distributions" as defined in the Canadian Securities Administrators' National Instrument 44-102-Shelf Distributions, including sales made directly on the Nasdaq, or any other recognized trading market upon which the Class B Shares are listed or quoted in the United States. No offers or sales of Class B Shares will be made in Canada on the CSE or other trading markets in Canada.</p>
    <p style="text-align: justify;"><i><b>Innovet License Agreement </b></i></p>
    <p style="text-align: justify;">In March 2021, the Corporation entered into a license agreement ("<b>Innovet License Agreement</b>") with Innovet Italia S.R.L. ("<b>Innovet</b>"), under which Innovet granted the Corporation a license to use ultra-micro PEA to develop FDA approved veterinary drugs for the treatment of gastro-intestinal diseases in canines and felines. Under the Innovet License Agreement, the Corporation is required to make payments to Innovet upon the achievement of certain milestones.</p>
    <p style="text-align: center;"><b>DESCRIPTION OF THE BUSINESS</b></p>
    <p style="text-align: justify;"><b>Overview</b></p>
    <p style="text-align: justify;">FSD Pharma Inc. ("FSD" or the "Corporation"), through its wholly-owned subsidiary FSD&#160; BioSciences, Inc. is a pharmaceutical R&amp;D company focused on developing over time multiple applications of its lead compound, ultra-micro PEA (FSD 201) by down-regulating the cytokines to effectuate an anti-inflammatory response.</p>
    <p style="text-align: justify;">The Company filed an IND with the FDA on August 28, 2020 and was approved on September 25, 2020 to initiate a phase 2 clinical trial for the use of FSD201 to treat COVID-19, the disease caused by the SARS-CoV-2 virus. The trial is currently underway and is expected to randomize 352 patients in a controlled, double-blind multicenter study.</p>
    <div id="footer_page_23">
        <p style="text-align: center;">- 23 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_24"></a>
    <p style="text-align: justify; margin-left: 1.4pt; text-indent: -0.7pt;"><i><b>Epitech License</b></i></p>
    <p style="text-align: justify;">As a result of the acquisition of Prismic, the Corporation acquired the Epitech License from Epitech to use, for pharmaceutical purposes, certain patents and other intellectual property rights to PEA. PEA is a naturally occurring substance that is produced within the body in response to inflammation and interacts with endocannabinoid receptors throughout the body, including the central nervous system. The Corporation is currently seeking to advance pharmaceutical development programs centered on PEA that meet one or more selected criteria. All efforts are intended to be founded on a biologic plausibility of an efficacious effect with a high safety profile. See also "<i>General Description of the Business - Three Year History - Epitech Licsence Agreement</i>" for additional information regarding the Epitech License.</p>
    <p style="text-align: justify;"><i><b>FV Pharma and the Facility</b></i></p>
    <p style="text-align: justify;">In light of challenging market conditions among Canadian licensed cannabis producers, the Corporation announced on July 30, 2020 that it has notified Health Canada of the Corporation's decision to forfeit the Cannabis Licenses of its wholly owned subsidiary, FV Pharma, and suspend all activities by FV Pharma within 30 days of the notification date. The Corporation is actively exploring the sale of the business and/or the underlying real estate, including the Facility. The Corporation owns the 70-acre property on which the Facility is located (the "<b>Facility Property</b>"). In March 2020, substantially all of the assets of FV Pharma were classified as being held for sale, and the Corporation is actively exploring a sale of the Facility and/or the Facility Property.</p>
    <p style="text-align: justify;"><i><b>Innovet License Agreement </b></i></p>
    <p style="text-align: justify;">The Innovet License Agreement, permits the Corporation opportunities to research and devleop veterinary drugs for the treatment of gastro-intestinal diseases in dogs and cats. Under the Innovet License Agreement, the Corporation is required to make payments to Innovet upon the achievement of certain milestones. An initial sum of US$500,000 has been paid to Innovet, and a second sum of US$250,000 will be due and payable on the first anniversary of the Innovet License Agreement. An initial sum of US$500,000 has been paid to Innovet, and a second sum of US$250,000 will be due and payable on the first anniversary of the Innovet License Agreement. The Innovet License Agreement provides that the Corporation shall develop products with a view to submitting an Investigational Animal Drug Application with the FDA within 36 months, and shall submit a New Animal Drug Application within 60 months. The Innovet License Agreement also provides for a 14% fee to Innovet in the event that the Corporation is paid for any sub-license to a third-party, and a 5% fee on the net sales of the products created under the Innovet License Agreement.</p>
    <p style="text-align: justify; margin-left: 54pt; text-indent: -54pt;"><b>Products and Sales</b></p>
    <p style="text-align: justify;">The Corporation is focused on pharmaceutical research and development of FDA approved prescription drugs, and is currently focused on developing multiple applications of its lead compound, FSD 201 or ultra-micro PEA over time, by down-regulating the pro-inflammatory cytokines to effectuate an anti-inflammatory response.</p>
    <p style="text-align: justify;">The Corporation filed an IND with the FDA on August 28, 2020 and was approved on September 25, 2020 to initiate a Phase 2 clinical trial for the use of FSD 201 to treat COVID-19, the disease caused by the SARS-CoV-2 virus. The trial is currently underway and is expected to randomize 352 patients in a controlled, double-blind multicenter study.</p>
    <p style="text-align: justify;">Severe COVID-19 is characterized by an over-exuberant inflammatory response that may lead to a cytokine storm and death. The Corporation is focused on developing ultra-micro PEA for its anti-inflammatory properties to avoid the cytokine storm associated with acute lung injury in hospitalized COVID-19 patients. The Corporation is not making any express or implied claim that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus) infection at this time.</p>
    <div id="footer_page_24">
        <p style="text-align: center;">- 24 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_25"></a>
    <p style="text-align: justify; margin-left: 54pt; text-indent: -54pt;"><b>Specialized Knowledge and Personnel </b></p>
    <p style="text-align: justify;">The Board and Executive Officers of the Corporation, led by Dr. Raza Bokhari as Executive Chairman and Chief Executive Officer, have a wide combination of skills, knowledge and experience that are necessary for the ongoing success of the Corporation. Our future growth and success depend on our ability to recruit, retain, manage and motivate our qualified employees. The inability to hire or retain experienced personnel in the pharmaceutical field could adversely affect our ability to execute our business plan and harm our operating results. Due to the specialized scientific and managerial nature of our business, we rely heavily on our ability to attract and retain qualified scientific, technical and managerial personnel. The competition for qualified personnel in the pharmaceutical field is intense. Due to this intense competition, we may be unable to continue to attract and retain qualified personnel necessary for the development of our business or to recruit suitable replacement personnel.</p>
    <p style="text-align: justify; margin-left: 54pt; text-indent: -54pt;"><b>Competitive Conditions</b></p>
    <p style="text-align: justify; margin-left: 1.4pt; text-indent: -0.7pt;">The pharmaceutical industry is highly competitive and subject to rapid change. The industry continues to expand and evolve as an increasing number of competitors and potential competitors enter the market. Many of these competitors and potential competitors have substantially greater financial, technological, managerial and research and development resources and experience than we have. Some of these competitors and potential competitors have more experience than we have in the development of pharmaceutical products, including validation procedures and regulatory matters. In addition, micro-PEA competes with, and our product candidates, if successfully developed, will compete with, product offerings from large and well-established companies that have greater marketing and sales experience and capabilities than we or our collaboration partners have. Other companies with greater resources than us may announce similar plans in the future. In addition, there are non-FDA approved competitive products and drugs also available in the market.</p>
    <p style="text-align: justify; margin-left: 54pt; text-indent: -54pt;"><b>Environmental Matters</b></p>
    <p style="text-align: justify;">The Corporation expects the financial and operational effects of environmental protection requirements on its capital expenditures, profit and competitive position in the current and future financial years to be minimal. For further information, see "<i>Risk Factors</i>" in this AIF.</p>
    <p style="text-align: justify; margin-left: 54pt; text-indent: -54pt;"><b>Employees</b></p>
    <p style="text-align: justify;">As at December 31, 2020, the Corporation directly employed 9 full-time employees and 11 consultants. The Corporation believes its relationship with its employees, consultants and contractors is good. None of the Corporation's employees are represented by a labour union or subject to a collective bargaining agreement nor are any of Prismic's employees.</p>
    <p style="text-align: justify; margin-left: 54pt; text-indent: -54pt;"><b>FSD Biosciences Inc., &amp; Industry Overview</b></p>
    <p style="text-align: justify;">Through the Prismic transaction, the Corporation acquired an exclusive, worldwide license (excluding Italy and Spain) to exploit, for certain specified pharmaceutical purposes, patents and other intellectual property rights to ultramicronized-PEA owned by Epitech. See "<i>General Description of Business - Three Year History - Epitech License Agreement"</i> above. PEA is a naturally occurring substance that is produced within the body in response to inflammation and interacts with endocannabinoid receptors throughout the body, including the central nervous system. FSD Pharma is currently seeking to advance pharmaceutical development programs centered on ultramicronized-PEA that meet one or more selected criteria. All efforts are intended to be founded on a biologic plausibility of an efficacious effect with a high safety profile.</p>
    <p style="text-align: justify;">FSD BioScience currently has 5 patients enrolled at its 5 clinical trial sites, with 348 patients remaining to be enrolled. FSD BioScience will be initiating additional clinical trial sites in Argentina, Peru, Colombia and Chile.</p>
    <p style="text-align: justify;"><b>Regulatory Environment</b></p>
    <p style="text-align: justify;">The Corporation is currently focused on obtaining regulatory approvals in the United States for the drug candidates it is developing through FSD Biosciences. In the future, the Corporation may consider seeking approvals for these drug candidates in Canada and elsewhere. The following is a summary of the FDA investigational new drug approval process that the Corporation is undertaking with ultramicronized-PEA in the United States. Assuming the Corporation is successful in obtaining FDA approvals pursuant to the process set out below, it may decide to seek comparable approvals in Canada and elsewhere, which would be subject to different and additional regulatory requirements.</p>
    <div id="footer_page_25">
        <p style="text-align: center;">- 25 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_26"></a>
    <p style="text-align: justify;">The Corporation will be subject to extensive regulations while it focuses on gaining FDA approvals for treatments it is developing with ultramicronized-PEA. The FDC Act and other federal and state statutes and regulations, govern, among other things, the research, development, testing, manufacture, storage, recordkeeping, approval, labelling, promotion and marketing, distribution, post-approval monitoring and reporting, sampling, and import and export of pharmaceutical product candidates. Failure to comply with applicable U.S. requirements may subject the Corporation to a variety of administrative or judicial sanctions, such as FDA refusals, warning letters, product candidate recalls, product candidate seizures, total or partial suspension of production or distribution, injunctions, fines, civil penalties and criminal prosecution.</p>
    <p style="text-align: justify;">Pharmaceutical product candidate development in the United States typically involves pre-clinical laboratory and animal tests, the submission to the FDA of an investigational new drug, which must be approved before clinical testing is allowed to commence, and adequate, well-controlled clinical trials to establish the safety and effectiveness of the drug for each application for which FDA approval is sought. The satisfaction of FDA pre-market approval requirements typically takes many years. The actual time required may vary substantially based upon the type, complexity and novelty of the product candidate or the diseases a product candidate targets.</p>
    <p style="text-align: justify;">Pre-clinical tests generally include laboratory evaluation of product candidate chemistry, formulation and toxicity, as well as animal trials to assess the characteristics and potential safety and efficacy of the product candidate. The conduct of the pre-clinical tests must comply with federal regulations and requirements, including good laboratory practices. The results of pre-clinical testing are submitted to the FDA as part of an investigational new drug along with other information, including information about product candidate chemistry, manufacturing and controls, and a proposed clinical trial protocol. Long term pre-clinical tests, such as animal tests of reproductive toxicity and carcinogenicity, may continue after the investigational new drug is submitted.</p>
    <p style="text-align: justify;">A 30-day waiting period after the submission of each investigational new drug is required before commencing clinical testing in humans. If the FDA has not imposed a clinical hold on the investigational new drug or otherwise commented or questioned the investigational new drug within this 30-day period, the clinical trial proposed in the investigational new drug may begin. Clinical trials involve the administration of the investigational new drug to healthy volunteers or patients under the supervision of a qualified investigator. Clinical trials must be conducted: (i) in compliance with federal regulations, (ii) in compliance with Good Clinical Practice, an international standard meant to protect the rights and health of patients and to define the roles of clinical trial sponsors, administrators and monitors, and (iii) under protocols detailing the objectives of the trial, the parameters to be used in monitoring safety and the effectiveness criteria to be evaluated. Each protocol involving testing on U.S. patients and subsequent protocol amendments must be submitted to the FDA as part of the investigational new drug.</p>
    <p style="text-align: justify;">The FDA may order the temporary, or permanent, discontinuation of a clinical trial at any time or impose other sanctions if it believes that the clinical trial either is not being conducted in accordance with FDA requirements or presents an unacceptable risk to the clinical trial patients. The trial protocol and informed consent information for patients in clinical trials must also be submitted to an institutional review board for approval. An institutional review board may also require the clinical trial at the site to be halted, either temporarily or permanently, for failure to comply with the institutional review board's requirements or may impose other conditions.</p>
    <p style="text-align: justify;">If the FSD-201 Trials are successful, the Corporation may pursue additional trials as required and may ultimately pursue a new drug application, which would involve applying to the FDA for the approvals required to market the Corporation's synthetic treatments in the United States. Should the FDA approve the Corporation's new drug application application, the Corporation may seek similar approvals in Canada and elsewhere. There is no assurance that the Corporation will be successful in receiving the required approvals, and the clinical trials are subject to numerous risks.</p>
    <div id="footer_page_26">
        <p style="text-align: center;">- 26 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_27"></a>
    <p style="text-align: justify;"><b>Reorganizations</b></p>
    <p style="text-align: justify;">Other than in connection with the Amalgamation, the Corporation has not completed any material reorganization within the three most recently completed financial years.</p>
    <p style="text-align: center;"><b>RISK FACTORS</b></p>
    <p style="text-align: justify;">An investment in securities of the Corporation should only be made by persons who can afford a significant or total loss of their investment.</p>
    <p style="text-align: justify;">We are exposed to a number of risks through the pursuit of our business objectives. The following risks and uncertainties identified below are those we believe may, individually or in combination with other risks and uncertainties, have a material impact on our business, but these are not the only risks and uncertainties we face. Additional risks and uncertainties not presently known to us, or risks that we currently deem immaterial, may also impair our business operations. If any of the following risks, or any other risks and uncertainties that we have not yet identified or that we currently consider not to be material, actually occur or become material risks, our business, financial condition, results of operations and cash flows, and consequently the price of the Class B Shares, could be materially and adversely affected. The risks discussed below also include Forward-Looking Statements and our actual results may differ substantially from those discussed in these Forward-Looking Statements. See "<i>Forward-Looking Statements</i>" in this AIF.</p>
    <p style="text-align: justify;"><b>Risks Relating to the Development of FSD-201</b></p>
    <p style="text-align: justify;"><i>Drug development is a highly uncertain undertaking and involves a substantial degree of risk. We have only one pharmaceutical product candidate, FSD-201, and no pharmaceutical product sales, which, together with our limited operating history, makes it difficult to evaluate our business and assess our future viability.</i></p>
    <p style="text-align: justify;">Pharmaceutical and biopharmaceutical product development is a highly speculative undertaking and involves a substantial degree of risk. We are a clinical-stage biopharmaceutical corporation with a limited operating history. We have no pharmaceutical products approved for commercial sale and have not generated any revenue from pharmaceutical product sales. We are currently focused on developing our only product candidate, FSD-201, which is in early stages of development and will require substantial additional development time, including extensive resources and clinical testing before it would be able to receive regulatory approvals and begin generating revenue from product sales.</p>
    <p style="text-align: justify;">We continue to incur significant research and development and other expenses related to ongoing operations and expect to incur losses for the foreseeable future. We anticipate these losses will increase and that we will not generate any revenue from product sales until after we have successfully completed clinical development and received regulatory approval for the commercial sale of FSD-201.</p>
    <p style="text-align: justify;">Because of the numerous risks and uncertainties associated with drug development, we are unable to predict the timing or amount of our expenses, or when we will be able to generate any meaningful revenue or achieve or maintain profitability, if ever. In addition, our expenses could increase beyond our current expectations if we are required by the FDA or comparable foreign regulatory authorities to perform nonclinical or preclinical studies or clinical trials in addition to those that we currently anticipate, or if there are any delays in any of our or our future collaborators' clinical trials. Even if FSD-201 is approved for commercial sale, we anticipate incurring significant costs associated with commercializing FSD-201 and ongoing compliance efforts.</p>
    <p style="text-align: justify;">We may never be able to develop or commercialize FSD-201 or achieve profitability. Revenue from the sale of FSD-201, if regulatory approval is obtained, will be dependent, in part, upon the size of the markets in the territories for which we obtain regulatory approval, the accepted price for the product, the ability to obtain reimbursement at any price and whether we own the commercial rights for that territory, as well as the efficiency and availability of any comparable products. Our growth strategy depends on our ability to generate revenue. In addition, if the number of addressable patients is less than anticipated, the indication approved by regulatory authorities is narrower than expected, or the reasonably accepted population for treatment is narrowed by competition, physician choice or treatment guidelines, we may not generate significant revenue from sales of FSD-201, even if approved. Even if we are able to generate revenue from the sale of FSD-201, we may not become profitable and may need to obtain additional funding to continue operations. Even if we achieve profitability in the future, we may not be able to sustain profitability in subsequent periods. Our failure to achieve sustained profitability would depress our value and could impair our ability to raise capital, expand our business, diversify our research and development pipeline, market FSD-201 and any other product candidates that we may identify and pursue or continue our operations.</p>
    <div id="footer_page_27">
        <p style="text-align: center;">- 27 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_28"></a>
    <p style="text-align: justify;"><i>FSD-201 trials are speculative and may not have conclusive or timely results, which may adversely affect the Corporation's business, financial condition and/or results of operations.</i></p>
    <p style="text-align: justify;">The Corporation's FSD-201 drug trials are still in early phases and the effectiveness of its products is not yet known. Therefore, the Corporation is subject to a number of financial risks and is unable to predict the timing or amount of expenses that may be required for ongoing trials, including further applications to the FDA. The Corporation may not have the ability to cure, contain or eliminate the COVID-19 infection in its patients at this time, or at all.</p>
    <p style="text-align: justify;"><i>FSD-201 may not receive regulatory approval, which is necessary before it can be commercialized.</i></p>
    <p style="text-align: justify;">Before obtaining marketing approval from regulatory authorities for the sale of FSD-201, we must conduct extensive clinical trials to demonstrate its safety and efficacy in humans. We cannot be certain that the FSD-201 Trials will be conducted as planned or completed on schedule, if at all. Our inability to successfully complete clinical development could result in additional costs to us and negatively impact our ability to generate revenue. Our future success is dependent on our ability to successfully develop, obtain regulatory approval for, and then successfully commercialize and market FSD-201. We may never be able to develop or successfully commercialize FSD-201.</p>
    <p style="text-align: justify;">FSD-201 requires significant additional development; management of clinical and manufacturing activities; and regulatory approval. In addition, we will need to obtain adequate manufacturing supply; build a commercial organization; commence marketing efforts; and obtain reimbursement, or contract for such services, before we generate any significant revenue from commercial product sales, if ever. We cannot be certain that FSD-201 will be successful in clinical trials or receive regulatory approval. Further, FSD-201 may not receive regulatory approval even if it is successful in clinical trials. If we do not receive regulatory approvals for FSD-201 or some other future product candidate that we may identify, we and our subsidiaries may not be able to continue operations, which may result in us out-licensing the technology or pursuing an alternative strategy.</p>
    <p style="text-align: justify;"><i>We rely solely on the Epitech License to use for pharmaceutical purposes certain patents and other intellectual property rights to ultramicronized-PEA that are material to our business and if the Epitech License were to be terminated or if other rights that may be necessary or we deem advisable for commercializing FSD-201 cannot be obtained, it would limit our ability to market FSD-201, which would have a material adverse effect on our business, operating results and financial condition.</i></p>
    <p style="text-align: justify;">Our principal asset is the Epitech License, which provides us with an exclusive, multi-jurisdictional license to use certain patents and other intellectual property rights to micro-PEA that are owned by Epitech.&#160; Under the Epitech License, we are obligated to use commercially reasonable efforts to develop FSD-201, with a view to filing a new drug application with the FDA as soon as practicable. We are also obligated to make milestone payments and royalties to Epitech, which may limit our future profitability and our ability to enter into marketing partnership agreements. If we materially breach any of the terms of the Epitech License (and fail to cure such breach with the specified time, to the extent a cure period is available for such breach), Epitech could terminate the agreement. If we were to lose or otherwise be unable to maintain the Epitech License on acceptable terms, or find that it is necessary or appropriate to secure new licenses from other third parties, we would not be able to market FSD-201, our only product candidate, and our current business model and plan would be impaired, which would have a material adverse effect on our business, operating results and financial condition. See also "<i>General Description of the Business - Three Year History - Epitech License Agreement</i>".</p>
    <div id="footer_page_28">
        <p style="text-align: center;">- 28 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_29"></a>
    <p style="text-align: justify;"><i>Patent terms may be inadequate to protect our competitive position on FSD-201 for an adequate amount of time.</i></p>
    <p style="text-align: justify;">Patents have a limited lifespan, and the principal patents relating to our use of ultramicronized-PEA expire in approximately nine years. In the United States, if all maintenance fees are timely paid, the natural expiration of a patent is generally 20 years from its earliest U.S. non-provisional or international patent application filing date. Various extensions may be available, but the life of a patent, and the protection it affords, is limited. Even if patents covering FSD-201 are extended, once the patent life has expired, we may be open to competition from competitive products, including generics or biosimilars. As a result, our owned and licensed patent portfolio may not provide us with sufficient rights to exclude others from commercializing products similar or identical FSD-201.</p>
    <p style="text-align: justify;"><i>Even if the FSD-201 Trials are successful and FSD-201 receives marketing approval, which may occur much later than anticipated or not at all, FSD-201 may fail to achieve the degree of market acceptance by physicians, patients, healthcare payors, and others in the medical community necessary for commercial success, including, due to the possibility that alternative, superior treatments for COVID-19 may be available prior to the approval and commercialization of FSD-201 for the treatment of COVID-19 or the COVID-19 pandemic will subside and no longer constitute a global health crisis.</i></p>
    <p style="text-align: justify;">The commercial success of FSD-201, including, specifically, of FSD-201 as a treatment for COVID-19, will depend upon their degree of market acceptance by physicians, patients, third-party payors, and others in the medical community. For example, even if the FSD-201 Trials are successful and FSD-201 receives marketing approval, which may occur much later than anticipated or not at all, FSD-201 may nonetheless fail to gain sufficient market acceptance by physicians, patients, healthcare payors, and others in the medical community. The degree of market acceptance of FSD-201 to treat COVID-19, if approved for commercial sale, will depend on a number of factors, including:</p>
    <ul style="padding-left: 0pt;" type="disc">
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the availability of alternative, superior treatments for COVID-19 prior to the approval and commercialization of FSD-201 for the treatment of COVID-19, including the mass production of vaccines that significantly limit and/or ultimately eliminate the market for FSD-201 by drastically reducing COVID-19 infections in the general population;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the COVID-19 pandemic could subside and no longer constitute a global health crisis;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the efficacy and safety of FSD-201;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the ability to offer FSD-201 for sale at competitive prices;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the ability to manufacture FSD-201 in sufficient quantities and to offer appropriate patient access programs, such as co-pay assistance;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>convenience and ease of dosing and administration compared to alternative treatments;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the clinical indications for which FSD-201 is approved by FDA, if it approved at all, or comparable regulatory agencies;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>product labeling or product insert requirements of the FDA or other comparable regulatory authorities, including any limitations, contraindications or warnings contained in a product's approved labeling;</p>
        </li>
    </ul>
    <div id="footer_page_29">
        <p style="text-align: center;">- 29 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_30"></a>
    <ul style="padding-left: 0pt;" type="disc">
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>restrictions on how FSD-201 is distributed;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>publicity concerning FSD-201 or competing products and treatments;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the strength of marketing and distribution support;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>favorable third-party coverage and sufficient reimbursement; and</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the prevalence and severity of any side effects or adverse effects.</p>
        </li>
    </ul>
    <p style="text-align: justify;">Sales of medical products also depend on the willingness of physicians to prescribe the treatment, which is likely to be based on a determination by these physicians that the products are safe, therapeutically effective and cost effective. In addition, the inclusion or exclusion of products from treatment guidelines established by various physician groups and the viewpoints of influential physicians can affect the willingness of other physicians to prescribe the treatment. We cannot predict whether physicians, physicians' organizations, hospitals, other healthcare providers, government agencies or private insurers will determine that FSD-201 is safe, therapeutically effective and cost effective as compared with competing treatments. If FSD-201 does not achieve an adequate level of acceptance, we may not generate significant product revenue, and we may not become profitable.</p>
    <p style="text-align: justify;"><i>We face significant competition in an environment of rapid technological and scientific change, and there is a possibility that our competitors may achieve regulatory approval for an effective COVID-19 treatment before us or develop therapies that are safer, more advanced or more effective than ours, which may negatively impact our ability to successfully market or commercialize FSD-201 and ultimately harm our financial condition.</i></p>
    <p style="text-align: justify;">The development and commercialization of new drug products is highly competitive. We face competition with respect to FSD-201 from major pharmaceutical companies, specialty pharmaceutical companies, and biotechnology companies worldwide. Potential competitors also include academic institutions, government agencies, and other public and private research organizations that conduct research, seek patent protection, and establish collaborative arrangements for research, development, manufacturing, and commercialization.</p>
    <p style="text-align: justify;">Significant competition exists in the treatment of COVID-19. We will need to compete with all current and future treatments within the indications where our development is focused. As of the date of this AIF, there are several viable vaccines being mass produced and deployed globally. Additionally, there are a significant number of COVID-19 antibody treatments in various stages of development, including certain monoclonal antibody treatments made to treat and possibly prevent COVID-19 that are currently in Phase 3 trials. Any current or future treatments that are successfully developed and fully-approved for marketing could represent significant competition for FSD-201 as a treatment of COVID-19 and/or eliminate the market for FSD-201 as such a treatment altogether.</p>
    <p style="text-align: justify;">Most of our current or potential competitors, either alone or with their strategic partners, have significantly greater financial resources and expertise in research and development, manufacturing, preclinical testing, conducting clinical trials, obtaining regulatory approvals, and marketing approved products than we do.</p>
    <p style="text-align: justify;">In addition, we could face litigation or other proceedings with respect to the scope, ownership, validity and/or enforceability of FSD-201 relating to our competitors' products and our competitors may allege that FSD-201 infringes, misappropriates or otherwise violates their intellectual property. The availability of our competitors' products could limit the demand, and the price we are able to charge, for any products that we may develop and commercialize.</p>
    <p style="text-align: justify;"><i>If we are unable to obtain regulatory approval in one or more jurisdictions for FSD-201, our business will be substantially harmed.</i></p>
    <p style="text-align: justify;">We cannot commercialize FSD-201 until the appropriate regulatory authorities have reviewed and approved the it. Approval by the FDA and comparable other regulatory authorities is a lengthy and&#160; unpredictable process, and depends upon numerous factors, including substantial discretion of the regulatory authorities. Approval policies, regulations, or the type and amount of nonclinical or clinical data necessary to gain approval may change during the course of FSD-201's development and may vary among jurisdictions, which may cause delays in the approval or the decision not to approve an application. We cannot be certain that FSD-201 will receive regulatory approval or be successfully commercialized even if we receive regulatory approval.</p>
    <div id="footer_page_30">
        <p style="text-align: center;">- 30 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_31"></a>
    <p style="text-align: justify;">Obtaining marketing approval is an extensive, lengthy, expensive and inherently uncertain process, and regulatory authorities may delay, limit or deny approval of FSD-201 for many reasons, including but not limited to:</p>
    <ul style="padding-left: 0pt;" type="disc">
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the inability to demonstrate to the satisfaction of the FDA or comparable other regulatory authorities that FSD-201 is safe and effective as a treatment for our targeted indications;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the FDA or comparable other regulatory authorities may disagree with the design, endpoints or implementation of our clinical trials;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the population studied in the clinical program may not be sufficiently broad or representative to assure safety or efficacy in the full population for which we seek approval;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the FDA or comparable other regulatory authorities may require additional preclinical studies or clinical trials beyond those that we currently anticipate;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the FDA or comparable other regulatory authorities may disagree with our interpretation of data from nonclinical studies or clinical trials;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the data collected from clinical trials of FSD-201 may not be sufficient to support the submission of an new drug application, biologics license application, or other submission for regulatory approval in the United States or elsewhere;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>we may be unable to demonstrate to the FDA or comparable other regulatory authorities that FSD-201's risk-benefit ratio for its proposed indication is acceptable;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the FDA or comparable other regulatory authorities may identify deficiencies in the manufacturing processes, test procedures and specifications, or facilities of third-party manufacturers with which we contract for clinical and commercial supplies; and</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the approval policies or regulations of the FDA or comparable other regulatory authorities may change in a manner that renders the clinical trial design or data insufficient for approval.</p>
        </li>
    </ul>
    <p style="text-align: justify;">The lengthy approval process, as well as the unpredictability of the results of clinical trials and evolving regulatory requirements, may result in our failure to obtain regulatory approval to market FSD-201, which would significantly harm our business, results of operations, financial condition and prospects.</p>
    <p style="text-align: justify;"><i>We may encounter substantial delays in the FSD-201 Trials or may not be able to conduct or complete clinical trials on the expected timelines, if at all.</i></p>
    <p style="text-align: justify;">Clinical testing is expensive, time consuming, and subject to significant uncertainty. We cannot guarantee that our ongoing and planned FSD-201 Trials will be conducted as planned or completed on schedule, if at all. Moreover, even if these trials are initiated or conducted on a timely basis, issues may arise that could result in the suspension or termination of such clinical trials. A failure of one or more clinical trials can occur at any stage of testing, and the FSD-201 Trials may not be successful. Events that may prevent successful or timely initiation or completion of clinical trials include:</p>
    <ul style="padding-left: 0pt;" type="disc">
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>inability to obtain the additional financing required to conduct the clinical trials;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>delays in reaching a consensus with regulatory agencies as to the design or implementation of our clinical studies;</p>
        </li>
    </ul>
    <div id="footer_page_31">
        <p style="text-align: center;">- 31 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_32"></a>
    <ul style="padding-left: 0pt;" type="disc">
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>inability to generate sufficient preclinical, toxicology, or other in vivo or in vitro data to support the initiation or continuation of clinical trials;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>delays in confirming target engagement, patient selection or other relevant biomarkers to be utilized in preclinical and clinical product candidate development;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>delays in reaching agreement on acceptable terms with prospective contract research organizations ("<b>CROs</b>"), and clinical trial sites, the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and clinical trial sites;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>delays in identifying, recruiting and training suitable clinical investigators;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>delays in obtaining required Institutional Review Board approval at each clinical trial site;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>imposition of a temporary or permanent clinical hold by regulatory agencies for a number of reasons, including after review of a new drug application or amendment, clinical trial application or amendment, or equivalent application or amendment, as a result of a new safety finding that presents unreasonable risk to clinical trial participants;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>a negative finding from an inspection of the FSD-201 Trials operations or study sites;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>developments in trials for other product candidates with the same targets or related modalities as our product candidates conducted by competitors that raise regulatory or safety concerns about risk to patients of the treatment;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>if the FDA or other regulatory authorities find that the investigational protocol or plan&#160; is clearly deficient to meet stated objectives;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>difficulties in securing access to materials for the comparator arm of certain of the FSD-201 Trials;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>delays in identifying, recruiting and enrolling suitable patients to participate in the FSD-201 Trials, and delays caused by patients withdrawing from the FSD-201 Trials or failing to return for post-treatment follow-up;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>difficulty collaborating with patient groups and investigators;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>failure by CROs, other third parties, or us to adhere to clinical trial requirements;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>failure to perform in accordance with the FDA's or any other regulatory authority's current good clinical practice, requirements, or regulatory guidelines in other countries;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>occurrence of adverse events associated with the product candidate that are viewed to outweigh its potential benefits;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>changes in regulatory requirements and guidance that require amending or submitting new clinical protocols;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>changes in the standard of care on which a clinical development plan was based, which may require new or additional trials;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the cost of clinical trials of any product candidates that we may identify and pursue being greater than we anticipate;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>clinical trials of any product candidates that we may identify and pursue producing negative or inconclusive results, which may result in our deciding, or regulators requiring us, to conduct additional clinical trials or abandon product development programs;</p>
        </li>
    </ul>
    <div id="footer_page_32">
        <p style="text-align: center;">- 32 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_33"></a>
    <ul style="padding-left: 0pt;" type="disc">
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>transfer of manufacturing processes to larger-scale facilities operated by a CMO, or by us, and delays or failure by our CMOs or us to make any necessary changes to such manufacturing process; and</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>delays in manufacturing, testing, releasing, validating, or importing/exporting sufficient stable quantities of product candidates that we may identify for use in clinical trials or the inability to do any of the foregoing.</p>
        </li>
    </ul>
    <p style="text-align: justify;">Any inability to successfully initiate or complete clinical trials could result in additional costs to us or impair our ability to generate revenue. In addition, if we make manufacturing or formulation changes to FSD-201, we may be required to or we may elect to conduct additional nonclinical studies or clinical trials to bridge data obtained from the modified product candidate to data obtained from nonclinical and clinical research conducted using earlier versions. Clinical trial delays could also shorten any periods during which FSD-201 has patent protection and may allow our competitors to bring products to market before we do, which could impair our ability to successfully commercialize product candidates and may harm our business, results of operations, financial condition and prospects.</p>
    <p style="text-align: justify;">We could also encounter delays if a clinical trial is suspended or terminated by us or by the data safety monitoring board or similar regulatory authority. Such authorities may suspend or terminate a clinical trial due to a number of factors, including failure to conduct the clinical trial in accordance with regulatory requirements or our clinical protocols, inspection of the clinical trial operations or trial site by the FDA or other regulatory authorities resulting in the imposition of a clinical hold, unforeseen safety issues or adverse side effects, failure to demonstrate a benefit from using a product candidate, changes in governmental regulations or administrative actions or lack of adequate funding to continue the clinical trial.</p>
    <p style="text-align: justify;">Moreover, principal investigators for our clinical trials may serve as scientific advisors or consultants to us from time to time and receive compensation in connection with such services. Under certain circumstances, we may be required to report some of these relationships to the FDA or comparable other regulatory authorities. The FDA or comparable other regulatory authority may conclude that a financial relationship between us and a principal investigator has created a conflict of interest or otherwise affected interpretation of the study. The FDA or comparable other regulatory authority may therefore question the integrity of the data generated at the applicable clinical trial site and the utility of the clinical trial itself may be jeopardized. This could result in a delay in approval, or rejection, of our marketing applications by the FDA or comparable other regulatory authority, as the case may be, and may ultimately lead to the denial of marketing approval of FSD-201.</p>
    <p style="text-align: justify;">Delays in the initiation, conduct or completion of any clinical trial of FSD-201 will increase our costs, slow down the product candidate development and approval process and delay or potentially jeopardize our ability to commence product sales and generate revenue. In addition, many of the factors that cause, or lead to, a delay in the commencement or completion of clinical trials may also ultimately lead to the denial of regulatory approval of FSD-201. Any of these events could have a material adverse effect on our business, results of operations, financial condition and prospects.</p>
    <p style="text-align: justify;"><i>The FSD-201 Trials may fail to demonstrate substantial evidence of the safety and/or effectiveness of FSD-201, which would prevent, delay or limit the scope of regulatory approval and commercialization.</i></p>
    <p style="text-align: justify;">Before obtaining regulatory approvals for the commercial sale of FSD-201, we must demonstrate through lengthy, complex and expensive nonclinical studies, preclinical studies and clinical trials that FSD-201 is both safe and effective for use in each target indication. FSD-201 must demonstrate an adequate risk versus benefit profile in its intended patient population and for its intended use.</p>
    <p style="text-align: justify;">Clinical testing is expensive and can take many months or years to complete, and its outcome is inherently uncertain. Failure may occur at any time during the clinical development process. Most product candidates that begin clinical trials are never approved by regulatory authorities for commercialization.</p>
    <div id="footer_page_33">
        <p style="text-align: center;">- 33 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_34"></a><font style="font-size: 13.3333px; text-align: justify;"><br></font>
    <p style="text-align: justify;"><font style="font-size: 13.3333px;">We cannot be certain that the FSD-201 Trials will be successful. Additionally, any safety concerns observed in the FSD-201 Trials in our targeted indications could limit the prospects for regulatory approval of FSD-201, which could have a material adverse effect on our business, results of operations, financial condition and prospects. In addition, even if such clinical trials are successfully completed, we cannot guarantee that the FDA or comparable other regulatory authorities will interpret the results as we do, and more trials could be required before we submit FSD-201 for approval. Moreover, results acceptable to support approval in one jurisdiction may be deemed inadequate by another regulatory authority to support regulatory approval in that other jurisdiction. To the extent that the results of the trials are not satisfactory to the FDA or comparable other regulatory authorities for support&#160; of a marketing application, we may be required to expend significant resources, which may not be available to us, to conduct additional trials in support of potential approval of FSD-201. Even if regulatory approval is secured for a product candidate, the terms of such approval may limit the scope and use of FSD-201, which may also limit its commercial potential.</font></p>
    <p style="text-align: justify;"><i>Results from future clinical research may draw opposing or negative conclusions regarding the potential of FSD-201 as a treatment for COVID-19, which could have a material adverse effect on our development plans, business, financial condition and results of operations.</i></p>
    <p style="text-align: justify;">Our rationale for pursuing development of FSD-201 for COVID-19 is derived from data from various studies and clinical trials of the anti-inflammatory potential of PEA conducted over the last 50 years (the "<b>Historical PEA Studies</b>"). However, we could have misinterpreted or performed a flawed analysis of such data. Factors that could have affected our interpretation and analysis of the Historical PEA Studies include:</p>
    <ul style="padding-left: 0pt;" type="disc">
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>none of the Historical PEA Studies directly evaluate the safety or efficacy profile of PEA with respect to COVID-19;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the Historical PEA Studies evaluated variable formulations, dosages, and patient populations; and</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>some of the Historical PEA Studies were conducted decades ago across several international jurisdictions and, as such, may have used clinical trial procedures and statistical analysis methods that differ significantly from currently accepted best practices.</p>
        </li>
    </ul>
    <p style="text-align: justify;">Given such factors, among others, investors should not place undue reliance on the Historical PEA Studies. Future research studies and clinical trials may draw opposing or negative conclusions regarding the potential of FSD-201 as a treatment for COVID-19, which could have a material adverse effect on our development plans business, financial condition and results of operations.</p>
    <p style="text-align: justify;"><i>Results of earlier studies or clinical trials may not be predictive of future clinical trial results, and initial studies or clinical trials may not establish an adequate safety or efficacy profile for FSD-201 to justify proceeding to advanced clinical trials or an application for regulatory approval.</i></p>
    <p style="text-align: justify;">The results of nonclinical and preclinical studies and clinical trials, including the Historical PEA Studies, may not be predictive of the results of later-stage clinical trials, and interim results of a clinical trial do not necessarily predict final results. The results of preclinical studies and clinical trials in one set of patients or disease indications, or from preclinical studies or clinical trials that we did not lead, may not be predictive of those obtained in another. In some instances, there can be significant variability in safety or efficacy results between different clinical trials of the same product candidate due to numerous factors, including changes in trial procedures set forth in protocols, differences in the size and type of the patient populations, changes in and adherence to the dosing regimen and other clinical trial protocols and the rate of dropout among clinical trial participants. In addition, preclinical and clinical data are often susceptible to various interpretations and analyses, and many companies that have believed their product candidates performed satisfactorily in preclinical studies and clinical trials have nonetheless failed to obtain marketing approval. Product candidates in later stages of clinical trials may fail to show the desired safety and efficacy profile despite having progressed through nonclinical studies and initial clinical trials. A number of companies in the pharmaceutical and biopharmaceutical industry have suffered significant setbacks in advanced clinical trials due to lack of efficacy or adverse safety profiles, notwithstanding promising results in earlier studies, and we cannot be certain that we will not face similar setbacks. Even if early-stage clinical trials are successful, we may need to conduct additional clinical trials of FSD-201 in additional patient populations or under different treatment conditions before we are able to seek approvals from the FDA and regulatory authorities outside the United States to market and sell this product candidate. Our failure to obtain marketing approval for FSD-201 would substantially harm our business, results of operations, financial condition and prospects.</p>
    <div id="footer_page_34">
        <p style="text-align: center;">- 34 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_35"></a>
    <p style="text-align: justify;"><i>Interim, "top-line," and preliminary data from our clinical trials that we announce or publish from time to time may change as more patient data becomes available or as additional analyses are conducted, and as the data are subject to audit and verification procedures that could result in material changes in the final data.</i></p>
    <p style="text-align: justify;">From time to time, we may publish interim, "top-line," or preliminary data from our clinical studies. For example, on June 22, 2020, we published "top-line" results from our Phase 1 randomized, double-blind, placebo-controlled study of FSD-201.&#160; Interim data from clinical trials that we may complete are subject to the risk that one or more of the clinical outcomes may materially change as patient enrollment continues and more patient data become available. Preliminary or "top-line" data also remain subject to audit and verification procedures that may result in the final data being materially different from the preliminary data we previously published. As a result, interim and preliminary data should be viewed with caution until the final data are available. Material adverse changes between preliminary, "top-line," or interim data and final data could significantly harm our business prospects. See "<i>General Description of the Business - Three Year History - Phase 1 (Australia) Trials</i>".</p>
    <p style="text-align: justify;"><i>Issued patents covering FSD-201 could be found invalid or unenforceable if challenged in court.</i></p>
    <p style="text-align: justify;">If we or one of our licensing partners initiated legal proceedings against a third party to enforce a patent covering FSD-201, the defendant could counterclaim that the patent covering FSD-201 is invalid and/or unenforceable. In patent litigation in the United States, defendant counterclaims alleging invalidity and/or unenforceability are commonplace. Grounds for a validity challenge could be an alleged failure to meet any of several statutory requirements, including patent eligibility, novelty, non-obviousness, written description or enablement. Grounds for an unenforceability assertion could be an allegation that someone connected with prosecution of the patent withheld relevant information from the U.S. Patent and Trademark Office, or made a misleading statement, during prosecution. Third parties may also raise similar claims before administrative bodies in the United States or abroad, even outside the context of litigation. Such mechanisms include re-examination, post grant review, and equivalent proceedings in other jurisdictions (e.g., opposition proceedings). Such proceedings could result in revocation or amendment to our patents in such a way that they no longer cover FSD-201. The outcome following legal assertions of invalidity and unenforceability is unpredictable. With respect to the validity question, for example, we cannot be certain that there is no invalidating prior art, of which we and the patent examiner were unaware during prosecution. If a defendant were to prevail on a legal assertion of invalidity and/or unenforceability, we would lose at least part, and perhaps all, of the patent protection on FSD-201. Such a loss of patent protection would have a material adverse impact on our business.</p>
    <p style="text-align: justify;"><i>The drug substance and drug product for FSD-201 are currently acquired from single-source suppliers. The loss of these suppliers, or their failure to supply us with the drug substance or drug product, could materially and adversely affect our business.</i></p>
    <p style="text-align: justify;">The drug substance and drug product for FSD-201 are grown or manufactured by single- source suppliers or CMOs under development and manufacturing contracts and services and quality agreements and purchase orders. We do not currently have any other suppliers for the drug substance or drug product of FSD-201 and, although we believe that there are alternate sources of supply that could satisfy our clinical and commercial requirements, we cannot assure you that identifying alternate sources and establishing relationships with such sources would not result in significant delay in the development of FSD-201. Furthermore, under the Epitech License, we must source any PEA used in FSD-201 that is sold outside of the United States or Canada from Epitech, except in certain limited circumstances described by the agreement.&#160;</p>
    <p style="text-align: justify;">Our dependence on single-source suppliers exposes us to certain risks, including the following:</p>
    <ul style="padding-left: 0pt;" type="disc">
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>our suppliers may cease or reduce production or deliveries, raise prices or renegotiate terms;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>delays caused by supply issues may harm our reputation; and</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>our ability to progress our business could be materially and adversely impacted if our single-source suppliers upon which we rely were to experience significant business challenges, disruption or failures due to issues such as financial difficulties or bankruptcy, issues relating to regulatory or quality compliance issues, or other legal or reputational issues.</p>
        </li>
    </ul>
    <div id="footer_page_35">
        <p style="text-align: center;">- 35 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_36"></a>
    <p style="text-align: justify;">Additionally, we may not be able to enter into supply arrangements with alternative suppliers on commercially reasonable terms, or at all. A delay in the development of FSD-201 or having to enter into a new agreement with a different third party on less favorable terms than we have with our current suppliers could have a material adverse impact upon on our business.</p>
    <p style="text-align: justify;"><i>We expect to rely on third parties to conduct the FSD-201 Trials and aspects of our research and preclinical testing, and those third parties may not perform satisfactorily, including failing to meet deadlines for the completion of such trials, research, or testing.</i></p>
    <p style="text-align: justify;">We currently rely and expect to continue to rely on third parties, such as CROs, clinical data management organizations, medical institutions, and clinical investigators, to conduct some aspects of research and preclinical testing and clinical trials. Any of these third parties may terminate their engagements with us or be unable to fulfill their contractual obligations. If any of our relationships with these third parties terminate, we may not be able to enter into arrangements with alternative third parties on commercially reasonable terms, or at all. If we need to enter into alternative arrangements, it would delay FSD-201 development activities.</p>
    <p style="text-align: justify;">Our reliance on these third parties for research and development activities reduces control over these activities but does not relieve us of our responsibilities. For example, we remain responsible for ensuring that the FSD-201 Trials is conducted in accordance with the general investigational plan and protocols for the trial and applicable legal, regulatory, and scientific standards, and our reliance on third parties does not relieve us of our regulatory responsibilities. In addition, the FDA and comparable other regulatory authorities require compliance with good clinical practices for conducting, recording, and reporting the results of clinical trials to assure that data and reported results are credible, reproducible and accurate and that the rights, integrity, and confidentiality of trial participants are protected. Regulatory authorities enforce these good clinical practices through periodic inspections of trial sponsors, principal investigators, and trial sites. If we or any of these third parties fail to comply with applicable good clinical practice regulations, some or all of the clinical data generated in the FSD-201 Trials may be deemed unreliable and the FDA or comparable other regulatory authorities may require us to perform additional nonclinical or clinical trials or to enroll additional patients before approving our marketing applications. We cannot be certain that, upon inspection, such regulatory authorities will determine that any of the FSD-201 Trials complies with the good clinical practice regulations. For any violations of laws and regulations during the conduct of clinical trials, we could be subject to untitled and warning letters or enforcement action that may include civil penalties up to and including criminal prosecution. We also are required to register ongoing clinical trials and post the results of completed clinical trials on a government-sponsored database within certain timeframes. Failure to do so can result in fines, adverse publicity, and civil and criminal sanctions.</p>
    <p style="text-align: justify;">If these third parties do not successfully carry out their contractual duties, meet expected deadlines, or conduct clinical trials in accordance with regulatory requirements or our stated protocols, we will not be able to obtain, or may be delayed in obtaining, marketing approvals for FSD-201 and will not be able to, or may be delayed in our efforts to, successfully commercialize FSD-201. Our failure or the failure of these third parties to comply applicable regulatory requirements or our stated protocols could also subject us to enforcement action.</p>
    <p style="text-align: justify;">We also expect to rely on other third parties to store and distribute drug supplies for the FSD-201 Trials. Any performance failure on the part of our distributors could delay clinical development or marketing approval of any product candidates we may develop or commercialization of our medicines, producing additional losses and depriving us of potential product revenue.</p>
    <p style="text-align: justify; margin-left: 54pt; text-indent: -54pt;"><b>Risks Related to the Pharmaceutical Business</b></p>
    <p style="text-align: justify;"><i>We may encounter difficulties enrolling patients in clinical trials, and clinical development activities could thereby be delayed or otherwise adversely affected.</i></p>
    <p style="text-align: justify;">The timely completion of clinical trials in accordance with their protocols depends, among other things, on our ability to enroll a sufficient number of patients who remain in the trial until its conclusion and we may not be able to identify and enroll a sufficient number of patients, or those with required or desired characteristics and criteria, in a timely manner.</p>
    <div id="footer_page_36">
        <p style="text-align: center;">- 36 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_37"></a>
    <p style="text-align: justify;">We may experience difficulties in patient enrollment in our clinical trials for a variety of reasons, including:</p>
    <ul style="padding-left: 0pt;" type="disc">
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the size and nature of a patient population;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>patient eligibility criteria defined in the applicable clinical trial protocols, which may limit the patient populations eligible for clinical trials to a greater extent than competing clinical trials for the same indication;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the size of the study population required for analysis of the trial's primary endpoints;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the proximity of patients to a trial site;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the design of the trial;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the ability to recruit clinical trial investigators with the appropriate competencies and experience;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the approval or concurrent enrollment of clinical trials involving competing product candidates currently under development, or competing clinical trials for similar therapies or targeting patient populations meeting our patient eligibility criteria;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>clinicians' and patients' perceptions as to the potential advantages and side effects of the product candidate being studied in relation to other available therapies and product candidates;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the ability to obtain and maintain patient consents; and</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the risk that patients enrolled in clinical trials will not complete such trials, for any reason.</p>
        </li>
    </ul>
    <p style="text-align: justify;">If we have difficulty enrolling sufficient numbers of patients to conduct clinical trials as planned, we may need to delay or terminate ongoing or planned clinical trials, either of which would have an adverse effect on our business.</p>
    <p style="text-align: justify;"><i>Use of our product candidates could be associated with side effects, adverse events or other properties or safety risks, which could delay or halt their clinical development, prevent their regulatory approval, cause us to suspend or discontinue clinical trials, abandon a product candidate, limit their commercial potential, if approved, or result in other significant negative consequences that could severely harm our business, prospects, operating results and financial condition.</i></p>
    <p style="text-align: justify;">As is the case with pharmaceuticals generally, it is likely that there may be side effects and adverse events associated with our product candidates' use. Results of our clinical trials could reveal a high and unacceptable severity and prevalence of side effects or unexpected characteristics. Undesirable side effects caused by our product candidates could cause us or regulatory authorities to interrupt, delay or halt clinical trials and could result in a more restrictive label or the delay or denial of regulatory approval by the FDA or comparable other regulatory authorities. The drug- related side effects could affect patient recruitment or the ability of enrolled patients to complete the trial or result in potential product liability claims. Any of these occurrences may harm our business, financial condition and prospects significantly.</p>
    <p style="text-align: justify;">Moreover, if our product candidates are associated with undesirable side effects in preclinical studies or clinical trials or have characteristics that are unexpected, we may elect to abandon their development or limit their development to more narrow uses or subpopulations in which the undesirable side effects or other characteristics are less prevalent, less severe or more acceptable from a risk-benefit perspective, which may limit the commercial expectations for the product candidate if approved. We may also be required to modify or terminate our study plans based on findings in our preclinical studies or clinical trials. Many product candidates that initially show promise in early-stage testing may later be found to cause side effects that prevent further development. As we work to advance existing product candidates and to identify new product candidates, we cannot be certain that later testing or trials of product candidates that initially showed promise in early testing will not be found to cause similar or different unacceptable side effects that prevent their further development. It is possible that as we test our product candidates in larger, longer and more extensive clinical trials, or as the use of these product candidates becomes more widespread if they receive regulatory approval, illnesses, injuries, discomforts and other adverse events that were observed in earlier trials, as well as conditions that did not occur or went undetected in previous trials, will be reported by subjects. If such side effects become known later in development or upon approval, if any, such findings may harm our business, financial condition and prospects significantly.</p>
    <div id="footer_page_37">
        <p style="text-align: center;">- 37 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_38"></a>
    <p style="text-align: justify;">Additionally, adverse developments in clinical trials of pharmaceutical and biopharmaceutical products conducted by others may cause the FDA or other regulatory oversight bodies to suspend or terminate our clinical trials or to change the requirements for approval of any of our product candidates.</p>
    <p style="text-align: justify;">In addition to side effects caused by the product candidate, the administration process or related procedures also can cause adverse side effects. If any such adverse events occur, our clinical trials could be suspended or terminated. If we are unable to demonstrate that any adverse events were caused by the administration process or related procedures, the FDA, Health Canada, the European Commission, the EMA, or other regulatory authorities could order us to cease further development of, or deny approval of, a product candidate for any or all targeted indications. Even if we can demonstrate that all future serious adverse events are not product-related, such occurrences could affect patient recruitment or the ability of enrolled patients to complete the trial. Moreover, if we elect, or are required, to not initiate, delay, suspend or terminate any future clinical trial of any of our product candidates, the commercial prospects of such product candidates may be harmed and our ability to generate product revenues from any of these product candidates may be delayed or eliminated. Any of these occurrences may harm our ability to develop other product candidates, and may harm our business, financial condition and prospects significantly.</p>
    <p style="text-align: justify;">Additionally, if any of our product candidates receives marketing approval, the FDA could impose a boxed warning in the labeling of our product and could require us to adopt a risk evaluation and mitigation strategy, and could apply elements to assure safe use to ensure that the benefits of the product outweigh its risks, which may include, among other things, a Medication Guide outlining the risks of the product for distribution to patients and a communication plan to health care practitioners. Furthermore, if we or others later identify undesirable side effects caused by our product candidates once approved, several potentially significant negative consequences could result, including:</p>
    <ul style="padding-left: 0pt;" type="disc">
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>regulatory authorities may suspend or withdraw approvals of such product candidate;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>regulatory authorities may require additional warnings on the label;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>we may be required by the FDA to implement a risk evaluation and mitigation strategy;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>we may be required to change the way a product candidate is administered or conduct additional clinical trials;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>we could be sued and held liable for harm caused to patients; and</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>our reputation may suffer.</p>
        </li>
    </ul>
    <p style="text-align: justify;">Any of these occurrences could prevent us from achieving or maintaining market acceptance of the particular product candidate, if approved, and may harm our business, financial condition and prospects significantly.</p>
    <p style="text-align: justify;"><i>We may in the future conduct clinical trials for product candidates outside the United States, and the FDA and comparable other regulatory authorities may not accept data from such trials.</i></p>
    <p style="text-align: justify;">We may in the future choose to conduct one or more clinical trials outside the United States, including in Canada, Europe or Asia. The acceptance of study data from clinical trials conducted outside the United States or another jurisdiction by the FDA or comparable other regulatory authority may be subject to certain conditions or may not be accepted at all. In cases where data from non-U.S. clinical trials are intended to serve as the basis for marketing approval in the United States, the FDA will generally not approve the application on the basis of non-U.S. data alone unless (i) the data are applicable to the U.S. population and U.S. medical practice; and (ii) the trials were performed by clinical investigators of recognized competence and pursuant to good clinical practice regulations. Additionally, the FDA's clinical trial requirements, including sufficient size of patient populations and statistical powering, must be met. Many non-U.S. regulatory authorities have similar approval requirements. In addition, such non-U.S. trials would be subject to the applicable local laws of the other jurisdictions where the trials are conducted. There can be no assurance that the FDA or any comparable other regulatory authority will accept data from trials conducted outside of the United States or the applicable jurisdiction. If the FDA or any comparable other regulatory authority does not accept such data, it would result in the need for additional trials, which would be costly and time-consuming and delay aspects of our business plan, and which may result in product candidates that we may develop not receiving approval or clearance for commercialization in the applicable jurisdiction.</p>
    <div id="footer_page_38">
        <p style="text-align: center;">- 38 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_39"></a>
    <p style="text-align: justify;"><i>Even if we obtain FDA approval for product candidates that we may identify and pursue in the United States, we may never obtain approval to commercialize any product candidates outside of the United States, which would limit our ability to realize their full market potential.</i></p>
    <p style="text-align: justify;">In order to market any products outside of the United States, we must establish and comply with numerous and varying regulatory requirements of other countries regarding safety and effectiveness. Clinical trials conducted in one country may not be accepted by regulatory authorities in other countries, and regulatory approval in one country does not mean that regulatory approval will be obtained in any other country. Approval processes vary among countries and can involve additional product testing and validation and additional or different administrative review periods from those in the United States, including additional preclinical studies or clinical trials, as clinical trials conducted in one jurisdiction may not be accepted by regulatory authorities in other jurisdictions. In many jurisdictions outside the United States, a product candidate must be approved for reimbursement before it can be approved for sale in that jurisdiction. In some cases, the price that we intend to charge for our products is also subject to approval.</p>
    <p style="text-align: justify;">Seeking non-U.S. regulatory approval could result in difficulties and costs and require additional nonclinical studies or clinical trials which could be costly and time-consuming. Regulatory requirements can vary widely from country to country and could delay or prevent the introduction of our product candidates in those countries. The non-U.S. regulatory approval process may include all of the risks associated with obtaining FDA approval, as well as additional risks. We do not have any product candidates approved for sale in any jurisdiction, including international markets, and we do not have experience in obtaining regulatory approval in international markets. If we fail to comply with regulatory requirements in international markets or to obtain and maintain required approvals, or if regulatory approval in international markets is delayed, our target market will be reduced and our ability to realize the full market potential of our products will be harmed.</p>
    <p style="text-align: justify;"><i>We could experience manufacturing problems that result in delays in our development or commercialization programs or otherwise harm our business.</i></p>
    <p style="text-align: justify;">Our CMOs must employ multiple steps to control the manufacturing process to assure that the process is reproducible and the product candidate is made strictly and consistently in compliance with the process. Problems with the manufacturing process, even minor deviations from the normal process, could result in product defects or manufacturing failures that result in lot failures, product recalls, product liability claims or insufficient inventory to conduct clinical trials or supply commercial markets. We may encounter problems achieving adequate quantities and quality of clinical-grade materials that meet the FDA, the EMA or other applicable standards or specifications with consistent and acceptable production yields and costs.</p>
    <p style="text-align: justify;">In addition, the FDA, the EMA and other regulatory authorities may require us to submit samples of any lot of any approved product together with the protocols showing the results of applicable tests at any time. Under some circumstances, the FDA, the EMA or other regulatory authorities may require that we not distribute a lot until the agency authorizes its release. Slight deviations in the manufacturing process, including those affecting quality attributes and stability, may result in unacceptable changes in the product that could result in lot failures or product recalls. Lot failures or product recalls could cause us to delay product launches or clinical trials, which could be costly to us and otherwise harm our business, results of operations, financial condition and prospects.</p>
    <div id="footer_page_39">
        <p style="text-align: center;">- 39 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_40"></a>
    <p style="text-align: justify;">Our CMOs also may encounter problems hiring and retaining the experienced scientific, quality assurance, quality-control and manufacturing personnel needed to operate our manufacturing processes, which could result in delays in production or difficulties in maintaining compliance with applicable regulatory requirements.</p>
    <p style="text-align: justify;">Any problems in our CMOs' manufacturing process or facilities could result in delays in planned clinical trials and increased costs, and could make us a less attractive collaborator for potential partners, including larger biotechnology companies and academic research institutions, which could limit access to additional attractive development programs. Problems in our manufacturing process could restrict our ability to meet potential future market demand for products.</p>
    <p style="text-align: justify;"><i>If we are unable to successfully validate, develop and obtain regulatory approval for companion diagnostic tests for our drug candidates that require or would commercially benefit from such tests, or experience significant delays in doing so, we may not realize the full commercial potential of these drug candidates.</i></p>
    <p style="text-align: justify;">In connection with the clinical development of our drug candidates for certain indications, we may work with collaborators to develop or obtain access to <i>in vitro </i>companion diagnostic tests to identify patient subsets within a disease category who may derive selective and meaningful benefit from our drug candidates. Such companion diagnostics would be used during our clinical trials as well as in connection with the commercialization of our product candidates. To be successful, we or our collaborators will need to address a number of scientific, technical, regulatory and logistical challenges. The FDA and comparable other regulatory authorities regulate <i>in vitro </i>companion diagnostics as medical devices and, under that regulatory framework, will likely require the conduct of clinical trials to demonstrate the safety and effectiveness of any diagnostics we may develop, which we expect will require separate regulatory clearance or approval prior to commercialization.</p>
    <p style="text-align: justify;">We may rely on third parties for the design, development and manufacture of companion diagnostic tests for our therapeutic drug candidates that may require such tests. If we enter into such collaborative agreements, we will be dependent on the sustained cooperation and effort of our future collaborators in developing and obtaining approval for these companion diagnostics. It may be necessary to resolve issues such as selectivity/specificity, analytical validation, reproducibility, or clinical validation of companion diagnostics during the development and regulatory approval processes. Moreover, even if data from preclinical studies and early clinical trials appear to support development of a companion diagnostic for a product candidate, data generated in later clinical trials may fail to support the analytical and clinical validation of the companion diagnostic. We and our future collaborators may encounter difficulties in developing, obtaining regulatory approval for, manufacturing and commercializing companion diagnostics similar to those we face with respect to our therapeutic candidates themselves, including issues with achieving regulatory clearance or approval, production of sufficient quantities at commercial scale and with appropriate quality standards, and in gaining market acceptance. If we are unable to successfully develop companion diagnostics for these therapeutic drug candidates, or experience delays in doing so, the development of these therapeutic drug candidates may be adversely affected, these therapeutic drug candidates may not obtain marketing approval, and we may not realize the full commercial potential of any of these therapeutics that obtain marketing approval. As a result, our business, results of operations and financial condition could be materially harmed. In addition, a diagnostic corporation with whom we contract may decide to discontinue selling or manufacturing the companion diagnostic test that we anticipate using in connection with development and commercialization of our product candidates or our relationship with such diagnostic corporation may otherwise terminate. We may not be able to enter into arrangements with another diagnostic corporation to obtain supplies of an alternative diagnostic test for use in connection with the development and commercialization of our product candidates or do so on commercially reasonable terms, which could adversely affect and/or delay the development or commercialization of our therapeutic candidates.</p>
    <p style="text-align: justify;"><i>If approved, our investigational products regulated as biologics may face competition from biosimilars approved through an abbreviated regulatory pathway.</i></p>
    <div id="footer_page_40">
        <p style="text-align: center;">- 40 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_41"></a>
    <p style="text-align: justify;">The ACA includes a subtitle called the BPCIA which created an abbreviated approval pathway for biological products that are biosimilar to or interchangeable with an FDA-licensed reference biological product. Under the BPCIA, an application for a biosimilar product may not be submitted to the FDA until four years following the date that the reference product was first licensed by the FDA. In addition, the approval of a biosimilar product may not be made effective by the FDA until 12 years from the date on which the reference product was first licensed. During this 12-year period of exclusivity, another corporation may still market a competing version of the reference product if the FDA approves a biologics license application for the competing product containing the sponsor's own preclinical data and data from adequate and well- controlled clinical trials to demonstrate the safety, purity, and potency of the other corporation's product. The law is complex and is still being interpreted and implemented by the FDA. As a result, its ultimate impact, implementation, and meaning are subject to uncertainty.</p>
    <p style="text-align: justify;">We believe that any of our product candidates approved as a biological product under a biologics license application should qualify for the 12-year period of exclusivity. However, there is a risk that this exclusivity could be shortened due to congressional action or otherwise, or that the FDA will not consider our investigational medicines to be reference products for competing products, potentially creating the opportunity for generic competition sooner than anticipated. Other aspects of the BPCIA, some of which may impact the BPCIA exclusivity provisions, have also been the subject of recent litigation. Moreover, the extent to which a biosimilar, once licensed, will be substituted for any one of our reference products in a way that is similar to traditional generic substitution for non-biological products is not yet clear, and will depend on a number of marketplace and regulatory factors that are still developing.</p>
    <p style="text-align: justify;">If competitors are able to obtain marketing approval for biosimilars referencing our products, our products may become subject to competition from such biosimilars, with the attendant competitive pressure and consequences.</p>
    <p style="text-align: justify;"><i>Changes in funding for the FDA and other government agencies could hinder their ability to hire and retain key leadership and other personnel, prevent new products and services from being developed or commercialized in a timely manner or otherwise prevent those agencies from performing normal functions on which the operation of our business may rely, which could negatively impact our business.</i></p>
    <p style="text-align: justify;">The ability of the FDA to review and approve new products or take action with respect to other regulatory matters can be affected by a variety of factors, including government budget and funding levels, ability to hire and retain key personnel and accept payment of user fees, and statutory, regulatory, and policy changes. Average review times at the agency have fluctuated in recent years as a result. In addition, government funding of other government agencies on which our operations may rely, including those that fund research and development activities is subject to the political process, which is inherently fluid and unpredictable. Disruptions at the FDA and other agencies may also slow the time necessary for new drugs to be reviewed and/or approved, or for other actions to be taken, by relevant government agencies, which would adversely affect our business. For example, over the last several years, including for 35 days beginning on December 22, 2018, the U.S. government has shut down several times and certain regulatory agencies, such as the FDA, have had to furlough critical FDA and other government employees and stop critical activities. If a prolonged government shutdown occurs, it could significantly impact the ability of the FDA to timely review and process our regulatory submissions, which could have a material adverse effect on our business. Similarly, a prolonged government shutdown could prevent the timely review of our patent applications by the USPTO, which could delay the issuance of any U.S. patents to which we might otherwise be entitled. Further, in our operations as a public corporation, future government shutdowns could impact our ability to access the public markets and obtain necessary capital in order to properly capitalize and continue our operations.</p>
    <p style="text-align: justify;"><i>Product liability lawsuits against us could cause us to incur substantial liabilities and could limit commercialization of any product candidates that we may develop.</i></p>
    <p style="text-align: justify;">We face an inherent risk of product liability exposure related to the testing of product candidates in human clinical trials and will face an even greater risk if we commercially sell any medicines that we may develop. If we cannot successfully defend ourselves against claims that our product candidates or medicines caused injuries, we could incur substantial liabilities. Regardless of merit or eventual outcome, liability claims may result in:</p>
    <div id="footer_page_41">
        <p style="text-align: center;">- 41 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_42"></a>
    <ul style="padding-left: 0pt;" type="disc">
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>decreased demand for any product candidates or medicines that we may develop;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>injury to our reputation and significant negative media attention;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>withdrawal of clinical trial participants;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>significant costs to defend the related litigation;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>substantial monetary awards to trial participants or patients;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>loss of revenue; and</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the inability to commercialize our product candidates.</p>
        </li>
    </ul>
    <p style="text-align: justify;">Although we intend to maintain product liability insurance, including coverage for clinical trials that we plan to sponsor, it may not be adequate to cover all liabilities that we may incur. We anticipate that we will need to increase our insurance coverage as we commence additional clinical trials and if we successfully commercialize any product candidates. The market for insurance coverage is increasingly expensive, and the costs of insurance coverage will increase as our clinical programs increase in size. We may not be able to maintain insurance coverage at a reasonable cost or in an amount adequate to satisfy any liability that may arise.</p>
    <p style="text-align: justify;"><i>Our employees, directors, independent contractors, consultants, commercial partners and vendors may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements.</i></p>
    <p style="text-align: justify;">We are exposed to the risk of fraud, misconduct or other illegal activity by our employees, directors, independent contractors, consultants, commercial partners and vendors. Misconduct by these parties could include intentional, reckless and negligent conduct that fails to: comply with the laws of the FDA and comparable other regulatory authorities; provide true, complete and accurate information to the FDA and comparable other regulatory authorities; comply with manufacturing standards we have established; comply with healthcare fraud and abuse laws in the United States and similar other fraudulent misconduct laws; or report financial information or data accurately or to disclose unauthorized activities. If we obtain FDA approval of our product candidates and begin commercializing those products in the United States, our potential exposure under such laws will increase significantly, and our costs associated with compliance with such laws are also likely to increase. In particular, research, sales, marketing, education and other business arrangements in the healthcare industry are subject to extensive laws designed to prevent fraud, kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, educating, marketing and promotion, sales and commission, certain customer incentive programs and other business arrangements generally. Activities subject to these laws also involve the improper use of information obtained in the course of patient recruitment for clinical trials, which could result in regulatory sanctions and cause serious harm to our reputation. We intend to adopt a code of business conduct and ethics, but it is not always possible to identify and deter misconduct by employees, directors and third parties, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business, including the imposition of significant fines or other sanctions.</p>
    <p style="text-align: justify;"><i>Even if we obtain regulatory approval for a product candidate, we will be subject to ongoing regulatory obligations and continued regulatory review, which may result in significant additional expense and we may be subject to penalties if we fail to comply with regulatory requirements or experience unanticipated problems with our product candidates.</i></p>
    <p style="text-align: justify;">If any of our product candidates are approved, they will be subject to ongoing regulatory requirements for manufacturing, labeling, packaging, storage, advertising, promotion, sampling, record-keeping, conduct of post- marketing studies, and submission of safety, efficacy, and other post-market information, including both U.S. federal and state requirements in the United States and requirements of comparable other regulatory authorities.</p>
    <div id="footer_page_42">
        <p style="text-align: center;">- 42 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_43"></a>
    <p style="text-align: justify;">Manufacturers and manufacturers' facilities are required to comply with extensive requirements imposed by the FDA and comparable other regulatory authorities, including ensuring that quality control and manufacturing procedures conform to good manufacturing practices, regulations. As such, we and our CMOs will be subject to continual review and inspections to assess compliance with good manufacturing practices and adherence to commitments made in any new drug application, biologics license application or marketing authorization application. Accordingly, we and others with whom we work must continue to expend time, money, and effort in all areas of regulatory compliance, including manufacturing, production and quality control.</p>
    <p style="text-align: justify;">Any regulatory approvals that we may receive for our product candidates will be subject to limitations on the approved indicated uses for which the product may be marketed and promoted or to the conditions of approval, or contain requirements for potentially costly post-marketing testing, including Phase 4 clinical trials and surveillance to monitor the safety and efficacy of the product candidate. We will be required to report certain adverse reactions and production problems, if any, to the FDA and comparable other regulatory authorities. Any new legislation addressing drug safety issues could result in delays in product development or commercialization, or increased costs to assure compliance.</p>
    <p style="text-align: justify;">The FDA and other agencies, including the Department of Justice, closely regulate and monitor the post- approval marketing, labeling, advertising and promotion of products to ensure that they are manufactured, marketed and distributed only for the approved indications and in accordance with the provisions of the approved label. We will have to comply with requirements concerning advertising and promotion for our products. Promotional communications with respect to prescription drugs are subject to a variety of legal and regulatory restrictions and must be consistent with the information in the product's approved label. As such, we may not promote our products for indications or uses for which they do not have approval.</p>
    <p style="text-align: justify;">The holder of an approved new drug application, biologics license application or marketing authorization application must submit new or supplemental applications and obtain approval for certain changes to the approved product, product labeling, or manufacturing process. We could also be asked to conduct post-marketing clinical trials to verify the safety and efficacy of our products in general or in specific patient subsets. If original marketing approval was obtained via the accelerated approval pathway, we could be required to conduct a successful post-marketing clinical trial to confirm clinical benefit for our products. An unsuccessful post-marketing study or failure to complete such a study could result in the withdrawal of marketing approval.</p>
    <p style="text-align: justify;">If a regulatory agency discovers previously unknown problems with a product, such as adverse events of unanticipated severity or frequency, or problems with the facility where the product is manufactured, or disagrees with the promotion, marketing or labeling of a product, such regulatory agency may impose restrictions on that product or us, including requiring withdrawal of the product from the market. If we fail to comply with applicable regulatory requirements, a regulatory agency or enforcement authority may, among other things:</p>
    <div id="footer_page_43">
        <p style="text-align: center;">- 43 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_44"></a>
    <ul style="padding-left: 0pt;" type="disc">
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>issue warning letters that would result in adverse publicity;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>impose civil or criminal penalties;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>suspend or withdraw regulatory approvals;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>suspend any of our ongoing clinical trials;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>refuse to approve pending applications or supplements to approved applications submitted by us;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>impose restrictions on our operations, including closing our CMOs' facilities;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>seize or detain products; or</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>require a product recall.</p>
        </li>
    </ul>
    <p style="text-align: justify;">Any government investigation of alleged violations of law could require us to expend significant time and resources in response, and could generate negative publicity. Any failure to comply with ongoing regulatory requirements may significantly and adversely affect our ability to commercialize and generate revenue from our products. If regulatory sanctions are applied or if regulatory approval is withdrawn, the value of our corporation and our operating results will be adversely affected.</p>
    <p style="text-align: justify;">The FDA's and other regulatory authorities' policies may change and additional government regulations may be enacted that could prevent, limit or delay regulatory approval of our product candidates.</p>
    <p style="text-align: justify;">We also cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation or administrative action, either in the United States or abroad. For example, certain policies of the Trump administration may impact our business and industry. Namely, the Trump administration has taken several executive actions, including the issuance of a number of Executive Orders, that could impose significant burdens on, or otherwise materially delay, the FDA's ability to engage in routine regulatory and oversight activities such as implementing statutes through rulemaking, issuance of guidance, and review and approval of marketing applications. If these executive actions impose constraints on FDA's ability to engage in oversight and implementation activities in the normal course, our business may be negatively impacted.</p>
    <p style="text-align: justify;"><i>The FDA and other regulatory agencies actively enforce the laws and regulations prohibiting the promotion of off- label uses.</i></p>
    <p style="text-align: justify;">If any of our product candidates are approved and we are found to have improperly promoted off-label uses of those products, we may become subject to significant liability. The FDA and other regulatory agencies strictly regulate the promotional claims that may be made about prescription products, if approved. In particular, while FDA permits the dissemination of truthful and non-misleading information about an approved product, a manufacturer may not promote a product for uses that are not approved by the FDA or such other regulatory agencies as reflected in the product's approved labeling. If we are found to have promoted such off-label uses, we may become subject to significant liability. The U.S. federal government has levied large civil and criminal fines against companies for alleged improper promotion of off-label use and has enjoined several companies from engaging in off-label promotion. The FDA has also requested that companies enter into consent decrees, corporate integrity agreements or permanent injunctions under which specified promotional conduct must be changed or curtailed. If we cannot successfully manage the promotion of our product candidates, if approved, we could become subject to significant liability, which would materially adversely affect our business and financial condition.</p>
    <p style="text-align: justify;"><i>If, in the future, we are unable to establish sales and marketing capabilities or enter into agreements with third parties to sell and market any product candidates we may develop, we may not be successful in commercializing those product candidates if and when they are approved.</i></p>
    <div id="footer_page_44">
        <p style="text-align: center;">- 44 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_45"></a>
    <p style="text-align: justify;">We do not have a sales or marketing infrastructure and have little experience in the sale, marketing, or distribution of pharmaceutical products. To achieve commercial success for any approved product for which we retain sales and marketing responsibilities, we must either develop a sales and marketing organization or outsource these functions to third parties. In the future, we may choose to build a focused sales, marketing, and commercial support infrastructure to market and sell our product candidates, if and when they are approved. We may also elect to enter into collaborations or strategic partnerships with third parties to engage in commercialization activities with respect to selected product candidates, indications or geographic territories, including territories outside the United States, although there is no guarantee we will be able to enter into these arrangements even if the intent is to do so.</p>
    <p style="text-align: justify;">There are risks involved with both establishing our own commercial capabilities and entering into arrangements with third parties to perform these services. For example, recruiting and training a sales force or reimbursement specialists is expensive and time consuming and could delay any product launch. If the commercial launch of a product candidate for which we recruit a sales force and establish marketing and other commercialization capabilities is delayed or does not occur for any reason, we would have prematurely or unnecessarily incurred these commercialization expenses. This may be costly, and our investment would be lost if we cannot retain or reposition commercialization personnel.</p>
    <p style="text-align: justify;">Factors that may inhibit our efforts to commercialize any approved product on our own include:</p>
    <ul style="padding-left: 0pt;" type="disc">
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the inability to recruit and retain adequate numbers of effective sales, marketing, reimbursement, customer service, medical affairs, and other support personnel;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the inability of sales personnel to obtain access to physicians or persuade adequate numbers of physicians to prescribe any future approved products;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the inability of reimbursement professionals to negotiate arrangements for formulary access, reimbursement, and other acceptance by payors;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the inability to price products at a sufficient price point to ensure an adequate and attractive level of profitability;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>restricted or closed distribution channels that make it difficult to distribute our products to segments of the patient population;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the lack of complementary products to be offered by sales personnel, which may put us at a competitive disadvantage relative to companies with more extensive product lines; and</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>unforeseen costs and expenses associated with creating an independent commercialization organization.</p>
        </li>
    </ul>
    <p style="text-align: justify;">If we enter into arrangements with third parties to perform sales, marketing, commercial support, and distribution services, our product revenue or the profitability of product revenue may be lower than if we were to market and sell any products we may develop internally. In addition, we may not be successful in entering into arrangements with third parties to commercialize our product candidates or may be unable to do so on terms that are favorable to us or them. We may have little control over such third parties, and any of them may fail to devote the necessary resources and attention to sell and market our products effectively or may expose us to legal and regulatory risk by not adhering to regulatory requirements and restrictions governing the sale and promotion of prescription drug products, including those restricting off-label promotion. If we do not establish commercialization capabilities successfully, either on our own or in collaboration with third parties, we will not be successful in commercializing our product candidates, if approved.</p>
    <p style="text-align: justify;"><i>The insurance coverage and reimbursement status of newly-approved products is uncertain. Our product candidates may become subject to unfavorable pricing regulations, third-party coverage and reimbursement practices, or healthcare reform initiatives, which would harm our business. Failure to obtain or maintain adequate coverage and reimbursement for new or current products could limit our ability to market those products and decrease our ability to generate revenue.</i></p>
    <div id="footer_page_45">
        <p style="text-align: center;">- 45 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_46"></a>
    <p style="text-align: justify;">The regulations that govern marketing approvals, pricing, coverage, and reimbursement for new drugs vary widely from country to country. In the United States, recently enacted legislation may significantly change the approval requirements in ways that could involve additional costs and cause delays in obtaining approvals. Some countries require approval of the sale price of a drug before it can be marketed. In many countries, the pricing review period begins after marketing or product licensing approval is granted. In some non-U.S. markets, prescription pharmaceutical pricing remains subject to continuing governmental control even after initial approval is granted. As a result, we might obtain marketing approval for a product in a particular country, but then be subject to price regulations that delay our commercial launch of the product, possibly for lengthy time periods, and negatively impact the revenue we are able to generate from the sale of the product in that country. Adverse pricing limitations may hinder our ability to recoup our investment in one or more product candidates, even if any product candidates we may develop obtain marketing approval.</p>
    <p style="text-align: justify;">Our ability to successfully commercialize our product candidates also will depend in part on the extent to which coverage and adequate reimbursement for these products and related treatments will be available from government health administration authorities, private health insurers, and other organizations. Government authorities and third-party payors, such as private health insurers and health maintenance organizations, decide which medications they will pay for and establish reimbursement levels. The availability of coverage and extent of reimbursement by governmental and private payors is essential for most patients to be able to afford treatments such as gene therapy products. Sales of these or other product candidates that we may identify will depend substantially, both domestically and abroad, on the extent to which the costs of our product candidates will be paid by health maintenance, managed care, pharmacy benefit and similar healthcare management organizations, or reimbursed by government health administration authorities, private health coverage insurers and other third-party payors. If coverage and adequate reimbursement is not available, or is available only to limited levels, we may not be able to successfully commercialize our product candidates. Even if coverage is provided, the approved reimbursement amount may not be high enough to allow us to establish or maintain pricing sufficient to realize a sufficient return on our investment.</p>
    <p style="text-align: justify;">A primary trend in the U.S. healthcare industry and elsewhere is cost containment. Government authorities and third-party payors have attempted to control costs by limiting coverage and the amount of reimbursement for particular medications. In many countries, the prices of medical products are subject to varying price control mechanisms as part of national health systems. In general, the prices of medicines under such systems are substantially lower than in the United States. Other countries allow companies to fix their own prices for medicines, but monitor and control corporation profits. Additional price controls or other changes in pricing regulation could restrict the amount that we are able to charge for our product candidates. Accordingly, in markets outside the United States, the reimbursement for products may be reduced compared with the United States and may be insufficient to generate commercially reasonable revenues and profits.</p>
    <p style="text-align: justify;">There is also significant uncertainty related to the insurance coverage and reimbursement of newly approved products and coverage may be more limited than the purposes for which the medicine is approved by the FDA or comparable other regulatory authorities. In the United States, the principal decisions about reimbursement for new medicines are typically made by the CMS, an agency within the U.S. Department of Health and Human Services. CMS decides whether and to what extent a new medicine will be covered and reimbursed under Medicare and private payors tend to follow CMS to a substantial degree. No uniform policy of coverage and reimbursement for products exists among third-party payors and coverage and reimbursement levels for products can differ significantly from payor to payor. As a result, the coverage determination process is often a time consuming and costly process that may require us to provide scientific and clinical support for the use of our products to each payor separately, with no assurance that coverage and adequate reimbursement will be applied consistently or obtained in the first instance. It is difficult to predict what CMS will decide with respect to reimbursement for fundamentally novel products such as ours, as there is no body of established practices and precedents for these new products. Reimbursement agencies in Europe may be more conservative than CMS. Moreover, eligibility for reimbursement does not imply that any drug will be paid for in all cases or at a rate that covers our costs, including research, development, manufacture, sale, and distribution. Interim reimbursement levels for new drugs, if applicable, may also not be sufficient to cover our costs and may not be made permanent. Reimbursement rates may vary according to the use of the drug and the clinical setting in which it is used, may be based on reimbursement levels already set for lower cost drugs and may be incorporated into existing payments for other services. Our inability to promptly obtain coverage and profitable payment rates from both government-funded and private payors for any approved products we may develop could have a material adverse effect on our operating results, our ability to raise capital needed to commercialize product candidates, and our overall financial condition.</p>
    <div id="footer_page_46">
        <p style="text-align: center;">- 46 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_47"></a>
    <p style="text-align: justify;">Net prices for drugs may be reduced by mandatory discounts or rebates required by government healthcare programs or private payors and by any future relaxation of laws that presently restrict imports of drugs from countries where they may be sold at lower prices than in the United States. Our inability to promptly obtain coverage and profitable reimbursement rates from third-party payors for any approved products that we develop could have a material adverse effect on our operating results, our ability to raise capital needed to commercialize products and our overall financial condition.</p>
    <p style="text-align: justify;">Increasingly, third-party payors are requiring that drug companies provide them with predetermined discounts from list prices and are challenging the prices charged for medical products. We cannot be sure that reimbursement will be available for any product candidate that we commercialize and, if reimbursement is available, the level of reimbursement. Reimbursement may impact the demand for, or the price of, any product candidate for which we obtain marketing approval. In order to obtain reimbursement, physicians may need to show that patients have superior treatment outcomes with our products compared to standard of care drugs, including lower-priced generic versions of standard of care drugs. We expect to experience pricing pressures in connection with the sale of any of our product candidates, due to the trend toward managed healthcare, the increasing influence of health maintenance organizations and additional legislative changes. The downward pressure on healthcare costs in general, particularly prescription drugs and surgical procedures and other treatments, has become very intense. As a result, increasingly high barriers are being erected to the entry of new products.</p>
    <p style="text-align: justify;">Additionally, we may develop companion diagnostic tests for use with our product candidates. We, or our collaborators, may be required to obtain coverage and reimbursement for these tests separate and apart from the coverage and reimbursement we seek for our product candidates, once approved. Even if we obtain regulatory approval or clearance for such companion diagnostics, there is significant uncertainty regarding our ability to obtain coverage and adequate reimbursement for the same reasons applicable to our product candidates. Medicare reimbursement methodologies, whether under Part A, Part B, or clinical laboratory fee schedule may be amended from time to time, and we cannot predict what effect any change to these methodologies would have on any product candidate or companion diagnostic for which we receive approval. Our inability to promptly obtain coverage and adequate reimbursement from both third-party payors for the companion diagnostic tests that we develop and for which we obtain regulatory approval could have a material and adverse effect on our business, results of operations, financial condition and prospects.</p>
    <p style="text-align: justify;"><i>Healthcare legislative measures aimed at reducing healthcare costs may have a material adverse effect on our business, results of operations, financial condition and prospects.</i></p>
    <p style="text-align: justify;">The United States and many other jurisdictions have enacted or proposed legislative and regulatory changes affecting the healthcare system that could prevent or delay marketing approval of our product candidates or any future product candidates, restrict or regulate post-approval activities and affect our ability to profitably sell any product for which we obtain marketing approval. Changes in regulations, statutes or the interpretation of existing regulations could impact our business in the future by requiring, for example: (i) changes to our manufacturing arrangements; (ii) additions or modifications to product labeling; (iii) the recall or discontinuation of our products; or (iv) additional record-keeping requirements. If any such changes were to be imposed, they could adversely affect the operation of our business.</p>
    <p style="text-align: justify;">There have been, and likely will continue to be, legislative and regulatory proposals in other jurisdictions as well as at the U.S. federal and state levels directed at containing or lowering the cost of healthcare. The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability, or commercialize our product. Such reforms could have an adverse effect on anticipated revenue from product candidates that we may successfully develop and for which we may obtain regulatory approval and may affect our overall financial condition and ability to develop product candidates. We cannot predict the initiatives that may be adopted in the future. The continuing efforts of the government, insurance companies, managed care organizations and other payors of healthcare services to contain or reduce costs of healthcare and/or impose price controls may adversely affect:</p>
    <div id="footer_page_47">
        <p style="text-align: center;">- 47 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_48"></a>
    <ul style="padding-left: 0pt;" type="disc">
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the demand for our product candidates, if approved;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>our ability to receive or set a price that we believe is fair for our products;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>our ability to generate revenue and achieve or maintain profitability;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the amount of taxes that we are required to pay; and</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the availability of capital.</p>
        </li>
    </ul>
    <p style="text-align: justify;">We expect that the ACA, as well as other healthcare reform measures that may be adopted in the future, may result in additional reductions in Medicare and other healthcare funding, more rigorous coverage criteria, lower reimbursement, and new payment methodologies. This could lower the price that we receive for any approved product. Any denial in coverage or reduction in reimbursement from Medicare or other government-funded programs may result in a similar denial or reduction in payments from private payors, which may prevent us from being able to generate sufficient revenue, attain profitability or commercialize our product candidates, if approved.</p>
    <p style="text-align: justify;"><i>If we fail to comply with healthcare laws, we could face substantial penalties and our business, operations and financial conditions could be adversely affected.</i></p>
    <p style="text-align: justify;">Healthcare providers, physicians and third-party payors in the United States and elsewhere play a primary role in the recommendation and prescription of pharmaceutical products. Arrangements with third-party payors and customers can expose pharmaceutical manufacturers to broadly applicable fraud and abuse and other healthcare laws and regulations, including, without limitation, the U.S. federal Anti-Kickback Statute and the U.S. federal <i>False Claims Act</i>, which may constrain the business or financial arrangements and relationships through which such companies sell, market and distribute pharmaceutical products. In particular, the promotion, sales and marketing of healthcare items and services, as well as certain business arrangements in the healthcare industry, are subject to extensive laws designed to prevent fraud, kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict or prohibit a wide range of ownership, pricing, discounting, marketing and promotion, structuring and commission(s), certain customer incentive programs and other business arrangements generally. Activities subject to these laws also involve the improper use of information obtained in the course of patient recruitment for clinical trials.</p>
    <p style="text-align: justify;">Because of the breadth of these laws and the narrowness of the statutory exceptions and regulatory safe harbors available, it is possible that some of our business activities, including compensation of physicians with stock or stock options, could, despite efforts to comply, be subject to challenge under one or more of such laws. Additionally, FDA or other regulators may not agree that we have mitigated any risk of bias in our clinical trials due to payments or equity interests provided to investigators or institutions which could limit a regulator's acceptance of those clinical trial data in support of a marketing application. Moreover, efforts to ensure that our business arrangements will comply with applicable healthcare laws may involve substantial costs. It is possible that governmental and enforcement authorities will conclude that our business practices may not comply with current or future statutes, regulations or case law interpreting applicable fraud and abuse or other healthcare laws and regulations. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business, including the imposition of significant civil, criminal and administrative penalties, damages, disgorgement, monetary fines, exclusion from participation in Medicare, Medicaid and other U.S. federal healthcare programs, integrity and oversight agreements to resolve allegations of non-compliance, contractual damages, reputational harm, diminished profits and future earnings, and curtailment or restructuring of our operations, any of which could adversely affect our ability to operate our business and our results of operations. In addition, the approval and commercialization of any of our product candidates outside the United States will also likely subject us to international equivalents of the healthcare laws mentioned above, among other local laws.</p>
    <div id="footer_page_48">
        <p style="text-align: center;">- 48 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_49"></a>
    <p style="text-align: justify;"><i>Failure to comply with health and data protection laws and regulations could lead to government enforcement actions (which could include civil or criminal penalties), private litigation, and/or adverse publicity and could negatively affect our operating results and business.</i></p>
    <p style="text-align: justify;">We and any potential collaborators may be subject to U.S. federal, state, and international data protection laws and regulations (i.e., laws and regulations that address privacy and data security). In the United States, numerous U.S. federal and state laws and regulations, including U.S. federal health information privacy laws, state data breach notification laws, state health information privacy laws, and U.S. federal and state consumer protection laws (e.g., Section 5 of the U.S. Federal Trade Commission Act), that govern the collection, use, disclosure and protection of health-related and other personal information could apply to our operations or the operations of our collaborators. In addition, we may obtain health information from third parties (including research institutions from which we obtain clinical trial data) that are subject to privacy and security requirements under HIPAA, as amended by the U.S. <i>Health Information Technology for Economic and Clinical Health Act</i>. Depending on the facts and circumstances, we could be subject to civil, criminal, and administrative penalties if we knowingly obtain, use, or disclose individually identifiable health information maintained by a HIPAA-covered entity in a manner that is not authorized or permitted by HIPAA.</p>
    <p style="text-align: justify;">Compliance with U.S. and international data protection laws and regulations could require us to take on more onerous obligations in our contracts, restrict our ability to collect, use and disclose data, or in some cases, impact our ability to operate in certain jurisdictions. Failure to comply with these laws and regulations could result in government enforcement actions (which could include civil, criminal and administrative penalties), private litigation, and/or adverse publicity and could negatively affect our operating results and business. Moreover, clinical trial subjects, employees and other individuals about whom we or our potential collaborators obtain personal information, as well as the providers who share this information with us, may limit our ability to collect, use and disclose the information. Claims that we have violated individuals' privacy rights, failed to comply with data protection laws, or breached our contractual obligations, even if we are not found liable, could be expensive and time-consuming to defend and could result in adverse publicity that could harm our business.</p>
    <p style="text-align: justify;"><i>We face significant competition in an environment of rapid technological and scientific change, and there is a possibility that our competitors may achieve regulatory approval before us or develop therapies that are safer, more advanced or more effective than ours, which may negatively impact our ability to successfully market or commercialize any product candidates we may develop and ultimately harm our financial condition.</i></p>
    <p style="text-align: justify;">The development and commercialization of new drug products is highly competitive. We may face competition with respect to any product candidates that we seek to develop or commercialize in the future from major pharmaceutical companies, specialty pharmaceutical companies, and biotechnology companies worldwide. Potential competitors also include academic institutions, government agencies, and other public and private research organizations that conduct research, seek patent protection, and establish collaborative arrangements for research, development, manufacturing, and commercialization.</p>
    <p style="text-align: justify;">If any of these competitors or competitors for our other product candidates receive FDA approval before we do, our product candidates would not be the first treatment on the market, and our market share may be limited.</p>
    <p style="text-align: justify;">In addition to competition from other companies targeting our target indications, any products we may develop may also face competition from other types of therapies.</p>
    <p style="text-align: justify;">Many of our current or potential competitors, either alone or with their strategic partners, have significantly greater financial resources and expertise in research and development, manufacturing, preclinical testing, conducting clinical trials, obtaining regulatory approvals, and marketing approved products than we do.</p>
    <div id="footer_page_49">
        <p style="text-align: center;">- 49 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_50"></a>
    <p style="text-align: justify;">Mergers and acquisitions in the pharmaceutical and biotechnology industries may result in even more resources being concentrated among a smaller number of our competitors. Smaller or early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These competitors also compete with us in recruiting and retaining qualified scientific and management personnel and establishing clinical trial sites and patient registration for clinical trials, as well as in acquiring technologies complementary to, or necessary for, our programs. Our commercial opportunity could be reduced or eliminated if our competitors develop and commercialize products that are safer, more effective, have fewer or less severe side effects, are more convenient, or are less expensive than any products that we may develop. Furthermore, currently approved products could be discovered to have application for treatment of our targeted disease indications or similar indications, which could give such products significant regulatory and market timing advantages over our product candidates. Our competitors also may obtain FDA or other regulatory approval for their products more rapidly than we may obtain approval for ours and may obtain orphan product exclusivity from the FDA for indications that we are targeting, which could result in our competitors establishing a strong market position before we are able to enter the market. Additionally, products or technologies developed by our competitors may render our potential product candidates uneconomical or obsolete and we may not be successful in marketing any product candidates we may develop against competitors.</p>
    <p style="text-align: justify;">In addition, we could face litigation or other proceedings with respect to the scope, ownership, validity and/or enforceability of our patents relating to our competitors' products and our competitors may allege that our products infringe, misappropriate or otherwise violate their intellectual property. The availability of our competitors' products could limit the demand, and the price we are able to charge, for any products that we may develop and commercialize.</p>
    <p style="text-align: justify;"><i>If the contract manufacturing facilities on which we rely do not continue to meet regulatory requirements or are unable to meet our supply demands, our business will be harmed.</i></p>
    <p style="text-align: justify;">All entities involved in the preparation of product candidates for clinical trials or commercial sale, including our existing CMOs for all of our product candidates, are subject to extensive regulation. Components of a finished therapeutic product approved for commercial sale or used in late-stage clinical trials must be manufactured in accordance with good manufacturing practices, or similar regulatory requirements outside the United States. These regulations govern manufacturing processes and procedures, including recordkeeping, and the implementation and operation of quality systems to control and assure the quality of investigational products and products approved for sale. Poor control of production processes can lead to the introduction of contaminants or to inadvertent changes in the properties or stability of our product candidates. Our failure, or the failure of third-party manufacturers, to comply with applicable regulations could result in sanctions being imposed on us, including clinical holds, fines, injunctions, civil penalties, delays, suspension or withdrawal of approvals, license revocation, suspension of production, seizures or recalls of product candidates or marketed drugs, operating restrictions and criminal prosecutions, any of which could significantly and adversely affect clinical or commercial supplies of our product candidates.</p>
    <p style="text-align: justify;">We or our CMOs must supply all necessary documentation in support of a new drug application, biologics license application or marketing authorization application on a timely basis and must adhere to regulations enforced by the FDA and other regulatory agencies through their facilities inspection program. Some of our CMOs have never produced a commercially approved pharmaceutical product and therefore have not obtained the requisite regulatory authority approvals to do so. The facilities and quality systems of some or all of our third-party contractors must pass a pre-approval inspection for compliance with the applicable regulations as a condition of regulatory approval of our product candidates or any of our other potential products. In addition, the regulatory authorities may, at any time, audit or inspect a manufacturing facility involved with the preparation of our product candidates or our other potential products or the associated quality systems for compliance with the regulations applicable to the activities being conducted. Although we oversee the CMOs, we cannot control the manufacturing process of, and are completely dependent on, our CMO partners for compliance with the regulatory requirements. If these facilities do not pass a pre-approval plant inspection, regulatory approval of the products may not be granted or may be substantially delayed until any violations are corrected to the satisfaction of the regulatory authority, if ever.</p>
    <div id="footer_page_50">
        <p style="text-align: center;">- 50 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_51"></a>
    <p style="text-align: justify;">The regulatory authorities also may, at any time following approval of a product for sale, audit the manufacturing facilities of our third-party contractors. If any such inspection or audit identifies a failure to comply with applicable regulations or if a violation of our product specifications or applicable regulations occurs independent of such an inspection or audit, we or the relevant regulatory authority may require remedial measures that may be costly and/or time consuming for us or a third party to implement, and that may include the temporary or permanent suspension of a clinical study or commercial sales or the temporary or permanent closure of a facility. Any such remedial measures imposed upon us or third parties with whom we contract could materially harm our business.</p>
    <p style="text-align: justify;">Additionally, if supply from one approved manufacturer is interrupted, an alternative manufacturer would need to be qualified through a new drug application, biologics license application supplement or marketing authorization application variation, or equivalent other regulatory filing, which could result in further delay. The regulatory agencies may also require additional studies if a new manufacturer is relied upon for commercial production. Switching manufacturers may involve substantial costs and is likely to result in a delay in our desired clinical and commercial timelines.</p>
    <p style="text-align: justify;">These factors could cause us to incur higher costs and could cause the delay or termination of clinical trials, regulatory submissions, required approvals, or commercialization of our product candidates. Furthermore, if our suppliers fail to meet contractual requirements and we are unable to secure one or more replacement suppliers capable of production at a substantially equivalent cost, our clinical trials may be delayed or we could lose potential revenue.</p>
    <p style="text-align: justify; margin-left: 54pt; text-indent: -54pt;"><b>Risks Related to our Intellectual Property</b></p>
    <p style="text-align: justify;"><i>If we are unable to obtain and maintain sufficient intellectual property protection for our products, or if the scope of the intellectual property protection obtained is not sufficiently broad, our competitors could develop and commercialize product candidates similar or identical to ours, and our ability to successfully commercialize our products may be impaired.</i></p>
    <p style="text-align: justify;">As is the case with other pharmaceutical and biopharmaceutical companies, our success depends in large part on our ability to obtain and maintain protection of the intellectual property we may own solely and jointly with others, particularly patents, in the United States and other countries with respect to our product candidates and technology. We seek to protect our proprietary position by filing patent applications in the United States and abroad related to micro-PEA or other product candidates that we may identify.</p>
    <p style="text-align: justify;">Obtaining and enforcing pharmaceutical and biopharmaceutical patents is costly, time consuming and complex, and we may not be able to file and prosecute all necessary or desirable patent applications, or maintain, enforce and license any patents that may issue from such patent applications, at a reasonable cost or in a timely manner. It is also possible that we will fail to identify patentable aspects of our research and development output before it is too late to obtain patent protection. We may not have the right to control the preparation, filing and prosecution of patent applications, or to maintain the rights to patents licensed to third parties. Therefore, these patents and applications may not be prosecuted and enforced in a manner consistent with the best interests of our business.</p>
    <p style="text-align: justify;">The patent position of biotechnology and pharmaceutical companies generally is highly uncertain, involves complex legal, technological and factual questions and has in recent years been the subject of much litigation. In addition, the laws of other countries may not protect our rights to the same extent as the laws of the United States, or vice versa. Further, we may not be aware of all third-party intellectual property rights potentially relating to our product candidates. Publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the United States and other jurisdictions are typically not published until 18 months after filing or, in some cases, not at all. Therefore, we cannot know with certainty whether we were the first to make the inventions claimed in our patents or pending patent applications, or that we were the first to file for patent protection of such inventions. Furthermore, the scope of a patent claim is determined by an interpretation of the law, the written disclosure in a patent and the patent's prosecution history and can involve other factors such as expert opinion. Our analysis of these issues, including interpreting the relevance or the scope of claims in a patent or a pending application, determining applicability of such claims to our proprietary technologies or product candidates, predicting whether a third party's pending patent application will issue with claims of relevant scope, and determining the expiration date of any patent in the United States or abroad that we consider relevant may be incorrect, which may negatively impact our ability to develop and market our product candidates. We do not always conduct independent reviews of pending patent applications of and patents issued to third parties. As a result, the issuance, scope, validity, enforceability and commercial value of our patent rights are highly uncertain. Our pending and future patent applications may not result in patents being issued that protect our product candidates, in whole or in part, or which effectively prevent others from commercializing competitive product candidates. Even if our patent applications issue as patents, they may not issue in a form that will provide us with any meaningful protection, prevent competitors from competing with us or otherwise provide us with any competitive advantage. Our competitors may be able to circumvent our patents by developing similar or alternative product candidates in a non-infringing manner.</p>
    <div id="footer_page_51">
        <p style="text-align: center;">- 51 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_52"></a>
    <p style="text-align: justify;">Our ability to enforce patent rights also depends on our ability to detect infringement. It may be difficult to detect infringers who do not advertise the components or methods that are used in connection with their products and services. Moreover, it may be difficult or impossible to obtain evidence of infringement in a competitor's or potential competitor's product or service. We may not prevail in any lawsuits that we initiate and the damages or other remedies awarded if we were to prevail may not be commercially meaningful. If we initiate lawsuits to protect or enforce our patents, or litigate against third-party claims, such proceedings would be expensive and would divert the attention of our management and technical personnel. Such proceedings could also provoke third parties to assert claims against us, including that some or all of the claims in one or more of our patents are invalid or otherwise unenforceable.</p>
    <p style="text-align: justify;">Moreover, we may be subject to a third-party pre-issuance submission of prior art to the USPTO, or become involved in opposition, derivation, reexamination, inter partes review, post-grant review or interference proceedings challenging our patent rights or the patent rights of others. An adverse determination in any such submission, proceeding or litigation could reduce the scope of, or invalidate, our patent rights, allow third parties to commercialize our product candidates and compete directly with us, without payment to us, or result in our inability to manufacture or commercialize drugs without infringing third- party patent rights. In addition, if the breadth or strength of protection provided by our patents and patent applications is threatened, regardless of the outcome, it could dissuade companies from collaborating with us to license, develop or commercialize current or future product candidates.</p>
    <p style="text-align: justify;">In addition, the issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability, and our patents may be challenged in the courts or patent offices in the United States and abroad. Such challenges may result in loss of exclusivity or freedom to operate or in patent claims being narrowed, invalidated or held unenforceable, in whole or in part, which could limit our ability to stop others from using or commercializing similar or identical product candidates to ours, or limit the duration of the patent protection of our product candidates. Given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting such candidates might expire before or shortly after such candidates are commercialized. As a result, our patent portfolio may not provide us with sufficient rights to exclude others from commercializing drugs similar or identical to ours.</p>
    <p style="text-align: justify;"><i>Third-party claims of intellectual property infringement may prevent or delay our development and commercialization efforts.</i></p>
    <p style="text-align: justify;">Our commercial success depends in part on our avoiding infringement of the patents and proprietary rights of third parties. However, our research, development and commercialization activities may be subject to claims that we infringe or otherwise violate patents or other intellectual property rights owned or controlled by third parties. There is a substantial amount of litigation, both within and outside the United States, involving patent and other intellectual property rights in the biotechnology and pharmaceutical industries, including patent infringement lawsuits, interferences, oppositions and inter partes re-examination proceedings before the USPTO, and corresponding patent offices in other countries. Numerous U.S. and international issued patents and pending patent applications, which are owned by third parties, exist in the fields in which we are pursuing development candidates. As the biotechnology and pharmaceutical industries expand and more patents are issued, the risk increases that our products may be subject to claims of infringement of the patent rights of third parties.</p>
    <div id="footer_page_52">
        <p style="text-align: center;">- 52 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_53"></a>
    <p style="text-align: justify;">Other third parties may assert that we are employing their proprietary technology without authorization. There may be other third-party patents or patent applications with claims to materials, formulations, methods of manufacture or methods for treatment related to the use or manufacture of micro-PEA. Because patent applications can take many years to issue, there may be currently pending patent applications which may later result in issued patents that micro-PEA or other product candidates that we may identify may infringe. In addition, third parties may obtain patents in the future and claim that use of our technologies infringes upon these patents. If any third-party patents were held by a court of competent jurisdiction to cover the manufacturing process of micro-PEA or other product candidates that we may identify, any molecules formed during the manufacturing process or any final product itself, the holders of any such patents may be able to block our ability to commercialize such product candidate unless we obtained a license under the applicable patents, or until such patents expire.</p>
    <p style="text-align: justify;">Similarly, if any third-party patents were held by a court of competent jurisdiction to cover aspects of our formulations, processes for manufacture or methods of use, including combination therapy, the holders of any such patents may be able to block our ability to develop and commercialize the applicable product candidate unless we obtained a license or until such patent expires. In either case, such a license may not be available on commercially reasonable terms or at all, or it may be non-exclusive, which could result in our competitors gaining access to the same intellectual property.</p>
    <p style="text-align: justify;">Parties making claims against us may obtain injunctive or other equitable relief, which could effectively block our ability to further develop and commercialize micro-PEA or other product candidates that we may identify. Defense of these claims, regardless of their merit, would involve substantial litigation expense and would be a substantial diversion of employee resources from our business. In the event of a successful claim of infringement against us, we may have to pay substantial damages, including treble damages and attorneys' fees for willful infringement, pay royalties, redesign our infringing products or obtain one or more licenses from third parties, which may be impossible or require substantial time and monetary expenditure.</p>
    <p style="text-align: justify;">Parties making claims against us, may be able to sustain the costs of complex patent litigation more effectively than we can because they have substantially greater resources. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation or administrative proceedings, there is a risk that some of our confidential information could be compromised by disclosure. In addition, any uncertainties resulting from the initiation and continuation of any litigation could have material adverse effect on ability to raise additional funds or otherwise have a material adverse effect on our business, results of operations, financial condition and prospects.</p>
    <p style="text-align: justify;"><i>Patent terms may be inadequate to protect our competitive position on product candidates for an adequate amount of time.</i></p>
    <p style="text-align: justify;">Patents have a limited lifespan. In the United States, if all maintenance fees are timely paid, the natural expiration of a patent is generally 20 years from its earliest U.S. non-provisional or international patent application filing date. Various extensions may be available, but the life of a patent, and the protection it affords, is limited. Even if patents covering our product candidates are obtained, once the patent life has expired, we may be open to competition from competitive products, including generics or biosimilars. Given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting such candidates might expire before or shortly after such candidates are commercialized. As a result, our owned and licensed patent portfolio may not provide us with sufficient rights to exclude others from commercializing products similar or identical to ours.</p>
    <p style="text-align: justify;"><i>If we are not able to obtain patent term extension or non-patent exclusivity in the United States under the Hatch- Waxman Act and in other countries under similar legislation, thereby potentially extending the marketing exclusivity term of our product candidates, our business may be materially harmed.</i></p>
    <div id="footer_page_53">
        <p style="text-align: center;">- 53 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_54"></a>
    <p style="text-align: justify;">Depending upon the timing, duration and specifics of FDA marketing approval of our product candidates, one of the U.S. patents covering each of such product candidates or the use thereof may be eligible for up to five years of patent term extension under the <i>Hatch-Waxman Act</i>. The<i> Hatch-Waxman Act </i>allows a maximum of one patent to be extended per FDA approved product as compensation for the patent term lost during the FDA regulatory review process. A patent term extension cannot extend the remaining term of a patent beyond a total of 14 years from the date of product approval and only those claims covering such approved drug product, a method for using it or a method for manufacturing it may be extended. Patent term extension also may be available in certain other countries upon regulatory approval of our product candidates. Nevertheless, we may not be granted patent term extension either in the United States or in any other country because of, for example, failing to exercise due diligence during the testing phase or regulatory review process, failing to apply within applicable deadlines, failing to apply prior to expiration of relevant patents or otherwise failing to satisfy applicable requirements. Moreover, the term of extension, as well as the scope of patent protection during any such extension, afforded by the governmental authority could be less than we request.</p>
    <p style="text-align: justify;">If we are unable to obtain patent term extension or restoration, or the term of any such extension is less than we request, the period during which we will have the right to exclusively market our product may be shortened and our competitors may obtain approval of competing products following our patent expiration sooner, and our revenue could be reduced, possibly materially.</p>
    <p style="text-align: justify;">It is possible that we will not obtain patent term extension under the Hatch-Waxman Act for a U.S. patent covering a product candidate even where that patent is eligible for patent term extension, or if we obtain such an extension, it may be for a shorter period than we had sought. Further, for certain of our licensed patents, we do not have the right to control prosecution, including filing with the USPTO, a petition for patent term extension under the Hatch-Waxman Act. Thus, if one of our licensed patents is eligible for patent term extension under the Hatch- Waxman Act, we may not be able to control whether a petition to obtain a patent term extension is filed, or obtained, from the USPTO.</p>
    <p style="text-align: justify;"><i>If we are unable to protect the confidentiality of our trade secrets, the value of our technology could be materially adversely affected and our business would be harmed.</i></p>
    <p style="text-align: justify;">We seek to protect our confidential proprietary information, in part, by confidentiality agreements and invention assignment agreements with our employees, consultants, scientific advisors, contractors and collaborators. These agreements are designed to protect our proprietary information. However, we cannot be certain that such agreements have been entered into with all relevant parties, and we cannot be certain that our trade secrets and other confidential proprietary information will not be disclosed or that competitors will not otherwise gain access to our trade secrets or independently develop substantially equivalent information and techniques. For example, any of these parties may breach the agreements and disclose proprietary information, including trade secrets, and we may not be able to obtain adequate remedies for such breaches. We also seek to preserve the integrity and confidentiality of our confidential proprietary information by maintaining physical security of our premises and physical and electronic security of our information technology systems, but it is possible that these security measures could be breached. If any of our confidential proprietary information were to be lawfully obtained or independently developed by a competitor, we would have no right to prevent such competitor from using that technology or information to compete with us, which could harm our competitive position.</p>
    <p style="text-align: justify;">Unauthorized parties may also attempt to copy or reverse engineer certain aspects of our products that we consider proprietary. We may not be able to obtain adequate remedies in the event of such unauthorized use. Enforcing a claim that a party illegally disclosed or misappropriated a trade secret can be difficult, expensive and time-consuming, and the outcome is unpredictable. In addition, some courts inside and outside the United States are less willing or unwilling to protect trade secrets. Trade secrets will also over time be disseminated within the industry through independent development, the publication of journal articles and the movement of personnel skilled in the art from corporation to corporation or academic to industry scientific positions. Though our agreements with third parties typically restrict the ability of our advisors, employees, collaborators, licensors, suppliers, third-party contractors and consultants to publish data potentially relating to our trade secrets, our agreements may contain certain limited publication rights. In addition, if any of our trade secrets were to be lawfully obtained or independently developed by a competitor, we would have no right to prevent such competitor from using that technology or information to compete with us, which could harm our competitive position. Despite employing the contractual and other security precautions described above, the need to share trade secrets increases the risk that such trade secrets become known by our competitors, are inadvertently incorporated into the technology of others, or are disclosed or used in violation of these agreements. If any of these events occurs or if we otherwise lose protection for our trade secrets, the value of this information may be greatly reduced and our competitive position, business, results of operations, financial conditions, and prospects would be harmed.</p>
    <div id="footer_page_54">
        <p style="text-align: center;">- 54 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_55"></a>
    <p style="text-align: justify;"><i>If our trademarks and trade names are not adequately protected, then we may not be able to build name recognition in our markets of interest and our business may be adversely affected.</i></p>
    <p style="text-align: justify;">Our registered or unregistered trademarks or trade names may be challenged, infringed, circumvented or declared generic or determined to be infringing on other marks. We may not be able to protect our rights to these trademarks and trade names, which we need to build name recognition among potential collaborators or customers in our markets of interest. At times, competitors may adopt trade names or trademarks similar to ours, thereby impeding our ability to build brand identity and possibly leading to market confusion. In addition, there could be potential trade name or trademark infringement claims brought by owners of other trademarks or trademarks that incorporate variations of our registered or unregistered trademarks or trade names. Over the long term, if we are unable to establish name recognition based on our trademarks and trade names, then we may not be able to compete effectively and our business may be adversely affected. We may license our trademarks and trade names to third parties, such as distributors. Though these license agreements may provide guidelines for how our trademarks and trade names may be used, a breach of these agreements or misuse of our trademarks and tradenames by our licensees may jeopardize our rights in or diminish the goodwill associated with our trademarks and trade names. Our efforts to enforce or protect our proprietary rights related to trademarks, trade names, trade secrets, domain names, copyrights or other intellectual property may be ineffective and could result in substantial costs and diversion of resources and could adversely affect our competitive position, business, results of operations, financial condition and prospects.</p>
    <p style="text-align: justify;"><i>We may be subject to claims challenging the inventorship of our patents and other intellectual property.</i></p>
    <p style="text-align: justify;">Our agreements with employees and our personnel policies provide that any inventions conceived by an individual in the course of rendering services to us shall be our exclusive property. Although our policy is to have all such individuals complete these agreements, we may not obtain these agreements in all circumstances, and individuals with whom we have these agreements may not comply with their terms. The assignment of intellectual property may not be automatic upon the creation of an invention and despite such agreement, such inventions may become assigned to third parties. In the event of unauthorized use or disclosure of our trade secrets or proprietary information, these agreements, even if obtained, may not provide meaningful protection, particularly for our trade secrets or other confidential information.</p>
    <p style="text-align: justify;">We or our licensors may be subject to claims that former employees, collaborators or other third parties have an interest in our owned or licensed patents, trade secrets, or other intellectual property as an inventor or co- inventor. For example, we or our licensors may have inventorship disputes arise from conflicting obligations of employees, consultants or others who are involved in developing our product candidates. Litigation may be necessary to defend against these and other claims challenging inventorship or our or our licensors' ownership of our owned or licensed patents, trade secrets or other intellectual property. If we or our licensors fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights, such as exclusive ownership of, or right to use, intellectual property that is important to our product candidates. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees.</p>
    <p style="text-align: justify;">Any of the foregoing could have a material adverse effect on our competitive position, business, results of operations, financial condition and prospects.</p>
    <div id="footer_page_55">
        <p style="text-align: center;">- 55 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_56"></a>
    <p style="text-align: justify;"><i>We may be subject to claims that our employees, consultants or independent contractors have wrongfully used or disclosed confidential information of third parties or that our employees have wrongfully used or disclosed alleged trade secrets of their former employers.</i></p>
    <p style="text-align: justify;">As is common in the biotechnology and pharmaceutical industry, we employ individuals who were previously employed at universities or other biotechnology or pharmaceutical companies, including our competitors or potential competitors. Although we try to ensure that our employees, consultants and independent contractors do not use the proprietary information or know-how of others in their work for us, we may be subject to claims that we or our employees, consultants or independent contractors have inadvertently or otherwise used or disclosed intellectual property, including trade secrets or other proprietary information, of any of our employee's former employer or other third parties. Litigation may be necessary to defend against these claims. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel, which could adversely impact our business. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees.</p>
    <p style="text-align: justify;"><i>We may not be able to protect our intellectual property rights throughout the world.</i></p>
    <p style="text-align: justify;">Filing, prosecuting and defending patents on our product candidates in all countries throughout the world would be prohibitively expensive, and our intellectual property rights in some countries outside the United States can be less extensive than those in the United States. In addition, the laws of some other countries do not protect intellectual property rights to the same extent as federal and state laws in the United States. Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the United States, or from selling or importing products made using our inventions in and into the United States or other jurisdictions. Competitors may use our technologies in jurisdictions where we have not obtained patent protection to develop their own products and may also export infringing products to territories where we have patent protection, but enforcement is not as strong as that in the U.S. These products may compete with our products and our patents or other intellectual property rights may not be effective or sufficient to prevent them from competing.</p>
    <p style="text-align: justify;">Many companies have encountered significant problems in protecting and defending intellectual property rights in other jurisdictions. The legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents, trade secrets, and other intellectual property protection, particularly those relating to biotechnology and pharmaceutical products, which could make it difficult for us to stop the infringement of our patents or marketing of competing products in violation of our proprietary rights generally. Proceedings to enforce our patent rights in other jurisdictions, whether or not successful, could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly and our patent applications at risk of not issuing and could provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate and the damages or other remedies awarded, if any, may not be commercially meaningful. Accordingly, our efforts to enforce our intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license.</p>
    <p style="text-align: justify; margin-left: 54pt; text-indent: -54pt;"><b>General Corporate Risks</b></p>
    <p style="text-align: justify;"><i>Public health crises, including the ongoing novel coronavirus (COVID-19) pandemic, could have significant economic and geopolitical impacts that may adversely affect the Corporation's business, financial condition and/or results of operations.</i></p>
    <p style="text-align: justify;">The Corporation's financial and/or operating performance could be materially adversely affected by the public health crisis resulting from the ongoing COVID-19 pandemic and other similar public health crises. Such public health crises, including the ongoing COVID-19 pandemic, and economic and geopolitical impacts caused as a result of such public health crises, can result in volatility and disruption to global supply chains, trade and market sentiment, mobility of people, and global financial markets, which could affect interest rates, credit ratings, credit risk, inflation, business, liquidity and volatility of capital markets, financing opportunities, financial conditions and results of operations, and other factors relevant to the Corporation. In addition, such public health crises may subject the Corporation to risks related to employee health and safety, slowdowns or temporary suspensions of operations in impacted locations, temporary or indefinite delays in the completion of our clinical trials, additional non-compensable costs, and/or the cancellation of contracts, all of which could negatively impact the Corporation's business, financial condition and/or results of operations.</p>
    <div id="footer_page_56">
        <p style="text-align: center;">- 56 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_57"></a>
    <p style="text-align: justify;"><i>The Corporation's limited operating history makes it difficult to evaluate its current business and future prospects and may increase the risk that it will not be successful. We have incurred significant losses since our inception, and we anticipate that we will continue to incur significant losses for the foreseeable future.</i></p>
    <p style="text-align: justify;">The Corporation is therefore subject to many of the risks common to early-stage enterprises, including undercapitalization, cash shortages, limitations with respect to personnel, financial, and other resources and lack of revenues. The Corporation's limited operating history makes it difficult to evaluate its current business and future prospects. There is no assurance that the Corporation will be successful in achieving a return on shareholders' investment and the likelihood of success must be considered in light of the early stage of operations.</p>
    <p style="text-align: justify;">Future transfers by holders of Class A Shares to arm's length parties or other than to permitted holders will generally result in those shares converting to Class B Shares, which will have the effect, over time, of increasing the relative voting power of those holders of Class A Shares who retain their shares. Such holders could, in the future, control a significant percentage of the combined voting power of Class A Shares and Class B Shares.</p>
    <p style="text-align: justify;">Each of the Corporation's directors and officers owes a fiduciary duty to the Corporation and must act honestly and in good faith with a view to the best interests of Corporation. However, any director and/or officer that is a shareholder, even a controlling shareholder, is entitled to vote its shares in its own interests, which may not always be in the interests of the Corporation's shareholders generally. The inability of the Class B Shares to control the matters affecting the Corporation, combined with the ability of holders of Class A Shares to control matters affecting the Corporation and to take actions that the holders of Class B Shares may not view as beneficial, may adversely affect the market price of the Class B Shares.</p>
    <p style="text-align: justify;"><i>The Corporation is vulnerable to rising energy costs.</i></p>
    <p style="text-align: justify;">Rising or volatile energy costs may adversely impact the business of the Corporation and its ability to operate profitably.</p>
    <p style="text-align: justify;"><i>The Corporation is required to comply with environmental, health and safety laws and regulations.</i></p>
    <p style="text-align: justify;">Our operations are subject to environmental and safety laws and regulations concerning, among other things, zoning, emissions and discharges to water, air and land, the handling and disposal of hazardous and non- hazardous materials and wastes, and employee health and safety. Failure to comply with applicable environmental laws, regulations and permitting requirements may result in enforcement actions thereunder, including orders issued by regulatory or judicial authorities causing operations to cease or be curtailed, and may include corrective measures requiring capital expenditures, installation of additional equipment, or remedial actions. We may be required to compensate those suffering loss or damage due to our operations and may have civil or criminal fines or penalties imposed for violations of applicable laws or regulations. In particular, the Corporation may face liabilities arising from environmental issues related to the former use of the Facility and the former owner of the Facility has no obligation to indemnify the Corporation in respect of any such liabilities. The Corporation is also subject to zoning and other local regulations that may interfere with the Corporation's activities. For example, several buildings on the Corporation's property have been designated by the Town of Cobourg as buildings of cultural heritage value under the <i>Ontario Heritage Act </i>and the Corporation is obligated to preserve, and in some cases to repair, such buildings. Changes in environmental, employee health and safety or other laws, more vigorous enforcement thereof or other unanticipated events could require extensive changes to our operations or give rise to material liabilities. If any of the foregoing matters were to occur it could have a material adverse effect on our business, results of operations, financial condition and prospects.</p>
    <div id="footer_page_57">
        <p style="text-align: center;">- 57 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_58"></a>
    <p style="text-align: justify;"><i>The Corporation is subject to insurance risks.</i></p>
    <p style="text-align: justify;">The Corporation's business is subject to a number of risks and hazards generally, including adverse environmental conditions, cybersecurity and other IT systems risks, accidents, labour disputes, product liability and changes in the regulatory environment. Such occurrences could result in damage to assets, personal injury or death, environmental damage, delays in operations, monetary losses and possible legal liability.</p>
    <p style="text-align: justify;">Although the Corporation maintains and intends to continue to maintain insurance to protect against certain risks in such amounts as it considers to be reasonable, its insurance will not cover all the potential risks associated with its operations. The Corporation may also be unable to maintain insurance to cover these risks at economically feasible premiums. Insurance coverage may not continue to be available or may not be adequate to cover any resulting liability. Moreover, insurance against risks such as environmental pollution or other hazards encountered in the operations of the Corporation is not generally available on acceptable terms. The Corporation might also become subject to liability for pollution or other hazards which may not be insured against or which the Corporation may elect not to insure against because of premium costs or other reasons. Losses from these events may cause the Corporation to incur significant costs that could have a material adverse effect upon its business, results of operations, financial condition and prospects.</p>
    <p style="text-align: justify;"><i>Any significant interruption in the supply chain for key inputs could materially impact the Corporation's business.</i></p>
    <p style="text-align: justify;">Our business is dependent on a number of key inputs and their related costs including raw materials and supplies, as well as electricity, water and other local utilities. Any significant interruption or negative change in the availability or economics of the supply chain for key inputs could materially impact our business, financial condition and operating results. Any inability to secure required supplies and services or to do so on appropriate terms could have a material adverse impact on our business, financial condition and operating results.</p>
    <p style="text-align: justify;"><i>No assurances can be given that the Corporation will be successful in maintaining its required supply of skilled labour, specialized knowledge, equipment, parts and components.</i></p>
    <p style="text-align: justify;">The ability of the Corporation to research and develop pharmaceutical products will be dependent on it having access to, at a reasonable cost and in a timely manner, skilled labour, individuals with specialized knowledge, equipment, parts and components. No assurances can be given that the Corporation will be successful in maintaining its required supply of skilled labour, individuals with specialized knowledge, equipment, parts and components. It is also possible that the final costs of the major equipment contemplated by the Corporation may be significantly greater than anticipated by management, and may be greater than funds available, in which circumstance the Corporation may curtail, or extend the timeframes for completing, its capital expenditure plans. This could have an adverse effect on the operations and financial results of the Corporation.</p>
    <p style="text-align: justify;">Our future growth and success depend on our ability to recruit, retain, manage and motivate our qualified employees. The inability to hire or retain experienced personnel in the pharmaceutical field could adversely affect our ability to execute our business plan and harm our operating results. Due to the specialized scientific and managerial nature of our business, the Corporation relies heavily on its ability to attract and retain qualified scientific, technical and managerial personnel.In addition, competition for highly qualified personnel may be intense and there can be no assurance that we will be successful in identifying, attracting, hiring and retaining such personnel in the future. In particular, specialized knowledge with respect to research and clinical development is important to the pharmaceutical industry. If we are unable to identify, attract, hire and retain qualified personnel in the future, such inability could have a material adverse effect on our business, operating results and financial condition.</p>
    <p style="text-align: justify;"><i>A potential sale of the Facility is subject to various potential problems and uncertainties and may be delayed or adversely affected by a number of factors beyond the Corporation's control.</i></p>
    <p style="text-align: justify;">Three buildings that are part of the Facility have been designated by the Town of Cobourg as heritage buildings. The buildings must be retained, and the Corporation must follow the Town of Cobourg's by-laws and official plan regulations with respect to upkeep.</p>
    <div id="footer_page_58">
        <p style="text-align: center;">- 58 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_59"></a>
    <p style="text-align: justify;">There are risks that may have a material adverse effect on our business, operating results and financial condition, if the Corporation cannot sell the Facility and/or the Facility Property on terms favourable to the Corporation.</p>
    <p style="text-align: justify;"><i>Changes in laws, regulations and guidelines may result in significant compliance costs for our business..</i></p>
    <p style="text-align: justify;">The Corporation's operations are subject not only to a variety of laws, regulations and guidelines relating to the pharmaceutical industry, but also to regulations relating to health and safety, privacy, the conduct of operations and the protection of the environment in the jurisdictions in which they operate. Changes to such laws, regulations and guidelines, including changes related to government taxes and levies, may materially and adversely affect the Corporation's businesses, financial</p>
    <p style="text-align: justify;"><i>The shelf life of inventory could unexpectedly change and write-down of inventory may be required.</i></p>
    <p style="text-align: justify;">Management regularly reviews the amount of inventory on hand, reviews the remaining shelf life and estimates the time required to manufacture and sell such inventory; however, write-down of inventory may still be required due to extraneous factors such as lower prices in the market. Any such write-down of inventory could have a material adverse effect on our business, financial condition, and results of operations.</p>
    <p style="text-align: justify;"><i>The Corporation's products may be subject to recalls for a variety of reasons, which could require the Corporation to expend significant management and capital resources.</i></p>
    <p style="text-align: justify;">Manufacturers and distributors of products are sometimes subject to the recall or return of their products for a variety of reasons, including product defects, such as contamination, unintended harmful side effects or interactions with other substances, packaging safety and inadequate or inaccurate labeling disclosure. If any of the Corporation's products are recalled due to an alleged product defect or for any other reason, the Corporation could be required to incur the unexpected expense of the recall and any legal proceedings that might arise in connection with the recall. The Corporation may lose a significant amount of sales and may not be able to replace those sales at an acceptable margin or at all. In addition, a product recall may require significant management attention. Although the Corporation has detailed procedures in place for testing its products, there can be no assurance that any quality, potency or contamination problems will be detected in time to avoid unforeseen product recalls, regulatory action or lawsuits. Additionally, if one of the Corporation's significant brands were subject to recall, the image of that brand and the Corporation could be harmed. A recall for any of the foregoing reasons could lead to decreased demand for the Corporation's products and could have a material adverse effect on the results of the operations and financial condition of the Corporation. Additionally, product recalls may lead to increased scrutiny of the Corporation's operations by Health Canada or other regulatory agencies, requiring further management attention and potential legal fees and other expenses.</p>
    <p style="text-align: justify;"><i>The Corporation may decide to invest with certain strategic investors and/or other third parties through joint ventures or other entities from time to time, thereby subjecting it to co-investment risks.</i></p>
    <p style="text-align: justify;">The Corporation has, and may decide in the future to invest with certain strategic investors and/or other third parties through joint ventures or other entities. These parties may have different interests or superior rights to those of the Corporation. Although it is the general intent of the Corporation to retain control and superior rights associated with its investments, all of our current investments involve non-controlling stakes, and in respect of future acquisitions, under certain circumstances, it may be possible that the Corporation relinquishes such rights over certain of its investments and, therefore, may have a limited ability to protect its position therein. In those cases where the Corporation does maintain a control position with respect to its investments, the Corporation's investments may be subject to typical risks associated with third-party involvement, including the possibility that a third-party may have financial difficulties resulting in a negative impact on such investment, may have economic or business interests or goals that are inconsistent with those of the Corporation, or may be in a position to take (or block) action in a manner contrary to the Corporation's objectives. The Corporation may also, in certain circumstances, be liable for the actions of its third party partners or co-investors.</p>
    <div id="footer_page_59">
        <p style="text-align: center;">- 59 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_60"></a>
    <p style="text-align: justify;"><i>Failure to comply with laws and regulations could subject the Corporation to regulatory or agency proceedings which could divert management's attention and resources and have a material adverse impact on the Corporation's business, financial condition and results of operation.</i></p>
    <p style="text-align: justify;">The Corporation's business requires compliance with many laws and regulations. Failure to comply with these laws and regulations could subject the Corporation to regulatory or agency proceedings or investigations and could also lead to damage awards, fines and penalties. The Corporation may become involved in a number of government or agency proceedings, investigations and audits. The outcome of any regulatory or agency proceedings, investigations, audits, and other contingencies could harm the Corporation's reputation, require the Corporation to take, or refrain from taking, actions that could harm its operations or require the Corporation to pay substantial amounts of money, harming its financial condition. There can be no assurance that any pending or future regulatory or agency proceedings, investigations and audits will not result in substantial costs or a diversion of management's attention and resources or have a material adverse impact on the Corporation's business, financial condition and results of operation.</p>
    <p style="text-align: justify;"><i>There is substantial doubt about the Corporation's ability to continue as a going concern and if the Corporation is unable to obtain additional financing from outside sources and/or eventually generate enough revenues, it may be forced to sell a portion or all of its assets or curtail or discontinue its operations.</i></p>
    <p style="text-align: justify;">The Corporation's auditor has indicated in the Corporation's audited annual financial statements that there is substantial doubt about the Corporation's ability to continue as a going concern. The Corporation is in the preliminary stages of its planned operations and has not yet determined whether its processes and business plans are economically viable. The continued operations of the Corporation and the recoverability of amounts shown for property, plant and equipment in the Corporation's audited annual financial statements are dependent upon the ability of the Corporation to obtain sufficient financing to complete the development of its facilities and extraction processes, and if they are proven successful, the existence of future profitable production, or alternatively, upon the Corporation's ability to dispose of its interest on an advantageous basis, all of which are uncertain. Importantly, the inclusion in the Corporation's financial statements of a going concern opinion may negatively impact the Corporation's ability to raise future financing and achieve future revenue. If the Corporation is unable to obtain additional financing from outside sources and/or eventually generate enough revenues, the Corporation may be forced to sell a portion or all of the Corporation's assets or curtail or discontinue its operations. If any of these events happens, a prospective purchaser could lose all or part of its investment. In addition, the Corporation's financial statements do not include any adjustments to the Corporation's recorded assets or liabilities that might be necessary if the Corporation becomes unable to continue as a going concern.</p>
    <p style="text-align: justify;"><i>The Corporation has a history of losses and may not be able to generate sufficient revenue to be profitable or to generate positive cash flow on a sustained basis.</i></p>
    <p style="text-align: justify;">The Corporation has incurred losses since its inception in 2011. The Corporation may not be able to generate revenue, achieve or maintain profitability and may continue to incur significant losses in the future. In addition, the Corporation expects to continue to increase operating expenses as it implements initiatives to continue to grow its business. If the Corporation's revenues do not increase to offset these expected increases in costs and operating expenses, it will not be profitable.</p>
    <p style="text-align: justify;">Additionally, our costs are expected to increase in future periods, which could negatively affect our future operating results and ability to achieve and sustain profitability. We expect to continue to expend substantial financial and other resources on expanding our processing capability and production capacity and to pursue the commercialization of pharmaceutical products. These investments may not result in increased revenue or growth in the business. If we cannot successfully earn revenue at a rate that exceeds the costs associated with our business, we will not be able to achieve or sustain profitability or generate positive cash flow on a sustained basis and our revenue growth rate may decline. If we fail to continue to grow our revenue and overall business, our business, results of operations, financial condition and prospects could be materially adversely affected.</p>
    <div id="footer_page_60">
        <p style="text-align: center;">- 60 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_61"></a>
    <p style="text-align: justify;"><i>The Corporation may be unable to raise the capital necessary for it to execute its strategy on favorable terms or at all.</i></p>
    <p style="text-align: justify;">There is no guarantee that the Corporation will be able to execute on its strategy. Developing biopharmaceutical products is expensive and time-consuming, and we expect to require substantial additional capital to conduct research, preclinical testing and human studies, to potentially establish pilot scale and commercial scale manufacturing processes and facilities, and to establish and develop quality control, regulatory, marketing, sales and administrative capabilities to support our existing programs and pursue potential additional programs. We are or may in the future also be responsible for the payments to third parties of expenses that may include milestone payments, license maintenance fees and royalties, including in the case of certain of our agreements with academic institutions or other companies from whom intellectual property rights underlying their respective programs have been licensed or acquired. Because the outcome of any preclinical or clinical development and regulatory approval process is highly uncertain, we cannot reasonably estimate the actual amounts necessary to successfully complete the development, regulatory approval process and commercialization of any product candidates we may identify.&#160;</p>
    <p style="text-align: justify;">Our future funding requirements for the development of pharmaceutical products will depend on many factors, including, but not limited to:</p>
    <ul style="padding-left: 0pt;" type="disc">
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>time and cost necessary to complete ongoing and planned clinical trials;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the time and cost necessary to pursue regulatory approvals for our product candidates, and the costs of post-marketing studies that could be required by regulatory authorities;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the progress, timing, scope and costs of our nonclinical studies, preclinical studies, clinical trials and other related activities, including the ability to enroll patients in a timely manner, for the ongoing and planned clinical trials set forth above, and potential future clinical trials;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the costs of obtaining clinical and commercial supplies of raw materials and drug products for our product candidates;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>our ability to successfully identify and negotiate acceptable terms for third-party supply and contract manufacturing agreements with CMOs;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>our ability to successfully commercialize product candidates;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the manufacturing, selling and marketing costs associated with our product candidates, including the cost and timing of expanding our internal sales and marketing capabilities or entering into strategic collaborations with third parties to leverage or access these capabilities;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the amount and timing of sales and other revenues from our product candidates, if any are approved, including the sales price and the availability of adequate third-party reimbursement;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the cash requirements of any future acquisitions or discovery of product candidates;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the time and cost necessary to respond to technological and market developments;</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the costs of acquiring, licensing or investing in intellectual property rights, products, product candidates and businesses;</p>
        </li>
    </ul>
    <div id="footer_page_61">
        <p style="text-align: center;">- 61 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_62"></a>
    <ul style="padding-left: 0pt;" type="disc">
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>our ability to attract, hire and retain qualified personnel; and</p>
        </li>
        <li style="text-align: justify; margin-left: 27.6pt; padding-left: 8.4pt;">
            <p>the costs of maintaining, expanding and protecting our intellectual property.</p>
        </li>
    </ul>
    <p style="text-align: justify;">Additional funds may not be available when we need them, on terms that are acceptable, or at all. If adequate funds are not available to us on a timely basis, we may be required to delay, limit or terminate one or more research or development programs or the commercialization of any product candidates or be unable to expand operations or otherwise capitalize on business opportunities, as desired, which could materially affect our business, results of operations, financial condition and prospects.</p>
    <p style="text-align: justify;">In addition, the continued development of the Corporation's pharmaceutical operations will require significant additional financing over several years. The failure to raise such capital could result in the delay or indefinite postponement of current business strategy or the Corporation ceasing to carry on business. There can be no assurance that additional capital or other types of financing will be available if needed or that, if available, the terms of such financing will be favorable to the Corporation, at times for reasons beyond the Corporation's control. For example, economic downturns or uncertain market conditions, whether affecting the economy in general or the pharmaceutical industry in particular, could adversely impact the Corporation's ability to raise capital through equity or debt financing. In addition, any further issuances of equity securities could have a significant dilutive effect on the holders of Class B Shares.</p>
    <p style="text-align: justify;">In addition, from time to time, the Corporation may enter into transactions to acquire assets or the shares of other companies. These transactions may be financed wholly or partially with debt, which may temporarily increase the Corporation's debt levels above industry standards. Any debt financing secured in the future could involve restrictive covenants relating to capital raising activities and other financial and operational matters, which may make it more difficult for the Corporation to obtain additional capital and to pursue business opportunities, including potential acquisitions.</p>
    <p style="text-align: justify;"><i>The success of the Corporation is dependent upon its senior management and key personnel and ability to hire skilled personnel, and any loss of the services of such individuals could have a material adverse effect on the Corporation's business, operating results or financial condition.</i></p>
    <p style="text-align: justify;">Another risk associated with the production and sale of pharmaceutical products is the loss of important staff members. The success of the Corporation will be dependent upon the ability, expertise, judgment, discretion and good faith of its senior management and key personnel. While employment agreements are customarily used as a primary method of retaining the services of key employees, these agreements cannot assure the continued services of such employees. For example, during the 2019 fiscal year the Corporation experienced significant turnover of its senior management. Rupert Haynes was terminated as Chief Executive Officer on February 6, 2019, less than three months after his appointment, and Dr. Raza Bokhari was re-appointed interim Chief Executive Officer of the Corporation. On March 13, 2019, the Corporation announced the departure of Thomas Fairfull as President of FV Pharma and the subsequent appointment of Dr. Sara May as President of FV Pharma. On June 3, 2019, the Corporation announced that Dr. Raza Bokhari was appointed as permanent Chief Executive Officer. The Board has also engaged a consulting firm and has commenced the process of finding a permanent Chief Financial Officer to replace the Corporation's interim Chief Financial Officer. In addition, in connection with the closing of the Prismic acquisition, Prismic founders Zachary Dutton and Peter Moriarty have joined FSD in the roles of Chief Executive Officer of Prismic and Chairman of the Biosciences/Pharmaceuticals Industry Advisory Board, respectively. On January 26, 2021, Mr. Zeeshan Saeed was terminated, for cause, as President. The Corporation may not be able to find appropriate replacements for key personnel on a timely basis. Furthermore, each of our executive officers may terminate their employment with us at any time. We do not maintain "key person" insurance for any of our executives or employees. Recruiting and retaining qualified scientific and clinical personnel and, if we progress the development of our drug pipeline toward scaling up for commercialization, sales and marketing personnel, will also be critical to our success. The loss of the services of key personnel as well as the diversion of management's and the Board's attention to replace the services of such individuals, could have a material adverse effect on the Corporation's business, operating results or financial condition.</p>
    <div id="footer_page_62">
        <p style="text-align: center;">- 62 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_63"></a>
    <p style="text-align: justify;">In addition, the Corporation's future success depends on its continuing ability to attract, develop, motivate and retain highly qualified and skilled employees. Qualified individuals are in high demand, and the Corporation may incur significant costs to attract and retain them, if it is able to hire them at all.</p>
    <p style="text-align: justify;"><i>The Corporation's dual class structure has the effect of concentrating voting control and the ability to influence corporate matters with a limited number of holders of Class A Shares.</i></p>
    <p style="text-align: justify;">The Corporation's dual class structure has the effect of concentrating voting control and the ability to influence corporate matters with those shareholders. Currently, all 72 outstanding Class A Shares are held by the Corporation's founders. Class A Shares have 276,660 votes per share and Class B Shares have one vote per share. Shareholders who hold Class A Shares together hold approximately 51% of the voting power of the Corporation's outstanding voting shares and therefore have significant influence over management and affairs of the Corporation and over all matters requiring shareholder approval.</p>
    <p style="text-align: justify;">In addition, because of the voting ratio between Class A Shares and Class B Shares, the holders of Class A Shares collectively continue to control a majority of the combined voting power of the voting shares even where the Class A Shares represent a substantially reduced percentage of the total outstanding shares. The different voting rights could diminish the value of the Class B Shares to the extent that investors or any potential future purchasers of the Class B Shares attribute value to the superior voting or other rights of the Class A Shares. Holders of the Class B Shares will only have a right to vote, as a class, in limited circumstances as described in its constating documents.</p>
    <p style="text-align: justify;">The concentrated voting control of holders of Class A Shares limits the ability of Class B Shareholders to influence corporate matters and all matters requiring shareholder approval, including the election of directors as well as with respect to decisions regarding amendment of the Corporation's share capital, creating and issuing additional classes of shares, making significant acquisitions, selling significant assets or parts of our business, merging with other companies and undertaking other significant transactions.</p>
    <p style="text-align: justify;">As a result, holders of Class A Shares have the ability to control substantially all matters affecting us and actions may be taken that our holders of Class B Shares may not view as beneficial. The market price of the Class B Shares could be adversely affected due to the significant influence and voting power of the holders of Class A Shares. Additionally, the significant voting interest of holders of Class A Shares may discourage transactions involving a change of control, including transactions in which an investor, as a holder of the Class B Shares, might otherwise receive a premium for the Class B Shares over the then-current market price, or discourage competing proposals if a going private transaction is proposed by one or more holders of Class A Shares.</p>
    <p style="text-align: justify;"><i>There are upcoming matters at the Corporation's annual meeting of shareholders that could alter the Board.</i></p>
    <p style="text-align: justify;">At the Corporation's annual meeting of shareholders on May 14, 2021, a requisition for a special meeting has been submitted to the Corporation by the Requisitioning Shareholders, claiming to hold in excess of 5.1% of the Class B Shares, including Mr. Zeeshan Saeed, the former President of the Corporation and Mr. Anthony Durkacz, who is a director of the Corporation. In addition to the Class B Shares controlled by this group, Mr. Saeed and Mr. Durkacz each hold 24 Class A Shares, with each Class A Share being entitled to 276,660 votes. Dr. Raza Bokhari, the Corporation's Executive Chairman and Chief Executive Officer, holds the remaining 24 Class A Shares. As of the date hereof, the Corporation has 72 Class A Shares and approximately 35,114,998 Class B Shares issued and outstanding. The Requisitioning Shareholders are seeking to reduce the size of the Board to five, and to replace six of the incumbent directors, including Dr. Raza Bokhari, with three directors selected by such shareholders.</p>
    <p style="text-align: justify;"><i>The Corporation may be unable to manage its growth, including capacity constraints and pressure on our internal systems and controls, which may have a material adverse effect on the Corporation's business, results of operations, financial conditions and prospects.</i></p>
    <p style="text-align: justify;">The Corporation may be subject to growth-related risks including capacity constraints and pressure on its internal systems and controls. The ability of the Corporation to manage growth effectively will require it to continue to implement and improve its operational and financial systems and to expand, train and manage its employee base. The inability of the Corporation to deal with this growth may have a material adverse effect on the Corporation's business, results of operations, financial condition and prospects.</p>
    <div id="footer_page_63">
        <p style="text-align: center;">- 63 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_64"></a>
    <p style="text-align: justify;"><i>Management may not be able to successfully implement and maintain adequate internal controls over financial reporting or disclosure controls and procedures.</i></p>
    <p style="text-align: justify;">Effective internal controls are necessary for the Corporation to provide reliable financial reports and to help prevent fraud. Although the Corporation has undertaken a number of procedures and has implemented a number of safeguards, in each case, in order to help ensure the reliability of its financial reports, including those imposed on the Corporation under Canadian securities law, the Corporation cannot be certain that such measures will ensure that the Corporation will maintain adequate control over financial processes and reporting. Failure to implement required new or improved controls, or difficulties encountered in their implementation, could harm the Corporation's results of operations or cause it to fail to meet its reporting obligations.</p>
    <p style="text-align: justify;">Effective systems of internal control over financial reporting and disclosure are critical to the operation of a public corporation. However, we do not expect that our disclosure controls and procedures or internal control over financial reporting will prevent all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system's objectives will be met. Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of such controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. Due to the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and may not be detected in a timely manner or at all. If we cannot provide reliable financial reports or prevent fraud, our reputation and operating results could be materially adversely affected, which could cause investors to lose confidence in us and our reported financial information, which in turn could result in a reduction in the value of the Class B Shares.</p>
    <p style="text-align: justify;"><i>To date, the Corporation has not been required to certify in connection with its reports under applicable Canadian securities legislation that it maintains effective internal control over financial reporting or effective disclosure controls and procedures.</i></p>
    <p style="text-align: justify;">In contrast to the certificates that are now required of the Corporation pursuant to Rule 15d-14(a) under the U.S. Exchange Act, as a public corporation in the United States and the certificates required under NI 52-109, the Corporation utilizes the Venture Issuer Basic Certificate which does not include representations relating to the establishment and maintenance of disclosure controls and procedures and internal control over financial reporting. In particular, the certifying officers who have filed the Corporation's certificates have not previously made any representations relating to the establishment and maintenance of: (a) controls and other procedures designed to provide reasonable assurance that information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and (b) a process to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with IFRS.</p>
    <p style="text-align: justify;"><i>We will incur increased costs as a result of operating as a public corporation in the United States and our management will be required to devote substantial time to new compliance initiatives.</i></p>
    <p style="text-align: justify;">As a public corporation in the United States, we will incur significant legal, accounting, insurance and other expenses that we did not incur prior to being listed in the United States. In addition, the U.S. <i>Sarbanes-Oxley Act </i>(2002) and rules implemented by the U.S. Securities and Exchange Commission and the Nasdaq, impose various other requirements on public companies, and we will need to spend time and resources to ensure compliance with our reporting obligations under Canadian securities laws, as well as our obligations in the United States.</p>
    <p style="text-align: justify;">Being a public corporation in the United States and complying with applicable rules and regulations have made and will continue to make it more expensive for us to obtain director and officer liability insurance, and we may continue to be required to incur substantially higher costs to obtain and maintain the same or similar coverage that is currently in place in Canada. These factors could also make it more difficult for us to attract and retain qualified executive officers and members of our Board.</p>
    <div id="footer_page_64">
        <p style="text-align: center;">- 64 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_65"></a>
    <p style="text-align: justify;"><i>Risks related to our status as a foreign private issuer.</i></p>
    <p style="text-align: justify;">As a foreign private issuer, in reliance on Nasdaq rules that permit a foreign private issuer to follow the corporate governance practices of its home country, the Corporation is permitted to follow certain Canadian corporate governance practices instead of those otherwise required under the corporate governance standards for U.S. domestic issuers.</p>
    <p style="text-align: justify;">Further, as a foreign private issuer, the Corporation is exempt from a number of requirements under U.S. securities laws that apply to public companies that are not foreign private issuers. In particular, the Corporation is exempt from the rules and regulations under the U.S. Exchange Act related to the furnishing and content of proxy statements, and its officers, directors and principal shareholders are exempt from the reporting and short-swing profit recovery provisions contained in Section 16 of the U.S.<i> </i>Exchange Act. The Corporation is exempt from the provisions of Regulation FD, which prohibits the selective disclosure of material non-public information to, among others, broker-dealers and holders of a company's securities under circumstances in which it is reasonably foreseeable that the holder will trade in the company's securities on the basis of the information. Even though Canadian securities law requirements regarding the disclosure of material and non-public information by public companies are similar to U.S. securities law requirements and the Corporation voluntarily complies with Regulation FD, these exemptions and leniencies will reduce the frequency and scope of information and protections to which purchasers are entitled as investors.<i> </i></p>
    <p style="text-align: justify;"><i>We are an emerging growth corporation and intend to take advantage of reduced disclosure requirements applicable to emerging growth companies, which could make the Class B Shares less attractive to investors.</i></p>
    <p style="text-align: justify;">We are an "emerging growth corporation" as defined in the JOBS Act and anticipate remaining an emerging growth corporation for the foreseeable future. For so long as we remain an emerging growth corporation, we are permitted to and intend to rely upon exemptions from certain disclosure requirements that are applicable to other public companies that are not emerging growth companies. These exemptions include not being required to comply with the auditor attestation requirements of Section 404 of the JOBS Act.</p>
    <p style="text-align: justify;">We may take advantage of some, but not all, of the available exemptions available to emerging growth companies. We cannot predict whether investors will find the Class B Shares less attractive if we rely on these exemptions. If some investors find the Class B Shares less attractive as a result, there may be a less active trading market for the Class B Shares and our share price may be more volatile.</p>
    <p style="text-align: justify;"><i>We may not be able to successfully identify and execute future acquisitions or dispositions or to successfully manage the impacts of such transactions on our operations.</i></p>
    <p style="text-align: justify;">The Corporation has made and may continue to pursue acquisition opportunities to advance its strategic plan. The successful integration of an acquired business typically requires the management of the pre-acquisition business strategy, including the retention and addition of senior management, customers, realization of identified synergies, retention of key staff and the development of a common corporate culture. Achieving the benefits of acquisitions depends in part on successfully consolidating functions and integrating operations and procedures in a timely and efficient manner, as well as the ability to realize anticipated growth opportunities and synergies from newly formed partnerships. Any failure to integrate an acquired business or realize the anticipated benefits of new partnerships may have a material adverse effect on the Corporation's business, results of operations, financial condition and prospects, including its future prospects for acquisitions or partnerships. There is no assurance that the Corporation will be able to successfully integrate an acquired business in order to maximize or realize the benefits associated with an acquisition.</p>
    <p style="text-align: justify;">In addition, from time to time the Corporation enters into letters of intent and memoranda of understanding with respect to which definitive agreements have not yet been, but are expected to be, executed. The Corporation may not be able to perform under these contracts as a result of operational or other breaches or due to events beyond its control, and the Corporation may not be able to ultimately execute a definitive agreement in cases where one does not currently exist.</p>
    <div id="footer_page_65">
        <p style="text-align: center;">- 65 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_66"></a>
    <p style="text-align: justify;"><i>Any expansion of our international operations will result in increased operational, regulatory and other risks.</i></p>
    <p style="text-align: justify;">We may in the future expand into other geographic areas, which could increase our operational, regulatory, compliance, reputational and foreign exchange rate risks. The failure of our operating infrastructure to support such expansion could result in operational failures and regulatory fines or sanctions.</p>
    <p style="text-align: justify;"><i>The Corporation is reliant on the operations of its partners and has little or no control over such operations.</i></p>
    <p style="text-align: justify;">The Corporation has made investments in strategic partners and relies on such partners to execute on their business plans. Other than with respect to certain contractual arrangements, the Corporation has little or no control in or influence over the operations of its partners. Further, the interests of the Corporation and its partners may not always be aligned. As a result, the Corporation's projected cash flows that are dependent upon the operation of its partners are subject to the risk that its partners may: (i) have business interests or targets that are inconsistent with those of the Corporation; (ii) take action contrary to the Corporation's policies or objectives; (iii) be unable or unwilling to fulfill their obligations under their agreements with the Corporation; or (iv) experience financial, operational or other difficulties, including insolvency, which could limit or suspend a partner's ability to perform its obligations. In addition, payments may flow through the Corporation's partners and there is a risk of delay and additional expense in receiving such revenues. Failure to receive payments in a timely fashion, or at all, under the agreements to which the Corporation is entitled may have a material adverse effect on the Corporation. In addition, the Corporation must rely, in part, on the accuracy and timeliness of the information it receives from its partners and uses such information in its analyses, forecasts and assessments relating to its own business. If the information provided to the Corporation by its partners contains material inaccuracies or omissions, the Corporation's ability to accurately forecast or achieve its stated objectives, or satisfy its reporting obligations, may be materially impaired.</p>
    <p style="text-align: justify;"><i>The Corporation may become party to litigation from time to time which could adversely affect its business.</i></p>
    <p style="text-align: justify;">The Corporation may become party to litigation from time to time in the ordinary course of business which could adversely affect its business. In addition, the Corporation may become subject to class actions, securities litigation and other actions, including anti-trust and anti-competitive actions. Should any litigation in which the Corporation becomes involved be determined against the Corporation, such a decision could adversely affect the Corporation's ability to continue operating and the market price for Corporation's Class B Shares and could result in the use of significant resources. Even if the Corporation is involved in litigation and wins, litigation can redirect significant corporate resources and management attention.</p>
    <p style="text-align: justify;"><i>Settlement Agreement.</i></p>
    <p style="text-align: justify;">On October 29, 2020, the Corporation announced that it has entered into the Settlement Agreement with respect to the class action litigation commenced by a plaintiff shareholder in the Ontario Superior Court of Justice in February 2019 relating to the build-out of its facility in Cobourg, Ontario. The Settlement Agreement was approved by the Ontario Superior Court of Justice on February 4, 2021. In entering into the Settlement Agreement, the Corporation made no admissions of liability whatsoever. The Settlement Agreement provides for a full and final release of the Corporation, its officers, directors and various other related parties from any and all claims that arose or could have arisen from the claim issued by the plaintiff within the Settled Action. The Settlement Agreement provides for a settlement amount of $5,500,000, of which $4,571,459 has been funded with the proceeds of insurance and the remaining $928,541 has been funded by the Corporation.</p>
    <p style="text-align: justify;"><i>Claims from suppliers.</i></p>
    <p style="text-align: justify;">A dismissed contractor commenced a lien action combined with a breach of contract action in Ontario Superior Court of Justice (Cobourg) (the "Cobourg Superior Court") in early 2019 claiming approximately $1.7 million in various purported damages, with a claim for lien component of $188,309 which claim was registered November 26, 2018. The Corporation is defending the action and has taken steps to obtain particulars and inspect documents of the plaintiff which remain unaddressed to date. The Corporation has paid monies into court totalling $235,387 to vacate the lien from title which funds stand as security for the lien claim and its costs in Cobourg Superior Court of Justice file no. CV-19-0002. As such, full provision for the lien claim and security for costs has been made; however, the 2019 breach of contract claim has not been provisioned as the Corporation intends to defend itself from this claim.</p>
    <div id="footer_page_66">
        <p style="text-align: center;">- 66 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_67"></a>
    <p style="text-align: justify;"><i>Conflicts of interest may arise between the Corporation and its directors and officers as a result of other business activities undertaken by such individuals. </i></p>
    <p style="text-align: justify;">Certain directors and officers of the Corporation are, and may in the future become, directors and officers of other entities, or are otherwise engaged, and will continue to be engaged, in activities that may put them in conflict with the business strategy of the Corporation. In particular, certain directors and officers of the Corporation serve as directors or officers of entities that may compete with or have conflicting interests with the Corporation.</p>
    <p style="text-align: justify;">In addition, the Corporation's directors and the officers are required to act honestly and in good faith with a view to its best interests. However, in conflict of interest situations, the Corporation's directors and officers may owe the same duty to another corporation and will need to balance their competing interests with their duties to the Corporation. Circumstances (including with respect to future corporate opportunities) may arise that may be resolved in a manner that is unfavorable to the Corporation. These business interests could require the investment of significant time and attention by our executive officers and directors. In some cases our executive officers and directors may have fiduciary obligations associated with business interests that interfere with their ability to devote time to our business and affairs, which could adversely affect our operations.</p>
    <p style="text-align: justify;"><i>The Corporation has not paid dividends in the past and does not anticipate paying dividends in the near future.</i></p>
    <p style="text-align: justify;">The Corporation has not paid dividends in the past and does not anticipate paying dividends in the near future. The Corporation expects to retain earnings to finance the development and enhancement of its products and to otherwise reinvest in the Corporation's businesses. Any decision to declare and pay dividends in the future will be made at the discretion of the Board and will depend on, among other things, financial results, cash requirements, contractual restrictions and other factors that the Board may deem relevant. As a result, investors may not receive any return on investment in Class B Shares unless they sell them for a share price that is greater than that at which such investors purchased them.</p>
    <p style="text-align: justify;"><i>The Corporation's operations depend, in part, on the maintenance and protection of its information technology systems and the information technology systems of its third-party research institution collaborators, CRO or other contractors or consultants, which could face cyber-attacks that cause material losses to our business.</i></p>
    <p style="text-align: justify;">We have entered into agreements with third parties for hardware, software, telecommunications and other IT services in connection with our operations. Our operations depend, in part, on how well we, our future CROs, other contractors, consultants and our suppliers protect networks, equipment, IT systems and software against damage from a number of threats, including, but not limited to, cable cuts, damage to physical plants, natural disasters, terrorism, fire, power loss, hacking, computer viruses, vandalism and theft. Our operations also depend on the timely maintenance, upgrade and replacement of networks, equipment, IT systems and software, as well as pre-emptive expenses to mitigate the risks of failures. Any of these and other events could result in information system failures, delays and/or increase in capital expenses. The failure of information systems or a component of information systems could, depending on the nature of any such failure, adversely impact our reputation and results of operations.</p>
    <p style="text-align: justify;">For example, the loss of, or damage to, clinical trial data from completed, ongoing or future clinical trials could result in delays in our regulatory approval efforts and significantly increase our costs to recover or reproduce the data. Likewise, we rely or expect to rely on third parties for research and development, the manufacture and supply of drug product and to conduct clinical trials, and similar events relating to their computer systems could also have a material adverse effect on our business. To the extent that any disruption or security breach were to result in a loss of, or damage to, our data or systems, or inappropriate disclosure of confidential or proprietary information, we could incur liability and the further development and commercialization of our product candidates could be delayed.</p>
    <p style="text-align: justify;">Certain data breaches must also be reported to affected individuals and the certain regulatory bodies, and in some cases may be required to be publicly disclosed, under provisions of HIPAA, as amended, other U.S. federal and state law, and requirements of non-U.S. jurisdictions, including federal and provincial data protection legislation in Canada, European Union Data Protection Directive, and financial or other penalties may also apply.</p>
    <div id="footer_page_67">
        <p style="text-align: center;">- 67 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_68"></a>
    <p style="text-align: justify;">Cyber incidents can result from deliberate attacks or unintentional events. Cyber-attacks could result in any person gaining unauthorized access to digital systems for purposes of misappropriating assets or sensitive information, including personally identifiable information, corrupting data, or causing operational disruption. Cyber- attacks could also result in important remediation costs, increased cyber security costs, lost revenues due to a disruption of activities, litigation and reputational harm affecting customer and investor confidence, which could materially adversely affect our business and financial results.</p>
    <p style="text-align: justify;">We have not experienced any material losses to date relating to cyber-attacks or other information security breaches, but there can be no assurance that we will not incur such losses in the future, which could be in excess of any available insurance and could materially adversely affect our business and financial results. Our risk and exposure to these matters cannot be fully mitigated because of, among other things, the evolving nature of these threats. As a result, cyber security and the continued development and enhancement of controls, processes and practices designed to protect systems, computers, software, data and networks from attack, damage or unauthorized access is a priority. As cyber threats continue to evolve, we may be required to expend additional resources to continue to modify or enhance protective measures or to investigate and remediate any security vulnerabilities.</p>
    <p style="text-align: justify;"><i>Tax and accounting requirements may change in ways that are unforeseen to us and we may face difficulty or be unable to implement or comply with any such changes.</i></p>
    <p style="text-align: justify;">We are subject to numerous tax and accounting requirements, and changes in existing accounting or taxation rules or practices, or varying interpretations of current rules or practices, could have a significant adverse effect on our financial results, the manner in which we conduct our business or the marketability of any of our products. We currently have international operations and plans to expand such operations in the future. These operations, and any expansion thereto, will require us to comply with the tax laws and regulations of multiple jurisdictions, which may vary substantially. Complying with the tax laws of these jurisdictions can be time consuming and expensive and could potentially subject us to penalties and fees in the future if we were to fail to comply.</p>
    <p style="text-align: justify;"><i>Tax risks related to our status as a "passive foreign investment corporation", or "PFIC".</i></p>
    <p style="text-align: justify;">Under the Internal Revenue Code of 1986, we will be a PFIC for any taxable year in which (1) 75% or more of our gross income consists of passive income or (2) 50% or more of the average quarterly value of our assets consists of assets that produce, or are held for the production of, passive income. For purposes of these tests, passive income includes dividends, interest, gains from the sale or exchange of investment property and certain rents and royalties. In addition, for purposes of the above calculations, a non-U.S. corporation that directly or indirectly owns at least 25% by value of the shares of another corporation is treated as holding and receiving directly its proportionate share of assets and income of such corporation. If we are a PFIC for any taxable year during which a U.S. holder holds our shares, the U.S. holder may be subject to adverse tax consequences regardless of whether we continue to qualify as a PFIC, including ineligibility for any preferred tax rates on capital gains or on actual or deemed dividends, interest charges on certain taxes treated as deferred and additional reporting requirements.</p>
    <p style="text-align: justify;">Based on our analysis of our income, assets, activities and market capitalization, we believe that we were a PFIC in the 2019 taxable year. We have not yet determined our PFIC status for the current taxable year, but we expect to be a PFIC. The determination of whether we are a PFIC is a fact-intensive determination made on an annual basis applying principles and methodologies that in some circumstances are unclear and subject to varying interpretation. As a result, there can be no assurance regarding whether we will be treated as a PFIC for the current year, or may be treated as a PFIC in the future. In addition, for our current and future taxable years, the total value of our assets for PFIC testing purposes may be determined in part by reference to the market price of our Class B Shares from time to time, which may fluctuate considerably. Under the income test, our status as a PFIC depends on the composition of our income which will depend on the transactions we enter into in the future and our corporate structure. The composition of our income and assets is also affected by how we spend the cash we raise in any offering.</p>
    <div id="footer_page_68">
        <p style="text-align: center;">- 68 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_69"></a>
    <p style="text-align: center;"><b>DIVIDENDS AND DISTRIBUTIONS</b></p>
    <p style="text-align: justify;">The future payment of dividends will be dependent upon the financial requirements of the Corporation to fund further growth, the financial condition of the Corporation and other factors which the Board may consider in the circumstances. It is not contemplated that any dividends will be paid in the immediate or foreseeable future, if at all.</p>
    <p style="text-align: center;"><b>DESCRIPTION OF CAPITAL STRUCTURE</b></p>
    <p style="text-align: justify; margin-left: 1.4pt; text-indent: -0.7pt;">The Corporation's authorized share capital consists of an unlimited number of Class A Shares and an unlimited number of Class B Shares. As of the date of this AIF, there were 72 Class A Shares issued and outstanding and 35,114,998 Class B Shares issued and outstanding. As of the date of this AIF, the Class B Shares represented approximately 49% of the voting rights attached to outstanding voting securities of the Corporation. The following is a summary of the rights, privileges, restrictions and conditions attached to the Class B Shares.</p>
    <p style="text-align: justify; margin-left: 1.4pt; text-indent: -0.7pt;"><i><b>Voting Rights</b></i></p>
    <p style="text-align: justify; margin-left: 0.95pt; text-indent: -0.5pt;">Except as otherwise prescribed by the OBCA, at a meeting of the Shareholders, each Class B Share entitles the holder thereof to one vote and each Class A Share entitles the holder thereof to 276,660 votes on all matters.</p>
    <p style="text-align: justify; margin-left: 1.4pt; text-indent: -0.7pt;"><i><b>Rank</b></i></p>
    <p style="text-align: justify; margin-left: 1.4pt; text-indent: -0.7pt;">The Class A Shares and Class B Shares rank pari passu with respect to the payment of dividends, return of capital and distribution of assets in the event of the liquidation, dissolution or winding up of the Corporation. In the event of the liquidation, dissolution or winding-up of the Corporation or any other distribution of its assets among its shareholders for the purpose of winding-up its affairs, whether voluntarily or involuntarily, the holders of Class A Shares and the holders of Class B Shares are entitled to participate equally, share for share, subject always to the rights of the holders of any class of shares ranking senior to the Class A Shares and the Class B Shares, in the remaining property and assets of the Corporation available for distribution to shareholders, without preference or distinction among or between the Class A Shares and the Class B Shares.</p>
    <p style="text-align: justify; margin-left: 1.4pt; text-indent: -0.7pt;"><i><b>Dividends</b></i></p>
    <p style="text-align: justify; margin-left: 0.95pt; text-indent: -0.5pt;">Holders of Class A Shares and Class B Shares are entitled to receive, subject always to the rights of the holders of any class of shares ranking senior to the Class A Shares and Class B Shares, dividends out of the assets of the Corporation legally available for the payment of dividends at such times and in such amount and form as the Board may from time to time determine and the Corporation will pay dividends thereon on a pari passu basis, if, as and when declared by the Board.</p>
    <p style="text-align: justify; margin-left: 1.4pt; text-indent: -0.7pt;"><i><b>Conversion</b></i></p>
    <p style="text-align: justify; margin-left: 0.95pt; text-indent: -0.5pt;">The Class B Shares are not convertible into any other class of shares. Each outstanding Class A Share may, at any time at the option of the holder, be converted into one Class B Share. Upon the first date that any Class A Share is held other than by a permitted holder, the permitted holder which held such Class A Share until such date, without any further action, shall automatically be deemed to have exercised his, her or its rights to convert such Class A Share into a fully paid and non-assessable Class B Share.</p>
    <p style="text-align: justify; margin-left: 1.4pt; text-indent: -0.7pt;"><i><b>Subdivision or Consolidation</b></i></p>
    <p style="text-align: justify; margin-left: 0.95pt; text-indent: -0.5pt;">No subdivision or consolidation of the Class A Shares or the Class B Shares may be carried out unless, at the same time, the Class A Shares or the Class B Shares, as the case may be, are subdivided or consolidated in the same manner and on the same basis.</p>
    <div id="footer_page_69">
        <p style="text-align: center;">- 69 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_70"></a>
    <p style="text-align: justify; margin-left: 0.95pt; text-indent: -0.5pt;">On October 16, 2019, the Corporation completed the Consolidation of all of its issued and outstanding Class A Shares and Class B Shares. Pursuant to the Consolidation of all of the issued and outstanding Class A Shares and Class B Shares on the basis of one post-Consolidation share for every 201 pre-Consolidation shares of each class.</p>
    <p style="text-align: justify; margin-left: 1.4pt; text-indent: -0.7pt;"><i><b>Change of Control Transactions</b></i></p>
    <p style="text-align: justify; margin-left: 0.95pt; text-indent: -0.5pt;">The holders of Class B Shares are entitled to participate on an equal basis with holders of Class A Shares in the event of a "Change of Control Transaction"<b> </b>requiring approval of the holders of Class A Shares and Class B Shares under the OBCA, unless different treatment of the shares of each such class is approved by a majority of the votes cast by the holders of outstanding Class A Shares and by a majority of the votes cast by the holders of outstanding Class B Shares each voting separately as a class.</p>
    <p style="text-align: justify; margin-left: 1.4pt; text-indent: -0.7pt;"><i><b>Proposals to Amend the Articles of Amendment</b></i></p>
    <p style="text-align: justify; margin-left: 0.95pt; text-indent: -0.5pt;">Neither the holders of the Class A Shares nor the holders of the Class B Shares are entitled to vote separately as a class upon a proposal to amend the Articles of Amendment in the case of an amendment referred to in paragraph (a) or (e) of subsection 170(1) of the OBCA.</p>
    <p style="text-align: justify; margin-left: 0.95pt; text-indent: -0.5pt;">Neither the holders of the Class A Shares nor the holders of the Class B Shares shall be entitled to vote separately as a class upon a proposal to amend the Articles of Amendment in the case of an amendment referred to in paragraph (b) of subsection 170(1) of the OBCA unless such exchange, reclassification or cancellation: (a) affects only the holders of that class; or (b) affects the holders of Class A Shares and Class B Shares differently, on a per share basis, and such holders are not otherwise entitled to vote separately as a class under any applicable law in respect of such exchange, reclassification or cancellation.</p>
    <p style="text-align: justify; margin-left: 1.4pt; text-indent: -0.7pt;"><i><b>Take-Over Bid Protection</b></i></p>
    <p style="text-align: justify; margin-left: 0.95pt; text-indent: -0.5pt;">Under applicable Canadian law, an offer to purchase Class A Shares would not necessarily require that an offer be made to purchase Class B Shares. In accordance with the rules of the CSE designed to ensure that, in the event of a take-over bid, the holders of Class B Shares will be entitled to participate on an equal footing with holders of Class A Shares, the holders of not less than 80% of the outstanding Class A Shares have entered into the Coattail Agreement. The Coattail Agreement contains provisions customary for dual class, publicly-traded<b> </b>corporations designed to prevent transactions that otherwise would deprive the holders of Class B Shares of rights under the take-over bid provisions of applicable Canadian securities legislation to which they would have been entitled if the Class A Shares had been Class B Shares.</p>
    <p style="text-align: justify; margin-left: 0.95pt; text-indent: -0.5pt;">The undertakings in the Coattail Agreement do not apply to prevent a sale of Class A Shares by a holder of Class A Shares party to the Coattail Agreement if concurrently an offer is made to purchase Class B Shares that:</p>
    <p style="text-align: justify; margin-left: 72pt; text-indent: -36pt;">(a)<font style="width: 25pt; text-indent: 0pt; display: inline-block;">&#160;</font>offers a price per Class B Share at least as high as the highest price per share paid or required to be paid pursuant to the take-over bid for the Class A Shares;</p>
    <p style="text-align: justify; margin-left: 72pt; text-indent: -36pt;">(b)<font style="width: 25pt; text-indent: 0pt; display: inline-block;">&#160;</font>provides that the percentage of outstanding Class B Shares to be taken up (exclusive of shares owned immediately prior to the offer by the offeror or persons acting jointly or in concert with the offeror) is at least as high as the percentage of outstanding Class A Shares to be sold (exclusive of Class A Shares owned immediately prior to the offer by the offeror and persons acting jointly or in concert with the offeror);</p>
    <p style="text-align: justify; margin-left: 72pt; text-indent: -36pt;">(c)<font style="width: 25pt; text-indent: 0pt; display: inline-block;">&#160;</font>has no condition attached other than the right not to take up and pay for Class B Shares tendered if no shares are purchased pursuant to the offer for Class A Shares; and</p>
    <div id="footer_page_70">
        <p style="text-align: center;">- 70 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_71"></a>
    <p style="text-align: justify; margin-left: 72pt; text-indent: -36pt;">(d)<font style="width: 25pt; text-indent: 0pt; display: inline-block;">&#160;</font>is in all other material respects identical to the offer for Class A Shares.</p>
    <p style="text-align: justify; margin-left: 0.95pt; text-indent: -0.5pt;">In addition, the Coattail Agreement does not prevent the sale of Class A Shares by a holder thereof to a permitted holder, provided such sale does not or would not constitute a take-over bid or, if so, is exempt or would be exempt from the formal bid requirements (as defined in applicable securities legislation). The conversion of Class A Shares into Class B Shares, shall not, in of itself constitute a sale of Class A Shares for the purposes of the Coattail Agreement.</p>
    <p style="text-align: justify; margin-left: 0.95pt; text-indent: -0.5pt;">Under the Coattail Agreement, any sale of Class A Shares (including a transfer to a pledgee as security) by a holder of Class A Shares party to the Coattail Agreement is conditional upon the transferee or pledgee becoming a party to the Coattail Agreement, to the extent such transferred Class A Shares are not automatically converted into Class B Shares in accordance with the Articles of Amendment.</p>
    <p style="text-align: justify; margin-left: 0.95pt; text-indent: -0.5pt;">The Coattail Agreement contains provisions for authorizing action by the trustee to enforce the rights under the Coattail Agreement on behalf of the holders of the Class B Shares. The obligation of the trustee to take such action will be conditional on the Corporation or holders of the Class B Shares providing such funds and indemnity as the trustee may require. No holder of Class B Shares has the right, other than through the trustee, to institute any action or proceeding or to exercise any other remedy to enforce any rights arising under the Coattail Agreement unless the trustee fails to act on a request authorized by holders of not less than 10% of the outstanding Class B Shares and reasonable funds and indemnity have been provided to the trustee.</p>
    <p style="text-align: justify; margin-left: 0.95pt; text-indent: -0.5pt;">The Coattail Agreement may not be amended, and no provision thereof may be waived, unless, prior to giving effect to such amendment or waiver, the following have been obtained: (a) the consent of the CSE and any other applicable securities regulatory authority in Canada and (b) the approval of at least 66&#8532;% of the votes cast by holders of Class B Shares represented at a meeting duly called for the purpose of considering such amendment or waiver, excluding votes attached to Class B Shares held directly or indirectly by holders of Class A Shares, their affiliates and related parties and any persons who have an agreement to purchase Class A Shares on terms which would constitute a sale for purposes of the Coattail Agreement other than as permitted thereby.</p>
    <p style="text-align: justify; margin-left: 0.95pt; text-indent: -0.5pt;">No provision of the Coattail Agreement limits the rights of any holders of Class B Shares under applicable law.</p>
    <p style="text-align: justify; margin-left: 0.95pt; text-indent: -0.5pt;">At the annual and special meeting of Shareholders of the Corporation held December 16, 2019, the Shareholders approved an amendment to the Articles to authorize certain transfers of Class A Shares. The Shareholders approved an amendment to permit the holders of Class A Shares to complete transfers of Class A Shares to a director, executive officer or Founder of the Corporation, such that a Founder who is no longer actively involved in the business and affairs of the Corporation could transfer that Founder's Class A Shares to those individuals who remain active.</p>
    <p style="text-align: center;"><b>MARKETS FOR SECURITIES</b></p>
    <p style="text-align: justify; margin-left: 54pt; text-indent: -54pt;"><b>Trading Price and Volume</b></p>
    <p style="text-align: justify;">The Class B Shares commenced trading on the CSE on May 29, 2018 under the symbol "HUGE". Prior to the CSE listing, there was no public trading in any securities of the Corporation. The following table sets out the high and low prices and aggregate volume of the Class B Shares traded through the CSE on a monthly basis for the most recent financial year ended December 31, 2020.</p>
    <div id="footer_page_71">
        <p style="text-align: center;">- 71 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_72"></a><br>
    <table style="width: 80.76%; margin-left: 31.5pt; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 27.94%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-bottom: 0.75pt solid #000000;">
                <p style="text-align: center;"><b>Month</b></p>
            </td>
            <td style="width: 3.5%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: justify;">&#160;</p>
            </td>
            <td style="width: 19.72%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-bottom: 0.75pt solid #000000;">
                <p style="text-align: center;"><b>High</b><br><b>(C$)</b></p>
            </td>
            <td style="width: 7.22%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: justify;">&#160;</p>
            </td>
            <td style="width: 17.76%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-bottom: 0.75pt solid #000000;">
                <p style="text-align: center;"><b>Low</b><br><b>(C$)</b></p>
            </td>
            <td style="width: 5.96%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: justify;">&#160;</p>
            </td>
            <td style="width: 17.88%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-bottom: 0.75pt solid #000000;">
                <p style="text-align: center;"><b>Total Volume</b></p>
            </td>
        </tr>
        <tr>
            <td style="width: 27.94%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">January 2020</p>
            </td>
            <td style="width: 3.5%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 19.72%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">15.10</p>
            </td>
            <td style="width: 7.22%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.76%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">7.14</p>
            </td>
            <td style="width: 5.96%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.88%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">1,390,028</p>
            </td>
        </tr>
        <tr>
            <td style="width: 27.94%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">February 2020</p>
            </td>
            <td style="width: 3.5%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 19.72%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">8.28</p>
            </td>
            <td style="width: 7.22%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.76%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">4.90</p>
            </td>
            <td style="width: 5.96%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.88%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">410,199</p>
            </td>
        </tr>
        <tr>
            <td style="width: 27.94%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">March 2020</p>
            </td>
            <td style="width: 3.5%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 19.72%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">7.15</p>
            </td>
            <td style="width: 7.22%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.76%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">3.51</p>
            </td>
            <td style="width: 5.96%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.88%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">755,243</p>
            </td>
        </tr>
        <tr>
            <td style="width: 27.94%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">April 2020</p>
            </td>
            <td style="width: 3.5%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 19.72%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">5.13</p>
            </td>
            <td style="width: 7.22%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.76%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">4.08</p>
            </td>
            <td style="width: 5.96%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.88%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">278,739</p>
            </td>
        </tr>
        <tr>
            <td style="width: 27.94%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">May 2020</p>
            </td>
            <td style="width: 3.5%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 19.72%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">4.65</p>
            </td>
            <td style="width: 7.22%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.76%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">3.60</p>
            </td>
            <td style="width: 5.96%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.88%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">189,782</p>
            </td>
        </tr>
        <tr>
            <td style="width: 27.94%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">June 2020</p>
            </td>
            <td style="width: 3.5%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 19.72%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">14.74</p>
            </td>
            <td style="width: 7.22%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.76%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">3.95</p>
            </td>
            <td style="width: 5.96%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.88%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">1,997,668</p>
            </td>
        </tr>
        <tr>
            <td style="width: 27.94%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">July&#160; 2020</p>
            </td>
            <td style="width: 3.5%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 19.72%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">9.09</p>
            </td>
            <td style="width: 7.22%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.76%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">4.78</p>
            </td>
            <td style="width: 5.96%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.88%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">1,375,554</p>
            </td>
        </tr>
        <tr>
            <td style="width: 27.94%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">August 2020</p>
            </td>
            <td style="width: 3.5%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 19.72%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">4.80</p>
            </td>
            <td style="width: 7.22%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.76%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">3.60</p>
            </td>
            <td style="width: 5.96%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.88%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">782,720</p>
            </td>
        </tr>
        <tr>
            <td style="width: 27.94%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">September 2020</p>
            </td>
            <td style="width: 3.5%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 19.72%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">4.01</p>
            </td>
            <td style="width: 7.22%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.76%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">3.33</p>
            </td>
            <td style="width: 5.96%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.88%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">293,301</p>
            </td>
        </tr>
        <tr>
            <td style="width: 27.94%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">October 2020</p>
            </td>
            <td style="width: 3.5%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 19.72%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">3.58</p>
            </td>
            <td style="width: 7.22%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.76%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">1.84</p>
            </td>
            <td style="width: 5.96%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.88%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">426,835</p>
            </td>
        </tr>
        <tr>
            <td style="width: 27.94%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">November 2020</p>
            </td>
            <td style="width: 3.5%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 19.72%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">3.00</p>
            </td>
            <td style="width: 7.22%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.76%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">1.70</p>
            </td>
            <td style="width: 5.96%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.88%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">1,089,453</p>
            </td>
        </tr>
        <tr>
            <td style="width: 27.94%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">December 2020</p>
            </td>
            <td style="width: 3.5%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 19.72%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">2.70</p>
            </td>
            <td style="width: 7.22%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.76%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">1.97</p>
            </td>
            <td style="width: 5.96%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.88%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">862,091</p>
            </td>
        </tr>
    </table>
    <p style="text-align: justify;"><br>The Class B Shares are also listed on the Nasdaq in the United States under the symbol "HUGE". The price range and trading volume of the Class B Shares for the prior 12 month period, as reported by the Nasdaq, are set out below:</p>
    <table style="width: 80.76%; margin-left: 31.5pt; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 27.96%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-bottom: 0.75pt solid #000000;">
                <p style="text-align: center;"><b>Month</b></p>
            </td>
            <td style="width: 3.5%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: justify;">&#160;</p>
            </td>
            <td style="width: 19.72%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-bottom: 0.75pt solid #000000;">
                <p style="text-align: center;"><b>High</b><br><b>(US$)</b></p>
            </td>
            <td style="width: 7.22%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: justify;">&#160;</p>
            </td>
            <td style="width: 17.76%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-bottom: 0.75pt solid #000000;">
                <p style="text-align: center;"><b>Low</b><br><b>(US$)</b></p>
            </td>
            <td style="width: 5.96%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: justify;">&#160;</p>
            </td>
            <td style="width: 17.88%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-bottom: 0.75pt solid #000000;">
                <p style="text-align: center;"><b>Total Volume</b></p>
            </td>
        </tr>
        <tr>
            <td style="width: 27.96%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">January 2020</p>
            </td>
            <td style="width: 3.5%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 19.72%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">10.39</p>
            </td>
            <td style="width: 7.22%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.76%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">5.67</p>
            </td>
            <td style="width: 5.96%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.88%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">66,694</p>
            </td>
        </tr>
        <tr>
            <td style="width: 27.96%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">February 2020</p>
            </td>
            <td style="width: 3.5%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 19.72%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">6.75</p>
            </td>
            <td style="width: 7.22%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.76%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">3.88</p>
            </td>
            <td style="width: 5.96%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.88%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">60,861</p>
            </td>
        </tr>
        <tr>
            <td style="width: 27.96%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">March 2020</p>
            </td>
            <td style="width: 3.5%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 19.72%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">5.50</p>
            </td>
            <td style="width: 7.22%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.76%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">2.39</p>
            </td>
            <td style="width: 5.96%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.88%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">74,919</p>
            </td>
        </tr>
        <tr>
            <td style="width: 27.96%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">April 2020</p>
            </td>
            <td style="width: 3.5%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 19.72%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">3.85</p>
            </td>
            <td style="width: 7.22%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.76%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">2.75</p>
            </td>
            <td style="width: 5.96%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.88%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">41,330</p>
            </td>
        </tr>
        <tr>
            <td style="width: 27.96%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">May 2020</p>
            </td>
            <td style="width: 3.5%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 19.72%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">3.39</p>
            </td>
            <td style="width: 7.22%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.76%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">2.55</p>
            </td>
            <td style="width: 5.96%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.88%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">42,495</p>
            </td>
        </tr>
        <tr>
            <td style="width: 27.96%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">June 2020</p>
            </td>
            <td style="width: 3.5%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 19.72%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">14.00</p>
            </td>
            <td style="width: 7.22%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.76%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">2.92</p>
            </td>
            <td style="width: 5.96%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.88%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">5,003,735</p>
            </td>
        </tr>
        <tr>
            <td style="width: 27.96%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">July&#160; 2020</p>
            </td>
            <td style="width: 3.5%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 19.72%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">6.87</p>
            </td>
            <td style="width: 7.22%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.76%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">3.56</p>
            </td>
            <td style="width: 5.96%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.88%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">25,215,300</p>
            </td>
        </tr>
        <tr>
            <td style="width: 27.96%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">August 2020</p>
            </td>
            <td style="width: 3.5%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 19.72%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">3.61</p>
            </td>
            <td style="width: 7.22%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.76%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">2.69</p>
            </td>
            <td style="width: 5.96%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.88%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">18,548,000</p>
            </td>
        </tr>
        <tr>
            <td style="width: 27.96%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">September 2020</p>
            </td>
            <td style="width: 3.5%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 19.72%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">3.08</p>
            </td>
            <td style="width: 7.22%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.76%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">2.50</p>
            </td>
            <td style="width: 5.96%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.88%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">518,021</p>
            </td>
        </tr>
        <tr>
            <td style="width: 27.96%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">October 2020</p>
            </td>
            <td style="width: 3.5%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 19.72%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">2.75</p>
            </td>
            <td style="width: 7.22%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.76%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">1.39</p>
            </td>
            <td style="width: 5.96%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.88%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">640,687</p>
            </td>
        </tr>
        <tr>
            <td style="width: 27.96%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">November 2020</p>
            </td>
            <td style="width: 3.5%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 19.72%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">2.37</p>
            </td>
            <td style="width: 7.22%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.76%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">1.28</p>
            </td>
            <td style="width: 5.96%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.88%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="text-align: center;">4,483,612</p>
            </td>
        </tr>
        <tr>
            <td style="width: 27.96%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">December 2020</p>
            </td>
            <td style="width: 3.5%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 19.72%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">2.07</p>
            </td>
            <td style="width: 7.22%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.76%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">1.55</p>
            </td>
            <td style="width: 5.96%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">&#160;</p>
            </td>
            <td style="width: 17.88%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: center;">2,389,322</p>
            </td>
        </tr>
    </table>
    <p style="text-align: justify;"><br>Our outstanding Class B Shares are also listed and posted for trading on the B&#246;rse Frankfurt or Frankfurt Stock Exchange under "WKN: A2JM6M" and the trading symbol "0K9A".</p>
    <p style="text-align: justify;"><b>Prior Sales</b></p>
    <p style="text-align: justify;">The following table sets forth details regarding all issuances of securities by the Corporation, including all convertible securities, during the most recently completed financial year ended December 31, 2020. All figures are shown on a post-Consolidation basis.</p>
    <div id="footer_page_72">
        <p style="text-align: center;">- 72 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_73"></a><br>
    <div style="margin-left: 20pt;">
        <table style="border-collapse: collapse; font-size: 10pt; width: 100%;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom;">
                    <p style="text-align: center; margin-left: 18pt; border-bottom: 0.75pt solid #000000;"><b>Date of Issuance</b></p>
                </td>
                <td style="width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom;">
                    <p style="text-align: center; margin-left: 13.65pt; border-bottom: 0.75pt solid #000000;"><b>Securities</b></p>
                </td>
                <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom;">
                    <p style="text-align: center; margin-left: 8.65pt; border-bottom: 0.75pt solid #000000;"><b>Number of Securities</b></p>
                </td>
                <td style="width: 24%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom;">
                    <p style="clear: both; border-bottom: 0.75pt solid #000000; text-align: center;"><font style="font-size: 13.3333px;"><b>Exercise or Weighted&#160;<br></b></font><font style="font-size: 13.3333px;"><b>Average Issue Price<br></b></font><b>per Security</b></p>
                </td>
            </tr>
            <tr>
                <td style="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="margin-left: 18pt; text-align: center;">October 20, 2020</p>
                </td>
                <td style="width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="margin-left: 13.65pt; text-align: center;">Warrants<sup>(1)</sup></p>
                </td>
                <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="text-align: center;">3,454,543</p>
                </td>
                <td style="width: 24%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="text-align: center;">US$2.60</p>
                </td>
            </tr>
            <tr>
                <td style="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                    <p style="margin-left: 18pt; text-align: center;">October 20, 2020</p>
                </td>
                <td style="width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                    <p style="margin-left: 13.65pt; text-align: center;">Class B Shares<sup>(1)</sup></p>
                </td>
                <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                    <p style="text-align: center;">4,318,179</p>
                </td>
                <td style="width: 24%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                    <p style="text-align: center;">US$2.20</p>
                </td>
            </tr>
            <tr>
                <td style="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="margin-left: 18pt; text-align: center;">July 30 to October 15, 2020</p>
                </td>
                <td style="width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="margin-left: 13.65pt; text-align: center;">Class B Shares<sup>(3)</sup></p>
                </td>
                <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="text-align: center;">5,531</p>
                </td>
                <td style="width: 24%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="text-align: center;">US$2.67</p>
                </td>
            </tr>
            <tr>
                <td style="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                    <p style="margin-left: 18pt; text-align: center;">August 6, 2020</p>
                </td>
                <td style="width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                    <p style="margin-left: 13.65pt; text-align: center;">Warrants<sup>(2)</sup></p>
                </td>
                <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                    <p style="text-align: center;">1,381,215</p>
                </td>
                <td style="width: 24%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                    <p style="text-align: center;">US$4.26</p>
                </td>
            </tr>
            <tr>
                <td style="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="margin-left: 18pt; text-align: center;">August 6, 2020</p>
                </td>
                <td style="width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="margin-left: 13.65pt; text-align: center;">Class B Shares<sup>(2)</sup></p>
                </td>
                <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="text-align: center;">2,762,430</p>
                </td>
                <td style="width: 24%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="text-align: center;">US$3.62</p>
                </td>
            </tr>
            <tr>
                <td style="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                    <p style="margin-left: 18pt; text-align: center;">July 15 to 29, 2020</p>
                </td>
                <td style="width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                    <p style="margin-left: 13.65pt; text-align: center;">Class B Shares<sup>(3)</sup></p>
                </td>
                <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                    <p style="text-align: center;">48,317</p>
                </td>
                <td style="width: 24%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                    <p style="text-align: center;">US$3.81</p>
                </td>
            </tr>
            <tr>
                <td style="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="margin-left: 18pt; text-align: center;">June 22, 2020</p>
                </td>
                <td style="width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="margin-left: 13.65pt; text-align: center;">Class B Shares<sup>(2)</sup></p>
                </td>
                <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="text-align: center;">22,382</p>
                </td>
                <td style="width: 24%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="text-align: center;">$2.61</p>
                </td>
            </tr>
            <tr>
                <td style="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                    <p style="margin-left: 18pt; text-align: center;">June 8, 2020</p>
                </td>
                <td style="width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                    <p style="margin-left: 13.65pt; text-align: center;">Warrants<sup>(3)</sup></p>
                </td>
                <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                    <p style="text-align: center;">1,500,000</p>
                </td>
                <td style="width: 24%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                    <p style="text-align: center;">$9.65</p>
                </td>
            </tr>
            <tr>
                <td style="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="margin-left: 18pt; text-align: center;">June 8, 2020</p>
                </td>
                <td style="width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="margin-left: 13.65pt; text-align: center;">Class B Shares<sup>(3)</sup></p>
                </td>
                <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="text-align: center;">1,500,000</p>
                </td>
                <td style="width: 24%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="text-align: center;">$6.75</p>
                </td>
            </tr>
            <tr>
                <td style="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                    <p style="margin-left: 18pt; text-align: center;">April 14, 2020</p>
                </td>
                <td style="width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                    <p style="margin-left: 13.65pt; text-align: center;">Options<sup>(4)</sup></p>
                </td>
                <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                    <p style="text-align: center;">110,000</p>
                </td>
                <td style="width: 24%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                    <p style="text-align: center;">$4.75</p>
                </td>
            </tr>
            <tr>
                <td style="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="margin-left: 18pt; text-align: center;">March 27, 2020</p>
                </td>
                <td style="width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="margin-left: 13.65pt; text-align: center;">Class B Shares<sup>(5)</sup></p>
                </td>
                <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="text-align: center;">7,485</p>
                </td>
                <td style="width: 24%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="text-align: center;">$3.50</p>
                </td>
            </tr>
            <tr>
                <td style="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                    <p style="margin-left: 18pt; text-align: center;">March 24, 2020</p>
                </td>
                <td style="width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                    <p style="margin-left: 13.65pt; text-align: center;">Options<sup>(4)</sup></p>
                </td>
                <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                    <p style="text-align: center;">872,139</p>
                </td>
                <td style="width: 24%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                    <p style="text-align: center;">$3.86</p>
                </td>
            </tr>
            <tr>
                <td style="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="margin-left: 18pt; text-align: center;">March 23, 2020</p>
                </td>
                <td style="width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="margin-left: 13.65pt; text-align: center;">Class B Shares<sup>(5)</sup></p>
                </td>
                <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="text-align: center;">56,229</p>
                </td>
                <td style="width: 24%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="text-align: center;">$2.57</p>
                </td>
            </tr>
            <tr>
                <td style="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                    <p style="margin-left: 18pt; text-align: center;">March 16, 2020</p>
                </td>
                <td style="width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                    <p style="margin-left: 13.65pt; text-align: center;">Class B Shares<sup>(6)(7)</sup></p>
                </td>
                <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                    <p style="text-align: center;">474,995</p>
                </td>
                <td style="width: 24%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                    <p style="text-align: center;">$4.35</p>
                </td>
            </tr>
            <tr>
                <td style="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="margin-left: 18pt; text-align: center;">March 13, 2020</p>
                </td>
                <td style="width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="margin-left: 13.65pt; text-align: center;">Class B Shares<sup>(8)</sup></p>
                </td>
                <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="text-align: center;">399,483</p>
                </td>
                <td style="width: 24%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="text-align: center;">$4.57</p>
                </td>
            </tr>
            <tr>
                <td style="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                    <p style="margin-left: 18pt; text-align: center;">March 6, 2020</p>
                </td>
                <td style="width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                    <p style="margin-left: 13.65pt; text-align: center;">Options<sup>(4)</sup></p>
                </td>
                <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                    <p style="text-align: center;">20,000</p>
                </td>
                <td style="width: 24%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                    <p style="text-align: center;">$6.16</p>
                </td>
            </tr>
            <tr>
                <td style="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="margin-left: 18pt; text-align: center;">February 4, 2020</p>
                </td>
                <td style="width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="margin-left: 13.65pt; text-align: center;">Class B Shares<sup>(9)</sup></p>
                </td>
                <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="text-align: center;">225,371</p>
                </td>
                <td style="width: 24%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="text-align: center;">$8.00</p>
                </td>
            </tr>
            <tr>
                <td style="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                    <p style="margin-left: 18pt; text-align: center;">January 21, 2020</p>
                </td>
                <td style="width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                    <p style="margin-left: 13.65pt; text-align: center;">Options<sup>(4)</sup></p>
                </td>
                <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                    <p style="text-align: center;">15,000</p>
                </td>
                <td style="width: 24%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                    <p style="text-align: center;">$9.54</p>
                </td>
            </tr>
            <tr>
                <td style="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="margin-left: 18pt; text-align: center;">January 2, 2020</p>
                </td>
                <td style="width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="margin-left: 13.65pt; text-align: center;">Class B Shares<sup>(10)</sup></p>
                </td>
                <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="text-align: center;">27,580</p>
                </td>
                <td style="width: 24%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                    <p style="text-align: center;">$7.31</p>
                </td>
            </tr>
        </table>
    </div>
    <p style="text-align: justify;"><b>Notes:</b></p>
    <p style="text-align: justify; margin-left: 18pt; margin-bottom: 0pt; text-indent: -18pt;">(1)<font style="width: 6.51pt; text-indent: 0pt; display: inline-block;">&#160;</font>Represents the Class B Shares and associated Warrants issued pursuant to the October Offering.</p>
    <p style="text-align: justify; margin-left: 18pt; margin-bottom: 0pt; text-indent: -18pt; margin-top: 0pt;">(2)<font style="width: 6.51pt; text-indent: 0pt; display: inline-block;">&#160;</font>Represents the Class B Shares and associated Warrants issued pursuant to the July Offering.</p>
    <p style="text-align: justify; margin-left: 18pt; margin-bottom: 0pt; text-indent: -18pt; margin-top: 0pt;">(3)<font style="width: 6.51pt; text-indent: 0pt; display: inline-block;">&#160;</font>Represents Class B shares issued pursuant to the Corporation's previous at-the-market equity distribution program.</p>
    <p style="text-align: justify; margin-left: 18pt; margin-bottom: 0pt; text-indent: -18pt; margin-top: 0pt;">(4)<font style="width: 6.51pt; text-indent: 0pt; display: inline-block;">&#160;</font>Represents Class B Shares issued upon the exercise of Options held by a former securityholder of Prismic.</p>
    <p style="text-align: justify; margin-left: 18pt; margin-bottom: 0pt; text-indent: -18pt; margin-top: 0pt;">(5)<font style="width: 6.51pt; text-indent: 0pt; display: inline-block;">&#160;</font>Represents the Class B Shares and associated Warrants issued pursuant to the June Private Placement.</p>
    <p style="text-align: justify; margin-left: 18pt; margin-bottom: 0pt; text-indent: -18pt; margin-top: 0pt;">(6)<font style="width: 6.51pt; text-indent: 0pt; display: inline-block;">&#160;</font>Represents the issuance of Options issued to a director, officer, employee, or consultant of the Corporation (or any of its subsidiaries) under the Stock Option Plan.</p>
    <p style="text-align: justify; margin-left: 18pt; margin-bottom: 0pt; text-indent: -18pt; margin-top: 0pt;">(7)<font style="width: 6.51pt; text-indent: 0pt; display: inline-block;">&#160;</font>Represents Class B Shares issued to certain holders of Prismic debt assumed by the Corporation in connection with the acquisition. For further information see "<i>General Development of the Business - Three Year History - Acquisition of Prismic" </i>in the 2019 AIF.</p>
    <p style="text-align: justify; margin-left: 18pt; margin-bottom: 0pt; text-indent: -18pt; margin-top: 0pt;">(8)<font style="width: 6.51pt; text-indent: 0pt; display: inline-block;">&#160;</font>Represents Class B Shares issued as part of share-based bonus to certain employees for performance related to the year ended December 31, 2019.</p>
    <p style="text-align: justify; margin-left: 18pt; margin-bottom: 0pt; text-indent: -18pt; margin-top: 0pt;">(9)<font style="width: 6.51pt; text-indent: 0pt; display: inline-block;">&#160;</font>Represents Class B Shares issued as part of share-based compensation to the Board for their annual compensation for the year ended December 31, 2019 in lieu of cash.</p>
    <p style="text-align: justify; margin-left: 18pt; text-indent: -18pt; margin-top: 0pt;">(10)<font style="width: 2.01pt; text-indent: 0pt; display: inline-block;">&#160;</font>Represents Class B Shares issued to certain officers of the Corporation as a bonus for services provided to the Corporation during the year ended December 31, 2019.</p>
    <p style="text-align: center;"><b>ESCROWED SECURITIES AND SECURITIES </b><br><b>SUBJECT TO CONTRACTUAL RESTRICTION ON TRANSFER</b></p>
    <p style="text-align: justify;">As of the date of this AIF, no securities are being held in escrow or subject to contractual restrictions on transfer.</p>
    <p style="text-align: center;"><b>DIRECTORS AND EXECUTIVE OFFICERS</b></p>
    <p style="text-align: justify; margin-left: 54pt; text-indent: -54pt;"><b>Name, Occupation and Security Holding</b></p>
    <p style="text-align: justify;">The following table sets out certain information regarding the directors and executive officers of the Corporation as at the date of this AIF. Each of the directors is elected to hold office until the next annual meeting of the shareholders of the Corporation or until a successor is duly elected or appointed. All figures are shown on a post-Consolidation basis.</p>
    <div id="footer_page_73">
        <p style="text-align: center;">- 73 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_74"></a>
    <p style="text-align: justify;">As of December 31, 2020, all of the Corporation's directors and executive officers, as a group, beneficially owned or exercised control or direction over, directly or indirectly, 72 Class A Shares, or approximately 100<b> </b>percent of the number of Class A Shares&#160; and 19,161,620 Class B Shares or approximately 49 percent of the number of Class B Shares that were outstanding as of such date. As of March 12, 2021 all of the Corporation's directors and executive officers, as a group, beneficially owned or exercised control or direction over, directly or indirectly, 72 Class A Shares, or approximately 100 percent of the number of Class A Shares and 24,283,865<b> </b>Class B Shares or approximately 69% percent of the number of Class B Shares that were outstanding as of such date.</p>
    <table style="width: 100%; border: 0.75pt solid #000000; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="background-color: #e7e6e6; width: 31.12%; vertical-align: bottom; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: center;"><b>Name, Position and</b><br><b>Province of Residence</b></p>
            </td>
            <td style="background-color: #e7e6e6; width: 27.18%; vertical-align: bottom; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; border-left: 0.75pt solid #000000; padding-left: 5.03pt;">
                <p style="text-align: center;"><b>Principal Occupation</b><br><b>During Last Five Years</b></p>
            </td>
            <td style="background-color: #e7e6e6; width: 15.92%; vertical-align: bottom; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; border-left: 0.75pt solid #000000; padding-left: 5.03pt;">
                <p style="text-align: center;"><b>Date Became Director or Executive Officer</b></p>
            </td>
            <td style="background-color: #e7e6e6; width: 13.1%; vertical-align: bottom; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; border-left: 0.75pt solid #000000; padding-left: 5.03pt;">
                <p style="text-align: center;"><b>Class A Shares Owned</b><br><b>or Controlled</b><sup><b>(1)</b></sup></p>
            </td>
            <td style="background-color: #e7e6e6; width: 12.68%; vertical-align: bottom; border-left: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: center;"><b>Class B Shares Owned or Controlled</b><sup><b>(1)</b></sup></p>
            </td>
        </tr>
        <tr>
            <td style="width: 31.12%; vertical-align: top; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p>Dr. Raza Bokhari, Chief Executive Officer, Executive Chairman and Director<sup>(12)</sup><sup>(30)</sup> <br><i>Pennsylvania, United States</i></p>
            </td>
            <td style="width: 27.18%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p>Managing Partner, RBx Capital LP; Chairman, Parkway Clinical Laboratories Inc.</p>
            </td>
            <td style="width: 15.92%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p style="text-align: center;">July 17, 2018</p>
            </td>
            <td style="width: 13.1%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p style="text-align: center;">24<sup>(2</sup><sup>6</sup><sup>)</sup></p>
            </td>
            <td style="border-left: 0.75pt solid #000000; width: 12.68%; vertical-align: top; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p style="text-align: center;">2,428,386<sup>(5</sup><sup>)</sup></p>
            </td>
        </tr>
        <tr>
            <td style="width: 31.12%; vertical-align: top; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p>Dr. Edward Brennan, Chief Medical Officer<br><i>Pennsylvania, United States</i></p>
            </td>
            <td style="width: 27.18%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p>Medical Director, Wyeth-Ayerst Research and GlaxoSmithKline; Founder, IndiPharm</p>
            </td>
            <td style="width: 15.92%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p style="text-align: center;">May 28, 2019</p>
            </td>
            <td style="width: 13.1%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p style="text-align: center;">Nil</p>
            </td>
            <td style="border-left: 0.75pt solid #000000; width: 12.68%; vertical-align: top; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p style="text-align: center;">112,920<sup>(18</sup><sup>)</sup></p>
            </td>
        </tr>
        <tr>
            <td style="width: 31.12%; vertical-align: top; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p>Stephen Buyer, Director<sup>(</sup><sup>9)(10)(29)</sup><br><i>Indiana, United States</i></p>
            </td>
            <td style="width: 27.18%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p>Managing Partner, 10-Square Solution, LLC; former Congressman, United States House of Representatives</p>
            </td>
            <td style="width: 15.92%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p style="text-align: center;">October 11, 2019</p>
            </td>
            <td style="width: 13.1%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p style="text-align: center;">Nil</p>
            </td>
            <td style="border-left: 0.75pt solid #000000; width: 12.68%; vertical-align: top; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p style="text-align: center;">163,726<sup>(14</sup><sup>)</sup></p>
            </td>
        </tr>
        <tr>
            <td style="width: 31.12%; vertical-align: top; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p>Donal Caroll, Chief Financial Officer, Former Director<br><i>Ontario, Canada</i></p>
            </td>
            <td style="width: 27.18%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p>Chief Financial Officer, FSD Pharma</p>
            </td>
            <td style="width: 15.92%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p style="text-align: center;">July 23, 2018</p>
            </td>
            <td style="width: 13.1%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p style="text-align: center;">Nil</p>
            </td>
            <td style="border-left: 0.75pt solid #000000; width: 12.68%; vertical-align: top; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p style="text-align: center;">85,357<sup>(16</sup><sup>)</sup></p>
            </td>
        </tr>
        <tr>
            <td style="width: 31.12%; vertical-align: top; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p>Robert J. Ciaruffoli, Director<sup>(7</sup><sup>)</sup><sup>(8)(10)</sup><sup>(1</sup><sup>3</sup><sup>)</sup><sup>(27)(29)</sup><br><i>Pennsylvania, United States</i></p>
            </td>
            <td style="width: 27.18%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p>Co-Founder and Vice-Chairman, Broad Street Angels; Former Chairman and CEO, Parente Beard/Baker Tilly</p>
            </td>
            <td style="width: 15.92%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p style="text-align: center;">June 12, 2019</p>
            </td>
            <td style="width: 13.1%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p style="text-align: center;">Nil</p>
            </td>
            <td style="border-left: 0.75pt solid #000000; width: 12.68%; vertical-align: top; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p style="text-align: center;">156,453<sup>(</sup><sup>19</sup><sup>)</sup></p>
            </td>
        </tr>
        <tr>
            <td style="width: 31.12%; vertical-align: top; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p>James A. Datin, Director<sup>(11)(17)(29)</sup><br><i>North Carolina, United States</i></p>
            </td>
            <td style="width: 27.18%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p>President &amp; Chief Executive Officer, BioAgilytix</p>
            </td>
            <td style="width: 15.92%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p style="text-align: center;">June 12, 2019</p>
            </td>
            <td style="width: 13.1%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p style="text-align: center;">Nil</p>
            </td>
            <td style="border-left: 0.75pt solid #000000; width: 12.68%; vertical-align: top; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p style="text-align: center;">98,961<sup>(</sup><sup>20)</sup></p>
            </td>
        </tr>
        <tr>
            <td style="width: 31.12%; vertical-align: top; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p>Anthony Durkacz, Director<br><i>Ontario, Canada</i></p>
            </td>
            <td style="width: 27.18%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p>Director and Executive Vice-President, First Republic Capital Corporation; Director and Chief Financial Officer, Snipp Interactive Inc.</p>
            </td>
            <td style="width: 15.92%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p style="text-align: center;">June 18, 2018</p>
            </td>
            <td style="width: 13.1%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p style="text-align: center;">24<sup>(2)(26</sup><sup>)</sup></p>
            </td>
            <td style="border-left: 0.75pt solid #000000; width: 12.68%; vertical-align: top; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p style="text-align: center;">450,058<sup>(3)(4)</sup></p>
            </td>
        </tr>
        <tr>
            <td style="width: 31.12%; vertical-align: top; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p>Gerald Goldberg, Director<sup>(6)</sup><sup>(</sup><sup>12</sup><sup>)</sup><sup>(27)(29)</sup> <br><i>Ontario, Canada</i></p>
            </td>
            <td style="width: 27.18%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p>Executive Chairman, Osoyoos Cannabis Inc.; Interim CEO, Canada House Wellness Group Inc.; CEO and President, Leo Acquisitions Corp.; Senior Partner, Schwartz, Levitsky, Feldman LLP; President, Victory Capital Corp.</p>
            </td>
            <td style="width: 15.92%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p style="text-align: center;">May 24, 2018</p>
            </td>
            <td style="width: 13.1%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p style="text-align: center;">Nil</p>
            </td>
            <td style="border-left: 0.75pt solid #000000; width: 12.68%; vertical-align: top; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p style="text-align: center;">60,211<sup>(2</sup><sup>1</sup><sup>)</sup></p>
                <p style="text-align: center;"><b>&#160;</b></p>
            </td>
        </tr>
        <tr>
            <td style="width: 31.12%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border-top: 0.75pt solid #000000; border-right: 0.75pt solid #000000;">
                <p>Dr. Larry Kaiser, Director<sup>(6)</sup><sup>(8)(28)(29)</sup><br><i>Pennsylvania, United States</i></p>
                <p><b>&#160;</b></p>
            </td>
            <td style="width: 27.18%; vertical-align: top; border-left: 0.75pt solid #000000; padding-right: 5.03pt; border-right: 0.75pt solid #000000; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p>Managing Director, Healthcare Industry Group, Alvarez and Marsal; formerly President and CEO, Temple University Health System; formerly Dean, Lewis Katz School of Medicine, Temple University; Senior Executive Vice President, Health Science, Temple University</p>
            </td>
            <td style="width: 15.92%; vertical-align: top; border-left: 0.75pt solid #000000; padding-right: 5.03pt; border-right: 0.75pt solid #000000; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p style="text-align: center;">January 22, 2020</p>
            </td>
            <td style="width: 13.1%; vertical-align: top; border-left: 0.75pt solid #000000; padding-right: 5.03pt; border-right: 0.75pt solid #000000; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p style="text-align: center;">Nil</p>
            </td>
            <td style="width: 12.68%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border-top: 0.75pt solid #000000; border-left: 0.75pt solid #000000;">
                <p style="text-align: center;">93,466<sup>(15</sup><sup>)</sup></p>
            </td>
        </tr>
    </table>
    <br>
    <div id="footer_page_74">
        <p style="text-align: center;">- 74 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_75"></a><br>
    <table style="width: 100%; border: 0.75pt solid #000000; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 31.12%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000;">
                <p>Dr. Sara May, President, FV Pharma <br><i>Ontario, Canada</i></p>
            </td>
            <td style="border-left: 0.75pt solid #000000; width: 27.18%; vertical-align: top; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p>President, FV Pharma; formerly Quality Assurance, FV Pharma; formerly Ecologist and GIS Manager, Beacon Environmental</p>
            </td>
            <td style="border-left: 0.75pt solid #000000; width: 15.92%; vertical-align: top; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: center;">March 13, 2019</p>
            </td>
            <td style="border-left: 0.75pt solid #000000; width: 13.1%; vertical-align: top; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: center;">Nil</p>
            </td>
            <td style="width: 12.68%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border-bottom: 0.75pt solid #000000; border-left: 0.75pt solid #000000;">
                <p style="text-align: center;">14,755<sup>(22)</sup></p>
            </td>
        </tr>
        <tr>
            <td style="width: 31.12%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border-top: 0.75pt solid #000000; border-right: 0.75pt solid #000000;">
                <p>Zeeshan Saeed, Former President and Director<sup>(2</sup><sup>3</sup><sup>)</sup><br><i>Ontario, Canada</i></p>
            </td>
            <td style="width: 27.18%; vertical-align: top; border-left: 0.75pt solid #000000; padding-right: 5.03pt; border-right: 0.75pt solid #000000; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p>Director and Executive Vice President, FV Pharma; <br>CEO, Platinum Telecommunications Inc.</p>
            </td>
            <td style="width: 15.92%; vertical-align: top; border-left: 0.75pt solid #000000; padding-right: 5.03pt; border-right: 0.75pt solid #000000; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p style="text-align: center;">May 24, 2018</p>
            </td>
            <td style="width: 13.1%; vertical-align: top; border-left: 0.75pt solid #000000; padding-right: 5.03pt; border-right: 0.75pt solid #000000; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p style="text-align: center;">24<sup> (2</sup><sup>4</sup><sup>)</sup><sup>(26)</sup></p>
            </td>
            <td style="width: 12.68%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border-top: 0.75pt solid #000000; border-left: 0.75pt solid #000000;">
                <p style="text-align: center;">504,476<sup>(2</sup><sup>5</sup><sup>)</sup></p>
            </td>
        </tr>
    </table>
    <p style="text-align: justify;"><b>Notes:</b></p>
    <p style="text-align: justify; margin-left: 22pt; margin-bottom: 0pt; text-indent: -22pt;">(1)<font style="width: 10pt; text-indent: 0pt; display: inline-block;">&#160;</font>The information as to the number of Class A Shares and/or Class B Shares beneficially owned or over which control or direction is exercised has been furnished by the respective nominee and has not been independently verified by the Corporation. Presented as of March 12, 2021.</p>
    <p style="text-align: justify; margin-left: 22pt; margin-bottom: 0pt; text-indent: -22pt; margin-top: 0pt;">(2)<font style="width: 10pt; text-indent: 0pt; display: inline-block;">&#160;</font>Fortius Research and Trading Corp., a corporation controlled by Anthony Durkacz, is the registered owner of the Class A Shares.</p>
    <p style="text-align: justify; margin-left: 22pt; margin-bottom: 0pt; text-indent: -22pt; margin-top: 0pt;">(3)<font style="width: 10pt; text-indent: 0pt; display: inline-block;">&#160;</font>Fortius Research and Trading Corp., a corporation controlled by Anthony Durkacz, is the registered owner of 106,043 Class B Shares and First Republic Capital Corporation, a corporation majority owned by Anthony Durkacz, is the registered owner of 170,418 Class B Shares.</p>
    <p style="text-align: justify; margin-left: 22pt; margin-bottom: 0pt; text-indent: -22pt; margin-top: 0pt;">(4)<font style="width: 10pt; text-indent: 0pt; display: inline-block;">&#160;</font>Anthony Durkacz also holds 199,004 warrants and 99,502 Stock Options.</p>
    <p style="text-align: justify; margin-left: 22pt; margin-bottom: 0pt; text-indent: -22pt; margin-top: 0pt;">(5)<font style="width: 10pt; text-indent: 0pt; display: inline-block;">&#160;</font>Dr. Bokhari also holds 412,932 Stock Options.</p>
    <p style="text-align: justify; margin-left: 22pt; margin-bottom: 0pt; text-indent: -22pt; margin-top: 0pt;">(6)<font style="width: 10pt; text-indent: 0pt; display: inline-block;">&#160;</font>Member of Audit and Risk Committee.</p>
    <p style="text-align: justify; margin-left: 22pt; margin-bottom: 0pt; text-indent: -22pt; margin-top: 0pt;">(7)<font style="width: 10pt; text-indent: 0pt; display: inline-block;">&#160;</font>Chairman of the Audit and Risk Committee.</p>
    <p style="text-align: justify; margin-left: 22pt; margin-bottom: 0pt; text-indent: -22pt; margin-top: 0pt;">(8)<font style="width: 10pt; text-indent: 0pt; display: inline-block;">&#160;</font>Member of the Governance Committee.</p>
    <p style="text-align: justify; margin-left: 22pt; margin-bottom: 0pt; text-indent: -22pt; margin-top: 0pt;">(9)<font style="width: 10pt; text-indent: 0pt; display: inline-block;">&#160;</font>Chairman of the Governance Committee.</p>
    <p style="text-align: justify; margin-left: 22pt; margin-bottom: 0pt; text-indent: -22pt; margin-top: 0pt;">(10)<font style="width: 5pt; text-indent: 0pt; display: inline-block;">&#160;</font>Member of the Compensation Committee.</p>
    <p style="text-align: justify; margin-left: 22pt; margin-bottom: 0pt; text-indent: -22pt; margin-top: 0pt;">(11)<font style="width: 5pt; text-indent: 0pt; display: inline-block;">&#160;</font>Chairman of the Compensation Committee.</p>
    <p style="text-align: justify; margin-left: 22pt; margin-bottom: 0pt; text-indent: -22pt; margin-top: 0pt;">(12)<font style="width: 5pt; text-indent: 0pt; display: inline-block;">&#160;</font>Member of the Corporate Disclosure Committee.</p>
    <p style="text-align: justify; margin-left: 22pt; margin-bottom: 0pt; text-indent: -22pt; margin-top: 0pt;">(13)<font style="width: 5pt; text-indent: 0pt; display: inline-block;">&#160;</font>Chairman of the Corporate Disclosure Committee.</p>
    <p style="text-align: justify; margin-left: 22pt; margin-bottom: 0pt; text-indent: -22pt; margin-top: 0pt;">(14)<font style="width: 5pt; text-indent: 0pt; display: inline-block;">&#160;</font>Mr. Buyer also holds 45,000 Stock Options.</p>
    <p style="text-align: justify; margin-left: 22pt; margin-bottom: 0pt; text-indent: -22pt; margin-top: 0pt;">(15)<font style="width: 5pt; text-indent: 0pt; display: inline-block;">&#160;</font>Dr. Kaiser also holds 64,900 Stock Options.</p>
    <p style="text-align: justify; margin-left: 22pt; margin-bottom: 0pt; text-indent: -22pt; margin-top: 0pt;">(16)<font style="width: 5pt; text-indent: 0pt; display: inline-block;">&#160;</font>Mr. Carroll also holds 104,774 Stock Options.</p>
    <p style="text-align: justify; margin-left: 22pt; margin-bottom: 0pt; text-indent: -22pt; margin-top: 0pt;">(17)<font style="width: 5pt; text-indent: 0pt; display: inline-block;">&#160;</font>Mr. Datin will be resigning from the Board of Directors effective April 30, 2021.</p>
    <p style="text-align: justify; margin-left: 22pt; margin-bottom: 0pt; text-indent: -22pt; margin-top: 0pt;">(18)<font style="width: 5pt; text-indent: 0pt; display: inline-block;">&#160;</font>Mr. Brennan also holds 127,115 Stock Options.</p>
    <p style="text-align: justify; margin-left: 22pt; margin-bottom: 0pt; text-indent: -22pt; margin-top: 0pt;">(19)<font style="width: 5pt; text-indent: 0pt; display: inline-block;">&#160;</font>Mr. Ciaruffoli also holds 82,313 Stock Options.</p>
    <p style="text-align: justify; margin-left: 22pt; margin-bottom: 0pt; text-indent: -22pt; margin-top: 0pt;">(20)<font style="width: 5pt; text-indent: 0pt; display: inline-block;">&#160;</font>Mr. Datin also holds 39,876 Stock Options.</p>
    <p style="text-align: justify; margin-left: 22pt; margin-bottom: 0pt; text-indent: -22pt; margin-top: 0pt;">(21)<font style="width: 5pt; text-indent: 0pt; display: inline-block;">&#160;</font>Mr. Goldberg also holds 39,875 Stock Options.</p>
    <p style="text-align: justify; margin-left: 22pt; margin-bottom: 0pt; text-indent: -22pt; margin-top: 0pt;">(22)<font style="width: 5pt; text-indent: 0pt; display: inline-block;">&#160;</font>Dr. May also holds 12,438 Stock Options.</p>
    <p style="text-align: justify; margin-left: 22pt; margin-bottom: 0pt; text-indent: -22pt; margin-top: 0pt;">(23)<font style="width: 5pt; text-indent: 0pt; display: inline-block;">&#160;</font>Mr. Saeed was terminated for cause from his positions of President and Director effective January 26, 2021.&#160;</p>
    <p style="text-align: justify; margin-left: 22pt; margin-bottom: 0pt; text-indent: -22pt; margin-top: 0pt;">(24)<font style="width: 5pt; text-indent: 0pt; display: inline-block;">&#160;</font>Xorax Family Trust, a trust of which Zeeshan Saeed is a beneficiary, is the registered owner of the Class A Shares.</p>
    <p style="text-align: justify; margin-left: 22pt; margin-bottom: 0pt; text-indent: -22pt; margin-top: 0pt;">(25)<font style="width: 5pt; text-indent: 0pt; display: inline-block;">&#160;</font>Xorax Family Trust, a trust of which Zeeshan Saeed is a beneficiary, is the registered owner of 317,543 Class B Shares. Mr. Saeed also holds 199,004 Stock Options.</p>
    <p style="text-align: justify; margin-left: 22pt; margin-bottom: 0pt; text-indent: -22pt; margin-top: 0pt;">(26)<font style="width: 5pt; text-indent: 0pt; display: inline-block;">&#160;</font>In March 2020,<b> </b>Dr. Bokhari entered into private agreements with Mr. Durkacz (as to 12 Class A Shares) and Mr. Saeed (as to 12 Class A Shares)&#160; in connection with the acquisition of 24 Class A Shares now currently held by Dr. Bokhari.</p>
    <p style="text-align: justify; margin-left: 22pt; margin-bottom: 0pt; text-indent: -22pt; margin-top: 0pt;">(27)<font style="width: 5pt; text-indent: 0pt; display: inline-block;">&#160;</font>Member of Nominating Committee.</p>
    <p style="text-align: justify; margin-left: 22pt; margin-bottom: 0pt; text-indent: -22pt; margin-top: 0pt;">(28)<font style="width: 5pt; text-indent: 0pt; display: inline-block;">&#160;</font>Chairman of Nominating Committee.</p>
    <p style="text-align: justify; margin-left: 22pt; margin-bottom: 0pt; text-indent: -22pt; margin-top: 0pt;">(29)<font style="width: 5pt; text-indent: 0pt; display: inline-block;">&#160;</font>Member of Executive Committee.</p>
    <p style="text-align: justify; margin-left: 22pt; text-indent: -22pt; margin-top: 0pt;">(30)<font style="width: 5pt; text-indent: 0pt; display: inline-block;">&#160;</font>Chairman of Executive Committee.</p>
    <p style="text-align: justify; margin-left: 54pt; text-indent: -54pt;"><b>Cease Trade Orders, Bankruptcies, Penalties or Sanctions</b></p>
    <p style="text-align: justify; margin-left: 1.4pt; text-indent: -0.7pt;"><i><b>Corporate Cease Trade Orders</b></i></p>
    <p style="text-align: justify;">To the best of management's knowledge, other than set out below, no director or executive officer of the Corporation is, or within the ten years before the date of this AIF has been, a director, chief executive officer or chief financial officer of any Corporation that:</p>
    <p style="text-align: justify; margin-left: 36pt; text-indent: -36pt;">(a)<font style="width: 24.9pt; text-indent: 0pt; display: inline-block;">&#160;</font>was subject to a cease trade order, an order similar to a cease trade order, or an order that denied the relevant corporation access to any exemption under securities legislation, that was in effect for a period of more than 30 consecutive days that was issued while the director or executive officer was acting in the capacity as director, chief executive officer or chief financial officer; or</p>
    <p style="text-align: justify; margin-left: 36pt; text-indent: -36pt;">(b)<font style="width: 24.34pt; text-indent: 0pt; display: inline-block;">&#160;</font>was subject to a cease trade order, an order similar to a cease trade order, or an order that denied the relevant corporation access to any exemption under securities legislation, that was in effect for a period of more than 30 consecutive days that was issued after the director or executive officer ceased to be a director, chief executive officer or chief financial officer and which resulted from an event that occurred while that person was acting in the capacity as director, chief executive officer or chief financial officer.</p>
    <div id="footer_page_75">
        <p style="text-align: center;">- 75 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_76"></a>
    <p style="text-align: justify;">Gerry Goldberg was the Interim Chief Executive Officer of Canada House when a MCTO was issued by the Ontario Securities Commission on September 13, 2017. The MCTO was issued in respect of Canada House's failure to file its audited financial statements and management discussion and analysis for the year ended April 30, 2017 before the August 28, 2017 filing deadline. The MCTO was lifted effective November 22, 2017.</p>
    <p style="text-align: justify; margin-left: 1.4pt; text-indent: -0.7pt;"><i><b>Bankruptcies</b></i></p>
    <p style="text-align: justify;">To the best of management's knowledge, no director or executive officer of the Corporation has: (i) within ten years before the date of this AIF, been a director or officer of any corporation that, while that person was acting in that capacity, or within a year of that person ceasing to act in that capacity, became bankrupt, made a proposal under any legislation relating to bankruptcy or insolvency, or was subject to or instituted any proceedings, arrangement or compromise with creditors, or had a receiver, receiver manager or trustee appointed to hold its assets; or (ii) within ten years before the date of this AIF, become bankrupt, made a proposal under any legislation relating to bankruptcy or insolvency, or become subject to or instituted any proceedings, arrangement or compromise with creditors, or had a receiver manager or trustee appointed to hold the assets of the director or executive officer.</p>
    <p style="text-align: justify; margin-left: 1.4pt; text-indent: -0.7pt;"><i><b>Penalties and Sanctions</b></i></p>
    <p style="text-align: justify;">To the best of management's knowledge, no director or executive officer of the Corporation has been subject to: (a) any penalties or sanctions imposed by a court relating to securities legislation or by a securities regulatory authority or has entered into a settlement agreement with any securities regulatory authority; or (b) any other penalties or sanctions imposed by a court or regulatory body that would likely be considered important to a reasonable security holder in deciding whether to vote for a director or executive officer.</p>
    <p style="text-align: justify; margin-left: 54pt; text-indent: -54pt;"><b>Conflicts of Interest</b></p>
    <p style="text-align: justify;">Conflicts of interest may arise as a result of the directors, officers and promoters of the Corporation also holding positions as directors or officers of other companies. Some of the individuals who will be directors and officers of the Corporation have been and will continue to be engaged in the identification and evaluation of assets, businesses and companies on their own behalf and on behalf of other companies, and situations may arise where the directors and officers of the Corporation will be in direct competition with the Corporation. Conflicts, if any, will be subject to the procedures and remedies provided under the OBCA.</p>
    <p style="text-align: center;"><b>PROMOTERS</b></p>
    <p style="text-align: justify;">There are currently no individuals who would be considered promoters of the Corporation.</p>
    <p style="text-align: center;"><b>LEGAL PROCEEDINGS AND REGULATORY ACTIONS</b></p>
    <p style="text-align: justify;"><b>Shareholder Settlement</b></p>
    <p style="text-align: justify;">The Corporation was the defendant in a proposed class action lawsuit filed at the Ontario Superior Court of Justice in Toronto on February 22, 2019 (the "<b>Settled Action</b>"). The plaintiff shareholder alleged that the Corporation misrepresented information with respect to the progress of the build-out of the first phase the Facility by the Corporation and Auxly. The plaintiff further alleges that when the Corporation subsequently announced that the Auxly Agreement had been terminated, the price of the Class B Shares on the CSE decreased causing losses to her and the other shareholders of the Corporation.</p>
    <p style="text-align: justify;">On October 29, 2020 the Corporation announced that it had entered into a definitive settlement agreement the "<b>Settlement Agreement</b>") before the Ontario Superior Court of Justice<b> </b>with respect to the Settled Action, pursuant to which the Corporation will pay $5,500,000, of which $4,571,459 has been funded with the proceeds of insurance and the remaining $928,541 has been funded by the Corporation. The Settlement Agreement provides for a full and final release of the Corporation, its officers, directors and various other related parties from any and all claims that arose or could have arisen from the claim issued by the plaintiff within the Settled Action. The Settlement Agreement was approved by the Ontario Superior Court of Justice on February 4, 2021.</p>
    <div id="footer_page_76">
        <p style="text-align: center;">- 76 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_77"></a>
    <p style="text-align: justify;"><b>Dismissed Supplier</b></p>
    <p style="text-align: justify;">A dismissed contractor commenced a lien action combined with a breach of contract action in the Cobourg Superior Court in early 2019 claiming approximately $1,700,000 in various purported damages, with a claim for lien component of $188,309 which claim was registered November 26, 2018. We are defending the action and have taken steps to obtain particulars and inspect documents of the plaintiff which remain unaddressed to date. The Corporation has paid monies into court totalling $235,387 to vacate the lien from title, which funds stand as security for the lien claim and its costs in Cobourg Superior Court file no. CV-19-0002. On October 7, 2020, FSD signed a settlement agreement of $198,000. The settlement will be paid from the funds held by the Cobourg Superior Court with the remaining funds being paid back to FSD. See "<i>Risk Factors - General Corporate Risks - Claims from suppliers</i>".</p>
    <p style="text-align: justify;">Other than stated above, there are no material legal proceedings or regulatory actions that the Corporation is or was a party to, or that any of its property is or was the subject of, during the years ended December 31, 2020, and no such proceedings are known by the Corporation to be contemplated. From time to time, however, the Corporation may be subject to various claims and legal actions arising in the course of its business.</p>
    <p style="text-align: justify;">Other than stated above, the Corporation is not aware of any settlement agreements, penalties or sanctions the Corporation has entered into before a court relating to securities legislation or with a securities regulatory authority or that would be material to a reasonable investor in making an investment decision.</p>
    <p style="text-align: justify;"><b>Former Employee</b></p>
    <p style="text-align: justify;">FSD hired an individual (the "<b>Claimant</b>") whose employment was subsequently terminated in the probationary period due to non-performance/cause in February 2019. The individual retained legal counsel in or around February 15, 2019 demanding that he be provided (i) unpaid wages; (ii) unpaid holiday pay, (iii) payment for wrongful dismissal (one week) and (iv) breach of contract.</p>
    <p style="text-align: justify;">The Corporation has a provision of $105,180 (&#163;59,748) in relation to the claimed amounts for unpaid wages and unpaid holiday pay. On July 29, 2020, a judgment was issued ordering the Corporation to pay unpaid wages and unpaid holiday pay in the amount of &#163;59,748. On August 6, 2020, the Corporation filed an application for reconsideration for that decision, as key evidence was not considered in determining the judgment. The ruling on the application for reconsideration is outstanding. On August 26, 2020, the Claimant filed a separate cost order against the Corporation. The ultimate outcome of the matter cannot be reliably determined at this time and no additional provision has been recorded for this matter as at December 31, 2020.</p>
    <p style="text-align: justify;"><b>2021 Special and General Meeting of Shareholders </b></p>
    <p style="text-align: justify;">At the Corporation's annual meeting of shareholders on May 14, 2021, a requisition for a special meeting has been submitted to the Corporation by the Requisitioning Shareholders claiming to hold in excess of 5.1% of the Class B Shares, including Mr. Zeeshan Saeed, the former President of the Corporation and Mr. Anthony Durkacz, who is a director of the Corporation. In addition to the Class B Shares controlled by this group, Mr. Saeed and Mr. Durkacz each hold 24 Class A Shares, with each Class A Share being entitled to 276,660 votes. Dr. Raza Bokhari, the Corporation's Executive Chairman and Chief Executive Officer, holds the remaining 24 Class A Shares. As of the date hereof, the Corporation has 72 Class A Shares and approximately 19,161,620 Class B Shares issued and outstanding. The Requisitioning Shareholders are seeking to reduce the size of the Board to five, and to replace six of the incumbent directors, including Dr. Raza Bokhari, with three directors selected by such shareholders.</p>
    <p style="text-align: center;"><b>INTEREST OF MANAGEMENT AND OTHERS IN MATERIAL TRANSACTIONS</b></p>
    <p style="text-align: justify;">Except as disclosed elsewhere in this AIF, no: (a) director or executive officer of the Corporation; (b) person or Corporation who beneficially owns, or controls or directs, directly or indirectly, more than 10% of any class or series of the Corporation's outstanding securities; or (c) any associate or affiliate of any of the foregoing, has had any material interest, direct or indirect, in any transaction within the three most recently completed financial years or during the current financial year that has materially affected or is reasonably expected to materially affect the Corporation, other than an interest arising solely from the ownership of shares where such person received no extra or special benefit or advantage not shared on a pro rata basis by all shareholders.</p>
    <div id="footer_page_77">
        <p style="text-align: center;">- 77 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_78"></a>
    <p style="text-align: center;"><b>TRANSFER AGENT AND REGISTRAR</b></p>
    <p style="text-align: justify;">The transfer agent and registrar of the Corporation is Computershare at its office located at 100 University Avenue, 8th Floor, Toronto, Ontario, Canada M5J 2Y1.</p>
    <p style="text-align: center;"><b>MATERIAL CONTRACTS</b></p>
    <p style="text-align: justify;">Other than those listed below, elsewhere in this AIF, and those entered into in the ordinary course of the Corporation's business, there are no material contracts of the Corporation which were entered into in the most recently completed financial year or which were entered into before the most recently completed financial year but are still in effect as of the date of this AIF:</p>
    <p style="text-align: justify; margin-left: 72.05pt; text-indent: -36pt;">(a)<font style="width: 25pt; text-indent: 0pt; display: inline-block;">&#160;</font>the Amalgamation Agreement;</p>
    <p style="text-align: justify; margin-left: 72.05pt; text-indent: -36pt;">(b)<font style="width: 25pt; text-indent: 0pt; display: inline-block;">&#160;</font>License Agreement;</p>
    <p style="text-align: justify; margin-left: 72pt; text-indent: -36pt;">(c)<font style="width: 25pt; text-indent: 0pt; display: inline-block;">&#160;</font>the Escrow Agreement; and</p>
    <p style="text-align: justify; margin-left: 72pt; text-indent: -36pt;">(d)<font style="width: 25pt; text-indent: 0pt; display: inline-block;">&#160;</font>the Coattail Agreement.</p>
    <p style="text-align: center;"><b>AUDIT COMMITTEE INFORMATION</b></p>
    <p style="text-align: justify;">The Audit Committee is governed by an Audit Committee charter, a copy of which is attached as Schedule "A".</p>
    <p style="text-align: justify; margin-left: 54pt; text-indent: -54pt;"><b>Composition of the Audit and Risk Committee</b></p>
    <p style="text-align: justify;">As of the date of this AIF, the following are the members of the Audit Committee:</p>
    <table style="border: 0.75pt solid #000000; border-collapse: collapse; font-size: 10pt; width: 100%;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="background-color: #e7e6e6; width: 33%; vertical-align: bottom; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: center;"><b>Name</b></p>
            </td>
            <td style="border-bottom: 0.75pt solid #000000; width: 33%; vertical-align: bottom; background-color: #e7e6e6; padding-right: 5.03pt; border-right: 0.75pt solid #000000; padding-left: 5.03pt; border-left: 0.75pt solid #000000;">
                <p style="text-align: center;"><b>Independent</b></p>
            </td>
            <td style="background-color: #e7e6e6; width: 33%; vertical-align: bottom; border-left: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: center;"><b>Financially Literate</b></p>
            </td>
        </tr>
        <tr>
            <td style="width: 33%; vertical-align: top; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p style="text-align: center;">Robert J. Ciaruffoli (Chair)</p>
            </td>
            <td style="width: 33%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p style="text-align: center;">Yes</p>
            </td>
            <td style="border-left: 0.75pt solid #000000; width: 33%; vertical-align: top; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p style="text-align: center;">Yes</p>
            </td>
        </tr>
        <tr>
            <td style="width: 33%; vertical-align: top; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p style="text-align: center;">Larry Kaiser</p>
            </td>
            <td style="width: 33%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border: 0.75pt solid #000000;">
                <p style="text-align: center;">Yes</p>
            </td>
            <td style="border-left: 0.75pt solid #000000; width: 33%; vertical-align: top; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p style="text-align: center;">Yes</p>
            </td>
        </tr>
        <tr>
            <td style="width: 33%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border-top: 0.75pt solid #000000; border-right: 0.75pt solid #000000;">
                <p style="text-align: center;">Gerald Goldberg</p>
            </td>
            <td style="width: 33%; vertical-align: top; border-left: 0.75pt solid #000000; padding-right: 5.03pt; border-right: 0.75pt solid #000000; padding-left: 5.03pt; border-top: 0.75pt solid #000000;">
                <p style="text-align: center;">Yes</p>
            </td>
            <td style="width: 33%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border-top: 0.75pt solid #000000; border-left: 0.75pt solid #000000;">
                <p style="text-align: center;">Yes</p>
            </td>
        </tr>
    </table>
    <p style="text-align: justify;">The Audit Committee's function include, but are not limited to: reviewing the integrity of the Corporation's financial statements, financial disclosures and internal controls over financial reporting; monitoring the Corporation's ongoing compliance with legal and regulatory requirements; selecting the external auditor for shareholder approval; and reviewing the qualifications, independence and performance of the external auditor. Information concerning the relevant education and experience of the Audit Committee members is set forth below.</p>
    <p style="text-align: justify; margin-left: 54pt; text-indent: -54pt;"><b>Relevant Education and Experience</b></p>
    <p style="text-align: justify;">The Board believes that the composition of the Audit Committee reflects financial literacy and expertise. Currently, all members of the Audit Committee have been determined by the Board to be "independent" and "financially literate" as such terms are defined under National Instrument 52-110 - <i>Audit Committees</i>. The Board has made these determinations based on the education as well as breadth and depth of experience of each member of the Audit Committee.</p>
    <p style="text-align: justify;">All the members of the Audit Committee have the education and/or practical experience required to understand and evaluate financial statements that present a breadth and level of complexity of accounting issues that are generally comparable to the breadth and complexity of issues that can reasonably be expected to be raised by the Corporation's financial statements. The following is a brief summary of the education and experience of each member of the Committee that is relevant to the performance of his or her responsibilities as an Audit Committee member:</p>
    <div id="footer_page_78">
        <p style="text-align: center;">- 78 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_79"></a>
    <p style="text-align: justify; margin-left: 1.4pt; text-indent: -0.7pt;"><i><b>Robert Ciaruffoli (Chair)</b></i></p>
    <p style="text-align: justify;">Mr. Ciaruffoli is a co-founder and vice-chairman of Broad Street Angels, a 100 member Philadelphia based angel investor network which invests in start-up entrepreneurial businesses with high growth potential. Broad Street Angels is the largest angel investor network in the Philadelphia region.</p>
    <p style="text-align: justify;">Mr. Ciaruffoli holds a Bachelor of Science in Accounting from Kings College, Wilkes-Barre, Pennsylvania. He holds the CPA designation and served as the Chairman and CEO of the ParenteBeard/Baker Tilly accounting and advisory firm. During his tenure as Chairman and CEO, he and his team transitioned the firm from a Pennsylvania practice to a multi-state, super-regional firm. In 2014, he orchestrated a merger of the ParenteBeard and Baker Tilly Virchow Krause firms to create the 12th largest U.S. accounting and advisory firm.</p>
    <p style="text-align: justify;">Mr. Ciaruffoli also served on the board of directors and executive committee of Baker Tilly International, the eighth largest global accounting network. During his tenure on the board and the executive committee, Baker Tilly International grew from an unranked network to the eighth largest global accounting network.</p>
    <p style="text-align: justify;">Throughout his career, Mr. Ciaruffoli has served on numerous for-profit and not-for-profit boards. Presently, he is the President of the board of directors of The Pennsylvania Society, a board member of Ben Franklin Technology Partners, a board member of eureQa - a SaaS cloud based automated platform for testing digital applications, and a member of the finance committee of the Archdiocese of Philadelphia. He was also the past chairman of the Pennsylvania State Board of Accountancy.</p>
    <p style="text-align: justify; margin-left: 1.4pt; text-indent: -0.7pt;"><i><b>Larry Kaiser</b></i></p>
    <p style="text-align: justify; margin-left: 1.4pt; text-indent: -0.7pt;">Dr. Kaiser was formerly President and Chief Executive Officer of the Temple University Health System and Senior Executive Vice-President for Health Affiars and the Lewis Katz Dean of the Lewis Katz School of Medicine at Temple University. He serves on multiple editorial boards including the Annals of Surgery, the American Journal of Surgery and the European Journal of Cardiothoracic Surgery.</p>
    <p style="text-align: justify; margin-left: 1.4pt; text-indent: -0.7pt;">Dr. Kaiser graduated from the Tulane University School of Medicine in 1977 and completed his residency in general surgery as well as a fellowship in surgical oncology at the University of Califonia, Los Angeles. He then completed a residency in cardiovascular and thoracic surgery at the University of Toronto. Following that, he held positions as attending thoracic surgeon at Memorial Sloan-Kettering Cancer Center and Assistant Professor of Surgery at Cornell University Medical College (New York) and subsequently as Associate Professor (with tenure) at the Washington University School of Medicine (St. Louis). At the University of Pennsylvania, Dr. Kaiser held a variety of positions, including chief of general thoracic surgery, founder and director of the university's lung transplantation program, director of its Center for Lung Cancers and Related Disorders, and co-director of the Thoracic Oncology Laboratory. In 1996 he was named as the first Eldridge Eliason Professor of Surgery and, in 2001 following a national search, was named the John Rhea Barton Professor and Chair of the Department of Surgery as well as Surgeon in Chief for the University of Pennsylvania Health System. He has been a director of both the American Board of Srugery and the American Board of Thoracic Surgery, and was elected to the National Academy of Medicine in 2005. He is the author or co-author of 17 books and more than 300 original papers.</p>
    <p style="text-align: justify;"><i><b>Gerald Goldberg</b></i></p>
    <p style="text-align: justify;">Mr. Goldberg the President at Leo Acquisitions Corp. since October 2009 and serves as its Chief Executive Officer. He serves as the President of SLF Capital Markets Inc. He joined the accounting firm of Schwartz Levitsky Feldman LLP in 1992 and currently serves as a Senior Partner and Head of the audit division. Mr. Goldberg served as Chief Executive Officer, President and Chief Financial Officer of Victory Capital Corp. until March 2017. Mr. Goldberg served as the Chief Executive Officer, President of Prime City One Capital Corp. until July 2016.</p>
    <div id="footer_page_79">
        <p style="text-align: center;">- 79 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_80"></a>
    <p style="text-align: justify;">Mr. Goldberg also served as a Partner in the predecessor firm of Grant Thornton for over 15 years before he headed the U.S. Public Company audit division of Academy Capital Corp. He has also served in various roles at the following companies: Gravitas Financial Inc., Gilla Inc., Capricorn Business Acquisitions Inc., Baymount Inc., Blue Nordic Partners Inc., InterAmerican Gaming Inc., Grasslands Entertainment Inc., Pinetree Capital Ltd., Emerge Resources Corp., Lakeside Minerals Inc. and Keyuan Petrochemicals Inc. He was Interim Chief Executive Officer of Canada House Wellness Group Inc. from April 2016 to December 2017.</p>
    <p style="text-align: justify; margin-left: 54pt; text-indent: -54pt;"><b>Pre-Approval Policies and Procedures</b></p>
    <p style="text-align: justify;">The Audit Committee will pre-approve all non-audit services to be provided to the Corporation by its external auditors. The Audit Committee may delegate to one or more of its members the authority to pre-approve non-audit services but preapproval by such member or members so delegated shall be presented to the full Audit Committee at its first scheduled meeting following such pre-approval.</p>
    <p style="text-align: justify; margin-left: 54pt; text-indent: -54pt;"><b>Reliance on Certain Exemptions</b></p>
    <p style="text-align: justify;">At no time since the commencement of the most recently completed financial year of the Corporation has the Corporation relied on the exemption in section 2.4 of NI 52-110 (De Minimis Non-Audit Services), or an exemption from the application of NI 52-110, in whole or in part, granted under Part 8 of NI 52-110 (Exemptions). The Corporation is relying upon the exemption in section 6.1 of NI 52-110.</p>
    <p style="text-align: justify; margin-left: 54pt; text-indent: -54pt;"><b>Auditors' Fees</b></p>
    <p style="text-align: justify;">The following table sets forth the fees paid by the Corporation to its auditor for services rendered during the years ended December 31, 2020 and December 31, 2019:</p>
    <table style="width: 100%; border: 0.75pt solid #000000; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 29%; padding: 1.08pt 5.38pt; vertical-align: bottom; background-color: #e7e6e6; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000;">
                <p style="text-align: center;"><b>Fee</b></p>
            </td>
            <td style="border-left: 0.75pt solid #000000; width: 30%; vertical-align: bottom; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; background-color: #e7e6e6; padding: 1.08pt 5.38pt;">
                <p style="text-align: center;"><b>For the year ended</b><br><b>December 31, 2019</b></p>
            </td>
            <td style="width: 32%; padding: 1.08pt 5.38pt; vertical-align: bottom; background-color: #e7e6e6; border-bottom: 0.75pt solid #000000; border-left: 0.75pt solid #000000;">
                <p style="text-align: center;"><b>For the year ended</b><br><b>December 31, 2020</b></p>
            </td>
        </tr>
        <tr>
            <td style="width: 29%; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-right: 0.75pt solid #000000; padding: 1.08pt 5.38pt; border-top: 0.75pt solid #000000;">
                <p style="text-align: center;">Audit Fees<sup>(1)</sup></p>
            </td>
            <td style="width: 30%; padding: 1.08pt 5.38pt; vertical-align: bottom; border: 0.75pt solid #000000;">
                <p style="text-align: center;">$199,135</p>
            </td>
            <td style="width: 32%; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-left: 0.75pt solid #000000; padding: 1.08pt 5.38pt; border-top: 0.75pt solid #000000;">
                <p style="text-align: center;">$460,000</p>
            </td>
        </tr>
        <tr>
            <td style="width: 29%; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-right: 0.75pt solid #000000; padding: 1.08pt 5.38pt; border-top: 0.75pt solid #000000;">
                <p style="text-align: center;">Audit-Related Fees<sup>(2)</sup></p>
            </td>
            <td style="width: 30%; padding: 1.08pt 5.38pt; vertical-align: bottom; border: 0.75pt solid #000000;">
                <p style="text-align: center;">Nil</p>
            </td>
            <td style="width: 32%; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-left: 0.75pt solid #000000; padding: 1.08pt 5.38pt; border-top: 0.75pt solid #000000;">
                <p style="text-align: center;">$2,000</p>
            </td>
        </tr>
        <tr>
            <td style="width: 29%; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-right: 0.75pt solid #000000; padding: 1.08pt 5.38pt; border-top: 0.75pt solid #000000;">
                <p style="text-align: center;">Tax Fees<sup>(3)</sup></p>
            </td>
            <td style="width: 30%; padding: 1.08pt 5.38pt; vertical-align: bottom; border: 0.75pt solid #000000;">
                <p style="text-align: center;">Nil</p>
            </td>
            <td style="width: 32%; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-left: 0.75pt solid #000000; padding: 1.08pt 5.38pt; border-top: 0.75pt solid #000000;">
                <p style="text-align: center;">$18,800</p>
            </td>
        </tr>
        <tr>
            <td style="width: 29%; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-right: 0.75pt solid #000000; padding: 1.08pt 5.38pt; border-top: 0.75pt solid #000000;">
                <p style="text-align: center;">All Other Fees<sup>(4)</sup></p>
            </td>
            <td style="width: 30%; padding: 1.08pt 5.38pt; vertical-align: bottom; border: 0.75pt solid #000000;">
                <p style="text-align: center;">Nil</p>
            </td>
            <td style="width: 32%; vertical-align: bottom; border-bottom: 0.75pt solid #000000; border-left: 0.75pt solid #000000; padding: 1.08pt 5.38pt; border-top: 0.75pt solid #000000;">
                <p style="text-align: center;">Nil</p>
            </td>
        </tr>
        <tr>
            <td style="width: 29%; padding: 1.08pt 5.38pt; vertical-align: bottom; border-top: 0.75pt solid #000000; border-right: 0.75pt solid #000000;">
                <p style="text-align: center;"><b>Total</b></p>
            </td>
            <td style="width: 30%; vertical-align: bottom; border-left: 0.75pt solid #000000; border-right: 0.75pt solid #000000; padding: 1.08pt 5.38pt; border-top: 0.75pt solid #000000;">
                <p style="text-align: center;">$<b>199,135</b></p>
            </td>
            <td style="width: 32%; padding: 1.08pt 5.38pt; vertical-align: bottom; border-top: 0.75pt solid #000000; border-left: 0.75pt solid #000000;">
                <p style="text-align: center;"><b>$480,800</b></p>
            </td>
        </tr>
    </table>
    <p style="text-align: justify;"><u><b>Notes:</b></u></p>
    <p style="text-align: justify; margin-left: 18pt; margin-bottom: 0pt; text-indent: -18pt;">(1)<font style="width: 6pt; text-indent: 0pt; display: inline-block;">&#160;</font>"Audit Fees" include fees necessary to perform the annual audit and quarterly reviews of the Corporation's consolidated financial statements. Audit Fees include fees for review of tax provisions and for accounting consultations on matters reflected in the financial statements. Audit Fees also include audit or other attest services required by legislation or regulation, such as comfort letters, consents, reviews of securities filings and statutory audits.</p>
    <p style="text-align: justify; margin-left: 18pt; margin-bottom: 0pt; text-indent: -18pt; margin-top: 0pt;">(2)<font style="width: 6pt; text-indent: 0pt; display: inline-block;">&#160;</font>"Audit-Related Fees" include services that are traditionally performed by the auditor. These audit-related services include employee benefit audits, due diligence assistance, accounting consultations on proposed transactions, internal control reviews and audit or attest services not required by legislation or regulation.</p>
    <p style="text-align: justify; margin-left: 18pt; margin-bottom: 0pt; text-indent: -18pt; margin-top: 0pt;">(3)<font style="width: 6pt; text-indent: 0pt; display: inline-block;">&#160;</font>"Tax Fees" include fees for all tax services other than those included in "Audit Fees" and "Audit-Related Fees". This category includes fees for tax compliance, tax planning and tax advice. Tax planning and tax advice includes assistance with tax audits and appeals, tax advice related to mergers and acquisitions, and requests for rulings or technical advice from tax authorities.</p>
    <p style="text-align: justify; margin-left: 18pt; text-indent: -18pt; margin-top: 0pt;">(4)<font style="width: 6pt; text-indent: 0pt; display: inline-block;">&#160;</font>"All Other Fees" include all other non-audit services.</p>
    <p style="text-align: justify;">All permissible categories of non-audit services require pre-approval by the Audit Committee, subject to certain statutory exemptions.</p>
    <p style="text-align: center;"><b>INTERESTS OF EXPERTS</b></p>
    <p style="text-align: justify;">The Corporation's auditors are MNP (the "<b>Auditor</b>"), who have prepared an independent auditor's report dated March 16, 2021, in respect of the Corporation's audited consolidated annual financial statements for the two most recent fiscal years ended December 31, 2020, and December 31, 2019. The Auditor has advised that they are independent with respect to the Corporation in&#160; accordance&#160; with&#160; the&#160; rules&#160; of&#160; professional conduct&#160; of&#160; the&#160; Institute&#160; of Chartered Professional Accountants of Ontario and within the meaning of the applicable rules and regulations adopted by the U.S. Securities Exchange Commission and the Public Company Accounting Oversight Board (United States).</p>
    <div id="footer_page_80">
        <p style="text-align: center;">- 80 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_81"></a>
    <p style="text-align: justify;">As of the date of this AIF, to the best of our knowledge, MNP and the partners and associates of MNP, beneficially own, directly or indirectly, in their respective groups, less than 1% of our outstanding securities.</p>
    <p style="text-align: justify;">No person or corporation whose profession or business gives authority to a statement made by the person or corporation and who is named as having prepared or certified a part of this AIF or as having prepared or certified a report or valuation described or included in this AIF holds any beneficial interest, direct or indirect, in any securities or property of the Corporation or of any associate or affiliate of the Corporation and no such person is expected to be elected, appointed or employed as a director, senior officer or employee of the Corporation or of any associate or affiliate of the Corporation and no such person is a promoter of the Corporation or any associate or affiliate of the Corporation.</p>
    <p style="text-align: center;"><b>ADDITIONAL INFORMATION</b></p>
    <p style="text-align: justify;">Additional information relating to the Corporation may be found on SEDAR at www.sedar.com. Additional information including directors' and officers' remuneration and indebtedness, principal holders of the Corporation's securities and securities authorized for issuance under equity compensation plans are contained in the Corporation's management information circular dated November 14, 2019, in respect of the annual and special meeting of Shareholders held on December 16, 2019, which is available on SEDAR at www.sedar.com. Additional financial information is provided in the Corporation's audited consolidated financial statements and management's discussion and analysis thereon for the years ended December 31, 2020 and 2019, which are also available under the Corporation's SEDAR profile.</p>
    <div id="footer_page_81">
        <p style="text-align: center;">- 81 -</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_82"></a>
    <p style="text-align: center;"><b>SCHEDULE "A"</b></p>
    <p style="text-align: center;"><u><b>AUDIT COMMITTEE CHARTER</b></u></p>
    <p style="text-align: center;">(<i>See attached</i>)</p>
    <div>
        <p style="text-align: center;">&#160;</p>
    </div>
    <div id="footer_page_82">
        <p style="text-align: center;">- 82 -</p>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_83"></a>
    <p style="text-align: center;"><img src="exhibit99-1xu001.jpg"></p>
    <p style="text-align: center;">&#160;</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_84"></a>
    <p style="text-align: center;"><img src="exhibit99-1xu003.jpg"></p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_85"></a>
    <p style="text-align: center;"><img src="exhibit99-1xu004.jpg"></p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_86"></a>
    <p style="text-align: center;"><img src="exhibit99-1xu005.jpg"></p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_87"></a>
    <p style="text-align: center;"><img src="exhibit99-1xu006.jpg"></p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_88"></a>
    <p style="text-align: center;"><img src="exhibit99-1xu007.jpg"></p>
    <hr width="100%" size="5" color="black" noshade="noshade">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>exhibit99-2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<html>

<head>
    <title>FSD Pharma Inc.: Exhibit 99.2 - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt; font-family:'Times New Roman';">
    <hr width="100%" size="3" color="black" noshade="noshade"><a name="page_1"></a>
    <div>
        <p style="text-align: justify;">&#160;</p>
    </div>
    <p style="margin-left: 75.6pt; margin-bottom: 0pt; text-indent: -3.6pt; text-align: justify;"><font style="font-size: 12pt;"><b>FSD Pharma Inc. </b></font></p>
    <p style="margin-top: 0pt; margin-left: 36pt; text-indent: 36pt; text-align: justify;"><b>Consolidated financial statements </b></p>
    <p style="margin-left: 72pt; margin-bottom: 0pt; text-align: justify;">For the years ended December 31, 2020 and 2019</p>
    <p style="margin-top: 0pt; margin-left: 72pt; text-align: justify;">[expressed in United States dollar, except per share amounts]</p>
    <p style="margin-top: 0pt; margin-left: 72pt; text-align: justify;">&#160;</p>
    <p style="margin-top: 0pt; margin-left: 72pt; text-align: justify;">&#160;</p>
    <p>&#160;</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade">
    <p style="text-align: right;"><img src="exhibit99-2xu001.jpg"></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 100%; border-bottom: 2px solid #000000;"><font style="font-size: 13.3333px;"><b>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></font></td>
        </tr>
    </table>
    <p>To the Board of Directors and Shareholders of FSD Pharma Inc.</p>
    <p><b>Opinion on the Consolidated Financial Statements</b></p>
    <p style="text-align: justify;">We have audited the accompanying consolidated statements of financial position of FSD Pharma Inc. (the Company) as of December 31, 2020 and 2019 and the related consolidated statements of loss and comprehensive loss, shareholders&#8217; equity, and cash flows for each of the years in the two-year period ended December 31, 2020, and the related notes (collectively referred to as the consolidated financial statements).</p>
    <p style="text-align: justify;">In our opinion, the consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Company as of December 31, 2020 and 2019, and the results of its consolidated operations and its consolidated cash flows for each of the years in the two-year period ended December 31, 2020, in conformity with International Financial Reporting Standards as issued by the International Accounting Standards Board.</p>
    <p style="text-align: justify;"><b>Change in Accounting Policy</b></p>
    <p style="text-align: justify;">As discussed in Note 2(d) to the consolidated financial statements, the Company has changed its presentation currency from Canadian dollars to U.S. dollars. The change in presentation currency is as of October 1, 2020, and this change has been retrospectively applied in the consolidated financial statements.</p>
    <p style="text-align: justify;">The consolidated financial statements of FSD Pharma Inc. as at December 31, 2018 were audited by another auditor who expressed an unmodified opinion on those statements on May 3, 2019.</p>
    <p style="text-align: justify;">We also have audited the adjustments to the December 31, 2018 consolidated statement of financial position to retrospectively apply the change in accounting policy, as described in Note 2(d). In our opinion, such adjustments are appropriate and have been properly applied. We were not engaged to audit, review, or apply any procedures to the December 31, 2018 consolidated financial statements of the Company other than with respect to the adjustments described in Note 2(d) and, accordingly, we do not express an opinion or any other form of assurance on the December 31, 2018 consolidated financial statements taken as a whole.</p>
    <p style="text-align: justify;"><b>Basis for Opinion</b></p>
    <p style="text-align: justify;">These consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s consolidated financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</p>
    <p style="text-align: justify;">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</p>
    <p style="text-align: justify;">Our audit included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audit provides a reasonable basis for our opinion.</p>
    <p><img src="exhibit99-2xu002.jpg"></p>
    <p>Chartered Professional Accountants<br>Licensed Public Accountants</p>
    <p>We have served as the Company&#8217;s auditor since 2019</p>
    <p>Toronto, Canada<br>March 15, 2021</p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade">
    <p><b><img src="exhibit99-2xu003.jpg"></b></p>
    <p><b>Report of Independent Registered Public Accounting Firm</b></p>
    <p>To the Board of Directors and Stockholders of FSD Pharma Inc.</p>
    <p><b>Opinion on the Consolidated Financial Statements</b></p>
    <p style="text-align: justify;">We have audited, before the effects of the adjustments to retrospectively apply the change in accounting policy described in Note 2(d), the consolidated statements of financial position of FSD Pharma Inc. (the Company) as of December 31, 2018 and 2017, and the related consolidated statements of operations and comprehensive loss, cash flows and changes in equity for the years ended December 31, 2018 and 2017, and the related notes (collectively referred to as the financial statements).</p>
    <p style="text-align: justify;">In our opinion, the financial statements, before the effects of the adjustments to retrospectively apply the change in accounting policy described in Note 2(d), present fairly, in all material respects, the consolidated financial position of the Company as of December 31, 2018 and 2017, and the results of its operations and its cash flows for the years ended December 31, 2018 and 2017, in conformity with International Financial Reporting Standards (&#8220;IFRS&#8221;) as issued by the International Accounting Standards Board.</p>
    <p style="text-align: justify;">We were not engaged to audit, review, or apply any procedures to the adjustments to retrospectively apply the change in accounting policy described in Note 2(d) and, accordingly, we do not express an opinion or any other form of assurance about whether such adjustments are appropriate and have been properly applied. Those adjustments were audited by MNP LLP.</p>
    <p style="text-align: justify;"><b>Basis for Opinion</b></p>
    <p style="text-align: justify;">These consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the</p>
    <p style="text-align: justify;">PCAOB.</p>
    <p style="text-align: justify;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.</p>
    <p><img src="exhibit99-2xu004.jpg"></p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade">
    <p>Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.</p>
    <p>We served as the Company&#8217;s auditor during 2019.</p>
    <p><b>McGovern Hurley LLP</b></p>
    <p><b><img src="exhibit99-2xu005.jpg"></b></p>
    <p><b>Chartered Professional Accountants<br></b><b>Licensed Public Accountants</b></p>
    <p>Toronto, Canada<br>May 3, 2019</p>
    <p>&#160;</p>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_2"></a>
    <div>
        <div><br></div>
        <table style="width: 100%; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 35%; vertical-align: bottom;">
                    <p style="text-align: left;"><b>FSD PHARMA INC.</b></p>
                </td>
            </tr>
            <tr>
                <td style="width: 83%; vertical-align: bottom;">
                    <p style="text-align: center;"><b>CONSOLIDATED STATEMENTS OF FINANCIAL POSITION</b></p>
                </td>
            </tr>
            <tr>
                <td style="width: 35%; vertical-align: bottom;">
                    <p style="text-align: center;">[expressed in United States dollars]</p>
                </td>
            </tr>
        </table>
        <br>
        <table style="width: 100%; font-size: 10pt; border-collapse: collapse; border-color: #000000;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><b>As at,</b></td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>December 31,</b></td>
                <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>December 31,</b></td>
                <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>January 1,</b></td>
                <td style="vertical-align: bottom; text-align: right;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>2020</b></td>
                <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>2019</b></td>
                <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>2019</b></td>
                <td style="vertical-align: bottom; text-align: right;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom;">&#160;</td>
                <td style="vertical-align: bottom;">&#160;</td>
                <td style="vertical-align: bottom;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">[Restated - note 2d]</td>
                <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">[Restated - note 2d]</td>
                <td style="vertical-align: bottom; text-align: right;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center;">Notes</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;"><b>$</b></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">$</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">$</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;"><b>ASSETS</b></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><b>Current assets</b></td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom;">&#160;</td>
                <td style="vertical-align: bottom;">&#160;</td>
                <td style="vertical-align: bottom;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Cash</td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><b>17,524,822</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">5,967,798</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">15,899,808</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;">Other receivables</td>
                <td style="vertical-align: bottom; text-align: center;">6</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><b>161,342</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;">1,557,302</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;">745,520</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Prepaid expenses and deposits</td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><b>569,401</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">323,776</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">334,096</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;">Inventories</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;"><b>&#8212;</b></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;">709,373</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;">&#8212;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><b>18,255,565</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">8,558,249</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">16,979,424</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><b>Assets held for sale</b></td>
                <td style="vertical-align: bottom; text-align: center;">5</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;"><b>8,610,504</b></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;">&#8212;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;">&#8212;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><b>26,866,069</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">8,558,249</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">16,979,424</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><b>Non-current assets</b></td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Investments</td>
                <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">7</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><b>1,676,745</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">8,862,744</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">13,589,954</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;">Right-of-use asset, net</td>
                <td style="vertical-align: bottom; text-align: center;">8</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><b>&#8212;</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;">95,851</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;">183,424</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Property, plant and equipment, net</td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><b>&#8212;</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">8,880,258</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">9,134,183</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;">Intangible assets, net</td>
                <td style="vertical-align: bottom; text-align: center;">9</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;"><b>13,424,391</b></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;">16,820,625</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;">&#8212;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><b>41,967,205</b></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 12%; background-color: #e6efff;">43,217,727</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 12%; background-color: #e6efff;">39,886,985</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><b>LIABILITIES</b></td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;"><b>Current liabilities</b></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;">Trade and other payables</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><b>3,700,103</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;">3,361,145</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;">1,311,865</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Lease obligations</td>
                <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">11</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><b>46,842</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">42,285</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">40,875</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;">Derivative liability</td>
                <td style="vertical-align: bottom; text-align: center;">7</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><b>&#8212;</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;">1,990,788</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Warrants liability</td>
                <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">12</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><b>1,447,910</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;">Notes payable</td>
                <td style="vertical-align: bottom; text-align: center;">10</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;"><b>384,647</b></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;">1,435,698</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;">&#8212;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><b>5,579,502</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">6,829,916</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">1,352,740</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><b>Non-current liabilities</b></td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Lease obligations</td>
                <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">11</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><b>79,120</b></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;">110,334</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;">142,549</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;"><b>5,658,622</b></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;">6,940,250</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;">1,495,289</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;"><b>SHAREHOLDER'S EQUITY</b></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;">Class A share capital</td>
                <td style="vertical-align: bottom; text-align: center;">13</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><b>151,588</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;">151,588</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;">151,588</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Class B share capital</td>
                <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">13</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><b>103,056,538</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">73,586,337</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">51,093,434</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;">Warrant reserve</td>
                <td style="vertical-align: bottom; text-align: center;">13</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><b>4,968,958</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;">4,321,989</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;">3,341,826</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Contributed surplus</td>
                <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">14</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><b>18,792,590</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">17,371,434</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">3,744,423</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;">Foreign exchange translation reserve</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;"><b>207,797</b></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;">(84,776</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">)</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;">&#8212;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Accumulated deficit</td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><b>(90,868,888</b></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;"><b>)</b></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;">(59,069,095</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">)</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;">(19,939,575</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">)</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;"><b>36,308,583</b></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;">36,277,477</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;">38,391,696</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><b>41,967,205</b></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 12%; background-color: #e6efff;">43,217,727</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 12%; background-color: #e6efff;">39,886,985</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;">Commitments and contingencies</td>
                <td style="vertical-align: bottom; text-align: center;">18</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Subsequent events</td>
                <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">23</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            </tr>
        </table>
        <p style="text-align: justify;"><i>The accompanying notes are an integral part of these consolidated financial statements.</i></p>
        <table style="width: 100%; font-size: 10pt; border-collapse: collapse;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 50%; vertical-align: bottom;">
                    <p style="text-align: left;">On behalf of the Board:</p>
                </td>
                <td style="width: 50%; vertical-align: bottom;">
                    <p style="text-align: left;">&#160;</p>
                </td>
            </tr>
            <tr>
                <td style="width: 50%; vertical-align: bottom;">&#160;</td>
                <td style="width: 50%; vertical-align: bottom;">&#160;</td>
            </tr>
            <tr>
                <td style="width: 50%; vertical-align: bottom;">
                    <p style="text-align: center;"><i>"Signed"</i></p>
                </td>
                <td style="width: 50%; vertical-align: bottom;">
                    <p style="text-align: center;"><i>"Signed"</i></p>
                </td>
            </tr>
            <tr>
                <td style="width: 50%; vertical-align: bottom;">
                    <p style="text-align: center;">Director - Raza Bokhari</p>
                </td>
                <td style="width: 50%; vertical-align: bottom;">
                    <p style="text-align: center;">Director - Robert Ciaruffoli</p>
                </td>
            </tr>
        </table>
        <p style="text-align: center;">1</p>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_3"></a>
    <div>
        <div><br></div>
        <p style="text-align: justify;"><b>FSD PHARMA INC.</b></p>
        <p style="margin-bottom: 0pt; text-align: center;"><b>CONSOLIDATED STATEMENTS OF LOSS AND COMPREHENSIVE LOSS</b></p>
        <p style="margin-top: 0pt; text-align: center;">[expressed in United States dollars, except number of shares]</p>
        <table style="width: 100%; font-size: 10pt; border-collapse: collapse; border-color: #000000;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="vertical-align: bottom;">For the years ended December 31,</td>
                <td style="vertical-align: bottom; text-align: center;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right;"><b>2020</b></td>
                <td style="vertical-align: bottom; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right;">2019</td>
                <td style="vertical-align: bottom; text-align: right;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">[Restated - note 2d]</td>
                <td style="vertical-align: bottom; text-align: right;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center;">Notes</td>
                <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;"><b>$</b></td>
                <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">$</td>
                <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><b>Expenses</b></td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom;">&#160;</td>
                <td style="vertical-align: bottom;">&#160;</td>
                <td style="vertical-align: bottom;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">General and administrative</td>
                <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">16</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><b>10,058,083</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">8,407,427</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;">External research and development fees</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><b>7,832,847</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Share-based payments</td>
                <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">13, 14</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><b>8,052,011</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">12,082,930</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;">Depreciation and amortization</td>
                <td style="vertical-align: bottom; text-align: center;">8, 9</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><b>3,900,458</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;">1,943,048</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Legal provision</td>
                <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">18</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><b>757,829</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;">Impairment of right-of-use asset</td>
                <td style="vertical-align: bottom; text-align: center;">8</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;"><b>89,860</b></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;">50,888</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;"><b>Total operating expenses</b></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><b>30,691,088</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">22,484,293</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;">&#160;</td>
                <td style="vertical-align: bottom;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;"><b>Loss from continuing operations</b></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><b>(30,691,088</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"><b>)</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">(22,484,293</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">)</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;">&#160;</td>
                <td style="vertical-align: bottom;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Other income</td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><b>(3,691</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"><b>)</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">(40,454</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">)</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;">Finance expense</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><b>235,581</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;">155,316</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Loss (gain) on settlement of financial liability</td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><b>(680,164</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"><b>)</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">18,665</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;">Loss (gain) on change in fair value of warrants and derivative liability</td>
                <td style="vertical-align: bottom;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><b>(2,561,456</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><b>)</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;">2,684,436</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Loss on changes in fair value of investments</td>
                <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">7</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><b>770,874</b></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;">8,778,707</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><b>Net loss from continuing operations</b></td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><b>(28,452,232</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><b>)</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;">(34,080,963</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">)</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;">Net loss from discontinued operations</td>
                <td style="vertical-align: bottom; text-align: center;">5</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;"><b>(3,347,561</b></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;"><b>)</b></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;">(5,048,557</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">)</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;"><b>Net loss for the period</b></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><b>(31,799,793</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"><b>)</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">(39,129,520</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">)</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;">&#160;</td>
                <td style="vertical-align: bottom;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;"><b>Other comprehensive income (loss)</b></td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;">Items that may be subsequently reclassified to income:</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; padding-left: 7.5pt; background-color: #e6efff;">Exchange gain (loss) on translation of foreign operations</td>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><b>292,573</b></td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;">(84,776</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">)</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;"><b>Comprehensive loss</b></td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 12%;"><b>(31,507,220</b></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%;"><b>)</b></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 12%;">(39,214,296</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%;">)</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;">Net loss per share</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Basic and diluted - continuing operations</td>
                <td style="vertical-align: bottom; text-align: center; background-color: #e6efff;">15</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><b>(2.36</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"><b>)</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">(4.83</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">)</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;">Basic and diluted - discontinued operations</td>
                <td style="vertical-align: bottom; text-align: center;">15</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><b>(0.28</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;"><b>)</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;">(0.72</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">)</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;">Weighted average number of shares outstanding &#8211; basic and diluted</td>
                <td style="vertical-align: bottom; text-align: center;">15</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;"><b>12,043,961</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 12%;">7,056,245</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            </tr>
        </table>
        <p style="text-align: justify;"><i>The accompanying notes are an integral part of these consolidated financial statements.</i></p>
        <p style="text-align: center;">2</p>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_4"></a>
    <div>
        <div><br></div>
        <p style="text-align: left;"><b>FSD PHARMA INC.</b></p>
        <p style="text-align: center;"><b>CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY<br></b>For the years ended December 31, 2020 and 2019<br>[expressed in United States dollars, except number of shares]</p>
        <br>
        <table style="width: 100%; font-size: 8pt; border-collapse: collapse; border-color: #000000;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center;"><b>Contributed</b></td>
                <td style="vertical-align: bottom; text-align: center;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center;"><b>exchange</b></td>
                <td style="vertical-align: bottom; text-align: center;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center;"><b>Accumulated</b></td>
                <td style="vertical-align: bottom; text-align: center;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;" colspan="4"><b>Class A shares</b></td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;" colspan="4"><b>Class B shares</b></td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;" colspan="4"><b>Warrants</b></td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;"><b>surplus</b></td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;"><b>translation</b></td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;"><b>deficit</b></td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;"><b>Total</b></td>
                <td style="vertical-align: bottom; text-align: right; border-bottom: 1px solid #000000;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;"><b>#</b></td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">$</td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;"><b>#</b></td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">$</td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;"><b>#</b></td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">$</td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">$</td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">$</td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">$</td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">&#160;</td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">$</td>
                <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;"><b>Balance, January 1, 2019 [Restated - note 2d]</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;"><b>72</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;"><b>151,588</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;"><b>6,843,780</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;"><b>51,093,434</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;"><b>546,212</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;"><b>3,341,826</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;"><b>3,744,423</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;"><b>(19,939,575</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"><b>)</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;"><b>38,391,696</b></td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;">Shares issued <i>[note 13]</i></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">408,651</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">8,681,103</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">8,681,103</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;"><font style="font-size: 10.6667px; background-color: #e6efff;">Issued on acquisition of net assets of Prismic </font>Pharmaceuticals, Inc. [note 13]</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">510,940</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">12,361,657</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">67,598</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">1,420,407</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">1,931,384</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">15,713,448</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;">Stock options exercised <i>[note 14]</i></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">12,082,930</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">12,082,930</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Share-based payments <i>[note 14]</i></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">130,189</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">1,340,929</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">(789,794</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">)</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">551,135</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;">Warrants exercised</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">12,167</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">109,214</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">(12,167</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">)</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">(37,753</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">)</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">71,461</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Warrants expired</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">(134,192</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">)</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">(402,491</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">)</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">402,491</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left;">Comprehensive loss for the year</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 5%;">(84,776</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">)</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 5%;">(39,129,520</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">)</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 5%;">(39,214,296</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">)</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; background-color: #e6efff;"><b>Balance, December 31, 2019 [Restated - note</b> <b>2d]</b></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 5%; background-color: #e6efff;"><b>72</b></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 5%; background-color: #e6efff;"><b>151,588</b></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 5%; background-color: #e6efff;"><b>7,905,727</b></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 5%; background-color: #e6efff;"><b>73,586,337</b></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 5%; background-color: #e6efff;"><b>467,451</b></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 5%; background-color: #e6efff;"><b>4,321,989</b></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 5%; background-color: #e6efff;"><b>17,371,434</b></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 5%; background-color: #e6efff;"><b>(84,776</b></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;"><b>)</b></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 5%; background-color: #e6efff;"><b>(59,069,095</b></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;"><b>)</b></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 5%; background-color: #e6efff;"><b>36,277,477</b></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;">Shares issued <i>[note 13]</i></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">8,925,942</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">22,242,975</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">6,335,758</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">1,110,904</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">(1,302,076</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">)</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">22,051,803</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Share-based payments <i>[note 13, 14]</i></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">2,307,569</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">6,663,479</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">2,763,482</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">9,426,961</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left;">Share options exercised <i>[note 14]</i></td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">22,382</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">563,747</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">(504,185</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">)</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%;">59,562</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Warrants expired</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">(54,100</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">)</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">(463,935</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">)</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">463,935</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; text-align: right; width: 5%; background-color: #e6efff;">&#8212;</td>
                <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left;">Comprehensive loss for the year</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 5%;">&#8212;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 5%;">292,573</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 5%;">(31,799,793</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">)</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 5%;">(31,507,220</td>
                <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">)</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; background-color: #e6efff;"><b>Balance, December 31, 2020</b></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 5%; background-color: #e6efff;"><b>72</b></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 5%; background-color: #e6efff;"><b>151,588</b></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 5%; background-color: #e6efff;"><b>19,161,620</b></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 5%; background-color: #e6efff;"><b>103,056,538</b></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 5%; background-color: #e6efff;"><b>6,749,109</b></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 5%; background-color: #e6efff;"><b>4,968,958</b></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 5%; background-color: #e6efff;"><b>18,792,590</b></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 5%; background-color: #e6efff;"><b>207,797</b></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 5%; background-color: #e6efff;"><b>(90,868,888</b></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;"><b>)</b></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 5%; background-color: #e6efff;"><b>36,308,583</b></td>
                <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            </tr>
        </table>
        <p style="text-align: justify;"><i>The accompanying notes are an integral part of these consolidated financial statements.</i></p>
        <p style="text-align: center;">3</p>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_5"></a>
    <div>
        <div><br></div>
        <div>
            <p style="text-align: justify; margin-bottom: 0pt;"><b>FSD PHARMA INC.</b></p>
            <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>CONSOLIDATED STATEMENTS OF CASH FLOWS</b></p>
            <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center;">For the years ended December 31, 2020 and 2019</p>
            <p style="margin-top: 0pt; text-align: center;">[expressed in United States dollars]</p>
            <table style="width: 100%; font-size: 10pt; border-collapse: collapse; border-color: #000000;" cellspacing="0" cellpadding="0">
                <tr>
                    <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right;"><b>2020</b></td>
                    <td style="vertical-align: bottom; text-align: right;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right;"><b>2019</b></td>
                    <td style="vertical-align: bottom; text-align: right;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom;">&#160;</td>
                    <td style="vertical-align: bottom;">&#160;</td>
                    <td style="vertical-align: bottom;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">[Restated - note 2d]</td>
                    <td style="vertical-align: bottom; text-align: right;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;"><b>$</b></td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">$</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;"><b>Operating activities</b></td>
                    <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left;">Net loss from continuing operations</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%;"><b>(28,452,232</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%;"><b>)</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%;">(34,080,963</td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%;">)</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Add (deduct) items not affecting cash</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left; padding-left: 7.5pt;">Depreciation and amortization</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%;"><b>3,900,458</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%;">1,943,048</td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left; padding-left: 7.5pt; background-color: #e6efff;">Impairment of right-of-use asset</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><b>89,860</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">183,161</td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left; padding-left: 7.5pt;">Interest expense</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%;"><b>7,860</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%;">155,315</td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left; padding-left: 7.5pt; background-color: #e6efff;">Share-based payments</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><b>8,052,011</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">12,082,930</td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left; padding-left: 7.5pt;">Change in fair value of investments</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%;"><b>770,874</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%;">8,778,707</td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left; padding-left: 7.5pt; background-color: #e6efff;">Change in fair value of derivative liability</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><b>(2,561,456</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"><b>)</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">2,684,436</td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left; padding-left: 7.5pt;">Unrealized foreign exchange loss (gain)</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%;"><b>(327,161</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%;"><b>)</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left; padding-left: 7.5pt; background-color: #e6efff;">Loss (gain) on settlement of financial liability</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><b>(680,164</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"><b>)</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">18,665</td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left;">Changes in non-cash working capital balances</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left; padding-left: 15pt; background-color: #e6efff;">Other receivables</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><b>435,183</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">(387,837</td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">)</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left; padding-left: 15pt;">Prepaid expenses and deposits</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%;"><b>(526,738</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%;"><b>)</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%;">(24,214</td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%;">)</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left; padding-left: 15pt; background-color: #e6efff;">Other payables</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><b>898,691</b></td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;">1,516,025</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left;"><b>Cash used in continuing operating activities</b></td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;"><b>(18,392,814</b></td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;"><b>)</b></td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;">(7,130,727</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">)</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;"><b>Cash used in discontinued operating activities</b></td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><b>(737,659</b></td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;"><b>)</b></td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;">(6,581,998</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">)</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left;"><b>Cash used in operating activities</b></td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;"><b>(19,130,473</b></td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;"><b>)</b></td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;">(13,712,725</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">)</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left;"><b>Investing activities</b></td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Cash acquired from acquisition of Prismic Pharmaceuticals Inc.</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><b>&#8212;</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">1,752</td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left;">Proceeds from sale of investments</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%;"><b>6,477,510</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%;">462,303</td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Additions to intangible assets</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><b>&#8212;</b></td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;">(293,126</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">)</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left;"><b>Cash provided by continuing investing activities</b></td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;"><b>6,477,510</b></td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;">170,929</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;"><b>Cash provided by (used in) discontinued investing activities</b></td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><b>36,616</b></td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;">(401,817</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">)</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left;"><b>Cash provided by (used in) investing activities</b></td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;"><b>6,514,126</b></td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;">(230,888</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">)</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left;"><b>Financing activities</b></td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Repayment of lease obligation</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><b>(39,993</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"><b>)</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">(42,285</td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">)</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left;">Proceeds from issuance of shares, net of issuance costs</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%;"><b>25,100,459</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%;">3,431,294</td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Repayment of notes payable</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;"><b>(946,643</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"><b>)</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left;">Proceeds from exercise of stock options</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%;"><b>59,548</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%;">551,133</td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;">Proceeds from exercise of warrants</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><b>&#8212;</b></td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;">71,461</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left;"><b>Cash provided by continuing financing activities</b></td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;"><b>24,173,371</b></td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;">4,011,603</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;"><b>Cash provided by discontinued financing activities</b></td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><b>&#8212;</b></td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%; background-color: #e6efff;">&#8212;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left;"><b>Cash provided by financing activities</b></td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;"><b>24,173,371</b></td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;">4,011,603</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left;"><b>Net increase (decrease)</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%;"><b>11,557,024</b></td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; text-align: right; width: 12%;">(9,932,010</td>
                    <td style="vertical-align: bottom; text-align: left; width: 2%;">)</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left;">Cash, beginning of the year</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;"><b>5,967,798</b></td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 1%;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right; width: 12%;">15,899,808</td>
                    <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: left; width: 2%;">&#160;</td>
                </tr>
                <tr>
                    <td style="vertical-align: bottom; text-align: left; background-color: #e6efff;"><b>Cash, end of the year</b></td>
                    <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 12%; background-color: #e6efff;"><b>17,524,822</b></td>
                    <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
                    <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: right; width: 12%; background-color: #e6efff;">5,967,798</td>
                    <td style="vertical-align: bottom; border-bottom: 2px solid #000000; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
                </tr>
            </table>
        </div>
        <div>
            <p style="text-align: justify;"><i>The accompanying notes are an integral part of these consolidated financial statements.</i></p>
            <p style="text-align: center;">4</p>
        </div>
    </div>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_6"></a>
    <div id="header_page_6">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><b>Notes to the consolidated financial statements </b></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in United States dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2020 and 2019<br><br></p>
                </td>
            </tr>
        </table>
    </div>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;"><b>1.</b><font style="width: 10.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Nature of business </b></p>
    <p style="text-align: justify;">FSD Pharma Inc. (&#8220;FSD&#8221; or the &#8220;Company&#8221;), through its wholly owned subsidiary, FSD Biosciences Inc., is focused on Pharmaceutical research and development ("R&amp;D") of its lead compound, FSD 201, ultra-micronized Palmitoyl ethylamine (&#8220;PEA&#8221;). FSD 201 is known to stabilize mast cells of the human body and down-regulate the pro-inflammatory cytokines to effectuate an anti-inflammatory response.</p>
    <p style="text-align: justify;">FV Pharma Inc. ("FV Pharma"), a wholly owned subsidiary of the Company, was a licensed producer of cannabis in Canada under the Cannabis Act (Canada) (together with the regulations promulgated thereunder (the "Cannabis Regulations"), the "Cannabis Act") and associated Cannabis Regulations. FV Pharma surrendered its cannabis license in September 2020. In March 2020, substantially all the assets of FV Pharma were classified as held for sale (refer to Note 5).</p>
    <p style="text-align: justify;">The Company's registered office is located at 1 Rossland Road West, Suite 202, Ajax, Ontario, L1Z 1Z2.</p>
    <p style="text-align: justify;">On October 16, 2019, the Company completed a reverse share split of 201 to 1 Class B Shares. All share and per share amounts for all periods presented in these financial statements have been adjusted retrospectively to reflect the reverse share split.</p>
    <p style="text-align: justify;"><b>Subsidiaries</b></p>
    <p style="text-align: justify;">These consolidated financial statements are comprised of the financial results of the Company and its subsidiaries, which are the entities over which FSD has control. An investor controls an investee when it is exposed, or has rights, to variable returns from its involvement with the investee and can affect those returns through its power over the investee.</p>
    <p style="text-align: justify;">The Company has the following subsidiaries:</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="7"><b>Ownership percentage as at</b></td>
            <td style="text-align: right; vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><b>Entity Name</b></td>
            <td style="vertical-align: bottom;"><b>Country</b></td>
            <td style="text-align: right; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;"><b>December&#160; 31, 2020</b></td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;"><b>December&#160; 31, 2019</b></td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;"><b>January 1, 2019</b></td>
            <td style="text-align: right; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;"><b>%</b></td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;"><b>%</b></td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;"><b>%</b></td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">FSD Biosciences Inc.</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">USA</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">100</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Prismic Pharmaceuticals Inc.</td>
            <td style="vertical-align: bottom;">USA</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">100</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">100</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">100</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background-color: #e6efff;">FV Pharma Inc.</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background-color: #e6efff;">Canada</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">100</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">100</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">100</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;"><b>Impact of COVID-19</b></p>
    <p style="text-align: justify;">The outbreak of the novel strain of coronavirus, specifically identified as "COVID-19," has resulted in governments worldwide enacting emergency measures to combat the spread of the virus. These measures, which include the implementation of travel bans, self-imposed quarantine periods and social distancing, have caused material disruption to businesses globally resulting in an economic slowdown. Governments and central banks have reacted with significant monetary and fiscal interventions designed to stabilize economic conditions. The extent to which COVID-19 and any other pandemic or public health crisis impacts the Company's business, affairs, operations, financial condition, liquidity, availability of credit and results of operations will depend on future developments that are highly uncertain and cannot be predicted with any meaningful precision, including new information which may emerge concerning the severity of the COVID-19 virus and the actions required to contain the COVID-19 virus or remedy its impact, among others. The duration and impact of the COVID-19 outbreak is unknown at this time, as is the efficacy of the government and central bank interventions. It is not possible to reliably estimate the length and severity of these developments and the impact on the financial results and condition of the Company and its operating subsidiaries in future periods.</p>
    <p style="text-align: center;">5</p>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_7"></a>
    <div id="header_page_7">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><b>Notes to the consolidated financial statements </b></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in United States dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2020 and 2019<br><br></p>
                </td>
            </tr>
        </table>
    </div>
    <p style="text-align: justify;">In order to mitigate the impact of COVID-19, the Company implemented a systematic and orderly scale back of FV Pharma's cultivation operations and a furlough policy for its workforce, except for certain personnel working staggered shifts to ensure continuity of operations and licensure effective March 23, 2020. In September 2020, FV Pharma surrendered its licenses and ceased all other operational activities. The Company&#8217;s clinical trials for the use of FSD-201, its lead compound, to treat suspected or confirmed cases of COVID-19 continued to proceed throughout the year and as a result the impact of COVID-19 did not have a material impact on the continuing operations or financial results of the Company for the year ended December 31, 2020.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;"><b>2.</b><font style="width: 10.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Basis of presentation </b></p>
    <p style="text-align: justify;"><b>[a] Statement of compliance </b></p>
    <p style="text-align: justify;">These financial statements have been prepared by management in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board ("IASB"). The policies set out below have been consistently applied to all periods presented, unless otherwise noted.</p>
    <p style="text-align: justify;">These financial statements were approved and authorized for issuance by the Board of Directors of the Company on March 15, 2021.</p>
    <p style="text-align: justify;"><b>[b] Basis of measurement</b></p>
    <p style="text-align: justify;">These financial statements have been prepared on a historical cost basis, except for certain financial instruments which are measured at fair value. Historical costs are generally based upon the fair value of the consideration given in exchange for goods and services received.</p>
    <p style="text-align: justify;">Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, regardless of whether that price is directly observable or estimated using another valuation technique. In estimating the fair value of an asset or a liability, the Company takes into account the characteristics of the asset or liability if market participants would take those characteristics into account when pricing the asset or liability at the measurement date. Fair value for measurement and/or disclosure purposes in these financial statements is determined on such a basis, except for share-based payment transactions that are within the scope of IFRS 2 <i>Share-based Payment</i> ("IFRS 2") and measurements that have some similarities to fair value, but are not fair value, such as value in use in IAS 36 <i>Impairment of Assets</i>.</p>
    <p style="text-align: justify;"><b>[c] Basis of presentation</b></p>
    <p style="text-align: justify;">The accompanying financial statements include the accounts of FSD and its subsidiaries, FV Pharma, FSD Biosciences and Prismic. The financial statements incorporate the assets and liabilities of the Company and its subsidiaries as at December 31, 2020 and 2019 and January 1, 2019 and the results of these subsidiaries for the years ended December 31, 2020 and 2019.</p>
    <p style="text-align: justify;">Subsidiaries are all those entities over which the Company has control. The Company controls an entity when it is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power over the entity. Subsidiaries are fully consolidated from the date on which control is transferred to the Company. All intra-entity assets and liabilities, revenue, expenses and cash flows relating to transactions between subsidiaries of the Company are eliminated in full on consolidation.</p>
    <div id="footer_page_7">
        <p style="text-align: center;">6</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_8"></a>
    <div id="header_page_8">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><b>Notes to the consolidated financial statements </b></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in United States dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2020 and 2019<br><br></p>
                </td>
            </tr>
        </table>
    </div>
    <p style="text-align: justify;"><b>[d] Functional currency and presentation currency </b></p>
    <p style="text-align: justify;">The financial statements of each company within the consolidated group are measured using their functional currency which is the currency of the primary economic environment in which an entity operates. The Company changed its functional currency from the Canadian dollar (C$) to the United States dollar (US$) as of October 1, 2020. The change in functional currency was the result of a review of the primary economic environment in which the entity operates and the currency that mainly influences the underlying transactions entered into by the Company. The Company's functional currency is the United States dollar and the functional currencies of its subsidiaries are as follows:</p>
    <p style="margin-bottom: 0pt; text-align: justify;"><font style="width: 31.5pt; display: inline-block;">&#160;</font>FSD Biosciences <font style="display: inline-block; width: 77.98pt;">&#160;</font>United States Dollars</p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"><font style="width: 31.5pt; display: inline-block;">&#160;</font>Prismic<font style="display: inline-block; width: 119pt;">&#160;</font>United States Dollars</p>
    <p style="margin-top: 0pt; text-align: justify;"><font style="width: 31.5pt; display: inline-block;">&#160;</font>FV Pharma<font style="display: inline-block; width: 103.49pt;">&#160;</font>Canadian Dollars</p>
    <p style="text-align: justify;">The Company has elected to change its presentation currency from the Canadian dollar to the United States dollar effective October 1, 2020. The change in presentation currency is a voluntary change which is accounted for retrospectively. The change in presentation currency was made to better reflect the Company's business activities.&#160; For comparative reporting purposes, historical financial information has been translated to United States dollars using the exchange rate as at October 1, 2020, which is the date of the change in the functional and presentation currency.</p>
    <p style="text-align: justify;">The following shows the restatement of prior period information:</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;"><b>December 31, 2018 </b><br><b>as reported,</b></td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;"><b>Foreign currency </b><br><b>translation</b></td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;"><b>December 31, 2018 </b><br><b>restated,</b></td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;"><b>Adoption of <br>IFRS 16</b></td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;"><b>January 1, <br>2019</b></td>
            <td style="text-align: right; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">C$</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">US$</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">US$</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">US$</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;"><b>ASSETS</b></td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><b>Current assets</b></td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Cash&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">21,134,930</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">(5,235,122</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">15,899,808</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">15,899,808</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Trade and other receivables&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">990,988</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">(245,468</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">745,520</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">745,520</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Prepaid expenses and deposits</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">444,099</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">(110,003</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">334,096</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">334,096</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">22,570,017</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">(5,590,593</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">16,979,424</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">16,979,424</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;"><b>Non-current assets</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Other investments&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">18,064,541</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">(4,474,587</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">13,589,954</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">13,589,954</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Right-of-use asset, net&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">183,424</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">183,424</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Property, plant and equipment, net&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;">12,141,676</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;">(3,007,493</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;">9,134,183</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;">&#8212;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;">9,134,183</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">52,776,234</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">(13,072,673</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">39,703,561</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">183,424</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">39,886,985</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><b>LIABILITIES</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;"><b>Current liabilities</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Trade and other payables</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">1,743,806</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">(431,941</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">1,311,865</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">1,311,865</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Lease obligations&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">40,875</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">40,875</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">1,743,806</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">(431,941</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">1,311,865</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">40,875</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">1,352,740</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;"><b>Non-current liabilities</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Lease obligations&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;">&#8212;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;">&#8212;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;">&#8212;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;">142,549</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;">142,549</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">1,743,806</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">(431,941</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">1,311,865</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">183,424</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">1,495,289</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><b>SHAREHOLDER'S EQUITY</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Class A share capital&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">201,500</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">(49,912</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">151,588</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">151,588</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Class B share capital&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">67,916,302</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">(16,822,868</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">51,093,434</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">51,093,434</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Warrant reserve</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">4,442,145</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">(1,100,319</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">3,341,826</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">3,341,826</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Contributed surplus&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">4,977,300</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">(1,232,877</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">3,744,423</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">3,744,423</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Accumulated deficit</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">(26,504,819</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">6,565,244</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">(19,939,575</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">(19,939,575</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;">51,032,428</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;">(12,640,732</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;">38,391,696</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;">&#8212;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;">38,391,696</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">52,776,234</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">(13,072,673</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">39,703,561</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">183,424</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">39,886,985</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;">&#160;</p>
    <div id="footer_page_8">
        <p style="text-align: center;">7</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_9"></a>
    <div id="header_page_9">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><b>Notes to the consolidated financial statements </b></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in United States dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2020 and 2019<br><br></p>
                </td>
            </tr>
        </table>
    </div>
    <p style="text-align: justify;"><b>[e] Use of estimates and judgments</b></p>
    <p style="text-align: justify;">The preparation of these financial statements in conformity with IFRS requires management to make estimates, judgments and assumptions that affect the application of accounting policies and the reported amounts of assets and liabilities as at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates.</p>
    <p style="text-align: justify;">Estimates are based on management's best knowledge of current events and actions that the Company may undertake in the future. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.</p>
    <p style="text-align: justify;">The following are the critical judgments, apart from those involving estimations, that management has made in the process of applying the Company's accounting policies and that have the most significant effect on the amounts recognized in the financial statements:</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">[i]<font style="width: 11pt; text-indent: 0pt; display: inline-block;">&#160;</font>Going concern</p>
    <p style="text-align: justify;">At each reporting period, management assesses the basis of preparation of the financial statements. These financial statements have been prepared on a going concern basis in accordance with IFRS. The going concern basis of presentation assumes that the Company will continue its operations for the foreseeable future and be able to realize its assets and discharge its liabilities and commitments in the normal course of business.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">[ii]<font style="width: 9pt; text-indent: 0pt; display: inline-block;">&#160;</font>Estimated useful lives, residual values and depreciation of property, plant and equipment</p>
    <p style="text-align: justify;">Depreciation of property, plant and equipment is dependent upon estimates of useful lives and residual values, which are determined through the exercise of judgment. The assessment of any impairment of these assets' is dependent upon estimates of recoverable amounts that take into account factors such as economic and market conditions and the useful lives of assets.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">[iii]<font style="width: 7pt; text-indent: 0pt; display: inline-block;">&#160;</font>Estimated useful life and amortization of intangible assets</p>
    <p style="text-align: justify;">The Company employs significant estimates to determine the estimated useful lives of intangible assets, considering the nature of the asset, contractual rights, expected use and review of asset useful lives. The Company reviews amortization methods and useful lives annually or when circumstances change and adjusts its amortization methods and assumptions prospectively.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">[iv]<font style="width: 6.5pt; text-indent: 0pt; display: inline-block;">&#160;</font>Assets held for sale</p>
    <p style="text-indent: 0.05pt; text-align: justify;">The determination as to whether a disposal group meets the requirements to be classified as held for sale, and the assets and liabilities to be included within that disposal group, requires management to exercise judgment when making these determinations.&#160; Management must also exercise judgment when determining at which date all of the criteria are satisfied to be classified as held for sale. Management must also use estimates when determining the fair value less costs to sell of the disposal group to assess if the carrying value of the disposal group is greater than its recoverable amount.</p>
    <div id="footer_page_9">
        <p style="text-align: center;">8</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_10"></a>
    <div id="header_page_10">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><b>Notes to the consolidated financial statements </b></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in United States dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2020 and 2019<br><br></p>
                </td>
            </tr>
        </table>
    </div>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">[v]<font style="width: 8.5pt; text-indent: 0pt; display: inline-block;">&#160;</font>Valuation of share-based payments and warrants</p>
    <p style="text-align: justify;">Management measures the costs for share-based payments and warrants using market-based option valuation techniques. Assumptions are made and estimates are used in applying the valuation techniques. These include estimating the future volatility of the share price, expected dividend yield, expected term, expected risk-free interest rate and the rate of forfeiture. Such estimates and assumptions are inherently uncertain. Changes in these assumptions affect the fair value estimates of share-based payments and warrants.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">[vi]<font style="width: 6.5pt; text-indent: 0pt; display: inline-block;">&#160;</font>Valuation of private company investments</p>
    <p style="text-align: justify;">The financial information of private companies may not always be available, or such information may be insufficient or unreliable for valuation purposes. In determining the fair value of shares held in private company investments, management is required to make certain estimates and assumptions regarding the fair value as of the reporting date. Assumptions are made and estimates are used in applying the valuation techniques to determine fair value. These include the most recently available financial statements of the investee, price for most recently completed financing, as well as closely comparable public companies and general market and economic conditions. Such investments are classified as Level 3 within the fair value hierarchy. The value at which the Company could ultimately realize upon disposition of these investments may differ from their carrying value and such differences could be material.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">[vii]<font style="width: 4.5pt; text-indent: 0pt; display: inline-block;">&#160;</font>Asset acquisition</p>
    <p style="text-align: justify;">In the acquisition of Prismic on June 28, 2019 judgment was required to determine if the acquisition represented either a business combination or an asset purchase. Management concluded that Prismic did not represent a business as the assets acquired were not an integrated set of activities with inputs, processes and outputs. Since it was concluded that the acquisition represented the purchase of assets, there was no goodwill recognized on the transaction and acquisition costs were capitalized to the assets purchased rather than expensed. The fair values of the net assets acquired were determined using estimates and judgments. Refer to Note 4 for additional information on the Company's asset acquisition.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">[viii]<font style="width: 2.5pt; text-indent: 0pt; display: inline-block;">&#160;</font>Functional currency</p>
    <p style="text-align: justify;">The Company and its subsidiaries are required to determine their functional currencies based on the primary economic environment in which each entity operates. In order to do that, management has to analyze several factors, including which currency mainly influences the cost of undertaking the business activities, in which currency the entity has received financing, and in which currency it keeps its receipts from operating activities. Management uses its judgment to determine which factors are most important when the above indicators are mixed and the functional currency is not obvious.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;"><b>3.</b><font style="width: 10.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Significant accounting policies</b></p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">[a]<font style="width: 7.99pt; text-indent: 0pt; display: inline-block;">&#160;</font>Cash</p>
    <p style="text-align: justify;">Cash consists of cash and cash held in trust accounts. There are no restrictions on cash held in trust.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">[b]<font style="width: 7.99pt; text-indent: 0pt; display: inline-block;">&#160;</font>Property, Plant and Equipment</p>
    <p style="text-align: justify;">Property, plant and equipment is measured at cost less accumulated depreciation and impairment losses, with the exception of land which is not depreciated.&#160; &#160; &#160; &#160; &#160; &#160; &#160;</p>
    <div id="footer_page_10">
        <p style="text-align: center;">9</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_11"></a>
    <div id="header_page_11">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><b>Notes to the consolidated financial statements </b></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in United States dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2020 and 2019<br><br></p>
                </td>
            </tr>
        </table>
    </div>
    <p style="text-align: justify;">When parts of an item of property, plant and equipment have different useful lives, they are accounted for as separate items (major components) of property, plant and equipment.</p>
    <p style="text-align: justify;">The cost of replacing part of an item of property, plant and equipment is recognized in the carrying amount of the item if it is probable that the future economic benefits embodied within the part will flow to the Company and its cost can be measured reliably. The carrying amount of the replaced part is derecognized. The costs of the day-to-day servicing of property, plant and equipment are recognized in consolidated statements of loss and comprehensive loss.</p>
    <p style="text-align: justify;">Subsequent costs are included in the asset's carrying amount or recognized as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Company and the cost of the item can be measured reliably. All other repairs and maintenance are charged to the consolidated statements of loss and comprehensive loss.</p>
    <p style="text-align: justify;">Gains and losses on disposal of an item of property, plant and equipment are determined by comparing the proceeds from disposal with the carrying amount and are recognized net within other income in the consolidated statements of loss and comprehensive loss.</p>
    <p style="text-align: justify;">Depreciation is based on the estimated useful lives of the assets provided as follows:</p>
    <table style="margin-left: 19.6pt; border-collapse: collapse; font-size: 10pt; width: 60%;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="margin-bottom: 0pt; text-align: justify;">Computer equipment</p>
            </td>
            <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="margin-bottom: 0pt; text-align: justify;">30% declining balance</p>
            </td>
        </tr>
        <tr>
            <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">Production equipment</td>
            <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">20% declining balance</td>
        </tr>
        <tr>
            <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="margin-bottom: 0pt; text-align: justify;">Furniture and fixtures</p>
            </td>
            <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">
                <p style="margin-bottom: 0pt; text-align: justify;">20% declining balance</p>
            </td>
        </tr>
        <tr>
            <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">Facility and related</td>
            <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">20 years under straight-line</td>
        </tr>
        <tr>
            <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">Land</td>
            <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;">Not amortized</td>
        </tr>
    </table>
    <p style="text-align: justify;">An item of property, plant and equipment and any significant part initially recognized are derecognized upon disposal or when no future economic benefits are expected from their use or disposal. Any gain or loss arising on derecognition of the asset (calculated as the difference between the net disposal proceeds and the carrying amount of the asset) is included in the consolidated statements of loss and comprehensive loss when the asset is derecognized. The assets' residual values, useful lives and methods of depreciation and the depreciation charge are adjusted prospectively, if appropriate.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">[c]<font style="width: 8.5pt; text-indent: 0pt; display: inline-block;">&#160;</font>Intangible Assets</p>
    <p style="text-align: justify;">Intangible assets are recorded at cost less accumulated amortization and accumulated impairment losses. Amortization is recognized in profit or loss on a straight-line basis over the following terms:</p>
    <table style="margin-left: 19.6pt; border-collapse: collapse; font-size: 10pt; width: 60%;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: justify;">Intellectual Property</p>
            </td>
            <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;">
                <p style="text-align: justify;">5 years</p>
            </td>
        </tr>
    </table>
    <p style="text-align: justify;">Expenditures on internally generated intangible assets during the development phase, which comprise deferred development costs, are initially capitalized and recognized in the consolidated balance sheet if they meet the recognition criteria. Subsequent to initial recognition, deferred development costs are accounted for at cost less accumulated amortization and are amortized on a straight-line basis over an estimated useful life beginning once the deferred development costs are used in commercial production. Expenditures on internally generated intangible assets during the research phase are expensed as incurred.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">[d]<font style="width: 7.99pt; text-indent: 0pt; display: inline-block;">&#160;</font>Revenue Recognition</p>
    <div id="footer_page_11">
        <p style="text-align: center;">10</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_12"></a>
    <div id="header_page_12">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><b>Notes to the consolidated financial statements </b></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in United States dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2020 and 2019<br><br></p>
                </td>
            </tr>
        </table>
    </div>
    <p style="text-align: justify;">The Company's accounting policy for revenue recognition under IFRS 15, Revenue from Contracts with Customers ("IFRS 15") is to follow a five step model to determine the amount and timing of revenue to be recognized i) identify the contract with a customer; ii) identify the performance obligations in the contract; iii) determine the transaction price; iv) allocate the transaction price to the performance obligations in the contract; and v) recognize revenue when (or as) the Company satisfies a performance obligation.</p>
    <p style="text-align: justify;">Revenue from the sale of cannabis is recognized when the Company transfers control of the good to the customer. This is generally considered to have occurred when products have been delivered to the location specified in the sales contract and accepted by the customer.</p>
    <p style="text-align: justify;">The Company recognizes revenue in an amount that reflects the consideration the Company expects to receive taking into account any variation that may result from rights of return.</p>
    <p style="text-align: justify;">The Company was required to remit excise tax to the Canada Revenue Agency on the sale of medical cannabis in Canada. The Company became liable for these excise duties when cannabis products were delivered to the customer. In accordance with IFRS 15, revenue presented within discontinued operations (Note 5) represents revenue from the sale of goods less applicable excise tax.</p>
    <p style="text-align: justify;">Areas of judgment include identifying the customer per the definition within IFRS 15 and determining whether control has passed to the customer.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">[e]<font style="width: 7.99pt; text-indent: 0pt; display: inline-block;">&#160;</font>Foreign Currency Translation&#160;</p>
    <p style="text-align: justify;">Foreign currency transactions are translated into United States dollars at exchange rates in effect on the date of the transactions. Monetary assets and liabilities denominated in foreign currencies at the statement of financial position date are translated to United States dollars at the foreign exchange rate applicable at that date. Realized and unrealized exchange gains and losses are recognized through profit or loss.</p>
    <p style="text-align: justify;">Non-monetary assets and liabilities that are measured in terms of historical cost in a foreign currency are translated using the exchange rate at the date of the transaction.</p>
    <p style="text-align: justify;">The assets and liabilities of foreign operations with functional currencies other than United States dollars, are translated into United States dollars at year-end exchange rates. Income and expenses, and cash flows of such foreign operations are translated into United States dollars using average exchange rates for the period. Exchange differences resulting from translating foreign operations are recognized in other comprehensive loss and accumulated in equity.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">[f]<font style="width: 10.5pt; text-indent: 0pt; display: inline-block;">&#160;</font>Financial Instruments</p>
    <p style="text-align: justify;">Financial assets and financial liabilities are recognized when the Company becomes a party to the contractual provisions of the instruments.</p>
    <p style="text-align: justify;">Financial assets and financial liabilities are initially measured at fair value. Transaction costs that are directly attributable to the acquisition or issue of financial assets and financial liabilities (other than financial assets and financial liabilities at fair value through profit or loss) are added to or deducted from the fair value of the financial assets or financial liabilities, as appropriate, on initial recognition. Transaction costs directly attributable to the acquisition of financial assets or financial liabilities at fair value through profit or loss are recognized immediately in profit or loss.</p>
    <div id="footer_page_12">
        <p style="text-align: center;">11</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_13"></a>
    <div id="header_page_13">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><b>Notes to the consolidated financial statements </b></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in United States dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2020 and 2019<br><br></p>
                </td>
            </tr>
        </table>
    </div>
    <p style="text-align: justify;">&#8226;<font style="width: 32.85pt; display: inline-block;">&#160;</font>Financial assets</p>
    <p style="margin-left: 36pt; text-align: justify;">On initial recognition, a financial asset is classified as measured at amortized cost, fair value through other comprehensive income (''FVOCI''), or fair value through profit and loss (''FVTPL''). The classification of financial assets is based on the business model in which a financial asset is managed and its contractual cash flow characteristics.</p>
    <p style="margin-left: 36pt; text-align: justify;">A financial asset is measured at amortized cost if it meets both of the following conditions and is not designated as at FVTPL:</p>
    <ul style="padding-left: 0pt;" type="disc">
        <li style="margin-left: 45.14pt; text-align: justify; padding-left: 8.86pt;">It is held within a business model whose objective is to hold assets to collect contractual cash flows; and</li>
        <li style="margin-left: 45.14pt; text-align: justify; padding-left: 8.86pt;">Its contractual terms give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.</li>
    </ul>
    <p style="margin-left: 36pt; text-align: justify;">A financial asset (unless it is a trade receivable without a significant financing component that is initially measured at the transaction price) is initially measured at fair value plus, for an item not at FVTPL, transaction costs that are directly attributable to its acquisition.</p>
    <p style="text-align: justify; margin-left: 36pt;">The following accounting policies apply to the subsequent measurement of financial assets.</p>
    <div style="margin-left: 36pt;">
        <table style="border: 0.75pt solid #000000; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 32%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-bottom: 5.03pt;">
                    <p style="text-align: justify;">Financial assets at FVTPL</p>
                </td>
                <td style="width: 67%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border-bottom: 0.75pt solid #000000; border-left: 0.75pt solid #000000; padding-bottom: 5.03pt;">
                    <p style="text-align: justify;">Subsequently measured at fair value. Net gains and losses, including any interest or dividend income, are recognized in profit or loss.</p>
                </td>
            </tr>
            <tr>
                <td style="width: 32%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border-top: 0.75pt solid #000000; border-right: 0.75pt solid #000000; padding-bottom: 5.03pt;">
                    <p style="text-align: justify;">Financial assets at amortized cost</p>
                </td>
                <td style="width: 67%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; border-top: 0.75pt solid #000000; border-left: 0.75pt solid #000000; padding-bottom: 5.03pt;">
                    <p style="text-align: justify;">Subsequently measured at amortized cost using the effective interest method, less any impairment losses. Interest income, foreign exchange gains and losses and impairment losses are recognized in profit or loss. Any gain or loss on derecognition is recognized in profit or loss.</p>
                </td>
            </tr>
        </table>
    </div>
    <p style="text-align: justify;">&#8226;<font style="width: 32.85pt; display: inline-block;">&#160;</font>Financial liabilities</p>
    <p style="margin-left: 36pt; text-align: justify;">The Company initially recognizes financial liabilities at fair value on the date at which the Company becomes a party to the contractual provisions of the instrument.</p>
    <p style="margin-left: 36pt; text-align: justify;">The Company classifies its financial liabilities as either financial liabilities at FVTPL or amortized cost.</p>
    <p style="margin-left: 36pt; text-align: justify;">Subsequent to initial recognition, other liabilities are measured at amortized cost using the effective interest method. Financial liabilities at FVTPL are stated at fair value with changes being recognized in profit or loss.</p>
    <p style="margin-left: 36pt; text-align: justify;">The Company derecognizes a financial liability when its contractual obligations are discharged or cancelled or expire.</p>
    <p style="text-align: justify;">&#8226;<font style="width: 32.85pt; display: inline-block;">&#160;</font>Financial liabilities and equity instruments</p>
    <p style="margin-left: 36pt; text-align: justify;">&#8226;<font style="width: 32.85pt; display: inline-block;">&#160;</font>Classification as debt or equity</p>
    <div id="footer_page_13">
        <p style="text-align: center;">12</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_14"></a>
    <div id="header_page_14">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><b>Notes to the consolidated financial statements </b></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in United States dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2020 and 2019<br><br></p>
                </td>
            </tr>
        </table>
    </div>
    <p style="margin-left: 72pt; text-align: justify;">Debt and equity instruments issued by the Company are classified as either financial liabilities or as equity in accordance with the substance of the contractual arrangements and the definitions of a financial liability and an equity instrument. The Company does not reclassify financial liabilities or equity after initial recognition due to a change in circumstance.</p>
    <p style="margin-left: 36pt; text-align: justify;">&#8226;<font style="width: 32.85pt; display: inline-block;">&#160;</font>Equity instruments</p>
    <p style="margin-left: 72pt; text-align: justify;">An equity instrument is any contract that evidences a residual interest in the assets of an entity after deducting all of its liabilities. Equity instruments issued by a group entity are recognized at the proceeds received, net of direct issue costs.</p>
    <p style="margin-left: 72pt; text-align: justify;">Repurchase of the Company's own equity instruments is recognized and deducted directly in equity. No gain or loss is recognized in profit or loss on the purchase, sale, issue or cancellation of the Company's own equity instruments.</p>
    <p style="text-align: justify;">&#8226;<font style="width: 32.85pt; display: inline-block;">&#160;</font>Classification of financial instruments</p>
    <p style="margin-left: 36pt; text-align: justify;">The Company classifies its financial assets and liabilities depending on the purpose for which the financial instruments were acquired, their characteristics and management intent as outlined below:</p>
    <p style="margin-left: 36pt; text-align: justify;"><b>Classification</b></p>
    <div style="margin-left: 36pt;">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 50%; background-color: #e6efff;">Cash</td>
                <td style="width: 50%; background-color: #e6efff;">Amortized cost</td>
            </tr>
            <tr>
                <td style="width: 50%;">Other receivables</td>
                <td style="width: 50%;">Amortized cost</td>
            </tr>
            <tr>
                <td style="width: 50%; background-color: #e6efff;">Investments</td>
                <td style="width: 50%; background-color: #e6efff;">Fair value through profit or loss</td>
            </tr>
            <tr>
                <td style="width: 50%;">Trade and other payables</td>
                <td style="width: 50%;">Amortized cost</td>
            </tr>
            <tr>
                <td style="width: 50%; background-color: #e6efff;">Derivative liability</td>
                <td style="width: 50%; background-color: #e6efff;">Fair value through profit or loss</td>
            </tr>
            <tr>
                <td style="width: 50%;">Warrants liability</td>
                <td style="width: 50%;">Fair value through profit or loss</td>
            </tr>
            <tr>
                <td style="width: 50%; background-color: #e6efff;">Notes payable</td>
                <td style="width: 50%; background-color: #e6efff;">Amortized cost</td>
            </tr>
        </table>
    </div>
    <p style="text-align: justify;">&#8226;<font style="width: 32.85pt; display: inline-block;">&#160;</font>Impairment of financial assets</p>
    <p style="margin-left: 36pt; text-align: justify;">An expected credit loss ("ECL") model applies to financial assets measured at amortized cost. The Company's financial assets measured at amortized cost and subject to the ECL model consist primarily of trade and other receivables. The Company applies the simplified approach to impairment for trade and other receivables by recognizing a loss allowance based on lifetime expected losses at each reporting date taking into considerations historical credit loss experience and financial factors specific to the debtors and general economic conditions. The Company has assessed the impairment of its trade and other receivables using the expected credit loss model, and no material difference was noted.&#160;</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">[g]<font style="width: 7.99pt; text-indent: 0pt; display: inline-block;">&#160;</font>Inventory</p>
    <p style="text-align: justify;">Inventory of harvested work-in-process and finished goods are valued at the lower of cost and net realizable value. Inventory of harvested cannabis is transferred from biological assets at their fair value at harvest, which becomes the initial deemed cost. Any subsequent post-harvest costs are capitalized to inventory to the extent that cost is less than net realizable value. Net realizable value is determined as the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated costs necessary to make the sale. Inventory for supplies and consumables are valued at the lower of cost and net realizable value, with cost determined using the average cost basis.</p>
    <div id="footer_page_14">
        <p style="text-align: center;">13</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_15"></a>
    <div id="header_page_15">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><b>Notes to the consolidated financial statements </b></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in United States dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2020 and 2019<br><br></p>
                </td>
            </tr>
        </table>
    </div>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">[h]<font style="width: 7.99pt; text-indent: 0pt; display: inline-block;">&#160;</font>Impairment of long-lived assets</p>
    <p style="text-align: justify;">Long-lived assets, including property, plant and equipment and intangible assets are tested for impairment when there are indicators of impairment at each reporting date or whenever events or changes in circumstances indicate that the carrying amount of an asset exceeds its recoverable amount. Intangible assets with an indefinite useful life are tested for impairment at least annually in the fourth quarter and whenever there is an indication that the asset may be impaired.</p>
    <p style="text-align: justify;">For the purpose of impairment testing, assets that cannot be tested individually are grouped together into the smallest group of assets that generates cash inflows from continuing use that are largely independent of the cash inflows of other assets or groups of assets (the cash-generating unit, or "CGU"). The recoverable amount of an asset or a CGU is the higher of its fair value, less costs to sell, and its value in use. If the carrying amount of an asset exceeds its recoverable amount, an impairment charge is recognized immediately in net loss equal to the amount by which the carrying amount exceeds the recoverable amount. Where an impairment loss subsequently reverses, the carrying amount of the asset is increased to the lesser of the revised estimate of recoverable amount, and the carrying amount that would have been recorded had no impairment loss been recognized previously.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">[i]<font style="width: 11pt; text-indent: 0pt; display: inline-block;">&#160;</font>Income Taxes</p>
    <p style="text-align: justify;">Income tax expense comprises of current and deferred tax. Current tax and deferred tax are recognized in net profit or loss except to the extent that it relates to a business combination or items recognized directly in equity or in other comprehensive loss.</p>
    <p style="text-align: justify;">Current income taxes are recognized for the estimated income taxes payable or receivable on taxable income or loss for the current year and any adjustment to income taxes payable in respect of previous years. Current income taxes are determined using tax rates and tax laws that have been enacted or substantively enacted by the year-end date.</p>
    <p style="text-align: justify;">Deferred tax assets and liabilities are recognized where the carrying amount of an asset or liability differs from its tax base, except for taxable temporary differences arising on the initial recognition of goodwill and temporary differences arising on the initial recognition of an asset or liability in a transaction which is not a business combination and at the time of the transaction affects neither accounting nor taxable profit or loss.</p>
    <p style="text-align: justify;">Recognition of deferred tax assets for unused tax losses, tax credits and deductible temporary differences is restricted to those instances where it is probable that future taxable profit will be available against which the deferred tax asset can be utilized. At the end of each reporting period, the Company reassesses unrecognized deferred tax assets. The Company recognizes a previously unrecognized deferred tax asset to the extent that it has become probable that future taxable profit will allow the deferred tax asset to be recovered.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">[j]<font style="width: 11pt; text-indent: 0pt; display: inline-block;">&#160;</font>Share-based Compensation</p>
    <p style="text-align: justify;">Share options and warrants awarded to non-employees are accounted for using the fair value of the instrument awarded or service provided, whichever is considered more reliable. Share options and warrants awarded to employees are accounted for using the fair value method.&#160; The fair value of such share options and warrants granted is recognized as an expense on a proportionate basis consistent with the vesting features of each tranche of the grant. The fair value is calculated using the Black-Scholes option pricing model with assumptions applicable at the date of grant.</p>
    <div id="footer_page_15">
        <p style="text-align: center;">14</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_16"></a>
    <div id="header_page_16">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><b>Notes to the consolidated financial statements </b></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in United States dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2020 and 2019<br><br></p>
                </td>
            </tr>
        </table>
    </div>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;">[k]<font style="width: 8.5pt; text-indent: 0pt; display: inline-block;">&#160;</font>Net Loss per Share</p>
    <p style="text-align: justify;">Net loss per share is calculated based on the loss for the financial year and the weighted average number of common shares outstanding during the year. Diluted net loss per share is calculated using the loss for the financial year adjusted for the effect of any dilutive instruments and the weighted average diluted number of shares [ignoring any potential issue of common shares that would be anti-dilutive] during the year.</p>
    <p style="text-align: justify;">[l] Leases</p>
    <p style="text-align: justify;">At inception of a contract, the Company assesses whether a contract is, or contains, a lease based on whether the contract conveys the right to control the use of identified asset for a period of time in exchange for consideration. The Company recognized a right-of-use asset and a lease liability at the lease commencement date. The right-of-use asset is initially measured based on the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date, plus any initial direct costs incurred and an estimate of the costs to dismantle and remove the underlying asset or to restore the underlying asset or the site on which it is located, less any lease incentives received. The right-of-use assets are depreciated to the earlier of the end of useful life of the right-of-use asset or the lease term using the straight-line method as this most closely reflects the expected pattern of the consumption of the future economic benefits. The lease term includes periods covered by an option to extend if the Company is reasonably certain to exercise that option. In addition, the right-of-use asset can be periodically reduced by impairment losses, if any, and adjusted for certain remeasurements of the lease liability. The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, and the Company's incremental borrowing rate.</p>
    <p style="text-align: justify;">The lease liability is measured at amortized cost using the effective interest method. It is remeasured when there is a change in future lease payments arising from the change in an index or rate, if there is a change in the Company's estimate of the amount expected to be payable under a residual value guarantee, or if the Company changes its assessment of whether it will exercise a purchase, extension or termination option. When the lease liability is remeasured in this way, a corresponding adjustment is made to the carrying amount of the right-of-use asset, unless it has been reduced to zero.</p>
    <p style="text-align: justify;">[m] External research and development</p>
    <p style="text-align: justify;">External research and development costs are expensed in the periods in which they are incurred, with the exception of development costs for new products with proven technical feasibility and for which a defined future market exists. Such development costs are capitalized in accordance with the Company's policy for intangible assets. The Company's external research and development costs consist primarily of third-party services.</p>
    <p style="text-align: justify;">[n] Discontinued operations</p>
    <p style="text-align: justify;">Discontinued operations are reported when a component of the Company, representing a separate major line of business or area of operations with clearly distinguishable cash flows, has been disposed of or is held for sale. Classification as a discontinued operation occurs upon disposal or when the operation meets the criteria to be classified as held for sale, if earlier. Discontinued operations are reported as a separate element of net income or loss on the consolidated statement of net and comprehensive loss for both the current and comparative periods. When a disposal group is classified as held for sale, assets and liabilities are aggregated and presented as separate line items, respectively, on the consolidated statement of financial position. Comparative periods are not restated on the consolidated statement of financial position. Assets held for sale are not depreciated and are measured at the lower of carrying value and fair value less costs to sell.</p>
    <div id="footer_page_16">
        <p style="text-align: center;">15</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_17"></a>
    <div id="header_page_17">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><b>Notes to the consolidated financial statements </b></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in United States dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2020 and 2019<br><br></p>
                </td>
            </tr>
        </table>
    </div>
    <p style="text-align: justify;"><b>New standards, amendment and interpretation adopted by the Company</b></p>
    <p style="text-align: justify;">IFRS 3 - <i>Business combinations </i>("IFRS 3")</p>
    <p style="text-align: justify;">Amendments to IFRS 3, issued in October 2018, provide clarification on the definition of a business. The amendments permit a simplified assessment to determine whether a transaction should be accounted for as a business combination or as an asset acquisition.</p>
    <p style="text-align: justify;">The amendments are effective for transactions for which the acquisition date is on or after the beginning of the first annual reporting period beginning on or after January 1, 2020. The amendment adoption did not have a significant impact on the Company's financial statements.</p>
    <p style="text-align: justify;">IAS 1 -<i> Presentation of financial statements </i>("IAS 1")</p>
    <p style="text-align: justify;">Amendments to IAS 1, issued in October 2018, provide clarification on the definition of material and how it should be applied. The amendments also align the definition of material across International Financial Reporting Standards and other publications.</p>
    <p style="text-align: justify;">The amendments are effective for annual periods beginning on or after January 1, 2020 and are required to be applied prospectively. The amendment adoption did not have a significant impact on the Company's financial statements.</p>
    <p style="text-align: justify; margin-left: 18pt; text-indent: -18pt;"><b>4.</b><font style="width: 10.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Acquisition of Prismic Pharmaceutical</b></p>
    <p style="text-align: justify;">On June 28, 2019, the Company closed the acquisition of Prismic by acquiring all of the issued and outstanding Prismic Shares from the holders thereof. Prismic is a U.S.-based specialty research and development pharmaceutical company that is developing non-addictive prescription drugs for the treatment of pain and inflammation. Prismic's goal is to address the opioid crisis based on formulations utilizing micro-PEA's complementary effect on certain drugs used to impact the body's endocannabinoid system.</p>
    <p style="text-align: justify;">It was determined that the acquisition of Prismic did not qualify as a business combination in accordance with IFRS 3 <i>Business Combinations </i>["IFRS 3"] and therefore it was accounted for as an asset acquisition. The individual identifiable assets acquired and liabilities assumed were identified and the purchase consideration was allocated based on the relative fair values of the acquired assets and assumed liabilities.</p>
    <p style="text-align: justify;">The total consideration for the purchase of Prismic was $15,713,448. The purchase consideration consisted of $12,361,657 of Class B subordinate voting shares, $1,931,384 of share options and $1,420,407 of warrants. The fair value of the Class B subordinate voting shares was determined based on a total of 510,940 shares issued and a fair value of C$32.16 per share, which reflects the share price on the date of acquisition. The fair value of the 89,898 share options and 67,598 warrants issued as part of the consideration were determined using a Black-Scholes options pricing model with the following assumptions:</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0">
        <tr>
            <td style="width: 33%; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="text-align: right; width: 25%; border-bottom: 1px solid #000000;"><b>Share Options</b></td>
            <td style="text-align: right; width: 25%; border-bottom: 1px solid #000000;"><b>Warrants&#160;</b></td>
        </tr>
        <tr>
            <td style="width: 33%; background-color: #e6efff;">Grant date share price</td>
            <td style="text-align: right; width: 25%; background-color: #e6efff;">C$32.16</td>
            <td style="text-align: right; width: 25%; background-color: #e6efff;">C$32.16</td>
        </tr>
        <tr>
            <td style="width: 33%;">Exercise price</td>
            <td style="text-align: right; width: 25%;">C$2.61 - C$17.89</td>
            <td style="text-align: right; width: 25%;">C$2.61 - C$26.73</td>
        </tr>
        <tr>
            <td style="width: 33%; background-color: #e6efff;">Expected dividend yield</td>
            <td style="text-align: right; width: 25%; background-color: #e6efff;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; -&#160;&#160;</td>
            <td style="text-align: right; width: 25%; background-color: #e6efff;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; -&#160;&#160;</td>
        </tr>
        <tr>
            <td style="width: 33%;">Risk free interest rate</td>
            <td style="text-align: right; width: 25%;">1.39% - 1.66%</td>
            <td style="text-align: right; width: 25%;">1.41% - 1.52%</td>
        </tr>
        <tr>
            <td style="width: 33%; background-color: #e6efff;">Expected life (years)</td>
            <td style="text-align: right; width: 25%; background-color: #e6efff;">0.98 - 16.21</td>
            <td style="text-align: right; width: 25%; background-color: #e6efff;">1.39 - 6.55</td>
        </tr>
        <tr>
            <td style="width: 33%;">Annualized volatility</td>
            <td style="text-align: right; width: 25%;">100%</td>
            <td style="text-align: right; width: 25%;">100%</td>
        </tr>
    </table>
    <p style="text-align: justify;">&#160;</p>
    <div id="footer_page_17">
        <p style="text-align: center;">16</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_18"></a>
    <div id="header_page_18">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><b>Notes to the consolidated financial statements </b></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in United States dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2020 and 2019<br><br></p>
                </td>
            </tr>
        </table>
    </div>
    <p style="text-align: justify;">The allocation of the total purchase consideration to the identifiable assets acquired and liabilities assumed as at the date of acquisition was as follows:</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;"><b>Fair value recognized on acquisition</b></td>
            <td style="text-align: right; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;"><b>$</b></td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Cash&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 17%; text-align: right; background-color: #e6efff;">1,752</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Prepaid expenses and deposits</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 17%; text-align: right;">19,691</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Intangible assets</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 17%; text-align: right; background-color: #e6efff;">18,543,379</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Trade and other payables</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 17%; text-align: right;">(1,404,732</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background-color: #e6efff;">Notes payable</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 17%; text-align: right; background-color: #e6efff;">(1,446,642</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 17%; text-align: right;"><b>15,713,448</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
    </table>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;"><b>5.</b><font style="width: 10.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Assets held for sale</b></p>
    <p style="text-align: justify;">In March 2020, the Company decided to focus its efforts and resources on the pharmaceutical business and initiated the process to sell its Cobourg facility and exit the medical cannabis industry. The Company expects that the sale of the facility will be completed within the next twelve months and is actively marketing the facility for sale.&#160;</p>
    <p style="text-align: justify;">Assets held for sale consists of the Cobourg facility. It is anticipated that no liabilities of the Company will be transferred as part of any proposed transaction. Results of operations related to the Cobourg facility are reported as discontinued operations for the years ended December 31, 2020 and 2019.</p>
    <p style="text-align: justify;">In accordance with IFRS 5 - <i>Non-current Assets Held for Sale and Discontinued Operations</i>, the assets held for sale were assessed for impairment based on fair value less costs to sell. The fair value was measured using the price at which the Company expects to receive for the disposal of the Cobourg facility in its current state less estimates for the costs of disposal. The fair value less costs to sell was higher than the carrying value of the Cobourg Facility resulting in recognition of the resulting group at carrying value.</p>
    <p style="text-align: justify;">Assets held for sale as at December 31, 2020 consisted of the following:</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">$</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background-color: #e6efff;">Property and plant</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">8,610,504</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;">During the year ended December 31, 2020, the Company sold equipment for proceeds of $36,616 resulting in a loss on sale of $100,337. As part of the sale of equipment the Company also sold all remaining inventory for $1 and recognized a loss on sale of inventory of $197,436 during the year ended December 31, 2020. As FV Pharma surrendered its cannabis license in September 2020, the Company determined that the carrying value of the remaining equipment was not recoverable resulting in recognition of impairment loss of $387,474 for the year ended December 31, 2020.&#160;</p>
    <p style="text-align: justify;">Net loss and comprehensive loss from discontinued operations for the year ended December 31, 2020 and 2019 is comprised of the following:</p>
    <div id="footer_page_18">
        <p style="text-align: center;">17</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_19"></a>
    <div id="header_page_19">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><b>Notes to the consolidated financial statements </b></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in United States dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2020 and 2019<br><br></p>
                </td>
            </tr>
        </table>
        <br>
    </div>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; white-space: nowrap;" colspan="4"><b>For the year ended December 31,</b></td>
            <td style="text-align: center; vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">Notes</td>
            <td style="text-align: right; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom;"><b>2020</b></td>
            <td style="text-align: right; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom;">2019</td>
            <td style="text-align: right; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;"><b>$</b></td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">$</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;"><b>Revenue</b></td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>14,514</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">193,416</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background-color: #e6efff;">Cost of revenue</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>1,032,010</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">1,473,839</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><b>Gross loss before fair value adjustments</b></td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>(1,017,496</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><b>)</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">(1,280,423</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Fair value adjustments on inventory sold</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>(945</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>)</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">16,738</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">Unrealized loss on changes in fair value of biological assets&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;"><b>166,886</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">513,625</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; background-color: #e6efff;">Gross loss&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>(1,183,437</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>)</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">(1,810,786</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;"><b>Expenses</b></td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">General and administrative&#160;</td>
            <td style="vertical-align: bottom;">16</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>1,665,541</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">2,735,286</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Depreciation and amortization</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>90,340</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">424,199</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">Impairment of property, plant and equipment</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;"><b>387,474</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">132,273</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; background-color: #e6efff;"><b>Total operating expenses</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>2,143,355</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">3,291,758</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; background-color: #e6efff;"><b>Loss from discontinued operations</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>(3,326,792</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>)</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">(5,102,544</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Other income</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>(79,568</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>)</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">(53,987</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">Loss on sale of equipment</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;"><b>100,337</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">&#8212;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; background-color: #e6efff;"><b>Net loss from discontinued operations</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>(3,347,561</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>)</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">(5,048,557</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
        </tr>
    </table>
    <p style="text-align: justify;">Cash flows from discontinued operations for the year ended December 31, 2020 and 2019 are comprised of the following:</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom;"><b>2020</b></td>
            <td style="text-align: right; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom;">2019</td>
            <td style="text-align: right; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;"><b>$</b></td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">$</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><b>Operating activities</b></td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Net loss from discontinued operations</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>(3,347,561</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>)</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">(5,048,557</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Add (deduct) items not affecting cash</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160; Depreciation and amortization</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>108,209</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">424,199</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;" colspan="1">&#160; Change in fair value adjustments on inventory sold</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>(945</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><b>)</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">16,738</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160; Impairment of inventory</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>534,814</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;" colspan="1">&#160; Impairment of property, plant and equipment</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>387,474</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160; Change in fair value of biological assets</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>166,886</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">513,625</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160; Loss on disposal of inventory</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>197,436</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160; Loss on sale of equipment</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>100,337</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;" colspan="1">Changes in non-cash working capital balances</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160; Trade and other receivables</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>960,778</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">(423,945</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160; Prepaid expenses and deposits</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>279,870</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">54,226</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160; Inventories</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>(21,932</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>)</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">(709,373</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160; Biological assets</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>(166,886</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><b>)</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">(513,625</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background-color: #e6efff;">&#160; Trade and other payables</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>63,861</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">(895,286</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
        </tr>
        <tr>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom;"><b>Cash used in operating activities</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 12%; text-align: right;"><b>(737,659</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left;"><b>)</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">(6,581,998</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><b>Investing activities</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Purchase of property, plant and equipment</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>&#8212;</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">(401,817</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">Proceeds from sale of equipment</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;"><b>36,616</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">&#8212;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background-color: #e6efff;" colspan="1"><b>Cash provided by (used in) investing activities</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>36,616</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">(401,817</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
        </tr>
    </table>
    <p style="text-align: justify;">&#160;</p>
    <div id="footer_page_19">
        <p style="text-align: center;">18</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_20"></a>
    <div id="header_page_20">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><b>Notes to the consolidated financial statements </b></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in United States dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2020 and 2019<br><br></p>
                </td>
            </tr>
        </table>
    </div>
    <p style="text-align: justify; margin-left: 18pt; text-indent: -18pt;"><b>6.</b><font style="width: 10.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Other receivables</b></p>
    <p style="text-align: justify;">The Company's other receivables are comprised of the following:</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;"><b>December 31, 2020</b></td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;">December 31, 2019</td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;">January 1, 2019</td>
            <td style="text-align: right; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; text-align: right; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; text-align: right; vertical-align: bottom;"><b>$</b></td>
            <td style="border-bottom: 1px solid #000000; text-align: right; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; text-align: right; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; text-align: right; vertical-align: bottom;">$</td>
            <td style="border-bottom: 1px solid #000000; text-align: right; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; text-align: right; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; text-align: right; vertical-align: bottom;">$</td>
            <td style="border-bottom: 1px solid #000000; text-align: right; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Sales tax recoverable</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>134,717</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">1,529,828</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">739,257</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Rent receivable</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>&#8212;</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">9,772</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">6,263</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background-color: #e6efff;">Other</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>26,625</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">17,702</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 12%; text-align: right;"><b>161,342</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">1,557,302</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">745,520</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;"><b>7.</b><font style="width: 10.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Investments</b></p>
    <p style="text-align: justify;">The following tables outline changes in investments during the periods:</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;"><b>Entity</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; white-space: nowrap;"><b>Instrument</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; white-space: nowrap;"><b>Note</b></td>
            <td style="text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000; white-space: nowrap;"><b>Balance at <br>January </b><br><b>1,<br>2019</b></td>
            <td style="text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000; white-space: nowrap;"><b>Additions</b></td>
            <td style="text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000; white-space: nowrap;"><b>Change in fair <br>value through <br>profit or loss</b></td>
            <td style="text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000; white-space: nowrap;"><b>Proceeds<br>from sale</b></td>
            <td style="text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000; white-space: nowrap;"><b>Balance at <br>December 31, <br>2019</b></td>
            <td style="text-align: right; vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Pharmadrug Inc.</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">Shares</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">(i)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">2,256,900</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">(2,001,825</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">255,075</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Cannara Biotech Inc.</td>
            <td style="vertical-align: bottom;">Shares</td>
            <td style="vertical-align: bottom;">(ii)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right;">8,437,342</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right;">(1,614,704</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right;">6,822,637</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Clover Cannastrip</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">Shares</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">(iii)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">1,128,450</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">(1,128,450</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">High Tide</td>
            <td style="vertical-align: bottom;">Shares</td>
            <td style="vertical-align: bottom;">(iv)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right;">1,352,665</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right;">(890,362</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right;">462,303</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">High Tide</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">Warrants</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">(iv)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">188,914</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">(188,914</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">HUGE Shops</td>
            <td style="vertical-align: bottom;">Shares</td>
            <td style="vertical-align: bottom;">(v)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right;">977,990</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right;">(405,589</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right;">572,401</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">SciCann Therapeutics</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">Shares</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">(vi)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">1,504,593</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">(968,769</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">535,824</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Solarvest BioEnergy Inc.&#160;</td>
            <td style="vertical-align: bottom;">Shares</td>
            <td style="vertical-align: bottom;">(vii)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right;">519,087</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right;">(191,837</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right;">327,251</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Solarvest BioEnergy Inc.&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">Warrants</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">(vii)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">290,225</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">(202,470</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">87,756</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">Solarvest BioEnergy Inc.&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">Convertible debenture</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">(vii)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 9%; text-align: right;">&#8212;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 9%; text-align: right;">1,447,588</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 9%; text-align: right;">(1,185,787</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 9%; text-align: right;">&#8212;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 9%; text-align: right;">261,800</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">13,589,954</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">4,513,800</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">(8,778,707</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">462,303</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">8,862,744</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 9%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 9%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 9%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 9%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 9%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><b>Entity</b></td>
            <td style="vertical-align: bottom; white-space: nowrap;"><b>Instrument</b></td>
            <td style="vertical-align: bottom; white-space: nowrap;"><b>Note</b></td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 9%; white-space: nowrap;"><b>Balance at <br>December 31, <br>2019</b></td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; white-space: nowrap;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 9%; white-space: nowrap;"><b>Change in fair <br>value through <br>profit or loss</b></td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; white-space: nowrap;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 9%; white-space: nowrap;"><b>Foreign <br>exchange <br>gain</b></td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; white-space: nowrap;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 9%; white-space: nowrap;"><b>Proceeds <br>from sale</b></td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; white-space: nowrap;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 9%; white-space: nowrap;"><b>Balance at <br>December 31, 2020</b></td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: left; border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom; width: 9%;"><font style="font-size: 13.3333px; text-align: left;"><b>$</b></font>&#160;</td>
            <td style="text-align: left; border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom; width: 9%;"><font style="font-size: 13.3333px; text-align: left;"><b>$</b></font>&#160;</td>
            <td style="text-align: left; border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom; width: 9%;"><font style="font-size: 13.3333px; text-align: left;"><b>$</b></font>&#160;</td>
            <td style="text-align: left; border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom; width: 9%;"><font style="font-size: 13.3333px; text-align: left;"><b>$</b></font>&#160;</td>
            <td style="text-align: left; border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom; width: 9%;"><font style="font-size: 13.3333px; text-align: left;"><b>$</b></font>&#160;</td>
            <td style="text-align: left; border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Pharmadrug Inc.</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">Shares</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">(i)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">255,075</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">397,006</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">652,081</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Cannara Biotech Inc.</td>
            <td style="vertical-align: bottom;">Shares</td>
            <td style="vertical-align: bottom;">(ii)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right;">6,822,637</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right;">(997,208</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right;">5,825,429</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Clover Cannastrip</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">Shares</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">(iii)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">HUGE Shops</td>
            <td style="vertical-align: bottom;">Shares</td>
            <td style="vertical-align: bottom;">(v)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right;">572,401</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right;">7,674</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right;">20,358</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right;">600,433</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">SciCann Therapeutics</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">Shares</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">(vi)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">535,824</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">(354,910</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">14,765</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">195,679</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Solarvest BioEnergy Inc.&#160;</td>
            <td style="vertical-align: bottom;">Shares</td>
            <td style="vertical-align: bottom;">(vii)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right;">327,251</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right;">106,380</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right;">14,047</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right;">447,678</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Solarvest BioEnergy Inc.&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">Warrants</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">(vii)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">87,756</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">(14,920</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">1,977</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">74,813</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">Solarvest BioEnergy Inc.&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">Convertible debenture</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">(vii)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 9%; text-align: right;">261,800</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 9%; text-align: right;">85,104</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 9%; text-align: right;">11,238</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 9%; text-align: right;">&#8212;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 9%; text-align: right;">358,142</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">8,862,744</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">(770,874</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">62,385</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">6,477,510</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 9%; text-align: right; background-color: #e6efff;">1,676,745</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;">(i) Pharmadrug Inc. (Formerly known as "Aura Health Inc.")</p>
    <p style="text-align: justify;">On April 16, 2019, the Company entered into a share exchange agreement with Aura Health Inc. ("Aura"). Pursuant to the share exchange agreement, FSD acquired 13,562,387 common shares at C$0.2212 per share in the capital of Aura in exchange for the issuance of 65,577 Class B shares of the Company at C$45.75 for a total value of $2,256,900. The FSD shares issued to Aura were subject to a purchase price adjustment, such that FSD would be required to issue additional shares to Aura should the weighted average trading price of FSD's shares fall below the issue price. As the number of additional shares to be issued under the agreement were dependent on the FSD share price, it was determined that this created a derivative liability. As a result of the decline in the Company's share price, on September 20, 2019, 61,892 additional Class B shares of the Company were issued to Aura in settlement for the derivative liability. In 2019, Aura Health Inc. changed its name change to Pharmadrug Inc.</p>
    <div id="footer_page_20">
        <p style="text-align: center;">19</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_21"></a>
    <div id="header_page_21">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><b>Notes to the consolidated financial statements </b></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in United States dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2020 and 2019<br><br></p>
                </td>
            </tr>
        </table>
    </div>
    <p style="text-align: justify;">During the year ended December 31, 2020, the Company sold 13,562,387 common shares for gross proceeds of $652,081.</p>
    <p style="text-align: justify;">(ii) Cannara Biotech Inc. ("Cannara")</p>
    <p style="text-align: justify;">On February 5, 2020, the Company sold its investment of 85,003,750 Class B shares of Cannara for total cash proceeds of $5,825,429. The Company recognized a loss on sale of investment of $997,208.</p>
    <p style="text-align: justify;">(iii) Clover Cannastrip Thin Film Technologies Corp. ("Clover")</p>
    <p style="text-align: justify;">On September 6, 2018, the Company subscribed for $1,128,450 of equity units in a brokered private placement by Clover. The equity investment is measured at fair value through profit or loss. Clover is not a publicly traded company therefore, the fair value was classified as level 3 within the fair value hierarchy. As at December 31, 2019 and as at December 31, 2020, the fair value was determined to be $nil based on the financial position of Clover and the Company's ability to recover its investment.</p>
    <p style="text-align: justify;">(iv) High Tide</p>
    <p style="text-align: justify;">The Company's investment in High Tide included 4,551,999 shares and 2,000,000 warrants. On November 22, 2019 the Company sold the shares and warrants of High Tide Inc. for total cash proceeds of $462,303.</p>
    <p style="text-align: justify;">(v) HUGE Shops</p>
    <p style="text-align: justify;">The Company's investment in HUGE Shops includes 17,333,333 shares based on the December 2018 subscription price of C$0.075 per share. The equity investment is measured at fair value through profit or loss. Huge Shops is not a publicly traded company therefore, the fair value was classified as level 3 within the fair value hierarchy. As at December 31, 2020, the Company determined the best information to assess the fair value of the investment was based on movement of comparable public companies' share prices, resulting in a nominal change in the fair value of the investment of 0% from December 31, 2019. Comparable companies were determined in looking at product offering, relative size of operations, geographical market and other factors. A change in this assumption of plus or minus 10% would result in a corresponding change in fair value of the investment of approximately $285.</p>
    <p style="text-align: justify;">(vi) SciCann Therapeutics Inc.</p>
    <p style="text-align: justify;">The investment includes 117,648 shares based on the subscription price in May of 2018 and October of 2018 of C$17 per share. The equity investment is measured at fair value through profit or loss. SciCann Therapeutics Inc. is not a publicly traded company therefore, the fair value was classified as level 3 within the fair value hierarchy. As at December 31, 2020, the Company determined the best information to assess the fair value of the investment was based on movement of comparable public companies' share prices, resulting in decline in the fair value of investment of 65% from December 31, 2019. Comparable companies were determined in looking at product offering, relative size of operations, geographical market and other factors. A change in this assumption of plus or minus 10% would result in a corresponding change in fair value of the investment of approximately $36,372.</p>
    <p style="text-align: justify;">(vii) Solarvest BioEnergy Inc. ("Solarvest")</p>
    <p style="text-align: justify;">On May 7, 2019, the Company acquired 3,000,000 common shares, 3,000,000 warrants and a convertible debenture at a principal amount of $1,805,520 for a total fair value of $2,256,900 of Solarvest in exchange for 49,751 Class B common shares of the Company with a fair value of $1,880,750 based on a market price of C$50.25 and recognition of a derivative liability of $376,150. Under the terms of the agreement, the Company has guaranteed a minimum liquidation value of its shares to Solarvest of $2,256,900 resulting in recognition of the derivative liability. If the liquidation value of the Company's shares is below $2,256,900, the Company would be required to issue additional shares for the difference in actual value realized and the minimum guaranteed value.</p>
    <div id="footer_page_21">
        <p style="text-align: center;">20</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_22"></a>
    <div id="header_page_22">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><b>Notes to the consolidated financial statements </b></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in United States dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2020 and 2019<br><br></p>
                </td>
            </tr>
        </table>
    </div>
    <p style="text-align: justify;">As at December 31, 2019, the fair value of the derivative liability was $1,990,788. The fair value was determined based on the additional common shares of the Company required to be issued to Solarvest to meet the minimum liquidation value of $2,256,900. On February 4, 2020, the Company issued 225,371 shares to Solarvest to settle the derivative liability. The fair value of the shares issued was $1,356,373 resulting in recognition of a gain of $634,415 on settlement of the derivative liability.</p>
    <p style="text-align: justify;">As at December 31, 2020, the fair value of the shares was determined based on the quoted market price of the shares at C$0.19 per share. The fair value of the associated warrants is based on the Black-Scholes model with the following assumptions: exercise price C$0.25, risk free rate 0.20%, expected volatility 112%, expected life 0.35 years and expected dividend yield of 0%. Fair value of the convertible debenture is calculated as the fair value of shares if converted at SVS share price as at December 31, 2020 of C$0.19. The shares have been classified as level 1 within the fair value hierarchy - quoted market price, and the warrants and convertible debenture have been classified as level 2 - valuation technique with observable market inputs.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;"><b>8.</b><font style="width: 10.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Right-of-use asset</b></p>
    <p style="text-align: justify;">The right-of-use asset as at December 31, 2020 is as follows:</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; text-align: right; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; text-align: right; vertical-align: bottom;"><b>$</b></td>
            <td style="border-bottom: 1px solid #000000; text-align: right; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Balance &#8211; January 1, 2019</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right; background-color: #e6efff;">183,424</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: left;">Depreciation</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right;">(36,685</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Impairment</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 22%; text-align: right; background-color: #e6efff;">(50,888</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Balance &#8211; December 31, 2019</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 22%; text-align: right;">95,851</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Depreciation</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right; background-color: #e6efff;">(5,991</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Impairment</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 22%; text-align: right;">(89,860</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Balance &#8211; December 31, 2020</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 22%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;">The right-of-use asset relates to an office lease. The right-of-use asset is carried at the lower of carrying value and present value of the expected future lease payments to be received from subleasing the premise over the remaining term of the lease. As of March 31, 2020, the Company did not occupy the leased premise and has been unsuccessful in subleasing the space. As a result, the Company recognized an impairment loss of $89,860 resulting in right-of-use asset balance of $nil. The Company recognized depreciation expense of $5,991 for the year ended December 31, 2020, respectively (2019 - $36,685).</p>
    <div id="footer_page_22">
        <p style="text-align: center;">21</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_23"></a>
    <div id="header_page_23">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><b>Notes to the consolidated financial statements </b></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in United States dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2020 and 2019<br><br></p>
                </td>
            </tr>
        </table>
    </div>
    <p style="text-align: justify; margin-left: 18pt; text-indent: -18pt;"><b>9.</b><font style="width: 10.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Intangible assets</b></p>
    <p style="text-align: justify;">Intangible assets as at December 31, 2020 are as follows:</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;"><b>Intangible Assets</b></td>
            <td style="text-align: right; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;"><b>Cost</b></td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;"><b>$</b></td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">As at January 1, 2019</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Acquisition of Prismic Pharmaceuticals Inc.</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right;">18,543,379</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Additions</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right; background-color: #e6efff;">293,126</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">Effects of foreign exchange</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 22%; text-align: right;">(140,276</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background-color: #e6efff;">As at December 31, 2019</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 22%; text-align: right; background-color: #e6efff;">18,696,229</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">Effects of foreign exchange</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 22%; text-align: right;">505,264</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; background-color: #e6efff;"><b>As at December 31, 2020</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 22%; text-align: right; background-color: #e6efff;"><b>19,201,493</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background-color: #e6efff;"><b>Accumulated amortization</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 22%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">As at January 1, 2019</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Amortization</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right; background-color: #e6efff;">1,906,363</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">Effects of foreign exchange</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 22%; text-align: right;">(30,759</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background-color: #e6efff;">As at December 31, 2019</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 22%; text-align: right; background-color: #e6efff;">1,875,604</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Amortization</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right;">3,894,467</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background-color: #e6efff;">Effects of foreign exchange</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 22%; text-align: right; background-color: #e6efff;">7,031</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom;"><b>As at December 31, 2020</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 22%; text-align: right;"><b>5,777,102</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;"><b>Net book value</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 22%; text-align: right;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background-color: #e6efff;">As at January 1, 2019</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 22%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">As at December 31, 2019</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 22%; text-align: right;">16,820,625</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; background-color: #e6efff;"><b>As at December 31, 2020</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 22%; text-align: right; background-color: #e6efff;"><b>13,424,391</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;">The Company acquired intellectual property as part of the acquisition of Prismic on June 28, 2019. Refer to Note 4 for additional details. The life of the intellectual property has been determined to be 5 years. Amortization of the intellectual property commenced on the date of acquisition. The Company recognized amortization expense of $3,894,467 for the year ended December 31, 2020 (2019 - $1,906,363).</p>
    <p style="text-align: justify; margin-left: 18pt; text-indent: -18pt;"><b>10.</b><font style="width: 5.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Notes payable</b></p>
    <p style="text-align: justify;">Notes payable consists of the following:</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;"><b>December 31, 2020</b></td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;">December 31, 2019</td>
            <td style="text-align: right; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;"><b>$</b></td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">$</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Short-term notes</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>49,647</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">145,943</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">Notes payable</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;"><b>335,000</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">1,289,755</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>384,647</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">1,435,698</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;"><i>Short-term notes</i></p>
    <p style="text-align: justify;">The short-term notes represent notes outstanding that the Company assumed on acquisition of Prismic. The notes have matured, are due on demand and accrue interest at a rate of 10% per annum. The notes are held by former Directors and Shareholders of Prismic.</p>
    <p style="text-align: justify;"><i>Notes payable</i></p>
    <p style="text-align: justify;">The notes payable represent notes outstanding that the Company assumed on acquisition of Prismic. The notes have matured and are due on demand. The notes accrue interest at a rate of 20% per annum. The notes are held by former Directors and Shareholders of Prismic. The Company recognized accrued interest of $227,366 during the year ended December 31, 2020 (2019 - $142,907).</p>
    <div id="footer_page_23">
        <p style="text-align: center;">22</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_24"></a>
    <div id="header_page_24">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><b>Notes to the consolidated financial statements </b></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in United States dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2020 and 2019<br><br></p>
                </td>
            </tr>
        </table>
    </div>
    <p style="text-align: justify;">During the year ended December 31, 2020, the Company settled notes payable in the amount of $1,084,719, accrued interest of $795,367, and $438,599 of other Prismic related liabilities with 63,714 Class B Common Shares with a fair value of $185,976 and cash of $1,484,369. A gain of $680,164 was recognized on settlement as the value of the consideration was less than the carrying value of the notes payable, accrued interest and other related Prismic liabilities.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;"><b>11.</b><font style="width: 5.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Lease obligations</b></p>
    <p style="text-align: justify;">The lease obligations as at December 31, 2020 are as follows:</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;<b>$&#160;</b></td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;"><b>Balance as at January 1, 2019</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">183,424</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Add: Interest Expense</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">11,480</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background-color: #e6efff;">Less: Lease Payments</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">(42,285</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
        </tr>
        <tr>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom;"><b>Balance &#8211; December 31, 2019</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 12%; text-align: right;"><b>152,619</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Add: Interest Expense</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">10,367</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Less: Lease Payments</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">(39,993</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background-color: #e6efff;">Effects of foreign exchange</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">2,969</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom;"><b>Balance &#8211; December 31, 2020</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 12%; text-align: right;"><b>125,962</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Current</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">46,842</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background-color: #e6efff;">Non-current&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">79,120</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom;"><b>Balance &#8211; December 31, 2020</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 12%; text-align: right;"><b>125,962</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;">Lease obligations are related to the Company's office lease. The Company recognized $10,367 interest expense for the year ended December 31, 2020 (2019 - $11,480).</p>
    <p style="text-align: justify;">As of December 31, 2020, the Company did not occupy the leased premise. The Company has commenced plans to sublease the premise, however, if or when the Company will be able to sublease the premise is unknown.</p>
    <p style="text-align: justify;">The following table sets out a maturity analysis of the lease payments payable, showing the undiscounted lease payments to be paid on an annual basis, reconciled to the lease obligation.</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;<b>$</b>&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Less than one year</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">46,842</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">One to two years</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">47,088</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Two to three years</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">47,088</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">Thereafter</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">&#8212;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Total undiscounted lease payments payable</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">141,018</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background-color: #e6efff;">Less: impact of present value</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">(15,056</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
        </tr>
        <tr>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom;"><b>Balance as at December 31, 2020</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 12%; text-align: right;"><b>125,962</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
    </table>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;"><b>12.</b><font style="width: 5.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Warrants Liability</b></p>
    <p style="text-align: justify;">In August 2020, the Company issued 2,762,430 Class B Common Shares and 1,381,215 warrants to purchase Class B Shares for total cash proceeds of $9,999,997. Each warrant is exercisable to purchase one Class B Common Share of the Company at an exercise price of $4.26 per share and expire five years from the date of issuance.</p>
    <div id="footer_page_24">
        <p style="text-align: center;">23</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_25"></a>
    <div id="header_page_25">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><b>Notes to the consolidated financial statements </b></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in United States dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2020 and 2019<br><br></p>
                </td>
            </tr>
        </table>
    </div>
    <p style="text-align: justify;">On initial recognition the Company determined that these warrants did not meet the IFRS definition of equity due to the exercise price being denominated in United States dollars, which was not the functional currency of the Company at the time resulting in variability in exercise price. The change in functional currency was determined to be a change in circumstance and, as such, the Company has made an accounting policy choice to continue to recognize the warrants as a financial liability classified at fair value through profit or loss. The classification of any new warrants issued from October 1, 2020 forward are assessed based on the new functional currency which is the United States dollar.</p>
    <p style="text-align: justify;">Transaction costs allocated to the warrants of $284,049 were expensed immediately. The fair value of these warrants is classified as Level 2 in the fair value hierarchy. As at the date of issuance the fair value of the warrants was determined to be $3,289,069 using the Black-Scholes option pricing model and the following assumptions: exercise price of $4.26, the underlying share price of $3.01 on date of issuance, risk free interest rate of 0.32% and annualized volatility of 121%.</p>
    <p style="text-align: justify;">The fair value of the warrants liability as at December 31, 2020 was $1,447,910 resulting in a gain on change in fair value of $1,927,041 for the year ended December 31, 2020. The fair value was determined using the Black-Scholes option pricing model and the following assumptions: exercise price of $4.26, the underlying share price of $1.56, risk free interest rate of 0.33% and annualized volatility of 117%.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;"><b>13.</b><font style="width: 5.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Share capital</b></p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;"><b>[a]</b><font style="width: 7pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Authorized</b></p>
    <p style="text-align: justify;">The Company is authorized to issue an unlimited number of Class A multiple voting shares ("Class A shares") and an unlimited number of Class B subordinate voting shares ("Class B shares"), all without par value. All shares are ranked equally with regards to the Company's residual assets.</p>
    <p style="text-align: justify;">The holders of Class A shares are entitled to 276,660 votes per Class A share held. Class A shares are held by certain Directors of the Company.&#160;</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;"><b>[b]</b><font style="width: 6.51pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Issued and outstanding</b></p>
    <p style="text-align: justify;">Reconciliation of the Company's share capital is as follows:</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;" colspan="4"><b>Class A shares</b></td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;" colspan="4"><b>Class B shares</b></td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;" colspan="4"><b>Warrants</b></td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;"><b>#</b></td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;"><b>$</b></td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;"><b>#</b></td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;"><b>$</b></td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;"><b>#</b></td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;"><b>$</b></td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Balance, January 1, 2019</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">72</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">151,588</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">6,843,780</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">51,093,434</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">546,212</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">3,341,826</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Shares issued [a] [b] [c] [d]</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">408,651</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">8,681,103</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Issued on acquisition of net assets of Prismic Pharmaceuticals, Inc. [e]</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">510,940</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">12,361,657</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">67,598</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">1,420,407</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Stock options exercised</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Share-based payments</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">130,189</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">1,340,929</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Warrants exercised</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">12,167</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">109,214</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">(12,167</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">(37,753</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background-color: #e6efff;">Warrants expired</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">(134,192</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">(402,491</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
        </tr>
        <tr>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom;"><b>Balance, December 31, 2019</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 8%; text-align: right;"><b>72</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 8%; text-align: right;"><b>151,588</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 8%; text-align: right;"><b>7,905,727</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 8%; text-align: right;"><b>73,586,337</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 8%; text-align: right;"><b>467,451</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 8%; text-align: right;"><b>4,321,989</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Shares issued [g] [j] [k] [l] [n] [o]</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">8,925,942</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">22,242,975</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">6,335,758</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">1,110,904</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Share-based payments [f] [h] [i] [m]</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">2,307,569</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">6,663,479</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Share options exercised</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">22,382</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">563,747</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">Warrants expired&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;">&#8212;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;">&#8212;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;">&#8212;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;">&#8212;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;">(54,100</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;">(463,935</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
        </tr>
        <tr>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; background-color: #e6efff;"><b>Balance, December 31, 2020</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;"><b>72</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;"><b>151,588</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;"><b>19,161,620</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;"><b>103,056,538</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;"><b>6,749,109</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;"><b>4,968,958</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;">&#160;</p>
    <div id="footer_page_25">
        <p style="text-align: center;">24</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_26"></a>
    <div id="header_page_26">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><b>Notes to the consolidated financial statements </b></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in United States dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2020 and 2019<br><br></p>
                </td>
            </tr>
        </table>
    </div>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify;">[a]<font style="width: 7.99pt; text-indent: 0pt; display: inline-block;">&#160;</font>On April 24, 2019, the Company entered into a share exchange agreement with Aura. Pursuant to the share exchange agreement, FSD acquired 13,562,386 common shares at C$0.2212 per share in the capital of Aura in exchange for the issuance of 65,577 Class B shares of the Company at C$45.75 for a total value of $2,256,900.</p>
    <p style="margin-left: 36pt; text-align: justify;">On September 20, 2019, the Company issued an additional 61,892 Class B shares as part of the adjustment of purchase price related to the share exchange agreement with Aura to settle the related derivative liability. As part of the settlement, the Company recognized a loss on change in the fair value of derivative liability of $1,069,798.</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify;">[b]<font style="width: 7.99pt; text-indent: 0pt; display: inline-block;">&#160;</font>On May 7, 2019, the Company entered into an agreement with Solarvest. Per the agreement the Company issued 49,751 Class B Shares to Solarvest in exchange for the investment in Solarvest for a total fair value of $1,880,750. Refer to Note 7 for details regarding the investment in Solarvest.</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify;">[c]<font style="width: 8.5pt; text-indent: 0pt; display: inline-block;">&#160;</font>On October 4, 2019, the Company issued 3,735 Class B shares in settlement for trade payables of $18,808.</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify;">[d]<font style="width: 7.99pt; text-indent: 0pt; display: inline-block;">&#160;</font>On November 4, 2019, the Company completed a private placement through the issuance of 228,670 Class B shares at a price of C$20.10 per share for total gross proceeds of $3,455,898.</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify;">[e]<font style="width: 7.99pt; text-indent: 0pt; display: inline-block;">&#160;</font>On June 29, 2019, the Company acquired all outstanding common and preferred shares of Prismic through the issuance of an aggregate of 510,940 Class B Shares. The Class B Shares issued to the Prismic shareholders were deposited into escrow upon closing of the transaction and were subject to an 18-month staggered escrow release.</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify;">[f]<font style="width: 8.5pt; text-indent: 0pt; display: inline-block;">&#160;</font>On January 2, 2020, the Company issued 27,580 Class B Common Shares as share-based compensation to certain members of the Board of Directors for services performed as directors for the fiscal year 2019 for the amount payable of $74,117, which was recorded as trade and other payables as at December 31, 2019.&#160;</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify;">[g]<font style="width: 6.99pt; text-indent: 0pt; display: inline-block;">&#160;</font>On February 4, 2020, the Company issued 225,371 Class B Common Shares to Solarvest as settlement under the Share Exchange Agreement to settle the derivative liability of $1,990,788.</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify;">[h]<font style="width: 6.99pt; text-indent: 0pt; display: inline-block;">&#160;</font>On March 16, 2020, the Company issued 405,926 Class B Common Shares as part of a share-based bonus to employees for performance related to fiscal year 2019 resulting in movement of $1,302,076 from contributed surplus to share capital and the recognition of an additional share-based compensation expense of $93,502 as a result of the increase in value of the shares issued.&#160;</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify;">[i]<font style="width: 9.5pt; text-indent: 0pt; display: inline-block;">&#160;</font>On March 16, 2020, the Company issued 69,069 Class B Common Shares to members of the Board of Directors as share-based compensation, in lieu of cash, for their annual compensation for the year ended December 31, 2020.</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify;">[j]<font style="width: 9pt; text-indent: 0pt; display: inline-block;">&#160;</font>On April 15, 2020, the Company issued 63,714 Class B Common Shares to settle Prismic notes payable of $226,385. The fair value of the Class B Common Shares was $185,976 resulting in a gain on settlement of liability of $40,409.</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify;">[k]<font style="width: 6.5pt; text-indent: 0pt; display: inline-block;">&#160;</font>On June 8, 2020, the Company issued 1,500,000 Class B Common Shares and 1,500,000 warrants as part of a private placement financing for total cash proceeds of C$10,125,000 ($7,617,038). The more reliably measured component, Class B Common Shares, were measured first, with the residual amount being allocated to the warrants. The fair value of the Class B Common Shares was $7,515,477 and the residual value allocated to the warrants was $101,561. The Company incurred issuance costs of $707,043, which has been allocated pro-rata to the common shares and warrants.&#160;</p>
    <div id="footer_page_26">
        <p style="text-align: center;">25</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_27"></a>
    <div id="header_page_27">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><b>Notes to the consolidated financial statements </b></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in United States dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2020 and 2019<br><br></p>
                </td>
            </tr>
        </table>
    </div>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify;">[l]<font style="width: 8.5pt; text-indent: 0pt; display: inline-block;">&#160;</font>On August 6, 2020, the Company issued 2,762,430 Class B Common Shares and 1,381,215 warrants as part of a direct offering for total cash proceeds of $9,999,997. Total cash proceeds were allocated to the warrants liability first with the residual amount allocated to the Class B Common Shares (Note 12). The fair value of the warrants liability was determined to be $3,289,069 and the residual amount of $6,710,928 was allocated to the Class B Common Shares. The Company incurred total cash transaction costs of $913,349. Transaction costs allocated to the warrants of $284,049 were expensed immediately and the transaction costs allocated to common shares were deducted from equity.</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify;">[m]<font style="width: 3.5pt; text-indent: 0pt; display: inline-block;">&#160;</font>In August 2020, the Company approved the issuance of 1,804,994 Class B Common Shares to members of the Board of Directors and certain officers and employees of the company in the form of a compensation bonus for past services provided. Total fair value of the share-based compensation bonus was $4,956,324.</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify;">[n]<font style="width: 5.99pt; text-indent: 0pt; display: inline-block;">&#160;</font>During the year ended December 31, 2020, the Company issued 56,248 Class B Common Shares through the Equity Distribution Agreement with A.G.P/Alliance Global Partners for net proceeds of $199,785.</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify;">[o]<font style="width: 5.99pt; text-indent: 0pt; display: inline-block;">&#160;</font>In October 2020, the Company issued 4,318,179 Class B Common Shares and 3,454,543 warrants as part of a direct offering for total proceeds of $9,499,994. The more reliably measured component, Class B Common Shares, were measured first, with the residual amount being allocated to the warrants. The fair value of the Class B Common Shares was $8,377,267 and the residual value allocated to the warrants was $1,122,727. The Company incurred issuance costs of $879,621, which has been allocated pro-rata to the common shares and warrants.&#160;</p>
    <p style="text-align: justify;">The changes in the number of warrants outstanding during the year ended December 31, 2020 and 2019 were as follows:</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;"><b>&#160;Number of warrants&#160;</b></td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;"><b>&#160;Weighted average <br>exercise price&#160;</b></td>
            <td style="text-align: right; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;"><b>&#160;#&#160;</b></td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;"><b>&#160;C$&#160;</b></td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Outstanding as at December 31, 2018</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">546,212</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">9.47</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Issued</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">67,598</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">10.45</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Exercised</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">(12,167</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">7.81</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Expired</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">(134,192</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">7.64</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Outstanding as at December 31, 2019</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">467,451</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">10.20</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Issued</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">6,335,758</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">5.27</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Expired</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">(54,100</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">4.97</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><b>Outstanding as at December 31, 2020</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 12%; text-align: right;"><b>6,749,109</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 12%; text-align: right;"><b>5.62</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;"><b>Measurement of fair values</b></p>
    <p style="text-align: justify;">The fair value of warrants issued during the year ended December 31, 2020 and 2019 were estimated at the date of grant using the Black-Scholes option pricing model with the following inputs:</p>
    <div id="footer_page_27">
        <p style="text-align: center;">26</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_28"></a>
    <div id="header_page_28">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><b>Notes to the consolidated financial statements </b></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in United States dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2020 and 2019<br><br></p>
                </td>
            </tr>
        </table>
        <br>
    </div>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0">
        <tr>
            <td>&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; width: 25%;"><b>2020</b></td>
            <td style="text-align: right; border-bottom: 1px solid #000000; width: 25%;"><b>2019</b></td>
        </tr>
        <tr>
            <td style="background-color: #e6efff;">Grant date share price</td>
            <td style="text-align: right; width: 25%; background-color: #e6efff;">C$2.58 - C$4.00</td>
            <td style="text-align: right; width: 25%; background-color: #e6efff;">C$32.16</td>
        </tr>
        <tr>
            <td>Exercise price</td>
            <td style="text-align: right; width: 25%;">C$3.46 - C$5.80</td>
            <td style="text-align: right; width: 25%;">C$2.61 - C$26.73</td>
        </tr>
        <tr>
            <td style="background-color: #e6efff;">Expected dividend yield</td>
            <td style="text-align: right; width: 25%; background-color: #e6efff;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8212;</td>
            <td style="text-align: right; width: 25%; background-color: #e6efff;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8212;</td>
        </tr>
        <tr>
            <td>Risk free interest rate</td>
            <td style="text-align: right; width: 25%;">0.32% 0.36%</td>
            <td style="text-align: right; width: 25%;">1.41% - 1.52%</td>
        </tr>
        <tr>
            <td style="background-color: #e6efff;">Expected life</td>
            <td style="text-align: right; width: 25%; background-color: #e6efff;">5 years</td>
            <td style="text-align: right; width: 25%; background-color: #e6efff;">1.39 - 6.55</td>
        </tr>
        <tr>
            <td>Expected volatility</td>
            <td style="text-align: right; width: 25%;">118% - 121%</td>
            <td style="text-align: right; width: 25%;">100%</td>
        </tr>
    </table>
    <p style="text-align: justify;">The following table is a summary of the Company's warrants outstanding as at December 31, 2020:</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="text-align: center; vertical-align: bottom;" colspan="6"><b>Warrants Outstanding</b></td>
            <td style="text-align: center; vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;"><b>Exercise price</b></td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;"><b>Number outstanding</b></td>
            <td style="text-align: right; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;"><b>Expiry Date</b></td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;"><b>C$</b></td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;"><b>#</b></td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff; text-align: center;">August 1, 2021</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">5.43</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">4,476</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: center;">May 24, 2022</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">18.09</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">163,535</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff; text-align: center;">September 15, 2022</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">4.42</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">199,005</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: center;">May 20, 2023</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">16.08</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">7,311</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff; text-align: center;">July 24, 2023</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">13.07</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">3,357</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: center;">September 11, 2023</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">5.43</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">22,382</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff; text-align: center;">May 4, 2025</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">26.73</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">3,730</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: center;">May 10, 2025</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">26.73</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">1,865</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff; text-align: center;">May 17, 2025</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">26.73</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">3,730</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: center;">May 31, 2025</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">26.73</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">1,865</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff; text-align: center;">June 8, 2025</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">9.65</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">1,500,000</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: center;">August 6, 2020 (i)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">5.42</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">1,381,215</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff; text-align: center;">October 20, 2020 (ii)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">3.31</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">3,454,543</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; text-align: center;">January 16, 2026</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">26.73</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">1,722</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background-color: #e6efff; text-align: center;">January 20, 2026</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">26.73</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">373</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">5.62</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">6,749,109</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
    </table>
    <p style="margin-left: 108pt; margin-bottom: 0pt; text-indent: -36pt; text-align: justify;">(i)<font style="width: 28.89pt; text-indent: 0pt; display: inline-block;">&#160;</font>Warrants were issued in US$ with exercise price of $4.26</p>
    <p style="margin-top: 0pt; margin-left: 108pt; text-indent: -36pt; text-align: justify;">(ii)<font style="width: 26.12pt; text-indent: 0pt; display: inline-block;">&#160;</font>Warrants were issued in US$ with exercise price of $2.60</p>
    <p style="text-align: justify;">The following table is a summary of the Company's warrants outstanding as at December 31, 2019:</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="text-align: center; vertical-align: bottom;" colspan="6"><b>Warrants Outstanding</b></td>
            <td style="text-align: center; vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;"><b>Exercise price</b></td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;"><b>Number outstanding</b></td>
            <td style="text-align: right; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: center; border-bottom: 1px solid #000000; vertical-align: bottom;"><b>Expiry Date</b></td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;"><b>C$</b></td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;"><b>#</b></td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: center; vertical-align: bottom; background-color: #e6efff;">January 5, 2020</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">6.03</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">37,313</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: center; vertical-align: bottom;">November 30, 2020</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">2.61</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">16,787</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: center; vertical-align: bottom; background-color: #e6efff;">August 1, 2021</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">5.43</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">4,476</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: center; vertical-align: bottom;">May 24, 2022</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">18.09</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">163,535</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: center; vertical-align: bottom; background-color: #e6efff;">September 15, 2022</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">4.42</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">199,005</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: center; vertical-align: bottom;">May 20, 2023</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">16.08</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">7,311</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: center; vertical-align: bottom; background-color: #e6efff;">July 24, 2023</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">13.07</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">3,357</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: center; vertical-align: bottom;">September 11, 2023</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">5.43</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">22,382</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: center; vertical-align: bottom; background-color: #e6efff;">May 4, 2025</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">26.73</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">3,730</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: center; vertical-align: bottom;">May 10, 2025</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">26.73</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">1,865</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: center; vertical-align: bottom; background-color: #e6efff;">May 17, 2025</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">26.73</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">3,730</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: center; vertical-align: bottom;">May 31, 2025</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">26.73</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">1,865</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: center; vertical-align: bottom; background-color: #e6efff;">January 16, 2026</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">26.73</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">1,722</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; text-align: center; vertical-align: bottom;">January 20, 2026</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">26.73</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">373</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">10.20</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">467,451</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;">&#160;</p>
    <div id="footer_page_28">
        <p style="text-align: center;">27</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_29"></a>
    <div id="header_page_29">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><b>Notes to the consolidated financial statements </b></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in United States dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2020 and 2019<br><br></p>
                </td>
            </tr>
        </table>
    </div>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;"><b>14.</b><font style="width: 5.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Share-based compensation </b></p>
    <p style="text-align: justify;">The Company has established a share option plan (the "Option Plan") for directors, officers, employees and consultants of the Company. The Company's Board of Directors determines, among other things, the eligibility of individuals to participate in the Option Plan, the term and vesting periods, and the exercise price of options granted to individuals under the Option Plan.</p>
    <p style="text-align: justify;">Each share option converts into one common share of the Company on exercise. No amounts are paid or payable by the individual on receipt of the option. The options carry neither rights to dividends nor voting rights. Options may be exercised at any time from the date of vesting to the date of their expiry.</p>
    <p style="text-align: justify;"><b>Share-based payment arrangements</b></p>
    <p style="text-align: justify;">The changes in the number of share options during the year ended December 31, 2020 and 2019 were as follows:</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;"><b>&#160;Number of <br>options&#160;</b></td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; white-space: nowrap;"><b>&#160;Weighted average <br>exercise price&#160;</b></td>
            <td style="text-align: right; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;"><b>&#160;#&#160;</b></td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;"><b>&#160;C$&#160;</b></td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Outstanding as at December 31, 2018</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 17%; text-align: right; background-color: #e6efff;">485,159</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 17%; text-align: right; background-color: #e6efff;">74.53</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Granted</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 17%; text-align: right;">1,363,322</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 17%; text-align: right;">20.68</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Exercised</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 17%; text-align: right; background-color: #e6efff;">(82,094</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 17%; text-align: right; background-color: #e6efff;">10.02</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Forfeited</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 17%; text-align: right;">(12,438</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 17%; text-align: right;">56.28</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Cancelled</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 17%; text-align: right; background-color: #e6efff;">(299,006</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 17%; text-align: right; background-color: #e6efff;">115.80</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Outstanding as at December 31, 2019</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 17%; text-align: right;">1,454,943</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 17%; text-align: right;">21.96</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Granted</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 17%; text-align: right; background-color: #e6efff;">1,082,639</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 17%; text-align: right; background-color: #e6efff;">4.14</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Exercised</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 17%; text-align: right;">(22,382</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 17%; text-align: right;">2.61</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Cancelled</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 17%; text-align: right; background-color: #e6efff;">(822,137</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 17%; text-align: right; background-color: #e6efff;">31.65</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><b>Outstanding as at December 31, 2020</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 17%; text-align: right;"><b>1,693,063</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 17%; text-align: right;"><b>6.11</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;"><b>Exercisable as at December 31, 2020</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 17%; text-align: right; background-color: #e6efff;"><b>1,528,186</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 17%; text-align: right; background-color: #e6efff;"><b>6.13</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;"><b>Measurement of fair values</b></p>
    <p style="text-align: justify;">The fair value of share options granted during the year ended December 31, 2020 and 2019 were estimated at the date of grant using the Black-Scholes option pricing model with the following inputs:</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0">
        <tr>
            <td style="width: 229px;">&#160;</td>
            <td style="text-align: right; width: 25%;">&#160;</td>
            <td style="text-align: right; width: 25%;">&#160;</td>
        </tr>
        <tr>
            <td>&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; width: 25%;"><b>&#160;2020&#160;</b></td>
            <td style="text-align: right; border-bottom: 1px solid #000000; width: 25%;"><b>&#160;2019&#160;</b></td>
        </tr>
        <tr>
            <td style="background-color: #e6efff;">Grant date share price</td>
            <td style="text-align: right; width: 25%; background-color: #e6efff;"><b>&#160;C$3.75 &#8212; C$9.54&#160;</b></td>
            <td style="text-align: right; width: 25%; background-color: #e6efff;">&#160;C$6.45 &#8212; C$75.38&#160;</td>
        </tr>
        <tr>
            <td>Exercise price</td>
            <td style="text-align: right; width: 25%;"><b>&#160;C$3.68 &#8212; C$9.80&#160;</b></td>
            <td style="text-align: right; width: 25%;">&#160;C$7.17 &#8212; C$75.38&#160;</td>
        </tr>
        <tr>
            <td style="background-color: #e6efff;">Expected dividend yield</td>
            <td style="text-align: right; width: 25%; background-color: #e6efff;"><b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8212;&#160;&#160;</b></td>
            <td style="text-align: right; width: 25%; background-color: #e6efff;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8212;&#160;&#160;</td>
        </tr>
        <tr>
            <td>Risk free interest rate</td>
            <td style="text-align: right; width: 25%;"><b>0.27% &#8212;&#160; 1.55%</b></td>
            <td style="text-align: right; width: 25%;">1.24% &#8212;&#160; 1.90%</td>
        </tr>
        <tr>
            <td style="background-color: #e6efff;">Expected life</td>
            <td style="text-align: right; width: 25%; background-color: #e6efff;"><b>&#160;4 &#8212; 9 years&#160;</b></td>
            <td style="text-align: right; width: 25%; background-color: #e6efff;">&#160;5 years&#160;</td>
        </tr>
        <tr>
            <td>Expected volatility</td>
            <td style="text-align: right; width: 25%;"><b>120%</b></td>
            <td style="text-align: right; width: 25%;">100%</td>
        </tr>
    </table>
    <p style="text-align: justify;">Expected volatility was estimated by using the annualized historical volatility of the Company. The expected option life represents the period of time that options granted are expected to be outstanding. The risk-free interest rate is based on Canadian government bonds with a remaining term equal to the expected life of the options.</p>
    <div id="footer_page_29">
        <p style="text-align: center;">28</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_30"></a>
    <div id="header_page_30">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><b>Notes to the consolidated financial statements </b></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in United States dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2020 and 2019<br><br></p>
                </td>
            </tr>
        </table>
    </div>
    <p style="text-align: justify;">The following table is a summary of the Company's share options outstanding as at December 31, 2020:</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: center; vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="text-align: center; vertical-align: bottom;" colspan="7"><b>Options outstanding</b></td>
            <td style="text-align: center; vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="text-align: center; vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="text-align: center; vertical-align: bottom;" colspan="4"><b>Options exercisable</b></td>
            <td style="text-align: center; vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: center; vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom;">Exercise price</td>
            <td style="text-align: center; vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom;">Number outstanding</td>
            <td style="text-align: center; vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom;">Weighted average remaining contractual life [years]</td>
            <td style="text-align: center; vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom;">Exercise price</td>
            <td style="text-align: center; vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom;">Number exercisable</td>
            <td style="text-align: center; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: center; vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; border-bottom: 1px solid #000000;">C$</td>
            <td style="text-align: center; vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; border-bottom: 1px solid #000000;">#</td>
            <td style="text-align: center; vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; border-bottom: 1px solid #000000;">#</td>
            <td style="text-align: center; vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; border-bottom: 1px solid #000000;">C$</td>
            <td style="text-align: center; vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom; border-bottom: 1px solid #000000;">#</td>
            <td style="text-align: center; vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">2.61</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">12,683</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">2.49</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">2.61</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">12,683</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">3.75</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">5,500</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">6.47</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">3.75</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">500</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">3.86</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">872,139</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">4.08</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">3.86</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">864,139</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">4.42</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">99,502</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">1.71</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">4.42</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">99,502</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">4.75</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">110,000</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">4.29</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">4.75</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">77,500</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">5.03</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">60,000</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">4.70</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">5.03</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">7,498</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">5.43</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">16,264</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">2.49</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">5.43</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">16,264</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">6.16</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">20,000</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">3.18</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">6.16</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">20,000</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">7.17</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">199,005</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">3.83</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">7.17</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">199,005</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">7.63</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">203,750</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">4.34</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">7.63</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">138,750</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">9.54</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">15,000</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">4.06</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">9.54</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">13,125</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">10.65</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">3,730</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">2.49</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">10.65</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">3,730</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">13.07</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">10,855</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">2.49</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">13.07</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">10,855</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">13.47</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">1,418</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">2.49</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">13.47</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">1,418</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">16.08</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">18,409</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">2.49</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">16.08</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">18,409</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">17.89</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">4,178</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">2.49</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">17.89</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">4,178</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">18.09</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">17,413</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">2.21</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">18.09</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">17,413</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">20.10</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">8,289</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">2.27</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">20.10</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">8,289</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">47.24</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">1,493</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">3.37</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">47.24</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">1,493</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">50.25</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">5,224</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">3.31</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">50.25</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">5,224</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">52.26</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">498</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">3.21</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">52.26</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">498</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">55.28</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">498</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">3.12</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">55.28</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">498</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">59.30</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">498</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">2.96</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">59.30</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">498</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">75.38</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">498</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">3.04</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">75.38</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">498</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">86.43</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">1,244</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">2.87</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">86.43</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">1,244</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%;">142.71</td>
            <td style="text-align: left; border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; text-align: right; vertical-align: bottom; width: 8%;">4,975</td>
            <td style="border-bottom: 1px solid #000000; text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; text-align: right; vertical-align: bottom; width: 8%;">2.74</td>
            <td style="border-bottom: 1px solid #000000; text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; text-align: right; vertical-align: bottom; width: 8%;">142.71</td>
            <td style="border-bottom: 1px solid #000000; text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; text-align: right; vertical-align: bottom; width: 8%;">4,975</td>
            <td style="border-bottom: 1px solid #000000; text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; border-bottom: 2px solid #000000; vertical-align: bottom; width: 8%; background-color: #e6efff;"><b>6.11</b></td>
            <td style="text-align: left; border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="border-bottom: 2px solid #000000; text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="border-bottom: 2px solid #000000; text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;"><b>1,693,063</b></td>
            <td style="border-bottom: 2px solid #000000; text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="border-bottom: 2px solid #000000; text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="border-bottom: 2px solid #000000; text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;"><b>3.88</b></td>
            <td style="border-bottom: 2px solid #000000; text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="border-bottom: 2px solid #000000; text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="border-bottom: 2px solid #000000; text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;"><b>6.13</b></td>
            <td style="border-bottom: 2px solid #000000; text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="border-bottom: 2px solid #000000; text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="border-bottom: 2px solid #000000; text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;"><b>1,528,186</b></td>
            <td style="border-bottom: 2px solid #000000; text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;">&#160;</p>
    <div id="footer_page_30">
        <p style="text-align: center;">29</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_31"></a>
    <div id="header_page_31">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><b>Notes to the consolidated financial statements </b></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in United States dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2020 and 2019<br><br></p>
                </td>
            </tr>
        </table>
    </div>
    <p style="text-align: justify;">The following table is a summary of the Company's share options outstanding as at December 31, 2019:</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="text-align: center; vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="text-align: center; vertical-align: bottom;" colspan="7"><b>Options outstanding</b></td>
            <td style="text-align: center; vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="text-align: center; vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="text-align: center; vertical-align: bottom;" colspan="4"><b>Options exercisable</b></td>
            <td style="text-align: center; vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: center; vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom;">Exercise price</td>
            <td style="text-align: center; vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom;">Number outstanding</td>
            <td style="text-align: center; vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom;">Weighted average remaining contractual life [years]</td>
            <td style="text-align: center; vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom;">Exercise price</td>
            <td style="text-align: center; vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom;">Number exercisable</td>
            <td style="text-align: center; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: center; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; border-bottom: 1px solid #000000; vertical-align: bottom;">C$</td>
            <td style="text-align: center; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; border-bottom: 1px solid #000000; vertical-align: bottom;">#</td>
            <td style="text-align: center; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; border-bottom: 1px solid #000000; vertical-align: bottom;">#</td>
            <td style="text-align: center; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; border-bottom: 1px solid #000000; vertical-align: bottom;">C$</td>
            <td style="text-align: center; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; border-bottom: 1px solid #000000; vertical-align: bottom;">#</td>
            <td style="text-align: center; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">2.61</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">35,065</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">3.49</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">2.61</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">35,065</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">4.42</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">99,502</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">2.71</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">4.42</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">99,502</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">5.43</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">16,264</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">3.49</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">5.43</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">16,264</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">10.65</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">3,730</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">3.49</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">10.65</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">3,730</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">13.07</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">10,855</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">3.49</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">13.07</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">10,855</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">13.47</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">1,418</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">3.49</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">13.47</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">1,418</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">16.08</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">18,409</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">3.49</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">16.08</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">18,409</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">17.89</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">4,178</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">3.49</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">17.89</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">4,178</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">18.09</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">37,313</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">3.34</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">18.09</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">37,313</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">20.10</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">493,363</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">4.72</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">20.10</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">493,363</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">21.11</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">12,438</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">4.67</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">21.11</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">12,438</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">24.12</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">9,950</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">4.59</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">24.12</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">6,219</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">26.13</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">14,925</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">3.62</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">26.13</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">14,925</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">40.20</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">29,851</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">4.45</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">40.20</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">22,388</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">44.22</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">2,488</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">3.41</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">44.22</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">2,488</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">47.24</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">1,493</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">4.37</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">47.24</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">1,493</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">50.25</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">227,861</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">5.09</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">50.25</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">129,353</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">52.26</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">498</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">4.21</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">52.26</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">498</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">55.28</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">498</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">4.12</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">55.28</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">498</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">59.30</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">498</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">3.96</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">59.30</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">498</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">7.17</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">199,005</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">4.83</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">7.17</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">199,005</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">75.38</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">498</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">4.04</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">75.38</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">498</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">7.63</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">203,750</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">5.34</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">7.63</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">58,750</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">86.43</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">1,244</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">3.88</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">86.43</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">1,244</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">88.44</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">14,925</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">3.87</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">88.44</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%; background-color: #e6efff;">14,925</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">120.60</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">9,950</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">3.71</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">120.60</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom; width: 8%;">9,950</td>
            <td style="text-align: left; vertical-align: bottom; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; background-color: #e6efff;">142.71</td>
            <td style="text-align: left; border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; background-color: #e6efff;">4,974</td>
            <td style="text-align: left; border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; background-color: #e6efff;">3.74</td>
            <td style="text-align: left; border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; background-color: #e6efff;">142.71</td>
            <td style="text-align: left; border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: left; border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; background-color: #e6efff;">4,975</td>
            <td style="text-align: left; border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="text-align: left; border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; border-bottom: 2px solid #000000; vertical-align: bottom; width: 8%;">21.96</td>
            <td style="text-align: left; border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; border-bottom: 2px solid #000000; vertical-align: bottom; width: 8%;">1,454,943</td>
            <td style="text-align: left; border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; border-bottom: 2px solid #000000; vertical-align: bottom; width: 8%;">4.59</td>
            <td style="text-align: left; border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; border-bottom: 2px solid #000000; vertical-align: bottom; width: 8%;">21.24</td>
            <td style="text-align: left; border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%;">&#160;</td>
            <td style="text-align: left; border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%;">&#160;</td>
            <td style="text-align: right; border-bottom: 2px solid #000000; vertical-align: bottom; width: 8%;">1,200,242</td>
            <td style="text-align: left; border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;">During the year ended December 31, 2020, the Company cancelled 822,137 share options outstanding and issued 822,137 replacement share options at an exercise price of C$3.86 resulting in incremental grant date fair value of $661,811 which was expensed immediately as all the replacement share options vested on date of replacement. The fair value was determined using the Black-Scholes option pricing model and the following assumptions: exercise price of C$3.86, the underlying share price of C$3.86, risk free interest rate of 0.72% and annualized volatility of 120%.</p>
    <p style="text-align: justify;">The Company recognized $8,052,011 of share-based compensation expenses during the year ended December 31, 2020 (2019 - $12,082,930).</p>
    <div id="footer_page_31">
        <p style="text-align: center;">30</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_32"></a>
    <div id="header_page_32">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><b>Notes to the consolidated financial statements </b></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in United States dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2020 and 2019<br><br></p>
                </td>
            </tr>
        </table>
    </div>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;"><b>15.</b><font style="width: 5.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Loss per share</b></p>
    <p style="text-align: justify;">Net loss per common share represents net loss attributable to common shareholders divided by the weighted average number of common shares outstanding during the year.</p>
    <p style="text-align: justify;">For all the periods presented, diluted loss per share equals basic loss per share due to the anti-dilutive effect of warrants and share options. The outstanding number and type of securities that could potentially dilute basic net loss per share in the future but would have decreased the loss per share (anti-dilutive) for the period ended December 31, 2020 and 2019 presented are as follows:</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="text-align: center; vertical-align: bottom;" colspan="4"><b>Year ended December 31,</b></td>
            <td style="text-align: center; vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom;"><b>2020</b></td>
            <td style="text-align: right; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom;">2019</td>
            <td style="text-align: right; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;"><b>#</b></td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">#</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Warrants</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right; background-color: #e6efff;"><b>6,749,109</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right; background-color: #e6efff;">467,451</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Share Options</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 22%; text-align: right;"><b>1,693,063</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 22%; text-align: right;">1,454,943</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 22%; text-align: right; background-color: #e6efff;"><b>8,442,172</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 22%; text-align: right; background-color: #e6efff;">1,922,394</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
    </table>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;"><b>16.</b><font style="width: 5.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>General and administrative</b></p>
    <p style="text-align: justify;">Components of general and administrative expenses for the year ended December 31, 2020 and 2019 were as follows:&#160;</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="text-align: center; vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="text-align: center; vertical-align: bottom;" colspan="4"><b>Year ended December 31,</b></td>
            <td style="text-align: center; vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom;"><b>2020</b></td>
            <td style="text-align: right; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom;">2019</td>
            <td style="text-align: right; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; text-align: right; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; text-align: right; vertical-align: bottom;"><b>$</b></td>
            <td style="border-bottom: 1px solid #000000; text-align: right; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; text-align: right; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; text-align: right; vertical-align: bottom;">$</td>
            <td style="border-bottom: 1px solid #000000; text-align: right; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Professional fees</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right; background-color: #e6efff;"><b>2,734,123</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right; background-color: #e6efff;">3,101,136</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">General office, insurance and administration expenditures</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right;"><b>3,616,159</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right;">1,742,550</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Consulting fees</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right; background-color: #e6efff;"><b>1,775,269</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right; background-color: #e6efff;">1,675,258</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Salaries, wages and benefits</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right;"><b>2,656,162</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right;">1,705,696</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Investor relations</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right; background-color: #e6efff;"><b>541,944</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right; background-color: #e6efff;">2,241,275</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Building and facility costs</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right;"><b>586,926</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right;">676,798</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Foreign exchange loss</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 22%; text-align: right; background-color: #e6efff;"><b>(186,959</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>)</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 22%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 22%; text-align: right;"><b>11,723,624</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 22%; text-align: right;">11,142,713</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Allocated to:</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Continuing operations</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right; background-color: #e6efff;"><b>10,058,083</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 22%; text-align: right; background-color: #e6efff;">8,407,427</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Discontinued operations</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 22%; text-align: right;"><b>1,665,541</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 22%; text-align: right;">2,735,286</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
    </table>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;"><b>17.</b><font style="width: 5.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Income taxes</b></p>
    <p>The reconciliation of income tax expense for the years ended December 31, 2020 and 2019 consists of the following:</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" cellspacing="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;"><b>2020</b></td>
            <td style="vertical-align: bottom; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;">2019</td>
            <td style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000;"><b>$</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000;">$</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Loss from continuing operations before income taxes</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>(28,452,232</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>)</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">(34,080,963</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">Statutory federal and provincial tax rate</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000;"><b>26.50%</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000;">26.50%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Income tax recovery at the statutory tax rate</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>(7,539,841</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>)</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">(9,031,455</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Permanent differences</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>2,235,657</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">5,866,153</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Book to filing adjustments</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>(1,545,244</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>)</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">4,765,959</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Share issuance cost booked directly to equity</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>(584,538</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><b>)</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Foreign exchange</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>(370,457</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>)</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">Change in tax benefits not recognized</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000;"><b>7,804,423</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000;">(1,600,657</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;"><b>&#8212;</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;">&#160;</p>
    <div id="footer_page_32">
        <p style="text-align: center;">31</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_33"></a>
    <div id="header_page_33">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><b>Notes to the consolidated financial statements </b></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in United States dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2020 and 2019<br><br></p>
                </td>
            </tr>
        </table>
    </div>
    <p style="text-align: justify;">Deferred taxes reflect the tax effects of temporary differences that arise due to the differences between the income tax values and the carrying amount of assets and liabilities. Deferred tax liabilities as at December 31, 2020 and 2019 are comprised of the following:</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" cellspacing="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;"><b>2020</b></td>
            <td style="vertical-align: bottom; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;">2019</td>
            <td style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000;"><b>$</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000;">$</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Other investments</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>&#8212;</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">-126,461</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">Capital losses carried forward</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000;"><b>&#8212;</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000;">126,461</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; background-color: #e6efff;"><b>Total</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;"><b>&#8212;</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
        </tr>
    </table>
    <p>Deferred tax assets have not been recognized in respect of the following temporary differences as at December 31, 2020 and 2019:</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" cellspacing="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;"><b>2020</b></td>
            <td style="vertical-align: bottom; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;">2019</td>
            <td style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000;"><b>$</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: right; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: right; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000;">$</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Non-capital losses - Canada</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>44,897,393</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">20,703,137</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Net-operating loss - US</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>5,032,915</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">206,480</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Unrealized foreign exchange loss</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>94,733</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Share-issuance costs</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>3,419,003</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">879,959</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Capital losses carried forward</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>&#8212;</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">263,666</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Other investments</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>4,449,544</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">968,811</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">IFRS 16</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>125,962</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">Property, plant and equipment</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000;"><b>88,248</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000;">30,290</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; background-color: #e6efff;"><b>Total</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;"><b>58,107,798</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">23,052,343</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
        </tr>
    </table>
    <p>The Company's Canadian non-capital income tax losses expire as follows:</p>
    <table style="width: 40%; border-collapse: collapse; font-size: 10pt; border-color: #000000; margin-left: auto;" cellspacing="0">
        <tr>
            <td style="vertical-align: bottom; width: 60%;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 30%; text-align: right; border-bottom: 1px solid #000000;">&#160;$&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 60%; background-color: #e6efff;">2032</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 30%; text-align: right; background-color: #e6efff;">26,982</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 60%;">2033</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 30%; text-align: right;">114,405</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 60%; background-color: #e6efff;">2034</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 30%; text-align: right; background-color: #e6efff;">144,411</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 60%;">2035</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 30%; text-align: right;">65,782</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 60%; background-color: #e6efff;">2036</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 30%; text-align: right; background-color: #e6efff;">689,676</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 60%;">2037</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 30%; text-align: right;">2,677,789</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 60%; background-color: #e6efff;">2038</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 30%; text-align: right; background-color: #e6efff;">6,092,686</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 60%;">2039</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 30%; text-align: right;">11,415,413</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 60%; background-color: #e6efff;">2040</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 30%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">23,670,249</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 60%;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 30%; text-align: right; border-bottom: 1px solid #000000;">44,897,393</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;">The company has cumulative United States federal net operating loss carryforwards of approximately $5.03M which will start to expire in 2032. Utilization of net operating loss carryforwards may be subject to limitations in the event of a change in ownership pursuant to IRC &#167; 382, and similar state provisions. As a result of the acquisition of Prismic on June 28, 2019, the preacquisition net operating loss carryforwards of approximately $4.93M could be subject to IRC &#167; 382 limitation as the acquisition could constitute a change of ownership.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;"><b>18.</b><font style="width: 5.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Commitments and contingencies</b></p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;"><b>Commitments</b></p>
    <p style="text-align: justify;"><i>Epitech License Agreement</i></p>
    <p style="text-align: justify;">Under the terms of the Company's License Agreement with Epitech Group SPA ("Epitech"), the Company has payments due to Epitech pending the achievement of specified milestones. Upon first notification by the Food and Drug Administration ("FDA") of approval of a New Drug Application, the non-refundable sum of $700,000 will be due and payable to Epitech. Within ten business days of the first notification of approval of a Supplemental New Drug Application by the FDA, the Company will pay the non-refundable sum of $1,000,000 to Epitech.</p>
    <p style="text-align: justify;">For non-prescription drug rights, any one-off lump sum payments received by the Company as consideration for granting a sub-license to a Commercial Partner with respect to a Licensed Product, shall require the Company to pay to Epitech 25% of the lump sum payment received by the Company. For prescription drug rights the Company shall pay 5% of any one-off lump sum payments to Epitech as consideration for granting a sub-license to a Commercial Partner with respect to a Licensed Product. The Company will pay the amounts payable on a quarterly basis within 60 days of the end of each calendar quarter.</p>
    <p style="text-align: justify;">The Company shall pay either a) 7% of Net Sales of the Licensed Product in a Product Regulatory Category other than prescription drugs place on the market by the Company; or b) 25% of Net Receipts received by the Company from Commercial Partners where Licensed Products in a Product Regulatory Category other than prescription drugs are placed on the market by such Commercial Partners; or c) 5% of Net Sales or Net receipts of the Licensed Products in the Product Regulatory Category of prescription drugs. The Company will pay the amounts payable on a quarterly basis within 60 days of the end of each calendar quarter.&#160; &#160;</p>
    <div id="footer_page_33">
        <p style="text-align: center;">32</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_34"></a>
    <div id="header_page_34">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><b>Notes to the consolidated financial statements </b></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in United States dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2020 and 2019<br><br></p>
                </td>
            </tr>
        </table>
    </div>
    <p style="text-align: justify;"><i>Heritage Building Restoration Commitment</i></p>
    <p style="text-align: justify;">The Company has a commitment to restore the designated heritage building on the Company's premises. The estimated commitment of remaining restoration work to be completed is $266,349.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;"><b>Contingencies</b></p>
    <p style="text-align: justify;"><i>Legal matters</i></p>
    <p style="text-align: justify;">From time to time, the Company is named as a party to claims or involved in proceedings, including legal, regulatory and tax related, in the ordinary course of its business. While the outcome of these matters may not be estimable at the reporting date, the Company makes provisions, where possible, for the estimated outcome of such claims or proceedings. Should a loss result from the resolution of any claims or proceedings that differs from these estimates, the difference will be accounted for as a charge to profit or loss in that period.</p>
    <p style="text-align: justify;"><i>Environmental </i></p>
    <p style="text-align: justify;">Management believes that there are no probable environmental related liabilities that will have a material adverse effect on the financial position or operating results of the Company.</p>
    <p style="text-align: justify;"><i>Claims from suppliers </i></p>
    <p style="text-align: justify;">A dismissed contractor commenced a lien action combined with a breach of contract action in the Cobourg Superior Court of Justice in early 2019 claiming approximately C$1,700,000 in various purported damages, with the claim for lien component of C$188,309 being registered on November 26, 2018. The Company has paid C$235,387 to the Cobourg Superior Court to vacate the lien from title for which the funds stand both as security for the lien claim as well as its costs with the Cobourg Superior Court of Justice.</p>
    <p style="text-align: justify;">On October 7, 2020, FSD signed a settlement agreement of C$198,000. On December 16, 2020, the settlement was paid from funds paid into court and the remaining balance was remitted to the Company in accordance with the settlement agreement.</p>
    <p style="text-align: justify;"><i>Former employee </i></p>
    <p style="text-align: justify;">FSD hired an individual by way of employment agreement. The individual's employment was subsequently terminated in the probationary period due to non-performance/cause in February 2019. The individual retained legal counsel in or around February 15, 2019 demanding that he be provided (i) unpaid wages; (ii) unpaid holiday pay, (iii) payment for wrongful dismissal (one week) and (iv) breach of contract.</p>
    <p style="text-align: justify;">The Company has a provision of $81,562 (&#163;59,748) in relation to the claimed amounts for unpaid wages and unpaid holiday pay.</p>
    <p style="text-align: justify;">On July 29, 2020, a judgment was issued ordering the Company to pay unpaid wages and unpaid holiday pay in the amount of &#163;59,748. On August 6, 2020, the Company filed an application for reconsideration for that decision which was refused by the Tribunal on October 24, 2020.</p>
    <div id="footer_page_34">
        <p style="text-align: center;">33</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_35"></a>
    <div id="header_page_35">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><b>Notes to the consolidated financial statements </b></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in United States dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2020 and 2019<br><br></p>
                </td>
            </tr>
        </table>
    </div>
    <p style="text-align: justify;">On August 25, 2020, the Claimant filed a separate cost order against the Company. To date, the Tribunal has not responded to this matter. The ultimate outcome of the matter cannot be reliably determined at this time and no additional provision has been recorded for this matter as at December 31, 2020.</p>
    <p style="text-align: justify;"><i>Class Action </i></p>
    <p style="text-align: justify;">On February 22, 2019, a shareholder in FSD commenced a proposed class action proceeding against the Company by issuing a statement of claim in the Ontario Superior Court. Amongst other causes of action, the individual seeks leave to bring a claim pursuant to s.138 of the Ontario Securities Act, alleging the Company made statements containing misrepresentations related to the build-out of the Company's Cobourg facility.</p>
    <p style="text-align: justify;">The Company has settled the class action by entering into a definitive settlement agreement in the amount of C$5.5M. In entering into the Settlement Agreement, the Company made no admissions of liability whatsoever. The Settlement Agreement provides for a full and final release of the Company, its officers, directors and various other related parties from any and all claims that arose or could have arisen from the claim issued by the plaintiff within the Settled Action.</p>
    <p style="text-align: justify;">During November 2020, the Company paid C$928,541 as part of the settlement with the remaining amount of C$4,571,459 covered by the Company's insurance policy. The Settlement Agreement was approved in the Superior Court of Justice of Ontario on February 4, 2021.</p>
    <p style="text-align: justify;"><i>Auxly Cannabis Group Inc. </i></p>
    <p style="text-align: justify;">On March 3, 2018, FSD entered into a Definitive Strategic Alliance and Streaming Agreement (the "Agreement") with Auxly Cannabis Group Inc. ("Auxly"). On February 6, 2019, the Company delivered to Auxly a Notice of Default, thereby terminating the Agreement effective immediately. Subsequent to the issuance of the Notice of Default, Auxly sent a Notice of Default to the Company on February 6, 2019 in response. To date, neither party has taken further legal action against the counter party.</p>
    <p style="text-align: justify;">To fund the development, Auxly purchased 37,313 Class B shares for the aggregate of $5,642,250 from the Company's treasury by way of private placement, which funds were placed in trust to be spent on construction and development costs. The funds were placed in a trust account to be administered by Auxly. Due to the termination and subsequent negotiations, it is indeterminable at this point as to the amount, if any, of these funds will be released to the Company. Should any funds be released to the Company, those amounts will be recognized in future periods.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;"><b>19.</b><font style="width: 5.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Related party transactions</b></p>
    <p style="text-align: justify;">Key management personnel are those persons having the authority and responsibility for planning, directing and controlling activities of the entity, directly or indirectly.</p>
    <p style="text-align: justify;">Transactions with key management and directors comprised the following:</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify;">&#8226;<font style="width: 14pt; text-indent: 0pt; display: inline-block;">&#160;</font>The Company paid expenses of $1,445,043 (2019 - $567,468) to a company owned by the CEO for the year ended December 31, 2020, included in the consolidated statement of loss and comprehensive loss under various expense line categories. As at December 31, 2020, the CEO has repaid a related party loan of $355,778 for withholding taxes paid by the Company on behalf of the CEO in relation to the Class B common shares issued during the year ended December 31, 2020.</p>
    <div id="footer_page_35">
        <p style="text-align: center;">34</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_36"></a>
    <div id="header_page_36">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><b>Notes to the consolidated financial statements </b></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in United States dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2020 and 2019<br><br></p>
                </td>
            </tr>
        </table>
    </div>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify;">&#8226;<font style="width: 14pt; text-indent: 0pt; display: inline-block;">&#160;</font>As at December 31, 2020, the President of FSD BioSciences Division has repaid a related party loan of $21,876 for withholding taxes paid by the Company on behalf of the President of FSD BioSciences Division in relation to the Class B common shares issued during the year ended December 31, 2020.</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify;">&#8226;<font style="width: 14pt; text-indent: 0pt; display: inline-block;">&#160;</font>The Company pays independent directors C$40,000 per annum, with the Chairman of each respective committee receiving an additional C$10,000 per annum. Directors compensation for the year ended December 31, 2020 was $246,226 (2019 - $153,109) which included $238,703 recognized as share-based compensation. As of December 31, 2020, directors have received their compensation for the 2020 fiscal year in advance, through the issuance of Class B shares.&#160;</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify;">&#8226;<font style="width: 14pt; text-indent: 0pt; display: inline-block;">&#160;</font>The Company issued 1,676,066 shares to key management and directors in the form of a compensation bonus for past services provided during the year ended December 31, 2020. The fair value of shares issued to key management and directors is $4,602,301 and is included in share-based payments and bonuses below.&#160;</p>
    <p style="text-align: justify;">Key management personnel compensation during the year ended December 31, 2020 and 2019 is comprised of:</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom;"><b>2020</b></td>
            <td style="text-align: right; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; vertical-align: bottom;">2019</td>
            <td style="text-align: right; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;"><b>$</b></td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">$</td>
            <td style="text-align: right; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Salaries, benefits, bonuses and consulting fees</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 15%; text-align: right; background-color: #e6efff;"><b>2,936,816</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 15%; text-align: right; background-color: #e6efff;">3,638,267</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">Share-based payments</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 15%; text-align: right;">7,045,994</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 15%; text-align: right;">9,385,984</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background-color: #e6efff;"><b>Total</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 15%; text-align: right; background-color: #e6efff;"><b>9,982,810</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 15%; text-align: right; background-color: #e6efff;">13,024,251</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
    </table>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;"><b>20.</b><font style="width: 5.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Capital Management </b></p>
    <p style="text-align: justify;">The Company's capital management objectives are to maintain financial flexibility in order to complete the pharmaceutical research and development program centered on the lead asset, micro-PEA. The Company defines capital as the aggregate of its capital stock and borrowings.</p>
    <p style="text-align: justify;">As at December 31, 2020, the Company's Share Capital was $103,208,126 (2019 - $73,737,925) The Company does not have any long-term debt. Outstanding Notes payable were assumed on acquisition of Prismic and are due on demand.</p>
    <p style="text-align: justify;">The Company manages its capital structure in accordance with changes in economic conditions. In order to maintain or adjust its capital structure, the Company may elect to issue or repay financial liabilities, issue shares, repurchase shares or undertake any other activities as deemed appropriate under the specific circumstances. The Company is not subject to any externally imposed capital requirements.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;"><b>21.</b><font style="width: 5.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Financial Instruments and Risk Management</b></p>
    <p style="text-align: justify;"><i>Credit risk</i></p>
    <p style="text-align: justify;">Credit risk is the risk of financial loss to the Company if a customer or counterparty to a financial instrument fails to meet its contractual obligations, and arises principally from deposits with banks and outstanding receivables. The Company trades only with recognized, creditworthy third parties. The Company does not currently have any material outstanding trade receivables with customers.</p>
    <p style="text-align: justify;">The Company does not hold any collateral as security but mitigates this risk by dealing only with what management believes to be financially sound counterparties and, accordingly, does not anticipate significant loss for non-performance.</p>
    <div id="footer_page_36">
        <p style="text-align: center;">35</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_37"></a>
    <div id="header_page_37">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><b>Notes to the consolidated financial statements </b></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in United States dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2020 and 2019<br><br></p>
                </td>
            </tr>
        </table>
    </div>
    <p style="text-align: justify;"><i>Liquidity risk</i></p>
    <p style="text-align: justify;">Liquidity risk is the risk the Company will not be able to meet its financial obligations as they come due. The Company's exposure to liquidity risk is dependent on the Company's ability to raise additional financing to meet its commitments and sustain operations. The Company mitigates liquidity risk by management of working capital, cash flows, the issuance of share capital and if desired, the issuance of debt. The Company's trade and other payables and notes payables are all due within twelve months from the date of these financial statements.</p>
    <p style="text-align: justify;">If unanticipated events occur that impact the Company's ability to carrying the planned clinical trials, the Company may need to take additional measures to increase its liquidity and capital resources, including issuing debt or additional equity financing or strategically altering the business forecast and plan. In this case, there is no guarantee that the Company will obtain satisfactory financing terms or adequate financing. Failure to obtain adequate financing on satisfactory terms could have a material adverse effect on the Company's results of operations or financial condition.</p>
    <p style="text-align: justify;"><i>Market risk</i></p>
    <p style="text-align: justify;">Market risk is the risk the fair value or future cash flows of a financial instrument will fluctuate because of changes in market prices. Market risk comprises three types of risk: foreign currency risk, interest rate risk and other price risk.</p>
    <p style="text-align: justify;">&#8226;<font style="width: 32.85pt; display: inline-block;">&#160;</font>Foreign currency risk</p>
    <p style="margin-left: 36pt; text-align: justify;">Foreign currency risk arises on financial instruments that are denominated in a currency other than the functional currency in which they are measured. The Company's primary exposure with respect to foreign currencies is from Canadian dollar denominated cash and other payables. A 1% change in the foreign exchange rates would not result in any significant impact to the financial statements.</p>
    <p style="text-align: justify;">&#8226;<font style="width: 32.85pt; display: inline-block;">&#160;</font>Interest rate risk</p>
    <p style="margin-left: 36pt; text-align: justify;">Interest rate risk is the risk the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company is not exposed to interest rate risk as at December 31, 2020 as there are no material long-term borrowings outstanding.</p>
    <p style="text-align: justify;">&#8226;<font style="width: 32.85pt; display: inline-block;">&#160;</font>Other price risk</p>
    <p style="margin-left: 36pt; text-align: justify;">Other price risk is the risk the fair value or future cash flows of a financial instrument will fluctuate because of changes in market prices (other than those arising from interest rate risk or currency risk), whether those changes are caused by factors specific to the individual financial instrument or its issuer, or factors affecting all similar financial instruments traded in the market. The Company is not exposed to other price risk as at December 31, 2020.</p>
    <p style="text-align: justify;"><i>Fair values</i></p>
    <p style="text-align: justify;">The carrying values of cash, other receivables, trade and other payables and notes payable approximate fair values due to the short-term nature of these items or they are being carried at fair value or, for notes payable, interest payables are close to the current market rates. The risk of material change in fair value is not considered to be significant. The Company does not use derivative financial instruments to manage this risk.</p>
    <p style="text-align: justify;">Financial instruments recorded at fair value on the consolidated statement of financial position are classified using a fair value hierarchy that reflects the significance of the inputs used in making the measurements. The Company categorizes its fair value measurements according to a three-level hierarchy. The hierarchy prioritizes the inputs used by the Company's valuation techniques. A level is assigned to each fair value measurement based on the lowest-level input significant to the fair value measurement in its entirety. The three levels of the fair value hierarchy are defined as follows:</p>
    <div id="footer_page_37">
        <p style="text-align: center;">36</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_38"></a>
    <div id="header_page_38">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><b>Notes to the consolidated financial statements </b></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in United States dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2020 and 2019<br><br></p>
                </td>
            </tr>
        </table>
    </div>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">&#8226;<font style="width: 32.85pt; text-indent: 0pt; display: inline-block;">&#160;</font>Level 1 - Unadjusted quoted prices as at the measurement date for identical assets or liabilities in active markets.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">&#8226;<font style="width: 32.85pt; text-indent: 0pt; display: inline-block;">&#160;</font>Level 2 - Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">&#8226;<font style="width: 32.85pt; text-indent: 0pt; display: inline-block;">&#160;</font>Level 3 - Significant unobservable inputs that are supported by little or no market activity. The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.</p>
    <p style="text-align: justify;">The fair value hierarchy requires the use of observable market inputs whenever such inputs exist. A financial instrument is classified to the lowest level of the hierarchy for which a significant input has been considered in measuring fair value.</p>
    <p style="text-align: justify;">Private company investments measured at fair value are classified as Level 3 financial instruments. The valuation method and significant assumptions used to determine the fair value of private company investments have been disclosed in the Investments note. During the year, there were no transfers of amounts between levels.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;"><b>22.</b><font style="width: 5.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Segmented information</b></p>
    <p style="text-align: justify;">The Company reports segment information based on internal reports used by the chief operating decision maker ("CODM") to make operating and resource decisions and to assess performance. The CODM is the Chief Executive Officer of the Company. The CODM makes decisions and assesses performance of the Company on a consolidated basis such that the Company is a single reportable operating segment.</p>
    <p style="margin-left: 18pt; text-indent: -18pt; text-align: justify;"><b>23.</b><font style="width: 5.49pt; text-indent: 0pt; display: inline-block;">&#160;</font><b>Subsequent events</b></p>
    <p style="text-align: justify;">On January 21, 2021, the Company approved the grant of 75,000 share options to certain board members.</p>
    <p style="text-align: justify;">January 22, 2021, the Corporation announced that it will hold its annual meeting of shareholders on June 29, 2021, at which, in addition to normal course matters, it will address matters contained in a requisition for a special meeting submitted to the Corporation by certain shareholders of the Corporation claiming to hold in excess of 5.1% of the Corporation&#8217;s class B subordinated voting shares, including two directors of the Corporation. These shareholders are seeking to reduce the size of the Corporation&#8217;s board of directors to five, and to replace six of the incumbent directors with three directors selected by such shareholders.</p>
    <p style="text-align: justify;">The annual meeting date of June 29, 2021 was contested by certain shareholders and, pursuant to a decision by the Superior Court of Justice, province of Ontario, issued on March 5, 2021, the annual meeting of shareholders and special meeting of the shareholders has been set for May 14, 2021. Furthermore, the annual meeting of shareholders shall be conducted by an independent chair and Class B Common Shares issued on February 17, 2021, to certain directors and officers of the Company will not be allowed to vote at the meeting.</p>
    <p style="text-align: justify;">From February 1, 2021 to February 10, 2021, the Company issued 7,356,326 Class B Common Shares through the Equity Distribution Agreement with A.G.P/Alliance Global Partners for gross proceeds of $19,770,762.</p>
    <p style="text-align: justify;">On February 11, 2021, the Company entered into an Equity Distribution Agreement (the &#8220;Equity Distribution Agreement&#8221;) with A.G.P./Alliance Global Partners. Under the Sales Agreement the Company may, at its discretion and from time-to-time during the term of the Sales Agreement, sell, through the Sales Agent, Class B Subordinate Voting Shares of the Company, with an aggregate offering price of up to $20,000,000.</p>
    <div id="footer_page_38">
        <p style="text-align: center;">37</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_39"></a>
    <div id="header_page_39">
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 100%;">
                    <p style="text-align: justify;"><b>FSD PHARMA INC. </b></p>
                    <p style="margin-bottom: 0pt; text-align: center;"><b>Notes to the consolidated financial statements </b></p>
                    <p style="margin-top: 0pt; text-align: center;">[expressed in United States dollars, except share and per share amounts]</p>
                    <p style="text-align: justify;">December 31, 2020 and 2019<br><br></p>
                </td>
            </tr>
        </table>
    </div>
    <p style="text-align: justify;">From February 11, 2021 to March 12, 2021, the Company issued 7,247,288 Class B Common Shares through the Equity Distribution Agreement with A.G.P/Alliance Global Partners for gross proceeds of $18,167,511.</p>
    <p style="text-align: justify;">On February 17, 2021, the Company issued 1,349,764 Class B Common Shares to certain directors and officers of the Company. The fair value of the shares based on the February 17, 2021 closing share price of $2.65 per Class B Common Share was $3,576,875.</p>
    <div>
        <p style="text-align: justify;">Effective March 1, 2021, Randell Mack was appointed as President of FSD Biosciences and Dr. Ed Brennan was name Chief Medical Officer of the Company.</p>
        <p style="text-align: justify;">In March 2021, the Corporation entered into a license agreement ("Innovet License Agreement") with Innovet Italia S.R.L. ("Innovet"), under which Innovet granted the Company a license to use ultra-micro PEA to develop FDA approved veterinary drugs for the treatment of gastro-intestinal diseases in canines and felines. Under the Innovet License Agreement, the Corporation is required to make payments to Innovet upon the achievement of certain milestones.</p>
    </div>
    <div id="footer_page_39">
        <p style="text-align: center;">38</p>
    </div>
    <hr width="100%" size="5" color="black" noshade="noshade">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>4
<FILENAME>exhibit99-3.htm
<DESCRIPTION>EXHIBIT 99.3
<TEXT>
<html>

<head>
    <title>FSD Pharma Inc.: Exhibit 99.3 - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt; font-family:'Times New Roman';">
    <hr width="100%" size="3" color="black" noshade="noshade"><a name="page_1"></a>
    <p style="text-align: center;"><b>FSD PHARMA INC.</b></p>
    <p style="margin-bottom: 0pt; text-align: center;"><b>MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF</b></p>
    <p style="margin-top: 0pt; text-align: center;"><b>OPERATIONS</b></p>
    <p style="text-align: justify;"><i>As used in this management's discussion and analysis of financial condition and results of operations ("MD&amp;A"), unless the context indicates or requires otherwise, all references to the "Company", "FSD", "we", "us" or "our" refer to FSD Pharma Inc., together with our subsidiaries, on a consolidated basis as constituted on December 31, 2020.</i></p>
    <p style="text-align: justify;"><i>This MD&amp;A for the three months and fiscal years ended December 31, 2020 and 2019 should be read in conjunction with the Company's audited consolidated financial statements and the accompanying notes for fiscal year ended December 31, 2020, and 2019. The financial information presented in this MD&amp;A is derived from the Company's audited consolidated financial statements for the three months and fiscal years ended December 31, 2020 and 2019 which have been prepared in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board ("IASB"). All amounts are in United States dollars except where otherwise indicated.</i></p>
    <p style="text-align: justify;"><i>This MD&amp;A is dated as of March 16, 2021.</i></p>
    <p style="text-align: justify;"><b>FORWARD-LOOKING INFORMATION</b></p>
    <p style="text-align: justify;"><i>The information provided in this MD&amp;A, including information incorporated by reference, may contain certain forward-looking statements and forward-looking information (collectively referred to as "forward-looking statements") within the meaning of applicable Canadian and U.S. securities legislation about our current expectations, estimates and projections about the future, based on certain assumptions made by us in light of the Company's experience and perception of historical trends.&#160; Although we believe that the expectations represented by such forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct. </i></p>
    <p style="text-align: justify;"><i>This forward-looking&#160; information is identified by words such as "anticipate", "believe", "expect", "plan", "forecast", "future", "target", "project", "capacity", "could", "should", "focus", "proposed", "scheduled", "outlook", "potential", "may" or similar expressions and includes suggestions of future outcomes; the Company's proposed partnership and joint ventures with, and investments in, other entities; the estimated costs of the Company's proposed capital projects and future investments; potential proceeds from the exercise of the Company's outstanding share purchase warrants; actions taken by the Company, or that the Company may take in the future, to adjust its capital structure; the undertaking of clinical research to study the effects of the Company's products on client health; the outcome of clinical trials related to ultra micro-palmitoylethanolamide (""ultramicronized-PEA" or "FSD-201"). Readers are cautioned not to place undue reliance on forward-looking information as the Company's actual results may differ materially from those expressed or implied.</i></p>
    <p style="text-align: justify;"><i>The Company has made certain assumptions with respect to the forward-looking statements regarding, among other things: the Company's ability to generate sufficient cash flow from operations and obtain financing, if needed, on acceptable terms or at all; general economic, financial market, regulatory and political conditions in which the Company operates; purchaser interest in the Company's products; anticipated and unanticipated costs; government regulation of the Company's activities and products; the timely receipt of any required regulatory approvals; the Company's ability to obtain qualified staff, equipment and services in a timely and cost efficient manner; the Company's ability to conduct operations in a safe, efficient and effective manner; and the Company's expansion plans and timeframe for completion of such plans.</i></p>
    <p style="text-align: justify;"><i>Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because no assurance can be given that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to: the limited operating history of the Company and history of losses; the Company's ability to continue as a going concern; the highly speculative nature of drug development; the Company's ability to generate sufficient revenue to be profitable; the Company's ability to raise the capital necessary for it to execute its strategy; impact of any future recall of the Company's products; the impact of any negative scientific studies on the effects of micro-PEA; the Company's inability to complete clinical trials and attain the regulatory approvals it needs to commercialize its pharmaceutical products; the Company's product candidates being in the preclinical development stage; the Company's ability to obtain regulatory approval in jurisdictions for any product candidates; delays in clinical trials; failure of clinical trials to demonstrate substantial evidence of the safety and/or effectiveness of product candidates; results of earlier studies or clinical trials not being predictive of future clinical trials; difficulties enrolling patients in clinical trials; potential side effects, adverse events or other properties or safety risks of pharmaceutical product candidates; regulatory regimes of locations for clinical trials outside of the United States; failure to obtain approval to commercialize product candidates outside of the United States; published clinical trial data may change in future trials; manufacturing problems resulting in delays in development or commercialization programs; inability to successfully validate, develop and obtain regulatory approval for companion diagnostic tests for drug candidates; changes in funding for the U.S. Food and Drug Administration ("FDA") and other government agencies; risks associated with development and commercialization of pharmaceutical products, including the inability to accurately predict timing or amounts of expenses, requirements of regulatory authorities, and completion of clinical studies; risks inherent in an agricultural business; rising energy costs; the Company's reliance on key persons; the Company's compliance with environmental, health and safety laws and regulations; insurance risks; interruptions in the supply chain for key inputs; demand for skilled labour, specialized knowledge, equipment, parts and components; the Company's ability to manage its growth; the Company's ability to successfully implement and maintain adequate internal controls over financial reporting or disclosure controls and procedures; the Company not having been required to certify that it maintains effective internal control over financial reporting or effective disclosure controls and procedures; increased costs as a result of operating as a public company in the United States; risks relating to our status as a foreign private issuer; the Company taking advantage of reduced disclosure requirements applicable to emerging growth companies; the Company's ability to successfully identify and execute future acquisitions or dispositions; expansion of international operations; reliance on the operations of the Company's partners; results of litigation; conflicts of interest between the Company and its directors and officers; payment of dividends; the partial dependence of the Company's operations on the maintenance and protection of its information technology systems; unforeseen tax and accounting requirements; tax risks related to the Company's status as a "passive foreign investment company"; changes in government; changes in government policy; failure of counterparties to perform contractual obligations; the Company's ability to successfully develop new products or find a market for their sale; the Company's ability to promote and sustain its brands; product liability claims or regulatory actions; reputational risks to third parties with whom the Company does business; the Company's ability to produce and sell its medical products outside of Canada; co-investment risks; failure to comply with laws and regulations; the Company's reliance on its own market research and forecasts; competition from synthetic production and new technologies; the Company's ability to transport its products; liability arising from any fraudulent or illegal activity; product liability lawsuits; misconduct or other improper activities by employees, independent contractors, consults, commercial partners and vendors; failure to achieve market acceptance in the medical community; inability to establish sales and marketing capabilities; failure to comply with health and data protection laws; reliance on third parties to conduct clinical trials; loss of single-source suppliers; reliance on contract manufacturing facilities; inability to obtain or maintain sufficient intellectual property protection for the Company's products; third-party claims of intellectual property infringement; patent terms being insufficient to protect competitive position on product candidates; inability to obtain patent term extensions or non-patent exclusivity; inability to protect the confidentiality of trade secrets; inability to protect trademarks and trade names; filing of claims challenging the inventorship of the Company's patents and other intellectual property; invalidity or unenforceability of patents; claims regarding wrongfully use or disclosed confidential information of third parties; inability to protect intellectual property rights around the world; the Company's dual class share structure; that additional issuances of the Company's shares could have a significant dilutive effect; public health crises; and other factors beyond the Company's control. </i></p>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_2"></a>
    <p style="text-align: justify;"><i>The Company cautions that the foregoing list of important factors is not exhaustive. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. There is no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. You should carefully consider the matters discussed under "Risks Factors" in our Annual Information Form for the year ended December 31, 2020, Short Form Base Shelf Prospectus dated June 16, 2020 and Prospectus Supplement dated February 11, 2021.</i></p>
    <p style="text-align: justify;"><i>The forward-looking statements contained or incorporated by reference in this MD&amp;A are made as of the date of this MD&amp;A or as otherwise specified. Except as required by applicable securities laws, we undertake no obligation to update publicly or otherwise revise any forward-looking statements or the foregoing list of factors affecting those statements, whether as a result of new information, future events or otherwise or the foregoing lists of factors affecting this information.</i></p>
    <p style="text-align: justify;"><i>All of the forward-looking information contained in this MD&amp;A is expressly qualified by the foregoing cautionary statements.</i></p>
    <p style="text-align: justify;"><i>Additional information relating to FSD can be found on SEDAR at </i><u><i>www.sedar.com</i></u><i> and on EDGAR at </i><u><i>www.sec.gov</i></u><i>.</i></p>
    <p style="text-align: justify;"><b>OVERVIEW</b></p>
    <p style="text-align: justify;">The Company was formed under and is governed by the provisions of the <i>Business Corporations Act </i>(Ontario) (the "OBCA") on November 1, 1998 pursuant to the amalgamation of Olympic ROM World Inc., 1305206 Ontario Company, 1305207 Ontario&#160;Inc., Century Financial Capital Group Inc. and Dunberry Graphic Associates Ltd. On May 24, 2018, pursuant to Articles of Amendment, the Company changed its name to "FSD Pharma Inc." Our head office is at 100 King St. West, Suite 3400, Toronto, Ontario, Canada. M5X 1A4. Our head office is located at First Canadian Place, 100 King Street West, Suite 3400, Toronto, Ontario, Canada M5X 1A4, and our registered office is at 1 Rossland Road West, Suite 202, Ajax, Ontario, Canada, M5C 1P1.</p>
    <p style="text-align: justify;">FSD Pharma Inc. (&#8220;FSD&#8221; or the &#8220;Company&#8221;), through its wholly owned subsidiary, FSD Biosciences, Inc. is a pharmaceutical research and development (&#8220;R&amp;D&#8221;) company focused on developing over time multiple applications of its lead compound, ultra-micro PEA (&#8220;FSD 201&#8221;) by down-regulating the cytokines to effectuate an anti-inflammatory response.</p>
    <div id="footer_page_2">
        <p style="text-align: right;">2</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_3"></a>
    <p style="text-align: justify;">The Company filed an IND with the FDA on August 28, 2020 and was approved on September 25, 2020 to initiate a phase 2 clinical trial for the use of FSD201 to treat COVID-19, the disease caused by the SARS-CoV-2 virus. The trial is currently underway and is expected to randomize 352 patients in a controlled, double-blind multicenter study.</p>
    <p style="text-align: justify;">As of the date hereof, the Company currently has two material subsidiaries: (i) FSD Biosciences Inc. (&#8220;FSD Biosciences&#8221;), which is wholly owned by the Company and incorporated under the laws of the State of Delaware; and (ii) FV Pharma Inc. ("FV Pharma"), which is wholly owned by the Company and incorporated pursuant to the OBCA.</p>
    <p style="text-align: justify;">The Company is not engaged in cannabis-related activities.</p>
    <p style="text-align: justify;"><i>FSD Pharma Inc.</i></p>
    <p style="text-align: justify;">Through the acquisition of Prismic Pharmaceuticals Inc. (&#8220;Prismic&#8221;), the Company acquired an exclusive, worldwide license (excluding Italy and Spain) to exploit for certain specified pharmaceutical purposes patents and other intellectual property rights to ultra micro-palmitoylethanolamide ("PEA") owned by Epitech Group SpA (&#8220;Epitech&#8221;). PEA is a naturally occurring substance that is produced within the body in response to inflammation. FSD Pharma is currently seeking to advance pharmaceutical development programs centered on FSD201 ultra micro-PEA that meet one or more selected criteria. All efforts are intended to be founded on a biologic plausibility of an efficacious effect with a high safety profile.</p>
    <p style="text-align: justify;">The Company has successfully completed Phase 1 first-in-human safety and tolerability study for FSD201 and has found the compound to be safe with no serious adverse side effects. This study also validated considerable scientific literature already published in the European Union that claims safety and tolerability of micro-PEA. Ultra-micro PEA is currently being dispensed in Italy and Spain as a prescription based medical food supplement since 2004.</p>
    <p style="text-align: justify;">The Company received permission from the FDA in June 2020 to submit an Investigational New Drug Application for the use of FSD201 to treat COVID-19, the disease caused by the SARS-CoV-2 virus.</p>
    <p style="text-align: justify;">The Company submitted to the FDA an Investigational New Drug Application for the use of FSD201 in August 2020.</p>
    <p style="text-align: justify;">In September 2020, the Company received authorization from the FDA to initiate Phase 2 study for the use of FSD201 to treat COVID-19.</p>
    <p style="text-align: justify;">The FSD201 COVID-19 study is currently underway and is expected to randomize 352 patients in a controlled, double-blind, multicenter study.</p>

    <p style="text-align: justify;">Severe COVID-19 is characterized by an over-exuberant inflammatory response that may lead to a cytokine storm and ultimately death. The Company is focused on developing FSD201 for its anti-inflammatory properties to down-regulate the over-expressed immune response and mitigate the cytokine storm associated with acute lung injury in hospitalized COVID-19 patients.</p>

    <p style="text-align: justify;"><i>Epitech License Agreement</i></p>
    <p style="text-align: justify;">On January 8, 2020, the Company entered into an amended and restated license agreement with Epitech (the "License Agreement"), which amended and restated the license agreement between Prismic and Epitech through which Prismic secured certain intellectual property rights to PEA from Epitech. The License Agreement grants the Company an exclusive, worldwide license (excluding Italy and Spain where the Company is not licensed and Epitech remains entitled to commercialize the Licensed Products (as defined herein), directly or indirectly) (the "Epitech License") to research, manufacture and commercialize products (the "Licensed Products") that are developed using certain proprietary formulations of PEA owned by Epitech and that are to be used to treat chronic kidney disease in humans or, if a prescription drug, any other human condition that is related to pain and chronic pain. The Epitech License also gives FSD the right to use the Licensed IP (as defined in the Epitech License) in the development of a prescription drug for the treatment of the cytokine storm associated with COVID-19. In addition, under the terms of the Epitech License, if Epitech develops or commercializes a prescription drug for the treatment of any other human condition unrelated to pain and chronic pain (a "Different Prescription Drug") in its territory, the Company has a first refusal right to use Epitech's patents to develop and commercialize this Different Prescription Drug in its territory (i.e. worldwide excluding Italy and Spain). Should the Company exercise this right, but then fail to demonstrate commercially reasonable efforts to develop the Different Prescription Drug in the two years following, Epitech would be free to exploit and/or license to third parties the use of the patents for the Different Prescription Drug. The FSD-201 COVID-19 Trials are subject to such requirements. Finally, the Epitech License provides the Company with a nonexclusive license to use Epitech's scientific and technical know-how with respect to ultramicronized-PEA in connection with the development or commercialization of the Licensed Products discussed above.</p>
    <div id="footer_page_3">
        <p style="text-align: right;">3</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_4"></a>
    <p style="text-align: justify;">Under the terms of the License Agreement, the Company is required to make payments to Epitech upon the achievement of specified milestones. Upon first notification by the FDA of approval of a New Drug Application, the non-refundable sum of $700,000 is due and payable to Epitech. Within ten business days of the first notification of approval of a Supplemental New Drug Application by the FDA, the Company is required to pay the non-refundable sum of $1,000,000 to Epitech.</p>
    <p style="text-align: justify;">The License Agreement also specifies certain royalty payments. Pursuant to the License Agreement, the Company must pay Epitech 25% (in the case of non-prescription drug rights) and 5% (in the case of prescription drug rights) of any one-off lump sum payments it receives as consideration for granting a sub-license to a third-party with respect to a Licensed Product. In addition, the Company is required to pay either: (a) 7% of net sales of the Licensed Products in a product regulatory category other than prescription drugs placed on the market by the Company; (b) 25% of the royalties received by the Company from sub-licensees (such royalties, the "Net Receipts") where Licensed Products in a product regulatory category other than prescription drugs are placed on the market by such sub-licensees; or (c) 5% of net sales or Net Receipts of the Licensed Products that are prescription drugs.</p>
    <p style="text-align: justify;">Unless otherwise terminated in accordance with its terms, the Epitech License will remain in force until the Company is no longer obligated to pay royalties under the License Agreement, which obligation will expire on a country-by-country basis when the last valid claim of the Licensed Patents covering the Licensed Products in a given country expires. The approval of a therapeutically equivalent, generic version of the Licensed Product(s) in a country will conclusively demonstrate that a valid claim does not cover the Licensed Products in that country. If there are no patents covering the Licensed Products in a country, royalties are payable for the license of the scientific and technical know-how under the Epitech License until expiration of the last-to expire Epitech patent that relates to PEA.</p>
    <p style="text-align: justify;">The above description of the License Agreement is qualified in its entirety by reference to the full text of such agreement, a copy of which is available under the Company's SEDAR and EDGAR profiles.</p>
    <p style="text-align: justify;"><i>Cannabis Licenses </i></p>
    <p style="text-align: justify;">The Company held three licenses from Health Canada: (i) a Cultivation License (defined below); (ii) a Processing License (defined below); and (iii) a Sale for Medical Purposes Licence (collectively, the "Licenses").</p>
    <p style="text-align: justify;">On July 30, 2020, the Company announced that it has notified Health Canada of the Company's decision to forfeit the licenses of FV Pharma and suspend all activities by FV Pharma within 30 days. As at September 30, 2020, the Company has ended all activities of FV Pharma and has surrendered its Licenses. The Company has actively been in the process of liquidating all of FV Pharma's assets, including the sale of its Facility and/or the adjacent real estate.</p>
    <p style="text-align: justify;"><i>The Facility </i></p>
    <p style="text-align: justify;">FV Pharma's facility is located at located at 520 William Street, Cobourg, Ontario, K9A 3A5 (the "Facility"). FV Pharma acquired the Facility in November 2017. The Facility hosts an existing 581,538 square feet of building space. The Company is actively exploring a sale of the Facility and/or the Facility Property. See further discussion below under "<i>Discontinued Operations</i>"<i>.</i></p>
    <p style="text-align: justify;">As of the date hereof, the Company has no contractual arrangements and has no commitments for capital expenditures with respect to the Facility. The Company owns the 70-acre property on which the Facility is located (the "Facility Property").</p>
    <p style="text-align: justify;">In July 2020, the Company decided to primarily focus its efforts and resources on the pharmaceutical business operated through FSD Biosciences. Inc.</p>
    <div id="footer_page_4">
        <p style="text-align: right;">4</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_5"></a>
    <p style="text-align: justify;"><b>IMPACT OF COVID-19</b></p>
    <p style="text-align: justify;">The outbreak of the novel strain of coronavirus, specifically identified as "COVID-19," has resulted in governments worldwide enacting emergency measures to combat the spread of the virus. These measures, which include the implementation of travel bans, self-imposed quarantine periods and social distancing, have caused material disruption to businesses globally resulting in an economic slowdown. Governments and central banks have reacted with significant monetary and fiscal interventions designed to stabilize economic conditions. The extent to which COVID-19 and any other pandemic or public health crisis impacts the Company's business, affairs, operations, financial condition, liquidity, availability of credit and results of operations will depend on future developments that are highly uncertain and cannot be predicted with any meaningful precision, including new information which may emerge concerning the severity of the COVID-19 virus and the actions required to contain the COVID-19 virus or remedy its impact, among others. The duration and impact of the COVID-19 outbreak is unknown at this time, as is the efficacy of the government and central bank interventions. It is not possible to reliably estimate the length and severity of these developments and the impact on the financial results and condition of the Company and its operating subsidiaries in future periods.</p>
    <p style="text-align: justify;">In order to mitigate the impact of COVID-19, the Company implemented a systematic and orderly scale back of FV Pharma's cultivation operations and a furlough policy for its workforce, except for certain personnel working staggered shifts to ensure continuity of operations and licensure effective March 23, 2020. In September 2020, FV Pharma surrendered its licenses and ceased all other operational activities. The Company&#8217;s clinical trials for the use of FSD-201, its lead compound, to treat suspected or confirmed cases of COVID-19 continued to proceed throughout the year and as a result the impact of COVID-19 did not have a material impact on the continuing operations or financial results of the Company for the year ended December 31, 2020.</p>
    <p style="text-align: justify;"><b>CHANGE IN FUNCTIONAL AND PRESENTATION CURRENCY TO UNITED STATES DOLLARS</b><font style="width: 1pt; display: inline-block;">&#160;</font></p>
    <p style="text-align: justify;">The Company changed its functional currency from the Canadian dollar (C$) to the United States dollar (US$) as of October 1, 2020. The change in functional currency was the result of a review of the primary economic environment in which the entity operates and the currency that mainly influences the underlying transactions entered into by the Company.</p>
    <p style="text-align: justify;">The Company has elected to change its presentation currency from the Canadian dollar to the United States dollar effective October 1, 2020. The change in presentation currency is a voluntary change which is accounted for retrospectively. The change in presentation currency was made to better reflect the Company's business activities. For comparative reporting purposes, historical financial information has been translated to United States dollars using the exchange rate as at October 1, 2020, which is the date of the change in the functional and presentation currency.</p>
    <p style="text-align: justify;"><b>DISCONTINUED OPERATIONS</b></p>
    <p style="text-align: justify;">As previously noted, in March 2020, the Company decided to focus its efforts and resources on the pharmaceutical business and initiated the process to sell its Cobourg facility and exit the medical cannabis industry. The Company expects that the sale of the facility will be completed within the next twelve months and is actively marketing the facility for sale.&#160;</p>
    <p style="text-align: justify;">Assets held for sale consists of the Cobourg facility. It is anticipated that no liabilities of the Company will be transferred as part of any proposed transaction. Results of operations related to the Cobourg facility are reported as discontinued operations for the years ended December 31, 2020 and 2019.</p>
    <p style="text-align: justify;">In accordance with IFRS 5 - Non-current Assets Held for Sale and Discontinued Operations, the assets held for sale were assessed for impairment based on fair value less costs to sell. The fair value was measured using the price at which the Company expects to receive for the disposal of the Cobourg facility in its current state less estimates for the costs of disposal. The fair value less costs to sell was higher than the carrying value of the Cobourg Facility resulting in recognition of the resulting group at carrying value.</p>
    <div id="footer_page_5">
        <p style="text-align: right;">5</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_6"></a>
    <p style="text-align: justify;"><b>SELECTED FINANCIAL HIGHLIGHTS </b></p>
    <p style="text-align: justify;">The following table presents selected financial information for the three months and years ended December 31, 2020 and 2019:</p>
    <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; white-space: nowrap;" colspan="4"><b>For the three months ended <br>December 31,</b></td>
            <td style="vertical-align: bottom; text-align: center; white-space: nowrap;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; white-space: nowrap;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; white-space: nowrap;" colspan="4"><b>For the year ended <br>December 31,</b></td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>2020</b></td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>2019</b></td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>2020</b></td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>2019</b></td>
            <td style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right; white-space: nowrap;"><b>$</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right; white-space: nowrap;"><b>$</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right; white-space: nowrap;"><b>$</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right; white-space: nowrap;"><b>$</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">General and administrative&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>2,323,347</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">2,413,316</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>10,058,083</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">8,407,427</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">External research and development fees</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;"><b>2,456,010</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;"><b>7,832,847</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Share-based payments</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>215,255</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">2,885,792</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>8,052,011</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">12,082,930</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Depreciation and amortization</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;"><b>967,957</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">979,389</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;"><b>3,900,458</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">1,943,048</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Legal provision</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>59,288</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>757,829</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">Impairment of right-of-use asset</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;"><b>&#8212;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;">50,888</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;"><b>89,860</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;">50,888</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background-color: #e6efff;">Total operating expenses</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>6,021,857</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">6,329,385</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>30,691,088</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">22,484,293</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">Net loss from continuing operations</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;"><b>(3,964,147</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;"><b>)</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;">(11,523,123</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;"><b>(28,452,232</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;"><b>)</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;">(34,080,963</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background-color: #e6efff;">Net loss from discontinued operations</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>(414,124</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>)</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">(1,313,844</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>(3,347,561</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>)</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">(5,048,557</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">Net loss for the period</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;"><b>(4,378,271</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;"><b>)</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;">(12,836,967</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;"><b>(31,799,793</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;"><b>)</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;">(39,129,520</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
        </tr>
    </table>
    <p style="text-align: justify;"><b>OVERALL FINANCIAL PERFORMANCE</b></p>
    <p style="text-align: justify;"><i>Three months ended December 31, 2020</i></p>
    <p style="text-align: justify;">For the three months ended December 31, 2020, general and administrative expenses were $2,323,347 compared to $2,413,316 for the comparative period in the prior year. This represents a decrease of $89,969 or 4% for the three months ended December 31, 2020.&#160;</p>
    <p style="text-align: justify;">For the three ended December 31, 2020, external research and development fees were $2,456,010 compared to $nil for the three months ended December 31, 2019, representing an increase of $2,456,010 or 100% for the three months ended December 31, 2020. The increase is related to expenses incurred for the research and development of PEA, for Phase 1 and 2 Safety and Tolerability testing, FDA IND Application and COVID-19 study.</p>
    <p style="text-align: justify;">For the three months ended December 31, 2020, share-based payments expense was $215,255 compared to $2,885,792 for the three months ended December 31, 2019. This represents decrease of $2,670,537 or 93% for the three months ended December 31, 2020, compared to the equivalent period in the prior year. The decrease in share-based payments is due to the variability in the number of options granted, vesting periods of the options, the grant date fair values and one time share-based payments approved by the Board of Directors as compensation in December 2019 of $1.3 million.</p>
    <p style="text-align: justify;">For the three months ended December 31, 2020, depreciation and amortization was $967,957 compared to $979,389 for the three months ended December 31, 2019. This represents a decrease of $11,432 or 1% for the three months ended December 31, 2020, compared to the equivalent period in the prior year. Depreciation and amortization is primarily related to the amortization of intellectual property acquired through the acquisition of Prismic on June 29, 2019.</p>
    <p style="text-align: justify;">For the three months ended December 31, 2020, net loss was $4,378,271 compared to $12,836,967 for the three months ended December 31, 2019. Net loss for the three months ended December 31, 2020 is comprised of net loss from continuing operations of $3,964,147 and net loss from discontinued operations of $414,124 compared to net loss from continuing operations of $11,523,123 and net loss from discontinued operations of $1,313,844 for the three months ended December 31, 2019.</p>
    <p style="text-align: justify;"><i>Year ended December 31, 2020</i></p>
    <p style="text-align: justify;">For the year ended December 31, 2020, general and administrative expenses were $10,058,083 compared to $8,407,427 for the comparative period in the prior year. This represents an increase of $1,650,656 or 20% for the year ended December 31, 2020, primarily related to expanded operations associated with the acquisition of Prismic in June 2019 and higher professional fees and insurance expense as a result of the NASDAQ listing in January 2020.</p>
    <p style="text-align: justify;">For the year ended December 31, 2020, external research and development fees were $7,832,847 compared to $nil for the year ended December 31, 2019, representing an increase of $7,832,847 or 100% for the year ended December 31, 2020. The increase is related to expenses incurred for the research and development of PEA, FDA Investigational New Drug Application, Phase 1 Safety and Tolerability testing, Phase 2 clinical trials, and COVID-19 study.</p>
    <div id="footer_page_6">
        <p style="text-align: right;">6</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_7"></a>
    <p style="text-align: justify;">For the year ended December 31, 2020, share-based payments expense were $8,052,011 compared to $12,082,930 for the year ended December 31, 2019. This represents a decrease of $4,030,919 or 33% for the year ended December 31, 2020, compared to the equivalent period in the prior year. The decrease in share-based payments is due to the variability in the number of options granted, vesting periods of the options, the grant date fair values and one-time share-based payments approved by the Board of Directors as compensation.</p>
    <p style="text-align: justify;">For the year ended December 31, 2020, depreciation and amortization was $3,900,458 compared to $1,943,048 for the year ended December 31, 2019. This represents an increase of $1,957,410 or 101% for the year ended December 31, 2020, compared to the equivalent period in the prior year. Depreciation and amortization is primarily related to the amortization of intellectual property acquired through the acquisition of Prismic on June 29, 2019.</p>
    <p style="text-align: justify;">For the year ended December 31, 2020, net loss was $31,799,793 compared to $39,129,520 for the year ended December 31, 2019. Net loss for the year ended December 31, 2020 is comprised of net loss from continuing operations of $28,452,232 and net loss from discontinued operations of $3,347,561, compared to net loss from continuing operations of $34,080,963 and net loss from discontinued operations of $5,048,557 for the year ended December 31, 2019.</p>
    <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; white-space: nowrap;"><b>As at December 31,</b></td>
            <td style="vertical-align: bottom; text-align: center; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; white-space: nowrap;"><b>As at December 31,</b></td>
            <td style="vertical-align: bottom; text-align: center; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center; white-space: nowrap;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center; white-space: nowrap;"><b>2020</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center; white-space: nowrap;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center; white-space: nowrap;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center; white-space: nowrap;"><b>2019</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center; white-space: nowrap;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center; white-space: nowrap;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center; white-space: nowrap;" colspan="4"><b>Change</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;"><b>$</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;"><b>$</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;"><b>$&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;"><b><font style="font-size: 13.3333px; text-align: center;">%</font></b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Cash</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">17,524,822</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">5,967,798</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">11,557,024</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><font style="font-size: 13.3333px; text-align: right;">194%</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Total assets</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">41,967,205</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">43,217,727</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;">(1,250,522</td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">)</td>
            <td style="vertical-align: bottom; text-align: left; width: 1%;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; width: 10%;"><font style="font-size: 13.3333px; text-align: right;">-3%</font></td>
            <td style="vertical-align: bottom; text-align: left; width: 2%;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background-color: #e6efff;">Total liabilities</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">5,658,622</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">6,940,250</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">(1,281,628</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;"><font style="font-size: 13.3333px; text-align: right;">-18%</font></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;">The Company concluded the year ended December 31, 2020 with cash of $17,524,822 (December 31, 2019 - $5,967,798).</p>
    <p style="text-align: justify;">Cash used in operating activities for the year ended December 31, 2020 was $19,130,473 compared to $13,712,725 for the year ended December 31, 2019.</p>
    <p style="text-align: justify;">Cash provided by investing activities for the year ended December 31, 2020 was $6,514,126 compared to cash used in investing activities of $230,888 for the year ended December 31, 2019. The change is primarily due to proceeds of $6,477,510 from the sale of investments during the year ended December 31, 2020 compared to proceeds of $462,303 from the sale of investments offset by additions to intangible assets of $293,126 for the year ended December 31, 2019.</p>
    <p style="text-align: justify;">Cash provided by financing activities for the year ended December 31, 2020 was $24,173,371 compared to cash provided by financing activities of $4,011,603 for the year ended December 31, 2019. The increase is primarily due to net proceeds of $25,100,459 from the issuance of shares, $59,548 from the exercise of stock options, offset by $946,643 repayment of notes payable and $39,993 repayment of lease obligation during the year ended December 31, 2020, compared to net proceeds of $3,431,294 from the issuance of shares, $622,594 from the exercise of stock options and warrants offset by the repayment of lease obligation of $42,285 during the year ended December 31, 2019.</p>
    <div id="footer_page_7">
        <p style="text-align: right;">7</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_8"></a>
    <p style="text-align: justify;"><b>RESULTS OF OPERATIONS</b></p>
    <p style="text-align: justify;"><b>REVIEW OF OPERATIONS FOR THE YEAR ENDED DECEMBER 31, 2020 AND 2019</b></p>
    <p style="text-align: justify;">The following table outlines our consolidated statements of loss for year ended December 31, 2020 and 2019:</p>
    <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="10"><b>&#160;For the year ended December 31,&#160;&#160;</b></td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;"><b>&#160;2020&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">2019</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="4">&#160;Change&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;"><b>&#160;$&#160;</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;$&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;$&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;%</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;"><b>Expenses</b></td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">General and administrative</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;"><b>10,058,083</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">8,407,427</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">1,650,656</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">20%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">External research and development fees</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>7,832,847</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">7,832,847</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">100%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Share-based payments</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;"><b>8,052,011</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">12,082,930</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">(4,030,919</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">-33%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Depreciation and amortization</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>3,900,458</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">1,943,048</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">1,957,410</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">101%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Legal provision</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;"><b>757,829</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">757,829</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">100%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Impairment of right-of-use asset</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;"><b>89,860</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">50,888</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">38,972</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">77%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><b>Total operating expenses</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;"><b>30,691,088</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">22,484,293</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">8,206,795</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">37%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Loss from continuing operations</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;"><b>(30,691,088</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><b>)</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">(22,484,293</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">(8,206,795</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">37%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Other income</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;"><b>(3,691</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><b>)</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">(40,454</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">36,763</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">-91%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Finance expense</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>235,581</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">155,316</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">80,265</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">52%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;Loss (gain) on settlement of financial liability&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;"><b>(680,164</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><b>)</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">18,665</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">(698,829</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">-3744%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Loss (gain) on change in fair value of <br>&#160;&#160;&#160; warrants and derivative liability</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>(2,561,456</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>)</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">2,684,436</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">(5,245,892</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">-195%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;Loss on changes in fair value of investments&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000;"><b>770,874</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000;">8,778,707</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000;">(8,007,833</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000;">-91%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;"><b>Net loss from continuing operations</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;"><b>(28,452,232</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;"><b>)</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">(34,080,963</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">5,628,731</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">-17%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Net loss from discontinued operations</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;"><b>(3,347,561</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;"><b>)</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">(5,048,557</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">1,700,996</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">-34%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><b>Net loss</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000;"><b>(31,799,793</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;"><b>)</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000;">(39,129,520</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000;">7,329,727</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000;">-19%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
    </table>
    <p style="margin-left: 36pt; text-align: justify;"><i>General and administrative</i></p>
    <p style="text-align: justify;">General and administrative expenses for the year ended December 31, 2020 and 2019 are comprised of:</p>
    <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="10"><b>&#160;For the year ended December 31,&#160;&#160;</b></td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;"><b>2020</b></td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">2019</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="4">&#160;Change&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;"><b>$</b></td>
            <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">$</td>
            <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">&#160;$&#160;</td>
            <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; border-bottom: 1px solid #000000;">&#160;%&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Professional fees</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>2,734,123</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">3,101,136</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">(367,013</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">-12%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">General office, insurance and administration expenditures</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;"><b>3,616,159</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">1,742,550</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">1,873,609</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">108%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Consulting fees</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>1,775,269</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">1,675,258</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">100,011</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">6%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Salaries, wages and benefits</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;"><b>2,656,162</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">1,705,696</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">950,466</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">56%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Investor relations</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>541,944</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">2,241,275</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">(1,699,331</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">-76%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Building and facility costs</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;"><b>586,926</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">676,798</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">(89,872</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">-13%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Foreign exchange gain</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;"><b>(186,959</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;"><b>)</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">(186,959</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">100%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000;"><b>11,723,624</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000;">11,142,713</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000;">580,911</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000;">5%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Allocated to:</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Continuing operations</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;"><b>10,058,083</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">8,407,427</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">1,650,656</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">20%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Discontinued operations</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;"><b>1,665,541</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">2,735,286</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">(1,069,745</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">-39%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;"><i>Professional fees</i></p>
    <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="10"><b>&#160;For the year ended December 31,&#160;&#160;</b></td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;"><b>2020</b></td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">2019</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="4">&#160;Change&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;"><b>$</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">$</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;$&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;%&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Professional fees</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;"><b>2,734,123</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">3,101,136</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">(367,013</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">-12%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
    </table>
    <p>&#160;</p>
    <div id="footer_page_8">
        <p style="text-align: right;"><br>8</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_9"></a>
    <p style="text-align: justify;">Professional fees decreased from $3,101,136 to $2,734,123 or 12% for the year ended December 31, 2020 compared to the equivalent period in the prior year. Professional fees fluctuate from period to period based on the nature of the transactions the Company undertakes.</p>
    <p style="text-align: justify;"><i>General office, insurance and administration expenditures </i></p>
    <p style="text-align: justify;">General office, insurance and administration expenditures for the year ended December 31, 2020 and 2019 are comprised of the following:</p>
    <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="10"><b>&#160;For the year ended December 31,&#160;&#160;</b></td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;"><b>2020</b></td>
            <td style="vertical-align: bottom; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;">2019</td>
            <td style="vertical-align: bottom; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;" colspan="4">&#160;Change&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;"><b>$</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">$</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;$&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;%&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Insurance, shareholder and public company costs</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>2,048,726</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">579,056</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">1,469,670</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">254%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Travel, meals and entertainment</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;"><b>608,876</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">750,642</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">(141,766</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">-19%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Office and general administrative</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;"><b>958,557</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">412,852</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">545,705</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">132%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">General office, Insurance and administrative expenditures</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000;"><b>3,616,159</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000;">1,742,550</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000;">1,873,609</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000;">108%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
    </table>
    <p style="text-indent: 36pt; text-align: justify;"><i>Insurance, shareholders and public company costs</i></p>
    <p style="text-align: justify;">Insurance, shareholders and public company costs increased from $579,056 to $2,048,726 or 254% for the year ended December 31, 2020, compared to the equivalent periods in the prior year. The increase is primarily due to higher insurance costs associated with being a NASDAQ listed entity as of January 9, 2020.</p>
    <p style="text-indent: 36pt; text-align: justify;"><i>Travel, meals and entertainment</i></p>
    <p style="text-align: justify;">Travel, meals and entertainment expenses decreased from $750,642 to $608,876 or 19% for the year ended December 31, 2020, compared to the equivalent period in the prior year. The decrease is primarily due to the impact of travel restrictions related to COVID-19 in 2020.</p>
    <p style="text-indent: 36pt; text-align: justify;"><i>Office and general administrative</i></p>
    <p style="text-align: justify;">Office and general administrative expenses increased from $412,852 to $958,557 or 132% for the year ended December 31, 2020, compared to the equivalent period in the prior year. The increase for the year ended December 31, 2020 compared to the equivalent period in the prior year is related to the acquisition of Prismic and growth of the BioScience operations and administrative costs incurred related to the research and development of PEA and ongoing clinical trials.</p>
    <p style="text-align: justify;"><i>Consulting fees</i></p>
    <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="10"><b>&#160;For the year ended December 31,&#160;&#160;</b></td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;"><b>2020</b></td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">2019</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="4">&#160;Change&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;"><b>$</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">$</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;$&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;%&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Consulting fees</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;"><b>1,775,269</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">1,675,258</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">100,011</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">6%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;">Consulting fees increased from $1,675,258 to $1,775,269 or 6% for the year ended December 31, 2020, compared to the equivalent period in the prior year. Consulting fees include fees paid to individuals and professional firms who provide advisory services to the Company and fluctuate from period to period based on the nature of the transactions the Company undertakes.<i></i></p>
    <p style="text-align: justify;"><i>Salaries, wages and benefits</i></p>
    <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="10"><b>&#160;For the year ended December 31,&#160;&#160;</b></td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;"><b>2020</b></td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">2019</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="4">&#160;Change&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;"><b>$</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">$</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;$&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;%&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Salaries, wages and benefits</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;"><b>2,656,162</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">1,705,696</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">950,466</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">56%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;">Salaries, wages and benefits expenses increased from $1,705,696 to $2,656,162 or 56% for the year ended December 31, 2020, compared to the equivalent period in the prior year. The increase is primarily due to key management personnel hired as full-time salaried employees during the year-ended December 31, 2020.<i></i></p>
    <p style="text-align: justify;"><i>Investor relations</i></p>
    <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="10"><b>&#160;For the year ended December 31,&#160;&#160;</b></td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;"><b>2020</b></td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">2019</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="4">&#160;Change&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;"><b>$</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">$</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;$&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;%&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Investor relations</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;"><b>541,944</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">2,241,275</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">(1,699,331</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">-76%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;">&#160;</p>
    <div id="footer_page_9">
        <p style="text-align: right;">9</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_10"></a>
    <p style="text-align: justify;">Investor relations expenses decreased from $2,241,275 to $541,944 or 76% for the year ended December 31, 2020, compared to the equivalent period in the prior year. The decrease is primarily related to lower spending on investor relations and marketing during the year ended December 31, 2020.</p>
    <p style="text-align: justify;"><i>Building and facility costs</i></p>
    <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="10"><b>&#160;For the year ended December 31,&#160;&#160;</b></td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;"><b>2020</b></td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">2019</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="4">&#160;Change&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;"><b>$</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">$</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;$&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;%&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Building and facility costs</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;"><b>586,926</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">676,798</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">(89,872</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">-13%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;">Building and facility costs decreased from $676,798 to $586,926 or 13% for the year ended December 31, 2020, compared to the equivalent period in the prior year. The decrease is primarily related to the discontinued operations of FV Pharma. Costs include property taxes, security services, repairs and maintenance expenditures and utilities.<i></i></p>
    <p style="text-align: justify;"><i>Foreign exchange gain</i></p>
    <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="10"><b>&#160;For the year ended December 31,&#160;&#160;</b></td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;"><b>2020</b></td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">2019</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="4">&#160;Change&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;"><b>$</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">$</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;$&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;%&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Foreign exchange gain</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;"><b>(186,959</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;"><b>)</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">(186,959</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">100%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;">Foreign exchange gain increased from $nil to $186,959 or 100% for the year ended December 31, 2020, compared to the equivalent period in the prior year. The primary reason for the foreign exchange gain was due to the increase in strength of the Canadian dollar relative to the US dollar and its impact on cash balances held in Canadian dollars.&#160;<i></i></p>
    <p style="text-align: justify;"><i>External research and development fees</i></p>
    <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="10"><b>&#160;For the year ended December 31,&#160;</b></td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;"><b>&#160;2020&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;2019&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="4">&#160;Change&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;"><b>&#160;$&#160;</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;$&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;$&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;%&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">External research and development fees</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;"><b>7,832,847</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">7,832,847</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">100%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;">External research and development fees increased from $nil to $7,832,847 or 100% for the year ended December 31, 2020, compared to the equivalent period in the prior year. The increase is related to expenses incurred for the research and development of PEA, FDA Investigational New Drug Application, Phase 1 Safety and Tolerability testing, Phase 2 clinical trials, and COVID-19 study.</p>
    <p style="text-align: justify;"><i>Share-based payments</i></p>
    <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="10"><b>&#160;For the year ended December 31,&#160;</b></td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;"><b>&#160;2020&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;2019&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="4">&#160;Change&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;"><b>&#160;$&#160;</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;$&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;$&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;%&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Share-based payments</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;"><b>8,052,011</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">12,082,930</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">(4,030,919</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">-33%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;">Share-based payments decreased from $12,082,930 to $8,052,011 or 33% for the year ended December 31, 2020, compared to the equivalent period in the prior year. The decrease in share-based payments is due to the variability in the number of options granted, vesting periods of the options, the grant date fair values and one-time share-based payments approved by the Board of Directors as compensation during 2019.<i></i></p>
    <p style="text-align: justify;"><i>Depreciation and amortization</i></p>
    <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="10"><b>&#160;For the year ended December 31,&#160;</b></td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;"><b>&#160;2020&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;2019&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="4">&#160;Change&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;"><b>&#160;$&#160;</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;$&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;$&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;%&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Depreciation and amortization</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;"><b>3,900,458</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">1,943,048</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">1,957,410</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">101%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;">Depreciation and amortization increased from $1,943,048 to $3,900,458 or 101% for the year ended December 31, 2020, compared to the equivalent period in the prior year. Depreciation and amortization is primarily related to the amortization of intellectual property acquired through the acquisition of Prismic on June 29, 2019.&#160;<i></i></p>
    <div id="footer_page_10">
        <p style="text-align: right;">10</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_11"></a>
    <p style="text-align: justify;"><i>Impairment of right-of-use asset</i></p>
    <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="10"><b>&#160;For the year ended December 31,&#160;</b></td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;"><b>&#160;2020&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;2019&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="4">&#160;Change&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;"><b>&#160;$&#160;</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;$&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;$&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;%&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Impairment of right-of-use asset</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;"><b>89,860</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">50,888</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">38,972</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">77%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;"><font style="font-size: 10pt;">For the year ended December 31, 2020, impairment of right-of-use asset was $89,860 compared to $50,888 for the year ended December 31, 2019. The increase is due to the impairment of the right-of-use asset related to an office lease. As of March 31, 2020, the Company did not occupy the leased premise and has been unsuccessful in subleasing the space. The Company recognized an impairment loss of $89,860 for the year ended December 31, 2020 resulting in right-of-use asset balance of $nil.</font><i></i></p>
    <p style="text-align: justify;"><i>Finance expense</i></p>
    <p style="text-align: justify;">For the year ended December 31, 2020, finance expense was $235,581, compared to $155,316 for the year ended December 31, 2019. Finance expense is primarily comprised of interest on notes payable assumed on acquisition of Prismic Pharmaceuticals in June 2019. The increase for the year ended December 31, 2020, compared to the equivalent period in the prior year is due to twelve months of interest recorded in 2020 compared to six months in 2019.</p>
    <p style="text-align: justify;"><i>Loss (gain) on settlement of financial liability</i></p>
    <p style="text-align: justify;">For the year ended December 31, 2020 the Company recognized a gain on settlement of financial liabilities of $680,164 compared to a loss on settlement of financial liabilities of $18,665 for the year ended December 31, 2019. The gain recognized during the year-ended December 31, 2020 is primarily due to the settlement of Prismic notes payable and trade and other payables for Class B common shares and cash. The difference between the carrying value of the notes payable and trade and other liabilities and the consideration given was recorded as gain on settlement.</p>
    <p style="text-align: justify;"><i>Loss (gain) on change in fair value of warrants and derivative liability</i></p>
    <p style="text-align: justify;">As at December 31, 2019, the fair value of the derivative liability was $1,990,788. The fair value was determined based on the additional common shares of the Company required to be issued to Solarvest BioEnergy Inc. ("Solarvest") to meet the minimum liquidation value of $2,256,900. On February 4, 2020, the Company issued 225,371 Class B subordinate voting shares to Solarvest as settlement of the derivative liability. The fair value of the shares issued was determined to be $1,356,373. The Company recognized a gain of $634,415 on settlement of the derivative liability.</p>
    <p style="margin-bottom: 0pt; text-align: justify;">In August of 2020 the Company issued warrants as part of a private placement that did not meet the IFRS definition of equity due to the exercise price being denominated in United States Dollars, which was not the functional currency of the Company at the time resulting in a variability in exercise price. As such, the warrants were recognized as a derivative liability with a fair value of $3,289,069 at the time of issuance. The derivative liability was remeasured at fair value of $1,447,910 on December 31, 2020. The Company recognized a gain on change in fair value of $1,927,041 for the year ended December 31, 2020.</p>
    <p style="text-align: justify;"><i>Loss on changes in fair value of investments</i></p>
    <p style="text-align: justify;">The Company has various investments accounted for at fair value through profit or loss resulting in recognition of loss/gain as the fair value fluctuates. The table below summarizes the change in fair value of these investments during the year.&#160;</p>
    <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;"><b>Entity</b></td>
            <td style="vertical-align: bottom; white-space: nowrap;"><b>Instrument</b></td>
            <td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>Balance at <br>December 31, <br>2019</b></td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>Change in fair <br>value through <br>profit or loss</b></td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>Foreign <br>exchange <br>gain</b></td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>Proceeds <br>from sale</b></td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>Balance at <br>December <br>31, 2020</b></td>
            <td style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;"><b>$</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;"><b>$</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;"><b>$</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;"><b>$</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;"><b>$</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Pharmadrug Inc.</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">Shares</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">255,075</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">397,006</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">652,081</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Cannara Biotech Inc.</td>
            <td style="vertical-align: bottom;">Shares</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">6,822,637</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">(997,208</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">5,825,429</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Clover Cannastrip</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">Shares</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">HUGE Shops</td>
            <td style="vertical-align: bottom;">Shares</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">572,401</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">7,674</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">20,358</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">600,433</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">SciCann Therapeutics</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">Shares</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">535,824</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">(354,910</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">14,765</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">195,679</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Solarvest BioEnergy Inc.&#160;</td>
            <td style="vertical-align: bottom;">Shares</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">327,251</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">106,380</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">14,047</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">447,678</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Solarvest BioEnergy Inc.&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">Warrants</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">87,756</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">(14,920</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">1,977</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">74,813</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">Solarvest BioEnergy Inc.&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">Convertible debenture</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; border-bottom: 1px solid #000000;">261,800</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; border-bottom: 1px solid #000000;">85,104</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; border-bottom: 1px solid #000000;">11,238</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; border-bottom: 1px solid #000000;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; border-bottom: 1px solid #000000;">358,142</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;"><b>8,862,744</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;"><b>(770,874</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;"><b>)</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;"><b>62,385</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;"><b>6,477,510</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;"><b>1,676,745</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
        </tr>
    </table>
    <p>&#160;</p>
    <div id="footer_page_11">
        <p style="text-align: right;">11</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_12"></a>
    <p style="text-align: justify;"><b>REVIEW OF OPERATIONS FOR THE THREE MONTHS ENDED DECEMBER 31, 2020 AND 2019</b></p>
    <p style="text-align: justify;">The following table outlines our consolidated statements of loss for three months ended December 31, 2020 and 2019:</p>
    <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="10"><b>&#160;Three months ended December 31,&#160;&#160;</b></td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;"><b>&#160;2020&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">2019&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="4">&#160;Change&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;"><b>&#160;$&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;$&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;$&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;%&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;"><b>Expenses</b></td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">General and administrative</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;"><b>2,323,347</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">2,413,316</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">(89,969</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">-4%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">External research and development fees</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>2,456,010</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">2,456,010</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">100%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Share-based payments</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;"><b>215,255</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">2,885,792</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">(2,670,537</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">-93%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Depreciation and amortization</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>967,957</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">979,389</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">(11,432</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">-1%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Legal provision</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;"><b>59,288</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">59,288</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">100%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Impairment of right-of-use asset</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">50,888</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">(50,888</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">-100%</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><b>Total operating expenses</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;"><b>6,021,857</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">6,329,385</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">(307,528</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">-5%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><b>Loss from continuing operations</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;"><b>(6,021,857</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><b>)</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">(6,329,385</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">307,528</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">-5%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Other income</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;"><b>(4</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><b>)</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">(38,084</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">38,080</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">-100%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Finance expense</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>32,967</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">83,199</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">(50,232</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">-60%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Loss (gain) on settlement of financial liability</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;"><b>(420,936</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><b>)</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">18,665</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">(439,601</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">-2355%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Loss (gain) on change in fair value of <br>&#160;&#160;&#160; warrants and derivative liability</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>(1,254,299</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>)</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">335,728</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">(1,590,027</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">-474%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Loss (gain) on changes in fair value of investments</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;"><b>(415,438</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;"><b>)</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;">4,794,230</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;">(5,209,668</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;">-109%</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;"><b>Net loss from continuing operations</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>(3,964,147</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>)</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">(11,523,123</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">7,558,976</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">-66%</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Net loss from discontinued operations</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>(414,124</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>)</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">(1,313,844</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">899,720</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">-68%</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><b>Net loss</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;"><b>(4,378,271</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;"><b>)</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;">(12,836,967</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;">8,458,696</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;">-66%</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;"><i>General and administrative</i></p>
    <p style="text-align: justify;">General and administrative expenses for the three months December 31, 2020 and 2019 are comprised of:</p>
    <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="10"><b>&#160;For the three months ended December 31,&#160;</b></td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;"><b>2020</b></td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">2019</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="4">&#160;Change&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;"><b>$</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">$</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;$&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;%&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Professional fees</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>498,295</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">953,062</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">(454,767</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">-48%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">General office, insurance and administration expenditures</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;"><b>897,745</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">436,172</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">461,573</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">106%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Consulting fees</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>435,090</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">445,065</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">(9,975</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">-2%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Salaries, wages and benefits</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;"><b>973,125</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">293,488</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">679,637</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">232%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Investor relations</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>54,630</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">393,236</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">(338,606</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">-86%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Building and facility costs</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;"><b>232,766</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">34,204</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">198,562</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">581%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Foreign exchange gain</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;"><b>(312,856</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;"><b>)</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">(312,856</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">100%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000;"><b>2,778,795</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000;">2,555,227</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000;">223,568</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000;">9%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Allocated to:</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Continuing operations</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;"><b>2,323,347</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">2,413,316</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">(89,969</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">-4%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Discontinued operations</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;"><b>455,448</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">141,911</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">313,537</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">221%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
    </table>
    <p style="text-indent: 36pt; text-align: justify;"><i>Professional fees</i></p>
    <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="10"><b>&#160;For the three months ended December 31,&#160;</b></td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;"><b>2020</b></td>
            <td style="vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;">2019</td>
            <td style="vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;" colspan="1"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;" colspan="4">&#160;Change&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;"><b>$</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">$</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;$&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;%&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Professional fees</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;"><b>498,295</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">953,062</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">(454,767</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">-48%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
        </tr>
    </table>
    <p style="text-indent: 0pt; text-align: justify;"><font style="font-size: 10pt;">Professional fees decreased from $953,062 to $498,295 or 48% for the three months ended December 31, 2020 compared to the equivalent period in the prior year. The decrease is primarily related to costs incurred during the three months ended December 31, 2019 associated with the NASDAQ listing. Professional fees fluctuate from period to period based on the nature of the transactions the Company undertakes.</font><i></i></p>
    <div id="footer_page_12">
        <p style="text-align: right;">12</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_13"></a>
    <p style="text-indent: 36pt; text-align: justify;"><i>General office, insurance and administration expenditures </i></p>
    <p style="text-align: justify;">General office, insurance and administration expenditures for the three months December 31, 2020 and 2019 are comprised of the following:</p>
    <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="10"><b>&#160;For the three months ended December 31,&#160;</b></td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;"><b>2020</b></td>
            <td style="vertical-align: bottom; text-align: right;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: right;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: right;">2019</td>
            <td style="vertical-align: bottom; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="4">&#160;Change&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;"><b>$</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">$</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;$&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: right;">&#160;%&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Insurance, shareholder and public company costs</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>360,126</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">303,514</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">56,612</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">19%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Travel, meals and entertainment</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;"><b>211,816</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">344,894</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">(133,078</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">-39%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Office and general administrative</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;"><b>325,803</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">(212,236</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">538,039</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">-254%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><b>General office, Insurance and administrative expenditures</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000;"><b>897,745</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000;">436,172</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000;">461,573</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000;">106%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
    </table>
    <p style="text-indent: 36pt; text-align: justify;"><i>Insurance, shareholders and public company costs</i></p>
    <p style="text-align: justify;">Insurance, shareholders and public company costs increased from $303,514 to $360,126 or 19% for the three months ended December 31, 2020, compared to the equivalent period in the prior year. The increase is primarily due to higher insurance costs associated with being a NASDAQ listed entity as of January 9, 2020.</p>
    <p style="text-indent: 36pt; text-align: justify;"><i>Travel, meals and entertainment</i></p>
    <p style="text-align: justify;">Travel, meals and entertainment expenses decreased from $344,894 to $211,816 or 39% for the three months ended December 31, 2020, compared to the equivalent period in the prior year. The decrease is primarily due to the impact of travel restrictions related to COVID-19 in 2020.</p>
    <p style="text-indent: 36pt; text-align: justify;"><i>Office and general administrative</i></p>
    <p style="text-align: justify;">Office and general administrative expenses are related to expenditures for continued operations. The increase for the three months ended December 31, 2020 compared to the equivalent period in the prior year is related to the growth of the BioScience operations and administrative costs incurred related to the research and development of PEA and ongoing clinical trials as the Company is focused on the growth of the operations.</p>
    <p style="text-align: justify;"><i>Consulting fees</i></p>
    <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="10"><b>&#160;For the three months ended December 31,&#160;</b></td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;"><b>2020</b></td>
            <td style="vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;">2019</td>
            <td style="vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;" colspan="1"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;" colspan="4">&#160;Change</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;"><b>$</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">$</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;$&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;%&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Consulting fees</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;"><b>435,090</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">445,065</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">(9,975</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">-2%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;">Consulting fees decreased from $445,065 to $435,090 or 2% for the three months ended December 31, 2020, compared to the equivalent period in the prior year. Consulting fees include fees paid to individuals and professional firms who provide advisory services to the Company and fluctuate from period to period based on the nature of the transactions the Company undertakes.<i></i></p>
    <p style="text-align: justify;"><i>Salaries, wages and benefits</i></p>
    <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="10"><b>&#160;For the three months ended December 31,&#160;</b></td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;"><b>2020</b></td>
            <td style="vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;">2019</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="4">&#160;Change&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;"><b>$</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">$</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;$&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;%&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Salaries, wages and benefits</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;"><b>973,125</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">293,488</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">679,637</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">232%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;">Salaries, wages and benefits expenses increased from $293,488 to $973,125 or 232% for the three months ended December 31, 2020, compared to the equivalent period in the prior year. The increase is primarily due to key management hired as salaried employees in January 2020 and severance expense recorded during the three months ended December 31, 2020.<i></i></p>
    <p style="text-align: justify;"><i>Investor relations</i></p>
    <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="10"><b>&#160;For the three months ended December 31,&#160;</b></td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;"><b>2020</b></td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">2019</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="4">&#160;Change&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;"><b>$</b></td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">$</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;$&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000; text-align: center;">&#160;%&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Investor relations</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;"><b>54,630</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">393,236</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">(338,606</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000; background-color: #e6efff;">-86%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000; background-color: #e6efff;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;">Investor relations expenses decreased from $393,236 to $54,630 or 86% for the three months ended December 31, 2020, compared to the equivalent period in the prior year. The decrease is primarily related to lower spending on investor relations and marketing during the three months ended December 31, 2020.<i></i></p>
    <div id="footer_page_13">
        <p style="text-align: right;">13</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_14"></a>
    <p style="text-align: justify;"><i>Building and facility costs</i></p>
    <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="10"><b>&#160;For the three months ended December 31,&#160;</b></td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;"><b>2020</b></td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">2019</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="4">&#160;Change&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;"><b>$</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">$</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;$&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;%&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Building and facility costs</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>232,766</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">34,204</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">198,562</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">581%</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;">Building and facility costs increased from $34,204 to a $232,766 or 581% for the three months ended December 31, 2020, compared to the equivalent period in the prior year. Such costs include property taxes, security services, repairs and maintenance expenditures and utilities. The increase for the three months ended December 31, 2020 compared to the equivalent period in the prior year is due these costs being recognized as an expense, whereas certain costs were capitalized to biological assets and inventory production in the prior period.<i></i></p>
    <p style="text-align: justify;"><i>Foreign exchange gain</i></p>
    <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="10"><b>&#160;For the three months ended December 31,&#160;</b></td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;"><b>2020</b></td>
            <td style="vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">2019</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="4">&#160;Change&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;"><b>$</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">$</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;$&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;%&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Foreign exchange gain</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>(312,856</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>)</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">(312,856</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">100%</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;"><font style="font-size: 10pt;">Foreign exchange gain increased from $nil to $312,856 or 100% for the three months ended December 31, 2020, compared to the equivalent period in the prior year. The primary reason for the foreign exchange gain was due to the increase in strength of the Canadian dollar relative to the US dollar and its impact on cash balances held in Canadian dollars.</font><i></i></p>
    <p style="text-align: justify;"><i>External research and development fees</i></p>
    <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="10"><b>&#160;For the three months ended December 31,&#160;</b></td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;"><b>&#160;2020&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;2019&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="4">&#160;Change&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;"><b>&#160;$&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;$&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;$&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;%&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">External research and development fees</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>2,456,010</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">2,456,010</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">100%</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;">External research and development fees increased from $nil to $2,456,010 or 100% for the three months ended December 31, 2020, compared to the equivalent period in the prior year. The increase is related to expenses incurred for the research and development of PEA, FDA Investigational New Drug Application, Phase 1 Safety and Tolerability testing, Phase 2 clinical trials, and COVID-19 study.<i></i></p>
    <p style="text-align: justify;"><i>Share-based payments</i></p>
    <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="10"><b>&#160;For the three months ended December 31,&#160;</b></td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;"><b>&#160;2020&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;2019&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="4">&#160;Change&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;"><b>&#160;$&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;$&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;$&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;%&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Share-based payments</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>215,255</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">2,885,792</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">(2,670,537</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">-93%</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;">Share-based payments decreased from $2,885,792 to $215,255 or 93% for the three months ended December 31, 2020, compared to the equivalent period in the prior year. The decrease in share-based payments is due to the variability in the number of options granted, vesting periods of the options, the grant date fair values and one-time share-based payments approved by the Board of Directors as compensation for the three months ended December 31, 2019.<i></i></p>
    <p style="text-align: justify;"><i>Depreciation and amortization</i></p>
    <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="10"><b>&#160;For the three months ended December 31,&#160;</b></td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;"><b>&#160;2020&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;2019&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="4">&#160;Change&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;"><b>&#160;$&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;$&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;$&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;%&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Depreciation and amortization</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>967,957</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">979,389</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">(11,432</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">-1%</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;">Depreciation and amortization decreased from $979,389 to $967,957 or 1% for the three months ended December 31, 2020, compared to the equivalent period in the prior year. Depreciation and amortization is primarily related to the intellectual property recognized on the acquisition of Prismic on June 29, 2019.<i></i></p>
    <p style="text-align: justify;"><i>Finance expense</i></p>
    <p style="text-align: justify;">For the three months ended December 31, 2020, finance expense was $32,967 compared to $83,199 for the three months ended December 31, 2019. Finance expense is primarily comprised of interest on notes payable assumed on acquisition of Prismic Pharmaceuticals in June 2019. During the year ended December 31, 2020, the Company has settled a significant balance of notes payable, resulting in lower finance expense for the three months ended December 31, 2020 compared to the equivalent period in the prior year.</p>
    <div id="footer_page_14">
        <p style="text-align: right;">14</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_15"></a>
    <p style="text-align: justify;"><i>Loss (gain) on settlement of financial liability</i></p>
    <p style="text-align: justify;">For the three months ended December 31, 2020 the gain on settlement of financial liability was $420,936. The gain recognized during the three months ended December 31, 2020 is primarily due to the settlement of Prismic notes payable and trade and other payables. The difference between the carrying value of the notes payable and trade and other liabilities and the consideration given was recorded as a gain on settlement.</p>
    <p style="text-align: justify;"><i>Loss (gain) on change in fair value of warrants and derivative liability</i></p>
    <p style="text-align: justify;">In August of 2020 the Company issued warrants as part of a private placement that did not meet the IFRS definition of equity due to the exercise price being denominated in United States Dollars, which was not the functional currency of the Company at the time resulting in a variability in exercise price. As such, the warrants were recognized as a derivative liability with a fair value of $3,289,069 at the time of issuance. The derivative liability was remeasured at fair value of $1,447,910 on December 31, 2020, resulting in a gain on change in fair value of $1,254,299 for the three months ended December 31, 2020.</p>
    <p style="text-align: justify;">For the three months ended December 31, 2019, loss on change in fair value of derivative liability is related to investments in Pharmadrug Inc. and Solarvest BioEnergy Inc. Both investments were acquired by issuing equity instruments in the Company and the investment agreements guaranteed a minimum value of the Company's equity to Pharmadrug Inc. and Solarvest BioEnergy Inc. resulting in recognition of derivative liability under IFRS. This expense represents change in the derivative liability from date of initial measurements to December 31, 2019. These investments were acquired during the year ended December 31, 2019.</p>
    <p style="text-align: justify;"><i>Loss (gain) on changes in fair value of investments</i></p>
    <p style="text-align: justify;">The Company has various investments accounted for at fair value through profit or loss resulting in recognition of loss/gain as the fair value fluctuates.</p>
    <p style="text-align: justify;"><b>REVIEW OF DISCONTINUED OPERATIONS FOR THE THREE MONTHS AND YEAR ENDED DECEMBER 31, 2020 AND 2019</b></p>
    <p style="text-align: justify;">The following table outlines our net loss from discontinued operations for the three months and year ended December 31, 2020 and 2019:</p>
    <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000; margin-left: auto; margin-right: auto;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="4"><b>For the three months ended December 31,</b></td>
            <td style="vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;" colspan="4"><b>For the year ended December 31,</b></td>
            <td style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;"><b>2020</b></td>
            <td style="vertical-align: bottom; text-align: right;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;">2019</td>
            <td style="vertical-align: bottom; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;"><b>2020</b></td>
            <td style="vertical-align: bottom; text-align: right;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;">2019</td>
            <td style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right;"><b>$</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right;">$</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right;"><b>$</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right;">$</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;"><b>&#160;</b></td>
            <td style="vertical-align: bottom;"><b>&#160;</b></td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;"><b>&#160;</b></td>
            <td style="vertical-align: bottom;"><b>&#160;</b></td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;"><b>Revenue</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>&#8212;</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">193,049</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>14,514</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">193,416</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background-color: #e6efff;">Cost of revenue</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>&#8212;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">834,422</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>1,032,010</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">1,473,839</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;"><b>Gross loss before fair value adjustments</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;"><b>&#8212;</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">(641,373</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;"><b>(1,017,496</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><b>)</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">(1,280,423</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Fair value adjustments on inventory sold</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>&#8212;</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">16,738</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>(945</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>)</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">16,738</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">Unrealized loss on changes in fair value of biological assets&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;"><b>&#8212;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;">281,548</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;"><b>166,886</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;">513,625</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background-color: #e6efff;"><b>Gross loss&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>&#8212;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">(939,659</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>(1,183,437</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>)</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">(1,810,786</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;"><b>Expenses</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">General and administrative&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;"><b>455,448</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">141,911</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;"><b>1,665,541</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">2,735,286</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Depreciation and amortization</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>&#8212;</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">119,256</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>90,340</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">424,199</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; border-bottom: 1px solid #000000;">Impairment of property, plant and equipment</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000;"><b>&#8212;</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000;">132,273</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000;"><b>387,474</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; border-bottom: 1px solid #000000;">132,273</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background-color: #e6efff;"><b>Total operating expenses</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>455,448</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">393,440</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>2,143,355</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">3,291,758</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background-color: #e6efff;"><b>Loss from discontinued operations</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>(455,448</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>)</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">(1,333,099</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>(3,326,792</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>)</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">(5,102,544</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Other income</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>(41,326</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>)</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">(19,255</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>(79,568</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>)</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">(53,987</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">Loss on sale of equipment</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;"><b>&#8212;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;">&#8212;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;"><b>100,337</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;">&#8212;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background-color: #e6efff;"><b>Net loss from discontinued operations</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>(414,122</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>)</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">(1,313,844</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;"><b>(3,347,561</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>)</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">(5,048,557</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
        </tr>
    </table>
    <p>&#160;</p>
    <div id="footer_page_15">
        <p style="text-align: right;">15</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_16"></a>
    <p style="text-align: justify;"><i>Revenue</i></p>
    <p style="text-align: justify;">Revenue was $nil and $14,514 from discontinued operations for the three months and year ended December 31, 2020 compared to $193,049 and $193,416 for the equivalent periods in the prior year. The decrease is due to the Company discontinuing its cannabis operations.</p>
    <p style="text-align: justify;"><i>Cost of revenue</i></p>
    <p style="text-align: justify;">For the three months and year ended December 31, 2020, cost of revenue from discontinued operations was $nil and $1,032,010, respectively, compared to $834,422 and $1,473,839 for the three months and year ended December 31, 2019. The decrease for the three months and year ended December 31, 2020 compared to the equivalent periods in the prior year is primarily due to FV Pharma forfeiting its licenses and ceasing all operations at the end of July 2020 and discontinuing the sale of cannabis. Cost of revenue includes the cost of inventory sold, production costs expensed and impairment charges. Direct and indirect production costs include labor, processing, testing, packaging, quality assurance, security, inventory, shipping, depreciation of production equipment, production management and other related expenses.</p>
    <p style="text-align: justify;"><i>Unrealized loss on changes in fair value of biological assets</i></p>
    <p style="text-align: justify;">Unrealized loss on change in fair value of biological assets for the three months and year ended December 31, 2020 was $nil and $166,886 compared to the loss from change in fair value of biological assets for the three months and year ended December 31, 2019 of $281,548 and $513,625. As of December 31, 2020, the Company did not have any biological assets.</p>
    <p style="text-align: justify;"><i>General and administrative</i></p>
    <table style="font-size: 8pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="10"><b>&#160;For the three months ended December 31,&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;" colspan="1"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;" colspan="1"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;" colspan="10"><b>&#160;For the year ended December 31,&#160;&#160;</b></td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;"><b>2020</b></td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">2019</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="4">&#160;Change&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;"><b>2020</b></td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">2019</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;" colspan="4">&#160;Change&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;"><b>$</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">$</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;$&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;%&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;"><b>$</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">$</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;$&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;">&#160;%&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">General office and administration</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;"><b>121,675</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">(87,649</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">209,324</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">-239%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;"><b>566,816</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">529,509</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">37,307</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">7%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Salaries, wages and benefits</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;"><b>101,006</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">195,356</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">(94,350</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">-48%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;"><b>511,799</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">1,528,979</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">(1,017,180</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">-67%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Building and facility costs</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;"><b>232,767</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">34,204</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">198,563</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">581%</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;"><b>586,926</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">676,798</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">(89,872</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">-13%</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;"><b>455,448</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;">141,911</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;">313,537</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;">221%</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;"><b>1,665,541</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;">2,735,286</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;">(1,069,745</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;">-39%</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;">General and administrative expenses from discontinued operations increased from $141,911 to $455,448 for the three months ended December 31, 2020 compared to the equivalent period in the prior year. The increase is primarily due to the discontinuance of operations and building and facility expenses that were recognized as general and administrative expenses for the three months ended December 31, 2020, whereas such costs were allocated and capitalized to the production of the biological assets and inventory for the equivalent period in the prior year. General and administrative expenses decreased from $2,735,286 to $1,665,541 for the year ended December 31, 2020 compared to the equivalent period in the prior year. The decrease was due to the Company discontinuing operations in March of 2020.&#160;<i></i></p>
    <p style="text-align: justify;"><i>Depreciation and amortization</i></p>
    <p style="text-align: justify;">Depreciation and amortization from discontinued operations for the three months and year ended December 31, 2020 was $nil and $90,340 compared to $119,256 and $424,199 for the equivalent periods in the prior year. Depreciation and amortization expense decreased as the Company stopped depreciating these assets upon recognition as being held for sale in March of 2020.</p>
    <p style="text-align: justify;"><i>Impairment of property, plant and equipment</i></p>
    <p style="text-align: justify;">Impairment of property, plant and equipment from discontinued operations for the three months and year ended December 31, 2020 was $nil and $387,474 compared to $132,273 and $132,273 for the equivalent periods in the prior year. Impairment charges related to the carrying value of certain items of equipment being greater than their recoverable amount.</p>
    <p style="text-align: justify;"><i>Loss on sale of equipment</i></p>
    <p style="text-align: justify;">During the year ended December 31, 2020, FV Pharma sold equipment and recognized a loss of $100,337 as a result of the proceeds from sale being less than the carrying value of the equipment.</p>
    <div id="footer_page_16">
        <p style="text-align: right;">16</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_17"></a>
    <p style="text-align: justify;"><b>SELECTED QUARTERLY INFORMATION</b></p>
    <p style="text-align: justify;">The following table sets forth selected unaudited quarterly statements of operations data for each of the eight quarters commencing January 1, 2019 and ending December 31, 2020. The information for each of these quarters has been prepared on the same basis as the audited annual financial statements for the year ended December 31, 2020. This data should be read in conjunction with our audited annual financial statements for the year ended December 31, 2020 and 2019. These quarterly operating results are not necessarily indicative of our operating results for a full year or any future period.</p>
    <table style="font-size: 8pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;"><b>December 31, 2020</b></td>
            <td style="vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;"><b>September 30, 2020</b></td>
            <td style="vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;"><b>June 30, </b><br><b>2020</b></td>
            <td style="vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;"><b>March 31, </b><br><b>2020</b></td>
            <td style="vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;"><b>December 31, 2019</b></td>
            <td style="vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;"><b>September 30, 2019</b></td>
            <td style="vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;"><b>June 30, </b><br><b>2019</b></td>
            <td style="vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;"><b>March 31, </b><br><b>2019</b></td>
            <td style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;"><b>$</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;"><b>$</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;"><b>$</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;"><b>$</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;"><b>$</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;"><b>$</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;"><b>$</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center;"><b>$</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;"><b>[restated]</b></td>
            <td style="vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;"><b>[restated]</b></td>
            <td style="vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center;"><b>[restated]</b></td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Other income (loss)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">4</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">(23,166</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">13,251</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">13,602</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">42,824</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">(2,370</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Net loss for the period</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">(4,378,271</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">(13,567,266</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">(4,492,484</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">(9,361,772</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">(12,836,967</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">(12,760,518</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">(11,803,787</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">(1,728,248</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Net loss per share - basic</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">(0.24</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">(1.07</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">(0.49</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">(1.15</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">(1.63</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">(1.69</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">(1.68</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">(0.25</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Net loss per share - diluted</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; border-bottom: 1px solid #000000;">(0.24</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; border-bottom: 1px solid #000000;">(1.07</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; border-bottom: 1px solid #000000;">(0.49</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; border-bottom: 1px solid #000000;">(1.15</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; border-bottom: 1px solid #000000;">(1.63</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; border-bottom: 1px solid #000000;">(1.69</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; border-bottom: 1px solid #000000;">(1.68</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; border-bottom: 1px solid #000000;">(0.25</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; border-bottom: 1px solid #000000;">)</td>
        </tr>
    </table>
    <p style="text-align: justify;"><b>Restatement of comparative figures and key metrics</b></p>
    <p style="text-align: justify;">In preparation of the December 31, 2020 condensed consolidated interim financial statements, certain errors to the previously issued December 31, 2019 consolidated financial statements were identified by management. The errors related to errors in the application of accounting for stock-based compensation, investments, and derivative liability.</p>
    <p style="text-align: justify;">The errors have been corrected by restating each of the affected financial statement line items for the three months ended December 31, 2019 as follows:</p>
    <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;"><b>Statement of Loss and Comprehensive Loss</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right;" colspan="8"><b>For the three months </b><br><b>ended December 31, 2019</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>&#160;As previously <br>reported&#160;&#160;</b></td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>&#160;Adjustments&#160;</b></td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: right; white-space: nowrap;"><b>&#160;As revised&#160;</b></td>
            <td style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right;"><b>&#160;$&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right;"><b>&#160;$&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right;"><b>&#160;$&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Share-based payments</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">3,137,045</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">(251,253</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff;">2,885,792</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">Loss on change in fair value of derivative liability</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;">1,405,525</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;">(1,069,797</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 10%; text-align: right;">335,728</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff; border-bottom: 1px solid #000000;"><b>Net loss for the period</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">(14,158,017</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">(1,321,050</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">&#160;</td>
            <td style="vertical-align: bottom; width: 10%; text-align: right; background-color: #e6efff; border-bottom: 1px solid #000000;">(12,836,967</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff; border-bottom: 1px solid #000000;">)</td>
        </tr>
    </table>
    <p style="text-align: justify;">The restatements were all non-cash and did not have any impact on cash used in operations, cash provided by investment activities and cash provided by financing activities.</p>
    <p style="text-align: justify;">The restatements above did not have any impact on the December 31, 2019 audited consolidated financial statements.</p>
    <div id="footer_page_17">
        <p style="text-align: right;">17</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_18"></a>
    <p style="text-align: justify;"><b>FINANCIAL POSITION</b></p>
    <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom; width: 5%;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; white-space: nowrap;"><b>&#160;As at&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center; white-space: nowrap;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center; white-space: nowrap;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center; white-space: nowrap;"><b>&#160;As at&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center; white-space: nowrap;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center; white-space: nowrap;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center; white-space: nowrap;"><b>&#160;As at&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center; white-space: nowrap;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center; white-space: nowrap;" rowspan="2"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center; white-space: nowrap;" colspan="4" rowspan="2"><b>&#160;Change December 31, 2020 <br>vs December 31, 2019&#160;</b></td>
            <td style="vertical-align: bottom;" rowspan="2">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 5%;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; white-space: nowrap;"><b>&#160;December 31,&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center; white-space: nowrap;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center; white-space: nowrap;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center; white-space: nowrap;"><b>&#160;December 31,&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center; white-space: nowrap;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center; white-space: nowrap;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center; white-space: nowrap;"><b>&#160;January 1,&#160;</b></td>
            <td style="vertical-align: bottom; text-align: center; white-space: nowrap;"><b>&#160;</b></td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 5%;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center; white-space: nowrap;"><b>&#160;2020&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center; white-space: nowrap;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center; white-space: nowrap;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center; white-space: nowrap;"><b>&#160;2019&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center; white-space: nowrap;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center; white-space: nowrap;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center; white-space: nowrap;"><b>&#160;2019&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center; white-space: nowrap;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center; white-space: nowrap;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center; white-space: nowrap;"><b>&#160;$&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center; white-space: nowrap;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center; white-space: nowrap;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: center; white-space: nowrap;"><b>&#160;%&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;" colspan="2"><b>&#160;ASSETS&#160;</b></td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;" colspan="2"><b>&#160;Current&#160;</b></td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff; width: 5%;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;Cash&#160;&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;"><b>17,524,822</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">5,967,798</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">15,899,808</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">11,557,024</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">194%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 5%;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;Other receivables&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;"><b>161,342</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">1,557,302</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">745,520</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">(1,395,960</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">-90%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff; width: 5%;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;Prepaid expenses and deposits&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;"><b>569,401</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">323,776</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">334,096</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">245,625</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">76%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 5%;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;Inventories&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;"><b>&#8212;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;">709,373</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;">&#8212;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;">(709,373</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;">-100%</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff; width: 5%;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;"><b>18,255,565</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">8,558,249</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">16,979,424</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">9,697,316</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">113%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;" colspan="2"><b>&#160;Assets held for sale&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;"><b>8,610,504</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;">&#8212;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;">&#8212;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;">8,610,504</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;">100%</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background-color: #e6efff; width: 5%;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;"><b>26,866,069</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">8,558,249</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">16,979,424</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">18,307,820</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">214%</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 5%;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;" colspan="2"><b>&#160;Non-current&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 5%;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;Investments&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff; width: 5%;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;Right-of-use asset, net&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;"><b>1,676,745</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">8,862,744</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">13,589,954</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">(7,185,999</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">-81%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 5%;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;Property, plant and equipment, net&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;"><b>&#8212;</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">95,851</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">183,424</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">(95,851</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">-100%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff; width: 5%;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;Intangible assets, net&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;"><b>&#8212;</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">8,880,258</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">9,134,183</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">(8,880,258</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">-100%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 5%;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;"><b>13,424,391</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;">16,820,625</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;">&#8212;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;">(3,396,234</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;">-20%</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background-color: #e6efff; width: 5%;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;"><b>15,101,136</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">34,659,478</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">22,907,561</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">(19,558,342</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">-56%</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 5%;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background-color: #e6efff;" colspan="2"><b>&#160;Total assets&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;"><b>41,967,205</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">43,217,727</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">39,886,985</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">(1,250,522</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">-3%</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 5%;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;" colspan="2"><b>&#160;LIABILITIES&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 5%;" colspan="2"><b>&#160;Current&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff; width: 5%;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;Trade and other payables&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;"><b>3,700,103</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">3,361,145</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">1,311,865</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">338,958</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">10%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 5%;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;Lease obligations&#160;&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;"><b>46,842</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">42,285</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">40,875</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">4,557</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">11%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff; width: 5%;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;Derivative liability&#160;&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;"><b>&#8212;</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">1,990,788</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">(1,990,788</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">-100%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 5%;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;Warrants liability&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;"><b>1,447,910</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">1,447,910</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">100%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background-color: #e6efff; width: 5%;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background-color: #e6efff;">&#160;Notes payable&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;"><b>384,647</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">1,435,698</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">(1,051,051</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">-73%</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 5%;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;"><b>5,579,502</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">6,829,916</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">1,352,740</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">(1,250,414</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">-18%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff; width: 5%;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;" colspan="2"><b>&#160;Non-current&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background-color: #e6efff; width: 5%;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background-color: #e6efff;">&#160;Lease obligations&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;"><b>79,120</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">110,334</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">142,549</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">(31,214</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">-28%</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;" colspan="2"><b>&#160;Total liabilities&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;"><b>5,658,622</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;">6,940,250</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;">1,495,289</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;">(1,281,628</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;">-18%</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff; width: 5%;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;" colspan="2"><b>&#160;SHAREHOLDERS' EQUITY&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff; width: 5%;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;Class A share capital&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;"><b>151,588</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">151,588</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">151,588</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">0%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 5%;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;Class B share capital&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;"><b>103,056,538</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">73,586,337</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">51,093,434</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">29,470,201</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">40%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff; width: 5%;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;Warrant reserve&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;"><b>4,968,958</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">4,321,989</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">3,341,826</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">646,969</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">15%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; width: 5%;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;Contributed surplus&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;"><b>18,792,590</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">17,371,434</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">3,744,423</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">1,421,156</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right;">8%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff; width: 5%;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;Foreign exchange translation reserve&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;"><b>207,797</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">(84,776</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">&#8212;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">292,573</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">-345%</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 5%;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;Accumulated deficit&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;"><b>(90,868,888</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;"><b>)</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;">(59,069,095</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;">(19,939,575</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;">(31,799,793</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;">54%</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background-color: #e6efff;" colspan="2"><b>&#160;Total shareholders' equity&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;"><b>36,308,583</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">36,277,477</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">38,391,696</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">31,106</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right; background-color: #e6efff;">0%</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;" colspan="2"><b>&#160;Total liabilities and shareholders' equity&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;"><b>41,967,205</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;">43,217,727</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;">39,886,985</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;">(1,250,522</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 8%; text-align: right;">-3%</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;"><font style="font-size: 10pt;"><b>Assets</b></font><b></b></p>
    <p style="text-align: justify;"><i>Current assets</i></p>
    <p style="text-align: justify;">Current assets increased by $18,307,820 or 214%, primarily due to increase in cash of $11,557,024 and assets held for sale of $8,610,504.&#160;</p>
    <p style="text-align: justify;">Cash increased by $11,557,024 or 194% primarily due to cash proceeds from financing activities and cash proceeds from sale of investments offset by cash used in operations.</p>
    <p style="margin-bottom: 0pt; text-align: justify;">Other receivables decreased by $1,395,960 or 90% primarily due to sales taxes receivable collected during the year.&#160;</p>
    <p style="margin-top: 0pt; text-align: justify;">Prepaid expenses and deposits increased by $245,625 or 76% due to additional prepaid purchases, primarily related to insurance policies associated with the Company's research and development activities.</p>
    <div id="footer_page_18">
        <p style="text-align: right;">18</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_19"></a>
    <p style="text-align: justify;"><i>Non-current assets</i></p>
    <p style="text-align: justify;">Investments decreased by $7,185,999 or 81%, due to the sale of the investment in Cannara Biotech Inc. for proceeds of $5,825,429, the sale of Pharmadrug Inc. shares for proceeds of $652,081, a loss due to change in fair value of $770,874 and a foreign exchange gain of $62,385 related to investments denominated in Canadian dollars at December 31, 2020.</p>
    <p style="text-align: justify;">Property, plant and equipment decreased by $8,880,258 or 100%, due to the disposal of equipment and classification to assets held for sale.</p>
    <p style="text-align: justify;">Intangible assets decreased by $3,396,234 or 20% primarily due to amortization expense incurred for the year ended December&#160;31, 2020.&#160;</p>
    <p style="text-align: justify;"><b>Assets Held for Sale</b></p>
    <p style="text-align: justify;">Assets held for sale consists of the Cobourg facility. It is anticipated that no liabilities of the Company will be transferred as part of any proposed transaction. Assets held for sale as at December 31, 2020 consisted of the following:</p>
    <table style="width: 70%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right;"><b>$</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background-color: #e6efff;">Property and plant</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>8,610,504</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;"><b>Liabilities</b></p>
    <p style="text-align: justify;"><i>Current liabilities</i></p>
    <p style="text-align: justify;">Trade and other payables increased by $338,958 or 10%, primarily due to the timing of invoice payments.</p>
    <p style="text-align: justify;">Derivative liability decreased to $nil, as the Company issued 225,371 shares on February 4, 2020 to Solarvest as settlement of the derivative liability. The fair value of the shares issued was $1,356,373 resulting in recognition of a gain of $634,415 on settlement of the derivative liability.</p>
    <p style="text-align: justify;">Warrants liability increased by $1,447,910, due to warrants issued as part of financing in August 2020. The Company determined that these warrants did not meet the IFRS definition of equity due to the exercise price being denominated in United States dollars which is not the functional currency of the Company resulting in variability in exercise price. Accordingly, these warrants are treated as a derivative financial liability measured at fair value through profit or loss. As at the date of issuance the fair value of the warrants was determined to be $3,289,069 using the Black-Scholes option pricing model and the following assumptions: exercise price of $4.26, the underlying share price of $3.01 on date of issuance, risk free interest rate of 0.32% and annualized volatility of 121%. The derivative liability was remeasured at fair value of $1,447,910 on December 31, 2020.</p>
    <p style="text-align: justify;">The Company recognized notes payable from the acquisition of Prismic on June 29, 2019, made up of convertible notes and short-term notes. The notes and short-term notes are due to former board members of Prismic. The notes carry an annual interest rate of 20% and the short-term notes carry an annual interest rate of 10%.&#160; During the year ended December 31, 2020, the Company settled notes payable in the amount of $1,084,719, accrued interest of $795,367, and $438,599 of other Prismic related liabilities with 63,714 Class B Common Shares with a fair value of $185,976 and cash of $1,484,369. A gain of $680,164 was recognized on settlement as the value of the consideration was less than the carrying value of the notes payable, accrued interest and other related Prismic liabilities.</p>
    <p style="text-align: justify;"><i>Non-current liabilities</i></p>
    <p style="text-align: justify;">Non-current portion of lease liability represents the Company's obligations under an office lease. The lease matures on December 31, 2023.</p>
    <p style="text-align: justify;"><b>Shareholders' equity</b></p>
    <p style="text-align: justify;">Shareholder's equity increased by $31,106 due to net loss of $31,799,793 for the year ended December 31, 2020 offset by $31,538,326 related to the issuance of shares and share-based payments and a gain of $292,573 related to the translation of foreign operations.</p>
    <p style="text-align: justify;"><b>LIQUIDITY, CAPITAL RESOURCES AND FINANCING</b></p>
    <p style="text-align: justify;">The general objectives of our capital management strategy are to preserve our capacity to continue operating, provide benefits to our stakeholders and provide an adequate return on investment to our shareholders by continuing to invest in our future that is commensurate with the level of operating risk we assume. We determine the total amount of capital required consistent with risk levels. This capital structure is adjusted on a timely basis depending on changes in the economic environment and risks of the underlying assets. We are not subject to any externally imposed capital requirements.</p>
    <div id="footer_page_19">
        <p style="text-align: right;">19</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_20"></a>
    <p style="text-align: justify;">The financial statements and this MD&amp;A have been prepared on the basis of accounting principles applicable to a going concern, which assumes that the Company will continue in operation for the foreseeable future and will be able to realize its assets and discharge its liabilities in the normal course of operations.</p>
    <p style="text-align: justify;">The Company is in the preliminary stages of its planned operations and has not yet determined whether its processes and business plans are economically viable. The continuing operations of the Company are dependent upon the ability of the Company to complete the pharmaceutical research and development program centered on the lead asset, micro-PEA. The discontinued operations of the Company are in the process of being sold to fund the continuing operations.</p>
    <p style="text-align: justify;">As at December 31, 2020 the Company had cash of $17,524,822 representing an increase of $11,557,024 from December 31, 2019. This increase is primarily due to $6,514,126 of cash provided by investing activities and $24,173,371 of cash provided by financing activities, offset by $19,130,473 of cash used in operating activities.</p>
    <p style="text-align: justify;"><i><b>Cash flows</b></i></p>
    <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="vertical-align: bottom; text-align: center; white-space: nowrap;" colspan="4"><b>For the year ended December 31,</b></td>
            <td style="vertical-align: bottom;" colspan="1">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;"><b>2020</b></td>
            <td style="vertical-align: bottom; text-align: right;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: right;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; text-align: right;">2019</td>
            <td style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right;"><b>$&#160;&#160;&#160;&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right;">$&#160;&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Net cash provided by (used in):</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160; &#160;Cash used in continuing operating activities</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>(18,392,814</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><b>)</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">(7,130,727</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160; &#160;Cash used in discontinued operating activities</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>(737,659</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>)</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">(6,581,998</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160; &#160;Cash used in operating activities</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;"><b>(19,130,473</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;"><b>)</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">(13,712,725</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160; &#160;Cash provided by continuing investing activities</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;"><b>6,477,510</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right;">170,929</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160; &#160;Cash provided by (used in) discontinued investing activities</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>36,616</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">(401,817</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160; &#160;Cash provided by (used in) investing activities</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;"><b>6,514,126</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">(230,888</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">&#160; &#160;Cash provided by continuing financing activities</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;"><b>24,173,371</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">4,011,603</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom;">Net increase (decrease) in cash during the period</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;"><b>11,557,024</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">(9,932,010</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">)</td>
        </tr>
    </table>
    <p style="text-align: justify;"><i>Cash Flows Used in Operating Activities</i></p>
    <p style="text-align: justify;">Cash flows used in continuing operating activities for the year ended December 31, 2020 were $18,392,814 compared to cash flows used in continuing operating activities of $7,130,727 for the year ended December 31, 2019. The increase in cash used for continuing operations is primarily related to increased activity for BioSciences operations and research and development activities. Cash flows used in discontinued operating activities for the year ended December 31, 2020 were $737,659 compared to cash flows used in discontinued operating activities of $6,581,998 for the year ended December 31, 2019.</p>
    <p style="text-align: justify;"><i>Cash Flows Provided by (Used in) Investing Activities</i></p>
    <p style="text-align: justify;">Cash flows provided by continuing investing activities for the year ended December 31, 2020 were $6,477,510 compared to cash flows of $170,929 provided by continuing investing activities for the year ended December 31, 2019. The change is due to proceeds from sale of investments of $6,477,510 for the year ended December 31, 2020. Cash flows provided by discontinued investing activities was $36,616 for the year ended December 31, 2020 compared to cash flows used in discontinued investing activities of $401,817 for the year ended December 31, 2019. The difference is due to proceeds of $36,616 from the sale of equipment for the year ended December 31, 2020, compared to the purchase of equipment of $401,817 for the year ended December 31, 2019.</p>
    <p style="text-align: justify;"><i>Cash Flows Provided by Financing Activities</i></p>
    <p style="text-align: justify;">Cash flows provided by financing activities for the year ended December 31, 2020 were $24,173,371 compared to cash flows of $4,011,603 provided by financing activities for the year ended December 31, 2019. The increase is primarily due to proceeds of $25,100,459 from the issuance of shares and proceeds from exercise of stock options of $59,548 offset by repayment of notes payable of $946,643 during the year ended December 31, 2020 compared to proceeds of $3,431,294 from the issuance of shares and $622,594 from the exercise of stock options and warrants during the year ended December 31, 2019.&#160;</p>
    <div id="footer_page_20">
        <p style="text-align: right;">20</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_21"></a>
    <p style="text-align: justify;"><b>CONTRACTUAL OBLIGATIONS</b></p>
    <p style="text-align: justify;">We have no significant contractual arrangements other than those noted in our financial statements.</p>
    <p style="text-align: justify;"><b>OFF-BALANCE SHEET ARRANGEMENTS</b></p>
    <p style="text-align: justify;">We have no off-balance sheet arrangements other than those noted in our financial statements.</p>
    <p style="text-align: justify;"><b>TRANSACTIONS WITH RELATED PARTIES</b></p>
    <p style="text-align: justify;">Key management personnel are those persons having the authority and responsibility for planning, directing and controlling activities of the entity, directly or indirectly.</p>
    <p style="text-align: justify;">Transactions with to key management and directors comprised the following:</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify;">&#9679;<font style="width: 11.06pt; text-indent: 0pt; display: inline-block;">&#160;</font>The Company paid expenses of $1,445,043 (2019 - $567,468) to a company owned by the CEO for the year ended December 31, 2020, included in the consolidated statement of loss and comprehensive loss under various expense line categories. As at December 31, 2020, the CEO has repaid a related party loan of $355,778 for withholding taxes paid by the Company on behalf of the CEO in relation to the Class B common shares issue during the year ended December 31, 2020.</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify;">&#9679;<font style="width: 11.06pt; text-indent: 0pt; display: inline-block;">&#160;</font>As at December 31, 2020, the President of FSD BioSciences Division has repaid a related party loan of $21,876 for withholding taxes paid by the Company on behalf of the President of FSD BioSciences Division in relation to the Class B common shares issued during the year ended December 31, 2020.</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify;">&#9679;<font style="width: 10.56pt; text-indent: 0pt; display: inline-block;">&#160;</font>The Company pays independent directors C$40,000 per annum, with the Chairman of each respective committee receiving an additional C$10,000 per annum. Directors compensation for the year ended December 31, 2020 was $246,226 (2019 - $153,109) which included $238,703 recognized as share-based compensation. As of December 31, 2020, directors have received their compensation for the 2020 fiscal year in advance, through the issuance of Class B shares.&#160;</p>
    <p style="margin-left: 36pt; text-indent: -18pt; text-align: justify;">&#9679;<font style="width: 12.56pt; text-indent: 0pt; display: inline-block;">&#160;</font>The Company issued 1,676,066 shares to key management and directors in the form of a compensation bonus for past services provided during the year ended December 31, 2020. The fair value of shares issued to key management and directors is $4,602,301 and is included in share-based payments and bonuses below.&#160;</p>
    <div style="margin-left: 38pt;">
        <table style="width: 80%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; vertical-align: bottom;"><b>Related Party&#160;</b></td>
                <td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
                <td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right; white-space: nowrap;"><b>&#160;Number of Securities&#160;&#160;</b></td>
                <td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right; white-space: nowrap;"><b>&#160;</b></td>
                <td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right; white-space: nowrap;"><b>&#160;</b></td>
                <td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right; white-space: nowrap;"><b>Total Amount</b></td>
                <td style="border-top: 1px solid #000000; border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; background-color: #e6efff;">Dr. Raza Bokhari</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">805,802</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">$</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">2,212,649</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;">Anthony Durkacz</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;">161,160</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">$</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;">442,528</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; background-color: #e6efff;">Zeeshan Saeed</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">161,160</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">$</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">442,528</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;">Donal Carroll</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;">80,580</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">$</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;">221,264</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; background-color: #e6efff;">Dr. Edward Brennan</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">80,580</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">$</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">221,264</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;">Robert Ciaruffoli</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;">80,580</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">$</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;">221,264</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; background-color: #e6efff;">David Urban</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">80,580</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">$</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">221,264</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;">Steve Buyer</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;">80,580</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">$</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;">221,264</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom; background-color: #e6efff;">Larry Kaiser</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">80,580</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">$</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">221,264</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="vertical-align: bottom;">Gerry Goldberg</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;">32,232</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
                <td style="vertical-align: bottom; width: 1%; text-align: left;">$</td>
                <td style="vertical-align: bottom; width: 12%; text-align: right;">88,506</td>
                <td style="vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            </tr>
            <tr>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; background-color: #e6efff;">Jim Datin</td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">32,232</td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">$</td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">88,506</td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            </tr>
            <tr>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;"><b>1,676,066</b></td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;"><b>&#160;</b></td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;"><b>$</b></td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;"><b>4,602,301</b></td>
                <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            </tr>
        </table>
    </div>
    <p style="text-align: justify;">Key management personnel compensation during the year ended December 31, 2020 and 2019 is comprised of:</p>
    <table style="font-size: 10pt; border-collapse: collapse; width: 100%; border-color: #000000;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;"><b>2020</b></td>
            <td style="vertical-align: bottom; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;">&#160;</td>
            <td style="vertical-align: bottom; text-align: right;">2019</td>
            <td style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right;"><b>$</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; text-align: right;">$</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="vertical-align: bottom; background-color: #e6efff;">Salaries, benefits, bonuses and consulting fees</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>2,936,816</b></td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">3,638,267</td>
            <td style="vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom;">Share-based payments</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;"><b>7,045,994</b></td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 1%; text-align: left;">&#160;</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 12%; text-align: right;">9,385,984</td>
            <td style="border-bottom: 1px solid #000000; vertical-align: bottom; width: 2%; text-align: left;">&#160;</td>
        </tr>
        <tr>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; background-color: #e6efff;"><b>Total</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;"><b>9,982,810</b></td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 1%; text-align: left; background-color: #e6efff;">&#160;</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 12%; text-align: right; background-color: #e6efff;">13,024,251</td>
            <td style="border-bottom: 2px solid #000000; vertical-align: bottom; width: 2%; text-align: left; background-color: #e6efff;">&#160;</td>
        </tr>
    </table>
    <p>&#160;</p>
    <div id="footer_page_21">
        <p style="text-align: right;">21</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_22"></a>
    <p style="text-align: justify;"><b>FINANCIAL INSTRUMENTS AND OTHER INSTRUMENTS</b></p>
    <p style="text-align: justify;"><i>Credit risk</i></p>
    <p style="text-align: justify;">Credit risk is the risk of financial loss to the Company if a customer or counterparty to a financial instrument fails to meet its contractual obligations, and arises principally from deposits with banks and outstanding receivables. The Company trades only with recognized, creditworthy third parties. The Company does not currently have any material outstanding trade receivables with customers.</p>
    <p style="text-align: justify;">The Company does not hold any collateral as security but mitigates this risk by dealing only with what management believes to be financially sound counterparties and, accordingly, does not anticipate significant loss for non-performance.</p>
    <p style="text-align: justify;"><i>Liquidity risk</i></p>
    <p style="text-align: justify;">Liquidity risk is the risk the Company will not be able to meet its financial obligations as they come due. The Company's exposure to liquidity risk is dependent on the Company's ability to raise additional financing to meet its commitments and sustain operations. The Company mitigates liquidity risk by management of working capital, cash flows, the issuance of share capital and if desired, the issuance of debt. The Company's trade and other payables and notes payables are all due within twelve months from the date of these financial statements.</p>
    <p style="text-align: justify;">If unanticipated events occur that impact the Company's ability to carrying the planned clinical trials, the Company may need to take additional measures to increase its liquidity and capital resources, including issuing debt or additional equity financing or strategically altering the business forecast and plan. In this case, there is no guarantee that the Company will obtain satisfactory financing terms or adequate financing. Failure to obtain adequate financing on satisfactory terms could have a material adverse effect on the Company's results of operations or financial condition.</p>
    <p style="text-align: justify;"><i>Market risk</i></p>
    <p style="text-align: justify;">Market risk is the risk the fair value or future cash flows of a financial instrument will fluctuate because of changes in market prices. Market risk comprises three types of risk: foreign currency risk, interest rate risk and other price risk.</p>
    <p style="text-align: justify;">&#8226;<font style="width: 32.85pt; display: inline-block;">&#160;</font>Foreign currency risk</p>
    <p style="text-align: justify;">Foreign currency risk arises on financial instruments that are denominated in a currency other than the functional currency in which they are measured. The Company's primary exposure with respect to foreign currencies is from Canadian dollar denominated cash and trade and other payables. A 1% change in the foreign exchange rates would not result in any significant impact to the financial statements.</p>
    <p style="text-align: justify;">&#8226;<font style="width: 32.85pt; display: inline-block;">&#160;</font>Interest rate risk</p>
    <p style="text-align: justify;">Interest rate risk is the risk the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company is not exposed to interest rate risk as at December 31, 2020 as there are no material long-term borrowings outstanding.</p>
    <p style="text-align: justify;">&#8226;<font style="width: 32.85pt; display: inline-block;">&#160;</font>Other price risk</p>
    <p style="text-align: justify;">Other price risk is the risk the fair value or future cash flows of a financial instrument will fluctuate because of changes in market prices (other than those arising from interest rate risk or currency risk), whether those changes are caused by factors specific to the individual financial instrument or its issuer, or factors affecting all similar financial instruments traded in the market. The Company is not exposed to other price risk as at December 31, 2020.</p>
    <p style="text-align: justify;"><i>Fair values</i></p>
    <p style="text-align: justify;">The carrying values of cash, other receivables, trade and other payables and notes payable approximate fair values due to the short-term nature of these items or they are being carried at fair value or, for notes payable, interest payables are close to the current market rates. The risk of material change in fair value is not considered to be significant. The Company does not use derivative financial instruments to manage this risk.</p>
    <p style="text-align: justify;">Financial instruments recorded at fair value on the consolidated statement of financial position are classified using a fair value hierarchy that reflects the significance of the inputs used in making the measurements. The Company categorizes its fair value measurements according to a three-level hierarchy. The hierarchy prioritizes the inputs used by the Company's valuation techniques. A level is assigned to each fair value measurement based on the lowest-level input significant to the fair value measurement in its entirety. The three levels of the fair value hierarchy are defined as follows:</p>
    <div id="footer_page_22">
        <p style="text-align: right;">22</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_23"></a>
    <p style="text-align: justify;">&#8226;<font style="width: 32.85pt; display: inline-block;">&#160;</font>Level 1 - Unadjusted quoted prices as at the measurement date for identical assets or liabilities in active markets.</p>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;">&#8226;<font style="width: 32.85pt; text-indent: 0pt; display: inline-block;">&#160;</font>Level 2 - Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.</p>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;">&#8226;<font style="width: 32.85pt; text-indent: 0pt; display: inline-block;">&#160;</font>Level 3 - Significant unobservable inputs that are supported by little or no market activity. The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.</p>
    <p style="text-align: justify;">The fair value hierarchy requires the use of observable market inputs whenever such inputs exist. A financial instrument is classified to the lowest level of the hierarchy for which a significant input has been considered in measuring fair value.</p>
    <p style="text-align: justify;">Private company investments measured at fair value are classified as Level 3 financial instruments. The valuation method and significant assumptions used to determine the fair value of private company investments have been disclosed in the Investments note. During the year, there were no transfers of amounts between levels.</p>
    <p style="text-align: justify;"><b>CRITICAL ACCOUNTING POLICIES AND ESTIMATES</b></p>
    <p style="text-align: justify;">Refer to note 2 and note 3 of the audited consolidated financial statements for a full discussion of our critical accounting policies and estimates.</p>
    <p style="text-align: justify;"><b>OUTSTANDING SHARE DATA</b></p>
    <p style="text-align: justify;">The Company is authorized to issue an unlimited number of Class A multiple voting shares ("Class A shares") and an unlimited number of Class B subordinate voting shares ("Class B shares"), all without par value. All shares are ranked equally with regards to the Company's residual assets.</p>
    <p style="text-align: justify;">The holders of Class A shares are entitled to 276,660 votes per Class A share held. Class A shares are held by certain Directors of the Company.&#160;</p>
    <p style="text-align: justify;">On October 16, 2019, the Company completed a reverse share split of 201 to 1 Class B Shares. All share and per share amounts for all periods presented in the financial statements and this MD&amp;A have been adjusted retrospectively to reflect the reverse share split.</p>
    <p style="text-align: justify;">The Company's outstanding capital was as follows as at the date of this MD&amp;A:</p>
    <table style="width: 50%; border-collapse: collapse; font-size: 10pt; border-color: #000000;" border="1" cellspacing="0" cellpadding="3">
        <tr>
            <td style="width: 57%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: justify;">Class A shares</p>
            </td>
            <td style="width: 42%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; text-align: right;">
                <p style="text-align: right;">72</p>
            </td>
        </tr>
        <tr>
            <td style="width: 57%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: justify;">Class B shares</p>
            </td>
            <td style="width: 42%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt; text-align: right;">
                <p style="text-align: right;">35,114,998</p>
            </td>
        </tr>
        <tr>
            <td style="width: 57%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt;">
                <p style="text-align: justify;">Share options</p>
            </td>
            <td style="width: 42%; vertical-align: top; padding-right: 5.03pt; padding-left: 5.03pt; text-align: right;">
                <p style="text-align: right;">1,628,013</p>
            </td>
        </tr>
        <tr>
            <td style="width: 57%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top;">
                <p style="text-align: justify;">Warrants</p>
            </td>
            <td style="width: 42%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: top; text-align: right;">
                <p style="text-align: right;">6,749,109</p>
            </td>
        </tr>
    </table>
    <p style="text-align: justify;"><b>SUBSEQUENT EVENTS</b></p>
    <p style="text-align: justify;">On January 21, 2021, the Company approved the grant of 75,000 share options to certain board members.</p>
    <p style="text-align: justify;">January 22, 2021, the Corporation announced that it will hold its annual meeting of shareholders on June 29, 2021, at which, in addition to normal course matters, it will address matters contained in a requisition for a special meeting submitted to the Corporation by certain shareholders of the Corporation claiming to hold in excess of 5.1% of the Corporation's class B subordinated voting shares, including two directors of the Corporation. These shareholders are seeking to reduce the size of the Corporation's board of directors to five, and to replace six of the incumbent directors with three directors selected by such shareholders.</p>
    <p style="text-align: justify;">The annual meeting date of June 29, 2021 was contested by certain shareholders and, pursuant to a decision by the Superior Court of Justice, province of Ontario, issued on March 5, 2021, the annual meeting of shareholders and special meeting of the shareholders has been set for May 14, 2021. Furthermore, the annual meeting of shareholders shall be conducted by an independent chair and Class B Common Shares issued on February 17, 2021, to certain directors and officers of the Company will not be allowed to vote at the meeting.</p>
    <p style="text-align: justify;">From February 1, 2021 to February 10, 2021, the Company issued 7,356,326 Class B Common Shares through the Equity Distribution Agreement with A.G.P/Alliance Global Partners for gross proceeds of $19,770,762.</p>
    <p style="text-align: justify;">On February 11, 2021, the Company entered into an Equity Distribution Agreement (the &#8220;Equity Distribution Agreement&#8221;) with A.G.P./Alliance Global Partners. Under the Sales Agreement the Company may, at its discretion and from time-to-time during the term of the Sales Agreement, sell, through the Sales Agent, Class B Subordinate Voting Shares of the Company, with an aggregate offering price of up to $20,000,000.</p>
    <p style="text-align: justify;">From February 11, 2021 to March 12, 2021, the Company issued 7,247,288 Class B Common Shares through the Equity Distribution Agreement with A.G.P/Alliance Global Partners for gross proceeds of $18,167,511.</p>
    <p style="text-align: justify;">On February 17, 2021, the Company issued 1,349,764 Class B Common Shares to certain directors and officers of the Company. The fair value of the shares based on the February 17, 2021 closing share price of $2.65 per Class B Common Share was $3,576,875.</p>

    <p style="text-align: justify;">Effective March 1, 2021, Randell Mack was appointed as President of FSD Biosciences and Dr. Ed Brennan was name Chief Medical Officer of the Company.</p>
    <p style="text-align: justify;">In March 2021, the Corporation entered into a license agreement ("Innovet License Agreement") with Innovet Italia S.R.L. ("Innovet"), under which Innovet granted the Company a license to use ultra-micro PEA to develop FDA approved veterinary drugs for the treatment of gastro-intestinal diseases in canines and felines. Under the Innovet License Agreement, the Corporation is required to make payments to Innovet upon the achievement of certain milestones.</p>

    <div id="footer_page_23">
        <p style="text-align: right;">23</p>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_24"></a>
    <p style="text-align: justify;">&#160;</p>
    <p style="text-align: justify;"><b>DISCLOSURE CONTROLS AND PROCEDURES AND INTERNAL CONTROLS OVER FINANCIAL REPORTING </b></p>
    <p style="text-align: justify;">The Chief Executive Officer and Chief Financial Officer have designed or caused to be designed under their supervision, disclosure controls and procedures which provide reasonable assurance that material information regarding the Company is accumulated and communicated to the Company's management, including its Chief Executive Officer and Chief Financial Officer, in a timely manner.</p>
    <p style="text-align: justify;">In addition, the Chief Executive Officer and Chief Financial Officer have designed or caused it to be designed under their supervision internal controls over financial reporting ("ICFR") to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements. The Chief Executive Officer and Chief Financial Officer have been advised that the control framework the Chief Executive Officer and the Chief Financial Officer used to design the Company's ICFR uses the framework and criteria established in the Internal Control - Integrated Framework (2013), issued by the Committee of Sponsoring Organizations of the Treadway Commission.</p>
    <p style="text-align: justify;">The Chief Executive Officer and the Chief Financial Officer have evaluated, or caused to be evaluated under their supervision, whether or not there were changes to its ICFR during the year ended December 31, 2020 that have materially affected or are reasonably likely to materially affect the Company's ICFR. No such changes were identified through their evaluation.</p>
    <p style="text-align: justify;">A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that its objectives are met. Due to inherent limitations in all such systems, no evaluations of controls can provide absolute assurance that all control issues, if any, within a company have been detected. Accordingly, our disclosure controls and procedures and our internal controls over financial reporting are effective in providing reasonable, not absolute, assurance that the objectives of our control systems have been met.</p>
    <div><br></div>
    <div id="footer_page_24">
        <p style="text-align: right;">24</p>
    </div>
    <hr width="100%" size="5" color="black" noshade="noshade">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.4
<SEQUENCE>5
<FILENAME>exhibit99-4.htm
<DESCRIPTION>EXHIBIT 99.4
<TEXT>
<html>

<head>
    <title>FSD Pharma Inc.: Exhibit 99.4 - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt;">
    <hr style="text-align: center;" width="100%" size="3" color="black" noshade="noshade"><a name="page_1"></a>
    <p style="text-align: right;"><b><font style="font-size: 13.3333px; text-align: start;">EXHIBIT 99.4</font></b></p>
    <p style="margin-bottom: 0pt; text-align: center;"><b>CERTIFICATION</b></p>
    <p style="margin-top: 0pt; text-align: center;"><b>PURSUANT TO RULE 13A-14 OR 15D-14 OF THE SECURITIES EXCHANGE ACT OF 1934</b></p>
    <p style="text-align: justify;">I, Raza Bokhari, certify that:</p>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;">1.<font style="width: 27.75pt; text-indent: 0pt; display: inline-block;">&#160;</font>I have reviewed this annual report on Form 40-F of FSD Pharma Inc.;</p>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;">2.<font style="width: 27.75pt; text-indent: 0pt; display: inline-block;">&#160;</font>Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</p>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;">3.<font style="width: 27.75pt; text-indent: 0pt; display: inline-block;">&#160;</font>Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;</p>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;">4.<font style="width: 27.75pt; text-indent: 0pt; display: inline-block;">&#160;</font>The company's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">a)<font style="width: 27.45pt; text-indent: 0pt; display: inline-block;">&#160;</font>Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">b)<font style="width: 26.84pt; text-indent: 0pt; display: inline-block;">&#160;</font>Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">c)<font style="width: 27.45pt; text-indent: 0pt; display: inline-block;">&#160;</font>Evaluated the effectiveness of the company's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">d)<font style="width: 26.84pt; text-indent: 0pt; display: inline-block;">&#160;</font>Disclosed in this report any change in the company's internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company's internal control over financial reporting; and</p>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;">5.<font style="width: 27.75pt; text-indent: 0pt; display: inline-block;">&#160;</font>The company's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company's auditors and the audit committee of the company's board of directors (or persons performing the equivalent functions):</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">a)<font style="width: 27.45pt; text-indent: 0pt; display: inline-block;">&#160;</font>All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company's ability to record, process, summarize and report financial information; and</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">b)<font style="width: 26.84pt; text-indent: 0pt; display: inline-block;">&#160;</font>Any fraud, whether or not material, that involves management or other employees who have a significant role in the company's internal control over financial reporting.</p>
    <br>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: bottom;">
                <p>By:</p>
            </td>
            <td style="width: 45%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: bottom; border-bottom: 0.75pt solid #000000;">
                <p>/s/ Raza Bokhari</p>
            </td>
            <td style="width: 33%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top;">
                <p>&#160;</p>
            </td>
            <td style="width: 45%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: bottom; border-top: 0.75pt solid #000000;">
                <p>Name: Raza Bokhari <br>Title: Executive Chairman and Chief Executive Officer</p>
            </td>
            <td style="width: 33%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top;">
                <p>&#160;</p>
            </td>
            <td style="width: 45%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: bottom;">
                <p>Date: March 16, 2021</p>
            </td>
            <td style="width: 33%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: bottom;">&#160;</td>
        </tr>
    </table>
    <br>
    <hr style="text-align: center;" width="100%" size="5" color="black">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.5
<SEQUENCE>6
<FILENAME>exhibit99-5.htm
<DESCRIPTION>EXHIBIT 99.5
<TEXT>
<html>

<head>
    <title>FSD Pharma Inc.: Exhibit 99.5 - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt;">
    <hr style="text-align: center;" width="100%" size="3" color="black" noshade="noshade"><a name="page_1"></a>
    <p style="text-align: right;"><b><font style="font-size: 13.3333px; text-align: start;">EXHIBIT 99.5</font></b></p>
    <p style="margin-bottom: 0pt; text-align: center;"><b>CERTIFICATION</b></p>
    <p style="margin-top: 0pt; text-align: center;"><b>PURSUANT TO RULE 13A-14 OR 15D-14 OF THE SECURITIES EXCHANGE ACT OF 1934</b></p>
    <p style="text-align: justify;">I, Donal Carroll, certify that:</p>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;">1.<font style="width: 27.75pt; text-indent: 0pt; display: inline-block;">&#160;</font>I have reviewed this annual report on Form 40-F of FSD Pharma Inc.;</p>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;">2.<font style="width: 27.75pt; text-indent: 0pt; display: inline-block;">&#160;</font>Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</p>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;">3.<font style="width: 27.75pt; text-indent: 0pt; display: inline-block;">&#160;</font>Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;</p>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;">4.<font style="width: 27.75pt; text-indent: 0pt; display: inline-block;">&#160;</font>The company's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">a)<font style="width: 27.45pt; text-indent: 0pt; display: inline-block;">&#160;</font>Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">b)<font style="width: 26.84pt; text-indent: 0pt; display: inline-block;">&#160;</font>Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">c)<font style="width: 27.45pt; text-indent: 0pt; display: inline-block;">&#160;</font>Evaluated the effectiveness of the company's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">d)<font style="width: 26.84pt; text-indent: 0pt; display: inline-block;">&#160;</font>Disclosed in this report any change in the company's internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company's internal control over financial reporting; and</p>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;">5.<font style="width: 27.75pt; text-indent: 0pt; display: inline-block;">&#160;</font>The company's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company's auditors and the audit committee of the company's board of directors (or persons performing the equivalent functions):</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">a)<font style="width: 27.45pt; text-indent: 0pt; display: inline-block;">&#160;</font>All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company's ability to record, process, summarize and report financial information; and</p>
    <p style="margin-left: 72pt; text-indent: -36pt; text-align: justify;">b)<font style="width: 26.84pt; text-indent: 0pt; display: inline-block;">&#160;</font>Any fraud, whether or not material, that involves management or other employees who have a significant role in the company's internal control over financial reporting.</p>
    <br>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: bottom;">
                <p>By:</p>
            </td>
            <td style="width: 45%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: bottom; border-bottom: 0.75pt solid #000000;">
                <p>/s/ Donal Carroll</p>
            </td>
            <td style="width: 33%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top;">
                <p>&#160;</p>
            </td>
            <td style="width: 45%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: bottom; border-top: 0.75pt solid #000000;">
                <p>Name: Donal Carroll<br>Title: Chief Financial Officer</p>
            </td>
            <td style="width: 33%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top;">
                <p>&#160;</p>
            </td>
            <td style="width: 45%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: bottom;">
                <p>Date: March 16, 2021</p>
            </td>
            <td style="width: 33%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: bottom;">&#160;</td>
        </tr>
    </table>

    <p>&#160;</p>
    <hr style="text-align: center;" width="100%" size="5" color="black">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.6
<SEQUENCE>7
<FILENAME>exhibit99-6.htm
<DESCRIPTION>EXHIBIT 99.6
<TEXT>
<html>

<head>
    <title>FSD Pharma Inc.: Exhibit 99.6 - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt;">
    <hr style="text-align: center;" width="100%" size="3" color="black" noshade="noshade"><a name="page_1"></a>
    <p style="text-align: right;"><b><font style="font-size: 13.3333px; text-align: start;">EXHIBIT 99.6</font></b></p>
    <p style="margin-bottom: 0pt; text-align: center;"><b>CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,</b></p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>AS ENACTED PURSUANT TO</b></p>
    <p style="margin-top: 0pt; text-align: center;"><b>SECTION 906 OF THE U.S. SARBANES-OXLEY ACT OF 2002</b></p>
    <p style="text-indent: 36pt; text-align: justify;">FSD Pharma Inc. (the "Company") is filing with the U.S. Securities and Exchange Commission on the date hereof, its annual report on Form 40-F for the fiscal year ended December 31, 2020 (the "Report"):</p>
    <p style="text-align: justify;">I, Raza Bokhari, Executive Chairman and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as enacted pursuant to section 906 of the U.S. Sarbanes-Oxley Act of 2002, that:</p>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;">1.<font style="width: 27.75pt; text-indent: 0pt; display: inline-block;">&#160;</font>the Report fully complies with the requirements of Section 13(a) or 15(d) of the U.S. Securities Exchange Act of 1934; and</p>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;">2.<font style="width: 27.75pt; text-indent: 0pt; display: inline-block;">&#160;</font>the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</p>
    <br>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: bottom;">
                <p>By:</p>
            </td>
            <td style="width: 45%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: bottom; border-bottom: 0.75pt solid #000000;">
                <p>/s/ Raza Bokhari</p>
            </td>
            <td style="width: 33%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top;">
                <p>&#160;</p>
            </td>
            <td style="width: 45%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: bottom; border-top: 0.75pt solid #000000;">
                <p>Name: Raza Bokhari <br>Title: Executive Chairman and Chief Executive Officer</p>
            </td>
            <td style="width: 33%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top;">
                <p>&#160;</p>
            </td>
            <td style="width: 45%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: bottom;">
                <p>Date: March 16, 2021</p>
            </td>
            <td style="width: 33%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: bottom;">&#160;</td>
        </tr>
    </table>
    <br>
    <hr style="text-align: center;" width="100%" size="5" color="black">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.7
<SEQUENCE>8
<FILENAME>exhibit99-7.htm
<DESCRIPTION>EXHIBIT 99.7
<TEXT>
<html>

<head>
    <title>FSD Pharma Inc.: Exhibit 99.7 - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt;">
    <hr style="text-align: center;" width="100%" size="3" color="black" noshade="noshade"><a name="page_1"></a>
    <p style="text-align: right;"><b><font style="font-size: 13.3333px;">EXHIBIT 99.7</font></b></p>
    <p style="margin-bottom: 0pt; text-align: center;"><b>CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,</b></p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>AS ENACTED PURSUANT TO</b></p>
    <p style="margin-top: 0pt; text-align: center;"><b>SECTION 906 OF THE U.S. SARBANES-OXLEY ACT OF 2002</b></p>
    <p style="text-indent: 36pt; text-align: justify;">FSD Pharma Inc. (the "Company") is filing with the U.S. Securities and Exchange Commission on the date hereof, its annual report on Form 40-F for the fiscal year ended December 31, 2020 (the "Report"):</p>
    <p style="text-align: justify;">I, Donal Carroll, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as enacted pursuant to section 906 of the U.S. Sarbanes-Oxley Act of 2002, that:</p>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;">1.<font style="width: 27.75pt; text-indent: 0pt; display: inline-block;">&#160;</font>the Report fully complies with the requirements of Section 13(a) or 15(d) of the U.S. Securities Exchange Act of 1934; and</p>
    <p style="margin-left: 36pt; text-indent: -36pt; text-align: justify;">2.<font style="width: 27.75pt; text-indent: 0pt; display: inline-block;">&#160;</font>the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</p>
    <br>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: bottom;">
                <p>By:</p>
            </td>
            <td style="width: 45%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: bottom; border-bottom: 0.75pt solid #000000;">
                <p>/s/ Donal Carroll</p>
            </td>
            <td style="width: 33%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top;">
                <p>&#160;</p>
            </td>
            <td style="width: 45%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: bottom; border-top: 0.75pt solid #000000;">
                <p>Name: Donal Carroll<br>Title: Chief Financial Officer</p>
            </td>
            <td style="width: 33%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 5%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: top;">
                <p>&#160;</p>
            </td>
            <td style="width: 45%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: bottom;">
                <p>Date: March 16, 2021</p>
            </td>
            <td style="width: 33%; padding-right: 3.6pt; padding-left: 3.6pt; vertical-align: bottom;">&#160;</td>
        </tr>
    </table>
    <br>
    <hr style="text-align: center;" width="100%" size="5" color="black">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.8
<SEQUENCE>9
<FILENAME>exhibit99-8.htm
<DESCRIPTION>EXHIBIT 99.8
<TEXT>
<html>

<head>
    <title>FSD Pharma Inc.: Exhibit 99.8 - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt;">
    <hr style="text-align: center;" width="100%" size="3" color="black" noshade="noshade"><a name="page_1"></a>&#160;
    <p style="text-align: right;"><b><font style="font-size: 13.3333px; text-align: start;">EXHIBIT 99.8</font></b></p>
    <p style="text-align: justify;">March 16, 2021</p>
    <p style="text-align: justify;"><b>Consent of Independent Auditor</b></p>
    <p style="text-align: justify;">We hereby consent to the inclusion in this Annual Report on Form 40-F for the year ended December 31, 2020 of FSD Pharma Inc. (the "Company") of our report dated March 15, 2021 relating to the consolidated financial statements of the Company as at December 31, 2020 and 2019 and for each of the years then ended (the "Report"). We also consent to the incorporation by reference of the Report in the Registration Statement on Form F-10 (No. 333-236780) of the Company.&#160;</p>
    <table style="width: 400.8pt; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: top; background-color: #ffffff;">
                <p style="background-color: #ffffff; border-bottom: 0.75pt solid #000000;">/s/ MNP LLP</p>
            </td>
        </tr>
        <tr>
            <td style="vertical-align: top; background-color: #ffffff;">
                <p style="margin-bottom: 0pt; background-color: #ffffff;">MNP LLP</p>
                <p style="margin-top: 0pt; background-color: #ffffff;">Toronto, Ontario, Canada</p>
            </td>
        </tr>
        <tr>
            <td style="vertical-align: top; background-color: #ffffff;">
                <p style="background-color: #ffffff;">Chartered Professional Accountants</p>
            </td>
        </tr>
        <tr>
            <td style="vertical-align: top; background-color: #ffffff;">
                <p style="background-color: #ffffff;">Licensed Public Accountants</p>
            </td>
        </tr>
    </table>
    <br>
    <hr style="text-align: center;" width="100%" size="5" color="black">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.9
<SEQUENCE>10
<FILENAME>exhibit99-9.htm
<DESCRIPTION>EXHIBIT 99.9
<TEXT>
<html>

<head>
    <title>FSD Pharma Inc.: Exhibit 99.9 - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt;">
    <hr style="text-align: center;" width="100%" size="3" color="black" noshade="noshade"><a name="page_1"></a>
    <p style="text-align: right;"><b><font style="font-size: 13.3333px; text-align: start;">EXHIBIT 99.9</font></b></p>
    <p style="text-align: justify;">March 16, 2021</p>
    <p style="text-align: justify;"><b>Consent of Independent Auditor</b></p>
    <p style="text-align: justify;"><font style="font-size: 13.3333px; text-align: start;">We hereby consent to the inclusion in this Annual Report on Form 40-F for the year ended December 31, 2020 of FSD Pharma Inc. (the "Company") of our report dated May 3, 2019 relating to the consolidated statement of financial position of the Company as at December 31, 2018,&#160;</font><font style="font-size: 10pt; text-align: start;">before t</font><font style="font-size: 13.3333px;">he effects of the&#160;</font><font style="text-align: start; font-size: 13.3333px;">ad</font><font style="font-size: 10pt; text-align: start;">justments to retrospectively apply the change in accounting policy described in Note 2(d)&#160;</font><font style="font-size: 10pt;">(the "Report"). We also consent to the incorporation by reference of the Report in the Registration Statement on Form F-10 (No. 333-236780) of the Company.</font></p>
    <p style="text-align: justify;"><b>McGovern Hurley LLP</b></p>
    <p style="text-align: justify;">/s/ McGovern Hurley LLP</p>
    <p style="margin-bottom: 0pt; text-align: justify;"><b>Chartered Professional Accountants</b></p>
    <p style="margin-top: 0pt; text-align: justify;"><b>Licensed Public Accountants</b></p>
    <p style="margin-bottom: 0pt; text-align: justify;">Toronto, Canada<br>March 16, 2021</p>
    <hr style="text-align: center; width: 100%;" size="5" color="black">
    <p>&#160;</p>

</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>11
<FILENAME>huge-20201231.xml
<DESCRIPTION>XBRL TAXONOMY INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--INTEGIX by Ez-XBRL-->
 <xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:huge="http://www.fsdpharma.com/20201231" xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2019-03-27/ifrs-full" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink">






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































  <link:schemaRef xlink:href="huge-20201231.xsd" xlink:type="simple"></link:schemaRef>
  <context id="C_20200101to20201231">



        <entity>


              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20201231">



        <entity>


              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20191231">



        <entity>


              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20190101">



        <entity>


              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
    </entity>
    <period>


              <instant>2019-01-01</instant>
    </period>
  </context>
  <context id="C_20190101_ifrsfullClassesOfShareCapitalAxis_hugeClassACommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassACommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-01-01</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullClassesOfShareCapitalAxis_hugeClassACommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassACommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20201231_ifrsfullClassesOfShareCapitalAxis_hugeClassACommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassACommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20190101_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-01-01</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20201231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20190102to20191231">



        <entity>


              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20181231">



        <entity>


              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="C_20190101_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-01-01</instant>
    </period>
  </context>
  <context id="C_20190101_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-01-01</instant>
    </period>
  </context>
  <context id="C_20190101_ifrsfullComponentsOfEquityAxis_hugeWarrantsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">huge:WarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-01-01</instant>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullComponentsOfEquityAxis_hugeWarrantsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">huge:WarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20191231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullComponentsOfEquityAxis_hugeWarrantsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">huge:WarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_hugeWarrantsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">huge:WarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20201231_ifrsfullComponentsOfEquityAxis_hugeWarrantsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">huge:WarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_ifrsfullSubsidiariesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_hugeSubsidiariesOneMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">huge:SubsidiariesOneMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_ifrsfullSubsidiariesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20180101to20181231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_ifrsfullSubsidiariesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_hugeSubsidiariesOneMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">huge:SubsidiariesOneMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20180101to20181231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_hugeSubsidiariesOneMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">huge:SubsidiariesOneMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_hugeSubsidiariesTwoMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">huge:SubsidiariesTwoMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_hugeSubsidiariesTwoMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">huge:SubsidiariesTwoMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20180101to20181231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_hugeSubsidiariesTwoMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">huge:SubsidiariesTwoMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="C_20181231_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullPreviouslyStatedMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:PreviouslyStatedMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="C_20181231_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_hugeIncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">huge:IncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="C_20190101_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullIncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-01-01</instant>
    </period>
  </context>
  <context id="C_20181231_ifrsfullClassesOfShareCapitalAxis_hugeClassACommonStockSharesMember_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullPreviouslyStatedMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassACommonStockSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:PreviouslyStatedMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="C_20181231_ifrsfullClassesOfShareCapitalAxis_hugeClassACommonStockSharesMember_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_hugeIncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassACommonStockSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">huge:IncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="C_20181231_ifrsfullClassesOfShareCapitalAxis_hugeClassACommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassACommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="C_20190101_ifrsfullClassesOfShareCapitalAxis_hugeClassACommonStockSharesMember_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullIncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassACommonStockSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-01-01</instant>
    </period>
  </context>
  <context id="C_20181231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullPreviouslyStatedMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:PreviouslyStatedMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="C_20181231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_hugeIncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">huge:IncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="C_20181231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="C_20190101_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullIncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-01-01</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullConstructionInProgressMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullFixturesAndFittingsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeProductionEquipmentMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">huge:ProductionEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:LegalEntitiesAxis">huge:PrismicPharmaceuticalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-06-28</instant>
    </period>
  </context>
  <context id="C_20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullBusinessCombinationsAxis_hugeClassBVotingSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:LegalEntitiesAxis">huge:PrismicPharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">huge:ClassBVotingSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-06-28</instant>
    </period>
  </context>
  <context id="C_20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullBusinessCombinationsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:LegalEntitiesAxis">huge:PrismicPharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-06-28</instant>
    </period>
  </context>
  <context id="C_20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullBusinessCombinationsAxis_hugeWarrantsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:LegalEntitiesAxis">huge:PrismicPharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">huge:WarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-06-28</instant>
    </period>
  </context>
  <context id="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullBusinessCombinationsAxis_hugeClassBVotingSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:LegalEntitiesAxis">huge:PrismicPharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">huge:ClassBVotingSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-06-01</startDate>
      <endDate>2019-06-28</endDate>
    </period>
  </context>
  <context id="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:LegalEntitiesAxis">huge:PrismicPharmaceuticalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-06-01</startDate>
      <endDate>2019-06-28</endDate>
    </period>
  </context>
  <context id="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:LegalEntitiesAxis">huge:PrismicPharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-06-01</startDate>
      <endDate>2019-06-28</endDate>
    </period>
  </context>
  <context id="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:LegalEntitiesAxis">huge:PrismicPharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-06-01</startDate>
      <endDate>2019-06-28</endDate>
    </period>
  </context>
  <context id="C_20190401to20190416_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:PharmadrugIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:SecuritiesExchangeAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-04-01</startDate>
      <endDate>2019-04-16</endDate>
    </period>
  </context>
  <context id="C_20190416_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:PharmadrugIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:SecuritiesExchangeAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-04-16</instant>
    </period>
  </context>
  <context id="C_20190401to20190416_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>




                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:PharmadrugIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:SecuritiesExchangeAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-04-01</startDate>
      <endDate>2019-04-16</endDate>
    </period>
  </context>
  <context id="C_20190901to20190920_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>




                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:PharmadrugIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:SecuritiesExchangeAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-09-01</startDate>
      <endDate>2019-09-20</endDate>
    </period>
  </context>
  <context id="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:PharmadrugIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20200201to20200205_hugeOtherInvestmentsNameOfEntityAxis_hugeCannaraBiotechIncMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:CannaraBiotechIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-02-01</startDate>
      <endDate>2020-02-05</endDate>
    </period>
  </context>
  <context id="C_20180901to20180906_hugeOtherInvestmentsNameOfEntityAxis_hugeCloverCannastripThinFilmTechnologiesCorpMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:CloverCannastripThinFilmTechnologiesCorpMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2018-09-01</startDate>
      <endDate>2018-09-06</endDate>
    </period>
  </context>
  <context id="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeHighTideIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:HighTideIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20191101to20191122_hugeOtherInvestmentsNameOfEntityAxis_hugeHighTideIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:HighTideIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-11-01</startDate>
      <endDate>2019-11-22</endDate>
    </period>
  </context>
  <context id="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeHugeShopsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:HugeShopsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20181231_hugeOtherInvestmentsNameOfEntityAxis_hugeHugeShopsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:HugeShopsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeScicannTherapeuticsIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:ScicannTherapeuticsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20181031_hugeOtherInvestmentsNameOfEntityAxis_hugeScicannTherapeuticsIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:ScicannTherapeuticsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-10-31</instant>
    </period>
  </context>
  <context id="C_20180531_hugeOtherInvestmentsNameOfEntityAxis_hugeScicannTherapeuticsIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:ScicannTherapeuticsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2018-05-31</instant>
    </period>
  </context>
  <context id="C_20190501to20190507_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-05-01</startDate>
      <endDate>2019-05-07</endDate>
    </period>
  </context>
  <context id="C_20190507_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-05-07</instant>
    </period>
  </context>
  <context id="C_20190501to20190507_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>




                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:SecuritiesExchangeAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-05-01</startDate>
      <endDate>2019-05-07</endDate>
    </period>
  </context>
  <context id="C_20190507_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:SecuritiesExchangeAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-05-07</instant>
    </period>
  </context>
  <context id="C_20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:SecuritiesExchangeAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20190102to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_hugeTypeOfArrangementsAxis_hugeShareExchangeAgreementMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:ShareExchangeAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20190101to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20200204_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_hugeTypeOfArrangementsAxis_hugeShareExchangeAgreementMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:ShareExchangeAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-02-04</instant>
    </period>
  </context>
  <context id="C_20200201to20200204_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_hugeTypeOfArrangementsAxis_hugeShareExchangeAgreementMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:ShareExchangeAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-02-01</startDate>
      <endDate>2020-02-04</endDate>
    </period>
  </context>
  <context id="C_20201231_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:PharmadrugIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:PharmadrugIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20191231_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:PharmadrugIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeCannaraBiotechIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:CannaraBiotechIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeCannaraBiotechIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:CannaraBiotechIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeCannaraBiotechIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:CannaraBiotechIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeCloverCannastripThinFilmTechnologiesCorpMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:CloverCannastripThinFilmTechnologiesCorpMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeCloverCannastripThinFilmTechnologiesCorpMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:CloverCannastripThinFilmTechnologiesCorpMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeCloverCannastripThinFilmTechnologiesCorpMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:CloverCannastripThinFilmTechnologiesCorpMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeHugeShopsMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:HugeShopsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeHugeShopsMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:HugeShopsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeHugeShopsMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:HugeShopsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeScicannTherapeuticsIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:ScicannTherapeuticsIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeScicannTherapeuticsIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:ScicannTherapeuticsIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeScicannTherapeuticsIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:ScicannTherapeuticsIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_hugeWarrantsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">huge:WarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_hugeWarrantsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">huge:WarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_hugeWarrantsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">huge:WarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_hugeConvertibleDebentureMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">huge:ConvertibleDebentureMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_hugeConvertibleDebentureMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">huge:ConvertibleDebentureMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_hugeConvertibleDebentureMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">huge:ConvertibleDebentureMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20190102to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:PharmadrugIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:PharmadrugIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-01-01</instant>
    </period>
  </context>
  <context id="C_20190102to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeCannaraBiotechIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:CannaraBiotechIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101_hugeOtherInvestmentsNameOfEntityAxis_hugeCannaraBiotechIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:CannaraBiotechIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-01-01</instant>
    </period>
  </context>
  <context id="C_20190102to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeCloverCannastripThinFilmTechnologiesCorpMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:CloverCannastripThinFilmTechnologiesCorpMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101_hugeOtherInvestmentsNameOfEntityAxis_hugeCloverCannastripThinFilmTechnologiesCorpMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:CloverCannastripThinFilmTechnologiesCorpMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-01-01</instant>
    </period>
  </context>
  <context id="C_20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeHighTideIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:HighTideIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20190102to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeHighTideIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:HighTideIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101_hugeOtherInvestmentsNameOfEntityAxis_hugeHighTideIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:HighTideIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-01-01</instant>
    </period>
  </context>
  <context id="C_20190102to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeHugeShopsMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:HugeShopsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101_hugeOtherInvestmentsNameOfEntityAxis_hugeHugeShopsMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:HugeShopsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-01-01</instant>
    </period>
  </context>
  <context id="C_20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeHighTideIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_hugeWarrantsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:HighTideIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">huge:WarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20190102to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeHighTideIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_hugeWarrantsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:HighTideIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">huge:WarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101_hugeOtherInvestmentsNameOfEntityAxis_hugeHighTideIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_hugeWarrantsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:HighTideIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">huge:WarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-01-01</instant>
    </period>
  </context>
  <context id="C_20190102to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeScicannTherapeuticsIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:ScicannTherapeuticsIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101_hugeOtherInvestmentsNameOfEntityAxis_hugeScicannTherapeuticsIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:ScicannTherapeuticsIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-01-01</instant>
    </period>
  </context>
  <context id="C_20190102to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-01-01</instant>
    </period>
  </context>
  <context id="C_20190102to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_hugeWarrantsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">huge:WarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_hugeWarrantsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">huge:WarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-01-01</instant>
    </period>
  </context>
  <context id="C_20190102to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_hugeConvertibleDebentureMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">huge:ConvertibleDebentureMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_hugeConvertibleDebentureMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">huge:ConvertibleDebentureMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-01-01</instant>
    </period>
  </context>
  <context id="C_20190101_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-01-01</instant>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20190101_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-01-01</instant>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20201231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20201231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20201231_ifrsfullMaturityAxis_ifrsfullLaterThanTwoYearsAndNotLaterThanThreeYearsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20201231_ifrsfullMaturityAxis_ifrsfullLaterThanFiveYearsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_hugeNotesPayableMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">huge:NotesPayableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_hugeNotesPayableMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">huge:NotesPayableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:LegalEntitiesAxis">huge:PrismicPharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_hugeNotesPayableMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">huge:NotesPayableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101to20191231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_hugeNotesPayableMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">huge:NotesPayableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-01</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20200101to20201231_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:LegalEntitiesAxis">huge:PrismicPharmaceuticalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20191101to20191104_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-11-01</startDate>
      <endDate>2019-11-04</endDate>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullClassesOfShareCapitalAxis_hugeClassACommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassACommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20190601to20190629_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:LegalEntitiesAxis">huge:PrismicPharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-06-01</startDate>
      <endDate>2019-06-29</endDate>
    </period>
  </context>
  <context id="C_20200101to20200102_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-01-02</endDate>
    </period>
  </context>
  <context id="C_20200102_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-01-02</instant>
    </period>
  </context>
  <context id="C_20200101to20200204_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>




                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:SecuritiesExchangeAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-02-04</endDate>
    </period>
  </context>
  <context id="C_20210204_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>




                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:SolarvestBioEnergyIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:SecuritiesExchangeAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2021-02-04</instant>
    </period>
  </context>
  <context id="C_20200301to20200316_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-03-01</startDate>
      <endDate>2020-03-16</endDate>
    </period>
  </context>
  <context id="C_20200401to20200415_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:LegalEntitiesAxis">huge:PrismicPharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-04-01</startDate>
      <endDate>2020-04-15</endDate>
    </period>
  </context>
  <context id="C_20200601to20200608_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-06-01</startDate>
      <endDate>2020-06-08</endDate>
    </period>
  </context>
  <context id="C_20200801to20200806_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-08-01</startDate>
      <endDate>2020-08-06</endDate>
    </period>
  </context>
  <context id="C_20200806_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-06</instant>
    </period>
  </context>
  <context id="C_20200801to20200831_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-08-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20200101to20201231_hugeLegalEntitiesAxis_hugeAllianceGlobalPartnersMember_hugeTypeOfArrangementsAxis_hugeEquityDistributionAgreementMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>




                    <xbrldi:explicitMember dimension="huge:LegalEntitiesAxis">huge:AllianceGlobalPartnersMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:EquityDistributionAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20201001to20201031_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-10-01</startDate>
      <endDate>2020-10-31</endDate>
    </period>
  </context>
  <context id="C_20190401to20190424_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:PharmadrugIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:SecuritiesExchangeAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-04-01</startDate>
      <endDate>2019-04-24</endDate>
    </period>
  </context>
  <context id="C_20190424_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:PharmadrugIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:SecuritiesExchangeAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-04-24</instant>
    </period>
  </context>
  <context id="C_20190401to20190424_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>




                    <xbrldi:explicitMember dimension="huge:OtherInvestmentsNameOfEntityAxis">huge:PharmadrugIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:SecuritiesExchangeAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-04-01</startDate>
      <endDate>2019-04-24</endDate>
    </period>
  </context>
  <context id="C_20201231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20201231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtSeptember15Th2022Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtSeptember15Th2022Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtAugust1St2021Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtAugust1St2021Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtSeptember11Th2023Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtSeptember11Th2023Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtJuly24Th2023Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtJuly24Th2023Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay20Th2023Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtMay20Th2023Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay24Th2022Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtMay24Th2022Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay4Th2025Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtMay4Th2025Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay10Th2025Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtMay10Th2025Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay17Th2025Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtMay17Th2025Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay31St2025Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtMay31St2025Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtJanuary16Th2026Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtJanuary16Th2026Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtJanuary20Th2026Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtJanuary20Th2026Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtJune8Th2025Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtJune8Th2025Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtAugust6Th2020Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtAugust6Th2020Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtOctober20Th2020Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtOctober20Th2020Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtJanuary5Th2020Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtJanuary5Th2020Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtNovember30Th2020Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtNovember30Th2020Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtAugust1St2021Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtAugust1St2021Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay24Th2022Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtMay24Th2022Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtSeptember15Th2022Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtSeptember15Th2022Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay20Th2023Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtMay20Th2023Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtSeptember11Th2023Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtSeptember11Th2023Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay4Th2025Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtMay4Th2025Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay10Th2025Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtMay10Th2025Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay17Th2025Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtMay17Th2025Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay31St2025Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtMay31St2025Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtJanuary16Th2026Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtJanuary16Th2026Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtJanuary20Th2026Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtJanuary20Th2026Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191001to20191004_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-10-01</startDate>
      <endDate>2019-10-04</endDate>
    </period>
  </context>
  <context id="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtJuly24Th2023Member">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:ClassesOfWarrantsAxis">huge:WarrantsByExpiryDateAtJuly24Th2023Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20190101_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-01-01</instant>
    </period>
  </context>
  <context id="C_20201231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwoPointSixOneMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceTwoPointSixOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwoPointSixOneMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceTwoPointSixOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFourPointFourTwoMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFourPointFourTwoMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFourPointFourTwoMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFourPointFourTwoMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFivePointFourThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFivePointFourThreeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTenPointSixFiveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceTenPointSixFiveMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTenPointSixFiveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceTenPointSixFiveMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThirteenPointZeroSevenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceThirteenPointZeroSevenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThirteenPointZeroSevenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceThirteenPointZeroSevenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThirteenPointFourSevenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceThirteenPointFourSevenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThirteenPointFourSevenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceThirteenPointFourSevenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSixteenPointZeroEightMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceSixteenPointZeroEightMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSixteenPointZeroEightMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceSixteenPointZeroEightMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSeventeenPointEightNineMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceSeventeenPointEightNineMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSeventeenPointEightNineMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceSeventeenPointEightNineMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEighteenPointZeroNineMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceEighteenPointZeroNineMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEighteenPointZeroNineMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceEighteenPointZeroNineMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyPointOneZeroMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceTwentyPointOneZeroMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyPointOneZeroMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceTwentyPointOneZeroMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyOnePointElevenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceTwentyOnePointElevenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyOnePointElevenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceTwentyOnePointElevenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyFourPointTwelveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceTwentyFourPointTwelveMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyFourPointTwelveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceTwentyFourPointTwelveMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentySixPointThirteenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceTwentySixPointThirteenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentySixPointThirteenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceTwentySixPointThirteenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortyPointTwentyMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFortyPointTwentyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortyPointTwentyMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFortyPointTwentyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortyFourPointTwentyTwoMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFortyFourPointTwentyTwoMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortyFourPointTwentyTwoMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFortyFourPointTwentyTwoMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortySevenPointTwentyFourMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFortySevenPointTwentyFourMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortySevenPointTwentyFourMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFortySevenPointTwentyFourMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyPointTwentyFiveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFiftyPointTwentyFiveMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyPointTwentyFiveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFiftyPointTwentyFiveMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyTwoPointTwentySixMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFiftyTwoPointTwentySixMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyTwoPointTwentySixMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFiftyTwoPointTwentySixMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyFivePointTwentyEightMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFiftyFivePointTwentyEightMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyFivePointTwentyEightMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFiftyFivePointTwentyEightMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyNinePointThirtyMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFiftyNinePointThirtyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyNinePointThirtyMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFiftyNinePointThirtyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointSeventeenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceSevenPointSeventeenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointSeventeenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceSevenPointSeventeenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSeventyFivePointThirtyEightMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceSeventyFivePointThirtyEightMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSeventyFivePointThirtyEightMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceSeventyFivePointThirtyEightMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointSixtyThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceSevenPointSixtyThreeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointSixtyThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceSevenPointSixtyThreeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightySixPointFortyThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceEightySixPointFortyThreeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightySixPointFortyThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceEightySixPointFortyThreeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightyEightPointFortyFourMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceEightyEightPointFortyFourMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightyEightPointFortyFourMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceEightyEightPointFortyFourMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredTwentyPointSixtyMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceOneHundredTwentyPointSixtyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredTwentyPointSixtyMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceOneHundredTwentyPointSixtyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredFortyTwoPointSeventyOneMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceOneHundredFortyTwoPointSeventyOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2019-12-31</instant>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredFortyTwoPointSeventyOneMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceOneHundredFortyTwoPointSeventyOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwoPointSixOneMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceTwoPointSixOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwoPointSixOneMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceTwoPointSixOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFourPointFourTwoMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFourPointFourTwoMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFourPointFourTwoMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFourPointFourTwoMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFivePointFourThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFivePointFourThreeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTenPointSixFiveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceTenPointSixFiveMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTenPointSixFiveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceTenPointSixFiveMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThirteenPointZeroSevenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceThirteenPointZeroSevenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThirteenPointZeroSevenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceThirteenPointZeroSevenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThirteenPointFourSevenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceThirteenPointFourSevenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThirteenPointFourSevenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceThirteenPointFourSevenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSixteenPointZeroEightMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceSixteenPointZeroEightMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSixteenPointZeroEightMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceSixteenPointZeroEightMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSeventeenPointEightNineMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceSeventeenPointEightNineMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSeventeenPointEightNineMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceSeventeenPointEightNineMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEighteenPointZeroNineMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceEighteenPointZeroNineMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEighteenPointZeroNineMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceEighteenPointZeroNineMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyPointOneZeroMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceTwentyPointOneZeroMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyPointOneZeroMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceTwentyPointOneZeroMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortySevenPointTwentyFourMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFortySevenPointTwentyFourMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortySevenPointTwentyFourMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFortySevenPointTwentyFourMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyPointTwentyFiveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFiftyPointTwentyFiveMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyPointTwentyFiveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFiftyPointTwentyFiveMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyTwoPointTwentySixMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFiftyTwoPointTwentySixMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyTwoPointTwentySixMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFiftyTwoPointTwentySixMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyFivePointTwentyEightMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFiftyFivePointTwentyEightMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyFivePointTwentyEightMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFiftyFivePointTwentyEightMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyNinePointThirtyMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFiftyNinePointThirtyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyNinePointThirtyMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFiftyNinePointThirtyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSeventyFivePointThirtyEightMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceSeventyFivePointThirtyEightMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSeventyFivePointThirtyEightMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceSeventyFivePointThirtyEightMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightySixPointFortyThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceEightySixPointFortyThreeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightySixPointFortyThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceEightySixPointFortyThreeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredFortyTwoPointSeventyOneMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceOneHundredFortyTwoPointSeventyOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredFortyTwoPointSeventyOneMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceOneHundredFortyTwoPointSeventyOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSixPointSixteenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceSixPointSixteenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSixPointSixteenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceSixPointSixteenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointSeventeenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceSevenPointSeventeenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointSeventeenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceSevenPointSeventeenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointSixtyThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceSevenPointSixtyThreeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointSixtyThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceSevenPointSixtyThreeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceNinePointFiveFourMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceNinePointFiveFourMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceNinePointFiveFourMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceNinePointFiveFourMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThreePointSevenFiveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceThreePointSevenFiveMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThreePointSevenFiveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceThreePointSevenFiveMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThreePointEightSixMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceThreePointEightSixMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThreePointEightSixMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceThreePointEightSixMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFourPointSevenFiveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFourPointSevenFiveMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFourPointSevenFiveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFourPointSevenFiveMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFivePointZeroThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFivePointZeroThreeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFivePointZeroThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFivePointZeroThreeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFivePointFourThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFivePointFourThreeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFivePointFourThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">huge:ExercisePriceFivePointFourThreeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullClassesOfOrdinarySharesAxis_hugeWarrantsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">huge:WarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullClassesOfOrdinarySharesAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullClassesOfOrdinarySharesAxis_hugeWarrantsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">huge:WarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullClassesOfOrdinarySharesAxis_hugeStockOptionsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">huge:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20201231_hugeTypeOfArrangementsAxis_hugeEpitechLicenseAgreementMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:EpitechLicenseAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_hugeTypeOfArrangementsAxis_hugeEpitechLicenseAgreementMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:EpitechLicenseAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20200101to20201231_hugeTypeOfArrangementsAxis_hugeHeritageBuildingRestorationCommitmentMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:HeritageBuildingRestorationCommitmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullClassesOfContingentLiabilitiesAxis_ifrsfullLegalProceedingsContingentLiabilityMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20200701to20200729">



        <entity>


              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
    </entity>
    <period>



              <startDate>2020-07-01</startDate>
      <endDate>2020-07-29</endDate>
    </period>
  </context>
  <context id="C_20200101to20201231_hugeTypeOfArrangementsAxis_hugeDefinitiveSettlementAgreementMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:DefinitiveSettlementAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20200101to20201231_hugeTypeOfArrangementsAxis_hugeDefinitiveStrategicAllianceAndStreamingAgreementMember_ifrsfullClassesOfContingentLiabilitiesAxis_hugeContingentLiabilityForConstructionAndDevelopmentCostsMember_ifrsfullCounterpartiesAxis_hugeAuxlyCannabisGroupIncMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>




                    <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:DefinitiveStrategicAllianceAndStreamingAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">huge:ContingentLiabilityForConstructionAndDevelopmentCostsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">huge:AuxlyCannabisGroupIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullCategoriesOfRelatedPartiesAxis_hugeChiefExecutiveOfficersMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">huge:ChiefExecutiveOfficersMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullCategoriesOfRelatedPartiesAxis_hugeChiefExecutiveOfficersMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">huge:ChiefExecutiveOfficersMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullCategoriesOfRelatedPartiesAxis_hugeIndependentDirectorMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">huge:IndependentDirectorMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullCategoriesOfRelatedPartiesAxis_hugePresidentsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">huge:PresidentsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullCategoriesOfRelatedPartiesAxis_hugeKeyManagementAndDirectorsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">huge:KeyManagementAndDirectorsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20201231_deiLegalEntityAxis_hugeFSDBiosciencesMember_ifrsfullCategoriesOfRelatedPartiesAxis_hugePresidentOfFSDMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">huge:PresidentOfFSDMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">huge:FSDBiosciencesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20201231_ifrsfullCategoriesOfRelatedPartiesAxis_hugeChiefExecutiveOfficersMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">huge:ChiefExecutiveOfficersMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20201231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis">ifrs-full:DisposalGroupsClassifiedAsHeldForSaleMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-12-31</instant>
    </period>
  </context>
  <context id="C_20200101to20201231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis">ifrs-full:DisposalGroupsClassifiedAsHeldForSaleMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-01-01</startDate>
      <endDate>2020-12-31</endDate>
    </period>
  </context>
  <context id="C_20190102to20191231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis">ifrs-full:DisposalGroupsClassifiedAsHeldForSaleMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2019-01-02</startDate>
      <endDate>2019-12-31</endDate>
    </period>
  </context>
  <context id="C_20200831_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">huge:ClassBCommonStockSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20200801to20200831_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2020-08-01</startDate>
      <endDate>2020-08-31</endDate>
    </period>
  </context>
  <context id="C_20200831_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>


                    <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>


              <instant>2020-08-31</instant>
    </period>
  </context>
  <context id="C_20210101to20210121_ifrsfullCategoriesOfRelatedPartiesAxis_hugeBoardMembersMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_hugeSubsequentEventsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">huge:BoardMembersMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">huge:SubsequentEventsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2021-01-01</startDate>
      <endDate>2021-01-21</endDate>
    </period>
  </context>
  <context id="C_20210101to20210122_ifrsfullClassesOfOrdinarySharesAxis_hugeClassBSubordinatedVotingSharesMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_hugeSubsequentEventsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>



                    <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">huge:ClassBSubordinatedVotingSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">huge:SubsequentEventsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2021-01-01</startDate>
      <endDate>2021-01-22</endDate>
    </period>
  </context>
  <context id="C_20210201to20210210_hugeTypeOfArrangementsAxis_hugeEquityDistributionAgreementMember_ifrsfullCategoriesOfRelatedPartiesAxis_hugeAllianceGlobalPartnersMember_ifrsfullClassesOfOrdinarySharesAxis_hugeClassBCommonSharesMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_hugeSubsequentEventsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>





                    <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:EquityDistributionAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">huge:AllianceGlobalPartnersMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">huge:ClassBCommonSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">huge:SubsequentEventsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2021-02-01</startDate>
      <endDate>2021-02-10</endDate>
    </period>
  </context>
  <context id="C_20210201to20210211_hugeTypeOfArrangementsAxis_hugeEquityDistributionAgreementMember_ifrsfullCategoriesOfRelatedPartiesAxis_hugeDirectorsAndOfficersMember_ifrsfullClassesOfOrdinarySharesAxis_hugeClassBCommonSharesMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_hugeSubsequentEventsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>





                    <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:EquityDistributionAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">huge:DirectorsAndOfficersMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">huge:ClassBCommonSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">huge:SubsequentEventsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2021-02-01</startDate>
      <endDate>2021-02-11</endDate>
    </period>
  </context>
  <context id="C_20210212to20210312_hugeTypeOfArrangementsAxis_hugeEquityDistributionAgreementMember_ifrsfullCategoriesOfRelatedPartiesAxis_hugeAllianceGlobalPartnersMember_ifrsfullClassesOfOrdinarySharesAxis_hugeClassBCommonSharesMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_hugeSubsequentEventsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>





                    <xbrldi:explicitMember dimension="huge:TypeOfArrangementsAxis">huge:EquityDistributionAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">huge:AllianceGlobalPartnersMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">huge:ClassBCommonSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">huge:SubsequentEventsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2021-02-12</startDate>
      <endDate>2021-03-12</endDate>
    </period>
  </context>
  <context id="C_20210101to20210217_ifrsfullCategoriesOfRelatedPartiesAxis_hugeDirectorsAndOfficersMember_ifrsfullClassesOfOrdinarySharesAxis_hugeClassBCommonSharesMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_hugeSubsequentEventsMember">



        <entity>



              <identifier scheme="http://www.sec.gov/CIK">0001771885</identifier>
      <segment>




                    <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">huge:DirectorsAndOfficersMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">huge:ClassBCommonSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">huge:SubsequentEventsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>



              <startDate>2021-01-01</startDate>
      <endDate>2021-02-17</endDate>
    </period>
  </context>
  <unit id="CAD">


        <measure>iso4217:CAD</measure>
  </unit>
  <unit id="CAD_per_Share">


        <divide>



              <unitNumerator>


                    <measure>iso4217:CAD</measure>
      </unitNumerator>
      <unitDenominator>


                    <measure>shares</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="EUR">


        <measure>iso4217:EUR</measure>
  </unit>
  <unit id="Pure">


        <measure>pure</measure>
  </unit>
  <unit id="Share">


        <measure>huge:Share</measure>
  </unit>
  <unit id="USD">


        <measure>iso4217:USD</measure>
  </unit>
  <unit id="USD_per_Share">


        <divide>



              <unitNumerator>


                    <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>


                    <measure>shares</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="Year">


        <measure>huge:Year</measure>
  </unit>
  <unit id="shares">


        <measure>shares</measure>
  </unit>
  <dei:EntityCentralIndexKey contextRef="C_20200101to20201231" id="Fdei_EntityCentralIndexKey_Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00">0001771885</dei:EntityCentralIndexKey>
  <dei:EntityCurrentReportingStatus contextRef="C_20200101to20201231" id="Fdei_EntityCurrentReportingStatus_Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00">Yes</dei:EntityCurrentReportingStatus>
  <dei:CurrentFiscalYearEndDate contextRef="C_20200101to20201231" id="Fdei_CurrentFiscalYearEndDate_Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00">--12-31</dei:CurrentFiscalYearEndDate>
  <dei:DocumentPeriodEndDate contextRef="C_20200101to20201231" id="Fdei_DocumentPeriodEndDate_Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00">2020-12-31</dei:DocumentPeriodEndDate>
  <dei:DocumentType contextRef="C_20200101to20201231" id="Fdei_DocumentType_Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00">40-F</dei:DocumentType>
  <dei:AmendmentFlag contextRef="C_20200101to20201231" id="Fdei_AmendmentFlag_Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00">false</dei:AmendmentFlag>
  <dei:DocumentFiscalYearFocus contextRef="C_20200101to20201231" id="Fdei_DocumentFiscalYearFocus_Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00">2020</dei:DocumentFiscalYearFocus>
  <dei:DocumentFiscalPeriodFocus contextRef="C_20200101to20201231" id="Fdei_DocumentFiscalPeriodFocus_Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00">FY</dei:DocumentFiscalPeriodFocus>
  <dei:EntityEmergingGrowthCompany contextRef="C_20200101to20201231" id="Fdei_EntityEmergingGrowthCompany_Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00">true</dei:EntityEmergingGrowthCompany>
  <dei:EntityExTransitionPeriod contextRef="C_20200101to20201231" id="Fdei_EntityExTransitionPeriod_Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00">false</dei:EntityExTransitionPeriod>
  <dei:EntityRegistrantName contextRef="C_20200101to20201231" id="Fdei_EntityRegistrantName_Context_FYE_01_Jan_2018T00_00_00_TO_31_Dec_2018T00_00_00">FSD Pharma Inc.</dei:EntityRegistrantName>
  <dei:EntityInteractiveDataCurrent contextRef="C_20200101to20201231">Yes</dei:EntityInteractiveDataCurrent>
  <dei:EntityCommonStockSharesOutstanding contextRef="C_20201231" decimals="0" id="Fxbrl_20200304021354315" unitRef="shares">19161620</dei:EntityCommonStockSharesOutstanding>
  <ifrs-full:CashAndCashEquivalents contextRef="C_20201231" decimals="0" id="Fxbrl_20210224172748667" unitRef="USD">17524822</ifrs-full:CashAndCashEquivalents>
  <ifrs-full:CashAndCashEquivalents contextRef="C_20191231" decimals="0" id="Fxbrl_20210224172752205" unitRef="USD">5967798</ifrs-full:CashAndCashEquivalents>
  <ifrs-full:CashAndCashEquivalents contextRef="C_20190101" decimals="0" id="Fxbrl_20210224172755718" unitRef="USD">15899808</ifrs-full:CashAndCashEquivalents>
  <ifrs-full:CashAndCashEquivalents contextRef="C_20181231" decimals="0" id="Fxbrl_20210224181757135_425" unitRef="USD">15899808</ifrs-full:CashAndCashEquivalents>
  <ifrs-full:CashAndCashEquivalents contextRef="C_20181231_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullPreviouslyStatedMember" decimals="0" id="Fxbrl_20210223184821907_52" unitRef="CAD">21134930</ifrs-full:CashAndCashEquivalents>
  <ifrs-full:CashAndCashEquivalents contextRef="C_20181231_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_hugeIncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember" decimals="0" id="Fxbrl_20210223184821907_55" unitRef="USD">-5235122</ifrs-full:CashAndCashEquivalents>
  <ifrs-full:CashAndCashEquivalents contextRef="C_20190101_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullIncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" decimals="0" id="Fxbrl_20210223184821907_511" unitRef="USD">0</ifrs-full:CashAndCashEquivalents>
  <ifrs-full:TradeAndOtherCurrentReceivables contextRef="C_20201231" decimals="0" id="Fxbrl_20210224173030235_xbrl_20210224172748667" unitRef="USD">161342</ifrs-full:TradeAndOtherCurrentReceivables>
  <ifrs-full:TradeAndOtherCurrentReceivables contextRef="C_20191231" decimals="0" id="Fxbrl_20210224173030235_xbrl_20210224172752205" unitRef="USD">1557302</ifrs-full:TradeAndOtherCurrentReceivables>
  <ifrs-full:TradeAndOtherCurrentReceivables contextRef="C_20190101" decimals="0" id="Fxbrl_20210224173030235_xbrl_20210224172755718" unitRef="USD">745520</ifrs-full:TradeAndOtherCurrentReceivables>
  <ifrs-full:TradeAndOtherCurrentReceivables contextRef="C_20181231_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullPreviouslyStatedMember" decimals="0" id="Fxbrl_20210223184821907_62" unitRef="CAD">990988</ifrs-full:TradeAndOtherCurrentReceivables>
  <ifrs-full:TradeAndOtherCurrentReceivables contextRef="C_20181231_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_hugeIncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember" decimals="0" id="Fxbrl_20210223184821907_65" unitRef="USD">-245468</ifrs-full:TradeAndOtherCurrentReceivables>
  <ifrs-full:TradeAndOtherCurrentReceivables contextRef="C_20181231" decimals="0" id="Fxbrl_20210223184821907_68" unitRef="USD">745520</ifrs-full:TradeAndOtherCurrentReceivables>
  <ifrs-full:TradeAndOtherCurrentReceivables contextRef="C_20190101_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullIncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" decimals="0" id="Fxbrl_20210223184821907_611" unitRef="USD">0</ifrs-full:TradeAndOtherCurrentReceivables>
  <ifrs-full:CurrentPrepaidExpenses contextRef="C_20201231" decimals="0" id="Fxbrl_20210224173038435_xbrl_20210224172748667" unitRef="USD">569401</ifrs-full:CurrentPrepaidExpenses>
  <ifrs-full:CurrentPrepaidExpenses contextRef="C_20191231" decimals="0" id="Fxbrl_20210224173038435_xbrl_20210224172752205" unitRef="USD">323776</ifrs-full:CurrentPrepaidExpenses>
  <ifrs-full:CurrentPrepaidExpenses contextRef="C_20190101" decimals="0" id="Fxbrl_20210224173038435_xbrl_20210224172755718" unitRef="USD">334096</ifrs-full:CurrentPrepaidExpenses>
  <ifrs-full:CurrentPrepaidExpenses contextRef="C_20181231_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullPreviouslyStatedMember" decimals="0" id="Fxbrl_20210223184821907_72" unitRef="CAD">444099</ifrs-full:CurrentPrepaidExpenses>
  <ifrs-full:CurrentPrepaidExpenses contextRef="C_20181231_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_hugeIncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember" decimals="0" id="Fxbrl_20210223184821907_75" unitRef="USD">-110003</ifrs-full:CurrentPrepaidExpenses>
  <ifrs-full:CurrentPrepaidExpenses contextRef="C_20181231" decimals="0" id="Fxbrl_20210223184821907_78" unitRef="USD">334096</ifrs-full:CurrentPrepaidExpenses>
  <ifrs-full:CurrentPrepaidExpenses contextRef="C_20190101_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullIncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" decimals="0" id="Fxbrl_20210223184821907_711" unitRef="USD">0</ifrs-full:CurrentPrepaidExpenses>
  <ifrs-full:Inventories contextRef="C_20201231" decimals="0" id="Fxbrl_20210224173041602_xbrl_20210224172748667" unitRef="USD">0</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="C_20191231" decimals="0" id="Fxbrl_20210224173041602_xbrl_20210224172752205" unitRef="USD">709373</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="C_20190101" decimals="0" id="Fxbrl_20210224173041602_xbrl_20210224172755718" unitRef="USD">0</ifrs-full:Inventories>
  <ifrs-full:CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners contextRef="C_20201231" decimals="0" id="Fxbrl_20210224173221785_xbrl_20210224172748667" unitRef="USD">18255565</ifrs-full:CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners>
  <ifrs-full:CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners contextRef="C_20191231" decimals="0" id="Fxbrl_20210224173221785_xbrl_20210224172752205" unitRef="USD">8558249</ifrs-full:CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners>
  <ifrs-full:CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners contextRef="C_20190101" decimals="0" id="Fxbrl_20210224173221785_xbrl_20210224172755718" unitRef="USD">16979424</ifrs-full:CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners>
  <ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners contextRef="C_20201231" decimals="0" id="Fxbrl_20210224173051669_xbrl_20210224172752205" unitRef="USD">8610504</ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners>
  <ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners contextRef="C_20191231" decimals="0" id="Fxbrl_20210224173051669_xbrl_20210224172755718" unitRef="USD">0</ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners>
  <ifrs-full:CurrentAssets contextRef="C_20201231" decimals="0" id="Fxbrl_20210224173228128_xbrl_20210224172748667" unitRef="USD">26866069</ifrs-full:CurrentAssets>
  <ifrs-full:CurrentAssets contextRef="C_20191231" decimals="0" id="Fxbrl_20210224173228128_xbrl_20210224172752205" unitRef="USD">8558249</ifrs-full:CurrentAssets>
  <ifrs-full:CurrentAssets contextRef="C_20190101" decimals="0" id="Fxbrl_20210224173228128_xbrl_20210224172755718" unitRef="USD">16979424</ifrs-full:CurrentAssets>
  <ifrs-full:CurrentAssets contextRef="C_20181231_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullPreviouslyStatedMember" decimals="0" id="Fxbrl_20210223185157480" unitRef="CAD">22570017</ifrs-full:CurrentAssets>
  <ifrs-full:CurrentAssets contextRef="C_20181231_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_hugeIncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember" decimals="0" id="Fxbrl_20210223185202514" unitRef="USD">-5590593</ifrs-full:CurrentAssets>
  <ifrs-full:CurrentAssets contextRef="C_20181231" decimals="0" id="Fxbrl_20210223185313199" unitRef="USD">16979424</ifrs-full:CurrentAssets>
  <ifrs-full:CurrentAssets contextRef="C_20190101_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullIncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" decimals="0" id="Fxbrl_20210223185317312" unitRef="USD">0</ifrs-full:CurrentAssets>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20201231" decimals="0" id="Fxbrl_20210224173059577_xbrl_20210224172748667" unitRef="USD">1676745</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20191231" decimals="0" id="Fxbrl_20210224173059577_xbrl_20210224172752205" unitRef="USD">8862744</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101" decimals="0" id="Fxbrl_20210224173059577_xbrl_20210224172755718" unitRef="USD">13589954</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20181231_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullPreviouslyStatedMember" decimals="0" id="Fxbrl_20210223184821907_102" unitRef="CAD">18064541</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20181231_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_hugeIncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember" decimals="0" id="Fxbrl_20210223184821907_105" unitRef="USD">-4474587</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20181231" decimals="0" id="Fxbrl_20210223184821907_108" unitRef="USD">13589954</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullIncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" decimals="0" id="Fxbrl_20210223184821907_1011" unitRef="USD">0</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173152499" unitRef="USD">0</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20191231_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173602304" unitRef="USD">255075</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101_hugeOtherInvestmentsNameOfEntityAxis_hugeCannaraBiotechIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173152499" unitRef="USD">8437342</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeCannaraBiotechIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173602304" unitRef="USD">6822637</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101_hugeOtherInvestmentsNameOfEntityAxis_hugeCloverCannastripThinFilmTechnologiesCorpMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224125620278_xbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173152499" unitRef="USD">1128450</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeCloverCannastripThinFilmTechnologiesCorpMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224125620278_xbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173602304" unitRef="USD">0</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101_hugeOtherInvestmentsNameOfEntityAxis_hugeHighTideIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224125710374_xbrl_20210224125620278_xbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173152499" unitRef="USD">1352665</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeHighTideIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224125710374_xbrl_20210224125620278_xbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173602304" unitRef="USD">0</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101_hugeOtherInvestmentsNameOfEntityAxis_hugeHighTideIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_hugeWarrantsMember" decimals="0" id="Fxbrl_20210224125942735_xbrl_20210224125710374_xbrl_20210224125620278_xbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173152499" unitRef="USD">188914</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeHighTideIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_hugeWarrantsMember" decimals="0" id="Fxbrl_20210224125942735_xbrl_20210224125710374_xbrl_20210224125620278_xbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173602304" unitRef="USD">0</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101_hugeOtherInvestmentsNameOfEntityAxis_hugeHugeShopsMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224125924314_xbrl_20210224125800887_xbrl_20210224125710374_xbrl_20210224125620278_xbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173152499" unitRef="USD">977990</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeHugeShopsMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224125924314_xbrl_20210224125800887_xbrl_20210224125710374_xbrl_20210224125620278_xbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173602304" unitRef="USD">572401</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101_hugeOtherInvestmentsNameOfEntityAxis_hugeScicannTherapeuticsIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224130103018_xbrl_20210224125924314_xbrl_20210224125800887_xbrl_20210224125710374_xbrl_20210224125620278_xbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173152499" unitRef="USD">1504593</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeScicannTherapeuticsIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224130103018_xbrl_20210224125924314_xbrl_20210224125800887_xbrl_20210224125710374_xbrl_20210224125620278_xbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173602304" unitRef="USD">535824</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224130204478_xbrl_20210224130103018_xbrl_20210224125924314_xbrl_20210224125800887_xbrl_20210224125710374_xbrl_20210224125620278_xbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173152499" unitRef="USD">0</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224130204478_xbrl_20210224130103018_xbrl_20210224125924314_xbrl_20210224125800887_xbrl_20210224125710374_xbrl_20210224125620278_xbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173602304" unitRef="USD">327251</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_hugeWarrantsMember" decimals="0" id="Fxbrl_20210224130406983_xbrl_20210224130204478_xbrl_20210224130103018_xbrl_20210224125924314_xbrl_20210224125800887_xbrl_20210224125710374_xbrl_20210224125620278_xbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173152499" unitRef="USD">0</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_hugeWarrantsMember" decimals="0" id="Fxbrl_20210224130406983_xbrl_20210224130204478_xbrl_20210224130103018_xbrl_20210224125924314_xbrl_20210224125800887_xbrl_20210224125710374_xbrl_20210224125620278_xbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173602304" unitRef="USD">87756</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190101_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_hugeConvertibleDebentureMember" decimals="0" id="Fxbrl_20210224130511263_xbrl_20210224130406983_xbrl_20210224130204478_xbrl_20210224130103018_xbrl_20210224125924314_xbrl_20210224125800887_xbrl_20210224125710374_xbrl_20210224125620278_xbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173152499" unitRef="USD">0</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_hugeConvertibleDebentureMember" decimals="0" id="Fxbrl_20210224130511263_xbrl_20210224130406983_xbrl_20210224130204478_xbrl_20210224130103018_xbrl_20210224125924314_xbrl_20210224125800887_xbrl_20210224125710374_xbrl_20210224125620278_xbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173602304" unitRef="USD">261800</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20201231_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224123305188_xbrl_20200219173602304" unitRef="USD">0</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeCannaraBiotechIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224123515633_xbrl_20210224123305188_xbrl_20200219173602304" unitRef="USD">0</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeCloverCannastripThinFilmTechnologiesCorpMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224123646446_xbrl_20210224123515633_xbrl_20210224123305188_xbrl_20200219173602304" unitRef="USD">0</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeHugeShopsMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224124229548_xbrl_20210224123646446_xbrl_20210224123515633_xbrl_20210224123305188_xbrl_20200219173602304" unitRef="USD">600433</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeScicannTherapeuticsIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224124342226_xbrl_20210224124229548_xbrl_20210224123646446_xbrl_20210224123515633_xbrl_20210224123305188_xbrl_20200219173602304" unitRef="USD">195679</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224124507412_xbrl_20210224124342226_xbrl_20210224124229548_xbrl_20210224123646446_xbrl_20210224123515633_xbrl_20210224123305188_xbrl_20200219173602304" unitRef="USD">447678</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_hugeWarrantsMember" decimals="0" id="Fxbrl_20210224124703291_xbrl_20210224124507412_xbrl_20210224124342226_xbrl_20210224124229548_xbrl_20210224123646446_xbrl_20210224123515633_xbrl_20210224123305188_xbrl_20200219173602304" unitRef="USD">74813</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_hugeConvertibleDebentureMember" decimals="0" id="Fxbrl_20210224124822994_xbrl_20210224124703291_xbrl_20210224124507412_xbrl_20210224124342226_xbrl_20210224124229548_xbrl_20210224123646446_xbrl_20210224123515633_xbrl_20210224123305188_xbrl_20200219173602304" unitRef="USD">358142</ifrs-full:NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:RightofuseAssets contextRef="C_20201231" decimals="0" id="Fxbrl_20210224173102298_xbrl_20210224172748667" unitRef="USD">0</ifrs-full:RightofuseAssets>
  <ifrs-full:RightofuseAssets contextRef="C_20191231" decimals="0" id="Fxbrl_20210224173102298_xbrl_20210224172752205" unitRef="USD">95851</ifrs-full:RightofuseAssets>
  <ifrs-full:RightofuseAssets contextRef="C_20190101" decimals="0" id="Fxbrl_20210224173102298_xbrl_20210224172755718" unitRef="USD">183424</ifrs-full:RightofuseAssets>
  <ifrs-full:RightofuseAssets contextRef="C_20181231_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullPreviouslyStatedMember" decimals="0" id="Fxbrl_20210223184821907_112" unitRef="CAD">0</ifrs-full:RightofuseAssets>
  <ifrs-full:RightofuseAssets contextRef="C_20181231_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_hugeIncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember" decimals="0" id="Fxbrl_20210223184821907_115" unitRef="USD">0</ifrs-full:RightofuseAssets>
  <ifrs-full:RightofuseAssets contextRef="C_20181231" decimals="0" id="Fxbrl_20210223184821907_118" unitRef="USD">0</ifrs-full:RightofuseAssets>
  <ifrs-full:RightofuseAssets contextRef="C_20190101_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullIncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" decimals="0" id="Fxbrl_20210223184821907_1111" unitRef="USD">183424</ifrs-full:RightofuseAssets>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20201231" decimals="0" id="Fxbrl_20210224173105056_xbrl_20210224172748667" unitRef="USD">0</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20191231" decimals="0" id="Fxbrl_20210224173105056_xbrl_20210224172752205" unitRef="USD">8880258</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20190101" decimals="0" id="Fxbrl_20210224173105056_xbrl_20210224172755718" unitRef="USD">9134183</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20181231_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullPreviouslyStatedMember" decimals="0" id="Fxbrl_20210223184821907_122" unitRef="CAD">12141676</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20181231_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_hugeIncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember" decimals="0" id="Fxbrl_20210223184821907_125" unitRef="USD">-3007493</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20181231" decimals="0" id="Fxbrl_20210223184821907_128" unitRef="USD">9134183</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20190101_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullIncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" decimals="0" id="Fxbrl_20210223184821907_1211" unitRef="USD">0</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="C_20201231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224174452657" unitRef="USD">8610504</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="C_20201231" decimals="0" id="Fxbrl_20210224173107563_xbrl_20210224172748667" unitRef="USD">13424391</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="C_20191231" decimals="0" id="Fxbrl_20210224173107563_xbrl_20210224172752205" unitRef="USD">16820625</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="C_20190101" decimals="0" id="Fxbrl_20210224173107563_xbrl_20210224172755718" unitRef="USD">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="C_20190101_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="0" id="Fxbrl_20210223195237666" unitRef="USD">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="0" id="Fxbrl_20210223195344313" unitRef="USD">18696229</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="0" id="Fxbrl_20210223195654205" unitRef="USD">19201493</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="C_20190101_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20210223195914155" unitRef="USD">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20210223200020752" unitRef="USD">1875604</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20210223200046321" unitRef="USD">5777102</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:Assets contextRef="C_20201231" decimals="0" id="Fxbrl_20210224173231628_xbrl_20210224172748667" unitRef="USD">41967205</ifrs-full:Assets>
  <ifrs-full:Assets contextRef="C_20191231" decimals="0" id="Fxbrl_20210224173231628_xbrl_20210224172752205" unitRef="USD">43217727</ifrs-full:Assets>
  <ifrs-full:Assets contextRef="C_20190101" decimals="0" id="Fxbrl_20210224173231628_xbrl_20210224172755718" unitRef="USD">39886985</ifrs-full:Assets>
  <ifrs-full:Assets contextRef="C_20181231_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullPreviouslyStatedMember" decimals="0" id="Fxbrl_20210223185327947" unitRef="CAD">52776234</ifrs-full:Assets>
  <ifrs-full:Assets contextRef="C_20181231_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_hugeIncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember" decimals="0" id="Fxbrl_20210223185333660" unitRef="USD">-13072673</ifrs-full:Assets>
  <ifrs-full:Assets contextRef="C_20181231" decimals="0" id="Fxbrl_20210223185402763" unitRef="USD">39703561</ifrs-full:Assets>
  <ifrs-full:Assets contextRef="C_20190101_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullIncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" decimals="0" id="Fxbrl_20210223185408160" unitRef="USD">183424</ifrs-full:Assets>
  <ifrs-full:TradeAndOtherCurrentPayables contextRef="C_20201231" decimals="0" id="Fxbrl_20210224173112314_xbrl_20210224172748667" unitRef="USD">3700103</ifrs-full:TradeAndOtherCurrentPayables>
  <ifrs-full:TradeAndOtherCurrentPayables contextRef="C_20191231" decimals="0" id="Fxbrl_20210224173112314_xbrl_20210224172752205" unitRef="USD">3361145</ifrs-full:TradeAndOtherCurrentPayables>
  <ifrs-full:TradeAndOtherCurrentPayables contextRef="C_20190101" decimals="0" id="Fxbrl_20210224173112314_xbrl_20210224172755718" unitRef="USD">1311865</ifrs-full:TradeAndOtherCurrentPayables>
  <ifrs-full:TradeAndOtherCurrentPayables contextRef="C_20181231_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullPreviouslyStatedMember" decimals="0" id="Fxbrl_20210223184821907_162" unitRef="CAD">1743806</ifrs-full:TradeAndOtherCurrentPayables>
  <ifrs-full:TradeAndOtherCurrentPayables contextRef="C_20181231_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_hugeIncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember" decimals="0" id="Fxbrl_20210223184821907_165" unitRef="USD">-431941</ifrs-full:TradeAndOtherCurrentPayables>
  <ifrs-full:TradeAndOtherCurrentPayables contextRef="C_20181231" decimals="0" id="Fxbrl_20210223184821907_168" unitRef="USD">1311865</ifrs-full:TradeAndOtherCurrentPayables>
  <ifrs-full:TradeAndOtherCurrentPayables contextRef="C_20190101_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullIncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" decimals="0" id="Fxbrl_20210223184821907_1611" unitRef="USD">0</ifrs-full:TradeAndOtherCurrentPayables>
  <ifrs-full:CurrentLeaseLiabilities contextRef="C_20201231" decimals="0" id="Fxbrl_20210224173114937_xbrl_20210224172748667" unitRef="USD">46842</ifrs-full:CurrentLeaseLiabilities>
  <ifrs-full:CurrentLeaseLiabilities contextRef="C_20191231" decimals="0" id="Fxbrl_20210224173114937_xbrl_20210224172752205" unitRef="USD">42285</ifrs-full:CurrentLeaseLiabilities>
  <ifrs-full:CurrentLeaseLiabilities contextRef="C_20190101" decimals="0" id="Fxbrl_20210224173114937_xbrl_20210224172755718" unitRef="USD">40875</ifrs-full:CurrentLeaseLiabilities>
  <ifrs-full:CurrentLeaseLiabilities contextRef="C_20181231_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullPreviouslyStatedMember" decimals="0" id="Fxbrl_20210223184821907_172" unitRef="CAD">0</ifrs-full:CurrentLeaseLiabilities>
  <ifrs-full:CurrentLeaseLiabilities contextRef="C_20181231_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_hugeIncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember" decimals="0" id="Fxbrl_20210223184821907_175" unitRef="USD">0</ifrs-full:CurrentLeaseLiabilities>
  <ifrs-full:CurrentLeaseLiabilities contextRef="C_20181231" decimals="0" id="Fxbrl_20210223184821907_178" unitRef="USD">0</ifrs-full:CurrentLeaseLiabilities>
  <ifrs-full:CurrentLeaseLiabilities contextRef="C_20190101_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullIncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" decimals="0" id="Fxbrl_20210223184821907_1711" unitRef="USD">40875</ifrs-full:CurrentLeaseLiabilities>
  <ifrs-full:CurrentDerivativeFinancialLiabilities contextRef="C_20201231" decimals="0" id="Fxbrl_20210224173117429_xbrl_20210224172748667" unitRef="USD">0</ifrs-full:CurrentDerivativeFinancialLiabilities>
  <ifrs-full:CurrentDerivativeFinancialLiabilities contextRef="C_20191231" decimals="0" id="Fxbrl_20210224173117429_xbrl_20210224172752205" unitRef="USD">1990788</ifrs-full:CurrentDerivativeFinancialLiabilities>
  <ifrs-full:CurrentDerivativeFinancialLiabilities contextRef="C_20190101" decimals="0" id="Fxbrl_20210224173117429_xbrl_20210224172755718" unitRef="USD">0</ifrs-full:CurrentDerivativeFinancialLiabilities>
  <ifrs-full:CurrentDerivativeFinancialLiabilities contextRef="C_20200204_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_hugeTypeOfArrangementsAxis_hugeShareExchangeAgreementMember" decimals="0" id="Fxbrl_20210224121022622" unitRef="USD">1990788</ifrs-full:CurrentDerivativeFinancialLiabilities>
  <ifrs-full:CurrentDerivativeFinancialLiabilities contextRef="C_20210204_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210223110335772" unitRef="USD">1990788</ifrs-full:CurrentDerivativeFinancialLiabilities>
  <huge:CurrentWarrantsLiability contextRef="C_20201231" decimals="0" id="Fxbrl_20210224173119911_xbrl_20210224172748667" unitRef="USD">1447910</huge:CurrentWarrantsLiability>
  <huge:CurrentWarrantsLiability contextRef="C_20191231" decimals="0" id="Fxbrl_20210224173119911_xbrl_20210224172752205" unitRef="USD">0</huge:CurrentWarrantsLiability>
  <huge:CurrentWarrantsLiability contextRef="C_20190101" decimals="0" id="Fxbrl_20210224173119911_xbrl_20210224172755718" unitRef="USD">0</huge:CurrentWarrantsLiability>
  <ifrs-full:CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued contextRef="C_20201231" decimals="0" id="Fxbrl_20210224173122457_xbrl_20210224172748667" unitRef="USD">384647</ifrs-full:CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued>
  <ifrs-full:CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued contextRef="C_20191231" decimals="0" id="Fxbrl_20210224173122457_xbrl_20210224172752205" unitRef="USD">1435698</ifrs-full:CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued>
  <ifrs-full:CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued contextRef="C_20190101" decimals="0" id="Fxbrl_20210224212155395" unitRef="USD">0</ifrs-full:CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued>
  <ifrs-full:CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued contextRef="C_20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember" decimals="0" id="Fxbrl_20210223123934561" unitRef="USD">49647</ifrs-full:CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued>
  <ifrs-full:CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued contextRef="C_20191231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember" decimals="0" id="Fxbrl_20210223123959394" unitRef="USD">145943</ifrs-full:CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued>
  <ifrs-full:CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued contextRef="C_20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_hugeNotesPayableMember" decimals="0" id="Fxbrl_20210223124034911" unitRef="USD">335000</ifrs-full:CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued>
  <ifrs-full:CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued contextRef="C_20191231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_hugeNotesPayableMember" decimals="0" id="Fxbrl_20210223124028654" unitRef="USD">1289755</ifrs-full:CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued>
  <ifrs-full:CurrentLiabilities contextRef="C_20201231" decimals="0" id="Fxbrl_20210224173307090_xbrl_20210224172748667" unitRef="USD">5579502</ifrs-full:CurrentLiabilities>
  <ifrs-full:CurrentLiabilities contextRef="C_20191231" decimals="0" id="Fxbrl_20210224173307090_xbrl_20210224172752205" unitRef="USD">6829916</ifrs-full:CurrentLiabilities>
  <ifrs-full:CurrentLiabilities contextRef="C_20190101" decimals="0" id="Fxbrl_20210224173307090_xbrl_20210224172755718" unitRef="USD">1352740</ifrs-full:CurrentLiabilities>
  <ifrs-full:CurrentLiabilities contextRef="C_20181231_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullPreviouslyStatedMember" decimals="0" id="Fxbrl_20210223190535186" unitRef="CAD">1743806</ifrs-full:CurrentLiabilities>
  <ifrs-full:CurrentLiabilities contextRef="C_20181231_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_hugeIncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember" decimals="0" id="Fxbrl_20210223190521646" unitRef="USD">-431941</ifrs-full:CurrentLiabilities>
  <ifrs-full:CurrentLiabilities contextRef="C_20181231" decimals="0" id="Fxbrl_20210223190541541" unitRef="USD">1311865</ifrs-full:CurrentLiabilities>
  <ifrs-full:CurrentLiabilities contextRef="C_20190101_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullIncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" decimals="0" id="Fxbrl_20210223190545468" unitRef="USD">40875</ifrs-full:CurrentLiabilities>
  <ifrs-full:NoncurrentLeaseLiabilities contextRef="C_20201231" decimals="0" id="Fxbrl_20210224173128191_xbrl_20210224172748667" unitRef="USD">79120</ifrs-full:NoncurrentLeaseLiabilities>
  <ifrs-full:NoncurrentLeaseLiabilities contextRef="C_20191231" decimals="0" id="Fxbrl_20210224173128191_xbrl_20210224172752205" unitRef="USD">110334</ifrs-full:NoncurrentLeaseLiabilities>
  <ifrs-full:NoncurrentLeaseLiabilities contextRef="C_20190101" decimals="0" id="Fxbrl_20210224173128191_xbrl_20210224172755718" unitRef="USD">142549</ifrs-full:NoncurrentLeaseLiabilities>
  <ifrs-full:NoncurrentLeaseLiabilities contextRef="C_20181231_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullPreviouslyStatedMember" decimals="0" id="Fxbrl_20210223184821907_202" unitRef="CAD">0</ifrs-full:NoncurrentLeaseLiabilities>
  <ifrs-full:NoncurrentLeaseLiabilities contextRef="C_20181231_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_hugeIncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember" decimals="0" id="Fxbrl_20210223184821907_205" unitRef="USD">0</ifrs-full:NoncurrentLeaseLiabilities>
  <ifrs-full:NoncurrentLeaseLiabilities contextRef="C_20181231" decimals="0" id="Fxbrl_20210223184821907_208" unitRef="USD">0</ifrs-full:NoncurrentLeaseLiabilities>
  <ifrs-full:NoncurrentLeaseLiabilities contextRef="C_20190101_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullIncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" decimals="0" id="Fxbrl_20210223184821907_2011" unitRef="USD">142549</ifrs-full:NoncurrentLeaseLiabilities>
  <ifrs-full:Liabilities contextRef="C_20201231" decimals="0" id="Fxbrl_20210224173240530_xbrl_20210224172748667" unitRef="USD">5658622</ifrs-full:Liabilities>
  <ifrs-full:Liabilities contextRef="C_20191231" decimals="0" id="Fxbrl_20210224173240530_xbrl_20210224172752205" unitRef="USD">6940250</ifrs-full:Liabilities>
  <ifrs-full:Liabilities contextRef="C_20190101" decimals="0" id="Fxbrl_20210224173240530_xbrl_20210224172755718" unitRef="USD">1495289</ifrs-full:Liabilities>
  <ifrs-full:Liabilities contextRef="C_20181231_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullPreviouslyStatedMember" decimals="0" id="Fxbrl_20210223190604976" unitRef="CAD">1743806</ifrs-full:Liabilities>
  <ifrs-full:Liabilities contextRef="C_20181231_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_hugeIncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember" decimals="0" id="Fxbrl_20210223190609629" unitRef="USD">-431941</ifrs-full:Liabilities>
  <ifrs-full:Liabilities contextRef="C_20181231" decimals="0" id="Fxbrl_20210223190621400" unitRef="USD">1311865</ifrs-full:Liabilities>
  <ifrs-full:Liabilities contextRef="C_20190101_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullIncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" decimals="0" id="Fxbrl_20210223190637288" unitRef="USD">183424</ifrs-full:Liabilities>
  <ifrs-full:IssuedCapital contextRef="C_20201231_ifrsfullClassesOfShareCapitalAxis_hugeClassACommonStockSharesMember" decimals="0" id="Fxbrl_20210224173135056_xbrl_20210224172748667" unitRef="USD">151588</ifrs-full:IssuedCapital>
  <ifrs-full:IssuedCapital contextRef="C_20191231_ifrsfullClassesOfShareCapitalAxis_hugeClassACommonStockSharesMember" decimals="0" id="Fxbrl_20210224173135056_xbrl_20210224172752205" unitRef="USD">151588</ifrs-full:IssuedCapital>
  <ifrs-full:IssuedCapital contextRef="C_20190101_ifrsfullClassesOfShareCapitalAxis_hugeClassACommonStockSharesMember" decimals="0" id="Fxbrl_20210224173135056_xbrl_20210224172755718" unitRef="USD">151588</ifrs-full:IssuedCapital>
  <ifrs-full:IssuedCapital contextRef="C_20201231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210224173137441_xbrl_20210224172748667" unitRef="USD">103056538</ifrs-full:IssuedCapital>
  <ifrs-full:IssuedCapital contextRef="C_20191231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210224173137441_xbrl_20210224172752205" unitRef="USD">73586337</ifrs-full:IssuedCapital>
  <ifrs-full:IssuedCapital contextRef="C_20190101_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210224173137441_xbrl_20210224172755718" unitRef="USD">51093434</ifrs-full:IssuedCapital>
  <ifrs-full:IssuedCapital contextRef="C_20181231_ifrsfullClassesOfShareCapitalAxis_hugeClassACommonStockSharesMember_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullPreviouslyStatedMember" decimals="0" id="Fxbrl_20210223184821907_232" unitRef="CAD">201500</ifrs-full:IssuedCapital>
  <ifrs-full:IssuedCapital contextRef="C_20181231_ifrsfullClassesOfShareCapitalAxis_hugeClassACommonStockSharesMember_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_hugeIncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember" decimals="0" id="Fxbrl_20210223184821907_235" unitRef="USD">-49912</ifrs-full:IssuedCapital>
  <ifrs-full:IssuedCapital contextRef="C_20181231_ifrsfullClassesOfShareCapitalAxis_hugeClassACommonStockSharesMember" decimals="0" id="Fxbrl_20210223184821907_238" unitRef="USD">151588</ifrs-full:IssuedCapital>
  <ifrs-full:IssuedCapital contextRef="C_20190101_ifrsfullClassesOfShareCapitalAxis_hugeClassACommonStockSharesMember_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullIncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" decimals="0" id="Fxbrl_20210223184821907_2311" unitRef="USD">0</ifrs-full:IssuedCapital>
  <ifrs-full:IssuedCapital contextRef="C_20181231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullPreviouslyStatedMember" decimals="0" id="Fxbrl_20210223184821907_242" unitRef="CAD">67916302</ifrs-full:IssuedCapital>
  <ifrs-full:IssuedCapital contextRef="C_20181231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_hugeIncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember" decimals="0" id="Fxbrl_20210223184821907_245" unitRef="USD">-16822868</ifrs-full:IssuedCapital>
  <ifrs-full:IssuedCapital contextRef="C_20181231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210223184821907_248" unitRef="USD">51093434</ifrs-full:IssuedCapital>
  <ifrs-full:IssuedCapital contextRef="C_20190101_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullIncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" decimals="0" id="Fxbrl_20210223184821907_2411" unitRef="USD">0</ifrs-full:IssuedCapital>
  <ifrs-full:IssuedCapital contextRef="C_20201231" decimals="0" id="Fxbrl_20200220045842293" unitRef="USD">103208126</ifrs-full:IssuedCapital>
  <ifrs-full:IssuedCapital contextRef="C_20191231" decimals="0" id="Fxbrl_20200220045835704" unitRef="USD">73737925</ifrs-full:IssuedCapital>
  <huge:Warrants contextRef="C_20201231" decimals="0" id="Fxbrl_20210224173140297_xbrl_20210224172748667" unitRef="USD">4968958</huge:Warrants>
  <huge:Warrants contextRef="C_20191231" decimals="0" id="Fxbrl_20210224173140297_xbrl_20210224172752205" unitRef="USD">4321989</huge:Warrants>
  <huge:Warrants contextRef="C_20190101" decimals="0" id="Fxbrl_20210224173140297_xbrl_20210224172755718" unitRef="USD">3341826</huge:Warrants>
  <huge:Warrants contextRef="C_20181231_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullPreviouslyStatedMember" decimals="0" id="Fxbrl_20210223184821907_252" unitRef="CAD">4442145</huge:Warrants>
  <huge:Warrants contextRef="C_20181231_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_hugeIncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember" decimals="0" id="Fxbrl_20210223184821907_255" unitRef="USD">-1100319</huge:Warrants>
  <huge:Warrants contextRef="C_20181231" decimals="0" id="Fxbrl_20210223184821907_258" unitRef="USD">3341826</huge:Warrants>
  <huge:Warrants contextRef="C_20190101_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullIncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" decimals="0" id="Fxbrl_20210223184821907_2511" unitRef="USD">0</huge:Warrants>
  <ifrs-full:SharePremium contextRef="C_20201231" decimals="0" id="Fxbrl_20210224173142680_xbrl_20210224172748667" unitRef="USD">18792590</ifrs-full:SharePremium>
  <ifrs-full:SharePremium contextRef="C_20191231" decimals="0" id="Fxbrl_20210224173142680_xbrl_20210224172752205" unitRef="USD">17371434</ifrs-full:SharePremium>
  <ifrs-full:SharePremium contextRef="C_20190101" decimals="0" id="Fxbrl_20210224173142680_xbrl_20210224172755718" unitRef="USD">3744423</ifrs-full:SharePremium>
  <ifrs-full:SharePremium contextRef="C_20181231_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullPreviouslyStatedMember" decimals="0" id="Fxbrl_20210223184821907_262" unitRef="CAD">4977300</ifrs-full:SharePremium>
  <ifrs-full:SharePremium contextRef="C_20181231_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_hugeIncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember" decimals="0" id="Fxbrl_20210223184821907_265" unitRef="USD">-1232877</ifrs-full:SharePremium>
  <ifrs-full:SharePremium contextRef="C_20181231" decimals="0" id="Fxbrl_20210223184821907_268" unitRef="USD">3744423</ifrs-full:SharePremium>
  <ifrs-full:SharePremium contextRef="C_20190101_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullIncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" decimals="0" id="Fxbrl_20210223184821907_2611" unitRef="USD">0</ifrs-full:SharePremium>
  <ifrs-full:ReserveOfExchangeDifferencesOnTranslation contextRef="C_20201231" decimals="0" id="Fxbrl_20210224173145089_xbrl_20210224172748667" unitRef="USD">207797</ifrs-full:ReserveOfExchangeDifferencesOnTranslation>
  <ifrs-full:ReserveOfExchangeDifferencesOnTranslation contextRef="C_20191231" decimals="0" id="Fxbrl_20210224173145089_xbrl_20210224172752205" unitRef="USD">-84776</ifrs-full:ReserveOfExchangeDifferencesOnTranslation>
  <ifrs-full:ReserveOfExchangeDifferencesOnTranslation contextRef="C_20190101" decimals="0" id="Fxbrl_20210224173145089_xbrl_20210224172755718" unitRef="USD">0</ifrs-full:ReserveOfExchangeDifferencesOnTranslation>
  <ifrs-full:RetainedEarnings contextRef="C_20201231" decimals="0" id="Fxbrl_20210224173147298_xbrl_20210224172748667" unitRef="USD">-90868888</ifrs-full:RetainedEarnings>
  <ifrs-full:RetainedEarnings contextRef="C_20191231" decimals="0" id="Fxbrl_20210224173147298_xbrl_20210224172752205" unitRef="USD">-59069095</ifrs-full:RetainedEarnings>
  <ifrs-full:RetainedEarnings contextRef="C_20190101" decimals="0" id="Fxbrl_20210224173147298_xbrl_20210224172755718" unitRef="USD">-19939575</ifrs-full:RetainedEarnings>
  <ifrs-full:RetainedEarnings contextRef="C_20181231_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullPreviouslyStatedMember" decimals="0" id="Fxbrl_20210223184821907_272" unitRef="CAD">-26504819</ifrs-full:RetainedEarnings>
  <ifrs-full:RetainedEarnings contextRef="C_20181231_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_hugeIncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember" decimals="0" id="Fxbrl_20210223184821907_275" unitRef="USD">6565244</ifrs-full:RetainedEarnings>
  <ifrs-full:RetainedEarnings contextRef="C_20181231" decimals="0" id="Fxbrl_20210223184821907_278" unitRef="USD">-19939575</ifrs-full:RetainedEarnings>
  <ifrs-full:RetainedEarnings contextRef="C_20190101_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullIncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" decimals="0" id="Fxbrl_20210223184821907_2711" unitRef="USD">0</ifrs-full:RetainedEarnings>
  <ifrs-full:Equity contextRef="C_20201231" decimals="0" id="Fxbrl_20210224173243568_xbrl_20210224172748667" unitRef="USD">36308583</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="C_20191231" decimals="0" id="Fxbrl_20210224173243568_xbrl_20210224172752205" unitRef="USD">36277477</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="C_20190101" decimals="0" id="Fxbrl_20210224173243568_xbrl_20210224172755718" unitRef="USD">38391696</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="C_20190101_ifrsfullClassesOfShareCapitalAxis_hugeClassACommonStockSharesMember" decimals="0" id="Fxbrl_20210224152655725_xbrl_20200220155257986" unitRef="USD">151588</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="C_20190101_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210224152655725_xbrl_20200220155322458" unitRef="USD">51093434</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="C_20190101_ifrsfullComponentsOfEquityAxis_hugeWarrantsMember" decimals="0" id="Fxbrl_20210224152655725_xbrl_20200220155350025" unitRef="USD">3341826</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="C_20190101_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember" decimals="0" id="Fxbrl_20210224152655725_xbrl_20200220155424631" unitRef="USD">3744423</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="C_20190101_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" decimals="0" id="Fxbrl_20210224152655725_xbrl_20200220155612448" unitRef="USD">-19939575</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="C_20191231_ifrsfullClassesOfShareCapitalAxis_hugeClassACommonStockSharesMember" decimals="0" id="Fxbrl_20210224153344429_xbrl_20200220163202328" unitRef="USD">151588</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="C_20191231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210224153344429_xbrl_20200220163254378" unitRef="USD">73586337</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="C_20191231_ifrsfullComponentsOfEquityAxis_hugeWarrantsMember" decimals="0" id="Fxbrl_20210224153344429_xbrl_20200220164216457" unitRef="USD">4321989</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="C_20191231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember" decimals="0" id="Fxbrl_20210224153344429_xbrl_20200220164435700" unitRef="USD">17371434</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="C_20191231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" decimals="0" id="Fxbrl_20210224153344429_xbrl_20200220164456080" unitRef="USD">-84776</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="C_20191231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" decimals="0" id="Fxbrl_20210224153344429_xbrl_20200220164606342" unitRef="USD">-59069095</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="C_20201231_ifrsfullClassesOfShareCapitalAxis_hugeClassACommonStockSharesMember" decimals="0" id="Fxbrl_20210224153901415_xbrl_20200220163202328" unitRef="USD">151588</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="C_20201231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210224153901415_xbrl_20200220163254378" unitRef="USD">103056538</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="C_20201231_ifrsfullComponentsOfEquityAxis_hugeWarrantsMember" decimals="0" id="Fxbrl_20210224153901415_xbrl_20200220164216457" unitRef="USD">4968958</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember" decimals="0" id="Fxbrl_20210224153901415_xbrl_20200220164435700" unitRef="USD">18792590</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" decimals="0" id="Fxbrl_20210224153901415_xbrl_20200220164456080" unitRef="USD">207797</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" decimals="0" id="Fxbrl_20210224153901415_xbrl_20200220164606342" unitRef="USD">-90868888</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="C_20181231_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullPreviouslyStatedMember" decimals="0" id="Fxbrl_20210223190705062" unitRef="CAD">51032428</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="C_20181231_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_hugeIncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember" decimals="0" id="Fxbrl_20210223190700896" unitRef="USD">-12640732</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="C_20181231" decimals="0" id="Fxbrl_20210223190656062" unitRef="USD">38391696</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="C_20190101_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullIncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" decimals="0" id="Fxbrl_20210223190651577" unitRef="USD">0</ifrs-full:Equity>
  <ifrs-full:EquityAndLiabilities contextRef="C_20201231" decimals="0" id="Fxbrl_20210224173245917_xbrl_20210224172748667" unitRef="USD">41967205</ifrs-full:EquityAndLiabilities>
  <ifrs-full:EquityAndLiabilities contextRef="C_20191231" decimals="0" id="Fxbrl_20210224173245917_xbrl_20210224172752205" unitRef="USD">43217727</ifrs-full:EquityAndLiabilities>
  <ifrs-full:EquityAndLiabilities contextRef="C_20190101" decimals="0" id="Fxbrl_20210224173245917_xbrl_20210224172755718" unitRef="USD">39886985</ifrs-full:EquityAndLiabilities>
  <ifrs-full:EquityAndLiabilities contextRef="C_20181231_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullPreviouslyStatedMember" decimals="0" id="Fxbrl_20210223190709952" unitRef="CAD">52776234</ifrs-full:EquityAndLiabilities>
  <ifrs-full:EquityAndLiabilities contextRef="C_20181231_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_hugeIncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember" decimals="0" id="Fxbrl_20210223190715296" unitRef="USD">-13072673</ifrs-full:EquityAndLiabilities>
  <ifrs-full:EquityAndLiabilities contextRef="C_20181231" decimals="0" id="Fxbrl_20210223190720660" unitRef="USD">39703561</ifrs-full:EquityAndLiabilities>
  <ifrs-full:EquityAndLiabilities contextRef="C_20190101_ifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfullIncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" decimals="0" id="Fxbrl_20210223190725278" unitRef="USD">183424</ifrs-full:EquityAndLiabilities>
  <ifrs-full:GeneralAndAdministrativeExpense contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224182525370_43" unitRef="USD">10058083</ifrs-full:GeneralAndAdministrativeExpense>
  <ifrs-full:GeneralAndAdministrativeExpense contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224183109897_xbrl_20210224182525370_43" unitRef="USD">8407427</ifrs-full:GeneralAndAdministrativeExpense>
  <ifrs-full:GeneralAndAdministrativeExpense contextRef="C_20200101to20201231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224174851354_133" unitRef="USD">1665541</ifrs-full:GeneralAndAdministrativeExpense>
  <ifrs-full:GeneralAndAdministrativeExpense contextRef="C_20190102to20191231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224174851354_136" unitRef="USD">2735286</ifrs-full:GeneralAndAdministrativeExpense>
  <ifrs-full:ResearchAndDevelopmentExpense contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224182525370_53" unitRef="USD">7832847</ifrs-full:ResearchAndDevelopmentExpense>
  <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224182525370_63" unitRef="USD">8052011</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
  <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224183109907_xbrl_20210224182525370_63" unitRef="USD">12082930</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224182525370_73" unitRef="USD">3900458</ifrs-full:DepreciationAndAmortisationExpense>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224183109911_xbrl_20210224182525370_73" unitRef="USD">1943048</ifrs-full:DepreciationAndAmortisationExpense>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="C_20200101to20201231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224174851354_143" unitRef="USD">90340</ifrs-full:DepreciationAndAmortisationExpense>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="C_20190102to20191231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224174851354_146" unitRef="USD">424199</ifrs-full:DepreciationAndAmortisationExpense>
  <huge:LegalProvision contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224182525370_83" unitRef="USD">757829</huge:LegalProvision>
  <huge:ImpairmentLossOnRightOfUseAsset contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224182525370_93" unitRef="USD">89860</huge:ImpairmentLossOnRightOfUseAsset>
  <huge:ImpairmentLossOnRightOfUseAsset contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224183109920_xbrl_20210224182525370_93" unitRef="USD">50888</huge:ImpairmentLossOnRightOfUseAsset>
  <ifrs-full:ExpenseByNature contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224182525370_103" unitRef="USD">30691088</ifrs-full:ExpenseByNature>
  <ifrs-full:ExpenseByNature contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224183109925_xbrl_20210224182525370_103" unitRef="USD">22484293</ifrs-full:ExpenseByNature>
  <ifrs-full:ProfitLossFromOperatingActivities contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224182525370_123" unitRef="USD">-30691088</ifrs-full:ProfitLossFromOperatingActivities>
  <ifrs-full:ProfitLossFromOperatingActivities contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224183109930_xbrl_20210224182525370_123" unitRef="USD">-22484293</ifrs-full:ProfitLossFromOperatingActivities>
  <ifrs-full:OtherIncome contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224182525370_143" unitRef="USD">3691</ifrs-full:OtherIncome>
  <ifrs-full:OtherIncome contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224183109934_xbrl_20210224182525370_143" unitRef="USD">40454</ifrs-full:OtherIncome>
  <ifrs-full:OtherIncome contextRef="C_20200101to20201231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224174851354_203" unitRef="USD">-79568</ifrs-full:OtherIncome>
  <ifrs-full:OtherIncome contextRef="C_20190102to20191231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224174851354_206" unitRef="USD">-53987</ifrs-full:OtherIncome>
  <ifrs-full:FinanceCosts contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224182525370_153" unitRef="USD">235581</ifrs-full:FinanceCosts>
  <ifrs-full:FinanceCosts contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224183109938_xbrl_20210224182525370_153" unitRef="USD">155316</ifrs-full:FinanceCosts>
  <huge:GainLossOnSettlementOfFinancialLiability contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224182525370_173" unitRef="USD">680164</huge:GainLossOnSettlementOfFinancialLiability>
  <huge:GainLossOnSettlementOfFinancialLiability contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224183109948_xbrl_20210224182525370_173" unitRef="USD">-18665</huge:GainLossOnSettlementOfFinancialLiability>
  <huge:GainLossOnSettlementOfFinancialLiability contextRef="C_20200401to20200415_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210223115058403" unitRef="USD">40409</huge:GainLossOnSettlementOfFinancialLiability>
  <ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224182525370_183" unitRef="USD">2561456</ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives>
  <ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224183109952_xbrl_20210224182525370_183" unitRef="USD">-2684436</ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives>
  <huge:LossGainOnChangesInFairValueOfOtherInvestments contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224182525370_193" unitRef="USD">770874</huge:LossGainOnChangesInFairValueOfOtherInvestments>
  <huge:LossGainOnChangesInFairValueOfOtherInvestments contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224183109956_xbrl_20210224182525370_193" unitRef="USD">8778707</huge:LossGainOnChangesInFairValueOfOtherInvestments>
  <ifrs-full:ProfitLossFromContinuingOperations contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224182525370_203" unitRef="USD">-28452232</ifrs-full:ProfitLossFromContinuingOperations>
  <ifrs-full:ProfitLossFromContinuingOperations contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224183109962_xbrl_20210224182525370_203" unitRef="USD">-34080963</ifrs-full:ProfitLossFromContinuingOperations>
  <ifrs-full:ProfitLossFromDiscontinuedOperations contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224182525370_223" unitRef="USD">-3347561</ifrs-full:ProfitLossFromDiscontinuedOperations>
  <ifrs-full:ProfitLossFromDiscontinuedOperations contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224183109967_xbrl_20210224182525370_223" unitRef="USD">-5048557</ifrs-full:ProfitLossFromDiscontinuedOperations>
  <ifrs-full:ProfitLossFromDiscontinuedOperations contextRef="C_20200101to20201231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224174851354_223" unitRef="USD">-3347561</ifrs-full:ProfitLossFromDiscontinuedOperations>
  <ifrs-full:ProfitLossFromDiscontinuedOperations contextRef="C_20190102to20191231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224174851354_226" unitRef="USD">-5048557</ifrs-full:ProfitLossFromDiscontinuedOperations>
  <ifrs-full:ProfitLoss contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224182525370_233" unitRef="USD">-31799793</ifrs-full:ProfitLoss>
  <ifrs-full:ProfitLoss contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224183109971_xbrl_20210224182525370_233" unitRef="USD">-39129520</ifrs-full:ProfitLoss>
  <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224182525370_273" unitRef="USD">292573</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
  <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224183109976_xbrl_20210224182525370_273" unitRef="USD">-84776</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
  <ifrs-full:ComprehensiveIncome contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224182525370_283" unitRef="USD">-31507220</ifrs-full:ComprehensiveIncome>
  <ifrs-full:ComprehensiveIncome contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224183109980_xbrl_20210224182525370_283" unitRef="USD">-39214296</ifrs-full:ComprehensiveIncome>
  <ifrs-full:ComprehensiveIncome contextRef="C_20190102to20191231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" decimals="0" id="Fxbrl_20210224153310282_xbrl_20200220162639912" unitRef="USD">-84776</ifrs-full:ComprehensiveIncome>
  <ifrs-full:ComprehensiveIncome contextRef="C_20190102to20191231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" decimals="0" id="Fxbrl_20210224153310282_xbrl_20200220162710132" unitRef="USD">-39129520</ifrs-full:ComprehensiveIncome>
  <ifrs-full:ComprehensiveIncome contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" decimals="0" id="Fxbrl_20210224153829975_xbrl_20200220162639912" unitRef="USD">292573</ifrs-full:ComprehensiveIncome>
  <ifrs-full:ComprehensiveIncome contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" decimals="0" id="Fxbrl_20210224153829975_xbrl_20200220162710132" unitRef="USD">-31799793</ifrs-full:ComprehensiveIncome>
  <ifrs-full:BasicAndDilutedEarningsLossPerShareFromContinuingOperations contextRef="C_20200101to20201231" decimals="2" id="Fxbrl_20210224182525370_313" unitRef="USD_per_Share">-2.36</ifrs-full:BasicAndDilutedEarningsLossPerShareFromContinuingOperations>
  <ifrs-full:BasicAndDilutedEarningsLossPerShareFromContinuingOperations contextRef="C_20190102to20191231" decimals="2" id="Fxbrl_20210224183109985_xbrl_20210224182525370_313" unitRef="USD_per_Share">-4.83</ifrs-full:BasicAndDilutedEarningsLossPerShareFromContinuingOperations>
  <ifrs-full:BasicAndDilutedEarningsLossPerShareFromDiscontinuedOperations contextRef="C_20200101to20201231" decimals="2" id="Fxbrl_20210224182525370_323" unitRef="USD_per_Share">-0.28</ifrs-full:BasicAndDilutedEarningsLossPerShareFromDiscontinuedOperations>
  <ifrs-full:BasicAndDilutedEarningsLossPerShareFromDiscontinuedOperations contextRef="C_20190102to20191231" decimals="2" id="Fxbrl_20210224183109989_xbrl_20210224182525370_323" unitRef="USD_per_Share">-0.72</ifrs-full:BasicAndDilutedEarningsLossPerShareFromDiscontinuedOperations>
  <ifrs-full:AdjustedWeightedAverageShares contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224182525370_343" unitRef="shares">12043961</ifrs-full:AdjustedWeightedAverageShares>
  <ifrs-full:AdjustedWeightedAverageShares contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224183109995_xbrl_20210224182525370_343" unitRef="shares">7056245</ifrs-full:AdjustedWeightedAverageShares>
  <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20200220173636660" unitRef="USD">3900458</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
  <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20200220173656353" unitRef="USD">1943048</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
  <ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224173217480" unitRef="USD">89860</ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224173237247" unitRef="USD">183161</ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:AdjustmentsForInterestExpense contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224173353258" unitRef="USD">7860</ifrs-full:AdjustmentsForInterestExpense>
  <ifrs-full:AdjustmentsForInterestExpense contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20200220173812663" unitRef="USD">155315</ifrs-full:AdjustmentsForInterestExpense>
  <ifrs-full:AdjustmentsForSharebasedPayments contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20200220173829498" unitRef="USD">8052011</ifrs-full:AdjustmentsForSharebasedPayments>
  <ifrs-full:AdjustmentsForSharebasedPayments contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20200220173843362" unitRef="USD">12082930</ifrs-full:AdjustmentsForSharebasedPayments>
  <ifrs-full:AdjustmentsForFairValueGainsLosses contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224173930452" unitRef="USD">770874</ifrs-full:AdjustmentsForFairValueGainsLosses>
  <ifrs-full:AdjustmentsForFairValueGainsLosses contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224174219566" unitRef="USD">8778707</ifrs-full:AdjustmentsForFairValueGainsLosses>
  <ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224174305663" unitRef="USD">2561456</ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives>
  <ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20200220174038496" unitRef="USD">-2684436</ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives>
  <ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224175825459" unitRef="USD">-327161</ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains>
  <huge:GainOnSettlementOfFinancialLiability contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224180401389" unitRef="USD">680164</huge:GainOnSettlementOfFinancialLiability>
  <huge:GainOnSettlementOfFinancialLiability contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210304005222449" unitRef="USD">-18665</huge:GainOnSettlementOfFinancialLiability>
  <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224180516501" unitRef="USD">435183</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables>
  <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224180525272" unitRef="USD">-387837</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables>
  <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables contextRef="C_20200101to20201231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224175956106_132" unitRef="USD">960778</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables>
  <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables contextRef="C_20190102to20191231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224175956106_135" unitRef="USD">-423945</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables>
  <huge:AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20200220174451412" unitRef="USD">-526738</huge:AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit>
  <huge:AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224222800260" unitRef="USD">-24214</huge:AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit>
  <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224180705802" unitRef="USD">898691</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables>
  <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224181650332" unitRef="USD">1516025</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables>
  <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables contextRef="C_20200101to20201231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224175956106_172" unitRef="USD">63861</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables>
  <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables contextRef="C_20190102to20191231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224175956106_175" unitRef="USD">-895286</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables>
  <ifrs-full:CashFlowsFromUsedInOperatingActivitiesContinuingOperations contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224181757135_182" unitRef="USD">-18392814</ifrs-full:CashFlowsFromUsedInOperatingActivitiesContinuingOperations>
  <ifrs-full:CashFlowsFromUsedInOperatingActivitiesContinuingOperations contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224181757135_185" unitRef="USD">-7130727</ifrs-full:CashFlowsFromUsedInOperatingActivitiesContinuingOperations>
  <ifrs-full:CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224181757135_192" unitRef="USD">-737659</ifrs-full:CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations>
  <ifrs-full:CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224181757135_195" unitRef="USD">-6581998</ifrs-full:CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations>
  <ifrs-full:CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations contextRef="C_20200101to20201231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224175956106_182" unitRef="USD">-737659</ifrs-full:CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations>
  <ifrs-full:CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations contextRef="C_20190102to20191231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224175956106_185" unitRef="USD">-6581998</ifrs-full:CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations>
  <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224214225813" unitRef="USD">-19130473</ifrs-full:CashFlowsFromUsedInOperatingActivities>
  <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224214247171" unitRef="USD">-13712725</ifrs-full:CashFlowsFromUsedInOperatingActivities>
  <huge:CashAcquiredOnAcquisition contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20200220175537995" unitRef="USD">1752</huge:CashAcquiredOnAcquisition>
  <ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224181757135_242" unitRef="USD">6477510</ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20200220175951906" unitRef="USD">462303</ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190102to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173437986" unitRef="USD">0</ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190102to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeCannaraBiotechIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173437986" unitRef="USD">0</ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190102to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeCloverCannastripThinFilmTechnologiesCorpMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224125620278_xbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173437986" unitRef="USD">0</ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190102to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeHighTideIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224125710374_xbrl_20210224125620278_xbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173437986" unitRef="USD">462303</ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190102to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeHighTideIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_hugeWarrantsMember" decimals="0" id="Fxbrl_20210224125942735_xbrl_20210224125710374_xbrl_20210224125620278_xbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173437986" unitRef="USD">0</ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190102to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeHugeShopsMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224125924314_xbrl_20210224125800887_xbrl_20210224125710374_xbrl_20210224125620278_xbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173437986" unitRef="USD">0</ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190102to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeScicannTherapeuticsIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224130103018_xbrl_20210224125924314_xbrl_20210224125800887_xbrl_20210224125710374_xbrl_20210224125620278_xbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173437986" unitRef="USD">0</ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190102to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224130204478_xbrl_20210224130103018_xbrl_20210224125924314_xbrl_20210224125800887_xbrl_20210224125710374_xbrl_20210224125620278_xbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173437986" unitRef="USD">0</ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190102to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_hugeWarrantsMember" decimals="0" id="Fxbrl_20210224130406983_xbrl_20210224130204478_xbrl_20210224130103018_xbrl_20210224125924314_xbrl_20210224125800887_xbrl_20210224125710374_xbrl_20210224125620278_xbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173437986" unitRef="USD">0</ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190102to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_hugeConvertibleDebentureMember" decimals="0" id="Fxbrl_20210224130511263_xbrl_20210224130406983_xbrl_20210224130204478_xbrl_20210224130103018_xbrl_20210224125924314_xbrl_20210224125800887_xbrl_20210224125710374_xbrl_20210224125620278_xbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173437986" unitRef="USD">0</ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224123305188_xbrl_20200219173437986" unitRef="USD">652081</ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeCannaraBiotechIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224123515633_xbrl_20210224123305188_xbrl_20200219173437986" unitRef="USD">5825429</ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeCloverCannastripThinFilmTechnologiesCorpMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224123646446_xbrl_20210224123515633_xbrl_20210224123305188_xbrl_20200219173437986" unitRef="USD">0</ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeHugeShopsMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224124229548_xbrl_20210224123646446_xbrl_20210224123515633_xbrl_20210224123305188_xbrl_20200219173437986" unitRef="USD">0</ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeScicannTherapeuticsIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224124342226_xbrl_20210224124229548_xbrl_20210224123646446_xbrl_20210224123515633_xbrl_20210224123305188_xbrl_20200219173437986" unitRef="USD">0</ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224124507412_xbrl_20210224124342226_xbrl_20210224124229548_xbrl_20210224123646446_xbrl_20210224123515633_xbrl_20210224123305188_xbrl_20200219173437986" unitRef="USD">0</ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_hugeWarrantsMember" decimals="0" id="Fxbrl_20210224124703291_xbrl_20210224124507412_xbrl_20210224124342226_xbrl_20210224124229548_xbrl_20210224123646446_xbrl_20210224123515633_xbrl_20210224123305188_xbrl_20200219173437986" unitRef="USD">0</ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_hugeConvertibleDebentureMember" decimals="0" id="Fxbrl_20210224124822994_xbrl_20210224124703291_xbrl_20210224124507412_xbrl_20210224124342226_xbrl_20210224124229548_xbrl_20210224123646446_xbrl_20210224123515633_xbrl_20210224123305188_xbrl_20200219173437986" unitRef="USD">0</ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember" decimals="0" id="Fxbrl_20210224113041970" unitRef="USD">652081</ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20200201to20200205_hugeOtherInvestmentsNameOfEntityAxis_hugeCannaraBiotechIncMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210224114032521" unitRef="USD">5825429</ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224213804942" unitRef="USD">293126</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
  <ifrs-full:CashFlowsFromUsedInInvestingActivitiesContinuingOperations contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224181757135_262" unitRef="USD">6477510</ifrs-full:CashFlowsFromUsedInInvestingActivitiesContinuingOperations>
  <ifrs-full:CashFlowsFromUsedInInvestingActivitiesContinuingOperations contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224181757135_265" unitRef="USD">170929</ifrs-full:CashFlowsFromUsedInInvestingActivitiesContinuingOperations>
  <ifrs-full:CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224181757135_272" unitRef="USD">36616</ifrs-full:CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations>
  <ifrs-full:CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224181757135_275" unitRef="USD">-401817</ifrs-full:CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations>
  <ifrs-full:CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations contextRef="C_20200101to20201231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224175956106_232" unitRef="USD">36616</ifrs-full:CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations>
  <ifrs-full:CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations contextRef="C_20190102to20191231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224175956106_235" unitRef="USD">-401817</ifrs-full:CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations>
  <ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224212757397" unitRef="USD">6514126</ifrs-full:CashFlowsFromUsedInInvestingActivities>
  <ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224181757135_285" unitRef="USD">-230888</ifrs-full:CashFlowsFromUsedInInvestingActivities>
  <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224181757135_312" unitRef="USD">39993</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
  <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20200227161115005" unitRef="USD">42285</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
  <ifrs-full:ProceedsFromIssuingShares contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20200220180246929" unitRef="USD">25100459</ifrs-full:ProceedsFromIssuingShares>
  <ifrs-full:ProceedsFromIssuingShares contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20200220180252548" unitRef="USD">3431294</ifrs-full:ProceedsFromIssuingShares>
  <ifrs-full:ProceedsFromIssuingShares contextRef="C_20191101to20191104_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20200219223035268" unitRef="USD">3455898</ifrs-full:ProceedsFromIssuingShares>
  <ifrs-full:ProceedsFromIssuingShares contextRef="C_20200101to20201231_hugeLegalEntitiesAxis_hugeAllianceGlobalPartnersMember_hugeTypeOfArrangementsAxis_hugeEquityDistributionAgreementMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210223124942047" unitRef="USD">199785</ifrs-full:ProceedsFromIssuingShares>
  <ifrs-full:ProceedsFromIssuingShares contextRef="C_20210201to20210210_hugeTypeOfArrangementsAxis_hugeEquityDistributionAgreementMember_ifrsfullCategoriesOfRelatedPartiesAxis_hugeAllianceGlobalPartnersMember_ifrsfullClassesOfOrdinarySharesAxis_hugeClassBCommonSharesMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_hugeSubsequentEventsMember" decimals="0" id="Fxbrl_20210224174538733" unitRef="USD">19770762</ifrs-full:ProceedsFromIssuingShares>
  <ifrs-full:ProceedsFromIssuingShares contextRef="C_20210212to20210312_hugeTypeOfArrangementsAxis_hugeEquityDistributionAgreementMember_ifrsfullCategoriesOfRelatedPartiesAxis_hugeAllianceGlobalPartnersMember_ifrsfullClassesOfOrdinarySharesAxis_hugeClassBCommonSharesMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_hugeSubsequentEventsMember" decimals="0" id="Fxbrl_20210224175425762" unitRef="USD">18167511</ifrs-full:ProceedsFromIssuingShares>
  <ifrs-full:ProceedsFromIssuingShares contextRef="C_20210101to20210217_ifrsfullCategoriesOfRelatedPartiesAxis_hugeDirectorsAndOfficersMember_ifrsfullClassesOfOrdinarySharesAxis_hugeClassBCommonSharesMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_hugeSubsequentEventsMember" decimals="0" id="Fxbrl_20210304005947089" unitRef="USD">3576875</ifrs-full:ProceedsFromIssuingShares>
  <ifrs-full:RepaymentsOfBondsNotesAndDebentures contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224181757135_332" unitRef="USD">946643</ifrs-full:RepaymentsOfBondsNotesAndDebentures>
  <ifrs-full:RepaymentsOfBondsNotesAndDebentures contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224181757135_335" unitRef="USD">0</ifrs-full:RepaymentsOfBondsNotesAndDebentures>
  <ifrs-full:ProceedsFromExerciseOfOptions contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224181757135_342" unitRef="USD">59548</ifrs-full:ProceedsFromExerciseOfOptions>
  <ifrs-full:ProceedsFromExerciseOfOptions contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224181757135_345" unitRef="USD">551133</ifrs-full:ProceedsFromExerciseOfOptions>
  <huge:ProceedsFromExerciseOfWarrants contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224181757135_355" unitRef="USD">71461</huge:ProceedsFromExerciseOfWarrants>
  <ifrs-full:CashFlowsFromUsedInFinancingActivitiesContinuingOperations contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224181757135_362" unitRef="USD">24173371</ifrs-full:CashFlowsFromUsedInFinancingActivitiesContinuingOperations>
  <ifrs-full:CashFlowsFromUsedInFinancingActivitiesContinuingOperations contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224181757135_365" unitRef="USD">4011603</ifrs-full:CashFlowsFromUsedInFinancingActivitiesContinuingOperations>
  <ifrs-full:CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224181757135_372" unitRef="USD">0</ifrs-full:CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations>
  <ifrs-full:CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224181757135_375" unitRef="USD">0</ifrs-full:CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations>
  <ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20200220180351595" unitRef="USD">24173371</ifrs-full:CashFlowsFromUsedInFinancingActivities>
  <ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20200220180355564" unitRef="USD">4011603</ifrs-full:CashFlowsFromUsedInFinancingActivities>
  <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224181757135_402" unitRef="USD">11557024</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
  <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224181757135_405" unitRef="USD">-9932010</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
  <ifrs-full:NumberOfSharesOutstanding contextRef="C_20190101_ifrsfullClassesOfShareCapitalAxis_hugeClassACommonStockSharesMember" decimals="INF" id="Fxbrl_20210224152655725_xbrl_20200220155155053" unitRef="shares">72</ifrs-full:NumberOfSharesOutstanding>
  <ifrs-full:NumberOfSharesOutstanding contextRef="C_20190101_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20210224152655725_xbrl_20200220155201003" unitRef="shares">6843780</ifrs-full:NumberOfSharesOutstanding>
  <ifrs-full:NumberOfSharesOutstanding contextRef="C_20190101_ifrsfullComponentsOfEquityAxis_hugeWarrantsMember" decimals="INF" id="Fxbrl_20210224152655725_xbrl_20200220155214238" unitRef="shares">546212</ifrs-full:NumberOfSharesOutstanding>
  <ifrs-full:NumberOfSharesOutstanding contextRef="C_20191231_ifrsfullClassesOfShareCapitalAxis_hugeClassACommonStockSharesMember" decimals="INF" id="Fxbrl_20210224153344429_xbrl_20200220163143722" unitRef="shares">72</ifrs-full:NumberOfSharesOutstanding>
  <ifrs-full:NumberOfSharesOutstanding contextRef="C_20191231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20210224153344429_xbrl_20200220163216811" unitRef="shares">7905727</ifrs-full:NumberOfSharesOutstanding>
  <ifrs-full:NumberOfSharesOutstanding contextRef="C_20191231_ifrsfullComponentsOfEquityAxis_hugeWarrantsMember" decimals="INF" id="Fxbrl_20210224153344429_xbrl_20200220163319912" unitRef="shares">467451</ifrs-full:NumberOfSharesOutstanding>
  <ifrs-full:NumberOfSharesOutstanding contextRef="C_20201231_ifrsfullClassesOfShareCapitalAxis_hugeClassACommonStockSharesMember" decimals="INF" id="Fxbrl_20210224153901415_xbrl_20200220163143722" unitRef="shares">72</ifrs-full:NumberOfSharesOutstanding>
  <ifrs-full:NumberOfSharesOutstanding contextRef="C_20201231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20210224153901415_xbrl_20200220163216811" unitRef="shares">19161620</ifrs-full:NumberOfSharesOutstanding>
  <ifrs-full:NumberOfSharesOutstanding contextRef="C_20201231_ifrsfullComponentsOfEquityAxis_hugeWarrantsMember" decimals="INF" id="Fxbrl_20210224153901415_xbrl_20200220163319912" unitRef="shares">6749109</ifrs-full:NumberOfSharesOutstanding>
  <huge:IssuanceOfShares contextRef="C_20190102to20191231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20210224152756997_xbrl_20200220155759265" unitRef="shares">408651</huge:IssuanceOfShares>
  <huge:IssuanceOfShares contextRef="C_20200101to20201231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20210224160159229" unitRef="shares">8925942</huge:IssuanceOfShares>
  <huge:IssuanceOfShares contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_hugeWarrantsMember" decimals="INF" id="Fxbrl_20210224160231613" unitRef="shares">6335758</huge:IssuanceOfShares>
  <huge:IssuanceOfShares contextRef="C_20210101to20210217_ifrsfullCategoriesOfRelatedPartiesAxis_hugeDirectorsAndOfficersMember_ifrsfullClassesOfOrdinarySharesAxis_hugeClassBCommonSharesMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_hugeSubsequentEventsMember" decimals="INF" id="Fxbrl_20210304005904436" unitRef="shares">1349764</huge:IssuanceOfShares>
  <ifrs-full:IssueOfEquity contextRef="C_20190102to20191231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210224152756997_xbrl_20200220155830624" unitRef="USD">8681103</ifrs-full:IssueOfEquity>
  <ifrs-full:IssueOfEquity contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224152756997_xbrl_20200220155911792" unitRef="USD">8681103</ifrs-full:IssueOfEquity>
  <ifrs-full:IssueOfEquity contextRef="C_20200101to20201231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210224160215043" unitRef="USD">22242975</ifrs-full:IssueOfEquity>
  <ifrs-full:IssueOfEquity contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_hugeWarrantsMember" decimals="0" id="Fxbrl_20210224153527412_xbrl_20200220161743109" unitRef="USD">1110904</ifrs-full:IssueOfEquity>
  <ifrs-full:IssueOfEquity contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember" decimals="0" id="Fxbrl_20210224153527412_xbrl_20200220161831522" unitRef="USD">-1302076</ifrs-full:IssueOfEquity>
  <ifrs-full:IssueOfEquity contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224153527412_xbrl_20200220161851177" unitRef="USD">22051803</ifrs-full:IssueOfEquity>
  <huge:IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares contextRef="C_20190102to20191231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20210224153437571_xbrl_20200220164843884" unitRef="shares">510940</huge:IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares>
  <huge:IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares contextRef="C_20190102to20191231_ifrsfullComponentsOfEquityAxis_hugeWarrantsMember" decimals="INF" id="Fxbrl_20210224153437571_xbrl_20200220164920883" unitRef="shares">67598</huge:IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares>
  <huge:IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset contextRef="C_20190102to20191231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210224153437571_xbrl_20200220164859723" unitRef="USD">12361657</huge:IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset>
  <huge:IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset contextRef="C_20190102to20191231_ifrsfullComponentsOfEquityAxis_hugeWarrantsMember" decimals="0" id="Fxbrl_20210224153437571_xbrl_20200220165008286" unitRef="USD">1420407</huge:IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset>
  <huge:IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset contextRef="C_20190102to20191231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember" decimals="0" id="Fxbrl_20210224153437571_xbrl_20200220165019791" unitRef="USD">1931384</huge:IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset>
  <huge:IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224153437571_xbrl_20200220165031919" unitRef="USD">15713448</huge:IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="C_20190102to20191231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember" decimals="0" id="Fxbrl_20210224152920575_xbrl_20200220160700188" unitRef="USD">12082930</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224152920575_xbrl_20200220160722698" unitRef="USD">12082930</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="C_20200101to20201231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210224153707259_xbrl_20200220162126055" unitRef="USD">563747</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember" decimals="0" id="Fxbrl_20210224153707259_xbrl_20200220162144703" unitRef="USD">-504185</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224153707259_xbrl_20200220162203260" unitRef="USD">59562</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
  <huge:IncreaseDecreaseThroughShareBasedPaymentTransactionsShares contextRef="C_20190102to20191231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20210224162318092" unitRef="shares">130189</huge:IncreaseDecreaseThroughShareBasedPaymentTransactionsShares>
  <huge:IncreaseDecreaseThroughShareBasedPaymentTransactionsShares contextRef="C_20200101to20201231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20210224161332894" unitRef="shares">2307569</huge:IncreaseDecreaseThroughShareBasedPaymentTransactionsShares>
  <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="C_20190102to20191231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210224153014412_xbrl_20200220160515940" unitRef="USD">1340929</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
  <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="C_20190102to20191231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember" decimals="0" id="Fxbrl_20210224153014412_xbrl_20200220160542799" unitRef="USD">-789794</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
  <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224153014412_xbrl_20200220160557038" unitRef="USD">551135</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
  <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="C_20200101to20201231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210224161325893" unitRef="USD">6663479</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
  <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember" decimals="0" id="Fxbrl_20210224153629760_xbrl_20200220162029828" unitRef="USD">2763482</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
  <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224153629760_xbrl_20200220162051607" unitRef="USD">9426961</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
  <huge:IncreaseDecreaseThroughExerciseOfWarrantsShares contextRef="C_20190102to20191231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20210224153155398_xbrl_20200220162219502" unitRef="shares">12167</huge:IncreaseDecreaseThroughExerciseOfWarrantsShares>
  <huge:IncreaseDecreaseThroughExerciseOfWarrantsShares contextRef="C_20190102to20191231_ifrsfullComponentsOfEquityAxis_hugeWarrantsMember" decimals="INF" id="Fxbrl_20210224153155398_xbrl_20200220162303555" unitRef="shares">-12167</huge:IncreaseDecreaseThroughExerciseOfWarrantsShares>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity contextRef="C_20190102to20191231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210224153155398_xbrl_20200220162243061" unitRef="USD">109214</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity contextRef="C_20190102to20191231_ifrsfullComponentsOfEquityAxis_hugeWarrantsMember" decimals="0" id="Fxbrl_20210224153155398_xbrl_20200220162347565" unitRef="USD">-37753</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224153155398_xbrl_20200220162516660" unitRef="USD">71461</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
  <huge:IncreaseDecreaseThroughExpiryOfWarrantsShares contextRef="C_20190102to20191231_ifrsfullComponentsOfEquityAxis_hugeWarrantsMember" decimals="INF" id="Fxbrl_20210224153238155_xbrl_20200220162547560" unitRef="shares">-134192</huge:IncreaseDecreaseThroughExpiryOfWarrantsShares>
  <huge:IncreaseDecreaseThroughExpiryOfWarrantsShares contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_hugeWarrantsMember" decimals="INF" id="Fxbrl_20210224153748104_xbrl_20200220162547560" unitRef="shares">-54100</huge:IncreaseDecreaseThroughExpiryOfWarrantsShares>
  <huge:IncreaseDecreaseThroughExpiryOfWarrantsValue contextRef="C_20190102to20191231_ifrsfullComponentsOfEquityAxis_hugeWarrantsMember" decimals="0" id="Fxbrl_20210224153238155_xbrl_20200220162613512" unitRef="USD">-402491</huge:IncreaseDecreaseThroughExpiryOfWarrantsValue>
  <huge:IncreaseDecreaseThroughExpiryOfWarrantsValue contextRef="C_20190102to20191231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember" decimals="0" id="Fxbrl_20210224153238155_xbrl_20200229164613633" unitRef="USD">402491</huge:IncreaseDecreaseThroughExpiryOfWarrantsValue>
  <huge:IncreaseDecreaseThroughExpiryOfWarrantsValue contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_hugeWarrantsMember" decimals="0" id="Fxbrl_20210224153748104_xbrl_20200220162613512" unitRef="USD">-463935</huge:IncreaseDecreaseThroughExpiryOfWarrantsValue>
  <huge:IncreaseDecreaseThroughExpiryOfWarrantsValue contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember" decimals="0" id="Fxbrl_20210224153748104_xbrl_20200229164613633" unitRef="USD">463935</huge:IncreaseDecreaseThroughExpiryOfWarrantsValue>
  <huge:IncreaseDecreaseThroughExerciseOfOptionShares contextRef="C_20200101to20201231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20210224153707259_xbrl_20200220162107532" unitRef="shares">22382</huge:IncreaseDecreaseThroughExerciseOfOptionShares>
  <huge:DisclosureOfNatureOfBusinessExplanatoryTextBlock contextRef="C_20200101to20201231" id="Fxbrl_20210223162039947">
    &lt;div&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;1.&amp;#160; &amp;#160; &amp;#160; &amp;#160;&lt;/strong&gt;&lt;strong&gt;Nature of business &lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;FSD FSD Pharma Inc. (&amp;#x201c;FSD&amp;#x201d; or the &amp;#x201c;Company&amp;#x201d;), through its wholly owned subsidiary, FSD Biosciences Inc., is focused on Pharmaceutical research and development ("R&amp;amp;D") of its lead compound, FSD 201, ultra-micronized Palmitoyl ethylamine (&amp;#x201c;PEA&amp;#x201d;). FSD 201 is known to stabilize mast cells of the human body and down-regulate the pro-inflammatory cytokines to effectuate an anti-inflammatory response.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;FV Pharma Inc. ("FV Pharma"), a wholly owned subsidiary of the Company, was a licensed producer of cannabis in Canada under the Cannabis Act (Canada) (together with the regulations promulgated thereunder (the "Cannabis Regulations"), the "Cannabis Act") and associated Cannabis Regulations. FV Pharma surrendered its cannabis license in September 2020. In March 2020, substantially all the assets of FV Pharma were classified as held for sale (refer to Note 5).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Company's registered office is located at 1 Rossland Road West, Suite 202, Ajax, Ontario, L1Z 1Z2.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;On October 16, 2019, the Company completed a reverse share split of 201 to 1 Class B Shares. All share and per share amounts for all periods presented in these financial statements have been adjusted retrospectively to reflect the reverse share split.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Subsidiaries&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;These consolidated financial statements are comprised of the financial results of the Company and its subsidiaries, which are the entities over which FSD has control. An investor controls an investee when it is exposed, or has rights, to variable returns from its involvement with the investee and can affect those returns through its power over the investee.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Company has the following subsidiaries:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-align:left"&gt;&amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160;&amp;#160;&amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;div&gt;
                &lt;div&gt;

                    &lt;table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;
                      &lt;tbody&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td colspan="1" style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td colspan="7" style="vertical-align:bottom;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Ownership percentage as at&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Entity Name&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Country&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;December&amp;#160; 31, 2020&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;December&amp;#160; 31, 2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;January 1, 2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;%&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;%&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;%&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;FSD Biosciences Inc.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;USA&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Prismic Pharmaceuticals Inc.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;USA&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;FV Pharma Inc.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Canada&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                        &lt;/tr&gt;
                      &lt;/tbody&gt;
                    &lt;/table&gt;

                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
      &lt;p&gt;&lt;br/&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Impact of COVID-19&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The outbreak of the novel strain of coronavirus, specifically identified as "COVID-19," has resulted in governments worldwide enacting emergency measures to combat the spread of the virus. These measures, which include the implementation of travel bans, self-imposed quarantine periods and social distancing, have caused material disruption to businesses globally resulting in an economic slowdown. Governments and central banks have reacted with significant monetary and fiscal interventions designed to stabilize economic conditions. The extent to which COVID-19 and any other pandemic or public health crisis impacts the Company's business, affairs, operations, financial condition, liquidity, availability of credit and results of operations will depend on future developments that are highly uncertain and cannot be predicted with any meaningful precision, including new information which may emerge concerning the severity of the COVID-19 virus and the actions required to contain the COVID-19 virus or remedy its impact, among others. The duration and impact of the COVID-19 outbreak is unknown at this time, as is the efficacy of the government and central bank interventions. It is not possible to reliably estimate the length and severity of these developments and the impact on the financial results and condition of the Company and its operating subsidiaries in future periods.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In order to mitigate the impact of COVID-19, the Company implemented a systematic and orderly scale back of FV Pharma's cultivation operations and a furlough policy for its workforce, except for certain personnel working staggered shifts to ensure continuity of operations and licensure effective March 23, 2020. In September 2020, FV Pharma surrendered its licenses and ceased all other operational activities. The Company&amp;#x2019;s clinical trials for the use of FSD-201, its lead compound, to treat suspected or confirmed cases of COVID-19 continued to proceed throughout the year and as a result the impact of COVID-19 did not have a material impact on the continuing operations or financial results of the Company for the year ended December 31, 2020.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </huge:DisclosureOfNatureOfBusinessExplanatoryTextBlock>
  <ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20210224181545794">
                    &lt;table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;
                      &lt;tbody&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td colspan="1" style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td colspan="7" style="vertical-align:bottom;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Ownership percentage as at&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Entity Name&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Country&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;December&amp;#160; 31, 2020&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;December&amp;#160; 31, 2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;January 1, 2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;%&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;%&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;%&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;FSD Biosciences Inc.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;USA&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Prismic Pharmaceuticals Inc.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;USA&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;FV Pharma Inc.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Canada&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                        &lt;/tr&gt;
                      &lt;/tbody&gt;
                    &lt;/table&gt;
                  </ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="C_20200101to20201231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_ifrsfullSubsidiariesMember" id="Fxbrl_20210224180726119">USA</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="C_20200101to20201231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_hugeSubsidiariesOneMember" id="Fxbrl_20210224180834700">USA</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="C_20200101to20201231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_hugeSubsidiariesTwoMember" id="Fxbrl_20210224181234951">Canada</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="C_20200101to20201231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_ifrsfullSubsidiariesMember" decimals="2" id="Fxbrl_20210224180955580" unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="C_20190102to20191231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_ifrsfullSubsidiariesMember" decimals="2" id="Fxbrl_20210224181003178" unitRef="Pure">0</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="C_20180101to20181231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_ifrsfullSubsidiariesMember" decimals="2" id="Fxbrl_20210224181017906" unitRef="Pure">0</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="C_20200101to20201231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_hugeSubsidiariesOneMember" decimals="2" id="Fxbrl_20210224181104412" unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="C_20190102to20191231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_hugeSubsidiariesOneMember" decimals="2" id="Fxbrl_20210224181121247" unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="C_20180101to20181231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_hugeSubsidiariesOneMember" decimals="2" id="Fxbrl_20210224181205050" unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="C_20200101to20201231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_hugeSubsidiariesTwoMember" decimals="2" id="Fxbrl_20210224181349675" unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="C_20190102to20191231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_hugeSubsidiariesTwoMember" decimals="2" id="Fxbrl_20210224181403161" unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="C_20180101to20181231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_hugeSubsidiariesTwoMember" decimals="2" id="Fxbrl_20210224181416721" unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20200228104752085">
    &lt;div&gt;
      &lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2.&lt;/strong&gt;&lt;span style="width:10.49pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;&lt;strong&gt;Basis of presentation &lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;[a] Statement of compliance &lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;These financial statements have been prepared by management in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board ("IASB"). The policies set out below have been consistently applied to all periods presented, unless otherwise noted.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;These financial statements were approved and authorized for issuance by the Board of Directors of the Company on March 15, 2021.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;[b] Basis of measurement&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;These financial statements have been prepared on a historical cost basis, except for certain financial instruments which are measured at fair value. Historical costs are generally based upon the fair value of the consideration given in exchange for goods and services received.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, regardless of whether that price is directly observable or estimated using another valuation technique. In estimating the fair value of an asset or a liability, the Company takes into account the characteristics of the asset or liability if market participants would take those characteristics into account when pricing the asset or liability at the measurement date. Fair value for measurement and/or disclosure purposes in these financial statements is determined on such a basis, except for share-based payment transactions that are within the scope of IFRS 2 &lt;i&gt;Share-based Payment&lt;/i&gt; ("IFRS 2") and measurements that have some similarities to fair value, but are not fair value, such as value in use in IAS 36 &lt;i&gt;Impairment of Assets&lt;/i&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;[c] Basis of presentation&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The accompanying financial statements include the accounts of FSD and its subsidiaries, FV Pharma, FSD Biosciences and Prismic. The financial statements incorporate the assets and liabilities of the Company and its subsidiaries as at December 31, 2020 and 2019 and January 1, 2019 and the results of these subsidiaries for the years ended December 31, 2020 and 2019.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Subsidiaries are all those entities over which the Company has control. The Company controls an entity when it is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power over the entity. Subsidiaries are fully consolidated from the date on which control is transferred to the Company. All intra-entity assets and liabilities, revenue, expenses and cash flows relating to transactions between subsidiaries of the Company are eliminated in full on consolidation.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;[d] Functional currency and presentation currency &lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The financial statements of each company within the consolidated group are measured using their functional currency which is the currency of the primary economic environment in which an entity operates. The Company changed its functional currency from the Canadian dollar (C$) to the United States dollar (US$) as of October 1, 2020. The change in functional currency was the result of a review of the primary economic environment in which the entity operates and the currency that mainly influences the underlying transactions entered into by the Company. The Company's functional currency is the United States dollar and the functional currencies of its subsidiaries are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="width:31.5pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;FSD Biosciences &lt;span style="display:inline-block;width:77.98pt"&gt;&amp;#160;&lt;/span&gt;United States Dollars&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="width:31.5pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Prismic&lt;span style="display:inline-block;width:119pt"&gt;&amp;#160;&lt;/span&gt;United States Dollars&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-top:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="width:31.5pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;FV Pharma&lt;span style="display:inline-block;width:103.49pt"&gt;&amp;#160;&lt;/span&gt;Canadian Dollars&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company has elected to change its presentation currency from the Canadian dollar to the United States dollar effective October 1, 2020. The change in presentation currency is a voluntary change which is accounted for retrospectively. The change in presentation currency was made to better reflect the Company's business activities.&amp;#160; For comparative reporting purposes, historical financial information has been translated to United States dollars using the exchange rate as at October 1, 2020, which is the date of the change in the functional and presentation currency.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following shows the restatement of prior period information:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

            &lt;table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;
              &lt;tbody&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;December 31, 2018 &lt;/strong&gt;&lt;br/&gt;&lt;strong&gt;as reported,&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Foreign currency &lt;/strong&gt;&lt;br/&gt;&lt;strong&gt;translation&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;December 31, 2018 &lt;/strong&gt;&lt;br/&gt;&lt;strong&gt;restated,&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Adoption of&lt;br/&gt;IFRS 16&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;January 1,&lt;br/&gt;2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;C$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;ASSETS&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Current assets&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21,134,930&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,235,122&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,899,808&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,899,808&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade and other receivables&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;990,988&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(245,468&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;745,520&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;745,520&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Prepaid expenses and deposits&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;444,099&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(110,003&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;334,096&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;334,096&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22,570,017&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,590,593&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,979,424&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,979,424&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Non-current assets&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other investments&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18,064,541&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,474,587&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,589,954&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,589,954&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Right-of-use asset, net&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;183,424&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;183,424&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property, plant and equipment, net&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,141,676&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,007,493&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,134,183&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,134,183&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;52,776,234&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(13,072,673&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;39,703,561&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;183,424&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;39,886,985&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;LIABILITIES&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Current liabilities&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade and other payables&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,743,806&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(431,941&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,311,865&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,311,865&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease obligations&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;40,875&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;40,875&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,743,806&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(431,941&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,311,865&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;40,875&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,352,740&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Non-current liabilities&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease obligations&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;142,549&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;142,549&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,743,806&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(431,941&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,311,865&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;183,424&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,495,289&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;SHAREHOLDER'S EQUITY&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Class A share capital&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;201,500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(49,912&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;151,588&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;151,588&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Class B share capital&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;67,916,302&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(16,822,868&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;51,093,434&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;51,093,434&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Warrant reserve&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,442,145&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,100,319&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,341,826&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,341,826&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Contributed surplus&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,977,300&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,232,877&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,744,423&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,744,423&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accumulated deficit&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(26,504,819&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,565,244&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(19,939,575&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(19,939,575&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;51,032,428&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,640,732&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;38,391,696&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;38,391,696&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;52,776,234&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(13,072,673&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;39,703,561&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;183,424&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;39,886,985&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
              &lt;/tbody&gt;
            &lt;/table&gt;

          &lt;p style="text-align:justify"&gt;&lt;br/&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;[e] Use of estimates and judgments&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The preparation of these financial statements in conformity with IFRS requires management to make estimates, judgments and assumptions that affect the application of accounting policies and the reported amounts of assets and liabilities as at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Estimates are based on management's best knowledge of current events and actions that the Company may undertake in the future. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following are the critical judgments, apart from those involving estimations, that management has made in the process of applying the Company's accounting policies and that have the most significant effect on the amounts recognized in the financial statements:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[i]&lt;span style="width:11pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Going concern&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At each reporting period, management assesses the basis of preparation of the financial statements. These financial statements have been prepared on a going concern basis in accordance with IFRS. The going concern basis of presentation assumes that the Company will continue its operations for the foreseeable future and be able to realize its assets and discharge its liabilities and commitments in the normal course of business.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[ii]&lt;span style="width:9pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Estimated useful lives, residual values and depreciation of property, plant and equipment&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation of property, plant and equipment is dependent upon estimates of useful lives and residual values, which are determined through the exercise of judgment. The assessment of any impairment of these assets' is dependent upon estimates of recoverable amounts that take into account factors such as economic and market conditions and the useful lives of assets.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[iii]&lt;span style="width:7pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Estimated useful life and amortization of intangible assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company employs significant estimates to determine the estimated useful lives of intangible assets, considering the nature of the asset, contractual rights, expected use and review of asset useful lives. The Company reviews amortization methods and useful lives annually or when circumstances change and adjusts its amortization methods and assumptions prospectively.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[iv]&lt;span style="width:6.5pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Assets held for sale&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-indent:0.05pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The determination as to whether a disposal group meets the requirements to be classified as held for sale, and the assets and liabilities to be included within that disposal group, requires management to exercise judgment when making these determinations.&amp;#160; Management must also exercise judgment when determining at which date all of the criteria are satisfied to be classified as held for sale. Management must also use estimates when determining the fair value less costs to sell of the disposal group to assess if the carrying value of the disposal group is greater than its recoverable amount.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[v]&lt;span style="width:8.5pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Valuation of share-based payments and warrants&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Management measures the costs for share-based payments and warrants using market-based option valuation techniques. Assumptions are made and estimates are used in applying the valuation techniques. These include estimating the future volatility of the share price, expected dividend yield, expected term, expected risk-free interest rate and the rate of forfeiture. Such estimates and assumptions are inherently uncertain. Changes in these assumptions affect the fair value estimates of share-based payments and warrants.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[vi]&lt;span style="width:6.5pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Valuation of private company investments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The financial information of private companies may not always be available, or such information may be insufficient or unreliable for valuation purposes. In determining the fair value of shares held in private company investments, management is required to make certain estimates and assumptions regarding the fair value as of the reporting date. Assumptions are made and estimates are used in applying the valuation techniques to determine fair value. These include the most recently available financial statements of the investee, price for most recently completed financing, as well as closely comparable public companies and general market and economic conditions. Such investments are classified as Level 3 within the fair value hierarchy. The value at which the Company could ultimately realize upon disposition of these investments may differ from their carrying value and such differences could be material.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[vii]&lt;span style="width:4.5pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Asset acquisition&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In the acquisition of Prismic on June 28, 2019 judgment was required to determine if the acquisition represented either a business combination or an asset purchase. Management concluded that Prismic did not represent a business as the assets acquired were not an integrated set of activities with inputs, processes and outputs. Since it was concluded that the acquisition represented the purchase of assets, there was no goodwill recognized on the transaction and acquisition costs were capitalized to the assets purchased rather than expensed. The fair values of the net assets acquired were determined using estimates and judgments. Refer to Note 4 for additional information on the Company's asset acquisition.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[viii]&lt;span style="width:2.5pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Functional currency&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company and its subsidiaries are required to determine their functional currencies based on the primary economic environment in which each entity operates. In order to do that, management has to analyze several factors, including which currency mainly influences the cost of undertaking the business activities, in which currency the entity has received financing, and in which currency it keeps its receipts from operating activities. Management uses its judgment to determine which factors are most important when the above indicators are mixed and the functional currency is not obvious.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory>
  <huge:DisclosureOfDetailedInformationAboutRestatementOfPriorPeriodExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20210223194640602">
            &lt;table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;
              &lt;tbody&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;December 31, 2018 &lt;/strong&gt;&lt;br/&gt;&lt;strong&gt;as reported,&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Foreign currency &lt;/strong&gt;&lt;br/&gt;&lt;strong&gt;translation&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;December 31, 2018 &lt;/strong&gt;&lt;br/&gt;&lt;strong&gt;restated,&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Adoption of&lt;br/&gt;IFRS 16&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;January 1,&lt;br/&gt;2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;C$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;ASSETS&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Current assets&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21,134,930&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,235,122&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,899,808&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,899,808&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade and other receivables&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;990,988&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(245,468&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;745,520&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;745,520&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Prepaid expenses and deposits&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;444,099&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(110,003&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;334,096&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;334,096&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22,570,017&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,590,593&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,979,424&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,979,424&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Non-current assets&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other investments&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18,064,541&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,474,587&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,589,954&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,589,954&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Right-of-use asset, net&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;183,424&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;183,424&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property, plant and equipment, net&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,141,676&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,007,493&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,134,183&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,134,183&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;52,776,234&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(13,072,673&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;39,703,561&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;183,424&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;39,886,985&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;LIABILITIES&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Current liabilities&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade and other payables&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,743,806&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(431,941&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,311,865&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,311,865&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease obligations&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;40,875&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;40,875&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,743,806&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(431,941&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,311,865&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;40,875&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,352,740&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Non-current liabilities&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease obligations&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;142,549&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;142,549&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,743,806&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(431,941&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,311,865&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;183,424&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,495,289&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;SHAREHOLDER'S EQUITY&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Class A share capital&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;201,500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(49,912&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;151,588&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;151,588&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Class B share capital&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;67,916,302&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(16,822,868&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;51,093,434&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;51,093,434&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Warrant reserve&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,442,145&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,100,319&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,341,826&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,341,826&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Contributed surplus&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,977,300&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,232,877&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,744,423&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,744,423&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accumulated deficit&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(26,504,819&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,565,244&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(19,939,575&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(19,939,575&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;51,032,428&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,640,732&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;38,391,696&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;38,391,696&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;52,776,234&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(13,072,673&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;39,703,561&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;183,424&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;39,886,985&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
              &lt;/tbody&gt;
            &lt;/table&gt;
          </huge:DisclosureOfDetailedInformationAboutRestatementOfPriorPeriodExplanatory>
  <ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20200220043929745">
    &lt;div&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;3.&lt;span style="width:10.49pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Significant accounting policies&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

            &lt;div&gt;
              &lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[a]&lt;span style="width:7.99pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Cash&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash consists of cash and cash held in trust accounts. There are no restrictions on cash held in trust.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/div&gt;


            &lt;div&gt;
              &lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[b]&lt;span style="width:7.99pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Property, Plant and Equipment&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property, plant and equipment is measured at cost less accumulated depreciation and impairment losses, with the exception of land which is not depreciated.&amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;When parts of an item of property, plant and equipment have different useful lives, they are accounted for as separate items (major components) of property, plant and equipment.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;The cost of replacing part of an item of property, plant and equipment is recognized in the carrying amount of the item if it is probable that the future economic benefits embodied within the part will flow to the Company and its cost can be measured reliably. The carrying amount of the replaced part is derecognized. The costs of the day-to-day servicing of property, plant and equipment are recognized in consolidated statements of loss and comprehensive loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Subsequent costs are included in the asset's carrying amount or recognized as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Company and the cost of the item can be measured reliably. All other repairs and maintenance are charged to the consolidated statements of loss and comprehensive loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Gains and losses on disposal of an item of property, plant and equipment are determined by comparing the proceeds from disposal with the carrying amount and are recognized net within other income in the consolidated statements of loss and comprehensive loss.&lt;br/&gt;&amp;#160;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation is based on the estimated useful lives of the assets provided as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;div&gt;

                  &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;margin-left:auto;margin-right:auto;width:75%"&gt;
                    &lt;tbody&gt;
                      &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                        &lt;td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;height:0px;background-color:rgb(204, 238, 255)"&gt;
                          &lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Computer equipment&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                        &lt;/td&gt;
                        &lt;td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;height:0px;background-color:rgb(204, 238, 255)"&gt;
                          &lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;30% declining balance&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                        &lt;td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Production equipment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20% declining balance&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                        &lt;td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Furniture and fixtures&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20% declining balance&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                        &lt;td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"&gt;
                          &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Facility and related&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&amp;#160;&lt;/span&gt;&lt;/p&gt;
                        &lt;/td&gt;
                        &lt;td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20 years under straight-line&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                        &lt;td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                          &lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Land&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                        &lt;/td&gt;
                        &lt;td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                          &lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Not amortized&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                    &lt;/tbody&gt;
                  &lt;/table&gt;

              &lt;/div&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;An item of property, plant and equipment and any significant part initially recognized are derecognized upon disposal or when no future economic benefits are expected from their use or disposal. Any gain or loss arising on derecognition of the asset (calculated as the difference between the net disposal proceeds and the carrying amount of the asset) is included in the consolidated statements of loss and comprehensive loss when the asset is derecognized. The assets' residual values, useful lives and methods of depreciation and the depreciation charge are adjusted prospectively, if appropriate.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/div&gt;


            &lt;div&gt;
              &lt;div&gt;
                &lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[c]&lt;span style="width:8.5pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Intangible Assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;intangible assets are recorded at cost less accumulated amortization and accumulated impairment losses. Amortization is recognized in profit or loss on a straight-line basis over the following terms:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;div&gt;
                  &lt;div&gt;


                      &lt;div&gt;
                        &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;margin-left:auto;margin-right:auto;width:75%"&gt;
                          &lt;tbody&gt;
                            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                              &lt;td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"&gt;
                                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Intellectual Property&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                              &lt;/td&gt;
                              &lt;td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"&gt;
                                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5 years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;
                          &lt;/tbody&gt;
                        &lt;/table&gt;
                      &lt;/div&gt;


                  &lt;/div&gt;
                &lt;/div&gt;
              &lt;/div&gt;
              &lt;div&gt;
                &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;br/&gt;Expenditures on internally generated intangible assets during the development phase, which comprise deferred development costs, are initially capitalized and recognized in the consolidated balance sheet if they meet the recognition criteria. Subsequent to initial recognition, deferred development costs are accounted for at cost less accumulated amortization and are amortized on a straight-line basis over an estimated useful life beginning once the deferred development costs are used in commercial production. Expenditures on internally generated intangible assets during the research phase are expensed as incurred.&lt;/p&gt;
              &lt;/div&gt;
            &lt;/div&gt;

          &lt;div&gt;

              &lt;div&gt;
                &lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[d]&lt;span style="width:7.99pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Revenue Recognition&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company's accounting policy for revenue recognition under IFRS 15, Revenue from Contracts with Customers ("IFRS 15") is to follow a five step model to determine the amount and timing of revenue to be recognized i) identify the contract with a customer; ii) identify the performance obligations in the contract; iii) determine the transaction price; iv) allocate the transaction price to the performance obligations in the contract; and v) recognize revenue when (or as) the Company satisfies a performance obligation.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue from the sale of cannabis is recognized when the Company transfers control of the good to the customer. This is generally considered to have occurred when products have been delivered to the location specified in the sales contract and accepted by the customer.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company recognizes revenue in an amount that reflects the consideration the Company expects to receive taking into account any variation that may result from rights of return.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify"&gt;The Company was required to remit excise tax to the Canada Revenue Agency on the sale of medical cannabis in Canada. The Company became liable for these excise duties when cannabis products were delivered to the customer. In accordance with IFRS 15, revenue presented within discontinued operations (Note 5) represents revenue from the sale of goods less applicable excise tax.&lt;/p&gt;
                &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;
                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Areas of judgment include identifying the customer per the definition within IFRS 15 and determining whether control has passed to the customer.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/div&gt;

          &lt;/div&gt;

            &lt;div&gt;
              &lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[e]&lt;span style="width:7.99pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Foreign Currency Translation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Foreign currency transactions are translated into United States dollars at exchange rates in effect on the date of the transactions. Monetary assets and liabilities denominated in foreign currencies at the statement of financial position date are translated to United States dollars at the foreign exchange rate applicable at that date. Realized and unrealized exchange gains and losses are recognized through profit or loss.&lt;/p&gt;
              &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-monetary assets and liabilities that are measured in terms of historical cost in a foreign currency are translated using the exchange rate at the date of the transaction.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;The assets and liabilities of foreign operations with functional currencies other than United States dollars, are translated into United States dollars at year-end exchange rates. Income and expenses, and cash flows of such foreign operations are translated into United States dollars using average exchange rates for the period. Exchange differences resulting from translating foreign operations are recognized in other comprehensive loss and accumulated in equity.&lt;br/&gt;&amp;#160;&lt;/p&gt;
            &lt;/div&gt;


            &lt;div&gt;
              &lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[f]&lt;span style="width:10.5pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Financial Instruments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial assets and financial liabilities are recognized when the Company becomes a party to the contractual provisions of the instruments.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial assets and financial liabilities are initially measured at fair value. Transaction costs that are directly attributable to the acquisition or issue of financial assets and financial liabilities (other than financial assets and financial liabilities at fair value through profit or loss) are added to or deducted from the fair value of the financial assets or financial liabilities, as appropriate, on initial recognition. Transaction costs directly attributable to the acquisition of financial assets or financial liabilities at fair value through profit or loss are recognized immediately in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:32.85pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Financial assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On initial recognition, a financial asset is classified as measured at amortized cost, fair value through other comprehensive income (''FVOCI''), or fair value through profit and loss (''FVTPL''). The classification of financial assets is based on the business model in which a financial asset is managed and its contractual cash flow characteristics.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;A financial asset is measured at amortized cost if it meets both of the following conditions and is not designated as at FVTPL:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;ul style="padding-left:0pt" type="disc"&gt;
                &lt;li style="margin-left:45.14pt;text-align:justify;padding-left:8.86pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;It is held within a business model whose objective is to hold assets to collect contractual cash flows; and&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;
                &lt;li style="margin-left:45.14pt;text-align:justify;padding-left:8.86pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Its contractual terms give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;
              &lt;/ul&gt;
              &lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;A financial asset (unless it is a trade receivable without a significant financing component that is initially measured at the transaction price) is initially measured at fair value plus, for an item not at FVTPL, transaction costs that are directly attributable to its acquisition.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-indent:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following accounting policies apply to the subsequent measurement of financial assets.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;table cellpadding="0" cellspacing="0" style="margin-left:36.65pt;border:0.75pt solid #000000;border-collapse:collapse;font-size:10pt"&gt;
                &lt;tbody&gt;
                  &lt;tr&gt;
                    &lt;td style="width:32%;padding-right:5.03pt;padding-left:5.03pt;vertical-align:top;border-right:0.75pt solid #000000;border-bottom:0.75pt solid #000000"&gt;
                      &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial assets at FVTPL&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="width:67%;padding-right:5.03pt;padding-left:5.03pt;vertical-align:top;border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000"&gt;
                      &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Subsequently measured at fair value. Net gains and losses, including any interest or dividend income, are recognized in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="width:32%;padding-right:5.03pt;padding-left:5.03pt;vertical-align:top;border-top:0.75pt solid #000000;border-right:0.75pt solid #000000"&gt;
                      &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial assets at amortized cost&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="width:67%;padding-right:5.03pt;padding-left:5.03pt;vertical-align:top;border-top:0.75pt solid #000000;border-left:0.75pt solid #000000"&gt;
                      &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Subsequently measured at amortized cost using the effective interest method, less any impairment losses. Interest income, foreign exchange gains and losses and impairment losses are recognized in profit or loss. Any gain or loss on derecognition is recognized in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                &lt;/tbody&gt;
              &lt;/table&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:32.85pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Financial liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company initially recognizes financial liabilities at fair value on the date at which the Company becomes a party to the contractual provisions of the instrument.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company classifies its financial liabilities as either financial liabilities at FVTPL or amortized cost.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Subsequent to initial recognition, other liabilities are measured at amortized cost using the effective interest method. Financial liabilities at FVTPL are stated at fair value with changes being recognized in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company derecognizes a financial liability when its contractual obligations are discharged or cancelled or expire.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:32.85pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Financial liabilities and equity instruments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:32.85pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Classification as debt or equity&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="margin-left:72pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Debt and equity instruments issued by the Company are classified as either financial liabilities or as equity in accordance with the substance of the contractual arrangements and the definitions of a financial liability and an equity instrument.&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company does not reclassify financial liabilities or equity after initial recognition due to a change in circumstance.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:32.85pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Equity instruments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="margin-left:72pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;An equity instrument is any contract that evidences a residual interest in the assets of an entity after deducting all of its liabilities. Equity instruments issued by a group entity are recognized at the proceeds received, net of direct issue costs.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="margin-left:72pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Repurchase of the Company's own equity instruments is recognized and deducted directly in equity. No gain or loss is recognized in profit or loss on the purchase, sale, issue or cancellation of the Company's own equity instruments.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:32.85pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Classification of financial instruments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company classifies its financial assets and liabilities depending on the purpose for which the financial instruments were acquired, their characteristics and management intent as outlined below:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Classification&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;margin-left:36pt;margin-right:auto;width:95%"&gt;
                &lt;tbody&gt;
                  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                    &lt;td style="width:50%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:50%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amortized cost&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="width:50%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other receivables&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:50%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amortized cost&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                    &lt;td style="width:50%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Investments&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:50%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value through profit or loss&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="width:50%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade and other payables&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:50%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amortized cost&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                    &lt;td style="width:50%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Derivative liability&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:50%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value through profit or loss&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="width:50%;background-color:rgb(255, 255, 255)"&gt;
                      &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Warrants liability&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="width:50%;background-color:rgb(255, 255, 255)"&gt;
                      &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Fair value through profit or loss&lt;/p&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                    &lt;td style="width:50%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Notes payable&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:50%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amortized cost&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                &lt;/tbody&gt;
              &lt;/table&gt;
              &lt;p style="margin-top:0pt;margin-left:36pt;margin-bottom:0pt;text-align:justify"&gt;&amp;#160;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:32.85pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Impairment of financial assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;An expected credit loss ("ECL") model applies to financial assets measured at amortized cost. The Company's financial assets measured at amortized cost and subject to the ECL model consist primarily of trade and other receivables. The Company applies the simplified approach to impairment for trade and other receivables by recognizing a loss allowance based on lifetime expected losses at each reporting date taking into considerations historical credit loss experience and financial factors specific to the debtors and general economic conditions. The Company has assessed the impairment of its trade and other receivables using the expected credit loss model, and no material difference was noted.&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/div&gt;


            &lt;div&gt;
              &lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;[g]&lt;span style="width:7.99pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;Inventory&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Inventory of harvested work-in-process and finished goods are valued at the lower of cost and net realizable value. Inventory of harvested cannabis is transferred from biological assets at their fair value at harvest, which becomes the initial deemed cost. Any subsequent post-harvest costs are capitalized to inventory to the extent that cost is less than net realizable value. Net realizable value is determined as the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated costs necessary to make the sale. Inventory for supplies and consumables are valued at the lower of cost and net realizable value, with cost determined using the average cost basis.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/div&gt;


            &lt;div&gt;
              &lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[h]&lt;span style="width:11pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Impairment of long-lived assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Long-lived assets, including property, plant and equipment and intangible assets are tested for impairment when there are indicators of impairment at each reporting date or whenever events or changes in circumstances indicate that the carrying amount of an asset exceeds its recoverable amount. Intangible assets with an indefinite useful life are tested for impairment at least annually in the fourth quarter and whenever there is an indication that the asset may be impaired.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For the purpose of impairment testing, assets that cannot be tested individually are grouped together into the smallest group of assets that generates cash inflows from continuing use that are largely independent of the cash inflows of other assets or groups of assets (the cash-generating unit, or "CGU"). The recoverable amount of an asset or a CGU is the higher of its fair value, less costs to sell, and its value in use. If the carrying amount of an asset exceeds its recoverable amount, an impairment charge is recognized immediately in net&amp;#160;loss&amp;#160;equal to the amount by which the carrying amount exceeds the recoverable amount. Where an impairment loss subsequently reverses, the carrying amount of the asset is increased to the lesser of the revised estimate of recoverable amount, and the carrying amount that would have been recorded had no impairment loss been recognized previously.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/div&gt;


            &lt;div&gt;
              &lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[i]&lt;span style="width:11pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Income Taxes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income tax expense comprises of current and deferred tax. Current tax and deferred tax are recognized in net profit or loss except to the extent that it relates to a business combination or items recognized directly in equity or in other comprehensive loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current income taxes are recognized for the estimated income taxes payable or receivable on taxable income or loss for the current year and any adjustment to income taxes payable in respect of previous years. Current income taxes are determined using tax rates and tax laws that have been enacted or substantively enacted by the year-end date.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred tax assets and liabilities are recognized where the carrying amount of an asset or liability differs from its tax base, except for taxable temporary differences arising on the initial recognition of goodwill and temporary differences arising on the initial recognition of an asset or liability in a transaction which is not a business combination and at the time of the transaction affects neither accounting nor taxable profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Recognition of deferred tax assets for unused tax losses, tax credits and deductible temporary differences is restricted to those instances where it is probable that future taxable profit will be available against which the deferred tax asset can be utilized. At the end of each reporting period, the Company reassesses unrecognized deferred tax assets. The Company recognizes a previously unrecognized deferred tax asset to the extent that it has become probable that future taxable profit will allow the deferred tax asset to be recovered.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/div&gt;


            &lt;div&gt;
              &lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[j]&lt;span style="width:8.5pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Share-based Compensation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify"&gt;Share options and warrants awarded to non-employees are accounted for using the fair value of the instrument awarded or service provided, whichever is considered more reliable. Share options and warrants awarded to employees are accounted for using the fair value method.&amp;#160; The fair value of such share options and warrants granted is recognized as an expense on a proportionate basis consistent with the vesting features of each tranche of the grant. The fair value is calculated using the Black-Scholes option pricing model with assumptions applicable at the date of grant.&lt;/p&gt;
            &lt;/div&gt;


            &lt;div&gt;
              &lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[k]&lt;span style="width:11pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Net Loss per Share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net loss per share is calculated based on the loss for the financial year and the weighted average number of common shares outstanding during the year. Diluted net loss per share is calculated using the loss for the financial year adjusted for the effect of any dilutive instruments and the weighted average diluted number of shares [ignoring any potential issue of common shares that would be anti-dilutive] during the year.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/div&gt;

          &lt;div&gt;

              &lt;div&gt;
                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[l] Leases&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At inception of a contract, the Company assesses whether a contract is, or contains, a lease based on whether the contract conveys the right to control the use of identified asset for a period of time in exchange for consideration. The Company recognized a right-of-use asset and a lease liability at the lease commencement date. The right-of-use asset is initially measured based on the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date, plus any initial direct costs incurred and an estimate of the costs to dismantle and remove the underlying asset or to restore the underlying asset or the site on which it is located, less any lease incentives received. The right-of-use assets are depreciated to the earlier of the end of useful life of the right-of-use asset or the lease term using the straight-line method as this most closely reflects the expected pattern of the consumption of the future economic benefits. The lease term includes periods covered by an option to extend if the Company is reasonably certain to exercise that option. In addition, the right-of-use asset can be periodically reduced by impairment losses, if any, and adjusted for certain remeasurements of the lease liability. The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, and the Company's incremental borrowing rate.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The lease liability is measured at amortized cost using the effective interest method. It is remeasured when there is a change in future lease payments arising from the change in an index or rate, if there is a change in the Company's estimate of the amount expected to be payable under a residual value guarantee, or if the Company changes its assessment of whether it will exercise a purchase, extension or termination option. When the lease liability is remeasured in this way, a corresponding adjustment is made to the carrying amount of the right-of-use asset, unless it has been reduced to zero.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/div&gt;

            &lt;div&gt;
              &lt;div&gt;

                  &lt;div&gt;
                    &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[m] External research and development&lt;span style="text-align:left"&gt;&amp;#160; &amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                    &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;External research and development costs are expensed in the periods in which they are incurred, with the exception of development costs for new products with proven technical feasibility and for which a defined future market exists. Such development costs are capitalized in accordance with the Company's policy for intangible assets. The Company's external research and development costs consist primarily of third-party services.&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left"&gt;&amp;#160; &amp;#160;&lt;/span&gt;&lt;/p&gt;
                  &lt;/div&gt;


                  &lt;div&gt;
                    &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[n] Discontinued operations&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left"&gt;&amp;#160; &amp;#160;&lt;/span&gt;&lt;/p&gt;
                    &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Discontinued operations are reported when a component of the Company, representing a separate major line of business or area of operations with clearly distinguishable cash flows, has been disposed of or is held for sale. Classification as a discontinued operation occurs upon disposal or when the operation meets the criteria to be classified as held for sale, if earlier. Discontinued operations are reported as a separate element of net income or loss on the consolidated statement of net and comprehensive loss for both the current and comparative periods. When a disposal group is classified as held for sale, assets and liabilities are aggregated and presented as separate line items, respectively, on the consolidated statement of financial position. Comparative periods are not restated on the consolidated statement of financial position. Assets held for sale are not depreciated and are measured at the lower of carrying value and fair value less costs to sell.&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left"&gt;&amp;#160;&lt;/span&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left"&gt;&amp;#160; &amp;#160; &amp;#160;&amp;#160;&lt;/span&gt;&lt;/p&gt;
                  &lt;/div&gt;

                &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/span&gt;&lt;/span&gt;

                  &lt;div&gt;
                    &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;New standards, amendment and interpretation adopted by the Company&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left"&gt;&amp;#160; &amp;#160;&lt;/span&gt;&lt;/p&gt;
                    &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;IFRS 3 - &lt;i&gt;Business combinations &lt;/i&gt;("IFRS 3")&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left"&gt;&amp;#160; &amp;#160;&lt;/span&gt;&lt;/p&gt;
                    &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amendments to IFRS 3, issued in October 2018, provide clarification on the definition of a business. The amendments permit a simplified assessment to determine whether a transaction should be accounted for as a business combination or as an asset acquisition.&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left"&gt;&amp;#160; &amp;#160;&lt;/span&gt;&lt;/p&gt;
                    &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The amendments are effective for transactions for which the acquisition date is on or after the beginning of the first annual reporting period beginning on or after January 1, 2020. The amendment adoption did not have a significant impact on the Company's financial statements.&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left"&gt;&amp;#160; &amp;#160;&lt;/span&gt;&lt;/p&gt;
                    &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;IAS 1 -&lt;i&gt; Presentation of financial statements &lt;/i&gt;("IAS 1")&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left"&gt;&amp;#160; &amp;#160;&lt;/span&gt;&lt;/p&gt;
                    &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amendments to IAS 1, issued in October 2018, provide clarification on the definition of material and how it should be applied. The amendments also align the definition of material across International Financial Reporting Standards and other publications.&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left"&gt;&amp;#160; &amp;#160;&lt;/span&gt;&lt;/p&gt;
                    &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The amendments are effective for annual periods beginning on or after January 1, 2020 and are required to be applied prospectively. The amendment adoption did not have a significant impact on the Company's financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/div&gt;







  </ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory>
  <ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents contextRef="C_20200101to20201231" id="Fxbrl_20200228123600385">
            &lt;div&gt;
              &lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[a]&lt;span style="width:7.99pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Cash&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash consists of cash and cash held in trust accounts. There are no restrictions on cash held in trust.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/div&gt;
          </ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents>
  <ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20200228123619688">
            &lt;div&gt;
              &lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[b]&lt;span style="width:7.99pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Property, Plant and Equipment&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property, plant and equipment is measured at cost less accumulated depreciation and impairment losses, with the exception of land which is not depreciated.&amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;When parts of an item of property, plant and equipment have different useful lives, they are accounted for as separate items (major components) of property, plant and equipment.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;The cost of replacing part of an item of property, plant and equipment is recognized in the carrying amount of the item if it is probable that the future economic benefits embodied within the part will flow to the Company and its cost can be measured reliably. The carrying amount of the replaced part is derecognized. The costs of the day-to-day servicing of property, plant and equipment are recognized in consolidated statements of loss and comprehensive loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Subsequent costs are included in the asset's carrying amount or recognized as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Company and the cost of the item can be measured reliably. All other repairs and maintenance are charged to the consolidated statements of loss and comprehensive loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Gains and losses on disposal of an item of property, plant and equipment are determined by comparing the proceeds from disposal with the carrying amount and are recognized net within other income in the consolidated statements of loss and comprehensive loss.&lt;br/&gt;&amp;#160;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation is based on the estimated useful lives of the assets provided as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;div&gt;

                  &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;margin-left:auto;margin-right:auto;width:75%"&gt;
                    &lt;tbody&gt;
                      &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                        &lt;td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;height:0px;background-color:rgb(204, 238, 255)"&gt;
                          &lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Computer equipment&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                        &lt;/td&gt;
                        &lt;td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;height:0px;background-color:rgb(204, 238, 255)"&gt;
                          &lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;30% declining balance&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                        &lt;td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Production equipment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20% declining balance&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                        &lt;td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Furniture and fixtures&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20% declining balance&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                        &lt;td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"&gt;
                          &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Facility and related&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&amp;#160;&lt;/span&gt;&lt;/p&gt;
                        &lt;/td&gt;
                        &lt;td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20 years under straight-line&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                        &lt;td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                          &lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Land&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                        &lt;/td&gt;
                        &lt;td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                          &lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Not amortized&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                    &lt;/tbody&gt;
                  &lt;/table&gt;

              &lt;/div&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;An item of property, plant and equipment and any significant part initially recognized are derecognized upon disposal or when no future economic benefits are expected from their use or disposal. Any gain or loss arising on derecognition of the asset (calculated as the difference between the net disposal proceeds and the carrying amount of the asset) is included in the consolidated statements of loss and comprehensive loss when the asset is derecognized. The assets' residual values, useful lives and methods of depreciation and the depreciation charge are adjusted prospectively, if appropriate.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/div&gt;
          </ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory>
  <huge:SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20210223204731170">
                  &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;margin-left:auto;margin-right:auto;width:75%"&gt;
                    &lt;tbody&gt;
                      &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                        &lt;td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;height:0px;background-color:rgb(204, 238, 255)"&gt;
                          &lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Computer equipment&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                        &lt;/td&gt;
                        &lt;td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;height:0px;background-color:rgb(204, 238, 255)"&gt;
                          &lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;30% declining balance&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                        &lt;td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Production equipment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20% declining balance&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                        &lt;td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Furniture and fixtures&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20% declining balance&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                        &lt;td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"&gt;
                          &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Facility and related&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&amp;#160;&lt;/span&gt;&lt;/p&gt;
                        &lt;/td&gt;
                        &lt;td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20 years under straight-line&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                        &lt;td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                          &lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Land&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                        &lt;/td&gt;
                        &lt;td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                          &lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Not amortized&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                    &lt;/tbody&gt;
                  &lt;/table&gt;


                      &lt;div&gt;
                        &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;margin-left:auto;margin-right:auto;width:75%"&gt;
                          &lt;tbody&gt;
                            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                              &lt;td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"&gt;
                                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Intellectual Property&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                              &lt;/td&gt;
                              &lt;td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"&gt;
                                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5 years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;
                          &lt;/tbody&gt;
                        &lt;/table&gt;
                      &lt;/div&gt;

              </huge:SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory>
  <ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment contextRef="C_20200101to20201231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" id="Fxbrl_20200228120644906">30%</ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment>
  <ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment contextRef="C_20200101to20201231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeProductionEquipmentMember" id="Fxbrl_20200228121743760">20%</ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment>
  <ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment contextRef="C_20200101to20201231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullFixturesAndFittingsMember" id="Fxbrl_20200228121716808">20%</ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment>
  <ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment contextRef="C_20200101to20201231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullConstructionInProgressMember" id="Fxbrl_20200228121634176">20 years</ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment>
  <ifrs-full:DepreciationMethodPropertyPlantAndEquipment contextRef="C_20200101to20201231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" id="Fxbrl_20200228120726268">declining balance</ifrs-full:DepreciationMethodPropertyPlantAndEquipment>
  <ifrs-full:DepreciationMethodPropertyPlantAndEquipment contextRef="C_20200101to20201231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_hugeProductionEquipmentMember" id="Fxbrl_20200228121759024">declining balance</ifrs-full:DepreciationMethodPropertyPlantAndEquipment>
  <ifrs-full:DepreciationMethodPropertyPlantAndEquipment contextRef="C_20200101to20201231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullFixturesAndFittingsMember" id="Fxbrl_20200228121730088">declining balance</ifrs-full:DepreciationMethodPropertyPlantAndEquipment>
  <ifrs-full:DepreciationMethodPropertyPlantAndEquipment contextRef="C_20200101to20201231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullConstructionInProgressMember" id="Fxbrl_20200228121657093">straight-line</ifrs-full:DepreciationMethodPropertyPlantAndEquipment>
  <ifrs-full:DepreciationMethodPropertyPlantAndEquipment contextRef="C_20200101to20201231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandMember" id="Fxbrl_20200228121615785">Not amortized</ifrs-full:DepreciationMethodPropertyPlantAndEquipment>
  <ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20210223204810849">
            &lt;div&gt;
              &lt;div&gt;
                &lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[c]&lt;span style="width:8.5pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Intangible Assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;intangible assets are recorded at cost less accumulated amortization and accumulated impairment losses. Amortization is recognized in profit or loss on a straight-line basis over the following terms:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;div&gt;
                  &lt;div&gt;


                      &lt;div&gt;
                        &lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;margin-left:auto;margin-right:auto;width:75%"&gt;
                          &lt;tbody&gt;
                            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                              &lt;td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"&gt;
                                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Intellectual Property&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                              &lt;/td&gt;
                              &lt;td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"&gt;
                                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5 years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;
                          &lt;/tbody&gt;
                        &lt;/table&gt;
                      &lt;/div&gt;


                  &lt;/div&gt;
                &lt;/div&gt;
              &lt;/div&gt;
              &lt;div&gt;
                &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;br/&gt;Expenditures on internally generated intangible assets during the development phase, which comprise deferred development costs, are initially capitalized and recognized in the consolidated balance sheet if they meet the recognition criteria. Subsequent to initial recognition, deferred development costs are accounted for at cost less accumulated amortization and are amortized on a straight-line basis over an estimated useful life beginning once the deferred development costs are used in commercial production. Expenditures on internally generated intangible assets during the research phase are expensed as incurred.&lt;/p&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          </ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory>
  <ifrs-full:DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill contextRef="C_20200101to20201231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" id="Fxbrl_20200228121542124">5 years</ifrs-full:DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue contextRef="C_20200101to20201231" id="Fxbrl_20210223202213214">
              &lt;div&gt;
                &lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[d]&lt;span style="width:7.99pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Revenue Recognition&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company's accounting policy for revenue recognition under IFRS 15, Revenue from Contracts with Customers ("IFRS 15") is to follow a five step model to determine the amount and timing of revenue to be recognized i) identify the contract with a customer; ii) identify the performance obligations in the contract; iii) determine the transaction price; iv) allocate the transaction price to the performance obligations in the contract; and v) recognize revenue when (or as) the Company satisfies a performance obligation.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue from the sale of cannabis is recognized when the Company transfers control of the good to the customer. This is generally considered to have occurred when products have been delivered to the location specified in the sales contract and accepted by the customer.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company recognizes revenue in an amount that reflects the consideration the Company expects to receive taking into account any variation that may result from rights of return.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify"&gt;The Company was required to remit excise tax to the Canada Revenue Agency on the sale of medical cannabis in Canada. The Company became liable for these excise duties when cannabis products were delivered to the customer. In accordance with IFRS 15, revenue presented within discontinued operations (Note 5) represents revenue from the sale of goods less applicable excise tax.&lt;/p&gt;
                &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;
                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Areas of judgment include identifying the customer per the definition within IFRS 15 and determining whether control has passed to the customer.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/div&gt;
            </ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue>
  <ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20200228123728743">
            &lt;div&gt;
              &lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[e]&lt;span style="width:7.99pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Foreign Currency Translation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Foreign currency transactions are translated into United States dollars at exchange rates in effect on the date of the transactions. Monetary assets and liabilities denominated in foreign currencies at the statement of financial position date are translated to United States dollars at the foreign exchange rate applicable at that date. Realized and unrealized exchange gains and losses are recognized through profit or loss.&lt;/p&gt;
              &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-monetary assets and liabilities that are measured in terms of historical cost in a foreign currency are translated using the exchange rate at the date of the transaction.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;The assets and liabilities of foreign operations with functional currencies other than United States dollars, are translated into United States dollars at year-end exchange rates. Income and expenses, and cash flows of such foreign operations are translated into United States dollars using average exchange rates for the period. Exchange differences resulting from translating foreign operations are recognized in other comprehensive loss and accumulated in equity.&lt;br/&gt;&amp;#160;&lt;/p&gt;
            &lt;/div&gt;
          </ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory>
  <ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20200228123756998">
            &lt;div&gt;
              &lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[f]&lt;span style="width:10.5pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Financial Instruments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial assets and financial liabilities are recognized when the Company becomes a party to the contractual provisions of the instruments.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial assets and financial liabilities are initially measured at fair value. Transaction costs that are directly attributable to the acquisition or issue of financial assets and financial liabilities (other than financial assets and financial liabilities at fair value through profit or loss) are added to or deducted from the fair value of the financial assets or financial liabilities, as appropriate, on initial recognition. Transaction costs directly attributable to the acquisition of financial assets or financial liabilities at fair value through profit or loss are recognized immediately in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:32.85pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Financial assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On initial recognition, a financial asset is classified as measured at amortized cost, fair value through other comprehensive income (''FVOCI''), or fair value through profit and loss (''FVTPL''). The classification of financial assets is based on the business model in which a financial asset is managed and its contractual cash flow characteristics.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;A financial asset is measured at amortized cost if it meets both of the following conditions and is not designated as at FVTPL:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;ul style="padding-left:0pt" type="disc"&gt;
                &lt;li style="margin-left:45.14pt;text-align:justify;padding-left:8.86pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;It is held within a business model whose objective is to hold assets to collect contractual cash flows; and&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;
                &lt;li style="margin-left:45.14pt;text-align:justify;padding-left:8.86pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Its contractual terms give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;
              &lt;/ul&gt;
              &lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;A financial asset (unless it is a trade receivable without a significant financing component that is initially measured at the transaction price) is initially measured at fair value plus, for an item not at FVTPL, transaction costs that are directly attributable to its acquisition.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-indent:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following accounting policies apply to the subsequent measurement of financial assets.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;table cellpadding="0" cellspacing="0" style="margin-left:36.65pt;border:0.75pt solid #000000;border-collapse:collapse;font-size:10pt"&gt;
                &lt;tbody&gt;
                  &lt;tr&gt;
                    &lt;td style="width:32%;padding-right:5.03pt;padding-left:5.03pt;vertical-align:top;border-right:0.75pt solid #000000;border-bottom:0.75pt solid #000000"&gt;
                      &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial assets at FVTPL&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="width:67%;padding-right:5.03pt;padding-left:5.03pt;vertical-align:top;border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000"&gt;
                      &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Subsequently measured at fair value. Net gains and losses, including any interest or dividend income, are recognized in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="width:32%;padding-right:5.03pt;padding-left:5.03pt;vertical-align:top;border-top:0.75pt solid #000000;border-right:0.75pt solid #000000"&gt;
                      &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial assets at amortized cost&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="width:67%;padding-right:5.03pt;padding-left:5.03pt;vertical-align:top;border-top:0.75pt solid #000000;border-left:0.75pt solid #000000"&gt;
                      &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Subsequently measured at amortized cost using the effective interest method, less any impairment losses. Interest income, foreign exchange gains and losses and impairment losses are recognized in profit or loss. Any gain or loss on derecognition is recognized in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                &lt;/tbody&gt;
              &lt;/table&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:32.85pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Financial liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company initially recognizes financial liabilities at fair value on the date at which the Company becomes a party to the contractual provisions of the instrument.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company classifies its financial liabilities as either financial liabilities at FVTPL or amortized cost.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Subsequent to initial recognition, other liabilities are measured at amortized cost using the effective interest method. Financial liabilities at FVTPL are stated at fair value with changes being recognized in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company derecognizes a financial liability when its contractual obligations are discharged or cancelled or expire.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:32.85pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Financial liabilities and equity instruments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:32.85pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Classification as debt or equity&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="margin-left:72pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Debt and equity instruments issued by the Company are classified as either financial liabilities or as equity in accordance with the substance of the contractual arrangements and the definitions of a financial liability and an equity instrument.&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company does not reclassify financial liabilities or equity after initial recognition due to a change in circumstance.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:32.85pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Equity instruments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="margin-left:72pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;An equity instrument is any contract that evidences a residual interest in the assets of an entity after deducting all of its liabilities. Equity instruments issued by a group entity are recognized at the proceeds received, net of direct issue costs.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="margin-left:72pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Repurchase of the Company's own equity instruments is recognized and deducted directly in equity. No gain or loss is recognized in profit or loss on the purchase, sale, issue or cancellation of the Company's own equity instruments.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:32.85pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Classification of financial instruments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company classifies its financial assets and liabilities depending on the purpose for which the financial instruments were acquired, their characteristics and management intent as outlined below:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Classification&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;margin-left:36pt;margin-right:auto;width:95%"&gt;
                &lt;tbody&gt;
                  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                    &lt;td style="width:50%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:50%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amortized cost&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="width:50%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other receivables&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:50%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amortized cost&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                    &lt;td style="width:50%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Investments&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:50%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value through profit or loss&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="width:50%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade and other payables&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:50%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amortized cost&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                    &lt;td style="width:50%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Derivative liability&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:50%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value through profit or loss&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="width:50%;background-color:rgb(255, 255, 255)"&gt;
                      &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Warrants liability&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="width:50%;background-color:rgb(255, 255, 255)"&gt;
                      &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Fair value through profit or loss&lt;/p&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                    &lt;td style="width:50%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Notes payable&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:50%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amortized cost&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                &lt;/tbody&gt;
              &lt;/table&gt;
              &lt;p style="margin-top:0pt;margin-left:36pt;margin-bottom:0pt;text-align:justify"&gt;&amp;#160;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:32.85pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Impairment of financial assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;An expected credit loss ("ECL") model applies to financial assets measured at amortized cost. The Company's financial assets measured at amortized cost and subject to the ECL model consist primarily of trade and other receivables. The Company applies the simplified approach to impairment for trade and other receivables by recognizing a loss allowance based on lifetime expected losses at each reporting date taking into considerations historical credit loss experience and financial factors specific to the debtors and general economic conditions. The Company has assessed the impairment of its trade and other receivables using the expected credit loss model, and no material difference was noted.&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/div&gt;
          </ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory>
  <ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories contextRef="C_20200101to20201231" id="Fxbrl_20200228123837927">
            &lt;div&gt;
              &lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;[g]&lt;span style="width:7.99pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;Inventory&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Inventory of harvested work-in-process and finished goods are valued at the lower of cost and net realizable value. Inventory of harvested cannabis is transferred from biological assets at their fair value at harvest, which becomes the initial deemed cost. Any subsequent post-harvest costs are capitalized to inventory to the extent that cost is less than net realizable value. Net realizable value is determined as the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated costs necessary to make the sale. Inventory for supplies and consumables are valued at the lower of cost and net realizable value, with cost determined using the average cost basis.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/div&gt;
          </ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories>
  <ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20200228141157503">
            &lt;div&gt;
              &lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[h]&lt;span style="width:11pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Impairment of long-lived assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Long-lived assets, including property, plant and equipment and intangible assets are tested for impairment when there are indicators of impairment at each reporting date or whenever events or changes in circumstances indicate that the carrying amount of an asset exceeds its recoverable amount. Intangible assets with an indefinite useful life are tested for impairment at least annually in the fourth quarter and whenever there is an indication that the asset may be impaired.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For the purpose of impairment testing, assets that cannot be tested individually are grouped together into the smallest group of assets that generates cash inflows from continuing use that are largely independent of the cash inflows of other assets or groups of assets (the cash-generating unit, or "CGU"). The recoverable amount of an asset or a CGU is the higher of its fair value, less costs to sell, and its value in use. If the carrying amount of an asset exceeds its recoverable amount, an impairment charge is recognized immediately in net&amp;#160;loss&amp;#160;equal to the amount by which the carrying amount exceeds the recoverable amount. Where an impairment loss subsequently reverses, the carrying amount of the asset is increased to the lesser of the revised estimate of recoverable amount, and the carrying amount that would have been recorded had no impairment loss been recognized previously.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/div&gt;
          </ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory>
  <ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20200228123901502">
            &lt;div&gt;
              &lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[i]&lt;span style="width:11pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Income Taxes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income tax expense comprises of current and deferred tax. Current tax and deferred tax are recognized in net profit or loss except to the extent that it relates to a business combination or items recognized directly in equity or in other comprehensive loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current income taxes are recognized for the estimated income taxes payable or receivable on taxable income or loss for the current year and any adjustment to income taxes payable in respect of previous years. Current income taxes are determined using tax rates and tax laws that have been enacted or substantively enacted by the year-end date.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred tax assets and liabilities are recognized where the carrying amount of an asset or liability differs from its tax base, except for taxable temporary differences arising on the initial recognition of goodwill and temporary differences arising on the initial recognition of an asset or liability in a transaction which is not a business combination and at the time of the transaction affects neither accounting nor taxable profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Recognition of deferred tax assets for unused tax losses, tax credits and deductible temporary differences is restricted to those instances where it is probable that future taxable profit will be available against which the deferred tax asset can be utilized. At the end of each reporting period, the Company reassesses unrecognized deferred tax assets. The Company recognizes a previously unrecognized deferred tax asset to the extent that it has become probable that future taxable profit will allow the deferred tax asset to be recovered.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/div&gt;
          </ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory>
  <ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20200228123918766">
            &lt;div&gt;
              &lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[j]&lt;span style="width:8.5pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Share-based Compensation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify"&gt;Share options and warrants awarded to non-employees are accounted for using the fair value of the instrument awarded or service provided, whichever is considered more reliable. Share options and warrants awarded to employees are accounted for using the fair value method.&amp;#160; The fair value of such share options and warrants granted is recognized as an expense on a proportionate basis consistent with the vesting features of each tranche of the grant. The fair value is calculated using the Black-Scholes option pricing model with assumptions applicable at the date of grant.&lt;/p&gt;
            &lt;/div&gt;
          </ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory>
  <ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20200228123950094">
            &lt;div&gt;
              &lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[k]&lt;span style="width:11pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Net Loss per Share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net loss per share is calculated based on the loss for the financial year and the weighted average number of common shares outstanding during the year. Diluted net loss per share is calculated using the loss for the financial year adjusted for the effect of any dilutive instruments and the weighted average diluted number of shares [ignoring any potential issue of common shares that would be anti-dilutive] during the year.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;/div&gt;
          </ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory>
  <ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20210223204853190">
              &lt;div&gt;
                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[l] Leases&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At inception of a contract, the Company assesses whether a contract is, or contains, a lease based on whether the contract conveys the right to control the use of identified asset for a period of time in exchange for consideration. The Company recognized a right-of-use asset and a lease liability at the lease commencement date. The right-of-use asset is initially measured based on the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date, plus any initial direct costs incurred and an estimate of the costs to dismantle and remove the underlying asset or to restore the underlying asset or the site on which it is located, less any lease incentives received. The right-of-use assets are depreciated to the earlier of the end of useful life of the right-of-use asset or the lease term using the straight-line method as this most closely reflects the expected pattern of the consumption of the future economic benefits. The lease term includes periods covered by an option to extend if the Company is reasonably certain to exercise that option. In addition, the right-of-use asset can be periodically reduced by impairment losses, if any, and adjusted for certain remeasurements of the lease liability. The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, and the Company's incremental borrowing rate.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The lease liability is measured at amortized cost using the effective interest method. It is remeasured when there is a change in future lease payments arising from the change in an index or rate, if there is a change in the Company's estimate of the amount expected to be payable under a residual value guarantee, or if the Company changes its assessment of whether it will exercise a purchase, extension or termination option. When the lease liability is remeasured in this way, a corresponding adjustment is made to the carrying amount of the right-of-use asset, unless it has been reduced to zero.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/div&gt;
            </ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory>
  <ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20210223204908264">
                  &lt;div&gt;
                    &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[m] External research and development&lt;span style="text-align:left"&gt;&amp;#160; &amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                    &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;External research and development costs are expensed in the periods in which they are incurred, with the exception of development costs for new products with proven technical feasibility and for which a defined future market exists. Such development costs are capitalized in accordance with the Company's policy for intangible assets. The Company's external research and development costs consist primarily of third-party services.&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left"&gt;&amp;#160; &amp;#160;&lt;/span&gt;&lt;/p&gt;
                  &lt;/div&gt;
                </ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory>
  <ifrs-full:DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20210223204924169">
                  &lt;div&gt;
                    &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;[n] Discontinued operations&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left"&gt;&amp;#160; &amp;#160;&lt;/span&gt;&lt;/p&gt;
                    &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Discontinued operations are reported when a component of the Company, representing a separate major line of business or area of operations with clearly distinguishable cash flows, has been disposed of or is held for sale. Classification as a discontinued operation occurs upon disposal or when the operation meets the criteria to be classified as held for sale, if earlier. Discontinued operations are reported as a separate element of net income or loss on the consolidated statement of net and comprehensive loss for both the current and comparative periods. When a disposal group is classified as held for sale, assets and liabilities are aggregated and presented as separate line items, respectively, on the consolidated statement of financial position. Comparative periods are not restated on the consolidated statement of financial position. Assets held for sale are not depreciated and are measured at the lower of carrying value and fair value less costs to sell.&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left"&gt;&amp;#160;&lt;/span&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left"&gt;&amp;#160; &amp;#160; &amp;#160;&amp;#160;&lt;/span&gt;&lt;/p&gt;
                  &lt;/div&gt;
                </ifrs-full:DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory>
  <huge:DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20210223204947120">
                  &lt;div&gt;
                    &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;New standards, amendment and interpretation adopted by the Company&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left"&gt;&amp;#160; &amp;#160;&lt;/span&gt;&lt;/p&gt;
                    &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;IFRS 3 - &lt;i&gt;Business combinations &lt;/i&gt;("IFRS 3")&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left"&gt;&amp;#160; &amp;#160;&lt;/span&gt;&lt;/p&gt;
                    &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amendments to IFRS 3, issued in October 2018, provide clarification on the definition of a business. The amendments permit a simplified assessment to determine whether a transaction should be accounted for as a business combination or as an asset acquisition.&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left"&gt;&amp;#160; &amp;#160;&lt;/span&gt;&lt;/p&gt;
                    &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The amendments are effective for transactions for which the acquisition date is on or after the beginning of the first annual reporting period beginning on or after January 1, 2020. The amendment adoption did not have a significant impact on the Company's financial statements.&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left"&gt;&amp;#160; &amp;#160;&lt;/span&gt;&lt;/p&gt;
                    &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;IAS 1 -&lt;i&gt; Presentation of financial statements &lt;/i&gt;("IAS 1")&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left"&gt;&amp;#160; &amp;#160;&lt;/span&gt;&lt;/p&gt;
                    &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amendments to IAS 1, issued in October 2018, provide clarification on the definition of material and how it should be applied. The amendments also align the definition of material across International Financial Reporting Standards and other publications.&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left"&gt;&amp;#160; &amp;#160;&lt;/span&gt;&lt;/p&gt;
                    &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The amendments are effective for annual periods beginning on or after January 1, 2020 and are required to be applied prospectively. The amendment adoption did not have a significant impact on the Company's financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/div&gt;
                </huge:DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory>
  <ifrs-full:DisclosureOfBusinessCombinationsExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20200220061908014">
      &lt;div&gt;
        &lt;div&gt;
          &lt;div&gt;
            &lt;p style="text-align:justify;margin-left:18pt;text-indent:-18pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;4.&lt;/strong&gt;&lt;span style="width:10.49pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;&lt;strong&gt;Acquisition of Prismic Pharmaceutical&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On June 28, 2019, the Company closed the acquisition of Prismic by acquiring all of the issued and outstanding Prismic Shares from the holders thereof. Prismic is a U.S.-based specialty research and development pharmaceutical company that is developing non-addictive prescription drugs for the treatment of pain and inflammation. Prismic's goal is to address the opioid crisis based on formulations utilizing micro-PEA's complementary effect on certain drugs used to impact the body's endocannabinoid system.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;It was determined that the acquisition of Prismic did not qualify as a business combination in accordance with IFRS 3 &lt;i&gt;Business Combinations &lt;/i&gt;["IFRS 3"] and therefore it was accounted for as an asset acquisition. The individual identifiable assets acquired and liabilities assumed were identified and the purchase consideration was allocated based on the relative fair values of the acquired assets and assumed liabilities.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;/div&gt;
        &lt;/div&gt;
        &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The total consideration for the purchase of Prismic was&lt;span&gt;&lt;span&gt; $15,713,448. &lt;/span&gt;&lt;/span&gt;The purchase consideration consisted of&lt;span&gt;&lt;span&gt; $12,361,657 &lt;/span&gt;&lt;/span&gt;of Class B subordinate voting shares,&lt;span&gt;&lt;span&gt; $1,931,384 &lt;/span&gt;&lt;/span&gt;of share options and&lt;span&gt;&lt;span&gt; $1,420,407 of warrants. &lt;/span&gt;&lt;/span&gt;The fair value of the Class B subordinate voting shares was determined based on a total of 510,940 shares issued and a fair value of C$32.16 per share, which reflects the share price on the date of acquisition. The fair value of the 89,898 share options and 67,598 warrants issued as part of the consideration were determined using a Black-Scholes options pricing model with the following assumptions:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

          &lt;div&gt;
            &lt;table border="0" cellpadding="0" cellspacing="0" style="border:0px;width:100%;border-collapse:collapse;margin:auto"&gt;
              &lt;tbody&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Share Options&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Warrants&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                  &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(230, 239, 255)"&gt;
                    &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Grant date share price&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;C$32.16&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;C$32.16&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(255, 255, 255)"&gt;
                    &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Exercise price&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;C$2.61 - C$17.89&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;C$2.61 - C$26.73&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                  &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(230, 239, 255)"&gt;
                    &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Expected dividend yield&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Risk free interest rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1.39% - 1.66%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1.41% - 1.52%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                  &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Expected life (years)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0.98&amp;#x2014;16.21&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1.39&amp;#x2014;6.55&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(255, 255, 255)"&gt;
                    &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Annualized volatility&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;
              &lt;/tbody&gt;
            &lt;/table&gt;
          &lt;/div&gt;

        &lt;p style="text-align:justify"&gt;&lt;br/&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The allocation of the total purchase consideration to the identifiable assets acquired and liabilities assumed as at the date of acquisition was as follows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;div style="margin-left:2.25pt"&gt;

            &lt;div&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;margin-left:auto;margin-right:auto;width:100%"&gt;
                &lt;tbody&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Fair value&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);text-align:right"&gt;
                      &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;recognized&amp;#160;on&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;acquisition&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Cash&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1,752&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(255, 255, 255)"&gt;
                      &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Prepaid expenses and deposits&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;19,691&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(230, 239, 255)"&gt;
                      &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Intangible assets&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;18,543,379&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Trade and other payables&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(1,404,732&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(230, 239, 255)"&gt;
                      &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Notes payable&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(1,446,642&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:1pt solid black;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:1pt solid black;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:1pt solid black;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;15,713,448&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:1pt solid black;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                &lt;/tbody&gt;
              &lt;/table&gt;
            &lt;/div&gt;

        &lt;/div&gt;
      &lt;/div&gt;
    </ifrs-full:DisclosureOfBusinessCombinationsExplanatory>
  <ifrs-full:EquityInterestsOfAcquirer contextRef="C_20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember" decimals="0" id="Fxbrl_20200220061955632" unitRef="USD">15713448</ifrs-full:EquityInterestsOfAcquirer>
  <ifrs-full:EquityInterestsOfAcquirer contextRef="C_20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullBusinessCombinationsAxis_hugeClassBVotingSharesMember" decimals="0" id="Fxbrl_20200220062006924" unitRef="USD">12361657</ifrs-full:EquityInterestsOfAcquirer>
  <ifrs-full:EquityInterestsOfAcquirer contextRef="C_20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullBusinessCombinationsAxis_hugeStockOptionsMember" decimals="0" id="Fxbrl_20200220062009866" unitRef="USD">1931384</ifrs-full:EquityInterestsOfAcquirer>
  <ifrs-full:EquityInterestsOfAcquirer contextRef="C_20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullBusinessCombinationsAxis_hugeWarrantsMember" decimals="0" id="Fxbrl_20200220062013143" unitRef="USD">1420407</ifrs-full:EquityInterestsOfAcquirer>
  <huge:IncreaseDecreaseThroughAcquisitionOfNetAssetsShares contextRef="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullBusinessCombinationsAxis_hugeClassBVotingSharesMember" decimals="0" id="Fxbrl_20200228174249252" unitRef="shares">510940</huge:IncreaseDecreaseThroughAcquisitionOfNetAssetsShares>
  <huge:IncreaseDecreaseThroughAcquisitionOfNetAssetsShares contextRef="C_20190102to20191231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20210223141922122_xbrl_20200219211843835" unitRef="shares">510940</huge:IncreaseDecreaseThroughAcquisitionOfNetAssetsShares>
  <huge:IncreaseDecreaseThroughAcquisitionOfNetAssetsShares contextRef="C_20190102to20191231_ifrsfullComponentsOfEquityAxis_hugeWarrantsMember" decimals="INF" id="Fxbrl_20210223141922122_xbrl_20200219211855470" unitRef="shares">67598</huge:IncreaseDecreaseThroughAcquisitionOfNetAssetsShares>
  <huge:IncreaseDecreaseThroughAcquisitionOfNetAssetsShares contextRef="C_20190601to20190629_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20210223101701366" unitRef="shares">510940</huge:IncreaseDecreaseThroughAcquisitionOfNetAssetsShares>
  <huge:ShareIssuePricePerShare contextRef="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullBusinessCombinationsAxis_hugeClassBVotingSharesMember" decimals="2" id="Fxbrl_20200228174418781" unitRef="CAD_per_Share">32.16</huge:ShareIssuePricePerShare>
  <huge:ShareIssuePricePerShare contextRef="C_20190401to20190416_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="2" id="Fxbrl_20210224111941752" unitRef="CAD_per_Share">45.75</huge:ShareIssuePricePerShare>
  <huge:ShareIssuePricePerShare contextRef="C_20190501to20190507_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="2" id="Fxbrl_20210224120059364" unitRef="CAD_per_Share">50.25</huge:ShareIssuePricePerShare>
  <huge:ShareIssuePricePerShare contextRef="C_20190401to20190424_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="2" id="Fxbrl_20210223144804976" unitRef="CAD_per_Share">45.75</huge:ShareIssuePricePerShare>
  <huge:ShareIssuePricePerShare contextRef="C_20191101to20191104_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="2" id="Fxbrl_20200224144443755" unitRef="CAD_per_Share">20.10</huge:ShareIssuePricePerShare>
  <huge:ShareIssuePricePerShare contextRef="C_20210101to20210217_ifrsfullCategoriesOfRelatedPartiesAxis_hugeDirectorsAndOfficersMember_ifrsfullClassesOfOrdinarySharesAxis_hugeClassBCommonSharesMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_hugeSubsequentEventsMember" decimals="2" id="Fxbrl_20210304010003471" unitRef="USD_per_Share">2.65</huge:ShareIssuePricePerShare>
  <ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable contextRef="C_20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullBusinessCombinationsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20200228174437534" unitRef="Share">89898</ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable>
  <ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable contextRef="C_20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullBusinessCombinationsAxis_hugeWarrantsMember" decimals="INF" id="Fxbrl_20200228174534811" unitRef="Share">67598</ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable>
  <huge:DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20200228181510836">
          &lt;div&gt;
            &lt;table border="0" cellpadding="0" cellspacing="0" style="border:0px;width:100%;border-collapse:collapse;margin:auto"&gt;
              &lt;tbody&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Share Options&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Warrants&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                  &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(230, 239, 255)"&gt;
                    &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Grant date share price&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;C$32.16&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;C$32.16&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(255, 255, 255)"&gt;
                    &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Exercise price&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;C$2.61 - C$17.89&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;C$2.61 - C$26.73&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                  &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(230, 239, 255)"&gt;
                    &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Expected dividend yield&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Risk free interest rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1.39% - 1.66%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1.41% - 1.52%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                  &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Expected life (years)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0.98&amp;#x2014;16.21&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1.39&amp;#x2014;6.55&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(255, 255, 255)"&gt;
                    &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Annualized volatility&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;
              &lt;/tbody&gt;
            &lt;/table&gt;
          &lt;/div&gt;
        </huge:DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory>
  <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 contextRef="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember" decimals="2" id="Fxbrl_20200228175851300" unitRef="CAD_per_Share">32.16</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
  <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 contextRef="C_20200101to20201231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223171446364" unitRef="CAD_per_Share">3.75</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
  <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 contextRef="C_20200101to20201231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223171609718" unitRef="CAD_per_Share">9.54</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
  <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 contextRef="C_20190102to20191231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223175017862" unitRef="CAD_per_Share">6.45</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
  <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 contextRef="C_20190102to20191231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223175103120" unitRef="CAD_per_Share">75.38</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
  <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 contextRef="C_20200101to20201231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223193648078" unitRef="CAD_per_Share">3.86</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
  <huge:WeightedAverageSharePriceOfWarrants contextRef="C_20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember" decimals="2" id="Fxbrl_20200228180039983" unitRef="CAD_per_Share">32.16</huge:WeightedAverageSharePriceOfWarrants>
  <huge:WeightedAverageSharePriceOfWarrants contextRef="C_20201231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" decimals="2" id="Fxbrl_20210223154310568" unitRef="CAD_per_Share">2.58</huge:WeightedAverageSharePriceOfWarrants>
  <huge:WeightedAverageSharePriceOfWarrants contextRef="C_20201231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" decimals="2" id="Fxbrl_20210223154414600" unitRef="CAD_per_Share">4.00</huge:WeightedAverageSharePriceOfWarrants>
  <huge:WeightedAverageSharePriceOfWarrants contextRef="C_20191231" decimals="2" id="Fxbrl_20210223154451380" unitRef="CAD_per_Share">32.16</huge:WeightedAverageSharePriceOfWarrants>
  <ifrs-full:ExercisePriceShareOptionsGranted2019 contextRef="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" decimals="2" id="Fxbrl_20200228180155132" unitRef="CAD_per_Share">2.61</ifrs-full:ExercisePriceShareOptionsGranted2019>
  <ifrs-full:ExercisePriceShareOptionsGranted2019 contextRef="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" decimals="2" id="Fxbrl_20200228180226004" unitRef="CAD_per_Share">17.89</ifrs-full:ExercisePriceShareOptionsGranted2019>
  <ifrs-full:ExercisePriceShareOptionsGranted2019 contextRef="C_20200101to20201231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223175142861" unitRef="CAD_per_Share">3.68</ifrs-full:ExercisePriceShareOptionsGranted2019>
  <ifrs-full:ExercisePriceShareOptionsGranted2019 contextRef="C_20200101to20201231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223175234652" unitRef="CAD_per_Share">9.80</ifrs-full:ExercisePriceShareOptionsGranted2019>
  <ifrs-full:ExercisePriceShareOptionsGranted2019 contextRef="C_20190102to20191231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223175311395" unitRef="CAD_per_Share">7.17</ifrs-full:ExercisePriceShareOptionsGranted2019>
  <ifrs-full:ExercisePriceShareOptionsGranted2019 contextRef="C_20190102to20191231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223175317675" unitRef="CAD_per_Share">75.38</ifrs-full:ExercisePriceShareOptionsGranted2019>
  <ifrs-full:ExercisePriceShareOptionsGranted2019 contextRef="C_20200101to20201231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223193635560" unitRef="CAD_per_Share">3.86</ifrs-full:ExercisePriceShareOptionsGranted2019>
  <huge:ExercisePriceOfWarrantsGranted contextRef="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" decimals="2" id="Fxbrl_20200228180204572" unitRef="CAD_per_Share">2.61</huge:ExercisePriceOfWarrantsGranted>
  <huge:ExercisePriceOfWarrantsGranted contextRef="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" decimals="2" id="Fxbrl_20200228180456653" unitRef="CAD_per_Share">26.73</huge:ExercisePriceOfWarrantsGranted>
  <huge:ExercisePriceOfWarrantsGranted contextRef="C_20200101to20201231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" decimals="2" id="Fxbrl_20210223154554339" unitRef="CAD_per_Share">3.46</huge:ExercisePriceOfWarrantsGranted>
  <huge:ExercisePriceOfWarrantsGranted contextRef="C_20200101to20201231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" decimals="2" id="Fxbrl_20210223154632167" unitRef="CAD_per_Share">5.80</huge:ExercisePriceOfWarrantsGranted>
  <huge:ExercisePriceOfWarrantsGranted contextRef="C_20190102to20191231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" decimals="2" id="Fxbrl_20210223154819927" unitRef="CAD_per_Share">2.61</huge:ExercisePriceOfWarrantsGranted>
  <huge:ExercisePriceOfWarrantsGranted contextRef="C_20190102to20191231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" decimals="2" id="Fxbrl_20210223154937777" unitRef="CAD_per_Share">26.73</huge:ExercisePriceOfWarrantsGranted>
  <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted contextRef="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember" decimals="2" id="Fxbrl_20200228180426077" unitRef="Pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
  <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted contextRef="C_20200101to20201231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223175327003_xbrl_20200220125956825" unitRef="Pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
  <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted contextRef="C_20190102to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223175327003_xbrl_20200220130004382" unitRef="Pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
  <huge:ExpectedDividendYieldOfWarrantsGranted contextRef="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember" decimals="2" id="Fxbrl_20200228180434610" unitRef="Pure">0</huge:ExpectedDividendYieldOfWarrantsGranted>
  <huge:ExpectedDividendYieldOfWarrantsGranted contextRef="C_20200101to20201231" decimals="2" id="Fxbrl_20210223155053431" unitRef="Pure">0</huge:ExpectedDividendYieldOfWarrantsGranted>
  <huge:ExpectedDividendYieldOfWarrantsGranted contextRef="C_20190102to20191231" decimals="2" id="Fxbrl_20210223155125695" unitRef="Pure">0</huge:ExpectedDividendYieldOfWarrantsGranted>
  <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" decimals="4" id="Fxbrl_20200228180607315" unitRef="Pure">0.0139</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
  <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" decimals="4" id="Fxbrl_20200228180620070" unitRef="Pure">0.0166</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
  <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="C_20200101to20201231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="4" id="Fxbrl_20210223175409280" unitRef="Pure">0.0027</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
  <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="C_20200101to20201231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="4" id="Fxbrl_20210223175438259" unitRef="Pure">0.0155</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
  <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="C_20190102to20191231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="4" id="Fxbrl_20210223175448200" unitRef="Pure">0.0124</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
  <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="C_20190102to20191231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="4" id="Fxbrl_20210223175457959" unitRef="Pure">0.0190</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
  <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="C_20200101to20201231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="4" id="Fxbrl_20210223193705379" unitRef="Pure">0.0072</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
  <huge:RiskFreeInterestRateOfWarrantsGranted contextRef="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" decimals="4" id="Fxbrl_20200228180614495" unitRef="Pure">0.0141</huge:RiskFreeInterestRateOfWarrantsGranted>
  <huge:RiskFreeInterestRateOfWarrantsGranted contextRef="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" decimals="4" id="Fxbrl_20200228180633126" unitRef="Pure">0.0152</huge:RiskFreeInterestRateOfWarrantsGranted>
  <huge:RiskFreeInterestRateOfWarrantsGranted contextRef="C_20200101to20201231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" decimals="4" id="Fxbrl_20210223155208801" unitRef="Pure">0.0032</huge:RiskFreeInterestRateOfWarrantsGranted>
  <huge:RiskFreeInterestRateOfWarrantsGranted contextRef="C_20200101to20201231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" decimals="4" id="Fxbrl_20210223155242588" unitRef="Pure">0.0036</huge:RiskFreeInterestRateOfWarrantsGranted>
  <huge:RiskFreeInterestRateOfWarrantsGranted contextRef="C_20190102to20191231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" decimals="4" id="Fxbrl_20210223155333162" unitRef="Pure">0.0141</huge:RiskFreeInterestRateOfWarrantsGranted>
  <huge:RiskFreeInterestRateOfWarrantsGranted contextRef="C_20190102to20191231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" decimals="4" id="Fxbrl_20210223155359612" unitRef="Pure">0.0152</huge:RiskFreeInterestRateOfWarrantsGranted>
  <huge:RiskFreeInterestRateOfWarrantsGranted contextRef="C_20200801to20200831_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember" decimals="4" id="Fxbrl_20210224163914267" unitRef="Pure">0.0032</huge:RiskFreeInterestRateOfWarrantsGranted>
  <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted contextRef="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" decimals="2" id="Fxbrl_20200228180859683" unitRef="Year">0.98</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
  <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted contextRef="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" decimals="2" id="Fxbrl_20200228181011219" unitRef="Year">16.21</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
  <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted contextRef="C_20200101to20201231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="0" id="Fxbrl_20210223175507935" unitRef="Year">4</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
  <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted contextRef="C_20200101to20201231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="0" id="Fxbrl_20210223175535917" unitRef="Year">9</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
  <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted contextRef="C_20190102to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="0" id="Fxbrl_20210223175607379" unitRef="Year">5</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
  <huge:ExpectedLifeOfWarrants contextRef="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" id="Fxbrl_20200228180909206">P1Y4M20D</huge:ExpectedLifeOfWarrants>
  <huge:ExpectedLifeOfWarrants contextRef="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" id="Fxbrl_20200228180953133">P6Y6M18D</huge:ExpectedLifeOfWarrants>
  <huge:ExpectedLifeOfWarrants contextRef="C_20200101to20201231" id="Fxbrl_20210223155428750">P5Y</huge:ExpectedLifeOfWarrants>
  <huge:ExpectedLifeOfWarrants contextRef="C_20190102to20191231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" id="Fxbrl_20210223155500908">P1Y4M20D</huge:ExpectedLifeOfWarrants>
  <huge:ExpectedLifeOfWarrants contextRef="C_20190102to20191231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" id="Fxbrl_20210223155603272">P6Y6M18D</huge:ExpectedLifeOfWarrants>
  <huge:ExpectedLifeOfWarrants contextRef="C_20200801to20200831_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" id="Fxbrl_20210224194946424">P5Y</huge:ExpectedLifeOfWarrants>
  <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember" decimals="2" id="Fxbrl_20200228180722339" unitRef="Pure">1</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
  <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="C_20200101to20201231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223175630272" unitRef="Pure">1.20</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
  <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="C_20190102to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223175645833" unitRef="Pure">1</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
  <huge:ExpectedVolatilityOfWarrantsGranted contextRef="C_20190601to20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember" decimals="2" id="Fxbrl_20200228180728624" unitRef="Pure">1</huge:ExpectedVolatilityOfWarrantsGranted>
  <huge:ExpectedVolatilityOfWarrantsGranted contextRef="C_20200101to20201231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" decimals="2" id="Fxbrl_20210223155627710" unitRef="Pure">1.18</huge:ExpectedVolatilityOfWarrantsGranted>
  <huge:ExpectedVolatilityOfWarrantsGranted contextRef="C_20200101to20201231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" decimals="2" id="Fxbrl_20210223155701932" unitRef="Pure">1.21</huge:ExpectedVolatilityOfWarrantsGranted>
  <huge:ExpectedVolatilityOfWarrantsGranted contextRef="C_20190102to20191231" decimals="2" id="Fxbrl_20210223155726890" unitRef="Pure">1</huge:ExpectedVolatilityOfWarrantsGranted>
  <huge:ExpectedVolatilityOfWarrantsGranted contextRef="C_20200801to20200831_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember" decimals="2" id="Fxbrl_20210224163938658" unitRef="Pure">1.21</huge:ExpectedVolatilityOfWarrantsGranted>
  <huge:ExpectedVolatilityOfWarrantsGranted contextRef="C_20200101to20201231" decimals="2" id="Fxbrl_20210224164729419" unitRef="Pure">1.17</huge:ExpectedVolatilityOfWarrantsGranted>
  <ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20200220061924801">
            &lt;div&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;margin-left:auto;margin-right:auto;width:100%"&gt;
                &lt;tbody&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Fair value&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);text-align:right"&gt;
                      &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;recognized&amp;#160;on&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;acquisition&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255);text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Cash&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1,752&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(255, 255, 255)"&gt;
                      &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Prepaid expenses and deposits&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;19,691&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(230, 239, 255)"&gt;
                      &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Intangible assets&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;18,543,379&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Trade and other payables&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(1,404,732&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(230, 239, 255)"&gt;
                      &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Notes payable&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(1,446,642&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:1pt solid black;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:1pt solid black;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:1pt solid black;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;15,713,448&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:1pt solid black;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                &lt;/tbody&gt;
              &lt;/table&gt;
            &lt;/div&gt;
          </ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory>
  <ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate contextRef="C_20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember" decimals="0" id="Fxbrl_20200220062120410" unitRef="USD">1752</ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate>
  <ifrs-full:CurrentAssetsRecognisedAsOfAcquisitionDate contextRef="C_20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember" decimals="0" id="Fxbrl_20200220062142654" unitRef="USD">19691</ifrs-full:CurrentAssetsRecognisedAsOfAcquisitionDate>
  <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate contextRef="C_20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember" decimals="0" id="Fxbrl_20200220062144259" unitRef="USD">18543379</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
  <ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate contextRef="C_20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember" decimals="0" id="Fxbrl_20200220062146011" unitRef="USD">1404732</ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate>
  <ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate contextRef="C_20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember" decimals="0" id="Fxbrl_20200220062150851" unitRef="USD">1446642</ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate>
  <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred contextRef="C_20190628_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember" decimals="0" id="Fxbrl_20200220062153313" unitRef="USD">15713448</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
  <ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20200219170838089">
    &lt;div&gt;
      &lt;p style="text-align:justify;margin-left:2.25pt"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6. Other receivables&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company's other receivables are comprised of the following:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

            &lt;div&gt;
              &lt;table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;
                &lt;tbody&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;December 31, 2020&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;January 1, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Sales tax recoverable&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;134,717&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,529,828&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;739,257&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rent receivable&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:12%;text-align:right"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:12%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,772&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:12%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,263&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26,625&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17,702&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:12%;text-align:right"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;161,342&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:12%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,557,302&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:12%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;745,520&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                &lt;/tbody&gt;
              &lt;/table&gt;
            &lt;/div&gt;

        &lt;/div&gt;
      &lt;/div&gt;
      &lt;div style="margin-left:2.25pt"&gt;&amp;#160;&lt;/div&gt;
    &lt;/div&gt;
  </ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory>
  <huge:DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20210223171255745">
            &lt;div&gt;
              &lt;table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;
                &lt;tbody&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;December 31, 2020&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;January 1, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Sales tax recoverable&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;134,717&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,529,828&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;739,257&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rent receivable&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:12%;text-align:right"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:12%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,772&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:12%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,263&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26,625&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17,702&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:12%;text-align:right"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;161,342&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:12%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,557,302&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:12%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;745,520&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                &lt;/tbody&gt;
              &lt;/table&gt;
            &lt;/div&gt;
          </huge:DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory>
  <huge:SalesTaxRecoverable contextRef="C_20201231" decimals="0" id="Fxbrl_20210223170716467" unitRef="USD">134717</huge:SalesTaxRecoverable>
  <huge:SalesTaxRecoverable contextRef="C_20191231" decimals="0" id="Fxbrl_20210223170752601" unitRef="USD">1529828</huge:SalesTaxRecoverable>
  <huge:SalesTaxRecoverable contextRef="C_20190101" decimals="0" id="Fxbrl_20210223171218818" unitRef="USD">739257</huge:SalesTaxRecoverable>
  <huge:RentReceivable contextRef="C_20201231" decimals="0" id="Fxbrl_20210223170729784" unitRef="USD">0</huge:RentReceivable>
  <huge:RentReceivable contextRef="C_20191231" decimals="0" id="Fxbrl_20210223170841621" unitRef="USD">9772</huge:RentReceivable>
  <huge:RentReceivable contextRef="C_20190101" decimals="0" id="Fxbrl_20210223171226189" unitRef="USD">6263</huge:RentReceivable>
  <ifrs-full:OtherReceivables contextRef="C_20201231" decimals="0" id="Fxbrl_20210223170736496" unitRef="USD">26625</ifrs-full:OtherReceivables>
  <ifrs-full:OtherReceivables contextRef="C_20191231" decimals="0" id="Fxbrl_20210223170914064" unitRef="USD">17702</ifrs-full:OtherReceivables>
  <ifrs-full:OtherReceivables contextRef="C_20190101" decimals="0" id="Fxbrl_20210223171235167" unitRef="USD">0</ifrs-full:OtherReceivables>
  <ifrs-full:TradeAndOtherReceivables contextRef="C_20201231" decimals="0" id="Fxbrl_20210223170745756" unitRef="USD">161342</ifrs-full:TradeAndOtherReceivables>
  <ifrs-full:TradeAndOtherReceivables contextRef="C_20191231" decimals="0" id="Fxbrl_20210223170941892" unitRef="USD">1557302</ifrs-full:TradeAndOtherReceivables>
  <ifrs-full:TradeAndOtherReceivables contextRef="C_20190101" decimals="0" id="Fxbrl_20210223171241500" unitRef="USD">745520</ifrs-full:TradeAndOtherReceivables>
  <ifrs-full:DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory contextRef="C_20200101to20201231" id="F9fd93cd0-52f9-11ea-80c4-2d332cd66d90">
    &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;7. Investments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The following tables outline changes in investments during the periods:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;div&gt;
      &lt;div&gt;

          &lt;div&gt;
            &lt;table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;
              &lt;tbody&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Entity&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Instrument&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Note&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Balance at&lt;br/&gt;January &lt;/strong&gt;&lt;br/&gt;&lt;strong&gt;1,&lt;br/&gt;2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);white-space:nowrap;width:10px"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);white-space:nowrap;width:120px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Additions&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Change in fair&lt;br/&gt;value through&lt;br/&gt;profit or loss&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Proceeds&lt;br/&gt;from sale&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Balance at&lt;br/&gt;December 31,&lt;br/&gt;2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Pharmadrug Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(i)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2,256,900&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(2,001,825&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;255,075&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Cannara Biotech Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(ii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;8,437,342&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(1,614,704&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;6,822,637&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Clover Cannastrip&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(iii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,128,450&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(1,128,450&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;High Tide&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(iv)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,352,665&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(890,362&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;462,303&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;High Tide&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Warrants&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(iv)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;188,914&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(188,914&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;HUGE Shops&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(v)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;977,990&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(405,589&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;572,401&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;SciCann Therapeutics&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(vi)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,504,593&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(968,769&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;535,824&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Solarvest BioEnergy Inc.&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(vii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;519,087&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(191,837&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;327,251&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Solarvest BioEnergy Inc.&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Warrants&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(vii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;290,225&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(202,470&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;87,756&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Solarvest BioEnergy Inc.&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Convertible debenture&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(vii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,447,588&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(1,185,787&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;261,800&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;13,589,954&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:10px;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:120px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4,513,800&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(8,778,707&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;462,303&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;8,862,744&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:bottom;width:10px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;width:120px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Entity&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Instrument&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Note&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;width:9%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Balance at&lt;br/&gt;December 31,&lt;br/&gt;2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:bottom;width:2%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:bottom;width:10px;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;width:120px;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Change in fair&lt;br/&gt;value through&lt;br/&gt;profit or loss&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:bottom;width:2%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;width:9%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Foreign&lt;br/&gt;exchange&lt;br/&gt;gain&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:bottom;width:2%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;width:9%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Proceeds&lt;br/&gt;from sale&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:bottom;width:2%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;width:9%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Balance at&lt;br/&gt;December 31, 2020&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="text-align:left"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:10px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:120px;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="text-align:left"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="text-align:left"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="text-align:left"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="text-align:left"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Pharmadrug Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(i)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;255,075&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;397,006&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;652,081&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Cannara Biotech Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(ii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;6,822,637&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(997,208&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;5,825,429&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Clover Cannastrip&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(iii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;HUGE Shops&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(v)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;572,401&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;7,674&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;20,358&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;600,433&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;SciCann Therapeutics&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(vi)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;535,824&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(354,910&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;14,765&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;195,679&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Solarvest BioEnergy Inc.&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(vii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;327,251&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;106,380&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;14,047&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;447,678&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Solarvest BioEnergy Inc.&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Warrants&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(vii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;87,756&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(14,920&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,977&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;74,813&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Solarvest BioEnergy Inc.&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Convertible debenture&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(vii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;261,800&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:10px;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:120px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;85,104&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;11,238&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;358,142&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;8,862,744&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(770,874&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;62,385&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;6,477,510&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,676,745&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
              &lt;/tbody&gt;
            &lt;/table&gt;
          &lt;/div&gt;
        &lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
        &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(i) Pharmadrug Inc. (Formerly known as "Aura Health Inc.")&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;/div&gt;
    &lt;/div&gt;
    &lt;div style="margin-left:0px"&gt;
      &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;On April 16, 2019, the Company entered into a share exchange agreement with Aura Health Inc. ("Aura"). Pursuant to the share exchange agreement, FSD acquired 13,562,387 common shares at C$0.2212 per share in the capital of Aura in exchange for the issuance of 65,577 Class B shares of the Company at C$45.75 for a total value of $2,256,900. The FSD shares issued to Aura were subject to a purchase price adjustment, such that FSD would be required to issue additional shares to Aura should the weighted average trading price of FSD's shares fall below the issue price. As the number of additional shares to be issued under the agreement were dependent on the FSD share price, it was determined that this created a derivative liability. As a result of the decline in the Company's share price, on September 20, 2019, 61,892 additional Class B shares of the Company were issued to Aura in settlement for the derivative liability. In 2019, Aura Health Inc. changed its name change to Pharmadrug Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;
      &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During the year ended December 31, 2020, the Company sold 13,562,387 common shares for gross proceeds of $652,081.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;
      &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(ii) Cannara Biotech Inc. ("Cannara")&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;
      &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On February 5, 2020, the Company sold its investment of 85,003,750 Class B shares of Cannara for total cash proceeds of $5,825,429. The Company recognized a loss on sale of investment of $997,208.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;
      &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(iii) Clover Cannastrip Thin Film Technologies Corp. ("Clover")&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;
      &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On September 6, 2018, the Company subscribed for $1,128,450 of equity units in a brokered private placement by Clover. The equity investment is measured at fair value through profit or loss. Clover is not a publicly traded company therefore, the fair value was classified as level 3 within the fair value hierarchy. As at December 31, 2019 and as at December 31, 2020, the fair value was determined to be $nil based on the financial position of Clover and the Company's ability to recover its investment.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;
      &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(iv) High Tide&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;
      &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company's investment in High Tide included 4,551,999 shares and 2,000,000 warrants. On November 22, 2019 the Company sold the shares and warrants of High Tide Inc. for total cash proceeds of $462,303.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;
      &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(v) HUGE Shops&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;
      &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company's investment in HUGE Shops includes 17,333,333 shares based on the December 2018 subscription price of C$0.075 per share. The equity investment is measured at fair value through profit or loss. Huge Shops is not a publicly traded company therefore, the fair value was classified as level 3 within the fair value hierarchy. As at December 31, 2020, the Company determined the best information to assess the fair value of the investment was based on movement of comparable public companies' share prices, resulting in a nominal change in the fair value of the investment of 0% from December 31, 2019. Comparable companies were determined in looking at product offering, relative size of operations, geographical market and other factors. A change in this assumption of plus or minus 10% would result in a corresponding change in fair value of the investment of approximately $285.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;
      &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(vi) SciCann Therapeutics Inc.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;
      &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The investment includes 117,648 shares based on the subscription price in May of 2018 and October of 2018 of C$17 per share. The equity investment is measured at fair value through profit or loss. SciCann Therapeutics Inc. is not a publicly traded company therefore, the fair value was classified as level 3 within the fair value hierarchy. As at December 31, 2020, the Company determined the best information to assess the fair value of the investment was based on movement of comparable public companies' share prices, resulting in decline in the fair value of investment of 65% from December 31, 2019. Comparable companies were determined in looking at product offering, relative size of operations, geographical market and other factors. A change in this assumption of plus or minus 10% would result in a corresponding change in fair value of the investment of approximately $36,372.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;
      &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(vii) Solarvest BioEnergy Inc. ("Solarvest")&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;
      &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On May 7, 2019, the Company acquired 3,000,000 common shares, 3,000,000 warrants and a convertible debenture at a principal amount of $1,805,520 for a total fair value of $2,256,900 of Solarvest in exchange for 49,751 Class B common shares of the Company with a fair value of $1,880,750 based on a market price of C$50.25 and recognition of a derivative liability of $376,150. Under the terms of the agreement, the Company has guaranteed a minimum liquidation value of its shares to Solarvest of $2,256,900 resulting in recognition of the derivative liability. If the liquidation value of the Company's shares is below $2,256,900, the Company would be required to issue additional shares for the difference in actual value realized and the minimum guaranteed value.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;
      &lt;/div&gt;
      &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As at December 31, 2019, the fair value of the derivative liability was $1,990,788. The fair value was determined based on the additional common shares of the Company required to be issued to Solarvest to meet the minimum liquidation value of $2,256,900. On February 4, 2020, the Company issued 225,371 shares to Solarvest to settle the derivative liability. The fair value of the shares issued was $1,356,373 resulting in recognition of a gain of $634,415 on settlement of the derivative liability.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;
      &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As at December 31, 2020, the fair value of the shares was determined based on the quoted market price of the shares at C$0.19 per share. The fair value of the associated warrants is based on the Black-Scholes model with the following assumptions: exercise price C$0.25, risk free rate 0.20%, expected volatility 112%, expected life 0.35 years and expected dividend yield of 0%. Fair value of the convertible debenture is calculated as the fair value of shares if converted at SVS share price as at December 31, 2020 of C$0.19. The shares have been classified as level 1 within the fair value hierarchy - quoted market price, and the warrants and convertible debenture have been classified as level 2 - valuation technique with observable market inputs.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

  </ifrs-full:DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory>
  <huge:DisclosureOfDetailedInformationAboutInvestmentsExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20210224130818630">
          &lt;div&gt;
            &lt;table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;
              &lt;tbody&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Entity&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Instrument&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Note&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Balance at&lt;br/&gt;January &lt;/strong&gt;&lt;br/&gt;&lt;strong&gt;1,&lt;br/&gt;2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);white-space:nowrap;width:10px"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);white-space:nowrap;width:120px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Additions&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Change in fair&lt;br/&gt;value through&lt;br/&gt;profit or loss&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Proceeds&lt;br/&gt;from sale&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Balance at&lt;br/&gt;December 31,&lt;br/&gt;2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Pharmadrug Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(i)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2,256,900&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(2,001,825&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;255,075&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Cannara Biotech Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(ii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;8,437,342&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(1,614,704&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;6,822,637&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Clover Cannastrip&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(iii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,128,450&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(1,128,450&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;High Tide&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(iv)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,352,665&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(890,362&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;462,303&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;High Tide&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Warrants&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(iv)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;188,914&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(188,914&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;HUGE Shops&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(v)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;977,990&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(405,589&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;572,401&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;SciCann Therapeutics&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(vi)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,504,593&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(968,769&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;535,824&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Solarvest BioEnergy Inc.&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(vii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;519,087&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(191,837&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;327,251&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Solarvest BioEnergy Inc.&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Warrants&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(vii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;290,225&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(202,470&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;87,756&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Solarvest BioEnergy Inc.&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Convertible debenture&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(vii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,447,588&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(1,185,787&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;261,800&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;13,589,954&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:10px;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:120px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4,513,800&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(8,778,707&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;462,303&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;8,862,744&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:bottom;width:10px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;width:120px;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Entity&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Instrument&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Note&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;width:9%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Balance at&lt;br/&gt;December 31,&lt;br/&gt;2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:bottom;width:2%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:bottom;width:10px;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;width:120px;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Change in fair&lt;br/&gt;value through&lt;br/&gt;profit or loss&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:bottom;width:2%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;width:9%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Foreign&lt;br/&gt;exchange&lt;br/&gt;gain&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:bottom;width:2%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;width:9%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Proceeds&lt;br/&gt;from sale&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:bottom;width:2%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom;width:9%;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Balance at&lt;br/&gt;December 31, 2020&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="text-align:left"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:10px;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:120px;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="text-align:left"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="text-align:left"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="text-align:left"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="text-align:left"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Pharmadrug Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(i)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;255,075&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;397,006&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;652,081&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Cannara Biotech Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(ii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;6,822,637&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(997,208&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;5,825,429&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Clover Cannastrip&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(iii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;HUGE Shops&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(v)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;572,401&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;7,674&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;20,358&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;600,433&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;SciCann Therapeutics&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(vi)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;535,824&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(354,910&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;14,765&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;195,679&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Solarvest BioEnergy Inc.&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(vii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;327,251&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;106,380&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;14,047&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;447,678&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Solarvest BioEnergy Inc.&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Warrants&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(vii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;87,756&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(14,920&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,977&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;74,813&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Solarvest BioEnergy Inc.&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Convertible debenture&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(vii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;261,800&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:10px;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:120px;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;85,104&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;11,238&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;358,142&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;8,862,744&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(770,874&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;62,385&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;6,477,510&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,676,745&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
              &lt;/tbody&gt;
            &lt;/table&gt;
          &lt;/div&gt;
        </huge:DisclosureOfDetailedInformationAboutInvestmentsExplanatory>
  <ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190102to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173308527" unitRef="USD">2256900</ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190102to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeCannaraBiotechIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173308527" unitRef="USD">0</ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190102to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeCloverCannastripThinFilmTechnologiesCorpMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224125620278_xbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173308527" unitRef="USD">0</ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190102to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeHighTideIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224125710374_xbrl_20210224125620278_xbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173308527" unitRef="USD">0</ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190102to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeHighTideIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_hugeWarrantsMember" decimals="0" id="Fxbrl_20210224125942735_xbrl_20210224125710374_xbrl_20210224125620278_xbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173308527" unitRef="USD">0</ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190102to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeHugeShopsMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224125924314_xbrl_20210224125800887_xbrl_20210224125710374_xbrl_20210224125620278_xbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173308527" unitRef="USD">0</ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190102to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeScicannTherapeuticsIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224130103018_xbrl_20210224125924314_xbrl_20210224125800887_xbrl_20210224125710374_xbrl_20210224125620278_xbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173308527" unitRef="USD">0</ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190102to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224130204478_xbrl_20210224130103018_xbrl_20210224125924314_xbrl_20210224125800887_xbrl_20210224125710374_xbrl_20210224125620278_xbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173308527" unitRef="USD">519087</ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190102to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_hugeWarrantsMember" decimals="0" id="Fxbrl_20210224130406983_xbrl_20210224130204478_xbrl_20210224130103018_xbrl_20210224125924314_xbrl_20210224125800887_xbrl_20210224125710374_xbrl_20210224125620278_xbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173308527" unitRef="USD">290225</ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190102to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_hugeConvertibleDebentureMember" decimals="0" id="Fxbrl_20210224130511263_xbrl_20210224130406983_xbrl_20210224130204478_xbrl_20210224130103018_xbrl_20210224125924314_xbrl_20210224125800887_xbrl_20210224125710374_xbrl_20210224125620278_xbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173308527" unitRef="USD">1447588</ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224130619952" unitRef="USD">4513800</ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190102to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173346380" unitRef="USD">-2001825</huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190102to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeCannaraBiotechIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173346380" unitRef="USD">-1614704</huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190102to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeCloverCannastripThinFilmTechnologiesCorpMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224125620278_xbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173346380" unitRef="USD">-1128450</huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190102to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeHighTideIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224125710374_xbrl_20210224125620278_xbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173346380" unitRef="USD">-890362</huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190102to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeHighTideIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_hugeWarrantsMember" decimals="0" id="Fxbrl_20210224125942735_xbrl_20210224125710374_xbrl_20210224125620278_xbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173346380" unitRef="USD">-188914</huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190102to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeHugeShopsMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224125924314_xbrl_20210224125800887_xbrl_20210224125710374_xbrl_20210224125620278_xbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173346380" unitRef="USD">-405589</huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190102to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeScicannTherapeuticsIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224130103018_xbrl_20210224125924314_xbrl_20210224125800887_xbrl_20210224125710374_xbrl_20210224125620278_xbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173346380" unitRef="USD">-968769</huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190102to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224130204478_xbrl_20210224130103018_xbrl_20210224125924314_xbrl_20210224125800887_xbrl_20210224125710374_xbrl_20210224125620278_xbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173346380" unitRef="USD">-191837</huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190102to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_hugeWarrantsMember" decimals="0" id="Fxbrl_20210224130406983_xbrl_20210224130204478_xbrl_20210224130103018_xbrl_20210224125924314_xbrl_20210224125800887_xbrl_20210224125710374_xbrl_20210224125620278_xbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173346380" unitRef="USD">-202470</huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190102to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_hugeConvertibleDebentureMember" decimals="0" id="Fxbrl_20210224130511263_xbrl_20210224130406983_xbrl_20210224130204478_xbrl_20210224130103018_xbrl_20210224125924314_xbrl_20210224125800887_xbrl_20210224125710374_xbrl_20210224125620278_xbrl_20210224125435544_xbrl_20210224125158781_xbrl_20210224123305188_xbrl_20200219173346380" unitRef="USD">-1185787</huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224130632376" unitRef="USD">-8778707</huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224123305188_xbrl_20200219173308527" unitRef="USD">397006</huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeCannaraBiotechIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224123515633_xbrl_20210224123305188_xbrl_20200219173308527" unitRef="USD">-997208</huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeCloverCannastripThinFilmTechnologiesCorpMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224123646446_xbrl_20210224123515633_xbrl_20210224123305188_xbrl_20200219173308527" unitRef="USD">0</huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeHugeShopsMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224124229548_xbrl_20210224123646446_xbrl_20210224123515633_xbrl_20210224123305188_xbrl_20200219173308527" unitRef="USD">7674</huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeScicannTherapeuticsIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224124342226_xbrl_20210224124229548_xbrl_20210224123646446_xbrl_20210224123515633_xbrl_20210224123305188_xbrl_20200219173308527" unitRef="USD">-354910</huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224124507412_xbrl_20210224124342226_xbrl_20210224124229548_xbrl_20210224123646446_xbrl_20210224123515633_xbrl_20210224123305188_xbrl_20200219173308527" unitRef="USD">106380</huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_hugeWarrantsMember" decimals="0" id="Fxbrl_20210224124703291_xbrl_20210224124507412_xbrl_20210224124342226_xbrl_20210224124229548_xbrl_20210224123646446_xbrl_20210224123515633_xbrl_20210224123305188_xbrl_20200219173308527" unitRef="USD">-14920</huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_hugeConvertibleDebentureMember" decimals="0" id="Fxbrl_20210224124822994_xbrl_20210224124703291_xbrl_20210224124507412_xbrl_20210224124342226_xbrl_20210224124229548_xbrl_20210224123646446_xbrl_20210224123515633_xbrl_20210224123305188_xbrl_20200219173308527" unitRef="USD">85104</huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224125101133" unitRef="USD">-770874</huge:ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
  <ifrs-full:NetForeignExchangeGain contextRef="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224123305188_xbrl_20200219173346380" unitRef="USD">0</ifrs-full:NetForeignExchangeGain>
  <ifrs-full:NetForeignExchangeGain contextRef="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeCannaraBiotechIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224123515633_xbrl_20210224123305188_xbrl_20200219173346380" unitRef="USD">0</ifrs-full:NetForeignExchangeGain>
  <ifrs-full:NetForeignExchangeGain contextRef="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeCloverCannastripThinFilmTechnologiesCorpMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224123646446_xbrl_20210224123515633_xbrl_20210224123305188_xbrl_20200219173346380" unitRef="USD">0</ifrs-full:NetForeignExchangeGain>
  <ifrs-full:NetForeignExchangeGain contextRef="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeHugeShopsMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224124229548_xbrl_20210224123646446_xbrl_20210224123515633_xbrl_20210224123305188_xbrl_20200219173346380" unitRef="USD">20358</ifrs-full:NetForeignExchangeGain>
  <ifrs-full:NetForeignExchangeGain contextRef="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeScicannTherapeuticsIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224124342226_xbrl_20210224124229548_xbrl_20210224123646446_xbrl_20210224123515633_xbrl_20210224123305188_xbrl_20200219173346380" unitRef="USD">14765</ifrs-full:NetForeignExchangeGain>
  <ifrs-full:NetForeignExchangeGain contextRef="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_ifrsfullOrdinarySharesMember" decimals="0" id="Fxbrl_20210224124507412_xbrl_20210224124342226_xbrl_20210224124229548_xbrl_20210224123646446_xbrl_20210224123515633_xbrl_20210224123305188_xbrl_20200219173346380" unitRef="USD">14047</ifrs-full:NetForeignExchangeGain>
  <ifrs-full:NetForeignExchangeGain contextRef="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_hugeWarrantsMember" decimals="0" id="Fxbrl_20210224124703291_xbrl_20210224124507412_xbrl_20210224124342226_xbrl_20210224124229548_xbrl_20210224123646446_xbrl_20210224123515633_xbrl_20210224123305188_xbrl_20200219173346380" unitRef="USD">1977</ifrs-full:NetForeignExchangeGain>
  <ifrs-full:NetForeignExchangeGain contextRef="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_ifrsfullClassesOfFinancialInstrumentsAxis_hugeConvertibleDebentureMember" decimals="0" id="Fxbrl_20210224124822994_xbrl_20210224124703291_xbrl_20210224124507412_xbrl_20210224124342226_xbrl_20210224124229548_xbrl_20210224123646446_xbrl_20210224123515633_xbrl_20210224123305188_xbrl_20200219173346380" unitRef="USD">11238</ifrs-full:NetForeignExchangeGain>
  <ifrs-full:NetForeignExchangeGain contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224125113246" unitRef="USD">62385</ifrs-full:NetForeignExchangeGain>
  <huge:NumberOfSharesAcquired contextRef="C_20190401to20190416_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember" decimals="INF" id="Fxbrl_20210224111834718" unitRef="shares">13562387</huge:NumberOfSharesAcquired>
  <huge:NumberOfSharesAcquired contextRef="C_20190401to20190424_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember" decimals="INF" id="Fxbrl_20210223144735252" unitRef="shares">13562386</huge:NumberOfSharesAcquired>
  <huge:SharePrices contextRef="C_20190416_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember" decimals="4" id="Fxbrl_20210224111850925" unitRef="CAD_per_Share">0.2212</huge:SharePrices>
  <huge:SharePrices contextRef="C_20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember" decimals="2" id="Fxbrl_20210224120616328" unitRef="CAD_per_Share">0.19</huge:SharePrices>
  <huge:SharePrices contextRef="C_20190424_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember" decimals="4" id="Fxbrl_20210223144744735" unitRef="CAD_per_Share">0.2212</huge:SharePrices>
  <huge:SharePrices contextRef="C_20200831_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember" decimals="2" id="Fxbrl_20210224163703877" unitRef="USD_per_Share">3.01</huge:SharePrices>
  <huge:NumberOfSharesIssuedInShareExchange contextRef="C_20190401to20190416_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20210224111918955" unitRef="shares">65577</huge:NumberOfSharesIssuedInShareExchange>
  <huge:NumberOfSharesIssuedInShareExchange contextRef="C_20190901to20190920_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20210224112039934" unitRef="shares">61892</huge:NumberOfSharesIssuedInShareExchange>
  <huge:NumberOfSharesIssuedInShareExchange contextRef="C_20190501to20190507_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20210224120029002" unitRef="shares">49751</huge:NumberOfSharesIssuedInShareExchange>
  <huge:NumberOfSharesIssuedInShareExchange contextRef="C_20190401to20190424_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20210223144754288" unitRef="shares">65577</huge:NumberOfSharesIssuedInShareExchange>
  <huge:NumberOfSharesIssuedInShareExchange contextRef="C_20200101to20200204_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20210223110221431" unitRef="shares">225371</huge:NumberOfSharesIssuedInShareExchange>
  <huge:ValueOfSharesIssuedInShareExchange contextRef="C_20190401to20190416_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210224112000460" unitRef="USD">2256900</huge:ValueOfSharesIssuedInShareExchange>
  <huge:ValueOfSharesIssuedInShareExchange contextRef="C_20190501to20190507_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210224120043521" unitRef="USD">1880750</huge:ValueOfSharesIssuedInShareExchange>
  <huge:ValueOfSharesIssuedInShareExchange contextRef="C_20200201to20200204_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_hugeTypeOfArrangementsAxis_hugeShareExchangeAgreementMember" decimals="0" id="Fxbrl_20210224121737412" unitRef="USD">1356373</huge:ValueOfSharesIssuedInShareExchange>
  <huge:ValueOfSharesIssuedInShareExchange contextRef="C_20190401to20190424_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210223144816722" unitRef="USD">2256900</huge:ValueOfSharesIssuedInShareExchange>
  <huge:NumberOfInvestmentSharesSold contextRef="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember" decimals="INF" id="Fxbrl_20210224113756715" unitRef="shares">13562387</huge:NumberOfInvestmentSharesSold>
  <huge:NumberOfInvestmentSharesSold contextRef="C_20200201to20200205_hugeOtherInvestmentsNameOfEntityAxis_hugeCannaraBiotechIncMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20210224114636184" unitRef="shares">85003750</huge:NumberOfInvestmentSharesSold>
  <ifrs-full:GainsLossesOnDisposalsOfInvestments contextRef="C_20200201to20200205_hugeOtherInvestmentsNameOfEntityAxis_hugeCannaraBiotechIncMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210224114728713" unitRef="USD">-997208</ifrs-full:GainsLossesOnDisposalsOfInvestments>
  <huge:ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement contextRef="C_20180901to20180906_hugeOtherInvestmentsNameOfEntityAxis_hugeCloverCannastripThinFilmTechnologiesCorpMember" decimals="0" id="Fxbrl_20210224114951223" unitRef="USD">1128450</huge:ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement>
  <huge:NumberOfSharesHeld contextRef="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeHighTideIncMember" decimals="0" id="Fxbrl_20210224115303226" unitRef="shares">4551999</huge:NumberOfSharesHeld>
  <huge:NumberOfSharesHeld contextRef="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeHugeShopsMember" decimals="0" id="Fxbrl_20210224115510928" unitRef="shares">17333333</huge:NumberOfSharesHeld>
  <huge:NumberOfSharesHeld contextRef="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeScicannTherapeuticsIncMember" decimals="0" id="Fxbrl_20210224115732380" unitRef="shares">117648</huge:NumberOfSharesHeld>
  <huge:NumberOfSharesHeld contextRef="C_20190501to20190507_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember" decimals="INF" id="Fxbrl_20210224115930607" unitRef="shares">3000000</huge:NumberOfSharesHeld>
  <huge:NumberOfWarrantsHeld contextRef="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeHighTideIncMember" decimals="0" id="Fxbrl_20210224115312425" unitRef="shares">2000000</huge:NumberOfWarrantsHeld>
  <huge:NumberOfWarrantsHeld contextRef="C_20190501to20190507_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember" decimals="INF" id="Fxbrl_20210224115943875" unitRef="shares">3000000</huge:NumberOfWarrantsHeld>
  <huge:ProceedsFromSaleOfSharesAndWarrants contextRef="C_20191101to20191122_hugeOtherInvestmentsNameOfEntityAxis_hugeHighTideIncMember" decimals="0" id="Fxbrl_20210224115324382" unitRef="USD">462303</huge:ProceedsFromSaleOfSharesAndWarrants>
  <huge:SubscriptionPricePerShare contextRef="C_20181231_hugeOtherInvestmentsNameOfEntityAxis_hugeHugeShopsMember" decimals="3" id="Fxbrl_20210224115525910" unitRef="CAD_per_Share">0.075</huge:SubscriptionPricePerShare>
  <huge:SubscriptionPricePerShare contextRef="C_20180531_hugeOtherInvestmentsNameOfEntityAxis_hugeScicannTherapeuticsIncMember" decimals="0" id="Fxbrl_202102241157433540" unitRef="CAD_per_Share">17</huge:SubscriptionPricePerShare>
  <huge:SubscriptionPricePerShare contextRef="C_20181031_hugeOtherInvestmentsNameOfEntityAxis_hugeScicannTherapeuticsIncMember" decimals="0" id="Fxbrl_20210224115743354" unitRef="CAD_per_Share">17</huge:SubscriptionPricePerShare>
  <huge:PercentageOfDeclineInFairValueOfInvestment contextRef="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeHugeShopsMember" decimals="2" id="Fxbrl_20210224115550783" unitRef="Pure">0</huge:PercentageOfDeclineInFairValueOfInvestment>
  <huge:PercentageOfDeclineInFairValueOfInvestment contextRef="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeScicannTherapeuticsIncMember" decimals="2" id="Fxbrl_20210224115804472" unitRef="Pure">0.65</huge:PercentageOfDeclineInFairValueOfInvestment>
  <huge:ChangeInFairValueOfInvestmentDueToTenPercentChangeInAssumptionsUsed contextRef="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeHugeShopsMember" decimals="0" id="Fxbrl_20210224115606400" unitRef="USD">285</huge:ChangeInFairValueOfInvestmentDueToTenPercentChangeInAssumptionsUsed>
  <huge:ChangeInFairValueOfInvestmentDueToTenPercentChangeInAssumptionsUsed contextRef="C_20200101to20201231_hugeOtherInvestmentsNameOfEntityAxis_hugeScicannTherapeuticsIncMember" decimals="0" id="Fxbrl_20210224115817435" unitRef="USD">36372</huge:ChangeInFairValueOfInvestmentDueToTenPercentChangeInAssumptionsUsed>
  <huge:PrincipalAmountOfBorrowings contextRef="C_20190507_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember" decimals="0" id="Fxbrl_20210224120000139" unitRef="USD">1805520</huge:PrincipalAmountOfBorrowings>
  <huge:FairValueOfSharesAndWarrantsAcquired contextRef="C_20190507_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember" decimals="0" id="Fxbrl_20210224120016769" unitRef="USD">2256900</huge:FairValueOfSharesAndWarrantsAcquired>
  <ifrs-full:DerivativeFinancialLiabilities contextRef="C_20190507_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember" decimals="0" id="Fxbrl_20210224120147712" unitRef="USD">376150</ifrs-full:DerivativeFinancialLiabilities>
  <huge:GuaranteedMinimumLiquidationValueOfShares contextRef="C_20190507_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember" decimals="0" id="Fxbrl_20210224120209272" unitRef="USD">2256900</huge:GuaranteedMinimumLiquidationValueOfShares>
  <huge:GuaranteedMinimumLiquidationValueOfShares contextRef="C_20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember" decimals="0" id="Fxbrl_20210224120348926" unitRef="CAD">2256900</huge:GuaranteedMinimumLiquidationValueOfShares>
  <ifrs-full:LossesOnChangeInFairValueOfDerivatives contextRef="C_20190102to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_hugeTypeOfArrangementsAxis_hugeShareExchangeAgreementMember" decimals="0" id="Fxbrl_20210224120421273" unitRef="CAD">225371</ifrs-full:LossesOnChangeInFairValueOfDerivatives>
  <ifrs-full:LossesOnChangeInFairValueOfDerivatives contextRef="C_20190901to20190920_hugeOtherInvestmentsNameOfEntityAxis_hugePharmadrugIncMember_hugeTypeOfArrangementsAxis_hugeSecuritiesExchangeAgreementMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20200228153126645" unitRef="USD">1069798</ifrs-full:LossesOnChangeInFairValueOfDerivatives>
  <huge:GainOnSettlementOfDerivativeLiability contextRef="C_20200204_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember_hugeTypeOfArrangementsAxis_hugeShareExchangeAgreementMember" decimals="0" id="Fxbrl_20210224121824746" unitRef="USD">634415</huge:GainOnSettlementOfDerivativeLiability>
  <huge:QuotedMarketPriceOfInvestments contextRef="C_20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember" decimals="2" id="Fxbrl_20210224120655390" unitRef="CAD_per_Share">0.19</huge:QuotedMarketPriceOfInvestments>
  <huge:ExercisePriceOfWarrants contextRef="C_20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember" decimals="2" id="Fxbrl_20210224120454461" unitRef="CAD_per_Share">0.25</huge:ExercisePriceOfWarrants>
  <huge:RiskFreeRateOfWarrants contextRef="C_20190101to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember" decimals="4" id="Fxbrl_20210224120506284" unitRef="Pure">0.0020</huge:RiskFreeRateOfWarrants>
  <huge:ExpectedVolatilityOfWarrants contextRef="C_20190101to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember" decimals="2" id="Fxbrl_20210224120517143" unitRef="Pure">1.12</huge:ExpectedVolatilityOfWarrants>
  <huge:ExpectedTermOfWarrants contextRef="C_20190101to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember" id="Fxbrl_20210224120526616">P0Y4M6D</huge:ExpectedTermOfWarrants>
  <huge:ExpectedDividendYieldOfWarrants contextRef="C_20190101to20191231_hugeOtherInvestmentsNameOfEntityAxis_hugeSolarvestBioEnergyIncMember" decimals="2" id="Fxbrl_20210224120556039" unitRef="Pure">0</huge:ExpectedDividendYieldOfWarrants>
  <ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20200220104442090">
    &lt;div&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;8.&lt;/strong&gt;&lt;span style="width:10.49pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;&lt;strong&gt;Right-of-use asset&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The right-of-use asset as at December 31, 2020 is as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

            &lt;div&gt;
              &lt;table border="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;width:100%"&gt;
                &lt;tbody&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance &amp;#x2013; January 1, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;183,424&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(36,685&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(50,888&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance &amp;#x2013; December 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;95,851&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,991&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(89,860&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance &amp;#x2013; December 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                &lt;/tbody&gt;
              &lt;/table&gt;
            &lt;/div&gt;

          &lt;p style="text-align:justify"&gt;&amp;#160;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The right-of-use asset relates to an office lease. The right-of-use asset is carried at the lower of carrying value and present value of the expected future lease payments to be received from subleasing the premise over the remaining term of the lease. As of March 31, 2020, the Company did not occupy the leased premise and has been unsuccessful in subleasing the space. As a result, the Company recognized an impairment loss of $89,860 resulting in right-of-use asset balance of $nil. The Company recognized depreciation expense of $5,991 for the year ended December 31, 2020, respectively (2019 - $36,685).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory>
  <huge:DisclosureOfDetailedInformationAboutRightOfUseAssets contextRef="C_20200101to20201231" id="Fxbrl_20210223153308338">
            &lt;div&gt;
              &lt;table border="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;width:100%"&gt;
                &lt;tbody&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance &amp;#x2013; January 1, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;183,424&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(36,685&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(50,888&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance &amp;#x2013; December 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;95,851&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,991&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(89,860&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance &amp;#x2013; December 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                &lt;/tbody&gt;
              &lt;/table&gt;
            &lt;/div&gt;
          </huge:DisclosureOfDetailedInformationAboutRightOfUseAssets>
  <ifrs-full:DepreciationRightofuseAssets contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210223153050918" unitRef="USD">36685</ifrs-full:DepreciationRightofuseAssets>
  <ifrs-full:DepreciationRightofuseAssets contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224180912648" unitRef="USD">5991</ifrs-full:DepreciationRightofuseAssets>
  <ifrs-full:DisclosureOfIntangibleAssetsExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20200220141045207">
    &lt;div&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;p style="text-align:justify;margin-left:18pt;text-indent:-18pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;9.&lt;/strong&gt;&lt;span style="width:10.49pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;&lt;strong&gt;Intangible assets&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Intangible assets as at December 31, 2020 are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

            &lt;div&gt;
              &lt;table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:rgb(0, 0, 0)"&gt;
                &lt;tbody&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Intangible Assets&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Cost&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As at January 1, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Acquisition of Prismic Pharmaceuticals Inc.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18,543,379&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;293,126&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effects of foreign exchange&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(140,276&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As at December 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18,696,229&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effects of foreign exchange&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;505,264&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;As at December 31, 2020&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;19,201,493&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:22%;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Accumulated amortization&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As at January 1, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amortization&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,906,363&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effects of foreign exchange&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(30,759&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As at December 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,875,604&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amortization&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,894,467&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effects of foreign exchange&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,031&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;As at December 31, 2020&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;5,777,102&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Net book value&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As at January 1, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As at December 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,820,625&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;As at December 31, 2020&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;13,424,391&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                &lt;/tbody&gt;
              &lt;/table&gt;
            &lt;/div&gt;

          &lt;p style="text-align:justify"&gt;&amp;#160;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company acquired intellectual property as part of the acquisition of Prismic on June 28, 2019. Refer to Note 4 for additional details. The life of the intellectual property has been determined to be 5 years. Amortization of the intellectual property commenced on the date of acquisition. The Company recognized amortization expense of $3,894,467 for the year ended December 31, 2020 (2019 - $1,906,363).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </ifrs-full:DisclosureOfIntangibleAssetsExplanatory>
  <ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20210223200923457">
            &lt;div&gt;
              &lt;table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:rgb(0, 0, 0)"&gt;
                &lt;tbody&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Intangible Assets&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Cost&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As at January 1, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Acquisition of Prismic Pharmaceuticals Inc.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18,543,379&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;293,126&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effects of foreign exchange&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(140,276&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As at December 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18,696,229&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effects of foreign exchange&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;505,264&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;As at December 31, 2020&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;19,201,493&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:22%;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Accumulated amortization&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As at January 1, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amortization&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,906,363&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effects of foreign exchange&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(30,759&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As at December 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,875,604&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amortization&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,894,467&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effects of foreign exchange&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,031&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;As at December 31, 2020&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;5,777,102&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Net book value&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As at January 1, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As at December 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,820,625&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;As at December 31, 2020&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;13,424,391&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                &lt;/tbody&gt;
              &lt;/table&gt;
            &lt;/div&gt;
          </ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory>
  <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="C_20190102to20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="0" id="Fxbrl_20210223195250738" unitRef="USD">18543379</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="C_20190102to20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="0" id="Fxbrl_20210223195300002" unitRef="USD">293126</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill contextRef="C_20190102to20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="0" id="Fxbrl_20210223195309684" unitRef="USD">-140276</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" decimals="0" id="Fxbrl_20210223195358683" unitRef="USD">505264</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill contextRef="C_20190102to20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20210223200010336" unitRef="USD">-30759</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20210223200038993" unitRef="USD">7031</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill contextRef="C_20190102to20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20210223195939263" unitRef="USD">1906363</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" decimals="0" id="Fxbrl_20210223200030770" unitRef="USD">3894467</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210223201839513" unitRef="USD">3894467</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210223201834562" unitRef="USD">1906363</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill contextRef="C_20200101to20201231" id="Fxbrl_20210223201514568">P5Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:DisclosureOfLeasesExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20200220141721748">
      &lt;div&gt;
        &lt;div&gt;
          &lt;div&gt;
            &lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;11.&lt;/strong&gt;&lt;span style="width:5.49pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;&lt;strong&gt;Lease obligations&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The lease obligations as at December 31, 2020 are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

              &lt;div&gt;
                &lt;table border="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;width:90%"&gt;
                  &lt;tbody&gt;
                    &lt;tr&gt;
                      &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160;&lt;strong&gt;$&amp;#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Balance as at January 1, 2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;183,424&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Add: Interest Expense&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:12%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,480&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less: Lease Payments&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(42,285&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Balance &amp;#x2013; December 31, 2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:12%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;152,619&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Add: Interest Expense&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,367&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less: Lease Payments&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:12%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(39,993&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effects of foreign exchange&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"&gt;
                        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2,969&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Balance &amp;#x2013; December 31, 2020&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:12%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;125,962&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:12%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;46,842&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-current&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;79,120&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Balance &amp;#x2013; December 31, 2020&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:12%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;125,962&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                  &lt;/tbody&gt;
                &lt;/table&gt;
              &lt;/div&gt;

            &lt;p style="margin:0pt"&gt;&amp;#160;&lt;/p&gt;
            &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease obligations are related to the Company's office lease. The Company recognized $10,367 interest expense for the year ended December 31, 2020 (2019 - $11,480).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of December 31, 2020, the Company did not occupy the leased premise. The Company has commenced plans to sublease the premise, however, if or when the Company will be able to sublease the premise is unknown.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following table sets out a maturity analysis of the lease payments payable, showing the undiscounted lease payments to be paid on an annual basis, reconciled to the lease obligation.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;/div&gt;
        &lt;/div&gt;
        &lt;div style="margin-left:1.5pt"&gt;

            &lt;div&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;font-size:10pt;border-collapse:collapse;border-color:#000000"&gt;
                &lt;tbody&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less than one year&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;46,842&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;One to two years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;47,088&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Two to three years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;47,088&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)"&gt;
                      &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Thereafter&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;
                      &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total undiscounted lease payments payable&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;141,018&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less: impact of present value&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(15,056&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;border-top:1pt solid black;border-bottom:2pt solid black;background-color:rgb(230, 239, 255)"&gt;
                      &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as at December 31, 2020&amp;#160;&amp;#160; &amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;border-top:1pt solid black;border-bottom:2pt solid black;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:17%;border-top:1pt solid black;border-bottom:2pt solid black;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;125,962&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;border-top:1pt solid black;border-bottom:2pt solid black;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                &lt;/tbody&gt;
              &lt;/table&gt;&lt;br/&gt;&amp;#160;
            &lt;/div&gt;

        &lt;/div&gt;
      &lt;/div&gt;
    </ifrs-full:DisclosureOfLeasesExplanatory>
  <huge:DisclosureOfOperatingLeaseObligationsTableTextBlock contextRef="C_20200101to20201231" id="Fxbrl_20210223115032209">
              &lt;div&gt;
                &lt;table border="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;width:90%"&gt;
                  &lt;tbody&gt;
                    &lt;tr&gt;
                      &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160;&lt;strong&gt;$&amp;#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Balance as at January 1, 2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;183,424&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Add: Interest Expense&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:12%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,480&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less: Lease Payments&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(42,285&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Balance &amp;#x2013; December 31, 2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:12%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;152,619&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Add: Interest Expense&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,367&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less: Lease Payments&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:12%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(39,993&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effects of foreign exchange&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"&gt;
                        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2,969&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Balance &amp;#x2013; December 31, 2020&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:12%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;125,962&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:12%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;46,842&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-current&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;79,120&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Balance &amp;#x2013; December 31, 2020&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:12%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;125,962&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                  &lt;/tbody&gt;
                &lt;/table&gt;
              &lt;/div&gt;
            </huge:DisclosureOfOperatingLeaseObligationsTableTextBlock>
  <ifrs-full:LeaseLiabilities contextRef="C_20190101" decimals="0" id="Fxbrl_20210223113052075" unitRef="USD">183424</ifrs-full:LeaseLiabilities>
  <ifrs-full:LeaseLiabilities contextRef="C_20191231" decimals="0" id="Fxbrl_20210223113055863" unitRef="USD">152619</ifrs-full:LeaseLiabilities>
  <ifrs-full:LeaseLiabilities contextRef="C_20201231" decimals="0" id="Fxbrl_20210223113114064" unitRef="USD">125962</ifrs-full:LeaseLiabilities>
  <ifrs-full:InterestExpenseOnLeaseLiabilities contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210223113215660" unitRef="USD">11480</ifrs-full:InterestExpenseOnLeaseLiabilities>
  <ifrs-full:InterestExpenseOnLeaseLiabilities contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210223113211294" unitRef="USD">10367</ifrs-full:InterestExpenseOnLeaseLiabilities>
  <ifrs-full:CashOutflowForLeases contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210223113349277" unitRef="USD">42285</ifrs-full:CashOutflowForLeases>
  <ifrs-full:CashOutflowForLeases contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210223113424267" unitRef="USD">39993</ifrs-full:CashOutflowForLeases>
  <huge:EffectsOfForeignExchangeOnLeaseLiabilities contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210223115844945" unitRef="USD">2969</huge:EffectsOfForeignExchangeOnLeaseLiabilities>
  <ifrs-full:DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20200220141615238">
            &lt;div&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;font-size:10pt;border-collapse:collapse;border-color:#000000"&gt;
                &lt;tbody&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less than one year&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;46,842&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;One to two years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;47,088&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Two to three years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;47,088&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)"&gt;
                      &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Thereafter&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;
                      &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total undiscounted lease payments payable&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;141,018&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less: impact of present value&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(15,056&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;border-top:1pt solid black;border-bottom:2pt solid black;background-color:rgb(230, 239, 255)"&gt;
                      &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as at December 31, 2020&amp;#160;&amp;#160; &amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;border-top:1pt solid black;border-bottom:2pt solid black;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:17%;border-top:1pt solid black;border-bottom:2pt solid black;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;125,962&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;border-top:1pt solid black;border-bottom:2pt solid black;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                &lt;/tbody&gt;
              &lt;/table&gt;&lt;br/&gt;&amp;#160;
            &lt;/div&gt;
          </ifrs-full:DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory>
  <huge:UndiscountedLeasePaymentsPayable contextRef="C_20201231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember" decimals="0" id="Fxbrl_20200220135825810" unitRef="USD">46842</huge:UndiscountedLeasePaymentsPayable>
  <huge:UndiscountedLeasePaymentsPayable contextRef="C_20201231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember" decimals="0" id="Fxbrl_20200220135831927" unitRef="USD">47088</huge:UndiscountedLeasePaymentsPayable>
  <huge:UndiscountedLeasePaymentsPayable contextRef="C_20201231_ifrsfullMaturityAxis_ifrsfullLaterThanTwoYearsAndNotLaterThanThreeYearsMember" decimals="0" id="Fxbrl_20200220135838172" unitRef="USD">47088</huge:UndiscountedLeasePaymentsPayable>
  <huge:UndiscountedLeasePaymentsPayable contextRef="C_20201231_ifrsfullMaturityAxis_ifrsfullLaterThanFiveYearsMember" decimals="0" id="Fxbrl_20200220140038923" unitRef="USD">0</huge:UndiscountedLeasePaymentsPayable>
  <huge:UndiscountedLeasePaymentsPayable contextRef="C_20201231" decimals="0" id="Fxbrl_20200220135855959" unitRef="USD">141018</huge:UndiscountedLeasePaymentsPayable>
  <huge:OperatingLeaseImpactOfPresentValue contextRef="C_20201231" decimals="0" id="Fxbrl_20200220200600857" unitRef="USD">15056</huge:OperatingLeaseImpactOfPresentValue>
  <ifrs-full:DisclosureOfBorrowingsExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20200220155026693">
    &lt;div&gt;
      &lt;p style="margin-top:0pt;margin-left:24px;margin-bottom:0pt;text-align:justify;text-indent:-18pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;strong&gt;10.&lt;/strong&gt;&lt;span style="width:5.49pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;&lt;strong&gt;Notes payable&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify"&gt;&amp;#160;&lt;/p&gt;
      &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Notes payable consists of the following:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;div&gt;
        &lt;div&gt;

            &lt;div&gt;
              &lt;table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;
                &lt;tbody&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;December 31, 2020&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Short-term notes&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;49,647&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;145,943&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Notes payable&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;335,000&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,289,755&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;384,647&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,435,698&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                &lt;/tbody&gt;
              &lt;/table&gt;
            &lt;/div&gt;

        &lt;/div&gt;
      &lt;/div&gt;
      &lt;p style="margin:0pt"&gt;&amp;#160;&lt;/p&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Short-term notes&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The short-term notes represent notes outstanding that the Company assumed on acquisition of Prismic. The notes have matured, are due on demand and accrue interest at a rate of 10% per annum. The notes are held by former Directors and Shareholders of Prismic.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Notes payable&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The notes payable represent notes outstanding that the Company assumed on acquisition of Prismic. The notes have matured and are due on demand. The notes accrue interest at a rate of 20% per annum. The notes are held by former Directors and Shareholders of Prismic. The Company recognized accrued interest of $227,366 during the year ended December 31, 2020 (2019 - $142,907).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During the year ended December 31, 2020, the Company settled notes payable in the amount of $1,084,719, accrued interest of $795,367, and $438,599 of other Prismic related liabilities with 63,714 Class B Common Shares with a fair value of $185,976 and cash of $1,484,369. A gain of $680,164 was recognized on settlement as the value of the consideration was less than the carrying value of the notes payable, accrued interest and other related Prismic liabilities.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </ifrs-full:DisclosureOfBorrowingsExplanatory>
  <ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20210223124155586">
            &lt;div&gt;
              &lt;table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;
                &lt;tbody&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;December 31, 2020&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Short-term notes&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;49,647&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;145,943&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Notes payable&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;335,000&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,289,755&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;384,647&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,435,698&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                &lt;/tbody&gt;
              &lt;/table&gt;
            &lt;/div&gt;
          </ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory>
  <ifrs-full:BorrowingsInterestRate contextRef="C_20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember" decimals="2" id="Fxbrl_20210223125837489" unitRef="Pure">0.10</ifrs-full:BorrowingsInterestRate>
  <ifrs-full:BorrowingsInterestRate contextRef="C_20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_hugeNotesPayableMember" decimals="2" id="Fxbrl_20210223125855023" unitRef="Pure">0.20</ifrs-full:BorrowingsInterestRate>
  <ifrs-full:InterestExpenseOnBorrowings contextRef="C_20200101to20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_hugeNotesPayableMember" decimals="0" id="Fxbrl_20210223134519779" unitRef="USD">227366</ifrs-full:InterestExpenseOnBorrowings>
  <ifrs-full:InterestExpenseOnBorrowings contextRef="C_20190101to20191231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_hugeNotesPayableMember" decimals="0" id="Fxbrl_20210223134526260" unitRef="USD">142907</ifrs-full:InterestExpenseOnBorrowings>
  <huge:BorrowingsSettled contextRef="C_20200101to20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_hugeNotesPayableMember" decimals="0" id="Fxbrl_20210223134444702" unitRef="USD">1084719</huge:BorrowingsSettled>
  <huge:BorrowingsSettled contextRef="C_20200101to20201231_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember" decimals="0" id="Fxbrl_20210223151433197" unitRef="USD">438599</huge:BorrowingsSettled>
  <huge:BorrowingsSettledAccruedInterestSettled contextRef="C_20200101to20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_hugeNotesPayableMember" decimals="0" id="Fxbrl_20210223151322323" unitRef="USD">795367</huge:BorrowingsSettledAccruedInterestSettled>
  <huge:IssuanceOfCommonStockForNotesPayable contextRef="C_20200101to20201231_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20210223131235491" unitRef="shares">63714</huge:IssuanceOfCommonStockForNotesPayable>
  <huge:IssuanceOfCommonStockForNotesPayable contextRef="C_20200401to20200415_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20210223114619086" unitRef="shares">63714</huge:IssuanceOfCommonStockForNotesPayable>
  <huge:FairValueOfCommonStockToSettleNotesPayable contextRef="C_20200101to20201231_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210223131354393" unitRef="USD">185976</huge:FairValueOfCommonStockToSettleNotesPayable>
  <huge:FairValueOfCommonStockToSettleNotesPayable contextRef="C_20200401to20200415_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210223115041453" unitRef="USD">185976</huge:FairValueOfCommonStockToSettleNotesPayable>
  <huge:CashReceiptsFromSalesOfDebtInstruments contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210223151541313" unitRef="USD">1484369</huge:CashReceiptsFromSalesOfDebtInstruments>
  <ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20200303195607682">
            &lt;div&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;13.&lt;/strong&gt;&lt;span style="width:5.49pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;&lt;strong&gt;Share capital&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;[a]&lt;/strong&gt;&lt;span style="width:7pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;&lt;strong&gt;Authorized&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The Company is authorized to issue an unlimited number of Class A multiple voting shares ("Class A shares") and an unlimited number of Class B subordinate voting shares ("Class B shares"), all without par value. All shares are ranked equally with regards to the Company's residual assets.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The holders of Class A shares are entitled to 276,660 votes per Class A share held.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&amp;#160;&lt;/span&gt;&lt;/span&gt;Class A shares are held by certain Directors of the Company.&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;
              &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong style="color:#000000;font-family:Times New Roman;font-size:13.3333px;font-style:normal;font-variant-ligatures:normal;font-variant-caps:normal;letter-spacing:normal;orphans:2;text-align:justify;text-indent:-24px;text-transform:none;white-space:normal;widows:2;word-spacing:0px;-webkit-text-stroke-width:0px;text-decoration-style:initial;text-decoration-color:initial"&gt;[b]&lt;/strong&gt;&lt;span style="color:#000000;font-family:Times New Roman;font-size:13.3333px;font-style:normal;font-variant-ligatures:normal;font-variant-caps:normal;font-weight:400;letter-spacing:normal;orphans:2;text-align:justify;text-transform:none;white-space:normal;widows:2;word-spacing:0px;-webkit-text-stroke-width:0px;text-decoration-style:initial;text-decoration-color:initial;width:6.51pt;text-indent:0pt;display:inline-block"&gt; &lt;/span&gt;&lt;strong style="color:#000000;font-family:Times New Roman;font-size:13.3333px;font-style:normal;font-variant-ligatures:normal;font-variant-caps:normal;letter-spacing:normal;orphans:2;text-align:justify;text-indent:-24px;text-transform:none;white-space:normal;widows:2;word-spacing:0px;-webkit-text-stroke-width:0px;text-decoration-style:initial;text-decoration-color:initial"&gt;Issued and outstanding&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;
              &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Reconciliation of the Company's share capital is as follows:&lt;/span&gt;&lt;/span&gt;&lt;span&gt;&amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;div&gt;
                &lt;div&gt;

                    &lt;table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;
                      &lt;tbody&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td colspan="4" style="border-bottom:1px solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Class A shares&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td colspan="4" style="border-bottom:1px solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Class B shares&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td colspan="4" style="border-bottom:1px solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Warrants&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;#&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;#&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;#&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Balance, January 1, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;72&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;151,588&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;6,843,780&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;51,093,434&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;546,212&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3,341,826&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Shares issued [a] [b] [c] [d]&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;408,651&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;8,681,103&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Issued on acquisition of net assets of Prismic Pharmaceuticals, Inc. [e]&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;510,940&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;12,361,657&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;67,598&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,420,407&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Stock options exercised&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Share-based payments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;130,189&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,340,929&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Warrants exercised&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;12,167&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;109,214&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(12,167&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(37,753&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Warrants expired&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(134,192&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(402,491&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Balance, December 31, 2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;72&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;151,588&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;7,905,727&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;73,586,337&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;467,451&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;4,321,989&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Shares issued [g] [j] [k] [l] [n] [o]&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;8,925,942&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;22,242,975&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;6,335,758&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,110,904&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Share-based payments [f] [h] [i] [m]&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2,307,569&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;6,663,479&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Share options exercised&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;22,382&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;563,747&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Warrants expired&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(54,100&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(463,935&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Balance, December 31, 2020&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;72&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;151,588&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;19,161,620&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;103,056,538&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;6,749,109&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;4,968,958&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                        &lt;/tr&gt;
                      &lt;/tbody&gt;
                    &lt;/table&gt;

                  &lt;p&gt;&amp;#160;&lt;/p&gt;
                  &lt;div&gt;
                    &lt;div&gt;
                      &lt;p style="margin-top:0pt;margin-left:20pt;margin-bottom:0pt;text-align:justify;text-indent:-18pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;[a]&lt;span style="width:7.99pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;On April 24, 2019, the Company entered into a share exchange agreement with Aura. Pursuant to the share exchange agreement, FSD acquired 13,562,386 common shares at C$0.2212 per share in the capital of Aura in exchange for the issuance of 65,577 Class B shares of the Company at C$45.75 for a total value of $2,256,900.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                      &lt;p style="margin-top:0pt;margin-left:48px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
              &lt;/div&gt;
              &lt;div style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:start;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-left:24px;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;On September 20, 2019, the Company issued an additional&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt; 61,892 &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;Class B shares as part of the adjustment of purchase price related to the share exchange agreement with Aura to settle the related derivative liability. As part of the settlement, the Company recognized a loss on change in the fair value of derivative liability of $1,069,798.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;[b]&lt;span style="width:7.75pt;display:inline-block"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;On May 7, 2019, the Company entered into an agreement with Solarvest. Per the agreement the Company issued 49,751 &lt;/span&gt;&lt;/span&gt;Class B Shares to Solarvest in exchange for the investment in Solarvest for a total fair value of $1,880,750. Refer to Note 7 for details regarding the investment in Solarvest.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;[c]&lt;span style="width:7.75pt;display:inline-block"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;On October 4, 2019, the Company issued 3,735 Class B shares in settlement for trade payables of $18,808.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;[d]&lt;span style="width:7.75pt;display:inline-block"&gt; &lt;/span&gt;On November 4, 2019, the Company completed a private placement &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;through&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt; the issuance of 228,670 Class B shares at a price of C$20.10 per share for total gross proceeds of $3,455,898.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;[e]&lt;span style="width:7.99pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;On June 29, 2019, the Company acquired all outstanding common and preferred shares of Prismic through the issuance of an aggregate of 510,940 Class B Shares. The Class B Shares issued to the Prismic shareholders were deposited into escrow upon closing of the transaction and were subject to an 18-month staggered escrow release.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;[f]&lt;span style="width:8.5pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;On January 2, 2020, the Company issued 27,580 Class B Common Shares as share-based compensation to certain members of the Board of Directors for services performed as directors for the fiscal year 2019 for the amount payable of $74,117, which was recorded as trade and other payables as at December 31, 2019.&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;[g]&lt;span style="width:6.99pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;On February 4, 2020, the Company issued 225,371 Class B Common Shares to Solarvest as settlement under the Share Exchange Agreement to settle the derivative liability of $1,990,788.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;[h]&lt;span style="width:6.99pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;On March 16, 2020, the Company issued 405,926 Class B Common Shares as part of a share-based bonus to employees for performance related to fiscal year 2019 resulting in movement of $1,302,076 from contributed surplus to share capital and the recognition of an additional share-based compensation expense of $93,502 as a result of the increase in value of the shares issued.&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;[i]&lt;span style="width:9.5pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;On March 16, 2020, the Company issued 69,069 Class B Common Shares to members of the Board of Directors as share-based compensation, in lieu of cash, for their annual compensation for the year ended December 31, 2020.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;[j]&lt;span style="width:9pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;On April 15, 2020, the Company issued 63,714 Class B Common Shares to settle Prismic notes payable of $226,385. The fair value of the Class B Common Shares was $185,976 resulting in a gain on settlement of liability of $40,409.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;[k]&lt;span style="width:6.5pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;On June 8, 2020, the Company issued 1,500,000 Class B Common Shares and 1,500,000 warrants as part of a private placement financing for total cash proceeds of C$10,125,000 ($7,617,038). The more reliably measured component, Class B Common Shares, were measured first, with the residual amount being allocated to the warrants. The fair value of the Class B Common Shares was $7,515,477 and the residual value allocated to the warrants was $101,561. The Company incurred issuance costs of $707,043, which has been allocated pro-rata to the common shares and warrants.&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="margin-top:0pt;margin-left:20pt;margin-bottom:0pt;text-align:justify;text-indent:-18pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;
                &lt;/div&gt;&lt;/div&gt;
                &lt;div style="text-align:start"&gt;
                  &lt;table style="width:100%;border-collapse:collapse;font-size:13px;border:0px"&gt;
                    &lt;tbody&gt;
                      &lt;tr&gt;
                        &lt;td style="width:1333px"&gt;
                          &lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;[l]&lt;span style="width:8.5pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;On August 6, 2020, the Company issued 2,762,430 Class B Common Shares and 1,381,215 warrants as part of a direct offering for total cash proceeds of $9,999,997. Total cash proceeds were allocated to the warrants liability first with the residual amount allocated to the Class B Common Shares (Note 12). The fair value of the warrants liability was determined to be $3,289,069 and the residual amount of $6,710,928 was allocated to the Class B Common Shares. The Company incurred total cash transaction costs of $913,349. Transaction costs allocated to the warrants of $284,049 were expensed immediately and the transaction costs allocated to common shares were deducted from equity.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                          &lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;
                          &lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;[m]&lt;span style="width:3.5pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;In August 2020, the Company approved the issuance of 1,804,994 Class B Common Shares to members of the Board of Directors and certain officers and employees of the company in the form of a compensation bonus for past services provided. Total fair value of the share-based compensation bonus was $4,956,324.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                          &lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;
                          &lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;[n]&lt;span style="width:5.99pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;During the year ended December 31, 2020, the Company issued 56,248 Class B Common Shares through the Equity Distribution Agreement with A.G.P/Alliance Global Partners for net proceeds of $199,785.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                          &lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;
                          &lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;[o]&lt;span style="width:5.99pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;In October 2020, the Company issued 4,318,179 Class B Common Shares and 3,454,543 warrants as part of a direct offering for total proceeds of $9,499,994. The more reliably measured component, Class B Common Shares, were measured first, with the residual amount being allocated to the warrants. The fair value of the Class B Common Shares was $8,377,267 and the residual value allocated to the warrants was $1,122,727. The Company incurred issuance costs of $879,621, which has been allocated pro-rata to the common shares and warrants.&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                    &lt;/tbody&gt;
                  &lt;/table&gt;
                &lt;/div&gt;
                &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The changes in the number of warrants outstanding during the year ended December 31, 2020 and 2019 were as follows:&lt;span&gt;&amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160;&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;div&gt;
                  &lt;div&gt;

                      &lt;table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;
                        &lt;tbody&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&amp;#160;Number of warrants&amp;#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&amp;#160;Weighted average&lt;br/&gt;exercise price&amp;#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&amp;#160;#&amp;#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&amp;#160;C$&amp;#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                            &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Outstanding as at December 31, 2018&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;546,212&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;9.47&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                            &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Issued&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;67,598&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;10.45&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                            &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Exercised&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(12,167&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;7.81&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                            &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Expired&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(134,192&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;7.64&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                            &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Outstanding as at December 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;467,451&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;10.20&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                            &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Issued&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;6,335,758&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;5.27&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                            &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Expired&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(54,100&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.97&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                            &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Outstanding as at December 31, 2020&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;6,749,109&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;5.62&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;/tr&gt;
                        &lt;/tbody&gt;
                      &lt;/table&gt;

                  &lt;/div&gt;
                &lt;/div&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Measurement of fair values&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The fair value of warrants&amp;#160;during the year&amp;#160;ended December 31, 2020&amp;#160;and 2019&amp;#160;were estimated at the date of grant using the Black-Scholes option pricing model with the following inputs:&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;
                &lt;div&gt;
                  &lt;div&gt;

                      &lt;table border="0" style="width:100%;border-collapse:collapse;font-size:10pt"&gt;
                        &lt;tbody&gt;
                          &lt;tr&gt;
                            &lt;td&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="text-align:right;border-bottom:1px solid #000000;width:25%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2020&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="text-align:right;border-bottom:1px solid #000000;width:25%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                            &lt;td style="background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Grant date share price&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;C$2.58 - C$4.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;C$32.16&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                            &lt;td style="background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercise price&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;C$3.46 - C$5.80&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;C$2.61 - C$26.73&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                            &lt;td style="background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected dividend yield&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                            &lt;td style="background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Risk free interest rate&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.32% 0.36%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.41% - 1.52%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                            &lt;td style="background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected life&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.39 - 6.55&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                            &lt;td style="background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected volatility&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;118% - 121%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;/tr&gt;
                        &lt;/tbody&gt;
                      &lt;/table&gt;

                  &lt;/div&gt;
                &lt;/div&gt;
                &lt;p&gt;&amp;#160;&lt;/p&gt;
                &lt;div&gt;
                  &lt;div&gt;

                      &lt;div&gt;
                        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following table is a summary of the Company's warrants outstanding as at December 31, 2019:&lt;span style="text-align:start"&gt;&amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                        &lt;div&gt;
                          &lt;div&gt;
                            &lt;table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;
                              &lt;tbody&gt;
                                &lt;tr&gt;
                                  &lt;td colspan="6" style="text-align:center;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Warrants Outstanding&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td colspan="1" style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Exercise price&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Number outstanding&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Expiry Date&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;C$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;#&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                                  &lt;td style="vertical-align:bottom;text-align:center;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;August 1, 2021&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.43&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,476&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                                  &lt;td style="vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;May 24, 2022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18.09&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;163,535&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                                  &lt;td style="vertical-align:bottom;text-align:center;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;September 15, 2022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.42&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;199,005&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                                  &lt;td style="vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;May 20, 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16.08&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,311&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                                  &lt;td style="vertical-align:bottom;text-align:center;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;July 24, 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13.07&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,357&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                                  &lt;td style="vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;September 11, 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.43&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22,382&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                                  &lt;td style="vertical-align:bottom;text-align:center;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;May 4, 2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.73&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,730&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                                  &lt;td style="vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;May 10, 2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.73&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,865&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                                  &lt;td style="vertical-align:bottom;text-align:center;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;May 17, 2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.73&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,730&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                                  &lt;td style="vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;May 31, 2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.73&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,865&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                                  &lt;td style="vertical-align:bottom;text-align:center;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;June 8, 2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9.65&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,500,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                                  &lt;td style="vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;August 6, 2020 (i)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.42&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,381,215&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                                  &lt;td style="vertical-align:bottom;text-align:center;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;October 20, 2020 (ii)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.31&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,454,543&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                                  &lt;td style="vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;January 16, 2026&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.73&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,722&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;January 20, 2026&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.73&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;373&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.62&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,749,109&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                              &lt;/tbody&gt;
                            &lt;/table&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/span&gt;&lt;/span&gt;
                            &lt;p style="margin-left:108pt;margin-bottom:0pt;text-indent:-36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(i)&lt;span style="width:28.89pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Warrants were issued in US$ with exercise price of $4.26&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/span&gt;&lt;/span&gt;
                            &lt;p style="margin-top:0pt;margin-left:108pt;text-indent:-36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(ii)&lt;span style="width:26.12pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Warrants were issued in US$ with exercise price of $2.60&lt;span style="text-align:start;text-indent:0px"&gt;&amp;#160; &amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                            &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following table is a summary of the Company's warrants outstanding as at December 31, 2019:&lt;span style="text-align:start"&gt;&amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160;&amp;#160;&amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160;&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                            &lt;table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;
                              &lt;tbody&gt;
                                &lt;tr&gt;
                                  &lt;td colspan="6" style="text-align:center;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Warrants Outstanding&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td colspan="1" style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Exercise price&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Number outstanding&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Expiry Date&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;C$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;#&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                                  &lt;td style="text-align:center;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;January 5, 2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6.03&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;37,313&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                                  &lt;td style="text-align:center;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;November 30, 2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.61&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,787&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                                  &lt;td style="text-align:center;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;August 1, 2021&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.43&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,476&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                                  &lt;td style="text-align:center;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;May 24, 2022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18.09&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;163,535&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                                  &lt;td style="text-align:center;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;September 15, 2022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.42&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;199,005&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                                  &lt;td style="text-align:center;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;May 20, 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16.08&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,311&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                                  &lt;td style="text-align:center;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;July 24, 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13.07&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,357&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                                  &lt;td style="text-align:center;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;September 11, 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.43&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22,382&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                                  &lt;td style="text-align:center;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;May 4, 2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.73&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,730&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                                  &lt;td style="text-align:center;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;May 10, 2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.73&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,865&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                                  &lt;td style="text-align:center;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;May 17, 2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.73&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,730&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                                  &lt;td style="text-align:center;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;May 31, 2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.73&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,865&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                                  &lt;td style="text-align:center;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;January 16, 2026&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.73&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,722&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:center;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;January 20, 2026&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.73&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;373&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10.20&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;467,451&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                              &lt;/tbody&gt;
                            &lt;/table&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;

                  &lt;/div&gt;
                &lt;/div&gt;
              </ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory>
  <huge:DescriptionOfVotingRights contextRef="C_20200101to20201231_ifrsfullClassesOfShareCapitalAxis_hugeClassACommonStockSharesMember" id="Fxbrl_20200221121542591">The holders of Class A shares are entitled to 276,660 votes per Class A share held.</huge:DescriptionOfVotingRights>
  <ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20210223143914390">
                    &lt;table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;
                      &lt;tbody&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td colspan="4" style="border-bottom:1px solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Class A shares&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td colspan="4" style="border-bottom:1px solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Class B shares&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td colspan="4" style="border-bottom:1px solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Warrants&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;#&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;#&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;#&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Balance, January 1, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;72&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;151,588&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;6,843,780&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;51,093,434&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;546,212&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3,341,826&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Shares issued [a] [b] [c] [d]&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;408,651&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;8,681,103&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Issued on acquisition of net assets of Prismic Pharmaceuticals, Inc. [e]&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;510,940&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;12,361,657&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;67,598&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,420,407&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Stock options exercised&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Share-based payments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;130,189&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,340,929&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Warrants exercised&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;12,167&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;109,214&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(12,167&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(37,753&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Warrants expired&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(134,192&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(402,491&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Balance, December 31, 2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;72&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;151,588&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;7,905,727&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;73,586,337&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;467,451&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;4,321,989&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Shares issued [g] [j] [k] [l] [n] [o]&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;8,925,942&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;22,242,975&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;6,335,758&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,110,904&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Share-based payments [f] [h] [i] [m]&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2,307,569&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;6,663,479&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Share options exercised&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;22,382&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;563,747&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Warrants expired&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(54,100&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(463,935&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Balance, December 31, 2020&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;72&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;151,588&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;19,161,620&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;103,056,538&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;6,749,109&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;4,968,958&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                        &lt;/tr&gt;
                      &lt;/tbody&gt;
                    &lt;/table&gt;
                  </ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory>
  <huge:IncreaseDecreaseThroughAcquisitionOfNetAssetsValue contextRef="C_20190102to20191231_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210223141922122_xbrl_20200219211848895" unitRef="USD">12361657</huge:IncreaseDecreaseThroughAcquisitionOfNetAssetsValue>
  <huge:IncreaseDecreaseThroughAcquisitionOfNetAssetsValue contextRef="C_20190102to20191231_ifrsfullComponentsOfEquityAxis_hugeWarrantsMember" decimals="0" id="Fxbrl_20210223141922122_xbrl_20200219211850923" unitRef="USD">1420407</huge:IncreaseDecreaseThroughAcquisitionOfNetAssetsValue>
  <huge:NumberOfSharesIssuedForDebtSettlement contextRef="C_20191001to20191004_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20210224203425723" unitRef="shares">3735</huge:NumberOfSharesIssuedForDebtSettlement>
  <huge:ValueOfSharesIssuedForDebtSettlement contextRef="C_20191001to20191004_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210224203445269" unitRef="USD">18808</huge:ValueOfSharesIssuedForDebtSettlement>
  <huge:NumberOfSharesIssuedInPrivatePlacement contextRef="C_20191101to20191104_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20200219222957637" unitRef="shares">228670</huge:NumberOfSharesIssuedInPrivatePlacement>
  <huge:IssuanceOfCommonStockOfShareBasedCompensation contextRef="C_20200101to20200102_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20210223102806989" unitRef="shares">27580</huge:IssuanceOfCommonStockOfShareBasedCompensation>
  <huge:ValueOfTradeAndOtherPayableOfSharesBasedCompensation contextRef="C_20200102_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210223103117420" unitRef="USD">74117</huge:ValueOfTradeAndOtherPayableOfSharesBasedCompensation>
  <huge:IssuanceOfCommonSharesOfShareBasedBonusToEmployeesForPerformance contextRef="C_20200301to20200316_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20210223111936322" unitRef="shares">405926</huge:IssuanceOfCommonSharesOfShareBasedBonusToEmployeesForPerformance>
  <huge:IssuanceOfCommonSharesOfShareBasedBonusToEmployeesForPerformance contextRef="C_20200801to20200831_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20210223124147343" unitRef="shares">1804994</huge:IssuanceOfCommonSharesOfShareBasedBonusToEmployeesForPerformance>
  <huge:FairValueOfShareBasedCompensationBonus contextRef="C_20200301to20200316_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210223111952975" unitRef="USD">1302076</huge:FairValueOfShareBasedCompensationBonus>
  <huge:FairValueOfShareBasedCompensationBonus contextRef="C_20200801to20200831_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210223124225313" unitRef="USD">4956324</huge:FairValueOfShareBasedCompensationBonus>
  <huge:ShareBasedPaymentExpenses contextRef="C_20200301to20200316_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210223112029769" unitRef="USD">93502</huge:ShareBasedPaymentExpenses>
  <huge:IssuanceOfCommonStockOfBoardOfDirectorsInLieuOfCash contextRef="C_20200301to20200316_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20210223112619449" unitRef="shares">69069</huge:IssuanceOfCommonStockOfBoardOfDirectorsInLieuOfCash>
  <huge:NotesSettledThroughIssuanceOfShares contextRef="C_20200401to20200415_hugeLegalEntitiesAxis_hugePrismicPharmaceuticalMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210223115006809" unitRef="USD">226385</huge:NotesSettledThroughIssuanceOfShares>
  <huge:CommonStockIssuedForPrivatePlacement contextRef="C_20200601to20200608_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20210223121837858" unitRef="shares">1500000</huge:CommonStockIssuedForPrivatePlacement>
  <huge:WarrantsIssuedForPrivatePlacement contextRef="C_20200601to20200608_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20210223121903522" unitRef="shares">1500000</huge:WarrantsIssuedForPrivatePlacement>
  <ifrs-full:ProceedsFromIssuingOtherEquityInstruments contextRef="C_20200601to20200608_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210223121801622" unitRef="CAD">10125000</ifrs-full:ProceedsFromIssuingOtherEquityInstruments>
  <ifrs-full:ProceedsFromIssuingOtherEquityInstruments contextRef="C_20200601to20200608_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210223121823058" unitRef="USD">7617038</ifrs-full:ProceedsFromIssuingOtherEquityInstruments>
  <ifrs-full:ProceedsFromIssuingOtherEquityInstruments contextRef="C_20200801to20200806_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210223123728169" unitRef="USD">9999997</ifrs-full:ProceedsFromIssuingOtherEquityInstruments>
  <ifrs-full:ProceedsFromIssuingOtherEquityInstruments contextRef="C_20201001to20201031_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210223125207281" unitRef="USD">9499994</ifrs-full:ProceedsFromIssuingOtherEquityInstruments>
  <ifrs-full:ProceedsFromIssuingOtherEquityInstruments contextRef="C_20200801to20200831_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210224162509104" unitRef="USD">9999997</ifrs-full:ProceedsFromIssuingOtherEquityInstruments>
  <huge:FairValueOfCommonSharesIssued contextRef="C_20200601to20200608_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210223121306523" unitRef="USD">7515477</huge:FairValueOfCommonSharesIssued>
  <huge:FairValueOfCommonSharesIssued contextRef="C_20200801to20200806_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210223123818376" unitRef="USD">6710928</huge:FairValueOfCommonSharesIssued>
  <huge:FairValueOfCommonSharesIssued contextRef="C_20201001to20201031_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210223125246985" unitRef="USD">8377267</huge:FairValueOfCommonSharesIssued>
  <huge:FairValueOfWarrantsIssued contextRef="C_20200601to20200608_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210223121255784" unitRef="USD">101561</huge:FairValueOfWarrantsIssued>
  <huge:FairValueOfWarrantsIssued contextRef="C_20201001to20201031_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210223125315020" unitRef="USD">1122727</huge:FairValueOfWarrantsIssued>
  <huge:IssuanceCostOfCommonSharesAndWarrants contextRef="C_20200601to20200608_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210223121721252" unitRef="USD">707043</huge:IssuanceCostOfCommonSharesAndWarrants>
  <huge:IssuanceCostOfCommonSharesAndWarrants contextRef="C_20201001to20201031_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210224204027845" unitRef="USD">879621</huge:IssuanceCostOfCommonSharesAndWarrants>
  <huge:IssuanceOfCommonStockOfDirectOffering contextRef="C_20200801to20200806_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20210223123532185" unitRef="shares">2762430</huge:IssuanceOfCommonStockOfDirectOffering>
  <huge:IssuanceOfCommonStockOfDirectOffering contextRef="C_20201001to20201031_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20210223125104985" unitRef="shares">4318179</huge:IssuanceOfCommonStockOfDirectOffering>
  <huge:IssuanceOfCommonStockOfDirectOffering contextRef="C_20200801to20200831_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20210224162339522" unitRef="shares">2762430</huge:IssuanceOfCommonStockOfDirectOffering>
  <huge:IssuanceOfWarrantsOfDirectOffering contextRef="C_20200801to20200806_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20210223123543383" unitRef="shares">1381215</huge:IssuanceOfWarrantsOfDirectOffering>
  <huge:IssuanceOfWarrantsOfDirectOffering contextRef="C_20201001to20201031_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20210223125136145" unitRef="shares">3454543</huge:IssuanceOfWarrantsOfDirectOffering>
  <huge:IssuanceOfWarrantsOfDirectOffering contextRef="C_20200801to20200831_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20210224162418891" unitRef="shares">1381215</huge:IssuanceOfWarrantsOfDirectOffering>
  <huge:FairValueOfWarrantLiability contextRef="C_20200806_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210223123757137" unitRef="USD">3289069</huge:FairValueOfWarrantLiability>
  <huge:FairValueOfWarrantLiability contextRef="C_20200831_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember" decimals="0" id="Fxbrl_20210224163544870" unitRef="USD">3289069</huge:FairValueOfWarrantLiability>
  <ifrs-full:PaymentsForShareIssueCosts contextRef="C_20200801to20200806_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210223123905055" unitRef="USD">913349</ifrs-full:PaymentsForShareIssueCosts>
  <huge:TransactionCostsAllocatedToWarrants contextRef="C_20200801to20200806_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="0" id="Fxbrl_20210223123929585" unitRef="USD">284049</huge:TransactionCostsAllocatedToWarrants>
  <huge:TransactionCostsAllocatedToWarrants contextRef="C_20200801to20200831_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember" decimals="0" id="Fxbrl_20210224163424783" unitRef="USD">284049</huge:TransactionCostsAllocatedToWarrants>
  <huge:NumberOfSharesIssuedThroughEquityDistributionAgreement contextRef="C_20200101to20201231_hugeLegalEntitiesAxis_hugeAllianceGlobalPartnersMember_hugeTypeOfArrangementsAxis_hugeEquityDistributionAgreementMember_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="INF" id="Fxbrl_20210223124838793" unitRef="shares">56248</huge:NumberOfSharesIssuedThroughEquityDistributionAgreement>
  <huge:NumberOfSharesIssuedThroughEquityDistributionAgreement contextRef="C_20210201to20210210_hugeTypeOfArrangementsAxis_hugeEquityDistributionAgreementMember_ifrsfullCategoriesOfRelatedPartiesAxis_hugeAllianceGlobalPartnersMember_ifrsfullClassesOfOrdinarySharesAxis_hugeClassBCommonSharesMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_hugeSubsequentEventsMember" decimals="INF" id="Fxbrl_20210224174439659" unitRef="shares">7356326</huge:NumberOfSharesIssuedThroughEquityDistributionAgreement>
  <huge:NumberOfSharesIssuedThroughEquityDistributionAgreement contextRef="C_20210212to20210312_hugeTypeOfArrangementsAxis_hugeEquityDistributionAgreementMember_ifrsfullCategoriesOfRelatedPartiesAxis_hugeAllianceGlobalPartnersMember_ifrsfullClassesOfOrdinarySharesAxis_hugeClassBCommonSharesMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_hugeSubsequentEventsMember" decimals="INF" id="Fxbrl_20210224175402014" unitRef="shares">7247288</huge:NumberOfSharesIssuedThroughEquityDistributionAgreement>
  <huge:DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20210223153505427">
                      &lt;table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;
                        &lt;tbody&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&amp;#160;Number of warrants&amp;#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&amp;#160;Weighted average&lt;br/&gt;exercise price&amp;#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&amp;#160;#&amp;#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&amp;#160;C$&amp;#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                            &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Outstanding as at December 31, 2018&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;546,212&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;9.47&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                            &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Issued&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;67,598&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;10.45&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                            &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Exercised&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(12,167&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;7.81&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                            &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Expired&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(134,192&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;7.64&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                            &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Outstanding as at December 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;467,451&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;10.20&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                            &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Issued&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;6,335,758&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;5.27&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                            &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Expired&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(54,100&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.97&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                            &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Outstanding as at December 31, 2020&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;6,749,109&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;5.62&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                          &lt;/tr&gt;
                        &lt;/tbody&gt;
                      &lt;/table&gt;
                    </huge:DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20190101" decimals="INF" id="Fxbrl_20210223145307080_xbrl_20200303142706780" unitRef="shares">546212</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20191231" decimals="INF" id="Fxbrl_20210223152927538_xbrl_20200303142712799" unitRef="shares">467451</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20201231" decimals="INF" id="Fxbrl_20210223153254407_xbrl_20200303142714491" unitRef="shares">6749109</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtAugust1St2021Member" decimals="INF" id="Fxbrl_20210223160209309_xbrl_20200303155849818" unitRef="shares">4476</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay24Th2022Member" decimals="INF" id="Fxbrl_20210223160209335_xbrl_20200303155859444" unitRef="shares">163535</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtSeptember15Th2022Member" decimals="INF" id="Fxbrl_20210223160209300_xbrl_20200303155848103" unitRef="shares">199005</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay20Th2023Member" decimals="INF" id="Fxbrl_20210223160209329_xbrl_20200303155857595" unitRef="shares">7311</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtJuly24Th2023Member" decimals="INF" id="Fxbrl_20210223160209323_xbrl_20200303155855738" unitRef="shares">3357</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtSeptember11Th2023Member" decimals="INF" id="Fxbrl_20210223160209315_xbrl_20200303155852002" unitRef="shares">22382</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay4Th2025Member" decimals="INF" id="Fxbrl_20210223160209342_xbrl_20200303155901179" unitRef="shares">3730</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay10Th2025Member" decimals="INF" id="Fxbrl_20210223160209348_xbrl_20200303155903083" unitRef="shares">1865</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay17Th2025Member" decimals="INF" id="Fxbrl_20210223160209356_xbrl_20200303155905403" unitRef="shares">3730</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay31St2025Member" decimals="INF" id="Fxbrl_20210223160209362_xbrl_20200303155907785" unitRef="shares">1865</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtJune8Th2025Member" decimals="INF" id="Fxbrl_20210223162515137_xbrl_20210223160209362_xbrl_20200303155907785" unitRef="shares">1500000</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtAugust6Th2020Member" decimals="INF" id="Fxbrl_20210223162608582_xbrl_20210223162515137_xbrl_20210223160209362_xbrl_20200303155907785" unitRef="shares">1381215</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtOctober20Th2020Member" decimals="INF" id="Fxbrl_20210223162741717_xbrl_20210223162608582_xbrl_20210223162515137_xbrl_20210223160209362_xbrl_20200303155907785" unitRef="shares">3454543</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtJanuary16Th2026Member" decimals="INF" id="Fxbrl_20210223160209370_xbrl_20200303155909785" unitRef="shares">1722</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtJanuary20Th2026Member" decimals="INF" id="Fxbrl_20210223160209376_xbrl_20200303155911849" unitRef="shares">373</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtJanuary5Th2020Member" decimals="INF" id="Fxbrl_20210223163146150_xbrl_20210223160209376_xbrl_20200303155911849" unitRef="shares">37313</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtNovember30Th2020Member" decimals="INF" id="Fxbrl_20210223163320133_xbrl_20210223163146150_xbrl_20210223160209376_xbrl_20200303155911849" unitRef="shares">16787</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtAugust1St2021Member" decimals="INF" id="Fxbrl_20210223163413659_xbrl_20210223160209309_xbrl_20200303155849818" unitRef="shares">4476</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay24Th2022Member" decimals="INF" id="Fxbrl_20210223163448043_xbrl_20210223160209335_xbrl_20200303155859444" unitRef="shares">163535</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtSeptember15Th2022Member" decimals="INF" id="Fxbrl_20210223163537851_xbrl_20210223160209300_xbrl_20200303155848103" unitRef="shares">199005</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay20Th2023Member" decimals="INF" id="Fxbrl_20210223163558990_xbrl_20210223160209329_xbrl_20200303155857595" unitRef="shares">7311</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtJuly24Th2023Member" decimals="INF" id="Fxbrl_20210224214406422" unitRef="shares">3357</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtSeptember11Th2023Member" decimals="INF" id="Fxbrl_20210223163640461_xbrl_20210223160209315_xbrl_20200303155852002" unitRef="shares">22382</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay4Th2025Member" decimals="INF" id="Fxbrl_20210223163656189_xbrl_20210223160209342_xbrl_20200303155901179" unitRef="shares">3730</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay10Th2025Member" decimals="INF" id="Fxbrl_20210223163714066_xbrl_20210223160209348_xbrl_20200303155903083" unitRef="shares">1865</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay17Th2025Member" decimals="INF" id="Fxbrl_20210223163737611_xbrl_20210223160209356_xbrl_20200303155905403" unitRef="shares">3730</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay31St2025Member" decimals="INF" id="Fxbrl_20210223163801106_xbrl_20210223160209362_xbrl_20200303155907785" unitRef="shares">1865</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtJanuary16Th2026Member" decimals="INF" id="Fxbrl_20210223163821826_xbrl_20210223160209370_xbrl_20200303155909785" unitRef="shares">1722</huge:NumberOfWarrantsOutstanding>
  <huge:NumberOfWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtJanuary20Th2026Member" decimals="INF" id="Fxbrl_20210223163839386_xbrl_20210223160209376_xbrl_20200303155911849" unitRef="shares">373</huge:NumberOfWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20190101" decimals="2" id="Fxbrl_20210223145307080_xbrl_20200303142837993" unitRef="CAD_per_Share">9.47</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20191231" decimals="2" id="Fxbrl_20210223152927538_xbrl_20200303142857817" unitRef="CAD_per_Share">10.20</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20201231" decimals="2" id="Fxbrl_20210223153254407_xbrl_20200303142901004" unitRef="CAD_per_Share">5.62</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtAugust1St2021Member" decimals="2" id="Fxbrl_20210223160209309_xbrl_20200303155718788" unitRef="CAD_per_Share">5.43</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay24Th2022Member" decimals="2" id="Fxbrl_20210223160209335_xbrl_20200303155730572" unitRef="CAD_per_Share">18.09</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtSeptember15Th2022Member" decimals="2" id="Fxbrl_20210223160209300_xbrl_20200303155716878" unitRef="CAD_per_Share">4.42</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay20Th2023Member" decimals="2" id="Fxbrl_20210223160209329_xbrl_20200303155728892" unitRef="CAD_per_Share">16.08</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtJuly24Th2023Member" decimals="2" id="Fxbrl_20210223160209323_xbrl_20200303155726404" unitRef="CAD_per_Share">13.07</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtSeptember11Th2023Member" decimals="2" id="Fxbrl_20210223160209315_xbrl_20200303155720404" unitRef="CAD_per_Share">5.43</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay4Th2025Member" decimals="2" id="Fxbrl_20210223160209342_xbrl_20200303155732236" unitRef="CAD_per_Share">26.73</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay10Th2025Member" decimals="2" id="Fxbrl_20210223160209348_xbrl_20200303155733756" unitRef="CAD_per_Share">26.73</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay17Th2025Member" decimals="2" id="Fxbrl_20210223160209356_xbrl_20200303155735796" unitRef="CAD_per_Share">26.73</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay31St2025Member" decimals="2" id="Fxbrl_20210223160209362_xbrl_20200303155737899" unitRef="CAD_per_Share">26.73</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtJune8Th2025Member" decimals="2" id="Fxbrl_20210223162515137_xbrl_20210223160209362_xbrl_20200303155737899" unitRef="CAD_per_Share">9.65</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtAugust6Th2020Member" decimals="2" id="Fxbrl_20210223162608582_xbrl_20210223162515137_xbrl_20210223160209362_xbrl_20200303155737899" unitRef="CAD_per_Share">5.42</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtOctober20Th2020Member" decimals="2" id="Fxbrl_20210223162741717_xbrl_20210223162608582_xbrl_20210223162515137_xbrl_20210223160209362_xbrl_20200303155737899" unitRef="CAD_per_Share">3.31</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtJanuary16Th2026Member" decimals="2" id="Fxbrl_20210223160209370_xbrl_20200303155739556" unitRef="CAD_per_Share">26.73</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtJanuary20Th2026Member" decimals="2" id="Fxbrl_20210223160209376_xbrl_20200303155741411" unitRef="CAD_per_Share">26.73</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtJanuary5Th2020Member" decimals="2" id="Fxbrl_20210223163146150_xbrl_20210223160209376_xbrl_20200303155741411" unitRef="CAD_per_Share">6.03</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtNovember30Th2020Member" decimals="2" id="Fxbrl_20210223163320133_xbrl_20210223163146150_xbrl_20210223160209376_xbrl_20200303155741411" unitRef="CAD_per_Share">2.61</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtAugust1St2021Member" decimals="2" id="Fxbrl_20210223163413659_xbrl_20210223160209309_xbrl_20200303155718788" unitRef="CAD_per_Share">5.43</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay24Th2022Member" decimals="2" id="Fxbrl_20210223163448043_xbrl_20210223160209335_xbrl_20200303155730572" unitRef="CAD_per_Share">18.09</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtSeptember15Th2022Member" decimals="2" id="Fxbrl_20210223163537851_xbrl_20210223160209300_xbrl_20200303155716878" unitRef="CAD_per_Share">4.42</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay20Th2023Member" decimals="2" id="Fxbrl_20210223163558990_xbrl_20210223160209329_xbrl_20200303155728892" unitRef="CAD_per_Share">16.08</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtJuly24Th2023Member" decimals="2" id="Fxbrl_20210224214326172" unitRef="CAD_per_Share">13.07</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtSeptember11Th2023Member" decimals="2" id="Fxbrl_20210223163640461_xbrl_20210223160209315_xbrl_20200303155720404" unitRef="CAD_per_Share">5.43</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay4Th2025Member" decimals="2" id="Fxbrl_20210223163656189_xbrl_20210223160209342_xbrl_20200303155732236" unitRef="CAD_per_Share">26.73</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay10Th2025Member" decimals="2" id="Fxbrl_20210223163714066_xbrl_20210223160209348_xbrl_20200303155733756" unitRef="CAD_per_Share">26.73</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay17Th2025Member" decimals="2" id="Fxbrl_20210223163737611_xbrl_20210223160209356_xbrl_20200303155735796" unitRef="CAD_per_Share">26.73</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtMay31St2025Member" decimals="2" id="Fxbrl_20210223163801106_xbrl_20210223160209362_xbrl_20200303155737899" unitRef="CAD_per_Share">26.73</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtJanuary16Th2026Member" decimals="2" id="Fxbrl_20210223163821826_xbrl_20210223160209370_xbrl_20200303155739556" unitRef="CAD_per_Share">26.73</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:WeightedAverageExercisePriceWarrantsOutstanding contextRef="C_20191231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtJanuary20Th2026Member" decimals="2" id="Fxbrl_20210223163839386_xbrl_20210223160209376_xbrl_20200303155741411" unitRef="CAD_per_Share">26.73</huge:WeightedAverageExercisePriceWarrantsOutstanding>
  <huge:NumberOfWarrantsIssued contextRef="C_20190102to20191231" decimals="INF" id="Fxbrl_20210223152830056_xbrl_20200303142612252" unitRef="shares">67598</huge:NumberOfWarrantsIssued>
  <huge:NumberOfWarrantsIssued contextRef="C_20200101to20201231" decimals="INF" id="Fxbrl_20210223153048658_xbrl_20200303142801956" unitRef="shares">6335758</huge:NumberOfWarrantsIssued>
  <huge:WeightedAverageExercisePricesWarrantIssued contextRef="C_20190102to20191231" decimals="2" id="Fxbrl_20210224212257121" unitRef="CAD_per_Share">10.45</huge:WeightedAverageExercisePricesWarrantIssued>
  <huge:WeightedAverageExercisePricesWarrantIssued contextRef="C_20200101to20201231" decimals="2" id="Fxbrl_20210224212902915" unitRef="CAD_per_Share">5.27</huge:WeightedAverageExercisePricesWarrantIssued>
  <huge:NumberOfWarrantsExercised contextRef="C_20190102to20191231" decimals="INF" id="Fxbrl_20210223145307099_xbrl_20200303142745107" unitRef="shares">12167</huge:NumberOfWarrantsExercised>
  <huge:WeightedAverageExercisePricesWarrantExercised contextRef="C_20190102to20191231" decimals="2" id="Fxbrl_20210223145307099_xbrl_20200303142937816" unitRef="CAD_per_Share">7.81</huge:WeightedAverageExercisePricesWarrantExercised>
  <huge:NumberOfWarrantsExpired contextRef="C_20190102to20191231" decimals="INF" id="Fxbrl_20210223145307115_xbrl_20200303142818271" unitRef="shares">134192</huge:NumberOfWarrantsExpired>
  <huge:NumberOfWarrantsExpired contextRef="C_20200101to20201231" decimals="INF" id="Fxbrl_20210223153218023_xbrl_20200303142818271" unitRef="shares">54100</huge:NumberOfWarrantsExpired>
  <huge:WeightedAverageExercisePricesWarrantExpired contextRef="C_20190102to20191231" decimals="2" id="Fxbrl_20210223145307115_xbrl_20200303143037600" unitRef="CAD_per_Share">7.64</huge:WeightedAverageExercisePricesWarrantExpired>
  <huge:WeightedAverageExercisePricesWarrantExpired contextRef="C_20200101to20201231" decimals="2" id="Fxbrl_20210223153218023_xbrl_20200303143037600" unitRef="CAD_per_Share">4.97</huge:WeightedAverageExercisePricesWarrantExpired>
  <huge:DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20210223155854990">
                      &lt;table border="0" style="width:100%;border-collapse:collapse;font-size:10pt"&gt;
                        &lt;tbody&gt;
                          &lt;tr&gt;
                            &lt;td&gt;&amp;#160;&lt;/td&gt;
                            &lt;td style="text-align:right;border-bottom:1px solid #000000;width:25%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2020&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="text-align:right;border-bottom:1px solid #000000;width:25%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                            &lt;td style="background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Grant date share price&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;C$2.58 - C$4.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;C$32.16&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                            &lt;td style="background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercise price&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;C$3.46 - C$5.80&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;C$2.61 - C$26.73&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                            &lt;td style="background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected dividend yield&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                            &lt;td style="background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Risk free interest rate&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.32% 0.36%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.41% - 1.52%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                            &lt;td style="background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected life&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.39 - 6.55&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                            &lt;td style="background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected volatility&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;118% - 121%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;/tr&gt;
                        &lt;/tbody&gt;
                      &lt;/table&gt;
                    </huge:DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory>
  <huge:DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20200303195951768">
                      &lt;div&gt;
                        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following table is a summary of the Company's warrants outstanding as at December 31, 2019:&lt;span style="text-align:start"&gt;&amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                        &lt;div&gt;
                          &lt;div&gt;
                            &lt;table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;
                              &lt;tbody&gt;
                                &lt;tr&gt;
                                  &lt;td colspan="6" style="text-align:center;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Warrants Outstanding&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td colspan="1" style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Exercise price&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Number outstanding&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Expiry Date&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;C$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;#&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                                  &lt;td style="vertical-align:bottom;text-align:center;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;August 1, 2021&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.43&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,476&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                                  &lt;td style="vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;May 24, 2022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18.09&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;163,535&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                                  &lt;td style="vertical-align:bottom;text-align:center;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;September 15, 2022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.42&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;199,005&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                                  &lt;td style="vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;May 20, 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16.08&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,311&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                                  &lt;td style="vertical-align:bottom;text-align:center;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;July 24, 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13.07&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,357&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                                  &lt;td style="vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;September 11, 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.43&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22,382&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                                  &lt;td style="vertical-align:bottom;text-align:center;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;May 4, 2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.73&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,730&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                                  &lt;td style="vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;May 10, 2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.73&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,865&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                                  &lt;td style="vertical-align:bottom;text-align:center;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;May 17, 2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.73&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,730&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                                  &lt;td style="vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;May 31, 2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.73&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,865&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                                  &lt;td style="vertical-align:bottom;text-align:center;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;June 8, 2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9.65&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,500,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                                  &lt;td style="vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;August 6, 2020 (i)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.42&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,381,215&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                                  &lt;td style="vertical-align:bottom;text-align:center;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;October 20, 2020 (ii)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.31&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,454,543&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                                  &lt;td style="vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;January 16, 2026&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.73&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,722&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;January 20, 2026&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.73&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;373&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.62&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,749,109&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                              &lt;/tbody&gt;
                            &lt;/table&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/span&gt;&lt;/span&gt;
                            &lt;p style="margin-left:108pt;margin-bottom:0pt;text-indent:-36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(i)&lt;span style="width:28.89pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Warrants were issued in US$ with exercise price of $4.26&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/span&gt;&lt;/span&gt;
                            &lt;p style="margin-top:0pt;margin-left:108pt;text-indent:-36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(ii)&lt;span style="width:26.12pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Warrants were issued in US$ with exercise price of $2.60&lt;span style="text-align:start;text-indent:0px"&gt;&amp;#160; &amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                            &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following table is a summary of the Company's warrants outstanding as at December 31, 2019:&lt;span style="text-align:start"&gt;&amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160;&amp;#160;&amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160;&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                            &lt;table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;
                              &lt;tbody&gt;
                                &lt;tr&gt;
                                  &lt;td colspan="6" style="text-align:center;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Warrants Outstanding&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td colspan="1" style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Exercise price&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Number outstanding&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Expiry Date&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;C$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;#&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                                  &lt;td style="text-align:center;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;January 5, 2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6.03&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;37,313&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                                  &lt;td style="text-align:center;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;November 30, 2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.61&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,787&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                                  &lt;td style="text-align:center;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;August 1, 2021&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.43&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,476&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                                  &lt;td style="text-align:center;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;May 24, 2022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18.09&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;163,535&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                                  &lt;td style="text-align:center;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;September 15, 2022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.42&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;199,005&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                                  &lt;td style="text-align:center;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;May 20, 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16.08&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,311&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                                  &lt;td style="text-align:center;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;July 24, 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13.07&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,357&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                                  &lt;td style="text-align:center;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;September 11, 2023&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.43&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22,382&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                                  &lt;td style="text-align:center;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;May 4, 2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.73&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,730&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                                  &lt;td style="text-align:center;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;May 10, 2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.73&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,865&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                                  &lt;td style="text-align:center;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;May 17, 2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.73&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,730&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                                  &lt;td style="text-align:center;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;May 31, 2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.73&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,865&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                                  &lt;td style="text-align:center;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;January 16, 2026&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.73&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,722&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:center;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;January 20, 2026&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.73&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;373&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10.20&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;467,451&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                                &lt;/tr&gt;
                              &lt;/tbody&gt;
                            &lt;/table&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    </huge:DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory>
  <huge:ExercisePriceOfWarrantIssue contextRef="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtAugust6Th2020Member" decimals="2" id="Fxbrl_20210223165215059" unitRef="USD_per_Share">4.26</huge:ExercisePriceOfWarrantIssue>
  <huge:ExercisePriceOfWarrantIssue contextRef="C_20201231_hugeClassesOfWarrantsAxis_hugeWarrantsByExpiryDateAtOctober20Th2020Member" decimals="2" id="Fxbrl_20210223165233293" unitRef="USD_per_Share">2.60</huge:ExercisePriceOfWarrantIssue>
  <huge:ExercisePriceOfWarrantIssue contextRef="C_20200831_ifrsfullClassesOfShareCapitalAxis_hugeClassBCommonStockSharesMember" decimals="2" id="Fxbrl_20210224162604314" unitRef="USD_per_Share">4.26</huge:ExercisePriceOfWarrantIssue>
  <huge:ExercisePriceOfWarrantIssue contextRef="C_20200831_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember" decimals="2" id="Fxbrl_20210224163642520" unitRef="USD_per_Share">4.26</huge:ExercisePriceOfWarrantIssue>
  <ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20200303014409835">
      &lt;div&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:-18pt;font-style:normal;font-weight:400;margin-left:24px;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;14.&lt;span style="width:5.49pt;text-indent:0pt;display:inline-block"&gt; &lt;/span&gt;Share-based compensation&lt;/strong&gt;&lt;br/&gt;&amp;#160;&lt;/p&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;The Company has established a share option plan (the "Option Plan") for directors, officers, employees and consultants of the Company. The Company's Board of Directors determines, among other things, the eligibility of individuals to participate in the Option Plan, the term and vesting periods, and the exercise price of options granted to individuals under the Option Plan.&lt;/p&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;Each share option converts into one common share of the Company on exercise. No amounts are paid or payable by the individual on receipt of the option. The options carry neither rights to dividends nor voting rights. Options may be exercised at any time from the date of vesting to the date of their expiry.&lt;/p&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-left:3px;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;
        &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left"&gt;Share-based payment arrangements&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;The changes in the number of share options during the year ended December 31, 2020 and 2019 were as follows:&lt;/p&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160;&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;div&gt;
          &lt;div&gt;

              &lt;table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;
                &lt;tbody&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&amp;#160;Number of&lt;br/&gt;options&amp;#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&amp;#160;Weighted average&lt;br/&gt;exercise price&amp;#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&amp;#160;#&amp;#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&amp;#160;C$&amp;#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding as at December 31, 2018&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;485,159&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;74.53&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Granted&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,363,322&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20.68&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercised&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(82,094&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10.02&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Forfeited&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,438&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;56.28&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cancelled&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(299,006&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;115.80&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding as at December 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,454,943&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21.96&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Granted&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,082,639&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.14&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercised&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(22,382&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.61&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cancelled&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(822,137&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;31.65&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Outstanding as at December 31, 2020&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;1,693,063&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;6.11&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Exercisable as at December 31, 2020&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;1,528,186&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;6.13&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                &lt;/tbody&gt;
              &lt;/table&gt;

          &lt;/div&gt;
        &lt;/div&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Measurement of fair values&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;The fair value of share options granted during the year ended December 31, 2020 and 2019 were estimated at the date of grant using the Black-Scholes option pricing model with the following inputs:&lt;/p&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;
        &lt;div&gt;
          &lt;div&gt;

              &lt;div&gt;
                &lt;table border="0" style="width:100%;border-collapse:collapse;font-size:10pt"&gt;
                  &lt;tbody&gt;
                    &lt;tr&gt;
                      &lt;td&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1px solid #000000;width:25%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&amp;#160;2020&amp;#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1px solid #000000;width:25%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&amp;#160;2019&amp;#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Grant date share price&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&amp;#160;C$3.75 &amp;#x2014; C$9.54&amp;#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160;C$6.45 &amp;#x2014; C$75.38&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercise price&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&amp;#160;C$3.68 &amp;#x2014; C$9.80&amp;#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160;C$7.17 &amp;#x2014; C$75.38&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected dividend yield&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&amp;#x2014;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Risk free interest rate&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;0.27% &amp;#x2014;&amp;#160; 1.55%&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.24% &amp;#x2014;&amp;#160; 1.90%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected life&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&amp;#160;4 &amp;#x2014; 9 years&amp;#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160;5 years&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected volatility&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;120%&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;/tr&gt;
                  &lt;/tbody&gt;
                &lt;/table&gt;
              &lt;/div&gt;

          &lt;/div&gt;
        &lt;/div&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Expected volatility was estimated by using the annualized historical volatility of the Company. The expected option life represents the period of time that options granted are expected to be outstanding. The risk-free interest rate is based on Canadian government bonds with a remaining term equal to the expected life of the options.&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;

          &lt;div&gt;
            &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;The following table is a summary of the Company's share options outstanding as at December 31, 2020:&lt;/p&gt;
            &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span&gt;&amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160;&lt;/span&gt;&lt;/p&gt;
            &lt;div&gt;
              &lt;div&gt;
                &lt;table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;
                  &lt;tbody&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td colspan="7" style="text-align:center;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Options outstanding&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td colspan="4" style="text-align:center;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Options exercisable&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercise price&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number outstanding&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted average remaining contractual life [years]&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercise price&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number exercisable&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;C$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;#&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;#&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;C$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;#&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.61&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,683&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.49&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.61&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,683&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6.47&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.86&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;872,139&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.08&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.86&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;864,139&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.42&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;99,502&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.71&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.42&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;99,502&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;110,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.29&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;77,500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.03&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;60,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.70&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.03&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,498&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.43&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,264&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.49&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.43&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,264&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6.16&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.18&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6.16&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.17&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;199,005&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.83&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.17&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;199,005&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.63&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;203,750&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.34&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.63&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;138,750&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9.54&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.06&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9.54&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,125&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10.65&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,730&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.49&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10.65&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,730&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13.07&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,855&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.49&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13.07&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,855&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13.47&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,418&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.49&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13.47&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,418&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16.08&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18,409&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.49&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16.08&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18,409&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17.89&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,178&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.49&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17.89&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,178&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18.09&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17,413&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.21&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18.09&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17,413&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20.10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,289&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.27&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20.10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,289&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;47.24&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,493&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.37&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;47.24&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,493&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;50.25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,224&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.31&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;50.25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,224&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;52.26&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.21&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;52.26&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;55.28&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.12&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;55.28&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;59.30&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.96&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;59.30&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;75.38&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.04&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;75.38&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;86.43&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,244&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.87&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;86.43&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,244&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;142.71&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,975&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.74&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;142.71&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,975&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6.11&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,693,063&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.88&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6.13&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,528,186&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                  &lt;/tbody&gt;
                &lt;/table&gt;
                &lt;div&gt;
                  &lt;p style="text-align:center"&gt;&amp;#160;&lt;/p&gt;
                &lt;/div&gt;
                &lt;div style="text-align:left"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="text-align:justify"&gt;The following table is a summary of the Company's share options outstanding as at December 31, 2019:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="text-align:left"&gt;&amp;#160;&lt;/div&gt;
                &lt;table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;
                  &lt;tbody&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td colspan="7" style="text-align:center;vertical-align:bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;strong&gt;Options outstanding&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td colspan="4" style="text-align:center;vertical-align:bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;strong&gt;Options exercisable&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Exercise price&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Number outstanding&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Weighted average remaining contractual life [years]&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Exercise price&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Number exercisable&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;C$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;#&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;#&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;C$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;#&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2.61&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;35,065&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;3.49&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2.61&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;35,065&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4.42&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;99,502&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2.71&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4.42&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;99,502&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;5.43&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;16,264&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;3.49&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;5.43&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;16,264&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;10.65&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;3,730&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;3.49&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;10.65&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;3,730&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;13.07&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;10,855&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;3.49&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;13.07&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;10,855&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;13.47&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,418&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;3.49&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;13.47&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,418&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;16.08&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;18,409&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;3.49&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;16.08&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;18,409&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;17.89&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4,178&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;3.49&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;17.89&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4,178&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;18.09&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;37,313&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;3.34&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;18.09&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;37,313&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;20.10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;493,363&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4.72&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;20.10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;493,363&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;21.11&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;12,438&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4.67&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;21.11&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;12,438&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;24.12&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;9,950&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4.59&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;24.12&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;6,219&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;26.13&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;14,925&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;3.62&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;26.13&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;14,925&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;40.20&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;29,851&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4.45&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;40.20&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;22,388&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;44.22&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2,488&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;3.41&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;44.22&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2,488&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;47.24&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,493&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4.37&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;47.24&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,493&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;50.25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;227,861&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;5.09&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;50.25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;129,353&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;52.26&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4.21&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;52.26&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;55.28&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4.12&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;55.28&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;59.30&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;3.96&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;59.30&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;7.17&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;199,005&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4.83&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;7.17&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;199,005&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;75.38&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4.04&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;75.38&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;7.63&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;203,750&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;5.34&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;7.63&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;58,750&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;86.43&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,244&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;3.88&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;86.43&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,244&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;88.44&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;14,925&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;3.87&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;88.44&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;14,925&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;120.60&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;9,950&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;3.71&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;120.60&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;9,950&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;142.71&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4,974&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;3.74&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;142.71&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4,975&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;border-bottom:1.5pt solid black;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1.5pt solid black;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;21.96&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;border-bottom:1.5pt solid black;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;border-bottom:1.5pt solid black;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1.5pt solid black;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,454,943&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;border-bottom:1.5pt solid black;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;border-bottom:1.5pt solid black;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1.5pt solid black;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4.59&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;border-bottom:1.5pt solid black;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;border-bottom:1.5pt solid black;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1.5pt solid black;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;21.24&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;border-bottom:1.5pt solid black;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;border-bottom:1.5pt solid black;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1.5pt solid black;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,200,242&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1.5pt solid black;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                  &lt;/tbody&gt;
                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;

      &lt;/div&gt;
      &lt;p style="margin:0pt"&gt;&amp;#160;&lt;/p&gt;
      &lt;p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During the year ended December 31, 2020, the Company cancelled 822,137 share options outstanding and issued 822,137 replacement share options at an exercise price of C$3.86 resulting in incremental grant date fair value of $661,811 which was expensed immediately as all the replacement share options vested on date of replacement. The fair value was determined using the Black-Scholes option pricing model and the following assumptions: exercise price of C$3.86, the underlying share price of C$3.86, risk free interest rate of 0.72% and annualized volatility of 120%.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;div&gt;
        &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company recognized $8,052,011 of share-based compensation expenses during the year ended December 31, 2020 (2019 - $12,082,930).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;/div&gt;
    </ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory>
  <ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20210223180052153">
              &lt;table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;
                &lt;tbody&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&amp;#160;Number of&lt;br/&gt;options&amp;#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&amp;#160;Weighted average&lt;br/&gt;exercise price&amp;#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&amp;#160;#&amp;#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&amp;#160;C$&amp;#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding as at December 31, 2018&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;485,159&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;74.53&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Granted&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,363,322&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20.68&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercised&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(82,094&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10.02&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Forfeited&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,438&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;56.28&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cancelled&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(299,006&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;115.80&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding as at December 31, 2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,454,943&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21.96&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Granted&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,082,639&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.14&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercised&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(22,382&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.61&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cancelled&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(822,137&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;31.65&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Outstanding as at December 31, 2020&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;1,693,063&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;6.11&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Exercisable as at December 31, 2020&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;1,528,186&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;6.13&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                &lt;/tbody&gt;
              &lt;/table&gt;
            </ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20190101_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223175945009_xbrl_20210223170247924_xbrl_20200219203155401" unitRef="Share">485159</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223180013095_xbrl_20210223170445078_xbrl_20200219203201399" unitRef="Share">1454943</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20201231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223175945060_xbrl_20210223170551151_xbrl_20200219203208500" unitRef="Share">1693063</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwoPointSixOneMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223182932789_xbrl_20210223181201397_xbrl_20200220170503442" unitRef="Share">12683</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThreePointSevenFiveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223184312190_xbrl_20210223182932789_xbrl_20210223181201397_xbrl_20200220170503442" unitRef="Share">5500</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThreePointEightSixMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223184418191_xbrl_20210223184312190_xbrl_20210223182932789_xbrl_20210223181201397_xbrl_20200220170503442" unitRef="Share">872139</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFourPointFourTwoMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223183056631_xbrl_20210223181201416_xbrl_20200220170527725" unitRef="Share">99502</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFourPointSevenFiveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223184535733_xbrl_20210223183056631_xbrl_20210223181201416_xbrl_20200220170527725" unitRef="Share">110000</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFivePointZeroThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223184710577_xbrl_20210223184535733_xbrl_20210223183056631_xbrl_20210223181201416_xbrl_20200220170527725" unitRef="Share">60000</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFivePointFourThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223183127381_xbrl_20210223181201434_xbrl_20200220170529488" unitRef="Share">16264</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSixPointSixteenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223183649207_xbrl_20210223183127381_xbrl_20210223181201434_xbrl_20200220170529488" unitRef="Share">20000</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointSeventeenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223183823596_xbrl_20210223183649207_xbrl_20210223183127381_xbrl_20210223181201434_xbrl_20200220170529488" unitRef="Share">199005</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointSixtyThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223184031562_xbrl_20210223183823596_xbrl_20210223183649207_xbrl_20210223183127381_xbrl_20210223181201434_xbrl_20200220170529488" unitRef="Share">203750</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceNinePointFiveFourMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223184200680_xbrl_20210223184031562_xbrl_20210223183823596_xbrl_20210223183649207_xbrl_20210223183127381_xbrl_20210223181201434_xbrl_20200220170529488" unitRef="Share">15000</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTenPointSixFiveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223183145803_xbrl_20210223181201450_xbrl_20200220170531181" unitRef="Share">3730</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThirteenPointZeroSevenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223183220286_xbrl_20210223181201466_xbrl_20200220170532836" unitRef="Share">10855</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThirteenPointFourSevenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223183240876_xbrl_20210223181201487_xbrl_20200220170534628" unitRef="Share">1418</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSixteenPointZeroEightMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223183300068_xbrl_20210223181201504_xbrl_20200220170536253" unitRef="Share">18409</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSeventeenPointEightNineMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223183320703_xbrl_20210223181201519_xbrl_20200220170538004" unitRef="Share">4178</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEighteenPointZeroNineMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223183337331_xbrl_20210223181201544_xbrl_20200220170539756" unitRef="Share">17413</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyPointOneZeroMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223183354998_xbrl_20210223181201566_xbrl_20200220170541612" unitRef="Share">8289</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortySevenPointTwentyFourMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223183410967_xbrl_20210223181201709_xbrl_20200220170556851" unitRef="Share">1493</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyPointTwentyFiveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223183424486_xbrl_20210223181201727_xbrl_20200220170558691" unitRef="Share">5224</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyTwoPointTwentySixMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223183439718_xbrl_20210223181201744_xbrl_20200220170601116" unitRef="Share">498</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyFivePointTwentyEightMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223183455873_xbrl_20210223181201762_xbrl_20200220170604011" unitRef="Share">498</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyNinePointThirtyMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223183512120_xbrl_20210223181201782_xbrl_20200220170605772" unitRef="Share">498</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSeventyFivePointThirtyEightMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223183524326_xbrl_20210223181201817_xbrl_20200220170640639" unitRef="Share">498</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightySixPointFortyThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223183559255_xbrl_20210223181201852_xbrl_20200220170644580" unitRef="Share">1244</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredFortyTwoPointSeventyOneMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223183614976_xbrl_20210223181201909_xbrl_20200220170652011" unitRef="Share">4975</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwoPointSixOneMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201397_xbrl_20200220170503442" unitRef="Share">35065</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFourPointFourTwoMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201416_xbrl_20200220170527725" unitRef="Share">99502</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFivePointFourThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201434_xbrl_20200220170529488" unitRef="Share">16264</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTenPointSixFiveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201450_xbrl_20200220170531181" unitRef="Share">3730</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThirteenPointZeroSevenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201466_xbrl_20200220170532836" unitRef="Share">10855</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThirteenPointFourSevenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201487_xbrl_20200220170534628" unitRef="Share">1418</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSixteenPointZeroEightMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201504_xbrl_20200220170536253" unitRef="Share">18409</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSeventeenPointEightNineMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201519_xbrl_20200220170538004" unitRef="Share">4178</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEighteenPointZeroNineMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201544_xbrl_20200220170539756" unitRef="Share">37313</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyPointOneZeroMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201566_xbrl_20200220170541612" unitRef="Share">493363</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyOnePointElevenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201590_xbrl_20200220170543364" unitRef="Share">12438</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyFourPointTwelveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201614_xbrl_20200220170544972" unitRef="Share">9950</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentySixPointThirteenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201640_xbrl_20200220170546916" unitRef="Share">14925</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortyPointTwentyMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201663_xbrl_20200220170548750" unitRef="Share">29851</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortyFourPointTwentyTwoMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201686_xbrl_20200220170554934" unitRef="Share">2488</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortySevenPointTwentyFourMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201709_xbrl_20200220170556851" unitRef="Share">1493</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyPointTwentyFiveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201727_xbrl_20200220170558691" unitRef="Share">227861</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyTwoPointTwentySixMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201744_xbrl_20200220170601116" unitRef="Share">498</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyFivePointTwentyEightMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201762_xbrl_20200220170604011" unitRef="Share">498</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyNinePointThirtyMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201782_xbrl_20200220170605772" unitRef="Share">498</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointSeventeenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201800_xbrl_20200220170636857" unitRef="Share">199005</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSeventyFivePointThirtyEightMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201817_xbrl_20200220170640639" unitRef="Share">498</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointSixtyThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201832_xbrl_20200220170642356" unitRef="Share">203750</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightySixPointFortyThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201852_xbrl_20200220170644580" unitRef="Share">1244</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightyEightPointFortyFourMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201867_xbrl_20200220170646861" unitRef="Share">14925</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredTwentyPointSixtyMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201885_xbrl_20200220170648949" unitRef="Share">9950</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredFortyTwoPointSeventyOneMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201909_xbrl_20200220170652011" unitRef="Share">4974</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20190101_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223175945009_xbrl_20210223170247924_xbrl_20200219203618356" unitRef="CAD_per_Share">74.53</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223180013095_xbrl_20210223170445078_xbrl_20200219203624298" unitRef="CAD_per_Share">21.96</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223175945060_xbrl_20210223170551151_xbrl_20200219203629819" unitRef="CAD_per_Share">6.11</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwoPointSixOneMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223182932789_xbrl_20210223181201397_xbrl_20200220170223034" unitRef="CAD_per_Share">2.61</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThreePointSevenFiveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223184312190_xbrl_20210223182932789_xbrl_20210223181201397_xbrl_20200220170223034" unitRef="CAD_per_Share">3.75</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThreePointEightSixMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223184418191_xbrl_20210223184312190_xbrl_20210223182932789_xbrl_20210223181201397_xbrl_20200220170223034" unitRef="CAD_per_Share">3.86</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFourPointFourTwoMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223183056631_xbrl_20210223181201416_xbrl_20200220170239854" unitRef="CAD_per_Share">4.42</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFourPointSevenFiveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223184535733_xbrl_20210223183056631_xbrl_20210223181201416_xbrl_20200220170239854" unitRef="CAD_per_Share">4.75</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFivePointZeroThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223184710577_xbrl_20210223184535733_xbrl_20210223183056631_xbrl_20210223181201416_xbrl_20200220170239854" unitRef="CAD_per_Share">5.03</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFivePointFourThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223183127381_xbrl_20210223181201434_xbrl_20200220170242183" unitRef="CAD_per_Share">5.43</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSixPointSixteenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223183649207_xbrl_20210223183127381_xbrl_20210223181201434_xbrl_20200220170242183" unitRef="CAD_per_Share">6.16</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointSeventeenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223183823596_xbrl_20210223183649207_xbrl_20210223183127381_xbrl_20210223181201434_xbrl_20200220170242183" unitRef="CAD_per_Share">7.17</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointSixtyThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223184031562_xbrl_20210223183823596_xbrl_20210223183649207_xbrl_20210223183127381_xbrl_20210223181201434_xbrl_20200220170242183" unitRef="CAD_per_Share">7.63</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceNinePointFiveFourMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223184200680_xbrl_20210223184031562_xbrl_20210223183823596_xbrl_20210223183649207_xbrl_20210223183127381_xbrl_20210223181201434_xbrl_20200220170242183" unitRef="CAD_per_Share">9.54</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTenPointSixFiveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223183145803_xbrl_20210223181201450_xbrl_20200220170245956" unitRef="CAD_per_Share">10.65</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThirteenPointZeroSevenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223183220286_xbrl_20210223181201466_xbrl_20200220170247724" unitRef="CAD_per_Share">13.07</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThirteenPointFourSevenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223183240876_xbrl_20210223181201487_xbrl_20200220170249570" unitRef="CAD_per_Share">13.47</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSixteenPointZeroEightMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223183300068_xbrl_20210223181201504_xbrl_20200220170251852" unitRef="CAD_per_Share">16.08</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSeventeenPointEightNineMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223183320703_xbrl_20210223181201519_xbrl_20200220170253804" unitRef="CAD_per_Share">17.89</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEighteenPointZeroNineMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223183337331_xbrl_20210223181201544_xbrl_20200220170255518" unitRef="CAD_per_Share">18.09</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyPointOneZeroMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223183354998_xbrl_20210223181201566_xbrl_20200220170257363" unitRef="CAD_per_Share">20.10</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortySevenPointTwentyFourMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223183410967_xbrl_20210223181201709_xbrl_20200220170309160" unitRef="CAD_per_Share">47.24</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyPointTwentyFiveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223183424486_xbrl_20210223181201727_xbrl_20200220170310849" unitRef="CAD_per_Share">50.25</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyTwoPointTwentySixMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223183439718_xbrl_20210223181201744_xbrl_20200220170322251" unitRef="CAD_per_Share">52.26</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyFivePointTwentyEightMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223183455873_xbrl_20210223181201762_xbrl_20200220170323916" unitRef="CAD_per_Share">55.28</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyNinePointThirtyMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223183512120_xbrl_20210223181201782_xbrl_20200220170325633" unitRef="CAD_per_Share">59.30</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSeventyFivePointThirtyEightMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223183524326_xbrl_20210223181201817_xbrl_20200220170438115" unitRef="CAD_per_Share">75.38</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightySixPointFortyThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223183559255_xbrl_20210223181201852_xbrl_20200220170441574" unitRef="CAD_per_Share">86.43</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredFortyTwoPointSeventyOneMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223183614976_xbrl_20210223181201909_xbrl_20200220170446798" unitRef="CAD_per_Share">142.71</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwoPointSixOneMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201397_xbrl_20200220170223034" unitRef="CAD_per_Share">2.61</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFourPointFourTwoMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201416_xbrl_20200220170239854" unitRef="CAD_per_Share">4.42</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFivePointFourThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201434_xbrl_20200220170242183" unitRef="CAD_per_Share">5.43</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTenPointSixFiveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201450_xbrl_20200220170245956" unitRef="CAD_per_Share">10.65</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThirteenPointZeroSevenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201466_xbrl_20200220170247724" unitRef="CAD_per_Share">13.07</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThirteenPointFourSevenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201487_xbrl_20200220170249570" unitRef="CAD_per_Share">13.47</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSixteenPointZeroEightMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201504_xbrl_20200220170251852" unitRef="CAD_per_Share">16.08</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSeventeenPointEightNineMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201519_xbrl_20200220170253804" unitRef="CAD_per_Share">17.89</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEighteenPointZeroNineMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201544_xbrl_20200220170255518" unitRef="CAD_per_Share">18.09</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyPointOneZeroMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201566_xbrl_20200220170257363" unitRef="CAD_per_Share">20.10</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyOnePointElevenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201590_xbrl_20200220170259188" unitRef="CAD_per_Share">21.11</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyFourPointTwelveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201614_xbrl_20200220170301108" unitRef="CAD_per_Share">24.12</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentySixPointThirteenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201640_xbrl_20200220170303156" unitRef="CAD_per_Share">26.13</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortyPointTwentyMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201663_xbrl_20200220170305364" unitRef="CAD_per_Share">40.20</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortyFourPointTwentyTwoMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201686_xbrl_20200220170307084" unitRef="CAD_per_Share">44.22</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortySevenPointTwentyFourMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201709_xbrl_20200220170309160" unitRef="CAD_per_Share">47.24</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyPointTwentyFiveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201727_xbrl_20200220170310849" unitRef="CAD_per_Share">50.25</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyTwoPointTwentySixMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201744_xbrl_20200220170322251" unitRef="CAD_per_Share">52.26</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyFivePointTwentyEightMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201762_xbrl_20200220170323916" unitRef="CAD_per_Share">55.28</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyNinePointThirtyMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201782_xbrl_20200220170325633" unitRef="CAD_per_Share">59.30</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointSeventeenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201800_xbrl_20200220170331611" unitRef="CAD_per_Share">7.17</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSeventyFivePointThirtyEightMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201817_xbrl_20200220170438115" unitRef="CAD_per_Share">75.38</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointSixtyThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201832_xbrl_20200220170439965" unitRef="CAD_per_Share">7.63</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightySixPointFortyThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201852_xbrl_20200220170441574" unitRef="CAD_per_Share">86.43</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightyEightPointFortyFourMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201867_xbrl_20200220170443540" unitRef="CAD_per_Share">88.44</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredTwentyPointSixtyMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201885_xbrl_20200220170445118" unitRef="CAD_per_Share">120.60</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredFortyTwoPointSeventyOneMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201909_xbrl_20200220170446798" unitRef="CAD_per_Share">142.71</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="C_20190102to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223175945015_xbrl_20210223170247932_xbrl_20200219203434205" unitRef="Share">1363322</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="C_20200101to20201231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223175945038_xbrl_20210223170247951_xbrl_20200219203439232" unitRef="Share">1082639</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 contextRef="C_20190102to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223175945015_xbrl_20210223170247932_xbrl_20200219203642617" unitRef="CAD_per_Share">20.68</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 contextRef="C_20200101to20201231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223175945038_xbrl_20210223170247951_xbrl_20200219203814874" unitRef="CAD_per_Share">4.14</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
  <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="C_20190102to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223175945021_xbrl_20210223170247938_xbrl_20200219203452623" unitRef="Share">82094</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="C_20200101to20201231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223175945044_xbrl_20210223170247957_xbrl_20200219203458951" unitRef="Share">22382</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019 contextRef="C_20190102to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223175945021_xbrl_20210223170247938_xbrl_20200219203730092" unitRef="CAD_per_Share">10.02</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019 contextRef="C_20200101to20201231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223175945044_xbrl_20210223170247957_xbrl_20200219204520976" unitRef="CAD_per_Share">2.61</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
  <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement contextRef="C_20190102to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223175945026_xbrl_20210223170247963_xbrl_20200219203538974" unitRef="Share">12438</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019 contextRef="C_20190102to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223175945026_xbrl_20210223170247963_xbrl_20200219204549144" unitRef="CAD_per_Share">56.28</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
  <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="C_20190102to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223175945032_xbrl_20210223170247945_xbrl_20200219203524831" unitRef="Share">299006</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="C_20200101to20201231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223175945050_xbrl_20210223170524161_xbrl_20200219203552929" unitRef="Share">822137</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019 contextRef="C_20190102to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223175945032_xbrl_20210223170247945_xbrl_20200219203745523" unitRef="CAD_per_Share">115.80</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019 contextRef="C_20200101to20201231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223175945050_xbrl_20210223170524161_xbrl_20200219204618572" unitRef="CAD_per_Share">31.65</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20201231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223175945074_xbrl_20210223170613161_xbrl_20200219203604716" unitRef="Share">1528186</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwoPointSixOneMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223182932789_xbrl_20210223181201397_xbrl_20200220171607115" unitRef="Share">12683</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThreePointSevenFiveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223184312190_xbrl_20210223182932789_xbrl_20210223181201397_xbrl_20200220171607115" unitRef="Share">500</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThreePointEightSixMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223184418191_xbrl_20210223184312190_xbrl_20210223182932789_xbrl_20210223181201397_xbrl_20200220171607115" unitRef="Share">864139</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFourPointFourTwoMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223183056631_xbrl_20210223181201416_xbrl_20200220172043767" unitRef="Share">99502</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFourPointSevenFiveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223184535733_xbrl_20210223183056631_xbrl_20210223181201416_xbrl_20200220172043767" unitRef="Share">77500</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFivePointZeroThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223184710577_xbrl_20210223184535733_xbrl_20210223183056631_xbrl_20210223181201416_xbrl_20200220172043767" unitRef="Share">7498</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFivePointFourThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223183127381_xbrl_20210223181201434_xbrl_20200220172045445" unitRef="Share">16264</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSixPointSixteenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223183649207_xbrl_20210223183127381_xbrl_20210223181201434_xbrl_20200220172045445" unitRef="Share">20000</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointSeventeenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223183823596_xbrl_20210223183649207_xbrl_20210223183127381_xbrl_20210223181201434_xbrl_20200220172045445" unitRef="Share">199005</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointSixtyThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223184031562_xbrl_20210223183823596_xbrl_20210223183649207_xbrl_20210223183127381_xbrl_20210223181201434_xbrl_20200220172045445" unitRef="Share">138750</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceNinePointFiveFourMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223184200680_xbrl_20210223184031562_xbrl_20210223183823596_xbrl_20210223183649207_xbrl_20210223183127381_xbrl_20210223181201434_xbrl_20200220172045445" unitRef="Share">13125</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTenPointSixFiveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223183145803_xbrl_20210223181201450_xbrl_20200220172047189" unitRef="Share">3730</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThirteenPointZeroSevenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223183220286_xbrl_20210223181201466_xbrl_20200220172048885" unitRef="Share">10855</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThirteenPointFourSevenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223183240876_xbrl_20210223181201487_xbrl_20200220172054621" unitRef="Share">1418</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSixteenPointZeroEightMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223183300068_xbrl_20210223181201504_xbrl_20200220172817608" unitRef="Share">18409</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSeventeenPointEightNineMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223183320703_xbrl_20210223181201519_xbrl_20200220172821173" unitRef="Share">4178</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEighteenPointZeroNineMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223183337331_xbrl_20210223181201544_xbrl_20200220172822791" unitRef="Share">17413</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyPointOneZeroMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223183354998_xbrl_20210223181201566_xbrl_20200220172830100" unitRef="Share">8289</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortySevenPointTwentyFourMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223183410967_xbrl_20210223181201709_xbrl_20200220172845837" unitRef="Share">1493</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyPointTwentyFiveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223183424486_xbrl_20210223181201727_xbrl_20200220172847381" unitRef="Share">5224</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyTwoPointTwentySixMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223183439718_xbrl_20210223181201744_xbrl_20200220172848837" unitRef="Share">498</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyFivePointTwentyEightMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223183455873_xbrl_20210223181201762_xbrl_20200220172850299" unitRef="Share">498</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyNinePointThirtyMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223183512120_xbrl_20210223181201782_xbrl_20200220172855221" unitRef="Share">498</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSeventyFivePointThirtyEightMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223183524326_xbrl_20210223181201817_xbrl_20200220172907060" unitRef="Share">498</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightySixPointFortyThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223183559255_xbrl_20210223181201852_xbrl_20200220172910445" unitRef="Share">1244</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredFortyTwoPointSeventyOneMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223183614976_xbrl_20210223181201909_xbrl_20200220172915213" unitRef="Share">4975</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwoPointSixOneMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201397_xbrl_20200220171607115" unitRef="Share">35065</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFourPointFourTwoMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201416_xbrl_20200220172043767" unitRef="Share">99502</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFivePointFourThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201434_xbrl_20200220172045445" unitRef="Share">16264</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTenPointSixFiveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201450_xbrl_20200220172047189" unitRef="Share">3730</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThirteenPointZeroSevenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201466_xbrl_20200220172048885" unitRef="Share">10855</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThirteenPointFourSevenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201487_xbrl_20200220172054621" unitRef="Share">1418</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSixteenPointZeroEightMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201504_xbrl_20200220172817608" unitRef="Share">18409</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSeventeenPointEightNineMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201519_xbrl_20200220172821173" unitRef="Share">4178</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEighteenPointZeroNineMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201544_xbrl_20200220172822791" unitRef="Share">37313</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyPointOneZeroMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201566_xbrl_20200220172830100" unitRef="Share">493363</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyOnePointElevenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201590_xbrl_20200220172838498" unitRef="Share">12438</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyFourPointTwelveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201614_xbrl_20200220172839911" unitRef="Share">6219</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentySixPointThirteenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201640_xbrl_20200220172841277" unitRef="Share">14925</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortyPointTwentyMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201663_xbrl_20200220172842679" unitRef="Share">22388</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortyFourPointTwentyTwoMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201686_xbrl_20200220172844302" unitRef="Share">2488</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortySevenPointTwentyFourMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201709_xbrl_20200220172845837" unitRef="Share">1493</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyPointTwentyFiveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201727_xbrl_20200220172847381" unitRef="Share">129353</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyTwoPointTwentySixMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201744_xbrl_20200220172848837" unitRef="Share">498</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyFivePointTwentyEightMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201762_xbrl_20200220172850299" unitRef="Share">498</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyNinePointThirtyMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201782_xbrl_20200220172855221" unitRef="Share">498</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointSeventeenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201800_xbrl_20200220172902877" unitRef="Share">199005</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSeventyFivePointThirtyEightMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201817_xbrl_20200220172907060" unitRef="Share">498</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointSixtyThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201832_xbrl_20200220172908998" unitRef="Share">58750</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightySixPointFortyThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201852_xbrl_20200220172910445" unitRef="Share">1244</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightyEightPointFortyFourMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201867_xbrl_20200220172912021" unitRef="Share">14925</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredTwentyPointSixtyMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201885_xbrl_20200220172913503" unitRef="Share">9950</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredFortyTwoPointSeventyOneMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201909_xbrl_20200220172915213" unitRef="Share">4975</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="INF" id="Fxbrl_20210223181201936_xbrl_20200220172916869" unitRef="Share">1200242</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223175945074_xbrl_20210223170613161_xbrl_20200219204633886" unitRef="CAD_per_Share">6.13</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwoPointSixOneMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223182932789_xbrl_20210223181201397_xbrl_20200220171428301" unitRef="CAD_per_Share">2.61</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThreePointSevenFiveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223184312190_xbrl_20210223182932789_xbrl_20210223181201397_xbrl_20200220171428301" unitRef="CAD_per_Share">3.75</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThreePointEightSixMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223184418191_xbrl_20210223184312190_xbrl_20210223182932789_xbrl_20210223181201397_xbrl_20200220171428301" unitRef="CAD_per_Share">3.86</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFourPointFourTwoMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223183056631_xbrl_20210223181201416_xbrl_20200220171443404" unitRef="CAD_per_Share">4.42</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFourPointSevenFiveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223184535733_xbrl_20210223183056631_xbrl_20210223181201416_xbrl_20200220171443404" unitRef="CAD_per_Share">4.75</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFivePointZeroThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223184710577_xbrl_20210223184535733_xbrl_20210223183056631_xbrl_20210223181201416_xbrl_20200220171443404" unitRef="CAD_per_Share">5.03</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFivePointFourThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223183127381_xbrl_20210223181201434_xbrl_20200220171445957" unitRef="CAD_per_Share">5.43</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSixPointSixteenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223183649207_xbrl_20210223183127381_xbrl_20210223181201434_xbrl_20200220171445957" unitRef="CAD_per_Share">6.16</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointSeventeenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223183823596_xbrl_20210223183649207_xbrl_20210223183127381_xbrl_20210223181201434_xbrl_20200220171445957" unitRef="CAD_per_Share">7.17</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointSixtyThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223184031562_xbrl_20210223183823596_xbrl_20210223183649207_xbrl_20210223183127381_xbrl_20210223181201434_xbrl_20200220171445957" unitRef="CAD_per_Share">7.63</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceNinePointFiveFourMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223184200680_xbrl_20210223184031562_xbrl_20210223183823596_xbrl_20210223183649207_xbrl_20210223183127381_xbrl_20210223181201434_xbrl_20200220171445957" unitRef="CAD_per_Share">9.54</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTenPointSixFiveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223183145803_xbrl_20210223181201450_xbrl_20200220171449652" unitRef="CAD_per_Share">10.65</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThirteenPointZeroSevenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223183220286_xbrl_20210223181201466_xbrl_20200220171451706" unitRef="CAD_per_Share">13.07</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThirteenPointFourSevenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223183240876_xbrl_20210223181201487_xbrl_20200220171453344" unitRef="CAD_per_Share">13.47</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSixteenPointZeroEightMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223183300068_xbrl_20210223181201504_xbrl_20200220171454943" unitRef="CAD_per_Share">16.08</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSeventeenPointEightNineMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223183320703_xbrl_20210223181201519_xbrl_20200220171456508" unitRef="CAD_per_Share">17.89</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEighteenPointZeroNineMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223183337331_xbrl_20210223181201544_xbrl_20200220171458212" unitRef="CAD_per_Share">18.09</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyPointOneZeroMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223183354998_xbrl_20210223181201566_xbrl_20200220171500090" unitRef="CAD_per_Share">20.10</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortySevenPointTwentyFourMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223183410967_xbrl_20210223181201709_xbrl_20200220171511869" unitRef="CAD_per_Share">47.24</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyPointTwentyFiveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223183424486_xbrl_20210223181201727_xbrl_20200220171514221" unitRef="CAD_per_Share">50.25</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyTwoPointTwentySixMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223183439718_xbrl_20210223181201744_xbrl_20200220171515973" unitRef="CAD_per_Share">52.26</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyFivePointTwentyEightMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223183455873_xbrl_20210223181201762_xbrl_20200220171517716" unitRef="CAD_per_Share">55.28</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyNinePointThirtyMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223183512120_xbrl_20210223181201782_xbrl_20200220171519404" unitRef="CAD_per_Share">59.30</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSeventyFivePointThirtyEightMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223183524326_xbrl_20210223181201817_xbrl_20200220171530116" unitRef="CAD_per_Share">75.38</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightySixPointFortyThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223183559255_xbrl_20210223181201852_xbrl_20200220171533572" unitRef="CAD_per_Share">86.43</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredFortyTwoPointSeventyOneMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223183614976_xbrl_20210223181201909_xbrl_20200220171539249" unitRef="CAD_per_Share">142.71</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwoPointSixOneMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201397_xbrl_20200220171428301" unitRef="CAD_per_Share">2.61</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFourPointFourTwoMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201416_xbrl_20200220171443404" unitRef="CAD_per_Share">4.42</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFivePointFourThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201434_xbrl_20200220171445957" unitRef="CAD_per_Share">5.43</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTenPointSixFiveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201450_xbrl_20200220171449652" unitRef="CAD_per_Share">10.65</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThirteenPointZeroSevenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201466_xbrl_20200220171451706" unitRef="CAD_per_Share">13.07</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThirteenPointFourSevenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201487_xbrl_20200220171453344" unitRef="CAD_per_Share">13.47</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSixteenPointZeroEightMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201504_xbrl_20200220171454943" unitRef="CAD_per_Share">16.08</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSeventeenPointEightNineMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201519_xbrl_20200220171456508" unitRef="CAD_per_Share">17.89</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEighteenPointZeroNineMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201544_xbrl_20200220171458212" unitRef="CAD_per_Share">18.09</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyPointOneZeroMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201566_xbrl_20200220171500090" unitRef="CAD_per_Share">20.10</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyOnePointElevenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201590_xbrl_20200220171501700" unitRef="CAD_per_Share">21.11</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyFourPointTwelveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201614_xbrl_20200220171503430" unitRef="CAD_per_Share">24.12</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentySixPointThirteenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201640_xbrl_20200220171505276" unitRef="CAD_per_Share">26.13</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortyPointTwentyMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201663_xbrl_20200220171507204" unitRef="CAD_per_Share">40.20</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortyFourPointTwentyTwoMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201686_xbrl_20200220171509964" unitRef="CAD_per_Share">44.22</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortySevenPointTwentyFourMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201709_xbrl_20200220171511869" unitRef="CAD_per_Share">47.24</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyPointTwentyFiveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201727_xbrl_20200220171514221" unitRef="CAD_per_Share">50.25</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyTwoPointTwentySixMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201744_xbrl_20200220171515973" unitRef="CAD_per_Share">52.26</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyFivePointTwentyEightMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201762_xbrl_20200220171517716" unitRef="CAD_per_Share">55.28</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyNinePointThirtyMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201782_xbrl_20200220171519404" unitRef="CAD_per_Share">59.30</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointSeventeenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201800_xbrl_20200220171525564" unitRef="CAD_per_Share">7.17</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSeventyFivePointThirtyEightMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201817_xbrl_20200220171530116" unitRef="CAD_per_Share">75.38</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointSixtyThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201832_xbrl_20200220171531756" unitRef="CAD_per_Share">7.63</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightySixPointFortyThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201852_xbrl_20200220171533572" unitRef="CAD_per_Share">86.43</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightyEightPointFortyFourMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201867_xbrl_20200220171535385" unitRef="CAD_per_Share">88.44</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredTwentyPointSixtyMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201885_xbrl_20200220171537476" unitRef="CAD_per_Share">120.60</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredFortyTwoPointSeventyOneMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201909_xbrl_20200220171539249" unitRef="CAD_per_Share">142.71</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="C_20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223181201936_xbrl_20200220171540881" unitRef="CAD_per_Share">21.24</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20210223175703859">
              &lt;div&gt;
                &lt;table border="0" style="width:100%;border-collapse:collapse;font-size:10pt"&gt;
                  &lt;tbody&gt;
                    &lt;tr&gt;
                      &lt;td&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1px solid #000000;width:25%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&amp;#160;2020&amp;#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1px solid #000000;width:25%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&amp;#160;2019&amp;#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Grant date share price&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&amp;#160;C$3.75 &amp;#x2014; C$9.54&amp;#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160;C$6.45 &amp;#x2014; C$75.38&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercise price&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&amp;#160;C$3.68 &amp;#x2014; C$9.80&amp;#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160;C$7.17 &amp;#x2014; C$75.38&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected dividend yield&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&amp;#x2014;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Risk free interest rate&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;0.27% &amp;#x2014;&amp;#160; 1.55%&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.24% &amp;#x2014;&amp;#160; 1.90%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected life&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&amp;#160;4 &amp;#x2014; 9 years&amp;#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160;5 years&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected volatility&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;120%&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;/tr&gt;
                  &lt;/tbody&gt;
                &lt;/table&gt;
              &lt;/div&gt;
            </ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory>
  <ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20200220141552831">
          &lt;div&gt;
            &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;The following table is a summary of the Company's share options outstanding as at December 31, 2020:&lt;/p&gt;
            &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span&gt;&amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160;&lt;/span&gt;&lt;/p&gt;
            &lt;div&gt;
              &lt;div&gt;
                &lt;table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;
                  &lt;tbody&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td colspan="7" style="text-align:center;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Options outstanding&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td colspan="4" style="text-align:center;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Options exercisable&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercise price&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number outstanding&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted average remaining contractual life [years]&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercise price&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number exercisable&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;C$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;#&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;#&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;C$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;#&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.61&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,683&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.49&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.61&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,683&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6.47&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.86&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;872,139&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.08&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.86&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;864,139&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.42&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;99,502&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.71&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.42&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;99,502&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;110,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.29&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;77,500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.03&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;60,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.70&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.03&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,498&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.43&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,264&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.49&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.43&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,264&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6.16&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.18&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6.16&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.17&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;199,005&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.83&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.17&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;199,005&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.63&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;203,750&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.34&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.63&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;138,750&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9.54&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.06&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9.54&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,125&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10.65&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,730&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.49&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10.65&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,730&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13.07&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,855&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.49&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13.07&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,855&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13.47&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,418&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.49&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13.47&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,418&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16.08&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18,409&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.49&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16.08&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18,409&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17.89&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,178&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.49&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17.89&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,178&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18.09&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17,413&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.21&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18.09&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17,413&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20.10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,289&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.27&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20.10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,289&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;47.24&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,493&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.37&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;47.24&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,493&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;50.25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,224&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.31&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;50.25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,224&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;52.26&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.21&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;52.26&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;55.28&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.12&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;55.28&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;59.30&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.96&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;59.30&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;75.38&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.04&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;75.38&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;86.43&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,244&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.87&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;86.43&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,244&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;142.71&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,975&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.74&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;142.71&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,975&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6.11&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,693,063&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.88&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6.13&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,528,186&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:2px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                  &lt;/tbody&gt;
                &lt;/table&gt;
                &lt;div&gt;
                  &lt;p style="text-align:center"&gt;&amp;#160;&lt;/p&gt;
                &lt;/div&gt;
                &lt;div style="text-align:left"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="text-align:justify"&gt;The following table is a summary of the Company's share options outstanding as at December 31, 2019:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="text-align:left"&gt;&amp;#160;&lt;/div&gt;
                &lt;table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;
                  &lt;tbody&gt;
                    &lt;tr&gt;
                      &lt;td colspan="1" style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td colspan="7" style="text-align:center;vertical-align:bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;strong&gt;Options outstanding&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td colspan="4" style="text-align:center;vertical-align:bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;strong&gt;Options exercisable&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Exercise price&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Number outstanding&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Weighted average remaining contractual life [years]&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Exercise price&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Number exercisable&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;C$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;#&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;#&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;C$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;#&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2.61&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;35,065&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;3.49&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2.61&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;35,065&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4.42&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;99,502&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2.71&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4.42&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;99,502&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;5.43&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;16,264&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;3.49&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;5.43&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;16,264&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;10.65&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;3,730&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;3.49&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;10.65&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;3,730&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;13.07&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;10,855&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;3.49&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;13.07&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;10,855&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;13.47&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,418&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;3.49&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;13.47&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,418&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;16.08&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;18,409&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;3.49&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;16.08&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;18,409&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;17.89&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4,178&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;3.49&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;17.89&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4,178&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;18.09&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;37,313&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;3.34&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;18.09&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;37,313&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;20.10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;493,363&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4.72&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;20.10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;493,363&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;21.11&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;12,438&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4.67&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;21.11&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;12,438&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;24.12&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;9,950&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4.59&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;24.12&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;6,219&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;26.13&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;14,925&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;3.62&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;26.13&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;14,925&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;40.20&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;29,851&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4.45&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;40.20&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;22,388&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;44.22&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2,488&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;3.41&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;44.22&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2,488&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;47.24&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,493&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4.37&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;47.24&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,493&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;50.25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;227,861&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;5.09&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;50.25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;129,353&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;52.26&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4.21&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;52.26&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;55.28&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4.12&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;55.28&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;59.30&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;3.96&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;59.30&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;7.17&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;199,005&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4.83&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;7.17&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;199,005&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;75.38&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4.04&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;75.38&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;7.63&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;203,750&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;5.34&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;7.63&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;58,750&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;86.43&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,244&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;3.88&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;86.43&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,244&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;88.44&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;14,925&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;3.87&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;88.44&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;14,925&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;120.60&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;9,950&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;3.71&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;120.60&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;9,950&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                      &lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;142.71&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4,974&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;3.74&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;142.71&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4,975&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="text-align:left;border-bottom:1.5pt solid black;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1.5pt solid black;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;21.96&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;border-bottom:1.5pt solid black;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;border-bottom:1.5pt solid black;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1.5pt solid black;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,454,943&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;border-bottom:1.5pt solid black;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;border-bottom:1.5pt solid black;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1.5pt solid black;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4.59&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;border-bottom:1.5pt solid black;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;border-bottom:1.5pt solid black;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1.5pt solid black;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;21.24&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:left;border-bottom:1.5pt solid black;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:left;border-bottom:1.5pt solid black;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1.5pt solid black;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,200,242&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1.5pt solid black;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                  &lt;/tbody&gt;
                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        </ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwoPointSixOneMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223182932789_xbrl_20210223181201397_xbrl_20200220170710890">P2Y5M26D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThreePointSevenFiveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223184312190_xbrl_20210223182932789_xbrl_20210223181201397_xbrl_20200220170710890">P6Y5M19D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThreePointEightSixMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223184418191_xbrl_20210223184312190_xbrl_20210223182932789_xbrl_20210223181201397_xbrl_20200220170710890">P4Y29D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFourPointFourTwoMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223183056631_xbrl_20210223181201416_xbrl_20200220170757756">P1Y8M15D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFourPointSevenFiveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223184535733_xbrl_20210223183056631_xbrl_20210223181201416_xbrl_20200220170757756">P4Y3M14D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFivePointZeroThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223184710577_xbrl_20210223184535733_xbrl_20210223183056631_xbrl_20210223181201416_xbrl_20200220170757756">P4Y8M12D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFivePointFourThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210224212854686">P2Y5M26D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSixPointSixteenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223183649207_xbrl_20210223183127381_xbrl_20210223181201434_xbrl_20200220170759384">P3Y2M4D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointSeventeenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223183823596_xbrl_20210223183649207_xbrl_20210223183127381_xbrl_20210223181201434_xbrl_20200220170759384">P3Y9M29D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointSixtyThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223184031562_xbrl_20210223183823596_xbrl_20210223183649207_xbrl_20210223183127381_xbrl_20210223181201434_xbrl_20200220170759384">P4Y4M2D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceNinePointFiveFourMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223184200680_xbrl_20210223184031562_xbrl_20210223183823596_xbrl_20210223183649207_xbrl_20210223183127381_xbrl_20210223181201434_xbrl_20200220170759384">P4Y21D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTenPointSixFiveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223183145803_xbrl_20210223181201450_xbrl_20200220170801033">P2Y5M26D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThirteenPointZeroSevenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223183220286_xbrl_20210223181201466_xbrl_20200220170802830">P2Y5M26D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThirteenPointFourSevenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223183240876_xbrl_20210223181201487_xbrl_20200220170804756">P2Y5M26D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSixteenPointZeroEightMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223183300068_xbrl_20210223181201504_xbrl_20200220170806468">P2Y5M26D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSeventeenPointEightNineMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223183320703_xbrl_20210223181201519_xbrl_20200220170815500">P2Y5M26D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEighteenPointZeroNineMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223183337331_xbrl_20210223181201544_xbrl_20200220170817215">P2Y2M15D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyPointOneZeroMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223183354998_xbrl_20210223181201566_xbrl_20200220170819236">P2Y3M7D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortySevenPointTwentyFourMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223183410967_xbrl_20210223181201709_xbrl_20200220170830940">P3Y4M13D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyPointTwentyFiveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223183424486_xbrl_20210223181201727_xbrl_20200220170836619">P3Y3M21D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyTwoPointTwentySixMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223183439718_xbrl_20210223181201744_xbrl_20200220170838590">P3Y2M15D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyFivePointTwentyEightMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223183455873_xbrl_20210223181201762_xbrl_20200220170840292">P3Y1M13D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyNinePointThirtyMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223183512120_xbrl_20210223181201782_xbrl_20200220170842236">P2Y11M15D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSeventyFivePointThirtyEightMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223183524326_xbrl_20210223181201817_xbrl_20200220170914607">P3Y14D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightySixPointFortyThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223183559255_xbrl_20210223181201852_xbrl_20200220170919180">P2Y10M13D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20200101to20201231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredFortyTwoPointSeventyOneMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223183614976_xbrl_20210223181201909_xbrl_20200220170928348">P2Y8M26D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20200101to20201231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223183634040_xbrl_20210223181201936_xbrl_20200220170930068">P3Y10M17D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwoPointSixOneMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223181201397_xbrl_20200220170710890">P3Y5M26D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFourPointFourTwoMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223181201416_xbrl_20200220170757756">P2Y8M15D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFivePointFourThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210224212835030">P3Y5M26D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTenPointSixFiveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223181201450_xbrl_20200220170801033">P3Y5M26D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThirteenPointZeroSevenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223181201466_xbrl_20200220170802830">P3Y5M26D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceThirteenPointFourSevenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223181201487_xbrl_20200220170804756">P3Y5M26D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSixteenPointZeroEightMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223181201504_xbrl_20200220170806468">P3Y5M26D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSeventeenPointEightNineMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223181201519_xbrl_20200220170815500">P3Y5M26D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEighteenPointZeroNineMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223181201544_xbrl_20200220170817215">P3Y4M2D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyPointOneZeroMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223181201566_xbrl_20200220170819236">P4Y8M19D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyOnePointElevenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223181201590_xbrl_20200220170820942">P4Y8M1D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentyFourPointTwelveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223181201614_xbrl_20200220170823268">P4Y7M2D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceTwentySixPointThirteenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223181201640_xbrl_20200220170825508">P3Y7M13D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortyPointTwentyMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223181201663_xbrl_20200220170827212">P4Y5M12D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortyFourPointTwentyTwoMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223181201686_xbrl_20200220170828868">P3Y4M28D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFortySevenPointTwentyFourMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223181201709_xbrl_20200220170830940">P4Y4M13D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyPointTwentyFiveMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223181201727_xbrl_20200220170836619">P5Y1M2D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyTwoPointTwentySixMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223181201744_xbrl_20200220170838590">P4Y2M15D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyFivePointTwentyEightMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223181201762_xbrl_20200220170840292">P4Y1M13D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceFiftyNinePointThirtyMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223181201782_xbrl_20200220170842236">P3Y11M15D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointSeventeenMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223181201800_xbrl_20200220170848083">P4Y9M29D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSeventyFivePointThirtyEightMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223181201817_xbrl_20200220170914607">P4Y14D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceSevenPointSixtyThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223181201832_xbrl_20200220170917116">P5Y4M2D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightySixPointFortyThreeMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223181201852_xbrl_20200220170919180">P3Y10M17D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceEightyEightPointFortyFourMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223181201867_xbrl_20200220170921509">P3Y10M13D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredTwentyPointSixtyMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223181201885_xbrl_20200220170923660">P3Y8M15D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190102to20191231_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_hugeExercisePriceOneHundredFortyTwoPointSeventyOneMember_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223181201909_xbrl_20200220170928348">P3Y8M26D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="C_20190102to20191231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" id="Fxbrl_20210223181201936_xbrl_20200220170930068">P4Y7M2D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <huge:NumberOfReplacementShareOptionsIssued contextRef="C_20200101to20201231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="0" id="Fxbrl_20210226115738518" unitRef="shares">822137</huge:NumberOfReplacementShareOptionsIssued>
  <huge:WeightedAverageExercisePriceForReplacementOfShareOptions contextRef="C_20201231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="2" id="Fxbrl_20210223192118494" unitRef="CAD_per_Share">3.86</huge:WeightedAverageExercisePriceForReplacementOfShareOptions>
  <ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted contextRef="C_20201231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_hugeStockOptionsMember" decimals="0" id="Fxbrl_20210223192814991" unitRef="USD">661811</ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted>
  <ifrs-full:DisclosureOfEarningsPerShareExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20200220154924867">
    &lt;div&gt;
      &lt;p style="text-align:justify"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15.&amp;#160; Loss per share&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
      &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net loss per common share represents net loss attributable to common shareholders divided by the weighted average number of common shares outstanding during the year.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For all the periods presented, diluted loss per share equals basic loss per share due to the anti-dilutive effect of warrants and share options. The outstanding number and type of securities that could potentially dilute basic net loss per share in the future but would have decreased the loss per share (anti-dilutive) for the period ended December 31, 2020 and 2019 presented are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

        &lt;div&gt;
          &lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;margin-left:auto;margin-right:auto;width:100%"&gt;
            &lt;tbody&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td colspan="4" rowspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;strong&gt;Year ended December 31,&lt;/strong&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2020&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;#&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;#&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Warrants&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;6,749,109&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;467,451&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share Options&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border:1pt none;vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border:1pt none;vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;1,693,063&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border:1pt none;vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border:1pt none;vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border:1pt none;vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,454,943&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border:1pt none;vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;8,442,172&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,922,394&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
            &lt;/tbody&gt;
          &lt;/table&gt;
        &lt;/div&gt;

    &lt;/div&gt;
  </ifrs-full:DisclosureOfEarningsPerShareExplanatory>
  <ifrs-full:EarningsPerShareExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20200220155021226">
        &lt;div&gt;
          &lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;margin-left:auto;margin-right:auto;width:100%"&gt;
            &lt;tbody&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td colspan="4" rowspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;strong&gt;Year ended December 31,&lt;/strong&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2020&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;#&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;#&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Warrants&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;6,749,109&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;467,451&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share Options&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border:1pt none;vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border:1pt none;vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;1,693,063&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border:1pt none;vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border:1pt none;vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border:1pt none;vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,454,943&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border:1pt none;vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;8,442,172&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,922,394&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
            &lt;/tbody&gt;
          &lt;/table&gt;
        &lt;/div&gt;
      </ifrs-full:EarningsPerShareExplanatory>
  <ifrs-full:DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares contextRef="C_20200101to20201231_ifrsfullClassesOfOrdinarySharesAxis_hugeWarrantsMember" decimals="0" id="Fxbrl_20200220154350768" unitRef="shares">6749109</ifrs-full:DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares>
  <ifrs-full:DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares contextRef="C_20190102to20191231_ifrsfullClassesOfOrdinarySharesAxis_hugeWarrantsMember" decimals="0" id="Fxbrl_20210223160455932" unitRef="shares">467451</ifrs-full:DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares>
  <ifrs-full:DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20200220154434138" unitRef="shares">8442172</ifrs-full:DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares>
  <ifrs-full:DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210223160630012" unitRef="shares">1922394</ifrs-full:DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares>
  <ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares contextRef="C_20200101to20201231_ifrsfullClassesOfOrdinarySharesAxis_hugeStockOptionsMember" decimals="0" id="Fxbrl_20200220154453089" unitRef="shares">1693063</ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares>
  <ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares contextRef="C_20190102to20191231_ifrsfullClassesOfOrdinarySharesAxis_hugeStockOptionsMember" decimals="0" id="Fxbrl_20210223160514768" unitRef="shares">1454943</ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares>
  <ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20200220052546210">
    &lt;div&gt;
      &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-left:3px;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;16.&lt;span style="width:5.25pt;display:inline-block"&gt; &lt;/span&gt;General and administrative&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-left:3px;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;
      &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Components of general and administrative expenses for the year ended December 31, 2020 and 2019 were as follows:&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-left:3px;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;

        &lt;div&gt;
          &lt;div&gt;
            &lt;table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;
              &lt;tbody&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td colspan="1" style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td colspan="4" style="text-align:center;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Year ended December 31,&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td colspan="1" style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2020&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Professional fees&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2,734,123&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,101,136&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;General office, insurance and administration expenditures&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;3,616,159&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,742,550&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Consulting fees&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;1,775,269&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,675,258&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Salaries, wages and benefits&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2,656,162&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,705,696&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Investor relations&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;541,944&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,241,275&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Building and facility costs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;586,926&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;676,798&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign exchange loss&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(186,959&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;11,723,624&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,142,713&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Allocated to:&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Continuing operations&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;10,058,083&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,407,427&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Discontinued operations&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;1,665,541&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,735,286&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
              &lt;/tbody&gt;
            &lt;/table&gt;
          &lt;/div&gt;
        &lt;/div&gt;

    &lt;/div&gt;
  </ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory>
  <huge:DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20200220052441357">
        &lt;div&gt;
          &lt;div&gt;
            &lt;table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;
              &lt;tbody&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td colspan="1" style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td colspan="4" style="text-align:center;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Year ended December 31,&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td colspan="1" style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2020&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Professional fees&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2,734,123&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,101,136&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;General office, insurance and administration expenditures&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;3,616,159&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,742,550&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Consulting fees&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;1,775,269&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,675,258&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Salaries, wages and benefits&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2,656,162&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,705,696&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Investor relations&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;541,944&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,241,275&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Building and facility costs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;586,926&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;676,798&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign exchange loss&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(186,959&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;11,723,624&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,142,713&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Allocated to:&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Continuing operations&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;10,058,083&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,407,427&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Discontinued operations&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;1,665,541&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,735,286&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
              &lt;/tbody&gt;
            &lt;/table&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      </huge:DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory>
  <ifrs-full:ProfessionalFeesExpense contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20200220055103333" unitRef="USD">2734123</ifrs-full:ProfessionalFeesExpense>
  <ifrs-full:ProfessionalFeesExpense contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20200220055109039" unitRef="USD">3101136</ifrs-full:ProfessionalFeesExpense>
  <huge:GeneralOfficeInsuranceAndAdministrationExpenditures contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224144504674_xbrl_20200220055103333" unitRef="USD">3616159</huge:GeneralOfficeInsuranceAndAdministrationExpenditures>
  <huge:GeneralOfficeInsuranceAndAdministrationExpenditures contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210224144504674_xbrl_20200220055109039" unitRef="USD">1742550</huge:GeneralOfficeInsuranceAndAdministrationExpenditures>
  <huge:ConsultingFeesExpenses contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20200220055155224" unitRef="USD">1775269</huge:ConsultingFeesExpenses>
  <huge:ConsultingFeesExpenses contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20200220055122873" unitRef="USD">1675258</huge:ConsultingFeesExpenses>
  <ifrs-full:WagesAndSalaries contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20200220055153288" unitRef="USD">2656162</ifrs-full:WagesAndSalaries>
  <ifrs-full:WagesAndSalaries contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20200220055120802" unitRef="USD">1705696</ifrs-full:WagesAndSalaries>
  <huge:InvestorRelationsExpenses contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20200220055151392" unitRef="USD">541944</huge:InvestorRelationsExpenses>
  <huge:InvestorRelationsExpenses contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20200220055118987" unitRef="USD">2241275</huge:InvestorRelationsExpenses>
  <huge:BuildingAndFacilityCosts contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210223200206643_xbrl_20200220055151392" unitRef="USD">586926</huge:BuildingAndFacilityCosts>
  <huge:BuildingAndFacilityCosts contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210223200206643_xbrl_20200220055118987" unitRef="USD">676798</huge:BuildingAndFacilityCosts>
  <ifrs-full:NetForeignExchangeLoss contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20200220055215056" unitRef="USD">186959</ifrs-full:NetForeignExchangeLoss>
  <ifrs-full:NetForeignExchangeLoss contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20200221040127095" unitRef="USD">0</ifrs-full:NetForeignExchangeLoss>
  <huge:GeneralAndAdministrativeExpenseContinuedAndDiscontinuedOperations contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210223200658600" unitRef="USD">11723624</huge:GeneralAndAdministrativeExpenseContinuedAndDiscontinuedOperations>
  <huge:GeneralAndAdministrativeExpenseContinuedAndDiscontinuedOperations contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210223200752517" unitRef="USD">11142713</huge:GeneralAndAdministrativeExpenseContinuedAndDiscontinuedOperations>
  <huge:GeneralAndAdministrativeExpenseDiscontinuedOperations contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210223200845251_xbrl_20210223200820605_xbrl_20210223200206643_xbrl_20200220055151392" unitRef="USD">1665541</huge:GeneralAndAdministrativeExpenseDiscontinuedOperations>
  <huge:GeneralAndAdministrativeExpenseDiscontinuedOperations contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210223200845251_xbrl_20210223200820605_xbrl_20210223200206643_xbrl_20200220055118987" unitRef="USD">2735286</huge:GeneralAndAdministrativeExpenseDiscontinuedOperations>
  <ifrs-full:DisclosureOfIncomeTaxExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20200228155150932">
    &lt;div&gt;
      &lt;p style="text-align:justify;margin-top:0pt;margin-left:5.25pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;&lt;span&gt;17.&lt;span style="width:5.25pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Income taxes&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="text-align:justify;margin-left:2.25pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;The reconciliation of income tax expense for the years ended December 31, 2020 and 2019 consists of the following:&lt;/span&gt;&lt;/p&gt;

        &lt;div&gt;
          &lt;div style="margin-left:39pt"&gt;&amp;#160;&lt;/div&gt;
          &lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;margin-right:auto;width:90%"&gt;
            &lt;tbody&gt;
              &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;2020&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;2019&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                &lt;td style="vertical-align:bottom;text-align:left;border-top:1pt solid black;background-color:rgb(230, 239, 255)"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Loss from continuing operations before income taxes&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;border-top:1pt solid black;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:17%;border-top:1pt solid black;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;(28,452,232&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;border-top:1pt solid black;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;border-top:1pt solid black;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:17%;border-top:1pt solid black;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;(34,080,963&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                &lt;td style="vertical-align:bottom;text-align:left;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Statutory federal and provincial tax rate&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;26.50%&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;26.50%&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(230, 239, 255)"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Income tax recovery at the statutory tax rate&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;(7,539,841&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;(9,031,455&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                &lt;td style="vertical-align:bottom;padding-left:0pt;background-color:rgb(255, 255, 255)"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span&gt;Permanent&amp;#160;&lt;/span&gt;&lt;span&gt;differences&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;2,235,657&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;5,866,153&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                &lt;td style="vertical-align:bottom;padding-left:0pt;background-color:rgb(230, 239, 255)"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Book to filing adjustments&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;(1,545,244&lt;/strong&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"&gt;)&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;4,765,959&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                &lt;td style="vertical-align:bottom;padding-left:0pt;background-color:rgb(255, 255, 255)"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Share issuance cost booked directly to equity&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;(584,538&lt;/strong&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;)&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&amp;#x2014;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                &lt;td style="vertical-align:bottom;padding-left:0pt;background-color:rgb(230, 239, 255)"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Foreign exchange&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;(370,457&lt;/strong&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"&gt;)&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"&gt;&amp;#x2014;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Change in tax benefits not recognized&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;7,804,423&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;(1,600,657&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                &lt;td style="vertical-align:bottom;text-align:left;padding-left:7.5pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:17%;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;&amp;#x2014;&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:17%;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;&amp;#x2014;&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
            &lt;/tbody&gt;
          &lt;/table&gt;
        &lt;/div&gt;

      &lt;div&gt;
        &lt;p&gt;&lt;br/&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Deferred taxes reflect the tax effects of temporary differences that arise due to the differences between the income tax values and the carrying amount of assets and liabilities. Deferred tax liabilities as at December 31, 2020 and 2019 are comprised of the following:&amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160;&lt;/span&gt;&lt;/p&gt;
        &lt;div&gt;
          &lt;div&gt;

              &lt;table cellspacing="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;width:90%"&gt;
                &lt;tbody&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;2020&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2019&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:12%;text-align:right;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:12%;text-align:right;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Other investments&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;&amp;#x2014;&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;(126,461&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;)&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Capital losses carried forward&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:12%;text-align:right;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;&amp;#x2014;&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:12%;text-align:right;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;126,461&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e6efff"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;Total&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1px solid #000000;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:12%;text-align:right;border-bottom:1px solid #000000;background-color:#e6efff"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;&amp;#x2014;&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1px solid #000000;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1px solid #000000;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:12%;text-align:right;border-bottom:1px solid #000000;background-color:#e6efff"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1px solid #000000;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                &lt;/tbody&gt;
              &lt;/table&gt;
            &lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/span&gt;
            &lt;p&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Deferred tax assets have not been recognized in respect of the following temporary differences as at December 31, 2020 and 2019:&lt;/span&gt;&lt;/p&gt;
          &lt;/div&gt;
        &lt;/div&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;
        &lt;div&gt;
          &lt;div&gt;

              &lt;div&gt;
                &lt;table border="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;width:90%"&gt;
                  &lt;tbody&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;2020&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2019&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                      &lt;td style="vertical-align:bottom;background-color:rgb(230, 239, 255)"&gt;
                        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Non-capital losses - Canada&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;44,897,393&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;20,703,137&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
                        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Net-operating loss - US&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(255, 255, 255)"&gt;
                        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;5,032,915&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(255, 255, 255)"&gt;
                        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;206,480&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                      &lt;td style="vertical-align:bottom;background-color:rgb(230, 239, 255)"&gt;
                        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Unrealized foreign exchange loss&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;94,733&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Share-issuance costs&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;3,419,003&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;879,959&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                      &lt;td style="vertical-align:bottom;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Capital losses carried forward&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;&amp;#x2014;&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;263,666&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Other investments&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;4,449,544&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;968,811&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                      &lt;td style="vertical-align:bottom;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;IFRS 16&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;125,962&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:15%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;88,248&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:15%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;30,290&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                      &lt;td style="vertical-align:bottom;border-bottom:1pt solid black;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;&lt;span&gt;Total&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1pt solid black;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right;border-bottom:1pt solid black;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;58,107,798&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1pt solid black;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1pt solid black;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right;border-bottom:1pt solid black;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;23,052,343&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1pt solid black;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                  &lt;/tbody&gt;
                &lt;/table&gt;
              &lt;/div&gt;

          &lt;/div&gt;
        &lt;/div&gt;
        &lt;p style="margin:0pt"&gt;&amp;#160;&lt;/p&gt;
        &lt;div&gt;
          &lt;div&gt;
            &lt;p&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;The Company's Canadian non-capital income tax losses expire as follows:&amp;#160;&amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160; &amp;#160;&amp;#160;&lt;/span&gt;&lt;/p&gt;
          &lt;/div&gt;
        &lt;/div&gt;
        &lt;div&gt;
          &lt;div&gt;

              &lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;width:90%;float:left" width="90%"&gt;
                &lt;tbody&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;border-bottom:1px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                    &lt;td style="vertical-align:bottom;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(230, 239, 255);width:89%"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2032&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(230, 239, 255);width:8%"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;26,982&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2033&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;114,405&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                    &lt;td style="vertical-align:bottom;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2034&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;144,411&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2035&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;65,782&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                    &lt;td style="vertical-align:bottom;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2036&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;689,676&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2037&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2,677,789&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                    &lt;td style="vertical-align:bottom;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2038&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;6,092,686&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2039&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;11,415,413&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                    &lt;td style="vertical-align:bottom;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2040&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:1px solid rgb(0, 0, 0);font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;23,670,249&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:1px solid rgb(0, 0, 0);font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)"&gt;44,897,393&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                &lt;/tbody&gt;
              &lt;/table&gt;

          &lt;/div&gt;
        &lt;/div&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;The company has cumulative United States federal net operating loss carryforwards of approximately $5.03M which will start to expire in 2032. Utilization of net operating loss carryforwards may be subject to limitations in the event of a change in ownership pursuant to IRC &amp;#xa7; 382, and similar state provisions. As a result of the acquisition of Prismic on June 28, 2019, the preacquisition net operating loss carryforwards of approximately $4.93M could be subject to IRC &amp;#xa7; 382 limitation as the acquisition could constitute a change of ownership.&lt;/p&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </ifrs-full:DisclosureOfIncomeTaxExplanatory>
  <huge:DisclosureOfProvisionForIncomeTaxesExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20200220142321860">
        &lt;div&gt;
          &lt;div style="margin-left:39pt"&gt;&amp;#160;&lt;/div&gt;
          &lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;margin-right:auto;width:90%"&gt;
            &lt;tbody&gt;
              &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;2020&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;2019&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                &lt;td style="vertical-align:bottom;text-align:left;border-top:1pt solid black;background-color:rgb(230, 239, 255)"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Loss from continuing operations before income taxes&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;border-top:1pt solid black;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:17%;border-top:1pt solid black;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;(28,452,232&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;border-top:1pt solid black;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;border-top:1pt solid black;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:17%;border-top:1pt solid black;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;(34,080,963&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                &lt;td style="vertical-align:bottom;text-align:left;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Statutory federal and provincial tax rate&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;26.50%&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;26.50%&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(230, 239, 255)"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Income tax recovery at the statutory tax rate&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;(7,539,841&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;(9,031,455&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                &lt;td style="vertical-align:bottom;padding-left:0pt;background-color:rgb(255, 255, 255)"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span&gt;Permanent&amp;#160;&lt;/span&gt;&lt;span&gt;differences&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;2,235,657&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;5,866,153&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                &lt;td style="vertical-align:bottom;padding-left:0pt;background-color:rgb(230, 239, 255)"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Book to filing adjustments&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;(1,545,244&lt;/strong&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"&gt;)&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;4,765,959&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                &lt;td style="vertical-align:bottom;padding-left:0pt;background-color:rgb(255, 255, 255)"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Share issuance cost booked directly to equity&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;(584,538&lt;/strong&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;)&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&amp;#x2014;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                &lt;td style="vertical-align:bottom;padding-left:0pt;background-color:rgb(230, 239, 255)"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Foreign exchange&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;(370,457&lt;/strong&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"&gt;)&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"&gt;&amp;#x2014;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Change in tax benefits not recognized&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;7,804,423&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;(1,600,657&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                &lt;td style="vertical-align:bottom;text-align:left;padding-left:7.5pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:17%;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;&amp;#x2014;&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:17%;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;&amp;#x2014;&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
            &lt;/tbody&gt;
          &lt;/table&gt;
        &lt;/div&gt;
      </huge:DisclosureOfProvisionForIncomeTaxesExplanatory>
  <ifrs-full:AccountingProfit contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20200219175757800" unitRef="USD">-28452232</ifrs-full:AccountingProfit>
  <ifrs-full:AccountingProfit contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20200219175805745" unitRef="USD">-34080963</ifrs-full:AccountingProfit>
  <ifrs-full:ApplicableTaxRate contextRef="C_20200101to20201231" decimals="4" id="Fxbrl_20200219175933392" unitRef="Pure">0.2650</ifrs-full:ApplicableTaxRate>
  <ifrs-full:ApplicableTaxRate contextRef="C_20190102to20191231" decimals="4" id="Fxbrl_20200219175939314" unitRef="Pure">0.2650</ifrs-full:ApplicableTaxRate>
  <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20200219180734238" unitRef="USD">-7539841</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
  <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20200219180738163" unitRef="USD">-9031455</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
  <ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20200219181817759" unitRef="USD">2235657</ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss>
  <ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20200228165031015" unitRef="USD">5866153</ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss>
  <huge:BookToFilingAdjustments contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210304005351648_xbrl_20200219181817759" unitRef="USD">-1545244</huge:BookToFilingAdjustments>
  <huge:BookToFilingAdjustments contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210304005351648_xbrl_20200228165031015" unitRef="USD">4765959</huge:BookToFilingAdjustments>
  <huge:ShareIssuanceCostBookedDirectlyToEquity contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210304005409472_xbrl_20210304005351648_xbrl_20200219181817759" unitRef="USD">-584538</huge:ShareIssuanceCostBookedDirectlyToEquity>
  <huge:ShareIssuanceCostBookedDirectlyToEquity contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210304005409472_xbrl_20210304005351648_xbrl_20200228165031015" unitRef="USD">0</huge:ShareIssuanceCostBookedDirectlyToEquity>
  <ifrs-full:TaxEffectOfForeignTaxRates contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210304005424815_xbrl_20210304005409472_xbrl_20210304005351648_xbrl_20200219181817759" unitRef="USD">-370457</ifrs-full:TaxEffectOfForeignTaxRates>
  <ifrs-full:TaxEffectOfForeignTaxRates contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210304005424815_xbrl_20210304005409472_xbrl_20210304005351648_xbrl_20200228165031015" unitRef="USD">0</ifrs-full:TaxEffectOfForeignTaxRates>
  <huge:TaxEffectOfDeferredTaxAssetNotRecognized contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20200302233159151" unitRef="USD">7804423</huge:TaxEffectOfDeferredTaxAssetNotRecognized>
  <huge:TaxEffectOfDeferredTaxAssetNotRecognized contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210223093424319" unitRef="USD">-1600657</huge:TaxEffectOfDeferredTaxAssetNotRecognized>
  <ifrs-full:DeferredTaxExpenseIncome contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20200219183112387" unitRef="USD">0</ifrs-full:DeferredTaxExpenseIncome>
  <ifrs-full:DeferredTaxExpenseIncome contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20200228160732578" unitRef="USD">0</ifrs-full:DeferredTaxExpenseIncome>
  <ifrs-full:DisclosureOfDeferredTaxesExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20210304022310504">
              &lt;table cellspacing="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;width:90%"&gt;
                &lt;tbody&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;2020&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2019&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:12%;text-align:right;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:12%;text-align:right;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Other investments&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;&amp;#x2014;&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;(126,461&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;)&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Capital losses carried forward&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:12%;text-align:right;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;&amp;#x2014;&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:12%;text-align:right;border-bottom:1px solid #000000"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;126,461&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1px solid #000000"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e6efff"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;Total&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1px solid #000000;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:12%;text-align:right;border-bottom:1px solid #000000;background-color:#e6efff"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;&amp;#x2014;&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1px solid #000000;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1px solid #000000;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:12%;text-align:right;border-bottom:1px solid #000000;background-color:#e6efff"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1px solid #000000;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                &lt;/tbody&gt;
              &lt;/table&gt;
            </ifrs-full:DisclosureOfDeferredTaxesExplanatory>
  <huge:DeferredTaxAssetsOtherInvestments contextRef="C_20201231" decimals="0" id="Fxbrl_20210304010806546" unitRef="USD">0</huge:DeferredTaxAssetsOtherInvestments>
  <huge:DeferredTaxAssetsOtherInvestments contextRef="C_20191231" decimals="0" id="Fxbrl_20210304010840148" unitRef="USD">-126461</huge:DeferredTaxAssetsOtherInvestments>
  <huge:DeferredTaxLiabilitiesCapitalLossesCarriedForward contextRef="C_20201231" decimals="0" id="Fxbrl_20210304010852497_xbrl_20210304010806546" unitRef="USD">0</huge:DeferredTaxLiabilitiesCapitalLossesCarriedForward>
  <huge:DeferredTaxLiabilitiesCapitalLossesCarriedForward contextRef="C_20191231" decimals="0" id="Fxbrl_20210304010852497_xbrl_20210304010840148" unitRef="USD">126461</huge:DeferredTaxLiabilitiesCapitalLossesCarriedForward>
  <huge:DeferredTaxAssetLiabilityNotRecognized contextRef="C_20201231" decimals="0" id="Fxbrl_20210304010910119_xbrl_20210304010852497_xbrl_20210304010806546" unitRef="USD">0</huge:DeferredTaxAssetLiabilityNotRecognized>
  <huge:DeferredTaxAssetLiabilityNotRecognized contextRef="C_20191231" decimals="0" id="Fxbrl_20210304010910119_xbrl_20210304010852497_xbrl_20210304010840148" unitRef="USD">0</huge:DeferredTaxAssetLiabilityNotRecognized>
  <huge:DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20210223100842456">
              &lt;div&gt;
                &lt;table border="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;width:90%"&gt;
                  &lt;tbody&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;2020&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2019&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                      &lt;td style="vertical-align:bottom;background-color:rgb(230, 239, 255)"&gt;
                        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Non-capital losses - Canada&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;44,897,393&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;20,703,137&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
                        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Net-operating loss - US&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(255, 255, 255)"&gt;
                        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;5,032,915&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(255, 255, 255)"&gt;
                        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;206,480&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                      &lt;td style="vertical-align:bottom;background-color:rgb(230, 239, 255)"&gt;
                        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Unrealized foreign exchange loss&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;94,733&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Share-issuance costs&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;3,419,003&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;879,959&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                      &lt;td style="vertical-align:bottom;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Capital losses carried forward&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;&amp;#x2014;&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;263,666&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Other investments&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;4,449,544&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;968,811&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                      &lt;td style="vertical-align:bottom;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;IFRS 16&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;125,962&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                      &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:15%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;88,248&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:15%;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;30,290&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                      &lt;td style="vertical-align:bottom;border-bottom:1pt solid black;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;&lt;span&gt;Total&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1pt solid black;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right;border-bottom:1pt solid black;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;58,107,798&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1pt solid black;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1pt solid black;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right;border-bottom:1pt solid black;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;23,052,343&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1pt solid black;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;/tr&gt;
                  &lt;/tbody&gt;
                &lt;/table&gt;
              &lt;/div&gt;
            </huge:DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory>
  <huge:DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised contextRef="C_20201231" decimals="0" id="Fxbrl_20210223094114173" unitRef="USD">44897393</huge:DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised>
  <huge:DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised contextRef="C_20191231" decimals="0" id="Fxbrl_20210223094129496" unitRef="USD">20703137</huge:DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised>
  <huge:DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised contextRef="C_20201231" decimals="0" id="Fxbrl_20210304012253711_xbrl_20210223094114173" unitRef="USD">5032915</huge:DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised>
  <huge:DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised contextRef="C_20191231" decimals="0" id="Fxbrl_20210304012253711_xbrl_20210223094129496" unitRef="USD">206480</huge:DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised>
  <huge:DeductibleTemporaryDifferencesOfForeignUnrealizedForeignExchangeLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised contextRef="C_20201231" decimals="0" id="Fxbrl_20210304012309346_xbrl_20210304012253711_xbrl_20210223094114173" unitRef="USD">94733</huge:DeductibleTemporaryDifferencesOfForeignUnrealizedForeignExchangeLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised>
  <huge:DeductibleTemporaryDifferencesOfForeignUnrealizedForeignExchangeLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised contextRef="C_20191231" decimals="0" id="Fxbrl_20210304012309346_xbrl_20210304012253711_xbrl_20210223094129496" unitRef="USD">0</huge:DeductibleTemporaryDifferencesOfForeignUnrealizedForeignExchangeLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised>
  <huge:DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised contextRef="C_20201231" decimals="0" id="Fxbrl_20210223094139146" unitRef="USD">3419003</huge:DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised>
  <huge:DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised contextRef="C_20191231" decimals="0" id="Fxbrl_20210223094157560" unitRef="USD">879959</huge:DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised>
  <huge:DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised contextRef="C_20201231" decimals="0" id="Fxbrl_20210223094223625" unitRef="USD">0</huge:DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised>
  <huge:DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised contextRef="C_20191231" decimals="0" id="Fxbrl_20210223094248866" unitRef="USD">263666</huge:DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised>
  <huge:DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised contextRef="C_20201231" decimals="0" id="Fxbrl_20210223094343246" unitRef="USD">4449544</huge:DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised>
  <huge:DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised contextRef="C_20191231" decimals="0" id="Fxbrl_20210223094346927" unitRef="USD">968811</huge:DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised>
  <huge:DeductibleTemporaryDifferencesOfIfrs16ForWhichNoDeferredTaxAssetIsRecognised contextRef="C_20201231" decimals="0" id="Fxbrl_20210223100721292" unitRef="USD">125962</huge:DeductibleTemporaryDifferencesOfIfrs16ForWhichNoDeferredTaxAssetIsRecognised>
  <huge:DeductibleTemporaryDifferencesOfIfrs16ForWhichNoDeferredTaxAssetIsRecognised contextRef="C_20191231" decimals="0" id="Fxbrl_20210223100730928" unitRef="USD">0</huge:DeductibleTemporaryDifferencesOfIfrs16ForWhichNoDeferredTaxAssetIsRecognised>
  <huge:DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised contextRef="C_20201231" decimals="0" id="Fxbrl_20210223094418208" unitRef="USD">88248</huge:DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised>
  <huge:DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised contextRef="C_20191231" decimals="0" id="Fxbrl_20210223094430807" unitRef="USD">30290</huge:DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised>
  <ifrs-full:NetDeferredTaxAssets contextRef="C_20201231" decimals="0" id="Fxbrl_20210223100616834" unitRef="USD">-58107798</ifrs-full:NetDeferredTaxAssets>
  <ifrs-full:NetDeferredTaxAssets contextRef="C_20191231" decimals="0" id="Fxbrl_20210223100637664" unitRef="USD">-23052343</ifrs-full:NetDeferredTaxAssets>
  <huge:ScheduleOfNonCapitalLossCarryforwardsTableTextBlock contextRef="C_20200101to20201231" id="Fxbrl_20210304015728063">
              &lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;width:90%;float:left" width="90%"&gt;
                &lt;tbody&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;border-bottom:1px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                    &lt;td style="vertical-align:bottom;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(230, 239, 255);width:89%"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2032&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(230, 239, 255);width:8%"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;26,982&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2033&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;114,405&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                    &lt;td style="vertical-align:bottom;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2034&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;144,411&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2035&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;65,782&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                    &lt;td style="vertical-align:bottom;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2036&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;689,676&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2037&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2,677,789&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                    &lt;td style="vertical-align:bottom;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2038&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;6,092,686&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2039&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;11,415,413&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                    &lt;td style="vertical-align:bottom;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;2040&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:1px solid rgb(0, 0, 0);font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;23,670,249&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                    &lt;td style="vertical-align:bottom;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:1px solid rgb(0, 0, 0);font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)"&gt;44,897,393&lt;/td&gt;
                    &lt;td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&amp;#160;&lt;/td&gt;
                  &lt;/tr&gt;
                &lt;/tbody&gt;
              &lt;/table&gt;
            </huge:ScheduleOfNonCapitalLossCarryforwardsTableTextBlock>
  <huge:NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyTwo contextRef="C_20201231" decimals="0" id="Fxbrl_20210304013223355" unitRef="USD">26982</huge:NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyTwo>
  <huge:NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyThree contextRef="C_20201231" decimals="0" id="Fxbrl_20210304013432020" unitRef="USD">114405</huge:NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyThree>
  <huge:NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFour contextRef="C_20201231" decimals="0" id="Fxbrl_20210304013440886" unitRef="USD">144411</huge:NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFour>
  <huge:NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFive contextRef="C_20201231" decimals="0" id="Fxbrl_20210304013450935" unitRef="USD">65782</huge:NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFive>
  <huge:NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySix contextRef="C_20201231" decimals="0" id="Fxbrl_20210304013500116" unitRef="USD">689676</huge:NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySix>
  <huge:NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySeven contextRef="C_20201231" decimals="0" id="Fxbrl_20210304013509772" unitRef="USD">2677789</huge:NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySeven>
  <huge:NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight contextRef="C_20201231" decimals="0" id="Fxbrl_20210304013220152" unitRef="USD">6092686</huge:NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight>
  <huge:NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine contextRef="C_20201231" decimals="0" id="Fxbrl_20210304013524259" unitRef="USD">11415413</huge:NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine>
  <huge:NonCapitalIncomeTaxLossesExpireOnTwoThousandFourty contextRef="C_20201231" decimals="0" id="Fxbrl_20210304013532588" unitRef="USD">23670249</huge:NonCapitalIncomeTaxLossesExpireOnTwoThousandFourty>
  <huge:NonCapitalLossCarryforwards contextRef="C_20201231" decimals="0" id="Fxbrl_20210304013557634" unitRef="USD">44897393</huge:NonCapitalLossCarryforwards>
  <huge:NetOperatingLossCarryforwardsLimitationsInUse contextRef="C_20200101to20201231" id="Fxbrl_20210304022154960">Utilization of net operating loss carryforwards may be subject to limitations in the event of a change in ownership pursuant to IRC &amp;#xa7; 382, and similar state provisions. As a result of the acquisition of Prismic on June 28, 2019, the preacquisition net operating loss carryforwards of approximately $4.93M could be subject to IRC &amp;#xa7; 382 limitation as the acquisition could constitute a change of ownership.</huge:NetOperatingLossCarryforwardsLimitationsInUse>
  <huge:PreacquisitionNetOperatingLossCarryforwards contextRef="C_20200101to20201231" decimals="-4" id="Fxbrl_20210304022109793" unitRef="USD">4930000</huge:PreacquisitionNetOperatingLossCarryforwards>
  <ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20210224131044975">
      &lt;div&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-left:3px;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18. Commitments and contingencies&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-left:3px;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-left:3px;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Commitments&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-left:3px;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;
        &lt;div&gt;
          &lt;div&gt;
            &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Epitech License Agreement&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Under the terms of the Company's License Agreement with Epitech Group SPA ("Epitech"), the Company has payments due to Epitech pending the achievement of specified milestones. Upon first notification by the Food and Drug Administration ("FDA") of approval of a New Drug Application, the non-refundable sum of $700,000 will be due and payable to Epitech. Within ten business days of the first notification of approval of a Supplemental New Drug Application by the FDA, the Company will pay the non-refundable sum of $1,000,000 to Epitech.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For non-prescription drug rights, any one-off lump sum payments received by the Company as consideration for granting a sub-license to a Commercial Partner with respect to a Licensed Product, shall require the Company to pay to Epitech 25% of the lump sum payment received by the Company. For prescription drug rights the Company shall pay 5% of any one-off lump sum payments to Epitech as consideration for granting a sub-license to a Commercial Partner with respect to a Licensed Product. The Company will pay the amounts payable on a quarterly basis within 60 days of the end of each calendar quarter.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company shall pay either a) 7% of Net Sales of the Licensed Product in a Product Regulatory Category other than prescription drugs place on the market by the Company; or b) 25% of Net Receipts received by the Company from Commercial Partners where Licensed Products in a Product Regulatory Category other than prescription drugs are placed on the market by such Commercial Partners; or c) 5% of Net Sales or Net receipts of the Licensed Products in the Product Regulatory Category of prescription drugs. The Company will pay the amounts payable on a quarterly basis within 60 days of the end of each calendar quarter.&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;div&gt;
              &lt;div&gt;
                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Heritage Building Restoration Commitment&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company has a commitment to restore the designated heritage building on the Company's premises. The estimated commitment of remaining restoration work to be completed is $266,349.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Contingencies&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Legal matters&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;From time to time, the Company is named as a party to claims or involved in proceedings, including legal, regulatory and tax related, in the ordinary course of its business. While the outcome of these matters may not be estimable at the reporting date, the Company makes provisions, where possible, for the estimated outcome of such claims or proceedings. Should a loss result from the resolution of any claims or proceedings that differs from these estimates, the difference will be accounted for as a charge to profit or loss in that period.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Environmental &lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Management believes that there are no probable environmental related liabilities that will have a material adverse effect on the financial position or operating results of the Company.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Claims from suppliers &lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;A dismissed contractor commenced a lien action combined with a breach of contract action in the Cobourg Superior Court of Justice in early 2019 claiming approximately C$1,700,000 in various purported damages, with the claim for lien component of C$188,309 being registered on November 26, 2018. The Company has paid C$235,387 to the Cobourg Superior Court to vacate the lien from title for which the funds stand both as security for the lien claim as well as its costs with the Cobourg Superior Court of Justice.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On October 7, 2020, FSD signed a settlement agreement of C$198,000. On December 16, 2020, the settlement was paid from funds paid into court and the remaining balance was remitted to the Company in accordance with the settlement agreement.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Former employee &lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;FSD hired an individual by way of employment agreement. The individual's employment was subsequently terminated in the probationary period due to non-performance/cause in February 2019. The individual retained legal counsel in or around February 15, 2019 demanding that he be provided (i) unpaid wages; (ii) unpaid holiday pay, (iii) payment for wrongful dismissal (one week) and (iv) breach of contract.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company has a provision of $81,562 (&amp;#xa3;59,748) in relation to the claimed amounts for unpaid wages and unpaid holiday pay.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On July 29, 2020, a judgment was issued ordering the Company to pay unpaid wages and unpaid holiday pay in the amount of &amp;#xa3;59,748. On August 6, 2020, the Company filed an application for reconsideration for that decision which was refused by the Tribunal on October 24, 2020.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/div&gt;
            &lt;/div&gt;
            &lt;div&gt;
              &lt;div&gt;
                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On August 25, 2020, the Claimant filed a separate cost order against the Company. To date, the Tribunal has not responded to this matter. The ultimate outcome of the matter cannot be reliably determined at this time and no additional provision has been recorded for this matter as at December 31, 2020.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Class Action &lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On February 22, 2019, a shareholder in FSD commenced a proposed class action proceeding against the Company by issuing a statement of claim in the Ontario Superior Court. Amongst other causes of action, the individual seeks leave to bring a claim pursuant to s.138 of the Ontario Securities Act, alleging the Company made statements containing misrepresentations related to the build-out of the Company's Cobourg facility.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company has settled the class action by entering into a definitive settlement agreement in the amount of C$5.5M. In entering into the Settlement Agreement, the Company made no admissions of liability whatsoever. The Settlement Agreement provides for a full and final release of the Company, its officers, directors and various other related parties from any and all claims that arose or could have arisen from the claim issued by the plaintiff within the Settled Action.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During November 2020, the Company paid C$928,541 as part of the settlement with the remaining amount of C$4,571,459 covered by the Company's insurance policy. The Settlement Agreement was approved in the Superior Court of Justice of Ontario on February 4, 2021.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Auxly Cannabis Group Inc. &lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On March 3, 2018, FSD entered into a Definitive Strategic Alliance and Streaming Agreement (the "Agreement") with Auxly Cannabis Group Inc. ("Auxly"). On February 6, 2019, the Company delivered to Auxly a Notice of Default, thereby terminating the Agreement effective immediately. Subsequent to the issuance of the Notice of Default, Auxly sent a Notice of Default to the Company on February 6, 2019 in response. To date, neither party has taken further legal action against the counter party.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;To fund the development, Auxly purchased 37,313 Class B shares for the aggregate of $5,642,250 from the Company's treasury by way of private placement, which funds were placed in trust to be spent on construction and development costs. The funds were placed in a trust account to be administered by Auxly. Due to the termination and subsequent negotiations, it is indeterminable at this point as to the amount, if any, of these funds will be released to the Company. Should any funds be released to the Company, those amounts will be recognized in future periods.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    </ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory>
  <huge:NonRefundableSumDueAndPayableUponFirstNotificationOfFda contextRef="C_20201231_hugeTypeOfArrangementsAxis_hugeEpitechLicenseAgreementMember" decimals="0" id="Fxbrl_20210224114114683" unitRef="USD">700000</huge:NonRefundableSumDueAndPayableUponFirstNotificationOfFda>
  <huge:NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFda contextRef="C_20201231_hugeTypeOfArrangementsAxis_hugeEpitechLicenseAgreementMember" decimals="0" id="Fxbrl_20210224114130438" unitRef="USD">1000000</huge:NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFda>
  <huge:PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights contextRef="C_20201231_hugeTypeOfArrangementsAxis_hugeEpitechLicenseAgreementMember" decimals="2" id="Fxbrl_20210224114159123" unitRef="Pure">0.25</huge:PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights>
  <huge:PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights contextRef="C_20201231_hugeTypeOfArrangementsAxis_hugeEpitechLicenseAgreementMember" decimals="2" id="Fxbrl_20210224114217930" unitRef="Pure">0.05</huge:PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights>
  <huge:PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition contextRef="C_20200101to20201231_hugeTypeOfArrangementsAxis_hugeEpitechLicenseAgreementMember" decimals="2" id="Fxbrl_20210224114238907" unitRef="Pure">0.07</huge:PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition>
  <huge:PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition contextRef="C_20200101to20201231_hugeTypeOfArrangementsAxis_hugeEpitechLicenseAgreementMember" decimals="2" id="Fxbrl_20210224114248360" unitRef="Pure">0.25</huge:PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition>
  <huge:PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition contextRef="C_20200101to20201231_hugeTypeOfArrangementsAxis_hugeEpitechLicenseAgreementMember" decimals="2" id="Fxbrl_20210224114304418" unitRef="Pure">0.05</huge:PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition>
  <huge:EstimatedCostOfRestorationInCommitment contextRef="C_20200101to20201231_hugeTypeOfArrangementsAxis_hugeHeritageBuildingRestorationCommitmentMember" decimals="0" id="Fxbrl_20210224114755995" unitRef="USD">266349</huge:EstimatedCostOfRestorationInCommitment>
  <huge:ClaimIssuedByContractorForVariousPurportedDamages contextRef="C_20200101to20201231_ifrsfullClassesOfContingentLiabilitiesAxis_ifrsfullLegalProceedingsContingentLiabilityMember" decimals="0" id="Fxbrl_20210224114906188" unitRef="CAD">1700000</huge:ClaimIssuedByContractorForVariousPurportedDamages>
  <huge:ClaimForLienComponent contextRef="C_20200101to20201231_ifrsfullClassesOfContingentLiabilitiesAxis_ifrsfullLegalProceedingsContingentLiabilityMember" decimals="0" id="Fxbrl_20210224114946179" unitRef="CAD">188309</huge:ClaimForLienComponent>
  <huge:SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees contextRef="C_20200101to20201231_ifrsfullClassesOfContingentLiabilitiesAxis_ifrsfullLegalProceedingsContingentLiabilityMember" decimals="0" id="Fxbrl_20210224115019972" unitRef="CAD">235387</huge:SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees>
  <huge:FundsPaidForSettlementAgreement contextRef="C_20200101to20201231_ifrsfullClassesOfContingentLiabilitiesAxis_ifrsfullLegalProceedingsContingentLiabilityMember" decimals="0" id="Fxbrl_20210224135737968" unitRef="CAD">198000</huge:FundsPaidForSettlementAgreement>
  <huge:ProvisionForEmployeeRelatedLiability contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224115322004" unitRef="USD">81562</huge:ProvisionForEmployeeRelatedLiability>
  <huge:ProvisionForEmployeeRelatedLiability contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224115326794" unitRef="EUR">59748</huge:ProvisionForEmployeeRelatedLiability>
  <huge:PaymentMadeToBeUnpaidWagesAndUnpaidHoliday contextRef="C_20200701to20200729" decimals="0" id="Fxbrl_20210224125952979" unitRef="EUR">59748</huge:PaymentMadeToBeUnpaidWagesAndUnpaidHoliday>
  <huge:PartialPaymentOfSettlementAmount contextRef="C_20200101to20201231_hugeTypeOfArrangementsAxis_hugeDefinitiveSettlementAgreementMember" decimals="0" id="Fxbrl_20210224130729944" unitRef="CAD">928541</huge:PartialPaymentOfSettlementAmount>
  <huge:ClaimSettlementAmountCoveredByInsurance contextRef="C_20200101to20201231_hugeTypeOfArrangementsAxis_hugeDefinitiveSettlementAgreementMember" decimals="0" id="Fxbrl_20210224130735345" unitRef="CAD">4571459</huge:ClaimSettlementAmountCoveredByInsurance>
  <huge:NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement contextRef="C_20200101to20201231_hugeTypeOfArrangementsAxis_hugeDefinitiveStrategicAllianceAndStreamingAgreementMember_ifrsfullClassesOfContingentLiabilitiesAxis_hugeContingentLiabilityForConstructionAndDevelopmentCostsMember_ifrsfullCounterpartiesAxis_hugeAuxlyCannabisGroupIncMember" decimals="0" id="Fxbrl_20210224130836877" unitRef="shares">37313</huge:NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement>
  <huge:AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement contextRef="C_20200101to20201231_hugeTypeOfArrangementsAxis_hugeDefinitiveStrategicAllianceAndStreamingAgreementMember_ifrsfullClassesOfContingentLiabilitiesAxis_hugeContingentLiabilityForConstructionAndDevelopmentCostsMember_ifrsfullCounterpartiesAxis_hugeAuxlyCannabisGroupIncMember" decimals="0" id="Fxbrl_20210224130854795" unitRef="USD">5642250</huge:AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement>
  <ifrs-full:DisclosureOfRelatedPartyExplanatory contextRef="C_20200101to20201231" id="F9fd98af0-52f9-11ea-80c4-2d332cd66d90">
    &lt;p style="text-align:justify"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;19.&lt;span style="width:5.25pt;display:inline-block"&gt; &lt;/span&gt;Related party transactions&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
    &lt;div style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:start;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Key management personnel are those persons having the authority and responsibility for planning, directing and controlling activities of the entity, directly or indirectly.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Transactions with key management and directors comprised the following:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:36pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:14pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;The Company paid expenses of $1,445,043 (2019 - $567,468) to a company owned by the CEO for the year ended December 31, 2020, included in the consolidated statement of loss and comprehensive loss under various expense line categories. As at December 31, 2020, the CEO has repaid a related party loan of $355,778 for withholding taxes paid by the Company on behalf of the CEO in relation to the Class B common shares issued during the year ended December 31, 2020.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:36pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:14pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;As at December 31, 2020, the President of FSD BioSciences Division has repaid a related party loan of $21,876 for withholding taxes paid by the Company on behalf of the President of FSD BioSciences Division in relation to the Class B common shares issued during the year ended December 31, 2020.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:36pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:14pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;The Company pays independent directors C$40,000 per annum, with the Chairman of each respective committee receiving an additional C$10,000 per annum. Directors compensation for the year ended December 31, 2020 was $246,226 (2019 - $153,109) which included $238,703 recognized as share-based compensation. As of December 31, 2020, directors have received their compensation for the 2020 fiscal year in advance, through the issuance of Class B shares.&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:36pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:14pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;The Company issued 1,676,066 shares to key management and directors in the form of a compensation bonus for past services provided during the year ended December 31, 2020. The fair value of shares issued to key management and directors is $4,602,301 and is included in share-based payments and bonuses below.&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
    &lt;div style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:start;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;
      &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Key management personnel compensation during the year ended December 31, 2020 and 2019 is comprised of:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;

        &lt;div&gt;
          &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;
          &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-right:auto"&gt;
            &lt;tbody&gt;
              &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2020&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                &lt;td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Salaries, benefits, bonuses and consulting fees&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,936,816&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,638,267&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;padding-left:1.5pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based payments&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,045,994&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,385,984&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                &lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;padding-left:1.5pt;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;Total&lt;/strong&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;9,982,810&lt;/strong&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;13,024,251&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
            &lt;/tbody&gt;
          &lt;/table&gt;
        &lt;/div&gt;

    &lt;/div&gt;
  </ifrs-full:DisclosureOfRelatedPartyExplanatory>
  <huge:PaymentOfExpenses contextRef="C_20200101to20201231_ifrsfullCategoriesOfRelatedPartiesAxis_hugeChiefExecutiveOfficersMember" decimals="0" id="Fxbrl_20210223103256263" unitRef="USD">1445043</huge:PaymentOfExpenses>
  <huge:PaymentOfExpenses contextRef="C_20190102to20191231_ifrsfullCategoriesOfRelatedPartiesAxis_hugeChiefExecutiveOfficersMember" decimals="0" id="Fxbrl_20210223103300280" unitRef="USD">567468</huge:PaymentOfExpenses>
  <ifrs-full:AmountsPayableRelatedPartyTransactions contextRef="C_20201231_ifrsfullCategoriesOfRelatedPartiesAxis_hugeChiefExecutiveOfficersMember" decimals="0" id="Fxbrl_20210224200510550" unitRef="USD">355778</ifrs-full:AmountsPayableRelatedPartyTransactions>
  <ifrs-full:AmountsPayableRelatedPartyTransactions contextRef="C_20201231_deiLegalEntityAxis_hugeFSDBiosciencesMember_ifrsfullCategoriesOfRelatedPartiesAxis_hugePresidentOfFSDMember" decimals="0" id="Fxbrl_20210223111511863" unitRef="USD">21876</ifrs-full:AmountsPayableRelatedPartyTransactions>
  <ifrs-full:DirectorsRemunerationExpense contextRef="C_20200101to20201231_ifrsfullCategoriesOfRelatedPartiesAxis_hugeIndependentDirectorMember" decimals="0" id="Fxbrl_20210223103718563" unitRef="CAD">40000</ifrs-full:DirectorsRemunerationExpense>
  <ifrs-full:DirectorsRemunerationExpense contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210223103939570" unitRef="USD">246226</ifrs-full:DirectorsRemunerationExpense>
  <ifrs-full:DirectorsRemunerationExpense contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20210223103943046" unitRef="USD">153109</ifrs-full:DirectorsRemunerationExpense>
  <huge:AdditionalRemuneration contextRef="C_20200101to20201231_ifrsfullCategoriesOfRelatedPartiesAxis_hugeIndependentDirectorMember" decimals="0" id="Fxbrl_20210223103759448" unitRef="CAD">10000</huge:AdditionalRemuneration>
  <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="C_20200101to20201231_ifrsfullCategoriesOfRelatedPartiesAxis_hugePresidentsMember" decimals="0" id="Fxbrl_20210223104049692" unitRef="USD">238703</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
  <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="C_20200101to20201231_ifrsfullCategoriesOfRelatedPartiesAxis_hugeKeyManagementAndDirectorsMember" decimals="0" id="Fxbrl_20210224200110081" unitRef="USD">4602301</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
  <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20200220164515570" unitRef="USD">7045994</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
  <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20200220164547955" unitRef="USD">9385984</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
  <huge:NumberOfSharesIssuedForCompensationBonus contextRef="C_20200101to20201231_ifrsfullCategoriesOfRelatedPartiesAxis_hugeKeyManagementAndDirectorsMember" decimals="INF" id="Fxbrl_20210223104516313" unitRef="shares">1676066</huge:NumberOfSharesIssuedForCompensationBonus>
  <ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20200220164842801">
        &lt;div&gt;
          &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;
          &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-right:auto"&gt;
            &lt;tbody&gt;
              &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                &lt;td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2020&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2019&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                &lt;td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Salaries, benefits, bonuses and consulting fees&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,936,816&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,638,267&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;padding-left:1.5pt;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based payments&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,045,994&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:17%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,385,984&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(230, 239, 255)"&gt;
                &lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;padding-left:1.5pt;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;Total&lt;/strong&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;9,982,810&lt;/strong&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;13,024,251&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
            &lt;/tbody&gt;
          &lt;/table&gt;
        &lt;/div&gt;
      </ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory>
  <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20200220164402824" unitRef="USD">2936816</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
  <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20200220164450330" unitRef="USD">3638267</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
  <ifrs-full:KeyManagementPersonnelCompensation contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20200228114631028" unitRef="USD">9982810</ifrs-full:KeyManagementPersonnelCompensation>
  <ifrs-full:KeyManagementPersonnelCompensation contextRef="C_20190102to20191231" decimals="0" id="Fxbrl_20200228114652381" unitRef="USD">13024251</ifrs-full:KeyManagementPersonnelCompensation>
  <ifrs-full:DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory contextRef="C_20200101to20201231" id="F9fd915c1-52f9-11ea-80c4-2d332cd66d90">
    &lt;p style="text-align:justify"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20.&lt;span style="width:5.25pt;display:inline-block"&gt; &lt;/span&gt;Capital Management&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
    &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify"&gt;The Company's capital management objectives are to maintain financial flexibility in order to complete the pharmaceutical research and development program centered on the lead asset, micro-PEA. The Company defines capital as the aggregate of its capital stock and borrowings.&lt;/p&gt;
    &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;
    &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;As at December 31, 2020, the Company's Share Capital was&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt; $103,208,126 (2019&amp;#160;- $73,737,925)&amp;#160;&lt;/span&gt;&lt;/span&gt;The Company does not have any long-term debt. Outstanding Notes payable were assumed on acquisition of Prismic and are due on demand.&lt;/p&gt;
    &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"&gt;&amp;#160;&lt;/p&gt;
    &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify"&gt;The Company manages its capital structure in accordance with changes in economic conditions. In order to maintain or adjust its capital structure, the Company may elect to issue or repay financial liabilities, issue shares, repurchase shares or undertake any other activities as deemed appropriate under the specific circumstances. The Company is not subject to any externally imposed capital requirements.&lt;/p&gt;
  </ifrs-full:DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory>
  <ifrs-full:DisclosureOfFinancialInstrumentsExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20200220043414270">
    &lt;div&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;21.&lt;/strong&gt;&lt;span style="width:5.49pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;&lt;strong&gt;Financial Instruments and Risk Management&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Credit risk&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Credit risk is the risk of financial loss to the Company if a customer or counterparty to a financial instrument fails to meet its contractual obligations, and arises principally from deposits with banks and outstanding receivables. The Company trades only with recognized, creditworthy third parties. The Company does not currently have any material outstanding trade receivables with customers.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company does not hold any collateral as security but mitigates this risk by dealing only with what management believes to be financially sound counterparties and, accordingly, does not anticipate significant loss for non-performance.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Liquidity risk&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Liquidity risk is the risk the Company will not be able to meet its financial obligations as they come due. The Company's exposure to liquidity risk is dependent on the Company's ability to raise additional financing to meet its commitments and sustain operations. The Company mitigates liquidity risk by management of working capital, cash flows, the issuance of share capital and if desired, the issuance of debt. The Company's trade and other payables and notes payables are all due within twelve months from the date of these financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;If unanticipated events occur that impact the Company's ability to carrying the planned clinical trials, the Company may need to take additional measures to increase its liquidity and capital resources, including issuing debt or additional equity financing or strategically altering the business forecast and plan. In this case, there is no guarantee that the Company will obtain satisfactory financing terms or adequate financing. Failure to obtain adequate financing on satisfactory terms could have a material adverse effect on the Company's results of operations or financial condition.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Market risk&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Market risk is the risk the fair value or future cash flows of a financial instrument will fluctuate because of changes in market prices. Market risk comprises three types of risk: foreign currency risk, interest rate risk and other price risk.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:32.85pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Foreign currency risk&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign currency risk arises on financial instruments that are denominated in a currency other than the functional currency in which they are measured. The Company's primary exposure with respect to foreign currencies is from Canadian dollar denominated cash and other payables. A 1% change in the foreign exchange rates would not result in any significant impact to the financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:32.85pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Interest rate risk&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Interest rate risk is the risk the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company is not exposed to interest rate risk as at December 31, 2020 as there are no material long-term borrowings outstanding.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:32.85pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Other price risk&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other price risk is the risk the fair value or future cash flows of a financial instrument will fluctuate because of changes in market prices (other than those arising from interest rate risk or currency risk), whether those changes are caused by factors specific to the individual financial instrument or its issuer, or factors affecting all similar financial instruments traded in the market. The Company is not exposed to other price risk as at December 31, 2020.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Fair values&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The carrying values of cash, other receivables, trade and other payables and notes payable approximate fair values due to the short-term nature of these items or they are being carried at fair value or, for notes payable, interest payables are close to the current market rates. The risk of material change in fair value is not considered to be significant. The Company does not use derivative financial instruments to manage this risk.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial instruments recorded at fair value on the consolidated statement of financial position are classified using a fair value hierarchy that reflects the significance of the inputs used in making the measurements. The Company categorizes its fair value measurements according to a three-level hierarchy. The hierarchy prioritizes the inputs used by the Company's valuation techniques. A level is assigned to each fair value measurement based on the lowest-level input significant to the fair value measurement in its entirety. The three levels of the fair value hierarchy are defined as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:72pt;text-indent:-36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:32.85pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Level 1 - Unadjusted quoted prices as at the measurement date for identical assets or liabilities in active markets.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:72pt;text-indent:-36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:32.85pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Level 2 - Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:72pt;text-indent:-36pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2022;&lt;span style="width:32.85pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;Level 3 - Significant unobservable inputs that are supported by little or no market activity. The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The fair value hierarchy requires the use of observable market inputs whenever such inputs exist. A financial instrument is classified to the lowest level of the hierarchy for which a significant input has been considered in measuring fair value.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Private company investments measured at fair value are classified as Level 3 financial instruments. The valuation method and significant assumptions used to determine the fair value of private company investments have been disclosed in the Investments note. During the year, there were no transfers of amounts between levels.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </ifrs-full:DisclosureOfFinancialInstrumentsExplanatory>
  <ifrs-full:DisclosureOfOperatingSegmentsExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20200228002343318">
    &lt;div&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;22.&lt;/strong&gt;&lt;span style="width:5.49pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;&lt;strong&gt;Segmented information&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company reports segment information based on internal reports used by the chief operating decision maker ("CODM") to make operating and resource decisions and to assess performance. The CODM is the Chief Executive Officer of the Company. The CODM makes decisions and assesses performance of the Company on a consolidated basis such that the Company is a single reportable operating segment.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </ifrs-full:DisclosureOfOperatingSegmentsExplanatory>
  <ifrs-full:DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20210224185112612">
      &lt;div&gt;
        &lt;p style="margin-top:0pt;margin-left:24px;margin-bottom:0pt;text-align:justify;text-indent:-18pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&lt;strong&gt;5.&lt;/strong&gt;&lt;span style="width:10.49pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;&lt;strong&gt;Assets held for sale&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin:0pt"&gt;&amp;#160;&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;In March 2020, the Company decided to focus its efforts and resources on the pharmaceutical business and initiated the process to sell its Cobourg facility and exit the medical cannabis industry. The Company expects that the sale of the facility will be completed within the next twelve months and is actively marketing the facility for sale.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin:0pt"&gt;&amp;#160;&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;Assets held for sale consists of the Cobourg facility. It is anticipated that no liabilities of the Company will be transferred as part of any proposed transaction. Results of operations related to the Cobourg facility are reported as discontinued operations for the years ended December 31, 2020 and 2019.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin:0pt"&gt;&amp;#160;&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;In accordance with IFRS 5 -&amp;#160;&lt;i&gt;Non-current Assets Held for Sale and Discontinued Operations&lt;/i&gt;, the assets held for sale were assessed for impairment based on fair value less costs to sell. The fair value was measured using the price at which the Company expects to receive for the disposal of the Cobourg facility in its current state less estimates for the costs of disposal. The fair value less costs to sell was higher than the carrying value of the Cobourg Facility resulting in recognition of the resulting group at carrying value.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin:0pt"&gt;&amp;#160;&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;Assets held for sale as at December 31, 2020 consisted of the following:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

          &lt;div&gt;
            &lt;p style="margin:0pt"&gt;&amp;#160;&lt;/p&gt;
            &lt;table style="font-family:Times New Roman;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial;width:100%;border-collapse:collapse;font-size:13px;border:0px"&gt;
              &lt;tbody&gt;
                &lt;tr&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property and plant&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,610,504&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
              &lt;/tbody&gt;
            &lt;/table&gt;
          &lt;/div&gt;

        &lt;p style="margin:0pt"&gt;&amp;#160;&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;During the year ended December 31, 2020, the Company sold equipment for proceeds of $36,616 resulting in a loss on sale of $100,337. As part of the sale of equipment the Company also sold all remaining inventory for $1 and recognized a loss on sale of inventory of $197,436 during the year ended December 31, 2020. As FV Pharma surrendered its cannabis license in September 2020, the Company determined that the carrying value of the remaining equipment was not recoverable resulting in recognition of impairment loss of $387,474 for the year ended December 31, 2020.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin:0pt"&gt;&amp;#160;&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;Net loss and comprehensive loss from discontinued operations for the year ended December 31, 2020 and 2019 is comprised of the following:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin:0pt"&gt;&amp;#160;&lt;/p&gt;
        &lt;/div&gt;

          &lt;table style="font-family:Times New Roman;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial;width:100%;border-collapse:collapse;font-size:13px;border:0px"&gt;
            &lt;tbody&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td colspan="1" style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td colspan="4" style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;For the year ended December 31,&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td colspan="1" style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Notes&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="text-align:right;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2020&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="text-align:right;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Revenue&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14,514&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;193,416&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cost of revenue&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,032,010&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,473,839&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Gross loss before fair value adjustments&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,017,496&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,280,423&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value adjustments on inventory sold&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(945&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,738&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Unrealized loss on changes in fair value of biological assets&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;166,886&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;513,625&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Gross loss&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,183,437&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,810,786&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Expenses&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;General and administrative&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,665,541&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,735,286&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation and amortization&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;90,340&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;424,199&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment of property, plant and equipment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;387,474&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;132,273&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Total operating expenses&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,143,355&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,291,758&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Loss from discontinued operations&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,326,792&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,102,544&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other income&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(79,568&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(53,987&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss on sale of equipment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100,337&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Net loss from discontinued operations&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,347,561&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,048,557&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
            &lt;/tbody&gt;
          &lt;/table&gt;

        &lt;p style="margin:0pt"&gt;&amp;#160;&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;Cash flows from discontinued operations for the year ended December 31, 2020 and 2019 are comprised of the following:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin:0pt"&gt;&amp;#160;&lt;/p&gt;

          &lt;table style="font-family:Times New Roman;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial;width:100%;border-collapse:collapse;font-size:13px;border:0px"&gt;
            &lt;tbody&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="text-align:right;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2020&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="text-align:right;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Operating activities&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net loss from discontinued operations&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(3,347,561&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,048,557&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Add (deduct) items not affecting cash&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160; Depreciation and amortization&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;108,209&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;424,199&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td colspan="1" style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160; Change in fair value adjustments on inventory sold&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(945&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,738&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160; Impairment of inventory&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;534,814&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td colspan="1" style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160; Impairment of property, plant and equipment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;387,474&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160; Change in fair value of biological assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;166,886&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;513,625&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160; Loss on disposal of inventory&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;197,436&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160; Loss on sale of equipment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;100,337&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td colspan="1" style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Changes in non-cash working capital balances&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160; Trade and other receivables&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;960,778&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(423,945&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160; Prepaid expenses and deposits&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;279,870&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;54,226&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160; Inventories&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(21,932&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(709,373&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160; Biological assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(166,886&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(513,625&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160; Trade and other payables&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;63,861&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(895,286&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Cash used in operating activities&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:157px;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(737,659&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:24px;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:157px;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(6,581,998&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:24px;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Investing activities&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Purchase of property, plant and equipment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&amp;#x2014;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(401,817&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Proceeds from sale of equipment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;36,616&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td colspan="1" style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Cash provided by (used in) investing activities&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;36,616&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(401,817&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
            &lt;/tbody&gt;
          &lt;/table&gt;

      </ifrs-full:DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory>
  <huge:ScheduleOfComponentsOfAssetsHeldForSaleExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20210224183023523">
          &lt;div&gt;
            &lt;p style="margin:0pt"&gt;&amp;#160;&lt;/p&gt;
            &lt;table style="font-family:Times New Roman;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial;width:100%;border-collapse:collapse;font-size:13px;border:0px"&gt;
              &lt;tbody&gt;
                &lt;tr&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property and plant&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,610,504&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;/tr&gt;
              &lt;/tbody&gt;
            &lt;/table&gt;
          &lt;/div&gt;
        </huge:ScheduleOfComponentsOfAssetsHeldForSaleExplanatory>
  <huge:ProceedsFromSalesOfInventory contextRef="C_20200101to20201231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224182135977" unitRef="USD">1</huge:ProceedsFromSalesOfInventory>
  <huge:LossOnSaleOfInventory contextRef="C_20200101to20201231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210226150351966" unitRef="USD">197436</huge:LossOnSaleOfInventory>
  <huge:ScheduleOfNetLossAndComprehensiveLossFromDiscontinuedOperationsExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20210224183111589">
          &lt;table style="font-family:Times New Roman;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial;width:100%;border-collapse:collapse;font-size:13px;border:0px"&gt;
            &lt;tbody&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td colspan="1" style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td colspan="4" style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;For the year ended December 31,&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td colspan="1" style="text-align:center;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Notes&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="text-align:right;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2020&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="text-align:right;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Revenue&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14,514&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;193,416&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cost of revenue&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,032,010&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,473,839&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Gross loss before fair value adjustments&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,017,496&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,280,423&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value adjustments on inventory sold&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(945&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,738&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Unrealized loss on changes in fair value of biological assets&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;166,886&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;513,625&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Gross loss&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,183,437&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,810,786&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Expenses&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;General and administrative&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,665,541&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,735,286&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation and amortization&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;90,340&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;424,199&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment of property, plant and equipment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;387,474&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;132,273&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Total operating expenses&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,143,355&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,291,758&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Loss from discontinued operations&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,326,792&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,102,544&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other income&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(79,568&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(53,987&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss on sale of equipment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100,337&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Net loss from discontinued operations&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,347,561&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,048,557&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
            &lt;/tbody&gt;
          &lt;/table&gt;
        </huge:ScheduleOfNetLossAndComprehensiveLossFromDiscontinuedOperationsExplanatory>
  <ifrs-full:Revenue contextRef="C_20200101to20201231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224174851354_43" unitRef="USD">14514</ifrs-full:Revenue>
  <ifrs-full:Revenue contextRef="C_20190102to20191231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224174851354_46" unitRef="USD">193416</ifrs-full:Revenue>
  <ifrs-full:CostOfSales contextRef="C_20200101to20201231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224174851354_63" unitRef="USD">1032010</ifrs-full:CostOfSales>
  <ifrs-full:CostOfSales contextRef="C_20190102to20191231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224174851354_66" unitRef="USD">1473839</ifrs-full:CostOfSales>
  <huge:GrossProfitLossBeforeFairValueAdjustments contextRef="C_20200101to20201231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224174851354_73" unitRef="USD">-1017496</huge:GrossProfitLossBeforeFairValueAdjustments>
  <huge:GrossProfitLossBeforeFairValueAdjustments contextRef="C_20190102to20191231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224174851354_76" unitRef="USD">-1280423</huge:GrossProfitLossBeforeFairValueAdjustments>
  <huge:FairValueAdjustmentsOnInventorySold contextRef="C_20200101to20201231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224174851354_83" unitRef="USD">-945</huge:FairValueAdjustmentsOnInventorySold>
  <huge:FairValueAdjustmentsOnInventorySold contextRef="C_20190102to20191231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224174851354_86" unitRef="USD">16738</huge:FairValueAdjustmentsOnInventorySold>
  <ifrs-full:GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets contextRef="C_20200101to20201231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224174851354_93" unitRef="USD">-166886</ifrs-full:GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets>
  <ifrs-full:GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets contextRef="C_20190102to20191231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224174851354_96" unitRef="USD">-513625</ifrs-full:GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets>
  <ifrs-full:GrossProfit contextRef="C_20200101to20201231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224174851354_103" unitRef="USD">-1183437</ifrs-full:GrossProfit>
  <ifrs-full:GrossProfit contextRef="C_20190102to20191231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224174851354_106" unitRef="USD">-1810786</ifrs-full:GrossProfit>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="C_20200101to20201231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224174851354_153" unitRef="USD">387474</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="C_20190102to20191231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224174851354_156" unitRef="USD">132273</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
  <ifrs-full:OperatingExpense contextRef="C_20200101to20201231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224174851354_163" unitRef="USD">2143355</ifrs-full:OperatingExpense>
  <ifrs-full:OperatingExpense contextRef="C_20190102to20191231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224174851354_166" unitRef="USD">3291758</ifrs-full:OperatingExpense>
  <huge:ProfitLossBeforeOtherIncomeAndGainLossOnSaleOfEquipmentFromDiscontinuedOperations contextRef="C_20200101to20201231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224174851354_183" unitRef="USD">-3326792</huge:ProfitLossBeforeOtherIncomeAndGainLossOnSaleOfEquipmentFromDiscontinuedOperations>
  <huge:ProfitLossBeforeOtherIncomeAndGainLossOnSaleOfEquipmentFromDiscontinuedOperations contextRef="C_20190102to20191231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224174851354_186" unitRef="USD">-5102544</huge:ProfitLossBeforeOtherIncomeAndGainLossOnSaleOfEquipmentFromDiscontinuedOperations>
  <huge:LossOnSaleOfEquipment contextRef="C_20200101to20201231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224174851354_213" unitRef="USD">100337</huge:LossOnSaleOfEquipment>
  <huge:LossOnSaleOfEquipment contextRef="C_20190102to20191231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224174851354_216" unitRef="USD">0</huge:LossOnSaleOfEquipment>
  <huge:ScheduleOfCashFlowsFromDiscontinuedOperationsExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20210224183140181">
          &lt;table style="font-family:Times New Roman;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial;width:100%;border-collapse:collapse;font-size:13px;border:0px"&gt;
            &lt;tbody&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="text-align:right;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2020&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="text-align:right;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2019&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Operating activities&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net loss from discontinued operations&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(3,347,561&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,048,557&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Add (deduct) items not affecting cash&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160; Depreciation and amortization&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;108,209&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;424,199&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td colspan="1" style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160; Change in fair value adjustments on inventory sold&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(945&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,738&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160; Impairment of inventory&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;534,814&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td colspan="1" style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160; Impairment of property, plant and equipment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;387,474&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160; Change in fair value of biological assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;166,886&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;513,625&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160; Loss on disposal of inventory&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;197,436&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160; Loss on sale of equipment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;100,337&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td colspan="1" style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Changes in non-cash working capital balances&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160; Trade and other receivables&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;960,778&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(423,945&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160; Prepaid expenses and deposits&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;279,870&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;54,226&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160; Inventories&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(21,932&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(709,373&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160; Biological assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(166,886&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(513,625&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#160; Trade and other payables&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;63,861&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(895,286&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Cash used in operating activities&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:157px;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(737,659&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:24px;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:157px;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(6,581,998&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:2px solid #000000;vertical-align:bottom;width:24px;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Investing activities&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Purchase of property, plant and equipment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&amp;#x2014;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(401,817&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Proceeds from sale of equipment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;36,616&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left"&gt;&amp;#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td colspan="1" style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Cash provided by (used in) investing activities&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;36,616&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff"&gt;&amp;#160;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(401,817&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
            &lt;/tbody&gt;
          &lt;/table&gt;
        </huge:ScheduleOfCashFlowsFromDiscontinuedOperationsExplanatory>
  <ifrs-full:AdjustmentsForDepreciationExpense contextRef="C_20200101to20201231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224175956106_52" unitRef="USD">108209</ifrs-full:AdjustmentsForDepreciationExpense>
  <ifrs-full:AdjustmentsForDepreciationExpense contextRef="C_20190102to20191231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224175956106_55" unitRef="USD">424199</ifrs-full:AdjustmentsForDepreciationExpense>
  <huge:AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold contextRef="C_20200101to20201231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224175956106_62" unitRef="USD">-945</huge:AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold>
  <huge:AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold contextRef="C_20190102to20191231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224175956106_65" unitRef="USD">16738</huge:AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold>
  <ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossInventories contextRef="C_20200101to20201231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224175956106_72" unitRef="USD">534814</ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossInventories>
  <ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossInventories contextRef="C_20190102to20191231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224175956106_75" unitRef="USD">0</ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossInventories>
  <ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="C_20200101to20201231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224175956106_82" unitRef="USD">387474</ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
  <ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="C_20190102to20191231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224175956106_85" unitRef="USD">0</ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
  <ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets contextRef="C_20200101to20201231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224175956106_92" unitRef="USD">166886</ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets>
  <ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets contextRef="C_20190102to20191231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224175956106_95" unitRef="USD">513625</ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets>
  <huge:AdjustmentsForLossesGainsOnDisposalOfInventory contextRef="C_20200101to20201231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224175956106_102" unitRef="USD">197436</huge:AdjustmentsForLossesGainsOnDisposalOfInventory>
  <huge:AdjustmentsForLossesGainsOnDisposalOfInventory contextRef="C_20190102to20191231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224175956106_105" unitRef="USD">0</huge:AdjustmentsForLossesGainsOnDisposalOfInventory>
  <huge:AdjustmentsForLossesGainsOnDisposalOfEquipment contextRef="C_20200101to20201231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224175956106_112" unitRef="USD">100337</huge:AdjustmentsForLossesGainsOnDisposalOfEquipment>
  <huge:AdjustmentsForLossesGainsOnDisposalOfEquipment contextRef="C_20190102to20191231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224175956106_115" unitRef="USD">0</huge:AdjustmentsForLossesGainsOnDisposalOfEquipment>
  <huge:AdjustmentsForIncreaseDecreaseInPrepaidExpensesAndDeposits contextRef="C_20200101to20201231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224175956106_142" unitRef="USD">279870</huge:AdjustmentsForIncreaseDecreaseInPrepaidExpensesAndDeposits>
  <huge:AdjustmentsForIncreaseDecreaseInPrepaidExpensesAndDeposits contextRef="C_20190102to20191231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224175956106_145" unitRef="USD">54226</huge:AdjustmentsForIncreaseDecreaseInPrepaidExpensesAndDeposits>
  <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories contextRef="C_20200101to20201231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224175956106_152" unitRef="USD">-21932</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
  <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories contextRef="C_20190102to20191231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224175956106_155" unitRef="USD">-709373</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
  <ifrs-full:AdjustmentsForDecreaseIncreaseInBiologicalAssets contextRef="C_20200101to20201231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224175956106_162" unitRef="USD">-166886</ifrs-full:AdjustmentsForDecreaseIncreaseInBiologicalAssets>
  <ifrs-full:AdjustmentsForDecreaseIncreaseInBiologicalAssets contextRef="C_20190102to20191231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224175956106_165" unitRef="USD">-513625</ifrs-full:AdjustmentsForDecreaseIncreaseInBiologicalAssets>
  <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="C_20200101to20201231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224175956106_212" unitRef="USD">0</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
  <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="C_20190102to20191231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224175956106_215" unitRef="USD">401817</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
  <ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="C_20200101to20201231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224175956106_222" unitRef="USD">36616</ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
  <ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="C_20190102to20191231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullDisposalGroupsClassifiedAsHeldForSaleMember" decimals="0" id="Fxbrl_20210224175956106_225" unitRef="USD">0</ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
  <huge:DisclosureOfWarrantLiabilitiesExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20210224165009096">
      &lt;div&gt;
        &lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;12.&lt;/strong&gt;&lt;span style="width:5.49pt;text-indent:0pt;display:inline-block"&gt;&amp;#160;&lt;/span&gt;&lt;strong&gt;Warrants Liability&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left"&gt;&amp;#160; &amp;#160;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In August 2020, the Company issued 2,762,430 Class B Common Shares and 1,381,215 warrants to purchase Class B Shares for total cash proceeds of $9,999,997. Each warrant is exercisable to purchase one Class B Common Share of the Company at an exercise price of $4.26 per share and expire five years from the date of issuance.&lt;span style="text-align:left"&gt;&amp;#160; &amp;#160; &amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;/div&gt;
        &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On initial recognition the Company determined that these warrants did not meet the IFRS definition of equity due to the exercise price being denominated in United States dollars, which was not the functional currency of the Company at the time resulting in variability in exercise price. The change in functional currency was determined to be a change in circumstance and, as such, the Company has made an accounting policy choice to continue to recognize the warrants as a financial liability classified at fair value through profit or loss. The classification of any new warrants issued from October 1, 2020 forward are assessed based on the new functional currency which is the United States dollar.&lt;span style="text-align:left"&gt;&amp;#160; &amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Transaction costs allocated to the warrants of $284,049 were expensed immediately. The fair value of these warrants is classified as Level 2 in the fair value hierarchy. As at the date of issuance the fair value of the warrants was determined to be $3,289,069 using the Black-Scholes option pricing model and the following assumptions: exercise price of $4.26, the underlying share price of $3.01 on date of issuance, risk free interest rate of 0.32% and annualized volatility of 121%.&lt;span style="text-align:left"&gt;&amp;#160; &amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The fair value of the warrants liability as at December 31, 2020 was $1,447,910 resulting in a gain on change in fair value of $1,927,041 for the year ended December 31, 2020. The fair value was determined using the Black-Scholes option pricing model and the following assumptions: exercise price of $4.26, the underlying share price of $1.56, risk free interest rate of 0.33% and annualized volatility of 117%.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      </huge:DisclosureOfWarrantLiabilitiesExplanatory>
  <huge:WarrantsLiability contextRef="C_20201231" decimals="0" id="Fxbrl_20210224164143306" unitRef="USD">1447910</huge:WarrantsLiability>
  <huge:ProfitLossOnChangeInFairValue contextRef="C_20200101to20201231" decimals="0" id="Fxbrl_20210224164621910" unitRef="USD">1927041</huge:ProfitLossOnChangeInFairValue>
  <huge:ExercisePriceOfWarrantsLiability contextRef="C_20201231" decimals="2" id="Fxbrl_20210224164658268" unitRef="USD_per_Share">4.26</huge:ExercisePriceOfWarrantsLiability>
  <huge:SharePricesOfWarrantsLiability contextRef="C_20201231" decimals="2" id="Fxbrl_20210224164710402" unitRef="USD_per_Share">1.56</huge:SharePricesOfWarrantsLiability>
  <huge:RiskFreeInterestRateOfWarrantsLiability contextRef="C_20200101to20201231" decimals="4" id="Fxbrl_20210224164720621" unitRef="Pure">0.0033</huge:RiskFreeInterestRateOfWarrantsLiability>
  <ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory contextRef="C_20200101to20201231" id="Fxbrl_20210224152957862">
        &lt;div&gt;
          &lt;p style="margin-left:18pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;strong&gt;23.&lt;/strong&gt;&lt;span style="width:5.49pt;text-indent:0pt;display:inline-block"&gt; &lt;/span&gt;&lt;strong&gt;Subsequent events&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;On January 21, 2021, the Company approved the grant of 75,000 share options to certain board members.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;January 22, 2021, the Corporation announced that it will hold its annual meeting of shareholders on June 29, 2021, at which, in addition to normal course matters, it will address matters contained in a requisition for a special meeting submitted to the Corporation by certain shareholders of the Corporation claiming to hold in excess of 5.1% of the Corporation's class B subordinated voting shares, including two directors of the Corporation. These shareholders are seeking to reduce the size of the Corporation's board of directors to five, and to replace six of the incumbent directors with three directors selected by such shareholders.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The annual meeting date of June 29, 2021 was contested by certain shareholders and, pursuant to a decision by the Superior Court of Justice, province of Ontario, issued on March 5, 2021, the annual meeting of shareholders and special meeting of the shareholders&amp;#160;has been set for May 14, 2021. Furthermore, the annual meeting of shareholders shall be conducted by an independent chair and Class B Common Shares issued on February 17, 2021, to certain directors and officers of the Company will not be allowed to vote at the meeting.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;From February 1, 2021 to February 10, 2021, the Company issued 7,356,326 Class B Common Shares through the Equity Distribution Agreement with A.G.P/Alliance Global Partners for gross proceeds of $19,770,762.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;On February 11, 2021, the Company entered into an Equity Distribution Agreement (the "Equity Distribution Agreement") with A.G.P./Alliance Global Partners. Under the Sales Agreement the Company may, at its discretion and from time-to-time during the term of the Sales Agreement, sell, through the Sales Agent, Class B Subordinate Voting Shares of the Company, with an aggregate offering price of up to $20,000,000.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;/div&gt;
          &lt;div&gt;
            &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify"&gt;From February 11, 2021 to March 12, 2021, the Company issued 7,247,288 Class B Common Shares through the Equity Distribution Agreement with A.G.P/Alliance Global Partners for gross proceeds of $18,167,511.&lt;/p&gt;
            &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&amp;#160;&lt;/p&gt;
            &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify"&gt;On February 17, 2021, the Company issued 1,349,764 Class B Common Shares to certain directors and officers of the Company. The fair value of the shares based on the February 17, 2021 closing share price of $2.65 per Class B Common Share was $3,576,875.&lt;/p&gt;
            &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify"&gt;&amp;#160;&lt;/p&gt;
            &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Effective March 1, 2021, Randell Mack was appointed as President of FSD Biosciences and Dr. Ed Brennan was name Chief Medical Officer of the Company.&amp;#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&amp;#160;&lt;/p&gt;
            &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;In March 2021, the Corporation entered into a license agreement ("Innovet License Agreement") with Innovet Italia S.R.L. ("Innovet"), under which Innovet granted the Company a license to use ultra-micro PEA to develop FDA approved veterinary drugs for the treatment of gastro-intestinal diseases in canines and felines. Under the Innovet License Agreement, the Corporation is required to make payments to Innovet upon the achievement of certain milestones.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;/div&gt;
        </ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory>
  <huge:NumberOfStockOptionsApprovedForIssuance contextRef="C_20210101to20210121_ifrsfullCategoriesOfRelatedPartiesAxis_hugeBoardMembersMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_hugeSubsequentEventsMember" decimals="0" id="Fxbrl_20210224174136252" unitRef="shares">75000</huge:NumberOfStockOptionsApprovedForIssuance>
  <huge:CertainShareholdersClaimingToHoldInExcessPercentageOfClassBSubordinatedVotingShares contextRef="C_20210101to20210122_ifrsfullClassesOfOrdinarySharesAxis_hugeClassBSubordinatedVotingSharesMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_hugeSubsequentEventsMember" decimals="3" id="Fxbrl_20210224174300521" unitRef="Pure">0.051</huge:CertainShareholdersClaimingToHoldInExcessPercentageOfClassBSubordinatedVotingShares>
  <huge:MaximumAggregateOfferingPrice contextRef="C_20210201to20210211_hugeTypeOfArrangementsAxis_hugeEquityDistributionAgreementMember_ifrsfullCategoriesOfRelatedPartiesAxis_hugeDirectorsAndOfficersMember_ifrsfullClassesOfOrdinarySharesAxis_hugeClassBCommonSharesMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_hugeSubsequentEventsMember" decimals="0" id="Fxbrl_20210224175250297" unitRef="USD">20000000</huge:MaximumAggregateOfferingPrice>
</xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>12
<FILENAME>huge-20201231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<schema xmlns:huge="http://www.fsdpharma.com/20201231" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2019-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2019-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:srt-types="http://fasb.org/srt-types/2019-01-31" xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2019-03-27/ifrs-full" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" targetNamespace="http://www.fsdpharma.com/20201231" elementFormDefault="qualified">
  <!-- INTEGIX by Ez-XBRL -->
  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/currency/2019-01-31" schemaLocation="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/exch/2019-01-31" schemaLocation="https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
  <import namespace="http://fasb.org/us-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd"/>
  <import namespace="http://fasb.org/srt/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd"/>
  <import namespace="http://fasb.org/srt-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd"/>
  <import namespace="http://xbrl.ifrs.org/taxonomy/2019-03-27/ifrs-full" schemaLocation="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd"/>
  <import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd"/>
  <annotation>
    <appinfo>
      <link:roleType roleURI="http://www.fsdpharma.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>0001 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION" id="CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION">
        <link:definition>0002 - Statement - CONSOLIDATED STATEMENTS OF FINANCIAL POSITION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFLOSSANDCOMPREHENSIVELOSS" id="CONSOLIDATEDSTATEMENTSOFLOSSANDCOMPREHENSIVELOSS">
        <link:definition>0003 - Statement - CONSOLIDATED STATEMENTS OF LOSS AND COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" id="CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY">
        <link:definition>0004 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDER'S EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>0005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/NatureOfBusiness" id="NatureOfBusiness">
        <link:definition>0006 - Disclosure - Nature of business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/BasisOfPresentation" id="BasisOfPresentation">
        <link:definition>0007 - Disclosure - Basis of presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/SignificantAccountingPolicies" id="SignificantAccountingPolicies">
        <link:definition>0008 - Disclosure - Significant accounting policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceutical" id="AcquisitionOfPrismicPharmaceutical">
        <link:definition>0009 - Disclosure - Acquisition of Prismic Pharmaceutical</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/AssetsHeldForSale" id="AssetsHeldForSale">
        <link:definition>0010 - Disclosure - Assets held for sale</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/TradeAndOtherReceivables" id="TradeAndOtherReceivables">
        <link:definition>0011 - Disclosure - Other receivables</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/OtherInvestments" id="OtherInvestments">
        <link:definition>0012 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/RightofuseAsset" id="RightofuseAsset">
        <link:definition>0013 - Disclosure - Right-of-use asset</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/IntangibleAssets" id="IntangibleAssets">
        <link:definition>0014 - Disclosure - Intangible assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/NotesPayable" id="NotesPayable">
        <link:definition>0015 - Disclosure - Notes payable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/LeaseObligations" id="LeaseObligations">
        <link:definition>0016 - Disclosure - Lease obligations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/WarrantsLiability" id="WarrantsLiability">
        <link:definition>0017 - Disclosure - Warrants Liability</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/ShareCapital" id="ShareCapital">
        <link:definition>0018 - Disclosure - Share capital</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/SharebasedCompensation" id="SharebasedCompensation">
        <link:definition>0019 - Disclosure - Share-based compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/LossPerShare" id="LossPerShare">
        <link:definition>0020 - Disclosure - Loss per share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/GeneralAndAdministrative" id="GeneralAndAdministrative">
        <link:definition>0021 - Disclosure - General and administrative</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/IncomeTaxes" id="IncomeTaxes">
        <link:definition>0022 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
        <link:definition>0023 - Disclosure - Commitments and contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
        <link:definition>0024 - Disclosure - Related party transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/CapitalManagement" id="CapitalManagement">
        <link:definition>0025 - Disclosure - Capital Management</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/FinancialInstrumentsAndRiskManagement" id="FinancialInstrumentsAndRiskManagement">
        <link:definition>0026 - Disclosure - Financial Instruments and Risk Management</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/SegmentedInformation" id="SegmentedInformation">
        <link:definition>0027 - Disclosure - Segmented information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/SubsequentEvents" id="SubsequentEvents">
        <link:definition>0028 - Disclosure - Subsequent events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/SignificantAccountingPoliciesPolicies" id="SignificantAccountingPoliciesPolicies">
        <link:definition>0029 - Disclosure - Significant accounting policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/NatureOfBusinessTable" id="NatureOfBusinessTable">
        <link:definition>0030 - Disclosure - Nature of business (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/BasisOfPresentationTables" id="BasisOfPresentationTables">
        <link:definition>0031 - Disclosure - Basis of presentation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/SignificantAccountingPoliciesTables" id="SignificantAccountingPoliciesTables">
        <link:definition>0032 - Disclosure - Significant accounting policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalTables" id="AcquisitionOfPrismicPharmaceuticalTables">
        <link:definition>0033 - Disclosure - Acquisition of Prismic Pharmaceutical (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/AssetsHeldForSaleTables" id="AssetsHeldForSaleTables">
        <link:definition>0034 - Disclosure - Assets held for sale (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/TradeAndOtherReceivablesTables" id="TradeAndOtherReceivablesTables">
        <link:definition>0035 - Disclosure - Other receivables (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/OtherinvestmentsTables" id="OtherinvestmentsTables">
        <link:definition>0036 - Disclosure - Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/RightofuseAssetTables" id="RightofuseAssetTables">
        <link:definition>0037 - Disclosure - Right-of-use asset (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/IntangibleAssetsTables" id="IntangibleAssetsTables">
        <link:definition>0038 - Disclosure - Intangible assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/NotesPayableTables" id="NotesPayableTables">
        <link:definition>0039 - Disclosure - Notes Payable (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/LeaseObligationsTables" id="LeaseObligationsTables">
        <link:definition>0040 - Disclosure - Lease obligations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/ShareCapitalTables" id="ShareCapitalTables">
        <link:definition>0041 - Disclosure - Share capital (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/SharebasedCompensationTables" id="SharebasedCompensationTables">
        <link:definition>0042 - Disclosure - Share-based compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/LossPerShareTables" id="LossPerShareTables">
        <link:definition>0043 - Disclosure - Loss per share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/GeneralAndAdministrativeTables" id="GeneralAndAdministrativeTables">
        <link:definition>0044 - Disclosure - General and administrative (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/IncometaxesTables" id="IncometaxesTables">
        <link:definition>0045 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/CommitmentsAndContingenciesTables" id="CommitmentsAndContingenciesTables">
        <link:definition>0046 - Disclosure - Commitments and contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/RelatedPartyTransactionsTables" id="RelatedPartyTransactionsTables">
        <link:definition>0047 - Disclosure - Related party transactions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/FinancialinstrumentsandriskexposuresTables" id="FinancialinstrumentsandriskexposuresTables">
        <link:definition>0048 - Disclosure - Financial Instruments and Risk Management (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/NatureOfBusinessScheduleOfOwnershipPercentageInSubsidiariesDetails" id="NatureOfBusinessScheduleOfOwnershipPercentageInSubsidiariesDetails">
        <link:definition>0049 - Disclosure - Nature of business - Schedule of ownership percentage in subsidiaries (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/BasisOfPresentationScheduleOfRestatementOfPriorPeriodInformationDetails" id="BasisOfPresentationScheduleOfRestatementOfPriorPeriodInformationDetails">
        <link:definition>0050 - Disclosure - Basis of presentation - Schedule of restatement of prior period information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/SignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfAssetsDetails" id="SignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfAssetsDetails">
        <link:definition>0051 - Disclosure - Significant accounting policies - Schedule of estimated useful lives of assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalNarrativeDetails" id="AcquisitionOfPrismicPharmaceuticalNarrativeDetails">
        <link:definition>0052 - Disclosure - Acquisition of Prismic Pharmaceutical (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalScheduleOfBlackScholesOptionsPricingModelDetails" id="AcquisitionOfPrismicPharmaceuticalScheduleOfBlackScholesOptionsPricingModelDetails">
        <link:definition>0053 - Disclosure - Acquisition of Prismic Pharmaceutical - Schedule of black scholes options pricing model (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" id="AcquisitionOfPrismicPharmaceuticalScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails">
        <link:definition>0054 - Disclosure - Acquisition of Prismic Pharmaceutical - Schedule of identifiable assets acquired and liabilities assumed (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/AssetsHeldForSaleDetailTextuals" id="AssetsHeldForSaleDetailTextuals">
        <link:definition>0055 - Disclosure - Assets held for sale (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/AssetsHeldForSaleDetails" id="AssetsHeldForSaleDetails">
        <link:definition>0056 - Disclosure - Assets held for sale - Schedule of components of assets held for sale (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/AssetsHeldForSaleDetails1" id="AssetsHeldForSaleDetails1">
        <link:definition>0057 - Disclosure - Assets held for sale - Schedule of net loss and comprehensive loss from discontinued operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/AssetsHeldForSaleDetails2" id="AssetsHeldForSaleDetails2">
        <link:definition>0058 - Disclosure - Assets held for sale - Schedule of cash flows from discontinued operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails" id="TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails">
        <link:definition>0059 - Disclosure - Other receivables - Schedule of other receivables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/OtherInvestmentsNarrativeDetails" id="OtherInvestmentsNarrativeDetails">
        <link:definition>0060 - Disclosure - Investments (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/OtherInvestmentsScheduleOfOtherInvestmentsDetails" id="OtherInvestmentsScheduleOfOtherInvestmentsDetails">
        <link:definition>0061 - Disclosure - Investments - Schedule of investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/RightofuseAssetNarrativeDetails" id="RightofuseAssetNarrativeDetails">
        <link:definition>0062 - Disclosure - Right-of-use asset (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/RightofuseAssetScheduleOfRightofuseAssetDetails" id="RightofuseAssetScheduleOfRightofuseAssetDetails">
        <link:definition>0063 - Disclosure - Right-of-use asset - Schedule of right-of-use asset (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/IntangibleAssetsNarrativeDetails" id="IntangibleAssetsNarrativeDetails">
        <link:definition>0064 - Disclosure - Intangible assets (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/IntangibleAssetsScheduleOfIntangibleAssetsDetails" id="IntangibleAssetsScheduleOfIntangibleAssetsDetails">
        <link:definition>0065 - Disclosure - Intangible assets - Schedule of intangible assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/NotesPayableNarrativeDetails" id="NotesPayableNarrativeDetails">
        <link:definition>0066 - Disclosure - Notes Payable (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/NotesPayableScheduleOfNotesPayableDetails" id="NotesPayableScheduleOfNotesPayableDetails">
        <link:definition>0067 - Disclosure - Notes Payable - Schedule of notes payable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/LeaseObligationsNarrativeDetails" id="LeaseObligationsNarrativeDetails">
        <link:definition>0068 - Disclosure - Lease obligations - (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/LeaseObligationsScheduleOfLeaseObligationsDetails" id="LeaseObligationsScheduleOfLeaseObligationsDetails">
        <link:definition>0069 - Disclosure - Lease obligations - Schedule of lease obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/LeaseObligationsScheduleOfMaturityAnalysisOfOperatingLeasePaymentsDetails" id="LeaseObligationsScheduleOfMaturityAnalysisOfOperatingLeasePaymentsDetails">
        <link:definition>0070 - Disclosure - Lease obligations - Schedule of maturity analysis of operating lease payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/WarrantsLiabilityDetailTextuals" id="WarrantsLiabilityDetailTextuals">
        <link:definition>0071 - Disclosure - Warrants Liability (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/ShareCapitalNarrativeDetails" id="ShareCapitalNarrativeDetails">
        <link:definition>0072 - Disclosure - Share capital (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/ShareCapitalScheduleOfReconciliationOfTheShareCapitalDetails" id="ShareCapitalScheduleOfReconciliationOfTheShareCapitalDetails">
        <link:definition>0073 - Disclosure - Share capital - Schedule of reconciliation of the share capital (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/ShareCapitalScheduleOfChangesInNumberOfWarrantsOutstandingDetails" id="ShareCapitalScheduleOfChangesInNumberOfWarrantsOutstandingDetails">
        <link:definition>0074 - Disclosure - Share capital - Schedule of changes in number of warrants outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/ShareCapitalScheduleOfFairValueAssumptionsOfWarrantsDetails" id="ShareCapitalScheduleOfFairValueAssumptionsOfWarrantsDetails">
        <link:definition>0075 - Disclosure - Share capital - Schedule of fair value assumptions of warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/ShareCapitalScheduleOfWarrantsOutstandingAndExercisePriceDetails" id="ShareCapitalScheduleOfWarrantsOutstandingAndExercisePriceDetails">
        <link:definition>0076 - Disclosure - Share capital - Schedule of warrants outstanding and exercise price (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/SharebasedCompensationNarrativeDetails" id="SharebasedCompensationNarrativeDetails">
        <link:definition>0077 - Disclosure - Share-based compensation (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/SharebasedCompensationScheduleOfChangesInNumberOfShareOptionsDetails" id="SharebasedCompensationScheduleOfChangesInNumberOfShareOptionsDetails">
        <link:definition>0078 - Disclosure - Share-based compensation - Schedule of changes in number of share options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/SharebasedCompensationScheduleOfFairValueAssumptionsOfShareOptionsGrantedDetails" id="SharebasedCompensationScheduleOfFairValueAssumptionsOfShareOptionsGrantedDetails">
        <link:definition>0079 - Disclosure - Share-based compensation - Schedule of fair value assumptions of share options granted (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/SharebasedCompensationScheduleOfExercisePriceAndWeightedAverageContractualTermOfShareOptionsOutstandingAndExercisableDetails" id="SharebasedCompensationScheduleOfExercisePriceAndWeightedAverageContractualTermOfShareOptionsOutstandingAndExercisableDetails">
        <link:definition>0080 - Disclosure - Share-based compensation - Schedule of exercise price and weighted average contractual term of share options outstanding  and exercisable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/LossPerShareDetails" id="LossPerShareDetails">
        <link:definition>0081 - Disclosure - Loss per share - Schedule of loss per share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/GeneralAndAdministrativeDetails" id="GeneralAndAdministrativeDetails">
        <link:definition>0082 - Disclosure - General and administrative - Schedule of general and administrative expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/IncomeTaxesNarrativeDetails" id="IncomeTaxesNarrativeDetails">
        <link:definition>0083 - Disclosure - Income Taxes (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/IncomeTaxesScheduleOfProvisionForIncomeTaxesDetails" id="IncomeTaxesScheduleOfProvisionForIncomeTaxesDetails">
        <link:definition>0084 - Disclosure - Income Taxes - Schedule of provision for income taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails" id="IncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails">
        <link:definition>0085 - Disclosure - Income Taxes - Schedule of deferred tax assets (liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/IncomeTaxesScheduleOfTemporaryDifferencesForWhichDeferredTaxAssetsNotRecognisedDetails" id="IncomeTaxesScheduleOfTemporaryDifferencesForWhichDeferredTaxAssetsNotRecognisedDetails">
        <link:definition>0086 - Disclosure - Income Taxes - Schedule of temporary differences for which deferred tax assets not recognised (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/IncomeTaxesScheduleOfNoncapitalLossCarryforwardsDetails" id="IncomeTaxesScheduleOfNoncapitalLossCarryforwardsDetails">
        <link:definition>0087 - Disclosure - Income Taxes - Schedule of non-capital loss carryforwards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/CommitmentsAndContingenciesNarrativeDetails" id="CommitmentsAndContingenciesNarrativeDetails">
        <link:definition>0088 - Disclosure - Commitments and contingencies (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/CommitmentsAndContingenciesScheduleOfQuantitiesOfCannabisAvailableToSupplyByFiscalPeriodDetails" id="CommitmentsAndContingenciesScheduleOfQuantitiesOfCannabisAvailableToSupplyByFiscalPeriodDetails">
        <link:definition>0089 - Disclosure - Commitments and contingencies - Schedule of quantities of cannabis available to supply by fiscal period (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/RelatedPartyTransactionsNarrativeDetails" id="RelatedPartyTransactionsNarrativeDetails">
        <link:definition>0090 - Disclosure - Related party transactions (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/RelatedPartyTransactionsScheduleOfKeyManagementPersonnelCompensationDetails" id="RelatedPartyTransactionsScheduleOfKeyManagementPersonnelCompensationDetails">
        <link:definition>0091 - Disclosure - Related party transactions - Schedule of key management personnel compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/CapitalManagementNarrativeDetails" id="CapitalManagementNarrativeDetails">
        <link:definition>0092 - Disclosure - Capital management (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/SubsequentEventsNarrativeDetails" id="SubsequentEventsNarrativeDetails">
        <link:definition>0093 - Disclosure - Subsequent events (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/FinancialInstrumentsAndRiskExposuresNarrativeDetails" id="FinancialInstrumentsAndRiskExposuresNarrativeDetails">
        <link:definition>0094 - Disclosure - Financial instruments and risk exposures (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/FinancialInstrumentsAndRiskExposuresScheduleOfFinancialObligationsBasedOnTheirDueDatesDetails" id="FinancialInstrumentsAndRiskExposuresScheduleOfFinancialObligationsBasedOnTheirDueDatesDetails">
        <link:definition>0095 - Disclosure - Financial instruments and risk exposures - Schedule of financial obligations based on their due dates (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/FinancialInstrumentsAndRiskExposuresScheduleOfFinancialAssetsAndFinancialLiabilitiesDetails" id="FinancialInstrumentsAndRiskExposuresScheduleOfFinancialAssetsAndFinancialLiabilitiesDetails">
        <link:definition>0096 - Disclosure - Financial instruments and risk exposures - Schedule of financial assets and financial liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.fsdpharma.com/role/FinancialInstrumentsAndRiskExposuresScheduleOfCreditRiskDetails" id="FinancialInstrumentsAndRiskExposuresScheduleOfCreditRiskDetails">
        <link:definition>0097 - Disclosure - Financial instruments and risk exposures - Schedule of credit risk (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="huge-20201231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="huge-20201231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="huge-20201231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="huge-20201231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
    </appinfo>
  </annotation>
  <element name="AcquisitionOfPrismicPharmaceuticalsInc" id="huge_AcquisitionOfPrismicPharmaceuticalsInc" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AddDeductItemsNotAffectingCashAbstract" id="huge_AddDeductItemsNotAffectingCashAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AdditionalInvestmentInExchangeForShares" id="huge_AdditionalInvestmentInExchangeForShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdditionalRemuneration" id="huge_AdditionalRemuneration" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAsset" id="huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAsset" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAssets" id="huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit" id="huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposits" id="huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustmentsForDecreaseIncreaseInSalesTaxesRecoverable" id="huge_AdjustmentsForDecreaseIncreaseInSalesTaxesRecoverable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold" id="huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AdjustmentsForIncreaseDecreaseInPrepaidExpensesAndDeposits" id="huge_AdjustmentsForIncreaseDecreaseInPrepaidExpensesAndDeposits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustmentsForListingExpense" id="huge_AdjustmentsForListingExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustmentsForLossesGainsOnDisposalOfEquipment" id="huge_AdjustmentsForLossesGainsOnDisposalOfEquipment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustmentsForLossesGainsOnDisposalOfInventory" id="huge_AdjustmentsForLossesGainsOnDisposalOfInventory" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustmentToExpectedIncomeTaxBenefitAbstract" id="huge_AdjustmentToExpectedIncomeTaxBenefitAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AdjustmentToExpectedIncomeTaxBenefitChangeInBenefitOfTaxAssetsNotRecognized" id="huge_AdjustmentToExpectedIncomeTaxBenefitChangeInBenefitOfTaxAssetsNotRecognized" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustmentToExpectedIncomeTaxBenefitFairValueChangeOfInvestments" id="huge_AdjustmentToExpectedIncomeTaxBenefitFairValueChangeOfInvestments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AdjustmentToExpectedIncomeTaxBenefitLossOnDerivativeLiability" id="huge_AdjustmentToExpectedIncomeTaxBenefitLossOnDerivativeLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AdjustmentToExpectedIncomeTaxBenefitShareIssueCosts" id="huge_AdjustmentToExpectedIncomeTaxBenefitShareIssueCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustmentToExpectedIncomeTaxBenefitStockBasedCompensation" id="huge_AdjustmentToExpectedIncomeTaxBenefitStockBasedCompensation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustmentToLeaseCommitments" id="huge_AdjustmentToLeaseCommitments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AfterHarvestCostToCompleteAndSellPerGramForDryFlower" id="huge_AfterHarvestCostToCompleteAndSellPerGramForDryFlower" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AfterHarvestCostToCompleteAndSellPerGramForDryTrim" id="huge_AfterHarvestCostToCompleteAndSellPerGramForDryTrim" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AggregateDiscountForSharesInEscrow" id="huge_AggregateDiscountForSharesInEscrow" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AggregateUnpaidAccounts" id="huge_AggregateUnpaidAccounts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AllianceGlobalPartnersMember" id="huge_AllianceGlobalPartnersMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AllowanceForImpairment" id="huge_AllowanceForImpairment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AmortizedCostOfFinancialAssetsMember" id="huge_AmortizedCostOfFinancialAssetsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AmortizedCostOfFinancialLiabilitiesMember" id="huge_AmortizedCostOfFinancialLiabilitiesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AmountOfAdditionalSharesIssuedAgainstOutstandingLiabilities" id="huge_AmountOfAdditionalSharesIssuedAgainstOutstandingLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AmountOfAgreementFallBelowMinimumValue" id="huge_AmountOfAgreementFallBelowMinimumValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AmountOfBrokerWarrantsRepresentingFeesAndCommissions" id="huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AmountOfDepositPaidToSupplier" id="huge_AmountOfDepositPaidToSupplier" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AmountOfMinimumIssueOfAdditionalCommonSharesUponLiquidation" id="huge_AmountOfMinimumIssueOfAdditionalCommonSharesUponLiquidation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AmountOfPurchasePricePaidAsSupplierLoan" id="huge_AmountOfPurchasePricePaidAsSupplierLoan" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement" id="huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AnthonyDurkaczMember" id="huge_AnthonyDurkaczMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AnticipatedPurchasePricePlusApplicableTaxesValue" id="huge_AnticipatedPurchasePricePlusApplicableTaxesValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="Apr82018Member" id="huge_Apr82018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Apr92018Member" id="huge_Apr92018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="April182018Member" id="huge_April182018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Aug142018Member" id="huge_Aug142018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Aug152018Member" id="huge_Aug152018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Aug82018Member" id="huge_Aug82018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AuraHealthIncMember" id="huge_AuraHealthIncMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AuxlyCannabisGroupIncMember" id="huge_AuxlyCannabisGroupIncMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AverageExpectedLifeOfWarrants" id="huge_AverageExpectedLifeOfWarrants" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BasisOfPresentationAbstract" id="huge_BasisOfPresentationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BiologicalAssetFairValueAdjustmentMember" id="huge_BiologicalAssetFairValueAdjustmentMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BoardMembersMember" id="huge_BoardMembersMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BonusExpenseToBePaidInSubsequentPeriod" id="huge_BonusExpenseToBePaidInSubsequentPeriod" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="BookToFilingAdjustments" id="huge_BookToFilingAdjustments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="BorrowingsSettled" id="huge_BorrowingsSettled" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="BorrowingsSettledAccruedInterestSettled" id="huge_BorrowingsSettledAccruedInterestSettled" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="BrokerWarrants" id="huge_BrokerWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="BrokerWarrantsIssuedInPrivatePlacements" id="huge_BrokerWarrantsIssuedInPrivatePlacements" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BuildingAndFacilityCosts" id="huge_BuildingAndFacilityCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="BusinessAcquisitionDomain" id="huge_BusinessAcquisitionDomain" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BusinessAcquisitionsAxis" id="huge_BusinessAcquisitionsAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="BusinessAcquisitionsBenefitsAxis" id="huge_BusinessAcquisitionsBenefitsAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="BusinessAcquisitionsBenefitsDomain" id="huge_BusinessAcquisitionsBenefitsDomain" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BusinessLicenseFees" id="huge_BusinessLicenseFees" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CannaraBiotechIncMember" id="huge_CannaraBiotechIncMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CanntabTherapeuticsLtdWorldClassExtractionsIncMember" id="huge_CanntabTherapeuticsLtdWorldClassExtractionsIncMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CapitalizedCostMember" id="huge_CapitalizedCostMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CapitalizedCosts" id="huge_CapitalizedCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CashAcquiredOnAcquisition" id="huge_CashAcquiredOnAcquisition" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CashProceedsFromIssuanceOfPrivatePlacement" id="huge_CashProceedsFromIssuanceOfPrivatePlacement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CashReceiptsFromSalesOfDebtInstruments" id="huge_CashReceiptsFromSalesOfDebtInstruments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CenturyAndFvPharmaMember" id="huge_CenturyAndFvPharmaMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CertainShareholdersClaimingToHoldInExcessPercentageOfClassBSubordinatedVotingShares" id="huge_CertainShareholdersClaimingToHoldInExcessPercentageOfClassBSubordinatedVotingShares" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ChangeInFairValueOfInvestment" id="huge_ChangeInFairValueOfInvestment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ChangeInFairValueOfInvestmentDueToTenPercentChangeInAssumptionsUsed" id="huge_ChangeInFairValueOfInvestmentDueToTenPercentChangeInAssumptionsUsed" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" id="huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ChangesInNoncashWorkingCapitalBalancesAbstract" id="huge_ChangesInNoncashWorkingCapitalBalancesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ChangesInNonCashWorkingCapitalItemsAbstract" id="huge_ChangesInNonCashWorkingCapitalItemsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ChangesInShareCapitalTransactionDateAxis" id="huge_ChangesInShareCapitalTransactionDateAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="ChangesInShareCapitalTransactionDateDomain" id="huge_ChangesInShareCapitalTransactionDateDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ChiefExecutiveOfficerAndExecutiveCoChairmanMember" id="huge_ChiefExecutiveOfficerAndExecutiveCoChairmanMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ChiefExecutiveOfficersMember" id="huge_ChiefExecutiveOfficersMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ChiefFinancialOfficersMember" id="huge_ChiefFinancialOfficersMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ChiefOperatingConsultantMember" id="huge_ChiefOperatingConsultantMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ClaimForLienComponent" id="huge_ClaimForLienComponent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ClaimIssuedByContractorForVariousPurportedDamages" id="huge_ClaimIssuedByContractorForVariousPurportedDamages" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ClaimIssuedByCreditorForAllegingNonpaymentOfAccounts" id="huge_ClaimIssuedByCreditorForAllegingNonpaymentOfAccounts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ClaimSettlementAmount" id="huge_ClaimSettlementAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ClaimSettlementAmountCoveredByInsurance" id="huge_ClaimSettlementAmountCoveredByInsurance" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ClassACommonStockSharesMember" id="huge_ClassACommonStockSharesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ClassBCommonSharesMember" id="huge_ClassBCommonSharesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ClassBCommonStockSharesMember" id="huge_ClassBCommonStockSharesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ClassBSharesHeldInEscrowMember" id="huge_ClassBSharesHeldInEscrowMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ClassBSubordinatedVotingSharesMember" id="huge_ClassBSubordinatedVotingSharesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ClassBSubordinateVotingSharesMember" id="huge_ClassBSubordinateVotingSharesMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ClassBVotingSharesMember" id="huge_ClassBVotingSharesMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ClassCommonStockSharesMember" id="huge_ClassCommonStockSharesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ClassesOfInventoriesLineItems" id="huge_ClassesOfInventoriesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ClassesOfInventoriesTable" id="huge_ClassesOfInventoriesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="ClassesOfWarrantsAxis" id="huge_ClassesOfWarrantsAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="ClassesOfWarrantsDomain" id="huge_ClassesOfWarrantsDomain" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CloverCannastripThinFilmTechnologiesCorpMember" id="huge_CloverCannastripThinFilmTechnologiesCorpMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CollectiveCommitmentToPurchaseProduct" id="huge_CollectiveCommitmentToPurchaseProduct" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="CommitmentsEquityInstruments" id="huge_CommitmentsEquityInstruments" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CommitmentsLineItems" id="huge_CommitmentsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CommitmentsTable" id="huge_CommitmentsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="CommitmentToIssueSharesMinimumValueUponLiquidation" id="huge_CommitmentToIssueSharesMinimumValueUponLiquidation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="CommonStockIssuedForPrivatePlacement" id="huge_CommonStockIssuedForPrivatePlacement" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ConsultingFeesExpenses" id="huge_ConsultingFeesExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ContingentLiabilityForConstructionAndDevelopmentCostsMember" id="huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ContractualCapitalCommitmentsEqualMonthlyInstalments" id="huge_ContractualCapitalCommitmentsEqualMonthlyInstalments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ConvertibleDebentureMember" id="huge_ConvertibleDebentureMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ConvertibleNotes" id="huge_ConvertibleNotes" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ConvertibleNotesMember" id="huge_ConvertibleNotesMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CorporateInformationAndNatureOfOperationsAbstract" id="huge_CorporateInformationAndNatureOfOperationsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CriticalAccountingEstimatesAndJudgmentsAbstract" id="huge_CriticalAccountingEstimatesAndJudgmentsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CurrentNotesPayable" id="huge_CurrentNotesPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="CurrentWarrantsLiability" id="huge_CurrentWarrantsLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DateOfExpiryOfShareOptions" id="huge_DateOfExpiryOfShareOptions" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DebtConversionRatio" id="huge_DebtConversionRatio" type="xbrli:pureItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Dec122017Member" id="huge_Dec122017Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Dec152018Member" id="huge_Dec152018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Dec212017Member" id="huge_Dec212017Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Dec232017Member" id="huge_Dec232017Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Dec292017Member" id="huge_Dec292017Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="December292017Member" id="huge_December292017Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" id="huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" id="huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DeductibleTemporaryDifferencesOfForeignNetOperatingLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" id="huge_DeductibleTemporaryDifferencesOfForeignNetOperatingLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" id="huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DeductibleTemporaryDifferencesOfForeignUnrealizedForeignExchangeLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" id="huge_DeductibleTemporaryDifferencesOfForeignUnrealizedForeignExchangeLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DeductibleTemporaryDifferencesOfIfrs16ForWhichNoDeferredTaxAssetIsRecognised" id="huge_DeductibleTemporaryDifferencesOfIfrs16ForWhichNoDeferredTaxAssetIsRecognised" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised" id="huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised" id="huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised" id="huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DeductibleTemporaryDifferencesOfUnrealizedFairValueOnBiologicalAssetsAndInventoryForWhichNoDeferredTaxAssetIsRecognised" id="huge_DeductibleTemporaryDifferencesOfUnrealizedFairValueOnBiologicalAssetsAndInventoryForWhichNoDeferredTaxAssetIsRecognised" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DeferredTaxAssetLiabilityNotRecognized" id="huge_DeferredTaxAssetLiabilityNotRecognized" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DeferredTaxAssetNotRecognized" id="huge_DeferredTaxAssetNotRecognized" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DeferredTaxAssetPropertyPlantAndEquipments" id="huge_DeferredTaxAssetPropertyPlantAndEquipments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DeferredTaxAssetsLiabilitiesAxis" id="huge_DeferredTaxAssetsLiabilitiesAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="DeferredTaxAssetsLiabilitiesDomain" id="huge_DeferredTaxAssetsLiabilitiesDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DeferredTaxAssetsOtherInvestments" id="huge_DeferredTaxAssetsOtherInvestments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DeferredTaxLiabilitiesCapitalLossesCarriedForward" id="huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DefinitiveBusinessCombinationAgreementMember" id="huge_DefinitiveBusinessCombinationAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DefinitiveCollaborationProfitSharingAgreementMember" id="huge_DefinitiveCollaborationProfitSharingAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DefinitiveSettlementAgreementMember" id="huge_DefinitiveSettlementAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DefinitiveStrategicAllianceAndStreamingAgreementMember" id="huge_DefinitiveStrategicAllianceAndStreamingAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DerivativeLiabilitiesSettledThroughIssuanceOfShares" id="huge_DerivativeLiabilitiesSettledThroughIssuanceOfShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DescriptionOfExpectedVolatilityWarrantsGranted" id="huge_DescriptionOfExpectedVolatilityWarrantsGranted" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfOptionLifeWarrantsGranted" id="huge_DescriptionOfOptionLifeWarrantsGranted" type="xbrli:decimalItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory" id="huge_DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfReverseShareSplit" id="huge_DescriptionOfReverseShareSplit" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfRiskFreeInterestRateWarrantsGranted" id="huge_DescriptionOfRiskFreeInterestRateWarrantsGranted" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfVotingRights" id="huge_DescriptionOfVotingRights" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DirectCashOfferingCost" id="huge_DirectCashOfferingCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DirectorsAndOfficersMember" id="huge_DirectorsAndOfficersMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DirectorsRemunerationPayable" id="huge_DirectorsRemunerationPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DisclosureOfAssetsHeldForSaleAbstract" id="huge_DisclosureOfAssetsHeldForSaleAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfAssetsHeldForSaleLineItems" id="huge_DisclosureOfAssetsHeldForSaleLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfAssetsHeldForSaleTable" id="huge_DisclosureOfAssetsHeldForSaleTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="DisclosureOfCapitalManagementAbstract" id="huge_DisclosureOfCapitalManagementAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory" id="huge_DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfCommitmentsAbstract" id="huge_DisclosureOfCommitmentsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfCommitmentsAndContingentLiabilitiesAbstract" id="huge_DisclosureOfCommitmentsAndContingentLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfCorporateInformationAndNatureOfOperationsExplanatory" id="huge_DisclosureOfCorporateInformationAndNatureOfOperationsExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutFairValueOfWarrantsWarrantsEstimatedOnDatesOfIssueUsingBlackScholesOptionPricingModelExplanatory" id="huge_DisclosureOfDetailedInformationAboutFairValueOfWarrantsWarrantsEstimatedOnDatesOfIssueUsingBlackScholesOptionPricingModelExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory" id="huge_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutInventoriesExplanatory" id="huge_DisclosureOfDetailedInformationAboutInventoriesExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutInvestmentsExplanatory" id="huge_DisclosureOfDetailedInformationAboutInvestmentsExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutNotesPayableExplanatory" id="huge_DisclosureOfDetailedInformationAboutNotesPayableExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutRestatementOfPriorPeriodExplanatory" id="huge_DisclosureOfDetailedInformationAboutRestatementOfPriorPeriodExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutRightOfUseAssets" id="huge_DisclosureOfDetailedInformationAboutRightOfUseAssets" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory" id="huge_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutWarrantActivityExplanatory" id="huge_DisclosureOfDetailedInformationAboutWarrantActivityExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory" id="huge_DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailsInformationAboutRightOfUseAssetExplanatory" id="huge_DisclosureOfDetailsInformationAboutRightOfUseAssetExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory" id="huge_DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfFairValueRecognizedOnAcquisitionTableTextBlock" id="huge_DisclosureOfFairValueRecognizedOnAcquisitionTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfFinancialAssetsAndLiabilitiesExplanatory" id="huge_DisclosureOfFinancialAssetsAndLiabilitiesExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfGeneralAndAdministrativeExpenses" id="huge_DisclosureOfGeneralAndAdministrativeExpenses" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfInvestmentsAbstract" id="huge_DisclosureOfInvestmentsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfInvestmentsLineItems" id="huge_DisclosureOfInvestmentsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfInvestmentsTable" id="huge_DisclosureOfInvestmentsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="DisclosureOfNatureOfBusinessAbstract" id="huge_DisclosureOfNatureOfBusinessAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfNatureOfBusinessExplanatoryTextBlock" id="huge_DisclosureOfNatureOfBusinessExplanatoryTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfNatureOfBusinessLineItems" id="huge_DisclosureOfNatureOfBusinessLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfNatureOfBusinessTable" id="huge_DisclosureOfNatureOfBusinessTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingAndExercisableShareOptionsExplanatory" id="huge_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingAndExercisableShareOptionsExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory" id="huge_DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfNumberOfWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory" id="huge_DisclosureOfNumberOfWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfOperatingLeaseObligationsTableTextBlock" id="huge_DisclosureOfOperatingLeaseObligationsTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfProvisionForIncomeTaxesExplanatory" id="huge_DisclosureOfProvisionForIncomeTaxesExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfQuantitiesAvailableToSupplyByFiscalPeriodUnderCommitmentExplanatory" id="huge_DisclosureOfQuantitiesAvailableToSupplyByFiscalPeriodUnderCommitmentExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfReverseTakeoverTransactionAbstract" id="huge_DisclosureOfReverseTakeoverTransactionAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfReverseTakeoverTransactionExplanatory" id="huge_DisclosureOfReverseTakeoverTransactionExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfShareBasedCompensationAndWarrantReserveAbstract" id="huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfShareBasedCompensationAndWarrantReserveExplanatory" id="huge_DisclosureOfShareBasedCompensationAndWarrantReserveExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory" id="huge_DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfUnrecognizedTemporaryTaxDifferencesExplanatory" id="huge_DisclosureOfUnrecognizedTemporaryTaxDifferencesExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfWarrantLiabilitiesExplanatory" id="huge_DisclosureOfWarrantLiabilitiesExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfWarrantsLineItems" id="huge_DisclosureOfWarrantsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfWarrantsTable" id="huge_DisclosureOfWarrantsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="DiscontinuedOperationsOfGeneralAndAdministrative" id="huge_DiscontinuedOperationsOfGeneralAndAdministrative" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DiscountOnProceedsOfSharesAndWarrantsSold" id="huge_DiscountOnProceedsOfSharesAndWarrantsSold" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DocumentAndEntityInformationAbstract" id="huge_DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EffectOfSharesIssuedDuringPeriodOnWeightedAverageNumberOfShares" id="huge_EffectOfSharesIssuedDuringPeriodOnWeightedAverageNumberOfShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EffectsOfForeignExchangeOnLeaseLiabilities" id="huge_EffectsOfForeignExchangeOnLeaseLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="EmployeeRelatedLiability" id="huge_EmployeeRelatedLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EpitechLicenseAgreementMember" id="huge_EpitechLicenseAgreementMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EquityDistributionAgreementMember" id="huge_EquityDistributionAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EstimatedCostOfRestorationInCommitment" id="huge_EstimatedCostOfRestorationInCommitment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ExercisePriceEighteenPointZeroNineMember" id="huge_ExercisePriceEighteenPointZeroNineMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceEightyEightPointFortyFourMember" id="huge_ExercisePriceEightyEightPointFortyFourMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceEightySixPointFortyThreeMember" id="huge_ExercisePriceEightySixPointFortyThreeMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceFiftyFivePointTwentyEightMember" id="huge_ExercisePriceFiftyFivePointTwentyEightMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceFiftyNinePointThirtyMember" id="huge_ExercisePriceFiftyNinePointThirtyMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceFiftyPointTwentyFiveMember" id="huge_ExercisePriceFiftyPointTwentyFiveMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceFiftySixPointTwentyEightMember" id="huge_ExercisePriceFiftySixPointTwentyEightMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceFiftyTwoPointTwentySixMember" id="huge_ExercisePriceFiftyTwoPointTwentySixMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceFivePointFourThreeMember" id="huge_ExercisePriceFivePointFourThreeMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceFivePointZeroThreeMember" id="huge_ExercisePriceFivePointZeroThreeMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceFortyFourPointTwentyTwoMember" id="huge_ExercisePriceFortyFourPointTwentyTwoMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceFortyPointTwentyMember" id="huge_ExercisePriceFortyPointTwentyMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceFortySevenPointTwentyFourMember" id="huge_ExercisePriceFortySevenPointTwentyFourMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceFourPointFourTwoMember" id="huge_ExercisePriceFourPointFourTwoMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceFourPointSevenFiveMember" id="huge_ExercisePriceFourPointSevenFiveMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceNinePointFiveFourMember" id="huge_ExercisePriceNinePointFiveFourMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceOfExercisableShareOptions" id="huge_ExercisePriceOfExercisableShareOptions" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceOfWarrantIssue" id="huge_ExercisePriceOfWarrantIssue" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceOfWarrants" id="huge_ExercisePriceOfWarrants" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceOfWarrantsGranted" id="huge_ExercisePriceOfWarrantsGranted" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceOfWarrantsLiability" id="huge_ExercisePriceOfWarrantsLiability" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceOneHundredFortyEightPointSeventyFourMember" id="huge_ExercisePriceOneHundredFortyEightPointSeventyFourMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceOneHundredFortyTwoPointSeventyOneMember" id="huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceOneHundredTwentyPointSixtyMember" id="huge_ExercisePriceOneHundredTwentyPointSixtyMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceSevenPointFiftyMember" id="huge_ExercisePriceSevenPointFiftyMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceSevenPointSeventeenMember" id="huge_ExercisePriceSevenPointSeventeenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceSevenPointSixtyThreeMember" id="huge_ExercisePriceSevenPointSixtyThreeMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceSevenPointZeroZeroMember" id="huge_ExercisePriceSevenPointZeroZeroMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceSeventeenPointEightNineMember" id="huge_ExercisePriceSeventeenPointEightNineMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceSeventyFivePointThirtyEightMember" id="huge_ExercisePriceSeventyFivePointThirtyEightMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceSeventyOnePointZeroSevenMember" id="huge_ExercisePriceSeventyOnePointZeroSevenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceSixPointSixteenMember" id="huge_ExercisePriceSixPointSixteenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceSixteenPointZeroEightMember" id="huge_ExercisePriceSixteenPointZeroEightMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceSixtyEightPointZeroOneMember" id="huge_ExercisePriceSixtyEightPointZeroOneMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceTenPointSixFiveMember" id="huge_ExercisePriceTenPointSixFiveMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceThirteenPointFourSevenMember" id="huge_ExercisePriceThirteenPointFourSevenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceThirteenPointZeroSevenMember" id="huge_ExercisePriceThirteenPointZeroSevenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceThreePointEightSixMember" id="huge_ExercisePriceThreePointEightSixMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceThreePointSevenFiveMember" id="huge_ExercisePriceThreePointSevenFiveMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceTwentyFourPointTwelveMember" id="huge_ExercisePriceTwentyFourPointTwelveMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceTwentyOnePointElevenMember" id="huge_ExercisePriceTwentyOnePointElevenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceTwentyOnePointNinetyOneMember" id="huge_ExercisePriceTwentyOnePointNinetyOneMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceTwentyOnePointTwentyTwoMember" id="huge_ExercisePriceTwentyOnePointTwentyTwoMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceTwentyPointOneZeroMember" id="huge_ExercisePriceTwentyPointOneZeroMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceTwentySixPointThirteenMember" id="huge_ExercisePriceTwentySixPointThirteenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceTwoPointSixOneMember" id="huge_ExercisePriceTwoPointSixOneMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpectedDividendAsPercentageWarrantsGranted" id="huge_ExpectedDividendAsPercentageWarrantsGranted" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpectedDividendYieldOfWarrants" id="huge_ExpectedDividendYieldOfWarrants" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpectedDividendYieldOfWarrantsGranted" id="huge_ExpectedDividendYieldOfWarrantsGranted" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpectedGrowthCycle" id="huge_ExpectedGrowthCycle" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpectedGrowthCycleCompleted" id="huge_ExpectedGrowthCycleCompleted" type="num:percentItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpectedLifeOfWarrants" id="huge_ExpectedLifeOfWarrants" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpectedNetSellingPricePerGramOfDriedFlower" id="huge_ExpectedNetSellingPricePerGramOfDriedFlower" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ExpectedNetSellingPricePerGramOfTrim" id="huge_ExpectedNetSellingPricePerGramOfTrim" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ExpectedSellingPricePerGramOfDriedFlower" id="huge_ExpectedSellingPricePerGramOfDriedFlower" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ExpectedSellingPricePerGramOfTrim" id="huge_ExpectedSellingPricePerGramOfTrim" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ExpectedTermOfWarrants" id="huge_ExpectedTermOfWarrants" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpectedVolatilityOfWarrants" id="huge_ExpectedVolatilityOfWarrants" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpectedVolatilityOfWarrantsGranted" id="huge_ExpectedVolatilityOfWarrantsGranted" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpectedVolatilityOfWarrantsLiability" id="huge_ExpectedVolatilityOfWarrantsLiability" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpectedYieldForCannabisPlantsOfDryFlowerPerPlant" id="huge_ExpectedYieldForCannabisPlantsOfDryFlowerPerPlant" type="num:massItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpectedYieldForCannabisPlantsOfDryTrimPerPlant" id="huge_ExpectedYieldForCannabisPlantsOfDryTrimPerPlant" type="num:massItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpectedYieldOfDryFlower" id="huge_ExpectedYieldOfDryFlower" type="num:massItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpectedYieldOfDryTrim" id="huge_ExpectedYieldOfDryTrim" type="num:massItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpiryDateOfWarrants" id="huge_ExpiryDateOfWarrants" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpiryTermOfWarrantsGranted" id="huge_ExpiryTermOfWarrantsGranted" type="xbrli:decimalItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FacilityRelatedExpenditures" id="huge_FacilityRelatedExpenditures" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="FacilityUnderDevelopmentMember" id="huge_FacilityUnderDevelopmentMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FairValueAdjustmentsOnInventorySold" id="huge_FairValueAdjustmentsOnInventorySold" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="FairValueOfCommonSharesApprovedForIssuance" id="huge_FairValueOfCommonSharesApprovedForIssuance" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="FairValueOfCommonSharesIssued" id="huge_FairValueOfCommonSharesIssued" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="FairValueOfCommonSharesOfResidualValue" id="huge_FairValueOfCommonSharesOfResidualValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="FairValueOfCommonStockOfNotesPayable" id="huge_FairValueOfCommonStockOfNotesPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="FairValueOfCommonStockToSettleNotesPayable" id="huge_FairValueOfCommonStockToSettleNotesPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="FairValueOfIssuanceOfCommonStockSharesApproved" id="huge_FairValueOfIssuanceOfCommonStockSharesApproved" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="FairValueOfShareBasedCompensationBonus" id="huge_FairValueOfShareBasedCompensationBonus" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="FairValueOfShares" id="huge_FairValueOfShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="FairValueOfSharesAndWarrantsAcquired" id="huge_FairValueOfSharesAndWarrantsAcquired" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FairValueOfWarrantLiability" id="huge_FairValueOfWarrantLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="FairValueOfWarrantLiabilityOfResidualAmount" id="huge_FairValueOfWarrantLiabilityOfResidualAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="FairValueOfWarrants" id="huge_FairValueOfWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="FairValueOfWarrantsIssued" id="huge_FairValueOfWarrantsIssued" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="Feb252018Member" id="huge_Feb252018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FindersFee" id="huge_FindersFee" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="FindersFeeShares" id="huge_FindersFeeShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="FirstRepublicCapitalCorporationMember" id="huge_FirstRepublicCapitalCorporationMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FormerChiefExecutiveOfficerMember" id="huge_FormerChiefExecutiveOfficerMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FormerChiefOperatingOfficerMember" id="huge_FormerChiefOperatingOfficerMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FSDBiosciencesMember" id="huge_FSDBiosciencesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FundsPaidForSettlementAgreement" id="huge_FundsPaidForSettlementAgreement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="FurnitureFixturesAndEquipmentMember" id="huge_FurnitureFixturesAndEquipmentMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FvPharmaIncMember" id="huge_FvPharmaIncMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GainLossOnChangeInFairValueOfDerivativeLiability" id="huge_GainLossOnChangeInFairValueOfDerivativeLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="GainLossOnSaleOfEquipment" id="huge_GainLossOnSaleOfEquipment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="GainLossOnSettlementOfFinancialLiability" id="huge_GainLossOnSettlementOfFinancialLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="GainOnSettlementOfDerivativeLiability" id="huge_GainOnSettlementOfDerivativeLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="GainOnSettlementOfFinancialLiability" id="huge_GainOnSettlementOfFinancialLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="GeneralAndAdministrativeExpenseContinuedAndDiscontinuedOperations" id="huge_GeneralAndAdministrativeExpenseContinuedAndDiscontinuedOperations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="GeneralAndAdministrativeExpenseDiscontinuedOperations" id="huge_GeneralAndAdministrativeExpenseDiscontinuedOperations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="GeneralOfficeInsuranceAndAdministrationExpenditures" id="huge_GeneralOfficeInsuranceAndAdministrationExpenditures" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="GrantDateAxis" id="huge_GrantDateAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="GrantDateDomain" id="huge_GrantDateDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GrossGeneralAndAdministrativeExpense" id="huge_GrossGeneralAndAdministrativeExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="GrossLossProfitBeforeFairValueAdjustments" id="huge_GrossLossProfitBeforeFairValueAdjustments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="GrossProfitLossBeforeFairValueAdjustments" id="huge_GrossProfitLossBeforeFairValueAdjustments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="GuaranteedMinimumLiquidationValueOfShares" id="huge_GuaranteedMinimumLiquidationValueOfShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="HarvestedCannabisMember" id="huge_HarvestedCannabisMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="HempProductsMember" id="huge_HempProductsMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="HeritageBuildingRestorationCommitmentMember" id="huge_HeritageBuildingRestorationCommitmentMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="HighTideIncMember" id="huge_HighTideIncMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="HugeShopsMember" id="huge_HugeShopsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ImpactOfPresentValue" id="huge_ImpactOfPresentValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ImpactOfPresentValueOnLeaseObligations" id="huge_ImpactOfPresentValueOnLeaseObligations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ImpairmentLossOfPropertyPlantAndEquipmentAndRightOfUseAsset" id="huge_ImpairmentLossOfPropertyPlantAndEquipmentAndRightOfUseAsset" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ImpairmentLossOnRightOfUseAsset" id="huge_ImpairmentLossOnRightOfUseAsset" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ImpairmentLossRecognisedInRightOfUseAsset" id="huge_ImpairmentLossRecognisedInRightOfUseAsset" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ImpairmentMember" id="huge_ImpairmentMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember" id="huge_IncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IncreaseDecreaseFromContributedSurplusToShareCapital" id="huge_IncreaseDecreaseFromContributedSurplusToShareCapital" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseDecreaseInFairValueOfOtherInvestments" id="huge_IncreaseDecreaseInFairValueOfOtherInvestments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="IncreaseDecreaseInSettlementOfLiabilityOfNotesPayable" id="huge_IncreaseDecreaseInSettlementOfLiabilityOfNotesPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseDecreaseThroughAcquisitionOfNetAssetsShares" id="huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IncreaseDecreaseThroughAcquisitionOfNetAssetsValue" id="huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseDecreaseThroughExerciseOfOptionShares" id="huge_IncreaseDecreaseThroughExerciseOfOptionShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IncreaseDecreaseThroughExerciseOfWarrantsShares" id="huge_IncreaseDecreaseThroughExerciseOfWarrantsShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IncreaseDecreaseThroughExpiryOfWarrantsShares" id="huge_IncreaseDecreaseThroughExpiryOfWarrantsShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IncreaseDecreaseThroughExpiryOfWarrantsValue" id="huge_IncreaseDecreaseThroughExpiryOfWarrantsValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset" id="huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares" id="huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IncreaseDecreaseThroughReverseAcquisition" id="huge_IncreaseDecreaseThroughReverseAcquisition" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseDecreaseThroughReverseAcquisitionShares" id="huge_IncreaseDecreaseThroughReverseAcquisitionShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IncreaseDecreaseThroughShareBasedPaymentTransactionsShares" id="huge_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IncreaseDecreaseThroughShareIssueRelatedCostShares" id="huge_IncreaseDecreaseThroughShareIssueRelatedCostShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IncreaseDecreaseThroughStockOptionsCancelled" id="huge_IncreaseDecreaseThroughStockOptionsCancelled" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseDecreaseThroughWarrantValuations" id="huge_IncreaseDecreaseThroughWarrantValuations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseDecreaseThroughWarrantValuationsShares" id="huge_IncreaseDecreaseThroughWarrantValuationsShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IncrementalBorrowingRateToDiscountLeaseLiabilities" id="huge_IncrementalBorrowingRateToDiscountLeaseLiabilities" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IndependentDirectorMember" id="huge_IndependentDirectorMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InsuredAmountForClaimSettlemnt" id="huge_InsuredAmountForClaimSettlemnt" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="InvestorRelationsExpenses" id="huge_InvestorRelationsExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="IssuanceCostOfCommonSharesAndWarrants" id="huge_IssuanceCostOfCommonSharesAndWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="IssuanceOfCommonSharesOfShareBasedBonusToEmployeesForPerformance" id="huge_IssuanceOfCommonSharesOfShareBasedBonusToEmployeesForPerformance" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IssuanceOfCommonStockForNotesPayable" id="huge_IssuanceOfCommonStockForNotesPayable" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IssuanceOfCommonStockOfBoardOfDirectorsInLieuOfCash" id="huge_IssuanceOfCommonStockOfBoardOfDirectorsInLieuOfCash" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IssuanceOfCommonStockOfDirectOffering" id="huge_IssuanceOfCommonStockOfDirectOffering" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IssuanceOfCommonStockOfShareBasedCompensation" id="huge_IssuanceOfCommonStockOfShareBasedCompensation" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IssuanceOfShares" id="huge_IssuanceOfShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IssuanceOfWarrantsOfDirectOffering" id="huge_IssuanceOfWarrantsOfDirectOffering" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Jan52018Member" id="huge_Jan52018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Jan52018WarrantMember" id="huge_Jan52018WarrantMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Jun112018Member" id="huge_Jun112018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Jun122018Member" id="huge_Jun122018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="KeyManagementAndDirectorsMember" id="huge_KeyManagementAndDirectorsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="KeyManagementPersonnelCarAllowance" id="huge_KeyManagementPersonnelCarAllowance" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="LeaseTermOnOfficeSpace" id="huge_LeaseTermOnOfficeSpace" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LegalEntitiesAxis" id="huge_LegalEntitiesAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="LegalEntitiesDomain" id="huge_LegalEntitiesDomain" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LegalProvision" id="huge_LegalProvision" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ListingExpense" id="huge_ListingExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="LossGainOnChangesInFairValueOfOtherInvestments" id="huge_LossGainOnChangesInFairValueOfOtherInvestments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="LossOnSaleOfEquipment" id="huge_LossOnSaleOfEquipment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="LossOnSaleOfInventory" id="huge_LossOnSaleOfInventory" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ManagementAndConsultingContractsMember" id="huge_ManagementAndConsultingContractsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ManagementFees" id="huge_ManagementFees" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="Mar222018Member" id="huge_Mar222018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Mar282018Member" id="huge_Mar282018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="March262018Member" id="huge_March262018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="March282018Member" id="huge_March282018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="March92018Member" id="huge_March92018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MarketPriceOfShares" id="huge_MarketPriceOfShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="MarketPriceOfWarrants" id="huge_MarketPriceOfWarrants" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MarketPriceShareOptionsGranted" id="huge_MarketPriceShareOptionsGranted" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MaximumAggregateOfferingPrice" id="huge_MaximumAggregateOfferingPrice" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="May242018Member" id="huge_May242018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="May242018WarrantMember" id="huge_May242018WarrantMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="May82018Member" id="huge_May82018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MealsAndEntertainment" id="huge_MealsAndEntertainment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="MinimumInvestmentReceivable" id="huge_MinimumInvestmentReceivable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="NetOperatingLossCarryforwardsLimitationsInUse" id="huge_NetOperatingLossCarryforwardsLimitationsInUse" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NetSellingPricePerGramForDryFlowerAfterHarvestCost" id="huge_NetSellingPricePerGramForDryFlowerAfterHarvestCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="NetSellingPricePerGramForDryTrimAfterHarvestCost" id="huge_NetSellingPricePerGramForDryTrimAfterHarvestCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="NonCapitalIncomeTaxLossesExpireOnTwoThousandFourty" id="huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandFourty" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight" id="huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFive" id="huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFive" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFour" id="huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFour" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine" id="huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySeven" id="huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySeven" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySix" id="huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySix" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyThree" id="huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyThree" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyTwo" id="huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyTwo" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="NonCapitalLossCarryforwards" id="huge_NonCapitalLossCarryforwards" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="NonCapitalLossCarryForwardsMember" id="huge_NonCapitalLossCarryForwardsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NonCapitalLossesMember" id="huge_NonCapitalLossesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NonRefundableSumDueAndPayableUponFirstNotificationOfFda" id="huge_NonRefundableSumDueAndPayableUponFirstNotificationOfFda" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFda" id="huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFda" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="NotesPayableMember" id="huge_NotesPayableMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NotesSettledThroughIssuanceOfShares" id="huge_NotesSettledThroughIssuanceOfShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="Nov12017Member" id="huge_Nov12017Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Nov122018Member" id="huge_Nov122018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Nov142017Member" id="huge_Nov142017Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Nov152018Member" id="huge_Nov152018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Nov212017Member" id="huge_Nov212017Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Nov262018Member" id="huge_Nov262018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfAdditionalSharesIssuedToSettleDerivativeLiability" id="huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfAgreement" id="huge_NumberOfAgreement" type="xbrli:integerItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfBrokerWarrantsGrantedForFeesAndCommissions" id="huge_NumberOfBrokerWarrantsGrantedForFeesAndCommissions" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfInvestmentSharesSold" id="huge_NumberOfInvestmentSharesSold" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfReplacementShareOptionsIssued" id="huge_NumberOfReplacementShareOptionsIssued" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfShareOptionsExercisedOrVestedInShareBasedPaymentArrangement" id="huge_NumberOfShareOptionsExercisedOrVestedInShareBasedPaymentArrangement" type="xbrli:decimalItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesAcquired" id="huge_NumberOfSharesAcquired" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesHeld" id="huge_NumberOfSharesHeld" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesHeldSubjectToEscrowArrangement" id="huge_NumberOfSharesHeldSubjectToEscrowArrangement" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesIssuedAsFindersFee" id="huge_NumberOfSharesIssuedAsFindersFee" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc" id="huge_NumberOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesIssuedForCompensationBonus" id="huge_NumberOfSharesIssuedForCompensationBonus" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesIssuedForDebtSettlement" id="huge_NumberOfSharesIssuedForDebtSettlement" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement" id="huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesIssuedInPrivatePlacement" id="huge_NumberOfSharesIssuedInPrivatePlacement" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesIssuedInShareExchange" id="huge_NumberOfSharesIssuedInShareExchange" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesIssuedThroughEquityDistributionAgreement" id="huge_NumberOfSharesIssuedThroughEquityDistributionAgreement" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesOutstandingSubjectToEscrowConditions" id="huge_NumberOfSharesOutstandingSubjectToEscrowConditions" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesSold" id="huge_NumberOfSharesSold" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesSubscribed" id="huge_NumberOfSharesSubscribed" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfStockOptionsApprovedForIssuance" id="huge_NumberOfStockOptionsApprovedForIssuance" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfWarrantsAcquired" id="huge_NumberOfWarrantsAcquired" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfWarrantsExercised" id="huge_NumberOfWarrantsExercised" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfWarrantsExpired" id="huge_NumberOfWarrantsExpired" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfWarrantsHeld" id="huge_NumberOfWarrantsHeld" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfWarrantsIssued" id="huge_NumberOfWarrantsIssued" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfWarrantsOutstanding" id="huge_NumberOfWarrantsOutstanding" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Oct202017Member" id="huge_Oct202017Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OfficeAndGeneralExpenses" id="huge_OfficeAndGeneralExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="OfficeLeaseAgreementMember" id="huge_OfficeLeaseAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OperatingExpensesAbstract" id="huge_OperatingExpensesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OperatingLeaseImpactOfPresentValue" id="huge_OperatingLeaseImpactOfPresentValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="OtherAllowances" id="huge_OtherAllowances" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="OtherFinancialLiabilitiesMember" id="huge_OtherFinancialLiabilitiesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OtherGeneralAndAdministrativeExpenses" id="huge_OtherGeneralAndAdministrativeExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="OtherInventoryMember" id="huge_OtherInventoryMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OtherInvestmentMember" id="huge_OtherInvestmentMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OtherInvestmentsNameOfEntityAxis" id="huge_OtherInvestmentsNameOfEntityAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="OtherInvestmentsNameOfEntityDomain" id="huge_OtherInvestmentsNameOfEntityDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OutstandingCommitmentToPurchaseAdditionalProduct" id="huge_OutstandingCommitmentToPurchaseAdditionalProduct" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="PartialPaymentOfSettlementAmount" id="huge_PartialPaymentOfSettlementAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="PatentMaintenanceFee" id="huge_PatentMaintenanceFee" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="PaymentMadeToBeUnpaidWagesAndUnpaidHoliday" id="huge_PaymentMadeToBeUnpaidWagesAndUnpaidHoliday" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="PaymentOfExpenses" id="huge_PaymentOfExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="PaymentOfOperatingLease" id="huge_PaymentOfOperatingLease" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="PercentageOfAggregateDiscountForSharesInEscrow" id="huge_PercentageOfAggregateDiscountForSharesInEscrow" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfDeclineInFairValueOfInvestment" id="huge_PercentageOfDeclineInFairValueOfInvestment" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfDiscountForTotalProceedsOfSharesAndWarrantsSold" id="huge_PercentageOfDiscountForTotalProceedsOfSharesAndWarrantsSold" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights" id="huge_PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights" type="num:percentItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition" id="huge_PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition" id="huge_PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition" id="huge_PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights" id="huge_PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights" type="num:percentItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PermanentDifferences" id="huge_PermanentDifferences" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PharmadrugIncMember" id="huge_PharmadrugIncMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PharmadrugProductionGMBHMember" id="huge_PharmadrugProductionGMBHMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PharmastripCorpMember" id="huge_PharmastripCorpMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PreacquisitionNetOperatingLossCarryforwards" id="huge_PreacquisitionNetOperatingLossCarryforwards" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="PresidentAndChiefExecutiveOfficerMember" id="huge_PresidentAndChiefExecutiveOfficerMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PresidentAndDirectorMember" id="huge_PresidentAndDirectorMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PresidentOfFsdBiosciencesMember" id="huge_PresidentOfFsdBiosciencesMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PresidentOfFSDMember" id="huge_PresidentOfFSDMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PresidentOfFVPharmaMember" id="huge_PresidentOfFVPharmaMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PresidentsMember" id="huge_PresidentsMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PrincipalAmountOfBorrowings" id="huge_PrincipalAmountOfBorrowings" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="PrismicPharmaceuticalMember" id="huge_PrismicPharmaceuticalMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PrismicPharmaceuticalsIncMember" id="huge_PrismicPharmaceuticalsIncMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ProceedsFromExerciseOfWarrants" id="huge_ProceedsFromExerciseOfWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProceedsFromNotesPayable" id="huge_ProceedsFromNotesPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProceedsFromSaleOfSharesAndWarrants" id="huge_ProceedsFromSaleOfSharesAndWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProceedsFromSalesOfInventory" id="huge_ProceedsFromSalesOfInventory" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProductionAndGrowingExpense" id="huge_ProductionAndGrowingExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProductionAndGrowingExpenses" id="huge_ProductionAndGrowingExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProductionEquipmentMember" id="huge_ProductionEquipmentMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ProfitLossBeforeOtherIncomeAndGainLossOnSaleOfEquipmentFromDiscontinuedOperations" id="huge_ProfitLossBeforeOtherIncomeAndGainLossOnSaleOfEquipmentFromDiscontinuedOperations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ProfitLossOnChangeInFairValue" id="huge_ProfitLossOnChangeInFairValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="PropertyPlantAndEquipmentAssetsHeldForSale" id="huge_PropertyPlantAndEquipmentAssetsHeldForSale" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="PropertyPlantAndEquipmentsMember" id="huge_PropertyPlantAndEquipmentsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ProvisionForEmployeeRelatedLiability" id="huge_ProvisionForEmployeeRelatedLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="QuantitiesAvailableToSupplyInFifthFiscalYear" id="huge_QuantitiesAvailableToSupplyInFifthFiscalYear" type="num:massItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="QuantitiesAvailableToSupplyInFourthFiscalYear" id="huge_QuantitiesAvailableToSupplyInFourthFiscalYear" type="num:massItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="QuantitiesAvailableToSupplyInNextFiscalYear" id="huge_QuantitiesAvailableToSupplyInNextFiscalYear" type="num:massItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="QuantitiesAvailableToSupplyInSecondFiscalYear" id="huge_QuantitiesAvailableToSupplyInSecondFiscalYear" type="num:massItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="QuantitiesAvailableToSupplyInThirdFiscalYear" id="huge_QuantitiesAvailableToSupplyInThirdFiscalYear" type="num:massItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="QuotedMarketPriceOfInvestments" id="huge_QuotedMarketPriceOfInvestments" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RecognitionOfLossOnChangeInFairValueOfDerivativeLiability" id="huge_RecognitionOfLossOnChangeInFairValueOfDerivativeLiability" type="xbrli:monetaryItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RentReceivable" id="huge_RentReceivable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ResearchAndDevelopmentAgreementMember" id="huge_ResearchAndDevelopmentAgreementMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RetrospectiveApplicationAndRetrospectiveRestatementLineItems" id="huge_RetrospectiveApplicationAndRetrospectiveRestatementLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RetrospectiveApplicationAndRetrospectiveRestatementTable" id="huge_RetrospectiveApplicationAndRetrospectiveRestatementTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="ReverseTakeoverTransaction" id="huge_ReverseTakeoverTransaction" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RightOfUseAssetsAndLeaseObligations" id="huge_RightOfUseAssetsAndLeaseObligations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RiskFreeInterestRateOfWarrants" id="huge_RiskFreeInterestRateOfWarrants" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RiskFreeInterestRateOfWarrantsGranted" id="huge_RiskFreeInterestRateOfWarrantsGranted" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RiskFreeInterestRateOfWarrantsLiability" id="huge_RiskFreeInterestRateOfWarrantsLiability" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RiskFreeRateOfWarrants" id="huge_RiskFreeRateOfWarrants" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SalesTaxRecoverable" id="huge_SalesTaxRecoverable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ScheduleOfCashFlowsFromDiscontinuedOperationsExplanatory" id="huge_ScheduleOfCashFlowsFromDiscontinuedOperationsExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ScheduleOfComponentsOfAssetsHeldForSaleExplanatory" id="huge_ScheduleOfComponentsOfAssetsHeldForSaleExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ScheduleOfNetLossAndComprehensiveLossFromDiscontinuedOperationsExplanatory" id="huge_ScheduleOfNetLossAndComprehensiveLossFromDiscontinuedOperationsExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ScheduleOfNonCapitalLossCarryforwardsTableTextBlock" id="huge_ScheduleOfNonCapitalLossCarryforwardsTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ScheduleOfStockClassLineItems" id="huge_ScheduleOfStockClassLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ScheduleOfStockClassTable" id="huge_ScheduleOfStockClassTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="ScheduleOfWarrantTable" id="huge_ScheduleOfWarrantTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory" id="huge_SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ScicannTherapeuticsIncMember" id="huge_ScicannTherapeuticsIncMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SecuritiesExchangeAgreementMember" id="huge_SecuritiesExchangeAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees" id="huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="Sep102018Member" id="huge_Sep102018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Sep112018Member" id="huge_Sep112018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Sep142018Member" id="huge_Sep142018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Sep152017Member" id="huge_Sep152017Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Sep152018Member" id="huge_Sep152018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Sep172017Member" id="huge_Sep172017Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Sep262018Member" id="huge_Sep262018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="September292018Member" id="huge_September292018Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="September302017Member" id="huge_September302017Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareBasedPaymentExpenses" id="huge_ShareBasedPaymentExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ShareExchangeAgreementMember" id="huge_ShareExchangeAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareholderAndPublicCompanyCosts" id="huge_ShareholderAndPublicCompanyCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ShareholdersAndPublicCompanyCosts" id="huge_ShareholdersAndPublicCompanyCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ShareIssuanceCostBookedDirectlyToEquity" id="huge_ShareIssuanceCostBookedDirectlyToEquity" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ShareIssueCostsMember" id="huge_ShareIssueCostsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareIssuePricePerShare" id="huge_ShareIssuePricePerShare" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareOptionsAbstract" id="huge_ShareOptionsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SharePriceOfSharesAndWarrants" id="huge_SharePriceOfSharesAndWarrants" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SharePrices" id="huge_SharePrices" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SharePricesOfWarrantsLiability" id="huge_SharePricesOfWarrantsLiability" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SharePurchaseAndSaleAgreementsMember" id="huge_SharePurchaseAndSaleAgreementsMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareSplitRatio" id="huge_ShareSplitRatio" type="xbrli:pureItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShortTermNotes" id="huge_ShortTermNotes" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="SolarvestBioEnergyIncMember" id="huge_SolarvestBioEnergyIncMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SpecialWarrantsMember" id="huge_SpecialWarrantsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StockOptionsMember" id="huge_StockOptionsMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StockOptionsOfAcquirer" id="huge_StockOptionsOfAcquirer" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="StockPromotionExpense" id="huge_StockPromotionExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="StrategicInvestmentValue" id="huge_StrategicInvestmentValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="SubscriptionPricePerShare" id="huge_SubscriptionPricePerShare" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SubsequentEventsMember" id="huge_SubsequentEventsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SubsidiariesOneMember" id="huge_SubsidiariesOneMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SubsidiariesTwoMember" id="huge_SubsidiariesTwoMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SummaryOfSignificantAccountingPoliciesAbstract" id="huge_SummaryOfSignificantAccountingPoliciesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SummaryOfSignificantAccountingPoliciesTable" id="huge_SummaryOfSignificantAccountingPoliciesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="SupplementalInformationAbstract" id="huge_SupplementalInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SupplyAgreementMember" id="huge_SupplyAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SupplyAgreementOptionToPurchaseAmount" id="huge_SupplyAgreementOptionToPurchaseAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="SupplyAgreementOptionToPurchasePeriod" id="huge_SupplyAgreementOptionToPurchasePeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SupplyAgreementOptionToPurchasePricePerKilogramPerPercentOfCannabidiolExtracted" id="huge_SupplyAgreementOptionToPurchasePricePerKilogramPerPercentOfCannabidiolExtracted" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TaxEffectOfDeferredTaxAssetNotRecognized" id="huge_TaxEffectOfDeferredTaxAssetNotRecognized" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="TaxEffectOfTemporaryDifferences" id="huge_TaxEffectOfTemporaryDifferences" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="TemporaryDifferences" id="huge_TemporaryDifferences" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TermsOfWarrantGranted" id="huge_TermsOfWarrantGranted" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ThomasFairfullMember" id="huge_ThomasFairfullMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TotalCashTransactionCosts" id="huge_TotalCashTransactionCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="TransactionCostsAllocatedToWarrants" id="huge_TransactionCostsAllocatedToWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="TypeOfArrangementsAxis" id="huge_TypeOfArrangementsAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="TypeOfArrangementsDomain" id="huge_TypeOfArrangementsDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TypeOfInventoriesAxis" id="huge_TypeOfInventoriesAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="TypeOfInventoriesDomain" id="huge_TypeOfInventoriesDomain" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UndiscountedLeasePaymentsPayable" id="huge_UndiscountedLeasePaymentsPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="UnobservableInputUsedToEstimateFairValueOfBiologicalAssetsTableTextBlock" id="huge_UnobservableInputUsedToEstimateFairValueOfBiologicalAssetsTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UnrealizedLoss" id="huge_UnrealizedLoss" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="UnrealizedLossOnChangesInFairValueOfBiologicalAssets" id="huge_UnrealizedLossOnChangesInFairValueOfBiologicalAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="UnrestrictedClassBSharesMember" id="huge_UnrestrictedClassBSharesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ValueOfBrokerWarrantsIssuedInPrivatePlacements" id="huge_ValueOfBrokerWarrantsIssuedInPrivatePlacements" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ValueOfCommonStockForNotesPayable" id="huge_ValueOfCommonStockForNotesPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ValueOfSharesAcquired" id="huge_ValueOfSharesAcquired" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ValueOfSharesIssued" id="huge_ValueOfSharesIssued" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ValueOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc" id="huge_ValueOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ValueOfSharesIssuedForDebtSettlement" id="huge_ValueOfSharesIssuedForDebtSettlement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ValueOfSharesIssuedInPrivatePlacement" id="huge_ValueOfSharesIssuedInPrivatePlacement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ValueOfSharesIssuedInShareExchange" id="huge_ValueOfSharesIssuedInShareExchange" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ValueOfStockOptionsExercised" id="huge_ValueOfStockOptionsExercised" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement" id="huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ValueOfTradeAndOtherPayableOfSharesBasedCompensation" id="huge_ValueOfTradeAndOtherPayableOfSharesBasedCompensation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ValueOfWarrantsExercised" id="huge_ValueOfWarrantsExercised" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ValueOfWarrantsOfResidualValue" id="huge_ValueOfWarrantsOfResidualValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantExercisePrice" id="huge_WarrantExercisePrice" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantLiabilitiesAbstract" id="huge_WarrantLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantLiabilitiesLineItems" id="huge_WarrantLiabilitiesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantLiabilitiesTable" id="huge_WarrantLiabilitiesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="WarrantLineItems" id="huge_WarrantLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Warrants" id="huge_Warrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="WarrantsAbstract" id="huge_WarrantsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsByExpiryDateAtAugust1St2021Member" id="huge_WarrantsByExpiryDateAtAugust1St2021Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsByExpiryDateAtAugust6Th2020Member" id="huge_WarrantsByExpiryDateAtAugust6Th2020Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsByExpiryDateAtDecember12Th2019Member" id="huge_WarrantsByExpiryDateAtDecember12Th2019Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsByExpiryDateAtDecember29Th2019Member" id="huge_WarrantsByExpiryDateAtDecember29Th2019Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsByExpiryDateAtJanuary16Th2026Member" id="huge_WarrantsByExpiryDateAtJanuary16Th2026Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsByExpiryDateAtJanuary20Th2026Member" id="huge_WarrantsByExpiryDateAtJanuary20Th2026Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsByExpiryDateAtJanuary5Th2020Member" id="huge_WarrantsByExpiryDateAtJanuary5Th2020Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsByExpiryDateAtJuly24Th2023Member" id="huge_WarrantsByExpiryDateAtJuly24Th2023Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsByExpiryDateAtJune8Th2025Member" id="huge_WarrantsByExpiryDateAtJune8Th2025Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsByExpiryDateAtMay10Th2025Member" id="huge_WarrantsByExpiryDateAtMay10Th2025Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsByExpiryDateAtMay17Th2025Member" id="huge_WarrantsByExpiryDateAtMay17Th2025Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsByExpiryDateAtMay20Th2023Member" id="huge_WarrantsByExpiryDateAtMay20Th2023Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsByExpiryDateAtMay24Th2022Member" id="huge_WarrantsByExpiryDateAtMay24Th2022Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsByExpiryDateAtMay31St2025Member" id="huge_WarrantsByExpiryDateAtMay31St2025Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsByExpiryDateAtMay4Th2025Member" id="huge_WarrantsByExpiryDateAtMay4Th2025Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsByExpiryDateAtNovember14Th2019Member" id="huge_WarrantsByExpiryDateAtNovember14Th2019Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsByExpiryDateAtNovember1St2019Member" id="huge_WarrantsByExpiryDateAtNovember1St2019Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsByExpiryDateAtNovember21St2019Member" id="huge_WarrantsByExpiryDateAtNovember21St2019Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsByExpiryDateAtNovember30Th2020Member" id="huge_WarrantsByExpiryDateAtNovember30Th2020Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsByExpiryDateAtOctober20Th2020Member" id="huge_WarrantsByExpiryDateAtOctober20Th2020Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsByExpiryDateAtSeptember11Th2023Member" id="huge_WarrantsByExpiryDateAtSeptember11Th2023Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsByExpiryDateAtSeptember15Th2022Member" id="huge_WarrantsByExpiryDateAtSeptember15Th2022Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsIssueDateAxis" id="huge_WarrantsIssueDateAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="WarrantsIssueDateDomain" id="huge_WarrantsIssueDateDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsIssuedForPrivatePlacement" id="huge_WarrantsIssuedForPrivatePlacement" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsLiability" id="huge_WarrantsLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="WarrantsMember" id="huge_WarrantsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsOptionsOfAcquirer" id="huge_WarrantsOptionsOfAcquirer" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="WeightedAverageExercisePriceForReplacementOfShareOptions" id="huge_WeightedAverageExercisePriceForReplacementOfShareOptions" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WeightedAverageExercisePricesWarrantExercised" id="huge_WeightedAverageExercisePricesWarrantExercised" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WeightedAverageExercisePricesWarrantExpired" id="huge_WeightedAverageExercisePricesWarrantExpired" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WeightedAverageExercisePricesWarrantIssued" id="huge_WeightedAverageExercisePricesWarrantIssued" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WeightedAverageExercisePriceWarrantsOutstanding" id="huge_WeightedAverageExercisePriceWarrantsOutstanding" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WeightedAverageSharePriceOfWarrants" id="huge_WeightedAverageSharePriceOfWarrants" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WorkingCapitalSurplus" id="huge_WorkingCapitalSurplus" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ZeeshanSaeedMember" id="huge_ZeeshanSaeedMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>13
<FILENAME>huge-20201231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION" roleURI="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#CONSOLIDATEDSTATEMENTSOFLOSSANDCOMPREHENSIVELOSS" roleURI="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFLOSSANDCOMPREHENSIVELOSS"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#IncomeTaxesScheduleOfNoncapitalLossCarryforwardsDetails" roleURI="http://www.fsdpharma.com/role/IncomeTaxesScheduleOfNoncapitalLossCarryforwardsDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#IncomeTaxesScheduleOfProvisionForIncomeTaxesDetails" roleURI="http://www.fsdpharma.com/role/IncomeTaxesScheduleOfProvisionForIncomeTaxesDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#IncomeTaxesScheduleOfTemporaryDifferencesForWhichDeferredTaxAssetsNotRecognisedDetails" roleURI="http://www.fsdpharma.com/role/IncomeTaxesScheduleOfTemporaryDifferencesForWhichDeferredTaxAssetsNotRecognisedDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#RelatedPartyTransactionsScheduleOfKeyManagementPersonnelCompensationDetails" roleURI="http://www.fsdpharma.com/role/RelatedPartyTransactionsScheduleOfKeyManagementPersonnelCompensationDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails" roleURI="http://www.fsdpharma.com/role/TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#IncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails" roleURI="http://www.fsdpharma.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails"/>
  <calculationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_4"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CashAcquiredOnAcquisition" xlink:label="loc_huge_CashAcquiredOnAcquisition_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RepaymentsOfBondsNotesAndDebentures" xlink:label="loc_ifrs-full_RepaymentsOfBondsNotesAndDebentures_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromExerciseOfOptions" xlink:label="loc_ifrs-full_ProceedsFromExerciseOfOptions_13"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProceedsFromExerciseOfWarrants" xlink:label="loc_huge_ProceedsFromExerciseOfWarrants_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations_16"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_4" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_4" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_4" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_4" xlink:to="loc_huge_CashAcquiredOnAcquisition_4" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_4" xlink:to="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_5" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_4" xlink:to="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_6" order="20" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_4" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_8" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_10" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_10" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_10" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_10" xlink:to="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_10" order="0" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_10" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_11" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_10" xlink:to="loc_ifrs-full_RepaymentsOfBondsNotesAndDebentures_12" order="20" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_10" xlink:to="loc_ifrs-full_ProceedsFromExerciseOfOptions_13" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_10" xlink:to="loc_huge_ProceedsFromExerciseOfWarrants_14" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_10" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations_16" order="10" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-full_Assets_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:label="loc_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="loc_ifrs-full_CurrentPrepaidExpenses_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentBiologicalAssets" xlink:label="loc_ifrs-full_CurrentBiologicalAssets_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:label="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-full_EquityAndLiabilities_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-full_Liabilities_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:label="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued" xlink:label="loc_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_18"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CurrentWarrantsLiability" xlink:label="loc_huge_CurrentWarrantsLiability_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_22"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Assets_0" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Assets_0" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Assets_0" xlink:to="loc_ifrs-full_RightofuseAssets_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Assets_0" xlink:to="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Assets_0" xlink:to="loc_ifrs-full_CurrentAssets_5" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_5" xlink:to="loc_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_5" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_5" xlink:to="loc_ifrs-full_Inventories_5" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_5" xlink:to="loc_ifrs-full_CurrentPrepaidExpenses_6" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_5" xlink:to="loc_ifrs-full_TradeAndOtherCurrentReceivables_7" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_5" xlink:to="loc_ifrs-full_CurrentBiologicalAssets_8" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_5" xlink:to="loc_ifrs-full_CashAndCashEquivalents_9" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_5" xlink:to="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_11" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAndLiabilities_13" xlink:to="loc_ifrs-full_Liabilities_14" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Liabilities_14" xlink:to="loc_ifrs-full_NoncurrentLeaseLiabilities_14" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Liabilities_14" xlink:to="loc_ifrs-full_CurrentLiabilities_15" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_15" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayables_15" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_15" xlink:to="loc_ifrs-full_CurrentLeaseLiabilities_16" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_15" xlink:to="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_17" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_15" xlink:to="loc_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_18" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_15" xlink:to="loc_huge_CurrentWarrantsLiability_19" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAndLiabilities_13" xlink:to="loc_ifrs-full_Equity_22" order="10" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFLOSSANDCOMPREHENSIVELOSS">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromContinuingOperations" xlink:label="loc_ifrs-full_ProfitLossFromContinuingOperations_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesRecognisedInProfitOrLossAttributableToChangeInUnrealisedGainsOrLossesForAssetsHeldAtEndOfPeriodFairValueMeasurement" xlink:label="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossAttributableToChangeInUnrealisedGainsOrLossesForAssetsHeldAtEndOfPeriodFairValueMeasurement_4"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GainLossOnSettlementOfFinancialLiability" xlink:label="loc_huge_GainLossOnSettlementOfFinancialLiability_5"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LossGainOnChangesInFairValueOfOtherInvestments" xlink:label="loc_huge_LossGainOnChangesInFairValueOfOtherInvestments_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherIncome" xlink:label="loc_ifrs-full_OtherIncome_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives" xlink:label="loc_ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseByNature" xlink:label="loc_ifrs-full_ExpenseByNature_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_GeneralAndAdministrativeExpense_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_15"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LegalProvision" xlink:label="loc_huge_LegalProvision_16"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ImpairmentLossOnRightOfUseAsset" xlink:label="loc_huge_ImpairmentLossOnRightOfUseAsset_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationAndAmortisationExpense" xlink:label="loc_ifrs-full_DepreciationAndAmortisationExpense_18"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncome_0" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncome_0" xlink:to="loc_ifrs-full_ProfitLoss_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss_2" xlink:to="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_2" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss_2" xlink:to="loc_ifrs-full_ProfitLossFromContinuingOperations_3" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromContinuingOperations_3" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities_3" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromContinuingOperations_3" xlink:to="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossAttributableToChangeInUnrealisedGainsOrLossesForAssetsHeldAtEndOfPeriodFairValueMeasurement_4" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromContinuingOperations_3" xlink:to="loc_huge_GainLossOnSettlementOfFinancialLiability_5" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromContinuingOperations_3" xlink:to="loc_huge_LossGainOnChangesInFairValueOfOtherInvestments_6" order="30" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromContinuingOperations_3" xlink:to="loc_ifrs-full_FinanceCosts_7" order="40" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromContinuingOperations_3" xlink:to="loc_ifrs-full_OtherIncome_8" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromContinuingOperations_3" xlink:to="loc_ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives_9" order="60" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ExpenseByNature_12" xlink:to="loc_ifrs-full_GeneralAndAdministrativeExpense_13" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ExpenseByNature_12" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_14" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ExpenseByNature_12" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_15" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ExpenseByNature_12" xlink:to="loc_huge_LegalProvision_16" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ExpenseByNature_12" xlink:to="loc_huge_ImpairmentLossOnRightOfUseAsset_17" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ExpenseByNature_12" xlink:to="loc_ifrs-full_DepreciationAndAmortisationExpense_18" order="50" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/IncomeTaxesScheduleOfNoncapitalLossCarryforwardsDetails">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalLossCarryforwards" xlink:label="loc_huge_NonCapitalLossCarryforwards_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyTwo" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyTwo_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyThree" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyThree_2"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFour" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFour_3"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFive" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFive_4"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySix" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySix_5"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySeven" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySeven_6"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight_7"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine_8"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandFourty" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandFourty_9"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_huge_NonCapitalLossCarryforwards_0" xlink:to="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyTwo_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_huge_NonCapitalLossCarryforwards_0" xlink:to="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyThree_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_huge_NonCapitalLossCarryforwards_0" xlink:to="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFour_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_huge_NonCapitalLossCarryforwards_0" xlink:to="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFive_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_huge_NonCapitalLossCarryforwards_0" xlink:to="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySix_5" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_huge_NonCapitalLossCarryforwards_0" xlink:to="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySeven_6" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_huge_NonCapitalLossCarryforwards_0" xlink:to="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight_7" order="60" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_huge_NonCapitalLossCarryforwards_0" xlink:to="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine_8" order="70" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_huge_NonCapitalLossCarryforwards_0" xlink:to="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandFourty_9" order="80" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/IncomeTaxesScheduleOfProvisionForIncomeTaxesDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxExpenseIncome" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncome_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxEffectOfForeignTaxRates" xlink:label="loc_ifrs-full_TaxEffectOfForeignTaxRates_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TaxEffectOfDeferredTaxAssetNotRecognized" xlink:label="loc_huge_TaxEffectOfDeferredTaxAssetNotRecognized_2"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BookToFilingAdjustments" xlink:label="loc_huge_BookToFilingAdjustments_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:label="loc_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_4"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShareIssuanceCostBookedDirectlyToEquity" xlink:label="loc_huge_ShareIssuanceCostBookedDirectlyToEquity_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:label="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_6"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_DeferredTaxExpenseIncome_0" xlink:to="loc_ifrs-full_TaxEffectOfForeignTaxRates_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_DeferredTaxExpenseIncome_0" xlink:to="loc_huge_TaxEffectOfDeferredTaxAssetNotRecognized_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_DeferredTaxExpenseIncome_0" xlink:to="loc_huge_BookToFilingAdjustments_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_DeferredTaxExpenseIncome_0" xlink:to="loc_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_DeferredTaxExpenseIncome_0" xlink:to="loc_huge_ShareIssuanceCostBookedDirectlyToEquity_5" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_DeferredTaxExpenseIncome_0" xlink:to="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_6" order="50" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/IncomeTaxesScheduleOfTemporaryDifferencesForWhichDeferredTaxAssetsNotRecognisedDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NetDeferredTaxAssets" xlink:label="loc_ifrs-full_NetDeferredTaxAssets_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfIfrs16ForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfIfrs16ForWhichNoDeferredTaxAssetIsRecognised_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised_2"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_3"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfForeignUnrealizedForeignExchangeLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfForeignUnrealizedForeignExchangeLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_4"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised_5"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_6"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_7"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised_8"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NetDeferredTaxAssets_0" xlink:to="loc_huge_DeductibleTemporaryDifferencesOfIfrs16ForWhichNoDeferredTaxAssetIsRecognised_1" order="0" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NetDeferredTaxAssets_0" xlink:to="loc_huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised_2" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NetDeferredTaxAssets_0" xlink:to="loc_huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_3" order="20" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NetDeferredTaxAssets_0" xlink:to="loc_huge_DeductibleTemporaryDifferencesOfForeignUnrealizedForeignExchangeLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_4" order="30" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NetDeferredTaxAssets_0" xlink:to="loc_huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised_5" order="40" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NetDeferredTaxAssets_0" xlink:to="loc_huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_6" order="50" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NetDeferredTaxAssets_0" xlink:to="loc_huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_7" order="60" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NetDeferredTaxAssets_0" xlink:to="loc_huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised_8" order="70" use="optional" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/RelatedPartyTransactionsScheduleOfKeyManagementPersonnelCompensationDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensation_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_2"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation_0" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation_0" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_2" order="10" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherReceivables" xlink:label="loc_ifrs-full_TradeAndOtherReceivables_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SalesTaxRecoverable" xlink:label="loc_huge_SalesTaxRecoverable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestReceivable" xlink:label="loc_ifrs-full_InterestReceivable_2"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_RentReceivable" xlink:label="loc_huge_RentReceivable_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherReceivables" xlink:label="loc_ifrs-full_OtherReceivables_4"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_TradeAndOtherReceivables_0" xlink:to="loc_huge_SalesTaxRecoverable_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_TradeAndOtherReceivables_0" xlink:to="loc_ifrs-full_InterestReceivable_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_TradeAndOtherReceivables_0" xlink:to="loc_huge_RentReceivable_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_TradeAndOtherReceivables_0" xlink:to="loc_ifrs-full_OtherReceivables_4" order="30" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeferredTaxAssetLiabilityNotRecognized" xlink:label="loc_huge_DeferredTaxAssetLiabilityNotRecognized_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeferredTaxAssetsOtherInvestments" xlink:label="loc_huge_DeferredTaxAssetsOtherInvestments_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward" xlink:label="loc_huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward_2"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_huge_DeferredTaxAssetLiabilityNotRecognized_0" xlink:to="loc_huge_DeferredTaxAssetsOtherInvestments_1" order="0" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_huge_DeferredTaxAssetLiabilityNotRecognized_0" xlink:to="loc_huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward_2" order="10" use="optional" weight="-1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>14
<FILENAME>huge-20201231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <!-- INTEGIX by Ez-XBRL -->
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#AcquisitionOfPrismicPharmaceuticalNarrativeDetails" roleURI="http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#AcquisitionOfPrismicPharmaceuticalScheduleOfBlackScholesOptionsPricingModelDetails" roleURI="http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalScheduleOfBlackScholesOptionsPricingModelDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#AcquisitionOfPrismicPharmaceuticalScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" roleURI="http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#CommitmentsAndContingenciesNarrativeDetails" roleURI="http://www.fsdpharma.com/role/CommitmentsAndContingenciesNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#CommitmentsAndContingenciesScheduleOfQuantitiesOfCannabisAvailableToSupplyByFiscalPeriodDetails" roleURI="http://www.fsdpharma.com/role/CommitmentsAndContingenciesScheduleOfQuantitiesOfCannabisAvailableToSupplyByFiscalPeriodDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" roleURI="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION" roleURI="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#FinancialInstrumentsAndRiskExposuresNarrativeDetails" roleURI="http://www.fsdpharma.com/role/FinancialInstrumentsAndRiskExposuresNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#FinancialInstrumentsAndRiskExposuresScheduleOfCreditRiskDetails" roleURI="http://www.fsdpharma.com/role/FinancialInstrumentsAndRiskExposuresScheduleOfCreditRiskDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#FinancialInstrumentsAndRiskExposuresScheduleOfFinancialAssetsAndFinancialLiabilitiesDetails" roleURI="http://www.fsdpharma.com/role/FinancialInstrumentsAndRiskExposuresScheduleOfFinancialAssetsAndFinancialLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#FinancialInstrumentsAndRiskExposuresScheduleOfFinancialObligationsBasedOnTheirDueDatesDetails" roleURI="http://www.fsdpharma.com/role/FinancialInstrumentsAndRiskExposuresScheduleOfFinancialObligationsBasedOnTheirDueDatesDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#IntangibleAssetsScheduleOfIntangibleAssetsDetails" roleURI="http://www.fsdpharma.com/role/IntangibleAssetsScheduleOfIntangibleAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#LeaseObligationsScheduleOfMaturityAnalysisOfOperatingLeasePaymentsDetails" roleURI="http://www.fsdpharma.com/role/LeaseObligationsScheduleOfMaturityAnalysisOfOperatingLeasePaymentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#LossPerShareDetails" roleURI="http://www.fsdpharma.com/role/LossPerShareDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#NatureOfBusinessScheduleOfOwnershipPercentageInSubsidiariesDetails" roleURI="http://www.fsdpharma.com/role/NatureOfBusinessScheduleOfOwnershipPercentageInSubsidiariesDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#NotesPayableNarrativeDetails" roleURI="http://www.fsdpharma.com/role/NotesPayableNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#NotesPayableScheduleOfNotesPayableDetails" roleURI="http://www.fsdpharma.com/role/NotesPayableScheduleOfNotesPayableDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#OtherInvestmentsNarrativeDetails" roleURI="http://www.fsdpharma.com/role/OtherInvestmentsNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#OtherInvestmentsScheduleOfOtherInvestmentsDetails" roleURI="http://www.fsdpharma.com/role/OtherInvestmentsScheduleOfOtherInvestmentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#RelatedPartyTransactionsNarrativeDetails" roleURI="http://www.fsdpharma.com/role/RelatedPartyTransactionsNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#SharebasedCompensationNarrativeDetails" roleURI="http://www.fsdpharma.com/role/SharebasedCompensationNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#SharebasedCompensationScheduleOfChangesInNumberOfShareOptionsDetails" roleURI="http://www.fsdpharma.com/role/SharebasedCompensationScheduleOfChangesInNumberOfShareOptionsDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#SharebasedCompensationScheduleOfExercisePriceAndWeightedAverageContractualTermOfShareOptionsOutstandingAndExercisableDetails" roleURI="http://www.fsdpharma.com/role/SharebasedCompensationScheduleOfExercisePriceAndWeightedAverageContractualTermOfShareOptionsOutstandingAndExercisableDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#SharebasedCompensationScheduleOfFairValueAssumptionsOfShareOptionsGrantedDetails" roleURI="http://www.fsdpharma.com/role/SharebasedCompensationScheduleOfFairValueAssumptionsOfShareOptionsGrantedDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#ShareCapitalNarrativeDetails" roleURI="http://www.fsdpharma.com/role/ShareCapitalNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#ShareCapitalScheduleOfFairValueAssumptionsOfWarrantsDetails" roleURI="http://www.fsdpharma.com/role/ShareCapitalScheduleOfFairValueAssumptionsOfWarrantsDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#ShareCapitalScheduleOfReconciliationOfTheShareCapitalDetails" roleURI="http://www.fsdpharma.com/role/ShareCapitalScheduleOfReconciliationOfTheShareCapitalDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#ShareCapitalScheduleOfWarrantsOutstandingAndExercisePriceDetails" roleURI="http://www.fsdpharma.com/role/ShareCapitalScheduleOfWarrantsOutstandingAndExercisePriceDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#SignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfAssetsDetails" roleURI="http://www.fsdpharma.com/role/SignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#SubsequentEventsNarrativeDetails" roleURI="http://www.fsdpharma.com/role/SubsequentEventsNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#BasisOfPresentationScheduleOfRestatementOfPriorPeriodInformationDetails" roleURI="http://www.fsdpharma.com/role/BasisOfPresentationScheduleOfRestatementOfPriorPeriodInformationDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#AssetsHeldForSaleDetails" roleURI="http://www.fsdpharma.com/role/AssetsHeldForSaleDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#AssetsHeldForSaleDetails2" roleURI="http://www.fsdpharma.com/role/AssetsHeldForSaleDetails2"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#AssetsHeldForSaleDetails1" roleURI="http://www.fsdpharma.com/role/AssetsHeldForSaleDetails1"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#AssetsHeldForSaleDetailTextuals" roleURI="http://www.fsdpharma.com/role/AssetsHeldForSaleDetailTextuals"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#WarrantsLiabilityDetailTextuals" roleURI="http://www.fsdpharma.com/role/WarrantsLiabilityDetailTextuals"/>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LegalEntitiesAxis" xlink:label="loc_huge_LegalEntitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LegalEntitiesDomain" xlink:label="loc_huge_LegalEntitiesDomain_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PrismicPharmaceuticalMember" xlink:label="loc_huge_PrismicPharmaceuticalMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LegalEntitiesDomain" xlink:label="loc_huge_LegalEntitiesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_5"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassBVotingSharesMember" xlink:label="loc_huge_ClassBVotingSharesMember_5"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_StockOptionsMember" xlink:label="loc_huge_StockOptionsMember_6"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsMember" xlink:label="loc_huge_WarrantsMember_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityInterestsOfAcquirer" xlink:label="loc_ifrs-full_EquityInterestsOfAcquirer_12"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares" xlink:label="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_13"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShareIssuePricePerShare" xlink:label="loc_huge_ShareIssuePricePerShare_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-full_IssueOfEquity_15"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfWarrantsIssued" xlink:label="loc_huge_NumberOfWarrantsIssued_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable" xlink:label="loc_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_17"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_huge_LegalEntitiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_huge_LegalEntitiesAxis_1" xlink:to="loc_huge_LegalEntitiesDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_LegalEntitiesDomain_1" xlink:to="loc_huge_PrismicPharmaceuticalMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_huge_LegalEntitiesAxis_1" xlink:to="loc_huge_LegalEntitiesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_5" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_5" xlink:to="loc_huge_ClassBVotingSharesMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_5" xlink:to="loc_huge_StockOptionsMember_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_5" xlink:to="loc_huge_WarrantsMember_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_5" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_EquityInterestsOfAcquirer_12" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_13" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_huge_ShareIssuePricePerShare_14" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_IssueOfEquity_15" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_huge_NumberOfWarrantsIssued_16" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_17" order="60" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalScheduleOfBlackScholesOptionsPricingModelDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LegalEntitiesAxis" xlink:label="loc_huge_LegalEntitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LegalEntitiesDomain" xlink:label="loc_huge_LegalEntitiesDomain_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PrismicPharmaceuticalMember" xlink:label="loc_huge_PrismicPharmaceuticalMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LegalEntitiesDomain" xlink:label="loc_huge_LegalEntitiesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_6"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShareOptionsAbstract" xlink:label="loc_huge_ShareOptionsAbstract_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_15"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsAbstract" xlink:label="loc_huge_WarrantsAbstract_17"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WeightedAverageSharePriceOfWarrants" xlink:label="loc_huge_WeightedAverageSharePriceOfWarrants_17"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceOfWarrantsGranted" xlink:label="loc_huge_ExercisePriceOfWarrantsGranted_18"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedDividendYieldOfWarrantsGranted" xlink:label="loc_huge_ExpectedDividendYieldOfWarrantsGranted_19"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_RiskFreeInterestRateOfWarrantsGranted" xlink:label="loc_huge_RiskFreeInterestRateOfWarrantsGranted_20"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedLifeOfWarrants" xlink:label="loc_huge_ExpectedLifeOfWarrants_21"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedVolatilityOfWarrantsGranted" xlink:label="loc_huge_ExpectedVolatilityOfWarrantsGranted_22"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_huge_LegalEntitiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_huge_LegalEntitiesAxis_1" xlink:to="loc_huge_LegalEntitiesDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_LegalEntitiesDomain_1" xlink:to="loc_huge_PrismicPharmaceuticalMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_huge_LegalEntitiesAxis_1" xlink:to="loc_huge_LegalEntitiesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_RangeAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_5" xlink:to="loc_ifrs-full_RangesMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_5" xlink:to="loc_ifrs-full_BottomOfRangeMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_5" xlink:to="loc_ifrs-full_TopOfRangeMember_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_huge_ShareOptionsAbstract_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ShareOptionsAbstract_10" xlink:to="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ShareOptionsAbstract_10" xlink:to="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_11" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ShareOptionsAbstract_10" xlink:to="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_12" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ShareOptionsAbstract_10" xlink:to="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_13" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ShareOptionsAbstract_10" xlink:to="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_14" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ShareOptionsAbstract_10" xlink:to="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_15" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_huge_WarrantsAbstract_17" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_WarrantsAbstract_17" xlink:to="loc_huge_WeightedAverageSharePriceOfWarrants_17" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_WarrantsAbstract_17" xlink:to="loc_huge_ExercisePriceOfWarrantsGranted_18" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_WarrantsAbstract_17" xlink:to="loc_huge_ExpectedDividendYieldOfWarrantsGranted_19" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_WarrantsAbstract_17" xlink:to="loc_huge_RiskFreeInterestRateOfWarrantsGranted_20" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_WarrantsAbstract_17" xlink:to="loc_huge_ExpectedLifeOfWarrants_21" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_WarrantsAbstract_17" xlink:to="loc_huge_ExpectedVolatilityOfWarrantsGranted_22" order="50" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LegalEntitiesAxis" xlink:label="loc_huge_LegalEntitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LegalEntitiesDomain" xlink:label="loc_huge_LegalEntitiesDomain_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PrismicPharmaceuticalMember" xlink:label="loc_huge_PrismicPharmaceuticalMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LegalEntitiesDomain" xlink:label="loc_huge_LegalEntitiesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_11"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_huge_LegalEntitiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_huge_LegalEntitiesAxis_1" xlink:to="loc_huge_LegalEntitiesDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_LegalEntitiesDomain_1" xlink:to="loc_huge_PrismicPharmaceuticalMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_huge_LegalEntitiesAxis_1" xlink:to="loc_huge_LegalEntitiesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_9" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_10" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_11" order="60" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/CommitmentsAndContingenciesNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesTable" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TypeOfArrangementsAxis" xlink:label="loc_huge_TypeOfArrangementsAxis_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TypeOfArrangementsDomain" xlink:label="loc_huge_TypeOfArrangementsDomain_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SupplyAgreementMember" xlink:label="loc_huge_SupplyAgreementMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_EpitechLicenseAgreementMember" xlink:label="loc_huge_EpitechLicenseAgreementMember_2"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_HeritageBuildingRestorationCommitmentMember" xlink:label="loc_huge_HeritageBuildingRestorationCommitmentMember_3"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DefinitiveStrategicAllianceAndStreamingAgreementMember" xlink:label="loc_huge_DefinitiveStrategicAllianceAndStreamingAgreementMember_4"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DefinitiveSettlementAgreementMember" xlink:label="loc_huge_DefinitiveSettlementAgreementMember_5"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TypeOfArrangementsDomain" xlink:label="loc_huge_TypeOfArrangementsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:label="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContingentLiabilitiesMember" xlink:label="loc_ifrs-full_ContingentLiabilitiesMember_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LegalProceedingsContingentLiabilityMember" xlink:label="loc_ifrs-full_LegalProceedingsContingentLiabilityMember_9"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember" xlink:label="loc_huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContingentLiabilitiesMember" xlink:label="loc_ifrs-full_ContingentLiabilitiesMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CounterpartiesAxis" xlink:label="loc_ifrs-full_CounterpartiesAxis_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CounterpartiesMember" xlink:label="loc_ifrs-full_CounterpartiesMember_14"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AuxlyCannabisGroupIncMember" xlink:label="loc_huge_AuxlyCannabisGroupIncMember_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CounterpartiesMember" xlink:label="loc_ifrs-full_CounterpartiesMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_18"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CanntabTherapeuticsLtdWorldClassExtractionsIncMember" xlink:label="loc_huge_CanntabTherapeuticsLtdWorldClassExtractionsIncMember_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_Default"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonRefundableSumDueAndPayableUponFirstNotificationOfFda" xlink:label="loc_huge_NonRefundableSumDueAndPayableUponFirstNotificationOfFda_23"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFda" xlink:label="loc_huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFda_24"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights" xlink:label="loc_huge_PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights_25"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights" xlink:label="loc_huge_PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights_26"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition" xlink:label="loc_huge_PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition_27"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition" xlink:label="loc_huge_PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition_28"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition" xlink:label="loc_huge_PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition_29"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_EstimatedCostOfRestorationInCommitment" xlink:label="loc_huge_EstimatedCostOfRestorationInCommitment_30"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PartialPaymentOfSettlementAmount" xlink:label="loc_huge_PartialPaymentOfSettlementAmount_31"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClaimSettlementAmountCoveredByInsurance" xlink:label="loc_huge_ClaimSettlementAmountCoveredByInsurance_32"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClaimIssuedByContractorForVariousPurportedDamages" xlink:label="loc_huge_ClaimIssuedByContractorForVariousPurportedDamages_33"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClaimForLienComponent" xlink:label="loc_huge_ClaimForLienComponent_34"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees" xlink:label="loc_huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees_35"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FundsPaidForSettlementAgreement" xlink:label="loc_huge_FundsPaidForSettlementAgreement_36"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProvisionForEmployeeRelatedLiability" xlink:label="loc_huge_ProvisionForEmployeeRelatedLiability_37"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PaymentMadeToBeUnpaidWagesAndUnpaidHoliday" xlink:label="loc_huge_PaymentMadeToBeUnpaidWagesAndUnpaidHoliday_38"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_InsuredAmountForClaimSettlemnt" xlink:label="loc_huge_InsuredAmountForClaimSettlemnt_39"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement" xlink:label="loc_huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement_40"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement" xlink:label="loc_huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement_41"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_huge_TypeOfArrangementsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_huge_TypeOfArrangementsAxis_1" xlink:to="loc_huge_TypeOfArrangementsDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_TypeOfArrangementsDomain_1" xlink:to="loc_huge_SupplyAgreementMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_TypeOfArrangementsDomain_1" xlink:to="loc_huge_EpitechLicenseAgreementMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_TypeOfArrangementsDomain_1" xlink:to="loc_huge_HeritageBuildingRestorationCommitmentMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_TypeOfArrangementsDomain_1" xlink:to="loc_huge_DefinitiveStrategicAllianceAndStreamingAgreementMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_TypeOfArrangementsDomain_1" xlink:to="loc_huge_DefinitiveSettlementAgreementMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_huge_TypeOfArrangementsAxis_1" xlink:to="loc_huge_TypeOfArrangementsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_9" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_9" xlink:to="loc_ifrs-full_ContingentLiabilitiesMember_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ContingentLiabilitiesMember_9" xlink:to="loc_ifrs-full_LegalProceedingsContingentLiabilityMember_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ContingentLiabilitiesMember_9" xlink:to="loc_huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_9" xlink:to="loc_ifrs-full_ContingentLiabilitiesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_ifrs-full_CounterpartiesAxis_14" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CounterpartiesAxis_14" xlink:to="loc_ifrs-full_CounterpartiesMember_14" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CounterpartiesMember_14" xlink:to="loc_huge_AuxlyCannabisGroupIncMember_14" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CounterpartiesAxis_14" xlink:to="loc_ifrs-full_CounterpartiesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_dei_LegalEntityAxis_18" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_18" xlink:to="loc_dei_EntityDomain_18" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_18" xlink:to="loc_huge_CanntabTherapeuticsLtdWorldClassExtractionsIncMember_18" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_18" xlink:to="loc_dei_EntityDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_NonRefundableSumDueAndPayableUponFirstNotificationOfFda_23" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFda_24" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights_25" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights_26" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition_27" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition_28" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition_29" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_EstimatedCostOfRestorationInCommitment_30" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_PartialPaymentOfSettlementAmount_31" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_ClaimSettlementAmountCoveredByInsurance_32" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_ClaimIssuedByContractorForVariousPurportedDamages_33" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_ClaimForLienComponent_34" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees_35" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_FundsPaidForSettlementAgreement_36" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_ProvisionForEmployeeRelatedLiability_37" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_PaymentMadeToBeUnpaidWagesAndUnpaidHoliday_38" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_InsuredAmountForClaimSettlemnt_39" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement_40" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement_41" order="190" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/CommitmentsAndContingenciesScheduleOfQuantitiesOfCannabisAvailableToSupplyByFiscalPeriodDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesTable" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CounterpartiesAxis" xlink:label="loc_ifrs-full_CounterpartiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CounterpartiesMember" xlink:label="loc_ifrs-full_CounterpartiesMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PharmadrugProductionGMBHMember" xlink:label="loc_huge_PharmadrugProductionGMBHMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TypeOfArrangementsAxis" xlink:label="loc_huge_TypeOfArrangementsAxis_4"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TypeOfArrangementsDomain" xlink:label="loc_huge_TypeOfArrangementsDomain_4"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SupplyAgreementMember" xlink:label="loc_huge_SupplyAgreementMember_4"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TypeOfArrangementsDomain" xlink:label="loc_huge_TypeOfArrangementsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_8"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FvPharmaIncMember" xlink:label="loc_huge_FvPharmaIncMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_Default"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_QuantitiesAvailableToSupplyInNextFiscalYear" xlink:label="loc_huge_QuantitiesAvailableToSupplyInNextFiscalYear_13"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_QuantitiesAvailableToSupplyInSecondFiscalYear" xlink:label="loc_huge_QuantitiesAvailableToSupplyInSecondFiscalYear_14"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_QuantitiesAvailableToSupplyInThirdFiscalYear" xlink:label="loc_huge_QuantitiesAvailableToSupplyInThirdFiscalYear_15"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_QuantitiesAvailableToSupplyInFifthFiscalYear" xlink:label="loc_huge_QuantitiesAvailableToSupplyInFifthFiscalYear_16"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_QuantitiesAvailableToSupplyInFourthFiscalYear" xlink:label="loc_huge_QuantitiesAvailableToSupplyInFourthFiscalYear_17"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_ifrs-full_CounterpartiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CounterpartiesAxis_1" xlink:to="loc_ifrs-full_CounterpartiesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CounterpartiesMember_1" xlink:to="loc_huge_PharmadrugProductionGMBHMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_huge_TypeOfArrangementsAxis_4" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_huge_TypeOfArrangementsAxis_4" xlink:to="loc_huge_TypeOfArrangementsDomain_4" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_TypeOfArrangementsDomain_4" xlink:to="loc_huge_SupplyAgreementMember_4" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_huge_TypeOfArrangementsAxis_4" xlink:to="loc_huge_TypeOfArrangementsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_dei_LegalEntityAxis_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_8" xlink:to="loc_dei_EntityDomain_8" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_8" xlink:to="loc_huge_FvPharmaIncMember_8" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_8" xlink:to="loc_dei_EntityDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_QuantitiesAvailableToSupplyInNextFiscalYear_13" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_QuantitiesAvailableToSupplyInSecondFiscalYear_14" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_QuantitiesAvailableToSupplyInThirdFiscalYear_15" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_QuantitiesAvailableToSupplyInFifthFiscalYear_16" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xlink:to="loc_huge_QuantitiesAvailableToSupplyInFourthFiscalYear_17" order="50" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassACommonStockSharesMember" xlink:label="loc_huge_ClassACommonStockSharesMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassBCommonStockSharesMember" xlink:label="loc_huge_ClassBCommonStockSharesMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_6"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsMember" xlink:label="loc_huge_WarrantsMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:label="loc_ifrs-full_ReserveOfSharebasedPaymentsMember_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetainedEarningsMember" xlink:label="loc_ifrs-full_RetainedEarningsMember_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-full_IssueOfEquity_16"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfShares" xlink:label="loc_huge_IssuanceOfShares_17"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset" xlink:label="loc_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset_18"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares" xlink:label="loc_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_20"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughExerciseOfOptionShares" xlink:label="loc_huge_IncreaseDecreaseThroughExerciseOfOptionShares_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_22"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares" xlink:label="loc_huge_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_24"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughExerciseOfWarrantsShares" xlink:label="loc_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares_25"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfWarrantsExercised" xlink:label="loc_huge_ValueOfWarrantsExercised_26"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughExpiryOfWarrantsValue" xlink:label="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue_27"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughExpiryOfWarrantsShares" xlink:label="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares_28"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_29"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_StatementOfChangesInEquityTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_1" xlink:to="loc_huge_ClassACommonStockSharesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_1" xlink:to="loc_huge_ClassBCommonStockSharesMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_1" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_6" xlink:to="loc_ifrs-full_EquityMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_6" xlink:to="loc_huge_WarrantsMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_6" xlink:to="loc_ifrs-full_ReserveOfSharebasedPaymentsMember_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_6" xlink:to="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_6" xlink:to="loc_ifrs-full_RetainedEarningsMember_9" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_6" xlink:to="loc_ifrs-full_EquityMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_Equity_14" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_NumberOfSharesOutstanding_15" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_IssueOfEquity_16" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_huge_IssuanceOfShares_17" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset_18" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares_19" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_20" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughExerciseOfOptionShares_21" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_22" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares_23" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_24" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares_25" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_huge_ValueOfWarrantsExercised_26" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue_27" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares_28" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_ComprehensiveIncome_29" order="160" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ScheduleOfStockClassLineItems" xlink:label="loc_huge_ScheduleOfStockClassLineItems_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ScheduleOfStockClassTable" xlink:label="loc_huge_ScheduleOfStockClassTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassACommonStockSharesMember" xlink:label="loc_huge_ClassACommonStockSharesMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassBCommonStockSharesMember" xlink:label="loc_huge_ClassBCommonStockSharesMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAbstract" xlink:label="loc_ifrs-full_AssetsAbstract_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="loc_ifrs-full_CurrentAssetsAbstract_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="loc_ifrs-full_CurrentPrepaidExpenses_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:label="loc_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:label="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="loc_ifrs-full_NoncurrentAssetsAbstract_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-full_Assets_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAndLiabilitiesAbstract" xlink:label="loc_ifrs-full_EquityAndLiabilitiesAbstract_22"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesAbstract" xlink:label="loc_ifrs-full_LiabilitiesAbstract_22"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_CurrentLiabilitiesAbstract_22"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_22"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:label="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_24"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CurrentWarrantsLiability" xlink:label="loc_huge_CurrentWarrantsLiability_25"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued" xlink:label="loc_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_26"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities_27"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_NoncurrentLiabilitiesAbstract_29"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_29"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-full_Liabilities_30"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAbstract" xlink:label="loc_ifrs-full_EquityAbstract_33"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital_33"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Warrants" xlink:label="loc_huge_Warrants_34"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharePremium" xlink:label="loc_ifrs-full_SharePremium_35"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_36"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-full_RetainedEarnings_37"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_38"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-full_EquityAndLiabilities_40"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_huge_ScheduleOfStockClassLineItems_0" xlink:to="loc_huge_ScheduleOfStockClassTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_huge_ScheduleOfStockClassTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_1" xlink:to="loc_huge_ClassACommonStockSharesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_1" xlink:to="loc_huge_ClassBCommonStockSharesMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ScheduleOfStockClassLineItems_0" xlink:to="loc_ifrs-full_AssetsAbstract_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAbstract_7" xlink:to="loc_ifrs-full_CurrentAssetsAbstract_7" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_7" xlink:to="loc_ifrs-full_CashAndCashEquivalents_7" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_7" xlink:to="loc_ifrs-full_TradeAndOtherCurrentReceivables_8" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_7" xlink:to="loc_ifrs-full_CurrentPrepaidExpenses_9" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_7" xlink:to="loc_ifrs-full_Inventories_10" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_7" xlink:to="loc_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_11" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_7" xlink:to="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_12" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_7" xlink:to="loc_ifrs-full_CurrentAssets_13" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAbstract_7" xlink:to="loc_ifrs-full_NoncurrentAssetsAbstract_15" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_15" xlink:to="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_15" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_15" xlink:to="loc_ifrs-full_RightofuseAssets_16" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_15" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_17" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_15" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_18" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAbstract_7" xlink:to="loc_ifrs-full_Assets_20" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ScheduleOfStockClassLineItems_0" xlink:to="loc_ifrs-full_EquityAndLiabilitiesAbstract_22" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_22" xlink:to="loc_ifrs-full_LiabilitiesAbstract_22" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesAbstract_22" xlink:to="loc_ifrs-full_CurrentLiabilitiesAbstract_22" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_22" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayables_22" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_22" xlink:to="loc_ifrs-full_CurrentLeaseLiabilities_23" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_22" xlink:to="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_24" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_22" xlink:to="loc_huge_CurrentWarrantsLiability_25" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_22" xlink:to="loc_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_26" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_22" xlink:to="loc_ifrs-full_CurrentLiabilities_27" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesAbstract_22" xlink:to="loc_ifrs-full_NoncurrentLiabilitiesAbstract_29" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_29" xlink:to="loc_ifrs-full_NoncurrentLeaseLiabilities_29" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_29" xlink:to="loc_ifrs-full_Liabilities_30" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_22" xlink:to="loc_ifrs-full_EquityAbstract_33" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityAbstract_33" xlink:to="loc_ifrs-full_IssuedCapital_33" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityAbstract_33" xlink:to="loc_huge_Warrants_34" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityAbstract_33" xlink:to="loc_ifrs-full_SharePremium_35" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityAbstract_33" xlink:to="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_36" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityAbstract_33" xlink:to="loc_ifrs-full_RetainedEarnings_37" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityAbstract_33" xlink:to="loc_ifrs-full_Equity_38" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_22" xlink:to="loc_ifrs-full_EquityAndLiabilities_40" order="20" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/FinancialInstrumentsAndRiskExposuresNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-full_TypesOfRisksAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-full_TypesOfRisksMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MarketRiskMember" xlink:label="loc_ifrs-full_MarketRiskMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AllLevelsOfFairValueHierarchyMember" xlink:label="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Level1OfFairValueHierarchyMember" xlink:label="loc_ifrs-full_Level1OfFairValueHierarchyMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Level2OfFairValueHierarchyMember" xlink:label="loc_ifrs-full_Level2OfFairValueHierarchyMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Level3OfFairValueHierarchyMember" xlink:label="loc_ifrs-full_Level3OfFairValueHierarchyMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ValueAtRisk" xlink:label="loc_ifrs-full_ValueAtRisk_11"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_TypesOfRisksAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfRisksAxis_1" xlink:to="loc_ifrs-full_TypesOfRisksMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksMember_1" xlink:to="loc_ifrs-full_MarketRiskMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_4" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_4" xlink:to="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_4" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_4" xlink:to="loc_ifrs-full_Level1OfFairValueHierarchyMember_4" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_4" xlink:to="loc_ifrs-full_Level2OfFairValueHierarchyMember_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_4" xlink:to="loc_ifrs-full_Level3OfFairValueHierarchyMember_6" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_ValueAtRisk_11" order="20" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/FinancialInstrumentsAndRiskExposuresScheduleOfCreditRiskDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearMember" xlink:label="loc_ifrs-full_LaterThanOneYearMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-full_TypesOfRisksAxis_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-full_TypesOfRisksMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CreditRiskMember" xlink:label="loc_ifrs-full_CreditRiskMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentReceivablesFromTaxesOtherThanIncomeTax" xlink:label="loc_ifrs-full_NoncurrentReceivablesFromTaxesOtherThanIncomeTax_10"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_MaturityAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_1" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanOneYearMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_TypesOfRisksAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfRisksAxis_5" xlink:to="loc_ifrs-full_TypesOfRisksMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksMember_5" xlink:to="loc_ifrs-full_CreditRiskMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_CashAndCashEquivalents_9" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_NoncurrentReceivablesFromTaxesOtherThanIncomeTax_10" order="20" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/FinancialInstrumentsAndRiskExposuresScheduleOfFinancialAssetsAndFinancialLiabilitiesDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialLiabilitiesCategoryMember" xlink:label="loc_ifrs-full_FinancialLiabilitiesCategoryMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AmortizedCostOfFinancialLiabilitiesMember" xlink:label="loc_huge_AmortizedCostOfFinancialLiabilitiesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_2"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OtherFinancialLiabilitiesMember" xlink:label="loc_huge_OtherFinancialLiabilitiesMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsCategoryMember" xlink:label="loc_ifrs-full_FinancialAssetsCategoryMember_6"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AmortizedCostOfFinancialAssetsMember" xlink:label="loc_huge_AmortizedCostOfFinancialAssetsMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LoansAndReceivablesCategoryMember" xlink:label="loc_ifrs-full_LoansAndReceivablesCategoryMember_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_14"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_1" xlink:to="loc_ifrs-full_FinancialLiabilitiesCategoryMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialLiabilitiesCategoryMember_1" xlink:to="loc_huge_AmortizedCostOfFinancialLiabilitiesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialLiabilitiesCategoryMember_1" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialLiabilitiesCategoryMember_1" xlink:to="loc_huge_OtherFinancialLiabilitiesMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_6" xlink:to="loc_ifrs-full_FinancialAssetsCategoryMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialAssetsCategoryMember_6" xlink:to="loc_huge_AmortizedCostOfFinancialAssetsMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialAssetsCategoryMember_6" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialAssetsCategoryMember_6" xlink:to="loc_ifrs-full_LoansAndReceivablesCategoryMember_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_CashAndCashEquivalents_12" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_13" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayables_14" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/FinancialInstrumentsAndRiskExposuresScheduleOfFinancialObligationsBasedOnTheirDueDatesDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-full_TypesOfRisksAxis_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-full_TypesOfRisksMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiquidityRiskMember" xlink:label="loc_ifrs-full_LiquidityRiskMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_10"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_MaturityAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_1" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_TypesOfRisksAxis_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfRisksAxis_6" xlink:to="loc_ifrs-full_TypesOfRisksMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksMember_6" xlink:to="loc_ifrs-full_LiquidityRiskMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayables_10" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/IntangibleAssetsScheduleOfIntangibleAssetsDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_11"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1" xlink:to="loc_ifrs-full_CarryingAmountMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_1" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_1" xlink:to="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1" xlink:to="loc_ifrs-full_CarryingAmountMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xlink:to="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_9" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xlink:to="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_10" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_11" order="50" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/LeaseObligationsScheduleOfMaturityAnalysisOfOperatingLeasePaymentsDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:label="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_Default"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_UndiscountedLeasePaymentsPayable" xlink:label="loc_huge_UndiscountedLeasePaymentsPayable_10"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OperatingLeaseImpactOfPresentValue" xlink:label="loc_huge_OperatingLeaseImpactOfPresentValue_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_12"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" xlink:to="loc_ifrs-full_MaturityAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_1" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_1" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_huge_UndiscountedLeasePaymentsPayable_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_huge_OperatingLeaseImpactOfPresentValue_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_ifrs-full_LeaseLiabilities_12" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/LossPerShareDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareLineItems" xlink:label="loc_ifrs-full_EarningsPerShareLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareTable" xlink:label="loc_ifrs-full_EarningsPerShareTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfOrdinarySharesAxis" xlink:label="loc_ifrs-full_ClassesOfOrdinarySharesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-full_OrdinarySharesMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsMember" xlink:label="loc_huge_WarrantsMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_StockOptionsMember" xlink:label="loc_huge_StockOptionsMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-full_OrdinarySharesMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares" xlink:label="loc_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:label="loc_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_8"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_EarningsPerShareLineItems_0" xlink:to="loc_ifrs-full_EarningsPerShareTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_EarningsPerShareTable_1" xlink:to="loc_ifrs-full_ClassesOfOrdinarySharesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfOrdinarySharesAxis_1" xlink:to="loc_ifrs-full_OrdinarySharesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_OrdinarySharesMember_1" xlink:to="loc_huge_WarrantsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_OrdinarySharesMember_1" xlink:to="loc_huge_StockOptionsMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfOrdinarySharesAxis_1" xlink:to="loc_ifrs-full_OrdinarySharesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EarningsPerShareLineItems_0" xlink:to="loc_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EarningsPerShareLineItems_0" xlink:to="loc_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_8" order="20" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/NatureOfBusinessScheduleOfOwnershipPercentageInSubsidiariesDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SubsidiariesMember" xlink:label="loc_ifrs-full_SubsidiariesMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SubsidiariesOneMember" xlink:label="loc_huge_SubsidiariesOneMember_2"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SubsidiariesTwoMember" xlink:label="loc_huge_SubsidiariesTwoMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary" xlink:label="loc_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_8"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_1" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_ifrs-full_SubsidiariesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_huge_SubsidiariesOneMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_huge_SubsidiariesTwoMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0" xlink:to="loc_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_8" order="20" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/NotesPayableNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LegalEntitiesAxis" xlink:label="loc_huge_LegalEntitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LegalEntitiesDomain" xlink:label="loc_huge_LegalEntitiesDomain_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PrismicPharmaceuticalMember" xlink:label="loc_huge_PrismicPharmaceuticalMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LegalEntitiesDomain" xlink:label="loc_huge_LegalEntitiesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_5"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassBCommonStockSharesMember" xlink:label="loc_huge_ClassBCommonStockSharesMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_9"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ConvertibleNotesMember" xlink:label="loc_huge_ConvertibleNotesMember_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShorttermBorrowingsMember" xlink:label="loc_ifrs-full_ShorttermBorrowingsMember_10"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NotesPayableMember" xlink:label="loc_huge_NotesPayableMember_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsInterestRate" xlink:label="loc_ifrs-full_BorrowingsInterestRate_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestExpenseOnBorrowings" xlink:label="loc_ifrs-full_InterestExpenseOnBorrowings_17"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BorrowingsSettled" xlink:label="loc_huge_BorrowingsSettled_18"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BorrowingsSettledAccruedInterestSettled" xlink:label="loc_huge_BorrowingsSettledAccruedInterestSettled_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SettlementOfLiabilitiesByEntityOnBehalfOfRelatedPartyRelatedPartyTransactions" xlink:label="loc_ifrs-full_SettlementOfLiabilitiesByEntityOnBehalfOfRelatedPartyRelatedPartyTransactions_20"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfCommonStockForNotesPayable" xlink:label="loc_huge_IssuanceOfCommonStockForNotesPayable_21"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfCommonStockToSettleNotesPayable" xlink:label="loc_huge_FairValueOfCommonStockToSettleNotesPayable_22"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CashReceiptsFromSalesOfDebtInstruments" xlink:label="loc_huge_CashReceiptsFromSalesOfDebtInstruments_23"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GainLossOnSettlementOfFinancialLiability" xlink:label="loc_huge_GainLossOnSettlementOfFinancialLiability_24"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1" xlink:to="loc_huge_LegalEntitiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_huge_LegalEntitiesAxis_1" xlink:to="loc_huge_LegalEntitiesDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_LegalEntitiesDomain_1" xlink:to="loc_huge_PrismicPharmaceuticalMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_huge_LegalEntitiesAxis_1" xlink:to="loc_huge_LegalEntitiesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_5" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_5" xlink:to="loc_huge_ClassBCommonStockSharesMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_5" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_9" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_9" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_9" xlink:to="loc_huge_ConvertibleNotesMember_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_9" xlink:to="loc_ifrs-full_ShorttermBorrowingsMember_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_9" xlink:to="loc_huge_NotesPayableMember_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_9" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0" xlink:to="loc_ifrs-full_BorrowingsInterestRate_16" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0" xlink:to="loc_ifrs-full_InterestExpenseOnBorrowings_17" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0" xlink:to="loc_huge_BorrowingsSettled_18" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0" xlink:to="loc_huge_BorrowingsSettledAccruedInterestSettled_19" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0" xlink:to="loc_ifrs-full_SettlementOfLiabilitiesByEntityOnBehalfOfRelatedPartyRelatedPartyTransactions_20" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0" xlink:to="loc_huge_IssuanceOfCommonStockForNotesPayable_21" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0" xlink:to="loc_huge_FairValueOfCommonStockToSettleNotesPayable_22" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0" xlink:to="loc_huge_CashReceiptsFromSalesOfDebtInstruments_23" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0" xlink:to="loc_huge_GainLossOnSettlementOfFinancialLiability_24" order="90" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/NotesPayableScheduleOfNotesPayableDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShorttermBorrowingsMember" xlink:label="loc_ifrs-full_ShorttermBorrowingsMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ConvertibleNotesMember" xlink:label="loc_huge_ConvertibleNotesMember_2"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NotesPayableMember" xlink:label="loc_huge_NotesPayableMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued" xlink:label="loc_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_8"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1" xlink:to="loc_ifrs-full_ShorttermBorrowingsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1" xlink:to="loc_huge_ConvertibleNotesMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1" xlink:to="loc_huge_NotesPayableMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0" xlink:to="loc_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_8" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/OtherInvestmentsNarrativeDetails">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfInvestmentsLineItems" xlink:label="loc_huge_DisclosureOfInvestmentsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfInvestmentsTable" xlink:label="loc_huge_DisclosureOfInvestmentsTable_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OtherInvestmentsNameOfEntityAxis" xlink:label="loc_huge_OtherInvestmentsNameOfEntityAxis_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OtherInvestmentsNameOfEntityDomain" xlink:label="loc_huge_OtherInvestmentsNameOfEntityDomain_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PharmadrugIncMember" xlink:label="loc_huge_PharmadrugIncMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CannaraBiotechIncMember" xlink:label="loc_huge_CannaraBiotechIncMember_2"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CloverCannastripThinFilmTechnologiesCorpMember" xlink:label="loc_huge_CloverCannastripThinFilmTechnologiesCorpMember_3"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_HighTideIncMember" xlink:label="loc_huge_HighTideIncMember_4"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_HugeShopsMember" xlink:label="loc_huge_HugeShopsMember_5"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ScicannTherapeuticsIncMember" xlink:label="loc_huge_ScicannTherapeuticsIncMember_6"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SolarvestBioEnergyIncMember" xlink:label="loc_huge_SolarvestBioEnergyIncMember_7"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OtherInvestmentsNameOfEntityDomain" xlink:label="loc_huge_OtherInvestmentsNameOfEntityDomain_Default"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TypeOfArrangementsAxis" xlink:label="loc_huge_TypeOfArrangementsAxis_11"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TypeOfArrangementsDomain" xlink:label="loc_huge_TypeOfArrangementsDomain_11"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SecuritiesExchangeAgreementMember" xlink:label="loc_huge_SecuritiesExchangeAgreementMember_11"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SharePurchaseAndSaleAgreementsMember" xlink:label="loc_huge_SharePurchaseAndSaleAgreementsMember_12"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShareExchangeAgreementMember" xlink:label="loc_huge_ShareExchangeAgreementMember_13"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TypeOfArrangementsDomain" xlink:label="loc_huge_TypeOfArrangementsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfOrdinarySharesAxis" xlink:label="loc_ifrs-full_ClassesOfOrdinarySharesAxis_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-full_OrdinarySharesMember_17"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_UnrestrictedClassBSharesMember" xlink:label="loc_huge_UnrestrictedClassBSharesMember_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-full_OrdinarySharesMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AllLevelsOfFairValueHierarchyMember" xlink:label="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Level1OfFairValueHierarchyMember" xlink:label="loc_ifrs-full_Level1OfFairValueHierarchyMember_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AllLevelsOfFairValueHierarchyMember" xlink:label="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_25"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_25"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SubsequentEventsMember" xlink:label="loc_huge_SubsequentEventsMember_25"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_29"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_29"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassBCommonStockSharesMember" xlink:label="loc_huge_ClassBCommonStockSharesMember_29"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_Default"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesAcquired" xlink:label="loc_huge_NumberOfSharesAcquired_34"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SharePrices" xlink:label="loc_huge_SharePrices_35"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfSharesAcquired" xlink:label="loc_huge_ValueOfSharesAcquired_36"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_37"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfInvestmentSharesSold" xlink:label="loc_huge_NumberOfInvestmentSharesSold_38"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_39"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnDisposalsOfInvestments" xlink:label="loc_ifrs-full_GainsLossesOnDisposalsOfInvestments_40"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesIssuedInShareExchange" xlink:label="loc_huge_NumberOfSharesIssuedInShareExchange_41"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShareIssuePricePerShare" xlink:label="loc_huge_ShareIssuePricePerShare_42"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfSharesIssuedInShareExchange" xlink:label="loc_huge_ValueOfSharesIssuedInShareExchange_43"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LossesOnChangeInFairValueOfDerivatives" xlink:label="loc_ifrs-full_LossesOnChangeInFairValueOfDerivatives_44"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement" xlink:label="loc_huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement_45"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesHeld" xlink:label="loc_huge_NumberOfSharesHeld_46"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfWarrantsHeld" xlink:label="loc_huge_NumberOfWarrantsHeld_47"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SharePriceOfSharesAndWarrants" xlink:label="loc_huge_SharePriceOfSharesAndWarrants_48"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DiscountOnProceedsOfSharesAndWarrantsSold" xlink:label="loc_huge_DiscountOnProceedsOfSharesAndWarrantsSold_49"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProceedsFromSaleOfSharesAndWarrants" xlink:label="loc_huge_ProceedsFromSaleOfSharesAndWarrants_50"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SubscriptionPricePerShare" xlink:label="loc_huge_SubscriptionPricePerShare_51"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PercentageOfDeclineInFairValueOfInvestment" xlink:label="loc_huge_PercentageOfDeclineInFairValueOfInvestment_52"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ChangeInFairValueOfInvestmentDueToTenPercentChangeInAssumptionsUsed" xlink:label="loc_huge_ChangeInFairValueOfInvestmentDueToTenPercentChangeInAssumptionsUsed_53"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfWarrantsAcquired" xlink:label="loc_huge_NumberOfWarrantsAcquired_54"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PrincipalAmountOfBorrowings" xlink:label="loc_huge_PrincipalAmountOfBorrowings_55"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfSharesAndWarrantsAcquired" xlink:label="loc_huge_FairValueOfSharesAndWarrantsAcquired_56"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceOfWarrants" xlink:label="loc_huge_ExercisePriceOfWarrants_57"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_QuotedMarketPriceOfInvestments" xlink:label="loc_huge_QuotedMarketPriceOfInvestments_58"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_59"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfShares" xlink:label="loc_huge_FairValueOfShares_60"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfWarrants" xlink:label="loc_huge_FairValueOfWarrants_61"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_MarketPriceOfShares" xlink:label="loc_huge_MarketPriceOfShares_62"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DerivativeFinancialLiabilities" xlink:label="loc_ifrs-full_DerivativeFinancialLiabilities_63"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GainOnSettlementOfDerivativeLiability" xlink:label="loc_huge_GainOnSettlementOfDerivativeLiability_64"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GuaranteedMinimumLiquidationValueOfShares" xlink:label="loc_huge_GuaranteedMinimumLiquidationValueOfShares_65"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_RiskFreeRateOfWarrants" xlink:label="loc_huge_RiskFreeRateOfWarrants_66"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedVolatilityOfWarrants" xlink:label="loc_huge_ExpectedVolatilityOfWarrants_67"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedTermOfWarrants" xlink:label="loc_huge_ExpectedTermOfWarrants_68"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedDividendYieldOfWarrants" xlink:label="loc_huge_ExpectedDividendYieldOfWarrants_69"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DebtConversionRatio" xlink:label="loc_huge_DebtConversionRatio_70"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability" xlink:label="loc_huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability_71"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:label="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_72"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_huge_DisclosureOfInvestmentsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_huge_DisclosureOfInvestmentsTable_1" xlink:to="loc_huge_OtherInvestmentsNameOfEntityAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_huge_OtherInvestmentsNameOfEntityAxis_1" xlink:to="loc_huge_OtherInvestmentsNameOfEntityDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_1" xlink:to="loc_huge_PharmadrugIncMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_1" xlink:to="loc_huge_CannaraBiotechIncMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_1" xlink:to="loc_huge_CloverCannastripThinFilmTechnologiesCorpMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_1" xlink:to="loc_huge_HighTideIncMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_1" xlink:to="loc_huge_HugeShopsMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_1" xlink:to="loc_huge_ScicannTherapeuticsIncMember_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_1" xlink:to="loc_huge_SolarvestBioEnergyIncMember_7" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_huge_OtherInvestmentsNameOfEntityAxis_1" xlink:to="loc_huge_OtherInvestmentsNameOfEntityDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_huge_DisclosureOfInvestmentsTable_1" xlink:to="loc_huge_TypeOfArrangementsAxis_11" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_huge_TypeOfArrangementsAxis_11" xlink:to="loc_huge_TypeOfArrangementsDomain_11" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_TypeOfArrangementsDomain_11" xlink:to="loc_huge_SecuritiesExchangeAgreementMember_11" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_TypeOfArrangementsDomain_11" xlink:to="loc_huge_SharePurchaseAndSaleAgreementsMember_12" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_TypeOfArrangementsDomain_11" xlink:to="loc_huge_ShareExchangeAgreementMember_13" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_huge_TypeOfArrangementsAxis_11" xlink:to="loc_huge_TypeOfArrangementsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_huge_DisclosureOfInvestmentsTable_1" xlink:to="loc_ifrs-full_ClassesOfOrdinarySharesAxis_17" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfOrdinarySharesAxis_17" xlink:to="loc_ifrs-full_OrdinarySharesMember_17" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_OrdinarySharesMember_17" xlink:to="loc_huge_UnrestrictedClassBSharesMember_17" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfOrdinarySharesAxis_17" xlink:to="loc_ifrs-full_OrdinarySharesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_huge_DisclosureOfInvestmentsTable_1" xlink:to="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_21" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_21" xlink:to="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_21" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_21" xlink:to="loc_ifrs-full_Level1OfFairValueHierarchyMember_21" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_21" xlink:to="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_huge_DisclosureOfInvestmentsTable_1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_25" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_25" xlink:to="loc_ifrs-full_NonadjustingEventsMember_25" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NonadjustingEventsMember_25" xlink:to="loc_huge_SubsequentEventsMember_25" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_25" xlink:to="loc_ifrs-full_NonadjustingEventsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_huge_DisclosureOfInvestmentsTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_29" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_29" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_29" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_29" xlink:to="loc_huge_ClassBCommonStockSharesMember_29" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_29" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_huge_NumberOfSharesAcquired_34" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_huge_SharePrices_35" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_huge_ValueOfSharesAcquired_36" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_ifrs-full_NumberOfSharesIssued_37" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_huge_NumberOfInvestmentSharesSold_38" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_39" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_ifrs-full_GainsLossesOnDisposalsOfInvestments_40" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_huge_NumberOfSharesIssuedInShareExchange_41" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_huge_ShareIssuePricePerShare_42" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_huge_ValueOfSharesIssuedInShareExchange_43" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_ifrs-full_LossesOnChangeInFairValueOfDerivatives_44" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement_45" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_huge_NumberOfSharesHeld_46" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_huge_NumberOfWarrantsHeld_47" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_huge_SharePriceOfSharesAndWarrants_48" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_huge_DiscountOnProceedsOfSharesAndWarrantsSold_49" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_huge_ProceedsFromSaleOfSharesAndWarrants_50" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_huge_SubscriptionPricePerShare_51" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_huge_PercentageOfDeclineInFairValueOfInvestment_52" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_huge_ChangeInFairValueOfInvestmentDueToTenPercentChangeInAssumptionsUsed_53" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_huge_NumberOfWarrantsAcquired_54" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_huge_PrincipalAmountOfBorrowings_55" order="220" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_huge_FairValueOfSharesAndWarrantsAcquired_56" order="230" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_huge_ExercisePriceOfWarrants_57" order="240" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_huge_QuotedMarketPriceOfInvestments_58" order="250" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_59" order="260" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_huge_FairValueOfShares_60" order="270" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_huge_FairValueOfWarrants_61" order="280" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_huge_MarketPriceOfShares_62" order="290" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_ifrs-full_DerivativeFinancialLiabilities_63" order="300" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_huge_GainOnSettlementOfDerivativeLiability_64" order="310" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_huge_GuaranteedMinimumLiquidationValueOfShares_65" order="320" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_huge_RiskFreeRateOfWarrants_66" order="330" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_huge_ExpectedVolatilityOfWarrants_67" order="340" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_huge_ExpectedTermOfWarrants_68" order="350" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_huge_ExpectedDividendYieldOfWarrants_69" order="360" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_huge_DebtConversionRatio_70" order="370" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability_71" order="380" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_72" order="390" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/OtherInvestmentsScheduleOfOtherInvestmentsDetails">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfInvestmentsLineItems" xlink:label="loc_huge_DisclosureOfInvestmentsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfInvestmentsTable" xlink:label="loc_huge_DisclosureOfInvestmentsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MeasurementAxis" xlink:label="loc_ifrs-full_MeasurementAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedMeasurementMember" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AtFairValueMember" xlink:label="loc_ifrs-full_AtFairValueMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedMeasurementMember" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_Default"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OtherInvestmentsNameOfEntityAxis" xlink:label="loc_huge_OtherInvestmentsNameOfEntityAxis_5"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OtherInvestmentsNameOfEntityDomain" xlink:label="loc_huge_OtherInvestmentsNameOfEntityDomain_5"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PharmadrugIncMember" xlink:label="loc_huge_PharmadrugIncMember_5"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CannaraBiotechIncMember" xlink:label="loc_huge_CannaraBiotechIncMember_6"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CloverCannastripThinFilmTechnologiesCorpMember" xlink:label="loc_huge_CloverCannastripThinFilmTechnologiesCorpMember_7"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_HugeShopsMember" xlink:label="loc_huge_HugeShopsMember_8"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_HighTideIncMember" xlink:label="loc_huge_HighTideIncMember_9"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ScicannTherapeuticsIncMember" xlink:label="loc_huge_ScicannTherapeuticsIncMember_10"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SolarvestBioEnergyIncMember" xlink:label="loc_huge_SolarvestBioEnergyIncMember_11"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OtherInvestmentsNameOfEntityDomain" xlink:label="loc_huge_OtherInvestmentsNameOfEntityDomain_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-full_OrdinarySharesMember_15"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsMember" xlink:label="loc_huge_WarrantsMember_16"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ConvertibleDebentureMember" xlink:label="loc_huge_ConvertibleDebentureMember_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_22"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_23"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_24"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NetForeignExchangeGain" xlink:label="loc_ifrs-full_NetForeignExchangeGain_25"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_26"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_huge_DisclosureOfInvestmentsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_huge_DisclosureOfInvestmentsTable_1" xlink:to="loc_ifrs-full_MeasurementAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MeasurementAxis_1" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_1" xlink:to="loc_ifrs-full_AtFairValueMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MeasurementAxis_1" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_huge_DisclosureOfInvestmentsTable_1" xlink:to="loc_huge_OtherInvestmentsNameOfEntityAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_huge_OtherInvestmentsNameOfEntityAxis_5" xlink:to="loc_huge_OtherInvestmentsNameOfEntityDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_5" xlink:to="loc_huge_PharmadrugIncMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_5" xlink:to="loc_huge_CannaraBiotechIncMember_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_5" xlink:to="loc_huge_CloverCannastripThinFilmTechnologiesCorpMember_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_5" xlink:to="loc_huge_HugeShopsMember_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_5" xlink:to="loc_huge_HighTideIncMember_9" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_5" xlink:to="loc_huge_ScicannTherapeuticsIncMember_10" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_5" xlink:to="loc_huge_SolarvestBioEnergyIncMember_11" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_huge_OtherInvestmentsNameOfEntityAxis_5" xlink:to="loc_huge_OtherInvestmentsNameOfEntityDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_huge_DisclosureOfInvestmentsTable_1" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_15" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_15" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_15" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_15" xlink:to="loc_ifrs-full_OrdinarySharesMember_15" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_15" xlink:to="loc_huge_WarrantsMember_16" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_15" xlink:to="loc_huge_ConvertibleDebentureMember_17" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_15" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_22" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_23" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_24" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_ifrs-full_NetForeignExchangeGain_25" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_0" xlink:to="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_26" order="50" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/RelatedPartyTransactionsNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FvPharmaIncMember" xlink:label="loc_huge_FvPharmaIncMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FSDBiosciencesMember" xlink:label="loc_huge_FSDBiosciencesMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_6"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PresidentAndChiefExecutiveOfficerMember" xlink:label="loc_huge_PresidentAndChiefExecutiveOfficerMember_6"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FormerChiefExecutiveOfficerMember" xlink:label="loc_huge_FormerChiefExecutiveOfficerMember_7"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ChiefExecutiveOfficersMember" xlink:label="loc_huge_ChiefExecutiveOfficersMember_8"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PresidentsMember" xlink:label="loc_huge_PresidentsMember_9"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PresidentOfFSDMember" xlink:label="loc_huge_PresidentOfFSDMember_10"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ChiefFinancialOfficersMember" xlink:label="loc_huge_ChiefFinancialOfficersMember_11"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ChiefOperatingConsultantMember" xlink:label="loc_huge_ChiefOperatingConsultantMember_12"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FormerChiefOperatingOfficerMember" xlink:label="loc_huge_FormerChiefOperatingOfficerMember_13"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IndependentDirectorMember" xlink:label="loc_huge_IndependentDirectorMember_14"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DirectorsAndOfficersMember" xlink:label="loc_huge_DirectorsAndOfficersMember_15"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_KeyManagementAndDirectorsMember" xlink:label="loc_huge_KeyManagementAndDirectorsMember_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_20"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassBCommonStockSharesMember" xlink:label="loc_huge_ClassBCommonStockSharesMember_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_Default"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PaymentOfExpenses" xlink:label="loc_huge_PaymentOfExpenses_25"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:label="loc_ifrs-full_AmountsPayableRelatedPartyTransactions_26"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DirectorsRemunerationExpense" xlink:label="loc_ifrs-full_DirectorsRemunerationExpense_27"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesIssuedForCompensationBonus" xlink:label="loc_huge_NumberOfSharesIssuedForCompensationBonus_28"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_29"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdditionalRemuneration" xlink:label="loc_huge_AdditionalRemuneration_30"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_31"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_dei_LegalEntityAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1" xlink:to="loc_dei_EntityDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_1" xlink:to="loc_huge_FvPharmaIncMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_1" xlink:to="loc_huge_FSDBiosciencesMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1" xlink:to="loc_dei_EntityDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_6" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_6" xlink:to="loc_huge_PresidentAndChiefExecutiveOfficerMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_6" xlink:to="loc_huge_FormerChiefExecutiveOfficerMember_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_6" xlink:to="loc_huge_ChiefExecutiveOfficersMember_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_6" xlink:to="loc_huge_PresidentsMember_9" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_6" xlink:to="loc_huge_PresidentOfFSDMember_10" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_6" xlink:to="loc_huge_ChiefFinancialOfficersMember_11" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_6" xlink:to="loc_huge_ChiefOperatingConsultantMember_12" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_6" xlink:to="loc_huge_FormerChiefOperatingOfficerMember_13" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_6" xlink:to="loc_huge_IndependentDirectorMember_14" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_6" xlink:to="loc_huge_DirectorsAndOfficersMember_15" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_6" xlink:to="loc_huge_KeyManagementAndDirectorsMember_16" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_6" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_20" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_20" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_20" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_20" xlink:to="loc_huge_ClassBCommonStockSharesMember_20" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_20" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_huge_PaymentOfExpenses_25" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ifrs-full_AmountsPayableRelatedPartyTransactions_26" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ifrs-full_DirectorsRemunerationExpense_27" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_huge_NumberOfSharesIssuedForCompensationBonus_28" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_29" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_huge_AdditionalRemuneration_30" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_31" order="70" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/SharebasedCompensationNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_StockOptionsMember" xlink:label="loc_huge_StockOptionsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_6"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfReplacementShareOptionsIssued" xlink:label="loc_huge_NumberOfReplacementShareOptionsIssued_7"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WeightedAverageExercisePriceForReplacementOfShareOptions" xlink:label="loc_huge_WeightedAverageExercisePriceForReplacementOfShareOptions_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" xlink:label="loc_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_14"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" xlink:to="loc_huge_StockOptionsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_huge_NumberOfReplacementShareOptionsIssued_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_huge_WeightedAverageExercisePriceForReplacementOfShareOptions_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_9" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_10" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_11" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_12" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_13" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_14" order="90" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/SharebasedCompensationScheduleOfChangesInNumberOfShareOptionsDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_StockOptionsMember" xlink:label="loc_huge_StockOptionsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_17"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" xlink:to="loc_huge_StockOptionsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_9" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_10" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_11" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_12" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_13" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_14" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_15" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_16" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_17" order="120" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/SharebasedCompensationScheduleOfExercisePriceAndWeightedAverageContractualTermOfShareOptionsOutstandingAndExercisableDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_StockOptionsMember" xlink:label="loc_huge_StockOptionsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceTwoPointSixOneMember" xlink:label="loc_huge_ExercisePriceTwoPointSixOneMember_5"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceThreePointSevenFiveMember" xlink:label="loc_huge_ExercisePriceThreePointSevenFiveMember_6"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceThreePointEightSixMember" xlink:label="loc_huge_ExercisePriceThreePointEightSixMember_7"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFourPointFourTwoMember" xlink:label="loc_huge_ExercisePriceFourPointFourTwoMember_8"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFourPointSevenFiveMember" xlink:label="loc_huge_ExercisePriceFourPointSevenFiveMember_9"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFivePointZeroThreeMember" xlink:label="loc_huge_ExercisePriceFivePointZeroThreeMember_10"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFivePointFourThreeMember" xlink:label="loc_huge_ExercisePriceFivePointFourThreeMember_11"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSixPointSixteenMember" xlink:label="loc_huge_ExercisePriceSixPointSixteenMember_12"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSevenPointSeventeenMember" xlink:label="loc_huge_ExercisePriceSevenPointSeventeenMember_13"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSevenPointSixtyThreeMember" xlink:label="loc_huge_ExercisePriceSevenPointSixtyThreeMember_14"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceNinePointFiveFourMember" xlink:label="loc_huge_ExercisePriceNinePointFiveFourMember_15"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceTenPointSixFiveMember" xlink:label="loc_huge_ExercisePriceTenPointSixFiveMember_16"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceThirteenPointZeroSevenMember" xlink:label="loc_huge_ExercisePriceThirteenPointZeroSevenMember_17"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceThirteenPointFourSevenMember" xlink:label="loc_huge_ExercisePriceThirteenPointFourSevenMember_18"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSixteenPointZeroEightMember" xlink:label="loc_huge_ExercisePriceSixteenPointZeroEightMember_19"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSeventeenPointEightNineMember" xlink:label="loc_huge_ExercisePriceSeventeenPointEightNineMember_20"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceEighteenPointZeroNineMember" xlink:label="loc_huge_ExercisePriceEighteenPointZeroNineMember_21"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceTwentyPointOneZeroMember" xlink:label="loc_huge_ExercisePriceTwentyPointOneZeroMember_22"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceTwentyOnePointElevenMember" xlink:label="loc_huge_ExercisePriceTwentyOnePointElevenMember_23"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceTwentyFourPointTwelveMember" xlink:label="loc_huge_ExercisePriceTwentyFourPointTwelveMember_24"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceTwentySixPointThirteenMember" xlink:label="loc_huge_ExercisePriceTwentySixPointThirteenMember_25"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFortyPointTwentyMember" xlink:label="loc_huge_ExercisePriceFortyPointTwentyMember_26"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFortyFourPointTwentyTwoMember" xlink:label="loc_huge_ExercisePriceFortyFourPointTwentyTwoMember_27"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFortySevenPointTwentyFourMember" xlink:label="loc_huge_ExercisePriceFortySevenPointTwentyFourMember_28"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFiftyPointTwentyFiveMember" xlink:label="loc_huge_ExercisePriceFiftyPointTwentyFiveMember_29"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFiftyTwoPointTwentySixMember" xlink:label="loc_huge_ExercisePriceFiftyTwoPointTwentySixMember_30"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFiftyFivePointTwentyEightMember" xlink:label="loc_huge_ExercisePriceFiftyFivePointTwentyEightMember_31"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFiftyNinePointThirtyMember" xlink:label="loc_huge_ExercisePriceFiftyNinePointThirtyMember_32"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSeventyFivePointThirtyEightMember" xlink:label="loc_huge_ExercisePriceSeventyFivePointThirtyEightMember_33"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceEightySixPointFortyThreeMember" xlink:label="loc_huge_ExercisePriceEightySixPointFortyThreeMember_34"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceEightyEightPointFortyFourMember" xlink:label="loc_huge_ExercisePriceEightyEightPointFortyFourMember_35"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceOneHundredTwentyPointSixtyMember" xlink:label="loc_huge_ExercisePriceOneHundredTwentyPointSixtyMember_36"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember" xlink:label="loc_huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember_37"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFiftySixPointTwentyEightMember" xlink:label="loc_huge_ExercisePriceFiftySixPointTwentyEightMember_38"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSevenPointZeroZeroMember" xlink:label="loc_huge_ExercisePriceSevenPointZeroZeroMember_39"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSevenPointFiftyMember" xlink:label="loc_huge_ExercisePriceSevenPointFiftyMember_40"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceTwentyOnePointNinetyOneMember" xlink:label="loc_huge_ExercisePriceTwentyOnePointNinetyOneMember_41"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceTwentyOnePointTwentyTwoMember" xlink:label="loc_huge_ExercisePriceTwentyOnePointTwentyTwoMember_42"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceOneHundredFortyEightPointSeventyFourMember" xlink:label="loc_huge_ExercisePriceOneHundredFortyEightPointSeventyFourMember_43"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSixtyEightPointZeroOneMember" xlink:label="loc_huge_ExercisePriceSixtyEightPointZeroOneMember_44"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSeventyOnePointZeroSevenMember" xlink:label="loc_huge_ExercisePriceSeventyOnePointZeroSevenMember_45"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_50"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_51"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_52"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_53"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_54"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" xlink:to="loc_huge_StockOptionsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_5" xlink:to="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceTwoPointSixOneMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceThreePointSevenFiveMember_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceThreePointEightSixMember_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceFourPointFourTwoMember_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceFourPointSevenFiveMember_9" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceFivePointZeroThreeMember_10" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceFivePointFourThreeMember_11" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceSixPointSixteenMember_12" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceSevenPointSeventeenMember_13" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceSevenPointSixtyThreeMember_14" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceNinePointFiveFourMember_15" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceTenPointSixFiveMember_16" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceThirteenPointZeroSevenMember_17" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceThirteenPointFourSevenMember_18" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceSixteenPointZeroEightMember_19" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceSeventeenPointEightNineMember_20" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceEighteenPointZeroNineMember_21" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceTwentyPointOneZeroMember_22" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceTwentyOnePointElevenMember_23" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceTwentyFourPointTwelveMember_24" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceTwentySixPointThirteenMember_25" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceFortyPointTwentyMember_26" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceFortyFourPointTwentyTwoMember_27" order="220" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceFortySevenPointTwentyFourMember_28" order="230" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceFiftyPointTwentyFiveMember_29" order="240" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceFiftyTwoPointTwentySixMember_30" order="250" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceFiftyFivePointTwentyEightMember_31" order="260" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceFiftyNinePointThirtyMember_32" order="270" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceSeventyFivePointThirtyEightMember_33" order="280" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceEightySixPointFortyThreeMember_34" order="290" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceEightyEightPointFortyFourMember_35" order="300" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceOneHundredTwentyPointSixtyMember_36" order="310" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember_37" order="320" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceFiftySixPointTwentyEightMember_38" order="330" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceSevenPointZeroZeroMember_39" order="340" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceSevenPointFiftyMember_40" order="350" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceTwentyOnePointNinetyOneMember_41" order="360" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceTwentyOnePointTwentyTwoMember_42" order="370" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceOneHundredFortyEightPointSeventyFourMember_43" order="380" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceSixtyEightPointZeroOneMember_44" order="390" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_5" xlink:to="loc_huge_ExercisePriceSeventyOnePointZeroSevenMember_45" order="400" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_5" xlink:to="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_50" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_51" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_52" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_53" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_54" order="50" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/SharebasedCompensationScheduleOfFairValueAssumptionsOfShareOptionsGrantedDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_StockOptionsMember" xlink:label="loc_huge_StockOptionsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_16"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" xlink:to="loc_huge_StockOptionsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_RangeAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_5" xlink:to="loc_ifrs-full_RangesMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_5" xlink:to="loc_ifrs-full_BottomOfRangeMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_5" xlink:to="loc_ifrs-full_TopOfRangeMember_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_5" xlink:to="loc_ifrs-full_RangesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_11" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_12" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_13" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_14" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_15" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_16" order="60" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/ShareCapitalNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassesOfWarrantsAxis" xlink:label="loc_huge_ClassesOfWarrantsAxis_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassesOfWarrantsDomain" xlink:label="loc_huge_ClassesOfWarrantsDomain_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtAugust6Th2020Member" xlink:label="loc_huge_WarrantsByExpiryDateAtAugust6Th2020Member_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtOctober20Th2020Member" xlink:label="loc_huge_WarrantsByExpiryDateAtOctober20Th2020Member_2"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassesOfWarrantsDomain" xlink:label="loc_huge_ClassesOfWarrantsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_6"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassACommonStockSharesMember" xlink:label="loc_huge_ClassACommonStockSharesMember_6"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassBCommonStockSharesMember" xlink:label="loc_huge_ClassBCommonStockSharesMember_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_Default"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TypeOfArrangementsAxis" xlink:label="loc_huge_TypeOfArrangementsAxis_11"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TypeOfArrangementsDomain" xlink:label="loc_huge_TypeOfArrangementsDomain_11"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SecuritiesExchangeAgreementMember" xlink:label="loc_huge_SecuritiesExchangeAgreementMember_11"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_EquityDistributionAgreementMember" xlink:label="loc_huge_EquityDistributionAgreementMember_12"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TypeOfArrangementsDomain" xlink:label="loc_huge_TypeOfArrangementsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OtherInvestmentsNameOfEntityAxis" xlink:label="loc_huge_OtherInvestmentsNameOfEntityAxis_16"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OtherInvestmentsNameOfEntityDomain" xlink:label="loc_huge_OtherInvestmentsNameOfEntityDomain_16"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PharmadrugIncMember" xlink:label="loc_huge_PharmadrugIncMember_16"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SolarvestBioEnergyIncMember" xlink:label="loc_huge_SolarvestBioEnergyIncMember_17"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OtherInvestmentsNameOfEntityDomain" xlink:label="loc_huge_OtherInvestmentsNameOfEntityDomain_Default"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LegalEntitiesAxis" xlink:label="loc_huge_LegalEntitiesAxis_21"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LegalEntitiesDomain" xlink:label="loc_huge_LegalEntitiesDomain_21"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PrismicPharmaceuticalMember" xlink:label="loc_huge_PrismicPharmaceuticalMember_21"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AllianceGlobalPartnersMember" xlink:label="loc_huge_AllianceGlobalPartnersMember_22"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LegalEntitiesDomain" xlink:label="loc_huge_LegalEntitiesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DescriptionOfVotingRights" xlink:label="loc_huge_DescriptionOfVotingRights_27"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesAcquired" xlink:label="loc_huge_NumberOfSharesAcquired_28"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SharePrices" xlink:label="loc_huge_SharePrices_29"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfSharesAcquired" xlink:label="loc_huge_ValueOfSharesAcquired_30"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_31"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesIssuedInShareExchange" xlink:label="loc_huge_NumberOfSharesIssuedInShareExchange_32"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesIssuedForDebtSettlement" xlink:label="loc_huge_NumberOfSharesIssuedForDebtSettlement_33"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfSharesIssuedForDebtSettlement" xlink:label="loc_huge_ValueOfSharesIssuedForDebtSettlement_34"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfSharesIssuedInShareExchange" xlink:label="loc_huge_ValueOfSharesIssuedInShareExchange_35"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShareSplitRatio" xlink:label="loc_huge_ShareSplitRatio_36"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesIssuedInPrivatePlacement" xlink:label="loc_huge_NumberOfSharesIssuedInPrivatePlacement_37"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShareIssuePricePerShare" xlink:label="loc_huge_ShareIssuePricePerShare_38"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfSharesIssued" xlink:label="loc_huge_ValueOfSharesIssued_39"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LossesOnChangeInFairValueOfDerivatives" xlink:label="loc_ifrs-full_LossesOnChangeInFairValueOfDerivatives_40"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:label="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_41"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares" xlink:label="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_42"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfCommonStockOfShareBasedCompensation" xlink:label="loc_huge_IssuanceOfCommonStockOfShareBasedCompensation_43"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfTradeAndOtherPayableOfSharesBasedCompensation" xlink:label="loc_huge_ValueOfTradeAndOtherPayableOfSharesBasedCompensation_44"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfCommonSharesOfShareBasedBonusToEmployeesForPerformance" xlink:label="loc_huge_IssuanceOfCommonSharesOfShareBasedBonusToEmployeesForPerformance_45"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfShareBasedCompensationBonus" xlink:label="loc_huge_FairValueOfShareBasedCompensationBonus_46"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShareBasedPaymentExpenses" xlink:label="loc_huge_ShareBasedPaymentExpenses_47"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfCommonStockOfBoardOfDirectorsInLieuOfCash" xlink:label="loc_huge_IssuanceOfCommonStockOfBoardOfDirectorsInLieuOfCash_48"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfCommonStockForNotesPayable" xlink:label="loc_huge_IssuanceOfCommonStockForNotesPayable_49"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NotesSettledThroughIssuanceOfShares" xlink:label="loc_huge_NotesSettledThroughIssuanceOfShares_50"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfCommonStockToSettleNotesPayable" xlink:label="loc_huge_FairValueOfCommonStockToSettleNotesPayable_51"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GainLossOnSettlementOfFinancialLiability" xlink:label="loc_huge_GainLossOnSettlementOfFinancialLiability_52"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CommonStockIssuedForPrivatePlacement" xlink:label="loc_huge_CommonStockIssuedForPrivatePlacement_53"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsIssuedForPrivatePlacement" xlink:label="loc_huge_WarrantsIssuedForPrivatePlacement_54"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesIssuedThroughEquityDistributionAgreement" xlink:label="loc_huge_NumberOfSharesIssuedThroughEquityDistributionAgreement_55"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_56"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CashProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_huge_CashProceedsFromIssuanceOfPrivatePlacement_57"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromIssuingOtherEquityInstruments" xlink:label="loc_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_58"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfWarrantsIssued" xlink:label="loc_huge_FairValueOfWarrantsIssued_59"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfCommonStockOfDirectOffering" xlink:label="loc_huge_IssuanceOfCommonStockOfDirectOffering_60"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceCostOfCommonSharesAndWarrants" xlink:label="loc_huge_IssuanceCostOfCommonSharesAndWarrants_61"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfWarrantsOfDirectOffering" xlink:label="loc_huge_IssuanceOfWarrantsOfDirectOffering_62"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfWarrantLiability" xlink:label="loc_huge_FairValueOfWarrantLiability_63"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfWarrantLiabilityOfResidualAmount" xlink:label="loc_huge_FairValueOfWarrantLiabilityOfResidualAmount_64"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TotalCashTransactionCosts" xlink:label="loc_huge_TotalCashTransactionCosts_65"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TransactionCostsAllocatedToWarrants" xlink:label="loc_huge_TransactionCostsAllocatedToWarrants_66"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfCommonSharesIssued" xlink:label="loc_huge_FairValueOfCommonSharesIssued_67"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsForShareIssueCosts" xlink:label="loc_ifrs-full_PaymentsForShareIssueCosts_68"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceOfWarrantsGranted" xlink:label="loc_huge_ExercisePriceOfWarrantsGranted_69"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceOfWarrantIssue" xlink:label="loc_huge_ExercisePriceOfWarrantIssue_70"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_huge_ClassesOfWarrantsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_huge_ClassesOfWarrantsAxis_1" xlink:to="loc_huge_ClassesOfWarrantsDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtAugust6Th2020Member_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtOctober20Th2020Member_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_huge_ClassesOfWarrantsAxis_1" xlink:to="loc_huge_ClassesOfWarrantsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_6" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_6" xlink:to="loc_huge_ClassACommonStockSharesMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_6" xlink:to="loc_huge_ClassBCommonStockSharesMember_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_6" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_huge_TypeOfArrangementsAxis_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_huge_TypeOfArrangementsAxis_11" xlink:to="loc_huge_TypeOfArrangementsDomain_11" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_TypeOfArrangementsDomain_11" xlink:to="loc_huge_SecuritiesExchangeAgreementMember_11" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_TypeOfArrangementsDomain_11" xlink:to="loc_huge_EquityDistributionAgreementMember_12" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_huge_TypeOfArrangementsAxis_11" xlink:to="loc_huge_TypeOfArrangementsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_huge_OtherInvestmentsNameOfEntityAxis_16" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_huge_OtherInvestmentsNameOfEntityAxis_16" xlink:to="loc_huge_OtherInvestmentsNameOfEntityDomain_16" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_16" xlink:to="loc_huge_PharmadrugIncMember_16" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_16" xlink:to="loc_huge_SolarvestBioEnergyIncMember_17" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_huge_OtherInvestmentsNameOfEntityAxis_16" xlink:to="loc_huge_OtherInvestmentsNameOfEntityDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_huge_LegalEntitiesAxis_21" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_huge_LegalEntitiesAxis_21" xlink:to="loc_huge_LegalEntitiesDomain_21" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_LegalEntitiesDomain_21" xlink:to="loc_huge_PrismicPharmaceuticalMember_21" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_LegalEntitiesDomain_21" xlink:to="loc_huge_AllianceGlobalPartnersMember_22" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_huge_LegalEntitiesAxis_21" xlink:to="loc_huge_LegalEntitiesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_DescriptionOfVotingRights_27" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_NumberOfSharesAcquired_28" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_SharePrices_29" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_ValueOfSharesAcquired_30" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_NumberOfSharesIssued_31" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_NumberOfSharesIssuedInShareExchange_32" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_NumberOfSharesIssuedForDebtSettlement_33" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_ValueOfSharesIssuedForDebtSettlement_34" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_ValueOfSharesIssuedInShareExchange_35" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_ShareSplitRatio_36" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_NumberOfSharesIssuedInPrivatePlacement_37" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_ShareIssuePricePerShare_38" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_ValueOfSharesIssued_39" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_LossesOnChangeInFairValueOfDerivatives_40" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_41" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_42" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_IssuanceOfCommonStockOfShareBasedCompensation_43" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_ValueOfTradeAndOtherPayableOfSharesBasedCompensation_44" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_IssuanceOfCommonSharesOfShareBasedBonusToEmployeesForPerformance_45" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_FairValueOfShareBasedCompensationBonus_46" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_ShareBasedPaymentExpenses_47" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_IssuanceOfCommonStockOfBoardOfDirectorsInLieuOfCash_48" order="220" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_IssuanceOfCommonStockForNotesPayable_49" order="230" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_NotesSettledThroughIssuanceOfShares_50" order="240" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_FairValueOfCommonStockToSettleNotesPayable_51" order="250" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_GainLossOnSettlementOfFinancialLiability_52" order="260" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_CommonStockIssuedForPrivatePlacement_53" order="270" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_WarrantsIssuedForPrivatePlacement_54" order="280" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_NumberOfSharesIssuedThroughEquityDistributionAgreement_55" order="290" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_56" order="300" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_CashProceedsFromIssuanceOfPrivatePlacement_57" order="310" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_58" order="320" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_FairValueOfWarrantsIssued_59" order="330" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_IssuanceOfCommonStockOfDirectOffering_60" order="340" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_IssuanceCostOfCommonSharesAndWarrants_61" order="350" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_IssuanceOfWarrantsOfDirectOffering_62" order="360" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_FairValueOfWarrantLiability_63" order="370" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_FairValueOfWarrantLiabilityOfResidualAmount_64" order="380" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_TotalCashTransactionCosts_65" order="390" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_TransactionCostsAllocatedToWarrants_66" order="400" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_FairValueOfCommonSharesIssued_67" order="410" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_PaymentsForShareIssueCosts_68" order="420" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_ExercisePriceOfWarrantsGranted_69" order="430" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_ExercisePriceOfWarrantIssue_70" order="440" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/ShareCapitalScheduleOfFairValueAssumptionsOfWarrantsDetails">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfWarrantsLineItems" xlink:label="loc_huge_DisclosureOfWarrantsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfWarrantsTable" xlink:label="loc_huge_DisclosureOfWarrantsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_Default"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WeightedAverageSharePriceOfWarrants" xlink:label="loc_huge_WeightedAverageSharePriceOfWarrants_7"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceOfWarrantsGranted" xlink:label="loc_huge_ExercisePriceOfWarrantsGranted_8"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedDividendYieldOfWarrantsGranted" xlink:label="loc_huge_ExpectedDividendYieldOfWarrantsGranted_9"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_RiskFreeInterestRateOfWarrantsGranted" xlink:label="loc_huge_RiskFreeInterestRateOfWarrantsGranted_10"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedLifeOfWarrants" xlink:label="loc_huge_ExpectedLifeOfWarrants_11"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedVolatilityOfWarrantsGranted" xlink:label="loc_huge_ExpectedVolatilityOfWarrantsGranted_12"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_huge_DisclosureOfWarrantsLineItems_0" xlink:to="loc_huge_DisclosureOfWarrantsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_huge_DisclosureOfWarrantsTable_1" xlink:to="loc_ifrs-full_RangeAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_1" xlink:to="loc_ifrs-full_RangesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_1" xlink:to="loc_ifrs-full_BottomOfRangeMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_1" xlink:to="loc_ifrs-full_TopOfRangeMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_1" xlink:to="loc_ifrs-full_RangesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfWarrantsLineItems_0" xlink:to="loc_huge_WeightedAverageSharePriceOfWarrants_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfWarrantsLineItems_0" xlink:to="loc_huge_ExercisePriceOfWarrantsGranted_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfWarrantsLineItems_0" xlink:to="loc_huge_ExpectedDividendYieldOfWarrantsGranted_9" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfWarrantsLineItems_0" xlink:to="loc_huge_RiskFreeInterestRateOfWarrantsGranted_10" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfWarrantsLineItems_0" xlink:to="loc_huge_ExpectedLifeOfWarrants_11" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfWarrantsLineItems_0" xlink:to="loc_huge_ExpectedVolatilityOfWarrantsGranted_12" order="60" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/ShareCapitalScheduleOfReconciliationOfTheShareCapitalDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsMember" xlink:label="loc_huge_WarrantsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_5"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassACommonStockSharesMember" xlink:label="loc_huge_ClassACommonStockSharesMember_5"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassBCommonStockSharesMember" xlink:label="loc_huge_ClassBCommonStockSharesMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-full_IssueOfEquity_13"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfShares" xlink:label="loc_huge_IssuanceOfShares_14"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue" xlink:label="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue_15"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares" xlink:label="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_17"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughShareIssueRelatedCostShares" xlink:label="loc_huge_IncreaseDecreaseThroughShareIssueRelatedCostShares_18"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughReverseAcquisition" xlink:label="loc_huge_IncreaseDecreaseThroughReverseAcquisition_19"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughReverseAcquisitionShares" xlink:label="loc_huge_IncreaseDecreaseThroughReverseAcquisitionShares_20"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughWarrantValuations" xlink:label="loc_huge_IncreaseDecreaseThroughWarrantValuations_21"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughWarrantValuationsShares" xlink:label="loc_huge_IncreaseDecreaseThroughWarrantValuationsShares_22"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_23"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares" xlink:label="loc_huge_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares_24"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_25"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughExerciseOfOptionShares" xlink:label="loc_huge_IncreaseDecreaseThroughExerciseOfOptionShares_26"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughStockOptionsCancelled" xlink:label="loc_huge_IncreaseDecreaseThroughStockOptionsCancelled_27"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_28"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughExerciseOfWarrantsShares" xlink:label="loc_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares_29"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughExpiryOfWarrantsValue" xlink:label="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue_30"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughExpiryOfWarrantsShares" xlink:label="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares_31"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_EquityMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_1" xlink:to="loc_huge_WarrantsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_EquityMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_5" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_5" xlink:to="loc_huge_ClassACommonStockSharesMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_5" xlink:to="loc_huge_ClassBCommonStockSharesMember_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_5" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_Equity_11" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_NumberOfSharesOutstanding_12" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_IssueOfEquity_13" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_IssuanceOfShares_14" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue_15" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_16" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_ShareIssueRelatedCost_17" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughShareIssueRelatedCostShares_18" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughReverseAcquisition_19" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughReverseAcquisitionShares_20" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughWarrantValuations_21" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughWarrantValuationsShares_22" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_23" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares_24" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_25" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughExerciseOfOptionShares_26" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughStockOptionsCancelled_27" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_28" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares_29" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue_30" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares_31" order="210" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/ShareCapitalScheduleOfWarrantsOutstandingAndExercisePriceDetails">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfWarrantsLineItems" xlink:label="loc_huge_DisclosureOfWarrantsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfWarrantsTable" xlink:label="loc_huge_DisclosureOfWarrantsTable_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassesOfWarrantsAxis" xlink:label="loc_huge_ClassesOfWarrantsAxis_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassesOfWarrantsDomain" xlink:label="loc_huge_ClassesOfWarrantsDomain_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtJanuary5Th2020Member" xlink:label="loc_huge_WarrantsByExpiryDateAtJanuary5Th2020Member_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtNovember30Th2020Member" xlink:label="loc_huge_WarrantsByExpiryDateAtNovember30Th2020Member_2"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtAugust1St2021Member" xlink:label="loc_huge_WarrantsByExpiryDateAtAugust1St2021Member_3"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtMay24Th2022Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay24Th2022Member_4"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtSeptember15Th2022Member" xlink:label="loc_huge_WarrantsByExpiryDateAtSeptember15Th2022Member_5"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtMay20Th2023Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay20Th2023Member_6"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtJuly24Th2023Member" xlink:label="loc_huge_WarrantsByExpiryDateAtJuly24Th2023Member_7"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtSeptember11Th2023Member" xlink:label="loc_huge_WarrantsByExpiryDateAtSeptember11Th2023Member_8"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtMay4Th2025Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay4Th2025Member_9"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtMay10Th2025Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay10Th2025Member_10"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtMay17Th2025Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay17Th2025Member_11"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtMay31St2025Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay31St2025Member_12"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtJune8Th2025Member" xlink:label="loc_huge_WarrantsByExpiryDateAtJune8Th2025Member_13"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtAugust6Th2020Member" xlink:label="loc_huge_WarrantsByExpiryDateAtAugust6Th2020Member_14"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtOctober20Th2020Member" xlink:label="loc_huge_WarrantsByExpiryDateAtOctober20Th2020Member_15"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtJanuary16Th2026Member" xlink:label="loc_huge_WarrantsByExpiryDateAtJanuary16Th2026Member_16"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtJanuary20Th2026Member" xlink:label="loc_huge_WarrantsByExpiryDateAtJanuary20Th2026Member_17"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtNovember1St2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtNovember1St2019Member_18"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtNovember14Th2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtNovember14Th2019Member_19"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtNovember21St2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtNovember21St2019Member_20"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtDecember12Th2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtDecember12Th2019Member_21"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtDecember29Th2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtDecember29Th2019Member_22"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassesOfWarrantsDomain" xlink:label="loc_huge_ClassesOfWarrantsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WeightedAverageExercisePriceWarrantsOutstanding" xlink:label="loc_huge_WeightedAverageExercisePriceWarrantsOutstanding_27"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfWarrantsOutstanding" xlink:label="loc_huge_NumberOfWarrantsOutstanding_28"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_huge_DisclosureOfWarrantsLineItems_0" xlink:to="loc_huge_DisclosureOfWarrantsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_huge_DisclosureOfWarrantsTable_1" xlink:to="loc_huge_ClassesOfWarrantsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_huge_ClassesOfWarrantsAxis_1" xlink:to="loc_huge_ClassesOfWarrantsDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtJanuary5Th2020Member_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtNovember30Th2020Member_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtAugust1St2021Member_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtMay24Th2022Member_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtSeptember15Th2022Member_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtMay20Th2023Member_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtJuly24Th2023Member_7" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtSeptember11Th2023Member_8" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtMay4Th2025Member_9" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtMay10Th2025Member_10" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtMay17Th2025Member_11" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtMay31St2025Member_12" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtJune8Th2025Member_13" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtAugust6Th2020Member_14" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtOctober20Th2020Member_15" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtJanuary16Th2026Member_16" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtJanuary20Th2026Member_17" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtNovember1St2019Member_18" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtNovember14Th2019Member_19" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtNovember21St2019Member_20" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtDecember12Th2019Member_21" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtDecember29Th2019Member_22" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_huge_ClassesOfWarrantsAxis_1" xlink:to="loc_huge_ClassesOfWarrantsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfWarrantsLineItems_0" xlink:to="loc_huge_WeightedAverageExercisePriceWarrantsOutstanding_27" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfWarrantsLineItems_0" xlink:to="loc_huge_NumberOfWarrantsOutstanding_28" order="20" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/SignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfAssetsDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SummaryOfSignificantAccountingPoliciesTable" xlink:label="loc_huge_SummaryOfSignificantAccountingPoliciesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" xlink:label="loc_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="loc_ifrs-full_ComputerEquipmentMember_5"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProductionEquipmentMember" xlink:label="loc_huge_ProductionEquipmentMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FixturesAndFittingsMember" xlink:label="loc_ifrs-full_FixturesAndFittingsMember_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ConstructionInProgressMember" xlink:label="loc_ifrs-full_ConstructionInProgressMember_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LandMember" xlink:label="loc_ifrs-full_LandMember_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationMethodPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DepreciationMethodPropertyPlantAndEquipment_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill_16"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_huge_SummaryOfSignificantAccountingPoliciesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesTable_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesTable_1" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_5" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_5" xlink:to="loc_ifrs-full_ComputerEquipmentMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_5" xlink:to="loc_huge_ProductionEquipmentMember_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_5" xlink:to="loc_ifrs-full_FixturesAndFittingsMember_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_5" xlink:to="loc_ifrs-full_ConstructionInProgressMember_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_5" xlink:to="loc_ifrs-full_LandMember_9" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_5" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_14" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_DepreciationMethodPropertyPlantAndEquipment_15" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill_16" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/SubsequentEventsNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SubsequentEventsMember" xlink:label="loc_huge_SubsequentEventsMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TypeOfArrangementsAxis" xlink:label="loc_huge_TypeOfArrangementsAxis_4"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TypeOfArrangementsDomain" xlink:label="loc_huge_TypeOfArrangementsDomain_4"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_EquityDistributionAgreementMember" xlink:label="loc_huge_EquityDistributionAgreementMember_4"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TypeOfArrangementsDomain" xlink:label="loc_huge_TypeOfArrangementsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_8"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BoardMembersMember" xlink:label="loc_huge_BoardMembersMember_8"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AllianceGlobalPartnersMember" xlink:label="loc_huge_AllianceGlobalPartnersMember_9"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DirectorsAndOfficersMember" xlink:label="loc_huge_DirectorsAndOfficersMember_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfOrdinarySharesAxis" xlink:label="loc_ifrs-full_ClassesOfOrdinarySharesAxis_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-full_OrdinarySharesMember_14"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassBSubordinatedVotingSharesMember" xlink:label="loc_huge_ClassBSubordinatedVotingSharesMember_14"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassBCommonSharesMember" xlink:label="loc_huge_ClassBCommonSharesMember_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-full_OrdinarySharesMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_20"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfStockOptionsApprovedForIssuance" xlink:label="loc_huge_NumberOfStockOptionsApprovedForIssuance_21"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CertainShareholdersClaimingToHoldInExcessPercentageOfClassBSubordinatedVotingShares" xlink:label="loc_huge_CertainShareholdersClaimingToHoldInExcessPercentageOfClassBSubordinatedVotingShares_22"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesIssuedThroughEquityDistributionAgreement" xlink:label="loc_huge_NumberOfSharesIssuedThroughEquityDistributionAgreement_23"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfShares" xlink:label="loc_huge_IssuanceOfShares_24"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShareIssuePricePerShare" xlink:label="loc_huge_ShareIssuePricePerShare_25"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_26"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DerivativeLiabilitiesSettledThroughIssuanceOfShares" xlink:label="loc_huge_DerivativeLiabilitiesSettledThroughIssuanceOfShares_27"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfCommonSharesApprovedForIssuance" xlink:label="loc_huge_FairValueOfCommonSharesApprovedForIssuance_28"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_MaximumAggregateOfferingPrice" xlink:label="loc_huge_MaximumAggregateOfferingPrice_29"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1" xlink:to="loc_ifrs-full_NonadjustingEventsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NonadjustingEventsMember_1" xlink:to="loc_huge_SubsequentEventsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_huge_TypeOfArrangementsAxis_4" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_huge_TypeOfArrangementsAxis_4" xlink:to="loc_huge_TypeOfArrangementsDomain_4" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_TypeOfArrangementsDomain_4" xlink:to="loc_huge_EquityDistributionAgreementMember_4" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_huge_TypeOfArrangementsAxis_4" xlink:to="loc_huge_TypeOfArrangementsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_8" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_8" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_8" xlink:to="loc_huge_BoardMembersMember_8" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_8" xlink:to="loc_huge_AllianceGlobalPartnersMember_9" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_8" xlink:to="loc_huge_DirectorsAndOfficersMember_10" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_8" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ifrs-full_ClassesOfOrdinarySharesAxis_14" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfOrdinarySharesAxis_14" xlink:to="loc_ifrs-full_OrdinarySharesMember_14" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_OrdinarySharesMember_14" xlink:to="loc_huge_ClassBSubordinatedVotingSharesMember_14" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_OrdinarySharesMember_14" xlink:to="loc_huge_ClassBCommonSharesMember_15" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfOrdinarySharesAxis_14" xlink:to="loc_ifrs-full_OrdinarySharesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_20" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_huge_NumberOfStockOptionsApprovedForIssuance_21" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_huge_CertainShareholdersClaimingToHoldInExcessPercentageOfClassBSubordinatedVotingShares_22" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_huge_NumberOfSharesIssuedThroughEquityDistributionAgreement_23" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_huge_IssuanceOfShares_24" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_huge_ShareIssuePricePerShare_25" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_26" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_huge_DerivativeLiabilitiesSettledThroughIssuanceOfShares_27" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_huge_FairValueOfCommonSharesApprovedForIssuance_28" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_huge_MaximumAggregateOfferingPrice_29" order="100" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/BasisOfPresentationScheduleOfRestatementOfPriorPeriodInformationDetails">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_RetrospectiveApplicationAndRetrospectiveRestatementLineItems" xlink:label="loc_huge_RetrospectiveApplicationAndRetrospectiveRestatementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_RetrospectiveApplicationAndRetrospectiveRestatementTable" xlink:label="loc_huge_RetrospectiveApplicationAndRetrospectiveRestatementTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassACommonStockSharesMember" xlink:label="loc_huge_ClassACommonStockSharesMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassBCommonStockSharesMember" xlink:label="loc_huge_ClassBCommonStockSharesMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:label="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RestatedMember" xlink:label="loc_ifrs-full_RestatedMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PreviouslyStatedMember" xlink:label="loc_ifrs-full_PreviouslyStatedMember_6"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember" xlink:label="loc_huge_IncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" xlink:label="loc_ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RestatedMember" xlink:label="loc_ifrs-full_RestatedMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAbstract" xlink:label="loc_ifrs-full_AssetsAbstract_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="loc_ifrs-full_CurrentAssetsAbstract_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="loc_ifrs-full_CurrentPrepaidExpenses_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="loc_ifrs-full_NoncurrentAssetsAbstract_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-full_Assets_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesAbstract" xlink:label="loc_ifrs-full_LiabilitiesAbstract_24"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_CurrentLiabilitiesAbstract_24"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_24"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_25"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities_26"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_NoncurrentLiabilitiesAbstract_28"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_28"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-full_Liabilities_29"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAbstract" xlink:label="loc_ifrs-full_EquityAbstract_31"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital_31"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Warrants" xlink:label="loc_huge_Warrants_32"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharePremium" xlink:label="loc_ifrs-full_SharePremium_33"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-full_RetainedEarnings_34"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_35"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-full_EquityAndLiabilities_37"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_huge_RetrospectiveApplicationAndRetrospectiveRestatementLineItems_0" xlink:to="loc_huge_RetrospectiveApplicationAndRetrospectiveRestatementTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_huge_RetrospectiveApplicationAndRetrospectiveRestatementTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_1" xlink:to="loc_huge_ClassACommonStockSharesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_1" xlink:to="loc_huge_ClassBCommonStockSharesMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_huge_RetrospectiveApplicationAndRetrospectiveRestatementTable_1" xlink:to="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_6" xlink:to="loc_ifrs-full_RestatedMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RestatedMember_6" xlink:to="loc_ifrs-full_PreviouslyStatedMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RestatedMember_6" xlink:to="loc_huge_IncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RestatedMember_6" xlink:to="loc_ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_6" xlink:to="loc_ifrs-full_RestatedMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_RetrospectiveApplicationAndRetrospectiveRestatementLineItems_0" xlink:to="loc_ifrs-full_AssetsAbstract_13" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAbstract_13" xlink:to="loc_ifrs-full_CurrentAssetsAbstract_13" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_13" xlink:to="loc_ifrs-full_CashAndCashEquivalents_13" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_13" xlink:to="loc_ifrs-full_TradeAndOtherCurrentReceivables_14" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_13" xlink:to="loc_ifrs-full_CurrentPrepaidExpenses_15" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_13" xlink:to="loc_ifrs-full_CurrentAssets_16" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAbstract_13" xlink:to="loc_ifrs-full_NoncurrentAssetsAbstract_18" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_18" xlink:to="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_18" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_18" xlink:to="loc_ifrs-full_RightofuseAssets_19" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_18" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_20" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_RetrospectiveApplicationAndRetrospectiveRestatementLineItems_0" xlink:to="loc_ifrs-full_Assets_23" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_RetrospectiveApplicationAndRetrospectiveRestatementLineItems_0" xlink:to="loc_ifrs-full_LiabilitiesAbstract_24" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesAbstract_24" xlink:to="loc_ifrs-full_CurrentLiabilitiesAbstract_24" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_24" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayables_24" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_24" xlink:to="loc_ifrs-full_CurrentLeaseLiabilities_25" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_24" xlink:to="loc_ifrs-full_CurrentLiabilities_26" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesAbstract_24" xlink:to="loc_ifrs-full_NoncurrentLiabilitiesAbstract_28" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_28" xlink:to="loc_ifrs-full_NoncurrentLeaseLiabilities_28" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_28" xlink:to="loc_ifrs-full_Liabilities_29" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesAbstract_24" xlink:to="loc_ifrs-full_EquityAbstract_31" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityAbstract_31" xlink:to="loc_ifrs-full_IssuedCapital_31" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityAbstract_31" xlink:to="loc_huge_Warrants_32" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityAbstract_31" xlink:to="loc_ifrs-full_SharePremium_33" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityAbstract_31" xlink:to="loc_ifrs-full_RetainedEarnings_34" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityAbstract_31" xlink:to="loc_ifrs-full_Equity_35" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesAbstract_24" xlink:to="loc_ifrs-full_EquityAndLiabilities_37" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/AssetsHeldForSaleDetails">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfAssetsHeldForSaleLineItems" xlink:label="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfAssetsHeldForSaleTable" xlink:label="loc_huge_DisclosureOfAssetsHeldForSaleTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember" xlink:label="loc_ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_6"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_0" xlink:to="loc_huge_DisclosureOfAssetsHeldForSaleTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleTable_1" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_1" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_1" xlink:to="loc_ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_1" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_0" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_6" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/AssetsHeldForSaleDetails2">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfAssetsHeldForSaleLineItems" xlink:label="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfAssetsHeldForSaleTable" xlink:label="loc_huge_DisclosureOfAssetsHeldForSaleTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember" xlink:label="loc_ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_6"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AddDeductItemsNotAffectingCashAbstract" xlink:label="loc_huge_AddDeductItemsNotAffectingCashAbstract_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDepreciationExpense" xlink:label="loc_ifrs-full_AdjustmentsForDepreciationExpense_7"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold" xlink:label="loc_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossInventories" xlink:label="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossInventories_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets" xlink:label="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_11"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentsForLossesGainsOnDisposalOfInventory" xlink:label="loc_huge_AdjustmentsForLossesGainsOnDisposalOfInventory_12"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentsForLossesGainsOnDisposalOfEquipment" xlink:label="loc_huge_AdjustmentsForLossesGainsOnDisposalOfEquipment_13"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ChangesInNoncashWorkingCapitalBalancesAbstract" xlink:label="loc_huge_ChangesInNoncashWorkingCapitalBalancesAbstract_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_15"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentsForIncreaseDecreaseInPrepaidExpensesAndDeposits" xlink:label="loc_huge_AdjustmentsForIncreaseDecreaseInPrepaidExpensesAndDeposits_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_24"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_25"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_0" xlink:to="loc_huge_DisclosureOfAssetsHeldForSaleTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleTable_1" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_1" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_1" xlink:to="loc_ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_1" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_6" xlink:to="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_6" xlink:to="loc_huge_AddDeductItemsNotAffectingCashAbstract_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_AddDeductItemsNotAffectingCashAbstract_7" xlink:to="loc_ifrs-full_AdjustmentsForDepreciationExpense_7" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_AddDeductItemsNotAffectingCashAbstract_7" xlink:to="loc_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold_8" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_AddDeductItemsNotAffectingCashAbstract_7" xlink:to="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossInventories_9" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_AddDeductItemsNotAffectingCashAbstract_7" xlink:to="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_10" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_AddDeductItemsNotAffectingCashAbstract_7" xlink:to="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_11" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_AddDeductItemsNotAffectingCashAbstract_7" xlink:to="loc_huge_AdjustmentsForLossesGainsOnDisposalOfInventory_12" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_AddDeductItemsNotAffectingCashAbstract_7" xlink:to="loc_huge_AdjustmentsForLossesGainsOnDisposalOfEquipment_13" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_6" xlink:to="loc_huge_ChangesInNoncashWorkingCapitalBalancesAbstract_15" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ChangesInNoncashWorkingCapitalBalancesAbstract_15" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_15" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ChangesInNoncashWorkingCapitalBalancesAbstract_15" xlink:to="loc_huge_AdjustmentsForIncreaseDecreaseInPrepaidExpensesAndDeposits_16" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ChangesInNoncashWorkingCapitalBalancesAbstract_15" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_17" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ChangesInNoncashWorkingCapitalBalancesAbstract_15" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_18" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_ChangesInNoncashWorkingCapitalBalancesAbstract_15" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_19" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_6" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_21" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_23" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_23" xlink:to="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_23" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_23" xlink:to="loc_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_24" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_23" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_25" order="20" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/AssetsHeldForSaleDetails1">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfAssetsHeldForSaleLineItems" xlink:label="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfAssetsHeldForSaleTable" xlink:label="loc_huge_DisclosureOfAssetsHeldForSaleTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember" xlink:label="loc_ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-full_CostOfSales_7"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GrossProfitLossBeforeFairValueAdjustments" xlink:label="loc_huge_GrossProfitLossBeforeFairValueAdjustments_8"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueAdjustmentsOnInventorySold" xlink:label="loc_huge_FairValueAdjustmentsOnInventorySold_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets" xlink:label="loc_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-full_GrossProfit_11"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OperatingExpensesAbstract" xlink:label="loc_huge_OperatingExpensesAbstract_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_GeneralAndAdministrativeExpense_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationAndAmortisationExpense" xlink:label="loc_ifrs-full_DepreciationAndAmortisationExpense_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OperatingExpense" xlink:label="loc_ifrs-full_OperatingExpense_15"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProfitLossBeforeOtherIncomeAndGainLossOnSaleOfEquipmentFromDiscontinuedOperations" xlink:label="loc_huge_ProfitLossBeforeOtherIncomeAndGainLossOnSaleOfEquipmentFromDiscontinuedOperations_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherIncome" xlink:label="loc_ifrs-full_OtherIncome_18"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LossOnSaleOfEquipment" xlink:label="loc_huge_LossOnSaleOfEquipment_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_20"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_0" xlink:to="loc_huge_DisclosureOfAssetsHeldForSaleTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleTable_1" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_1" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_1" xlink:to="loc_ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_1" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_0" xlink:to="loc_ifrs-full_Revenue_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_0" xlink:to="loc_ifrs-full_CostOfSales_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_0" xlink:to="loc_huge_GrossProfitLossBeforeFairValueAdjustments_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_0" xlink:to="loc_huge_FairValueAdjustmentsOnInventorySold_9" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_0" xlink:to="loc_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets_10" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_0" xlink:to="loc_ifrs-full_GrossProfit_11" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_0" xlink:to="loc_huge_OperatingExpensesAbstract_12" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_OperatingExpensesAbstract_12" xlink:to="loc_ifrs-full_GeneralAndAdministrativeExpense_12" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_OperatingExpensesAbstract_12" xlink:to="loc_ifrs-full_DepreciationAndAmortisationExpense_13" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_OperatingExpensesAbstract_12" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_14" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_OperatingExpensesAbstract_12" xlink:to="loc_ifrs-full_OperatingExpense_15" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_0" xlink:to="loc_huge_ProfitLossBeforeOtherIncomeAndGainLossOnSaleOfEquipmentFromDiscontinuedOperations_17" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_0" xlink:to="loc_ifrs-full_OtherIncome_18" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_0" xlink:to="loc_huge_LossOnSaleOfEquipment_19" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_0" xlink:to="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_20" order="110" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/AssetsHeldForSaleDetailTextuals">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfAssetsHeldForSaleLineItems" xlink:label="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfAssetsHeldForSaleTable" xlink:label="loc_huge_DisclosureOfAssetsHeldForSaleTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember" xlink:label="loc_ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_6"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LossOnSaleOfEquipment" xlink:label="loc_huge_LossOnSaleOfEquipment_7"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProceedsFromSalesOfInventory" xlink:label="loc_huge_ProceedsFromSalesOfInventory_8"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LossOnSaleOfInventory" xlink:label="loc_huge_LossOnSaleOfInventory_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_10"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_0" xlink:to="loc_huge_DisclosureOfAssetsHeldForSaleTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleTable_1" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_1" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_1" xlink:to="loc_ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_1" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_0" xlink:to="loc_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_0" xlink:to="loc_huge_LossOnSaleOfEquipment_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_0" xlink:to="loc_huge_ProceedsFromSalesOfInventory_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_0" xlink:to="loc_huge_LossOnSaleOfInventory_9" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_0" xlink:to="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_10" order="50" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/WarrantsLiabilityDetailTextuals">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantLineItems" xlink:label="loc_huge_WarrantLineItems_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantLiabilitiesTable" xlink:label="loc_huge_WarrantLiabilitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassBCommonStockSharesMember" xlink:label="loc_huge_ClassBCommonStockSharesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AllLevelsOfFairValueHierarchyMember" xlink:label="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Level2OfFairValueHierarchyMember" xlink:label="loc_ifrs-full_Level2OfFairValueHierarchyMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AllLevelsOfFairValueHierarchyMember" xlink:label="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_Default"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfCommonStockOfDirectOffering" xlink:label="loc_huge_IssuanceOfCommonStockOfDirectOffering_10"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfWarrantsOfDirectOffering" xlink:label="loc_huge_IssuanceOfWarrantsOfDirectOffering_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromIssuingOtherEquityInstruments" xlink:label="loc_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_12"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceOfWarrantIssue" xlink:label="loc_huge_ExercisePriceOfWarrantIssue_13"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedLifeOfWarrants" xlink:label="loc_huge_ExpectedLifeOfWarrants_14"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TransactionCostsAllocatedToWarrants" xlink:label="loc_huge_TransactionCostsAllocatedToWarrants_15"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfWarrantLiability" xlink:label="loc_huge_FairValueOfWarrantLiability_16"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SharePrices" xlink:label="loc_huge_SharePrices_17"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_RiskFreeInterestRateOfWarrantsGranted" xlink:label="loc_huge_RiskFreeInterestRateOfWarrantsGranted_18"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsLiability" xlink:label="loc_huge_WarrantsLiability_19"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProfitLossOnChangeInFairValue" xlink:label="loc_huge_ProfitLossOnChangeInFairValue_20"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceOfWarrantsLiability" xlink:label="loc_huge_ExercisePriceOfWarrantsLiability_21"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SharePricesOfWarrantsLiability" xlink:label="loc_huge_SharePricesOfWarrantsLiability_22"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_RiskFreeInterestRateOfWarrantsLiability" xlink:label="loc_huge_RiskFreeInterestRateOfWarrantsLiability_23"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedVolatilityOfWarrantsGranted" xlink:label="loc_huge_ExpectedVolatilityOfWarrantsGranted_24"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_huge_WarrantLineItems_0" xlink:to="loc_huge_WarrantLiabilitiesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_huge_WarrantLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_1" xlink:to="loc_huge_ClassBCommonStockSharesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_huge_WarrantLiabilitiesTable_1" xlink:to="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_5" xlink:to="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_5" xlink:to="loc_ifrs-full_Level2OfFairValueHierarchyMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_5" xlink:to="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_WarrantLineItems_0" xlink:to="loc_huge_IssuanceOfCommonStockOfDirectOffering_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_WarrantLineItems_0" xlink:to="loc_huge_IssuanceOfWarrantsOfDirectOffering_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_WarrantLineItems_0" xlink:to="loc_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_12" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_WarrantLineItems_0" xlink:to="loc_huge_ExercisePriceOfWarrantIssue_13" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_WarrantLineItems_0" xlink:to="loc_huge_ExpectedLifeOfWarrants_14" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_WarrantLineItems_0" xlink:to="loc_huge_TransactionCostsAllocatedToWarrants_15" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_WarrantLineItems_0" xlink:to="loc_huge_FairValueOfWarrantLiability_16" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_WarrantLineItems_0" xlink:to="loc_huge_SharePrices_17" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_WarrantLineItems_0" xlink:to="loc_huge_RiskFreeInterestRateOfWarrantsGranted_18" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_WarrantLineItems_0" xlink:to="loc_huge_WarrantsLiability_19" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_WarrantLineItems_0" xlink:to="loc_huge_ProfitLossOnChangeInFairValue_20" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_WarrantLineItems_0" xlink:to="loc_huge_ExercisePriceOfWarrantsLiability_21" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_WarrantLineItems_0" xlink:to="loc_huge_SharePricesOfWarrantsLiability_22" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_WarrantLineItems_0" xlink:to="loc_huge_RiskFreeInterestRateOfWarrantsLiability_23" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_huge_WarrantLineItems_0" xlink:to="loc_huge_ExpectedVolatilityOfWarrantsGranted_24" order="150" use="optional"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>15
<FILENAME>huge-20201231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_18"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AcquisitionOfPrismicPharmaceuticalsInc" xlink:label="loc_huge_AcquisitionOfPrismicPharmaceuticalsInc_19"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AcquisitionOfPrismicPharmaceuticalsInc" xlink:label="loc_huge_AcquisitionOfPrismicPharmaceuticalsInc_20"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AcquisitionOfPrismicPharmaceuticalsInc" xlink:label="loc_huge_AcquisitionOfPrismicPharmaceuticalsInc_21"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AddDeductItemsNotAffectingCashAbstract" xlink:label="loc_huge_AddDeductItemsNotAffectingCashAbstract_22"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AddDeductItemsNotAffectingCashAbstract" xlink:label="loc_huge_AddDeductItemsNotAffectingCashAbstract_23"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdditionalInvestmentInExchangeForShares" xlink:label="loc_huge_AdditionalInvestmentInExchangeForShares_24"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdditionalInvestmentInExchangeForShares" xlink:label="loc_huge_AdditionalInvestmentInExchangeForShares_25"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdditionalInvestmentInExchangeForShares" xlink:label="loc_huge_AdditionalInvestmentInExchangeForShares_26"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdditionalRemuneration" xlink:label="loc_huge_AdditionalRemuneration_27"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdditionalRemuneration" xlink:label="loc_huge_AdditionalRemuneration_28"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdditionalRemuneration" xlink:label="loc_huge_AdditionalRemuneration_29"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAsset" xlink:label="loc_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAsset_30"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAsset" xlink:label="loc_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAsset_31"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAssets" xlink:label="loc_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAssets_32"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAssets" xlink:label="loc_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAssets_33"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAssets" xlink:label="loc_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAssets_34"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAssets" xlink:label="loc_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAssets_35"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit" xlink:label="loc_huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit_36"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit" xlink:label="loc_huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit_37"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit" xlink:label="loc_huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit_38"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposits" xlink:label="loc_huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposits_39"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentsForDecreaseIncreaseInSalesTaxesRecoverable" xlink:label="loc_huge_AdjustmentsForDecreaseIncreaseInSalesTaxesRecoverable_40"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentsForDecreaseIncreaseInSalesTaxesRecoverable" xlink:label="loc_huge_AdjustmentsForDecreaseIncreaseInSalesTaxesRecoverable_41"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentsForDecreaseIncreaseInSalesTaxesRecoverable" xlink:label="loc_huge_AdjustmentsForDecreaseIncreaseInSalesTaxesRecoverable_42"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentsForDecreaseIncreaseInSalesTaxesRecoverable" xlink:label="loc_huge_AdjustmentsForDecreaseIncreaseInSalesTaxesRecoverable_43"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold" xlink:label="loc_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold_44"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold" xlink:label="loc_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold_45"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold" xlink:label="loc_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold_46"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold" xlink:label="loc_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold_47"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentsForIncreaseDecreaseInPrepaidExpensesAndDeposits" xlink:label="loc_huge_AdjustmentsForIncreaseDecreaseInPrepaidExpensesAndDeposits_48"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentsForIncreaseDecreaseInPrepaidExpensesAndDeposits" xlink:label="loc_huge_AdjustmentsForIncreaseDecreaseInPrepaidExpensesAndDeposits_49"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentsForIncreaseDecreaseInPrepaidExpensesAndDeposits" xlink:label="loc_huge_AdjustmentsForIncreaseDecreaseInPrepaidExpensesAndDeposits_50"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentsForListingExpense" xlink:label="loc_huge_AdjustmentsForListingExpense_51"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentsForListingExpense" xlink:label="loc_huge_AdjustmentsForListingExpense_52"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentsForListingExpense" xlink:label="loc_huge_AdjustmentsForListingExpense_53"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentsForLossesGainsOnDisposalOfEquipment" xlink:label="loc_huge_AdjustmentsForLossesGainsOnDisposalOfEquipment_54"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentsForLossesGainsOnDisposalOfEquipment" xlink:label="loc_huge_AdjustmentsForLossesGainsOnDisposalOfEquipment_55"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentsForLossesGainsOnDisposalOfEquipment" xlink:label="loc_huge_AdjustmentsForLossesGainsOnDisposalOfEquipment_56"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentsForLossesGainsOnDisposalOfInventory" xlink:label="loc_huge_AdjustmentsForLossesGainsOnDisposalOfInventory_57"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentsForLossesGainsOnDisposalOfInventory" xlink:label="loc_huge_AdjustmentsForLossesGainsOnDisposalOfInventory_58"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentsForLossesGainsOnDisposalOfInventory" xlink:label="loc_huge_AdjustmentsForLossesGainsOnDisposalOfInventory_59"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentToExpectedIncomeTaxBenefitAbstract" xlink:label="loc_huge_AdjustmentToExpectedIncomeTaxBenefitAbstract_60"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentToExpectedIncomeTaxBenefitAbstract" xlink:label="loc_huge_AdjustmentToExpectedIncomeTaxBenefitAbstract_61"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentToExpectedIncomeTaxBenefitChangeInBenefitOfTaxAssetsNotRecognized" xlink:label="loc_huge_AdjustmentToExpectedIncomeTaxBenefitChangeInBenefitOfTaxAssetsNotRecognized_62"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentToExpectedIncomeTaxBenefitChangeInBenefitOfTaxAssetsNotRecognized" xlink:label="loc_huge_AdjustmentToExpectedIncomeTaxBenefitChangeInBenefitOfTaxAssetsNotRecognized_63"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentToExpectedIncomeTaxBenefitChangeInBenefitOfTaxAssetsNotRecognized" xlink:label="loc_huge_AdjustmentToExpectedIncomeTaxBenefitChangeInBenefitOfTaxAssetsNotRecognized_64"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentToExpectedIncomeTaxBenefitChangeInBenefitOfTaxAssetsNotRecognized" xlink:label="loc_huge_AdjustmentToExpectedIncomeTaxBenefitChangeInBenefitOfTaxAssetsNotRecognized_65"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentToExpectedIncomeTaxBenefitFairValueChangeOfInvestments" xlink:label="loc_huge_AdjustmentToExpectedIncomeTaxBenefitFairValueChangeOfInvestments_66"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentToExpectedIncomeTaxBenefitFairValueChangeOfInvestments" xlink:label="loc_huge_AdjustmentToExpectedIncomeTaxBenefitFairValueChangeOfInvestments_67"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentToExpectedIncomeTaxBenefitFairValueChangeOfInvestments" xlink:label="loc_huge_AdjustmentToExpectedIncomeTaxBenefitFairValueChangeOfInvestments_68"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentToExpectedIncomeTaxBenefitLossOnDerivativeLiability" xlink:label="loc_huge_AdjustmentToExpectedIncomeTaxBenefitLossOnDerivativeLiability_69"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentToExpectedIncomeTaxBenefitLossOnDerivativeLiability" xlink:label="loc_huge_AdjustmentToExpectedIncomeTaxBenefitLossOnDerivativeLiability_70"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentToExpectedIncomeTaxBenefitLossOnDerivativeLiability" xlink:label="loc_huge_AdjustmentToExpectedIncomeTaxBenefitLossOnDerivativeLiability_71"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentToExpectedIncomeTaxBenefitShareIssueCosts" xlink:label="loc_huge_AdjustmentToExpectedIncomeTaxBenefitShareIssueCosts_72"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentToExpectedIncomeTaxBenefitShareIssueCosts" xlink:label="loc_huge_AdjustmentToExpectedIncomeTaxBenefitShareIssueCosts_73"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentToExpectedIncomeTaxBenefitShareIssueCosts" xlink:label="loc_huge_AdjustmentToExpectedIncomeTaxBenefitShareIssueCosts_74"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentToExpectedIncomeTaxBenefitStockBasedCompensation" xlink:label="loc_huge_AdjustmentToExpectedIncomeTaxBenefitStockBasedCompensation_75"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentToExpectedIncomeTaxBenefitStockBasedCompensation" xlink:label="loc_huge_AdjustmentToExpectedIncomeTaxBenefitStockBasedCompensation_76"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentToExpectedIncomeTaxBenefitStockBasedCompensation" xlink:label="loc_huge_AdjustmentToExpectedIncomeTaxBenefitStockBasedCompensation_77"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentToLeaseCommitments" xlink:label="loc_huge_AdjustmentToLeaseCommitments_78"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentToLeaseCommitments" xlink:label="loc_huge_AdjustmentToLeaseCommitments_79"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentToLeaseCommitments" xlink:label="loc_huge_AdjustmentToLeaseCommitments_80"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AfterHarvestCostToCompleteAndSellPerGramForDryFlower" xlink:label="loc_huge_AfterHarvestCostToCompleteAndSellPerGramForDryFlower_81"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AfterHarvestCostToCompleteAndSellPerGramForDryFlower" xlink:label="loc_huge_AfterHarvestCostToCompleteAndSellPerGramForDryFlower_82"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AfterHarvestCostToCompleteAndSellPerGramForDryFlower" xlink:label="loc_huge_AfterHarvestCostToCompleteAndSellPerGramForDryFlower_83"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AfterHarvestCostToCompleteAndSellPerGramForDryTrim" xlink:label="loc_huge_AfterHarvestCostToCompleteAndSellPerGramForDryTrim_84"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AfterHarvestCostToCompleteAndSellPerGramForDryTrim" xlink:label="loc_huge_AfterHarvestCostToCompleteAndSellPerGramForDryTrim_85"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AfterHarvestCostToCompleteAndSellPerGramForDryTrim" xlink:label="loc_huge_AfterHarvestCostToCompleteAndSellPerGramForDryTrim_86"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AggregateDiscountForSharesInEscrow" xlink:label="loc_huge_AggregateDiscountForSharesInEscrow_87"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AggregateDiscountForSharesInEscrow" xlink:label="loc_huge_AggregateDiscountForSharesInEscrow_88"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AggregateDiscountForSharesInEscrow" xlink:label="loc_huge_AggregateDiscountForSharesInEscrow_89"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AggregateUnpaidAccounts" xlink:label="loc_huge_AggregateUnpaidAccounts_90"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AggregateUnpaidAccounts" xlink:label="loc_huge_AggregateUnpaidAccounts_91"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AggregateUnpaidAccounts" xlink:label="loc_huge_AggregateUnpaidAccounts_92"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AllianceGlobalPartnersMember" xlink:label="loc_huge_AllianceGlobalPartnersMember_93"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AllianceGlobalPartnersMember" xlink:label="loc_huge_AllianceGlobalPartnersMember_94"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AllianceGlobalPartnersMember" xlink:label="loc_huge_AllianceGlobalPartnersMember_95"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AllowanceForImpairment" xlink:label="loc_huge_AllowanceForImpairment_96"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AllowanceForImpairment" xlink:label="loc_huge_AllowanceForImpairment_97"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AllowanceForImpairment" xlink:label="loc_huge_AllowanceForImpairment_98"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AmortizedCostOfFinancialAssetsMember" xlink:label="loc_huge_AmortizedCostOfFinancialAssetsMember_99"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AmortizedCostOfFinancialAssetsMember" xlink:label="loc_huge_AmortizedCostOfFinancialAssetsMember_100"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AmortizedCostOfFinancialAssetsMember" xlink:label="loc_huge_AmortizedCostOfFinancialAssetsMember_101"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AmortizedCostOfFinancialLiabilitiesMember" xlink:label="loc_huge_AmortizedCostOfFinancialLiabilitiesMember_102"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AmortizedCostOfFinancialLiabilitiesMember" xlink:label="loc_huge_AmortizedCostOfFinancialLiabilitiesMember_103"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AmortizedCostOfFinancialLiabilitiesMember" xlink:label="loc_huge_AmortizedCostOfFinancialLiabilitiesMember_104"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AmountOfAdditionalSharesIssuedAgainstOutstandingLiabilities" xlink:label="loc_huge_AmountOfAdditionalSharesIssuedAgainstOutstandingLiabilities_105"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AmountOfAdditionalSharesIssuedAgainstOutstandingLiabilities" xlink:label="loc_huge_AmountOfAdditionalSharesIssuedAgainstOutstandingLiabilities_106"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AmountOfAdditionalSharesIssuedAgainstOutstandingLiabilities" xlink:label="loc_huge_AmountOfAdditionalSharesIssuedAgainstOutstandingLiabilities_107"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AmountOfAgreementFallBelowMinimumValue" xlink:label="loc_huge_AmountOfAgreementFallBelowMinimumValue_108"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AmountOfAgreementFallBelowMinimumValue" xlink:label="loc_huge_AmountOfAgreementFallBelowMinimumValue_109"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AmountOfAgreementFallBelowMinimumValue" xlink:label="loc_huge_AmountOfAgreementFallBelowMinimumValue_110"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions" xlink:label="loc_huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions_111"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions" xlink:label="loc_huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions_112"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions" xlink:label="loc_huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions_113"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions" xlink:label="loc_huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions_114"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions" xlink:label="loc_huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions_115"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AmountOfDepositPaidToSupplier" xlink:label="loc_huge_AmountOfDepositPaidToSupplier_116"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AmountOfDepositPaidToSupplier" xlink:label="loc_huge_AmountOfDepositPaidToSupplier_117"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AmountOfDepositPaidToSupplier" xlink:label="loc_huge_AmountOfDepositPaidToSupplier_118"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AmountOfMinimumIssueOfAdditionalCommonSharesUponLiquidation" xlink:label="loc_huge_AmountOfMinimumIssueOfAdditionalCommonSharesUponLiquidation_119"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AmountOfMinimumIssueOfAdditionalCommonSharesUponLiquidation" xlink:label="loc_huge_AmountOfMinimumIssueOfAdditionalCommonSharesUponLiquidation_120"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AmountOfMinimumIssueOfAdditionalCommonSharesUponLiquidation" xlink:label="loc_huge_AmountOfMinimumIssueOfAdditionalCommonSharesUponLiquidation_121"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AmountOfPurchasePricePaidAsSupplierLoan" xlink:label="loc_huge_AmountOfPurchasePricePaidAsSupplierLoan_122"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AmountOfPurchasePricePaidAsSupplierLoan" xlink:label="loc_huge_AmountOfPurchasePricePaidAsSupplierLoan_123"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AmountOfPurchasePricePaidAsSupplierLoan" xlink:label="loc_huge_AmountOfPurchasePricePaidAsSupplierLoan_124"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement" xlink:label="loc_huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement_125"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement" xlink:label="loc_huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement_126"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement" xlink:label="loc_huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement_127"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AnthonyDurkaczMember" xlink:label="loc_huge_AnthonyDurkaczMember_128"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AnthonyDurkaczMember" xlink:label="loc_huge_AnthonyDurkaczMember_129"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AnthonyDurkaczMember" xlink:label="loc_huge_AnthonyDurkaczMember_130"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AnticipatedPurchasePricePlusApplicableTaxesValue" xlink:label="loc_huge_AnticipatedPurchasePricePlusApplicableTaxesValue_131"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AnticipatedPurchasePricePlusApplicableTaxesValue" xlink:label="loc_huge_AnticipatedPurchasePricePlusApplicableTaxesValue_132"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AnticipatedPurchasePricePlusApplicableTaxesValue" xlink:label="loc_huge_AnticipatedPurchasePricePlusApplicableTaxesValue_133"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Apr82018Member" xlink:label="loc_huge_Apr82018Member_134"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Apr82018Member" xlink:label="loc_huge_Apr82018Member_135"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Apr82018Member" xlink:label="loc_huge_Apr82018Member_136"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Apr92018Member" xlink:label="loc_huge_Apr92018Member_137"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Apr92018Member" xlink:label="loc_huge_Apr92018Member_138"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Apr92018Member" xlink:label="loc_huge_Apr92018Member_139"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_April182018Member" xlink:label="loc_huge_April182018Member_140"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_April182018Member" xlink:label="loc_huge_April182018Member_141"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_April182018Member" xlink:label="loc_huge_April182018Member_142"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Aug142018Member" xlink:label="loc_huge_Aug142018Member_143"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Aug142018Member" xlink:label="loc_huge_Aug142018Member_144"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Aug142018Member" xlink:label="loc_huge_Aug142018Member_145"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Aug152018Member" xlink:label="loc_huge_Aug152018Member_146"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Aug152018Member" xlink:label="loc_huge_Aug152018Member_147"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Aug152018Member" xlink:label="loc_huge_Aug152018Member_148"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Aug82018Member" xlink:label="loc_huge_Aug82018Member_149"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Aug82018Member" xlink:label="loc_huge_Aug82018Member_150"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Aug82018Member" xlink:label="loc_huge_Aug82018Member_151"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AuraHealthIncMember" xlink:label="loc_huge_AuraHealthIncMember_152"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AuraHealthIncMember" xlink:label="loc_huge_AuraHealthIncMember_153"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AuraHealthIncMember" xlink:label="loc_huge_AuraHealthIncMember_154"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AuxlyCannabisGroupIncMember" xlink:label="loc_huge_AuxlyCannabisGroupIncMember_155"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AuxlyCannabisGroupIncMember" xlink:label="loc_huge_AuxlyCannabisGroupIncMember_156"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AuxlyCannabisGroupIncMember" xlink:label="loc_huge_AuxlyCannabisGroupIncMember_157"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AverageExpectedLifeOfWarrants" xlink:label="loc_huge_AverageExpectedLifeOfWarrants_158"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AverageExpectedLifeOfWarrants" xlink:label="loc_huge_AverageExpectedLifeOfWarrants_159"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AverageExpectedLifeOfWarrants" xlink:label="loc_huge_AverageExpectedLifeOfWarrants_160"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BasisOfPresentationAbstract" xlink:label="loc_huge_BasisOfPresentationAbstract_161"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BiologicalAssetFairValueAdjustmentMember" xlink:label="loc_huge_BiologicalAssetFairValueAdjustmentMember_162"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BiologicalAssetFairValueAdjustmentMember" xlink:label="loc_huge_BiologicalAssetFairValueAdjustmentMember_163"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BiologicalAssetFairValueAdjustmentMember" xlink:label="loc_huge_BiologicalAssetFairValueAdjustmentMember_164"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BoardMembersMember" xlink:label="loc_huge_BoardMembersMember_165"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BoardMembersMember" xlink:label="loc_huge_BoardMembersMember_166"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BoardMembersMember" xlink:label="loc_huge_BoardMembersMember_167"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BonusExpenseToBePaidInSubsequentPeriod" xlink:label="loc_huge_BonusExpenseToBePaidInSubsequentPeriod_168"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BonusExpenseToBePaidInSubsequentPeriod" xlink:label="loc_huge_BonusExpenseToBePaidInSubsequentPeriod_169"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BonusExpenseToBePaidInSubsequentPeriod" xlink:label="loc_huge_BonusExpenseToBePaidInSubsequentPeriod_170"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BookToFilingAdjustments" xlink:label="loc_huge_BookToFilingAdjustments_171"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BookToFilingAdjustments" xlink:label="loc_huge_BookToFilingAdjustments_172"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BookToFilingAdjustments" xlink:label="loc_huge_BookToFilingAdjustments_173"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BorrowingsSettled" xlink:label="loc_huge_BorrowingsSettled_174"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BorrowingsSettled" xlink:label="loc_huge_BorrowingsSettled_175"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BorrowingsSettled" xlink:label="loc_huge_BorrowingsSettled_176"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BorrowingsSettledAccruedInterestSettled" xlink:label="loc_huge_BorrowingsSettledAccruedInterestSettled_177"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BorrowingsSettledAccruedInterestSettled" xlink:label="loc_huge_BorrowingsSettledAccruedInterestSettled_178"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BorrowingsSettledAccruedInterestSettled" xlink:label="loc_huge_BorrowingsSettledAccruedInterestSettled_179"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BrokerWarrants" xlink:label="loc_huge_BrokerWarrants_180"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BrokerWarrants" xlink:label="loc_huge_BrokerWarrants_181"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BrokerWarrantsIssuedInPrivatePlacements" xlink:label="loc_huge_BrokerWarrantsIssuedInPrivatePlacements_182"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BrokerWarrantsIssuedInPrivatePlacements" xlink:label="loc_huge_BrokerWarrantsIssuedInPrivatePlacements_183"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BrokerWarrantsIssuedInPrivatePlacements" xlink:label="loc_huge_BrokerWarrantsIssuedInPrivatePlacements_184"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BuildingAndFacilityCosts" xlink:label="loc_huge_BuildingAndFacilityCosts_185"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BuildingAndFacilityCosts" xlink:label="loc_huge_BuildingAndFacilityCosts_186"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BuildingAndFacilityCosts" xlink:label="loc_huge_BuildingAndFacilityCosts_187"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BusinessAcquisitionDomain" xlink:label="loc_huge_BusinessAcquisitionDomain_188"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BusinessAcquisitionDomain" xlink:label="loc_huge_BusinessAcquisitionDomain_189"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BusinessAcquisitionsAxis" xlink:label="loc_huge_BusinessAcquisitionsAxis_190"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BusinessAcquisitionsAxis" xlink:label="loc_huge_BusinessAcquisitionsAxis_191"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BusinessAcquisitionsBenefitsAxis" xlink:label="loc_huge_BusinessAcquisitionsBenefitsAxis_192"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BusinessAcquisitionsBenefitsAxis" xlink:label="loc_huge_BusinessAcquisitionsBenefitsAxis_193"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BusinessAcquisitionsBenefitsDomain" xlink:label="loc_huge_BusinessAcquisitionsBenefitsDomain_194"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BusinessAcquisitionsBenefitsDomain" xlink:label="loc_huge_BusinessAcquisitionsBenefitsDomain_195"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BusinessLicenseFees" xlink:label="loc_huge_BusinessLicenseFees_196"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BusinessLicenseFees" xlink:label="loc_huge_BusinessLicenseFees_197"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BusinessLicenseFees" xlink:label="loc_huge_BusinessLicenseFees_198"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CannaraBiotechIncMember" xlink:label="loc_huge_CannaraBiotechIncMember_199"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CannaraBiotechIncMember" xlink:label="loc_huge_CannaraBiotechIncMember_200"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CannaraBiotechIncMember" xlink:label="loc_huge_CannaraBiotechIncMember_201"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CanntabTherapeuticsLtdWorldClassExtractionsIncMember" xlink:label="loc_huge_CanntabTherapeuticsLtdWorldClassExtractionsIncMember_202"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CanntabTherapeuticsLtdWorldClassExtractionsIncMember" xlink:label="loc_huge_CanntabTherapeuticsLtdWorldClassExtractionsIncMember_203"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CanntabTherapeuticsLtdWorldClassExtractionsIncMember" xlink:label="loc_huge_CanntabTherapeuticsLtdWorldClassExtractionsIncMember_204"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CapitalizedCostMember" xlink:label="loc_huge_CapitalizedCostMember_205"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CapitalizedCostMember" xlink:label="loc_huge_CapitalizedCostMember_206"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CapitalizedCostMember" xlink:label="loc_huge_CapitalizedCostMember_207"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CapitalizedCosts" xlink:label="loc_huge_CapitalizedCosts_208"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CapitalizedCosts" xlink:label="loc_huge_CapitalizedCosts_209"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CapitalizedCosts" xlink:label="loc_huge_CapitalizedCosts_210"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CashAcquiredOnAcquisition" xlink:label="loc_huge_CashAcquiredOnAcquisition_211"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CashAcquiredOnAcquisition" xlink:label="loc_huge_CashAcquiredOnAcquisition_212"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CashAcquiredOnAcquisition" xlink:label="loc_huge_CashAcquiredOnAcquisition_213"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CashAcquiredOnAcquisition" xlink:label="loc_huge_CashAcquiredOnAcquisition_214"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CashProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_huge_CashProceedsFromIssuanceOfPrivatePlacement_215"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CashProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_huge_CashProceedsFromIssuanceOfPrivatePlacement_216"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CashProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_huge_CashProceedsFromIssuanceOfPrivatePlacement_217"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CashReceiptsFromSalesOfDebtInstruments" xlink:label="loc_huge_CashReceiptsFromSalesOfDebtInstruments_218"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CashReceiptsFromSalesOfDebtInstruments" xlink:label="loc_huge_CashReceiptsFromSalesOfDebtInstruments_219"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CashReceiptsFromSalesOfDebtInstruments" xlink:label="loc_huge_CashReceiptsFromSalesOfDebtInstruments_220"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CenturyAndFvPharmaMember" xlink:label="loc_huge_CenturyAndFvPharmaMember_221"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CenturyAndFvPharmaMember" xlink:label="loc_huge_CenturyAndFvPharmaMember_222"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CenturyAndFvPharmaMember" xlink:label="loc_huge_CenturyAndFvPharmaMember_223"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CertainShareholdersClaimingToHoldInExcessPercentageOfClassBSubordinatedVotingShares" xlink:label="loc_huge_CertainShareholdersClaimingToHoldInExcessPercentageOfClassBSubordinatedVotingShares_224"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CertainShareholdersClaimingToHoldInExcessPercentageOfClassBSubordinatedVotingShares" xlink:label="loc_huge_CertainShareholdersClaimingToHoldInExcessPercentageOfClassBSubordinatedVotingShares_225"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CertainShareholdersClaimingToHoldInExcessPercentageOfClassBSubordinatedVotingShares" xlink:label="loc_huge_CertainShareholdersClaimingToHoldInExcessPercentageOfClassBSubordinatedVotingShares_226"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ChangeInFairValueOfInvestment" xlink:label="loc_huge_ChangeInFairValueOfInvestment_227"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ChangeInFairValueOfInvestment" xlink:label="loc_huge_ChangeInFairValueOfInvestment_228"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ChangeInFairValueOfInvestmentDueToTenPercentChangeInAssumptionsUsed" xlink:label="loc_huge_ChangeInFairValueOfInvestmentDueToTenPercentChangeInAssumptionsUsed_229"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ChangeInFairValueOfInvestmentDueToTenPercentChangeInAssumptionsUsed" xlink:label="loc_huge_ChangeInFairValueOfInvestmentDueToTenPercentChangeInAssumptionsUsed_230"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ChangeInFairValueOfInvestmentDueToTenPercentChangeInAssumptionsUsed" xlink:label="loc_huge_ChangeInFairValueOfInvestmentDueToTenPercentChangeInAssumptionsUsed_231"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_232"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_233"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_234"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ChangesInNoncashWorkingCapitalBalancesAbstract" xlink:label="loc_huge_ChangesInNoncashWorkingCapitalBalancesAbstract_235"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ChangesInNoncashWorkingCapitalBalancesAbstract" xlink:label="loc_huge_ChangesInNoncashWorkingCapitalBalancesAbstract_236"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ChangesInNonCashWorkingCapitalItemsAbstract" xlink:label="loc_huge_ChangesInNonCashWorkingCapitalItemsAbstract_237"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ChangesInNonCashWorkingCapitalItemsAbstract" xlink:label="loc_huge_ChangesInNonCashWorkingCapitalItemsAbstract_238"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ChangesInShareCapitalTransactionDateAxis" xlink:label="loc_huge_ChangesInShareCapitalTransactionDateAxis_239"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ChangesInShareCapitalTransactionDateAxis" xlink:label="loc_huge_ChangesInShareCapitalTransactionDateAxis_240"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ChangesInShareCapitalTransactionDateDomain" xlink:label="loc_huge_ChangesInShareCapitalTransactionDateDomain_241"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ChangesInShareCapitalTransactionDateDomain" xlink:label="loc_huge_ChangesInShareCapitalTransactionDateDomain_242"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ChiefExecutiveOfficerAndExecutiveCoChairmanMember" xlink:label="loc_huge_ChiefExecutiveOfficerAndExecutiveCoChairmanMember_243"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ChiefExecutiveOfficerAndExecutiveCoChairmanMember" xlink:label="loc_huge_ChiefExecutiveOfficerAndExecutiveCoChairmanMember_244"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ChiefExecutiveOfficerAndExecutiveCoChairmanMember" xlink:label="loc_huge_ChiefExecutiveOfficerAndExecutiveCoChairmanMember_245"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ChiefExecutiveOfficersMember" xlink:label="loc_huge_ChiefExecutiveOfficersMember_246"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ChiefExecutiveOfficersMember" xlink:label="loc_huge_ChiefExecutiveOfficersMember_247"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ChiefExecutiveOfficersMember" xlink:label="loc_huge_ChiefExecutiveOfficersMember_248"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ChiefFinancialOfficersMember" xlink:label="loc_huge_ChiefFinancialOfficersMember_249"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ChiefFinancialOfficersMember" xlink:label="loc_huge_ChiefFinancialOfficersMember_250"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ChiefFinancialOfficersMember" xlink:label="loc_huge_ChiefFinancialOfficersMember_251"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ChiefOperatingConsultantMember" xlink:label="loc_huge_ChiefOperatingConsultantMember_252"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ChiefOperatingConsultantMember" xlink:label="loc_huge_ChiefOperatingConsultantMember_253"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ChiefOperatingConsultantMember" xlink:label="loc_huge_ChiefOperatingConsultantMember_254"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClaimForLienComponent" xlink:label="loc_huge_ClaimForLienComponent_255"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClaimForLienComponent" xlink:label="loc_huge_ClaimForLienComponent_256"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClaimForLienComponent" xlink:label="loc_huge_ClaimForLienComponent_257"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClaimIssuedByContractorForVariousPurportedDamages" xlink:label="loc_huge_ClaimIssuedByContractorForVariousPurportedDamages_258"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClaimIssuedByContractorForVariousPurportedDamages" xlink:label="loc_huge_ClaimIssuedByContractorForVariousPurportedDamages_259"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClaimIssuedByContractorForVariousPurportedDamages" xlink:label="loc_huge_ClaimIssuedByContractorForVariousPurportedDamages_260"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClaimIssuedByCreditorForAllegingNonpaymentOfAccounts" xlink:label="loc_huge_ClaimIssuedByCreditorForAllegingNonpaymentOfAccounts_261"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClaimIssuedByCreditorForAllegingNonpaymentOfAccounts" xlink:label="loc_huge_ClaimIssuedByCreditorForAllegingNonpaymentOfAccounts_262"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClaimIssuedByCreditorForAllegingNonpaymentOfAccounts" xlink:label="loc_huge_ClaimIssuedByCreditorForAllegingNonpaymentOfAccounts_263"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClaimSettlementAmount" xlink:label="loc_huge_ClaimSettlementAmount_264"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClaimSettlementAmount" xlink:label="loc_huge_ClaimSettlementAmount_265"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClaimSettlementAmount" xlink:label="loc_huge_ClaimSettlementAmount_266"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClaimSettlementAmountCoveredByInsurance" xlink:label="loc_huge_ClaimSettlementAmountCoveredByInsurance_267"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClaimSettlementAmountCoveredByInsurance" xlink:label="loc_huge_ClaimSettlementAmountCoveredByInsurance_268"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClaimSettlementAmountCoveredByInsurance" xlink:label="loc_huge_ClaimSettlementAmountCoveredByInsurance_269"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassACommonStockSharesMember" xlink:label="loc_huge_ClassACommonStockSharesMember_270"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassACommonStockSharesMember" xlink:label="loc_huge_ClassACommonStockSharesMember_271"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassACommonStockSharesMember" xlink:label="loc_huge_ClassACommonStockSharesMember_272"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassBCommonSharesMember" xlink:label="loc_huge_ClassBCommonSharesMember_273"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassBCommonSharesMember" xlink:label="loc_huge_ClassBCommonSharesMember_274"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassBCommonSharesMember" xlink:label="loc_huge_ClassBCommonSharesMember_275"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassBCommonStockSharesMember" xlink:label="loc_huge_ClassBCommonStockSharesMember_276"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassBCommonStockSharesMember" xlink:label="loc_huge_ClassBCommonStockSharesMember_277"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassBCommonStockSharesMember" xlink:label="loc_huge_ClassBCommonStockSharesMember_278"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassBSharesHeldInEscrowMember" xlink:label="loc_huge_ClassBSharesHeldInEscrowMember_279"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassBSharesHeldInEscrowMember" xlink:label="loc_huge_ClassBSharesHeldInEscrowMember_280"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassBSharesHeldInEscrowMember" xlink:label="loc_huge_ClassBSharesHeldInEscrowMember_281"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassBSubordinatedVotingSharesMember" xlink:label="loc_huge_ClassBSubordinatedVotingSharesMember_282"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassBSubordinatedVotingSharesMember" xlink:label="loc_huge_ClassBSubordinatedVotingSharesMember_283"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassBSubordinatedVotingSharesMember" xlink:label="loc_huge_ClassBSubordinatedVotingSharesMember_284"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassBSubordinateVotingSharesMember" xlink:label="loc_huge_ClassBSubordinateVotingSharesMember_285"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassBSubordinateVotingSharesMember" xlink:label="loc_huge_ClassBSubordinateVotingSharesMember_286"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassBSubordinateVotingSharesMember" xlink:label="loc_huge_ClassBSubordinateVotingSharesMember_287"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassBVotingSharesMember" xlink:label="loc_huge_ClassBVotingSharesMember_288"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassBVotingSharesMember" xlink:label="loc_huge_ClassBVotingSharesMember_289"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassBVotingSharesMember" xlink:label="loc_huge_ClassBVotingSharesMember_290"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassCommonStockSharesMember" xlink:label="loc_huge_ClassCommonStockSharesMember_291"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassCommonStockSharesMember" xlink:label="loc_huge_ClassCommonStockSharesMember_292"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassCommonStockSharesMember" xlink:label="loc_huge_ClassCommonStockSharesMember_293"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassesOfInventoriesLineItems" xlink:label="loc_huge_ClassesOfInventoriesLineItems_294"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassesOfInventoriesLineItems" xlink:label="loc_huge_ClassesOfInventoriesLineItems_295"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassesOfInventoriesTable" xlink:label="loc_huge_ClassesOfInventoriesTable_296"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassesOfInventoriesTable" xlink:label="loc_huge_ClassesOfInventoriesTable_297"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassesOfWarrantsAxis" xlink:label="loc_huge_ClassesOfWarrantsAxis_298"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassesOfWarrantsAxis" xlink:label="loc_huge_ClassesOfWarrantsAxis_299"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassesOfWarrantsDomain" xlink:label="loc_huge_ClassesOfWarrantsDomain_300"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassesOfWarrantsDomain" xlink:label="loc_huge_ClassesOfWarrantsDomain_301"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CloverCannastripThinFilmTechnologiesCorpMember" xlink:label="loc_huge_CloverCannastripThinFilmTechnologiesCorpMember_302"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CloverCannastripThinFilmTechnologiesCorpMember" xlink:label="loc_huge_CloverCannastripThinFilmTechnologiesCorpMember_303"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CloverCannastripThinFilmTechnologiesCorpMember" xlink:label="loc_huge_CloverCannastripThinFilmTechnologiesCorpMember_304"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CloverCannastripThinFilmTechnologiesCorpMember" xlink:label="loc_huge_CloverCannastripThinFilmTechnologiesCorpMember_305"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CollectiveCommitmentToPurchaseProduct" xlink:label="loc_huge_CollectiveCommitmentToPurchaseProduct_306"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CollectiveCommitmentToPurchaseProduct" xlink:label="loc_huge_CollectiveCommitmentToPurchaseProduct_307"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CommitmentsEquityInstruments" xlink:label="loc_huge_CommitmentsEquityInstruments_308"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CommitmentsEquityInstruments" xlink:label="loc_huge_CommitmentsEquityInstruments_309"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CommitmentsEquityInstruments" xlink:label="loc_huge_CommitmentsEquityInstruments_310"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CommitmentsLineItems" xlink:label="loc_huge_CommitmentsLineItems_311"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CommitmentsTable" xlink:label="loc_huge_CommitmentsTable_312"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CommitmentToIssueSharesMinimumValueUponLiquidation" xlink:label="loc_huge_CommitmentToIssueSharesMinimumValueUponLiquidation_313"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CommitmentToIssueSharesMinimumValueUponLiquidation" xlink:label="loc_huge_CommitmentToIssueSharesMinimumValueUponLiquidation_314"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CommitmentToIssueSharesMinimumValueUponLiquidation" xlink:label="loc_huge_CommitmentToIssueSharesMinimumValueUponLiquidation_315"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CommonStockIssuedForPrivatePlacement" xlink:label="loc_huge_CommonStockIssuedForPrivatePlacement_316"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CommonStockIssuedForPrivatePlacement" xlink:label="loc_huge_CommonStockIssuedForPrivatePlacement_317"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CommonStockIssuedForPrivatePlacement" xlink:label="loc_huge_CommonStockIssuedForPrivatePlacement_318"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ConsultingFeesExpenses" xlink:label="loc_huge_ConsultingFeesExpenses_319"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ConsultingFeesExpenses" xlink:label="loc_huge_ConsultingFeesExpenses_320"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ConsultingFeesExpenses" xlink:label="loc_huge_ConsultingFeesExpenses_321"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ConsultingFeesExpenses" xlink:label="loc_huge_ConsultingFeesExpenses_322"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember" xlink:label="loc_huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember_323"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember" xlink:label="loc_huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember_324"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember" xlink:label="loc_huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember_325"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ContractualCapitalCommitmentsEqualMonthlyInstalments" xlink:label="loc_huge_ContractualCapitalCommitmentsEqualMonthlyInstalments_326"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ContractualCapitalCommitmentsEqualMonthlyInstalments" xlink:label="loc_huge_ContractualCapitalCommitmentsEqualMonthlyInstalments_327"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ContractualCapitalCommitmentsEqualMonthlyInstalments" xlink:label="loc_huge_ContractualCapitalCommitmentsEqualMonthlyInstalments_328"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ConvertibleDebentureMember" xlink:label="loc_huge_ConvertibleDebentureMember_329"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ConvertibleDebentureMember" xlink:label="loc_huge_ConvertibleDebentureMember_330"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ConvertibleDebentureMember" xlink:label="loc_huge_ConvertibleDebentureMember_331"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ConvertibleNotes" xlink:label="loc_huge_ConvertibleNotes_332"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ConvertibleNotes" xlink:label="loc_huge_ConvertibleNotes_333"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ConvertibleNotes" xlink:label="loc_huge_ConvertibleNotes_334"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ConvertibleNotes" xlink:label="loc_huge_ConvertibleNotes_335"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ConvertibleNotesMember" xlink:label="loc_huge_ConvertibleNotesMember_336"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ConvertibleNotesMember" xlink:label="loc_huge_ConvertibleNotesMember_337"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ConvertibleNotesMember" xlink:label="loc_huge_ConvertibleNotesMember_338"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CorporateInformationAndNatureOfOperationsAbstract" xlink:label="loc_huge_CorporateInformationAndNatureOfOperationsAbstract_339"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CriticalAccountingEstimatesAndJudgmentsAbstract" xlink:label="loc_huge_CriticalAccountingEstimatesAndJudgmentsAbstract_340"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CurrentNotesPayable" xlink:label="loc_huge_CurrentNotesPayable_341"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CurrentNotesPayable" xlink:label="loc_huge_CurrentNotesPayable_342"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CurrentNotesPayable" xlink:label="loc_huge_CurrentNotesPayable_343"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CurrentNotesPayable" xlink:label="loc_huge_CurrentNotesPayable_344"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CurrentWarrantsLiability" xlink:label="loc_huge_CurrentWarrantsLiability_345"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CurrentWarrantsLiability" xlink:label="loc_huge_CurrentWarrantsLiability_346"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CurrentWarrantsLiability" xlink:label="loc_huge_CurrentWarrantsLiability_347"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DateOfExpiryOfShareOptions" xlink:label="loc_huge_DateOfExpiryOfShareOptions_348"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DateOfExpiryOfShareOptions" xlink:label="loc_huge_DateOfExpiryOfShareOptions_349"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DateOfExpiryOfShareOptions" xlink:label="loc_huge_DateOfExpiryOfShareOptions_350"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DebtConversionRatio" xlink:label="loc_huge_DebtConversionRatio_351"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DebtConversionRatio" xlink:label="loc_huge_DebtConversionRatio_352"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Dec122017Member" xlink:label="loc_huge_Dec122017Member_353"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Dec122017Member" xlink:label="loc_huge_Dec122017Member_354"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Dec122017Member" xlink:label="loc_huge_Dec122017Member_355"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Dec152018Member" xlink:label="loc_huge_Dec152018Member_356"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Dec152018Member" xlink:label="loc_huge_Dec152018Member_357"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Dec152018Member" xlink:label="loc_huge_Dec152018Member_358"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Dec212017Member" xlink:label="loc_huge_Dec212017Member_359"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Dec212017Member" xlink:label="loc_huge_Dec212017Member_360"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Dec212017Member" xlink:label="loc_huge_Dec212017Member_361"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Dec232017Member" xlink:label="loc_huge_Dec232017Member_362"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Dec232017Member" xlink:label="loc_huge_Dec232017Member_363"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Dec232017Member" xlink:label="loc_huge_Dec232017Member_364"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Dec292017Member" xlink:label="loc_huge_Dec292017Member_365"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Dec292017Member" xlink:label="loc_huge_Dec292017Member_366"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Dec292017Member" xlink:label="loc_huge_Dec292017Member_367"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_December292017Member" xlink:label="loc_huge_December292017Member_368"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_December292017Member" xlink:label="loc_huge_December292017Member_369"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_December292017Member" xlink:label="loc_huge_December292017Member_370"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_371"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_372"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_373"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_374"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_375"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_376"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_377"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfForeignNetOperatingLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfForeignNetOperatingLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_378"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfForeignNetOperatingLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfForeignNetOperatingLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_379"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfForeignNetOperatingLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfForeignNetOperatingLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_380"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_381"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_382"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_383"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfForeignUnrealizedForeignExchangeLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfForeignUnrealizedForeignExchangeLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_384"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfForeignUnrealizedForeignExchangeLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfForeignUnrealizedForeignExchangeLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_385"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfForeignUnrealizedForeignExchangeLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfForeignUnrealizedForeignExchangeLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_386"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfIfrs16ForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfIfrs16ForWhichNoDeferredTaxAssetIsRecognised_387"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfIfrs16ForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfIfrs16ForWhichNoDeferredTaxAssetIsRecognised_388"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfIfrs16ForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfIfrs16ForWhichNoDeferredTaxAssetIsRecognised_389"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised_390"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised_391"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised_392"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised_393"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised_394"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised_395"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised_396"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised_397"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised_398"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfUnrealizedFairValueOnBiologicalAssetsAndInventoryForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfUnrealizedFairValueOnBiologicalAssetsAndInventoryForWhichNoDeferredTaxAssetIsRecognised_399"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfUnrealizedFairValueOnBiologicalAssetsAndInventoryForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfUnrealizedFairValueOnBiologicalAssetsAndInventoryForWhichNoDeferredTaxAssetIsRecognised_400"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfUnrealizedFairValueOnBiologicalAssetsAndInventoryForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfUnrealizedFairValueOnBiologicalAssetsAndInventoryForWhichNoDeferredTaxAssetIsRecognised_401"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeferredTaxAssetLiabilityNotRecognized" xlink:label="loc_huge_DeferredTaxAssetLiabilityNotRecognized_402"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeferredTaxAssetLiabilityNotRecognized" xlink:label="loc_huge_DeferredTaxAssetLiabilityNotRecognized_403"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeferredTaxAssetLiabilityNotRecognized" xlink:label="loc_huge_DeferredTaxAssetLiabilityNotRecognized_404"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeferredTaxAssetLiabilityNotRecognized" xlink:label="loc_huge_DeferredTaxAssetLiabilityNotRecognized_405"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeferredTaxAssetLiabilityNotRecognized" xlink:label="loc_huge_DeferredTaxAssetLiabilityNotRecognized_406"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeferredTaxAssetNotRecognized" xlink:label="loc_huge_DeferredTaxAssetNotRecognized_407"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeferredTaxAssetNotRecognized" xlink:label="loc_huge_DeferredTaxAssetNotRecognized_408"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeferredTaxAssetNotRecognized" xlink:label="loc_huge_DeferredTaxAssetNotRecognized_409"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeferredTaxAssetPropertyPlantAndEquipments" xlink:label="loc_huge_DeferredTaxAssetPropertyPlantAndEquipments_410"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeferredTaxAssetPropertyPlantAndEquipments" xlink:label="loc_huge_DeferredTaxAssetPropertyPlantAndEquipments_411"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeferredTaxAssetPropertyPlantAndEquipments" xlink:label="loc_huge_DeferredTaxAssetPropertyPlantAndEquipments_412"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeferredTaxAssetPropertyPlantAndEquipments" xlink:label="loc_huge_DeferredTaxAssetPropertyPlantAndEquipments_413"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeferredTaxAssetsLiabilitiesAxis" xlink:label="loc_huge_DeferredTaxAssetsLiabilitiesAxis_414"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeferredTaxAssetsLiabilitiesAxis" xlink:label="loc_huge_DeferredTaxAssetsLiabilitiesAxis_415"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeferredTaxAssetsLiabilitiesDomain" xlink:label="loc_huge_DeferredTaxAssetsLiabilitiesDomain_416"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeferredTaxAssetsLiabilitiesDomain" xlink:label="loc_huge_DeferredTaxAssetsLiabilitiesDomain_417"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeferredTaxAssetsOtherInvestments" xlink:label="loc_huge_DeferredTaxAssetsOtherInvestments_418"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeferredTaxAssetsOtherInvestments" xlink:label="loc_huge_DeferredTaxAssetsOtherInvestments_419"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeferredTaxAssetsOtherInvestments" xlink:label="loc_huge_DeferredTaxAssetsOtherInvestments_420"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeferredTaxAssetsOtherInvestments" xlink:label="loc_huge_DeferredTaxAssetsOtherInvestments_421"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward" xlink:label="loc_huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward_422"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward" xlink:label="loc_huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward_423"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward" xlink:label="loc_huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward_424"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward" xlink:label="loc_huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward_425"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DefinitiveBusinessCombinationAgreementMember" xlink:label="loc_huge_DefinitiveBusinessCombinationAgreementMember_426"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DefinitiveBusinessCombinationAgreementMember" xlink:label="loc_huge_DefinitiveBusinessCombinationAgreementMember_427"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DefinitiveBusinessCombinationAgreementMember" xlink:label="loc_huge_DefinitiveBusinessCombinationAgreementMember_428"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DefinitiveCollaborationProfitSharingAgreementMember" xlink:label="loc_huge_DefinitiveCollaborationProfitSharingAgreementMember_429"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DefinitiveCollaborationProfitSharingAgreementMember" xlink:label="loc_huge_DefinitiveCollaborationProfitSharingAgreementMember_430"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DefinitiveCollaborationProfitSharingAgreementMember" xlink:label="loc_huge_DefinitiveCollaborationProfitSharingAgreementMember_431"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DefinitiveSettlementAgreementMember" xlink:label="loc_huge_DefinitiveSettlementAgreementMember_432"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DefinitiveSettlementAgreementMember" xlink:label="loc_huge_DefinitiveSettlementAgreementMember_433"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DefinitiveSettlementAgreementMember" xlink:label="loc_huge_DefinitiveSettlementAgreementMember_434"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DefinitiveStrategicAllianceAndStreamingAgreementMember" xlink:label="loc_huge_DefinitiveStrategicAllianceAndStreamingAgreementMember_435"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DefinitiveStrategicAllianceAndStreamingAgreementMember" xlink:label="loc_huge_DefinitiveStrategicAllianceAndStreamingAgreementMember_436"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DefinitiveStrategicAllianceAndStreamingAgreementMember" xlink:label="loc_huge_DefinitiveStrategicAllianceAndStreamingAgreementMember_437"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DerivativeLiabilitiesSettledThroughIssuanceOfShares" xlink:label="loc_huge_DerivativeLiabilitiesSettledThroughIssuanceOfShares_438"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DerivativeLiabilitiesSettledThroughIssuanceOfShares" xlink:label="loc_huge_DerivativeLiabilitiesSettledThroughIssuanceOfShares_439"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DescriptionOfExpectedVolatilityWarrantsGranted" xlink:label="loc_huge_DescriptionOfExpectedVolatilityWarrantsGranted_440"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DescriptionOfExpectedVolatilityWarrantsGranted" xlink:label="loc_huge_DescriptionOfExpectedVolatilityWarrantsGranted_441"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DescriptionOfExpectedVolatilityWarrantsGranted" xlink:label="loc_huge_DescriptionOfExpectedVolatilityWarrantsGranted_442"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DescriptionOfExpectedVolatilityWarrantsGranted" xlink:label="loc_huge_DescriptionOfExpectedVolatilityWarrantsGranted_443"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DescriptionOfOptionLifeWarrantsGranted" xlink:label="loc_huge_DescriptionOfOptionLifeWarrantsGranted_444"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DescriptionOfOptionLifeWarrantsGranted" xlink:label="loc_huge_DescriptionOfOptionLifeWarrantsGranted_445"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DescriptionOfOptionLifeWarrantsGranted" xlink:label="loc_huge_DescriptionOfOptionLifeWarrantsGranted_446"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DescriptionOfOptionLifeWarrantsGranted" xlink:label="loc_huge_DescriptionOfOptionLifeWarrantsGranted_447"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory" xlink:label="loc_huge_DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory_448"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory" xlink:label="loc_huge_DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory_449"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory" xlink:label="loc_huge_DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory_450"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DescriptionOfReverseShareSplit" xlink:label="loc_huge_DescriptionOfReverseShareSplit_451"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DescriptionOfReverseShareSplit" xlink:label="loc_huge_DescriptionOfReverseShareSplit_452"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DescriptionOfRiskFreeInterestRateWarrantsGranted" xlink:label="loc_huge_DescriptionOfRiskFreeInterestRateWarrantsGranted_453"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DescriptionOfRiskFreeInterestRateWarrantsGranted" xlink:label="loc_huge_DescriptionOfRiskFreeInterestRateWarrantsGranted_454"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DescriptionOfRiskFreeInterestRateWarrantsGranted" xlink:label="loc_huge_DescriptionOfRiskFreeInterestRateWarrantsGranted_455"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DescriptionOfRiskFreeInterestRateWarrantsGranted" xlink:label="loc_huge_DescriptionOfRiskFreeInterestRateWarrantsGranted_456"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DescriptionOfVotingRights" xlink:label="loc_huge_DescriptionOfVotingRights_457"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DescriptionOfVotingRights" xlink:label="loc_huge_DescriptionOfVotingRights_458"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DescriptionOfVotingRights" xlink:label="loc_huge_DescriptionOfVotingRights_459"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DirectCashOfferingCost" xlink:label="loc_huge_DirectCashOfferingCost_460"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DirectCashOfferingCost" xlink:label="loc_huge_DirectCashOfferingCost_461"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DirectCashOfferingCost" xlink:label="loc_huge_DirectCashOfferingCost_462"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DirectorsAndOfficersMember" xlink:label="loc_huge_DirectorsAndOfficersMember_463"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DirectorsAndOfficersMember" xlink:label="loc_huge_DirectorsAndOfficersMember_464"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DirectorsAndOfficersMember" xlink:label="loc_huge_DirectorsAndOfficersMember_465"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DirectorsAndOfficersMember" xlink:label="loc_huge_DirectorsAndOfficersMember_466"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DirectorsRemunerationPayable" xlink:label="loc_huge_DirectorsRemunerationPayable_467"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DirectorsRemunerationPayable" xlink:label="loc_huge_DirectorsRemunerationPayable_468"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DirectorsRemunerationPayable" xlink:label="loc_huge_DirectorsRemunerationPayable_469"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfAssetsHeldForSaleAbstract" xlink:label="loc_huge_DisclosureOfAssetsHeldForSaleAbstract_470"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfAssetsHeldForSaleLineItems" xlink:label="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_471"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfAssetsHeldForSaleLineItems" xlink:label="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_472"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfAssetsHeldForSaleTable" xlink:label="loc_huge_DisclosureOfAssetsHeldForSaleTable_473"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfAssetsHeldForSaleTable" xlink:label="loc_huge_DisclosureOfAssetsHeldForSaleTable_474"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfCapitalManagementAbstract" xlink:label="loc_huge_DisclosureOfCapitalManagementAbstract_475"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory" xlink:label="loc_huge_DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_476"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory" xlink:label="loc_huge_DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_477"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory" xlink:label="loc_huge_DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_478"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfCommitmentsAbstract" xlink:label="loc_huge_DisclosureOfCommitmentsAbstract_479"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfCommitmentsAndContingentLiabilitiesAbstract" xlink:label="loc_huge_DisclosureOfCommitmentsAndContingentLiabilitiesAbstract_480"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfCorporateInformationAndNatureOfOperationsExplanatory" xlink:label="loc_huge_DisclosureOfCorporateInformationAndNatureOfOperationsExplanatory_481"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfCorporateInformationAndNatureOfOperationsExplanatory" xlink:label="loc_huge_DisclosureOfCorporateInformationAndNatureOfOperationsExplanatory_482"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfCorporateInformationAndNatureOfOperationsExplanatory" xlink:label="loc_huge_DisclosureOfCorporateInformationAndNatureOfOperationsExplanatory_483"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfDetailedInformationAboutFairValueOfWarrantsWarrantsEstimatedOnDatesOfIssueUsingBlackScholesOptionPricingModelExplanatory" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutFairValueOfWarrantsWarrantsEstimatedOnDatesOfIssueUsingBlackScholesOptionPricingModelExplanatory_484"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfDetailedInformationAboutFairValueOfWarrantsWarrantsEstimatedOnDatesOfIssueUsingBlackScholesOptionPricingModelExplanatory" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutFairValueOfWarrantsWarrantsEstimatedOnDatesOfIssueUsingBlackScholesOptionPricingModelExplanatory_485"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfDetailedInformationAboutFairValueOfWarrantsWarrantsEstimatedOnDatesOfIssueUsingBlackScholesOptionPricingModelExplanatory" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutFairValueOfWarrantsWarrantsEstimatedOnDatesOfIssueUsingBlackScholesOptionPricingModelExplanatory_486"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory_487"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory_488"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory_489"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory_490"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfDetailedInformationAboutInventoriesExplanatory" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutInventoriesExplanatory_491"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfDetailedInformationAboutInventoriesExplanatory" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutInventoriesExplanatory_492"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfDetailedInformationAboutInventoriesExplanatory" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutInventoriesExplanatory_493"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfDetailedInformationAboutInvestmentsExplanatory" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutInvestmentsExplanatory_494"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfDetailedInformationAboutInvestmentsExplanatory" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutInvestmentsExplanatory_495"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfDetailedInformationAboutInvestmentsExplanatory" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutInvestmentsExplanatory_496"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfDetailedInformationAboutInvestmentsExplanatory" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutInvestmentsExplanatory_497"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfDetailedInformationAboutNotesPayableExplanatory" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutNotesPayableExplanatory_498"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfDetailedInformationAboutNotesPayableExplanatory" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutNotesPayableExplanatory_499"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfDetailedInformationAboutNotesPayableExplanatory" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutNotesPayableExplanatory_500"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfDetailedInformationAboutRestatementOfPriorPeriodExplanatory" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutRestatementOfPriorPeriodExplanatory_501"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfDetailedInformationAboutRestatementOfPriorPeriodExplanatory" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutRestatementOfPriorPeriodExplanatory_502"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfDetailedInformationAboutRestatementOfPriorPeriodExplanatory" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutRestatementOfPriorPeriodExplanatory_503"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfDetailedInformationAboutRightOfUseAssets" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutRightOfUseAssets_504"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfDetailedInformationAboutRightOfUseAssets" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutRightOfUseAssets_505"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfDetailedInformationAboutRightOfUseAssets" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutRightOfUseAssets_506"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory_507"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory_508"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory_509"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfDetailedInformationAboutWarrantActivityExplanatory" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutWarrantActivityExplanatory_510"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfDetailedInformationAboutWarrantActivityExplanatory" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutWarrantActivityExplanatory_511"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfDetailedInformationAboutWarrantActivityExplanatory" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutWarrantActivityExplanatory_512"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory" xlink:label="loc_huge_DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory_513"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory" xlink:label="loc_huge_DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory_514"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory" xlink:label="loc_huge_DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory_515"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfDetailsInformationAboutRightOfUseAssetExplanatory" xlink:label="loc_huge_DisclosureOfDetailsInformationAboutRightOfUseAssetExplanatory_516"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfDetailsInformationAboutRightOfUseAssetExplanatory" xlink:label="loc_huge_DisclosureOfDetailsInformationAboutRightOfUseAssetExplanatory_517"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory" xlink:label="loc_huge_DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory_518"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory" xlink:label="loc_huge_DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory_519"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory" xlink:label="loc_huge_DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory_520"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfFairValueRecognizedOnAcquisitionTableTextBlock" xlink:label="loc_huge_DisclosureOfFairValueRecognizedOnAcquisitionTableTextBlock_521"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfFairValueRecognizedOnAcquisitionTableTextBlock" xlink:label="loc_huge_DisclosureOfFairValueRecognizedOnAcquisitionTableTextBlock_522"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfFairValueRecognizedOnAcquisitionTableTextBlock" xlink:label="loc_huge_DisclosureOfFairValueRecognizedOnAcquisitionTableTextBlock_523"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfFinancialAssetsAndLiabilitiesExplanatory" xlink:label="loc_huge_DisclosureOfFinancialAssetsAndLiabilitiesExplanatory_524"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfFinancialAssetsAndLiabilitiesExplanatory" xlink:label="loc_huge_DisclosureOfFinancialAssetsAndLiabilitiesExplanatory_525"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfFinancialAssetsAndLiabilitiesExplanatory" xlink:label="loc_huge_DisclosureOfFinancialAssetsAndLiabilitiesExplanatory_526"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfGeneralAndAdministrativeExpenses" xlink:label="loc_huge_DisclosureOfGeneralAndAdministrativeExpenses_527"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfGeneralAndAdministrativeExpenses" xlink:label="loc_huge_DisclosureOfGeneralAndAdministrativeExpenses_528"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfInvestmentsAbstract" xlink:label="loc_huge_DisclosureOfInvestmentsAbstract_529"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfInvestmentsLineItems" xlink:label="loc_huge_DisclosureOfInvestmentsLineItems_530"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfInvestmentsTable" xlink:label="loc_huge_DisclosureOfInvestmentsTable_531"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfInvestmentsTable" xlink:label="loc_huge_DisclosureOfInvestmentsTable_532"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfNatureOfBusinessAbstract" xlink:label="loc_huge_DisclosureOfNatureOfBusinessAbstract_533"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfNatureOfBusinessAbstract" xlink:label="loc_huge_DisclosureOfNatureOfBusinessAbstract_534"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfNatureOfBusinessAbstract" xlink:label="loc_huge_DisclosureOfNatureOfBusinessAbstract_535"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfNatureOfBusinessExplanatoryTextBlock" xlink:label="loc_huge_DisclosureOfNatureOfBusinessExplanatoryTextBlock_536"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfNatureOfBusinessExplanatoryTextBlock" xlink:label="loc_huge_DisclosureOfNatureOfBusinessExplanatoryTextBlock_537"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfNatureOfBusinessExplanatoryTextBlock" xlink:label="loc_huge_DisclosureOfNatureOfBusinessExplanatoryTextBlock_538"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfNatureOfBusinessLineItems" xlink:label="loc_huge_DisclosureOfNatureOfBusinessLineItems_539"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfNatureOfBusinessTable" xlink:label="loc_huge_DisclosureOfNatureOfBusinessTable_540"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfNatureOfBusinessTable" xlink:label="loc_huge_DisclosureOfNatureOfBusinessTable_541"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingAndExercisableShareOptionsExplanatory" xlink:label="loc_huge_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingAndExercisableShareOptionsExplanatory_542"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingAndExercisableShareOptionsExplanatory" xlink:label="loc_huge_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingAndExercisableShareOptionsExplanatory_543"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingAndExercisableShareOptionsExplanatory" xlink:label="loc_huge_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingAndExercisableShareOptionsExplanatory_544"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory" xlink:label="loc_huge_DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory_545"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory" xlink:label="loc_huge_DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory_546"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory" xlink:label="loc_huge_DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory_547"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfNumberOfWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory" xlink:label="loc_huge_DisclosureOfNumberOfWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_548"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfNumberOfWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory" xlink:label="loc_huge_DisclosureOfNumberOfWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_549"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfNumberOfWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory" xlink:label="loc_huge_DisclosureOfNumberOfWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_550"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfOperatingLeaseObligationsTableTextBlock" xlink:label="loc_huge_DisclosureOfOperatingLeaseObligationsTableTextBlock_551"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfOperatingLeaseObligationsTableTextBlock" xlink:label="loc_huge_DisclosureOfOperatingLeaseObligationsTableTextBlock_552"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfOperatingLeaseObligationsTableTextBlock" xlink:label="loc_huge_DisclosureOfOperatingLeaseObligationsTableTextBlock_553"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfProvisionForIncomeTaxesExplanatory" xlink:label="loc_huge_DisclosureOfProvisionForIncomeTaxesExplanatory_554"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfProvisionForIncomeTaxesExplanatory" xlink:label="loc_huge_DisclosureOfProvisionForIncomeTaxesExplanatory_555"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfProvisionForIncomeTaxesExplanatory" xlink:label="loc_huge_DisclosureOfProvisionForIncomeTaxesExplanatory_556"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfQuantitiesAvailableToSupplyByFiscalPeriodUnderCommitmentExplanatory" xlink:label="loc_huge_DisclosureOfQuantitiesAvailableToSupplyByFiscalPeriodUnderCommitmentExplanatory_557"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfQuantitiesAvailableToSupplyByFiscalPeriodUnderCommitmentExplanatory" xlink:label="loc_huge_DisclosureOfQuantitiesAvailableToSupplyByFiscalPeriodUnderCommitmentExplanatory_558"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfQuantitiesAvailableToSupplyByFiscalPeriodUnderCommitmentExplanatory" xlink:label="loc_huge_DisclosureOfQuantitiesAvailableToSupplyByFiscalPeriodUnderCommitmentExplanatory_559"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfReverseTakeoverTransactionAbstract" xlink:label="loc_huge_DisclosureOfReverseTakeoverTransactionAbstract_560"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfReverseTakeoverTransactionExplanatory" xlink:label="loc_huge_DisclosureOfReverseTakeoverTransactionExplanatory_561"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfReverseTakeoverTransactionExplanatory" xlink:label="loc_huge_DisclosureOfReverseTakeoverTransactionExplanatory_562"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfReverseTakeoverTransactionExplanatory" xlink:label="loc_huge_DisclosureOfReverseTakeoverTransactionExplanatory_563"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfReverseTakeoverTransactionExplanatory" xlink:label="loc_huge_DisclosureOfReverseTakeoverTransactionExplanatory_564"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract" xlink:label="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract_565"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfShareBasedCompensationAndWarrantReserveExplanatory" xlink:label="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveExplanatory_566"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfShareBasedCompensationAndWarrantReserveExplanatory" xlink:label="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveExplanatory_567"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfShareBasedCompensationAndWarrantReserveExplanatory" xlink:label="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveExplanatory_568"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory" xlink:label="loc_huge_DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory_569"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory" xlink:label="loc_huge_DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory_570"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory" xlink:label="loc_huge_DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory_571"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfUnrecognizedTemporaryTaxDifferencesExplanatory" xlink:label="loc_huge_DisclosureOfUnrecognizedTemporaryTaxDifferencesExplanatory_572"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfUnrecognizedTemporaryTaxDifferencesExplanatory" xlink:label="loc_huge_DisclosureOfUnrecognizedTemporaryTaxDifferencesExplanatory_573"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfUnrecognizedTemporaryTaxDifferencesExplanatory" xlink:label="loc_huge_DisclosureOfUnrecognizedTemporaryTaxDifferencesExplanatory_574"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfWarrantLiabilitiesExplanatory" xlink:label="loc_huge_DisclosureOfWarrantLiabilitiesExplanatory_575"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfWarrantLiabilitiesExplanatory" xlink:label="loc_huge_DisclosureOfWarrantLiabilitiesExplanatory_576"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfWarrantLiabilitiesExplanatory" xlink:label="loc_huge_DisclosureOfWarrantLiabilitiesExplanatory_577"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfWarrantsLineItems" xlink:label="loc_huge_DisclosureOfWarrantsLineItems_578"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfWarrantsLineItems" xlink:label="loc_huge_DisclosureOfWarrantsLineItems_579"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfWarrantsTable" xlink:label="loc_huge_DisclosureOfWarrantsTable_580"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfWarrantsTable" xlink:label="loc_huge_DisclosureOfWarrantsTable_581"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DiscontinuedOperationsOfGeneralAndAdministrative" xlink:label="loc_huge_DiscontinuedOperationsOfGeneralAndAdministrative_582"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DiscontinuedOperationsOfGeneralAndAdministrative" xlink:label="loc_huge_DiscontinuedOperationsOfGeneralAndAdministrative_583"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DiscontinuedOperationsOfGeneralAndAdministrative" xlink:label="loc_huge_DiscontinuedOperationsOfGeneralAndAdministrative_584"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DiscountOnProceedsOfSharesAndWarrantsSold" xlink:label="loc_huge_DiscountOnProceedsOfSharesAndWarrantsSold_585"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DiscountOnProceedsOfSharesAndWarrantsSold" xlink:label="loc_huge_DiscountOnProceedsOfSharesAndWarrantsSold_586"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DiscountOnProceedsOfSharesAndWarrantsSold" xlink:label="loc_huge_DiscountOnProceedsOfSharesAndWarrantsSold_587"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DocumentAndEntityInformationAbstract" xlink:label="loc_huge_DocumentAndEntityInformationAbstract_588"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_EffectOfSharesIssuedDuringPeriodOnWeightedAverageNumberOfShares" xlink:label="loc_huge_EffectOfSharesIssuedDuringPeriodOnWeightedAverageNumberOfShares_589"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_EffectOfSharesIssuedDuringPeriodOnWeightedAverageNumberOfShares" xlink:label="loc_huge_EffectOfSharesIssuedDuringPeriodOnWeightedAverageNumberOfShares_590"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_EffectOfSharesIssuedDuringPeriodOnWeightedAverageNumberOfShares" xlink:label="loc_huge_EffectOfSharesIssuedDuringPeriodOnWeightedAverageNumberOfShares_591"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_EffectsOfForeignExchangeOnLeaseLiabilities" xlink:label="loc_huge_EffectsOfForeignExchangeOnLeaseLiabilities_592"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_EffectsOfForeignExchangeOnLeaseLiabilities" xlink:label="loc_huge_EffectsOfForeignExchangeOnLeaseLiabilities_593"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_EffectsOfForeignExchangeOnLeaseLiabilities" xlink:label="loc_huge_EffectsOfForeignExchangeOnLeaseLiabilities_594"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_EmployeeRelatedLiability" xlink:label="loc_huge_EmployeeRelatedLiability_595"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_EmployeeRelatedLiability" xlink:label="loc_huge_EmployeeRelatedLiability_596"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_EpitechLicenseAgreementMember" xlink:label="loc_huge_EpitechLicenseAgreementMember_597"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_EpitechLicenseAgreementMember" xlink:label="loc_huge_EpitechLicenseAgreementMember_598"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_EpitechLicenseAgreementMember" xlink:label="loc_huge_EpitechLicenseAgreementMember_599"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_EquityDistributionAgreementMember" xlink:label="loc_huge_EquityDistributionAgreementMember_600"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_EquityDistributionAgreementMember" xlink:label="loc_huge_EquityDistributionAgreementMember_601"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_EquityDistributionAgreementMember" xlink:label="loc_huge_EquityDistributionAgreementMember_602"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_EstimatedCostOfRestorationInCommitment" xlink:label="loc_huge_EstimatedCostOfRestorationInCommitment_603"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_EstimatedCostOfRestorationInCommitment" xlink:label="loc_huge_EstimatedCostOfRestorationInCommitment_604"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceEighteenPointZeroNineMember" xlink:label="loc_huge_ExercisePriceEighteenPointZeroNineMember_605"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceEighteenPointZeroNineMember" xlink:label="loc_huge_ExercisePriceEighteenPointZeroNineMember_606"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceEighteenPointZeroNineMember" xlink:label="loc_huge_ExercisePriceEighteenPointZeroNineMember_607"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceEightyEightPointFortyFourMember" xlink:label="loc_huge_ExercisePriceEightyEightPointFortyFourMember_608"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceEightyEightPointFortyFourMember" xlink:label="loc_huge_ExercisePriceEightyEightPointFortyFourMember_609"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceEightyEightPointFortyFourMember" xlink:label="loc_huge_ExercisePriceEightyEightPointFortyFourMember_610"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceEightySixPointFortyThreeMember" xlink:label="loc_huge_ExercisePriceEightySixPointFortyThreeMember_611"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceEightySixPointFortyThreeMember" xlink:label="loc_huge_ExercisePriceEightySixPointFortyThreeMember_612"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceEightySixPointFortyThreeMember" xlink:label="loc_huge_ExercisePriceEightySixPointFortyThreeMember_613"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFiftyFivePointTwentyEightMember" xlink:label="loc_huge_ExercisePriceFiftyFivePointTwentyEightMember_614"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFiftyFivePointTwentyEightMember" xlink:label="loc_huge_ExercisePriceFiftyFivePointTwentyEightMember_615"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFiftyFivePointTwentyEightMember" xlink:label="loc_huge_ExercisePriceFiftyFivePointTwentyEightMember_616"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFiftyNinePointThirtyMember" xlink:label="loc_huge_ExercisePriceFiftyNinePointThirtyMember_617"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFiftyNinePointThirtyMember" xlink:label="loc_huge_ExercisePriceFiftyNinePointThirtyMember_618"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFiftyNinePointThirtyMember" xlink:label="loc_huge_ExercisePriceFiftyNinePointThirtyMember_619"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFiftyPointTwentyFiveMember" xlink:label="loc_huge_ExercisePriceFiftyPointTwentyFiveMember_620"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFiftyPointTwentyFiveMember" xlink:label="loc_huge_ExercisePriceFiftyPointTwentyFiveMember_621"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFiftyPointTwentyFiveMember" xlink:label="loc_huge_ExercisePriceFiftyPointTwentyFiveMember_622"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFiftySixPointTwentyEightMember" xlink:label="loc_huge_ExercisePriceFiftySixPointTwentyEightMember_623"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFiftySixPointTwentyEightMember" xlink:label="loc_huge_ExercisePriceFiftySixPointTwentyEightMember_624"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFiftySixPointTwentyEightMember" xlink:label="loc_huge_ExercisePriceFiftySixPointTwentyEightMember_625"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFiftyTwoPointTwentySixMember" xlink:label="loc_huge_ExercisePriceFiftyTwoPointTwentySixMember_626"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFiftyTwoPointTwentySixMember" xlink:label="loc_huge_ExercisePriceFiftyTwoPointTwentySixMember_627"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFiftyTwoPointTwentySixMember" xlink:label="loc_huge_ExercisePriceFiftyTwoPointTwentySixMember_628"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFivePointFourThreeMember" xlink:label="loc_huge_ExercisePriceFivePointFourThreeMember_629"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFivePointFourThreeMember" xlink:label="loc_huge_ExercisePriceFivePointFourThreeMember_630"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFivePointFourThreeMember" xlink:label="loc_huge_ExercisePriceFivePointFourThreeMember_631"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFivePointZeroThreeMember" xlink:label="loc_huge_ExercisePriceFivePointZeroThreeMember_632"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFivePointZeroThreeMember" xlink:label="loc_huge_ExercisePriceFivePointZeroThreeMember_633"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFivePointZeroThreeMember" xlink:label="loc_huge_ExercisePriceFivePointZeroThreeMember_634"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFortyFourPointTwentyTwoMember" xlink:label="loc_huge_ExercisePriceFortyFourPointTwentyTwoMember_635"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFortyFourPointTwentyTwoMember" xlink:label="loc_huge_ExercisePriceFortyFourPointTwentyTwoMember_636"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFortyFourPointTwentyTwoMember" xlink:label="loc_huge_ExercisePriceFortyFourPointTwentyTwoMember_637"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFortyPointTwentyMember" xlink:label="loc_huge_ExercisePriceFortyPointTwentyMember_638"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFortyPointTwentyMember" xlink:label="loc_huge_ExercisePriceFortyPointTwentyMember_639"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFortyPointTwentyMember" xlink:label="loc_huge_ExercisePriceFortyPointTwentyMember_640"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFortySevenPointTwentyFourMember" xlink:label="loc_huge_ExercisePriceFortySevenPointTwentyFourMember_641"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFortySevenPointTwentyFourMember" xlink:label="loc_huge_ExercisePriceFortySevenPointTwentyFourMember_642"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFortySevenPointTwentyFourMember" xlink:label="loc_huge_ExercisePriceFortySevenPointTwentyFourMember_643"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFourPointFourTwoMember" xlink:label="loc_huge_ExercisePriceFourPointFourTwoMember_644"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFourPointFourTwoMember" xlink:label="loc_huge_ExercisePriceFourPointFourTwoMember_645"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFourPointFourTwoMember" xlink:label="loc_huge_ExercisePriceFourPointFourTwoMember_646"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFourPointSevenFiveMember" xlink:label="loc_huge_ExercisePriceFourPointSevenFiveMember_647"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFourPointSevenFiveMember" xlink:label="loc_huge_ExercisePriceFourPointSevenFiveMember_648"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFourPointSevenFiveMember" xlink:label="loc_huge_ExercisePriceFourPointSevenFiveMember_649"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceNinePointFiveFourMember" xlink:label="loc_huge_ExercisePriceNinePointFiveFourMember_650"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceNinePointFiveFourMember" xlink:label="loc_huge_ExercisePriceNinePointFiveFourMember_651"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceNinePointFiveFourMember" xlink:label="loc_huge_ExercisePriceNinePointFiveFourMember_652"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceOfExercisableShareOptions" xlink:label="loc_huge_ExercisePriceOfExercisableShareOptions_653"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceOfExercisableShareOptions" xlink:label="loc_huge_ExercisePriceOfExercisableShareOptions_654"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceOfWarrantIssue" xlink:label="loc_huge_ExercisePriceOfWarrantIssue_655"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceOfWarrantIssue" xlink:label="loc_huge_ExercisePriceOfWarrantIssue_656"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceOfWarrantIssue" xlink:label="loc_huge_ExercisePriceOfWarrantIssue_657"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceOfWarrants" xlink:label="loc_huge_ExercisePriceOfWarrants_658"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceOfWarrants" xlink:label="loc_huge_ExercisePriceOfWarrants_659"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceOfWarrantsGranted" xlink:label="loc_huge_ExercisePriceOfWarrantsGranted_660"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceOfWarrantsGranted" xlink:label="loc_huge_ExercisePriceOfWarrantsGranted_661"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceOfWarrantsGranted" xlink:label="loc_huge_ExercisePriceOfWarrantsGranted_662"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceOfWarrantsLiability" xlink:label="loc_huge_ExercisePriceOfWarrantsLiability_663"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceOfWarrantsLiability" xlink:label="loc_huge_ExercisePriceOfWarrantsLiability_664"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceOneHundredFortyEightPointSeventyFourMember" xlink:label="loc_huge_ExercisePriceOneHundredFortyEightPointSeventyFourMember_665"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceOneHundredFortyEightPointSeventyFourMember" xlink:label="loc_huge_ExercisePriceOneHundredFortyEightPointSeventyFourMember_666"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceOneHundredFortyEightPointSeventyFourMember" xlink:label="loc_huge_ExercisePriceOneHundredFortyEightPointSeventyFourMember_667"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember" xlink:label="loc_huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember_668"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember" xlink:label="loc_huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember_669"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember" xlink:label="loc_huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember_670"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceOneHundredTwentyPointSixtyMember" xlink:label="loc_huge_ExercisePriceOneHundredTwentyPointSixtyMember_671"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceOneHundredTwentyPointSixtyMember" xlink:label="loc_huge_ExercisePriceOneHundredTwentyPointSixtyMember_672"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceOneHundredTwentyPointSixtyMember" xlink:label="loc_huge_ExercisePriceOneHundredTwentyPointSixtyMember_673"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSevenPointFiftyMember" xlink:label="loc_huge_ExercisePriceSevenPointFiftyMember_674"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSevenPointFiftyMember" xlink:label="loc_huge_ExercisePriceSevenPointFiftyMember_675"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSevenPointFiftyMember" xlink:label="loc_huge_ExercisePriceSevenPointFiftyMember_676"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSevenPointSeventeenMember" xlink:label="loc_huge_ExercisePriceSevenPointSeventeenMember_677"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSevenPointSeventeenMember" xlink:label="loc_huge_ExercisePriceSevenPointSeventeenMember_678"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSevenPointSeventeenMember" xlink:label="loc_huge_ExercisePriceSevenPointSeventeenMember_679"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSevenPointSixtyThreeMember" xlink:label="loc_huge_ExercisePriceSevenPointSixtyThreeMember_680"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSevenPointSixtyThreeMember" xlink:label="loc_huge_ExercisePriceSevenPointSixtyThreeMember_681"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSevenPointSixtyThreeMember" xlink:label="loc_huge_ExercisePriceSevenPointSixtyThreeMember_682"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSevenPointZeroZeroMember" xlink:label="loc_huge_ExercisePriceSevenPointZeroZeroMember_683"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSevenPointZeroZeroMember" xlink:label="loc_huge_ExercisePriceSevenPointZeroZeroMember_684"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSevenPointZeroZeroMember" xlink:label="loc_huge_ExercisePriceSevenPointZeroZeroMember_685"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSeventeenPointEightNineMember" xlink:label="loc_huge_ExercisePriceSeventeenPointEightNineMember_686"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSeventeenPointEightNineMember" xlink:label="loc_huge_ExercisePriceSeventeenPointEightNineMember_687"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSeventeenPointEightNineMember" xlink:label="loc_huge_ExercisePriceSeventeenPointEightNineMember_688"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSeventyFivePointThirtyEightMember" xlink:label="loc_huge_ExercisePriceSeventyFivePointThirtyEightMember_689"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSeventyFivePointThirtyEightMember" xlink:label="loc_huge_ExercisePriceSeventyFivePointThirtyEightMember_690"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSeventyFivePointThirtyEightMember" xlink:label="loc_huge_ExercisePriceSeventyFivePointThirtyEightMember_691"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSeventyOnePointZeroSevenMember" xlink:label="loc_huge_ExercisePriceSeventyOnePointZeroSevenMember_692"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSeventyOnePointZeroSevenMember" xlink:label="loc_huge_ExercisePriceSeventyOnePointZeroSevenMember_693"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSeventyOnePointZeroSevenMember" xlink:label="loc_huge_ExercisePriceSeventyOnePointZeroSevenMember_694"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSixPointSixteenMember" xlink:label="loc_huge_ExercisePriceSixPointSixteenMember_695"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSixPointSixteenMember" xlink:label="loc_huge_ExercisePriceSixPointSixteenMember_696"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSixPointSixteenMember" xlink:label="loc_huge_ExercisePriceSixPointSixteenMember_697"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSixteenPointZeroEightMember" xlink:label="loc_huge_ExercisePriceSixteenPointZeroEightMember_698"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSixteenPointZeroEightMember" xlink:label="loc_huge_ExercisePriceSixteenPointZeroEightMember_699"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSixteenPointZeroEightMember" xlink:label="loc_huge_ExercisePriceSixteenPointZeroEightMember_700"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSixtyEightPointZeroOneMember" xlink:label="loc_huge_ExercisePriceSixtyEightPointZeroOneMember_701"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSixtyEightPointZeroOneMember" xlink:label="loc_huge_ExercisePriceSixtyEightPointZeroOneMember_702"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSixtyEightPointZeroOneMember" xlink:label="loc_huge_ExercisePriceSixtyEightPointZeroOneMember_703"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceTenPointSixFiveMember" xlink:label="loc_huge_ExercisePriceTenPointSixFiveMember_704"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceTenPointSixFiveMember" xlink:label="loc_huge_ExercisePriceTenPointSixFiveMember_705"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceTenPointSixFiveMember" xlink:label="loc_huge_ExercisePriceTenPointSixFiveMember_706"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceThirteenPointFourSevenMember" xlink:label="loc_huge_ExercisePriceThirteenPointFourSevenMember_707"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceThirteenPointFourSevenMember" xlink:label="loc_huge_ExercisePriceThirteenPointFourSevenMember_708"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceThirteenPointFourSevenMember" xlink:label="loc_huge_ExercisePriceThirteenPointFourSevenMember_709"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceThirteenPointZeroSevenMember" xlink:label="loc_huge_ExercisePriceThirteenPointZeroSevenMember_710"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceThirteenPointZeroSevenMember" xlink:label="loc_huge_ExercisePriceThirteenPointZeroSevenMember_711"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceThirteenPointZeroSevenMember" xlink:label="loc_huge_ExercisePriceThirteenPointZeroSevenMember_712"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceThreePointEightSixMember" xlink:label="loc_huge_ExercisePriceThreePointEightSixMember_713"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceThreePointEightSixMember" xlink:label="loc_huge_ExercisePriceThreePointEightSixMember_714"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceThreePointEightSixMember" xlink:label="loc_huge_ExercisePriceThreePointEightSixMember_715"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceThreePointSevenFiveMember" xlink:label="loc_huge_ExercisePriceThreePointSevenFiveMember_716"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceThreePointSevenFiveMember" xlink:label="loc_huge_ExercisePriceThreePointSevenFiveMember_717"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceThreePointSevenFiveMember" xlink:label="loc_huge_ExercisePriceThreePointSevenFiveMember_718"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceTwentyFourPointTwelveMember" xlink:label="loc_huge_ExercisePriceTwentyFourPointTwelveMember_719"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceTwentyFourPointTwelveMember" xlink:label="loc_huge_ExercisePriceTwentyFourPointTwelveMember_720"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceTwentyFourPointTwelveMember" xlink:label="loc_huge_ExercisePriceTwentyFourPointTwelveMember_721"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceTwentyOnePointElevenMember" xlink:label="loc_huge_ExercisePriceTwentyOnePointElevenMember_722"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceTwentyOnePointElevenMember" xlink:label="loc_huge_ExercisePriceTwentyOnePointElevenMember_723"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceTwentyOnePointElevenMember" xlink:label="loc_huge_ExercisePriceTwentyOnePointElevenMember_724"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceTwentyOnePointNinetyOneMember" xlink:label="loc_huge_ExercisePriceTwentyOnePointNinetyOneMember_725"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceTwentyOnePointNinetyOneMember" xlink:label="loc_huge_ExercisePriceTwentyOnePointNinetyOneMember_726"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceTwentyOnePointNinetyOneMember" xlink:label="loc_huge_ExercisePriceTwentyOnePointNinetyOneMember_727"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceTwentyOnePointTwentyTwoMember" xlink:label="loc_huge_ExercisePriceTwentyOnePointTwentyTwoMember_728"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceTwentyOnePointTwentyTwoMember" xlink:label="loc_huge_ExercisePriceTwentyOnePointTwentyTwoMember_729"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceTwentyOnePointTwentyTwoMember" xlink:label="loc_huge_ExercisePriceTwentyOnePointTwentyTwoMember_730"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceTwentyPointOneZeroMember" xlink:label="loc_huge_ExercisePriceTwentyPointOneZeroMember_731"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceTwentyPointOneZeroMember" xlink:label="loc_huge_ExercisePriceTwentyPointOneZeroMember_732"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceTwentyPointOneZeroMember" xlink:label="loc_huge_ExercisePriceTwentyPointOneZeroMember_733"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceTwentySixPointThirteenMember" xlink:label="loc_huge_ExercisePriceTwentySixPointThirteenMember_734"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceTwentySixPointThirteenMember" xlink:label="loc_huge_ExercisePriceTwentySixPointThirteenMember_735"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceTwentySixPointThirteenMember" xlink:label="loc_huge_ExercisePriceTwentySixPointThirteenMember_736"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceTwoPointSixOneMember" xlink:label="loc_huge_ExercisePriceTwoPointSixOneMember_737"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceTwoPointSixOneMember" xlink:label="loc_huge_ExercisePriceTwoPointSixOneMember_738"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceTwoPointSixOneMember" xlink:label="loc_huge_ExercisePriceTwoPointSixOneMember_739"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedDividendAsPercentageWarrantsGranted" xlink:label="loc_huge_ExpectedDividendAsPercentageWarrantsGranted_740"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedDividendAsPercentageWarrantsGranted" xlink:label="loc_huge_ExpectedDividendAsPercentageWarrantsGranted_741"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedDividendAsPercentageWarrantsGranted" xlink:label="loc_huge_ExpectedDividendAsPercentageWarrantsGranted_742"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedDividendAsPercentageWarrantsGranted" xlink:label="loc_huge_ExpectedDividendAsPercentageWarrantsGranted_743"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedDividendYieldOfWarrants" xlink:label="loc_huge_ExpectedDividendYieldOfWarrants_744"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedDividendYieldOfWarrants" xlink:label="loc_huge_ExpectedDividendYieldOfWarrants_745"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedDividendYieldOfWarrants" xlink:label="loc_huge_ExpectedDividendYieldOfWarrants_746"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedDividendYieldOfWarrantsGranted" xlink:label="loc_huge_ExpectedDividendYieldOfWarrantsGranted_747"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedDividendYieldOfWarrantsGranted" xlink:label="loc_huge_ExpectedDividendYieldOfWarrantsGranted_748"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedDividendYieldOfWarrantsGranted" xlink:label="loc_huge_ExpectedDividendYieldOfWarrantsGranted_749"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedGrowthCycle" xlink:label="loc_huge_ExpectedGrowthCycle_750"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedGrowthCycle" xlink:label="loc_huge_ExpectedGrowthCycle_751"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedGrowthCycle" xlink:label="loc_huge_ExpectedGrowthCycle_752"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedGrowthCycleCompleted" xlink:label="loc_huge_ExpectedGrowthCycleCompleted_753"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedGrowthCycleCompleted" xlink:label="loc_huge_ExpectedGrowthCycleCompleted_754"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedGrowthCycleCompleted" xlink:label="loc_huge_ExpectedGrowthCycleCompleted_755"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedLifeOfWarrants" xlink:label="loc_huge_ExpectedLifeOfWarrants_756"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedLifeOfWarrants" xlink:label="loc_huge_ExpectedLifeOfWarrants_757"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedLifeOfWarrants" xlink:label="loc_huge_ExpectedLifeOfWarrants_758"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedNetSellingPricePerGramOfDriedFlower" xlink:label="loc_huge_ExpectedNetSellingPricePerGramOfDriedFlower_759"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedNetSellingPricePerGramOfDriedFlower" xlink:label="loc_huge_ExpectedNetSellingPricePerGramOfDriedFlower_760"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedNetSellingPricePerGramOfTrim" xlink:label="loc_huge_ExpectedNetSellingPricePerGramOfTrim_761"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedNetSellingPricePerGramOfTrim" xlink:label="loc_huge_ExpectedNetSellingPricePerGramOfTrim_762"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedNetSellingPricePerGramOfTrim" xlink:label="loc_huge_ExpectedNetSellingPricePerGramOfTrim_763"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedSellingPricePerGramOfDriedFlower" xlink:label="loc_huge_ExpectedSellingPricePerGramOfDriedFlower_764"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedSellingPricePerGramOfDriedFlower" xlink:label="loc_huge_ExpectedSellingPricePerGramOfDriedFlower_765"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedSellingPricePerGramOfTrim" xlink:label="loc_huge_ExpectedSellingPricePerGramOfTrim_766"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedSellingPricePerGramOfTrim" xlink:label="loc_huge_ExpectedSellingPricePerGramOfTrim_767"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedSellingPricePerGramOfTrim" xlink:label="loc_huge_ExpectedSellingPricePerGramOfTrim_768"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedTermOfWarrants" xlink:label="loc_huge_ExpectedTermOfWarrants_769"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedTermOfWarrants" xlink:label="loc_huge_ExpectedTermOfWarrants_770"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedTermOfWarrants" xlink:label="loc_huge_ExpectedTermOfWarrants_771"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedVolatilityOfWarrants" xlink:label="loc_huge_ExpectedVolatilityOfWarrants_772"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedVolatilityOfWarrants" xlink:label="loc_huge_ExpectedVolatilityOfWarrants_773"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedVolatilityOfWarrants" xlink:label="loc_huge_ExpectedVolatilityOfWarrants_774"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedVolatilityOfWarrants" xlink:label="loc_huge_ExpectedVolatilityOfWarrants_775"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedVolatilityOfWarrantsGranted" xlink:label="loc_huge_ExpectedVolatilityOfWarrantsGranted_776"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedVolatilityOfWarrantsGranted" xlink:label="loc_huge_ExpectedVolatilityOfWarrantsGranted_777"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedVolatilityOfWarrantsGranted" xlink:label="loc_huge_ExpectedVolatilityOfWarrantsGranted_778"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedVolatilityOfWarrantsLiability" xlink:label="loc_huge_ExpectedVolatilityOfWarrantsLiability_779"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedVolatilityOfWarrantsLiability" xlink:label="loc_huge_ExpectedVolatilityOfWarrantsLiability_780"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedYieldForCannabisPlantsOfDryFlowerPerPlant" xlink:label="loc_huge_ExpectedYieldForCannabisPlantsOfDryFlowerPerPlant_781"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedYieldForCannabisPlantsOfDryFlowerPerPlant" xlink:label="loc_huge_ExpectedYieldForCannabisPlantsOfDryFlowerPerPlant_782"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedYieldForCannabisPlantsOfDryFlowerPerPlant" xlink:label="loc_huge_ExpectedYieldForCannabisPlantsOfDryFlowerPerPlant_783"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedYieldForCannabisPlantsOfDryTrimPerPlant" xlink:label="loc_huge_ExpectedYieldForCannabisPlantsOfDryTrimPerPlant_784"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedYieldForCannabisPlantsOfDryTrimPerPlant" xlink:label="loc_huge_ExpectedYieldForCannabisPlantsOfDryTrimPerPlant_785"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedYieldForCannabisPlantsOfDryTrimPerPlant" xlink:label="loc_huge_ExpectedYieldForCannabisPlantsOfDryTrimPerPlant_786"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedYieldOfDryFlower" xlink:label="loc_huge_ExpectedYieldOfDryFlower_787"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedYieldOfDryFlower" xlink:label="loc_huge_ExpectedYieldOfDryFlower_788"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedYieldOfDryFlower" xlink:label="loc_huge_ExpectedYieldOfDryFlower_789"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedYieldOfDryTrim" xlink:label="loc_huge_ExpectedYieldOfDryTrim_790"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedYieldOfDryTrim" xlink:label="loc_huge_ExpectedYieldOfDryTrim_791"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedYieldOfDryTrim" xlink:label="loc_huge_ExpectedYieldOfDryTrim_792"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpiryDateOfWarrants" xlink:label="loc_huge_ExpiryDateOfWarrants_793"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpiryDateOfWarrants" xlink:label="loc_huge_ExpiryDateOfWarrants_794"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpiryDateOfWarrants" xlink:label="loc_huge_ExpiryDateOfWarrants_795"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpiryTermOfWarrantsGranted" xlink:label="loc_huge_ExpiryTermOfWarrantsGranted_796"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpiryTermOfWarrantsGranted" xlink:label="loc_huge_ExpiryTermOfWarrantsGranted_797"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpiryTermOfWarrantsGranted" xlink:label="loc_huge_ExpiryTermOfWarrantsGranted_798"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FacilityRelatedExpenditures" xlink:label="loc_huge_FacilityRelatedExpenditures_799"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FacilityRelatedExpenditures" xlink:label="loc_huge_FacilityRelatedExpenditures_800"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FacilityRelatedExpenditures" xlink:label="loc_huge_FacilityRelatedExpenditures_801"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FacilityUnderDevelopmentMember" xlink:label="loc_huge_FacilityUnderDevelopmentMember_802"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FacilityUnderDevelopmentMember" xlink:label="loc_huge_FacilityUnderDevelopmentMember_803"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FacilityUnderDevelopmentMember" xlink:label="loc_huge_FacilityUnderDevelopmentMember_804"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueAdjustmentsOnInventorySold" xlink:label="loc_huge_FairValueAdjustmentsOnInventorySold_805"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueAdjustmentsOnInventorySold" xlink:label="loc_huge_FairValueAdjustmentsOnInventorySold_806"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueAdjustmentsOnInventorySold" xlink:label="loc_huge_FairValueAdjustmentsOnInventorySold_807"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueAdjustmentsOnInventorySold" xlink:label="loc_huge_FairValueAdjustmentsOnInventorySold_808"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfCommonSharesApprovedForIssuance" xlink:label="loc_huge_FairValueOfCommonSharesApprovedForIssuance_809"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfCommonSharesApprovedForIssuance" xlink:label="loc_huge_FairValueOfCommonSharesApprovedForIssuance_810"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfCommonSharesApprovedForIssuance" xlink:label="loc_huge_FairValueOfCommonSharesApprovedForIssuance_811"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfCommonSharesIssued" xlink:label="loc_huge_FairValueOfCommonSharesIssued_812"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfCommonSharesIssued" xlink:label="loc_huge_FairValueOfCommonSharesIssued_813"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfCommonSharesOfResidualValue" xlink:label="loc_huge_FairValueOfCommonSharesOfResidualValue_814"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfCommonSharesOfResidualValue" xlink:label="loc_huge_FairValueOfCommonSharesOfResidualValue_815"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfCommonSharesOfResidualValue" xlink:label="loc_huge_FairValueOfCommonSharesOfResidualValue_816"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfCommonStockOfNotesPayable" xlink:label="loc_huge_FairValueOfCommonStockOfNotesPayable_817"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfCommonStockOfNotesPayable" xlink:label="loc_huge_FairValueOfCommonStockOfNotesPayable_818"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfCommonStockOfNotesPayable" xlink:label="loc_huge_FairValueOfCommonStockOfNotesPayable_819"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfCommonStockToSettleNotesPayable" xlink:label="loc_huge_FairValueOfCommonStockToSettleNotesPayable_820"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfCommonStockToSettleNotesPayable" xlink:label="loc_huge_FairValueOfCommonStockToSettleNotesPayable_821"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfCommonStockToSettleNotesPayable" xlink:label="loc_huge_FairValueOfCommonStockToSettleNotesPayable_822"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfIssuanceOfCommonStockSharesApproved" xlink:label="loc_huge_FairValueOfIssuanceOfCommonStockSharesApproved_823"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfIssuanceOfCommonStockSharesApproved" xlink:label="loc_huge_FairValueOfIssuanceOfCommonStockSharesApproved_824"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfIssuanceOfCommonStockSharesApproved" xlink:label="loc_huge_FairValueOfIssuanceOfCommonStockSharesApproved_825"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfShareBasedCompensationBonus" xlink:label="loc_huge_FairValueOfShareBasedCompensationBonus_826"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfShareBasedCompensationBonus" xlink:label="loc_huge_FairValueOfShareBasedCompensationBonus_827"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfShareBasedCompensationBonus" xlink:label="loc_huge_FairValueOfShareBasedCompensationBonus_828"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfShares" xlink:label="loc_huge_FairValueOfShares_829"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfShares" xlink:label="loc_huge_FairValueOfShares_830"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfShares" xlink:label="loc_huge_FairValueOfShares_831"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfSharesAndWarrantsAcquired" xlink:label="loc_huge_FairValueOfSharesAndWarrantsAcquired_832"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfSharesAndWarrantsAcquired" xlink:label="loc_huge_FairValueOfSharesAndWarrantsAcquired_833"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfSharesAndWarrantsAcquired" xlink:label="loc_huge_FairValueOfSharesAndWarrantsAcquired_834"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfWarrantLiability" xlink:label="loc_huge_FairValueOfWarrantLiability_835"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfWarrantLiability" xlink:label="loc_huge_FairValueOfWarrantLiability_836"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfWarrantLiability" xlink:label="loc_huge_FairValueOfWarrantLiability_837"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfWarrantLiabilityOfResidualAmount" xlink:label="loc_huge_FairValueOfWarrantLiabilityOfResidualAmount_838"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfWarrantLiabilityOfResidualAmount" xlink:label="loc_huge_FairValueOfWarrantLiabilityOfResidualAmount_839"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfWarrantLiabilityOfResidualAmount" xlink:label="loc_huge_FairValueOfWarrantLiabilityOfResidualAmount_840"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfWarrants" xlink:label="loc_huge_FairValueOfWarrants_841"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfWarrants" xlink:label="loc_huge_FairValueOfWarrants_842"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfWarrants" xlink:label="loc_huge_FairValueOfWarrants_843"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfWarrants" xlink:label="loc_huge_FairValueOfWarrants_844"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfWarrantsIssued" xlink:label="loc_huge_FairValueOfWarrantsIssued_845"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfWarrantsIssued" xlink:label="loc_huge_FairValueOfWarrantsIssued_846"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfWarrantsIssued" xlink:label="loc_huge_FairValueOfWarrantsIssued_847"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Feb252018Member" xlink:label="loc_huge_Feb252018Member_848"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Feb252018Member" xlink:label="loc_huge_Feb252018Member_849"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Feb252018Member" xlink:label="loc_huge_Feb252018Member_850"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FindersFee" xlink:label="loc_huge_FindersFee_851"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FindersFee" xlink:label="loc_huge_FindersFee_852"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FindersFee" xlink:label="loc_huge_FindersFee_853"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FindersFeeShares" xlink:label="loc_huge_FindersFeeShares_854"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FindersFeeShares" xlink:label="loc_huge_FindersFeeShares_855"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FirstRepublicCapitalCorporationMember" xlink:label="loc_huge_FirstRepublicCapitalCorporationMember_856"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FirstRepublicCapitalCorporationMember" xlink:label="loc_huge_FirstRepublicCapitalCorporationMember_857"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FirstRepublicCapitalCorporationMember" xlink:label="loc_huge_FirstRepublicCapitalCorporationMember_858"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FormerChiefExecutiveOfficerMember" xlink:label="loc_huge_FormerChiefExecutiveOfficerMember_859"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FormerChiefExecutiveOfficerMember" xlink:label="loc_huge_FormerChiefExecutiveOfficerMember_860"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FormerChiefExecutiveOfficerMember" xlink:label="loc_huge_FormerChiefExecutiveOfficerMember_861"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FormerChiefOperatingOfficerMember" xlink:label="loc_huge_FormerChiefOperatingOfficerMember_862"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FormerChiefOperatingOfficerMember" xlink:label="loc_huge_FormerChiefOperatingOfficerMember_863"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FormerChiefOperatingOfficerMember" xlink:label="loc_huge_FormerChiefOperatingOfficerMember_864"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FSDBiosciencesMember" xlink:label="loc_huge_FSDBiosciencesMember_865"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FSDBiosciencesMember" xlink:label="loc_huge_FSDBiosciencesMember_866"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FSDBiosciencesMember" xlink:label="loc_huge_FSDBiosciencesMember_867"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FundsPaidForSettlementAgreement" xlink:label="loc_huge_FundsPaidForSettlementAgreement_868"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FundsPaidForSettlementAgreement" xlink:label="loc_huge_FundsPaidForSettlementAgreement_869"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FundsPaidForSettlementAgreement" xlink:label="loc_huge_FundsPaidForSettlementAgreement_870"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FurnitureFixturesAndEquipmentMember" xlink:label="loc_huge_FurnitureFixturesAndEquipmentMember_871"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FurnitureFixturesAndEquipmentMember" xlink:label="loc_huge_FurnitureFixturesAndEquipmentMember_872"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FurnitureFixturesAndEquipmentMember" xlink:label="loc_huge_FurnitureFixturesAndEquipmentMember_873"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FvPharmaIncMember" xlink:label="loc_huge_FvPharmaIncMember_874"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FvPharmaIncMember" xlink:label="loc_huge_FvPharmaIncMember_875"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FvPharmaIncMember" xlink:label="loc_huge_FvPharmaIncMember_876"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GainLossOnChangeInFairValueOfDerivativeLiability" xlink:label="loc_huge_GainLossOnChangeInFairValueOfDerivativeLiability_877"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GainLossOnChangeInFairValueOfDerivativeLiability" xlink:label="loc_huge_GainLossOnChangeInFairValueOfDerivativeLiability_878"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GainLossOnSaleOfEquipment" xlink:label="loc_huge_GainLossOnSaleOfEquipment_879"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GainLossOnSaleOfEquipment" xlink:label="loc_huge_GainLossOnSaleOfEquipment_880"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GainLossOnSaleOfEquipment" xlink:label="loc_huge_GainLossOnSaleOfEquipment_881"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GainLossOnSettlementOfFinancialLiability" xlink:label="loc_huge_GainLossOnSettlementOfFinancialLiability_882"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GainLossOnSettlementOfFinancialLiability" xlink:label="loc_huge_GainLossOnSettlementOfFinancialLiability_883"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GainLossOnSettlementOfFinancialLiability" xlink:label="loc_huge_GainLossOnSettlementOfFinancialLiability_884"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GainLossOnSettlementOfFinancialLiability" xlink:label="loc_huge_GainLossOnSettlementOfFinancialLiability_885"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GainLossOnSettlementOfFinancialLiability" xlink:label="loc_huge_GainLossOnSettlementOfFinancialLiability_886"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GainLossOnSettlementOfFinancialLiability" xlink:label="loc_huge_GainLossOnSettlementOfFinancialLiability_887"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GainOnSettlementOfDerivativeLiability" xlink:label="loc_huge_GainOnSettlementOfDerivativeLiability_888"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GainOnSettlementOfDerivativeLiability" xlink:label="loc_huge_GainOnSettlementOfDerivativeLiability_889"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GainOnSettlementOfDerivativeLiability" xlink:label="loc_huge_GainOnSettlementOfDerivativeLiability_890"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GainOnSettlementOfFinancialLiability" xlink:label="loc_huge_GainOnSettlementOfFinancialLiability_891"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GainOnSettlementOfFinancialLiability" xlink:label="loc_huge_GainOnSettlementOfFinancialLiability_892"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GainOnSettlementOfFinancialLiability" xlink:label="loc_huge_GainOnSettlementOfFinancialLiability_893"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GainOnSettlementOfFinancialLiability" xlink:label="loc_huge_GainOnSettlementOfFinancialLiability_894"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GeneralAndAdministrativeExpenseContinuedAndDiscontinuedOperations" xlink:label="loc_huge_GeneralAndAdministrativeExpenseContinuedAndDiscontinuedOperations_895"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GeneralAndAdministrativeExpenseContinuedAndDiscontinuedOperations" xlink:label="loc_huge_GeneralAndAdministrativeExpenseContinuedAndDiscontinuedOperations_896"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GeneralAndAdministrativeExpenseContinuedAndDiscontinuedOperations" xlink:label="loc_huge_GeneralAndAdministrativeExpenseContinuedAndDiscontinuedOperations_897"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GeneralAndAdministrativeExpenseDiscontinuedOperations" xlink:label="loc_huge_GeneralAndAdministrativeExpenseDiscontinuedOperations_898"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GeneralAndAdministrativeExpenseDiscontinuedOperations" xlink:label="loc_huge_GeneralAndAdministrativeExpenseDiscontinuedOperations_899"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GeneralAndAdministrativeExpenseDiscontinuedOperations" xlink:label="loc_huge_GeneralAndAdministrativeExpenseDiscontinuedOperations_900"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GeneralOfficeInsuranceAndAdministrationExpenditures" xlink:label="loc_huge_GeneralOfficeInsuranceAndAdministrationExpenditures_901"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GeneralOfficeInsuranceAndAdministrationExpenditures" xlink:label="loc_huge_GeneralOfficeInsuranceAndAdministrationExpenditures_902"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GeneralOfficeInsuranceAndAdministrationExpenditures" xlink:label="loc_huge_GeneralOfficeInsuranceAndAdministrationExpenditures_903"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GrantDateAxis" xlink:label="loc_huge_GrantDateAxis_904"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GrantDateAxis" xlink:label="loc_huge_GrantDateAxis_905"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GrantDateDomain" xlink:label="loc_huge_GrantDateDomain_906"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GrantDateDomain" xlink:label="loc_huge_GrantDateDomain_907"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GrossGeneralAndAdministrativeExpense" xlink:label="loc_huge_GrossGeneralAndAdministrativeExpense_908"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GrossGeneralAndAdministrativeExpense" xlink:label="loc_huge_GrossGeneralAndAdministrativeExpense_909"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GrossGeneralAndAdministrativeExpense" xlink:label="loc_huge_GrossGeneralAndAdministrativeExpense_910"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GrossLossProfitBeforeFairValueAdjustments" xlink:label="loc_huge_GrossLossProfitBeforeFairValueAdjustments_911"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GrossLossProfitBeforeFairValueAdjustments" xlink:label="loc_huge_GrossLossProfitBeforeFairValueAdjustments_912"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GrossLossProfitBeforeFairValueAdjustments" xlink:label="loc_huge_GrossLossProfitBeforeFairValueAdjustments_913"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GrossProfitLossBeforeFairValueAdjustments" xlink:label="loc_huge_GrossProfitLossBeforeFairValueAdjustments_914"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GrossProfitLossBeforeFairValueAdjustments" xlink:label="loc_huge_GrossProfitLossBeforeFairValueAdjustments_915"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GrossProfitLossBeforeFairValueAdjustments" xlink:label="loc_huge_GrossProfitLossBeforeFairValueAdjustments_916"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GuaranteedMinimumLiquidationValueOfShares" xlink:label="loc_huge_GuaranteedMinimumLiquidationValueOfShares_917"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GuaranteedMinimumLiquidationValueOfShares" xlink:label="loc_huge_GuaranteedMinimumLiquidationValueOfShares_918"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_HarvestedCannabisMember" xlink:label="loc_huge_HarvestedCannabisMember_919"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_HarvestedCannabisMember" xlink:label="loc_huge_HarvestedCannabisMember_920"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_HarvestedCannabisMember" xlink:label="loc_huge_HarvestedCannabisMember_921"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_HempProductsMember" xlink:label="loc_huge_HempProductsMember_922"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_HempProductsMember" xlink:label="loc_huge_HempProductsMember_923"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_HempProductsMember" xlink:label="loc_huge_HempProductsMember_924"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_HeritageBuildingRestorationCommitmentMember" xlink:label="loc_huge_HeritageBuildingRestorationCommitmentMember_925"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_HeritageBuildingRestorationCommitmentMember" xlink:label="loc_huge_HeritageBuildingRestorationCommitmentMember_926"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_HeritageBuildingRestorationCommitmentMember" xlink:label="loc_huge_HeritageBuildingRestorationCommitmentMember_927"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_HighTideIncMember" xlink:label="loc_huge_HighTideIncMember_928"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_HighTideIncMember" xlink:label="loc_huge_HighTideIncMember_929"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_HighTideIncMember" xlink:label="loc_huge_HighTideIncMember_930"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_HugeShopsMember" xlink:label="loc_huge_HugeShopsMember_931"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_HugeShopsMember" xlink:label="loc_huge_HugeShopsMember_932"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_HugeShopsMember" xlink:label="loc_huge_HugeShopsMember_933"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ImpactOfPresentValue" xlink:label="loc_huge_ImpactOfPresentValue_934"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ImpactOfPresentValue" xlink:label="loc_huge_ImpactOfPresentValue_935"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ImpactOfPresentValue" xlink:label="loc_huge_ImpactOfPresentValue_936"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ImpactOfPresentValueOnLeaseObligations" xlink:label="loc_huge_ImpactOfPresentValueOnLeaseObligations_937"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ImpactOfPresentValueOnLeaseObligations" xlink:label="loc_huge_ImpactOfPresentValueOnLeaseObligations_938"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ImpactOfPresentValueOnLeaseObligations" xlink:label="loc_huge_ImpactOfPresentValueOnLeaseObligations_939"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ImpairmentLossOfPropertyPlantAndEquipmentAndRightOfUseAsset" xlink:label="loc_huge_ImpairmentLossOfPropertyPlantAndEquipmentAndRightOfUseAsset_940"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ImpairmentLossOfPropertyPlantAndEquipmentAndRightOfUseAsset" xlink:label="loc_huge_ImpairmentLossOfPropertyPlantAndEquipmentAndRightOfUseAsset_941"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ImpairmentLossOfPropertyPlantAndEquipmentAndRightOfUseAsset" xlink:label="loc_huge_ImpairmentLossOfPropertyPlantAndEquipmentAndRightOfUseAsset_942"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ImpairmentLossOnRightOfUseAsset" xlink:label="loc_huge_ImpairmentLossOnRightOfUseAsset_943"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ImpairmentLossOnRightOfUseAsset" xlink:label="loc_huge_ImpairmentLossOnRightOfUseAsset_944"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ImpairmentLossOnRightOfUseAsset" xlink:label="loc_huge_ImpairmentLossOnRightOfUseAsset_945"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ImpairmentLossOnRightOfUseAsset" xlink:label="loc_huge_ImpairmentLossOnRightOfUseAsset_946"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ImpairmentLossOnRightOfUseAsset" xlink:label="loc_huge_ImpairmentLossOnRightOfUseAsset_947"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ImpairmentLossRecognisedInRightOfUseAsset" xlink:label="loc_huge_ImpairmentLossRecognisedInRightOfUseAsset_948"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ImpairmentLossRecognisedInRightOfUseAsset" xlink:label="loc_huge_ImpairmentLossRecognisedInRightOfUseAsset_949"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ImpairmentLossRecognisedInRightOfUseAsset" xlink:label="loc_huge_ImpairmentLossRecognisedInRightOfUseAsset_950"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ImpairmentLossRecognisedInRightOfUseAsset" xlink:label="loc_huge_ImpairmentLossRecognisedInRightOfUseAsset_951"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ImpairmentMember" xlink:label="loc_huge_ImpairmentMember_952"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ImpairmentMember" xlink:label="loc_huge_ImpairmentMember_953"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ImpairmentMember" xlink:label="loc_huge_ImpairmentMember_954"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember" xlink:label="loc_huge_IncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember_955"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember" xlink:label="loc_huge_IncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember_956"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember" xlink:label="loc_huge_IncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember_957"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseFromContributedSurplusToShareCapital" xlink:label="loc_huge_IncreaseDecreaseFromContributedSurplusToShareCapital_958"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseFromContributedSurplusToShareCapital" xlink:label="loc_huge_IncreaseDecreaseFromContributedSurplusToShareCapital_959"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseFromContributedSurplusToShareCapital" xlink:label="loc_huge_IncreaseDecreaseFromContributedSurplusToShareCapital_960"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseInFairValueOfOtherInvestments" xlink:label="loc_huge_IncreaseDecreaseInFairValueOfOtherInvestments_961"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseInFairValueOfOtherInvestments" xlink:label="loc_huge_IncreaseDecreaseInFairValueOfOtherInvestments_962"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseInFairValueOfOtherInvestments" xlink:label="loc_huge_IncreaseDecreaseInFairValueOfOtherInvestments_963"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseInFairValueOfOtherInvestments" xlink:label="loc_huge_IncreaseDecreaseInFairValueOfOtherInvestments_964"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseInSettlementOfLiabilityOfNotesPayable" xlink:label="loc_huge_IncreaseDecreaseInSettlementOfLiabilityOfNotesPayable_965"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseInSettlementOfLiabilityOfNotesPayable" xlink:label="loc_huge_IncreaseDecreaseInSettlementOfLiabilityOfNotesPayable_966"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseInSettlementOfLiabilityOfNotesPayable" xlink:label="loc_huge_IncreaseDecreaseInSettlementOfLiabilityOfNotesPayable_967"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares" xlink:label="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_968"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares" xlink:label="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_969"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares" xlink:label="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_970"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue" xlink:label="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue_971"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue" xlink:label="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue_972"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue" xlink:label="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue_973"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughExerciseOfOptionShares" xlink:label="loc_huge_IncreaseDecreaseThroughExerciseOfOptionShares_974"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughExerciseOfOptionShares" xlink:label="loc_huge_IncreaseDecreaseThroughExerciseOfOptionShares_975"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughExerciseOfOptionShares" xlink:label="loc_huge_IncreaseDecreaseThroughExerciseOfOptionShares_976"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughExerciseOfOptionShares" xlink:label="loc_huge_IncreaseDecreaseThroughExerciseOfOptionShares_977"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughExerciseOfWarrantsShares" xlink:label="loc_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares_978"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughExerciseOfWarrantsShares" xlink:label="loc_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares_979"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughExerciseOfWarrantsShares" xlink:label="loc_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares_980"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughExpiryOfWarrantsShares" xlink:label="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares_981"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughExpiryOfWarrantsShares" xlink:label="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares_982"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughExpiryOfWarrantsShares" xlink:label="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares_983"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughExpiryOfWarrantsValue" xlink:label="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue_984"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughExpiryOfWarrantsValue" xlink:label="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue_985"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughExpiryOfWarrantsValue" xlink:label="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue_986"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset" xlink:label="loc_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset_987"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset" xlink:label="loc_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset_988"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset" xlink:label="loc_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset_989"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares" xlink:label="loc_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares_990"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares" xlink:label="loc_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares_991"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares" xlink:label="loc_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares_992"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughReverseAcquisition" xlink:label="loc_huge_IncreaseDecreaseThroughReverseAcquisition_993"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughReverseAcquisition" xlink:label="loc_huge_IncreaseDecreaseThroughReverseAcquisition_994"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughReverseAcquisition" xlink:label="loc_huge_IncreaseDecreaseThroughReverseAcquisition_995"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughReverseAcquisitionShares" xlink:label="loc_huge_IncreaseDecreaseThroughReverseAcquisitionShares_996"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughReverseAcquisitionShares" xlink:label="loc_huge_IncreaseDecreaseThroughReverseAcquisitionShares_997"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughReverseAcquisitionShares" xlink:label="loc_huge_IncreaseDecreaseThroughReverseAcquisitionShares_998"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughReverseAcquisitionShares" xlink:label="loc_huge_IncreaseDecreaseThroughReverseAcquisitionShares_999"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares" xlink:label="loc_huge_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares_1000"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares" xlink:label="loc_huge_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares_1001"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares" xlink:label="loc_huge_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares_1002"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughShareIssueRelatedCostShares" xlink:label="loc_huge_IncreaseDecreaseThroughShareIssueRelatedCostShares_1003"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughShareIssueRelatedCostShares" xlink:label="loc_huge_IncreaseDecreaseThroughShareIssueRelatedCostShares_1004"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughShareIssueRelatedCostShares" xlink:label="loc_huge_IncreaseDecreaseThroughShareIssueRelatedCostShares_1005"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughShareIssueRelatedCostShares" xlink:label="loc_huge_IncreaseDecreaseThroughShareIssueRelatedCostShares_1006"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughStockOptionsCancelled" xlink:label="loc_huge_IncreaseDecreaseThroughStockOptionsCancelled_1007"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughStockOptionsCancelled" xlink:label="loc_huge_IncreaseDecreaseThroughStockOptionsCancelled_1008"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughStockOptionsCancelled" xlink:label="loc_huge_IncreaseDecreaseThroughStockOptionsCancelled_1009"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughStockOptionsCancelled" xlink:label="loc_huge_IncreaseDecreaseThroughStockOptionsCancelled_1010"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughWarrantValuations" xlink:label="loc_huge_IncreaseDecreaseThroughWarrantValuations_1011"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughWarrantValuations" xlink:label="loc_huge_IncreaseDecreaseThroughWarrantValuations_1012"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughWarrantValuations" xlink:label="loc_huge_IncreaseDecreaseThroughWarrantValuations_1013"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughWarrantValuationsShares" xlink:label="loc_huge_IncreaseDecreaseThroughWarrantValuationsShares_1014"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughWarrantValuationsShares" xlink:label="loc_huge_IncreaseDecreaseThroughWarrantValuationsShares_1015"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughWarrantValuationsShares" xlink:label="loc_huge_IncreaseDecreaseThroughWarrantValuationsShares_1016"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughWarrantValuationsShares" xlink:label="loc_huge_IncreaseDecreaseThroughWarrantValuationsShares_1017"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncrementalBorrowingRateToDiscountLeaseLiabilities" xlink:label="loc_huge_IncrementalBorrowingRateToDiscountLeaseLiabilities_1018"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncrementalBorrowingRateToDiscountLeaseLiabilities" xlink:label="loc_huge_IncrementalBorrowingRateToDiscountLeaseLiabilities_1019"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncrementalBorrowingRateToDiscountLeaseLiabilities" xlink:label="loc_huge_IncrementalBorrowingRateToDiscountLeaseLiabilities_1020"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IndependentDirectorMember" xlink:label="loc_huge_IndependentDirectorMember_1021"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IndependentDirectorMember" xlink:label="loc_huge_IndependentDirectorMember_1022"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IndependentDirectorMember" xlink:label="loc_huge_IndependentDirectorMember_1023"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IndependentDirectorMember" xlink:label="loc_huge_IndependentDirectorMember_1024"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_InsuredAmountForClaimSettlemnt" xlink:label="loc_huge_InsuredAmountForClaimSettlemnt_1025"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_InsuredAmountForClaimSettlemnt" xlink:label="loc_huge_InsuredAmountForClaimSettlemnt_1026"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_InsuredAmountForClaimSettlemnt" xlink:label="loc_huge_InsuredAmountForClaimSettlemnt_1027"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_InvestorRelationsExpenses" xlink:label="loc_huge_InvestorRelationsExpenses_1028"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_InvestorRelationsExpenses" xlink:label="loc_huge_InvestorRelationsExpenses_1029"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_InvestorRelationsExpenses" xlink:label="loc_huge_InvestorRelationsExpenses_1030"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceCostOfCommonSharesAndWarrants" xlink:label="loc_huge_IssuanceCostOfCommonSharesAndWarrants_1031"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceCostOfCommonSharesAndWarrants" xlink:label="loc_huge_IssuanceCostOfCommonSharesAndWarrants_1032"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceCostOfCommonSharesAndWarrants" xlink:label="loc_huge_IssuanceCostOfCommonSharesAndWarrants_1033"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfCommonSharesOfShareBasedBonusToEmployeesForPerformance" xlink:label="loc_huge_IssuanceOfCommonSharesOfShareBasedBonusToEmployeesForPerformance_1034"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfCommonSharesOfShareBasedBonusToEmployeesForPerformance" xlink:label="loc_huge_IssuanceOfCommonSharesOfShareBasedBonusToEmployeesForPerformance_1035"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfCommonSharesOfShareBasedBonusToEmployeesForPerformance" xlink:label="loc_huge_IssuanceOfCommonSharesOfShareBasedBonusToEmployeesForPerformance_1036"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfCommonStockForNotesPayable" xlink:label="loc_huge_IssuanceOfCommonStockForNotesPayable_1037"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfCommonStockForNotesPayable" xlink:label="loc_huge_IssuanceOfCommonStockForNotesPayable_1038"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfCommonStockForNotesPayable" xlink:label="loc_huge_IssuanceOfCommonStockForNotesPayable_1039"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfCommonStockOfBoardOfDirectorsInLieuOfCash" xlink:label="loc_huge_IssuanceOfCommonStockOfBoardOfDirectorsInLieuOfCash_1040"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfCommonStockOfBoardOfDirectorsInLieuOfCash" xlink:label="loc_huge_IssuanceOfCommonStockOfBoardOfDirectorsInLieuOfCash_1041"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfCommonStockOfBoardOfDirectorsInLieuOfCash" xlink:label="loc_huge_IssuanceOfCommonStockOfBoardOfDirectorsInLieuOfCash_1042"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfCommonStockOfDirectOffering" xlink:label="loc_huge_IssuanceOfCommonStockOfDirectOffering_1043"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfCommonStockOfDirectOffering" xlink:label="loc_huge_IssuanceOfCommonStockOfDirectOffering_1044"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfCommonStockOfDirectOffering" xlink:label="loc_huge_IssuanceOfCommonStockOfDirectOffering_1045"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfCommonStockOfShareBasedCompensation" xlink:label="loc_huge_IssuanceOfCommonStockOfShareBasedCompensation_1046"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfCommonStockOfShareBasedCompensation" xlink:label="loc_huge_IssuanceOfCommonStockOfShareBasedCompensation_1047"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfCommonStockOfShareBasedCompensation" xlink:label="loc_huge_IssuanceOfCommonStockOfShareBasedCompensation_1048"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfShares" xlink:label="loc_huge_IssuanceOfShares_1049"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfShares" xlink:label="loc_huge_IssuanceOfShares_1050"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfShares" xlink:label="loc_huge_IssuanceOfShares_1051"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfShares" xlink:label="loc_huge_IssuanceOfShares_1052"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfWarrantsOfDirectOffering" xlink:label="loc_huge_IssuanceOfWarrantsOfDirectOffering_1053"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfWarrantsOfDirectOffering" xlink:label="loc_huge_IssuanceOfWarrantsOfDirectOffering_1054"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfWarrantsOfDirectOffering" xlink:label="loc_huge_IssuanceOfWarrantsOfDirectOffering_1055"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Jan52018Member" xlink:label="loc_huge_Jan52018Member_1056"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Jan52018Member" xlink:label="loc_huge_Jan52018Member_1057"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Jan52018Member" xlink:label="loc_huge_Jan52018Member_1058"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Jan52018WarrantMember" xlink:label="loc_huge_Jan52018WarrantMember_1059"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Jan52018WarrantMember" xlink:label="loc_huge_Jan52018WarrantMember_1060"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Jan52018WarrantMember" xlink:label="loc_huge_Jan52018WarrantMember_1061"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Jun112018Member" xlink:label="loc_huge_Jun112018Member_1062"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Jun112018Member" xlink:label="loc_huge_Jun112018Member_1063"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Jun112018Member" xlink:label="loc_huge_Jun112018Member_1064"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Jun122018Member" xlink:label="loc_huge_Jun122018Member_1065"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Jun122018Member" xlink:label="loc_huge_Jun122018Member_1066"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Jun122018Member" xlink:label="loc_huge_Jun122018Member_1067"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_KeyManagementAndDirectorsMember" xlink:label="loc_huge_KeyManagementAndDirectorsMember_1068"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_KeyManagementAndDirectorsMember" xlink:label="loc_huge_KeyManagementAndDirectorsMember_1069"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_KeyManagementAndDirectorsMember" xlink:label="loc_huge_KeyManagementAndDirectorsMember_1070"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_KeyManagementPersonnelCarAllowance" xlink:label="loc_huge_KeyManagementPersonnelCarAllowance_1071"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_KeyManagementPersonnelCarAllowance" xlink:label="loc_huge_KeyManagementPersonnelCarAllowance_1072"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_KeyManagementPersonnelCarAllowance" xlink:label="loc_huge_KeyManagementPersonnelCarAllowance_1073"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LeaseTermOnOfficeSpace" xlink:label="loc_huge_LeaseTermOnOfficeSpace_1074"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LeaseTermOnOfficeSpace" xlink:label="loc_huge_LeaseTermOnOfficeSpace_1075"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LeaseTermOnOfficeSpace" xlink:label="loc_huge_LeaseTermOnOfficeSpace_1076"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LegalEntitiesAxis" xlink:label="loc_huge_LegalEntitiesAxis_1077"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LegalEntitiesAxis" xlink:label="loc_huge_LegalEntitiesAxis_1078"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LegalEntitiesDomain" xlink:label="loc_huge_LegalEntitiesDomain_1079"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LegalEntitiesDomain" xlink:label="loc_huge_LegalEntitiesDomain_1080"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LegalProvision" xlink:label="loc_huge_LegalProvision_1081"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LegalProvision" xlink:label="loc_huge_LegalProvision_1082"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LegalProvision" xlink:label="loc_huge_LegalProvision_1083"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ListingExpense" xlink:label="loc_huge_ListingExpense_1084"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ListingExpense" xlink:label="loc_huge_ListingExpense_1085"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ListingExpense" xlink:label="loc_huge_ListingExpense_1086"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LossGainOnChangesInFairValueOfOtherInvestments" xlink:label="loc_huge_LossGainOnChangesInFairValueOfOtherInvestments_1087"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LossGainOnChangesInFairValueOfOtherInvestments" xlink:label="loc_huge_LossGainOnChangesInFairValueOfOtherInvestments_1088"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LossGainOnChangesInFairValueOfOtherInvestments" xlink:label="loc_huge_LossGainOnChangesInFairValueOfOtherInvestments_1089"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LossGainOnChangesInFairValueOfOtherInvestments" xlink:label="loc_huge_LossGainOnChangesInFairValueOfOtherInvestments_1090"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LossOnSaleOfEquipment" xlink:label="loc_huge_LossOnSaleOfEquipment_1091"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LossOnSaleOfEquipment" xlink:label="loc_huge_LossOnSaleOfEquipment_1092"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LossOnSaleOfEquipment" xlink:label="loc_huge_LossOnSaleOfEquipment_1093"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LossOnSaleOfInventory" xlink:label="loc_huge_LossOnSaleOfInventory_1094"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LossOnSaleOfInventory" xlink:label="loc_huge_LossOnSaleOfInventory_1095"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LossOnSaleOfInventory" xlink:label="loc_huge_LossOnSaleOfInventory_1096"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ManagementAndConsultingContractsMember" xlink:label="loc_huge_ManagementAndConsultingContractsMember_1097"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ManagementAndConsultingContractsMember" xlink:label="loc_huge_ManagementAndConsultingContractsMember_1098"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ManagementAndConsultingContractsMember" xlink:label="loc_huge_ManagementAndConsultingContractsMember_1099"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ManagementFees" xlink:label="loc_huge_ManagementFees_1100"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ManagementFees" xlink:label="loc_huge_ManagementFees_1101"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ManagementFees" xlink:label="loc_huge_ManagementFees_1102"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Mar222018Member" xlink:label="loc_huge_Mar222018Member_1103"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Mar222018Member" xlink:label="loc_huge_Mar222018Member_1104"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Mar222018Member" xlink:label="loc_huge_Mar222018Member_1105"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Mar282018Member" xlink:label="loc_huge_Mar282018Member_1106"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Mar282018Member" xlink:label="loc_huge_Mar282018Member_1107"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Mar282018Member" xlink:label="loc_huge_Mar282018Member_1108"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_March262018Member" xlink:label="loc_huge_March262018Member_1109"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_March262018Member" xlink:label="loc_huge_March262018Member_1110"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_March262018Member" xlink:label="loc_huge_March262018Member_1111"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_March282018Member" xlink:label="loc_huge_March282018Member_1112"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_March282018Member" xlink:label="loc_huge_March282018Member_1113"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_March282018Member" xlink:label="loc_huge_March282018Member_1114"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_March92018Member" xlink:label="loc_huge_March92018Member_1115"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_March92018Member" xlink:label="loc_huge_March92018Member_1116"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_March92018Member" xlink:label="loc_huge_March92018Member_1117"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_MarketPriceOfShares" xlink:label="loc_huge_MarketPriceOfShares_1118"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_MarketPriceOfShares" xlink:label="loc_huge_MarketPriceOfShares_1119"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_MarketPriceOfShares" xlink:label="loc_huge_MarketPriceOfShares_1120"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_MarketPriceOfWarrants" xlink:label="loc_huge_MarketPriceOfWarrants_1121"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_MarketPriceOfWarrants" xlink:label="loc_huge_MarketPriceOfWarrants_1122"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_MarketPriceOfWarrants" xlink:label="loc_huge_MarketPriceOfWarrants_1123"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_MarketPriceShareOptionsGranted" xlink:label="loc_huge_MarketPriceShareOptionsGranted_1124"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_MarketPriceShareOptionsGranted" xlink:label="loc_huge_MarketPriceShareOptionsGranted_1125"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_MarketPriceShareOptionsGranted" xlink:label="loc_huge_MarketPriceShareOptionsGranted_1126"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_MaximumAggregateOfferingPrice" xlink:label="loc_huge_MaximumAggregateOfferingPrice_1127"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_MaximumAggregateOfferingPrice" xlink:label="loc_huge_MaximumAggregateOfferingPrice_1128"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_MaximumAggregateOfferingPrice" xlink:label="loc_huge_MaximumAggregateOfferingPrice_1129"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_May242018Member" xlink:label="loc_huge_May242018Member_1130"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_May242018Member" xlink:label="loc_huge_May242018Member_1131"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_May242018Member" xlink:label="loc_huge_May242018Member_1132"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_May242018WarrantMember" xlink:label="loc_huge_May242018WarrantMember_1133"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_May242018WarrantMember" xlink:label="loc_huge_May242018WarrantMember_1134"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_May242018WarrantMember" xlink:label="loc_huge_May242018WarrantMember_1135"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_May82018Member" xlink:label="loc_huge_May82018Member_1136"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_May82018Member" xlink:label="loc_huge_May82018Member_1137"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_May82018Member" xlink:label="loc_huge_May82018Member_1138"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_MealsAndEntertainment" xlink:label="loc_huge_MealsAndEntertainment_1139"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_MealsAndEntertainment" xlink:label="loc_huge_MealsAndEntertainment_1140"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_MealsAndEntertainment" xlink:label="loc_huge_MealsAndEntertainment_1141"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_MinimumInvestmentReceivable" xlink:label="loc_huge_MinimumInvestmentReceivable_1142"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_MinimumInvestmentReceivable" xlink:label="loc_huge_MinimumInvestmentReceivable_1143"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_MinimumInvestmentReceivable" xlink:label="loc_huge_MinimumInvestmentReceivable_1144"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NetOperatingLossCarryforwardsLimitationsInUse" xlink:label="loc_huge_NetOperatingLossCarryforwardsLimitationsInUse_1145"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NetOperatingLossCarryforwardsLimitationsInUse" xlink:label="loc_huge_NetOperatingLossCarryforwardsLimitationsInUse_1146"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NetOperatingLossCarryforwardsLimitationsInUse" xlink:label="loc_huge_NetOperatingLossCarryforwardsLimitationsInUse_1147"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NetSellingPricePerGramForDryFlowerAfterHarvestCost" xlink:label="loc_huge_NetSellingPricePerGramForDryFlowerAfterHarvestCost_1148"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NetSellingPricePerGramForDryFlowerAfterHarvestCost" xlink:label="loc_huge_NetSellingPricePerGramForDryFlowerAfterHarvestCost_1149"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NetSellingPricePerGramForDryFlowerAfterHarvestCost" xlink:label="loc_huge_NetSellingPricePerGramForDryFlowerAfterHarvestCost_1150"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NetSellingPricePerGramForDryTrimAfterHarvestCost" xlink:label="loc_huge_NetSellingPricePerGramForDryTrimAfterHarvestCost_1151"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NetSellingPricePerGramForDryTrimAfterHarvestCost" xlink:label="loc_huge_NetSellingPricePerGramForDryTrimAfterHarvestCost_1152"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NetSellingPricePerGramForDryTrimAfterHarvestCost" xlink:label="loc_huge_NetSellingPricePerGramForDryTrimAfterHarvestCost_1153"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandFourty" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandFourty_1154"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandFourty" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandFourty_1155"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandFourty" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandFourty_1156"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight_1157"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight_1158"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight_1159"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFive" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFive_1160"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFive" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFive_1161"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFive" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFive_1162"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFour" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFour_1163"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFour" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFour_1164"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFour" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFour_1165"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine_1166"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine_1167"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine_1168"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySeven" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySeven_1169"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySeven" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySeven_1170"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySeven" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySeven_1171"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySix" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySix_1172"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySix" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySix_1173"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySix" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySix_1174"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyThree" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyThree_1175"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyThree" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyThree_1176"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyThree" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyThree_1177"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyTwo" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyTwo_1178"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyTwo" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyTwo_1179"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyTwo" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyTwo_1180"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalLossCarryforwards" xlink:label="loc_huge_NonCapitalLossCarryforwards_1181"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalLossCarryforwards" xlink:label="loc_huge_NonCapitalLossCarryforwards_1182"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalLossCarryforwards" xlink:label="loc_huge_NonCapitalLossCarryforwards_1183"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalLossCarryForwardsMember" xlink:label="loc_huge_NonCapitalLossCarryForwardsMember_1184"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalLossCarryForwardsMember" xlink:label="loc_huge_NonCapitalLossCarryForwardsMember_1185"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalLossCarryForwardsMember" xlink:label="loc_huge_NonCapitalLossCarryForwardsMember_1186"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalLossesMember" xlink:label="loc_huge_NonCapitalLossesMember_1187"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalLossesMember" xlink:label="loc_huge_NonCapitalLossesMember_1188"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalLossesMember" xlink:label="loc_huge_NonCapitalLossesMember_1189"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonRefundableSumDueAndPayableUponFirstNotificationOfFda" xlink:label="loc_huge_NonRefundableSumDueAndPayableUponFirstNotificationOfFda_1190"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonRefundableSumDueAndPayableUponFirstNotificationOfFda" xlink:label="loc_huge_NonRefundableSumDueAndPayableUponFirstNotificationOfFda_1191"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFda" xlink:label="loc_huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFda_1192"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFda" xlink:label="loc_huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFda_1193"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFda" xlink:label="loc_huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFda_1194"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NotesPayableMember" xlink:label="loc_huge_NotesPayableMember_1195"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NotesPayableMember" xlink:label="loc_huge_NotesPayableMember_1196"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NotesPayableMember" xlink:label="loc_huge_NotesPayableMember_1197"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NotesSettledThroughIssuanceOfShares" xlink:label="loc_huge_NotesSettledThroughIssuanceOfShares_1198"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NotesSettledThroughIssuanceOfShares" xlink:label="loc_huge_NotesSettledThroughIssuanceOfShares_1199"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NotesSettledThroughIssuanceOfShares" xlink:label="loc_huge_NotesSettledThroughIssuanceOfShares_1200"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Nov12017Member" xlink:label="loc_huge_Nov12017Member_1201"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Nov12017Member" xlink:label="loc_huge_Nov12017Member_1202"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Nov12017Member" xlink:label="loc_huge_Nov12017Member_1203"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Nov122018Member" xlink:label="loc_huge_Nov122018Member_1204"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Nov122018Member" xlink:label="loc_huge_Nov122018Member_1205"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Nov122018Member" xlink:label="loc_huge_Nov122018Member_1206"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Nov142017Member" xlink:label="loc_huge_Nov142017Member_1207"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Nov142017Member" xlink:label="loc_huge_Nov142017Member_1208"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Nov142017Member" xlink:label="loc_huge_Nov142017Member_1209"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Nov152018Member" xlink:label="loc_huge_Nov152018Member_1210"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Nov152018Member" xlink:label="loc_huge_Nov152018Member_1211"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Nov152018Member" xlink:label="loc_huge_Nov152018Member_1212"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Nov212017Member" xlink:label="loc_huge_Nov212017Member_1213"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Nov212017Member" xlink:label="loc_huge_Nov212017Member_1214"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Nov212017Member" xlink:label="loc_huge_Nov212017Member_1215"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Nov262018Member" xlink:label="loc_huge_Nov262018Member_1216"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Nov262018Member" xlink:label="loc_huge_Nov262018Member_1217"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Nov262018Member" xlink:label="loc_huge_Nov262018Member_1218"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability" xlink:label="loc_huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability_1219"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability" xlink:label="loc_huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability_1220"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability" xlink:label="loc_huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability_1221"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfAgreement" xlink:label="loc_huge_NumberOfAgreement_1222"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfAgreement" xlink:label="loc_huge_NumberOfAgreement_1223"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfBrokerWarrantsGrantedForFeesAndCommissions" xlink:label="loc_huge_NumberOfBrokerWarrantsGrantedForFeesAndCommissions_1224"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfBrokerWarrantsGrantedForFeesAndCommissions" xlink:label="loc_huge_NumberOfBrokerWarrantsGrantedForFeesAndCommissions_1225"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfBrokerWarrantsGrantedForFeesAndCommissions" xlink:label="loc_huge_NumberOfBrokerWarrantsGrantedForFeesAndCommissions_1226"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfBrokerWarrantsGrantedForFeesAndCommissions" xlink:label="loc_huge_NumberOfBrokerWarrantsGrantedForFeesAndCommissions_1227"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfInvestmentSharesSold" xlink:label="loc_huge_NumberOfInvestmentSharesSold_1228"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfInvestmentSharesSold" xlink:label="loc_huge_NumberOfInvestmentSharesSold_1229"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfInvestmentSharesSold" xlink:label="loc_huge_NumberOfInvestmentSharesSold_1230"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfReplacementShareOptionsIssued" xlink:label="loc_huge_NumberOfReplacementShareOptionsIssued_1231"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfReplacementShareOptionsIssued" xlink:label="loc_huge_NumberOfReplacementShareOptionsIssued_1232"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfReplacementShareOptionsIssued" xlink:label="loc_huge_NumberOfReplacementShareOptionsIssued_1233"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfShareOptionsExercisedOrVestedInShareBasedPaymentArrangement" xlink:label="loc_huge_NumberOfShareOptionsExercisedOrVestedInShareBasedPaymentArrangement_1234"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfShareOptionsExercisedOrVestedInShareBasedPaymentArrangement" xlink:label="loc_huge_NumberOfShareOptionsExercisedOrVestedInShareBasedPaymentArrangement_1235"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfShareOptionsExercisedOrVestedInShareBasedPaymentArrangement" xlink:label="loc_huge_NumberOfShareOptionsExercisedOrVestedInShareBasedPaymentArrangement_1236"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesAcquired" xlink:label="loc_huge_NumberOfSharesAcquired_1237"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesAcquired" xlink:label="loc_huge_NumberOfSharesAcquired_1238"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesAcquired" xlink:label="loc_huge_NumberOfSharesAcquired_1239"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesHeld" xlink:label="loc_huge_NumberOfSharesHeld_1240"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesHeld" xlink:label="loc_huge_NumberOfSharesHeld_1241"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesHeld" xlink:label="loc_huge_NumberOfSharesHeld_1242"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesHeldSubjectToEscrowArrangement" xlink:label="loc_huge_NumberOfSharesHeldSubjectToEscrowArrangement_1243"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesHeldSubjectToEscrowArrangement" xlink:label="loc_huge_NumberOfSharesHeldSubjectToEscrowArrangement_1244"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesHeldSubjectToEscrowArrangement" xlink:label="loc_huge_NumberOfSharesHeldSubjectToEscrowArrangement_1245"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesIssuedAsFindersFee" xlink:label="loc_huge_NumberOfSharesIssuedAsFindersFee_1246"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesIssuedAsFindersFee" xlink:label="loc_huge_NumberOfSharesIssuedAsFindersFee_1247"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesIssuedAsFindersFee" xlink:label="loc_huge_NumberOfSharesIssuedAsFindersFee_1248"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc" xlink:label="loc_huge_NumberOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_1249"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc" xlink:label="loc_huge_NumberOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_1250"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc" xlink:label="loc_huge_NumberOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_1251"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesIssuedForCompensationBonus" xlink:label="loc_huge_NumberOfSharesIssuedForCompensationBonus_1252"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesIssuedForCompensationBonus" xlink:label="loc_huge_NumberOfSharesIssuedForCompensationBonus_1253"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesIssuedForCompensationBonus" xlink:label="loc_huge_NumberOfSharesIssuedForCompensationBonus_1254"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesIssuedForDebtSettlement" xlink:label="loc_huge_NumberOfSharesIssuedForDebtSettlement_1255"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesIssuedForDebtSettlement" xlink:label="loc_huge_NumberOfSharesIssuedForDebtSettlement_1256"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesIssuedForDebtSettlement" xlink:label="loc_huge_NumberOfSharesIssuedForDebtSettlement_1257"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement" xlink:label="loc_huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement_1258"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement" xlink:label="loc_huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement_1259"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement" xlink:label="loc_huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement_1260"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesIssuedInPrivatePlacement" xlink:label="loc_huge_NumberOfSharesIssuedInPrivatePlacement_1261"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesIssuedInPrivatePlacement" xlink:label="loc_huge_NumberOfSharesIssuedInPrivatePlacement_1262"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesIssuedInPrivatePlacement" xlink:label="loc_huge_NumberOfSharesIssuedInPrivatePlacement_1263"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesIssuedInPrivatePlacement" xlink:label="loc_huge_NumberOfSharesIssuedInPrivatePlacement_1264"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesIssuedInShareExchange" xlink:label="loc_huge_NumberOfSharesIssuedInShareExchange_1265"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesIssuedInShareExchange" xlink:label="loc_huge_NumberOfSharesIssuedInShareExchange_1266"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesIssuedInShareExchange" xlink:label="loc_huge_NumberOfSharesIssuedInShareExchange_1267"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesIssuedThroughEquityDistributionAgreement" xlink:label="loc_huge_NumberOfSharesIssuedThroughEquityDistributionAgreement_1268"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesIssuedThroughEquityDistributionAgreement" xlink:label="loc_huge_NumberOfSharesIssuedThroughEquityDistributionAgreement_1269"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesIssuedThroughEquityDistributionAgreement" xlink:label="loc_huge_NumberOfSharesIssuedThroughEquityDistributionAgreement_1270"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesOutstandingSubjectToEscrowConditions" xlink:label="loc_huge_NumberOfSharesOutstandingSubjectToEscrowConditions_1271"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesOutstandingSubjectToEscrowConditions" xlink:label="loc_huge_NumberOfSharesOutstandingSubjectToEscrowConditions_1272"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesOutstandingSubjectToEscrowConditions" xlink:label="loc_huge_NumberOfSharesOutstandingSubjectToEscrowConditions_1273"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesSold" xlink:label="loc_huge_NumberOfSharesSold_1274"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesSold" xlink:label="loc_huge_NumberOfSharesSold_1275"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesSold" xlink:label="loc_huge_NumberOfSharesSold_1276"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesSubscribed" xlink:label="loc_huge_NumberOfSharesSubscribed_1277"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesSubscribed" xlink:label="loc_huge_NumberOfSharesSubscribed_1278"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesSubscribed" xlink:label="loc_huge_NumberOfSharesSubscribed_1279"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesSubscribed" xlink:label="loc_huge_NumberOfSharesSubscribed_1280"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesSubscribed" xlink:label="loc_huge_NumberOfSharesSubscribed_1281"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesSubscribed" xlink:label="loc_huge_NumberOfSharesSubscribed_1282"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfStockOptionsApprovedForIssuance" xlink:label="loc_huge_NumberOfStockOptionsApprovedForIssuance_1283"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfStockOptionsApprovedForIssuance" xlink:label="loc_huge_NumberOfStockOptionsApprovedForIssuance_1284"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfStockOptionsApprovedForIssuance" xlink:label="loc_huge_NumberOfStockOptionsApprovedForIssuance_1285"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfWarrantsAcquired" xlink:label="loc_huge_NumberOfWarrantsAcquired_1286"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfWarrantsAcquired" xlink:label="loc_huge_NumberOfWarrantsAcquired_1287"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfWarrantsExercised" xlink:label="loc_huge_NumberOfWarrantsExercised_1288"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfWarrantsExercised" xlink:label="loc_huge_NumberOfWarrantsExercised_1289"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfWarrantsExercised" xlink:label="loc_huge_NumberOfWarrantsExercised_1290"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfWarrantsExercised" xlink:label="loc_huge_NumberOfWarrantsExercised_1291"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfWarrantsExpired" xlink:label="loc_huge_NumberOfWarrantsExpired_1292"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfWarrantsExpired" xlink:label="loc_huge_NumberOfWarrantsExpired_1293"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfWarrantsExpired" xlink:label="loc_huge_NumberOfWarrantsExpired_1294"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfWarrantsExpired" xlink:label="loc_huge_NumberOfWarrantsExpired_1295"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfWarrantsHeld" xlink:label="loc_huge_NumberOfWarrantsHeld_1296"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfWarrantsHeld" xlink:label="loc_huge_NumberOfWarrantsHeld_1297"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfWarrantsHeld" xlink:label="loc_huge_NumberOfWarrantsHeld_1298"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfWarrantsIssued" xlink:label="loc_huge_NumberOfWarrantsIssued_1299"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfWarrantsIssued" xlink:label="loc_huge_NumberOfWarrantsIssued_1300"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfWarrantsIssued" xlink:label="loc_huge_NumberOfWarrantsIssued_1301"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfWarrantsIssued" xlink:label="loc_huge_NumberOfWarrantsIssued_1302"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfWarrantsOutstanding" xlink:label="loc_huge_NumberOfWarrantsOutstanding_1303"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfWarrantsOutstanding" xlink:label="loc_huge_NumberOfWarrantsOutstanding_1304"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfWarrantsOutstanding" xlink:label="loc_huge_NumberOfWarrantsOutstanding_1305"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfWarrantsOutstanding" xlink:label="loc_huge_NumberOfWarrantsOutstanding_1306"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfWarrantsOutstanding" xlink:label="loc_huge_NumberOfWarrantsOutstanding_1307"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Oct202017Member" xlink:label="loc_huge_Oct202017Member_1308"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Oct202017Member" xlink:label="loc_huge_Oct202017Member_1309"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Oct202017Member" xlink:label="loc_huge_Oct202017Member_1310"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OfficeAndGeneralExpenses" xlink:label="loc_huge_OfficeAndGeneralExpenses_1311"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OfficeAndGeneralExpenses" xlink:label="loc_huge_OfficeAndGeneralExpenses_1312"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OfficeAndGeneralExpenses" xlink:label="loc_huge_OfficeAndGeneralExpenses_1313"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OfficeLeaseAgreementMember" xlink:label="loc_huge_OfficeLeaseAgreementMember_1314"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OfficeLeaseAgreementMember" xlink:label="loc_huge_OfficeLeaseAgreementMember_1315"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OfficeLeaseAgreementMember" xlink:label="loc_huge_OfficeLeaseAgreementMember_1316"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OperatingExpensesAbstract" xlink:label="loc_huge_OperatingExpensesAbstract_1317"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OperatingExpensesAbstract" xlink:label="loc_huge_OperatingExpensesAbstract_1318"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OperatingLeaseImpactOfPresentValue" xlink:label="loc_huge_OperatingLeaseImpactOfPresentValue_1319"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OperatingLeaseImpactOfPresentValue" xlink:label="loc_huge_OperatingLeaseImpactOfPresentValue_1320"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OperatingLeaseImpactOfPresentValue" xlink:label="loc_huge_OperatingLeaseImpactOfPresentValue_1321"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OperatingLeaseImpactOfPresentValue" xlink:label="loc_huge_OperatingLeaseImpactOfPresentValue_1322"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OtherAllowances" xlink:label="loc_huge_OtherAllowances_1323"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OtherAllowances" xlink:label="loc_huge_OtherAllowances_1324"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OtherFinancialLiabilitiesMember" xlink:label="loc_huge_OtherFinancialLiabilitiesMember_1325"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OtherFinancialLiabilitiesMember" xlink:label="loc_huge_OtherFinancialLiabilitiesMember_1326"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OtherFinancialLiabilitiesMember" xlink:label="loc_huge_OtherFinancialLiabilitiesMember_1327"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OtherGeneralAndAdministrativeExpenses" xlink:label="loc_huge_OtherGeneralAndAdministrativeExpenses_1328"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OtherGeneralAndAdministrativeExpenses" xlink:label="loc_huge_OtherGeneralAndAdministrativeExpenses_1329"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OtherGeneralAndAdministrativeExpenses" xlink:label="loc_huge_OtherGeneralAndAdministrativeExpenses_1330"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OtherInventoryMember" xlink:label="loc_huge_OtherInventoryMember_1331"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OtherInventoryMember" xlink:label="loc_huge_OtherInventoryMember_1332"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OtherInventoryMember" xlink:label="loc_huge_OtherInventoryMember_1333"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OtherInvestmentMember" xlink:label="loc_huge_OtherInvestmentMember_1334"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OtherInvestmentMember" xlink:label="loc_huge_OtherInvestmentMember_1335"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OtherInvestmentMember" xlink:label="loc_huge_OtherInvestmentMember_1336"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OtherInvestmentsNameOfEntityAxis" xlink:label="loc_huge_OtherInvestmentsNameOfEntityAxis_1337"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OtherInvestmentsNameOfEntityAxis" xlink:label="loc_huge_OtherInvestmentsNameOfEntityAxis_1338"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OtherInvestmentsNameOfEntityDomain" xlink:label="loc_huge_OtherInvestmentsNameOfEntityDomain_1339"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OtherInvestmentsNameOfEntityDomain" xlink:label="loc_huge_OtherInvestmentsNameOfEntityDomain_1340"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OutstandingCommitmentToPurchaseAdditionalProduct" xlink:label="loc_huge_OutstandingCommitmentToPurchaseAdditionalProduct_1341"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OutstandingCommitmentToPurchaseAdditionalProduct" xlink:label="loc_huge_OutstandingCommitmentToPurchaseAdditionalProduct_1342"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PartialPaymentOfSettlementAmount" xlink:label="loc_huge_PartialPaymentOfSettlementAmount_1343"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PartialPaymentOfSettlementAmount" xlink:label="loc_huge_PartialPaymentOfSettlementAmount_1344"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PartialPaymentOfSettlementAmount" xlink:label="loc_huge_PartialPaymentOfSettlementAmount_1345"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PatentMaintenanceFee" xlink:label="loc_huge_PatentMaintenanceFee_1346"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PatentMaintenanceFee" xlink:label="loc_huge_PatentMaintenanceFee_1347"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PatentMaintenanceFee" xlink:label="loc_huge_PatentMaintenanceFee_1348"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PaymentMadeToBeUnpaidWagesAndUnpaidHoliday" xlink:label="loc_huge_PaymentMadeToBeUnpaidWagesAndUnpaidHoliday_1349"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PaymentMadeToBeUnpaidWagesAndUnpaidHoliday" xlink:label="loc_huge_PaymentMadeToBeUnpaidWagesAndUnpaidHoliday_1350"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PaymentMadeToBeUnpaidWagesAndUnpaidHoliday" xlink:label="loc_huge_PaymentMadeToBeUnpaidWagesAndUnpaidHoliday_1351"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PaymentOfExpenses" xlink:label="loc_huge_PaymentOfExpenses_1352"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PaymentOfExpenses" xlink:label="loc_huge_PaymentOfExpenses_1353"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PaymentOfOperatingLease" xlink:label="loc_huge_PaymentOfOperatingLease_1354"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PaymentOfOperatingLease" xlink:label="loc_huge_PaymentOfOperatingLease_1355"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PaymentOfOperatingLease" xlink:label="loc_huge_PaymentOfOperatingLease_1356"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PaymentOfOperatingLease" xlink:label="loc_huge_PaymentOfOperatingLease_1357"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PaymentOfOperatingLease" xlink:label="loc_huge_PaymentOfOperatingLease_1358"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PaymentOfOperatingLease" xlink:label="loc_huge_PaymentOfOperatingLease_1359"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PercentageOfAggregateDiscountForSharesInEscrow" xlink:label="loc_huge_PercentageOfAggregateDiscountForSharesInEscrow_1360"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PercentageOfAggregateDiscountForSharesInEscrow" xlink:label="loc_huge_PercentageOfAggregateDiscountForSharesInEscrow_1361"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PercentageOfAggregateDiscountForSharesInEscrow" xlink:label="loc_huge_PercentageOfAggregateDiscountForSharesInEscrow_1362"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PercentageOfDeclineInFairValueOfInvestment" xlink:label="loc_huge_PercentageOfDeclineInFairValueOfInvestment_1363"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PercentageOfDeclineInFairValueOfInvestment" xlink:label="loc_huge_PercentageOfDeclineInFairValueOfInvestment_1364"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PercentageOfDeclineInFairValueOfInvestment" xlink:label="loc_huge_PercentageOfDeclineInFairValueOfInvestment_1365"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PercentageOfDiscountForTotalProceedsOfSharesAndWarrantsSold" xlink:label="loc_huge_PercentageOfDiscountForTotalProceedsOfSharesAndWarrantsSold_1366"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PercentageOfDiscountForTotalProceedsOfSharesAndWarrantsSold" xlink:label="loc_huge_PercentageOfDiscountForTotalProceedsOfSharesAndWarrantsSold_1367"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights" xlink:label="loc_huge_PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights_1368"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights" xlink:label="loc_huge_PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights_1369"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition" xlink:label="loc_huge_PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition_1370"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition" xlink:label="loc_huge_PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition_1371"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition" xlink:label="loc_huge_PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition_1372"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition" xlink:label="loc_huge_PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition_1373"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition" xlink:label="loc_huge_PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition_1374"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition" xlink:label="loc_huge_PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition_1375"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights" xlink:label="loc_huge_PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights_1376"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights" xlink:label="loc_huge_PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights_1377"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PermanentDifferences" xlink:label="loc_huge_PermanentDifferences_1378"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PermanentDifferences" xlink:label="loc_huge_PermanentDifferences_1379"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PermanentDifferences" xlink:label="loc_huge_PermanentDifferences_1380"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PharmadrugIncMember" xlink:label="loc_huge_PharmadrugIncMember_1381"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PharmadrugIncMember" xlink:label="loc_huge_PharmadrugIncMember_1382"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PharmadrugIncMember" xlink:label="loc_huge_PharmadrugIncMember_1383"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PharmadrugProductionGMBHMember" xlink:label="loc_huge_PharmadrugProductionGMBHMember_1384"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PharmadrugProductionGMBHMember" xlink:label="loc_huge_PharmadrugProductionGMBHMember_1385"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PharmadrugProductionGMBHMember" xlink:label="loc_huge_PharmadrugProductionGMBHMember_1386"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PharmastripCorpMember" xlink:label="loc_huge_PharmastripCorpMember_1387"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PharmastripCorpMember" xlink:label="loc_huge_PharmastripCorpMember_1388"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PharmastripCorpMember" xlink:label="loc_huge_PharmastripCorpMember_1389"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PreacquisitionNetOperatingLossCarryforwards" xlink:label="loc_huge_PreacquisitionNetOperatingLossCarryforwards_1390"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PreacquisitionNetOperatingLossCarryforwards" xlink:label="loc_huge_PreacquisitionNetOperatingLossCarryforwards_1391"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PreacquisitionNetOperatingLossCarryforwards" xlink:label="loc_huge_PreacquisitionNetOperatingLossCarryforwards_1392"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PresidentAndChiefExecutiveOfficerMember" xlink:label="loc_huge_PresidentAndChiefExecutiveOfficerMember_1393"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PresidentAndChiefExecutiveOfficerMember" xlink:label="loc_huge_PresidentAndChiefExecutiveOfficerMember_1394"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PresidentAndChiefExecutiveOfficerMember" xlink:label="loc_huge_PresidentAndChiefExecutiveOfficerMember_1395"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PresidentAndDirectorMember" xlink:label="loc_huge_PresidentAndDirectorMember_1396"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PresidentAndDirectorMember" xlink:label="loc_huge_PresidentAndDirectorMember_1397"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PresidentAndDirectorMember" xlink:label="loc_huge_PresidentAndDirectorMember_1398"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PresidentOfFsdBiosciencesMember" xlink:label="loc_huge_PresidentOfFsdBiosciencesMember_1399"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PresidentOfFsdBiosciencesMember" xlink:label="loc_huge_PresidentOfFsdBiosciencesMember_1400"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PresidentOfFsdBiosciencesMember" xlink:label="loc_huge_PresidentOfFsdBiosciencesMember_1401"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PresidentOfFSDMember" xlink:label="loc_huge_PresidentOfFSDMember_1402"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PresidentOfFSDMember" xlink:label="loc_huge_PresidentOfFSDMember_1403"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PresidentOfFSDMember" xlink:label="loc_huge_PresidentOfFSDMember_1404"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PresidentOfFVPharmaMember" xlink:label="loc_huge_PresidentOfFVPharmaMember_1405"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PresidentOfFVPharmaMember" xlink:label="loc_huge_PresidentOfFVPharmaMember_1406"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PresidentOfFVPharmaMember" xlink:label="loc_huge_PresidentOfFVPharmaMember_1407"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PresidentsMember" xlink:label="loc_huge_PresidentsMember_1408"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PresidentsMember" xlink:label="loc_huge_PresidentsMember_1409"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PrincipalAmountOfBorrowings" xlink:label="loc_huge_PrincipalAmountOfBorrowings_1410"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PrincipalAmountOfBorrowings" xlink:label="loc_huge_PrincipalAmountOfBorrowings_1411"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PrincipalAmountOfBorrowings" xlink:label="loc_huge_PrincipalAmountOfBorrowings_1412"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PrismicPharmaceuticalMember" xlink:label="loc_huge_PrismicPharmaceuticalMember_1413"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PrismicPharmaceuticalMember" xlink:label="loc_huge_PrismicPharmaceuticalMember_1414"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PrismicPharmaceuticalMember" xlink:label="loc_huge_PrismicPharmaceuticalMember_1415"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PrismicPharmaceuticalsIncMember" xlink:label="loc_huge_PrismicPharmaceuticalsIncMember_1416"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PrismicPharmaceuticalsIncMember" xlink:label="loc_huge_PrismicPharmaceuticalsIncMember_1417"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PrismicPharmaceuticalsIncMember" xlink:label="loc_huge_PrismicPharmaceuticalsIncMember_1418"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProceedsFromExerciseOfWarrants" xlink:label="loc_huge_ProceedsFromExerciseOfWarrants_1419"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProceedsFromExerciseOfWarrants" xlink:label="loc_huge_ProceedsFromExerciseOfWarrants_1420"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProceedsFromExerciseOfWarrants" xlink:label="loc_huge_ProceedsFromExerciseOfWarrants_1421"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProceedsFromNotesPayable" xlink:label="loc_huge_ProceedsFromNotesPayable_1422"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProceedsFromNotesPayable" xlink:label="loc_huge_ProceedsFromNotesPayable_1423"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProceedsFromSaleOfSharesAndWarrants" xlink:label="loc_huge_ProceedsFromSaleOfSharesAndWarrants_1424"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProceedsFromSaleOfSharesAndWarrants" xlink:label="loc_huge_ProceedsFromSaleOfSharesAndWarrants_1425"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProceedsFromSalesOfInventory" xlink:label="loc_huge_ProceedsFromSalesOfInventory_1426"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProceedsFromSalesOfInventory" xlink:label="loc_huge_ProceedsFromSalesOfInventory_1427"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProceedsFromSalesOfInventory" xlink:label="loc_huge_ProceedsFromSalesOfInventory_1428"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProductionAndGrowingExpense" xlink:label="loc_huge_ProductionAndGrowingExpense_1429"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProductionAndGrowingExpense" xlink:label="loc_huge_ProductionAndGrowingExpense_1430"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProductionAndGrowingExpense" xlink:label="loc_huge_ProductionAndGrowingExpense_1431"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProductionAndGrowingExpenses" xlink:label="loc_huge_ProductionAndGrowingExpenses_1432"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProductionAndGrowingExpenses" xlink:label="loc_huge_ProductionAndGrowingExpenses_1433"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProductionAndGrowingExpenses" xlink:label="loc_huge_ProductionAndGrowingExpenses_1434"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProductionEquipmentMember" xlink:label="loc_huge_ProductionEquipmentMember_1435"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProductionEquipmentMember" xlink:label="loc_huge_ProductionEquipmentMember_1436"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProductionEquipmentMember" xlink:label="loc_huge_ProductionEquipmentMember_1437"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProductionEquipmentMember" xlink:label="loc_huge_ProductionEquipmentMember_1438"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProfitLossBeforeOtherIncomeAndGainLossOnSaleOfEquipmentFromDiscontinuedOperations" xlink:label="loc_huge_ProfitLossBeforeOtherIncomeAndGainLossOnSaleOfEquipmentFromDiscontinuedOperations_1439"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProfitLossBeforeOtherIncomeAndGainLossOnSaleOfEquipmentFromDiscontinuedOperations" xlink:label="loc_huge_ProfitLossBeforeOtherIncomeAndGainLossOnSaleOfEquipmentFromDiscontinuedOperations_1440"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProfitLossBeforeOtherIncomeAndGainLossOnSaleOfEquipmentFromDiscontinuedOperations" xlink:label="loc_huge_ProfitLossBeforeOtherIncomeAndGainLossOnSaleOfEquipmentFromDiscontinuedOperations_1441"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProfitLossOnChangeInFairValue" xlink:label="loc_huge_ProfitLossOnChangeInFairValue_1442"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProfitLossOnChangeInFairValue" xlink:label="loc_huge_ProfitLossOnChangeInFairValue_1443"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProfitLossOnChangeInFairValue" xlink:label="loc_huge_ProfitLossOnChangeInFairValue_1444"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PropertyPlantAndEquipmentAssetsHeldForSale" xlink:label="loc_huge_PropertyPlantAndEquipmentAssetsHeldForSale_1445"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PropertyPlantAndEquipmentAssetsHeldForSale" xlink:label="loc_huge_PropertyPlantAndEquipmentAssetsHeldForSale_1446"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PropertyPlantAndEquipmentAssetsHeldForSale" xlink:label="loc_huge_PropertyPlantAndEquipmentAssetsHeldForSale_1447"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PropertyPlantAndEquipmentsMember" xlink:label="loc_huge_PropertyPlantAndEquipmentsMember_1448"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PropertyPlantAndEquipmentsMember" xlink:label="loc_huge_PropertyPlantAndEquipmentsMember_1449"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PropertyPlantAndEquipmentsMember" xlink:label="loc_huge_PropertyPlantAndEquipmentsMember_1450"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProvisionForEmployeeRelatedLiability" xlink:label="loc_huge_ProvisionForEmployeeRelatedLiability_1451"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProvisionForEmployeeRelatedLiability" xlink:label="loc_huge_ProvisionForEmployeeRelatedLiability_1452"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProvisionForEmployeeRelatedLiability" xlink:label="loc_huge_ProvisionForEmployeeRelatedLiability_1453"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_QuantitiesAvailableToSupplyInFifthFiscalYear" xlink:label="loc_huge_QuantitiesAvailableToSupplyInFifthFiscalYear_1454"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_QuantitiesAvailableToSupplyInFifthFiscalYear" xlink:label="loc_huge_QuantitiesAvailableToSupplyInFifthFiscalYear_1455"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_QuantitiesAvailableToSupplyInFifthFiscalYear" xlink:label="loc_huge_QuantitiesAvailableToSupplyInFifthFiscalYear_1456"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_QuantitiesAvailableToSupplyInFourthFiscalYear" xlink:label="loc_huge_QuantitiesAvailableToSupplyInFourthFiscalYear_1457"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_QuantitiesAvailableToSupplyInFourthFiscalYear" xlink:label="loc_huge_QuantitiesAvailableToSupplyInFourthFiscalYear_1458"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_QuantitiesAvailableToSupplyInFourthFiscalYear" xlink:label="loc_huge_QuantitiesAvailableToSupplyInFourthFiscalYear_1459"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_QuantitiesAvailableToSupplyInNextFiscalYear" xlink:label="loc_huge_QuantitiesAvailableToSupplyInNextFiscalYear_1460"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_QuantitiesAvailableToSupplyInNextFiscalYear" xlink:label="loc_huge_QuantitiesAvailableToSupplyInNextFiscalYear_1461"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_QuantitiesAvailableToSupplyInNextFiscalYear" xlink:label="loc_huge_QuantitiesAvailableToSupplyInNextFiscalYear_1462"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_QuantitiesAvailableToSupplyInSecondFiscalYear" xlink:label="loc_huge_QuantitiesAvailableToSupplyInSecondFiscalYear_1463"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_QuantitiesAvailableToSupplyInSecondFiscalYear" xlink:label="loc_huge_QuantitiesAvailableToSupplyInSecondFiscalYear_1464"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_QuantitiesAvailableToSupplyInSecondFiscalYear" xlink:label="loc_huge_QuantitiesAvailableToSupplyInSecondFiscalYear_1465"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_QuantitiesAvailableToSupplyInThirdFiscalYear" xlink:label="loc_huge_QuantitiesAvailableToSupplyInThirdFiscalYear_1466"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_QuantitiesAvailableToSupplyInThirdFiscalYear" xlink:label="loc_huge_QuantitiesAvailableToSupplyInThirdFiscalYear_1467"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_QuantitiesAvailableToSupplyInThirdFiscalYear" xlink:label="loc_huge_QuantitiesAvailableToSupplyInThirdFiscalYear_1468"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_QuotedMarketPriceOfInvestments" xlink:label="loc_huge_QuotedMarketPriceOfInvestments_1469"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_QuotedMarketPriceOfInvestments" xlink:label="loc_huge_QuotedMarketPriceOfInvestments_1470"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_QuotedMarketPriceOfInvestments" xlink:label="loc_huge_QuotedMarketPriceOfInvestments_1471"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_RecognitionOfLossOnChangeInFairValueOfDerivativeLiability" xlink:label="loc_huge_RecognitionOfLossOnChangeInFairValueOfDerivativeLiability_1472"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_RecognitionOfLossOnChangeInFairValueOfDerivativeLiability" xlink:label="loc_huge_RecognitionOfLossOnChangeInFairValueOfDerivativeLiability_1473"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_RecognitionOfLossOnChangeInFairValueOfDerivativeLiability" xlink:label="loc_huge_RecognitionOfLossOnChangeInFairValueOfDerivativeLiability_1474"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_RentReceivable" xlink:label="loc_huge_RentReceivable_1475"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_RentReceivable" xlink:label="loc_huge_RentReceivable_1476"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_RentReceivable" xlink:label="loc_huge_RentReceivable_1477"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ResearchAndDevelopmentAgreementMember" xlink:label="loc_huge_ResearchAndDevelopmentAgreementMember_1478"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ResearchAndDevelopmentAgreementMember" xlink:label="loc_huge_ResearchAndDevelopmentAgreementMember_1479"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ResearchAndDevelopmentAgreementMember" xlink:label="loc_huge_ResearchAndDevelopmentAgreementMember_1480"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_RetrospectiveApplicationAndRetrospectiveRestatementLineItems" xlink:label="loc_huge_RetrospectiveApplicationAndRetrospectiveRestatementLineItems_1481"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_RetrospectiveApplicationAndRetrospectiveRestatementLineItems" xlink:label="loc_huge_RetrospectiveApplicationAndRetrospectiveRestatementLineItems_1482"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_RetrospectiveApplicationAndRetrospectiveRestatementTable" xlink:label="loc_huge_RetrospectiveApplicationAndRetrospectiveRestatementTable_1483"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_RetrospectiveApplicationAndRetrospectiveRestatementTable" xlink:label="loc_huge_RetrospectiveApplicationAndRetrospectiveRestatementTable_1484"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ReverseTakeoverTransaction" xlink:label="loc_huge_ReverseTakeoverTransaction_1485"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ReverseTakeoverTransaction" xlink:label="loc_huge_ReverseTakeoverTransaction_1486"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ReverseTakeoverTransaction" xlink:label="loc_huge_ReverseTakeoverTransaction_1487"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_RightOfUseAssetsAndLeaseObligations" xlink:label="loc_huge_RightOfUseAssetsAndLeaseObligations_1488"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_RightOfUseAssetsAndLeaseObligations" xlink:label="loc_huge_RightOfUseAssetsAndLeaseObligations_1489"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_RightOfUseAssetsAndLeaseObligations" xlink:label="loc_huge_RightOfUseAssetsAndLeaseObligations_1490"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_RiskFreeInterestRateOfWarrants" xlink:label="loc_huge_RiskFreeInterestRateOfWarrants_1491"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_RiskFreeInterestRateOfWarrants" xlink:label="loc_huge_RiskFreeInterestRateOfWarrants_1492"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_RiskFreeInterestRateOfWarrants" xlink:label="loc_huge_RiskFreeInterestRateOfWarrants_1493"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_RiskFreeInterestRateOfWarrantsGranted" xlink:label="loc_huge_RiskFreeInterestRateOfWarrantsGranted_1494"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_RiskFreeInterestRateOfWarrantsGranted" xlink:label="loc_huge_RiskFreeInterestRateOfWarrantsGranted_1495"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_RiskFreeInterestRateOfWarrantsGranted" xlink:label="loc_huge_RiskFreeInterestRateOfWarrantsGranted_1496"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_RiskFreeInterestRateOfWarrantsLiability" xlink:label="loc_huge_RiskFreeInterestRateOfWarrantsLiability_1497"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_RiskFreeInterestRateOfWarrantsLiability" xlink:label="loc_huge_RiskFreeInterestRateOfWarrantsLiability_1498"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_RiskFreeRateOfWarrants" xlink:label="loc_huge_RiskFreeRateOfWarrants_1499"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_RiskFreeRateOfWarrants" xlink:label="loc_huge_RiskFreeRateOfWarrants_1500"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_RiskFreeRateOfWarrants" xlink:label="loc_huge_RiskFreeRateOfWarrants_1501"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SalesTaxRecoverable" xlink:label="loc_huge_SalesTaxRecoverable_1502"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SalesTaxRecoverable" xlink:label="loc_huge_SalesTaxRecoverable_1503"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SalesTaxRecoverable" xlink:label="loc_huge_SalesTaxRecoverable_1504"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SalesTaxRecoverable" xlink:label="loc_huge_SalesTaxRecoverable_1505"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ScheduleOfCashFlowsFromDiscontinuedOperationsExplanatory" xlink:label="loc_huge_ScheduleOfCashFlowsFromDiscontinuedOperationsExplanatory_1506"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ScheduleOfCashFlowsFromDiscontinuedOperationsExplanatory" xlink:label="loc_huge_ScheduleOfCashFlowsFromDiscontinuedOperationsExplanatory_1507"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ScheduleOfCashFlowsFromDiscontinuedOperationsExplanatory" xlink:label="loc_huge_ScheduleOfCashFlowsFromDiscontinuedOperationsExplanatory_1508"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ScheduleOfComponentsOfAssetsHeldForSaleExplanatory" xlink:label="loc_huge_ScheduleOfComponentsOfAssetsHeldForSaleExplanatory_1509"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ScheduleOfComponentsOfAssetsHeldForSaleExplanatory" xlink:label="loc_huge_ScheduleOfComponentsOfAssetsHeldForSaleExplanatory_1510"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ScheduleOfComponentsOfAssetsHeldForSaleExplanatory" xlink:label="loc_huge_ScheduleOfComponentsOfAssetsHeldForSaleExplanatory_1511"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ScheduleOfNetLossAndComprehensiveLossFromDiscontinuedOperationsExplanatory" xlink:label="loc_huge_ScheduleOfNetLossAndComprehensiveLossFromDiscontinuedOperationsExplanatory_1512"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ScheduleOfNetLossAndComprehensiveLossFromDiscontinuedOperationsExplanatory" xlink:label="loc_huge_ScheduleOfNetLossAndComprehensiveLossFromDiscontinuedOperationsExplanatory_1513"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ScheduleOfNetLossAndComprehensiveLossFromDiscontinuedOperationsExplanatory" xlink:label="loc_huge_ScheduleOfNetLossAndComprehensiveLossFromDiscontinuedOperationsExplanatory_1514"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ScheduleOfNonCapitalLossCarryforwardsTableTextBlock" xlink:label="loc_huge_ScheduleOfNonCapitalLossCarryforwardsTableTextBlock_1515"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ScheduleOfNonCapitalLossCarryforwardsTableTextBlock" xlink:label="loc_huge_ScheduleOfNonCapitalLossCarryforwardsTableTextBlock_1516"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ScheduleOfNonCapitalLossCarryforwardsTableTextBlock" xlink:label="loc_huge_ScheduleOfNonCapitalLossCarryforwardsTableTextBlock_1517"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ScheduleOfStockClassLineItems" xlink:label="loc_huge_ScheduleOfStockClassLineItems_1518"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ScheduleOfStockClassLineItems" xlink:label="loc_huge_ScheduleOfStockClassLineItems_1519"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ScheduleOfStockClassTable" xlink:label="loc_huge_ScheduleOfStockClassTable_1520"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ScheduleOfStockClassTable" xlink:label="loc_huge_ScheduleOfStockClassTable_1521"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ScheduleOfWarrantTable" xlink:label="loc_huge_ScheduleOfWarrantTable_1522"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ScheduleOfWarrantTable" xlink:label="loc_huge_ScheduleOfWarrantTable_1523"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory" xlink:label="loc_huge_SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory_1524"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory" xlink:label="loc_huge_SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory_1525"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory" xlink:label="loc_huge_SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory_1526"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ScicannTherapeuticsIncMember" xlink:label="loc_huge_ScicannTherapeuticsIncMember_1527"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ScicannTherapeuticsIncMember" xlink:label="loc_huge_ScicannTherapeuticsIncMember_1528"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ScicannTherapeuticsIncMember" xlink:label="loc_huge_ScicannTherapeuticsIncMember_1529"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SecuritiesExchangeAgreementMember" xlink:label="loc_huge_SecuritiesExchangeAgreementMember_1530"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SecuritiesExchangeAgreementMember" xlink:label="loc_huge_SecuritiesExchangeAgreementMember_1531"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees" xlink:label="loc_huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees_1532"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees" xlink:label="loc_huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees_1533"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees" xlink:label="loc_huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees_1534"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Sep102018Member" xlink:label="loc_huge_Sep102018Member_1535"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Sep102018Member" xlink:label="loc_huge_Sep102018Member_1536"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Sep102018Member" xlink:label="loc_huge_Sep102018Member_1537"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Sep112018Member" xlink:label="loc_huge_Sep112018Member_1538"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Sep112018Member" xlink:label="loc_huge_Sep112018Member_1539"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Sep112018Member" xlink:label="loc_huge_Sep112018Member_1540"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Sep142018Member" xlink:label="loc_huge_Sep142018Member_1541"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Sep142018Member" xlink:label="loc_huge_Sep142018Member_1542"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Sep152017Member" xlink:label="loc_huge_Sep152017Member_1543"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Sep152017Member" xlink:label="loc_huge_Sep152017Member_1544"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Sep152017Member" xlink:label="loc_huge_Sep152017Member_1545"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Sep152018Member" xlink:label="loc_huge_Sep152018Member_1546"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Sep152018Member" xlink:label="loc_huge_Sep152018Member_1547"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Sep152018Member" xlink:label="loc_huge_Sep152018Member_1548"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Sep172017Member" xlink:label="loc_huge_Sep172017Member_1549"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Sep172017Member" xlink:label="loc_huge_Sep172017Member_1550"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Sep172017Member" xlink:label="loc_huge_Sep172017Member_1551"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Sep262018Member" xlink:label="loc_huge_Sep262018Member_1552"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Sep262018Member" xlink:label="loc_huge_Sep262018Member_1553"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Sep262018Member" xlink:label="loc_huge_Sep262018Member_1554"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_September292018Member" xlink:label="loc_huge_September292018Member_1555"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_September292018Member" xlink:label="loc_huge_September292018Member_1556"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_September292018Member" xlink:label="loc_huge_September292018Member_1557"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_September302017Member" xlink:label="loc_huge_September302017Member_1558"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_September302017Member" xlink:label="loc_huge_September302017Member_1559"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_September302017Member" xlink:label="loc_huge_September302017Member_1560"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShareBasedPaymentExpenses" xlink:label="loc_huge_ShareBasedPaymentExpenses_1561"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShareBasedPaymentExpenses" xlink:label="loc_huge_ShareBasedPaymentExpenses_1562"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShareBasedPaymentExpenses" xlink:label="loc_huge_ShareBasedPaymentExpenses_1563"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShareExchangeAgreementMember" xlink:label="loc_huge_ShareExchangeAgreementMember_1564"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShareExchangeAgreementMember" xlink:label="loc_huge_ShareExchangeAgreementMember_1565"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShareExchangeAgreementMember" xlink:label="loc_huge_ShareExchangeAgreementMember_1566"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShareholderAndPublicCompanyCosts" xlink:label="loc_huge_ShareholderAndPublicCompanyCosts_1567"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShareholderAndPublicCompanyCosts" xlink:label="loc_huge_ShareholderAndPublicCompanyCosts_1568"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShareholderAndPublicCompanyCosts" xlink:label="loc_huge_ShareholderAndPublicCompanyCosts_1569"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShareholdersAndPublicCompanyCosts" xlink:label="loc_huge_ShareholdersAndPublicCompanyCosts_1570"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShareholdersAndPublicCompanyCosts" xlink:label="loc_huge_ShareholdersAndPublicCompanyCosts_1571"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShareholdersAndPublicCompanyCosts" xlink:label="loc_huge_ShareholdersAndPublicCompanyCosts_1572"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShareIssuanceCostBookedDirectlyToEquity" xlink:label="loc_huge_ShareIssuanceCostBookedDirectlyToEquity_1573"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShareIssuanceCostBookedDirectlyToEquity" xlink:label="loc_huge_ShareIssuanceCostBookedDirectlyToEquity_1574"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShareIssuanceCostBookedDirectlyToEquity" xlink:label="loc_huge_ShareIssuanceCostBookedDirectlyToEquity_1575"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShareIssueCostsMember" xlink:label="loc_huge_ShareIssueCostsMember_1576"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShareIssueCostsMember" xlink:label="loc_huge_ShareIssueCostsMember_1577"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShareIssueCostsMember" xlink:label="loc_huge_ShareIssueCostsMember_1578"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShareIssuePricePerShare" xlink:label="loc_huge_ShareIssuePricePerShare_1579"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShareIssuePricePerShare" xlink:label="loc_huge_ShareIssuePricePerShare_1580"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShareOptionsAbstract" xlink:label="loc_huge_ShareOptionsAbstract_1581"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SharePriceOfSharesAndWarrants" xlink:label="loc_huge_SharePriceOfSharesAndWarrants_1582"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SharePriceOfSharesAndWarrants" xlink:label="loc_huge_SharePriceOfSharesAndWarrants_1583"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SharePrices" xlink:label="loc_huge_SharePrices_1584"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SharePrices" xlink:label="loc_huge_SharePrices_1585"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SharePrices" xlink:label="loc_huge_SharePrices_1586"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SharePrices" xlink:label="loc_huge_SharePrices_1587"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SharePricesOfWarrantsLiability" xlink:label="loc_huge_SharePricesOfWarrantsLiability_1588"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SharePricesOfWarrantsLiability" xlink:label="loc_huge_SharePricesOfWarrantsLiability_1589"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SharePurchaseAndSaleAgreementsMember" xlink:label="loc_huge_SharePurchaseAndSaleAgreementsMember_1590"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SharePurchaseAndSaleAgreementsMember" xlink:label="loc_huge_SharePurchaseAndSaleAgreementsMember_1591"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SharePurchaseAndSaleAgreementsMember" xlink:label="loc_huge_SharePurchaseAndSaleAgreementsMember_1592"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShareSplitRatio" xlink:label="loc_huge_ShareSplitRatio_1593"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShareSplitRatio" xlink:label="loc_huge_ShareSplitRatio_1594"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShareSplitRatio" xlink:label="loc_huge_ShareSplitRatio_1595"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShortTermNotes" xlink:label="loc_huge_ShortTermNotes_1596"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShortTermNotes" xlink:label="loc_huge_ShortTermNotes_1597"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShortTermNotes" xlink:label="loc_huge_ShortTermNotes_1598"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShortTermNotes" xlink:label="loc_huge_ShortTermNotes_1599"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SolarvestBioEnergyIncMember" xlink:label="loc_huge_SolarvestBioEnergyIncMember_1600"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SolarvestBioEnergyIncMember" xlink:label="loc_huge_SolarvestBioEnergyIncMember_1601"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SolarvestBioEnergyIncMember" xlink:label="loc_huge_SolarvestBioEnergyIncMember_1602"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SpecialWarrantsMember" xlink:label="loc_huge_SpecialWarrantsMember_1603"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SpecialWarrantsMember" xlink:label="loc_huge_SpecialWarrantsMember_1604"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SpecialWarrantsMember" xlink:label="loc_huge_SpecialWarrantsMember_1605"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_StockOptionsMember" xlink:label="loc_huge_StockOptionsMember_1606"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_StockOptionsMember" xlink:label="loc_huge_StockOptionsMember_1607"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_StockOptionsMember" xlink:label="loc_huge_StockOptionsMember_1608"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_StockOptionsOfAcquirer" xlink:label="loc_huge_StockOptionsOfAcquirer_1609"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_StockOptionsOfAcquirer" xlink:label="loc_huge_StockOptionsOfAcquirer_1610"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_StockOptionsOfAcquirer" xlink:label="loc_huge_StockOptionsOfAcquirer_1611"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_StockPromotionExpense" xlink:label="loc_huge_StockPromotionExpense_1612"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_StockPromotionExpense" xlink:label="loc_huge_StockPromotionExpense_1613"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_StockPromotionExpense" xlink:label="loc_huge_StockPromotionExpense_1614"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_StrategicInvestmentValue" xlink:label="loc_huge_StrategicInvestmentValue_1615"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_StrategicInvestmentValue" xlink:label="loc_huge_StrategicInvestmentValue_1616"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_StrategicInvestmentValue" xlink:label="loc_huge_StrategicInvestmentValue_1617"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SubscriptionPricePerShare" xlink:label="loc_huge_SubscriptionPricePerShare_1618"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SubscriptionPricePerShare" xlink:label="loc_huge_SubscriptionPricePerShare_1619"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SubscriptionPricePerShare" xlink:label="loc_huge_SubscriptionPricePerShare_1620"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SubsequentEventsMember" xlink:label="loc_huge_SubsequentEventsMember_1621"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SubsequentEventsMember" xlink:label="loc_huge_SubsequentEventsMember_1622"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SubsequentEventsMember" xlink:label="loc_huge_SubsequentEventsMember_1623"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SubsidiariesOneMember" xlink:label="loc_huge_SubsidiariesOneMember_1624"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SubsidiariesOneMember" xlink:label="loc_huge_SubsidiariesOneMember_1625"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SubsidiariesTwoMember" xlink:label="loc_huge_SubsidiariesTwoMember_1626"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SubsidiariesTwoMember" xlink:label="loc_huge_SubsidiariesTwoMember_1627"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SubsidiariesTwoMember" xlink:label="loc_huge_SubsidiariesTwoMember_1628"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SummaryOfSignificantAccountingPoliciesAbstract" xlink:label="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_1629"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SummaryOfSignificantAccountingPoliciesTable" xlink:label="loc_huge_SummaryOfSignificantAccountingPoliciesTable_1630"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SummaryOfSignificantAccountingPoliciesTable" xlink:label="loc_huge_SummaryOfSignificantAccountingPoliciesTable_1631"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SupplementalInformationAbstract" xlink:label="loc_huge_SupplementalInformationAbstract_1632"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SupplementalInformationAbstract" xlink:label="loc_huge_SupplementalInformationAbstract_1633"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SupplyAgreementMember" xlink:label="loc_huge_SupplyAgreementMember_1634"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SupplyAgreementMember" xlink:label="loc_huge_SupplyAgreementMember_1635"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SupplyAgreementMember" xlink:label="loc_huge_SupplyAgreementMember_1636"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SupplyAgreementOptionToPurchaseAmount" xlink:label="loc_huge_SupplyAgreementOptionToPurchaseAmount_1637"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SupplyAgreementOptionToPurchaseAmount" xlink:label="loc_huge_SupplyAgreementOptionToPurchaseAmount_1638"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SupplyAgreementOptionToPurchaseAmount" xlink:label="loc_huge_SupplyAgreementOptionToPurchaseAmount_1639"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SupplyAgreementOptionToPurchasePeriod" xlink:label="loc_huge_SupplyAgreementOptionToPurchasePeriod_1640"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SupplyAgreementOptionToPurchasePeriod" xlink:label="loc_huge_SupplyAgreementOptionToPurchasePeriod_1641"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SupplyAgreementOptionToPurchasePeriod" xlink:label="loc_huge_SupplyAgreementOptionToPurchasePeriod_1642"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SupplyAgreementOptionToPurchasePricePerKilogramPerPercentOfCannabidiolExtracted" xlink:label="loc_huge_SupplyAgreementOptionToPurchasePricePerKilogramPerPercentOfCannabidiolExtracted_1643"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SupplyAgreementOptionToPurchasePricePerKilogramPerPercentOfCannabidiolExtracted" xlink:label="loc_huge_SupplyAgreementOptionToPurchasePricePerKilogramPerPercentOfCannabidiolExtracted_1644"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SupplyAgreementOptionToPurchasePricePerKilogramPerPercentOfCannabidiolExtracted" xlink:label="loc_huge_SupplyAgreementOptionToPurchasePricePerKilogramPerPercentOfCannabidiolExtracted_1645"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TaxEffectOfDeferredTaxAssetNotRecognized" xlink:label="loc_huge_TaxEffectOfDeferredTaxAssetNotRecognized_1646"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TaxEffectOfDeferredTaxAssetNotRecognized" xlink:label="loc_huge_TaxEffectOfDeferredTaxAssetNotRecognized_1647"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TaxEffectOfDeferredTaxAssetNotRecognized" xlink:label="loc_huge_TaxEffectOfDeferredTaxAssetNotRecognized_1648"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TaxEffectOfTemporaryDifferences" xlink:label="loc_huge_TaxEffectOfTemporaryDifferences_1649"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TaxEffectOfTemporaryDifferences" xlink:label="loc_huge_TaxEffectOfTemporaryDifferences_1650"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TaxEffectOfTemporaryDifferences" xlink:label="loc_huge_TaxEffectOfTemporaryDifferences_1651"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TemporaryDifferences" xlink:label="loc_huge_TemporaryDifferences_1652"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TemporaryDifferences" xlink:label="loc_huge_TemporaryDifferences_1653"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TemporaryDifferences" xlink:label="loc_huge_TemporaryDifferences_1654"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TermsOfWarrantGranted" xlink:label="loc_huge_TermsOfWarrantGranted_1655"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TermsOfWarrantGranted" xlink:label="loc_huge_TermsOfWarrantGranted_1656"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TermsOfWarrantGranted" xlink:label="loc_huge_TermsOfWarrantGranted_1657"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ThomasFairfullMember" xlink:label="loc_huge_ThomasFairfullMember_1658"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ThomasFairfullMember" xlink:label="loc_huge_ThomasFairfullMember_1659"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ThomasFairfullMember" xlink:label="loc_huge_ThomasFairfullMember_1660"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TotalCashTransactionCosts" xlink:label="loc_huge_TotalCashTransactionCosts_1661"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TotalCashTransactionCosts" xlink:label="loc_huge_TotalCashTransactionCosts_1662"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TotalCashTransactionCosts" xlink:label="loc_huge_TotalCashTransactionCosts_1663"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TransactionCostsAllocatedToWarrants" xlink:label="loc_huge_TransactionCostsAllocatedToWarrants_1664"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TransactionCostsAllocatedToWarrants" xlink:label="loc_huge_TransactionCostsAllocatedToWarrants_1665"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TransactionCostsAllocatedToWarrants" xlink:label="loc_huge_TransactionCostsAllocatedToWarrants_1666"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TypeOfArrangementsAxis" xlink:label="loc_huge_TypeOfArrangementsAxis_1667"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TypeOfArrangementsDomain" xlink:label="loc_huge_TypeOfArrangementsDomain_1668"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TypeOfInventoriesAxis" xlink:label="loc_huge_TypeOfInventoriesAxis_1669"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TypeOfInventoriesAxis" xlink:label="loc_huge_TypeOfInventoriesAxis_1670"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TypeOfInventoriesDomain" xlink:label="loc_huge_TypeOfInventoriesDomain_1671"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TypeOfInventoriesDomain" xlink:label="loc_huge_TypeOfInventoriesDomain_1672"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_UndiscountedLeasePaymentsPayable" xlink:label="loc_huge_UndiscountedLeasePaymentsPayable_1673"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_UndiscountedLeasePaymentsPayable" xlink:label="loc_huge_UndiscountedLeasePaymentsPayable_1674"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_UndiscountedLeasePaymentsPayable" xlink:label="loc_huge_UndiscountedLeasePaymentsPayable_1675"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_UnobservableInputUsedToEstimateFairValueOfBiologicalAssetsTableTextBlock" xlink:label="loc_huge_UnobservableInputUsedToEstimateFairValueOfBiologicalAssetsTableTextBlock_1676"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_UnobservableInputUsedToEstimateFairValueOfBiologicalAssetsTableTextBlock" xlink:label="loc_huge_UnobservableInputUsedToEstimateFairValueOfBiologicalAssetsTableTextBlock_1677"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_UnobservableInputUsedToEstimateFairValueOfBiologicalAssetsTableTextBlock" xlink:label="loc_huge_UnobservableInputUsedToEstimateFairValueOfBiologicalAssetsTableTextBlock_1678"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_UnrealizedLoss" xlink:label="loc_huge_UnrealizedLoss_1679"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_UnrealizedLoss" xlink:label="loc_huge_UnrealizedLoss_1680"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_UnrealizedLoss" xlink:label="loc_huge_UnrealizedLoss_1681"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_UnrealizedLoss" xlink:label="loc_huge_UnrealizedLoss_1682"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_UnrealizedLossOnChangesInFairValueOfBiologicalAssets" xlink:label="loc_huge_UnrealizedLossOnChangesInFairValueOfBiologicalAssets_1683"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_UnrealizedLossOnChangesInFairValueOfBiologicalAssets" xlink:label="loc_huge_UnrealizedLossOnChangesInFairValueOfBiologicalAssets_1684"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_UnrealizedLossOnChangesInFairValueOfBiologicalAssets" xlink:label="loc_huge_UnrealizedLossOnChangesInFairValueOfBiologicalAssets_1685"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_UnrestrictedClassBSharesMember" xlink:label="loc_huge_UnrestrictedClassBSharesMember_1686"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_UnrestrictedClassBSharesMember" xlink:label="loc_huge_UnrestrictedClassBSharesMember_1687"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_UnrestrictedClassBSharesMember" xlink:label="loc_huge_UnrestrictedClassBSharesMember_1688"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfBrokerWarrantsIssuedInPrivatePlacements" xlink:label="loc_huge_ValueOfBrokerWarrantsIssuedInPrivatePlacements_1689"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfBrokerWarrantsIssuedInPrivatePlacements" xlink:label="loc_huge_ValueOfBrokerWarrantsIssuedInPrivatePlacements_1690"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfBrokerWarrantsIssuedInPrivatePlacements" xlink:label="loc_huge_ValueOfBrokerWarrantsIssuedInPrivatePlacements_1691"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfBrokerWarrantsIssuedInPrivatePlacements" xlink:label="loc_huge_ValueOfBrokerWarrantsIssuedInPrivatePlacements_1692"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfCommonStockForNotesPayable" xlink:label="loc_huge_ValueOfCommonStockForNotesPayable_1693"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfCommonStockForNotesPayable" xlink:label="loc_huge_ValueOfCommonStockForNotesPayable_1694"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfCommonStockForNotesPayable" xlink:label="loc_huge_ValueOfCommonStockForNotesPayable_1695"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfSharesAcquired" xlink:label="loc_huge_ValueOfSharesAcquired_1696"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfSharesAcquired" xlink:label="loc_huge_ValueOfSharesAcquired_1697"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfSharesAcquired" xlink:label="loc_huge_ValueOfSharesAcquired_1698"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfSharesIssued" xlink:label="loc_huge_ValueOfSharesIssued_1699"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfSharesIssued" xlink:label="loc_huge_ValueOfSharesIssued_1700"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfSharesIssued" xlink:label="loc_huge_ValueOfSharesIssued_1701"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc" xlink:label="loc_huge_ValueOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_1702"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc" xlink:label="loc_huge_ValueOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_1703"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc" xlink:label="loc_huge_ValueOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_1704"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfSharesIssuedForDebtSettlement" xlink:label="loc_huge_ValueOfSharesIssuedForDebtSettlement_1705"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfSharesIssuedForDebtSettlement" xlink:label="loc_huge_ValueOfSharesIssuedForDebtSettlement_1706"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfSharesIssuedForDebtSettlement" xlink:label="loc_huge_ValueOfSharesIssuedForDebtSettlement_1707"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfSharesIssuedInPrivatePlacement" xlink:label="loc_huge_ValueOfSharesIssuedInPrivatePlacement_1708"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfSharesIssuedInPrivatePlacement" xlink:label="loc_huge_ValueOfSharesIssuedInPrivatePlacement_1709"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfSharesIssuedInPrivatePlacement" xlink:label="loc_huge_ValueOfSharesIssuedInPrivatePlacement_1710"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfSharesIssuedInShareExchange" xlink:label="loc_huge_ValueOfSharesIssuedInShareExchange_1711"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfSharesIssuedInShareExchange" xlink:label="loc_huge_ValueOfSharesIssuedInShareExchange_1712"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfSharesIssuedInShareExchange" xlink:label="loc_huge_ValueOfSharesIssuedInShareExchange_1713"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfStockOptionsExercised" xlink:label="loc_huge_ValueOfStockOptionsExercised_1714"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfStockOptionsExercised" xlink:label="loc_huge_ValueOfStockOptionsExercised_1715"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfStockOptionsExercised" xlink:label="loc_huge_ValueOfStockOptionsExercised_1716"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement" xlink:label="loc_huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement_1717"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement" xlink:label="loc_huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement_1718"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement" xlink:label="loc_huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement_1719"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfTradeAndOtherPayableOfSharesBasedCompensation" xlink:label="loc_huge_ValueOfTradeAndOtherPayableOfSharesBasedCompensation_1720"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfTradeAndOtherPayableOfSharesBasedCompensation" xlink:label="loc_huge_ValueOfTradeAndOtherPayableOfSharesBasedCompensation_1721"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfTradeAndOtherPayableOfSharesBasedCompensation" xlink:label="loc_huge_ValueOfTradeAndOtherPayableOfSharesBasedCompensation_1722"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfWarrantsExercised" xlink:label="loc_huge_ValueOfWarrantsExercised_1723"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfWarrantsExercised" xlink:label="loc_huge_ValueOfWarrantsExercised_1724"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfWarrantsExercised" xlink:label="loc_huge_ValueOfWarrantsExercised_1725"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfWarrantsOfResidualValue" xlink:label="loc_huge_ValueOfWarrantsOfResidualValue_1726"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfWarrantsOfResidualValue" xlink:label="loc_huge_ValueOfWarrantsOfResidualValue_1727"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfWarrantsOfResidualValue" xlink:label="loc_huge_ValueOfWarrantsOfResidualValue_1728"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantExercisePrice" xlink:label="loc_huge_WarrantExercisePrice_1729"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantExercisePrice" xlink:label="loc_huge_WarrantExercisePrice_1730"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantExercisePrice" xlink:label="loc_huge_WarrantExercisePrice_1731"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantLiabilitiesAbstract" xlink:label="loc_huge_WarrantLiabilitiesAbstract_1732"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantLiabilitiesAbstract" xlink:label="loc_huge_WarrantLiabilitiesAbstract_1733"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantLiabilitiesLineItems" xlink:label="loc_huge_WarrantLiabilitiesLineItems_1734"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantLiabilitiesLineItems" xlink:label="loc_huge_WarrantLiabilitiesLineItems_1735"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantLiabilitiesTable" xlink:label="loc_huge_WarrantLiabilitiesTable_1736"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantLiabilitiesTable" xlink:label="loc_huge_WarrantLiabilitiesTable_1737"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantLineItems" xlink:label="loc_huge_WarrantLineItems_1738"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantLineItems" xlink:label="loc_huge_WarrantLineItems_1739"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Warrants" xlink:label="loc_huge_Warrants_1740"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Warrants" xlink:label="loc_huge_Warrants_1741"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Warrants" xlink:label="loc_huge_Warrants_1742"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Warrants" xlink:label="loc_huge_Warrants_1743"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsAbstract" xlink:label="loc_huge_WarrantsAbstract_1744"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtAugust1St2021Member" xlink:label="loc_huge_WarrantsByExpiryDateAtAugust1St2021Member_1745"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtAugust1St2021Member" xlink:label="loc_huge_WarrantsByExpiryDateAtAugust1St2021Member_1746"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtAugust1St2021Member" xlink:label="loc_huge_WarrantsByExpiryDateAtAugust1St2021Member_1747"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtAugust6Th2020Member" xlink:label="loc_huge_WarrantsByExpiryDateAtAugust6Th2020Member_1748"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtAugust6Th2020Member" xlink:label="loc_huge_WarrantsByExpiryDateAtAugust6Th2020Member_1749"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtAugust6Th2020Member" xlink:label="loc_huge_WarrantsByExpiryDateAtAugust6Th2020Member_1750"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtDecember12Th2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtDecember12Th2019Member_1751"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtDecember12Th2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtDecember12Th2019Member_1752"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtDecember12Th2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtDecember12Th2019Member_1753"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtDecember29Th2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtDecember29Th2019Member_1754"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtDecember29Th2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtDecember29Th2019Member_1755"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtDecember29Th2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtDecember29Th2019Member_1756"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtJanuary16Th2026Member" xlink:label="loc_huge_WarrantsByExpiryDateAtJanuary16Th2026Member_1757"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtJanuary16Th2026Member" xlink:label="loc_huge_WarrantsByExpiryDateAtJanuary16Th2026Member_1758"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtJanuary16Th2026Member" xlink:label="loc_huge_WarrantsByExpiryDateAtJanuary16Th2026Member_1759"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtJanuary20Th2026Member" xlink:label="loc_huge_WarrantsByExpiryDateAtJanuary20Th2026Member_1760"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtJanuary20Th2026Member" xlink:label="loc_huge_WarrantsByExpiryDateAtJanuary20Th2026Member_1761"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtJanuary20Th2026Member" xlink:label="loc_huge_WarrantsByExpiryDateAtJanuary20Th2026Member_1762"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtJanuary5Th2020Member" xlink:label="loc_huge_WarrantsByExpiryDateAtJanuary5Th2020Member_1763"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtJanuary5Th2020Member" xlink:label="loc_huge_WarrantsByExpiryDateAtJanuary5Th2020Member_1764"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtJanuary5Th2020Member" xlink:label="loc_huge_WarrantsByExpiryDateAtJanuary5Th2020Member_1765"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtJuly24Th2023Member" xlink:label="loc_huge_WarrantsByExpiryDateAtJuly24Th2023Member_1766"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtJuly24Th2023Member" xlink:label="loc_huge_WarrantsByExpiryDateAtJuly24Th2023Member_1767"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtJuly24Th2023Member" xlink:label="loc_huge_WarrantsByExpiryDateAtJuly24Th2023Member_1768"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtJune8Th2025Member" xlink:label="loc_huge_WarrantsByExpiryDateAtJune8Th2025Member_1769"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtJune8Th2025Member" xlink:label="loc_huge_WarrantsByExpiryDateAtJune8Th2025Member_1770"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtJune8Th2025Member" xlink:label="loc_huge_WarrantsByExpiryDateAtJune8Th2025Member_1771"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtMay10Th2025Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay10Th2025Member_1772"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtMay10Th2025Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay10Th2025Member_1773"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtMay10Th2025Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay10Th2025Member_1774"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtMay17Th2025Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay17Th2025Member_1775"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtMay17Th2025Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay17Th2025Member_1776"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtMay17Th2025Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay17Th2025Member_1777"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtMay20Th2023Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay20Th2023Member_1778"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtMay20Th2023Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay20Th2023Member_1779"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtMay20Th2023Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay20Th2023Member_1780"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtMay24Th2022Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay24Th2022Member_1781"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtMay24Th2022Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay24Th2022Member_1782"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtMay24Th2022Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay24Th2022Member_1783"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtMay31St2025Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay31St2025Member_1784"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtMay31St2025Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay31St2025Member_1785"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtMay31St2025Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay31St2025Member_1786"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtMay4Th2025Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay4Th2025Member_1787"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtMay4Th2025Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay4Th2025Member_1788"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtMay4Th2025Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay4Th2025Member_1789"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtNovember14Th2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtNovember14Th2019Member_1790"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtNovember14Th2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtNovember14Th2019Member_1791"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtNovember14Th2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtNovember14Th2019Member_1792"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtNovember1St2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtNovember1St2019Member_1793"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtNovember1St2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtNovember1St2019Member_1794"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtNovember1St2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtNovember1St2019Member_1795"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtNovember21St2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtNovember21St2019Member_1796"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtNovember21St2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtNovember21St2019Member_1797"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtNovember21St2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtNovember21St2019Member_1798"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtNovember30Th2020Member" xlink:label="loc_huge_WarrantsByExpiryDateAtNovember30Th2020Member_1799"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtNovember30Th2020Member" xlink:label="loc_huge_WarrantsByExpiryDateAtNovember30Th2020Member_1800"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtNovember30Th2020Member" xlink:label="loc_huge_WarrantsByExpiryDateAtNovember30Th2020Member_1801"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtOctober20Th2020Member" xlink:label="loc_huge_WarrantsByExpiryDateAtOctober20Th2020Member_1802"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtOctober20Th2020Member" xlink:label="loc_huge_WarrantsByExpiryDateAtOctober20Th2020Member_1803"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtOctober20Th2020Member" xlink:label="loc_huge_WarrantsByExpiryDateAtOctober20Th2020Member_1804"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtSeptember11Th2023Member" xlink:label="loc_huge_WarrantsByExpiryDateAtSeptember11Th2023Member_1805"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtSeptember11Th2023Member" xlink:label="loc_huge_WarrantsByExpiryDateAtSeptember11Th2023Member_1806"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtSeptember11Th2023Member" xlink:label="loc_huge_WarrantsByExpiryDateAtSeptember11Th2023Member_1807"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtSeptember15Th2022Member" xlink:label="loc_huge_WarrantsByExpiryDateAtSeptember15Th2022Member_1808"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtSeptember15Th2022Member" xlink:label="loc_huge_WarrantsByExpiryDateAtSeptember15Th2022Member_1809"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtSeptember15Th2022Member" xlink:label="loc_huge_WarrantsByExpiryDateAtSeptember15Th2022Member_1810"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsIssueDateAxis" xlink:label="loc_huge_WarrantsIssueDateAxis_1811"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsIssueDateAxis" xlink:label="loc_huge_WarrantsIssueDateAxis_1812"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsIssueDateDomain" xlink:label="loc_huge_WarrantsIssueDateDomain_1813"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsIssueDateDomain" xlink:label="loc_huge_WarrantsIssueDateDomain_1814"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsIssuedForPrivatePlacement" xlink:label="loc_huge_WarrantsIssuedForPrivatePlacement_1815"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsIssuedForPrivatePlacement" xlink:label="loc_huge_WarrantsIssuedForPrivatePlacement_1816"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsIssuedForPrivatePlacement" xlink:label="loc_huge_WarrantsIssuedForPrivatePlacement_1817"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsLiability" xlink:label="loc_huge_WarrantsLiability_1818"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsLiability" xlink:label="loc_huge_WarrantsLiability_1819"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsLiability" xlink:label="loc_huge_WarrantsLiability_1820"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsLiability" xlink:label="loc_huge_WarrantsLiability_1821"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsMember" xlink:label="loc_huge_WarrantsMember_1822"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsMember" xlink:label="loc_huge_WarrantsMember_1823"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsMember" xlink:label="loc_huge_WarrantsMember_1824"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsMember" xlink:label="loc_huge_WarrantsMember_1825"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsOptionsOfAcquirer" xlink:label="loc_huge_WarrantsOptionsOfAcquirer_1826"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsOptionsOfAcquirer" xlink:label="loc_huge_WarrantsOptionsOfAcquirer_1827"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsOptionsOfAcquirer" xlink:label="loc_huge_WarrantsOptionsOfAcquirer_1828"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WeightedAverageExercisePriceForReplacementOfShareOptions" xlink:label="loc_huge_WeightedAverageExercisePriceForReplacementOfShareOptions_1829"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WeightedAverageExercisePriceForReplacementOfShareOptions" xlink:label="loc_huge_WeightedAverageExercisePriceForReplacementOfShareOptions_1830"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WeightedAverageExercisePriceForReplacementOfShareOptions" xlink:label="loc_huge_WeightedAverageExercisePriceForReplacementOfShareOptions_1831"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WeightedAverageExercisePriceForReplacementOfShareOptions" xlink:label="loc_huge_WeightedAverageExercisePriceForReplacementOfShareOptions_1832"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WeightedAverageExercisePriceForReplacementOfShareOptions" xlink:label="loc_huge_WeightedAverageExercisePriceForReplacementOfShareOptions_1833"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WeightedAverageExercisePricesWarrantExercised" xlink:label="loc_huge_WeightedAverageExercisePricesWarrantExercised_1834"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WeightedAverageExercisePricesWarrantExercised" xlink:label="loc_huge_WeightedAverageExercisePricesWarrantExercised_1835"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WeightedAverageExercisePricesWarrantExercised" xlink:label="loc_huge_WeightedAverageExercisePricesWarrantExercised_1836"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WeightedAverageExercisePricesWarrantExpired" xlink:label="loc_huge_WeightedAverageExercisePricesWarrantExpired_1837"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WeightedAverageExercisePricesWarrantExpired" xlink:label="loc_huge_WeightedAverageExercisePricesWarrantExpired_1838"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WeightedAverageExercisePricesWarrantExpired" xlink:label="loc_huge_WeightedAverageExercisePricesWarrantExpired_1839"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WeightedAverageExercisePricesWarrantIssued" xlink:label="loc_huge_WeightedAverageExercisePricesWarrantIssued_1840"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WeightedAverageExercisePricesWarrantIssued" xlink:label="loc_huge_WeightedAverageExercisePricesWarrantIssued_1841"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WeightedAverageExercisePricesWarrantIssued" xlink:label="loc_huge_WeightedAverageExercisePricesWarrantIssued_1842"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WeightedAverageExercisePriceWarrantsOutstanding" xlink:label="loc_huge_WeightedAverageExercisePriceWarrantsOutstanding_1843"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WeightedAverageExercisePriceWarrantsOutstanding" xlink:label="loc_huge_WeightedAverageExercisePriceWarrantsOutstanding_1844"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WeightedAverageExercisePriceWarrantsOutstanding" xlink:label="loc_huge_WeightedAverageExercisePriceWarrantsOutstanding_1845"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WeightedAverageExercisePriceWarrantsOutstanding" xlink:label="loc_huge_WeightedAverageExercisePriceWarrantsOutstanding_1846"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WeightedAverageExercisePriceWarrantsOutstanding" xlink:label="loc_huge_WeightedAverageExercisePriceWarrantsOutstanding_1847"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WeightedAverageSharePriceOfWarrants" xlink:label="loc_huge_WeightedAverageSharePriceOfWarrants_1848"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WeightedAverageSharePriceOfWarrants" xlink:label="loc_huge_WeightedAverageSharePriceOfWarrants_1849"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WeightedAverageSharePriceOfWarrants" xlink:label="loc_huge_WeightedAverageSharePriceOfWarrants_1850"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WorkingCapitalSurplus" xlink:label="loc_huge_WorkingCapitalSurplus_1851"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WorkingCapitalSurplus" xlink:label="loc_huge_WorkingCapitalSurplus_1852"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WorkingCapitalSurplus" xlink:label="loc_huge_WorkingCapitalSurplus_1853"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ZeeshanSaeedMember" xlink:label="loc_huge_ZeeshanSaeedMember_1854"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ZeeshanSaeedMember" xlink:label="loc_huge_ZeeshanSaeedMember_1855"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ZeeshanSaeedMember" xlink:label="loc_huge_ZeeshanSaeedMember_1856"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccountingProfit" xlink:label="loc_ifrs-full_AccountingProfit_1857"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccountingProfit" xlink:label="loc_ifrs-full_AccountingProfit_1858"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_1859"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_1860"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_1861"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_1862"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_1863"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_1864"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_1865"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:label="loc_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_1866"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:label="loc_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_1867"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:label="loc_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_1868"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_1869"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_1870"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsFromPurchasesBiologicalAssets" xlink:label="loc_ifrs-full_AdditionsFromPurchasesBiologicalAssets_1871"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsFromPurchasesBiologicalAssets" xlink:label="loc_ifrs-full_AdditionsFromPurchasesBiologicalAssets_1872"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_1873"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_1874"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_1875"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_1876"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="loc_ifrs-full_AdjustedWeightedAverageShares_1877"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="loc_ifrs-full_AdjustedWeightedAverageShares_1878"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="loc_ifrs-full_AdjustedWeightedAverageShares_1879"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="loc_ifrs-full_AdjustedWeightedAverageShares_1880"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_1881"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_1882"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_1883"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_1884"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_1885"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_1886"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_1887"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_1888"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_1889"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:label="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_1890"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDepreciationExpense" xlink:label="loc_ifrs-full_AdjustmentsForDepreciationExpense_1891"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDepreciationExpense" xlink:label="loc_ifrs-full_AdjustmentsForDepreciationExpense_1892"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForFairValueGainsLosses" xlink:label="loc_ifrs-full_AdjustmentsForFairValueGainsLosses_1893"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForFairValueGainsLosses" xlink:label="loc_ifrs-full_AdjustmentsForFairValueGainsLosses_1894"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets" xlink:label="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_1895"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets" xlink:label="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_1896"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets" xlink:label="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_1897"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets" xlink:label="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_1898"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets" xlink:label="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_1899"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives" xlink:label="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_1900"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives" xlink:label="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_1901"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives" xlink:label="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_1902"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_1903"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_1904"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_1905"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_1906"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossInventories" xlink:label="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossInventories_1907"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossInventories" xlink:label="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossInventories_1908"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_1909"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_1910"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities_1911"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities_1912"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_1913"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_1914"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_1915"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_1916"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForInterestExpense" xlink:label="loc_ifrs-full_AdjustmentsForInterestExpense_1917"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForInterestExpense" xlink:label="loc_ifrs-full_AdjustmentsForInterestExpense_1918"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_1919"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_1920"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_1921"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_1922"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_1923"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:label="loc_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_1924"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:label="loc_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_1925"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdvertisingExpense" xlink:label="loc_ifrs-full_AdvertisingExpense_1926"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdvertisingExpense" xlink:label="loc_ifrs-full_AdvertisingExpense_1927"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedMeasurementMember" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_1928"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_1929"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AllLevelsOfFairValueHierarchyMember" xlink:label="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_1930"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_1931"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_1932"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_1933"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:label="loc_ifrs-full_AmountsPayableRelatedPartyTransactions_1934"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:label="loc_ifrs-full_AmountsPayableRelatedPartyTransactions_1935"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ApplicableTaxRate" xlink:label="loc_ifrs-full_ApplicableTaxRate_1936"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ApplicableTaxRate" xlink:label="loc_ifrs-full_ApplicableTaxRate_1937"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-full_Assets_1938"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-full_Assets_1939"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAbstract" xlink:label="loc_ifrs-full_AssetsAbstract_1940"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_1941"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_1942"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AtFairValueMember" xlink:label="loc_ifrs-full_AtFairValueMember_1943"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AtFairValueMember" xlink:label="loc_ifrs-full_AtFairValueMember_1944"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BasicAndDilutedEarningsLossPerShareFromContinuingOperations" xlink:label="loc_ifrs-full_BasicAndDilutedEarningsLossPerShareFromContinuingOperations_1945"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BasicAndDilutedEarningsLossPerShareFromContinuingOperations" xlink:label="loc_ifrs-full_BasicAndDilutedEarningsLossPerShareFromContinuingOperations_1946"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BasicAndDilutedEarningsLossPerShareFromDiscontinuedOperations" xlink:label="loc_ifrs-full_BasicAndDilutedEarningsLossPerShareFromDiscontinuedOperations_1947"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BasicAndDilutedEarningsLossPerShareFromDiscontinuedOperations" xlink:label="loc_ifrs-full_BasicAndDilutedEarningsLossPerShareFromDiscontinuedOperations_1948"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="loc_ifrs-full_BasicEarningsLossPerShare_1949"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="loc_ifrs-full_BasicEarningsLossPerShare_1950"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BiologicalAssets" xlink:label="loc_ifrs-full_BiologicalAssets_1951"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BiologicalAssets" xlink:label="loc_ifrs-full_BiologicalAssets_1952"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BiologicalAssets" xlink:label="loc_ifrs-full_BiologicalAssets_1953"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BiologicalAssets" xlink:label="loc_ifrs-full_BiologicalAssets_1954"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BiologicalAssetsByGroupAxis" xlink:label="loc_ifrs-full_BiologicalAssetsByGroupAxis_1955"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BiologicalAssetsGroupMember" xlink:label="loc_ifrs-full_BiologicalAssetsGroupMember_1956"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsAbstract" xlink:label="loc_ifrs-full_BorrowingsAbstract_1957"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsInterestRate" xlink:label="loc_ifrs-full_BorrowingsInterestRate_1958"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsInterestRate" xlink:label="loc_ifrs-full_BorrowingsInterestRate_1959"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_1960"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_1961"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_1962"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_1963"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_1964"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_1965"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BusinessCombinationsMember" xlink:label="loc_ifrs-full_BusinessCombinationsMember_1966"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1967"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_1968"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Cash" xlink:label="loc_ifrs-full_Cash_1969"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Cash" xlink:label="loc_ifrs-full_Cash_1970"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Cash" xlink:label="loc_ifrs-full_Cash_1971"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAbstract" xlink:label="loc_ifrs-full_CashAbstract_1972"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_1973"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_1974"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_1975"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_1976"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_1977"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_1978"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_1979"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_1980"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_1981"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_1982"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_1983"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_1984"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_1985"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_1986"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_1987"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations_1988"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations_1989"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations_1990"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_1991"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_1992"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_1993"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_1994"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_1995"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_1996"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_1997"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_1998"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_1999"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_2000"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_2001"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_2002"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_2003"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations_2004"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations_2005"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations_2006"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_2007"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_2008"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_2009"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_2010"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashOutflowForLeases" xlink:label="loc_ifrs-full_CashOutflowForLeases_2011"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashOutflowForLeases" xlink:label="loc_ifrs-full_CashOutflowForLeases_2012"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashOutflowForLeases" xlink:label="loc_ifrs-full_CashOutflowForLeases_2013"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashOutflowForLeases" xlink:label="loc_ifrs-full_CashOutflowForLeases_2014"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashOutflowForLeases" xlink:label="loc_ifrs-full_CashOutflowForLeases_2015"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties" xlink:label="loc_ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties_2016"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties" xlink:label="loc_ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties_2017"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashTransferred" xlink:label="loc_ifrs-full_CashTransferred_2018"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_2019"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_2020"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_2021"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract" xlink:label="loc_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract_2022"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:label="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_2023"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_2024"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_2025"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_2026"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfInventoriesAbstract" xlink:label="loc_ifrs-full_ClassesOfInventoriesAbstract_2027"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfOrdinarySharesAxis" xlink:label="loc_ifrs-full_ClassesOfOrdinarySharesAxis_2028"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_2029"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_2030"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_2031"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClosingForeignExchangeRate" xlink:label="loc_ifrs-full_ClosingForeignExchangeRate_2032"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClosingForeignExchangeRate" xlink:label="loc_ifrs-full_ClosingForeignExchangeRate_2033"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CommercialPapersIssued" xlink:label="loc_ifrs-full_CommercialPapersIssued_2034"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CommercialPapersIssued" xlink:label="loc_ifrs-full_CommercialPapersIssued_2035"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_2036"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:label="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_2037"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:label="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_2038"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_2039"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_2040"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_2041"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_2042"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="loc_ifrs-full_ComputerEquipmentMember_2043"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="loc_ifrs-full_ComputerEquipmentMember_2044"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="loc_ifrs-full_ComputerEquipmentMember_2045"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ConstructionInProgressMember" xlink:label="loc_ifrs-full_ConstructionInProgressMember_2046"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ConstructionInProgressMember" xlink:label="loc_ifrs-full_ConstructionInProgressMember_2047"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContingentLiabilitiesMember" xlink:label="loc_ifrs-full_ContingentLiabilitiesMember_2048"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContractualCapitalCommitments" xlink:label="loc_ifrs-full_ContractualCapitalCommitments_2049"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContractualCapitalCommitments" xlink:label="loc_ifrs-full_ContractualCapitalCommitments_2050"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContractualCapitalCommitments" xlink:label="loc_ifrs-full_ContractualCapitalCommitments_2051"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" xlink:label="loc_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_2052"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" xlink:label="loc_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_2053"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-full_CostOfSales_2054"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-full_CostOfSales_2055"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-full_CostOfSales_2056"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CounterpartiesAxis" xlink:label="loc_ifrs-full_CounterpartiesAxis_2057"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CounterpartiesMember" xlink:label="loc_ifrs-full_CounterpartiesMember_2058"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CreditRiskMember" xlink:label="loc_ifrs-full_CreditRiskMember_2059"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CreditRiskMember" xlink:label="loc_ifrs-full_CreditRiskMember_2060"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets_2061"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets_2062"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets_2063"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="loc_ifrs-full_CurrentAssetsAbstract_2064"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="loc_ifrs-full_CurrentAssetsAbstract_2065"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:label="loc_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_2066"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:label="loc_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_2067"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:label="loc_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_2068"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate_2069"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate_2070"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate_2071"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentDebtInstrumentsIssued" xlink:label="loc_ifrs-full_CurrentDebtInstrumentsIssued_2072"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentDebtInstrumentsIssued" xlink:label="loc_ifrs-full_CurrentDebtInstrumentsIssued_2073"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:label="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_2074"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:label="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_2075"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_2076"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_2077"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_2078"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities_2079"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities_2080"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities_2081"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_CurrentLiabilitiesAbstract_2082"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_CurrentLiabilitiesAbstract_2083"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued" xlink:label="loc_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_2084"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued" xlink:label="loc_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_2085"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued" xlink:label="loc_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_2086"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="loc_ifrs-full_CurrentPrepaidExpenses_2087"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="loc_ifrs-full_CurrentPrepaidExpenses_2088"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="loc_ifrs-full_CurrentPrepaidExpenses_2089"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DecreaseDueToHarvestBiologicalAssets" xlink:label="loc_ifrs-full_DecreaseDueToHarvestBiologicalAssets_2090"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DecreaseDueToHarvestBiologicalAssets" xlink:label="loc_ifrs-full_DecreaseDueToHarvestBiologicalAssets_2091"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DecreaseDueToHarvestBiologicalAssets" xlink:label="loc_ifrs-full_DecreaseDueToHarvestBiologicalAssets_2092"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DecreaseDueToHarvestBiologicalAssets" xlink:label="loc_ifrs-full_DecreaseDueToHarvestBiologicalAssets_2093"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxAssets" xlink:label="loc_ifrs-full_DeferredTaxAssets_2094"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxAssets" xlink:label="loc_ifrs-full_DeferredTaxAssets_2095"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxExpenseIncome" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncome_2096"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxExpenseIncome" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncome_2097"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxExpenseIncome" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncome_2098"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="loc_ifrs-full_DeferredTaxLiabilities_2099"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="loc_ifrs-full_DeferredTaxLiabilities_2100"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset" xlink:label="loc_ifrs-full_DeferredTaxLiabilityAsset_2101"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset" xlink:label="loc_ifrs-full_DeferredTaxLiabilityAsset_2102"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset" xlink:label="loc_ifrs-full_DeferredTaxLiabilityAsset_2103"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset" xlink:label="loc_ifrs-full_DeferredTaxLiabilityAsset_2104"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset" xlink:label="loc_ifrs-full_DeferredTaxLiabilityAsset_2105"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset" xlink:label="loc_ifrs-full_DeferredTaxLiabilityAsset_2106"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationAndAmortisationExpense" xlink:label="loc_ifrs-full_DepreciationAndAmortisationExpense_2107"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationAndAmortisationExpense" xlink:label="loc_ifrs-full_DepreciationAndAmortisationExpense_2108"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationAndAmortisationExpense" xlink:label="loc_ifrs-full_DepreciationAndAmortisationExpense_2109"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationAndAmortisationExpense" xlink:label="loc_ifrs-full_DepreciationAndAmortisationExpense_2110"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationBiologicalAssets" xlink:label="loc_ifrs-full_DepreciationBiologicalAssets_2111"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationBiologicalAssets" xlink:label="loc_ifrs-full_DepreciationBiologicalAssets_2112"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationBiologicalAssets" xlink:label="loc_ifrs-full_DepreciationBiologicalAssets_2113"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationExpense" xlink:label="loc_ifrs-full_DepreciationExpense_2114"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationExpense" xlink:label="loc_ifrs-full_DepreciationExpense_2115"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationMethodPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DepreciationMethodPropertyPlantAndEquipment_2116"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationMethodPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DepreciationMethodPropertyPlantAndEquipment_2117"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_2118"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_2119"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="loc_ifrs-full_DepreciationRightofuseAssets_2120"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="loc_ifrs-full_DepreciationRightofuseAssets_2121"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="loc_ifrs-full_DepreciationRightofuseAssets_2122"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="loc_ifrs-full_DepreciationRightofuseAssets_2123"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DerivativeFinancialLiabilities" xlink:label="loc_ifrs-full_DerivativeFinancialLiabilities_2124"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForDecommissioningRestorationAndRehabilitationProvisionsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForDecommissioningRestorationAndRehabilitationProvisionsExplanatory_2125"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory_2126"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory_2127"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory_2128"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_2129"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_2130"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_2131"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_2132"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_2133"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_2134"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_2135"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_2136"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory_2137"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_2138"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_2139"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_2140"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_2141"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_2142"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_2143"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_2144"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_2145"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_2146"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_2147"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_2148"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_2149"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_2150"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_2151"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_2152"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForReclassificationOfFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForReclassificationOfFinancialInstrumentsExplanatory_2153"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_2154"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_2155"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_2156"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_2157"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_2158"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_2159"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_2160"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_2161"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_2162"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_2163"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_2164"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_2165"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_2166"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_2167"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_2168"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_2169"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_2170"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements" xlink:label="loc_ifrs-full_DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements_2171"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_2172"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_2173"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_2174"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill_2175"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill_2176"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_2177"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_2178"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShare_2179"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShare_2180"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShare_2181"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares" xlink:label="loc_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_2182"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares" xlink:label="loc_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_2183"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:label="loc_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_2184"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DirectorsRemunerationExpense" xlink:label="loc_ifrs-full_DirectorsRemunerationExpense_2185"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DirectorsRemunerationExpense" xlink:label="loc_ifrs-full_DirectorsRemunerationExpense_2186"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_2187"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_2188"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_2189"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_2190"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBorrowingsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfBorrowingsExplanatory_2191"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBorrowingsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfBorrowingsExplanatory_2192"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_2193"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_2194"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_2195"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_2196"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_2197"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_2198"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_2199"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_2200"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_2201"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_2202"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_2203"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_2204"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_2205"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfCommitmentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfCommitmentsExplanatory_2206"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfCommitmentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfCommitmentsExplanatory_2207"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_2208"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_2209"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_2210"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_2211"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesTable" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_2212"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfCreditRiskExplanatory" xlink:label="loc_ifrs-full_DisclosureOfCreditRiskExplanatory_2213"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfCreditRiskExplanatory" xlink:label="loc_ifrs-full_DisclosureOfCreditRiskExplanatory_2214"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDeferredTaxesExplanatory_2215"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDeferredTaxesExplanatory_2216"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory_2217"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory_2218"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_2219"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory_2220"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory_2221"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems_2222"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsTable_2223"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_2224"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_2225"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_2226"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_2227"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_2228"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_2229"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_2230"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_2231"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_2232"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_2233"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_2234"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_2235"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_2236"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_2237"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_2238"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_2239"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_2240"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_2241"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_2242"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_2243"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_2244"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_2245"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_2246"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_2247"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_2248"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_2249"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_2250"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_2251"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_2252"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_2253"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_2254"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_2255"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_2256"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_2257"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_2258"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfInventoriesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfInventoriesExplanatory_2259"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfInventoriesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfInventoriesExplanatory_2260"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_2261"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_2262"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfLeasesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfLeasesExplanatory_2263"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfLeasesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfLeasesExplanatory_2264"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfLiquidityRiskExplanatory" xlink:label="loc_ifrs-full_DisclosureOfLiquidityRiskExplanatory_2265"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfLiquidityRiskExplanatory" xlink:label="loc_ifrs-full_DisclosureOfLiquidityRiskExplanatory_2266"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_2267"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_2268"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_2269"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_2270"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_2271"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_2272"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_2273"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_2274"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_2275"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_2276"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory_2277"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory_2278"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_2279"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_2280"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_2281"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_2282"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory" xlink:label="loc_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_2283"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory" xlink:label="loc_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_2284"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_2285"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_2286"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_2287"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_2288"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_2289"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_2290"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_2291"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_2292"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_2293"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_2294"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory_2295"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_2296"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_2297"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:label="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_2298"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:label="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_2299"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfRepurchaseAndReverseRepurchaseAgreementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfRepurchaseAndReverseRepurchaseAgreementsExplanatory_2300"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfRepurchaseAndReverseRepurchaseAgreementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfRepurchaseAndReverseRepurchaseAgreementsExplanatory_2301"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfRepurchaseAndReverseRepurchaseAgreementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfRepurchaseAndReverseRepurchaseAgreementsExplanatory_2302"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReservesWithinEquityAbstract" xlink:label="loc_ifrs-full_DisclosureOfReservesWithinEquityAbstract_2303"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_2304"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_2305"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:label="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_2306"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:label="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_2307"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:label="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_2308"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_2309"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_2310"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_2311"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_2312"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_2313"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_2314"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_2315"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_2316"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_2317"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_2318"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_2319"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_2320"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_2321"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_2322"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_2323"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_2324"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_2325"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_2326"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory_2327"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory_2328"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember" xlink:label="loc_ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember_2329"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember" xlink:label="loc_ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember_2330"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisposalsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DisposalsPropertyPlantAndEquipment_2331"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisposalsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DisposalsPropertyPlantAndEquipment_2332"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisposalsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DisposalsPropertyPlantAndEquipment_2333"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DistributionCosts" xlink:label="loc_ifrs-full_DistributionCosts_2334"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DistributionCosts" xlink:label="loc_ifrs-full_DistributionCosts_2335"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_2336"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_2337"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareExplanatory" xlink:label="loc_ifrs-full_EarningsPerShareExplanatory_2338"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareExplanatory" xlink:label="loc_ifrs-full_EarningsPerShareExplanatory_2339"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareExplanatory" xlink:label="loc_ifrs-full_EarningsPerShareExplanatory_2340"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareLineItems" xlink:label="loc_ifrs-full_EarningsPerShareLineItems_2341"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareTable" xlink:label="loc_ifrs-full_EarningsPerShareTable_2342"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_2343"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_2344"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_2345"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_2346"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_2347"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_2348"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_2349"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_2350"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_2351"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAbstract" xlink:label="loc_ifrs-full_EquityAbstract_2352"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAbstract" xlink:label="loc_ifrs-full_EquityAbstract_2353"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-full_EquityAndLiabilities_2354"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-full_EquityAndLiabilities_2355"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAndLiabilitiesAbstract" xlink:label="loc_ifrs-full_EquityAndLiabilitiesAbstract_2356"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAndLiabilitiesAbstract" xlink:label="loc_ifrs-full_EquityAndLiabilitiesAbstract_2357"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityInterestsOfAcquirer" xlink:label="loc_ifrs-full_EquityInterestsOfAcquirer_2358"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityInterestsOfAcquirer" xlink:label="loc_ifrs-full_EquityInterestsOfAcquirer_2359"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityInterestsOfAcquirer" xlink:label="loc_ifrs-full_EquityInterestsOfAcquirer_2360"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityInterestsOfAcquirer" xlink:label="loc_ifrs-full_EquityInterestsOfAcquirer_2361"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityInterestsOfAcquirer" xlink:label="loc_ifrs-full_EquityInterestsOfAcquirer_2362"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_2363"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExercisePriceOfOutstandingShareOptions2019" xlink:label="loc_ifrs-full_ExercisePriceOfOutstandingShareOptions2019_2364"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_2365"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_2366"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_2367"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_2368"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_2369"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseByNature" xlink:label="loc_ifrs-full_ExpenseByNature_2370"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseByNature" xlink:label="loc_ifrs-full_ExpenseByNature_2371"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseByNatureAbstract" xlink:label="loc_ifrs-full_ExpenseByNatureAbstract_2372"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseByNatureAbstract" xlink:label="loc_ifrs-full_ExpenseByNatureAbstract_2373"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseByNatureAbstract" xlink:label="loc_ifrs-full_ExpenseByNatureAbstract_2374"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_2375"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_2376"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_2377"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExplanationOfDesignatedFinancialAssetsThatAreHeldOutsideLegalEntityThatIssuesContractsWithinScopeOfIFRS4" xlink:label="loc_ifrs-full_ExplanationOfDesignatedFinancialAssetsThatAreHeldOutsideLegalEntityThatIssuesContractsWithinScopeOfIFRS4_2378"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FairValueOfAcquiredReceivables" xlink:label="loc_ifrs-full_FairValueOfAcquiredReceivables_2379"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FairValueOfAcquiredReceivables" xlink:label="loc_ifrs-full_FairValueOfAcquiredReceivables_2380"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_2381"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_2382"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_2383"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_2384"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_2385"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsCategoryMember" xlink:label="loc_ifrs-full_FinancialAssetsCategoryMember_2386"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_2387"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_2388"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialLiabilitiesCategoryMember" xlink:label="loc_ifrs-full_FinancialLiabilitiesCategoryMember_2389"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinishedGoods" xlink:label="loc_ifrs-full_FinishedGoods_2390"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinishedGoods" xlink:label="loc_ifrs-full_FinishedGoods_2391"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FixturesAndFittingsMember" xlink:label="loc_ifrs-full_FixturesAndFittingsMember_2392"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FixturesAndFittingsMember" xlink:label="loc_ifrs-full_FixturesAndFittingsMember_2393"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives" xlink:label="loc_ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives_2394"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives" xlink:label="loc_ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives_2395"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives" xlink:label="loc_ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives_2396"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives" xlink:label="loc_ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives_2397"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnDisposalsOfInvestments" xlink:label="loc_ifrs-full_GainsLossesOnDisposalsOfInvestments_2398"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnDisposalsOfInvestments" xlink:label="loc_ifrs-full_GainsLossesOnDisposalsOfInvestments_2399"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnDisposalsOfInvestments" xlink:label="loc_ifrs-full_GainsLossesOnDisposalsOfInvestments_2400"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnDisposalsOfInvestments" xlink:label="loc_ifrs-full_GainsLossesOnDisposalsOfInvestments_2401"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_2402"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_2403"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_2404"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets" xlink:label="loc_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_2405"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets" xlink:label="loc_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_2406"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets" xlink:label="loc_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_2407"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets" xlink:label="loc_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_2408"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets" xlink:label="loc_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_2409"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets" xlink:label="loc_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets_2410"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets" xlink:label="loc_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets_2411"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets" xlink:label="loc_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets_2412"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" xlink:label="loc_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_2413"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" xlink:label="loc_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_2414"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" xlink:label="loc_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_2415"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" xlink:label="loc_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_2416"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesRecognisedInProfitOrLossAttributableToChangeInUnrealisedGainsOrLossesForAssetsHeldAtEndOfPeriodFairValueMeasurement" xlink:label="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossAttributableToChangeInUnrealisedGainsOrLossesForAssetsHeldAtEndOfPeriodFairValueMeasurement_2417"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesRecognisedInProfitOrLossAttributableToChangeInUnrealisedGainsOrLossesForAssetsHeldAtEndOfPeriodFairValueMeasurement" xlink:label="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossAttributableToChangeInUnrealisedGainsOrLossesForAssetsHeldAtEndOfPeriodFairValueMeasurement_2418"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesRecognisedInProfitOrLossAttributableToChangeInUnrealisedGainsOrLossesForAssetsHeldAtEndOfPeriodFairValueMeasurement" xlink:label="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossAttributableToChangeInUnrealisedGainsOrLossesForAssetsHeldAtEndOfPeriodFairValueMeasurement_2419"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_GeneralAndAdministrativeExpense_2420"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_GeneralAndAdministrativeExpense_2421"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_GeneralAndAdministrativeExpense_2422"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_GeneralAndAdministrativeExpense_2423"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_2424"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_2425"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_2426"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossLeaseLiabilities" xlink:label="loc_ifrs-full_GrossLeaseLiabilities_2427"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossLoanCommitments" xlink:label="loc_ifrs-full_GrossLoanCommitments_2428"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossLoanCommitments" xlink:label="loc_ifrs-full_GrossLoanCommitments_2429"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-full_GrossProfit_2430"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-full_GrossProfit_2431"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-full_GrossProfit_2432"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-full_GrossProfit_2433"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:label="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_2434"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:label="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_2435"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_2436"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_2437"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_2438"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_2439"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_2440"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_2441"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLossOnFinancialAssets" xlink:label="loc_ifrs-full_ImpairmentLossOnFinancialAssets_2442"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLossOnFinancialAssets" xlink:label="loc_ifrs-full_ImpairmentLossOnFinancialAssets_2443"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_2444"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_2445"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_2446"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeStatementAbstract" xlink:label="loc_ifrs-full_IncomeStatementAbstract_2447"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundAbstract" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_2448"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" xlink:label="loc_ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember_2449"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" xlink:label="loc_ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember_2450"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_2451"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_2452"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_2453"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_2454"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_2455"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_2456"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_2457"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_2458"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_2459"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_2460"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesInvestmentProperty" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesInvestmentProperty_2461"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesInvestmentProperty" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesInvestmentProperty_2462"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_2463"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_2464"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_2465"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InsuranceExpense" xlink:label="loc_ifrs-full_InsuranceExpense_2466"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InsuranceExpense" xlink:label="loc_ifrs-full_InsuranceExpense_2467"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_2468"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_2469"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_2470"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_2471"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_2472"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_2473"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_2474"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife" xlink:label="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife_2475"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife" xlink:label="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife_2476"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestExpenseOnBorrowings" xlink:label="loc_ifrs-full_InterestExpenseOnBorrowings_2477"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_2478"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_2479"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_2480"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestReceivable" xlink:label="loc_ifrs-full_InterestReceivable_2481"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestReceivable" xlink:label="loc_ifrs-full_InterestReceivable_2482"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_2483"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_2484"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_2485"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InventoryWritedown2011" xlink:label="loc_ifrs-full_InventoryWritedown2011_2486"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InventoryWritedown2011" xlink:label="loc_ifrs-full_InventoryWritedown2011_2487"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital_2488"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital_2489"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital_2490"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital_2491"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-full_IssueOfEquity_2492"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-full_IssueOfEquity_2493"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-full_IssueOfEquity_2494"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensation_2495"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensation_2496"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensation_2497"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_2498"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_2499"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_2500"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_2501"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_2502"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_2503"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_2504"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_2505"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LandMember" xlink:label="loc_ifrs-full_LandMember_2506"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LandMember" xlink:label="loc_ifrs-full_LandMember_2507"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_2508"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_2509"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_2510"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_2511"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_2512"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_2513"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_2514"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_2515"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_2516"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_2517"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearMember" xlink:label="loc_ifrs-full_LaterThanOneYearMember_2518"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearMember" xlink:label="loc_ifrs-full_LaterThanOneYearMember_2519"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearMember" xlink:label="loc_ifrs-full_LaterThanOneYearMember_2520"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_2521"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_2522"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_2523"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:label="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_2524"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:label="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_2525"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:label="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_2526"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_2527"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_2528"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_2529"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_2530"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_2531"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_2532"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_2533"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilitiesAbstract" xlink:label="loc_ifrs-full_LeaseLiabilitiesAbstract_2534"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LegalProceedingsContingentLiabilityMember" xlink:label="loc_ifrs-full_LegalProceedingsContingentLiabilityMember_2535"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LegalProceedingsContingentLiabilityMember" xlink:label="loc_ifrs-full_LegalProceedingsContingentLiabilityMember_2536"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Level1OfFairValueHierarchyMember" xlink:label="loc_ifrs-full_Level1OfFairValueHierarchyMember_2537"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Level1OfFairValueHierarchyMember" xlink:label="loc_ifrs-full_Level1OfFairValueHierarchyMember_2538"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Level2OfFairValueHierarchyMember" xlink:label="loc_ifrs-full_Level2OfFairValueHierarchyMember_2539"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Level2OfFairValueHierarchyMember" xlink:label="loc_ifrs-full_Level2OfFairValueHierarchyMember_2540"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Level3OfFairValueHierarchyMember" xlink:label="loc_ifrs-full_Level3OfFairValueHierarchyMember_2541"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Level3OfFairValueHierarchyMember" xlink:label="loc_ifrs-full_Level3OfFairValueHierarchyMember_2542"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_2543"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-full_Liabilities_2544"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-full_Liabilities_2545"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-full_Liabilities_2546"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-full_Liabilities_2547"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-full_Liabilities_2548"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-full_Liabilities_2549"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-full_Liabilities_2550"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesAbstract" xlink:label="loc_ifrs-full_LiabilitiesAbstract_2551"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesAbstract" xlink:label="loc_ifrs-full_LiabilitiesAbstract_2552"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_2553"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_2554"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiquidityRiskMember" xlink:label="loc_ifrs-full_LiquidityRiskMember_2555"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiquidityRiskMember" xlink:label="loc_ifrs-full_LiquidityRiskMember_2556"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LoansAndReceivablesCategoryMember" xlink:label="loc_ifrs-full_LoansAndReceivablesCategoryMember_2557"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LoansAndReceivablesCategoryMember" xlink:label="loc_ifrs-full_LoansAndReceivablesCategoryMember_2558"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LossesOnChangeInFairValueOfDerivatives" xlink:label="loc_ifrs-full_LossesOnChangeInFairValueOfDerivatives_2559"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LossesOnChangeInFairValueOfDerivatives" xlink:label="loc_ifrs-full_LossesOnChangeInFairValueOfDerivatives_2560"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LossesOnChangeInFairValueOfDerivatives" xlink:label="loc_ifrs-full_LossesOnChangeInFairValueOfDerivatives_2561"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MachineryMember" xlink:label="loc_ifrs-full_MachineryMember_2562"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MachineryMember" xlink:label="loc_ifrs-full_MachineryMember_2563"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MarketRiskMember" xlink:label="loc_ifrs-full_MarketRiskMember_2564"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MarketRiskMember" xlink:label="loc_ifrs-full_MarketRiskMember_2565"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_2566"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MeasurementAxis" xlink:label="loc_ifrs-full_MeasurementAxis_2567"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MediaProductionExpense" xlink:label="loc_ifrs-full_MediaProductionExpense_2568"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MediaProductionExpense" xlink:label="loc_ifrs-full_MediaProductionExpense_2569"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NetDeferredTaxAssets" xlink:label="loc_ifrs-full_NetDeferredTaxAssets_2570"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NetDeferredTaxAssets" xlink:label="loc_ifrs-full_NetDeferredTaxAssets_2571"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NetDeferredTaxAssets" xlink:label="loc_ifrs-full_NetDeferredTaxAssets_2572"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NetDeferredTaxAssets" xlink:label="loc_ifrs-full_NetDeferredTaxAssets_2573"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NetForeignExchangeGain" xlink:label="loc_ifrs-full_NetForeignExchangeGain_2574"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NetForeignExchangeGain" xlink:label="loc_ifrs-full_NetForeignExchangeGain_2575"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NetForeignExchangeGain" xlink:label="loc_ifrs-full_NetForeignExchangeGain_2576"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NetForeignExchangeLoss" xlink:label="loc_ifrs-full_NetForeignExchangeLoss_2577"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NetForeignExchangeLoss" xlink:label="loc_ifrs-full_NetForeignExchangeLoss_2578"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NetForeignExchangeLoss" xlink:label="loc_ifrs-full_NetForeignExchangeLoss_2579"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NetForeignExchangeLoss" xlink:label="loc_ifrs-full_NetForeignExchangeLoss_2580"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_2581"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_2582"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="loc_ifrs-full_NoncurrentAssetsAbstract_2583"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="loc_ifrs-full_NoncurrentAssetsAbstract_2584"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:label="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_2585"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:label="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_2586"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_2587"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_2588"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_2589"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_2590"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_2591"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_2592"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_2593"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-full_NoncurrentLiabilities_2594"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-full_NoncurrentLiabilities_2595"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_NoncurrentLiabilitiesAbstract_2596"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_NoncurrentLiabilitiesAbstract_2597"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotesAndDebenturesIssued" xlink:label="loc_ifrs-full_NotesAndDebenturesIssued_2598"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotesAndDebenturesIssued" xlink:label="loc_ifrs-full_NotesAndDebenturesIssued_2599"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_2600"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_2601"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_2602"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_2603"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_2604"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable" xlink:label="loc_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_2605"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable" xlink:label="loc_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_2606"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_2607"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_2608"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_2609"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_2610"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_2611"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_2612"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_2613"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_2614"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_2615"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_2616"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_2617"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_2618"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_2619"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_2620"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_2621"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_2622"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_2623"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_2624"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_2625"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_2626"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_2627"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_2628"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_2629"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_2630"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_2631"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_2632"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_2633"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_2634"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_2635"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_2636"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_2637"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_2638"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_2639"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_2640"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_2641"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_2642"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_2643"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_2644"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_2645"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_2646"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_2647"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_2648"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_2649"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_2650"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_2651"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_2652"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OccupancyExpense" xlink:label="loc_ifrs-full_OccupancyExpense_2653"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OccupancyExpense" xlink:label="loc_ifrs-full_OccupancyExpense_2654"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OperatingExpense" xlink:label="loc_ifrs-full_OperatingExpense_2655"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OperatingExpense" xlink:label="loc_ifrs-full_OperatingExpense_2656"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OptionPricingModelMember" xlink:label="loc_ifrs-full_OptionPricingModelMember_2657"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OptionPricingModelMember" xlink:label="loc_ifrs-full_OptionPricingModelMember_2658"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-full_OrdinarySharesMember_2659"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-full_OrdinarySharesMember_2660"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeAbstract" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeAbstract_2661"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeAbstract" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeAbstract_2662"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_2663"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_2664"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_2665"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_2666"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherIncome" xlink:label="loc_ifrs-full_OtherIncome_2667"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherIncome" xlink:label="loc_ifrs-full_OtherIncome_2668"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherIncome" xlink:label="loc_ifrs-full_OtherIncome_2669"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherIncome" xlink:label="loc_ifrs-full_OtherIncome_2670"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherReceivables" xlink:label="loc_ifrs-full_OtherReceivables_2671"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherReceivables" xlink:label="loc_ifrs-full_OtherReceivables_2672"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherTangibleOrIntangibleAssetsTransferred" xlink:label="loc_ifrs-full_OtherTangibleOrIntangibleAssetsTransferred_2673"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsForShareIssueCosts" xlink:label="loc_ifrs-full_PaymentsForShareIssueCosts_2674"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsForShareIssueCosts" xlink:label="loc_ifrs-full_PaymentsForShareIssueCosts_2675"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsForShareIssueCosts" xlink:label="loc_ifrs-full_PaymentsForShareIssueCosts_2676"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsForShareIssueCosts" xlink:label="loc_ifrs-full_PaymentsForShareIssueCosts_2677"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_2678"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_2679"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_2680"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_2681"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_2682"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PlantsMember" xlink:label="loc_ifrs-full_PlantsMember_2683"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PlantsMember" xlink:label="loc_ifrs-full_PlantsMember_2684"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PreviouslyStatedMember" xlink:label="loc_ifrs-full_PreviouslyStatedMember_2685"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PreviouslyStatedMember" xlink:label="loc_ifrs-full_PreviouslyStatedMember_2686"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary" xlink:label="loc_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary_2687"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary" xlink:label="loc_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary_2688"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromExerciseOfOptions" xlink:label="loc_ifrs-full_ProceedsFromExerciseOfOptions_2689"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromExerciseOfOptions" xlink:label="loc_ifrs-full_ProceedsFromExerciseOfOptions_2690"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromExerciseOfOptions" xlink:label="loc_ifrs-full_ProceedsFromExerciseOfOptions_2691"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromIssuingOtherEquityInstruments" xlink:label="loc_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_2692"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromIssuingOtherEquityInstruments" xlink:label="loc_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_2693"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromIssuingOtherEquityInstruments" xlink:label="loc_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_2694"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_2695"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_2696"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_2697"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_2698"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_2699"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_2700"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_2701"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_2702"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_2703"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProductionSupplies" xlink:label="loc_ifrs-full_ProductionSupplies_2704"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProductionSupplies" xlink:label="loc_ifrs-full_ProductionSupplies_2705"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfessionalFeesExpense" xlink:label="loc_ifrs-full_ProfessionalFeesExpense_2706"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfessionalFeesExpense" xlink:label="loc_ifrs-full_ProfessionalFeesExpense_2707"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_2708"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_2709"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_2710"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_2711"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_2712"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossAbstract" xlink:label="loc_ifrs-full_ProfitLossAbstract_2713"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossAbstract" xlink:label="loc_ifrs-full_ProfitLossAbstract_2714"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:label="loc_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_2715"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:label="loc_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_2716"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromContinuingOperations" xlink:label="loc_ifrs-full_ProfitLossFromContinuingOperations_2717"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromContinuingOperations" xlink:label="loc_ifrs-full_ProfitLossFromContinuingOperations_2718"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromContinuingOperations" xlink:label="loc_ifrs-full_ProfitLossFromContinuingOperations_2719"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromContinuingOperations" xlink:label="loc_ifrs-full_ProfitLossFromContinuingOperations_2720"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_2721"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_2722"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_2723"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_2724"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_2725"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_2726"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_2727"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_2728"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_2729"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_2730"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_2731"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_2732"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_2733"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_2734"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_2735"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_2736"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_2737"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_2738"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_2739"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_2740"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_2741"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_2742"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_2743"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_2744"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_2745"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_2746"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_2747"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_2748"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_2749"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_2750"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_2751"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RawMaterials" xlink:label="loc_ifrs-full_RawMaterials_2752"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RawMaterials" xlink:label="loc_ifrs-full_RawMaterials_2753"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RentalIncome" xlink:label="loc_ifrs-full_RentalIncome_2754"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RentalIncome" xlink:label="loc_ifrs-full_RentalIncome_2755"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RepaymentsOfBondsNotesAndDebentures" xlink:label="loc_ifrs-full_RepaymentsOfBondsNotesAndDebentures_2756"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RepaymentsOfBondsNotesAndDebentures" xlink:label="loc_ifrs-full_RepaymentsOfBondsNotesAndDebentures_2757"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_2758"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_2759"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_2760"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_2761"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_2762"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_2763"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:label="loc_ifrs-full_ReserveOfSharebasedPaymentsMember_2764"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:label="loc_ifrs-full_ReserveOfSharebasedPaymentsMember_2765"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RestatedMember" xlink:label="loc_ifrs-full_RestatedMember_2766"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-full_RetainedEarnings_2767"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-full_RetainedEarnings_2768"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-full_RetainedEarnings_2769"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-full_RetainedEarnings_2770"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-full_RetainedEarnings_2771"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetainedEarningsMember" xlink:label="loc_ifrs-full_RetainedEarningsMember_2772"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetainedEarningsMember" xlink:label="loc_ifrs-full_RetainedEarningsMember_2773"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:label="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_2774"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_2775"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_2776"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_2777"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_2778"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_2779"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_2780"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_2781"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SeparateManagementEntitiesAxis" xlink:label="loc_ifrs-full_SeparateManagementEntitiesAxis_2782"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SeparateManagementEntitiesMember" xlink:label="loc_ifrs-full_SeparateManagementEntitiesMember_2783"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SettlementOfLiabilitiesByEntityOnBehalfOfRelatedPartyRelatedPartyTransactions" xlink:label="loc_ifrs-full_SettlementOfLiabilitiesByEntityOnBehalfOfRelatedPartyRelatedPartyTransactions_2784"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SettlementOfLiabilitiesByEntityOnBehalfOfRelatedPartyRelatedPartyTransactions" xlink:label="loc_ifrs-full_SettlementOfLiabilitiesByEntityOnBehalfOfRelatedPartyRelatedPartyTransactions_2785"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_2786"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_2787"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_2788"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_2789"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_2790"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_2791"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharePremium" xlink:label="loc_ifrs-full_SharePremium_2792"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShorttermBorrowingsMember" xlink:label="loc_ifrs-full_ShorttermBorrowingsMember_2793"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShorttermBorrowingsMember" xlink:label="loc_ifrs-full_ShorttermBorrowingsMember_2794"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_2795"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfCashFlowsAbstract" xlink:label="loc_ifrs-full_StatementOfCashFlowsAbstract_2796"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityAbstract" xlink:label="loc_ifrs-full_StatementOfChangesInEquityAbstract_2797"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_2798"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_2799"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfFinancialPositionAbstract" xlink:label="loc_ifrs-full_StatementOfFinancialPositionAbstract_2800"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SubsidiariesMember" xlink:label="loc_ifrs-full_SubsidiariesMember_2801"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SubsidiariesMember" xlink:label="loc_ifrs-full_SubsidiariesMember_2802"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:label="loc_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_2803"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:label="loc_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_2804"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:label="loc_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_2805"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxEffectOfForeignTaxRates" xlink:label="loc_ifrs-full_TaxEffectOfForeignTaxRates_2806"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxEffectOfForeignTaxRates" xlink:label="loc_ifrs-full_TaxEffectOfForeignTaxRates_2807"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:label="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_2808"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:label="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_2809"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_2810"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_2811"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_2812"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_2813"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_2814"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_2815"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_2816"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_2817"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables_2818"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables_2819"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables_2820"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables_2821"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_2822"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_2823"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_2824"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_2825"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherReceivables" xlink:label="loc_ifrs-full_TradeAndOtherReceivables_2826"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherReceivables" xlink:label="loc_ifrs-full_TradeAndOtherReceivables_2827"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherReceivables" xlink:label="loc_ifrs-full_TradeAndOtherReceivables_2828"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherReceivablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherReceivablesAbstract_2829"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherReceivablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherReceivablesAbstract_2830"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TravelExpense" xlink:label="loc_ifrs-full_TravelExpense_2831"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TravelExpense" xlink:label="loc_ifrs-full_TravelExpense_2832"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-full_TypesOfRisksAxis_2833"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-full_TypesOfRisksMember_2834"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_2835"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived" xlink:label="loc_ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived_2836"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived" xlink:label="loc_ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived_2837"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_2838"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_2839"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_2840"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ValuationTechniquesMember" xlink:label="loc_ifrs-full_ValuationTechniquesMember_2841"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ValueAtRisk" xlink:label="loc_ifrs-full_ValueAtRisk_2842"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ValueAtRisk" xlink:label="loc_ifrs-full_ValueAtRisk_2843"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WagesAndSalaries" xlink:label="loc_ifrs-full_WagesAndSalaries_2844"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WagesAndSalaries" xlink:label="loc_ifrs-full_WagesAndSalaries_2845"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_2846"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_2847"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_2848"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_2849"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_2850"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_2851"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_2852"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_2853"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_2854"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_2855"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_2856"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_2857"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_2858"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_2859"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_2860"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_2861"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" xlink:label="loc_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_2862"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" xlink:label="loc_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_2863"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" xlink:label="loc_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_2864"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_2865"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_2866"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_2867"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_2868"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_2869"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageShares" xlink:label="loc_ifrs-full_WeightedAverageShares_2870"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageShares" xlink:label="loc_ifrs-full_WeightedAverageShares_2871"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract" xlink:label="loc_ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_2872"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract" xlink:label="loc_ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_2873"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract" xlink:label="loc_ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_2874"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WorkInProgress" xlink:label="loc_ifrs-full_WorkInProgress_2875"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WorkInProgress" xlink:label="loc_ifrs-full_WorkInProgress_2876"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_PresidentMember" xlink:label="loc_srt_PresidentMember_2877"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_PresidentMember" xlink:label="loc_srt_PresidentMember_2878"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AmendmentFlag_0" xml:lang="en-US">Amendment Flag</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CurrentFiscalYearEndDate_0" xml:lang="en-US">Current Fiscal Year End Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFiscalPeriodFocus_0" xml:lang="en-US">Document Fiscal Period Focus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFiscalYearFocus_0" xml:lang="en-US">Document Fiscal Year Focus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentPeriodEndDate_0" xml:lang="en-US">Document Period End Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentType_0" xml:lang="en-US">Document Type</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCentralIndexKey_0" xml:lang="en-US">Entity Central Index Key</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCommonStockSharesOutstanding_0" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCurrentReportingStatus_0" xml:lang="en-US">Entity Current Reporting Status</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityDomain_0" xml:lang="en-US">Entity [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityEmergingGrowthCompany_0" xml:lang="en-US">Entity Emerging Growth Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityExTransitionPeriod_0" xml:lang="en-US">Entity Ex Transition Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityFilerCategory_0" xml:lang="en-US">Entity Filer Category</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityInteractiveDataCurrent_0" xml:lang="en-US">Entity Interactive Data Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityRegistrantName_0" xml:lang="en-US">Entity Registrant Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityVoluntaryFilers_0" xml:lang="en-US">Entity Voluntary Filers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer_0" xml:lang="en-US">Entity Well-known Seasoned Issuer</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_LegalEntityAxis_0" xml:lang="en-US">Legal Entity [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AcquisitionOfPrismicPharmaceuticalsInc_0" xml:lang="en-US">Acquisition of Prismic Pharmaceuticals Inc</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AcquisitionOfPrismicPharmaceuticalsInc_1" xml:lang="en-US">Represents amount of Acquisition of Prismic Pharmaceuticals Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AcquisitionOfPrismicPharmaceuticalsInc_2" xml:lang="en-US">Acquisition of Prismic Pharmaceuticals Inc</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AddDeductItemsNotAffectingCashAbstract_0" xml:lang="en-US">Add (Deduct) Items Not Affecting Cash [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AddDeductItemsNotAffectingCashAbstract_1" xml:lang="en-US">Add (deduct) items not affecting cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AdditionalInvestmentInExchangeForShares_0" xml:lang="en-US">Additional Investment In Exchange For Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AdditionalInvestmentInExchangeForShares_1" xml:lang="en-US">Represents the amount related to additional investment in exchange for shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AdditionalInvestmentInExchangeForShares_2" xml:lang="en-US">Additional investment in exchange for shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AdditionalRemuneration_0" xml:lang="en-US">Amount of additional remuneration.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AdditionalRemuneration_1" xml:lang="en-US">Additional Remuneration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_AdditionalRemuneration_2" xml:lang="en-US">Additional remuneration as Chairman</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAsset_0" xml:lang="en-US">Adjustments for decrease (increase) in prepaid and deposits to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other assets; Profit (loss)]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAsset_1" xml:lang="en-US">Adjustments For Decrease Increase In Prepaid And Other Asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAssets_0" xml:lang="en-US">Adjustments for decrease (increase) in prepaid and other assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other assets; Profit (loss)]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAssets_1" xml:lang="en-US">Adjustments For Decrease Increase In Prepaid And Other Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAssets_2" xml:lang="en-US">Adjustments For Decrease Increase In Prepaid And Other Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAssets_3" xml:lang="en-US">Prepaid and other assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit_0" xml:lang="en-US">Adjustments for decrease (increase) in prepaid and deposits to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other assets; Profit (loss)]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit_1" xml:lang="en-US">Adjustments For Decrease Increase In Prepaid Expenses and deposit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit_2" xml:lang="en-US">Prepaid expenses and deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposits_0" xml:lang="en-US">Adjustments For Decrease Increase In Prepaid expenses and deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AdjustmentsForDecreaseIncreaseInSalesTaxesRecoverable_0" xml:lang="en-US">Represents adjustments for decrease increase in sales taxes recoverable during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AdjustmentsForDecreaseIncreaseInSalesTaxesRecoverable_1" xml:lang="en-US">Adjustments For Decrease Increase In Sales Taxes Recoverable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_AdjustmentsForDecreaseIncreaseInSalesTaxesRecoverable_2" xml:lang="en-US">Income taxes refund, classified as operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AdjustmentsForDecreaseIncreaseInSalesTaxesRecoverable_3" xml:lang="en-US">Sales taxes recoverable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold_0" xml:lang="en-US">Adjustments for gains losses on changes in the fair value of inventory sold to reconcile profit (loss) to net cash flow from used in operating activities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold_1" xml:lang="en-US">Change in fair value adjustments on inventory sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold_2" xml:lang="en-US">Adjustments For Gains Losses On Change In Fair Value Of Inventory Sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold_3" xml:lang="en-US">Change in fair value adjustments on inventory sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AdjustmentsForIncreaseDecreaseInPrepaidExpensesAndDeposits_0" xml:lang="en-US">Adjustments For Increase (Decrease) In Prepaid Expenses And Deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AdjustmentsForIncreaseDecreaseInPrepaidExpensesAndDeposits_1" xml:lang="en-US">Adjustments for increase (decrease) in prepaid expenses and deposits to reconcile profit (loss) to net cash flow from (used in) operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AdjustmentsForIncreaseDecreaseInPrepaidExpensesAndDeposits_2" xml:lang="en-US">Prepaid expenses and deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AdjustmentsForListingExpense_0" xml:lang="en-US">Represents adjustments for listing expense during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AdjustmentsForListingExpense_1" xml:lang="en-US">Adjustments For Listing Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AdjustmentsForListingExpense_2" xml:lang="en-US">Listing expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AdjustmentsForLossesGainsOnDisposalOfEquipment_0" xml:lang="en-US">Adjustments For Losses (Gains) On Disposal Of Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AdjustmentsForLossesGainsOnDisposalOfEquipment_1" xml:lang="en-US">Adjustments for losses (gains) on disposal of equipment to reconcile profit (loss) to net cash flow from (used in) operating activities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AdjustmentsForLossesGainsOnDisposalOfEquipment_2" xml:lang="en-US">Loss on sale of equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AdjustmentsForLossesGainsOnDisposalOfInventory_0" xml:lang="en-US">Adjustments For Losses (Gains) On Disposal Of Inventory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AdjustmentsForLossesGainsOnDisposalOfInventory_1" xml:lang="en-US">Adjustments for losses (gains) on disposal of inventory to reconcile profit (loss) to net cash flow from (used in) operating activities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AdjustmentsForLossesGainsOnDisposalOfInventory_2" xml:lang="en-US">Loss on disposal of inventory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AdjustmentToExpectedIncomeTaxBenefitAbstract_0" xml:lang="en-US">Adjustment To Expected Income Tax Benefit [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AdjustmentToExpectedIncomeTaxBenefitAbstract_1" xml:lang="en-US">Adjustment to expected income tax benefit:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AdjustmentToExpectedIncomeTaxBenefitChangeInBenefitOfTaxAssetsNotRecognized_0" xml:lang="en-US">Adjustment to expected income tax benefit Change in benefit of tax assets not recognized.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AdjustmentToExpectedIncomeTaxBenefitChangeInBenefitOfTaxAssetsNotRecognized_1" xml:lang="en-US">Adjustment To Expected Income Tax Benefit Change In Benefit Of Tax Assets Not Recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_AdjustmentToExpectedIncomeTaxBenefitChangeInBenefitOfTaxAssetsNotRecognized_2" xml:lang="en-US">Change in benefit of tax assets not recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AdjustmentToExpectedIncomeTaxBenefitChangeInBenefitOfTaxAssetsNotRecognized_3" xml:lang="en-US">Change in Benefit of tax assets not recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AdjustmentToExpectedIncomeTaxBenefitFairValueChangeOfInvestments_0" xml:lang="en-US">Represents Adjustment To Expected Income Tax Benefit fair value change of investments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AdjustmentToExpectedIncomeTaxBenefitFairValueChangeOfInvestments_1" xml:lang="en-US">Adjustment To Expected Income Tax Benefit Fair Value Change Of Investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AdjustmentToExpectedIncomeTaxBenefitFairValueChangeOfInvestments_2" xml:lang="en-US">Fair value change of investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AdjustmentToExpectedIncomeTaxBenefitLossOnDerivativeLiability_0" xml:lang="en-US">Represents adjustment to income tax benefit Loss on derivative liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AdjustmentToExpectedIncomeTaxBenefitLossOnDerivativeLiability_1" xml:lang="en-US">Adjustment To Expected Income Tax Benefit Loss on derivative liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AdjustmentToExpectedIncomeTaxBenefitLossOnDerivativeLiability_2" xml:lang="en-US">Loss on derivative liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AdjustmentToExpectedIncomeTaxBenefitShareIssueCosts_0" xml:lang="en-US">The amount of Adjustment to expected income tax benefit Share issue costs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AdjustmentToExpectedIncomeTaxBenefitShareIssueCosts_1" xml:lang="en-US">Adjustment To Expected Income Tax Benefit Share Issue Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AdjustmentToExpectedIncomeTaxBenefitShareIssueCosts_2" xml:lang="en-US">Share issuance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AdjustmentToExpectedIncomeTaxBenefitStockBasedCompensation_0" xml:lang="en-US">The amount of Adjustment to expected income tax benefit Stock Based Compensation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AdjustmentToExpectedIncomeTaxBenefitStockBasedCompensation_1" xml:lang="en-US">Adjustment To Expected Income Tax Benefit Stock Based Compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AdjustmentToExpectedIncomeTaxBenefitStockBasedCompensation_2" xml:lang="en-US">Share based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AdjustmentToLeaseCommitments_0" xml:lang="en-US">Represents adjustment to lease commitments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AdjustmentToLeaseCommitments_1" xml:lang="en-US">Adjustment To Lease Commitments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AdjustmentToLeaseCommitments_2" xml:lang="en-US">Less: Adjustment to lease commitments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AfterHarvestCostToCompleteAndSellPerGramForDryFlower_0" xml:lang="en-US">After harvest cost to complete and sell per gram for dry flower</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AfterHarvestCostToCompleteAndSellPerGramForDryFlower_1" xml:lang="en-US">Represents after harvest cost to complete and sell per gram for dry flower.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AfterHarvestCostToCompleteAndSellPerGramForDryFlower_2" xml:lang="en-US">After harvest cost to complete and sell per gram for dry flower</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AfterHarvestCostToCompleteAndSellPerGramForDryTrim_0" xml:lang="en-US">After harvest cost to complete and sell per gram for dry trim</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AfterHarvestCostToCompleteAndSellPerGramForDryTrim_1" xml:lang="en-US">Represents after harvest cost to complete and sell per gram for dry trim.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AfterHarvestCostToCompleteAndSellPerGramForDryTrim_2" xml:lang="en-US">After harvest cost to complete and sell per gram for dry trim</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AggregateDiscountForSharesInEscrow_0" xml:lang="en-US">Represents the amount related to aggregate discount for shares in escrow.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AggregateDiscountForSharesInEscrow_1" xml:lang="en-US">Aggregate Discount For Shares In Escrow</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AggregateDiscountForSharesInEscrow_2" xml:lang="en-US">Aggregate discount for shares in escrow</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AggregateUnpaidAccounts_0" xml:lang="en-US">Represents the amount related to unpaid accounts.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AggregateUnpaidAccounts_1" xml:lang="en-US">Aggregate Unpaid Accounts</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AggregateUnpaidAccounts_2" xml:lang="en-US">Aggregate unpaid accounts with respect to stainless steel table manufacturing</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AllianceGlobalPartnersMember_0" xml:lang="en-US">Alliance Global Partners [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AllianceGlobalPartnersMember_1" xml:lang="en-US">This member stands for Alliance Global Partners.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AllianceGlobalPartnersMember_2" xml:lang="en-US">A.G.P/Alliance Global Partners</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AllowanceForImpairment_0" xml:lang="en-US">Allowance for impairment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AllowanceForImpairment_1" xml:lang="en-US">Represents the amount related to allowance for impairment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AllowanceForImpairment_2" xml:lang="en-US">Allowance for impairment of Auxly funds</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AmortizedCostOfFinancialAssetsMember_0" xml:lang="en-US">Represents information regarding amortized cost of financial assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AmortizedCostOfFinancialAssetsMember_1" xml:lang="en-US">Amortized Cost Of Financial Assets [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AmortizedCostOfFinancialAssetsMember_2" xml:lang="en-US">Amortized cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AmortizedCostOfFinancialLiabilitiesMember_0" xml:lang="en-US">Represents information reagarding amortized cost of financial liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AmortizedCostOfFinancialLiabilitiesMember_1" xml:lang="en-US">Amortized Cost Of Financial Liabilities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AmortizedCostOfFinancialLiabilitiesMember_2" xml:lang="en-US">Amortized cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AmountOfAdditionalSharesIssuedAgainstOutstandingLiabilities_0" xml:lang="en-US">Information related to amount of additional shares issued against outstanding liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AmountOfAdditionalSharesIssuedAgainstOutstandingLiabilities_1" xml:lang="en-US">Amount Of Additional Shares Issued Against Outstanding Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_AmountOfAdditionalSharesIssuedAgainstOutstandingLiabilities_2" xml:lang="en-US">Amount of additional shares issued against outstanding liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AmountOfAgreementFallBelowMinimumValue_0" xml:lang="en-US">It represents amount of agreement fall below minimum value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AmountOfAgreementFallBelowMinimumValue_1" xml:lang="en-US">Amount Of Agreement Fall Below Minimum Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AmountOfAgreementFallBelowMinimumValue_2" xml:lang="en-US">Amount of agreement fall below minimum value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions_0" xml:lang="en-US">Amount of broker warrants representing fees and commissions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions_1" xml:lang="en-US">Broker warrants fees and commissions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions_2" xml:lang="en-US">Amount Of Broker Warrants Representing Fees And Commissions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions_3" xml:lang="en-US">Share issuance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions_4" xml:lang="en-US">Amount Of Broker Warrants Representing Fees And Commissions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AmountOfDepositPaidToSupplier_0" xml:lang="en-US">Information about amount of deposit paid to supplier.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AmountOfDepositPaidToSupplier_1" xml:lang="en-US">Amount Of Deposit Paid To Supplier</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AmountOfDepositPaidToSupplier_2" xml:lang="en-US">Amount of deposit paid to supplier</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AmountOfMinimumIssueOfAdditionalCommonSharesUponLiquidation_0" xml:lang="en-US">It represents amount of minimum issue of additional common shares upon liquidation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AmountOfMinimumIssueOfAdditionalCommonSharesUponLiquidation_1" xml:lang="en-US">Amount Of Minimum Issue Of Additional Common Shares Upon liquidation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AmountOfMinimumIssueOfAdditionalCommonSharesUponLiquidation_2" xml:lang="en-US">Amount of minimum issue of additional common shares upon liquidation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AmountOfPurchasePricePaidAsSupplierLoan_0" xml:lang="en-US">Information about amount of purchase price paid as supplier loan.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AmountOfPurchasePricePaidAsSupplierLoan_1" xml:lang="en-US">Amount Of Purchase Price Paid As Supplier Loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AmountOfPurchasePricePaidAsSupplierLoan_2" xml:lang="en-US">Amount of purchase price paid as supplier loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement_0" xml:lang="en-US">Represents the amount of shares issued from entitys treasury by way of private placement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement_1" xml:lang="en-US">Amount Of Shares Issued From Treasury Under Private Placement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement_2" xml:lang="en-US">Amount of Class B shares issued from treasury under private placement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AnthonyDurkaczMember_0" xml:lang="en-US">Represents information of anthony durkacz.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AnthonyDurkaczMember_1" xml:lang="en-US">Anthony Durkacz [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_AnthonyDurkaczMember_2" xml:lang="en-US">Anthony Durkacz</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AnticipatedPurchasePricePlusApplicableTaxesValue_0" xml:lang="en-US">Information about anticipated purchase price plus applicable taxes value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AnticipatedPurchasePricePlusApplicableTaxesValue_1" xml:lang="en-US">Anticipated Purchase Price Plus Applicable Taxes Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AnticipatedPurchasePricePlusApplicableTaxesValue_2" xml:lang="en-US">Anticipated purchase price plus applicable taxes value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Apr82018Member_0" xml:lang="en-US">Represents the information of stock option grant date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Apr82018Member_1" xml:lang="en-US">Apr 8 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Apr82018Member_2" xml:lang="en-US">Apr 8 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Apr92018Member_0" xml:lang="en-US">Represents the information of stock option grant date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Apr92018Member_1" xml:lang="en-US">Apr 9 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Apr92018Member_2" xml:lang="en-US">Apr 9 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_April182018Member_0" xml:lang="en-US">Represents information of Class B shares transaction date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_April182018Member_1" xml:lang="en-US">April 18, 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_April182018Member_2" xml:lang="en-US">April 18, 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Aug142018Member_0" xml:lang="en-US">Represents the information of stock option grant date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Aug142018Member_1" xml:lang="en-US">Aug 14 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Aug142018Member_2" xml:lang="en-US">Aug 14 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Aug152018Member_0" xml:lang="en-US">Represents the information of stock option grant date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Aug152018Member_1" xml:lang="en-US">Aug 15 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Aug152018Member_2" xml:lang="en-US">Aug 15 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Aug82018Member_0" xml:lang="en-US">Represents information of warrants issue date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Aug82018Member_1" xml:lang="en-US">Aug 8 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Aug82018Member_2" xml:lang="en-US">Aug 8 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AuraHealthIncMember_0" xml:lang="en-US">Information about Aura Health Inc. ("Aura").</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AuraHealthIncMember_1" xml:lang="en-US">Aura Health Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AuraHealthIncMember_2" xml:lang="en-US">Aura Health Inc ("Aura")</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AuxlyCannabisGroupIncMember_0" xml:lang="en-US">Auxly Cannabis Group Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AuxlyCannabisGroupIncMember_1" xml:lang="en-US">Auxly Cannabis Group Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AuxlyCannabisGroupIncMember_2" xml:lang="en-US">Auxly Cannabis Group Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_AverageExpectedLifeOfWarrants_0" xml:lang="en-US">Represents average expected life of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_AverageExpectedLifeOfWarrants_1" xml:lang="en-US">Average Expected Life Of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_AverageExpectedLifeOfWarrants_2" xml:lang="en-US">Average Expected Life (years)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_BasisOfPresentationAbstract_0" xml:lang="en-US">Basis Of Presentation [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_BiologicalAssetFairValueAdjustmentMember_0" xml:lang="en-US">This member stands for Biological asset fair value adjustment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_BiologicalAssetFairValueAdjustmentMember_1" xml:lang="en-US">Biological Asset Fair Value Adjustment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_BiologicalAssetFairValueAdjustmentMember_2" xml:lang="en-US">Biological asset fair value adjustment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_BoardMembersMember_0" xml:lang="en-US">Board Members [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_BoardMembersMember_1" xml:lang="en-US">Represents information of board members.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_BoardMembersMember_2" xml:lang="en-US">Board members</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_BonusExpenseToBePaidInSubsequentPeriod_0" xml:lang="en-US">Bonus Expense To Be Paid in subsequent period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_BonusExpenseToBePaidInSubsequentPeriod_1" xml:lang="en-US">Represents the amount related to bonus expense to be paid in subsequent period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_BonusExpenseToBePaidInSubsequentPeriod_2" xml:lang="en-US">Bonus expense to be paid in subsequent period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_BookToFilingAdjustments_0" xml:lang="en-US">Book To Filing Adjustments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_BookToFilingAdjustments_1" xml:lang="en-US">It represents book to filing adjustments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_BookToFilingAdjustments_2" xml:lang="en-US">Book to filing adjustments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_BorrowingsSettled_0" xml:lang="en-US">Borrowings Settled</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_BorrowingsSettled_1" xml:lang="en-US">Represents amount of borrowings settled.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_BorrowingsSettled_2" xml:lang="en-US">Settlement of notes payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_BorrowingsSettledAccruedInterestSettled_0" xml:lang="en-US">Borrowings Settled Accrued Interest Settled</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_BorrowingsSettledAccruedInterestSettled_1" xml:lang="en-US">Represents amount of borrowings settled accrued interest settled.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_BorrowingsSettledAccruedInterestSettled_2" xml:lang="en-US">Accrued interest settled</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_BrokerWarrants_0" xml:lang="en-US">Represents amount related to broker warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_BrokerWarrants_1" xml:lang="en-US">Broker warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_BrokerWarrantsIssuedInPrivatePlacements_0" xml:lang="en-US">Number of broker warrants issued in private placements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_BrokerWarrantsIssuedInPrivatePlacements_1" xml:lang="en-US">Broker Warrants Issued In Private Placements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_BrokerWarrantsIssuedInPrivatePlacements_2" xml:lang="en-US">Number of broker warrants issued in private placements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_BuildingAndFacilityCosts_0" xml:lang="en-US">Building And Facility Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_BuildingAndFacilityCosts_1" xml:lang="en-US">The amount of expenses arising from building and facility costs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_BuildingAndFacilityCosts_2" xml:lang="en-US">Building and facility costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_BusinessAcquisitionDomain_0" xml:lang="en-US">Represents business acquisition domain.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_BusinessAcquisitionDomain_1" xml:lang="en-US">Business Acquisition [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_BusinessAcquisitionsAxis_0" xml:lang="en-US">Represents Business Acquisition Axis.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_BusinessAcquisitionsAxis_1" xml:lang="en-US">Business Acquisitions [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_BusinessAcquisitionsBenefitsAxis_0" xml:lang="en-US">Represents Business Acquisitions axis.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_BusinessAcquisitionsBenefitsAxis_1" xml:lang="en-US">Business Acquisitions benefits [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_BusinessAcquisitionsBenefitsDomain_0" xml:lang="en-US">Represents business acquisitions domain.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_BusinessAcquisitionsBenefitsDomain_1" xml:lang="en-US">Business Acquisitions benefits [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_BusinessLicenseFees_0" xml:lang="en-US">Information about business license fees.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_BusinessLicenseFees_1" xml:lang="en-US">Business License Fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_BusinessLicenseFees_2" xml:lang="en-US">Business license fee</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_CannaraBiotechIncMember_0" xml:lang="en-US">Cannara Biotech Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_CannaraBiotechIncMember_1" xml:lang="en-US">Cannara Biotech Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_CannaraBiotechIncMember_2" xml:lang="en-US">Cannara Biotech Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_CanntabTherapeuticsLtdWorldClassExtractionsIncMember_0" xml:lang="en-US">Information about Canntab Therapeutics Ltd. and World Class Extractions Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_CanntabTherapeuticsLtdWorldClassExtractionsIncMember_1" xml:lang="en-US">Canntab Therapeutics Ltd World Class Extractions Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_CanntabTherapeuticsLtdWorldClassExtractionsIncMember_2" xml:lang="en-US">Canntab Therapeutics Ltd ("Canntab") World Class Extractions Inc ("World Class")</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_CapitalizedCostMember_0" xml:lang="en-US">This member stands for capitalized cost.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_CapitalizedCostMember_1" xml:lang="en-US">Capitalized Cost [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_CapitalizedCostMember_2" xml:lang="en-US">Capitalized Cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_CapitalizedCosts_0" xml:lang="en-US">Represents amount of capitalized costs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_CapitalizedCosts_1" xml:lang="en-US">Capitalized costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_CapitalizedCosts_2" xml:lang="en-US">Capitalized costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_CashAcquiredOnAcquisition_0" xml:lang="en-US">Represents amount related to cash inflow during acquisition.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_CashAcquiredOnAcquisition_1" xml:lang="en-US">Cash acquired On acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_CashAcquiredOnAcquisition_2" xml:lang="en-US">Cash acquired from acquisition Prismic Pharmaceuticals Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_CashAcquiredOnAcquisition_3" xml:lang="en-US">Cash acquired from acquisition of Prismic Pharmaceuticals Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_CashProceedsFromIssuanceOfPrivatePlacement_0" xml:lang="en-US">Cash Proceeds From Issuance Of Private Placement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_CashProceedsFromIssuanceOfPrivatePlacement_1" xml:lang="en-US">It represents cash proceeds from issuance of private placement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_CashProceedsFromIssuanceOfPrivatePlacement_2" xml:lang="en-US">Cash proceeds from issuance of private placement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_CashReceiptsFromSalesOfDebtInstruments_0" xml:lang="en-US">Cash Receipts From Sales Of Debt Instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_CashReceiptsFromSalesOfDebtInstruments_1" xml:lang="en-US">Represents the amount of cash receipt from sale of debt instrument.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_CashReceiptsFromSalesOfDebtInstruments_2" xml:lang="en-US">Cash receipts from sales of debt instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_CenturyAndFvPharmaMember_0" xml:lang="en-US">Name of companies.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_CenturyAndFvPharmaMember_1" xml:lang="en-US">Century And Fv Pharma [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_CenturyAndFvPharmaMember_2" xml:lang="en-US">Century and FV Pharma</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_CertainShareholdersClaimingToHoldInExcessPercentageOfClassBSubordinatedVotingShares_0" xml:lang="en-US">Certain Shareholders Claiming To Hold In Excess Percentage Of Class B Subordinated Voting Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_CertainShareholdersClaimingToHoldInExcessPercentageOfClassBSubordinatedVotingShares_1" xml:lang="en-US">Represents information of Certain Shareholders claiming to hold in excess percentage of class B subordinated voting shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_CertainShareholdersClaimingToHoldInExcessPercentageOfClassBSubordinatedVotingShares_2" xml:lang="en-US">Certain shareholders claiming to hold in excess percentage of class B subordinated voting shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ChangeInFairValueOfInvestment_0" xml:lang="en-US">Change in fair value of investment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ChangeInFairValueOfInvestment_1" xml:lang="en-US">Represents the amount related to change in fair value of the investment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ChangeInFairValueOfInvestmentDueToTenPercentChangeInAssumptionsUsed_0" xml:lang="en-US">Change In Fair Value Of Investment Due To Ten Percent Change In Assumptions Used</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ChangeInFairValueOfInvestmentDueToTenPercentChangeInAssumptionsUsed_1" xml:lang="en-US">Change in fair value of investment due to ten percent change in assumptions used.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ChangeInFairValueOfInvestmentDueToTenPercentChangeInAssumptionsUsed_2" xml:lang="en-US">Change in fair value of investment due to ten percent change in assumptions used</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_0" xml:lang="en-US">Represents the amount related to change in fair value through profit or loss of investments other than investments accounted for using equity method.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_1" xml:lang="en-US">Change in fair value through profit or loss of investments other than investments accounted for using equity method</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_2" xml:lang="en-US">Change in fair value through profit or loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ChangesInNoncashWorkingCapitalBalancesAbstract_0" xml:lang="en-US">Changes In Noncash Working Capital Balances [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ChangesInNoncashWorkingCapitalBalancesAbstract_1" xml:lang="en-US">Changes in non-cash working capital balances</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ChangesInNonCashWorkingCapitalItemsAbstract_0" xml:lang="en-US">Changes In Non Cash Working Capital Items Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ChangesInNonCashWorkingCapitalItemsAbstract_1" xml:lang="en-US">Changes in non-cash working capital balances</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ChangesInShareCapitalTransactionDateAxis_0" xml:lang="en-US">Represents information of changes in share capital transaction date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ChangesInShareCapitalTransactionDateAxis_1" xml:lang="en-US">Changes In Share Capital Transaction Date [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ChangesInShareCapitalTransactionDateDomain_0" xml:lang="en-US">Represents information of changes in share capital transaction date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ChangesInShareCapitalTransactionDateDomain_1" xml:lang="en-US">Changes In Share Capital Transaction Date [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ChiefExecutiveOfficerAndExecutiveCoChairmanMember_0" xml:lang="en-US">This member stands for chief executive officer and executive co-chairman.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ChiefExecutiveOfficerAndExecutiveCoChairmanMember_1" xml:lang="en-US">Chief Executive Officer And Executive Co Chairman [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ChiefExecutiveOfficerAndExecutiveCoChairmanMember_2" xml:lang="en-US">Chief Executive Officer and Executive Co-Chairman</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ChiefExecutiveOfficersMember_0" xml:lang="en-US">This member stands for chief executive officer.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ChiefExecutiveOfficersMember_1" xml:lang="en-US">Chief Executive Officers [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ChiefExecutiveOfficersMember_2" xml:lang="en-US">Chief Executive Officer</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ChiefFinancialOfficersMember_0" xml:lang="en-US">This member stands for chief financial officer.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ChiefFinancialOfficersMember_1" xml:lang="en-US">Chief Financial Officers [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ChiefFinancialOfficersMember_2" xml:lang="en-US">Chief Financial Officer</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ChiefOperatingConsultantMember_0" xml:lang="en-US">Chief Operating Consultant [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ChiefOperatingConsultantMember_1" xml:lang="en-US">Chief Operating Consultant [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ChiefOperatingConsultantMember_2" xml:lang="en-US">Chief Operating Consultant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ClaimForLienComponent_0" xml:lang="en-US">Represents information about claim for lien component.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ClaimForLienComponent_1" xml:lang="en-US">claim for lien component</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ClaimForLienComponent_2" xml:lang="en-US">Claim for lien component</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ClaimIssuedByContractorForVariousPurportedDamages_0" xml:lang="en-US">Represents information about claim issued by contractor for various purported damages.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ClaimIssuedByContractorForVariousPurportedDamages_1" xml:lang="en-US">claim issued by contractor for various purported damages</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ClaimIssuedByContractorForVariousPurportedDamages_2" xml:lang="en-US">Claim issued by contractor for various purported damages</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ClaimIssuedByCreditorForAllegingNonpaymentOfAccounts_0" xml:lang="en-US">Represents the amount related to claim issued by creditor for alleging non-payment of accounts.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ClaimIssuedByCreditorForAllegingNonpaymentOfAccounts_1" xml:lang="en-US">Claim Issued By Creditor For Alleging Nonpayment Of Accounts</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ClaimIssuedByCreditorForAllegingNonpaymentOfAccounts_2" xml:lang="en-US">Claim issued by creditor for alleging nonpayment of accounts</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ClaimSettlementAmount_0" xml:lang="en-US">Claim Settlement Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ClaimSettlementAmount_1" xml:lang="en-US">Represents the claim settlement amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ClaimSettlementAmount_2" xml:lang="en-US">Claim Settlement Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ClaimSettlementAmountCoveredByInsurance_0" xml:lang="en-US">Claim Settlement Amount Covered By Insurance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ClaimSettlementAmountCoveredByInsurance_1" xml:lang="en-US">Represents amount of claim settlement amount covered by insurance.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ClaimSettlementAmountCoveredByInsurance_2" xml:lang="en-US">Claim settlement amount covered by insurance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ClassACommonStockSharesMember_0" xml:lang="en-US">Class A Common Stock Shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ClassACommonStockSharesMember_1" xml:lang="en-US">This member stands for Class A common stock.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ClassACommonStockSharesMember_2" xml:lang="en-US">Class A shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ClassBCommonSharesMember_0" xml:lang="en-US">Class B Common Shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ClassBCommonSharesMember_1" xml:lang="en-US">Represents information of Class B common shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ClassBCommonSharesMember_2" xml:lang="en-US">Class B Common Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ClassBCommonStockSharesMember_0" xml:lang="en-US">Represents information of class B common stock shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ClassBCommonStockSharesMember_1" xml:lang="en-US">Class B Common Stock Shares Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ClassBCommonStockSharesMember_2" xml:lang="en-US">Class B shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ClassBSharesHeldInEscrowMember_0" xml:lang="en-US">Class B shares held in escrow [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ClassBSharesHeldInEscrowMember_1" xml:lang="en-US">Class B shares held in escrow.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ClassBSharesHeldInEscrowMember_2" xml:lang="en-US">Class B shares held in escrow</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ClassBSubordinatedVotingSharesMember_0" xml:lang="en-US">Class B Subordinated Voting Shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ClassBSubordinatedVotingSharesMember_1" xml:lang="en-US">Represents information of class B subordinated voting shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ClassBSubordinatedVotingSharesMember_2" xml:lang="en-US">Class B Subordinated Voting Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ClassBSubordinateVotingSharesMember_0" xml:lang="en-US">Class B subordinate voting shares ("Class B shares").</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ClassBSubordinateVotingSharesMember_1" xml:lang="en-US">Class B Subordinate Voting Shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ClassBSubordinateVotingSharesMember_2" xml:lang="en-US">Class B shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ClassBVotingSharesMember_0" xml:lang="en-US">Represents Class B subordinate voting shares member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ClassBVotingSharesMember_1" xml:lang="en-US">Class B voting shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ClassBVotingSharesMember_2" xml:lang="en-US">Class B subordinate voting shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ClassCommonStockSharesMember_0" xml:lang="en-US">Represents information of Class A Common Stock Shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ClassCommonStockSharesMember_1" xml:lang="en-US">Class Common Stock Shares Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ClassCommonStockSharesMember_2" xml:lang="en-US">Class A shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ClassesOfInventoriesLineItems_0" xml:lang="en-US">Represents class of inventory line item.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ClassesOfInventoriesLineItems_1" xml:lang="en-US">Classes Of Inventories [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ClassesOfInventoriesTable_0" xml:lang="en-US">Represents class of inventories table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ClassesOfInventoriesTable_1" xml:lang="en-US">Classes of inventories [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ClassesOfWarrantsAxis_0" xml:lang="en-US">Classes of warrants [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ClassesOfWarrantsAxis_1" xml:lang="en-US">Represents different classes of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ClassesOfWarrantsDomain_0" xml:lang="en-US">Classes of warrants [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ClassesOfWarrantsDomain_1" xml:lang="en-US">Represents the different classes of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_CloverCannastripThinFilmTechnologiesCorpMember_0" xml:lang="en-US">Clover Cannastrip Thin Film Technologies Corp.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_CloverCannastripThinFilmTechnologiesCorpMember_1" xml:lang="en-US">Clover Cannastrip Thin Film Technologies Corp [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_CloverCannastripThinFilmTechnologiesCorpMember_2" xml:lang="en-US">Clover Cannastrip</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_CloverCannastripThinFilmTechnologiesCorpMember_3" xml:lang="en-US">Clover Cannastrip Thin Film Technologies Corp.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_CollectiveCommitmentToPurchaseProduct_0" xml:lang="en-US">Collective commitment to purchase product</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_CollectiveCommitmentToPurchaseProduct_1" xml:lang="en-US">Represents the amount related to collective commitment to purchase product.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_CommitmentsEquityInstruments_0" xml:lang="en-US">Represents amount of commitments, equity instruments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_CommitmentsEquityInstruments_1" xml:lang="en-US">Commitments Equity Instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_CommitmentsEquityInstruments_2" xml:lang="en-US">Commitments, equity instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_CommitmentsLineItems_0" xml:lang="en-US">Commitments [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_CommitmentsTable_0" xml:lang="en-US">Commitments [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_CommitmentToIssueSharesMinimumValueUponLiquidation_0" xml:lang="en-US">Commitment to issue shares, minimum value upon liquidation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_CommitmentToIssueSharesMinimumValueUponLiquidation_1" xml:lang="en-US">Represents the amount related to commitment to issue shares, minimum value upon liquidation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_CommitmentToIssueSharesMinimumValueUponLiquidation_2" xml:lang="en-US">Commitment to issue shares, minimum value upon liquidation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_CommonStockIssuedForPrivatePlacement_0" xml:lang="en-US">Common Stock Issued For Private Placement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_CommonStockIssuedForPrivatePlacement_1" xml:lang="en-US">It represents common stock issued for private placement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_CommonStockIssuedForPrivatePlacement_2" xml:lang="en-US">Common stock issued for private placement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ConsultingFeesExpenses_0" xml:lang="en-US">Amount of expenses of consulting fees.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ConsultingFeesExpenses_1" xml:lang="en-US">Consulting Fees Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ConsultingFeesExpenses_2" xml:lang="en-US">Consulting fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ConsultingFeesExpenses_3" xml:lang="en-US">Consulting fees expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember_0" xml:lang="en-US">Contingent liability for construction and development costs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember_1" xml:lang="en-US">Contingent Liability For Construction And Development Costs [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember_2" xml:lang="en-US">Contingent liability for construction and development costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ContractualCapitalCommitmentsEqualMonthlyInstalments_0" xml:lang="en-US">Information about contractual capital commitments equal monthly instalments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ContractualCapitalCommitmentsEqualMonthlyInstalments_1" xml:lang="en-US">Contractual Capital Commitments Equal Monthly Instalments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ContractualCapitalCommitmentsEqualMonthlyInstalments_2" xml:lang="en-US">Commitments, equal monthly instalments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ConvertibleDebentureMember_0" xml:lang="en-US">Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ConvertibleDebentureMember_1" xml:lang="en-US">Convertible debenture [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ConvertibleDebentureMember_2" xml:lang="en-US">Convertible debenture</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ConvertibleNotes_0" xml:lang="en-US">Represents convertible notes.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_huge_ConvertibleNotes_1" xml:lang="en-US">Convertible notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ConvertibleNotes_2" xml:lang="en-US">Convertible notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ConvertibleNotes_3" xml:lang="en-US">Convertible notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ConvertibleNotesMember_0" xml:lang="en-US">This member stands for convertible notes.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ConvertibleNotesMember_1" xml:lang="en-US">Convertible Notes [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ConvertibleNotesMember_2" xml:lang="en-US">Convertible notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_CorporateInformationAndNatureOfOperationsAbstract_0" xml:lang="en-US">Corporate Information And Nature Of Operations [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_CriticalAccountingEstimatesAndJudgmentsAbstract_0" xml:lang="en-US">Critical Accounting Estimates And Judgments [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_CurrentNotesPayable_0" xml:lang="en-US">Represents amount related to notes payable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_CurrentNotesPayable_1" xml:lang="en-US">current Notes payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_CurrentNotesPayable_2" xml:lang="en-US">Balance as at December 31, 2019</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_CurrentNotesPayable_3" xml:lang="en-US">Notes payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_CurrentWarrantsLiability_0" xml:lang="en-US">Current Warrants Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_CurrentWarrantsLiability_1" xml:lang="en-US">Amount of warrants liability.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_CurrentWarrantsLiability_2" xml:lang="en-US">Warrants liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DateOfExpiryOfShareOptions_0" xml:lang="en-US">Date of expiry of share options.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DateOfExpiryOfShareOptions_1" xml:lang="en-US">Date Of Expiry Of Share Options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DateOfExpiryOfShareOptions_2" xml:lang="en-US">Expiry Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DebtConversionRatio_0" xml:lang="en-US">Represents the Debt conversion ratio.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DebtConversionRatio_1" xml:lang="en-US">Debt conversion ratio</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Dec122017Member_0" xml:lang="en-US">Represents information of warrants issue date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Dec122017Member_1" xml:lang="en-US">Dec 12 2017 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Dec122017Member_2" xml:lang="en-US">Dec 12 2017</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Dec152018Member_0" xml:lang="en-US">Represents the information of stock option grant date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Dec152018Member_1" xml:lang="en-US">Dec 15 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Dec152018Member_2" xml:lang="en-US">Dec 15 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Dec212017Member_0" xml:lang="en-US">Represents information of warrants issue date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Dec212017Member_1" xml:lang="en-US">Dec 21 2017 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Dec212017Member_2" xml:lang="en-US">Dec 21 2017</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Dec232017Member_0" xml:lang="en-US">Represents the information of stock option grant date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Dec232017Member_1" xml:lang="en-US">Dec 23 2017 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Dec232017Member_2" xml:lang="en-US">Dec 23 2017</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Dec292017Member_0" xml:lang="en-US">Represents information of warrants issue date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Dec292017Member_1" xml:lang="en-US">Dec 29 2017 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Dec292017Member_2" xml:lang="en-US">Dec 29 2017</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_December292017Member_0" xml:lang="en-US">Represents information of Class B shares transaction date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_December292017Member_1" xml:lang="en-US">December 29, 2017 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_December292017Member_2" xml:lang="en-US">December 29, 2017</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_0" xml:lang="en-US">Deductible Temporary Differences Of Capital losses carried forward, For Which No Deferred Tax Asset Is Recognised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_1" xml:lang="en-US">The amount of deductible temporary differences of capital losses carried forward for which no deferred tax asset is recognised in the statement of financial position.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_2" xml:lang="en-US">Capital losses carried forward</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_0" xml:lang="en-US">Deductible Temporary Differences Of Domestic Non capital losses carried forward, For Which No Deferred Tax Asset Is Recognised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_1" xml:lang="en-US">The amount of deductible temporary differences of domestic non-capital losses carried forward for which no deferred tax asset is recognised in the statement of financial position.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_2" xml:lang="en-US">Net operating losses carried forward - US</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_3" xml:lang="en-US">Net-operating loss - US</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfForeignNetOperatingLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_0" xml:lang="en-US">Deductible Temporary Differences Of Foreign Net Operating Loss Carried Forward For Which No Deferred Tax Asset Is Recognised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfForeignNetOperatingLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_1" xml:lang="en-US">It represents deductible temporary differences of foreign net operating loss carried forward for which no deferred tax asset is recognised.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfForeignNetOperatingLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_2" xml:lang="en-US">Net-operating loss - US</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_0" xml:lang="en-US">Deductible Temporary Differences Of Foreign Non capital losses carried forward, For Which No Deferred Tax Asset Is Recognised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_1" xml:lang="en-US">The amount of deductible temporary differences of foreign non-capital losses carried forward for which no deferred tax asset is recognised in the statement of financial position.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_2" xml:lang="en-US">Non-capital losses - Canada</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfForeignUnrealizedForeignExchangeLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_0" xml:lang="en-US">Deductible Temporary Differences Of Foreign Unrealized Foreign Exchange Loss Carried Forward For Which No Deferred Tax Asset Is Recognised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfForeignUnrealizedForeignExchangeLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_1" xml:lang="en-US">It represents deductible temporary differences of foreign unrealized foreign exchange loss carried forward for which no deferred tax asset is recognised.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfForeignUnrealizedForeignExchangeLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_2" xml:lang="en-US">Unrealized foreign exchange loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfIfrs16ForWhichNoDeferredTaxAssetIsRecognised_0" xml:lang="en-US">Deductible Temporary Differences Of Ifrs 16 For Which No Deferred Tax Asset Is Recognised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfIfrs16ForWhichNoDeferredTaxAssetIsRecognised_1" xml:lang="en-US">The amount of deductible temporary differences of IFRS 16 for which no deferred tax asset is recognised in the statement of financial position.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfIfrs16ForWhichNoDeferredTaxAssetIsRecognised_2" xml:lang="en-US">IFRS 16</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised_0" xml:lang="en-US">Deductible Temporary Differences Of Other Investments, For Which No Deferred Tax Asset Is Recognised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised_1" xml:lang="en-US">The amount of deductible temporary differences of other Investments for which no deferred tax asset is recognised in the statement of financial position.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised_2" xml:lang="en-US">Other investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised_0" xml:lang="en-US">Deductible Temporary Differences of property, Plant And Equipment, For Which No Deferred Tax Asset Is Recognised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised_1" xml:lang="en-US">The amount of deductible temporary differences of Property, plant and equipment for which no deferred tax asset is recognised in the statement of financial position.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised_2" xml:lang="en-US">Property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised_0" xml:lang="en-US">Deductible Temporary Differences Of Share issuance costs, For Which No Deferred Tax Asset Is Recognised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised_1" xml:lang="en-US">The amount of deductible temporary differences of share issuance costs for which no deferred tax asset is recognised in the statement of financial position.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised_2" xml:lang="en-US">Share-issuance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfUnrealizedFairValueOnBiologicalAssetsAndInventoryForWhichNoDeferredTaxAssetIsRecognised_0" xml:lang="en-US">Deductible Temporary Differences Of Unrealized fair value on biological assets and inventory, For Which No Deferred Tax Asset Is Recognised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfUnrealizedFairValueOnBiologicalAssetsAndInventoryForWhichNoDeferredTaxAssetIsRecognised_1" xml:lang="en-US">The amount of deductible temporary differences of unrealized fair value on biological assets and inventory for which no deferred tax asset is recognised in the statement of financial position.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DeductibleTemporaryDifferencesOfUnrealizedFairValueOnBiologicalAssetsAndInventoryForWhichNoDeferredTaxAssetIsRecognised_2" xml:lang="en-US">Unrealized fair value on biological assets and inventory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DeferredTaxAssetLiabilityNotRecognized_0" xml:lang="en-US">Deferred tax asset liability not recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DeferredTaxAssetLiabilityNotRecognized_1" xml:lang="en-US">Deferred tax (asset) / liability not recognized.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_DeferredTaxAssetLiabilityNotRecognized_2" xml:lang="en-US">Deferred tax liabilities not recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_huge_DeferredTaxAssetLiabilityNotRecognized_3" xml:lang="en-US">Property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_huge_DeferredTaxAssetLiabilityNotRecognized_4" xml:lang="en-US">Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DeferredTaxAssetNotRecognized_0" xml:lang="en-US">Deferred tax asset not recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DeferredTaxAssetNotRecognized_1" xml:lang="en-US">Deferred tax asset not recognized.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_DeferredTaxAssetNotRecognized_2" xml:lang="en-US">Deferred tax asset not recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DeferredTaxAssetPropertyPlantAndEquipments_0" xml:lang="en-US">Deferred Tax Asset, Property, Plant and Equipments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DeferredTaxAssetPropertyPlantAndEquipments_1" xml:lang="en-US">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_DeferredTaxAssetPropertyPlantAndEquipments_2" xml:lang="en-US">Property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_huge_DeferredTaxAssetPropertyPlantAndEquipments_3" xml:lang="en-US">Property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DeferredTaxAssetsLiabilitiesAxis_0" xml:lang="en-US">Axis for deferred tax assets/liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DeferredTaxAssetsLiabilitiesAxis_1" xml:lang="en-US">Deferred Tax Assets Liabilities [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DeferredTaxAssetsLiabilitiesDomain_0" xml:lang="en-US">Domain for deferred tax assets/liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DeferredTaxAssetsLiabilitiesDomain_1" xml:lang="en-US">Deferred Tax Assets Liabilities [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DeferredTaxAssetsOtherInvestments_0" xml:lang="en-US">Deferred Tax Assets Other investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DeferredTaxAssetsOtherInvestments_1" xml:lang="en-US">Amount of other investments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_DeferredTaxAssetsOtherInvestments_2" xml:lang="en-US">Other investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_huge_DeferredTaxAssetsOtherInvestments_3" xml:lang="en-US">Other investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward_0" xml:lang="en-US">Deferred Tax Liabilities Capital Losses Carried Forward</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward_1" xml:lang="en-US">Represents amount of capital losses carried forward.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward_2" xml:lang="en-US">Capital losses carried forward</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward_3" xml:lang="en-US">Property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DefinitiveBusinessCombinationAgreementMember_0" xml:lang="en-US">Type of agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DefinitiveBusinessCombinationAgreementMember_1" xml:lang="en-US">Definitive Business Combination Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DefinitiveBusinessCombinationAgreementMember_2" xml:lang="en-US">Definitive business combination agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DefinitiveCollaborationProfitSharingAgreementMember_0" xml:lang="en-US">Information about definitive collaboration and profit sharing agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DefinitiveCollaborationProfitSharingAgreementMember_1" xml:lang="en-US">Definitive Collaboration Profit Sharing Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DefinitiveCollaborationProfitSharingAgreementMember_2" xml:lang="en-US">Definitive collaboration and profit sharing agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DefinitiveSettlementAgreementMember_0" xml:lang="en-US">Definitive Settlement Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DefinitiveSettlementAgreementMember_1" xml:lang="en-US">Represents definitive settlement agreement member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_DefinitiveSettlementAgreementMember_2" xml:lang="en-US">Definitive settlement agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DefinitiveStrategicAllianceAndStreamingAgreementMember_0" xml:lang="en-US">Definitive Strategic Alliance and Streaming Agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DefinitiveStrategicAllianceAndStreamingAgreementMember_1" xml:lang="en-US">Definitive Strategic Alliance And Streaming Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DefinitiveStrategicAllianceAndStreamingAgreementMember_2" xml:lang="en-US">Definitive Strategic Alliance and Streaming Agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DerivativeLiabilitiesSettledThroughIssuanceOfShares_0" xml:lang="en-US">Derivative liabilities settled through issuance of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DerivativeLiabilitiesSettledThroughIssuanceOfShares_1" xml:lang="en-US">Represents the amount related to derivative liabilities settled through issuance of shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DescriptionOfExpectedVolatilityWarrantsGranted_0" xml:lang="en-US">The expected volatility of the share price used to calculate the fair value of the warrants granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DescriptionOfExpectedVolatilityWarrantsGranted_1" xml:lang="en-US">Description Of Expected Volatility Warrants Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_DescriptionOfExpectedVolatilityWarrantsGranted_2" xml:lang="en-US">Expected volatility</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DescriptionOfExpectedVolatilityWarrantsGranted_3" xml:lang="en-US">Expected Volatility Range</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DescriptionOfOptionLifeWarrantsGranted_0" xml:lang="en-US">The option life of warrants granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DescriptionOfOptionLifeWarrantsGranted_1" xml:lang="en-US">Description Of Option Life Warrants Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_DescriptionOfOptionLifeWarrantsGranted_2" xml:lang="en-US">Expected maturity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DescriptionOfOptionLifeWarrantsGranted_3" xml:lang="en-US">Average Expected Life (years)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory_0" xml:lang="en-US">Represents description of recent accounting pronouncements adopted policy.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory_1" xml:lang="en-US">Description Of Recent Accounting Pronouncements Adopted Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory_2" xml:lang="en-US">New standards, amendments and interpretations adopted by the Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DescriptionOfReverseShareSplit_0" xml:lang="en-US">Description of reverse share split</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DescriptionOfReverseShareSplit_1" xml:lang="en-US">Represents the description of reverse share split.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DescriptionOfRiskFreeInterestRateWarrantsGranted_0" xml:lang="en-US">The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for warrants granted is expressed, with a remaining term equal to the expected term of the warrants being valued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DescriptionOfRiskFreeInterestRateWarrantsGranted_1" xml:lang="en-US">Description Of Risk Free Interest Rate Warrants Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_DescriptionOfRiskFreeInterestRateWarrantsGranted_2" xml:lang="en-US">Risk free interest rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DescriptionOfRiskFreeInterestRateWarrantsGranted_3" xml:lang="en-US">Risk Free Interest Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DescriptionOfVotingRights_0" xml:lang="en-US">Description of voting rights.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DescriptionOfVotingRights_1" xml:lang="en-US">Description Of Voting Rights</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DescriptionOfVotingRights_2" xml:lang="en-US">Description of voting rights</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DirectCashOfferingCost_0" xml:lang="en-US">Direct Cash Offering Cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DirectCashOfferingCost_1" xml:lang="en-US">It represents direct offering cost.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DirectCashOfferingCost_2" xml:lang="en-US">Direct cash offering cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DirectorsAndOfficersMember_0" xml:lang="en-US">This member stands for directors and officers.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DirectorsAndOfficersMember_1" xml:lang="en-US">Directors And Officers [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_DirectorsAndOfficersMember_2" xml:lang="en-US">Directors and officers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DirectorsAndOfficersMember_3" xml:lang="en-US">Officers and Directors</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DirectorsRemunerationPayable_0" xml:lang="en-US">Represents the value of directors remuneration payable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DirectorsRemunerationPayable_1" xml:lang="en-US">Directors Remuneration Payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DirectorsRemunerationPayable_2" xml:lang="en-US">Director's remuneration payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfAssetsHeldForSaleAbstract_0" xml:lang="en-US">Disclosure Of Assets Held For Sale [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfAssetsHeldForSaleLineItems_0" xml:lang="en-US">Disclosure Of Assets Held For Sale [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfAssetsHeldForSaleLineItems_1" xml:lang="en-US">Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfAssetsHeldForSaleTable_0" xml:lang="en-US">Disclosure Of Assets Held For Sale [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfAssetsHeldForSaleTable_1" xml:lang="en-US">Schedule disclosing information related to the assets held for sale.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfCapitalManagementAbstract_0" xml:lang="en-US">Disclosure Of Capital Management [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_0" xml:lang="en-US">Disclosure of changes in warrants outstanding and weighted average exercise price explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_1" xml:lang="en-US">Represents the tabular disclosure of changes in warrants outstanding and weighted average exercise price.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_2" xml:lang="en-US">Schedule of changes in warrants outstanding and weighted average exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfCommitmentsAbstract_0" xml:lang="en-US">Disclosure Of Commitments [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfCommitmentsAndContingentLiabilitiesAbstract_0" xml:lang="en-US">Disclosure Of Commitments And Contingent Liabilities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfCorporateInformationAndNatureOfOperationsExplanatory_0" xml:lang="en-US">Represents information related to corporate and nature of operations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfCorporateInformationAndNatureOfOperationsExplanatory_1" xml:lang="en-US">Disclosure Of Corporate Information And Nature Of Operations Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfCorporateInformationAndNatureOfOperationsExplanatory_2" xml:lang="en-US">Corporate information and nature of operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutFairValueOfWarrantsWarrantsEstimatedOnDatesOfIssueUsingBlackScholesOptionPricingModelExplanatory_0" xml:lang="en-US">Represents information of fair value of warrants estimated on dates of issue using the Black Scholes option pricing model.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutFairValueOfWarrantsWarrantsEstimatedOnDatesOfIssueUsingBlackScholesOptionPricingModelExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Fair Value Of Warrants Warrants Estimated On Dates Of Issue Using Black Scholes Option Pricing Model Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutFairValueOfWarrantsWarrantsEstimatedOnDatesOfIssueUsingBlackScholesOptionPricingModelExplanatory_2" xml:lang="en-US">Schedule of warrants estimated on dates of issue using the black scholes option pricing model</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory_0" xml:lang="en-US">Disclosure Of Detailed Information About General And Administrative Expense Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory_1" xml:lang="en-US">Tabular disclosure of General and administrative expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory_2" xml:lang="en-US">General and administrative</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory_3" xml:lang="en-US">Schedule of general and administrative expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutInventoriesExplanatory_0" xml:lang="en-US">Represents the tabular disclosure of inventories.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutInventoriesExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Inventories Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutInventoriesExplanatory_2" xml:lang="en-US">Schedule of inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutInvestmentsExplanatory_0" xml:lang="en-US">Represents the tabular disclosure of other investments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutInvestmentsExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Investments Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutInvestmentsExplanatory_2" xml:lang="en-US">Schedule of interests held in other companies related to cannabis industry</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutInvestmentsExplanatory_3" xml:lang="en-US">Schedule of investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutNotesPayableExplanatory_0" xml:lang="en-US">The entire disclosure for notes payable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutNotesPayableExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Notes Payable Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutNotesPayableExplanatory_2" xml:lang="en-US">Schedule of notes payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutRestatementOfPriorPeriodExplanatory_0" xml:lang="en-US">Disclosure Of Detailed Information About Restatement Of Prior Period Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutRestatementOfPriorPeriodExplanatory_1" xml:lang="en-US">The disclosure of detailed information about restatement of prior period information.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutRestatementOfPriorPeriodExplanatory_2" xml:lang="en-US">Schedule of restatement of prior period information</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutRightOfUseAssets_0" xml:lang="en-US">Disclosure Of Detailed Information About Right Of Use Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutRightOfUseAssets_1" xml:lang="en-US">Represents information on right of use assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutRightOfUseAssets_2" xml:lang="en-US">Schedule of Right-of-use asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory_0" xml:lang="en-US">Disclosure Of Detailed Information About Share Options And Warrants Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory_1" xml:lang="en-US">The disclosure of detailed information about Share Options and Warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory_2" xml:lang="en-US">Schedule of share options and warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutWarrantActivityExplanatory_0" xml:lang="en-US">The disclosure of detailed information about warrant activity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutWarrantActivityExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Warrant Activity Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfDetailedInformationAboutWarrantActivityExplanatory_2" xml:lang="en-US">Schedule of warrant activity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory_0" xml:lang="en-US">The entire disclosure for trade and other receivables.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory_1" xml:lang="en-US">Disclosure of detail information about trade and other receivables explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory_2" xml:lang="en-US">Schedule of other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfDetailsInformationAboutRightOfUseAssetExplanatory_0" xml:lang="en-US">Disclosure of details information about Right of use asset Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfDetailsInformationAboutRightOfUseAssetExplanatory_1" xml:lang="en-US">Schedule of Right-of-use asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory_0" xml:lang="en-US">Disclosure Of fair value assumptions of warrants outstanding explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory_1" xml:lang="en-US">Represents the tabular disclosure of fair value assumption of warrants outstanding.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory_2" xml:lang="en-US">Schedule of fair value assumptions of warrants outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfFairValueRecognizedOnAcquisitionTableTextBlock_0" xml:lang="en-US">Represents information related to Acquisition.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfFairValueRecognizedOnAcquisitionTableTextBlock_1" xml:lang="en-US">Disclosure Of Fair Value Recognized On Acquisition [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfFairValueRecognizedOnAcquisitionTableTextBlock_2" xml:lang="en-US">Schedule of allocation total purchase consideration to identifiable assets acquired and liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfFinancialAssetsAndLiabilitiesExplanatory_0" xml:lang="en-US">Represents detailed information of financial assets and liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfFinancialAssetsAndLiabilitiesExplanatory_1" xml:lang="en-US">Disclosure Of Financial Assets And Liabilities Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfFinancialAssetsAndLiabilitiesExplanatory_2" xml:lang="en-US">Schedule of financial assets and financial liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfGeneralAndAdministrativeExpenses_0" xml:lang="en-US">Disclosure Of General And Administrative Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_DisclosureOfGeneralAndAdministrativeExpenses_1" xml:lang="en-US">Schedule of general and administrative expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfInvestmentsAbstract_0" xml:lang="en-US">Disclosure Of Investments [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfInvestmentsLineItems_0" xml:lang="en-US">Disclosure Of Investments [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfInvestmentsTable_0" xml:lang="en-US">Represents the tabular information of other investments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfInvestmentsTable_1" xml:lang="en-US">Disclosure Of Investments [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfNatureOfBusinessAbstract_0" xml:lang="en-US">Represents Nature of business abstract.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfNatureOfBusinessAbstract_1" xml:lang="en-US">Disclosure of Nature of business [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfNatureOfBusinessAbstract_2" xml:lang="en-US">Nature of business</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfNatureOfBusinessExplanatoryTextBlock_0" xml:lang="en-US">Represents nature of business.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfNatureOfBusinessExplanatoryTextBlock_1" xml:lang="en-US">Disclosure Of Nature Of Business Explanatory [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfNatureOfBusinessExplanatoryTextBlock_2" xml:lang="en-US">Nature of business</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfNatureOfBusinessLineItems_0" xml:lang="en-US">Disclosure of nature of business [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfNatureOfBusinessTable_0" xml:lang="en-US">Disclosure of nature of business [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfNatureOfBusinessTable_1" xml:lang="en-US">Represents the tabular information of nature of business.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingAndExercisableShareOptionsExplanatory_0" xml:lang="en-US">The disclosure of the number and weighted average remaining contractual life of outstanding and exercisable share options.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingAndExercisableShareOptionsExplanatory_1" xml:lang="en-US">Disclosure Of Number And Weighted Average Remaining Contractual Life Of Outstanding And Exercisable Share Options Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingAndExercisableShareOptionsExplanatory_2" xml:lang="en-US">Schedule of number and weighted average remaining contractual life of outstanding and exercisable share options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory_0" xml:lang="en-US">Disclosure Of number of warrants outstanding and exercise price explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory_1" xml:lang="en-US">Represents the tabular disclosure of number of warrants outstanding and exercise price.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory_2" xml:lang="en-US">Schedule of number of warrants outstanding and exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfNumberOfWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_0" xml:lang="en-US">Disclosure Of Number Of Warrants Outstanding And Weighted average exercise price explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfNumberOfWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_1" xml:lang="en-US">Represents the tabular disclosure of number of warrants outstanding and its weighted average exercise price.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfNumberOfWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_2" xml:lang="en-US">Disclosure of number of warrants outstanding and weighted average exercise price explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfOperatingLeaseObligationsTableTextBlock_0" xml:lang="en-US">The disclosure of operating lease obligations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfOperatingLeaseObligationsTableTextBlock_1" xml:lang="en-US">Disclosure Of Operating Lease obligations [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfOperatingLeaseObligationsTableTextBlock_2" xml:lang="en-US">Schedule of lease obligations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfProvisionForIncomeTaxesExplanatory_0" xml:lang="en-US">Represents the tabular disclosure of provision for income taxes.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfProvisionForIncomeTaxesExplanatory_1" xml:lang="en-US">Disclosure Of Provision For Income Taxes Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfProvisionForIncomeTaxesExplanatory_2" xml:lang="en-US">Schedule of provision for income taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfQuantitiesAvailableToSupplyByFiscalPeriodUnderCommitmentExplanatory_0" xml:lang="en-US">Disclosure Of Quantities Available To Supply By Fiscal Period Under Commitment Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfQuantitiesAvailableToSupplyByFiscalPeriodUnderCommitmentExplanatory_1" xml:lang="en-US">Represents the tabular disclosure of quantities available to supply by fiscal period, under the supply commitment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfQuantitiesAvailableToSupplyByFiscalPeriodUnderCommitmentExplanatory_2" xml:lang="en-US">Disclosure of quantities available to supply by fiscal period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfReverseTakeoverTransactionAbstract_0" xml:lang="en-US">Disclosure Of Reverse Takeover Transaction [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfReverseTakeoverTransactionExplanatory_0" xml:lang="en-US">Disclosure Of Reverse Takeover Transaction Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfReverseTakeoverTransactionExplanatory_1" xml:lang="en-US">Represents information of reverse takeover transaction.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_DisclosureOfReverseTakeoverTransactionExplanatory_2" xml:lang="en-US">Reverse Takeover Transaction</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfReverseTakeoverTransactionExplanatory_3" xml:lang="en-US">Acquisition of Prismic Pharmaceutical</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract_0" xml:lang="en-US">Disclosure of Share based compensation and warrant reserve [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfShareBasedCompensationAndWarrantReserveExplanatory_0" xml:lang="en-US">Disclosure of Share based compensation and warrant reserve explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfShareBasedCompensationAndWarrantReserveExplanatory_1" xml:lang="en-US">Represents the entire disclosure of share based compensation and warrant reserve.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfShareBasedCompensationAndWarrantReserveExplanatory_2" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory_0" xml:lang="en-US">Disclosure of temporary differences for which no deferred tax asset is recognised explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory_1" xml:lang="en-US">Represents the tabular disclosure of temporary differences for which no deferred tax asset is recognised.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory_2" xml:lang="en-US">Schedule of temporary differences for which no deferred tax asset is recognised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfUnrecognizedTemporaryTaxDifferencesExplanatory_0" xml:lang="en-US">Represents the tabular disclosure of unrecognized temporary tax differences.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfUnrecognizedTemporaryTaxDifferencesExplanatory_1" xml:lang="en-US">Disclosure Of Unrecognized Temporary Tax Differences Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfUnrecognizedTemporaryTaxDifferencesExplanatory_2" xml:lang="en-US">Schedule of unrecognized temporary tax differences</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfWarrantLiabilitiesExplanatory_0" xml:lang="en-US">Disclosure Of Warrant Liabilities Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfWarrantLiabilitiesExplanatory_1" xml:lang="en-US">The entire disclosure of warrant liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DisclosureOfWarrantLiabilitiesExplanatory_2" xml:lang="en-US">Warrants Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfWarrantsLineItems_0" xml:lang="en-US">Disclosure of warrants [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfWarrantsLineItems_1" xml:lang="en-US">Disclosure of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DisclosureOfWarrantsTable_0" xml:lang="en-US">Disclosure of warrants [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DisclosureOfWarrantsTable_1" xml:lang="en-US">Represents the tabular information of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DiscontinuedOperationsOfGeneralAndAdministrative_0" xml:lang="en-US">Discontinued Operations Of General And Administrative</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DiscontinuedOperationsOfGeneralAndAdministrative_1" xml:lang="en-US">Represents amount related to discontinued operations of general and administration.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DiscontinuedOperationsOfGeneralAndAdministrative_2" xml:lang="en-US">Discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DiscountOnProceedsOfSharesAndWarrantsSold_0" xml:lang="en-US">Discount on proceeds of shares and warrants sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_DiscountOnProceedsOfSharesAndWarrantsSold_1" xml:lang="en-US">Represents the percentage for discount on proceeds of shares and warrants sold.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_DiscountOnProceedsOfSharesAndWarrantsSold_2" xml:lang="en-US">Discount on proceeds of shares and warrants sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_DocumentAndEntityInformationAbstract_0" xml:lang="en-US">Document And Entity Information [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_EffectOfSharesIssuedDuringPeriodOnWeightedAverageNumberOfShares_0" xml:lang="en-US">Effect of shares issued during period on weighted average number of shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_EffectOfSharesIssuedDuringPeriodOnWeightedAverageNumberOfShares_1" xml:lang="en-US">Effect Of Shares Issued During Period On Weighted Average Number Of Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_EffectOfSharesIssuedDuringPeriodOnWeightedAverageNumberOfShares_2" xml:lang="en-US">Effect of common shares issued during the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_EffectsOfForeignExchangeOnLeaseLiabilities_0" xml:lang="en-US">Effects Of Foreign Exchange On Lease Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_EffectsOfForeignExchangeOnLeaseLiabilities_1" xml:lang="en-US">Represents the effect of foreign exchange on lease liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_EffectsOfForeignExchangeOnLeaseLiabilities_2" xml:lang="en-US">Effects of foreign exchange</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_EmployeeRelatedLiability_0" xml:lang="en-US">Information about employee related liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_EmployeeRelatedLiability_1" xml:lang="en-US">Employee Related Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_EpitechLicenseAgreementMember_0" xml:lang="en-US">Epitech License Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_EpitechLicenseAgreementMember_1" xml:lang="en-US">Epitech License Agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_EpitechLicenseAgreementMember_2" xml:lang="en-US">Epitech License Agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_EquityDistributionAgreementMember_0" xml:lang="en-US">Equity Distribution Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_EquityDistributionAgreementMember_1" xml:lang="en-US">This member stands for Equity Distribution Agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_EquityDistributionAgreementMember_2" xml:lang="en-US">Equity distribution agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_EstimatedCostOfRestorationInCommitment_0" xml:lang="en-US">Estimated cost of restoration in commitment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_EstimatedCostOfRestorationInCommitment_1" xml:lang="en-US">Represents the amount related to estimated cost of restoration.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceEighteenPointZeroNineMember_0" xml:lang="en-US">Exercise price 18.09</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceEighteenPointZeroNineMember_1" xml:lang="en-US">Exercise Price Eighteen Point Zero Nine [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceEighteenPointZeroNineMember_2" xml:lang="en-US">18.09</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceEightyEightPointFortyFourMember_0" xml:lang="en-US">Exercise price 88.44</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceEightyEightPointFortyFourMember_1" xml:lang="en-US">Exercise Price Eighty eight point forty four [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceEightyEightPointFortyFourMember_2" xml:lang="en-US">88.44</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceEightySixPointFortyThreeMember_0" xml:lang="en-US">Exercise price 86.43</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceEightySixPointFortyThreeMember_1" xml:lang="en-US">Exercise Price Eighty Six Point Forty Three [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceEightySixPointFortyThreeMember_2" xml:lang="en-US">86.43</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceFiftyFivePointTwentyEightMember_0" xml:lang="en-US">Exercise price 55.28</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceFiftyFivePointTwentyEightMember_1" xml:lang="en-US">Exercise Price Fifty Five Point Twenty Eight [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceFiftyFivePointTwentyEightMember_2" xml:lang="en-US">55.28</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceFiftyNinePointThirtyMember_0" xml:lang="en-US">Exercise price 59.30</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceFiftyNinePointThirtyMember_1" xml:lang="en-US">Exercise Price Fifty Nine Point Thirty [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceFiftyNinePointThirtyMember_2" xml:lang="en-US">59.30</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceFiftyPointTwentyFiveMember_0" xml:lang="en-US">Exercise price 50.25</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceFiftyPointTwentyFiveMember_1" xml:lang="en-US">Exercise Price Fifty Point Twenty Five [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceFiftyPointTwentyFiveMember_2" xml:lang="en-US">50.25</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceFiftySixPointTwentyEightMember_0" xml:lang="en-US">Exercise price 56.28</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceFiftySixPointTwentyEightMember_1" xml:lang="en-US">Exercise price Fifty Six Point Twenty Eight [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceFiftySixPointTwentyEightMember_2" xml:lang="en-US">56.28</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceFiftyTwoPointTwentySixMember_0" xml:lang="en-US">Exercise price 52.26</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceFiftyTwoPointTwentySixMember_1" xml:lang="en-US">Exercise Price Fifty Two Point Twenty Six [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceFiftyTwoPointTwentySixMember_2" xml:lang="en-US">52.26</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceFivePointFourThreeMember_0" xml:lang="en-US">Exercise price 5.43</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceFivePointFourThreeMember_1" xml:lang="en-US">Exercise Price Five Point Four Three [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceFivePointFourThreeMember_2" xml:lang="en-US">5.43</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceFivePointZeroThreeMember_0" xml:lang="en-US">Exercise price 5.03</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceFivePointZeroThreeMember_1" xml:lang="en-US">Exercise price Five Point Zero Three [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceFivePointZeroThreeMember_2" xml:lang="en-US">5.03</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceFortyFourPointTwentyTwoMember_0" xml:lang="en-US">Exercise price 44.22</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceFortyFourPointTwentyTwoMember_1" xml:lang="en-US">Exercise Price Forty Four Point Twenty Two [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceFortyFourPointTwentyTwoMember_2" xml:lang="en-US">44.22</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceFortyPointTwentyMember_0" xml:lang="en-US">Exercise price 40.20</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceFortyPointTwentyMember_1" xml:lang="en-US">Exercise Price Forty Point Twenty [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceFortyPointTwentyMember_2" xml:lang="en-US">40.20</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceFortySevenPointTwentyFourMember_0" xml:lang="en-US">Exercise price 47.24</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceFortySevenPointTwentyFourMember_1" xml:lang="en-US">Exercise Price Forty Seven Point Twenty Four [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceFortySevenPointTwentyFourMember_2" xml:lang="en-US">47.24</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceFourPointFourTwoMember_0" xml:lang="en-US">Exercise price 4.42</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceFourPointFourTwoMember_1" xml:lang="en-US">Exercise Price Four Point Four Two [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceFourPointFourTwoMember_2" xml:lang="en-US">4.42</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceFourPointSevenFiveMember_0" xml:lang="en-US">Exercise Price Four Point Seven Five [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceFourPointSevenFiveMember_1" xml:lang="en-US">Exercise price 4.75</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceFourPointSevenFiveMember_2" xml:lang="en-US">4.75</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceNinePointFiveFourMember_0" xml:lang="en-US">Exercise Price Nine Point Five Four [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceNinePointFiveFourMember_1" xml:lang="en-US">Exercise price 9.54</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceNinePointFiveFourMember_2" xml:lang="en-US">9.54</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceOfExercisableShareOptions_0" xml:lang="en-US">Exercise price of exercisable Share options.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceOfExercisableShareOptions_1" xml:lang="en-US">Exercise price of exercisable Share options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceOfWarrantIssue_0" xml:lang="en-US">Exercise Price Of Warrant Issue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceOfWarrantIssue_1" xml:lang="en-US">It represents exercise price of warrant issue.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceOfWarrantIssue_2" xml:lang="en-US">Exercise price of warrant issue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceOfWarrants_0" xml:lang="en-US">Represents the price per share of excercise price of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceOfWarrants_1" xml:lang="en-US">Exercise price of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceOfWarrantsGranted_0" xml:lang="en-US">Exercise price of warrants granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceOfWarrantsGranted_1" xml:lang="en-US">Represents the exercise price of warrants granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ExercisePriceOfWarrantsGranted_2" xml:lang="en-US">Exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceOfWarrantsLiability_0" xml:lang="en-US">Exercise Price Of Warrants Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceOfWarrantsLiability_1" xml:lang="en-US">It represents exercise price of warrants liability.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceOneHundredFortyEightPointSeventyFourMember_0" xml:lang="en-US">Exercise price 148.74</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceOneHundredFortyEightPointSeventyFourMember_1" xml:lang="en-US">Exercise Price One Hundred Forty Eight Point Seventy Four [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ExercisePriceOneHundredFortyEightPointSeventyFourMember_2" xml:lang="en-US">148.74</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember_0" xml:lang="en-US">Exercise price 142.71</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember_1" xml:lang="en-US">Exercise Price One Hundred Forty Two Point Seventy One [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember_2" xml:lang="en-US">142.71</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceOneHundredTwentyPointSixtyMember_0" xml:lang="en-US">Exercise price 120.60</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceOneHundredTwentyPointSixtyMember_1" xml:lang="en-US">Exercise Price One Hundred Twenty Point Sixty [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceOneHundredTwentyPointSixtyMember_2" xml:lang="en-US">120.60</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceSevenPointFiftyMember_0" xml:lang="en-US">Exercise price 7.50</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceSevenPointFiftyMember_1" xml:lang="en-US">Exercise Price Seven Point Fifty [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceSevenPointFiftyMember_2" xml:lang="en-US">7.50</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceSevenPointSeventeenMember_0" xml:lang="en-US">Exercise price 7.17</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceSevenPointSeventeenMember_1" xml:lang="en-US">Exercise Price Seven Point Seventeen [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceSevenPointSeventeenMember_2" xml:lang="en-US">7.17</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceSevenPointSixtyThreeMember_0" xml:lang="en-US">Exercise price 7.63</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceSevenPointSixtyThreeMember_1" xml:lang="en-US">Exercise price Seven Point Sixty Three [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceSevenPointSixtyThreeMember_2" xml:lang="en-US">7.63</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceSevenPointZeroZeroMember_0" xml:lang="en-US">Exercise price 7.00</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceSevenPointZeroZeroMember_1" xml:lang="en-US">Exercise Price Seven Point Zero Zero [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceSevenPointZeroZeroMember_2" xml:lang="en-US">7.00</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceSeventeenPointEightNineMember_0" xml:lang="en-US">Exercise price 17.89</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceSeventeenPointEightNineMember_1" xml:lang="en-US">Exercise Price Seventeen Point Eight Nine [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceSeventeenPointEightNineMember_2" xml:lang="en-US">17.89</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceSeventyFivePointThirtyEightMember_0" xml:lang="en-US">Exercise price 75.38</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceSeventyFivePointThirtyEightMember_1" xml:lang="en-US">Exercise price seventy five point thirty eight [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceSeventyFivePointThirtyEightMember_2" xml:lang="en-US">75.38</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceSeventyOnePointZeroSevenMember_0" xml:lang="en-US">Exercise price 71.07</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceSeventyOnePointZeroSevenMember_1" xml:lang="en-US">Exercise Price Seventy One Point Zero Seven [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceSeventyOnePointZeroSevenMember_2" xml:lang="en-US">71.07</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceSixPointSixteenMember_0" xml:lang="en-US">Exercise price 6.16</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceSixPointSixteenMember_1" xml:lang="en-US">Exercise Price Six Point Sixteen [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceSixPointSixteenMember_2" xml:lang="en-US">6.16</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceSixteenPointZeroEightMember_0" xml:lang="en-US">Exercise price 16.08</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceSixteenPointZeroEightMember_1" xml:lang="en-US">Exercise Price Sixteen Point Zero Eight [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceSixteenPointZeroEightMember_2" xml:lang="en-US">16.08</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceSixtyEightPointZeroOneMember_0" xml:lang="en-US">Exercise price 68.01</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceSixtyEightPointZeroOneMember_1" xml:lang="en-US">Exercise Price Sixty Eight Point Zero One [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceSixtyEightPointZeroOneMember_2" xml:lang="en-US">68.01</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceTenPointSixFiveMember_0" xml:lang="en-US">Exercise price 10.65</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceTenPointSixFiveMember_1" xml:lang="en-US">Exercise Price Ten point six five [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ExercisePriceTenPointSixFiveMember_2" xml:lang="en-US">10.65</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceThirteenPointFourSevenMember_0" xml:lang="en-US">Exercise price 13.47</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceThirteenPointFourSevenMember_1" xml:lang="en-US">Exercise Price Thirteen Point Four Seven [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceThirteenPointFourSevenMember_2" xml:lang="en-US">13.47</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceThirteenPointZeroSevenMember_0" xml:lang="en-US">Exercise price 13.07</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceThirteenPointZeroSevenMember_1" xml:lang="en-US">Exercise Price Thirteen Point Zero Seven [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceThirteenPointZeroSevenMember_2" xml:lang="en-US">13.07</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceThreePointEightSixMember_0" xml:lang="en-US">Exercise Price Three Point Eight Six [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceThreePointEightSixMember_1" xml:lang="en-US">Exercise price 3.86</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceThreePointEightSixMember_2" xml:lang="en-US">3.86</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceThreePointSevenFiveMember_0" xml:lang="en-US">Exercise Price Three Point Seven Five [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceThreePointSevenFiveMember_1" xml:lang="en-US">Exercise price 3.75</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceThreePointSevenFiveMember_2" xml:lang="en-US">3.75</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceTwentyFourPointTwelveMember_0" xml:lang="en-US">24.12</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceTwentyFourPointTwelveMember_1" xml:lang="en-US">Exercise price Twenty Four Point Twelve [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceTwentyFourPointTwelveMember_2" xml:lang="en-US">24.12</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceTwentyOnePointElevenMember_0" xml:lang="en-US">Exercise price 21.11</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceTwentyOnePointElevenMember_1" xml:lang="en-US">Exercise Price Twenty One Point Eleven [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceTwentyOnePointElevenMember_2" xml:lang="en-US">21.11</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceTwentyOnePointNinetyOneMember_0" xml:lang="en-US">Exercise price 21.91</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceTwentyOnePointNinetyOneMember_1" xml:lang="en-US">Exercise Price Twenty One Point Ninety One [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceTwentyOnePointNinetyOneMember_2" xml:lang="en-US">21.91</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceTwentyOnePointTwentyTwoMember_0" xml:lang="en-US">Exercise price 21.22</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceTwentyOnePointTwentyTwoMember_1" xml:lang="en-US">Exercise Price Twenty One Point Twenty Two [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceTwentyOnePointTwentyTwoMember_2" xml:lang="en-US">21.22</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceTwentyPointOneZeroMember_0" xml:lang="en-US">Exercise price 20.10</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceTwentyPointOneZeroMember_1" xml:lang="en-US">Exercise Price Twenty Point One Zero [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceTwentyPointOneZeroMember_2" xml:lang="en-US">20.10</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceTwentySixPointThirteenMember_0" xml:lang="en-US">Exercise price 26.13</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceTwentySixPointThirteenMember_1" xml:lang="en-US">Exercise price Twenty Six Point Thirteen [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceTwentySixPointThirteenMember_2" xml:lang="en-US">26.13</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExercisePriceTwoPointSixOneMember_0" xml:lang="en-US">Exercise price 2.61</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExercisePriceTwoPointSixOneMember_1" xml:lang="en-US">Exercise Price Two Point Six One [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExercisePriceTwoPointSixOneMember_2" xml:lang="en-US">2.61</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExpectedDividendAsPercentageWarrantsGranted_0" xml:lang="en-US">The percentage of an expected dividend used to calculate the fair value of warrants granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExpectedDividendAsPercentageWarrantsGranted_1" xml:lang="en-US">Expected Dividend As Percentage Warrants Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ExpectedDividendAsPercentageWarrantsGranted_2" xml:lang="en-US">Expected dividend yield</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExpectedDividendAsPercentageWarrantsGranted_3" xml:lang="en-US">Expected Dividend Yield</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExpectedDividendYieldOfWarrants_0" xml:lang="en-US">Expected dividend yield of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExpectedDividendYieldOfWarrants_1" xml:lang="en-US">Expected Dividend Yield Of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExpectedDividendYieldOfWarrants_2" xml:lang="en-US">Expected dividend yield</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExpectedDividendYieldOfWarrantsGranted_0" xml:lang="en-US">Expected dividend yield of warrants granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExpectedDividendYieldOfWarrantsGranted_1" xml:lang="en-US">Represents expected dividend yield of warrants granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ExpectedDividendYieldOfWarrantsGranted_2" xml:lang="en-US">Expected dividend yield</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExpectedGrowthCycle_0" xml:lang="en-US">Represents period of expected growth cycle.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExpectedGrowthCycle_1" xml:lang="en-US">Expected growth cycle</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExpectedGrowthCycle_2" xml:lang="en-US">Expected growth cycle</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExpectedGrowthCycleCompleted_0" xml:lang="en-US">Represents expected growth cycle completed.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExpectedGrowthCycleCompleted_1" xml:lang="en-US">Expected growth cycle completed</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExpectedGrowthCycleCompleted_2" xml:lang="en-US">Expected growth cycle completed</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExpectedLifeOfWarrants_0" xml:lang="en-US">Expected life of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExpectedLifeOfWarrants_1" xml:lang="en-US">Represents expected life of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ExpectedLifeOfWarrants_2" xml:lang="en-US">Expected life (years)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExpectedNetSellingPricePerGramOfDriedFlower_0" xml:lang="en-US">Represents expected net selling price per gram of dried flower.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExpectedNetSellingPricePerGramOfDriedFlower_1" xml:lang="en-US">Expected net selling price per gram of dried flower</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExpectedNetSellingPricePerGramOfTrim_0" xml:lang="en-US">Represents expected net selling price per gram of trim.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExpectedNetSellingPricePerGramOfTrim_1" xml:lang="en-US">Expected net selling price per gram of trim</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExpectedNetSellingPricePerGramOfTrim_2" xml:lang="en-US">Expected net selling price per gram of trim</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExpectedSellingPricePerGramOfDriedFlower_0" xml:lang="en-US">Expected selling price per gram of dried flower</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExpectedSellingPricePerGramOfDriedFlower_1" xml:lang="en-US">Represents expected selling price per gram of dried flower.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExpectedSellingPricePerGramOfTrim_0" xml:lang="en-US">Expected selling price per gram of trim</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExpectedSellingPricePerGramOfTrim_1" xml:lang="en-US">Represents expected selling price per gram of trim.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExpectedSellingPricePerGramOfTrim_2" xml:lang="en-US">Expected selling price per gram of trim</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExpectedTermOfWarrants_0" xml:lang="en-US">Represents the expected term of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExpectedTermOfWarrants_1" xml:lang="en-US">Expected Term Of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExpectedTermOfWarrants_2" xml:lang="en-US">Expected term of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExpectedVolatilityOfWarrants_0" xml:lang="en-US">Represents expected volatility of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExpectedVolatilityOfWarrants_1" xml:lang="en-US">Expected Volatility Of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ExpectedVolatilityOfWarrants_2" xml:lang="en-US">Expected volatility of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExpectedVolatilityOfWarrants_3" xml:lang="en-US">Expected Volatility Range</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExpectedVolatilityOfWarrantsGranted_0" xml:lang="en-US">Expected volatility of warrants granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExpectedVolatilityOfWarrantsGranted_1" xml:lang="en-US">Represents expected volatility of warrants granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ExpectedVolatilityOfWarrantsGranted_2" xml:lang="en-US">Annualized volatility</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExpectedVolatilityOfWarrantsLiability_0" xml:lang="en-US">Expected Volatility Of Warrants Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExpectedVolatilityOfWarrantsLiability_1" xml:lang="en-US">Represents expected volatility of warrants liability.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExpectedYieldForCannabisPlantsOfDryFlowerPerPlant_0" xml:lang="en-US">Expected yield for cannabis plants of dry flower, per plant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExpectedYieldForCannabisPlantsOfDryFlowerPerPlant_1" xml:lang="en-US">Represents expected yield for cannabis plants of dry flower, per plant.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExpectedYieldForCannabisPlantsOfDryFlowerPerPlant_2" xml:lang="en-US">Expected yield for cannabis plants of dry flower, per plant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExpectedYieldForCannabisPlantsOfDryTrimPerPlant_0" xml:lang="en-US">Expected yield for cannabis plants of dry trim, per plant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExpectedYieldForCannabisPlantsOfDryTrimPerPlant_1" xml:lang="en-US">Represents expected yield for cannabis plants of dry trim, per plant.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExpectedYieldForCannabisPlantsOfDryTrimPerPlant_2" xml:lang="en-US">Expected yield for cannabis plants of dry trim, per plant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExpectedYieldOfDryFlower_0" xml:lang="en-US">Represents expected yield of dry flower.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExpectedYieldOfDryFlower_1" xml:lang="en-US">Expected yield of dry flower</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExpectedYieldOfDryFlower_2" xml:lang="en-US">Expected yield of dry flower</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExpectedYieldOfDryTrim_0" xml:lang="en-US">Represents expected yield of dry trim.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExpectedYieldOfDryTrim_1" xml:lang="en-US">Expected yield of dry trim</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExpectedYieldOfDryTrim_2" xml:lang="en-US">Expected yield of dry trim</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExpiryDateOfWarrants_0" xml:lang="en-US">Represents expiry date of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExpiryDateOfWarrants_1" xml:lang="en-US">Expiry Date Of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExpiryDateOfWarrants_2" xml:lang="en-US">Expiry Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ExpiryTermOfWarrantsGranted_0" xml:lang="en-US">Represents term of expiry of warrants granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ExpiryTermOfWarrantsGranted_1" xml:lang="en-US">Expiry Term Of Warrants Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ExpiryTermOfWarrantsGranted_2" xml:lang="en-US">Expiry term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_FacilityRelatedExpenditures_0" xml:lang="en-US">information about facility related expenditures.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_FacilityRelatedExpenditures_1" xml:lang="en-US">Facility related expenditures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_FacilityRelatedExpenditures_2" xml:lang="en-US">Facility related expenditures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_FacilityUnderDevelopmentMember_0" xml:lang="en-US">This member stands for Facility under development.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_FacilityUnderDevelopmentMember_1" xml:lang="en-US">Facility Under Development [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_FacilityUnderDevelopmentMember_2" xml:lang="en-US">Facility and related</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_FairValueAdjustmentsOnInventorySold_0" xml:lang="en-US">Represents amount of Fair value adjustments on inventory sold.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_huge_FairValueAdjustmentsOnInventorySold_1" xml:lang="en-US">Fair value adjustments on inventory sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_FairValueAdjustmentsOnInventorySold_2" xml:lang="en-US">Fair value adjustments on inventory sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_FairValueAdjustmentsOnInventorySold_3" xml:lang="en-US">Fair value adjustments on inventory sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_FairValueOfCommonSharesApprovedForIssuance_0" xml:lang="en-US">Fair Value Of Common Shares Approved For Issuance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_FairValueOfCommonSharesApprovedForIssuance_1" xml:lang="en-US">Represents amount of fair value of common shares approved for issuance.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_FairValueOfCommonSharesApprovedForIssuance_2" xml:lang="en-US">Fair value of common shares approved for issuance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_FairValueOfCommonSharesIssued_0" xml:lang="en-US">Fair Value Of Common Shares Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_FairValueOfCommonSharesIssued_1" xml:lang="en-US">Fair value of common shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_FairValueOfCommonSharesOfResidualValue_0" xml:lang="en-US">Fair Value Of Common Shares Of Residual Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_FairValueOfCommonSharesOfResidualValue_1" xml:lang="en-US">It represents fair value of common shares of residual value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_FairValueOfCommonSharesOfResidualValue_2" xml:lang="en-US">Fair value of common shares of residual value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_FairValueOfCommonStockOfNotesPayable_0" xml:lang="en-US">Fair Value Of Common Stock Of Notes Payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_FairValueOfCommonStockOfNotesPayable_1" xml:lang="en-US">Fair value of common stock of notes payable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_FairValueOfCommonStockOfNotesPayable_2" xml:lang="en-US">Fair value of common stock of notes payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_FairValueOfCommonStockToSettleNotesPayable_0" xml:lang="en-US">Fair Value Of Common Stock To Settle Notes Payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_FairValueOfCommonStockToSettleNotesPayable_1" xml:lang="en-US">Represents amount of fair value of common stock to settle notes payable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_FairValueOfCommonStockToSettleNotesPayable_2" xml:lang="en-US">Fair value of common stock to settle notes payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_FairValueOfIssuanceOfCommonStockSharesApproved_0" xml:lang="en-US">Fair Value Of Issuance Of Common Stock Shares Approved</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_FairValueOfIssuanceOfCommonStockSharesApproved_1" xml:lang="en-US">Represents amount of fair value of issuance Of common stock shares approved.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_FairValueOfIssuanceOfCommonStockSharesApproved_2" xml:lang="en-US">Fair value of issuance of common stock shares approved</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_FairValueOfShareBasedCompensationBonus_0" xml:lang="en-US">Fair Value Of Share Based Compensation Bonus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_FairValueOfShareBasedCompensationBonus_1" xml:lang="en-US">Represents amount of fair value of share based compensation bonus.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_FairValueOfShareBasedCompensationBonus_2" xml:lang="en-US">Fair value of share-based compensation bonus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_FairValueOfShares_0" xml:lang="en-US">Represents the amount related to fair value of shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_FairValueOfShares_1" xml:lang="en-US">Fair Value Of Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_FairValueOfShares_2" xml:lang="en-US">Fair value of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_FairValueOfSharesAndWarrantsAcquired_0" xml:lang="en-US">Fair Value Of Shares And Warrants acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_FairValueOfSharesAndWarrantsAcquired_1" xml:lang="en-US">Represents the fair value of shares and warrants acquired.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_FairValueOfSharesAndWarrantsAcquired_2" xml:lang="en-US">Fair value of shares and warrants acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_FairValueOfWarrantLiability_0" xml:lang="en-US">Fair Value Of Warrant Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_FairValueOfWarrantLiability_1" xml:lang="en-US">It represents fair value of warrant liability.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_FairValueOfWarrantLiability_2" xml:lang="en-US">Fair value of warrant liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_FairValueOfWarrantLiabilityOfResidualAmount_0" xml:lang="en-US">Fair Value Of Warrant Liability Of Residual Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_FairValueOfWarrantLiabilityOfResidualAmount_1" xml:lang="en-US">It represents fair value of warrant liability of residual amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_FairValueOfWarrantLiabilityOfResidualAmount_2" xml:lang="en-US">Fair value of warrant liability of residual amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_FairValueOfWarrants_0" xml:lang="en-US">Represents fair value of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_FairValueOfWarrants_1" xml:lang="en-US">Fair Value Of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_FairValueOfWarrants_2" xml:lang="en-US">Fair Values</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_FairValueOfWarrants_3" xml:lang="en-US">Fair value of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_FairValueOfWarrantsIssued_0" xml:lang="en-US">Fair Value Of Warrants Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_FairValueOfWarrantsIssued_1" xml:lang="en-US">Represents amount of fair value of warrants issued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_FairValueOfWarrantsIssued_2" xml:lang="en-US">Fair value of warrants issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Feb252018Member_0" xml:lang="en-US">Represents the information of stock option grant date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Feb252018Member_1" xml:lang="en-US">Feb 25 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Feb252018Member_2" xml:lang="en-US">Feb 25 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_FindersFee_0" xml:lang="en-US">Information about finders fee.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_FindersFee_1" xml:lang="en-US">Finders Fee</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_FindersFee_2" xml:lang="en-US">Finders fee</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_FindersFeeShares_0" xml:lang="en-US">Represents amount related to finders fee shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_FindersFeeShares_1" xml:lang="en-US">Finders fee shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_FirstRepublicCapitalCorporationMember_0" xml:lang="en-US">This member stands for first republic capital corporation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_FirstRepublicCapitalCorporationMember_1" xml:lang="en-US">First Republic Capital Corporation [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_FirstRepublicCapitalCorporationMember_2" xml:lang="en-US">FRCC</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_FormerChiefExecutiveOfficerMember_0" xml:lang="en-US">Represents information about former chief executive officer.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_FormerChiefExecutiveOfficerMember_1" xml:lang="en-US">Former Chief executive Officer [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_FormerChiefExecutiveOfficerMember_2" xml:lang="en-US">Former CEO</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_FormerChiefOperatingOfficerMember_0" xml:lang="en-US">This members stands for former chief operating officer.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_FormerChiefOperatingOfficerMember_1" xml:lang="en-US">Former Chief Operating Officer [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_FormerChiefOperatingOfficerMember_2" xml:lang="en-US">Former Chief Operating Officer</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_FSDBiosciencesMember_0" xml:lang="en-US">FSD Biosciences [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_FSDBiosciencesMember_1" xml:lang="en-US">F S D Biosciences [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_FSDBiosciencesMember_2" xml:lang="en-US">FSD Biosciences</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_FundsPaidForSettlementAgreement_0" xml:lang="en-US">Funds Paid For Settlement Agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_FundsPaidForSettlementAgreement_1" xml:lang="en-US">Represents the amount of fund paid for the Settlement Agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_FundsPaidForSettlementAgreement_2" xml:lang="en-US">Funds paid for settlement agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_FurnitureFixturesAndEquipmentMember_0" xml:lang="en-US">This member stands for furniture fixtures and equipment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_FurnitureFixturesAndEquipmentMember_1" xml:lang="en-US">Furniture Fixtures And Equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_FurnitureFixturesAndEquipmentMember_2" xml:lang="en-US">Furniture and fixtures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_FvPharmaIncMember_0" xml:lang="en-US">Represents information for FV Pharma Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_FvPharmaIncMember_1" xml:lang="en-US">Fv Pharma Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_FvPharmaIncMember_2" xml:lang="en-US">FV Pharma Inc</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_GainLossOnChangeInFairValueOfDerivativeLiability_0" xml:lang="en-US">Represents the amount related to gain (loss) on change in fair value of derivative liability.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_GainLossOnChangeInFairValueOfDerivativeLiability_1" xml:lang="en-US">Gain (loss) on change in fair value of derivative liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_GainLossOnSaleOfEquipment_0" xml:lang="en-US">Gain (Loss) On Sale Of Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_GainLossOnSaleOfEquipment_1" xml:lang="en-US">Represents the amount of gain (loss) on sale of equipment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_GainLossOnSaleOfEquipment_2" xml:lang="en-US">Loss on sale of equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_GainLossOnSettlementOfFinancialLiability_0" xml:lang="en-US">Gain Loss On Settlement Of Financial Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_GainLossOnSettlementOfFinancialLiability_1" xml:lang="en-US">Represents amount of gain loss on settlement of financial liability.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_GainLossOnSettlementOfFinancialLiability_2" xml:lang="en-US">Loss (gain) on settlement of financial liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_GainLossOnSettlementOfFinancialLiability_3" xml:lang="en-US">Gain on settlement of financial liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_huge_GainLossOnSettlementOfFinancialLiability_4" xml:lang="en-US">Loss (gain) on settlement of financial liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="lab_huge_GainLossOnSettlementOfFinancialLiability_5" xml:lang="en-US">Gain (loss) on settlement of financial liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_GainOnSettlementOfDerivativeLiability_0" xml:lang="en-US">Gain On Settlement Of Derivative Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_GainOnSettlementOfDerivativeLiability_1" xml:lang="en-US">Gain on settlement of derivative liability.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_GainOnSettlementOfDerivativeLiability_2" xml:lang="en-US">Gain on settlement of derivative liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_GainOnSettlementOfFinancialLiability_0" xml:lang="en-US">Represents amount of gain on settlement of financial liability.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_GainOnSettlementOfFinancialLiability_1" xml:lang="en-US">Gain On Settlement Of Financial Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_GainOnSettlementOfFinancialLiability_2" xml:lang="en-US">Loss on settlement of financial liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_huge_GainOnSettlementOfFinancialLiability_3" xml:lang="en-US">Loss (gain) on settlement of financial liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_GeneralAndAdministrativeExpenseContinuedAndDiscontinuedOperations_0" xml:lang="en-US">General And Administrative Expense Continued And Discontinued Operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_GeneralAndAdministrativeExpenseContinuedAndDiscontinuedOperations_1" xml:lang="en-US">Represents amount of general and administrative expense continued and discontinued operations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_GeneralAndAdministrativeExpenseContinuedAndDiscontinuedOperations_2" xml:lang="en-US">General and administrative</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_GeneralAndAdministrativeExpenseDiscontinuedOperations_0" xml:lang="en-US">General And Administrative Expense Discontinued Operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_GeneralAndAdministrativeExpenseDiscontinuedOperations_1" xml:lang="en-US">Represents amount of general and administrative expense discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_GeneralAndAdministrativeExpenseDiscontinuedOperations_2" xml:lang="en-US">Discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_GeneralOfficeInsuranceAndAdministrationExpenditures_0" xml:lang="en-US">General Office Insurance And Administration Expenditures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_GeneralOfficeInsuranceAndAdministrationExpenditures_1" xml:lang="en-US">The amount of expense arising from general office, insurance and administration expenditures.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_GeneralOfficeInsuranceAndAdministrationExpenditures_2" xml:lang="en-US">General office, insurance and administration expenditures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_GrantDateAxis_0" xml:lang="en-US">Information by date or year award under share-based payment arrangement is granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_GrantDateAxis_1" xml:lang="en-US">Grant Date [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_GrantDateDomain_0" xml:lang="en-US">Date or year award under share-based payment arrangement is granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_GrantDateDomain_1" xml:lang="en-US">Grant Date [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_GrossGeneralAndAdministrativeExpense_0" xml:lang="en-US">Gross General And Administrative Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_GrossGeneralAndAdministrativeExpense_1" xml:lang="en-US">Represents amount related to gross general and administrative expense.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_GrossGeneralAndAdministrativeExpense_2" xml:lang="en-US">General and administrative</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_GrossLossProfitBeforeFairValueAdjustments_0" xml:lang="en-US">Represents amount of Gross (loss) profit before fair value adjustments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_GrossLossProfitBeforeFairValueAdjustments_1" xml:lang="en-US">Gross loss profit before fair value adjustments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_huge_GrossLossProfitBeforeFairValueAdjustments_2" xml:lang="en-US">Gross loss before fair value adjustments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_GrossProfitLossBeforeFairValueAdjustments_0" xml:lang="en-US">Gross Profit (Loss) Before Fair Value Adjustments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_GrossProfitLossBeforeFairValueAdjustments_1" xml:lang="en-US">Represents the amount of gross profit (loss) before fair value adjustments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_GrossProfitLossBeforeFairValueAdjustments_2" xml:lang="en-US">Gross loss before fair value adjustments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_GuaranteedMinimumLiquidationValueOfShares_0" xml:lang="en-US">Guaranteed minimum liquidation value of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_GuaranteedMinimumLiquidationValueOfShares_1" xml:lang="en-US">Represents guaranteed minimum liquidation value of shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_HarvestedCannabisMember_0" xml:lang="en-US">This member stands for Harvested cannabis.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_HarvestedCannabisMember_1" xml:lang="en-US">Harvested cannabis [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_HarvestedCannabisMember_2" xml:lang="en-US">Harvested cannabis</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_HempProductsMember_0" xml:lang="en-US">This member stands for Hemp products.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_HempProductsMember_1" xml:lang="en-US">Hemp products [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_HempProductsMember_2" xml:lang="en-US">Hemp products</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_HeritageBuildingRestorationCommitmentMember_0" xml:lang="en-US">Heritage Building Restoration Commitment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_HeritageBuildingRestorationCommitmentMember_1" xml:lang="en-US">Heritage Building Restoration Commitment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_HeritageBuildingRestorationCommitmentMember_2" xml:lang="en-US">Heritage Building Restoration Commitment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_HighTideIncMember_0" xml:lang="en-US">High Tide Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_HighTideIncMember_1" xml:lang="en-US">High Tide Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_HighTideIncMember_2" xml:lang="en-US">High Tide Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_HugeShopsMember_0" xml:lang="en-US">HUGE Shops</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_HugeShopsMember_1" xml:lang="en-US">Huge Shops [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_HugeShopsMember_2" xml:lang="en-US">HUGE Shops</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ImpactOfPresentValue_0" xml:lang="en-US">Represents impact of present value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ImpactOfPresentValue_1" xml:lang="en-US">Impact of present value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ImpactOfPresentValue_2" xml:lang="en-US">Less: Impact of present value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ImpactOfPresentValueOnLeaseObligations_0" xml:lang="en-US">Impact of present value on lease obligations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ImpactOfPresentValueOnLeaseObligations_1" xml:lang="en-US">Represents the amount related to impact of present value on lease obligations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ImpactOfPresentValueOnLeaseObligations_2" xml:lang="en-US">Less: Impact of present value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ImpairmentLossOfPropertyPlantAndEquipmentAndRightOfUseAsset_0" xml:lang="en-US">Impairment Loss of property, plant and equipment and right of use asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ImpairmentLossOfPropertyPlantAndEquipmentAndRightOfUseAsset_1" xml:lang="en-US">Represents the amount related to impairment Loss of property, plant and equipment and right-of-use asset.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ImpairmentLossOfPropertyPlantAndEquipmentAndRightOfUseAsset_2" xml:lang="en-US">Impairment of property, plant and equipment and right-of-use asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ImpairmentLossOnRightOfUseAsset_0" xml:lang="en-US">Impairment Loss On Right Of Use Asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ImpairmentLossOnRightOfUseAsset_1" xml:lang="en-US">Represents the amount related to impairment Loss of right-of-use asset.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ImpairmentLossOnRightOfUseAsset_2" xml:lang="en-US">Impairment loss on right of use asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_huge_ImpairmentLossOnRightOfUseAsset_3" xml:lang="en-US">Impairment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ImpairmentLossOnRightOfUseAsset_4" xml:lang="en-US">Impairment of right-of-use asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ImpairmentLossRecognisedInRightOfUseAsset_0" xml:lang="en-US">Impairment Loss Recognised In Right of use asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ImpairmentLossRecognisedInRightOfUseAsset_1" xml:lang="en-US">Impairment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_huge_ImpairmentLossRecognisedInRightOfUseAsset_2" xml:lang="en-US">Impairment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ImpairmentLossRecognisedInRightOfUseAsset_3" xml:lang="en-US">Impairment of right-of-use asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ImpairmentMember_0" xml:lang="en-US">This member stands for impairment member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ImpairmentMember_1" xml:lang="en-US">Impairment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ImpairmentMember_2" xml:lang="en-US">Impairment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember_0" xml:lang="en-US">Increase Decrease Due To Changes In Foreign Currency Translation [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember_1" xml:lang="en-US">Represents foreign currency translation member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_IncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember_2" xml:lang="en-US">Foreign currency translation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IncreaseDecreaseFromContributedSurplusToShareCapital_0" xml:lang="en-US">Increase Decrease From Contributed Surplus To Share Capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IncreaseDecreaseFromContributedSurplusToShareCapital_1" xml:lang="en-US">It represents increase decrease from contributed surplus to share capital.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_IncreaseDecreaseFromContributedSurplusToShareCapital_2" xml:lang="en-US">Increase from contributed surplus to share capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IncreaseDecreaseInFairValueOfOtherInvestments_0" xml:lang="en-US">Amount of increase Decrease In Fair Value of other investments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_huge_IncreaseDecreaseInFairValueOfOtherInvestments_1" xml:lang="en-US">Increase in fair value of other investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IncreaseDecreaseInFairValueOfOtherInvestments_2" xml:lang="en-US">Increase Decrease In Fair Value Of Other Investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_IncreaseDecreaseInFairValueOfOtherInvestments_3" xml:lang="en-US">Increase in fair value of other investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IncreaseDecreaseInSettlementOfLiabilityOfNotesPayable_0" xml:lang="en-US">Increase Decrease In Settlement Of Liability Of Notes Payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IncreaseDecreaseInSettlementOfLiabilityOfNotesPayable_1" xml:lang="en-US">it represents increase decrease in settlement of liability of notes payable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_IncreaseDecreaseInSettlementOfLiabilityOfNotesPayable_2" xml:lang="en-US">Increase in settlement of liability of notes payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_0" xml:lang="en-US">The increase (decrease) in equity shares resulting from acquisition of net assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_1" xml:lang="en-US">Increase (decrease) Through acquisition of net assets, Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_2" xml:lang="en-US">Issued on acquisition of net assets of Prismic Pharmaceuticals, Inc (shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue_0" xml:lang="en-US">The increase (decrease) in equity resulting from acquisition of net assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue_1" xml:lang="en-US">Increase (decrease) Through acquisition of net assets, Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue_2" xml:lang="en-US">Issued on acquisition of net assets of Prismic Pharmaceuticals, Inc</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IncreaseDecreaseThroughExerciseOfOptionShares_0" xml:lang="en-US">The increase (decrease) in equity resulting from exercise of option.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IncreaseDecreaseThroughExerciseOfOptionShares_1" xml:lang="en-US">Increase Decrease Through Exercise Of Option Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_IncreaseDecreaseThroughExerciseOfOptionShares_2" xml:lang="en-US">Stock options exercised (shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_IncreaseDecreaseThroughExerciseOfOptionShares_3" xml:lang="en-US">Share options exercised (shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares_0" xml:lang="en-US">The increase (decrease) in equity shares resulting from warrants exercised.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares_1" xml:lang="en-US">Increase Decrease Through Exercise Of Warrants Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares_2" xml:lang="en-US">Warrants exercised (shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares_0" xml:lang="en-US">The increase (decrease) in equity shares resulting from warrants expired.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares_1" xml:lang="en-US">Increase (decrease) Through expiry Of Warrants Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares_2" xml:lang="en-US">Warrants expired (shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue_0" xml:lang="en-US">The increase (decrease) in equity resulting from warrants expired.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue_1" xml:lang="en-US">Increase (decrease) Through expiry Of Warrants Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue_2" xml:lang="en-US">Warrants expired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset_0" xml:lang="en-US">It represents Increase Decrease Through issued on acquisition of net assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset_1" xml:lang="en-US">Increase Decrease Through issued on acquisition of net asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset_2" xml:lang="en-US">Issued on acquisition of net assets of Prismic Pharmaceuticals, Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares_0" xml:lang="en-US">It represents Increase Decrease Through issued on acquisition of net assets shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares_1" xml:lang="en-US">Increase Decrease Through issued on acquisition of net assets shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares_2" xml:lang="en-US">Issued on acquisition of net assets of Prismic Pharmaceuticals, Inc. (shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IncreaseDecreaseThroughReverseAcquisition_0" xml:lang="en-US">The increase (decrease) in equity resulting from reverse acquisition.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IncreaseDecreaseThroughReverseAcquisition_1" xml:lang="en-US">Increase Decrease Through Reverse Acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_IncreaseDecreaseThroughReverseAcquisition_2" xml:lang="en-US">Reverse acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IncreaseDecreaseThroughReverseAcquisitionShares_0" xml:lang="en-US">The increase (decrease) in equity shares resulting from reverse acquisition.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IncreaseDecreaseThroughReverseAcquisitionShares_1" xml:lang="en-US">Increase Decrease Through Reverse Acquisition Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_IncreaseDecreaseThroughReverseAcquisitionShares_2" xml:lang="en-US">Reverse acquisition (shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_IncreaseDecreaseThroughReverseAcquisitionShares_3" xml:lang="en-US">Warrant valuations (shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares_0" xml:lang="en-US">Increase Decrease Through Share Based Payment Transactions Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares_1" xml:lang="en-US">It represents increase decrease through share based payment transactions shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares_2" xml:lang="en-US">Share-based payments (shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IncreaseDecreaseThroughShareIssueRelatedCostShares_0" xml:lang="en-US">Increase decrease through share issue related cost shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IncreaseDecreaseThroughShareIssueRelatedCostShares_1" xml:lang="en-US">Increase Decrease Through Share Issue Related Cost Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_IncreaseDecreaseThroughShareIssueRelatedCostShares_2" xml:lang="en-US">Number of broker warrants representing fees and commissions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_IncreaseDecreaseThroughShareIssueRelatedCostShares_3" xml:lang="en-US">Shares issued (shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IncreaseDecreaseThroughStockOptionsCancelled_0" xml:lang="en-US">The increase (decrease) in equity resulting from stock options cancelled.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IncreaseDecreaseThroughStockOptionsCancelled_1" xml:lang="en-US">Increase Decrease Through Stock Options Cancelled</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_IncreaseDecreaseThroughStockOptionsCancelled_2" xml:lang="en-US">Stock options cancelled</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_IncreaseDecreaseThroughStockOptionsCancelled_3" xml:lang="en-US">Share options cancelled</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IncreaseDecreaseThroughWarrantValuations_0" xml:lang="en-US">The increase (decrease) in equity resulting from warrant valuations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IncreaseDecreaseThroughWarrantValuations_1" xml:lang="en-US">Increase Decrease Through Warrant Valuations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_IncreaseDecreaseThroughWarrantValuations_2" xml:lang="en-US">Warrant valuations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IncreaseDecreaseThroughWarrantValuationsShares_0" xml:lang="en-US">The increase (decrease) in equity shares resulting from warrant valuations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IncreaseDecreaseThroughWarrantValuationsShares_1" xml:lang="en-US">Increase Decrease Through Warrant Valuations Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_IncreaseDecreaseThroughWarrantValuationsShares_2" xml:lang="en-US">Warrant valuations (shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_IncreaseDecreaseThroughWarrantValuationsShares_3" xml:lang="en-US">Increase Decrease Through Warrant Valuations Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IncrementalBorrowingRateToDiscountLeaseLiabilities_0" xml:lang="en-US">Incremental borrowing rate to discount lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IncrementalBorrowingRateToDiscountLeaseLiabilities_1" xml:lang="en-US">Represents the percentage related to incremental borrowing rate to discount the lease liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_IncrementalBorrowingRateToDiscountLeaseLiabilities_2" xml:lang="en-US">Incremental borrowing rate to discount lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IndependentDirectorMember_0" xml:lang="en-US">This member stands for independent director.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IndependentDirectorMember_1" xml:lang="en-US">Independent Director [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_IndependentDirectorMember_2" xml:lang="en-US">Former Chief Operating Officer</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_IndependentDirectorMember_3" xml:lang="en-US">Independent directors</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_InsuredAmountForClaimSettlemnt_0" xml:lang="en-US">Insured Amount For Claim Settlemnt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_InsuredAmountForClaimSettlemnt_1" xml:lang="en-US">Represents the insured claim settlement amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_InsuredAmountForClaimSettlemnt_2" xml:lang="en-US">Insured amount for settlement of claim</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_InvestorRelationsExpenses_0" xml:lang="en-US">Information about investor relations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_InvestorRelationsExpenses_1" xml:lang="en-US">Investor Relations Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_InvestorRelationsExpenses_2" xml:lang="en-US">Investor relations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IssuanceCostOfCommonSharesAndWarrants_0" xml:lang="en-US">Issuance Cost Of Common Shares And Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IssuanceCostOfCommonSharesAndWarrants_1" xml:lang="en-US">It represents issuance cost of common shares and warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_IssuanceCostOfCommonSharesAndWarrants_2" xml:lang="en-US">Issuance cost of common shares and warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IssuanceOfCommonSharesOfShareBasedBonusToEmployeesForPerformance_0" xml:lang="en-US">Issuance Of Common Shares Of Share Based Bonus To Employees For Performance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IssuanceOfCommonSharesOfShareBasedBonusToEmployeesForPerformance_1" xml:lang="en-US">It represents issuance of common shares of share based bonus to employees for performance.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_IssuanceOfCommonSharesOfShareBasedBonusToEmployeesForPerformance_2" xml:lang="en-US">Issuance of common shares of share based bonus to employees for performance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IssuanceOfCommonStockForNotesPayable_0" xml:lang="en-US">Issuance Of Common Stock For Notes Payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IssuanceOfCommonStockForNotesPayable_1" xml:lang="en-US">It represents issuance of common stock for notes payable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_IssuanceOfCommonStockForNotesPayable_2" xml:lang="en-US">Issuance of common stock for notes payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IssuanceOfCommonStockOfBoardOfDirectorsInLieuOfCash_0" xml:lang="en-US">Issuance Of Common Stock Of Board Of Directors In Lieu Of Cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IssuanceOfCommonStockOfBoardOfDirectorsInLieuOfCash_1" xml:lang="en-US">It represents issuance of common stock of board of directors in lieu of cash.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_IssuanceOfCommonStockOfBoardOfDirectorsInLieuOfCash_2" xml:lang="en-US">Issuance of common stock of board of directors in lieu of cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IssuanceOfCommonStockOfDirectOffering_0" xml:lang="en-US">Issuance Of Common Stock Of Direct Offering</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IssuanceOfCommonStockOfDirectOffering_1" xml:lang="en-US">It represents Issuance of common stock of direct offering.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_IssuanceOfCommonStockOfDirectOffering_2" xml:lang="en-US">Issuance of common stock of direct offering</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IssuanceOfCommonStockOfShareBasedCompensation_0" xml:lang="en-US">Issuance Of Common Stock Of Share Based Compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IssuanceOfCommonStockOfShareBasedCompensation_1" xml:lang="en-US">It represents issuance of common stock of share based compensation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_IssuanceOfCommonStockOfShareBasedCompensation_2" xml:lang="en-US">Issuance of common stock of share based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IssuanceOfShares_0" xml:lang="en-US">Number of shares issued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IssuanceOfShares_1" xml:lang="en-US">Issuance Of Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_IssuanceOfShares_2" xml:lang="en-US">Shares issued (shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_IssuanceOfShares_3" xml:lang="en-US">Number of shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_IssuanceOfWarrantsOfDirectOffering_0" xml:lang="en-US">Issuance Of Warrants Of Direct Offering</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_IssuanceOfWarrantsOfDirectOffering_1" xml:lang="en-US">It represents Issuance of warrants of direct offering.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_IssuanceOfWarrantsOfDirectOffering_2" xml:lang="en-US">Issuance of warrants of direct offering</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Jan52018Member_0" xml:lang="en-US">Represents the information of grant date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Jan52018Member_1" xml:lang="en-US">Jan 5 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Jan52018Member_2" xml:lang="en-US">Jan 5 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Jan52018WarrantMember_0" xml:lang="en-US">Represents information of warrants issue date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Jan52018WarrantMember_1" xml:lang="en-US">Jan 5 2018 Warrant [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Jan52018WarrantMember_2" xml:lang="en-US">Jan 5 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Jun112018Member_0" xml:lang="en-US">Represents the information of stock option grant date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Jun112018Member_1" xml:lang="en-US">Jun 11 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Jun112018Member_2" xml:lang="en-US">Jun 11 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Jun122018Member_0" xml:lang="en-US">Represents the information of stock option grant date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Jun122018Member_1" xml:lang="en-US">Jun 12 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Jun122018Member_2" xml:lang="en-US">Jun 12 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_KeyManagementAndDirectorsMember_0" xml:lang="en-US">Key Management And Directors [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_KeyManagementAndDirectorsMember_1" xml:lang="en-US">Information about key management and directors.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_KeyManagementAndDirectorsMember_2" xml:lang="en-US">Key management and directors</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_KeyManagementPersonnelCarAllowance_0" xml:lang="en-US">The amount of car allowance to key management personnel.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_KeyManagementPersonnelCarAllowance_1" xml:lang="en-US">Key Management Personnel Car Allowance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_KeyManagementPersonnelCarAllowance_2" xml:lang="en-US">Amount of car allowance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_LeaseTermOnOfficeSpace_0" xml:lang="en-US">Information about lease term on office space.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_LeaseTermOnOfficeSpace_1" xml:lang="en-US">Lease Term On Office Space</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_LeaseTermOnOfficeSpace_2" xml:lang="en-US">Lease term on office space</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_LegalEntitiesAxis_0" xml:lang="en-US">Represents legal entities axis.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_LegalEntitiesAxis_1" xml:lang="en-US">Legal Entities [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_LegalEntitiesDomain_0" xml:lang="en-US">Represents legal entities domain.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_LegalEntitiesDomain_1" xml:lang="en-US">Legal Entities [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_LegalProvision_0" xml:lang="en-US">Legal Provision</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_LegalProvision_1" xml:lang="en-US">Represents the amount of legal provision.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_LegalProvision_2" xml:lang="en-US">Legal provision</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ListingExpense_0" xml:lang="en-US">Listing expense.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ListingExpense_1" xml:lang="en-US">Listing expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ListingExpense_2" xml:lang="en-US">Listing expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_LossGainOnChangesInFairValueOfOtherInvestments_0" xml:lang="en-US">Represents amount of Loss (gain) on changes in fair value of other investments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_huge_LossGainOnChangesInFairValueOfOtherInvestments_1" xml:lang="en-US">Loss on changes in fair value of investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_LossGainOnChangesInFairValueOfOtherInvestments_2" xml:lang="en-US">Loss gain on changes in fair value of other investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_LossGainOnChangesInFairValueOfOtherInvestments_3" xml:lang="en-US">Loss on changes in fair value of investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_LossOnSaleOfEquipment_0" xml:lang="en-US">Loss On Sale Of Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_LossOnSaleOfEquipment_1" xml:lang="en-US">Represents the amount of Loss on sale of equipment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_LossOnSaleOfEquipment_2" xml:lang="en-US">Loss on sale of equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_LossOnSaleOfInventory_0" xml:lang="en-US">Loss On Sale Of Inventory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_LossOnSaleOfInventory_1" xml:lang="en-US">Represents the amount of Loss on sale of inventory.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_LossOnSaleOfInventory_2" xml:lang="en-US">Loss on disposal of inventory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ManagementAndConsultingContractsMember_0" xml:lang="en-US">Information of management and consulting contracts.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ManagementAndConsultingContractsMember_1" xml:lang="en-US">Management And Consulting Contracts [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ManagementAndConsultingContractsMember_2" xml:lang="en-US">Management and consulting contracts</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ManagementFees_0" xml:lang="en-US">Amount paid for management fees.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ManagementFees_1" xml:lang="en-US">Management Fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ManagementFees_2" xml:lang="en-US">Management fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Mar222018Member_0" xml:lang="en-US">Represents the information of stock option grant date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Mar222018Member_1" xml:lang="en-US">Mar 22 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Mar222018Member_2" xml:lang="en-US">Mar 22 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Mar282018Member_0" xml:lang="en-US">Represents the information of stock option grant date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Mar282018Member_1" xml:lang="en-US">Mar 28 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Mar282018Member_2" xml:lang="en-US">Mar 28 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_March262018Member_0" xml:lang="en-US">Represents information of Class B shares transaction date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_March262018Member_1" xml:lang="en-US">March 26, 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_March262018Member_2" xml:lang="en-US">March 26, 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_March282018Member_0" xml:lang="en-US">Represents information of Class B shares transaction date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_March282018Member_1" xml:lang="en-US">March 28, 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_March282018Member_2" xml:lang="en-US">March 28, 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_March92018Member_0" xml:lang="en-US">Represents information of Class B shares transaction date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_March92018Member_1" xml:lang="en-US">March 9, 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_March92018Member_2" xml:lang="en-US">March 9, 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_MarketPriceOfShares_0" xml:lang="en-US">Market price of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_MarketPriceOfShares_1" xml:lang="en-US">Represents the market price of shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_MarketPriceOfShares_2" xml:lang="en-US">Market price of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_MarketPriceOfWarrants_0" xml:lang="en-US">Represents market price of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_MarketPriceOfWarrants_1" xml:lang="en-US">Market Price Of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_MarketPriceOfWarrants_2" xml:lang="en-US">Market Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_MarketPriceShareOptionsGranted_0" xml:lang="en-US">The market price share options granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_MarketPriceShareOptionsGranted_1" xml:lang="en-US">Market Price Share Options Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_MarketPriceShareOptionsGranted_2" xml:lang="en-US">Market Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_MaximumAggregateOfferingPrice_0" xml:lang="en-US">Maximum Aggregate Offering Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_MaximumAggregateOfferingPrice_1" xml:lang="en-US">Represents amount of maximum offering price.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_MaximumAggregateOfferingPrice_2" xml:lang="en-US">Maximum aggregate offering price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_May242018Member_0" xml:lang="en-US">Represents information of Class B shares transaction date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_May242018Member_1" xml:lang="en-US">May 24, 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_May242018Member_2" xml:lang="en-US">May 24, 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_May242018WarrantMember_0" xml:lang="en-US">Represents information of warrants issue date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_May242018WarrantMember_1" xml:lang="en-US">May 24 2018 Warrant [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_May242018WarrantMember_2" xml:lang="en-US">May 24 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_May82018Member_0" xml:lang="en-US">Represents information of Class B shares transaction date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_May82018Member_1" xml:lang="en-US">May 8, 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_May82018Member_2" xml:lang="en-US">May 8, 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_MealsAndEntertainment_0" xml:lang="en-US">Meals and entertainment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_MealsAndEntertainment_1" xml:lang="en-US">Meals and entertainment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_MealsAndEntertainment_2" xml:lang="en-US">Meals and entertainment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_MinimumInvestmentReceivable_0" xml:lang="en-US">Minimum investment receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_MinimumInvestmentReceivable_1" xml:lang="en-US">Represents the amount of minimum investment receivable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_MinimumInvestmentReceivable_2" xml:lang="en-US">Minimum investment receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NetOperatingLossCarryforwardsLimitationsInUse_0" xml:lang="en-US">Net Operating Loss Carryforwards Limitations In Use</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NetOperatingLossCarryforwardsLimitationsInUse_1" xml:lang="en-US">Represents limitations in utilization of net operating loss carryforwards.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_NetOperatingLossCarryforwardsLimitationsInUse_2" xml:lang="en-US">Description for limitations of utilization of net operating loss carryforwards</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NetSellingPricePerGramForDryFlowerAfterHarvestCost_0" xml:lang="en-US">net selling price per gram for dry flower After harvest cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NetSellingPricePerGramForDryFlowerAfterHarvestCost_1" xml:lang="en-US">Represents amount related to after harvest cost to sell flower.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NetSellingPricePerGramForDryFlowerAfterHarvestCost_2" xml:lang="en-US">Net selling price per gram for dry flower after harvest cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NetSellingPricePerGramForDryTrimAfterHarvestCost_0" xml:lang="en-US">net selling price per gram for dry trim After harvest cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NetSellingPricePerGramForDryTrimAfterHarvestCost_1" xml:lang="en-US">Represents amount related to net selling price per gram for dry trim after harvest cost.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NetSellingPricePerGramForDryTrimAfterHarvestCost_2" xml:lang="en-US">Net selling price per gram for dry trim After harvest cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandFourty_0" xml:lang="en-US">Non Capital Income Tax Losses Expire On Two Thousand Fourty</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandFourty_1" xml:lang="en-US">Represents amount of Non capital income tax losses expire on 2040.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandFourty_2" xml:lang="en-US">2040</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight_0" xml:lang="en-US">Non Capital Income Tax Losses Expire on Two Thousand Thirty Eight</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight_1" xml:lang="en-US">Represents amount of Non capital income tax losses expire on 2038.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight_2" xml:lang="en-US">2038</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFive_0" xml:lang="en-US">Non Capital Income Tax Losses Expire On Two Thousand Thirty Five</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFive_1" xml:lang="en-US">Represents amount of Non capital income tax losses expire on 2035.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFive_2" xml:lang="en-US">2035</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFour_0" xml:lang="en-US">Non Capital Income Tax Losses Expire On Two Thousand Thirty Four</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFour_1" xml:lang="en-US">Represents amount of Non capital income tax losses expire on 2034.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFour_2" xml:lang="en-US">2034</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine_0" xml:lang="en-US">Non capital income tax losses expire On Two Thousand Thirty Nine</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine_1" xml:lang="en-US">Represents amount of Non capital income tax losses expire on 2039.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine_2" xml:lang="en-US">2039</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySeven_0" xml:lang="en-US">Non Capital Income Tax Losses Expire On Two Thousand Thirty Seven</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySeven_1" xml:lang="en-US">Represents amount of Non capital income tax losses expire on 2037.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySeven_2" xml:lang="en-US">2037</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySix_0" xml:lang="en-US">Non Capital Income Tax Losses Expire On Two Thousand Thirty Six</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySix_1" xml:lang="en-US">Represents amount of Non capital income tax losses expire on 2036.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySix_2" xml:lang="en-US">2036</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyThree_0" xml:lang="en-US">Non Capital Income Tax Losses Expire On Two Thousand Thirty Three</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyThree_1" xml:lang="en-US">Represents amount of Non capital income tax losses expire on 2033.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyThree_2" xml:lang="en-US">2033</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyTwo_0" xml:lang="en-US">Non Capital Income Tax Losses Expire On Two Thousand Thirty Two</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyTwo_1" xml:lang="en-US">Represents amount of Non capital income tax losses expire on 2032.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyTwo_2" xml:lang="en-US">2032</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NonCapitalLossCarryforwards_0" xml:lang="en-US">Non Capital loss carryforwards</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NonCapitalLossCarryforwards_1" xml:lang="en-US">Amount of non-capital loss carryforwards.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_huge_NonCapitalLossCarryforwards_2" xml:lang="en-US">Non-capital income tax losses expire</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NonCapitalLossCarryForwardsMember_0" xml:lang="en-US">Non-capital loss carry-forwards member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NonCapitalLossCarryForwardsMember_1" xml:lang="en-US">Non Capital Loss Carry Forwards [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NonCapitalLossCarryForwardsMember_2" xml:lang="en-US">Non-capital loss carry-forwards</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NonCapitalLossesMember_0" xml:lang="en-US">Information about Non-Capital Losses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NonCapitalLossesMember_1" xml:lang="en-US">Non Capital Losses [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_NonCapitalLossesMember_2" xml:lang="en-US">Non-capital losses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NonRefundableSumDueAndPayableUponFirstNotificationOfFda_0" xml:lang="en-US">Non Refundable Sum Due And Payable Upon First Notification Of Fda</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NonRefundableSumDueAndPayableUponFirstNotificationOfFda_1" xml:lang="en-US">Non refundable sum due and payable upon first notification of FDA</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFda_0" xml:lang="en-US">Non Refundable Sum Payable Within Ten Business Days Of First Notification Fda</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFda_1" xml:lang="en-US">Represents the amount related to non refundable sum payable within ten business days of first notification FDA.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFda_2" xml:lang="en-US">Non refundable sum payable within ten business days of first notification FDA</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NotesPayableMember_0" xml:lang="en-US">Notes payable [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NotesPayableMember_1" xml:lang="en-US">A written promise to pay a note to a bank.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NotesPayableMember_2" xml:lang="en-US">Notes payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NotesSettledThroughIssuanceOfShares_0" xml:lang="en-US">Notes Settled Through Issuance Of Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NotesSettledThroughIssuanceOfShares_1" xml:lang="en-US">Represents amount of notes settled through issuance of shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NotesSettledThroughIssuanceOfShares_2" xml:lang="en-US">Notes settled through issuance of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Nov12017Member_0" xml:lang="en-US">Represents information of warrants issue date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Nov12017Member_1" xml:lang="en-US">Nov 1 2017 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Nov12017Member_2" xml:lang="en-US">Nov 1 2017</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Nov122018Member_0" xml:lang="en-US">Represents the information of stock option grant date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Nov122018Member_1" xml:lang="en-US">Nov 12 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Nov122018Member_2" xml:lang="en-US">Nov 12 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Nov142017Member_0" xml:lang="en-US">Represents information of warrants issue date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Nov142017Member_1" xml:lang="en-US">Nov 14 2017 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Nov142017Member_2" xml:lang="en-US">Nov 14 2017</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Nov152018Member_0" xml:lang="en-US">Represents the information of stock option grant date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Nov152018Member_1" xml:lang="en-US">Nov 15 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Nov152018Member_2" xml:lang="en-US">Nov 15 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Nov212017Member_0" xml:lang="en-US">Represents information of warrants issue date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Nov212017Member_1" xml:lang="en-US">Nov 21 2017 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Nov212017Member_2" xml:lang="en-US">Nov 21 2017</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Nov262018Member_0" xml:lang="en-US">Represents the information of stock option grant date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Nov262018Member_1" xml:lang="en-US">Nov 26 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Nov262018Member_2" xml:lang="en-US">Nov 26 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability_0" xml:lang="en-US">Number Of Additional Shares Issued to settle derivative liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability_1" xml:lang="en-US">Represents the number of additional shares issued to settle derivative liability.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability_2" xml:lang="en-US">Number of additional shares issued to settle derivative liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfAgreement_0" xml:lang="en-US">It represents number of agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfAgreement_1" xml:lang="en-US">Number of agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfBrokerWarrantsGrantedForFeesAndCommissions_0" xml:lang="en-US">The Number of broker warrants granted for fees and commissions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfBrokerWarrantsGrantedForFeesAndCommissions_1" xml:lang="en-US">Number Of Broker Warrants Granted For Fees And Commissions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_NumberOfBrokerWarrantsGrantedForFeesAndCommissions_2" xml:lang="en-US">Number of broker warrants representing fees and commissions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NumberOfBrokerWarrantsGrantedForFeesAndCommissions_3" xml:lang="en-US">Share issuance costs (shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfInvestmentSharesSold_0" xml:lang="en-US">Number Of Investment Shares Sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfInvestmentSharesSold_1" xml:lang="en-US">Represents the number of investment shares sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_NumberOfInvestmentSharesSold_2" xml:lang="en-US">Number of investment shares sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfReplacementShareOptionsIssued_0" xml:lang="en-US">Number Of Replacement Share Options Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfReplacementShareOptionsIssued_1" xml:lang="en-US">Represents number of replacement share options issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NumberOfReplacementShareOptionsIssued_2" xml:lang="en-US">Number of replacement share options issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfShareOptionsExercisedOrVestedInShareBasedPaymentArrangement_0" xml:lang="en-US">Number Of Share Options Exercised Or Vested In Share Based Payment Arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfShareOptionsExercisedOrVestedInShareBasedPaymentArrangement_1" xml:lang="en-US">It represents number of share options exercised or vested in share based payment arrangement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NumberOfShareOptionsExercisedOrVestedInShareBasedPaymentArrangement_2" xml:lang="en-US">Number of share options exercised or vested in share based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfSharesAcquired_0" xml:lang="en-US">Number of shares acquired.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfSharesAcquired_1" xml:lang="en-US">Number Of Shares Acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NumberOfSharesAcquired_2" xml:lang="en-US">Number of shares acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfSharesHeld_0" xml:lang="en-US">Represents the number of shares held.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfSharesHeld_1" xml:lang="en-US">Number Of Shares Held</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NumberOfSharesHeld_2" xml:lang="en-US">Number of shares held</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfSharesHeldSubjectToEscrowArrangement_0" xml:lang="en-US">Represents the number of shares held subject to escrow arrangement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfSharesHeldSubjectToEscrowArrangement_1" xml:lang="en-US">Number Of Shares Held Subject To Escrow Arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NumberOfSharesHeldSubjectToEscrowArrangement_2" xml:lang="en-US">Number of shares held subject to escrow arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfSharesIssuedAsFindersFee_0" xml:lang="en-US">Represents number of shares issued as finders fee.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfSharesIssuedAsFindersFee_1" xml:lang="en-US">Number Of Shares Issued As Finders Fee</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NumberOfSharesIssuedAsFindersFee_2" xml:lang="en-US">Number of shares issued as finders fee</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_0" xml:lang="en-US"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_1" xml:lang="en-US">Number Of Shares Issued For Acquisition Of Century Financial Capital Group Inc</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NumberOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_2" xml:lang="en-US">Number of shares issued for Acquisition of Century Financial Capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfSharesIssuedForCompensationBonus_0" xml:lang="en-US">Number Of Shares Issued For Compensation Bonus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfSharesIssuedForCompensationBonus_1" xml:lang="en-US">Represents number of number of shares issued for compensation bonus.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NumberOfSharesIssuedForCompensationBonus_2" xml:lang="en-US">Number of shares issued for compensation bonus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfSharesIssuedForDebtSettlement_0" xml:lang="en-US">Represents the number of shares issued for debt settlement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfSharesIssuedForDebtSettlement_1" xml:lang="en-US">Number of shares issued for debt settlement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_NumberOfSharesIssuedForDebtSettlement_2" xml:lang="en-US">Number of shares issued for debt settlement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement_0" xml:lang="en-US">Represents the number of shares issued from entitys treasury by way of private placement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement_1" xml:lang="en-US">Number Of Shares Issued From Treasury Under Private Placement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement_2" xml:lang="en-US">Number of Class B shares issued from treasury under private placement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfSharesIssuedInPrivatePlacement_0" xml:lang="en-US">Represents number of shares issued in private placement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfSharesIssuedInPrivatePlacement_1" xml:lang="en-US">Number Of Shares Issued In Private Placement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_NumberOfSharesIssuedInPrivatePlacement_2" xml:lang="en-US">Number of shares issued in private placement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NumberOfSharesIssuedInPrivatePlacement_3" xml:lang="en-US">Number of shares issued in private placement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfSharesIssuedInShareExchange_0" xml:lang="en-US">Number of shares issued in share exchange</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfSharesIssuedInShareExchange_1" xml:lang="en-US">Represents the number of shares issued in share exchange.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NumberOfSharesIssuedInShareExchange_2" xml:lang="en-US">Number of shares issued in share exchange</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfSharesIssuedThroughEquityDistributionAgreement_0" xml:lang="en-US">Number Of Shares Issued Through Equity Distribution Agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfSharesIssuedThroughEquityDistributionAgreement_1" xml:lang="en-US">Represents number of shares issued through equity distribution agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NumberOfSharesIssuedThroughEquityDistributionAgreement_2" xml:lang="en-US">Number of shares issued through equity distribution agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfSharesOutstandingSubjectToEscrowConditions_0" xml:lang="en-US">Number of shares outstanding subject to escrow conditions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfSharesOutstandingSubjectToEscrowConditions_1" xml:lang="en-US">Number Of Shares Outstanding Subject To Escrow Conditions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NumberOfSharesOutstandingSubjectToEscrowConditions_2" xml:lang="en-US">Number of shares outstanding subject to escrow conditions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfSharesSold_0" xml:lang="en-US">Number Of Shares Sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfSharesSold_1" xml:lang="en-US">Represents number of shares sold.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NumberOfSharesSold_2" xml:lang="en-US">Number of shares sold for investment in Cannara</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfSharesSubscribed_0" xml:lang="en-US">Represents amount of number of shares subscribed.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_huge_NumberOfSharesSubscribed_1" xml:lang="en-US">Number of Shares, ending balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_huge_NumberOfSharesSubscribed_2" xml:lang="en-US">Number of Shares, beginning balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfSharesSubscribed_3" xml:lang="en-US">Number Of Shares Subscribed</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_NumberOfSharesSubscribed_4" xml:lang="en-US">Number of shares subscribed</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NumberOfSharesSubscribed_5" xml:lang="en-US">Number of Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfStockOptionsApprovedForIssuance_0" xml:lang="en-US">Number Of Stock Options Approved For Issuance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfStockOptionsApprovedForIssuance_1" xml:lang="en-US">Represents amount of number of stock options approved for issuance.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NumberOfStockOptionsApprovedForIssuance_2" xml:lang="en-US">Number of stock options approved for issuance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfWarrantsAcquired_0" xml:lang="en-US">Number of warrants acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfWarrantsAcquired_1" xml:lang="en-US">Represents the number of warrants acquired.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfWarrantsExercised_0" xml:lang="en-US">Number of warrants Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfWarrantsExercised_1" xml:lang="en-US">Represents number of number of warrants exercised.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NumberOfWarrantsExercised_2" xml:lang="en-US">Warrants, Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_huge_NumberOfWarrantsExercised_3" xml:lang="en-US">Warrants, Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfWarrantsExpired_0" xml:lang="en-US">Number of warrants Expired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfWarrantsExpired_1" xml:lang="en-US">Represents number of warrants expired.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NumberOfWarrantsExpired_2" xml:lang="en-US">Warrants, Expired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_huge_NumberOfWarrantsExpired_3" xml:lang="en-US">Warrants, Expired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfWarrantsHeld_0" xml:lang="en-US">Represents the number of warrants held.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfWarrantsHeld_1" xml:lang="en-US">Number Of Warrants Held</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NumberOfWarrantsHeld_2" xml:lang="en-US">Number of warrants held</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfWarrantsIssued_0" xml:lang="en-US">Number Of Warrants Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfWarrantsIssued_1" xml:lang="en-US">Represents number of warrants issued during period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NumberOfWarrantsIssued_2" xml:lang="en-US">Warrants, Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_NumberOfWarrantsIssued_3" xml:lang="en-US">Number of warrants issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_NumberOfWarrantsOutstanding_0" xml:lang="en-US">Number of warrants Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_NumberOfWarrantsOutstanding_1" xml:lang="en-US">Represents number of warrants outstanding.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_huge_NumberOfWarrantsOutstanding_2" xml:lang="en-US">Warrants outstanding, Opening balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_huge_NumberOfWarrantsOutstanding_3" xml:lang="en-US">Warrants outstanding, Closing Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_NumberOfWarrantsOutstanding_4" xml:lang="en-US">Number of warrants outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Oct202017Member_0" xml:lang="en-US">Represents information of warrants issue date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Oct202017Member_1" xml:lang="en-US">Oct 20 2017 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Oct202017Member_2" xml:lang="en-US">Oct 20 2017</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_OfficeAndGeneralExpenses_0" xml:lang="en-US">Information about office and general expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_OfficeAndGeneralExpenses_1" xml:lang="en-US">Office And General expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_OfficeAndGeneralExpenses_2" xml:lang="en-US">Office and general</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_OfficeLeaseAgreementMember_0" xml:lang="en-US">Information about agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_OfficeLeaseAgreementMember_1" xml:lang="en-US">Office Lease Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_OfficeLeaseAgreementMember_2" xml:lang="en-US">Office lease agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_OperatingExpensesAbstract_0" xml:lang="en-US">Operating Expenses [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_OperatingExpensesAbstract_1" xml:lang="en-US">Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_OperatingLeaseImpactOfPresentValue_0" xml:lang="en-US">Represents operating lease impact of present value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_OperatingLeaseImpactOfPresentValue_1" xml:lang="en-US">Operating Lease impact of present value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_OperatingLeaseImpactOfPresentValue_2" xml:lang="en-US">Less: impact of present value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_huge_OperatingLeaseImpactOfPresentValue_3" xml:lang="en-US">Less: impact of present value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_OtherAllowances_0" xml:lang="en-US">Represents the value of other allowances.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_OtherAllowances_1" xml:lang="en-US">Other allowances</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_OtherFinancialLiabilitiesMember_0" xml:lang="en-US">This member stands for Other financial liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_OtherFinancialLiabilitiesMember_1" xml:lang="en-US">Other Financial Liabilities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_OtherFinancialLiabilitiesMember_2" xml:lang="en-US">Other liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_OtherGeneralAndAdministrativeExpenses_0" xml:lang="en-US">Other general and administrative expense.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_OtherGeneralAndAdministrativeExpenses_1" xml:lang="en-US">Other General And Administrative Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_OtherGeneralAndAdministrativeExpenses_2" xml:lang="en-US">Other</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_OtherInventoryMember_0" xml:lang="en-US">This member stands for Other inventory member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_OtherInventoryMember_1" xml:lang="en-US">Other inventory [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_OtherInventoryMember_2" xml:lang="en-US">Other inventory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_OtherInvestmentMember_0" xml:lang="en-US">Other investments member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_OtherInvestmentMember_1" xml:lang="en-US">Other Investment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_OtherInvestmentMember_2" xml:lang="en-US">Other investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_OtherInvestmentsNameOfEntityAxis_0" xml:lang="en-US">Represents the name of entities in which company hold interests in other investments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_OtherInvestmentsNameOfEntityAxis_1" xml:lang="en-US">Other Investments, Name Of Entity [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_OtherInvestmentsNameOfEntityDomain_0" xml:lang="en-US">Represents the name of entities in which company hold interests in other investments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_OtherInvestmentsNameOfEntityDomain_1" xml:lang="en-US">Other Investments, Name Of Entity [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_OutstandingCommitmentToPurchaseAdditionalProduct_0" xml:lang="en-US">Outstanding commitment to purchase additional product</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_OutstandingCommitmentToPurchaseAdditionalProduct_1" xml:lang="en-US">Represents the amount related to outstanding commitment to purchase an additional product.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PartialPaymentOfSettlementAmount_0" xml:lang="en-US">Partial Payment Of Settlement Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PartialPaymentOfSettlementAmount_1" xml:lang="en-US">Represents the amount of partial payment for settlement amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_PartialPaymentOfSettlementAmount_2" xml:lang="en-US">Partial payment for settlement amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PatentMaintenanceFee_0" xml:lang="en-US">Patent maintenance fee</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PatentMaintenanceFee_1" xml:lang="en-US">Represents amount related to patent maintenance fee.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_PatentMaintenanceFee_2" xml:lang="en-US">Patent maintenance fee</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PaymentMadeToBeUnpaidWagesAndUnpaidHoliday_0" xml:lang="en-US">Payment Made To Be Unpaid Wages And Unpaid Holiday</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PaymentMadeToBeUnpaidWagesAndUnpaidHoliday_1" xml:lang="en-US">Represents the amount of payment made to be unpaid wages and unpaid holiday.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_PaymentMadeToBeUnpaidWagesAndUnpaidHoliday_2" xml:lang="en-US">Payment made to be unpaid wages and unpaid holiday</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PaymentOfExpenses_0" xml:lang="en-US">Represents the amount of payment of expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PaymentOfExpenses_1" xml:lang="en-US">Payment of expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PaymentOfOperatingLease_0" xml:lang="en-US">Represents operating lease payments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_huge_PaymentOfOperatingLease_1" xml:lang="en-US">Less: Lease Payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_huge_PaymentOfOperatingLease_2" xml:lang="en-US">Repayment of lease obligation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PaymentOfOperatingLease_3" xml:lang="en-US">Payment of operating lease</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_PaymentOfOperatingLease_4" xml:lang="en-US">Repayment of lease obligation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_PaymentOfOperatingLease_5" xml:lang="en-US">Less: Lease Payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PercentageOfAggregateDiscountForSharesInEscrow_0" xml:lang="en-US">Represents the percentage of Percentage of aggregate discount for shares in escrow.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PercentageOfAggregateDiscountForSharesInEscrow_1" xml:lang="en-US">Percentage Of Aggregate Discount For Shares In Escrow</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_PercentageOfAggregateDiscountForSharesInEscrow_2" xml:lang="en-US">Percentage of aggregate discount for escrow</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PercentageOfDeclineInFairValueOfInvestment_0" xml:lang="en-US">Percentage Of Decline In Fair value of investment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PercentageOfDeclineInFairValueOfInvestment_1" xml:lang="en-US">Represents the percentage of decline in fair value of investment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_PercentageOfDeclineInFairValueOfInvestment_2" xml:lang="en-US">Percentage of decline in fair value of investment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PercentageOfDiscountForTotalProceedsOfSharesAndWarrantsSold_0" xml:lang="en-US">Represents the amount related to percentage of discount for total proceeds of shares and warrants sold during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PercentageOfDiscountForTotalProceedsOfSharesAndWarrantsSold_1" xml:lang="en-US">Percentage Of Discount for total proceeds of shares and warrants sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights_0" xml:lang="en-US">Percentage of lump sum payment received to pay for non prescription drug rights</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights_1" xml:lang="en-US">Represents the percentage of lump sum payment received to pay for non prescription drug rights.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition_0" xml:lang="en-US">Percentage of net receipts from commercial partners as second payment condition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition_1" xml:lang="en-US">Represents the percentage of net receipts from commercial partners as second payment condition under the agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition_0" xml:lang="en-US">Percentage of net sales of Licensed Product as first payment condition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition_1" xml:lang="en-US">Represents the percentage of net sale of licensed product as first payment condition under the agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition_0" xml:lang="en-US">Percentage of net sales or net receipts of licensed products as third payment condition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition_1" xml:lang="en-US">Represents the percentage of net sales of net receipts of licensed products as third payment condition under the agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights_0" xml:lang="en-US">Percentage of one off lump sum payment to pay for prescription drug rights</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights_1" xml:lang="en-US">Represents the percentage of one off lump sum payment to pay for prescription drug rights.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PermanentDifferences_0" xml:lang="en-US">Permanent Differences</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PermanentDifferences_1" xml:lang="en-US">Permanent differences between income tax expense.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_PermanentDifferences_2" xml:lang="en-US">Permanent differences</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PharmadrugIncMember_0" xml:lang="en-US">Pharmadrug Inc</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PharmadrugIncMember_1" xml:lang="en-US">Pharmadrug Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_PharmadrugIncMember_2" xml:lang="en-US">Pharmadrug Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PharmadrugProductionGMBHMember_0" xml:lang="en-US">Pharmadrug Production G M B H [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PharmadrugProductionGMBHMember_1" xml:lang="en-US">Pharmadrug Production GMBH</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_PharmadrugProductionGMBHMember_2" xml:lang="en-US">Pharmadrug Production GMBH</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PharmastripCorpMember_0" xml:lang="en-US">Information about pharmastrip corp.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PharmastripCorpMember_1" xml:lang="en-US">Pharmastrip Corp [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_PharmastripCorpMember_2" xml:lang="en-US">Pharmastrip Corp. ("Pharmastrip")</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PreacquisitionNetOperatingLossCarryforwards_0" xml:lang="en-US">Preacquisition Net Operating Loss Carryforwards</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PreacquisitionNetOperatingLossCarryforwards_1" xml:lang="en-US">Represents preacquisition net operating loss carryforwards.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_PreacquisitionNetOperatingLossCarryforwards_2" xml:lang="en-US">Preacquisition net operating loss carryforwards</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PresidentAndChiefExecutiveOfficerMember_0" xml:lang="en-US">This member stands for president and chief executive officer.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PresidentAndChiefExecutiveOfficerMember_1" xml:lang="en-US">President And Chief Executive Officer [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_PresidentAndChiefExecutiveOfficerMember_2" xml:lang="en-US">Former President and CEO</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PresidentAndDirectorMember_0" xml:lang="en-US">This member stands for president and director.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PresidentAndDirectorMember_1" xml:lang="en-US">President And Director [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_PresidentAndDirectorMember_2" xml:lang="en-US">President and director</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PresidentOfFsdBiosciencesMember_0" xml:lang="en-US">President Of Fsd Biosciences [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PresidentOfFsdBiosciencesMember_1" xml:lang="en-US">Represents president of fsd biosciences member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_PresidentOfFsdBiosciencesMember_2" xml:lang="en-US">President of FSD Biosciences</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PresidentOfFSDMember_0" xml:lang="en-US">President Of F S D [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PresidentOfFSDMember_1" xml:lang="en-US">Represents president of FSD member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_PresidentOfFSDMember_2" xml:lang="en-US">President of FSD</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PresidentOfFVPharmaMember_0" xml:lang="en-US">President Of F V Pharma [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PresidentOfFVPharmaMember_1" xml:lang="en-US">Represents president of fv pharma member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_PresidentOfFVPharmaMember_2" xml:lang="en-US">President of FV Pharma</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PresidentsMember_0" xml:lang="en-US">Presidents [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_PresidentsMember_1" xml:lang="en-US">President</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PrincipalAmountOfBorrowings_0" xml:lang="en-US">Represents the amount related to principal amount of borrowings.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PrincipalAmountOfBorrowings_1" xml:lang="en-US">Principal amount of borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_PrincipalAmountOfBorrowings_2" xml:lang="en-US">Principal amount of convertible debenture</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PrismicPharmaceuticalMember_0" xml:lang="en-US">Represents prismic pharmaceutical member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PrismicPharmaceuticalMember_1" xml:lang="en-US">Prismic Pharmaceutical [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_PrismicPharmaceuticalMember_2" xml:lang="en-US">Prismic Pharmaceuticals Inc. ("Prismic")</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PrismicPharmaceuticalsIncMember_0" xml:lang="en-US">Information about Prismic Pharmaceuticals Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PrismicPharmaceuticalsIncMember_1" xml:lang="en-US">Prismic Pharmaceuticals Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_PrismicPharmaceuticalsIncMember_2" xml:lang="en-US">Prismic Pharmaceuticals Inc. ("Prismic")</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ProceedsFromExerciseOfWarrants_0" xml:lang="en-US">Represents proceeds from exercise of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ProceedsFromExerciseOfWarrants_1" xml:lang="en-US">Proceeds From Exercise Of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ProceedsFromExerciseOfWarrants_2" xml:lang="en-US">Proceeds from exercise of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ProceedsFromNotesPayable_0" xml:lang="en-US">Proceeds From Notes Payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ProceedsFromNotesPayable_1" xml:lang="en-US">Represents the settlement of proceeds From ootes payable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ProceedsFromSaleOfSharesAndWarrants_0" xml:lang="en-US">Represents the amount related to proceeds from sale of shares and warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ProceedsFromSaleOfSharesAndWarrants_1" xml:lang="en-US">Proceeds from sale of shares and warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ProceedsFromSalesOfInventory_0" xml:lang="en-US">Proceeds From Sales Of Inventory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ProceedsFromSalesOfInventory_1" xml:lang="en-US">The cash inflow from sales of inventory.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ProceedsFromSalesOfInventory_2" xml:lang="en-US">Proceeds from sales of inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ProductionAndGrowingExpense_0" xml:lang="en-US">Production and growing expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ProductionAndGrowingExpense_1" xml:lang="en-US">Represents the amount related to production and growing expense.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ProductionAndGrowingExpense_2" xml:lang="en-US">Production and growing</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ProductionAndGrowingExpenses_0" xml:lang="en-US">The amount of expense arising from production and growing expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ProductionAndGrowingExpenses_1" xml:lang="en-US">Production And Growing Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ProductionAndGrowingExpenses_2" xml:lang="en-US">Production and growing expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ProductionEquipmentMember_0" xml:lang="en-US">Represents production equipment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ProductionEquipmentMember_1" xml:lang="en-US">Production equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ProductionEquipmentMember_2" xml:lang="en-US">Production equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ProductionEquipmentMember_3" xml:lang="en-US">Production equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ProfitLossBeforeOtherIncomeAndGainLossOnSaleOfEquipmentFromDiscontinuedOperations_0" xml:lang="en-US">Profit (Loss) Before Other Income And Gain (Loss) On Sale Of Equipment From Discontinued Operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ProfitLossBeforeOtherIncomeAndGainLossOnSaleOfEquipmentFromDiscontinuedOperations_1" xml:lang="en-US">Represents the profit (loss) before other income and gain (loss) on sale of equipment from discontinued operations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ProfitLossBeforeOtherIncomeAndGainLossOnSaleOfEquipmentFromDiscontinuedOperations_2" xml:lang="en-US">Loss from discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ProfitLossOnChangeInFairValue_0" xml:lang="en-US">Profit Loss On Change In Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ProfitLossOnChangeInFairValue_1" xml:lang="en-US">It represents profit loss on change in fair value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ProfitLossOnChangeInFairValue_2" xml:lang="en-US">Gain on change in fair value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PropertyPlantAndEquipmentAssetsHeldForSale_0" xml:lang="en-US">Property, Plant And Equipment, Assets Held For Sale</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PropertyPlantAndEquipmentAssetsHeldForSale_1" xml:lang="en-US">The amount of property, plant and equipment that are recognised as assets held for sale.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_PropertyPlantAndEquipmentAssetsHeldForSale_2" xml:lang="en-US">Property and plant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_PropertyPlantAndEquipmentsMember_0" xml:lang="en-US">Property, plant and equipment member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_PropertyPlantAndEquipmentsMember_1" xml:lang="en-US">Property Plant And Equipments [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_PropertyPlantAndEquipmentsMember_2" xml:lang="en-US">Property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ProvisionForEmployeeRelatedLiability_0" xml:lang="en-US">Provision For Employee Related Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ProvisionForEmployeeRelatedLiability_1" xml:lang="en-US">Represents information about provision for employee related liability.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ProvisionForEmployeeRelatedLiability_2" xml:lang="en-US">Provision for employee related liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_QuantitiesAvailableToSupplyInFifthFiscalYear_0" xml:lang="en-US">Quantities available to supply in fifth fiscal year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_QuantitiesAvailableToSupplyInFifthFiscalYear_1" xml:lang="en-US">Represents the quantities available to supply in fifth fiscal year from the balance sheet fiscal year.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_QuantitiesAvailableToSupplyInFifthFiscalYear_2" xml:lang="en-US">2023</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_QuantitiesAvailableToSupplyInFourthFiscalYear_0" xml:lang="en-US">Quantities available to supply in fourth fiscal year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_QuantitiesAvailableToSupplyInFourthFiscalYear_1" xml:lang="en-US">Represents the quantities available to supply in fourth fiscal year from the balance sheet fiscal year.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_QuantitiesAvailableToSupplyInFourthFiscalYear_2" xml:lang="en-US">2024</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_QuantitiesAvailableToSupplyInNextFiscalYear_0" xml:lang="en-US">Quantities Available To Supply in Next Fiscal Year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_QuantitiesAvailableToSupplyInNextFiscalYear_1" xml:lang="en-US">Represents the quantities available to supply in next fiscal year from the balance sheet fiscal year.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_QuantitiesAvailableToSupplyInNextFiscalYear_2" xml:lang="en-US">2020</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_QuantitiesAvailableToSupplyInSecondFiscalYear_0" xml:lang="en-US">Quantities available to supply in second fiscal year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_QuantitiesAvailableToSupplyInSecondFiscalYear_1" xml:lang="en-US">Represents the quantities available to supply in second fiscal year from the balance sheet fiscal year.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_QuantitiesAvailableToSupplyInSecondFiscalYear_2" xml:lang="en-US">2021</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_QuantitiesAvailableToSupplyInThirdFiscalYear_0" xml:lang="en-US">Quantities available to supply in third fiscal year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_QuantitiesAvailableToSupplyInThirdFiscalYear_1" xml:lang="en-US">Represents the quantities available to supply in third fiscal year from the balance sheet fiscal year.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_QuantitiesAvailableToSupplyInThirdFiscalYear_2" xml:lang="en-US">2022</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_QuotedMarketPriceOfInvestments_0" xml:lang="en-US">Represents the price per share related to quoted market price of investment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_QuotedMarketPriceOfInvestments_1" xml:lang="en-US">Quoted Market Price Of Investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_QuotedMarketPriceOfInvestments_2" xml:lang="en-US">Quoted market price of investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_RecognitionOfLossOnChangeInFairValueOfDerivativeLiability_0" xml:lang="en-US">recognition of loss on change in fair value of derivative liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_RecognitionOfLossOnChangeInFairValueOfDerivativeLiability_1" xml:lang="en-US">Represents amount of recognition of loss on change in fair value of derivative liability.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_RecognitionOfLossOnChangeInFairValueOfDerivativeLiability_2" xml:lang="en-US">Recognition of loss on change in fair value of derivative liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_RentReceivable_0" xml:lang="en-US">Amount of rent receivable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_RentReceivable_1" xml:lang="en-US">Rent receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_RentReceivable_2" xml:lang="en-US">Rent receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ResearchAndDevelopmentAgreementMember_0" xml:lang="en-US">This member stands for Research and Development Agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ResearchAndDevelopmentAgreementMember_1" xml:lang="en-US">Research and Development Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ResearchAndDevelopmentAgreementMember_2" xml:lang="en-US">Research and Development Agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_RetrospectiveApplicationAndRetrospectiveRestatementLineItems_0" xml:lang="en-US">Retrospective Application And Retrospective Restatement [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_RetrospectiveApplicationAndRetrospectiveRestatementLineItems_1" xml:lang="en-US">Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_RetrospectiveApplicationAndRetrospectiveRestatementTable_0" xml:lang="en-US">Retrospective Application And Retrospective Restatement [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_RetrospectiveApplicationAndRetrospectiveRestatementTable_1" xml:lang="en-US">Table represents information about retrospective application and retrospective restatement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ReverseTakeoverTransaction_0" xml:lang="en-US">Represents information about reverse takeover transaction.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ReverseTakeoverTransaction_1" xml:lang="en-US">Reverse Takeover Transaction</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ReverseTakeoverTransaction_2" xml:lang="en-US">Reverse Takeover Transaction</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_RightOfUseAssetsAndLeaseObligations_0" xml:lang="en-US">Represents Right-of-use assets and lease obligations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_RightOfUseAssetsAndLeaseObligations_1" xml:lang="en-US">Right of use assets and lease obligations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_RightOfUseAssetsAndLeaseObligations_2" xml:lang="en-US">Right of use assets and lease obligations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_RiskFreeInterestRateOfWarrants_0" xml:lang="en-US">Represents risk free interest rate of warrant.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_RiskFreeInterestRateOfWarrants_1" xml:lang="en-US">Risk Free Interest Rate Of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_RiskFreeInterestRateOfWarrants_2" xml:lang="en-US">Risk Free Interest Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_RiskFreeInterestRateOfWarrantsGranted_0" xml:lang="en-US">Risk free interest rate of warrants granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_RiskFreeInterestRateOfWarrantsGranted_1" xml:lang="en-US">Represents risk free interest rate of warrants granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_RiskFreeInterestRateOfWarrantsGranted_2" xml:lang="en-US">Risk free interest rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_RiskFreeInterestRateOfWarrantsLiability_0" xml:lang="en-US">Risk Free Interest Rate Of Warrants Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_RiskFreeInterestRateOfWarrantsLiability_1" xml:lang="en-US">Represents risk free interest rate of warrants liability.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_RiskFreeRateOfWarrants_0" xml:lang="en-US">Represents the risk free rate of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_RiskFreeRateOfWarrants_1" xml:lang="en-US">Risk Free Rate Of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_RiskFreeRateOfWarrants_2" xml:lang="en-US">Risk free rate of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_SalesTaxRecoverable_0" xml:lang="en-US">The amount for sales taxes recoverable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_SalesTaxRecoverable_1" xml:lang="en-US">Sales tax recoverable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_SalesTaxRecoverable_2" xml:lang="en-US">Sales tax recoverable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_SalesTaxRecoverable_3" xml:lang="en-US">Sales taxes recoverable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ScheduleOfCashFlowsFromDiscontinuedOperationsExplanatory_0" xml:lang="en-US">Schedule Of Cash Flows From Discontinued Operations Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ScheduleOfCashFlowsFromDiscontinuedOperationsExplanatory_1" xml:lang="en-US">The disclosure of detailed information about the cash flows from discontinued operations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ScheduleOfCashFlowsFromDiscontinuedOperationsExplanatory_2" xml:lang="en-US">Schedule of cash flows from discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ScheduleOfComponentsOfAssetsHeldForSaleExplanatory_0" xml:lang="en-US">Schedule Of Components Of Assets Held For Sale Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ScheduleOfComponentsOfAssetsHeldForSaleExplanatory_1" xml:lang="en-US">The disclosure of detailed information about the assets held for sale.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ScheduleOfComponentsOfAssetsHeldForSaleExplanatory_2" xml:lang="en-US">Schedule of components of assets held for sale</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ScheduleOfNetLossAndComprehensiveLossFromDiscontinuedOperationsExplanatory_0" xml:lang="en-US">Schedule Of Net Loss And Comprehensive Loss From Discontinued Operations Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ScheduleOfNetLossAndComprehensiveLossFromDiscontinuedOperationsExplanatory_1" xml:lang="en-US">The disclosure of detailed information about the net loss and comprehensive loss from discontinued operations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ScheduleOfNetLossAndComprehensiveLossFromDiscontinuedOperationsExplanatory_2" xml:lang="en-US">Schedule of net loss and comprehensive loss from discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ScheduleOfNonCapitalLossCarryforwardsTableTextBlock_0" xml:lang="en-US">Schedule Of Non Capital Loss Carryforwards [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ScheduleOfNonCapitalLossCarryforwardsTableTextBlock_1" xml:lang="en-US">Schedule of non-capital loss carryforwards.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ScheduleOfNonCapitalLossCarryforwardsTableTextBlock_2" xml:lang="en-US">Schedule of non-capital loss carryforwards</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ScheduleOfStockClassLineItems_0" xml:lang="en-US">Represents schedule of stock by class [Line item].</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ScheduleOfStockClassLineItems_1" xml:lang="en-US">Schedule Of Stock Class [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ScheduleOfStockClassTable_0" xml:lang="en-US">Represents schedule of stock by class [Table].</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ScheduleOfStockClassTable_1" xml:lang="en-US">Schedule Of Stock Class [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ScheduleOfWarrantTable_0" xml:lang="en-US">Represents information of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ScheduleOfWarrantTable_1" xml:lang="en-US">Schedule Of Warrant [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory_0" xml:lang="en-US">Represents information related to estimated useful lives of assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory_1" xml:lang="en-US">Schedules Of Estimated Useful Lives Of Assets Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory_2" xml:lang="en-US">Schedule of estimated useful lives of assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ScicannTherapeuticsIncMember_0" xml:lang="en-US">SciCann Therapeutics Inc</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ScicannTherapeuticsIncMember_1" xml:lang="en-US">Scicann Therapeutics Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ScicannTherapeuticsIncMember_2" xml:lang="en-US">SciCann Therapeutics Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_SecuritiesExchangeAgreementMember_0" xml:lang="en-US">Securities Exchange Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_SecuritiesExchangeAgreementMember_1" xml:lang="en-US">Share Exchange Agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees_0" xml:lang="en-US">Represents the amount of security deposit with the court in respect of amount claimed and estimated legal fees.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees_1" xml:lang="en-US">Security Deposit In Respect Of Amount Claimed And Estimated Legal Fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees_2" xml:lang="en-US">Security deposit in respect of amount claimed and estimated legal fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Sep102018Member_0" xml:lang="en-US">Represents the information of stock option grant date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Sep102018Member_1" xml:lang="en-US">Sep 10 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Sep102018Member_2" xml:lang="en-US">Sep 10 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Sep112018Member_0" xml:lang="en-US">Represents the information of stock option grant date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Sep112018Member_1" xml:lang="en-US">Sep 11 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Sep112018Member_2" xml:lang="en-US">Sep 11 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Sep142018Member_0" xml:lang="en-US">Sep 14 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Sep142018Member_1" xml:lang="en-US">Sep 14 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Sep152017Member_0" xml:lang="en-US">Represents information of warrants issue date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Sep152017Member_1" xml:lang="en-US">Sep 15 2017 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Sep152017Member_2" xml:lang="en-US">Sep 15 2017</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Sep152018Member_0" xml:lang="en-US">Represents the information of stock option grant date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Sep152018Member_1" xml:lang="en-US">Sep 15 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Sep152018Member_2" xml:lang="en-US">Sep 15 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Sep172017Member_0" xml:lang="en-US">Represents the information of stock option grant date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Sep172017Member_1" xml:lang="en-US">Sep 17 2017 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Sep172017Member_2" xml:lang="en-US">Sep 17 2017</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Sep262018Member_0" xml:lang="en-US">Represents the information of stock option grant date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Sep262018Member_1" xml:lang="en-US">Sep 26 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Sep262018Member_2" xml:lang="en-US">Sep 26 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_September292018Member_0" xml:lang="en-US">Represents information of Class B shares transaction date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_September292018Member_1" xml:lang="en-US">September 29, 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_September292018Member_2" xml:lang="en-US">September 29, 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_September302017Member_0" xml:lang="en-US">Represents information of Class B shares transaction date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_September302017Member_1" xml:lang="en-US">September 30, 2017 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_September302017Member_2" xml:lang="en-US">September 30, 2017</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ShareBasedPaymentExpenses_0" xml:lang="en-US">Share Based Payment Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ShareBasedPaymentExpenses_1" xml:lang="en-US">It represents share based payment expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ShareBasedPaymentExpenses_2" xml:lang="en-US">Share based payment expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ShareExchangeAgreementMember_0" xml:lang="en-US">Share Exchange Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ShareExchangeAgreementMember_1" xml:lang="en-US">Share Exchange Agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ShareExchangeAgreementMember_2" xml:lang="en-US">Share exchange agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ShareholderAndPublicCompanyCosts_0" xml:lang="en-US">Amount of expenses related to shareholder and public company.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ShareholderAndPublicCompanyCosts_1" xml:lang="en-US">Shareholder And Public Company Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ShareholderAndPublicCompanyCosts_2" xml:lang="en-US">Shareholder and public company costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ShareholdersAndPublicCompanyCosts_0" xml:lang="en-US">Information about shareholder and public company costs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ShareholdersAndPublicCompanyCosts_1" xml:lang="en-US">Shareholders And Public Company Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ShareholdersAndPublicCompanyCosts_2" xml:lang="en-US">Shareholder and public company costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ShareIssuanceCostBookedDirectlyToEquity_0" xml:lang="en-US">Share Issuance Cost Booked Directly To Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ShareIssuanceCostBookedDirectlyToEquity_1" xml:lang="en-US">It represents share issuance cost booked directly to equity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ShareIssuanceCostBookedDirectlyToEquity_2" xml:lang="en-US">Share issuance cost booked directly to equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ShareIssueCostsMember_0" xml:lang="en-US">Share Issue Costs [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ShareIssueCostsMember_1" xml:lang="en-US">Share Issue Costs [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ShareIssueCostsMember_2" xml:lang="en-US">Share issue costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ShareIssuePricePerShare_0" xml:lang="en-US">Represents the price per share of shares issued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ShareIssuePricePerShare_1" xml:lang="en-US">Share issue price per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ShareOptionsAbstract_0" xml:lang="en-US">Share Options [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_SharePriceOfSharesAndWarrants_0" xml:lang="en-US">Represents the price per share related to share price of shares and warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_SharePriceOfSharesAndWarrants_1" xml:lang="en-US">Share price of shares and warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_SharePrices_0" xml:lang="en-US">Represents Share price per share.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_SharePrices_1" xml:lang="en-US">Share Prices</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_SharePrices_2" xml:lang="en-US">Share price per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_SharePrices_3" xml:lang="en-US">Par value of shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_SharePricesOfWarrantsLiability_0" xml:lang="en-US">Share Prices Of Warrants Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_SharePricesOfWarrantsLiability_1" xml:lang="en-US">It represents share price of warrants liability.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_SharePurchaseAndSaleAgreementsMember_0" xml:lang="en-US">Share Purchase and Sale Agreements [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_SharePurchaseAndSaleAgreementsMember_1" xml:lang="en-US">This member stands for share purchase and sale agreements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_SharePurchaseAndSaleAgreementsMember_2" xml:lang="en-US">Share Purchase and Sale Agreements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ShareSplitRatio_0" xml:lang="en-US">Represents the share split ratio.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ShareSplitRatio_1" xml:lang="en-US">Share Split Ratio</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ShareSplitRatio_2" xml:lang="en-US">Share split ratio</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ShortTermNotes_0" xml:lang="en-US">Represents Short-term notes.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_huge_ShortTermNotes_1" xml:lang="en-US">Short-term notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ShortTermNotes_2" xml:lang="en-US">Short term notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ShortTermNotes_3" xml:lang="en-US">Short-term notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_SolarvestBioEnergyIncMember_0" xml:lang="en-US">Solarvest BioEnergy Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_SolarvestBioEnergyIncMember_1" xml:lang="en-US">Solarvest Bio Energy Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_SolarvestBioEnergyIncMember_2" xml:lang="en-US">Solarvest BioEnergy Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_SpecialWarrantsMember_0" xml:lang="en-US">Represents information of special warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_SpecialWarrantsMember_1" xml:lang="en-US">Special Warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_SpecialWarrantsMember_2" xml:lang="en-US">Special warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_StockOptionsMember_0" xml:lang="en-US">Represenr the information of stock option.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_StockOptionsMember_1" xml:lang="en-US">Stock Options [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_StockOptionsMember_2" xml:lang="en-US">Stock options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_StockOptionsOfAcquirer_0" xml:lang="en-US">The fair value, at the acquisition date, of stock options of the acquirer transferred as consideration in a business combination.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_StockOptionsOfAcquirer_1" xml:lang="en-US">Stock Options Of Acquirer</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_StockOptionsOfAcquirer_2" xml:lang="en-US">Exchange of stock options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_StockPromotionExpense_0" xml:lang="en-US">Stock Promotion Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_StockPromotionExpense_1" xml:lang="en-US">The amount of expense arising from stock promotion.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_StockPromotionExpense_2" xml:lang="en-US">Stock promotion</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_StrategicInvestmentValue_0" xml:lang="en-US">Information about strategic investment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_StrategicInvestmentValue_1" xml:lang="en-US">Strategic Investment Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_StrategicInvestmentValue_2" xml:lang="en-US">Strategic investment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_SubscriptionPricePerShare_0" xml:lang="en-US">Represents the subscription price per share.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_SubscriptionPricePerShare_1" xml:lang="en-US">Subscription Price Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_SubscriptionPricePerShare_2" xml:lang="en-US">Subscription price per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_SubsequentEventsMember_0" xml:lang="en-US">Information about subsequent events.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_SubsequentEventsMember_1" xml:lang="en-US">Subsequent Events [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_SubsequentEventsMember_2" xml:lang="en-US">Subsequent events</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_SubsidiariesOneMember_0" xml:lang="en-US">Subsidiaries one [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_SubsidiariesOneMember_1" xml:lang="en-US">Prismic Pharmaceuticals Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_SubsidiariesTwoMember_0" xml:lang="en-US">Represents subsidiaries two member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_SubsidiariesTwoMember_1" xml:lang="en-US">Subsidiaries two [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_SubsidiariesTwoMember_2" xml:lang="en-US">FV Pharma Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xml:lang="en-US">Summary Of Significant Accounting Policies [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_SummaryOfSignificantAccountingPoliciesTable_0" xml:lang="en-US">Represents summary of significant accounting policies table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_SummaryOfSignificantAccountingPoliciesTable_1" xml:lang="en-US">Summary Of Significant Accounting Policies [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_SupplementalInformationAbstract_0" xml:lang="en-US">Supplemental Information Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_SupplementalInformationAbstract_1" xml:lang="en-US">Supplemental information</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_SupplyAgreementMember_0" xml:lang="en-US">Information about supply agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_SupplyAgreementMember_1" xml:lang="en-US">Supply Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_SupplyAgreementMember_2" xml:lang="en-US">Supply agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_SupplyAgreementOptionToPurchaseAmount_0" xml:lang="en-US">Information about supplier grants Purchasers right and option to purchase amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_SupplyAgreementOptionToPurchaseAmount_1" xml:lang="en-US">Supply Agreement Option To Purchase Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_SupplyAgreementOptionToPurchaseAmount_2" xml:lang="en-US">Supply agreement, option to purchase amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_SupplyAgreementOptionToPurchasePeriod_0" xml:lang="en-US">Information about supplier grants Purchasers right and option to purchase period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_SupplyAgreementOptionToPurchasePeriod_1" xml:lang="en-US">Supply Agreement Option To Purchase Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_SupplyAgreementOptionToPurchasePeriod_2" xml:lang="en-US">Supply agreement, option purchase period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_SupplyAgreementOptionToPurchasePricePerKilogramPerPercentOfCannabidiolExtracted_0" xml:lang="en-US">Information about supplier grants purchasers right and option to purchase price per kg per 1% of CBD extracted from the flower.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_SupplyAgreementOptionToPurchasePricePerKilogramPerPercentOfCannabidiolExtracted_1" xml:lang="en-US">Supply Agreement Option To Purchase Price Per Kilogram Per Percent Of Cannabidiol Extracted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_SupplyAgreementOptionToPurchasePricePerKilogramPerPercentOfCannabidiolExtracted_2" xml:lang="en-US">Purchase price per kg per 1% of CBD extracted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_TaxEffectOfDeferredTaxAssetNotRecognized_0" xml:lang="en-US">Tax effect of deferred tax asset not recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_TaxEffectOfDeferredTaxAssetNotRecognized_1" xml:lang="en-US">Represents the amount related to tax effect of deferred tax asset not recognized.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_TaxEffectOfDeferredTaxAssetNotRecognized_2" xml:lang="en-US">Change in tax benefits not recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_TaxEffectOfTemporaryDifferences_0" xml:lang="en-US">Tax effect of temporary differences</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_TaxEffectOfTemporaryDifferences_1" xml:lang="en-US">Represents the amount related to tax effect of temporary differences.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_TaxEffectOfTemporaryDifferences_2" xml:lang="en-US">Other adjustments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_TemporaryDifferences_0" xml:lang="en-US">Temporary differences</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_TemporaryDifferences_1" xml:lang="en-US">Differences between the carrying amount of an asset or liability in the statement of financial position and its tax base.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_TemporaryDifferences_2" xml:lang="en-US">Temporary differences</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_TermsOfWarrantGranted_0" xml:lang="en-US">Represents term of warrant granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_TermsOfWarrantGranted_1" xml:lang="en-US">Terms Of Warrant Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_TermsOfWarrantGranted_2" xml:lang="en-US">Terms of warrants granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ThomasFairfullMember_0" xml:lang="en-US">This member stands for thomas fairfull.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ThomasFairfullMember_1" xml:lang="en-US">Thomas Fairfull [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ThomasFairfullMember_2" xml:lang="en-US">Thomas Fairfull</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_TotalCashTransactionCosts_0" xml:lang="en-US">Total Cash Transaction Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_TotalCashTransactionCosts_1" xml:lang="en-US">It represents total cash transaction costs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_TotalCashTransactionCosts_2" xml:lang="en-US">Total cash transaction costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_TransactionCostsAllocatedToWarrants_0" xml:lang="en-US">Transaction Costs Allocated To Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_TransactionCostsAllocatedToWarrants_1" xml:lang="en-US">It represents transaction costs allocated to warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_TransactionCostsAllocatedToWarrants_2" xml:lang="en-US">Transaction costs allocated to warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_TypeOfArrangementsAxis_0" xml:lang="en-US">Type Of Arrangements [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_TypeOfArrangementsDomain_0" xml:lang="en-US">Type Of Arrangements [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_TypeOfInventoriesAxis_0" xml:lang="en-US">The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_TypeOfInventoriesAxis_1" xml:lang="en-US">Type of inventories [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_TypeOfInventoriesDomain_0" xml:lang="en-US">This member stands for all inventories when disaggregated by type. It also represents the standard value for the 'inventories by type' axis if no other member is used.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_TypeOfInventoriesDomain_1" xml:lang="en-US">Type of Inventories [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_UndiscountedLeasePaymentsPayable_0" xml:lang="en-US">Undiscounted lease payments payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_UndiscountedLeasePaymentsPayable_1" xml:lang="en-US">Represents the amount related to undiscounted lease payments payable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_UndiscountedLeasePaymentsPayable_2" xml:lang="en-US">Total undiscounted lease payments payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_UnobservableInputUsedToEstimateFairValueOfBiologicalAssetsTableTextBlock_0" xml:lang="en-US">unobservable input used to estimate fair value of biological assets [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_UnobservableInputUsedToEstimateFairValueOfBiologicalAssetsTableTextBlock_1" xml:lang="en-US">Represents unobservable input used to estimate the fair value of biological assets table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_UnobservableInputUsedToEstimateFairValueOfBiologicalAssetsTableTextBlock_2" xml:lang="en-US">Schedule of unobservable input used to estimate fair value of biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_UnrealizedLoss_0" xml:lang="en-US">Unrealized Loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_UnrealizedLoss_1" xml:lang="en-US">Represents the amount relating to unrealized loss.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_UnrealizedLoss_2" xml:lang="en-US">Unrealized loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_huge_UnrealizedLoss_3" xml:lang="en-US">Unrealized loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_UnrealizedLossOnChangesInFairValueOfBiologicalAssets_0" xml:lang="en-US">Unrealized loss on changes in fair value of biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_UnrealizedLossOnChangesInFairValueOfBiologicalAssets_1" xml:lang="en-US">Represents information about unrealized loss on changes in fair value of biological assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_UnrealizedLossOnChangesInFairValueOfBiologicalAssets_2" xml:lang="en-US">Unrealized loss on changes in fair value of biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_UnrestrictedClassBSharesMember_0" xml:lang="en-US">Unrestricted Class B Shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_UnrestrictedClassBSharesMember_1" xml:lang="en-US">Represents unrestricted Class B shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_UnrestrictedClassBSharesMember_2" xml:lang="en-US">Unrestricted Class B shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ValueOfBrokerWarrantsIssuedInPrivatePlacements_0" xml:lang="en-US">Represents amount of broker warrants issued in private placements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_huge_ValueOfBrokerWarrantsIssuedInPrivatePlacements_1" xml:lang="en-US">Broker warrants issued in private placements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ValueOfBrokerWarrantsIssuedInPrivatePlacements_2" xml:lang="en-US">Value Of Broker Warrants Issued In Private Placements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ValueOfBrokerWarrantsIssuedInPrivatePlacements_3" xml:lang="en-US">Broker warrants issued in private placements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ValueOfCommonStockForNotesPayable_0" xml:lang="en-US">Value Of Common Stock For Notes Payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ValueOfCommonStockForNotesPayable_1" xml:lang="en-US">it represents Value of common stock for notes payable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ValueOfCommonStockForNotesPayable_2" xml:lang="en-US">Value of common stock for notes payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ValueOfSharesAcquired_0" xml:lang="en-US">Represents value of shares acquired.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ValueOfSharesAcquired_1" xml:lang="en-US">Value Of Shares Acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ValueOfSharesAcquired_2" xml:lang="en-US">Value of shares acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ValueOfSharesIssued_0" xml:lang="en-US">Represents the amount related to shares issued during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ValueOfSharesIssued_1" xml:lang="en-US">Value of shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_huge_ValueOfSharesIssued_2" xml:lang="en-US">Gain (loss) on sale of investment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ValueOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_0" xml:lang="en-US">Represents value of shares issued for acquisition of Century Financial Capital Group Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ValueOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_1" xml:lang="en-US">Value Of Shares Issued For Acquisition Of Century Financial Capital Group Inc</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ValueOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_2" xml:lang="en-US">Value of shares issued for acquisition of Century Financial Capital Group Inc</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ValueOfSharesIssuedForDebtSettlement_0" xml:lang="en-US">Value of shares issued for debt settlement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ValueOfSharesIssuedForDebtSettlement_1" xml:lang="en-US">Represents amount of shares issued for debt settlement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ValueOfSharesIssuedForDebtSettlement_2" xml:lang="en-US">Value of shares issued for debt settlement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ValueOfSharesIssuedInPrivatePlacement_0" xml:lang="en-US">Represents value of shares issued in private placement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ValueOfSharesIssuedInPrivatePlacement_1" xml:lang="en-US">Value Of Shares Issued In Private Placement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ValueOfSharesIssuedInPrivatePlacement_2" xml:lang="en-US">Value of shares issued in private placement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ValueOfSharesIssuedInShareExchange_0" xml:lang="en-US">Value of shares issued in share exchange</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ValueOfSharesIssuedInShareExchange_1" xml:lang="en-US">Represents the amount related to shares issued in share exchange.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ValueOfSharesIssuedInShareExchange_2" xml:lang="en-US">Value of shares issued in share exchange</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ValueOfStockOptionsExercised_0" xml:lang="en-US">Represents value of stock options exercised.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ValueOfStockOptionsExercised_1" xml:lang="en-US">Value Of Stock Options Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ValueOfStockOptionsExercised_2" xml:lang="en-US">Value of stock options exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement_0" xml:lang="en-US">Represents the value of subscribed equity units in brokered private placement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement_1" xml:lang="en-US">Value Of Subscribed equity units in brokered private placement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement_2" xml:lang="en-US">Value of subscribed equity units in brokered private placement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ValueOfTradeAndOtherPayableOfSharesBasedCompensation_0" xml:lang="en-US">Value Of Trade And Other Payable Of Shares Based Compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ValueOfTradeAndOtherPayableOfSharesBasedCompensation_1" xml:lang="en-US">It represents value of trade and other payable of shares based compensation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ValueOfTradeAndOtherPayableOfSharesBasedCompensation_2" xml:lang="en-US">Value of trade and other payable of shares based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ValueOfWarrantsExercised_0" xml:lang="en-US">Represents value of warrants exercised.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ValueOfWarrantsExercised_1" xml:lang="en-US">Value Of Warrants Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ValueOfWarrantsExercised_2" xml:lang="en-US">Value of warrants exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ValueOfWarrantsOfResidualValue_0" xml:lang="en-US">Value Of Warrants Of Residual Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ValueOfWarrantsOfResidualValue_1" xml:lang="en-US">It represents value of warrants of residual Value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ValueOfWarrantsOfResidualValue_2" xml:lang="en-US">Value of warrants of residual value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantExercisePrice_0" xml:lang="en-US">Exercise price per warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantExercisePrice_1" xml:lang="en-US">Warrant Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantExercisePrice_2" xml:lang="en-US">Warrant exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantLiabilitiesAbstract_0" xml:lang="en-US">Warrant Liabilities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantLiabilitiesAbstract_1" xml:lang="en-US">Warrant Liabilities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantLiabilitiesLineItems_0" xml:lang="en-US">Warrant Liabilities [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantLiabilitiesLineItems_1" xml:lang="en-US">Warrant Liabilities [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantLiabilitiesTable_0" xml:lang="en-US">Warrant Liabilities [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantLiabilitiesTable_1" xml:lang="en-US">Warrant Liabilities [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantLineItems_0" xml:lang="en-US">Represents information of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantLineItems_1" xml:lang="en-US">Warrant [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_Warrants_0" xml:lang="en-US">Represents amount related to warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_Warrants_1" xml:lang="en-US">Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_Warrants_2" xml:lang="en-US">Warrant reserve</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_Warrants_3" xml:lang="en-US">Warrant liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsAbstract_0" xml:lang="en-US">Warrants [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsByExpiryDateAtAugust1St2021Member_0" xml:lang="en-US">Warrants By Expiry Date At August 1 St 2021 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsByExpiryDateAtAugust1St2021Member_1" xml:lang="en-US">Warrants by expiry date at August 1st 2021.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsByExpiryDateAtAugust1St2021Member_2" xml:lang="en-US">Warrants by expiry date at August 1, 2021</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsByExpiryDateAtAugust6Th2020Member_0" xml:lang="en-US">Warrants By Expiry Date At August 6 Th 2020 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsByExpiryDateAtAugust6Th2020Member_1" xml:lang="en-US">Warrants by expiry date at August 6th 2020.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsByExpiryDateAtAugust6Th2020Member_2" xml:lang="en-US">Warrants by expiry date at August 6, 2020</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsByExpiryDateAtDecember12Th2019Member_0" xml:lang="en-US">Warrants By Expiry Date At December 12 Th 2019 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsByExpiryDateAtDecember12Th2019Member_1" xml:lang="en-US">Warrants by expiry date at December 12st 2019.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsByExpiryDateAtDecember12Th2019Member_2" xml:lang="en-US">Warrants by expiry date at December 12, 2019</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsByExpiryDateAtDecember29Th2019Member_0" xml:lang="en-US">Warrants By Expiry Date At December 29 Th 2019 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsByExpiryDateAtDecember29Th2019Member_1" xml:lang="en-US">Warrants by expiry date at December 29th 2019.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsByExpiryDateAtDecember29Th2019Member_2" xml:lang="en-US">Warrants by expiry date at December 29, 2019</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsByExpiryDateAtJanuary16Th2026Member_0" xml:lang="en-US">Warrants By Expiry Date At January 16 Th 2026 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsByExpiryDateAtJanuary16Th2026Member_1" xml:lang="en-US">Warrants by expiry date at January 16th 2026.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsByExpiryDateAtJanuary16Th2026Member_2" xml:lang="en-US">Warrants by expiry date at January 16, 2026</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsByExpiryDateAtJanuary20Th2026Member_0" xml:lang="en-US">Warrants By Expiry Date At January 20 Th 2026 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsByExpiryDateAtJanuary20Th2026Member_1" xml:lang="en-US">Warrants by expiry date at January 20th 2026.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsByExpiryDateAtJanuary20Th2026Member_2" xml:lang="en-US">Warrants by expiry date at January 20, 2026</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsByExpiryDateAtJanuary5Th2020Member_0" xml:lang="en-US">Warrants By Expiry Date At January 5 Th 2020 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsByExpiryDateAtJanuary5Th2020Member_1" xml:lang="en-US">Warrants by expiry date at January 5th 2020.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsByExpiryDateAtJanuary5Th2020Member_2" xml:lang="en-US">Warrants by expiry date at January 5, 2020</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsByExpiryDateAtJuly24Th2023Member_0" xml:lang="en-US">Warrants By Expiry Date At July 24 Th 2023 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsByExpiryDateAtJuly24Th2023Member_1" xml:lang="en-US">Warrants by expiry date at July 24th 2023.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsByExpiryDateAtJuly24Th2023Member_2" xml:lang="en-US">Warrants by expiry date at July 24, 2023</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsByExpiryDateAtJune8Th2025Member_0" xml:lang="en-US">Warrants By Expiry Date At June 8 Th 2025 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsByExpiryDateAtJune8Th2025Member_1" xml:lang="en-US">Warrants by expiry date at June 8th 2025.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsByExpiryDateAtJune8Th2025Member_2" xml:lang="en-US">Warrants by expiry date at June 8, 2025</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsByExpiryDateAtMay10Th2025Member_0" xml:lang="en-US">Warrants By Expiry Date At May 10 Th 2025 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsByExpiryDateAtMay10Th2025Member_1" xml:lang="en-US">Warrants by expiry date at May 10th 2025.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsByExpiryDateAtMay10Th2025Member_2" xml:lang="en-US">Warrants by expiry date at May 10, 2025</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsByExpiryDateAtMay17Th2025Member_0" xml:lang="en-US">Warrants By Expiry Date At May 17 Th, 2025 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsByExpiryDateAtMay17Th2025Member_1" xml:lang="en-US">Warrants by expiry date at May 17th, 2025.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsByExpiryDateAtMay17Th2025Member_2" xml:lang="en-US">Warrants by expiry date at May 17, 2025</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsByExpiryDateAtMay20Th2023Member_0" xml:lang="en-US">Warrants By Expiry Date At May 20 Th 2023 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsByExpiryDateAtMay20Th2023Member_1" xml:lang="en-US">Warrants by expiry date at May 20th 2023.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsByExpiryDateAtMay20Th2023Member_2" xml:lang="en-US">Warrants by expiry date at May 20, 2023</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsByExpiryDateAtMay24Th2022Member_0" xml:lang="en-US">Warrants By Expiry Date At May 24 Th 2022 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsByExpiryDateAtMay24Th2022Member_1" xml:lang="en-US">Warrants by expiry date at May 24th 2022.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsByExpiryDateAtMay24Th2022Member_2" xml:lang="en-US">Warrants by expiry date at May 24, 2022</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsByExpiryDateAtMay31St2025Member_0" xml:lang="en-US">Warrants By Expiry Date At May 31 St 2025 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsByExpiryDateAtMay31St2025Member_1" xml:lang="en-US">Warrants by expiry date at May 31st 2025.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsByExpiryDateAtMay31St2025Member_2" xml:lang="en-US">Warrants by expiry date at May 31, 2025</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsByExpiryDateAtMay4Th2025Member_0" xml:lang="en-US">Warrants By Expiry Date At May 4 Th 2025 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsByExpiryDateAtMay4Th2025Member_1" xml:lang="en-US">Warrants by expiry date at May 4th 2025.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsByExpiryDateAtMay4Th2025Member_2" xml:lang="en-US">Warrants by expiry date at May 4, 2025</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsByExpiryDateAtNovember14Th2019Member_0" xml:lang="en-US">Warrants By Expiry Date At November 14 Th 2019 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsByExpiryDateAtNovember14Th2019Member_1" xml:lang="en-US">Warrants by expiry date at November 14th 2019.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsByExpiryDateAtNovember14Th2019Member_2" xml:lang="en-US">Warrants by expiry date at November 14, 2019</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsByExpiryDateAtNovember1St2019Member_0" xml:lang="en-US">Warrants By Expiry Date At November 1 St 2019 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsByExpiryDateAtNovember1St2019Member_1" xml:lang="en-US">Warrants by expiry date at November 1st 2019.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsByExpiryDateAtNovember1St2019Member_2" xml:lang="en-US">Warrants by expiry date at November 1, 2019</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsByExpiryDateAtNovember21St2019Member_0" xml:lang="en-US">Warrants By Expiry Date At November 21 St 2019 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsByExpiryDateAtNovember21St2019Member_1" xml:lang="en-US">Warrants by expiry date at November 21st 2019.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsByExpiryDateAtNovember21St2019Member_2" xml:lang="en-US">Warrants by expiry date at November 21, 2019</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsByExpiryDateAtNovember30Th2020Member_0" xml:lang="en-US">Warrants By Expiry Date At November 30 Th 2020 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsByExpiryDateAtNovember30Th2020Member_1" xml:lang="en-US">Warrants by expiry date at November 30th 2020.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsByExpiryDateAtNovember30Th2020Member_2" xml:lang="en-US">Warrants by expiry date at November 30, 2020</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsByExpiryDateAtOctober20Th2020Member_0" xml:lang="en-US">Warrants By Expiry Date At October 20 Th 2020 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsByExpiryDateAtOctober20Th2020Member_1" xml:lang="en-US">Warrants by expiry date at October 20th 2020.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsByExpiryDateAtOctober20Th2020Member_2" xml:lang="en-US">Warrants by expiry date at October 20, 2020</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsByExpiryDateAtSeptember11Th2023Member_0" xml:lang="en-US">Warrants By Expiry Date At September 11 Th 2023 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsByExpiryDateAtSeptember11Th2023Member_1" xml:lang="en-US">Warrants by expiry date at September 11th 2023.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsByExpiryDateAtSeptember11Th2023Member_2" xml:lang="en-US">Warrants by expiry date at September 11, 2023</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsByExpiryDateAtSeptember15Th2022Member_0" xml:lang="en-US">Warrants By Expiry Date At September 15 Th 2022 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsByExpiryDateAtSeptember15Th2022Member_1" xml:lang="en-US">Warrants by expiry date at September 15th 2022.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsByExpiryDateAtSeptember15Th2022Member_2" xml:lang="en-US">Warrants by expiry date at September 15, 2022</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsIssueDateAxis_0" xml:lang="en-US">Represents information of warrants issue date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsIssueDateAxis_1" xml:lang="en-US">Warrants Issue Date [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsIssueDateDomain_0" xml:lang="en-US">Represents information of warrants issue date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsIssueDateDomain_1" xml:lang="en-US">Warrants Issue Date [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsIssuedForPrivatePlacement_0" xml:lang="en-US">Warrants Issued For Private Placement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsIssuedForPrivatePlacement_1" xml:lang="en-US">it represents warrants issued for private placement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsIssuedForPrivatePlacement_2" xml:lang="en-US">Warrants issued for private placement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsLiability_0" xml:lang="en-US">Warrants Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsLiability_1" xml:lang="en-US">Represents the value of warrants liability.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsLiability_2" xml:lang="en-US">Warrant reserve</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_WarrantsLiability_3" xml:lang="en-US">Warrant liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsMember_0" xml:lang="en-US">Represents information of warrant.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsMember_1" xml:lang="en-US">Warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_WarrantsMember_2" xml:lang="en-US">Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsMember_3" xml:lang="en-US">Options or warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WarrantsOptionsOfAcquirer_0" xml:lang="en-US">The fair value, at the acquisition date, of warrants of the acquirer transferred as consideration in a business combination.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WarrantsOptionsOfAcquirer_1" xml:lang="en-US">Warrants Options Of Acquirer</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WarrantsOptionsOfAcquirer_2" xml:lang="en-US">Exchange of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WeightedAverageExercisePriceForReplacementOfShareOptions_0" xml:lang="en-US">Weighted Average Exercise Price For Replacement Of Share Options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WeightedAverageExercisePriceForReplacementOfShareOptions_1" xml:lang="en-US">Weighted Average Exercise Price.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WeightedAverageExercisePriceForReplacementOfShareOptions_2" xml:lang="en-US">Weighted average exercise price, Exercisable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_WeightedAverageExercisePriceForReplacementOfShareOptions_3" xml:lang="en-US">Exercise price of exercisable Share options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveVerboseLabel" xlink:label="lab_huge_WeightedAverageExercisePriceForReplacementOfShareOptions_4" xml:lang="en-US">Share option exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WeightedAverageExercisePricesWarrantExercised_0" xml:lang="en-US">Weighted Average Exercise Prices Warrant Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WeightedAverageExercisePricesWarrantExercised_1" xml:lang="en-US">Represents weighted average exercise price warrants exercised.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WeightedAverageExercisePricesWarrantExercised_2" xml:lang="en-US">Weighted average exercise price warrants exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WeightedAverageExercisePricesWarrantExpired_0" xml:lang="en-US">Weighted Average Exercise Prices Warrant Expired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WeightedAverageExercisePricesWarrantExpired_1" xml:lang="en-US">Represents weighted average exercise price warrants expired.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_WeightedAverageExercisePricesWarrantExpired_2" xml:lang="en-US">Weighted average exercise price warrants expired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WeightedAverageExercisePricesWarrantIssued_0" xml:lang="en-US">Weighted Average Exercise Prices Warrant Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WeightedAverageExercisePricesWarrantIssued_1" xml:lang="en-US">Represents weighted average exercise price warrants issued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WeightedAverageExercisePricesWarrantIssued_2" xml:lang="en-US">Weighted average exercise price warrants issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WeightedAverageExercisePriceWarrantsOutstanding_0" xml:lang="en-US">Weighted average exercise Price warrants Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WeightedAverageExercisePriceWarrantsOutstanding_1" xml:lang="en-US">Represents weighted average exercise Price warrants outstanding.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_huge_WeightedAverageExercisePriceWarrantsOutstanding_2" xml:lang="en-US">Weighted average exercise price, Warrants outstanding opening balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_huge_WeightedAverageExercisePriceWarrantsOutstanding_3" xml:lang="en-US">Weighted average exercise price, Warrants outstanding closing balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_WeightedAverageExercisePriceWarrantsOutstanding_4" xml:lang="en-US">Exercise price of warrants outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WeightedAverageSharePriceOfWarrants_0" xml:lang="en-US">Weighted average share price of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WeightedAverageSharePriceOfWarrants_1" xml:lang="en-US">Represents the weighted average share price of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_WeightedAverageSharePriceOfWarrants_2" xml:lang="en-US">Grant date share price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_WorkingCapitalSurplus_0" xml:lang="en-US">Working Capital Surplus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_WorkingCapitalSurplus_1" xml:lang="en-US">Represents amount of working capital surplus.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_huge_WorkingCapitalSurplus_2" xml:lang="en-US">Working capital surplus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_huge_ZeeshanSaeedMember_0" xml:lang="en-US">This member stands for Zeeshan Saeed.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_huge_ZeeshanSaeedMember_1" xml:lang="en-US">Zeeshan Saeed [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_huge_ZeeshanSaeedMember_2" xml:lang="en-US">Zeeshan Saeed</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AccountingProfit_0" xml:lang="en-US">Accounting profit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AccountingProfit_1" xml:lang="en-US">Loss from continuing operations before income taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AccumulatedDepreciationAndAmortisationMember_0" xml:lang="en-US">Accumulated depreciation and amortisation [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AccumulatedDepreciationAndAmortisationMember_1" xml:lang="en-US">Accumulated amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AccumulatedDepreciationAndAmortisationMember_2" xml:lang="en-US">Accumulated depreciation:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_0" xml:lang="en-US">Consideration transferred, acquisition-date fair value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_1" xml:lang="en-US">Total consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_2" xml:lang="en-US">Total consideration transferred, acquisition-date fair value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_3" xml:lang="en-US">Total consideration transferred, acquisition-date fair value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_0" xml:lang="en-US">Acquisition-related costs recognised as expense for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_1" xml:lang="en-US">Listing expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_2" xml:lang="en-US">Listing expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">Acquisitions through business combinations, intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_1" xml:lang="en-US">Acquisition of Prismic Pharmaceuticals Inc</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdditionsFromPurchasesBiologicalAssets_0" xml:lang="en-US">Additions from purchases, biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdditionsFromPurchasesBiologicalAssets_1" xml:lang="en-US">Capitalized costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">Additions other than through business combinations, intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_1" xml:lang="en-US">Additions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_0" xml:lang="en-US">Additions other than through business combinations, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_1" xml:lang="en-US">Additions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustedWeightedAverageShares_0" xml:lang="en-US">Adjusted weighted average number of ordinary shares outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustedWeightedAverageShares_1" xml:lang="en-US">Weighted average number of shares outstanding - diluted (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_AdjustedWeightedAverageShares_2" xml:lang="en-US">Balance, end of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustedWeightedAverageShares_3" xml:lang="en-US">Weighted average number of shares outstanding - basic and diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_0" xml:lang="en-US">Adjustments for decrease (increase) in biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_1" xml:lang="en-US">Biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_2" xml:lang="en-US">Change in fair value of biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_0" xml:lang="en-US">Inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_1" xml:lang="en-US">Adjustments for decrease (increase) in inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_2" xml:lang="en-US">Inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_0" xml:lang="en-US">Adjustments for decrease (increase) in trade and other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_1" xml:lang="en-US">Trade and other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveVerboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_2" xml:lang="en-US">Other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_0" xml:lang="en-US">Depreciation and amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForDepreciationExpense_0" xml:lang="en-US">Adjustments for depreciation expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForDepreciationExpense_1" xml:lang="en-US">Depreciation and amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForFairValueGainsLosses_0" xml:lang="en-US">Adjustments for fair value losses (gains)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForFairValueGainsLosses_1" xml:lang="en-US">Change in fair value of investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_0" xml:lang="en-US">Change in fair value of biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_1" xml:lang="en-US">Unrealized loss on changes in fair value of biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_2" xml:lang="en-US">Adjustments for gains (losses) on change in fair value less costs to sell, biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_3" xml:lang="en-US">Unrealized loss on changes in fair value of biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_4" xml:lang="en-US">Change in fair value of biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_0" xml:lang="en-US">Change in fair value of derivative liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_1" xml:lang="en-US">Adjustments for gains (losses) on change in fair value of derivatives</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_2" xml:lang="en-US">Change in fair value of derivative liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_0" xml:lang="en-US">Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_1" xml:lang="en-US">Impairment loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_2" xml:lang="en-US">Impairment of property, plant and equipment and right-of-use asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel" xlink:label="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_3" xml:lang="en-US">Impairment of right-of-use asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossInventories_0" xml:lang="en-US">Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossInventories_1" xml:lang="en-US">Impairment of inventory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_0" xml:lang="en-US">Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_1" xml:lang="en-US">Impairment of property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities_0" xml:lang="en-US">Adjustments for increase (decrease) in derivative financial liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities_1" xml:lang="en-US">Change in fair value of derivative liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_0" xml:lang="en-US">Adjustments for increase (decrease) in trade and other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_1" xml:lang="en-US">Adjustments for increase (decrease) in trade and other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_2" xml:lang="en-US">Trade and other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_3" xml:lang="en-US">Other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForInterestExpense_0" xml:lang="en-US">Adjustments for interest expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForInterestExpense_1" xml:lang="en-US">Interest expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_0" xml:lang="en-US">Adjustments for:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_1" xml:lang="en-US">Add (deduct) items not affecting cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForSharebasedPayments_0" xml:lang="en-US">Adjustments for share based payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForSharebasedPayments_1" xml:lang="en-US">Share-based payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForSharebasedPayments_2" xml:lang="en-US">Adjustments for share-based payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_0" xml:lang="en-US">Adjustments for unrealised foreign exchange losses (gains)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_1" xml:lang="en-US">Unrealized foreign exchange loss (gain)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdvertisingExpense_0" xml:lang="en-US">Advertising expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdvertisingExpense_1" xml:lang="en-US">Advertising and promotion</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AggregatedMeasurementMember_0" xml:lang="en-US">Aggregated measurement [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AggregatedTimeBandsMember_0" xml:lang="en-US">Aggregated time bands [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AllLevelsOfFairValueHierarchyMember_0" xml:lang="en-US">All levels of fair value hierarchy [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">Amortisation, intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_1" xml:lang="en-US">Amortisation, intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_2" xml:lang="en-US">Amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AmountsPayableRelatedPartyTransactions_0" xml:lang="en-US">Amounts payable, related party transactions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AmountsPayableRelatedPartyTransactions_1" xml:lang="en-US">Related party payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ApplicableTaxRate_0" xml:lang="en-US">Statutory Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ApplicableTaxRate_1" xml:lang="en-US">Statutory federal and provincial tax rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Assets_0" xml:lang="en-US">Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_Assets_1" xml:lang="en-US">Total assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AssetsAbstract_0" xml:lang="en-US">ASSETS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_0" xml:lang="en-US">Assets and liabilities classified as held for sale [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_0" xml:lang="en-US">Assets and liabilities classified as held for sale [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AtFairValueMember_0" xml:lang="en-US">At fair value [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AtFairValueMember_1" xml:lang="en-US">Fair value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BasicAndDilutedEarningsLossPerShareFromContinuingOperations_0" xml:lang="en-US">Basic and diluted earnings (loss) per share from continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_BasicAndDilutedEarningsLossPerShareFromContinuingOperations_1" xml:lang="en-US">Basic and diluted - continuing operations (in dollars per share)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BasicAndDilutedEarningsLossPerShareFromDiscontinuedOperations_0" xml:lang="en-US">Basic and diluted earnings (loss) per share from discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_BasicAndDilutedEarningsLossPerShareFromDiscontinuedOperations_1" xml:lang="en-US">Basic and diluted - discontinued operations (in dollars per share)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BasicEarningsLossPerShare_0" xml:lang="en-US">Basic earnings (loss) per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_BasicEarningsLossPerShare_1" xml:lang="en-US">Net (loss) income per share - basic (in dollars per share)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_BiologicalAssets_0" xml:lang="en-US">Biological assets at end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_BiologicalAssets_1" xml:lang="en-US">Biological assets at beginning of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BiologicalAssets_2" xml:lang="en-US">Biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_BiologicalAssets_3" xml:lang="en-US">Biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BiologicalAssetsByGroupAxis_0" xml:lang="en-US">Biological assets by group [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BiologicalAssetsGroupMember_0" xml:lang="en-US">Biological assets, group [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BorrowingsAbstract_0" xml:lang="en-US">Borrowings [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BorrowingsInterestRate_0" xml:lang="en-US">Borrowings, interest rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_BorrowingsInterestRate_1" xml:lang="en-US">Notes payable, interest rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">Notes payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Borrowings recognised as of acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_2" xml:lang="en-US">Convertible notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BottomOfRangeMember_0" xml:lang="en-US">Bottom of range [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_BottomOfRangeMember_1" xml:lang="en-US">Bottom of range</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BusinessCombinationsAxis_0" xml:lang="en-US">Business combinations [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BusinessCombinationsMember_0" xml:lang="en-US">Business combinations [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_0" xml:lang="en-US">Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CarryingAmountMember_0" xml:lang="en-US">Carrying amount [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Cash_0" xml:lang="en-US">Cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_Cash_1" xml:lang="en-US">Total cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_Cash_2" xml:lang="en-US">Cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashAbstract_0" xml:lang="en-US">Cash [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_CashAndCashEquivalents_0" xml:lang="en-US">Cash, end of the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_CashAndCashEquivalents_1" xml:lang="en-US">Cash, beginning of the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashAndCashEquivalents_2" xml:lang="en-US">Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashAndCashEquivalents_3" xml:lang="en-US">Cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CashAndCashEquivalents_4" xml:lang="en-US">Cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">Cash and cash equivalents recognised as of acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_2" xml:lang="en-US">Total cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_0" xml:lang="en-US">Cash flows from (used in) financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_1" xml:lang="en-US">Cash provided by financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_2" xml:lang="en-US">Cash flows from financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_0" xml:lang="en-US">Cash provided by (used in) financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_1" xml:lang="en-US">Financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_0" xml:lang="en-US">Cash flows from (used in) financing activities, continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_1" xml:lang="en-US">Cash provided by continuing financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations_0" xml:lang="en-US">Cash flows from (used in) financing activities, discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations_1" xml:lang="en-US">Cash provided by discontinued financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations_2" xml:lang="en-US">Cash provided by discontinued financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities_0" xml:lang="en-US">Cash flows from (used in) investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities_1" xml:lang="en-US">Cash provided by (used in) investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_0" xml:lang="en-US">Cash flows from (used in) investing activities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_1" xml:lang="en-US">Investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_0" xml:lang="en-US">Cash flows from (used in) investing activities, continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_1" xml:lang="en-US">Cash provided by continuing investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_0" xml:lang="en-US">Cash flows from (used in) investing activities, discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_1" xml:lang="en-US">Cash provided by (used in) discontinued investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_2" xml:lang="en-US">Cash provided by (used in) discontinued investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_0" xml:lang="en-US">Cash flows from (used in) operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" xml:lang="en-US">Cash used in operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_0" xml:lang="en-US">Cash flows from (used in) operating activities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" xml:lang="en-US">Operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations_0" xml:lang="en-US">Cash flows from (used in) operating activities, continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations_1" xml:lang="en-US">Cash used in continuing operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations_2" xml:lang="en-US">Cash used in continuing operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_0" xml:lang="en-US">Cash flows from (used in) operating activities, discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_1" xml:lang="en-US">Cash used in discontinued operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_2" xml:lang="en-US">Cash used in operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_3" xml:lang="en-US">Cash used in discontinued operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashOutflowForLeases_0" xml:lang="en-US">Cash outflow for leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_CashOutflowForLeases_1" xml:lang="en-US">Less: Lease Payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_CashOutflowForLeases_2" xml:lang="en-US">Repayment of lease obligation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashOutflowForLeases_3" xml:lang="en-US">Repayment of lease obligation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CashOutflowForLeases_4" xml:lang="en-US">Less: Lease Payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties_0" xml:lang="en-US">Advance from shareholder</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties_1" xml:lang="en-US">Cash repayments of advances and loans from related parties</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashTransferred_0" xml:lang="en-US">Cash transferred</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CategoriesOfFinancialAssetsAxis_0" xml:lang="en-US">Categories of financial assets [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_0" xml:lang="en-US">Categories of financial liabilities [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CategoriesOfRelatedPartiesAxis_0" xml:lang="en-US">Categories of related parties [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract_0" xml:lang="en-US">Changes in intangible assets other than goodwill [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfContingentLiabilitiesAxis_0" xml:lang="en-US">Classes of contingent liabilities [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfFinancialInstrumentsAxis_0" xml:lang="en-US">Classes of financial instruments [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfFinancialInstrumentsMember_0" xml:lang="en-US">Financial instruments, class [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_0" xml:lang="en-US">Classes of intangible assets other than goodwill [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfInventoriesAbstract_0" xml:lang="en-US">Classes of current inventories [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfOrdinarySharesAxis_0" xml:lang="en-US">Classes of ordinary shares [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_0" xml:lang="en-US">Classes of property, plant and equipment [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfShareCapitalAxis_0" xml:lang="en-US">Classes of share capital [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfShareCapitalMember_0" xml:lang="en-US">Share capital [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClosingForeignExchangeRate_0" xml:lang="en-US">Closing foreign exchange rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ClosingForeignExchangeRate_1" xml:lang="en-US">Exchange rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CommercialPapersIssued_0" xml:lang="en-US">Commercial papers issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CommercialPapersIssued_1" xml:lang="en-US">Short-term notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ComponentsOfEquityAxis_0" xml:lang="en-US">Components of equity [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_0" xml:lang="en-US">Components of other comprehensive income that will be reclassified to profit or loss, net of tax [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_1" xml:lang="en-US">Items that may be subsequently reclassified to income:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ComprehensiveIncome_0" xml:lang="en-US">Comprehensive income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ComprehensiveIncome_1" xml:lang="en-US">Loss before the undernoted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ComprehensiveIncome_2" xml:lang="en-US">Comprehensive loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ComprehensiveIncome_3" xml:lang="en-US">Comprehensive loss for the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ComputerEquipmentMember_0" xml:lang="en-US">Computer equipment [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ComputerEquipmentMember_1" xml:lang="en-US">Computer hardware and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ComputerEquipmentMember_2" xml:lang="en-US">Computer equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ConstructionInProgressMember_0" xml:lang="en-US">Construction in progress [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ConstructionInProgressMember_1" xml:lang="en-US">Facility and related</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ContingentLiabilitiesMember_0" xml:lang="en-US">Contingent liabilities [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ContractualCapitalCommitments_0" xml:lang="en-US">Contractual capital commitments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ContractualCapitalCommitments_1" xml:lang="en-US">Commitments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ContractualCapitalCommitments_2" xml:lang="en-US">Total rent payments on office space</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_0" xml:lang="en-US">Copyrights, patents and other industrial property rights, service and operating rights [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_1" xml:lang="en-US">Intellectual Property</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_CostOfSales_0" xml:lang="en-US">Cost of revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CostOfSales_1" xml:lang="en-US">Cost of sales</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CostOfSales_2" xml:lang="en-US">Cost of revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CounterpartiesAxis_0" xml:lang="en-US">Counterparties [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CounterpartiesMember_0" xml:lang="en-US">Counterparties [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CreditRiskMember_0" xml:lang="en-US">Credit risk [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CreditRiskMember_1" xml:lang="en-US">Credit risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentAssets_0" xml:lang="en-US">Current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CurrentAssets_1" xml:lang="en-US">Total current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentAssets_2" xml:lang="en-US">Total current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentAssetsAbstract_0" xml:lang="en-US">Current Assets Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentAssetsAbstract_1" xml:lang="en-US">Current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_0" xml:lang="en-US">Current assets other than non-current assets or disposal groups classified as held for sale or as held for distribution to owners</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_1" xml:lang="en-US">Current assets other than assets held for sale</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_2" xml:lang="en-US">Current assets other than assets held for sale</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">Current assets recognised as of acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Prepaid expenses and deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate_2" xml:lang="en-US">Prepaid expenses and deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentDebtInstrumentsIssued_0" xml:lang="en-US">Current debt instruments issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentDebtInstrumentsIssued_1" xml:lang="en-US">Short-term notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentDerivativeFinancialLiabilities_0" xml:lang="en-US">Current derivative financial liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentDerivativeFinancialLiabilities_1" xml:lang="en-US">Derivative liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentLeaseLiabilities_0" xml:lang="en-US">Current lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentLeaseLiabilities_1" xml:lang="en-US">Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentLeaseLiabilities_2" xml:lang="en-US">Lease obligations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentLiabilities_0" xml:lang="en-US">Current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CurrentLiabilities_1" xml:lang="en-US">Total current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentLiabilities_2" xml:lang="en-US">Total current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentLiabilitiesAbstract_0" xml:lang="en-US">Current Liabilities Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentLiabilitiesAbstract_1" xml:lang="en-US">Current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_0" xml:lang="en-US">Current notes and debentures issued and current portion of non-current notes and debentures issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_1" xml:lang="en-US">Balance as at December 31, 2019</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_2" xml:lang="en-US">Notes payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentPrepaidExpenses_0" xml:lang="en-US">Current prepaid expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentPrepaidExpenses_1" xml:lang="en-US">Prepaids</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentPrepaidExpenses_2" xml:lang="en-US">Prepaid expenses and deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_DecreaseDueToHarvestBiologicalAssets_0" xml:lang="en-US">Decrease due to harvest, biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DecreaseDueToHarvestBiologicalAssets_1" xml:lang="en-US">Decrease due to harvest, biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DecreaseDueToHarvestBiologicalAssets_2" xml:lang="en-US">Transferred to inventory upon harvest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_DecreaseDueToHarvestBiologicalAssets_3" xml:lang="en-US">Transferred to inventory upon harvest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_DeferredTaxAssets_0" xml:lang="en-US">Deferred tax assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DeferredTaxAssets_1" xml:lang="en-US">Deferred tax assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DeferredTaxExpenseIncome_0" xml:lang="en-US">Deferred income tax provision (recovery)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DeferredTaxExpenseIncome_1" xml:lang="en-US">Deferred income tax provision (recovery)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_DeferredTaxExpenseIncome_2" xml:lang="en-US">Total Income tax expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DeferredTaxLiabilities_0" xml:lang="en-US">Deferred tax liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_DeferredTaxLiabilities_1" xml:lang="en-US">Deferred income tax liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DeferredTaxLiabilityAsset_0" xml:lang="en-US">Deferred tax liability (asset)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DeferredTaxLiabilityAsset_1" xml:lang="en-US">Deferred income tax liability (asset)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="lab_ifrs-full_DeferredTaxLiabilityAsset_2" xml:lang="en-US">Net deferred tax liability (asset)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_DeferredTaxLiabilityAsset_3" xml:lang="en-US">Deferred tax liability (asset) at beginning of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_DeferredTaxLiabilityAsset_4" xml:lang="en-US">Deferred tax liability (asset) at end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_DeferredTaxLiabilityAsset_5" xml:lang="en-US">Deferred tax assets (liabilities)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_DepreciationAndAmortisationExpense_0" xml:lang="en-US">Depreciation and amortisation expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DepreciationAndAmortisationExpense_1" xml:lang="en-US">Depreciation and amortisation expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_DepreciationAndAmortisationExpense_2" xml:lang="en-US">Total depreciation and amortisation expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DepreciationAndAmortisationExpense_3" xml:lang="en-US">Depreciation and amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_DepreciationBiologicalAssets_0" xml:lang="en-US">Depreciation, biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DepreciationBiologicalAssets_1" xml:lang="en-US">Depreciation, biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DepreciationBiologicalAssets_2" xml:lang="en-US">Depreciation on production of biological assets and inventory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DepreciationExpense_0" xml:lang="en-US">Depreciation expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DepreciationExpense_1" xml:lang="en-US">Depreciation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DepreciationMethodPropertyPlantAndEquipment_0" xml:lang="en-US">Depreciation method, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DepreciationMethodPropertyPlantAndEquipment_1" xml:lang="en-US">Method of amortized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DepreciationPropertyPlantAndEquipment_0" xml:lang="en-US">Depreciation, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DepreciationPropertyPlantAndEquipment_1" xml:lang="en-US">Depreciation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_DepreciationRightofuseAssets_0" xml:lang="en-US">Depreciation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DepreciationRightofuseAssets_1" xml:lang="en-US">Depreciation, right-of-use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DepreciationRightofuseAssets_2" xml:lang="en-US">Amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DepreciationRightofuseAssets_3" xml:lang="en-US">Depreciation on right of use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DerivativeFinancialLiabilities_0" xml:lang="en-US">Derivative financial liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForDecommissioningRestorationAndRehabilitationProvisionsExplanatory_0" xml:lang="en-US">Restoration, rehabilitation and environmental obligations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory_0" xml:lang="en-US">Derecognition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory_0" xml:lang="en-US">Description of accounting policy for discontinued operations [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory_1" xml:lang="en-US">Discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_0" xml:lang="en-US">Earnings/loss per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_1" xml:lang="en-US">Net Loss per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_0" xml:lang="en-US">Description of accounting policy for financial instruments [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_1" xml:lang="en-US">Financial Instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_0" xml:lang="en-US">Description of accounting policy for foreign currency translation [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_1" xml:lang="en-US">Foreign Currency Translation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_0" xml:lang="en-US">Description of accounting policy for impairment of assets [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_1" xml:lang="en-US">Impairment of long-lived assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory_0" xml:lang="en-US">Impairment of financial assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_0" xml:lang="en-US">Impairment of non-financial assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_0" xml:lang="en-US">Income taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_1" xml:lang="en-US">Income Taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_0" xml:lang="en-US">Description of accounting policy for intangible assets other than goodwill [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_1" xml:lang="en-US">Intangible Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_0" xml:lang="en-US">Description of accounting policy for investments other than investments accounted for using equity method [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_1" xml:lang="en-US">Investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_0" xml:lang="en-US">Share capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_0" xml:lang="en-US">Description of accounting policy for leases [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_1" xml:lang="en-US">Leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_0" xml:lang="en-US">Inventory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_1" xml:lang="en-US">Inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_0" xml:lang="en-US">Description Of Accounting Policy For Property Plant And Equipment Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_1" xml:lang="en-US">Property, Plant and Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_0" xml:lang="en-US">Provisions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForReclassificationOfFinancialInstrumentsExplanatory_0" xml:lang="en-US">Classification</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_0" xml:lang="en-US">Description of accounting policy for recognition of revenue [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_1" xml:lang="en-US">Revenue Recognition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_0" xml:lang="en-US">Description of accounting policy for research and development expense [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_1" xml:lang="en-US">External research and development</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_0" xml:lang="en-US">Description Of Accounting Policy For Sharebased Payment Transactions Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_1" xml:lang="en-US">Description of accounting policy for share-based payment transactions [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_2" xml:lang="en-US">Share-based Compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_0" xml:lang="en-US">Description Of Accounting Policy To Determine Components Of Cash And Cash Equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_1" xml:lang="en-US">Description of accounting policy for determining components of cash and cash equivalents [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_2" xml:lang="en-US">Cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_0" xml:lang="en-US">Expected volatility, share options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_1" xml:lang="en-US">Annualized volatility</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_2" xml:lang="en-US">Expected Volatility Range</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_3" xml:lang="en-US">Expected volatility</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_0" xml:lang="en-US">Option life, share options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_1" xml:lang="en-US">Expected maturity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_2" xml:lang="en-US">Expected life (years)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements_0" xml:lang="en-US">Accounting Standards Issued But Not Yet Applied</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_0" xml:lang="en-US">Risk free interest rate, share options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_1" xml:lang="en-US">Risk free interest rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_2" xml:lang="en-US">Risk Free Interest Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">Description of useful life, intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill_1" xml:lang="en-US">Estimated useful lives for intangible assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_0" xml:lang="en-US">Description of useful life, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_1" xml:lang="en-US">Estimated useful lives</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DilutedEarningsLossPerShare_0" xml:lang="en-US">Diluted earnings (loss) per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_DilutedEarningsLossPerShare_1" xml:lang="en-US">Total diluted earnings (loss) per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DilutedEarningsLossPerShare_2" xml:lang="en-US">Net (loss) income per share - diluted (in dollars per share)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_0" xml:lang="en-US">Dilutive effect of convertible instruments on number of ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_1" xml:lang="en-US">Dilutive effect of convertible instruments on number of ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_0" xml:lang="en-US">Dilutive effect of share options on number of ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DirectorsRemunerationExpense_0" xml:lang="en-US">Directors remuneration expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DirectorsRemunerationExpense_1" xml:lang="en-US">Directors remuneration expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_0" xml:lang="en-US">Disclosure of accounting judgements and estimates [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_1" xml:lang="en-US">Critical accounting estimates and judgments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_0" xml:lang="en-US">Disclosure of basis of preparation of financial statements [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_1" xml:lang="en-US">Basis of presentation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfBorrowingsExplanatory_0" xml:lang="en-US">Disclosure of borrowings [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfBorrowingsExplanatory_1" xml:lang="en-US">Notes payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0" xml:lang="en-US">Disclosure of detailed information about business combination [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsAbstract_1" xml:lang="en-US">Nature of business</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_0" xml:lang="en-US">Disclosure of business combinations [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_1" xml:lang="en-US">Reverse Takeover Transaction</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_2" xml:lang="en-US">Acquisition of Prismic Pharmaceutical</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xml:lang="en-US">Disclosure of detailed information about business combination [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsTable_0" xml:lang="en-US">Disclosure of detailed information about business combination [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_0" xml:lang="en-US">Disclosure of classes of share capital [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_1" xml:lang="en-US">Schedule of changes in share capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xml:lang="en-US">Disclosure of classes of share capital [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalTable_0" xml:lang="en-US">Disclosure of classes of share capital [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_0" xml:lang="en-US">Disclosure of commitments and contingent liabilities [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_1" xml:lang="en-US">Commitments and contingencies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfCommitmentsExplanatory_0" xml:lang="en-US">Disclosure of commitments [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfCommitmentsExplanatory_1" xml:lang="en-US">Commitments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_0" xml:lang="en-US">Disclosure of contingent liabilities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_0" xml:lang="en-US">Disclosure of contingent liabilities [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_1" xml:lang="en-US">Contingencies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0" xml:lang="en-US">Disclosure of contingent liabilities [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfContingentLiabilitiesTable_0" xml:lang="en-US">Disclosure of contingent liabilities [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfCreditRiskExplanatory_0" xml:lang="en-US">Disclosure of credit risk [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfCreditRiskExplanatory_1" xml:lang="en-US">Schedule of credit risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDeferredTaxesExplanatory_0" xml:lang="en-US">Disclosure of deferred taxes [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfDeferredTaxesExplanatory_1" xml:lang="en-US">Schedule of deferred tax assets (liabilities)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory_0" xml:lang="en-US">Disclosure of derivative financial instruments [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory_1" xml:lang="en-US">Derivative liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xml:lang="en-US">Disclosure of detailed information about biological assets [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory_0" xml:lang="en-US">Disclosure of detailed information about biological assets [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory_1" xml:lang="en-US">Biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems_0" xml:lang="en-US">Disclosure of detailed information about biological assets [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsTable_0" xml:lang="en-US">Disclosure of detailed information about biological assets [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_0" xml:lang="en-US">Disclosure of detailed information about borrowings [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_0" xml:lang="en-US">Disclosure of detailed information about borrowings [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_1" xml:lang="en-US">Notes Payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_2" xml:lang="en-US">Schedule of notes payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_0" xml:lang="en-US">Disclosure of detailed information about business combination [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_1" xml:lang="en-US">Acquisition of Prismic Pharmaceutical</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_2" xml:lang="en-US">Schedule of identifiable assets acquired and liabilities assumed</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_0" xml:lang="en-US">Disclosure of detailed information about intangible assets [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_1" xml:lang="en-US">Schedule of intangible assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_0" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_1" xml:lang="en-US">Schedule of property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory_0" xml:lang="en-US">Disclosure of earnings per share [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory_1" xml:lang="en-US">Loss per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory_2" xml:lang="en-US">Basic and diluted loss per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xml:lang="en-US">Disclosure of detailed information about financial instruments [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_0" xml:lang="en-US">Disclosure of financial instruments [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_1" xml:lang="en-US">Financial Instruments and Risk Management</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xml:lang="en-US">Disclosure of detailed information about financial instruments [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsTable_0" xml:lang="en-US">Disclosure of detailed information about financial instruments [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_0" xml:lang="en-US">Disclosure of financial liabilities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_0" xml:lang="en-US">Disclosure of financial liabilities [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinancialLiabilitiesTable_0" xml:lang="en-US">Disclosure of financial liabilities [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_0" xml:lang="en-US">Disclosure of general and administrative expense [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_1" xml:lang="en-US">General and administrative</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_2" xml:lang="en-US">Schedule of general and administrative expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory_0" xml:lang="en-US">Disclosure of income tax [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory_1" xml:lang="en-US">Income taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_0" xml:lang="en-US">Disclosure of indirect measurement of fair value of goods or services received, share options granted during period [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_1" xml:lang="en-US">Schedule of fair values of options granted using the Black-Scholes option pricing model</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_0" xml:lang="en-US">Disclosure of information about key management personnel [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_1" xml:lang="en-US">Schedule of key management personnel compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_0" xml:lang="en-US">Disclosure of intangible assets [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_1" xml:lang="en-US">Intangible assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xml:lang="en-US">Disclosure of detailed information about intangible assets [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsTable_0" xml:lang="en-US">Disclosure of detailed information about intangible assets [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfInventoriesExplanatory_0" xml:lang="en-US">Disclosure of inventories [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfInventoriesExplanatory_1" xml:lang="en-US">Inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_0" xml:lang="en-US">Disclosure of investments other than investments accounted for using equity method [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_1" xml:lang="en-US">Investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfLeasesExplanatory_0" xml:lang="en-US">Disclosure of leases [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfLeasesExplanatory_1" xml:lang="en-US">Lease obligations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfLiquidityRiskExplanatory_0" xml:lang="en-US">Disclosure of liquidity risk [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfLiquidityRiskExplanatory_1" xml:lang="en-US">Schedule of financial obligations based on their due dates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_0" xml:lang="en-US">Disclosure of maturity analysis of operating lease payments [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_1" xml:lang="en-US">Schedule of maturity analysis of operating lease payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_2" xml:lang="en-US">Schedule of office lease commitments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xml:lang="en-US">Disclosure of maturity analysis of operating lease payments [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_0" xml:lang="en-US">Disclosure of maturity analysis of operating lease payments [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_0" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_0" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_1" xml:lang="en-US">Subsequent events</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_0" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory_0" xml:lang="en-US">Disclosure of non-current assets held for sale and discontinued operations [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory_1" xml:lang="en-US">Assets held for sale</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_0" xml:lang="en-US">Disclosure of number and weighted average exercise prices of share options [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_1" xml:lang="en-US">Schedule of stock options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_0" xml:lang="en-US">Disclosure of number and weighted average remaining contractual life of outstanding share options [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_1" xml:lang="en-US">Schedule of number and weighted average remaining contractual life of outstanding and exercisable share options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_0" xml:lang="en-US">Disclosure of objectives, policies and processes for managing capital [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_1" xml:lang="en-US">Capital Management</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xml:lang="en-US">Disclosure of operating segments [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_0" xml:lang="en-US">Disclosure of operating segments [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_1" xml:lang="en-US">Segmented information</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_0" xml:lang="en-US">Disclosure of property, plant and equipment [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_1" xml:lang="en-US">Property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_0" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_0" xml:lang="en-US">Disclosure of quantitative information about right-of-use assets [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_0" xml:lang="en-US">Disclosure of quantitative information about right-of-use assets [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_1" xml:lang="en-US">Right-of-use asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory_0" xml:lang="en-US">Disclosure of reconciliation of changes in biological assets [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0" xml:lang="en-US">Disclosure of reconciliation of liabilities arising from financing activities [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_0" xml:lang="en-US">Disclosure of reconciliation of liabilities arising from financing activities [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory_0" xml:lang="en-US">Disclosure of related party [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory_1" xml:lang="en-US">Related party transactions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfRepurchaseAndReverseRepurchaseAgreementsExplanatory_0" xml:lang="en-US">Disclosure of repurchase and reverse repurchase agreements [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfRepurchaseAndReverseRepurchaseAgreementsExplanatory_1" xml:lang="en-US">Reverse Takeover Transaction</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfRepurchaseAndReverseRepurchaseAgreementsExplanatory_2" xml:lang="en-US">Acquisition of Prismic Pharmaceutical</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfReservesWithinEquityAbstract_0" xml:lang="en-US">Disclosure of reserves within equity [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_0" xml:lang="en-US">Disclosure of share-based payment arrangements [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_1" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_0" xml:lang="en-US">Disclosure of share capital, reserves and other equity interest [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_1" xml:lang="en-US">Share capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_2" xml:lang="en-US">Share capital and reserves</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_0" xml:lang="en-US">Disclosure of subsidiaries [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_1" xml:lang="en-US">Schedule of ownership percentage in subsidiaries</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0" xml:lang="en-US">Disclosure of subsidiaries [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_0" xml:lang="en-US">Disclosure of subsidiaries [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_0" xml:lang="en-US">Disclosure of significant accounting policies [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_1" xml:lang="en-US">Significant accounting policies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_0" xml:lang="en-US">Disclosure of temporary difference, unused tax losses and unused tax credits [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_1" xml:lang="en-US">Schedule of recognized deferred tax assets and liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_0" xml:lang="en-US">Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_0" xml:lang="en-US">Disclosure of temporary difference, unused tax losses and unused tax credits [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_0" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_0" xml:lang="en-US">Disclosure of trade and other receivables [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_1" xml:lang="en-US">Other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xml:lang="en-US">Disclosure of transactions between related parties [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xml:lang="en-US">Disclosure of transactions between related parties [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_0" xml:lang="en-US">Disclosure of transactions between related parties [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory_0" xml:lang="en-US">Disclosure of transactions recognised separately from acquisition of assets and assumption of liabilities in business combination [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory_1" xml:lang="en-US">Schedule of acquisition breakdown of transaction</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember_0" xml:lang="en-US">Disposal groups classified as held for sale [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember_1" xml:lang="en-US">Cobourg facility</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_DisposalsPropertyPlantAndEquipment_0" xml:lang="en-US">Disposals</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisposalsPropertyPlantAndEquipment_1" xml:lang="en-US">Disposals, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisposalsPropertyPlantAndEquipment_2" xml:lang="en-US">Disposals</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_DistributionCosts_0" xml:lang="en-US">Distribution costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DistributionCosts_1" xml:lang="en-US">Distribution costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EarningsPerShareAbstract_0" xml:lang="en-US">Earnings per share [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_EarningsPerShareAbstract_1" xml:lang="en-US">Income (loss) per Class B share:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EarningsPerShareExplanatory_0" xml:lang="en-US">Earnings per share [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_EarningsPerShareExplanatory_1" xml:lang="en-US">Schedule of loss per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_EarningsPerShareExplanatory_2" xml:lang="en-US">Schedule of basic and diluted loss per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EarningsPerShareLineItems_0" xml:lang="en-US">Earnings per share [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EarningsPerShareTable_0" xml:lang="en-US">Earnings per share [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EntitysTotalForBusinessCombinationsMember_0" xml:lang="en-US">Entitys total for business combinations [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EntitysTotalForRelatedPartiesMember_0" xml:lang="en-US">Entity's total for related parties [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EntitysTotalForSubsidiariesMember_0" xml:lang="en-US">Entitys total for subsidiaries [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_Equity_0" xml:lang="en-US">Ending balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_Equity_1" xml:lang="en-US">Beginning balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Equity_2" xml:lang="en-US">Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_Equity_3" xml:lang="en-US">Balances</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_Equity_4" xml:lang="en-US">Total equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_Equity_5" xml:lang="en-US">Total equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EquityAbstract_0" xml:lang="en-US">SHAREHOLDERS EQUITY</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_EquityAbstract_1" xml:lang="en-US">SHAREHOLDER'S EQUITY</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EquityAndLiabilities_0" xml:lang="en-US">Equity and liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_EquityAndLiabilities_1" xml:lang="en-US">Total equity and liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EquityAndLiabilitiesAbstract_0" xml:lang="en-US">Equity And Liabilities Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_EquityAndLiabilitiesAbstract_1" xml:lang="en-US">Equity and liabilities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EquityInterestsOfAcquirer_0" xml:lang="en-US">Equity interests of acquirer</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_EquityInterestsOfAcquirer_1" xml:lang="en-US">Exchange of Class B shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_EquityInterestsOfAcquirer_2" xml:lang="en-US">Total consideration transferred, acquisition-date fair value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_EquityInterestsOfAcquirer_3" xml:lang="en-US">Total consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="lab_ifrs-full_EquityInterestsOfAcquirer_4" xml:lang="en-US">Consideration transferred, acquisition-date fair value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EquityMember_0" xml:lang="en-US">Equity [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExercisePriceOfOutstandingShareOptions2019_0" xml:lang="en-US">Exercise price of outstanding share options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExercisePriceShareOptionsGranted2019_0" xml:lang="en-US">Exercise price, share options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ExercisePriceShareOptionsGranted2019_1" xml:lang="en-US">Exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_0" xml:lang="en-US">Expected dividend as percentage, share options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_1" xml:lang="en-US">Expected dividend yield</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_2" xml:lang="en-US">Expected dividend yield</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExpenseByNature_0" xml:lang="en-US">Expenses, by nature</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ExpenseByNature_1" xml:lang="en-US">Total operating expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExpenseByNatureAbstract_0" xml:lang="en-US">Expenses by nature [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ExpenseByNatureAbstract_1" xml:lang="en-US">Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ExpenseByNatureAbstract_2" xml:lang="en-US">Allocated to:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_0" xml:lang="en-US">Expense from share-based payment transactions with employees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_1" xml:lang="en-US">Share-based payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_2" xml:lang="en-US">Share-based compensation expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExplanationOfDesignatedFinancialAssetsThatAreHeldOutsideLegalEntityThatIssuesContractsWithinScopeOfIFRS4_0" xml:lang="en-US">Explanation of designated financial assets that are held outside legal entity that issues contracts within scope of IFRS 4</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FairValueOfAcquiredReceivables_0" xml:lang="en-US">Fair value of acquired receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_FairValueOfAcquiredReceivables_1" xml:lang="en-US">Total fair value recognized on acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_FinanceCosts_0" xml:lang="en-US">Finance expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinanceCosts_1" xml:lang="en-US">Finance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_FinanceCosts_2" xml:lang="en-US">Finance expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_0" xml:lang="en-US">Financial assets at fair value through profit or loss, category [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_1" xml:lang="en-US">Assets at fair value through profit/loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinancialAssetsCategoryMember_0" xml:lang="en-US">Financial assets, category [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_0" xml:lang="en-US">Financial liabilities at fair value through profit or loss, category [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_1" xml:lang="en-US">Liabilities at fair value through profit/loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinancialLiabilitiesCategoryMember_0" xml:lang="en-US">Financial liabilities, category [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinishedGoods_0" xml:lang="en-US">Current finished goods</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_FinishedGoods_1" xml:lang="en-US">Finished good</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FixturesAndFittingsMember_0" xml:lang="en-US">Fixtures and fittings [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_FixturesAndFittingsMember_1" xml:lang="en-US">Furniture and fixtures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives_0" xml:lang="en-US">Gains (losses) on change in fair value of derivatives</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="lab_ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives_1" xml:lang="en-US">Net gains (losses) on change in fair value of derivatives</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives_2" xml:lang="en-US">Loss (gain) on change in fair value of warrants and derivative liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives_3" xml:lang="en-US">Loss (gain) on change in fair value of warrants and derivative liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GainsLossesOnDisposalsOfInvestments_0" xml:lang="en-US">Gains (losses) on disposals of investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="lab_ifrs-full_GainsLossesOnDisposalsOfInvestments_1" xml:lang="en-US">Net gains (losses) on disposals of investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_GainsLossesOnDisposalsOfInvestments_2" xml:lang="en-US">Gain (loss) on sale of investment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_GainsLossesOnDisposalsOfInvestments_3" xml:lang="en-US">Gain (loss) on sale of investment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_0" xml:lang="en-US">Foreign exchange gain (loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_1" xml:lang="en-US">Foreign exchange loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_2" xml:lang="en-US">Foreign exchange gain</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_0" xml:lang="en-US">Gains (losses) on fair value adjustment attributable to physical changes, biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/commentaryGuidance" xlink:label="lab_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_1" xml:lang="en-US">A positive or negative XBRL value can be entered for this element. Refer to the standard element label to determine the correct sign. Use a negative value for terms in brackets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_2" xml:lang="en-US">Total gains (losses) on fair value adjustment, biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_3" xml:lang="en-US">Change in fair value less costs to sell due to biological transformation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_4" xml:lang="en-US">Change in fair value less costs to sell due to biological transformation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets_0" xml:lang="en-US">Gains (losses) on fair value adjustment attributable to price changes, biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets_1" xml:lang="en-US">Unrealized loss on changes in fair value of biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets_2" xml:lang="en-US">Unrealized loss on changes in fair value of biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_0" xml:lang="en-US">Gains (losses) on fair value adjustment, biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_1" xml:lang="en-US">Total gains (losses) on fair value adjustment, biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_2" xml:lang="en-US">Change in fair value less costs to sell due to biological transformation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_3" xml:lang="en-US">Change in fair value less costs to sell due to biological transformation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GainsLossesRecognisedInProfitOrLossAttributableToChangeInUnrealisedGainsOrLossesForAssetsHeldAtEndOfPeriodFairValueMeasurement_0" xml:lang="en-US">Gains (losses) recognised in profit or loss attributable to change in unrealised gains or losses for assets held at end of period, fair value measurement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_GainsLossesRecognisedInProfitOrLossAttributableToChangeInUnrealisedGainsOrLossesForAssetsHeldAtEndOfPeriodFairValueMeasurement_1" xml:lang="en-US">Unrealized loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_GainsLossesRecognisedInProfitOrLossAttributableToChangeInUnrealisedGainsOrLossesForAssetsHeldAtEndOfPeriodFairValueMeasurement_2" xml:lang="en-US">Unrealized loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GeneralAndAdministrativeExpense_0" xml:lang="en-US">General and administrative expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_GeneralAndAdministrativeExpense_1" xml:lang="en-US">General and administrative</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_GeneralAndAdministrativeExpense_2" xml:lang="en-US">Profit (loss) from continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_GeneralAndAdministrativeExpense_3" xml:lang="en-US">Continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GrossCarryingAmountMember_0" xml:lang="en-US">Gross carrying amount [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_GrossCarryingAmountMember_1" xml:lang="en-US">Cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_GrossCarryingAmountMember_2" xml:lang="en-US">Cost:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GrossLeaseLiabilities_0" xml:lang="en-US">Gross lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GrossLoanCommitments_0" xml:lang="en-US">Gross loan commitments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_GrossLoanCommitments_1" xml:lang="en-US">Aggregate lease commitments as disclosed at December 31, 2018</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="lab_ifrs-full_GrossProfit_0" xml:lang="en-US">Gross profit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GrossProfit_1" xml:lang="en-US">Gross profit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_GrossProfit_2" xml:lang="en-US">Gross loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_GrossProfit_3" xml:lang="en-US">Gross loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_0" xml:lang="en-US">Identifiable assets acquired (liabilities assumed)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_1" xml:lang="en-US">Net assets received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">Identifiable intangible assets recognised as of acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Intangible assets other than goodwill at end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_2" xml:lang="en-US">Total intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_3" xml:lang="en-US">Intangible assets other than goodwill at beginning of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_4" xml:lang="en-US">Intangible assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_5" xml:lang="en-US">Intangible assets, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ImpairmentLossOnFinancialAssets_0" xml:lang="en-US">Impairment loss on financial assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ImpairmentLossOnFinancialAssets_1" xml:lang="en-US">Cost of inventory impairment charges</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_0" xml:lang="en-US">Impairment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_1" xml:lang="en-US">Impairment loss recognised in profit or loss, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_2" xml:lang="en-US">Impairment of property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncomeStatementAbstract_0" xml:lang="en-US">Income Statement [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xml:lang="en-US">Income taxes paid (refund) [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember_0" xml:lang="en-US">Increase (decrease) due to changes in accounting policy required by IFRSs [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember_1" xml:lang="en-US">Adoption of IFRS 16</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_1" xml:lang="en-US">Net increase (decrease)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_0" xml:lang="en-US">Increase (decrease) through exercise of options, equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_1" xml:lang="en-US">Share options exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_2" xml:lang="en-US">Value of stock options exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_0" xml:lang="en-US">Increase (decrease) through exercise of warrants, equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_1" xml:lang="en-US">Warrants exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_2" xml:lang="en-US">Warrants exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">Increase (decrease) through net exchange differences, intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_1" xml:lang="en-US">Effects of foreign exchange</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesInvestmentProperty_0" xml:lang="en-US">Increase (decrease) through net exchange differences, investment property</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesInvestmentProperty_1" xml:lang="en-US">Foreign exchange gain</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_0" xml:lang="en-US">Increase (decrease) through share-based payment transactions, equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_1" xml:lang="en-US">Share based payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_2" xml:lang="en-US">Increase in share-based compensation expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InsuranceExpense_0" xml:lang="en-US">Insurance expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_InsuranceExpense_1" xml:lang="en-US">Insurance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">Ending balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_1" xml:lang="en-US">Beginning balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_2" xml:lang="en-US">Intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_3" xml:lang="en-US">Intellectual Property</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_4" xml:lang="en-US">Total intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_5" xml:lang="en-US">Intangible assets, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_0" xml:lang="en-US">Intangible assets other than goodwill [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife_0" xml:lang="en-US">Intangible assets with indefinite useful life</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife_1" xml:lang="en-US">Estimated useful lives for intangible assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InterestExpenseOnBorrowings_0" xml:lang="en-US">Interest expense on borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InterestExpenseOnLeaseLiabilities_0" xml:lang="en-US">Interest expense on lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_InterestExpenseOnLeaseLiabilities_1" xml:lang="en-US">Add: Interest Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_InterestExpenseOnLeaseLiabilities_2" xml:lang="en-US">Interest expense on lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InterestReceivable_0" xml:lang="en-US">Interest receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_InterestReceivable_1" xml:lang="en-US">Interest receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Inventories_0" xml:lang="en-US">Current inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_Inventories_1" xml:lang="en-US">Total current inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_Inventories_2" xml:lang="en-US">Inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InventoryWritedown2011_0" xml:lang="en-US">Inventory write-down</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_InventoryWritedown2011_1" xml:lang="en-US">Cost of inventory impairment charges</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_IssuedCapital_0" xml:lang="en-US">Share Capital, ending balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_IssuedCapital_1" xml:lang="en-US">Share Capital, beginning balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IssuedCapital_2" xml:lang="en-US">Issued capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IssuedCapital_3" xml:lang="en-US">Share capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IssueOfEquity_0" xml:lang="en-US">Issue of equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IssueOfEquity_1" xml:lang="en-US">Shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IssueOfEquity_2" xml:lang="en-US">Number of shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensation_0" xml:lang="en-US">Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensation_1" xml:lang="en-US">Salaries and benefits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensation_2" xml:lang="en-US">Key management personnel compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_0" xml:lang="en-US">Share-based payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_1" xml:lang="en-US">Key management personnel compensation, share-based payment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_2" xml:lang="en-US">Salaries, benefits, bonuses and consulting fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_3" xml:lang="en-US">Share-based payments expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_0" xml:lang="en-US">Key management personnel compensation, short-term employee benefits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_1" xml:lang="en-US">Bonuses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_2" xml:lang="en-US">Amount of bonus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_3" xml:lang="en-US">Salaries, benefits, bonuses and consulting fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LandMember_0" xml:lang="en-US">Land [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LandMember_1" xml:lang="en-US">Land</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LaterThanFiveYearsMember_0" xml:lang="en-US">Later than five years [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LaterThanFiveYearsMember_1" xml:lang="en-US">Therafter</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LaterThanFiveYearsMember_2" xml:lang="en-US">More than 5 years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_0" xml:lang="en-US">Later than four years and not later than five years [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_1" xml:lang="en-US">More than four year and not later than five years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_0" xml:lang="en-US">Later than one year and not later than five years [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_1" xml:lang="en-US">1-5 years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_0" xml:lang="en-US">Later than one year and not later than two years [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_1" xml:lang="en-US">More than one year and not later than two years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_2" xml:lang="en-US">One to two years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LaterThanOneYearMember_0" xml:lang="en-US">Later than one year [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LaterThanOneYearMember_1" xml:lang="en-US">2020 to 2023 inclusive</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LaterThanOneYearMember_2" xml:lang="en-US">More than 1 year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_0" xml:lang="en-US">Later than three years and not later than four years [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_1" xml:lang="en-US">More than three year and not later than four years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_2" xml:lang="en-US">Three to four years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_0" xml:lang="en-US">Later than two years and not later than three years [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_1" xml:lang="en-US">More than two year and not later than three years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_2" xml:lang="en-US">Two to three years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_LeaseLiabilities_0" xml:lang="en-US">Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_LeaseLiabilities_1" xml:lang="en-US">Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LeaseLiabilities_2" xml:lang="en-US">Lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LeaseLiabilities_3" xml:lang="en-US">Balance as at December 31, 2020</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_LeaseLiabilities_4" xml:lang="en-US">Total lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LeaseLiabilities_5" xml:lang="en-US">Lease obligation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveVerboseLabel" xlink:label="lab_ifrs-full_LeaseLiabilities_6" xml:lang="en-US">Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LeaseLiabilitiesAbstract_0" xml:lang="en-US">Lease liabilities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LegalProceedingsContingentLiabilityMember_0" xml:lang="en-US">Legal proceedings contingent liability [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LegalProceedingsContingentLiabilityMember_1" xml:lang="en-US">Legal proceedings contingent liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Level1OfFairValueHierarchyMember_0" xml:lang="en-US">Level 1 of fair value hierarchy [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_Level1OfFairValueHierarchyMember_1" xml:lang="en-US">Level 1</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Level2OfFairValueHierarchyMember_0" xml:lang="en-US">Level 2 of fair value hierarchy [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_Level2OfFairValueHierarchyMember_1" xml:lang="en-US">Level 2</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Level3OfFairValueHierarchyMember_0" xml:lang="en-US">Level 3 of fair value hierarchy [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_Level3OfFairValueHierarchyMember_1" xml:lang="en-US">Level 3</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LevelsOfFairValueHierarchyAxis_0" xml:lang="en-US">Levels of fair value hierarchy [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_Liabilities_0" xml:lang="en-US">Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_Liabilities_1" xml:lang="en-US">Liabilities at end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_Liabilities_2" xml:lang="en-US">Liabilities at beginning of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_Liabilities_3" xml:lang="en-US">Total liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Liabilities_4" xml:lang="en-US">Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_Liabilities_5" xml:lang="en-US">Balance as at December 31, 2019</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_Liabilities_6" xml:lang="en-US">Total Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LiabilitiesAbstract_0" xml:lang="en-US">Liabilities Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LiabilitiesAbstract_1" xml:lang="en-US">LIABILITIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_0" xml:lang="en-US">Liabilities arising from financing activities [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_0" xml:lang="en-US">Liabilities arising from financing activities [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LiquidityRiskMember_0" xml:lang="en-US">Liquidity risk [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LiquidityRiskMember_1" xml:lang="en-US">Liquidity risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LoansAndReceivablesCategoryMember_0" xml:lang="en-US">Loans and receivables, category [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LoansAndReceivablesCategoryMember_1" xml:lang="en-US">Loans and receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_LossesOnChangeInFairValueOfDerivatives_0" xml:lang="en-US">Losses on change in fair value of derivatives</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LossesOnChangeInFairValueOfDerivatives_1" xml:lang="en-US">Losses on change in fair value of derivatives</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LossesOnChangeInFairValueOfDerivatives_2" xml:lang="en-US">Loss on change in fair value of derivative liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MachineryMember_0" xml:lang="en-US">Machinery [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_MachineryMember_1" xml:lang="en-US">Production equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MarketRiskMember_0" xml:lang="en-US">Market risk [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_MarketRiskMember_1" xml:lang="en-US">Market price risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MaturityAxis_0" xml:lang="en-US">Maturity [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MeasurementAxis_0" xml:lang="en-US">Measurement [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MediaProductionExpense_0" xml:lang="en-US">Media production expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_MediaProductionExpense_1" xml:lang="en-US">Production and growing</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NetDeferredTaxAssets_0" xml:lang="en-US">Net deferred tax assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NetDeferredTaxAssets_1" xml:lang="en-US">Total deferred tax asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_NetDeferredTaxAssets_2" xml:lang="en-US">Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="lab_ifrs-full_NetDeferredTaxAssets_3" xml:lang="en-US">Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NetForeignExchangeGain_0" xml:lang="en-US">Net foreign exchange gain</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NetForeignExchangeGain_1" xml:lang="en-US">Foreign exchange loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NetForeignExchangeGain_2" xml:lang="en-US">Foreign exchange gain</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NetForeignExchangeLoss_0" xml:lang="en-US">Net foreign exchange loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NetForeignExchangeLoss_1" xml:lang="en-US">Foreign exchange loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NetForeignExchangeLoss_2" xml:lang="en-US">Foreign exchange gain</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_NetForeignExchangeLoss_3" xml:lang="en-US">Foreign exchange loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_0" xml:lang="en-US">Non-adjusting events after reporting period [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NonadjustingEventsMember_0" xml:lang="en-US">Non-adjusting events after reporting period [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentAssetsAbstract_0" xml:lang="en-US">Non-current assets [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NoncurrentAssetsAbstract_1" xml:lang="en-US">Non-current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_0" xml:lang="en-US">Non-current assets or disposal groups classified as held for sale or as held for distribution to owners</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_1" xml:lang="en-US">Assets held for sale</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_0" xml:lang="en-US">Ending balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_1" xml:lang="en-US">Beginning balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_2" xml:lang="en-US">Non-current investments other than investments accounted for using equity method</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_3" xml:lang="en-US">Investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentLeaseLiabilities_0" xml:lang="en-US">Non-current lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NoncurrentLeaseLiabilities_1" xml:lang="en-US">Non-current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NoncurrentLeaseLiabilities_2" xml:lang="en-US">Lease obligations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentLiabilities_0" xml:lang="en-US">Non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_NoncurrentLiabilities_1" xml:lang="en-US">Total non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentLiabilitiesAbstract_0" xml:lang="en-US">Non-current liabilities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NoncurrentLiabilitiesAbstract_1" xml:lang="en-US">Non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NotesAndDebenturesIssued_0" xml:lang="en-US">Notes and debentures issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NotesAndDebenturesIssued_1" xml:lang="en-US">Convertible notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NotLaterThanOneYearMember_0" xml:lang="en-US">Not later than one year [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NotLaterThanOneYearMember_1" xml:lang="en-US">2019</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NotLaterThanOneYearMember_2" xml:lang="en-US">Less than one year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_0" xml:lang="en-US">Number of instruments granted in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_1" xml:lang="en-US">Number of share issued for share-based bonus expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_0" xml:lang="en-US">Number of instruments or interests issued or issuable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_1" xml:lang="en-US">Number of shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_0" xml:lang="en-US">Number of other equity instruments granted in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_1" xml:lang="en-US">Number of warrants granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_2" xml:lang="en-US">Warrants granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_0" xml:lang="en-US">Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_1" xml:lang="en-US">Number of other equity instruments exercised or vested in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_2" xml:lang="en-US">Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_3" xml:lang="en-US">Number of warrants exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_0" xml:lang="en-US">Expired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_1" xml:lang="en-US">Number of other equity instruments expired in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_2" xml:lang="en-US">Expired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_0" xml:lang="en-US">Closing Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_1" xml:lang="en-US">Opening Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_2" xml:lang="en-US">Number of other equity instruments outstanding in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_NumberOfOutstandingShareOptions_0" xml:lang="en-US">Closing Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_NumberOfOutstandingShareOptions_1" xml:lang="en-US">Opening Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfOutstandingShareOptions_2" xml:lang="en-US">Number of share options outstanding in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfOutstandingShareOptions_3" xml:lang="en-US">Number of share options outstanding and issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_0" xml:lang="en-US">Opening Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_1" xml:lang="en-US">Number of share options exercisable in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_2" xml:lang="en-US">Exercisable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_0" xml:lang="en-US">Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_1" xml:lang="en-US">Number of share options exercised in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_2" xml:lang="en-US">Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_3" xml:lang="en-US">Number of stock options exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_0" xml:lang="en-US">Cancelled</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_1" xml:lang="en-US">Number of share options expired in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_2" xml:lang="en-US">Expired / cancelled</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_3" xml:lang="en-US">Number of share options cancelled</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_0" xml:lang="en-US">Number of share options forfeited in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_1" xml:lang="en-US">Forfeited</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_2" xml:lang="en-US">Forfeited</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_0" xml:lang="en-US">Number of share options granted in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_1" xml:lang="en-US">Number of stock options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_2" xml:lang="en-US">Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_NumberOfSharesIssued_0" xml:lang="en-US">Number of Shares, ending balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_NumberOfSharesIssued_1" xml:lang="en-US">Number of Shares, beginning balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfSharesIssued_2" xml:lang="en-US">Number of shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NumberOfSharesIssued_3" xml:lang="en-US">Number of shares subscribed</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_NumberOfSharesIssued_4" xml:lang="en-US">Total number of shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfSharesIssued_5" xml:lang="en-US">Number of Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel" xlink:label="lab_ifrs-full_NumberOfSharesIssued_6" xml:lang="en-US">Number of shares sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_NumberOfSharesOutstanding_0" xml:lang="en-US">Ending balance (shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_NumberOfSharesOutstanding_1" xml:lang="en-US">Beginning balance (shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfSharesOutstanding_2" xml:lang="en-US">Number of shares outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NumberOfSharesOutstanding_3" xml:lang="en-US">Number of Class B shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfSharesOutstanding_4" xml:lang="en-US">Balance, beginning of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OccupancyExpense_0" xml:lang="en-US">Occupancy expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OccupancyExpense_1" xml:lang="en-US">Occupancy costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OperatingExpense_0" xml:lang="en-US">Operating expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_OperatingExpense_1" xml:lang="en-US">Total operating expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OptionPricingModelMember_0" xml:lang="en-US">Option pricing model [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OptionPricingModelMember_1" xml:lang="en-US">Black-Scholes option pricing model [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OrdinarySharesMember_0" xml:lang="en-US">Ordinary shares [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_OrdinarySharesMember_1" xml:lang="en-US">Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeAbstract_0" xml:lang="en-US">Other comprehensive loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeAbstract_1" xml:lang="en-US">Other comprehensive income (loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_0" xml:lang="en-US">Other comprehensive income, net of tax, exchange differences on translation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_1" xml:lang="en-US">Exchange loss on translation of foreign operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_2" xml:lang="en-US">Exchange gain (loss) on translation of foreign operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_3" xml:lang="en-US">Exchange gain (loss) on translation of foreign operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherIncome_0" xml:lang="en-US">Other income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherIncome_1" xml:lang="en-US">Other income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_OtherIncome_2" xml:lang="en-US">Other income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_OtherIncome_3" xml:lang="en-US">Other income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherReceivables_0" xml:lang="en-US">Other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherReceivables_1" xml:lang="en-US">Other</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherTangibleOrIntangibleAssetsTransferred_0" xml:lang="en-US">Other tangible or intangible assets transferred</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PaymentsForShareIssueCosts_0" xml:lang="en-US">Share issue costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_PaymentsForShareIssueCosts_1" xml:lang="en-US">Costs of issue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PaymentsForShareIssueCosts_2" xml:lang="en-US">Payments for share issue costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_PaymentsForShareIssueCosts_3" xml:lang="en-US">Share issue costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_0" xml:lang="en-US">Payments of lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_1" xml:lang="en-US">Payments of lease liabilities, classified as financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_2" xml:lang="en-US">Repayment of lease obligation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PercentageOfVotingEquityInterestsAcquired_0" xml:lang="en-US">Percentage of voting equity interests acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_PercentageOfVotingEquityInterestsAcquired_1" xml:lang="en-US">Percentage of voting equity interests acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PlantsMember_0" xml:lang="en-US">Plants [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_PlantsMember_1" xml:lang="en-US">Cannabis plants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PreviouslyStatedMember_0" xml:lang="en-US">Previously stated [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_PreviouslyStatedMember_1" xml:lang="en-US">December 31, 2018 as reported</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary_0" xml:lang="en-US">Principal place of business of subsidiary</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary_1" xml:lang="en-US">Country</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProceedsFromExerciseOfOptions_0" xml:lang="en-US">Proceeds from exercise of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProceedsFromExerciseOfOptions_1" xml:lang="en-US">Proceeds from exercise of stock options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProceedsFromExerciseOfOptions_2" xml:lang="en-US">Stock options exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_0" xml:lang="en-US">Proceeds from issuing other equity instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_1" xml:lang="en-US">Proceeds from equity issuance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_2" xml:lang="en-US">Proceeds from direct offering</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProceedsFromIssuingShares_0" xml:lang="en-US">Proceeds from issuing shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProceedsFromIssuingShares_1" xml:lang="en-US">Proceeds from issuing shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProceedsFromIssuingShares_2" xml:lang="en-US">Proceeds from issuance of shares, net of issuance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_ProceedsFromIssuingShares_3" xml:lang="en-US">Proceeds from issuance of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_0" xml:lang="en-US">Proceeds from sales of investments other than investments accounted for using equity method</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_1" xml:lang="en-US">Proceeds from sale of investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_2" xml:lang="en-US">Proceeds from sale</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_0" xml:lang="en-US">Proceeds from sales of property, plant and equipment, classified as investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_1" xml:lang="en-US">Proceeds from sale of equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProductionSupplies_0" xml:lang="en-US">Current production supplies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProductionSupplies_1" xml:lang="en-US">Supplies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfessionalFeesExpense_0" xml:lang="en-US">Professional fees expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProfessionalFeesExpense_1" xml:lang="en-US">Professional fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_ProfitLoss_0" xml:lang="en-US">Net loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLoss_1" xml:lang="en-US">Profit (loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProfitLoss_2" xml:lang="en-US">Net loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ProfitLoss_3" xml:lang="en-US">Net loss for the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProfitLoss_4" xml:lang="en-US">Net comprehensive loss for the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossAbstract_0" xml:lang="en-US">Profit (loss) [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProfitLossAbstract_1" xml:lang="en-US">Revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_0" xml:lang="en-US">Profit (loss), attributable to ordinary equity holders of parent entity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_1" xml:lang="en-US">Loss attributable to Class B shareholders</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossFromContinuingOperations_0" xml:lang="en-US">Profit (loss) from continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ProfitLossFromContinuingOperations_1" xml:lang="en-US">Net loss from continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProfitLossFromContinuingOperations_2" xml:lang="en-US">Continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProfitLossFromContinuingOperations_3" xml:lang="en-US">Net loss from continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossFromDiscontinuedOperations_0" xml:lang="en-US">Profit (loss) from discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProfitLossFromDiscontinuedOperations_1" xml:lang="en-US">Discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProfitLossFromDiscontinuedOperations_2" xml:lang="en-US">Net loss from discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossFromOperatingActivities_0" xml:lang="en-US">Profit (loss) from operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ProfitLossFromOperatingActivities_1" xml:lang="en-US">Loss from continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProfitLossFromOperatingActivities_2" xml:lang="en-US">Loss from continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_ProfitLossFromOperatingActivities_3" xml:lang="en-US">Loss from continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment_0" xml:lang="en-US">Property, plant and equipment at end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment_1" xml:lang="en-US">Property, plant and equipment at beginning of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment_2" xml:lang="en-US">Property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment_3" xml:lang="en-US">Property, plant and equipment, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment_4" xml:lang="en-US">Total property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment_5" xml:lang="en-US">Property and plant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PropertyPlantAndEquipmentAbstract_0" xml:lang="en-US">Property, plant and equipment [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PropertyPlantAndEquipmentMember_0" xml:lang="en-US">Property, plant and equipment [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_0" xml:lang="en-US">Proportion of ownership interest in subsidiary</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_1" xml:lang="en-US">Ownership percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_0" xml:lang="en-US">Purchase of intangible assets, classified as investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_1" xml:lang="en-US">Purchase of intangible assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_2" xml:lang="en-US">Additions to intangible assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_0" xml:lang="en-US">Purchase of other investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_1" xml:lang="en-US">Purchase of investments other than investments accounted for using equity method</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_2" xml:lang="en-US">Additions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_0" xml:lang="en-US">Purchase of property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_1" xml:lang="en-US">Purchase of property, plant and equipment, classified as investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_2" xml:lang="en-US">Property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_3" xml:lang="en-US">Purchase of property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RangeAxis_0" xml:lang="en-US">Range [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RangesMember_0" xml:lang="en-US">Ranges [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_0" xml:lang="en-US">Ranges of exercise prices for outstanding share options [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_0" xml:lang="en-US">Ranges of exercise prices for outstanding share options [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RawMaterials_0" xml:lang="en-US">Current raw materials</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_RawMaterials_1" xml:lang="en-US">Raw materials</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RentalIncome_0" xml:lang="en-US">Rental income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_RentalIncome_1" xml:lang="en-US">Rental income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RepaymentsOfBondsNotesAndDebentures_0" xml:lang="en-US">Repayments of bonds, notes and debentures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_RepaymentsOfBondsNotesAndDebentures_1" xml:lang="en-US">Repayment of notes payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ResearchAndDevelopmentExpense_0" xml:lang="en-US">Research and development expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ResearchAndDevelopmentExpense_1" xml:lang="en-US">External research and development fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_0" xml:lang="en-US">Reserve of exchange differences on translation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_1" xml:lang="en-US">Foreign exchange translation reserve</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_0" xml:lang="en-US">Reserve of exchange differences on translation [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_1" xml:lang="en-US">exchange translation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ReserveOfSharebasedPaymentsMember_0" xml:lang="en-US">Reserve of share-based payments [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ReserveOfSharebasedPaymentsMember_1" xml:lang="en-US">Contributed surplus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RestatedMember_0" xml:lang="en-US">Currently stated [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_RetainedEarnings_0" xml:lang="en-US">Deficit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_RetainedEarnings_1" xml:lang="en-US">Accumulated deficit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RetainedEarnings_2" xml:lang="en-US">Retained earnings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_RetainedEarnings_3" xml:lang="en-US">Accumulated deficit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_RetainedEarnings_4" xml:lang="en-US">Accumulated deficit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RetainedEarningsMember_0" xml:lang="en-US">Retained earnings [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_RetainedEarningsMember_1" xml:lang="en-US">Accumulated deficit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_0" xml:lang="en-US">Retrospective application and retrospective restatement [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Revenue_0" xml:lang="en-US">Revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_Revenue_1" xml:lang="en-US">Total revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_RightofuseAssets_0" xml:lang="en-US">Ending balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_RightofuseAssets_1" xml:lang="en-US">Beginning balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RightofuseAssets_2" xml:lang="en-US">Right-of-use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_RightofuseAssets_3" xml:lang="en-US">Right-of-use asset, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0" xml:lang="en-US">Selling, general and administrative expense [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SeparateManagementEntitiesAxis_0" xml:lang="en-US">Separate management entities [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SeparateManagementEntitiesMember_0" xml:lang="en-US">Separate management entities [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SettlementOfLiabilitiesByEntityOnBehalfOfRelatedPartyRelatedPartyTransactions_0" xml:lang="en-US">Settlement of liabilities by entity on behalf of related party, related party transactions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_SettlementOfLiabilitiesByEntityOnBehalfOfRelatedPartyRelatedPartyTransactions_1" xml:lang="en-US">Other prismic related liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SharebasedPaymentArrangementsMember_0" xml:lang="en-US">Share-based payment arrangements [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_ShareIssueRelatedCost_0" xml:lang="en-US">Shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_ShareIssueRelatedCost_1" xml:lang="en-US">Share issuance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ShareIssueRelatedCost_2" xml:lang="en-US">Share issue related cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ShareIssueRelatedCost_3" xml:lang="en-US">Shareholder and public company costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ShareIssueRelatedCost_4" xml:lang="en-US">Commissions and corporate finance fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SharePremium_0" xml:lang="en-US">Contributed surplus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ShorttermBorrowingsMember_0" xml:lang="en-US">Short-term borrowings [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ShorttermBorrowingsMember_1" xml:lang="en-US">Short-term notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_0" xml:lang="en-US">Subsidiaries [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfCashFlowsAbstract_0" xml:lang="en-US">Statement of cash flows [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfChangesInEquityAbstract_0" xml:lang="en-US">Statement of changes in equity [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfChangesInEquityLineItems_0" xml:lang="en-US">Statement of changes in equity [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfChangesInEquityTable_0" xml:lang="en-US">Statement of changes in equity [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfFinancialPositionAbstract_0" xml:lang="en-US">Statement of financial position [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SubsidiariesMember_0" xml:lang="en-US">Subsidiaries [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_SubsidiariesMember_1" xml:lang="en-US">FSD Biosciences Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_0" xml:lang="en-US">Tax effect of expense not deductible in determining taxable profit (tax loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_1" xml:lang="en-US">Non-deductible expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_2" xml:lang="en-US">Permanent differences</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TaxEffectOfForeignTaxRates_0" xml:lang="en-US">Tax effect of foreign tax rates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TaxEffectOfForeignTaxRates_1" xml:lang="en-US">Foreign exchange</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_0" xml:lang="en-US">Tax expense (income) at applicable tax rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_1" xml:lang="en-US">Income tax recovery at the statutory tax rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_0" xml:lang="en-US">Temporary difference, unused tax losses and unused tax credits [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_0" xml:lang="en-US">Temporary difference, unused tax losses and unused tax credits [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TopOfRangeMember_0" xml:lang="en-US">Top of range [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TopOfRangeMember_1" xml:lang="en-US">Top of range</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayables_0" xml:lang="en-US">Trade and other current payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayables_1" xml:lang="en-US">Total trade and other current payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayables_2" xml:lang="en-US">Trade and other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0" xml:lang="en-US">Trade and other current payables [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradeAndOtherCurrentReceivables_0" xml:lang="en-US">Trade and other current receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_TradeAndOtherCurrentReceivables_1" xml:lang="en-US">Total trade and other current receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TradeAndOtherCurrentReceivables_2" xml:lang="en-US">Trade and other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TradeAndOtherCurrentReceivables_3" xml:lang="en-US">Other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">Trade and other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Trade and other payables recognised as of acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_2" xml:lang="en-US">Total trade and other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_3" xml:lang="en-US">Trade and other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradeAndOtherReceivables_0" xml:lang="en-US">Trade and other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_TradeAndOtherReceivables_1" xml:lang="en-US">Total trade and other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TradeAndOtherReceivables_2" xml:lang="en-US">Trade and other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradeAndOtherReceivablesAbstract_0" xml:lang="en-US">Trade and other receivables [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TradeAndOtherReceivablesAbstract_1" xml:lang="en-US">Other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TravelExpense_0" xml:lang="en-US">Travel expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TravelExpense_1" xml:lang="en-US">Travel</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TypesOfRisksAxis_0" xml:lang="en-US">Types of risks [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TypesOfRisksMember_0" xml:lang="en-US">Risks [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_0" xml:lang="en-US">Types of share-based payment arrangements [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived_0" xml:lang="en-US">Undiscounted operating lease payments to be received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived_1" xml:lang="en-US">Total undiscounted lease payments payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">Useful life measured as period of time, intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_1" xml:lang="en-US">Useful life of intellectual property</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_0" xml:lang="en-US">Useful life measured as period of time, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ValuationTechniquesMember_0" xml:lang="en-US">Valuation techniques [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ValueAtRisk_0" xml:lang="en-US">Value at risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ValueAtRisk_1" xml:lang="en-US">Profit or loss on other investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WagesAndSalaries_0" xml:lang="en-US">Wages and salaries</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_WagesAndSalaries_1" xml:lang="en-US">Salaries, wages and benefits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_0" xml:lang="en-US">Weighted average exercise price of share options exercisable in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_1" xml:lang="en-US">Weighted average exercise price, Exercisable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_2" xml:lang="en-US">Exercise price of exercisable Share options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveVerboseLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_3" xml:lang="en-US">Share option exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_0" xml:lang="en-US">Weighted average exercise price of share options exercised in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_1" xml:lang="en-US">Weighted average exercise price, Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_0" xml:lang="en-US">Weighted average exercise price of share options expired in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_1" xml:lang="en-US">Weighted average exercise price, Cancelled</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_0" xml:lang="en-US">Weighted average exercise price of share options forfeited in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_1" xml:lang="en-US">Weighted average exercise price, Forfeited</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_0" xml:lang="en-US">Weighted average exercise price of share options granted in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_1" xml:lang="en-US">Weighted average exercise price, Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_0" xml:lang="en-US">Weighted average exercise price of share options outstanding in share-based payment arrangement at end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_1" xml:lang="en-US">Weighted average exercise price of share options outstanding in share-based payment arrangement at beginning of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_2" xml:lang="en-US">Weighted average exercise price of share options outstanding in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_3" xml:lang="en-US">Exercise price of options outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_0" xml:lang="en-US">Weighted average fair value at measurement date, share options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_1" xml:lang="en-US">Fair Values</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_2" xml:lang="en-US">Incremental grant date fair value of share options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_0" xml:lang="en-US">Weighted average remaining contractual life of outstanding share options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_0" xml:lang="en-US">Weighted average share price, share options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_1" xml:lang="en-US">Grant date share price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_2" xml:lang="en-US">Share issued price per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_3" xml:lang="en-US">Underlying share price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageShares_0" xml:lang="en-US">Weighted average number of ordinary shares outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_WeightedAverageShares_1" xml:lang="en-US">Weighted average number of shares outstanding - basic (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_0" xml:lang="en-US">Weighted average ordinary shares and adjusted weighted average ordinary shares [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_1" xml:lang="en-US">Weighted average number of Class B subordinate voting shares outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_2" xml:lang="en-US">Weighted average number of Class B shares:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WorkInProgress_0" xml:lang="en-US">Current work in progress</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_WorkInProgress_1" xml:lang="en-US">Work in process</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_PresidentMember_0" xml:lang="en-US">President [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_srt_PresidentMember_1" xml:lang="en-US">President</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag_1" xlink:to="lab_dei_AmendmentFlag_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate_2" xlink:to="lab_dei_CurrentFiscalYearEndDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus_3" xlink:to="lab_dei_DocumentFiscalPeriodFocus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus_4" xlink:to="lab_dei_DocumentFiscalYearFocus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate_5" xlink:to="lab_dei_DocumentPeriodEndDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType_6" xlink:to="lab_dei_DocumentType_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey_7" xlink:to="lab_dei_EntityCentralIndexKey_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding_8" xlink:to="lab_dei_EntityCommonStockSharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus_9" xlink:to="lab_dei_EntityCurrentReportingStatus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain_10" xlink:to="lab_dei_EntityDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany_11" xlink:to="lab_dei_EntityEmergingGrowthCompany_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod_12" xlink:to="lab_dei_EntityExTransitionPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory_13" xlink:to="lab_dei_EntityFilerCategory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent_14" xlink:to="lab_dei_EntityInteractiveDataCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName_15" xlink:to="lab_dei_EntityRegistrantName_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers_16" xlink:to="lab_dei_EntityVoluntaryFilers_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer_17" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis_18" xlink:to="lab_dei_LegalEntityAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AcquisitionOfPrismicPharmaceuticalsInc_19" xlink:to="lab_huge_AcquisitionOfPrismicPharmaceuticalsInc_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AcquisitionOfPrismicPharmaceuticalsInc_20" xlink:to="lab_huge_AcquisitionOfPrismicPharmaceuticalsInc_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AcquisitionOfPrismicPharmaceuticalsInc_21" xlink:to="lab_huge_AcquisitionOfPrismicPharmaceuticalsInc_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AddDeductItemsNotAffectingCashAbstract_22" xlink:to="lab_huge_AddDeductItemsNotAffectingCashAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AddDeductItemsNotAffectingCashAbstract_23" xlink:to="lab_huge_AddDeductItemsNotAffectingCashAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdditionalInvestmentInExchangeForShares_24" xlink:to="lab_huge_AdditionalInvestmentInExchangeForShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdditionalInvestmentInExchangeForShares_25" xlink:to="lab_huge_AdditionalInvestmentInExchangeForShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdditionalInvestmentInExchangeForShares_26" xlink:to="lab_huge_AdditionalInvestmentInExchangeForShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdditionalRemuneration_27" xlink:to="lab_huge_AdditionalRemuneration_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdditionalRemuneration_28" xlink:to="lab_huge_AdditionalRemuneration_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdditionalRemuneration_29" xlink:to="lab_huge_AdditionalRemuneration_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAsset_30" xlink:to="lab_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAsset_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAsset_31" xlink:to="lab_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAsset_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAssets_32" xlink:to="lab_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAssets_33" xlink:to="lab_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAssets_34" xlink:to="lab_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAssets_35" xlink:to="lab_huge_AdjustmentsForDecreaseIncreaseInPrepaidAndOtherAssets_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit_36" xlink:to="lab_huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit_37" xlink:to="lab_huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit_38" xlink:to="lab_huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposits_39" xlink:to="lab_huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForDecreaseIncreaseInSalesTaxesRecoverable_40" xlink:to="lab_huge_AdjustmentsForDecreaseIncreaseInSalesTaxesRecoverable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForDecreaseIncreaseInSalesTaxesRecoverable_41" xlink:to="lab_huge_AdjustmentsForDecreaseIncreaseInSalesTaxesRecoverable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForDecreaseIncreaseInSalesTaxesRecoverable_42" xlink:to="lab_huge_AdjustmentsForDecreaseIncreaseInSalesTaxesRecoverable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForDecreaseIncreaseInSalesTaxesRecoverable_43" xlink:to="lab_huge_AdjustmentsForDecreaseIncreaseInSalesTaxesRecoverable_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold_44" xlink:to="lab_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold_45" xlink:to="lab_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold_46" xlink:to="lab_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold_47" xlink:to="lab_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForIncreaseDecreaseInPrepaidExpensesAndDeposits_48" xlink:to="lab_huge_AdjustmentsForIncreaseDecreaseInPrepaidExpensesAndDeposits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForIncreaseDecreaseInPrepaidExpensesAndDeposits_49" xlink:to="lab_huge_AdjustmentsForIncreaseDecreaseInPrepaidExpensesAndDeposits_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForIncreaseDecreaseInPrepaidExpensesAndDeposits_50" xlink:to="lab_huge_AdjustmentsForIncreaseDecreaseInPrepaidExpensesAndDeposits_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForListingExpense_51" xlink:to="lab_huge_AdjustmentsForListingExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForListingExpense_52" xlink:to="lab_huge_AdjustmentsForListingExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForListingExpense_53" xlink:to="lab_huge_AdjustmentsForListingExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForLossesGainsOnDisposalOfEquipment_54" xlink:to="lab_huge_AdjustmentsForLossesGainsOnDisposalOfEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForLossesGainsOnDisposalOfEquipment_55" xlink:to="lab_huge_AdjustmentsForLossesGainsOnDisposalOfEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForLossesGainsOnDisposalOfEquipment_56" xlink:to="lab_huge_AdjustmentsForLossesGainsOnDisposalOfEquipment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForLossesGainsOnDisposalOfInventory_57" xlink:to="lab_huge_AdjustmentsForLossesGainsOnDisposalOfInventory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForLossesGainsOnDisposalOfInventory_58" xlink:to="lab_huge_AdjustmentsForLossesGainsOnDisposalOfInventory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentsForLossesGainsOnDisposalOfInventory_59" xlink:to="lab_huge_AdjustmentsForLossesGainsOnDisposalOfInventory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentToExpectedIncomeTaxBenefitAbstract_60" xlink:to="lab_huge_AdjustmentToExpectedIncomeTaxBenefitAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentToExpectedIncomeTaxBenefitAbstract_61" xlink:to="lab_huge_AdjustmentToExpectedIncomeTaxBenefitAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentToExpectedIncomeTaxBenefitChangeInBenefitOfTaxAssetsNotRecognized_62" xlink:to="lab_huge_AdjustmentToExpectedIncomeTaxBenefitChangeInBenefitOfTaxAssetsNotRecognized_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentToExpectedIncomeTaxBenefitChangeInBenefitOfTaxAssetsNotRecognized_63" xlink:to="lab_huge_AdjustmentToExpectedIncomeTaxBenefitChangeInBenefitOfTaxAssetsNotRecognized_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentToExpectedIncomeTaxBenefitChangeInBenefitOfTaxAssetsNotRecognized_64" xlink:to="lab_huge_AdjustmentToExpectedIncomeTaxBenefitChangeInBenefitOfTaxAssetsNotRecognized_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentToExpectedIncomeTaxBenefitChangeInBenefitOfTaxAssetsNotRecognized_65" xlink:to="lab_huge_AdjustmentToExpectedIncomeTaxBenefitChangeInBenefitOfTaxAssetsNotRecognized_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentToExpectedIncomeTaxBenefitFairValueChangeOfInvestments_66" xlink:to="lab_huge_AdjustmentToExpectedIncomeTaxBenefitFairValueChangeOfInvestments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentToExpectedIncomeTaxBenefitFairValueChangeOfInvestments_67" xlink:to="lab_huge_AdjustmentToExpectedIncomeTaxBenefitFairValueChangeOfInvestments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentToExpectedIncomeTaxBenefitFairValueChangeOfInvestments_68" xlink:to="lab_huge_AdjustmentToExpectedIncomeTaxBenefitFairValueChangeOfInvestments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentToExpectedIncomeTaxBenefitLossOnDerivativeLiability_69" xlink:to="lab_huge_AdjustmentToExpectedIncomeTaxBenefitLossOnDerivativeLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentToExpectedIncomeTaxBenefitLossOnDerivativeLiability_70" xlink:to="lab_huge_AdjustmentToExpectedIncomeTaxBenefitLossOnDerivativeLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentToExpectedIncomeTaxBenefitLossOnDerivativeLiability_71" xlink:to="lab_huge_AdjustmentToExpectedIncomeTaxBenefitLossOnDerivativeLiability_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentToExpectedIncomeTaxBenefitShareIssueCosts_72" xlink:to="lab_huge_AdjustmentToExpectedIncomeTaxBenefitShareIssueCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentToExpectedIncomeTaxBenefitShareIssueCosts_73" xlink:to="lab_huge_AdjustmentToExpectedIncomeTaxBenefitShareIssueCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentToExpectedIncomeTaxBenefitShareIssueCosts_74" xlink:to="lab_huge_AdjustmentToExpectedIncomeTaxBenefitShareIssueCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentToExpectedIncomeTaxBenefitStockBasedCompensation_75" xlink:to="lab_huge_AdjustmentToExpectedIncomeTaxBenefitStockBasedCompensation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentToExpectedIncomeTaxBenefitStockBasedCompensation_76" xlink:to="lab_huge_AdjustmentToExpectedIncomeTaxBenefitStockBasedCompensation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentToExpectedIncomeTaxBenefitStockBasedCompensation_77" xlink:to="lab_huge_AdjustmentToExpectedIncomeTaxBenefitStockBasedCompensation_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentToLeaseCommitments_78" xlink:to="lab_huge_AdjustmentToLeaseCommitments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentToLeaseCommitments_79" xlink:to="lab_huge_AdjustmentToLeaseCommitments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AdjustmentToLeaseCommitments_80" xlink:to="lab_huge_AdjustmentToLeaseCommitments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AfterHarvestCostToCompleteAndSellPerGramForDryFlower_81" xlink:to="lab_huge_AfterHarvestCostToCompleteAndSellPerGramForDryFlower_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AfterHarvestCostToCompleteAndSellPerGramForDryFlower_82" xlink:to="lab_huge_AfterHarvestCostToCompleteAndSellPerGramForDryFlower_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AfterHarvestCostToCompleteAndSellPerGramForDryFlower_83" xlink:to="lab_huge_AfterHarvestCostToCompleteAndSellPerGramForDryFlower_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AfterHarvestCostToCompleteAndSellPerGramForDryTrim_84" xlink:to="lab_huge_AfterHarvestCostToCompleteAndSellPerGramForDryTrim_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AfterHarvestCostToCompleteAndSellPerGramForDryTrim_85" xlink:to="lab_huge_AfterHarvestCostToCompleteAndSellPerGramForDryTrim_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AfterHarvestCostToCompleteAndSellPerGramForDryTrim_86" xlink:to="lab_huge_AfterHarvestCostToCompleteAndSellPerGramForDryTrim_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AggregateDiscountForSharesInEscrow_87" xlink:to="lab_huge_AggregateDiscountForSharesInEscrow_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AggregateDiscountForSharesInEscrow_88" xlink:to="lab_huge_AggregateDiscountForSharesInEscrow_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AggregateDiscountForSharesInEscrow_89" xlink:to="lab_huge_AggregateDiscountForSharesInEscrow_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AggregateUnpaidAccounts_90" xlink:to="lab_huge_AggregateUnpaidAccounts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AggregateUnpaidAccounts_91" xlink:to="lab_huge_AggregateUnpaidAccounts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AggregateUnpaidAccounts_92" xlink:to="lab_huge_AggregateUnpaidAccounts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AllianceGlobalPartnersMember_93" xlink:to="lab_huge_AllianceGlobalPartnersMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AllianceGlobalPartnersMember_94" xlink:to="lab_huge_AllianceGlobalPartnersMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AllianceGlobalPartnersMember_95" xlink:to="lab_huge_AllianceGlobalPartnersMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AllowanceForImpairment_96" xlink:to="lab_huge_AllowanceForImpairment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AllowanceForImpairment_97" xlink:to="lab_huge_AllowanceForImpairment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AllowanceForImpairment_98" xlink:to="lab_huge_AllowanceForImpairment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmortizedCostOfFinancialAssetsMember_99" xlink:to="lab_huge_AmortizedCostOfFinancialAssetsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmortizedCostOfFinancialAssetsMember_100" xlink:to="lab_huge_AmortizedCostOfFinancialAssetsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmortizedCostOfFinancialAssetsMember_101" xlink:to="lab_huge_AmortizedCostOfFinancialAssetsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmortizedCostOfFinancialLiabilitiesMember_102" xlink:to="lab_huge_AmortizedCostOfFinancialLiabilitiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmortizedCostOfFinancialLiabilitiesMember_103" xlink:to="lab_huge_AmortizedCostOfFinancialLiabilitiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmortizedCostOfFinancialLiabilitiesMember_104" xlink:to="lab_huge_AmortizedCostOfFinancialLiabilitiesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfAdditionalSharesIssuedAgainstOutstandingLiabilities_105" xlink:to="lab_huge_AmountOfAdditionalSharesIssuedAgainstOutstandingLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfAdditionalSharesIssuedAgainstOutstandingLiabilities_106" xlink:to="lab_huge_AmountOfAdditionalSharesIssuedAgainstOutstandingLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfAdditionalSharesIssuedAgainstOutstandingLiabilities_107" xlink:to="lab_huge_AmountOfAdditionalSharesIssuedAgainstOutstandingLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfAgreementFallBelowMinimumValue_108" xlink:to="lab_huge_AmountOfAgreementFallBelowMinimumValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfAgreementFallBelowMinimumValue_109" xlink:to="lab_huge_AmountOfAgreementFallBelowMinimumValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfAgreementFallBelowMinimumValue_110" xlink:to="lab_huge_AmountOfAgreementFallBelowMinimumValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions_111" xlink:to="lab_huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions_112" xlink:to="lab_huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions_113" xlink:to="lab_huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions_114" xlink:to="lab_huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions_115" xlink:to="lab_huge_AmountOfBrokerWarrantsRepresentingFeesAndCommissions_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfDepositPaidToSupplier_116" xlink:to="lab_huge_AmountOfDepositPaidToSupplier_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfDepositPaidToSupplier_117" xlink:to="lab_huge_AmountOfDepositPaidToSupplier_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfDepositPaidToSupplier_118" xlink:to="lab_huge_AmountOfDepositPaidToSupplier_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfMinimumIssueOfAdditionalCommonSharesUponLiquidation_119" xlink:to="lab_huge_AmountOfMinimumIssueOfAdditionalCommonSharesUponLiquidation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfMinimumIssueOfAdditionalCommonSharesUponLiquidation_120" xlink:to="lab_huge_AmountOfMinimumIssueOfAdditionalCommonSharesUponLiquidation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfMinimumIssueOfAdditionalCommonSharesUponLiquidation_121" xlink:to="lab_huge_AmountOfMinimumIssueOfAdditionalCommonSharesUponLiquidation_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfPurchasePricePaidAsSupplierLoan_122" xlink:to="lab_huge_AmountOfPurchasePricePaidAsSupplierLoan_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfPurchasePricePaidAsSupplierLoan_123" xlink:to="lab_huge_AmountOfPurchasePricePaidAsSupplierLoan_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfPurchasePricePaidAsSupplierLoan_124" xlink:to="lab_huge_AmountOfPurchasePricePaidAsSupplierLoan_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement_125" xlink:to="lab_huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement_126" xlink:to="lab_huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement_127" xlink:to="lab_huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AnthonyDurkaczMember_128" xlink:to="lab_huge_AnthonyDurkaczMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AnthonyDurkaczMember_129" xlink:to="lab_huge_AnthonyDurkaczMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AnthonyDurkaczMember_130" xlink:to="lab_huge_AnthonyDurkaczMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AnticipatedPurchasePricePlusApplicableTaxesValue_131" xlink:to="lab_huge_AnticipatedPurchasePricePlusApplicableTaxesValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AnticipatedPurchasePricePlusApplicableTaxesValue_132" xlink:to="lab_huge_AnticipatedPurchasePricePlusApplicableTaxesValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AnticipatedPurchasePricePlusApplicableTaxesValue_133" xlink:to="lab_huge_AnticipatedPurchasePricePlusApplicableTaxesValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Apr82018Member_134" xlink:to="lab_huge_Apr82018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Apr82018Member_135" xlink:to="lab_huge_Apr82018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Apr82018Member_136" xlink:to="lab_huge_Apr82018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Apr92018Member_137" xlink:to="lab_huge_Apr92018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Apr92018Member_138" xlink:to="lab_huge_Apr92018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Apr92018Member_139" xlink:to="lab_huge_Apr92018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_April182018Member_140" xlink:to="lab_huge_April182018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_April182018Member_141" xlink:to="lab_huge_April182018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_April182018Member_142" xlink:to="lab_huge_April182018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Aug142018Member_143" xlink:to="lab_huge_Aug142018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Aug142018Member_144" xlink:to="lab_huge_Aug142018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Aug142018Member_145" xlink:to="lab_huge_Aug142018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Aug152018Member_146" xlink:to="lab_huge_Aug152018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Aug152018Member_147" xlink:to="lab_huge_Aug152018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Aug152018Member_148" xlink:to="lab_huge_Aug152018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Aug82018Member_149" xlink:to="lab_huge_Aug82018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Aug82018Member_150" xlink:to="lab_huge_Aug82018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Aug82018Member_151" xlink:to="lab_huge_Aug82018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AuraHealthIncMember_152" xlink:to="lab_huge_AuraHealthIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AuraHealthIncMember_153" xlink:to="lab_huge_AuraHealthIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AuraHealthIncMember_154" xlink:to="lab_huge_AuraHealthIncMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AuxlyCannabisGroupIncMember_155" xlink:to="lab_huge_AuxlyCannabisGroupIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AuxlyCannabisGroupIncMember_156" xlink:to="lab_huge_AuxlyCannabisGroupIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AuxlyCannabisGroupIncMember_157" xlink:to="lab_huge_AuxlyCannabisGroupIncMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AverageExpectedLifeOfWarrants_158" xlink:to="lab_huge_AverageExpectedLifeOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AverageExpectedLifeOfWarrants_159" xlink:to="lab_huge_AverageExpectedLifeOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_AverageExpectedLifeOfWarrants_160" xlink:to="lab_huge_AverageExpectedLifeOfWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BasisOfPresentationAbstract_161" xlink:to="lab_huge_BasisOfPresentationAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BiologicalAssetFairValueAdjustmentMember_162" xlink:to="lab_huge_BiologicalAssetFairValueAdjustmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BiologicalAssetFairValueAdjustmentMember_163" xlink:to="lab_huge_BiologicalAssetFairValueAdjustmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BiologicalAssetFairValueAdjustmentMember_164" xlink:to="lab_huge_BiologicalAssetFairValueAdjustmentMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BoardMembersMember_165" xlink:to="lab_huge_BoardMembersMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BoardMembersMember_166" xlink:to="lab_huge_BoardMembersMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BoardMembersMember_167" xlink:to="lab_huge_BoardMembersMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BonusExpenseToBePaidInSubsequentPeriod_168" xlink:to="lab_huge_BonusExpenseToBePaidInSubsequentPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BonusExpenseToBePaidInSubsequentPeriod_169" xlink:to="lab_huge_BonusExpenseToBePaidInSubsequentPeriod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BonusExpenseToBePaidInSubsequentPeriod_170" xlink:to="lab_huge_BonusExpenseToBePaidInSubsequentPeriod_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BookToFilingAdjustments_171" xlink:to="lab_huge_BookToFilingAdjustments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BookToFilingAdjustments_172" xlink:to="lab_huge_BookToFilingAdjustments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BookToFilingAdjustments_173" xlink:to="lab_huge_BookToFilingAdjustments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BorrowingsSettled_174" xlink:to="lab_huge_BorrowingsSettled_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BorrowingsSettled_175" xlink:to="lab_huge_BorrowingsSettled_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BorrowingsSettled_176" xlink:to="lab_huge_BorrowingsSettled_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BorrowingsSettledAccruedInterestSettled_177" xlink:to="lab_huge_BorrowingsSettledAccruedInterestSettled_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BorrowingsSettledAccruedInterestSettled_178" xlink:to="lab_huge_BorrowingsSettledAccruedInterestSettled_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BorrowingsSettledAccruedInterestSettled_179" xlink:to="lab_huge_BorrowingsSettledAccruedInterestSettled_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BrokerWarrants_180" xlink:to="lab_huge_BrokerWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BrokerWarrants_181" xlink:to="lab_huge_BrokerWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BrokerWarrantsIssuedInPrivatePlacements_182" xlink:to="lab_huge_BrokerWarrantsIssuedInPrivatePlacements_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BrokerWarrantsIssuedInPrivatePlacements_183" xlink:to="lab_huge_BrokerWarrantsIssuedInPrivatePlacements_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BrokerWarrantsIssuedInPrivatePlacements_184" xlink:to="lab_huge_BrokerWarrantsIssuedInPrivatePlacements_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BuildingAndFacilityCosts_185" xlink:to="lab_huge_BuildingAndFacilityCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BuildingAndFacilityCosts_186" xlink:to="lab_huge_BuildingAndFacilityCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BuildingAndFacilityCosts_187" xlink:to="lab_huge_BuildingAndFacilityCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BusinessAcquisitionDomain_188" xlink:to="lab_huge_BusinessAcquisitionDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BusinessAcquisitionDomain_189" xlink:to="lab_huge_BusinessAcquisitionDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BusinessAcquisitionsAxis_190" xlink:to="lab_huge_BusinessAcquisitionsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BusinessAcquisitionsAxis_191" xlink:to="lab_huge_BusinessAcquisitionsAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BusinessAcquisitionsBenefitsAxis_192" xlink:to="lab_huge_BusinessAcquisitionsBenefitsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BusinessAcquisitionsBenefitsAxis_193" xlink:to="lab_huge_BusinessAcquisitionsBenefitsAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BusinessAcquisitionsBenefitsDomain_194" xlink:to="lab_huge_BusinessAcquisitionsBenefitsDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BusinessAcquisitionsBenefitsDomain_195" xlink:to="lab_huge_BusinessAcquisitionsBenefitsDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BusinessLicenseFees_196" xlink:to="lab_huge_BusinessLicenseFees_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BusinessLicenseFees_197" xlink:to="lab_huge_BusinessLicenseFees_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_BusinessLicenseFees_198" xlink:to="lab_huge_BusinessLicenseFees_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CannaraBiotechIncMember_199" xlink:to="lab_huge_CannaraBiotechIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CannaraBiotechIncMember_200" xlink:to="lab_huge_CannaraBiotechIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CannaraBiotechIncMember_201" xlink:to="lab_huge_CannaraBiotechIncMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CanntabTherapeuticsLtdWorldClassExtractionsIncMember_202" xlink:to="lab_huge_CanntabTherapeuticsLtdWorldClassExtractionsIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CanntabTherapeuticsLtdWorldClassExtractionsIncMember_203" xlink:to="lab_huge_CanntabTherapeuticsLtdWorldClassExtractionsIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CanntabTherapeuticsLtdWorldClassExtractionsIncMember_204" xlink:to="lab_huge_CanntabTherapeuticsLtdWorldClassExtractionsIncMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CapitalizedCostMember_205" xlink:to="lab_huge_CapitalizedCostMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CapitalizedCostMember_206" xlink:to="lab_huge_CapitalizedCostMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CapitalizedCostMember_207" xlink:to="lab_huge_CapitalizedCostMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CapitalizedCosts_208" xlink:to="lab_huge_CapitalizedCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CapitalizedCosts_209" xlink:to="lab_huge_CapitalizedCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CapitalizedCosts_210" xlink:to="lab_huge_CapitalizedCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CashAcquiredOnAcquisition_211" xlink:to="lab_huge_CashAcquiredOnAcquisition_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CashAcquiredOnAcquisition_212" xlink:to="lab_huge_CashAcquiredOnAcquisition_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CashAcquiredOnAcquisition_213" xlink:to="lab_huge_CashAcquiredOnAcquisition_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CashAcquiredOnAcquisition_214" xlink:to="lab_huge_CashAcquiredOnAcquisition_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CashProceedsFromIssuanceOfPrivatePlacement_215" xlink:to="lab_huge_CashProceedsFromIssuanceOfPrivatePlacement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CashProceedsFromIssuanceOfPrivatePlacement_216" xlink:to="lab_huge_CashProceedsFromIssuanceOfPrivatePlacement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CashProceedsFromIssuanceOfPrivatePlacement_217" xlink:to="lab_huge_CashProceedsFromIssuanceOfPrivatePlacement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CashReceiptsFromSalesOfDebtInstruments_218" xlink:to="lab_huge_CashReceiptsFromSalesOfDebtInstruments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CashReceiptsFromSalesOfDebtInstruments_219" xlink:to="lab_huge_CashReceiptsFromSalesOfDebtInstruments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CashReceiptsFromSalesOfDebtInstruments_220" xlink:to="lab_huge_CashReceiptsFromSalesOfDebtInstruments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CenturyAndFvPharmaMember_221" xlink:to="lab_huge_CenturyAndFvPharmaMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CenturyAndFvPharmaMember_222" xlink:to="lab_huge_CenturyAndFvPharmaMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CenturyAndFvPharmaMember_223" xlink:to="lab_huge_CenturyAndFvPharmaMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CertainShareholdersClaimingToHoldInExcessPercentageOfClassBSubordinatedVotingShares_224" xlink:to="lab_huge_CertainShareholdersClaimingToHoldInExcessPercentageOfClassBSubordinatedVotingShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CertainShareholdersClaimingToHoldInExcessPercentageOfClassBSubordinatedVotingShares_225" xlink:to="lab_huge_CertainShareholdersClaimingToHoldInExcessPercentageOfClassBSubordinatedVotingShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CertainShareholdersClaimingToHoldInExcessPercentageOfClassBSubordinatedVotingShares_226" xlink:to="lab_huge_CertainShareholdersClaimingToHoldInExcessPercentageOfClassBSubordinatedVotingShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChangeInFairValueOfInvestment_227" xlink:to="lab_huge_ChangeInFairValueOfInvestment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChangeInFairValueOfInvestment_228" xlink:to="lab_huge_ChangeInFairValueOfInvestment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChangeInFairValueOfInvestmentDueToTenPercentChangeInAssumptionsUsed_229" xlink:to="lab_huge_ChangeInFairValueOfInvestmentDueToTenPercentChangeInAssumptionsUsed_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChangeInFairValueOfInvestmentDueToTenPercentChangeInAssumptionsUsed_230" xlink:to="lab_huge_ChangeInFairValueOfInvestmentDueToTenPercentChangeInAssumptionsUsed_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChangeInFairValueOfInvestmentDueToTenPercentChangeInAssumptionsUsed_231" xlink:to="lab_huge_ChangeInFairValueOfInvestmentDueToTenPercentChangeInAssumptionsUsed_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_232" xlink:to="lab_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_233" xlink:to="lab_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_234" xlink:to="lab_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChangesInNoncashWorkingCapitalBalancesAbstract_235" xlink:to="lab_huge_ChangesInNoncashWorkingCapitalBalancesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChangesInNoncashWorkingCapitalBalancesAbstract_236" xlink:to="lab_huge_ChangesInNoncashWorkingCapitalBalancesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChangesInNonCashWorkingCapitalItemsAbstract_237" xlink:to="lab_huge_ChangesInNonCashWorkingCapitalItemsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChangesInNonCashWorkingCapitalItemsAbstract_238" xlink:to="lab_huge_ChangesInNonCashWorkingCapitalItemsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChangesInShareCapitalTransactionDateAxis_239" xlink:to="lab_huge_ChangesInShareCapitalTransactionDateAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChangesInShareCapitalTransactionDateAxis_240" xlink:to="lab_huge_ChangesInShareCapitalTransactionDateAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChangesInShareCapitalTransactionDateDomain_241" xlink:to="lab_huge_ChangesInShareCapitalTransactionDateDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChangesInShareCapitalTransactionDateDomain_242" xlink:to="lab_huge_ChangesInShareCapitalTransactionDateDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChiefExecutiveOfficerAndExecutiveCoChairmanMember_243" xlink:to="lab_huge_ChiefExecutiveOfficerAndExecutiveCoChairmanMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChiefExecutiveOfficerAndExecutiveCoChairmanMember_244" xlink:to="lab_huge_ChiefExecutiveOfficerAndExecutiveCoChairmanMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChiefExecutiveOfficerAndExecutiveCoChairmanMember_245" xlink:to="lab_huge_ChiefExecutiveOfficerAndExecutiveCoChairmanMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChiefExecutiveOfficersMember_246" xlink:to="lab_huge_ChiefExecutiveOfficersMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChiefExecutiveOfficersMember_247" xlink:to="lab_huge_ChiefExecutiveOfficersMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChiefExecutiveOfficersMember_248" xlink:to="lab_huge_ChiefExecutiveOfficersMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChiefFinancialOfficersMember_249" xlink:to="lab_huge_ChiefFinancialOfficersMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChiefFinancialOfficersMember_250" xlink:to="lab_huge_ChiefFinancialOfficersMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChiefFinancialOfficersMember_251" xlink:to="lab_huge_ChiefFinancialOfficersMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChiefOperatingConsultantMember_252" xlink:to="lab_huge_ChiefOperatingConsultantMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChiefOperatingConsultantMember_253" xlink:to="lab_huge_ChiefOperatingConsultantMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ChiefOperatingConsultantMember_254" xlink:to="lab_huge_ChiefOperatingConsultantMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClaimForLienComponent_255" xlink:to="lab_huge_ClaimForLienComponent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClaimForLienComponent_256" xlink:to="lab_huge_ClaimForLienComponent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClaimForLienComponent_257" xlink:to="lab_huge_ClaimForLienComponent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClaimIssuedByContractorForVariousPurportedDamages_258" xlink:to="lab_huge_ClaimIssuedByContractorForVariousPurportedDamages_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClaimIssuedByContractorForVariousPurportedDamages_259" xlink:to="lab_huge_ClaimIssuedByContractorForVariousPurportedDamages_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClaimIssuedByContractorForVariousPurportedDamages_260" xlink:to="lab_huge_ClaimIssuedByContractorForVariousPurportedDamages_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClaimIssuedByCreditorForAllegingNonpaymentOfAccounts_261" xlink:to="lab_huge_ClaimIssuedByCreditorForAllegingNonpaymentOfAccounts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClaimIssuedByCreditorForAllegingNonpaymentOfAccounts_262" xlink:to="lab_huge_ClaimIssuedByCreditorForAllegingNonpaymentOfAccounts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClaimIssuedByCreditorForAllegingNonpaymentOfAccounts_263" xlink:to="lab_huge_ClaimIssuedByCreditorForAllegingNonpaymentOfAccounts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClaimSettlementAmount_264" xlink:to="lab_huge_ClaimSettlementAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClaimSettlementAmount_265" xlink:to="lab_huge_ClaimSettlementAmount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClaimSettlementAmount_266" xlink:to="lab_huge_ClaimSettlementAmount_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClaimSettlementAmountCoveredByInsurance_267" xlink:to="lab_huge_ClaimSettlementAmountCoveredByInsurance_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClaimSettlementAmountCoveredByInsurance_268" xlink:to="lab_huge_ClaimSettlementAmountCoveredByInsurance_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClaimSettlementAmountCoveredByInsurance_269" xlink:to="lab_huge_ClaimSettlementAmountCoveredByInsurance_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassACommonStockSharesMember_270" xlink:to="lab_huge_ClassACommonStockSharesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassACommonStockSharesMember_271" xlink:to="lab_huge_ClassACommonStockSharesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassACommonStockSharesMember_272" xlink:to="lab_huge_ClassACommonStockSharesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassBCommonSharesMember_273" xlink:to="lab_huge_ClassBCommonSharesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassBCommonSharesMember_274" xlink:to="lab_huge_ClassBCommonSharesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassBCommonSharesMember_275" xlink:to="lab_huge_ClassBCommonSharesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassBCommonStockSharesMember_276" xlink:to="lab_huge_ClassBCommonStockSharesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassBCommonStockSharesMember_277" xlink:to="lab_huge_ClassBCommonStockSharesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassBCommonStockSharesMember_278" xlink:to="lab_huge_ClassBCommonStockSharesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassBSharesHeldInEscrowMember_279" xlink:to="lab_huge_ClassBSharesHeldInEscrowMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassBSharesHeldInEscrowMember_280" xlink:to="lab_huge_ClassBSharesHeldInEscrowMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassBSharesHeldInEscrowMember_281" xlink:to="lab_huge_ClassBSharesHeldInEscrowMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassBSubordinatedVotingSharesMember_282" xlink:to="lab_huge_ClassBSubordinatedVotingSharesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassBSubordinatedVotingSharesMember_283" xlink:to="lab_huge_ClassBSubordinatedVotingSharesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassBSubordinatedVotingSharesMember_284" xlink:to="lab_huge_ClassBSubordinatedVotingSharesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassBSubordinateVotingSharesMember_285" xlink:to="lab_huge_ClassBSubordinateVotingSharesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassBSubordinateVotingSharesMember_286" xlink:to="lab_huge_ClassBSubordinateVotingSharesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassBSubordinateVotingSharesMember_287" xlink:to="lab_huge_ClassBSubordinateVotingSharesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassBVotingSharesMember_288" xlink:to="lab_huge_ClassBVotingSharesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassBVotingSharesMember_289" xlink:to="lab_huge_ClassBVotingSharesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassBVotingSharesMember_290" xlink:to="lab_huge_ClassBVotingSharesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassCommonStockSharesMember_291" xlink:to="lab_huge_ClassCommonStockSharesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassCommonStockSharesMember_292" xlink:to="lab_huge_ClassCommonStockSharesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassCommonStockSharesMember_293" xlink:to="lab_huge_ClassCommonStockSharesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassesOfInventoriesLineItems_294" xlink:to="lab_huge_ClassesOfInventoriesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassesOfInventoriesLineItems_295" xlink:to="lab_huge_ClassesOfInventoriesLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassesOfInventoriesTable_296" xlink:to="lab_huge_ClassesOfInventoriesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassesOfInventoriesTable_297" xlink:to="lab_huge_ClassesOfInventoriesTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassesOfWarrantsAxis_298" xlink:to="lab_huge_ClassesOfWarrantsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassesOfWarrantsAxis_299" xlink:to="lab_huge_ClassesOfWarrantsAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassesOfWarrantsDomain_300" xlink:to="lab_huge_ClassesOfWarrantsDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ClassesOfWarrantsDomain_301" xlink:to="lab_huge_ClassesOfWarrantsDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CloverCannastripThinFilmTechnologiesCorpMember_302" xlink:to="lab_huge_CloverCannastripThinFilmTechnologiesCorpMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CloverCannastripThinFilmTechnologiesCorpMember_303" xlink:to="lab_huge_CloverCannastripThinFilmTechnologiesCorpMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CloverCannastripThinFilmTechnologiesCorpMember_304" xlink:to="lab_huge_CloverCannastripThinFilmTechnologiesCorpMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CloverCannastripThinFilmTechnologiesCorpMember_305" xlink:to="lab_huge_CloverCannastripThinFilmTechnologiesCorpMember_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CollectiveCommitmentToPurchaseProduct_306" xlink:to="lab_huge_CollectiveCommitmentToPurchaseProduct_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CollectiveCommitmentToPurchaseProduct_307" xlink:to="lab_huge_CollectiveCommitmentToPurchaseProduct_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CommitmentsEquityInstruments_308" xlink:to="lab_huge_CommitmentsEquityInstruments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CommitmentsEquityInstruments_309" xlink:to="lab_huge_CommitmentsEquityInstruments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CommitmentsEquityInstruments_310" xlink:to="lab_huge_CommitmentsEquityInstruments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CommitmentsLineItems_311" xlink:to="lab_huge_CommitmentsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CommitmentsTable_312" xlink:to="lab_huge_CommitmentsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CommitmentToIssueSharesMinimumValueUponLiquidation_313" xlink:to="lab_huge_CommitmentToIssueSharesMinimumValueUponLiquidation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CommitmentToIssueSharesMinimumValueUponLiquidation_314" xlink:to="lab_huge_CommitmentToIssueSharesMinimumValueUponLiquidation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CommitmentToIssueSharesMinimumValueUponLiquidation_315" xlink:to="lab_huge_CommitmentToIssueSharesMinimumValueUponLiquidation_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CommonStockIssuedForPrivatePlacement_316" xlink:to="lab_huge_CommonStockIssuedForPrivatePlacement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CommonStockIssuedForPrivatePlacement_317" xlink:to="lab_huge_CommonStockIssuedForPrivatePlacement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CommonStockIssuedForPrivatePlacement_318" xlink:to="lab_huge_CommonStockIssuedForPrivatePlacement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ConsultingFeesExpenses_319" xlink:to="lab_huge_ConsultingFeesExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ConsultingFeesExpenses_320" xlink:to="lab_huge_ConsultingFeesExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ConsultingFeesExpenses_321" xlink:to="lab_huge_ConsultingFeesExpenses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ConsultingFeesExpenses_322" xlink:to="lab_huge_ConsultingFeesExpenses_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember_323" xlink:to="lab_huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember_324" xlink:to="lab_huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember_325" xlink:to="lab_huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ContractualCapitalCommitmentsEqualMonthlyInstalments_326" xlink:to="lab_huge_ContractualCapitalCommitmentsEqualMonthlyInstalments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ContractualCapitalCommitmentsEqualMonthlyInstalments_327" xlink:to="lab_huge_ContractualCapitalCommitmentsEqualMonthlyInstalments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ContractualCapitalCommitmentsEqualMonthlyInstalments_328" xlink:to="lab_huge_ContractualCapitalCommitmentsEqualMonthlyInstalments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ConvertibleDebentureMember_329" xlink:to="lab_huge_ConvertibleDebentureMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ConvertibleDebentureMember_330" xlink:to="lab_huge_ConvertibleDebentureMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ConvertibleDebentureMember_331" xlink:to="lab_huge_ConvertibleDebentureMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ConvertibleNotes_332" xlink:to="lab_huge_ConvertibleNotes_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ConvertibleNotes_333" xlink:to="lab_huge_ConvertibleNotes_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ConvertibleNotes_334" xlink:to="lab_huge_ConvertibleNotes_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ConvertibleNotes_335" xlink:to="lab_huge_ConvertibleNotes_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ConvertibleNotesMember_336" xlink:to="lab_huge_ConvertibleNotesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ConvertibleNotesMember_337" xlink:to="lab_huge_ConvertibleNotesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ConvertibleNotesMember_338" xlink:to="lab_huge_ConvertibleNotesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CorporateInformationAndNatureOfOperationsAbstract_339" xlink:to="lab_huge_CorporateInformationAndNatureOfOperationsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CriticalAccountingEstimatesAndJudgmentsAbstract_340" xlink:to="lab_huge_CriticalAccountingEstimatesAndJudgmentsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CurrentNotesPayable_341" xlink:to="lab_huge_CurrentNotesPayable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CurrentNotesPayable_342" xlink:to="lab_huge_CurrentNotesPayable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CurrentNotesPayable_343" xlink:to="lab_huge_CurrentNotesPayable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CurrentNotesPayable_344" xlink:to="lab_huge_CurrentNotesPayable_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CurrentWarrantsLiability_345" xlink:to="lab_huge_CurrentWarrantsLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CurrentWarrantsLiability_346" xlink:to="lab_huge_CurrentWarrantsLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_CurrentWarrantsLiability_347" xlink:to="lab_huge_CurrentWarrantsLiability_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DateOfExpiryOfShareOptions_348" xlink:to="lab_huge_DateOfExpiryOfShareOptions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DateOfExpiryOfShareOptions_349" xlink:to="lab_huge_DateOfExpiryOfShareOptions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DateOfExpiryOfShareOptions_350" xlink:to="lab_huge_DateOfExpiryOfShareOptions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DebtConversionRatio_351" xlink:to="lab_huge_DebtConversionRatio_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DebtConversionRatio_352" xlink:to="lab_huge_DebtConversionRatio_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Dec122017Member_353" xlink:to="lab_huge_Dec122017Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Dec122017Member_354" xlink:to="lab_huge_Dec122017Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Dec122017Member_355" xlink:to="lab_huge_Dec122017Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Dec152018Member_356" xlink:to="lab_huge_Dec152018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Dec152018Member_357" xlink:to="lab_huge_Dec152018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Dec152018Member_358" xlink:to="lab_huge_Dec152018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Dec212017Member_359" xlink:to="lab_huge_Dec212017Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Dec212017Member_360" xlink:to="lab_huge_Dec212017Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Dec212017Member_361" xlink:to="lab_huge_Dec212017Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Dec232017Member_362" xlink:to="lab_huge_Dec232017Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Dec232017Member_363" xlink:to="lab_huge_Dec232017Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Dec232017Member_364" xlink:to="lab_huge_Dec232017Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Dec292017Member_365" xlink:to="lab_huge_Dec292017Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Dec292017Member_366" xlink:to="lab_huge_Dec292017Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Dec292017Member_367" xlink:to="lab_huge_Dec292017Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_December292017Member_368" xlink:to="lab_huge_December292017Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_December292017Member_369" xlink:to="lab_huge_December292017Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_December292017Member_370" xlink:to="lab_huge_December292017Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_371" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_372" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_373" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_374" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_375" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_376" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_377" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfForeignNetOperatingLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_378" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfForeignNetOperatingLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfForeignNetOperatingLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_379" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfForeignNetOperatingLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfForeignNetOperatingLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_380" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfForeignNetOperatingLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_381" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_382" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_383" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfForeignUnrealizedForeignExchangeLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_384" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfForeignUnrealizedForeignExchangeLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfForeignUnrealizedForeignExchangeLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_385" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfForeignUnrealizedForeignExchangeLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfForeignUnrealizedForeignExchangeLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_386" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfForeignUnrealizedForeignExchangeLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfIfrs16ForWhichNoDeferredTaxAssetIsRecognised_387" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfIfrs16ForWhichNoDeferredTaxAssetIsRecognised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfIfrs16ForWhichNoDeferredTaxAssetIsRecognised_388" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfIfrs16ForWhichNoDeferredTaxAssetIsRecognised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfIfrs16ForWhichNoDeferredTaxAssetIsRecognised_389" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfIfrs16ForWhichNoDeferredTaxAssetIsRecognised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised_390" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised_391" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised_392" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised_393" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised_394" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised_395" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised_396" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised_397" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised_398" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfUnrealizedFairValueOnBiologicalAssetsAndInventoryForWhichNoDeferredTaxAssetIsRecognised_399" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfUnrealizedFairValueOnBiologicalAssetsAndInventoryForWhichNoDeferredTaxAssetIsRecognised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfUnrealizedFairValueOnBiologicalAssetsAndInventoryForWhichNoDeferredTaxAssetIsRecognised_400" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfUnrealizedFairValueOnBiologicalAssetsAndInventoryForWhichNoDeferredTaxAssetIsRecognised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeductibleTemporaryDifferencesOfUnrealizedFairValueOnBiologicalAssetsAndInventoryForWhichNoDeferredTaxAssetIsRecognised_401" xlink:to="lab_huge_DeductibleTemporaryDifferencesOfUnrealizedFairValueOnBiologicalAssetsAndInventoryForWhichNoDeferredTaxAssetIsRecognised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxAssetLiabilityNotRecognized_402" xlink:to="lab_huge_DeferredTaxAssetLiabilityNotRecognized_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxAssetLiabilityNotRecognized_403" xlink:to="lab_huge_DeferredTaxAssetLiabilityNotRecognized_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxAssetLiabilityNotRecognized_404" xlink:to="lab_huge_DeferredTaxAssetLiabilityNotRecognized_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxAssetLiabilityNotRecognized_405" xlink:to="lab_huge_DeferredTaxAssetLiabilityNotRecognized_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxAssetLiabilityNotRecognized_406" xlink:to="lab_huge_DeferredTaxAssetLiabilityNotRecognized_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxAssetNotRecognized_407" xlink:to="lab_huge_DeferredTaxAssetNotRecognized_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxAssetNotRecognized_408" xlink:to="lab_huge_DeferredTaxAssetNotRecognized_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxAssetNotRecognized_409" xlink:to="lab_huge_DeferredTaxAssetNotRecognized_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxAssetPropertyPlantAndEquipments_410" xlink:to="lab_huge_DeferredTaxAssetPropertyPlantAndEquipments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxAssetPropertyPlantAndEquipments_411" xlink:to="lab_huge_DeferredTaxAssetPropertyPlantAndEquipments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxAssetPropertyPlantAndEquipments_412" xlink:to="lab_huge_DeferredTaxAssetPropertyPlantAndEquipments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxAssetPropertyPlantAndEquipments_413" xlink:to="lab_huge_DeferredTaxAssetPropertyPlantAndEquipments_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxAssetsLiabilitiesAxis_414" xlink:to="lab_huge_DeferredTaxAssetsLiabilitiesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxAssetsLiabilitiesAxis_415" xlink:to="lab_huge_DeferredTaxAssetsLiabilitiesAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxAssetsLiabilitiesDomain_416" xlink:to="lab_huge_DeferredTaxAssetsLiabilitiesDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxAssetsLiabilitiesDomain_417" xlink:to="lab_huge_DeferredTaxAssetsLiabilitiesDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxAssetsOtherInvestments_418" xlink:to="lab_huge_DeferredTaxAssetsOtherInvestments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxAssetsOtherInvestments_419" xlink:to="lab_huge_DeferredTaxAssetsOtherInvestments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxAssetsOtherInvestments_420" xlink:to="lab_huge_DeferredTaxAssetsOtherInvestments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxAssetsOtherInvestments_421" xlink:to="lab_huge_DeferredTaxAssetsOtherInvestments_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward_422" xlink:to="lab_huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward_423" xlink:to="lab_huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward_424" xlink:to="lab_huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward_425" xlink:to="lab_huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DefinitiveBusinessCombinationAgreementMember_426" xlink:to="lab_huge_DefinitiveBusinessCombinationAgreementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DefinitiveBusinessCombinationAgreementMember_427" xlink:to="lab_huge_DefinitiveBusinessCombinationAgreementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DefinitiveBusinessCombinationAgreementMember_428" xlink:to="lab_huge_DefinitiveBusinessCombinationAgreementMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DefinitiveCollaborationProfitSharingAgreementMember_429" xlink:to="lab_huge_DefinitiveCollaborationProfitSharingAgreementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DefinitiveCollaborationProfitSharingAgreementMember_430" xlink:to="lab_huge_DefinitiveCollaborationProfitSharingAgreementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DefinitiveCollaborationProfitSharingAgreementMember_431" xlink:to="lab_huge_DefinitiveCollaborationProfitSharingAgreementMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DefinitiveSettlementAgreementMember_432" xlink:to="lab_huge_DefinitiveSettlementAgreementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DefinitiveSettlementAgreementMember_433" xlink:to="lab_huge_DefinitiveSettlementAgreementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DefinitiveSettlementAgreementMember_434" xlink:to="lab_huge_DefinitiveSettlementAgreementMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DefinitiveStrategicAllianceAndStreamingAgreementMember_435" xlink:to="lab_huge_DefinitiveStrategicAllianceAndStreamingAgreementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DefinitiveStrategicAllianceAndStreamingAgreementMember_436" xlink:to="lab_huge_DefinitiveStrategicAllianceAndStreamingAgreementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DefinitiveStrategicAllianceAndStreamingAgreementMember_437" xlink:to="lab_huge_DefinitiveStrategicAllianceAndStreamingAgreementMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DerivativeLiabilitiesSettledThroughIssuanceOfShares_438" xlink:to="lab_huge_DerivativeLiabilitiesSettledThroughIssuanceOfShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DerivativeLiabilitiesSettledThroughIssuanceOfShares_439" xlink:to="lab_huge_DerivativeLiabilitiesSettledThroughIssuanceOfShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DescriptionOfExpectedVolatilityWarrantsGranted_440" xlink:to="lab_huge_DescriptionOfExpectedVolatilityWarrantsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DescriptionOfExpectedVolatilityWarrantsGranted_441" xlink:to="lab_huge_DescriptionOfExpectedVolatilityWarrantsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DescriptionOfExpectedVolatilityWarrantsGranted_442" xlink:to="lab_huge_DescriptionOfExpectedVolatilityWarrantsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DescriptionOfExpectedVolatilityWarrantsGranted_443" xlink:to="lab_huge_DescriptionOfExpectedVolatilityWarrantsGranted_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DescriptionOfOptionLifeWarrantsGranted_444" xlink:to="lab_huge_DescriptionOfOptionLifeWarrantsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DescriptionOfOptionLifeWarrantsGranted_445" xlink:to="lab_huge_DescriptionOfOptionLifeWarrantsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DescriptionOfOptionLifeWarrantsGranted_446" xlink:to="lab_huge_DescriptionOfOptionLifeWarrantsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DescriptionOfOptionLifeWarrantsGranted_447" xlink:to="lab_huge_DescriptionOfOptionLifeWarrantsGranted_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory_448" xlink:to="lab_huge_DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory_449" xlink:to="lab_huge_DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory_450" xlink:to="lab_huge_DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DescriptionOfReverseShareSplit_451" xlink:to="lab_huge_DescriptionOfReverseShareSplit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DescriptionOfReverseShareSplit_452" xlink:to="lab_huge_DescriptionOfReverseShareSplit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DescriptionOfRiskFreeInterestRateWarrantsGranted_453" xlink:to="lab_huge_DescriptionOfRiskFreeInterestRateWarrantsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DescriptionOfRiskFreeInterestRateWarrantsGranted_454" xlink:to="lab_huge_DescriptionOfRiskFreeInterestRateWarrantsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DescriptionOfRiskFreeInterestRateWarrantsGranted_455" xlink:to="lab_huge_DescriptionOfRiskFreeInterestRateWarrantsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DescriptionOfRiskFreeInterestRateWarrantsGranted_456" xlink:to="lab_huge_DescriptionOfRiskFreeInterestRateWarrantsGranted_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DescriptionOfVotingRights_457" xlink:to="lab_huge_DescriptionOfVotingRights_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DescriptionOfVotingRights_458" xlink:to="lab_huge_DescriptionOfVotingRights_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DescriptionOfVotingRights_459" xlink:to="lab_huge_DescriptionOfVotingRights_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DirectCashOfferingCost_460" xlink:to="lab_huge_DirectCashOfferingCost_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DirectCashOfferingCost_461" xlink:to="lab_huge_DirectCashOfferingCost_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DirectCashOfferingCost_462" xlink:to="lab_huge_DirectCashOfferingCost_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DirectorsAndOfficersMember_463" xlink:to="lab_huge_DirectorsAndOfficersMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DirectorsAndOfficersMember_464" xlink:to="lab_huge_DirectorsAndOfficersMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DirectorsAndOfficersMember_465" xlink:to="lab_huge_DirectorsAndOfficersMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DirectorsAndOfficersMember_466" xlink:to="lab_huge_DirectorsAndOfficersMember_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DirectorsRemunerationPayable_467" xlink:to="lab_huge_DirectorsRemunerationPayable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DirectorsRemunerationPayable_468" xlink:to="lab_huge_DirectorsRemunerationPayable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DirectorsRemunerationPayable_469" xlink:to="lab_huge_DirectorsRemunerationPayable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleAbstract_470" xlink:to="lab_huge_DisclosureOfAssetsHeldForSaleAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_471" xlink:to="lab_huge_DisclosureOfAssetsHeldForSaleLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_472" xlink:to="lab_huge_DisclosureOfAssetsHeldForSaleLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleTable_473" xlink:to="lab_huge_DisclosureOfAssetsHeldForSaleTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleTable_474" xlink:to="lab_huge_DisclosureOfAssetsHeldForSaleTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfCapitalManagementAbstract_475" xlink:to="lab_huge_DisclosureOfCapitalManagementAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_476" xlink:to="lab_huge_DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_477" xlink:to="lab_huge_DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_478" xlink:to="lab_huge_DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfCommitmentsAbstract_479" xlink:to="lab_huge_DisclosureOfCommitmentsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfCommitmentsAndContingentLiabilitiesAbstract_480" xlink:to="lab_huge_DisclosureOfCommitmentsAndContingentLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfCorporateInformationAndNatureOfOperationsExplanatory_481" xlink:to="lab_huge_DisclosureOfCorporateInformationAndNatureOfOperationsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfCorporateInformationAndNatureOfOperationsExplanatory_482" xlink:to="lab_huge_DisclosureOfCorporateInformationAndNatureOfOperationsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfCorporateInformationAndNatureOfOperationsExplanatory_483" xlink:to="lab_huge_DisclosureOfCorporateInformationAndNatureOfOperationsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutFairValueOfWarrantsWarrantsEstimatedOnDatesOfIssueUsingBlackScholesOptionPricingModelExplanatory_484" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutFairValueOfWarrantsWarrantsEstimatedOnDatesOfIssueUsingBlackScholesOptionPricingModelExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutFairValueOfWarrantsWarrantsEstimatedOnDatesOfIssueUsingBlackScholesOptionPricingModelExplanatory_485" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutFairValueOfWarrantsWarrantsEstimatedOnDatesOfIssueUsingBlackScholesOptionPricingModelExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutFairValueOfWarrantsWarrantsEstimatedOnDatesOfIssueUsingBlackScholesOptionPricingModelExplanatory_486" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutFairValueOfWarrantsWarrantsEstimatedOnDatesOfIssueUsingBlackScholesOptionPricingModelExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory_487" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory_488" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory_489" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory_490" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutInventoriesExplanatory_491" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutInventoriesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutInventoriesExplanatory_492" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutInventoriesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutInventoriesExplanatory_493" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutInventoriesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutInvestmentsExplanatory_494" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutInvestmentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutInvestmentsExplanatory_495" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutInvestmentsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutInvestmentsExplanatory_496" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutInvestmentsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutInvestmentsExplanatory_497" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutInvestmentsExplanatory_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutNotesPayableExplanatory_498" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutNotesPayableExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutNotesPayableExplanatory_499" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutNotesPayableExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutNotesPayableExplanatory_500" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutNotesPayableExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutRestatementOfPriorPeriodExplanatory_501" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutRestatementOfPriorPeriodExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutRestatementOfPriorPeriodExplanatory_502" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutRestatementOfPriorPeriodExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutRestatementOfPriorPeriodExplanatory_503" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutRestatementOfPriorPeriodExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutRightOfUseAssets_504" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutRightOfUseAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutRightOfUseAssets_505" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutRightOfUseAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutRightOfUseAssets_506" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutRightOfUseAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory_507" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory_508" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory_509" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutWarrantActivityExplanatory_510" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutWarrantActivityExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutWarrantActivityExplanatory_511" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutWarrantActivityExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailedInformationAboutWarrantActivityExplanatory_512" xlink:to="lab_huge_DisclosureOfDetailedInformationAboutWarrantActivityExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory_513" xlink:to="lab_huge_DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory_514" xlink:to="lab_huge_DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory_515" xlink:to="lab_huge_DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailsInformationAboutRightOfUseAssetExplanatory_516" xlink:to="lab_huge_DisclosureOfDetailsInformationAboutRightOfUseAssetExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfDetailsInformationAboutRightOfUseAssetExplanatory_517" xlink:to="lab_huge_DisclosureOfDetailsInformationAboutRightOfUseAssetExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory_518" xlink:to="lab_huge_DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory_519" xlink:to="lab_huge_DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory_520" xlink:to="lab_huge_DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfFairValueRecognizedOnAcquisitionTableTextBlock_521" xlink:to="lab_huge_DisclosureOfFairValueRecognizedOnAcquisitionTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfFairValueRecognizedOnAcquisitionTableTextBlock_522" xlink:to="lab_huge_DisclosureOfFairValueRecognizedOnAcquisitionTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfFairValueRecognizedOnAcquisitionTableTextBlock_523" xlink:to="lab_huge_DisclosureOfFairValueRecognizedOnAcquisitionTableTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfFinancialAssetsAndLiabilitiesExplanatory_524" xlink:to="lab_huge_DisclosureOfFinancialAssetsAndLiabilitiesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfFinancialAssetsAndLiabilitiesExplanatory_525" xlink:to="lab_huge_DisclosureOfFinancialAssetsAndLiabilitiesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfFinancialAssetsAndLiabilitiesExplanatory_526" xlink:to="lab_huge_DisclosureOfFinancialAssetsAndLiabilitiesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfGeneralAndAdministrativeExpenses_527" xlink:to="lab_huge_DisclosureOfGeneralAndAdministrativeExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfGeneralAndAdministrativeExpenses_528" xlink:to="lab_huge_DisclosureOfGeneralAndAdministrativeExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfInvestmentsAbstract_529" xlink:to="lab_huge_DisclosureOfInvestmentsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_530" xlink:to="lab_huge_DisclosureOfInvestmentsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfInvestmentsTable_531" xlink:to="lab_huge_DisclosureOfInvestmentsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfInvestmentsTable_532" xlink:to="lab_huge_DisclosureOfInvestmentsTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfNatureOfBusinessAbstract_533" xlink:to="lab_huge_DisclosureOfNatureOfBusinessAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfNatureOfBusinessAbstract_534" xlink:to="lab_huge_DisclosureOfNatureOfBusinessAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfNatureOfBusinessAbstract_535" xlink:to="lab_huge_DisclosureOfNatureOfBusinessAbstract_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfNatureOfBusinessExplanatoryTextBlock_536" xlink:to="lab_huge_DisclosureOfNatureOfBusinessExplanatoryTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfNatureOfBusinessExplanatoryTextBlock_537" xlink:to="lab_huge_DisclosureOfNatureOfBusinessExplanatoryTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfNatureOfBusinessExplanatoryTextBlock_538" xlink:to="lab_huge_DisclosureOfNatureOfBusinessExplanatoryTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfNatureOfBusinessLineItems_539" xlink:to="lab_huge_DisclosureOfNatureOfBusinessLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfNatureOfBusinessTable_540" xlink:to="lab_huge_DisclosureOfNatureOfBusinessTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfNatureOfBusinessTable_541" xlink:to="lab_huge_DisclosureOfNatureOfBusinessTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingAndExercisableShareOptionsExplanatory_542" xlink:to="lab_huge_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingAndExercisableShareOptionsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingAndExercisableShareOptionsExplanatory_543" xlink:to="lab_huge_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingAndExercisableShareOptionsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingAndExercisableShareOptionsExplanatory_544" xlink:to="lab_huge_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingAndExercisableShareOptionsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory_545" xlink:to="lab_huge_DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory_546" xlink:to="lab_huge_DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory_547" xlink:to="lab_huge_DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfNumberOfWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_548" xlink:to="lab_huge_DisclosureOfNumberOfWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfNumberOfWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_549" xlink:to="lab_huge_DisclosureOfNumberOfWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfNumberOfWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_550" xlink:to="lab_huge_DisclosureOfNumberOfWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfOperatingLeaseObligationsTableTextBlock_551" xlink:to="lab_huge_DisclosureOfOperatingLeaseObligationsTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfOperatingLeaseObligationsTableTextBlock_552" xlink:to="lab_huge_DisclosureOfOperatingLeaseObligationsTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfOperatingLeaseObligationsTableTextBlock_553" xlink:to="lab_huge_DisclosureOfOperatingLeaseObligationsTableTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfProvisionForIncomeTaxesExplanatory_554" xlink:to="lab_huge_DisclosureOfProvisionForIncomeTaxesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfProvisionForIncomeTaxesExplanatory_555" xlink:to="lab_huge_DisclosureOfProvisionForIncomeTaxesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfProvisionForIncomeTaxesExplanatory_556" xlink:to="lab_huge_DisclosureOfProvisionForIncomeTaxesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfQuantitiesAvailableToSupplyByFiscalPeriodUnderCommitmentExplanatory_557" xlink:to="lab_huge_DisclosureOfQuantitiesAvailableToSupplyByFiscalPeriodUnderCommitmentExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfQuantitiesAvailableToSupplyByFiscalPeriodUnderCommitmentExplanatory_558" xlink:to="lab_huge_DisclosureOfQuantitiesAvailableToSupplyByFiscalPeriodUnderCommitmentExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfQuantitiesAvailableToSupplyByFiscalPeriodUnderCommitmentExplanatory_559" xlink:to="lab_huge_DisclosureOfQuantitiesAvailableToSupplyByFiscalPeriodUnderCommitmentExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfReverseTakeoverTransactionAbstract_560" xlink:to="lab_huge_DisclosureOfReverseTakeoverTransactionAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfReverseTakeoverTransactionExplanatory_561" xlink:to="lab_huge_DisclosureOfReverseTakeoverTransactionExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfReverseTakeoverTransactionExplanatory_562" xlink:to="lab_huge_DisclosureOfReverseTakeoverTransactionExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfReverseTakeoverTransactionExplanatory_563" xlink:to="lab_huge_DisclosureOfReverseTakeoverTransactionExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfReverseTakeoverTransactionExplanatory_564" xlink:to="lab_huge_DisclosureOfReverseTakeoverTransactionExplanatory_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract_565" xlink:to="lab_huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveExplanatory_566" xlink:to="lab_huge_DisclosureOfShareBasedCompensationAndWarrantReserveExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveExplanatory_567" xlink:to="lab_huge_DisclosureOfShareBasedCompensationAndWarrantReserveExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveExplanatory_568" xlink:to="lab_huge_DisclosureOfShareBasedCompensationAndWarrantReserveExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory_569" xlink:to="lab_huge_DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory_570" xlink:to="lab_huge_DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory_571" xlink:to="lab_huge_DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfUnrecognizedTemporaryTaxDifferencesExplanatory_572" xlink:to="lab_huge_DisclosureOfUnrecognizedTemporaryTaxDifferencesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfUnrecognizedTemporaryTaxDifferencesExplanatory_573" xlink:to="lab_huge_DisclosureOfUnrecognizedTemporaryTaxDifferencesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfUnrecognizedTemporaryTaxDifferencesExplanatory_574" xlink:to="lab_huge_DisclosureOfUnrecognizedTemporaryTaxDifferencesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfWarrantLiabilitiesExplanatory_575" xlink:to="lab_huge_DisclosureOfWarrantLiabilitiesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfWarrantLiabilitiesExplanatory_576" xlink:to="lab_huge_DisclosureOfWarrantLiabilitiesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfWarrantLiabilitiesExplanatory_577" xlink:to="lab_huge_DisclosureOfWarrantLiabilitiesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfWarrantsLineItems_578" xlink:to="lab_huge_DisclosureOfWarrantsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfWarrantsLineItems_579" xlink:to="lab_huge_DisclosureOfWarrantsLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfWarrantsTable_580" xlink:to="lab_huge_DisclosureOfWarrantsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DisclosureOfWarrantsTable_581" xlink:to="lab_huge_DisclosureOfWarrantsTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DiscontinuedOperationsOfGeneralAndAdministrative_582" xlink:to="lab_huge_DiscontinuedOperationsOfGeneralAndAdministrative_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DiscontinuedOperationsOfGeneralAndAdministrative_583" xlink:to="lab_huge_DiscontinuedOperationsOfGeneralAndAdministrative_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DiscontinuedOperationsOfGeneralAndAdministrative_584" xlink:to="lab_huge_DiscontinuedOperationsOfGeneralAndAdministrative_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DiscountOnProceedsOfSharesAndWarrantsSold_585" xlink:to="lab_huge_DiscountOnProceedsOfSharesAndWarrantsSold_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DiscountOnProceedsOfSharesAndWarrantsSold_586" xlink:to="lab_huge_DiscountOnProceedsOfSharesAndWarrantsSold_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DiscountOnProceedsOfSharesAndWarrantsSold_587" xlink:to="lab_huge_DiscountOnProceedsOfSharesAndWarrantsSold_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_DocumentAndEntityInformationAbstract_588" xlink:to="lab_huge_DocumentAndEntityInformationAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_EffectOfSharesIssuedDuringPeriodOnWeightedAverageNumberOfShares_589" xlink:to="lab_huge_EffectOfSharesIssuedDuringPeriodOnWeightedAverageNumberOfShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_EffectOfSharesIssuedDuringPeriodOnWeightedAverageNumberOfShares_590" xlink:to="lab_huge_EffectOfSharesIssuedDuringPeriodOnWeightedAverageNumberOfShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_EffectOfSharesIssuedDuringPeriodOnWeightedAverageNumberOfShares_591" xlink:to="lab_huge_EffectOfSharesIssuedDuringPeriodOnWeightedAverageNumberOfShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_EffectsOfForeignExchangeOnLeaseLiabilities_592" xlink:to="lab_huge_EffectsOfForeignExchangeOnLeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_EffectsOfForeignExchangeOnLeaseLiabilities_593" xlink:to="lab_huge_EffectsOfForeignExchangeOnLeaseLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_EffectsOfForeignExchangeOnLeaseLiabilities_594" xlink:to="lab_huge_EffectsOfForeignExchangeOnLeaseLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_EmployeeRelatedLiability_595" xlink:to="lab_huge_EmployeeRelatedLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_EmployeeRelatedLiability_596" xlink:to="lab_huge_EmployeeRelatedLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_EpitechLicenseAgreementMember_597" xlink:to="lab_huge_EpitechLicenseAgreementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_EpitechLicenseAgreementMember_598" xlink:to="lab_huge_EpitechLicenseAgreementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_EpitechLicenseAgreementMember_599" xlink:to="lab_huge_EpitechLicenseAgreementMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_EquityDistributionAgreementMember_600" xlink:to="lab_huge_EquityDistributionAgreementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_EquityDistributionAgreementMember_601" xlink:to="lab_huge_EquityDistributionAgreementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_EquityDistributionAgreementMember_602" xlink:to="lab_huge_EquityDistributionAgreementMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_EstimatedCostOfRestorationInCommitment_603" xlink:to="lab_huge_EstimatedCostOfRestorationInCommitment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_EstimatedCostOfRestorationInCommitment_604" xlink:to="lab_huge_EstimatedCostOfRestorationInCommitment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceEighteenPointZeroNineMember_605" xlink:to="lab_huge_ExercisePriceEighteenPointZeroNineMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceEighteenPointZeroNineMember_606" xlink:to="lab_huge_ExercisePriceEighteenPointZeroNineMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceEighteenPointZeroNineMember_607" xlink:to="lab_huge_ExercisePriceEighteenPointZeroNineMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceEightyEightPointFortyFourMember_608" xlink:to="lab_huge_ExercisePriceEightyEightPointFortyFourMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceEightyEightPointFortyFourMember_609" xlink:to="lab_huge_ExercisePriceEightyEightPointFortyFourMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceEightyEightPointFortyFourMember_610" xlink:to="lab_huge_ExercisePriceEightyEightPointFortyFourMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceEightySixPointFortyThreeMember_611" xlink:to="lab_huge_ExercisePriceEightySixPointFortyThreeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceEightySixPointFortyThreeMember_612" xlink:to="lab_huge_ExercisePriceEightySixPointFortyThreeMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceEightySixPointFortyThreeMember_613" xlink:to="lab_huge_ExercisePriceEightySixPointFortyThreeMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFiftyFivePointTwentyEightMember_614" xlink:to="lab_huge_ExercisePriceFiftyFivePointTwentyEightMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFiftyFivePointTwentyEightMember_615" xlink:to="lab_huge_ExercisePriceFiftyFivePointTwentyEightMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFiftyFivePointTwentyEightMember_616" xlink:to="lab_huge_ExercisePriceFiftyFivePointTwentyEightMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFiftyNinePointThirtyMember_617" xlink:to="lab_huge_ExercisePriceFiftyNinePointThirtyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFiftyNinePointThirtyMember_618" xlink:to="lab_huge_ExercisePriceFiftyNinePointThirtyMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFiftyNinePointThirtyMember_619" xlink:to="lab_huge_ExercisePriceFiftyNinePointThirtyMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFiftyPointTwentyFiveMember_620" xlink:to="lab_huge_ExercisePriceFiftyPointTwentyFiveMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFiftyPointTwentyFiveMember_621" xlink:to="lab_huge_ExercisePriceFiftyPointTwentyFiveMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFiftyPointTwentyFiveMember_622" xlink:to="lab_huge_ExercisePriceFiftyPointTwentyFiveMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFiftySixPointTwentyEightMember_623" xlink:to="lab_huge_ExercisePriceFiftySixPointTwentyEightMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFiftySixPointTwentyEightMember_624" xlink:to="lab_huge_ExercisePriceFiftySixPointTwentyEightMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFiftySixPointTwentyEightMember_625" xlink:to="lab_huge_ExercisePriceFiftySixPointTwentyEightMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFiftyTwoPointTwentySixMember_626" xlink:to="lab_huge_ExercisePriceFiftyTwoPointTwentySixMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFiftyTwoPointTwentySixMember_627" xlink:to="lab_huge_ExercisePriceFiftyTwoPointTwentySixMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFiftyTwoPointTwentySixMember_628" xlink:to="lab_huge_ExercisePriceFiftyTwoPointTwentySixMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFivePointFourThreeMember_629" xlink:to="lab_huge_ExercisePriceFivePointFourThreeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFivePointFourThreeMember_630" xlink:to="lab_huge_ExercisePriceFivePointFourThreeMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFivePointFourThreeMember_631" xlink:to="lab_huge_ExercisePriceFivePointFourThreeMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFivePointZeroThreeMember_632" xlink:to="lab_huge_ExercisePriceFivePointZeroThreeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFivePointZeroThreeMember_633" xlink:to="lab_huge_ExercisePriceFivePointZeroThreeMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFivePointZeroThreeMember_634" xlink:to="lab_huge_ExercisePriceFivePointZeroThreeMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFortyFourPointTwentyTwoMember_635" xlink:to="lab_huge_ExercisePriceFortyFourPointTwentyTwoMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFortyFourPointTwentyTwoMember_636" xlink:to="lab_huge_ExercisePriceFortyFourPointTwentyTwoMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFortyFourPointTwentyTwoMember_637" xlink:to="lab_huge_ExercisePriceFortyFourPointTwentyTwoMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFortyPointTwentyMember_638" xlink:to="lab_huge_ExercisePriceFortyPointTwentyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFortyPointTwentyMember_639" xlink:to="lab_huge_ExercisePriceFortyPointTwentyMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFortyPointTwentyMember_640" xlink:to="lab_huge_ExercisePriceFortyPointTwentyMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFortySevenPointTwentyFourMember_641" xlink:to="lab_huge_ExercisePriceFortySevenPointTwentyFourMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFortySevenPointTwentyFourMember_642" xlink:to="lab_huge_ExercisePriceFortySevenPointTwentyFourMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFortySevenPointTwentyFourMember_643" xlink:to="lab_huge_ExercisePriceFortySevenPointTwentyFourMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFourPointFourTwoMember_644" xlink:to="lab_huge_ExercisePriceFourPointFourTwoMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFourPointFourTwoMember_645" xlink:to="lab_huge_ExercisePriceFourPointFourTwoMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFourPointFourTwoMember_646" xlink:to="lab_huge_ExercisePriceFourPointFourTwoMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFourPointSevenFiveMember_647" xlink:to="lab_huge_ExercisePriceFourPointSevenFiveMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFourPointSevenFiveMember_648" xlink:to="lab_huge_ExercisePriceFourPointSevenFiveMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceFourPointSevenFiveMember_649" xlink:to="lab_huge_ExercisePriceFourPointSevenFiveMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceNinePointFiveFourMember_650" xlink:to="lab_huge_ExercisePriceNinePointFiveFourMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceNinePointFiveFourMember_651" xlink:to="lab_huge_ExercisePriceNinePointFiveFourMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceNinePointFiveFourMember_652" xlink:to="lab_huge_ExercisePriceNinePointFiveFourMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceOfExercisableShareOptions_653" xlink:to="lab_huge_ExercisePriceOfExercisableShareOptions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceOfExercisableShareOptions_654" xlink:to="lab_huge_ExercisePriceOfExercisableShareOptions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceOfWarrantIssue_655" xlink:to="lab_huge_ExercisePriceOfWarrantIssue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceOfWarrantIssue_656" xlink:to="lab_huge_ExercisePriceOfWarrantIssue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceOfWarrantIssue_657" xlink:to="lab_huge_ExercisePriceOfWarrantIssue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceOfWarrants_658" xlink:to="lab_huge_ExercisePriceOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceOfWarrants_659" xlink:to="lab_huge_ExercisePriceOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceOfWarrantsGranted_660" xlink:to="lab_huge_ExercisePriceOfWarrantsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceOfWarrantsGranted_661" xlink:to="lab_huge_ExercisePriceOfWarrantsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceOfWarrantsGranted_662" xlink:to="lab_huge_ExercisePriceOfWarrantsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceOfWarrantsLiability_663" xlink:to="lab_huge_ExercisePriceOfWarrantsLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceOfWarrantsLiability_664" xlink:to="lab_huge_ExercisePriceOfWarrantsLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceOneHundredFortyEightPointSeventyFourMember_665" xlink:to="lab_huge_ExercisePriceOneHundredFortyEightPointSeventyFourMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceOneHundredFortyEightPointSeventyFourMember_666" xlink:to="lab_huge_ExercisePriceOneHundredFortyEightPointSeventyFourMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceOneHundredFortyEightPointSeventyFourMember_667" xlink:to="lab_huge_ExercisePriceOneHundredFortyEightPointSeventyFourMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember_668" xlink:to="lab_huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember_669" xlink:to="lab_huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember_670" xlink:to="lab_huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceOneHundredTwentyPointSixtyMember_671" xlink:to="lab_huge_ExercisePriceOneHundredTwentyPointSixtyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceOneHundredTwentyPointSixtyMember_672" xlink:to="lab_huge_ExercisePriceOneHundredTwentyPointSixtyMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceOneHundredTwentyPointSixtyMember_673" xlink:to="lab_huge_ExercisePriceOneHundredTwentyPointSixtyMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSevenPointFiftyMember_674" xlink:to="lab_huge_ExercisePriceSevenPointFiftyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSevenPointFiftyMember_675" xlink:to="lab_huge_ExercisePriceSevenPointFiftyMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSevenPointFiftyMember_676" xlink:to="lab_huge_ExercisePriceSevenPointFiftyMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSevenPointSeventeenMember_677" xlink:to="lab_huge_ExercisePriceSevenPointSeventeenMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSevenPointSeventeenMember_678" xlink:to="lab_huge_ExercisePriceSevenPointSeventeenMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSevenPointSeventeenMember_679" xlink:to="lab_huge_ExercisePriceSevenPointSeventeenMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSevenPointSixtyThreeMember_680" xlink:to="lab_huge_ExercisePriceSevenPointSixtyThreeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSevenPointSixtyThreeMember_681" xlink:to="lab_huge_ExercisePriceSevenPointSixtyThreeMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSevenPointSixtyThreeMember_682" xlink:to="lab_huge_ExercisePriceSevenPointSixtyThreeMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSevenPointZeroZeroMember_683" xlink:to="lab_huge_ExercisePriceSevenPointZeroZeroMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSevenPointZeroZeroMember_684" xlink:to="lab_huge_ExercisePriceSevenPointZeroZeroMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSevenPointZeroZeroMember_685" xlink:to="lab_huge_ExercisePriceSevenPointZeroZeroMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSeventeenPointEightNineMember_686" xlink:to="lab_huge_ExercisePriceSeventeenPointEightNineMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSeventeenPointEightNineMember_687" xlink:to="lab_huge_ExercisePriceSeventeenPointEightNineMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSeventeenPointEightNineMember_688" xlink:to="lab_huge_ExercisePriceSeventeenPointEightNineMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSeventyFivePointThirtyEightMember_689" xlink:to="lab_huge_ExercisePriceSeventyFivePointThirtyEightMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSeventyFivePointThirtyEightMember_690" xlink:to="lab_huge_ExercisePriceSeventyFivePointThirtyEightMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSeventyFivePointThirtyEightMember_691" xlink:to="lab_huge_ExercisePriceSeventyFivePointThirtyEightMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSeventyOnePointZeroSevenMember_692" xlink:to="lab_huge_ExercisePriceSeventyOnePointZeroSevenMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSeventyOnePointZeroSevenMember_693" xlink:to="lab_huge_ExercisePriceSeventyOnePointZeroSevenMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSeventyOnePointZeroSevenMember_694" xlink:to="lab_huge_ExercisePriceSeventyOnePointZeroSevenMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSixPointSixteenMember_695" xlink:to="lab_huge_ExercisePriceSixPointSixteenMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSixPointSixteenMember_696" xlink:to="lab_huge_ExercisePriceSixPointSixteenMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSixPointSixteenMember_697" xlink:to="lab_huge_ExercisePriceSixPointSixteenMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSixteenPointZeroEightMember_698" xlink:to="lab_huge_ExercisePriceSixteenPointZeroEightMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSixteenPointZeroEightMember_699" xlink:to="lab_huge_ExercisePriceSixteenPointZeroEightMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSixteenPointZeroEightMember_700" xlink:to="lab_huge_ExercisePriceSixteenPointZeroEightMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSixtyEightPointZeroOneMember_701" xlink:to="lab_huge_ExercisePriceSixtyEightPointZeroOneMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSixtyEightPointZeroOneMember_702" xlink:to="lab_huge_ExercisePriceSixtyEightPointZeroOneMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceSixtyEightPointZeroOneMember_703" xlink:to="lab_huge_ExercisePriceSixtyEightPointZeroOneMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTenPointSixFiveMember_704" xlink:to="lab_huge_ExercisePriceTenPointSixFiveMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTenPointSixFiveMember_705" xlink:to="lab_huge_ExercisePriceTenPointSixFiveMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTenPointSixFiveMember_706" xlink:to="lab_huge_ExercisePriceTenPointSixFiveMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceThirteenPointFourSevenMember_707" xlink:to="lab_huge_ExercisePriceThirteenPointFourSevenMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceThirteenPointFourSevenMember_708" xlink:to="lab_huge_ExercisePriceThirteenPointFourSevenMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceThirteenPointFourSevenMember_709" xlink:to="lab_huge_ExercisePriceThirteenPointFourSevenMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceThirteenPointZeroSevenMember_710" xlink:to="lab_huge_ExercisePriceThirteenPointZeroSevenMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceThirteenPointZeroSevenMember_711" xlink:to="lab_huge_ExercisePriceThirteenPointZeroSevenMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceThirteenPointZeroSevenMember_712" xlink:to="lab_huge_ExercisePriceThirteenPointZeroSevenMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceThreePointEightSixMember_713" xlink:to="lab_huge_ExercisePriceThreePointEightSixMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceThreePointEightSixMember_714" xlink:to="lab_huge_ExercisePriceThreePointEightSixMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceThreePointEightSixMember_715" xlink:to="lab_huge_ExercisePriceThreePointEightSixMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceThreePointSevenFiveMember_716" xlink:to="lab_huge_ExercisePriceThreePointSevenFiveMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceThreePointSevenFiveMember_717" xlink:to="lab_huge_ExercisePriceThreePointSevenFiveMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceThreePointSevenFiveMember_718" xlink:to="lab_huge_ExercisePriceThreePointSevenFiveMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTwentyFourPointTwelveMember_719" xlink:to="lab_huge_ExercisePriceTwentyFourPointTwelveMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTwentyFourPointTwelveMember_720" xlink:to="lab_huge_ExercisePriceTwentyFourPointTwelveMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTwentyFourPointTwelveMember_721" xlink:to="lab_huge_ExercisePriceTwentyFourPointTwelveMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTwentyOnePointElevenMember_722" xlink:to="lab_huge_ExercisePriceTwentyOnePointElevenMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTwentyOnePointElevenMember_723" xlink:to="lab_huge_ExercisePriceTwentyOnePointElevenMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTwentyOnePointElevenMember_724" xlink:to="lab_huge_ExercisePriceTwentyOnePointElevenMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTwentyOnePointNinetyOneMember_725" xlink:to="lab_huge_ExercisePriceTwentyOnePointNinetyOneMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTwentyOnePointNinetyOneMember_726" xlink:to="lab_huge_ExercisePriceTwentyOnePointNinetyOneMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTwentyOnePointNinetyOneMember_727" xlink:to="lab_huge_ExercisePriceTwentyOnePointNinetyOneMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTwentyOnePointTwentyTwoMember_728" xlink:to="lab_huge_ExercisePriceTwentyOnePointTwentyTwoMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTwentyOnePointTwentyTwoMember_729" xlink:to="lab_huge_ExercisePriceTwentyOnePointTwentyTwoMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTwentyOnePointTwentyTwoMember_730" xlink:to="lab_huge_ExercisePriceTwentyOnePointTwentyTwoMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTwentyPointOneZeroMember_731" xlink:to="lab_huge_ExercisePriceTwentyPointOneZeroMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTwentyPointOneZeroMember_732" xlink:to="lab_huge_ExercisePriceTwentyPointOneZeroMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTwentyPointOneZeroMember_733" xlink:to="lab_huge_ExercisePriceTwentyPointOneZeroMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTwentySixPointThirteenMember_734" xlink:to="lab_huge_ExercisePriceTwentySixPointThirteenMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTwentySixPointThirteenMember_735" xlink:to="lab_huge_ExercisePriceTwentySixPointThirteenMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTwentySixPointThirteenMember_736" xlink:to="lab_huge_ExercisePriceTwentySixPointThirteenMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTwoPointSixOneMember_737" xlink:to="lab_huge_ExercisePriceTwoPointSixOneMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTwoPointSixOneMember_738" xlink:to="lab_huge_ExercisePriceTwoPointSixOneMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExercisePriceTwoPointSixOneMember_739" xlink:to="lab_huge_ExercisePriceTwoPointSixOneMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedDividendAsPercentageWarrantsGranted_740" xlink:to="lab_huge_ExpectedDividendAsPercentageWarrantsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedDividendAsPercentageWarrantsGranted_741" xlink:to="lab_huge_ExpectedDividendAsPercentageWarrantsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedDividendAsPercentageWarrantsGranted_742" xlink:to="lab_huge_ExpectedDividendAsPercentageWarrantsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedDividendAsPercentageWarrantsGranted_743" xlink:to="lab_huge_ExpectedDividendAsPercentageWarrantsGranted_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedDividendYieldOfWarrants_744" xlink:to="lab_huge_ExpectedDividendYieldOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedDividendYieldOfWarrants_745" xlink:to="lab_huge_ExpectedDividendYieldOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedDividendYieldOfWarrants_746" xlink:to="lab_huge_ExpectedDividendYieldOfWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedDividendYieldOfWarrantsGranted_747" xlink:to="lab_huge_ExpectedDividendYieldOfWarrantsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedDividendYieldOfWarrantsGranted_748" xlink:to="lab_huge_ExpectedDividendYieldOfWarrantsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedDividendYieldOfWarrantsGranted_749" xlink:to="lab_huge_ExpectedDividendYieldOfWarrantsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedGrowthCycle_750" xlink:to="lab_huge_ExpectedGrowthCycle_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedGrowthCycle_751" xlink:to="lab_huge_ExpectedGrowthCycle_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedGrowthCycle_752" xlink:to="lab_huge_ExpectedGrowthCycle_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedGrowthCycleCompleted_753" xlink:to="lab_huge_ExpectedGrowthCycleCompleted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedGrowthCycleCompleted_754" xlink:to="lab_huge_ExpectedGrowthCycleCompleted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedGrowthCycleCompleted_755" xlink:to="lab_huge_ExpectedGrowthCycleCompleted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedLifeOfWarrants_756" xlink:to="lab_huge_ExpectedLifeOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedLifeOfWarrants_757" xlink:to="lab_huge_ExpectedLifeOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedLifeOfWarrants_758" xlink:to="lab_huge_ExpectedLifeOfWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedNetSellingPricePerGramOfDriedFlower_759" xlink:to="lab_huge_ExpectedNetSellingPricePerGramOfDriedFlower_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedNetSellingPricePerGramOfDriedFlower_760" xlink:to="lab_huge_ExpectedNetSellingPricePerGramOfDriedFlower_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedNetSellingPricePerGramOfTrim_761" xlink:to="lab_huge_ExpectedNetSellingPricePerGramOfTrim_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedNetSellingPricePerGramOfTrim_762" xlink:to="lab_huge_ExpectedNetSellingPricePerGramOfTrim_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedNetSellingPricePerGramOfTrim_763" xlink:to="lab_huge_ExpectedNetSellingPricePerGramOfTrim_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedSellingPricePerGramOfDriedFlower_764" xlink:to="lab_huge_ExpectedSellingPricePerGramOfDriedFlower_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedSellingPricePerGramOfDriedFlower_765" xlink:to="lab_huge_ExpectedSellingPricePerGramOfDriedFlower_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedSellingPricePerGramOfTrim_766" xlink:to="lab_huge_ExpectedSellingPricePerGramOfTrim_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedSellingPricePerGramOfTrim_767" xlink:to="lab_huge_ExpectedSellingPricePerGramOfTrim_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedSellingPricePerGramOfTrim_768" xlink:to="lab_huge_ExpectedSellingPricePerGramOfTrim_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedTermOfWarrants_769" xlink:to="lab_huge_ExpectedTermOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedTermOfWarrants_770" xlink:to="lab_huge_ExpectedTermOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedTermOfWarrants_771" xlink:to="lab_huge_ExpectedTermOfWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedVolatilityOfWarrants_772" xlink:to="lab_huge_ExpectedVolatilityOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedVolatilityOfWarrants_773" xlink:to="lab_huge_ExpectedVolatilityOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedVolatilityOfWarrants_774" xlink:to="lab_huge_ExpectedVolatilityOfWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedVolatilityOfWarrants_775" xlink:to="lab_huge_ExpectedVolatilityOfWarrants_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedVolatilityOfWarrantsGranted_776" xlink:to="lab_huge_ExpectedVolatilityOfWarrantsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedVolatilityOfWarrantsGranted_777" xlink:to="lab_huge_ExpectedVolatilityOfWarrantsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedVolatilityOfWarrantsGranted_778" xlink:to="lab_huge_ExpectedVolatilityOfWarrantsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedVolatilityOfWarrantsLiability_779" xlink:to="lab_huge_ExpectedVolatilityOfWarrantsLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedVolatilityOfWarrantsLiability_780" xlink:to="lab_huge_ExpectedVolatilityOfWarrantsLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedYieldForCannabisPlantsOfDryFlowerPerPlant_781" xlink:to="lab_huge_ExpectedYieldForCannabisPlantsOfDryFlowerPerPlant_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedYieldForCannabisPlantsOfDryFlowerPerPlant_782" xlink:to="lab_huge_ExpectedYieldForCannabisPlantsOfDryFlowerPerPlant_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedYieldForCannabisPlantsOfDryFlowerPerPlant_783" xlink:to="lab_huge_ExpectedYieldForCannabisPlantsOfDryFlowerPerPlant_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedYieldForCannabisPlantsOfDryTrimPerPlant_784" xlink:to="lab_huge_ExpectedYieldForCannabisPlantsOfDryTrimPerPlant_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedYieldForCannabisPlantsOfDryTrimPerPlant_785" xlink:to="lab_huge_ExpectedYieldForCannabisPlantsOfDryTrimPerPlant_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedYieldForCannabisPlantsOfDryTrimPerPlant_786" xlink:to="lab_huge_ExpectedYieldForCannabisPlantsOfDryTrimPerPlant_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedYieldOfDryFlower_787" xlink:to="lab_huge_ExpectedYieldOfDryFlower_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedYieldOfDryFlower_788" xlink:to="lab_huge_ExpectedYieldOfDryFlower_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedYieldOfDryFlower_789" xlink:to="lab_huge_ExpectedYieldOfDryFlower_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedYieldOfDryTrim_790" xlink:to="lab_huge_ExpectedYieldOfDryTrim_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedYieldOfDryTrim_791" xlink:to="lab_huge_ExpectedYieldOfDryTrim_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpectedYieldOfDryTrim_792" xlink:to="lab_huge_ExpectedYieldOfDryTrim_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpiryDateOfWarrants_793" xlink:to="lab_huge_ExpiryDateOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpiryDateOfWarrants_794" xlink:to="lab_huge_ExpiryDateOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpiryDateOfWarrants_795" xlink:to="lab_huge_ExpiryDateOfWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpiryTermOfWarrantsGranted_796" xlink:to="lab_huge_ExpiryTermOfWarrantsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpiryTermOfWarrantsGranted_797" xlink:to="lab_huge_ExpiryTermOfWarrantsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ExpiryTermOfWarrantsGranted_798" xlink:to="lab_huge_ExpiryTermOfWarrantsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FacilityRelatedExpenditures_799" xlink:to="lab_huge_FacilityRelatedExpenditures_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FacilityRelatedExpenditures_800" xlink:to="lab_huge_FacilityRelatedExpenditures_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FacilityRelatedExpenditures_801" xlink:to="lab_huge_FacilityRelatedExpenditures_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FacilityUnderDevelopmentMember_802" xlink:to="lab_huge_FacilityUnderDevelopmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FacilityUnderDevelopmentMember_803" xlink:to="lab_huge_FacilityUnderDevelopmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FacilityUnderDevelopmentMember_804" xlink:to="lab_huge_FacilityUnderDevelopmentMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueAdjustmentsOnInventorySold_805" xlink:to="lab_huge_FairValueAdjustmentsOnInventorySold_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueAdjustmentsOnInventorySold_806" xlink:to="lab_huge_FairValueAdjustmentsOnInventorySold_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueAdjustmentsOnInventorySold_807" xlink:to="lab_huge_FairValueAdjustmentsOnInventorySold_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueAdjustmentsOnInventorySold_808" xlink:to="lab_huge_FairValueAdjustmentsOnInventorySold_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfCommonSharesApprovedForIssuance_809" xlink:to="lab_huge_FairValueOfCommonSharesApprovedForIssuance_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfCommonSharesApprovedForIssuance_810" xlink:to="lab_huge_FairValueOfCommonSharesApprovedForIssuance_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfCommonSharesApprovedForIssuance_811" xlink:to="lab_huge_FairValueOfCommonSharesApprovedForIssuance_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfCommonSharesIssued_812" xlink:to="lab_huge_FairValueOfCommonSharesIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfCommonSharesIssued_813" xlink:to="lab_huge_FairValueOfCommonSharesIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfCommonSharesOfResidualValue_814" xlink:to="lab_huge_FairValueOfCommonSharesOfResidualValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfCommonSharesOfResidualValue_815" xlink:to="lab_huge_FairValueOfCommonSharesOfResidualValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfCommonSharesOfResidualValue_816" xlink:to="lab_huge_FairValueOfCommonSharesOfResidualValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfCommonStockOfNotesPayable_817" xlink:to="lab_huge_FairValueOfCommonStockOfNotesPayable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfCommonStockOfNotesPayable_818" xlink:to="lab_huge_FairValueOfCommonStockOfNotesPayable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfCommonStockOfNotesPayable_819" xlink:to="lab_huge_FairValueOfCommonStockOfNotesPayable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfCommonStockToSettleNotesPayable_820" xlink:to="lab_huge_FairValueOfCommonStockToSettleNotesPayable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfCommonStockToSettleNotesPayable_821" xlink:to="lab_huge_FairValueOfCommonStockToSettleNotesPayable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfCommonStockToSettleNotesPayable_822" xlink:to="lab_huge_FairValueOfCommonStockToSettleNotesPayable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfIssuanceOfCommonStockSharesApproved_823" xlink:to="lab_huge_FairValueOfIssuanceOfCommonStockSharesApproved_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfIssuanceOfCommonStockSharesApproved_824" xlink:to="lab_huge_FairValueOfIssuanceOfCommonStockSharesApproved_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfIssuanceOfCommonStockSharesApproved_825" xlink:to="lab_huge_FairValueOfIssuanceOfCommonStockSharesApproved_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfShareBasedCompensationBonus_826" xlink:to="lab_huge_FairValueOfShareBasedCompensationBonus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfShareBasedCompensationBonus_827" xlink:to="lab_huge_FairValueOfShareBasedCompensationBonus_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfShareBasedCompensationBonus_828" xlink:to="lab_huge_FairValueOfShareBasedCompensationBonus_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfShares_829" xlink:to="lab_huge_FairValueOfShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfShares_830" xlink:to="lab_huge_FairValueOfShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfShares_831" xlink:to="lab_huge_FairValueOfShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfSharesAndWarrantsAcquired_832" xlink:to="lab_huge_FairValueOfSharesAndWarrantsAcquired_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfSharesAndWarrantsAcquired_833" xlink:to="lab_huge_FairValueOfSharesAndWarrantsAcquired_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfSharesAndWarrantsAcquired_834" xlink:to="lab_huge_FairValueOfSharesAndWarrantsAcquired_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfWarrantLiability_835" xlink:to="lab_huge_FairValueOfWarrantLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfWarrantLiability_836" xlink:to="lab_huge_FairValueOfWarrantLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfWarrantLiability_837" xlink:to="lab_huge_FairValueOfWarrantLiability_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfWarrantLiabilityOfResidualAmount_838" xlink:to="lab_huge_FairValueOfWarrantLiabilityOfResidualAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfWarrantLiabilityOfResidualAmount_839" xlink:to="lab_huge_FairValueOfWarrantLiabilityOfResidualAmount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfWarrantLiabilityOfResidualAmount_840" xlink:to="lab_huge_FairValueOfWarrantLiabilityOfResidualAmount_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfWarrants_841" xlink:to="lab_huge_FairValueOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfWarrants_842" xlink:to="lab_huge_FairValueOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfWarrants_843" xlink:to="lab_huge_FairValueOfWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfWarrants_844" xlink:to="lab_huge_FairValueOfWarrants_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfWarrantsIssued_845" xlink:to="lab_huge_FairValueOfWarrantsIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfWarrantsIssued_846" xlink:to="lab_huge_FairValueOfWarrantsIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FairValueOfWarrantsIssued_847" xlink:to="lab_huge_FairValueOfWarrantsIssued_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Feb252018Member_848" xlink:to="lab_huge_Feb252018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Feb252018Member_849" xlink:to="lab_huge_Feb252018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Feb252018Member_850" xlink:to="lab_huge_Feb252018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FindersFee_851" xlink:to="lab_huge_FindersFee_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FindersFee_852" xlink:to="lab_huge_FindersFee_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FindersFee_853" xlink:to="lab_huge_FindersFee_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FindersFeeShares_854" xlink:to="lab_huge_FindersFeeShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FindersFeeShares_855" xlink:to="lab_huge_FindersFeeShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FirstRepublicCapitalCorporationMember_856" xlink:to="lab_huge_FirstRepublicCapitalCorporationMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FirstRepublicCapitalCorporationMember_857" xlink:to="lab_huge_FirstRepublicCapitalCorporationMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FirstRepublicCapitalCorporationMember_858" xlink:to="lab_huge_FirstRepublicCapitalCorporationMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FormerChiefExecutiveOfficerMember_859" xlink:to="lab_huge_FormerChiefExecutiveOfficerMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FormerChiefExecutiveOfficerMember_860" xlink:to="lab_huge_FormerChiefExecutiveOfficerMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FormerChiefExecutiveOfficerMember_861" xlink:to="lab_huge_FormerChiefExecutiveOfficerMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FormerChiefOperatingOfficerMember_862" xlink:to="lab_huge_FormerChiefOperatingOfficerMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FormerChiefOperatingOfficerMember_863" xlink:to="lab_huge_FormerChiefOperatingOfficerMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FormerChiefOperatingOfficerMember_864" xlink:to="lab_huge_FormerChiefOperatingOfficerMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FSDBiosciencesMember_865" xlink:to="lab_huge_FSDBiosciencesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FSDBiosciencesMember_866" xlink:to="lab_huge_FSDBiosciencesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FSDBiosciencesMember_867" xlink:to="lab_huge_FSDBiosciencesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FundsPaidForSettlementAgreement_868" xlink:to="lab_huge_FundsPaidForSettlementAgreement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FundsPaidForSettlementAgreement_869" xlink:to="lab_huge_FundsPaidForSettlementAgreement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FundsPaidForSettlementAgreement_870" xlink:to="lab_huge_FundsPaidForSettlementAgreement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FurnitureFixturesAndEquipmentMember_871" xlink:to="lab_huge_FurnitureFixturesAndEquipmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FurnitureFixturesAndEquipmentMember_872" xlink:to="lab_huge_FurnitureFixturesAndEquipmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FurnitureFixturesAndEquipmentMember_873" xlink:to="lab_huge_FurnitureFixturesAndEquipmentMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FvPharmaIncMember_874" xlink:to="lab_huge_FvPharmaIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FvPharmaIncMember_875" xlink:to="lab_huge_FvPharmaIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_FvPharmaIncMember_876" xlink:to="lab_huge_FvPharmaIncMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GainLossOnChangeInFairValueOfDerivativeLiability_877" xlink:to="lab_huge_GainLossOnChangeInFairValueOfDerivativeLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GainLossOnChangeInFairValueOfDerivativeLiability_878" xlink:to="lab_huge_GainLossOnChangeInFairValueOfDerivativeLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GainLossOnSaleOfEquipment_879" xlink:to="lab_huge_GainLossOnSaleOfEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GainLossOnSaleOfEquipment_880" xlink:to="lab_huge_GainLossOnSaleOfEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GainLossOnSaleOfEquipment_881" xlink:to="lab_huge_GainLossOnSaleOfEquipment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GainLossOnSettlementOfFinancialLiability_882" xlink:to="lab_huge_GainLossOnSettlementOfFinancialLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GainLossOnSettlementOfFinancialLiability_883" xlink:to="lab_huge_GainLossOnSettlementOfFinancialLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GainLossOnSettlementOfFinancialLiability_884" xlink:to="lab_huge_GainLossOnSettlementOfFinancialLiability_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GainLossOnSettlementOfFinancialLiability_885" xlink:to="lab_huge_GainLossOnSettlementOfFinancialLiability_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GainLossOnSettlementOfFinancialLiability_886" xlink:to="lab_huge_GainLossOnSettlementOfFinancialLiability_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GainLossOnSettlementOfFinancialLiability_887" xlink:to="lab_huge_GainLossOnSettlementOfFinancialLiability_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GainOnSettlementOfDerivativeLiability_888" xlink:to="lab_huge_GainOnSettlementOfDerivativeLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GainOnSettlementOfDerivativeLiability_889" xlink:to="lab_huge_GainOnSettlementOfDerivativeLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GainOnSettlementOfDerivativeLiability_890" xlink:to="lab_huge_GainOnSettlementOfDerivativeLiability_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GainOnSettlementOfFinancialLiability_891" xlink:to="lab_huge_GainOnSettlementOfFinancialLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GainOnSettlementOfFinancialLiability_892" xlink:to="lab_huge_GainOnSettlementOfFinancialLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GainOnSettlementOfFinancialLiability_893" xlink:to="lab_huge_GainOnSettlementOfFinancialLiability_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GainOnSettlementOfFinancialLiability_894" xlink:to="lab_huge_GainOnSettlementOfFinancialLiability_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GeneralAndAdministrativeExpenseContinuedAndDiscontinuedOperations_895" xlink:to="lab_huge_GeneralAndAdministrativeExpenseContinuedAndDiscontinuedOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GeneralAndAdministrativeExpenseContinuedAndDiscontinuedOperations_896" xlink:to="lab_huge_GeneralAndAdministrativeExpenseContinuedAndDiscontinuedOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GeneralAndAdministrativeExpenseContinuedAndDiscontinuedOperations_897" xlink:to="lab_huge_GeneralAndAdministrativeExpenseContinuedAndDiscontinuedOperations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GeneralAndAdministrativeExpenseDiscontinuedOperations_898" xlink:to="lab_huge_GeneralAndAdministrativeExpenseDiscontinuedOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GeneralAndAdministrativeExpenseDiscontinuedOperations_899" xlink:to="lab_huge_GeneralAndAdministrativeExpenseDiscontinuedOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GeneralAndAdministrativeExpenseDiscontinuedOperations_900" xlink:to="lab_huge_GeneralAndAdministrativeExpenseDiscontinuedOperations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GeneralOfficeInsuranceAndAdministrationExpenditures_901" xlink:to="lab_huge_GeneralOfficeInsuranceAndAdministrationExpenditures_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GeneralOfficeInsuranceAndAdministrationExpenditures_902" xlink:to="lab_huge_GeneralOfficeInsuranceAndAdministrationExpenditures_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GeneralOfficeInsuranceAndAdministrationExpenditures_903" xlink:to="lab_huge_GeneralOfficeInsuranceAndAdministrationExpenditures_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GrantDateAxis_904" xlink:to="lab_huge_GrantDateAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GrantDateAxis_905" xlink:to="lab_huge_GrantDateAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GrantDateDomain_906" xlink:to="lab_huge_GrantDateDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GrantDateDomain_907" xlink:to="lab_huge_GrantDateDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GrossGeneralAndAdministrativeExpense_908" xlink:to="lab_huge_GrossGeneralAndAdministrativeExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GrossGeneralAndAdministrativeExpense_909" xlink:to="lab_huge_GrossGeneralAndAdministrativeExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GrossGeneralAndAdministrativeExpense_910" xlink:to="lab_huge_GrossGeneralAndAdministrativeExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GrossLossProfitBeforeFairValueAdjustments_911" xlink:to="lab_huge_GrossLossProfitBeforeFairValueAdjustments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GrossLossProfitBeforeFairValueAdjustments_912" xlink:to="lab_huge_GrossLossProfitBeforeFairValueAdjustments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GrossLossProfitBeforeFairValueAdjustments_913" xlink:to="lab_huge_GrossLossProfitBeforeFairValueAdjustments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GrossProfitLossBeforeFairValueAdjustments_914" xlink:to="lab_huge_GrossProfitLossBeforeFairValueAdjustments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GrossProfitLossBeforeFairValueAdjustments_915" xlink:to="lab_huge_GrossProfitLossBeforeFairValueAdjustments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GrossProfitLossBeforeFairValueAdjustments_916" xlink:to="lab_huge_GrossProfitLossBeforeFairValueAdjustments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GuaranteedMinimumLiquidationValueOfShares_917" xlink:to="lab_huge_GuaranteedMinimumLiquidationValueOfShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_GuaranteedMinimumLiquidationValueOfShares_918" xlink:to="lab_huge_GuaranteedMinimumLiquidationValueOfShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_HarvestedCannabisMember_919" xlink:to="lab_huge_HarvestedCannabisMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_HarvestedCannabisMember_920" xlink:to="lab_huge_HarvestedCannabisMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_HarvestedCannabisMember_921" xlink:to="lab_huge_HarvestedCannabisMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_HempProductsMember_922" xlink:to="lab_huge_HempProductsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_HempProductsMember_923" xlink:to="lab_huge_HempProductsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_HempProductsMember_924" xlink:to="lab_huge_HempProductsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_HeritageBuildingRestorationCommitmentMember_925" xlink:to="lab_huge_HeritageBuildingRestorationCommitmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_HeritageBuildingRestorationCommitmentMember_926" xlink:to="lab_huge_HeritageBuildingRestorationCommitmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_HeritageBuildingRestorationCommitmentMember_927" xlink:to="lab_huge_HeritageBuildingRestorationCommitmentMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_HighTideIncMember_928" xlink:to="lab_huge_HighTideIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_HighTideIncMember_929" xlink:to="lab_huge_HighTideIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_HighTideIncMember_930" xlink:to="lab_huge_HighTideIncMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_HugeShopsMember_931" xlink:to="lab_huge_HugeShopsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_HugeShopsMember_932" xlink:to="lab_huge_HugeShopsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_HugeShopsMember_933" xlink:to="lab_huge_HugeShopsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ImpactOfPresentValue_934" xlink:to="lab_huge_ImpactOfPresentValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ImpactOfPresentValue_935" xlink:to="lab_huge_ImpactOfPresentValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ImpactOfPresentValue_936" xlink:to="lab_huge_ImpactOfPresentValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ImpactOfPresentValueOnLeaseObligations_937" xlink:to="lab_huge_ImpactOfPresentValueOnLeaseObligations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ImpactOfPresentValueOnLeaseObligations_938" xlink:to="lab_huge_ImpactOfPresentValueOnLeaseObligations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ImpactOfPresentValueOnLeaseObligations_939" xlink:to="lab_huge_ImpactOfPresentValueOnLeaseObligations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ImpairmentLossOfPropertyPlantAndEquipmentAndRightOfUseAsset_940" xlink:to="lab_huge_ImpairmentLossOfPropertyPlantAndEquipmentAndRightOfUseAsset_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ImpairmentLossOfPropertyPlantAndEquipmentAndRightOfUseAsset_941" xlink:to="lab_huge_ImpairmentLossOfPropertyPlantAndEquipmentAndRightOfUseAsset_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ImpairmentLossOfPropertyPlantAndEquipmentAndRightOfUseAsset_942" xlink:to="lab_huge_ImpairmentLossOfPropertyPlantAndEquipmentAndRightOfUseAsset_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ImpairmentLossOnRightOfUseAsset_943" xlink:to="lab_huge_ImpairmentLossOnRightOfUseAsset_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ImpairmentLossOnRightOfUseAsset_944" xlink:to="lab_huge_ImpairmentLossOnRightOfUseAsset_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ImpairmentLossOnRightOfUseAsset_945" xlink:to="lab_huge_ImpairmentLossOnRightOfUseAsset_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ImpairmentLossOnRightOfUseAsset_946" xlink:to="lab_huge_ImpairmentLossOnRightOfUseAsset_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ImpairmentLossOnRightOfUseAsset_947" xlink:to="lab_huge_ImpairmentLossOnRightOfUseAsset_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ImpairmentLossRecognisedInRightOfUseAsset_948" xlink:to="lab_huge_ImpairmentLossRecognisedInRightOfUseAsset_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ImpairmentLossRecognisedInRightOfUseAsset_949" xlink:to="lab_huge_ImpairmentLossRecognisedInRightOfUseAsset_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ImpairmentLossRecognisedInRightOfUseAsset_950" xlink:to="lab_huge_ImpairmentLossRecognisedInRightOfUseAsset_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ImpairmentLossRecognisedInRightOfUseAsset_951" xlink:to="lab_huge_ImpairmentLossRecognisedInRightOfUseAsset_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ImpairmentMember_952" xlink:to="lab_huge_ImpairmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ImpairmentMember_953" xlink:to="lab_huge_ImpairmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ImpairmentMember_954" xlink:to="lab_huge_ImpairmentMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember_955" xlink:to="lab_huge_IncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember_956" xlink:to="lab_huge_IncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember_957" xlink:to="lab_huge_IncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseFromContributedSurplusToShareCapital_958" xlink:to="lab_huge_IncreaseDecreaseFromContributedSurplusToShareCapital_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseFromContributedSurplusToShareCapital_959" xlink:to="lab_huge_IncreaseDecreaseFromContributedSurplusToShareCapital_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseFromContributedSurplusToShareCapital_960" xlink:to="lab_huge_IncreaseDecreaseFromContributedSurplusToShareCapital_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseInFairValueOfOtherInvestments_961" xlink:to="lab_huge_IncreaseDecreaseInFairValueOfOtherInvestments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseInFairValueOfOtherInvestments_962" xlink:to="lab_huge_IncreaseDecreaseInFairValueOfOtherInvestments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseInFairValueOfOtherInvestments_963" xlink:to="lab_huge_IncreaseDecreaseInFairValueOfOtherInvestments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseInFairValueOfOtherInvestments_964" xlink:to="lab_huge_IncreaseDecreaseInFairValueOfOtherInvestments_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseInSettlementOfLiabilityOfNotesPayable_965" xlink:to="lab_huge_IncreaseDecreaseInSettlementOfLiabilityOfNotesPayable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseInSettlementOfLiabilityOfNotesPayable_966" xlink:to="lab_huge_IncreaseDecreaseInSettlementOfLiabilityOfNotesPayable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseInSettlementOfLiabilityOfNotesPayable_967" xlink:to="lab_huge_IncreaseDecreaseInSettlementOfLiabilityOfNotesPayable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_968" xlink:to="lab_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_969" xlink:to="lab_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_970" xlink:to="lab_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue_971" xlink:to="lab_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue_972" xlink:to="lab_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue_973" xlink:to="lab_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughExerciseOfOptionShares_974" xlink:to="lab_huge_IncreaseDecreaseThroughExerciseOfOptionShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughExerciseOfOptionShares_975" xlink:to="lab_huge_IncreaseDecreaseThroughExerciseOfOptionShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughExerciseOfOptionShares_976" xlink:to="lab_huge_IncreaseDecreaseThroughExerciseOfOptionShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughExerciseOfOptionShares_977" xlink:to="lab_huge_IncreaseDecreaseThroughExerciseOfOptionShares_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares_978" xlink:to="lab_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares_979" xlink:to="lab_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares_980" xlink:to="lab_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares_981" xlink:to="lab_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares_982" xlink:to="lab_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares_983" xlink:to="lab_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue_984" xlink:to="lab_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue_985" xlink:to="lab_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue_986" xlink:to="lab_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset_987" xlink:to="lab_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset_988" xlink:to="lab_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset_989" xlink:to="lab_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares_990" xlink:to="lab_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares_991" xlink:to="lab_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares_992" xlink:to="lab_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughReverseAcquisition_993" xlink:to="lab_huge_IncreaseDecreaseThroughReverseAcquisition_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughReverseAcquisition_994" xlink:to="lab_huge_IncreaseDecreaseThroughReverseAcquisition_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughReverseAcquisition_995" xlink:to="lab_huge_IncreaseDecreaseThroughReverseAcquisition_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughReverseAcquisitionShares_996" xlink:to="lab_huge_IncreaseDecreaseThroughReverseAcquisitionShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughReverseAcquisitionShares_997" xlink:to="lab_huge_IncreaseDecreaseThroughReverseAcquisitionShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughReverseAcquisitionShares_998" xlink:to="lab_huge_IncreaseDecreaseThroughReverseAcquisitionShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughReverseAcquisitionShares_999" xlink:to="lab_huge_IncreaseDecreaseThroughReverseAcquisitionShares_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares_1000" xlink:to="lab_huge_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares_1001" xlink:to="lab_huge_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares_1002" xlink:to="lab_huge_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughShareIssueRelatedCostShares_1003" xlink:to="lab_huge_IncreaseDecreaseThroughShareIssueRelatedCostShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughShareIssueRelatedCostShares_1004" xlink:to="lab_huge_IncreaseDecreaseThroughShareIssueRelatedCostShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughShareIssueRelatedCostShares_1005" xlink:to="lab_huge_IncreaseDecreaseThroughShareIssueRelatedCostShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughShareIssueRelatedCostShares_1006" xlink:to="lab_huge_IncreaseDecreaseThroughShareIssueRelatedCostShares_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughStockOptionsCancelled_1007" xlink:to="lab_huge_IncreaseDecreaseThroughStockOptionsCancelled_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughStockOptionsCancelled_1008" xlink:to="lab_huge_IncreaseDecreaseThroughStockOptionsCancelled_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughStockOptionsCancelled_1009" xlink:to="lab_huge_IncreaseDecreaseThroughStockOptionsCancelled_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughStockOptionsCancelled_1010" xlink:to="lab_huge_IncreaseDecreaseThroughStockOptionsCancelled_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughWarrantValuations_1011" xlink:to="lab_huge_IncreaseDecreaseThroughWarrantValuations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughWarrantValuations_1012" xlink:to="lab_huge_IncreaseDecreaseThroughWarrantValuations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughWarrantValuations_1013" xlink:to="lab_huge_IncreaseDecreaseThroughWarrantValuations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughWarrantValuationsShares_1014" xlink:to="lab_huge_IncreaseDecreaseThroughWarrantValuationsShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughWarrantValuationsShares_1015" xlink:to="lab_huge_IncreaseDecreaseThroughWarrantValuationsShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughWarrantValuationsShares_1016" xlink:to="lab_huge_IncreaseDecreaseThroughWarrantValuationsShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncreaseDecreaseThroughWarrantValuationsShares_1017" xlink:to="lab_huge_IncreaseDecreaseThroughWarrantValuationsShares_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncrementalBorrowingRateToDiscountLeaseLiabilities_1018" xlink:to="lab_huge_IncrementalBorrowingRateToDiscountLeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncrementalBorrowingRateToDiscountLeaseLiabilities_1019" xlink:to="lab_huge_IncrementalBorrowingRateToDiscountLeaseLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IncrementalBorrowingRateToDiscountLeaseLiabilities_1020" xlink:to="lab_huge_IncrementalBorrowingRateToDiscountLeaseLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IndependentDirectorMember_1021" xlink:to="lab_huge_IndependentDirectorMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IndependentDirectorMember_1022" xlink:to="lab_huge_IndependentDirectorMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IndependentDirectorMember_1023" xlink:to="lab_huge_IndependentDirectorMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IndependentDirectorMember_1024" xlink:to="lab_huge_IndependentDirectorMember_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_InsuredAmountForClaimSettlemnt_1025" xlink:to="lab_huge_InsuredAmountForClaimSettlemnt_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_InsuredAmountForClaimSettlemnt_1026" xlink:to="lab_huge_InsuredAmountForClaimSettlemnt_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_InsuredAmountForClaimSettlemnt_1027" xlink:to="lab_huge_InsuredAmountForClaimSettlemnt_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_InvestorRelationsExpenses_1028" xlink:to="lab_huge_InvestorRelationsExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_InvestorRelationsExpenses_1029" xlink:to="lab_huge_InvestorRelationsExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_InvestorRelationsExpenses_1030" xlink:to="lab_huge_InvestorRelationsExpenses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IssuanceCostOfCommonSharesAndWarrants_1031" xlink:to="lab_huge_IssuanceCostOfCommonSharesAndWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IssuanceCostOfCommonSharesAndWarrants_1032" xlink:to="lab_huge_IssuanceCostOfCommonSharesAndWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IssuanceCostOfCommonSharesAndWarrants_1033" xlink:to="lab_huge_IssuanceCostOfCommonSharesAndWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IssuanceOfCommonSharesOfShareBasedBonusToEmployeesForPerformance_1034" xlink:to="lab_huge_IssuanceOfCommonSharesOfShareBasedBonusToEmployeesForPerformance_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IssuanceOfCommonSharesOfShareBasedBonusToEmployeesForPerformance_1035" xlink:to="lab_huge_IssuanceOfCommonSharesOfShareBasedBonusToEmployeesForPerformance_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IssuanceOfCommonSharesOfShareBasedBonusToEmployeesForPerformance_1036" xlink:to="lab_huge_IssuanceOfCommonSharesOfShareBasedBonusToEmployeesForPerformance_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IssuanceOfCommonStockForNotesPayable_1037" xlink:to="lab_huge_IssuanceOfCommonStockForNotesPayable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IssuanceOfCommonStockForNotesPayable_1038" xlink:to="lab_huge_IssuanceOfCommonStockForNotesPayable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IssuanceOfCommonStockForNotesPayable_1039" xlink:to="lab_huge_IssuanceOfCommonStockForNotesPayable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IssuanceOfCommonStockOfBoardOfDirectorsInLieuOfCash_1040" xlink:to="lab_huge_IssuanceOfCommonStockOfBoardOfDirectorsInLieuOfCash_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IssuanceOfCommonStockOfBoardOfDirectorsInLieuOfCash_1041" xlink:to="lab_huge_IssuanceOfCommonStockOfBoardOfDirectorsInLieuOfCash_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IssuanceOfCommonStockOfBoardOfDirectorsInLieuOfCash_1042" xlink:to="lab_huge_IssuanceOfCommonStockOfBoardOfDirectorsInLieuOfCash_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IssuanceOfCommonStockOfDirectOffering_1043" xlink:to="lab_huge_IssuanceOfCommonStockOfDirectOffering_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IssuanceOfCommonStockOfDirectOffering_1044" xlink:to="lab_huge_IssuanceOfCommonStockOfDirectOffering_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IssuanceOfCommonStockOfDirectOffering_1045" xlink:to="lab_huge_IssuanceOfCommonStockOfDirectOffering_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IssuanceOfCommonStockOfShareBasedCompensation_1046" xlink:to="lab_huge_IssuanceOfCommonStockOfShareBasedCompensation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IssuanceOfCommonStockOfShareBasedCompensation_1047" xlink:to="lab_huge_IssuanceOfCommonStockOfShareBasedCompensation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IssuanceOfCommonStockOfShareBasedCompensation_1048" xlink:to="lab_huge_IssuanceOfCommonStockOfShareBasedCompensation_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IssuanceOfShares_1049" xlink:to="lab_huge_IssuanceOfShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IssuanceOfShares_1050" xlink:to="lab_huge_IssuanceOfShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IssuanceOfShares_1051" xlink:to="lab_huge_IssuanceOfShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IssuanceOfShares_1052" xlink:to="lab_huge_IssuanceOfShares_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IssuanceOfWarrantsOfDirectOffering_1053" xlink:to="lab_huge_IssuanceOfWarrantsOfDirectOffering_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IssuanceOfWarrantsOfDirectOffering_1054" xlink:to="lab_huge_IssuanceOfWarrantsOfDirectOffering_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_IssuanceOfWarrantsOfDirectOffering_1055" xlink:to="lab_huge_IssuanceOfWarrantsOfDirectOffering_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Jan52018Member_1056" xlink:to="lab_huge_Jan52018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Jan52018Member_1057" xlink:to="lab_huge_Jan52018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Jan52018Member_1058" xlink:to="lab_huge_Jan52018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Jan52018WarrantMember_1059" xlink:to="lab_huge_Jan52018WarrantMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Jan52018WarrantMember_1060" xlink:to="lab_huge_Jan52018WarrantMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Jan52018WarrantMember_1061" xlink:to="lab_huge_Jan52018WarrantMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Jun112018Member_1062" xlink:to="lab_huge_Jun112018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Jun112018Member_1063" xlink:to="lab_huge_Jun112018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Jun112018Member_1064" xlink:to="lab_huge_Jun112018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Jun122018Member_1065" xlink:to="lab_huge_Jun122018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Jun122018Member_1066" xlink:to="lab_huge_Jun122018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Jun122018Member_1067" xlink:to="lab_huge_Jun122018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_KeyManagementAndDirectorsMember_1068" xlink:to="lab_huge_KeyManagementAndDirectorsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_KeyManagementAndDirectorsMember_1069" xlink:to="lab_huge_KeyManagementAndDirectorsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_KeyManagementAndDirectorsMember_1070" xlink:to="lab_huge_KeyManagementAndDirectorsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_KeyManagementPersonnelCarAllowance_1071" xlink:to="lab_huge_KeyManagementPersonnelCarAllowance_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_KeyManagementPersonnelCarAllowance_1072" xlink:to="lab_huge_KeyManagementPersonnelCarAllowance_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_KeyManagementPersonnelCarAllowance_1073" xlink:to="lab_huge_KeyManagementPersonnelCarAllowance_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_LeaseTermOnOfficeSpace_1074" xlink:to="lab_huge_LeaseTermOnOfficeSpace_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_LeaseTermOnOfficeSpace_1075" xlink:to="lab_huge_LeaseTermOnOfficeSpace_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_LeaseTermOnOfficeSpace_1076" xlink:to="lab_huge_LeaseTermOnOfficeSpace_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_LegalEntitiesAxis_1077" xlink:to="lab_huge_LegalEntitiesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_LegalEntitiesAxis_1078" xlink:to="lab_huge_LegalEntitiesAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_LegalEntitiesDomain_1079" xlink:to="lab_huge_LegalEntitiesDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_LegalEntitiesDomain_1080" xlink:to="lab_huge_LegalEntitiesDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_LegalProvision_1081" xlink:to="lab_huge_LegalProvision_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_LegalProvision_1082" xlink:to="lab_huge_LegalProvision_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_LegalProvision_1083" xlink:to="lab_huge_LegalProvision_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ListingExpense_1084" xlink:to="lab_huge_ListingExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ListingExpense_1085" xlink:to="lab_huge_ListingExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ListingExpense_1086" xlink:to="lab_huge_ListingExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_LossGainOnChangesInFairValueOfOtherInvestments_1087" xlink:to="lab_huge_LossGainOnChangesInFairValueOfOtherInvestments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_LossGainOnChangesInFairValueOfOtherInvestments_1088" xlink:to="lab_huge_LossGainOnChangesInFairValueOfOtherInvestments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_LossGainOnChangesInFairValueOfOtherInvestments_1089" xlink:to="lab_huge_LossGainOnChangesInFairValueOfOtherInvestments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_LossGainOnChangesInFairValueOfOtherInvestments_1090" xlink:to="lab_huge_LossGainOnChangesInFairValueOfOtherInvestments_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_LossOnSaleOfEquipment_1091" xlink:to="lab_huge_LossOnSaleOfEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_LossOnSaleOfEquipment_1092" xlink:to="lab_huge_LossOnSaleOfEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_LossOnSaleOfEquipment_1093" xlink:to="lab_huge_LossOnSaleOfEquipment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_LossOnSaleOfInventory_1094" xlink:to="lab_huge_LossOnSaleOfInventory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_LossOnSaleOfInventory_1095" xlink:to="lab_huge_LossOnSaleOfInventory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_LossOnSaleOfInventory_1096" xlink:to="lab_huge_LossOnSaleOfInventory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ManagementAndConsultingContractsMember_1097" xlink:to="lab_huge_ManagementAndConsultingContractsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ManagementAndConsultingContractsMember_1098" xlink:to="lab_huge_ManagementAndConsultingContractsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ManagementAndConsultingContractsMember_1099" xlink:to="lab_huge_ManagementAndConsultingContractsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ManagementFees_1100" xlink:to="lab_huge_ManagementFees_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ManagementFees_1101" xlink:to="lab_huge_ManagementFees_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ManagementFees_1102" xlink:to="lab_huge_ManagementFees_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Mar222018Member_1103" xlink:to="lab_huge_Mar222018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Mar222018Member_1104" xlink:to="lab_huge_Mar222018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Mar222018Member_1105" xlink:to="lab_huge_Mar222018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Mar282018Member_1106" xlink:to="lab_huge_Mar282018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Mar282018Member_1107" xlink:to="lab_huge_Mar282018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Mar282018Member_1108" xlink:to="lab_huge_Mar282018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_March262018Member_1109" xlink:to="lab_huge_March262018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_March262018Member_1110" xlink:to="lab_huge_March262018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_March262018Member_1111" xlink:to="lab_huge_March262018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_March282018Member_1112" xlink:to="lab_huge_March282018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_March282018Member_1113" xlink:to="lab_huge_March282018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_March282018Member_1114" xlink:to="lab_huge_March282018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_March92018Member_1115" xlink:to="lab_huge_March92018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_March92018Member_1116" xlink:to="lab_huge_March92018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_March92018Member_1117" xlink:to="lab_huge_March92018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_MarketPriceOfShares_1118" xlink:to="lab_huge_MarketPriceOfShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_MarketPriceOfShares_1119" xlink:to="lab_huge_MarketPriceOfShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_MarketPriceOfShares_1120" xlink:to="lab_huge_MarketPriceOfShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_MarketPriceOfWarrants_1121" xlink:to="lab_huge_MarketPriceOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_MarketPriceOfWarrants_1122" xlink:to="lab_huge_MarketPriceOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_MarketPriceOfWarrants_1123" xlink:to="lab_huge_MarketPriceOfWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_MarketPriceShareOptionsGranted_1124" xlink:to="lab_huge_MarketPriceShareOptionsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_MarketPriceShareOptionsGranted_1125" xlink:to="lab_huge_MarketPriceShareOptionsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_MarketPriceShareOptionsGranted_1126" xlink:to="lab_huge_MarketPriceShareOptionsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_MaximumAggregateOfferingPrice_1127" xlink:to="lab_huge_MaximumAggregateOfferingPrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_MaximumAggregateOfferingPrice_1128" xlink:to="lab_huge_MaximumAggregateOfferingPrice_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_MaximumAggregateOfferingPrice_1129" xlink:to="lab_huge_MaximumAggregateOfferingPrice_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_May242018Member_1130" xlink:to="lab_huge_May242018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_May242018Member_1131" xlink:to="lab_huge_May242018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_May242018Member_1132" xlink:to="lab_huge_May242018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_May242018WarrantMember_1133" xlink:to="lab_huge_May242018WarrantMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_May242018WarrantMember_1134" xlink:to="lab_huge_May242018WarrantMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_May242018WarrantMember_1135" xlink:to="lab_huge_May242018WarrantMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_May82018Member_1136" xlink:to="lab_huge_May82018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_May82018Member_1137" xlink:to="lab_huge_May82018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_May82018Member_1138" xlink:to="lab_huge_May82018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_MealsAndEntertainment_1139" xlink:to="lab_huge_MealsAndEntertainment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_MealsAndEntertainment_1140" xlink:to="lab_huge_MealsAndEntertainment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_MealsAndEntertainment_1141" xlink:to="lab_huge_MealsAndEntertainment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_MinimumInvestmentReceivable_1142" xlink:to="lab_huge_MinimumInvestmentReceivable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_MinimumInvestmentReceivable_1143" xlink:to="lab_huge_MinimumInvestmentReceivable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_MinimumInvestmentReceivable_1144" xlink:to="lab_huge_MinimumInvestmentReceivable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NetOperatingLossCarryforwardsLimitationsInUse_1145" xlink:to="lab_huge_NetOperatingLossCarryforwardsLimitationsInUse_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NetOperatingLossCarryforwardsLimitationsInUse_1146" xlink:to="lab_huge_NetOperatingLossCarryforwardsLimitationsInUse_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NetOperatingLossCarryforwardsLimitationsInUse_1147" xlink:to="lab_huge_NetOperatingLossCarryforwardsLimitationsInUse_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NetSellingPricePerGramForDryFlowerAfterHarvestCost_1148" xlink:to="lab_huge_NetSellingPricePerGramForDryFlowerAfterHarvestCost_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NetSellingPricePerGramForDryFlowerAfterHarvestCost_1149" xlink:to="lab_huge_NetSellingPricePerGramForDryFlowerAfterHarvestCost_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NetSellingPricePerGramForDryFlowerAfterHarvestCost_1150" xlink:to="lab_huge_NetSellingPricePerGramForDryFlowerAfterHarvestCost_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NetSellingPricePerGramForDryTrimAfterHarvestCost_1151" xlink:to="lab_huge_NetSellingPricePerGramForDryTrimAfterHarvestCost_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NetSellingPricePerGramForDryTrimAfterHarvestCost_1152" xlink:to="lab_huge_NetSellingPricePerGramForDryTrimAfterHarvestCost_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NetSellingPricePerGramForDryTrimAfterHarvestCost_1153" xlink:to="lab_huge_NetSellingPricePerGramForDryTrimAfterHarvestCost_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandFourty_1154" xlink:to="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandFourty_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandFourty_1155" xlink:to="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandFourty_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandFourty_1156" xlink:to="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandFourty_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight_1157" xlink:to="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight_1158" xlink:to="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight_1159" xlink:to="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFive_1160" xlink:to="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFive_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFive_1161" xlink:to="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFive_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFive_1162" xlink:to="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFive_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFour_1163" xlink:to="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFour_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFour_1164" xlink:to="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFour_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFour_1165" xlink:to="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFour_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine_1166" xlink:to="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine_1167" xlink:to="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine_1168" xlink:to="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySeven_1169" xlink:to="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySeven_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySeven_1170" xlink:to="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySeven_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySeven_1171" xlink:to="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySeven_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySix_1172" xlink:to="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySix_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySix_1173" xlink:to="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySix_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySix_1174" xlink:to="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySix_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyThree_1175" xlink:to="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyThree_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyThree_1176" xlink:to="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyThree_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyThree_1177" xlink:to="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyThree_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyTwo_1178" xlink:to="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyTwo_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyTwo_1179" xlink:to="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyTwo_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyTwo_1180" xlink:to="lab_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyTwo_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalLossCarryforwards_1181" xlink:to="lab_huge_NonCapitalLossCarryforwards_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalLossCarryforwards_1182" xlink:to="lab_huge_NonCapitalLossCarryforwards_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalLossCarryforwards_1183" xlink:to="lab_huge_NonCapitalLossCarryforwards_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalLossCarryForwardsMember_1184" xlink:to="lab_huge_NonCapitalLossCarryForwardsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalLossCarryForwardsMember_1185" xlink:to="lab_huge_NonCapitalLossCarryForwardsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalLossCarryForwardsMember_1186" xlink:to="lab_huge_NonCapitalLossCarryForwardsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalLossesMember_1187" xlink:to="lab_huge_NonCapitalLossesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalLossesMember_1188" xlink:to="lab_huge_NonCapitalLossesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonCapitalLossesMember_1189" xlink:to="lab_huge_NonCapitalLossesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonRefundableSumDueAndPayableUponFirstNotificationOfFda_1190" xlink:to="lab_huge_NonRefundableSumDueAndPayableUponFirstNotificationOfFda_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonRefundableSumDueAndPayableUponFirstNotificationOfFda_1191" xlink:to="lab_huge_NonRefundableSumDueAndPayableUponFirstNotificationOfFda_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFda_1192" xlink:to="lab_huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFda_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFda_1193" xlink:to="lab_huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFda_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFda_1194" xlink:to="lab_huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFda_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NotesPayableMember_1195" xlink:to="lab_huge_NotesPayableMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NotesPayableMember_1196" xlink:to="lab_huge_NotesPayableMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NotesPayableMember_1197" xlink:to="lab_huge_NotesPayableMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NotesSettledThroughIssuanceOfShares_1198" xlink:to="lab_huge_NotesSettledThroughIssuanceOfShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NotesSettledThroughIssuanceOfShares_1199" xlink:to="lab_huge_NotesSettledThroughIssuanceOfShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NotesSettledThroughIssuanceOfShares_1200" xlink:to="lab_huge_NotesSettledThroughIssuanceOfShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Nov12017Member_1201" xlink:to="lab_huge_Nov12017Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Nov12017Member_1202" xlink:to="lab_huge_Nov12017Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Nov12017Member_1203" xlink:to="lab_huge_Nov12017Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Nov122018Member_1204" xlink:to="lab_huge_Nov122018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Nov122018Member_1205" xlink:to="lab_huge_Nov122018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Nov122018Member_1206" xlink:to="lab_huge_Nov122018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Nov142017Member_1207" xlink:to="lab_huge_Nov142017Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Nov142017Member_1208" xlink:to="lab_huge_Nov142017Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Nov142017Member_1209" xlink:to="lab_huge_Nov142017Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Nov152018Member_1210" xlink:to="lab_huge_Nov152018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Nov152018Member_1211" xlink:to="lab_huge_Nov152018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Nov152018Member_1212" xlink:to="lab_huge_Nov152018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Nov212017Member_1213" xlink:to="lab_huge_Nov212017Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Nov212017Member_1214" xlink:to="lab_huge_Nov212017Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Nov212017Member_1215" xlink:to="lab_huge_Nov212017Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Nov262018Member_1216" xlink:to="lab_huge_Nov262018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Nov262018Member_1217" xlink:to="lab_huge_Nov262018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Nov262018Member_1218" xlink:to="lab_huge_Nov262018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability_1219" xlink:to="lab_huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability_1220" xlink:to="lab_huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability_1221" xlink:to="lab_huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfAgreement_1222" xlink:to="lab_huge_NumberOfAgreement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfAgreement_1223" xlink:to="lab_huge_NumberOfAgreement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfBrokerWarrantsGrantedForFeesAndCommissions_1224" xlink:to="lab_huge_NumberOfBrokerWarrantsGrantedForFeesAndCommissions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfBrokerWarrantsGrantedForFeesAndCommissions_1225" xlink:to="lab_huge_NumberOfBrokerWarrantsGrantedForFeesAndCommissions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfBrokerWarrantsGrantedForFeesAndCommissions_1226" xlink:to="lab_huge_NumberOfBrokerWarrantsGrantedForFeesAndCommissions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfBrokerWarrantsGrantedForFeesAndCommissions_1227" xlink:to="lab_huge_NumberOfBrokerWarrantsGrantedForFeesAndCommissions_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfInvestmentSharesSold_1228" xlink:to="lab_huge_NumberOfInvestmentSharesSold_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfInvestmentSharesSold_1229" xlink:to="lab_huge_NumberOfInvestmentSharesSold_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfInvestmentSharesSold_1230" xlink:to="lab_huge_NumberOfInvestmentSharesSold_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfReplacementShareOptionsIssued_1231" xlink:to="lab_huge_NumberOfReplacementShareOptionsIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfReplacementShareOptionsIssued_1232" xlink:to="lab_huge_NumberOfReplacementShareOptionsIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfReplacementShareOptionsIssued_1233" xlink:to="lab_huge_NumberOfReplacementShareOptionsIssued_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfShareOptionsExercisedOrVestedInShareBasedPaymentArrangement_1234" xlink:to="lab_huge_NumberOfShareOptionsExercisedOrVestedInShareBasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfShareOptionsExercisedOrVestedInShareBasedPaymentArrangement_1235" xlink:to="lab_huge_NumberOfShareOptionsExercisedOrVestedInShareBasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfShareOptionsExercisedOrVestedInShareBasedPaymentArrangement_1236" xlink:to="lab_huge_NumberOfShareOptionsExercisedOrVestedInShareBasedPaymentArrangement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesAcquired_1237" xlink:to="lab_huge_NumberOfSharesAcquired_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesAcquired_1238" xlink:to="lab_huge_NumberOfSharesAcquired_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesAcquired_1239" xlink:to="lab_huge_NumberOfSharesAcquired_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesHeld_1240" xlink:to="lab_huge_NumberOfSharesHeld_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesHeld_1241" xlink:to="lab_huge_NumberOfSharesHeld_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesHeld_1242" xlink:to="lab_huge_NumberOfSharesHeld_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesHeldSubjectToEscrowArrangement_1243" xlink:to="lab_huge_NumberOfSharesHeldSubjectToEscrowArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesHeldSubjectToEscrowArrangement_1244" xlink:to="lab_huge_NumberOfSharesHeldSubjectToEscrowArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesHeldSubjectToEscrowArrangement_1245" xlink:to="lab_huge_NumberOfSharesHeldSubjectToEscrowArrangement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedAsFindersFee_1246" xlink:to="lab_huge_NumberOfSharesIssuedAsFindersFee_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedAsFindersFee_1247" xlink:to="lab_huge_NumberOfSharesIssuedAsFindersFee_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedAsFindersFee_1248" xlink:to="lab_huge_NumberOfSharesIssuedAsFindersFee_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_1249" xlink:to="lab_huge_NumberOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_1250" xlink:to="lab_huge_NumberOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_1251" xlink:to="lab_huge_NumberOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedForCompensationBonus_1252" xlink:to="lab_huge_NumberOfSharesIssuedForCompensationBonus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedForCompensationBonus_1253" xlink:to="lab_huge_NumberOfSharesIssuedForCompensationBonus_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedForCompensationBonus_1254" xlink:to="lab_huge_NumberOfSharesIssuedForCompensationBonus_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedForDebtSettlement_1255" xlink:to="lab_huge_NumberOfSharesIssuedForDebtSettlement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedForDebtSettlement_1256" xlink:to="lab_huge_NumberOfSharesIssuedForDebtSettlement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedForDebtSettlement_1257" xlink:to="lab_huge_NumberOfSharesIssuedForDebtSettlement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement_1258" xlink:to="lab_huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement_1259" xlink:to="lab_huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement_1260" xlink:to="lab_huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedInPrivatePlacement_1261" xlink:to="lab_huge_NumberOfSharesIssuedInPrivatePlacement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedInPrivatePlacement_1262" xlink:to="lab_huge_NumberOfSharesIssuedInPrivatePlacement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedInPrivatePlacement_1263" xlink:to="lab_huge_NumberOfSharesIssuedInPrivatePlacement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedInPrivatePlacement_1264" xlink:to="lab_huge_NumberOfSharesIssuedInPrivatePlacement_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedInShareExchange_1265" xlink:to="lab_huge_NumberOfSharesIssuedInShareExchange_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedInShareExchange_1266" xlink:to="lab_huge_NumberOfSharesIssuedInShareExchange_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedInShareExchange_1267" xlink:to="lab_huge_NumberOfSharesIssuedInShareExchange_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedThroughEquityDistributionAgreement_1268" xlink:to="lab_huge_NumberOfSharesIssuedThroughEquityDistributionAgreement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedThroughEquityDistributionAgreement_1269" xlink:to="lab_huge_NumberOfSharesIssuedThroughEquityDistributionAgreement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesIssuedThroughEquityDistributionAgreement_1270" xlink:to="lab_huge_NumberOfSharesIssuedThroughEquityDistributionAgreement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesOutstandingSubjectToEscrowConditions_1271" xlink:to="lab_huge_NumberOfSharesOutstandingSubjectToEscrowConditions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesOutstandingSubjectToEscrowConditions_1272" xlink:to="lab_huge_NumberOfSharesOutstandingSubjectToEscrowConditions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesOutstandingSubjectToEscrowConditions_1273" xlink:to="lab_huge_NumberOfSharesOutstandingSubjectToEscrowConditions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesSold_1274" xlink:to="lab_huge_NumberOfSharesSold_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesSold_1275" xlink:to="lab_huge_NumberOfSharesSold_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesSold_1276" xlink:to="lab_huge_NumberOfSharesSold_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesSubscribed_1277" xlink:to="lab_huge_NumberOfSharesSubscribed_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesSubscribed_1278" xlink:to="lab_huge_NumberOfSharesSubscribed_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesSubscribed_1279" xlink:to="lab_huge_NumberOfSharesSubscribed_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesSubscribed_1280" xlink:to="lab_huge_NumberOfSharesSubscribed_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesSubscribed_1281" xlink:to="lab_huge_NumberOfSharesSubscribed_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfSharesSubscribed_1282" xlink:to="lab_huge_NumberOfSharesSubscribed_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfStockOptionsApprovedForIssuance_1283" xlink:to="lab_huge_NumberOfStockOptionsApprovedForIssuance_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfStockOptionsApprovedForIssuance_1284" xlink:to="lab_huge_NumberOfStockOptionsApprovedForIssuance_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfStockOptionsApprovedForIssuance_1285" xlink:to="lab_huge_NumberOfStockOptionsApprovedForIssuance_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsAcquired_1286" xlink:to="lab_huge_NumberOfWarrantsAcquired_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsAcquired_1287" xlink:to="lab_huge_NumberOfWarrantsAcquired_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsExercised_1288" xlink:to="lab_huge_NumberOfWarrantsExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsExercised_1289" xlink:to="lab_huge_NumberOfWarrantsExercised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsExercised_1290" xlink:to="lab_huge_NumberOfWarrantsExercised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsExercised_1291" xlink:to="lab_huge_NumberOfWarrantsExercised_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsExpired_1292" xlink:to="lab_huge_NumberOfWarrantsExpired_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsExpired_1293" xlink:to="lab_huge_NumberOfWarrantsExpired_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsExpired_1294" xlink:to="lab_huge_NumberOfWarrantsExpired_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsExpired_1295" xlink:to="lab_huge_NumberOfWarrantsExpired_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsHeld_1296" xlink:to="lab_huge_NumberOfWarrantsHeld_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsHeld_1297" xlink:to="lab_huge_NumberOfWarrantsHeld_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsHeld_1298" xlink:to="lab_huge_NumberOfWarrantsHeld_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsIssued_1299" xlink:to="lab_huge_NumberOfWarrantsIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsIssued_1300" xlink:to="lab_huge_NumberOfWarrantsIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsIssued_1301" xlink:to="lab_huge_NumberOfWarrantsIssued_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsIssued_1302" xlink:to="lab_huge_NumberOfWarrantsIssued_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsOutstanding_1303" xlink:to="lab_huge_NumberOfWarrantsOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsOutstanding_1304" xlink:to="lab_huge_NumberOfWarrantsOutstanding_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsOutstanding_1305" xlink:to="lab_huge_NumberOfWarrantsOutstanding_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsOutstanding_1306" xlink:to="lab_huge_NumberOfWarrantsOutstanding_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_NumberOfWarrantsOutstanding_1307" xlink:to="lab_huge_NumberOfWarrantsOutstanding_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Oct202017Member_1308" xlink:to="lab_huge_Oct202017Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Oct202017Member_1309" xlink:to="lab_huge_Oct202017Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Oct202017Member_1310" xlink:to="lab_huge_Oct202017Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OfficeAndGeneralExpenses_1311" xlink:to="lab_huge_OfficeAndGeneralExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OfficeAndGeneralExpenses_1312" xlink:to="lab_huge_OfficeAndGeneralExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OfficeAndGeneralExpenses_1313" xlink:to="lab_huge_OfficeAndGeneralExpenses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OfficeLeaseAgreementMember_1314" xlink:to="lab_huge_OfficeLeaseAgreementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OfficeLeaseAgreementMember_1315" xlink:to="lab_huge_OfficeLeaseAgreementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OfficeLeaseAgreementMember_1316" xlink:to="lab_huge_OfficeLeaseAgreementMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OperatingExpensesAbstract_1317" xlink:to="lab_huge_OperatingExpensesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OperatingExpensesAbstract_1318" xlink:to="lab_huge_OperatingExpensesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OperatingLeaseImpactOfPresentValue_1319" xlink:to="lab_huge_OperatingLeaseImpactOfPresentValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OperatingLeaseImpactOfPresentValue_1320" xlink:to="lab_huge_OperatingLeaseImpactOfPresentValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OperatingLeaseImpactOfPresentValue_1321" xlink:to="lab_huge_OperatingLeaseImpactOfPresentValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OperatingLeaseImpactOfPresentValue_1322" xlink:to="lab_huge_OperatingLeaseImpactOfPresentValue_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OtherAllowances_1323" xlink:to="lab_huge_OtherAllowances_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OtherAllowances_1324" xlink:to="lab_huge_OtherAllowances_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OtherFinancialLiabilitiesMember_1325" xlink:to="lab_huge_OtherFinancialLiabilitiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OtherFinancialLiabilitiesMember_1326" xlink:to="lab_huge_OtherFinancialLiabilitiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OtherFinancialLiabilitiesMember_1327" xlink:to="lab_huge_OtherFinancialLiabilitiesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OtherGeneralAndAdministrativeExpenses_1328" xlink:to="lab_huge_OtherGeneralAndAdministrativeExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OtherGeneralAndAdministrativeExpenses_1329" xlink:to="lab_huge_OtherGeneralAndAdministrativeExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OtherGeneralAndAdministrativeExpenses_1330" xlink:to="lab_huge_OtherGeneralAndAdministrativeExpenses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OtherInventoryMember_1331" xlink:to="lab_huge_OtherInventoryMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OtherInventoryMember_1332" xlink:to="lab_huge_OtherInventoryMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OtherInventoryMember_1333" xlink:to="lab_huge_OtherInventoryMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OtherInvestmentMember_1334" xlink:to="lab_huge_OtherInvestmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OtherInvestmentMember_1335" xlink:to="lab_huge_OtherInvestmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OtherInvestmentMember_1336" xlink:to="lab_huge_OtherInvestmentMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OtherInvestmentsNameOfEntityAxis_1337" xlink:to="lab_huge_OtherInvestmentsNameOfEntityAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OtherInvestmentsNameOfEntityAxis_1338" xlink:to="lab_huge_OtherInvestmentsNameOfEntityAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_1339" xlink:to="lab_huge_OtherInvestmentsNameOfEntityDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_1340" xlink:to="lab_huge_OtherInvestmentsNameOfEntityDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OutstandingCommitmentToPurchaseAdditionalProduct_1341" xlink:to="lab_huge_OutstandingCommitmentToPurchaseAdditionalProduct_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_OutstandingCommitmentToPurchaseAdditionalProduct_1342" xlink:to="lab_huge_OutstandingCommitmentToPurchaseAdditionalProduct_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PartialPaymentOfSettlementAmount_1343" xlink:to="lab_huge_PartialPaymentOfSettlementAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PartialPaymentOfSettlementAmount_1344" xlink:to="lab_huge_PartialPaymentOfSettlementAmount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PartialPaymentOfSettlementAmount_1345" xlink:to="lab_huge_PartialPaymentOfSettlementAmount_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PatentMaintenanceFee_1346" xlink:to="lab_huge_PatentMaintenanceFee_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PatentMaintenanceFee_1347" xlink:to="lab_huge_PatentMaintenanceFee_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PatentMaintenanceFee_1348" xlink:to="lab_huge_PatentMaintenanceFee_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PaymentMadeToBeUnpaidWagesAndUnpaidHoliday_1349" xlink:to="lab_huge_PaymentMadeToBeUnpaidWagesAndUnpaidHoliday_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PaymentMadeToBeUnpaidWagesAndUnpaidHoliday_1350" xlink:to="lab_huge_PaymentMadeToBeUnpaidWagesAndUnpaidHoliday_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PaymentMadeToBeUnpaidWagesAndUnpaidHoliday_1351" xlink:to="lab_huge_PaymentMadeToBeUnpaidWagesAndUnpaidHoliday_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PaymentOfExpenses_1352" xlink:to="lab_huge_PaymentOfExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PaymentOfExpenses_1353" xlink:to="lab_huge_PaymentOfExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PaymentOfOperatingLease_1354" xlink:to="lab_huge_PaymentOfOperatingLease_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PaymentOfOperatingLease_1355" xlink:to="lab_huge_PaymentOfOperatingLease_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PaymentOfOperatingLease_1356" xlink:to="lab_huge_PaymentOfOperatingLease_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PaymentOfOperatingLease_1357" xlink:to="lab_huge_PaymentOfOperatingLease_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PaymentOfOperatingLease_1358" xlink:to="lab_huge_PaymentOfOperatingLease_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PaymentOfOperatingLease_1359" xlink:to="lab_huge_PaymentOfOperatingLease_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PercentageOfAggregateDiscountForSharesInEscrow_1360" xlink:to="lab_huge_PercentageOfAggregateDiscountForSharesInEscrow_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PercentageOfAggregateDiscountForSharesInEscrow_1361" xlink:to="lab_huge_PercentageOfAggregateDiscountForSharesInEscrow_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PercentageOfAggregateDiscountForSharesInEscrow_1362" xlink:to="lab_huge_PercentageOfAggregateDiscountForSharesInEscrow_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PercentageOfDeclineInFairValueOfInvestment_1363" xlink:to="lab_huge_PercentageOfDeclineInFairValueOfInvestment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PercentageOfDeclineInFairValueOfInvestment_1364" xlink:to="lab_huge_PercentageOfDeclineInFairValueOfInvestment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PercentageOfDeclineInFairValueOfInvestment_1365" xlink:to="lab_huge_PercentageOfDeclineInFairValueOfInvestment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PercentageOfDiscountForTotalProceedsOfSharesAndWarrantsSold_1366" xlink:to="lab_huge_PercentageOfDiscountForTotalProceedsOfSharesAndWarrantsSold_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PercentageOfDiscountForTotalProceedsOfSharesAndWarrantsSold_1367" xlink:to="lab_huge_PercentageOfDiscountForTotalProceedsOfSharesAndWarrantsSold_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights_1368" xlink:to="lab_huge_PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights_1369" xlink:to="lab_huge_PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition_1370" xlink:to="lab_huge_PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition_1371" xlink:to="lab_huge_PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition_1372" xlink:to="lab_huge_PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition_1373" xlink:to="lab_huge_PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition_1374" xlink:to="lab_huge_PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition_1375" xlink:to="lab_huge_PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights_1376" xlink:to="lab_huge_PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights_1377" xlink:to="lab_huge_PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PermanentDifferences_1378" xlink:to="lab_huge_PermanentDifferences_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PermanentDifferences_1379" xlink:to="lab_huge_PermanentDifferences_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PermanentDifferences_1380" xlink:to="lab_huge_PermanentDifferences_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PharmadrugIncMember_1381" xlink:to="lab_huge_PharmadrugIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PharmadrugIncMember_1382" xlink:to="lab_huge_PharmadrugIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PharmadrugIncMember_1383" xlink:to="lab_huge_PharmadrugIncMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PharmadrugProductionGMBHMember_1384" xlink:to="lab_huge_PharmadrugProductionGMBHMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PharmadrugProductionGMBHMember_1385" xlink:to="lab_huge_PharmadrugProductionGMBHMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PharmadrugProductionGMBHMember_1386" xlink:to="lab_huge_PharmadrugProductionGMBHMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PharmastripCorpMember_1387" xlink:to="lab_huge_PharmastripCorpMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PharmastripCorpMember_1388" xlink:to="lab_huge_PharmastripCorpMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PharmastripCorpMember_1389" xlink:to="lab_huge_PharmastripCorpMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PreacquisitionNetOperatingLossCarryforwards_1390" xlink:to="lab_huge_PreacquisitionNetOperatingLossCarryforwards_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PreacquisitionNetOperatingLossCarryforwards_1391" xlink:to="lab_huge_PreacquisitionNetOperatingLossCarryforwards_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PreacquisitionNetOperatingLossCarryforwards_1392" xlink:to="lab_huge_PreacquisitionNetOperatingLossCarryforwards_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PresidentAndChiefExecutiveOfficerMember_1393" xlink:to="lab_huge_PresidentAndChiefExecutiveOfficerMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PresidentAndChiefExecutiveOfficerMember_1394" xlink:to="lab_huge_PresidentAndChiefExecutiveOfficerMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PresidentAndChiefExecutiveOfficerMember_1395" xlink:to="lab_huge_PresidentAndChiefExecutiveOfficerMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PresidentAndDirectorMember_1396" xlink:to="lab_huge_PresidentAndDirectorMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PresidentAndDirectorMember_1397" xlink:to="lab_huge_PresidentAndDirectorMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PresidentAndDirectorMember_1398" xlink:to="lab_huge_PresidentAndDirectorMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PresidentOfFsdBiosciencesMember_1399" xlink:to="lab_huge_PresidentOfFsdBiosciencesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PresidentOfFsdBiosciencesMember_1400" xlink:to="lab_huge_PresidentOfFsdBiosciencesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PresidentOfFsdBiosciencesMember_1401" xlink:to="lab_huge_PresidentOfFsdBiosciencesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PresidentOfFSDMember_1402" xlink:to="lab_huge_PresidentOfFSDMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PresidentOfFSDMember_1403" xlink:to="lab_huge_PresidentOfFSDMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PresidentOfFSDMember_1404" xlink:to="lab_huge_PresidentOfFSDMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PresidentOfFVPharmaMember_1405" xlink:to="lab_huge_PresidentOfFVPharmaMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PresidentOfFVPharmaMember_1406" xlink:to="lab_huge_PresidentOfFVPharmaMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PresidentOfFVPharmaMember_1407" xlink:to="lab_huge_PresidentOfFVPharmaMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PresidentsMember_1408" xlink:to="lab_huge_PresidentsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PresidentsMember_1409" xlink:to="lab_huge_PresidentsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PrincipalAmountOfBorrowings_1410" xlink:to="lab_huge_PrincipalAmountOfBorrowings_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PrincipalAmountOfBorrowings_1411" xlink:to="lab_huge_PrincipalAmountOfBorrowings_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PrincipalAmountOfBorrowings_1412" xlink:to="lab_huge_PrincipalAmountOfBorrowings_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PrismicPharmaceuticalMember_1413" xlink:to="lab_huge_PrismicPharmaceuticalMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PrismicPharmaceuticalMember_1414" xlink:to="lab_huge_PrismicPharmaceuticalMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PrismicPharmaceuticalMember_1415" xlink:to="lab_huge_PrismicPharmaceuticalMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PrismicPharmaceuticalsIncMember_1416" xlink:to="lab_huge_PrismicPharmaceuticalsIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PrismicPharmaceuticalsIncMember_1417" xlink:to="lab_huge_PrismicPharmaceuticalsIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PrismicPharmaceuticalsIncMember_1418" xlink:to="lab_huge_PrismicPharmaceuticalsIncMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProceedsFromExerciseOfWarrants_1419" xlink:to="lab_huge_ProceedsFromExerciseOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProceedsFromExerciseOfWarrants_1420" xlink:to="lab_huge_ProceedsFromExerciseOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProceedsFromExerciseOfWarrants_1421" xlink:to="lab_huge_ProceedsFromExerciseOfWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProceedsFromNotesPayable_1422" xlink:to="lab_huge_ProceedsFromNotesPayable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProceedsFromNotesPayable_1423" xlink:to="lab_huge_ProceedsFromNotesPayable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProceedsFromSaleOfSharesAndWarrants_1424" xlink:to="lab_huge_ProceedsFromSaleOfSharesAndWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProceedsFromSaleOfSharesAndWarrants_1425" xlink:to="lab_huge_ProceedsFromSaleOfSharesAndWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProceedsFromSalesOfInventory_1426" xlink:to="lab_huge_ProceedsFromSalesOfInventory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProceedsFromSalesOfInventory_1427" xlink:to="lab_huge_ProceedsFromSalesOfInventory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProceedsFromSalesOfInventory_1428" xlink:to="lab_huge_ProceedsFromSalesOfInventory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProductionAndGrowingExpense_1429" xlink:to="lab_huge_ProductionAndGrowingExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProductionAndGrowingExpense_1430" xlink:to="lab_huge_ProductionAndGrowingExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProductionAndGrowingExpense_1431" xlink:to="lab_huge_ProductionAndGrowingExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProductionAndGrowingExpenses_1432" xlink:to="lab_huge_ProductionAndGrowingExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProductionAndGrowingExpenses_1433" xlink:to="lab_huge_ProductionAndGrowingExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProductionAndGrowingExpenses_1434" xlink:to="lab_huge_ProductionAndGrowingExpenses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProductionEquipmentMember_1435" xlink:to="lab_huge_ProductionEquipmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProductionEquipmentMember_1436" xlink:to="lab_huge_ProductionEquipmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProductionEquipmentMember_1437" xlink:to="lab_huge_ProductionEquipmentMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProductionEquipmentMember_1438" xlink:to="lab_huge_ProductionEquipmentMember_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProfitLossBeforeOtherIncomeAndGainLossOnSaleOfEquipmentFromDiscontinuedOperations_1439" xlink:to="lab_huge_ProfitLossBeforeOtherIncomeAndGainLossOnSaleOfEquipmentFromDiscontinuedOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProfitLossBeforeOtherIncomeAndGainLossOnSaleOfEquipmentFromDiscontinuedOperations_1440" xlink:to="lab_huge_ProfitLossBeforeOtherIncomeAndGainLossOnSaleOfEquipmentFromDiscontinuedOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProfitLossBeforeOtherIncomeAndGainLossOnSaleOfEquipmentFromDiscontinuedOperations_1441" xlink:to="lab_huge_ProfitLossBeforeOtherIncomeAndGainLossOnSaleOfEquipmentFromDiscontinuedOperations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProfitLossOnChangeInFairValue_1442" xlink:to="lab_huge_ProfitLossOnChangeInFairValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProfitLossOnChangeInFairValue_1443" xlink:to="lab_huge_ProfitLossOnChangeInFairValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProfitLossOnChangeInFairValue_1444" xlink:to="lab_huge_ProfitLossOnChangeInFairValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PropertyPlantAndEquipmentAssetsHeldForSale_1445" xlink:to="lab_huge_PropertyPlantAndEquipmentAssetsHeldForSale_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PropertyPlantAndEquipmentAssetsHeldForSale_1446" xlink:to="lab_huge_PropertyPlantAndEquipmentAssetsHeldForSale_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PropertyPlantAndEquipmentAssetsHeldForSale_1447" xlink:to="lab_huge_PropertyPlantAndEquipmentAssetsHeldForSale_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PropertyPlantAndEquipmentsMember_1448" xlink:to="lab_huge_PropertyPlantAndEquipmentsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PropertyPlantAndEquipmentsMember_1449" xlink:to="lab_huge_PropertyPlantAndEquipmentsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_PropertyPlantAndEquipmentsMember_1450" xlink:to="lab_huge_PropertyPlantAndEquipmentsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProvisionForEmployeeRelatedLiability_1451" xlink:to="lab_huge_ProvisionForEmployeeRelatedLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProvisionForEmployeeRelatedLiability_1452" xlink:to="lab_huge_ProvisionForEmployeeRelatedLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ProvisionForEmployeeRelatedLiability_1453" xlink:to="lab_huge_ProvisionForEmployeeRelatedLiability_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_QuantitiesAvailableToSupplyInFifthFiscalYear_1454" xlink:to="lab_huge_QuantitiesAvailableToSupplyInFifthFiscalYear_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_QuantitiesAvailableToSupplyInFifthFiscalYear_1455" xlink:to="lab_huge_QuantitiesAvailableToSupplyInFifthFiscalYear_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_QuantitiesAvailableToSupplyInFifthFiscalYear_1456" xlink:to="lab_huge_QuantitiesAvailableToSupplyInFifthFiscalYear_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_QuantitiesAvailableToSupplyInFourthFiscalYear_1457" xlink:to="lab_huge_QuantitiesAvailableToSupplyInFourthFiscalYear_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_QuantitiesAvailableToSupplyInFourthFiscalYear_1458" xlink:to="lab_huge_QuantitiesAvailableToSupplyInFourthFiscalYear_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_QuantitiesAvailableToSupplyInFourthFiscalYear_1459" xlink:to="lab_huge_QuantitiesAvailableToSupplyInFourthFiscalYear_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_QuantitiesAvailableToSupplyInNextFiscalYear_1460" xlink:to="lab_huge_QuantitiesAvailableToSupplyInNextFiscalYear_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_QuantitiesAvailableToSupplyInNextFiscalYear_1461" xlink:to="lab_huge_QuantitiesAvailableToSupplyInNextFiscalYear_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_QuantitiesAvailableToSupplyInNextFiscalYear_1462" xlink:to="lab_huge_QuantitiesAvailableToSupplyInNextFiscalYear_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_QuantitiesAvailableToSupplyInSecondFiscalYear_1463" xlink:to="lab_huge_QuantitiesAvailableToSupplyInSecondFiscalYear_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_QuantitiesAvailableToSupplyInSecondFiscalYear_1464" xlink:to="lab_huge_QuantitiesAvailableToSupplyInSecondFiscalYear_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_QuantitiesAvailableToSupplyInSecondFiscalYear_1465" xlink:to="lab_huge_QuantitiesAvailableToSupplyInSecondFiscalYear_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_QuantitiesAvailableToSupplyInThirdFiscalYear_1466" xlink:to="lab_huge_QuantitiesAvailableToSupplyInThirdFiscalYear_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_QuantitiesAvailableToSupplyInThirdFiscalYear_1467" xlink:to="lab_huge_QuantitiesAvailableToSupplyInThirdFiscalYear_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_QuantitiesAvailableToSupplyInThirdFiscalYear_1468" xlink:to="lab_huge_QuantitiesAvailableToSupplyInThirdFiscalYear_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_QuotedMarketPriceOfInvestments_1469" xlink:to="lab_huge_QuotedMarketPriceOfInvestments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_QuotedMarketPriceOfInvestments_1470" xlink:to="lab_huge_QuotedMarketPriceOfInvestments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_QuotedMarketPriceOfInvestments_1471" xlink:to="lab_huge_QuotedMarketPriceOfInvestments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_RecognitionOfLossOnChangeInFairValueOfDerivativeLiability_1472" xlink:to="lab_huge_RecognitionOfLossOnChangeInFairValueOfDerivativeLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_RecognitionOfLossOnChangeInFairValueOfDerivativeLiability_1473" xlink:to="lab_huge_RecognitionOfLossOnChangeInFairValueOfDerivativeLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_RecognitionOfLossOnChangeInFairValueOfDerivativeLiability_1474" xlink:to="lab_huge_RecognitionOfLossOnChangeInFairValueOfDerivativeLiability_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_RentReceivable_1475" xlink:to="lab_huge_RentReceivable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_RentReceivable_1476" xlink:to="lab_huge_RentReceivable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_RentReceivable_1477" xlink:to="lab_huge_RentReceivable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ResearchAndDevelopmentAgreementMember_1478" xlink:to="lab_huge_ResearchAndDevelopmentAgreementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ResearchAndDevelopmentAgreementMember_1479" xlink:to="lab_huge_ResearchAndDevelopmentAgreementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ResearchAndDevelopmentAgreementMember_1480" xlink:to="lab_huge_ResearchAndDevelopmentAgreementMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_RetrospectiveApplicationAndRetrospectiveRestatementLineItems_1481" xlink:to="lab_huge_RetrospectiveApplicationAndRetrospectiveRestatementLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_RetrospectiveApplicationAndRetrospectiveRestatementLineItems_1482" xlink:to="lab_huge_RetrospectiveApplicationAndRetrospectiveRestatementLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_RetrospectiveApplicationAndRetrospectiveRestatementTable_1483" xlink:to="lab_huge_RetrospectiveApplicationAndRetrospectiveRestatementTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_RetrospectiveApplicationAndRetrospectiveRestatementTable_1484" xlink:to="lab_huge_RetrospectiveApplicationAndRetrospectiveRestatementTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ReverseTakeoverTransaction_1485" xlink:to="lab_huge_ReverseTakeoverTransaction_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ReverseTakeoverTransaction_1486" xlink:to="lab_huge_ReverseTakeoverTransaction_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ReverseTakeoverTransaction_1487" xlink:to="lab_huge_ReverseTakeoverTransaction_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_RightOfUseAssetsAndLeaseObligations_1488" xlink:to="lab_huge_RightOfUseAssetsAndLeaseObligations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_RightOfUseAssetsAndLeaseObligations_1489" xlink:to="lab_huge_RightOfUseAssetsAndLeaseObligations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_RightOfUseAssetsAndLeaseObligations_1490" xlink:to="lab_huge_RightOfUseAssetsAndLeaseObligations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_RiskFreeInterestRateOfWarrants_1491" xlink:to="lab_huge_RiskFreeInterestRateOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_RiskFreeInterestRateOfWarrants_1492" xlink:to="lab_huge_RiskFreeInterestRateOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_RiskFreeInterestRateOfWarrants_1493" xlink:to="lab_huge_RiskFreeInterestRateOfWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_RiskFreeInterestRateOfWarrantsGranted_1494" xlink:to="lab_huge_RiskFreeInterestRateOfWarrantsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_RiskFreeInterestRateOfWarrantsGranted_1495" xlink:to="lab_huge_RiskFreeInterestRateOfWarrantsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_RiskFreeInterestRateOfWarrantsGranted_1496" xlink:to="lab_huge_RiskFreeInterestRateOfWarrantsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_RiskFreeInterestRateOfWarrantsLiability_1497" xlink:to="lab_huge_RiskFreeInterestRateOfWarrantsLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_RiskFreeInterestRateOfWarrantsLiability_1498" xlink:to="lab_huge_RiskFreeInterestRateOfWarrantsLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_RiskFreeRateOfWarrants_1499" xlink:to="lab_huge_RiskFreeRateOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_RiskFreeRateOfWarrants_1500" xlink:to="lab_huge_RiskFreeRateOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_RiskFreeRateOfWarrants_1501" xlink:to="lab_huge_RiskFreeRateOfWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SalesTaxRecoverable_1502" xlink:to="lab_huge_SalesTaxRecoverable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SalesTaxRecoverable_1503" xlink:to="lab_huge_SalesTaxRecoverable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SalesTaxRecoverable_1504" xlink:to="lab_huge_SalesTaxRecoverable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SalesTaxRecoverable_1505" xlink:to="lab_huge_SalesTaxRecoverable_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ScheduleOfCashFlowsFromDiscontinuedOperationsExplanatory_1506" xlink:to="lab_huge_ScheduleOfCashFlowsFromDiscontinuedOperationsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ScheduleOfCashFlowsFromDiscontinuedOperationsExplanatory_1507" xlink:to="lab_huge_ScheduleOfCashFlowsFromDiscontinuedOperationsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ScheduleOfCashFlowsFromDiscontinuedOperationsExplanatory_1508" xlink:to="lab_huge_ScheduleOfCashFlowsFromDiscontinuedOperationsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ScheduleOfComponentsOfAssetsHeldForSaleExplanatory_1509" xlink:to="lab_huge_ScheduleOfComponentsOfAssetsHeldForSaleExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ScheduleOfComponentsOfAssetsHeldForSaleExplanatory_1510" xlink:to="lab_huge_ScheduleOfComponentsOfAssetsHeldForSaleExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ScheduleOfComponentsOfAssetsHeldForSaleExplanatory_1511" xlink:to="lab_huge_ScheduleOfComponentsOfAssetsHeldForSaleExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ScheduleOfNetLossAndComprehensiveLossFromDiscontinuedOperationsExplanatory_1512" xlink:to="lab_huge_ScheduleOfNetLossAndComprehensiveLossFromDiscontinuedOperationsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ScheduleOfNetLossAndComprehensiveLossFromDiscontinuedOperationsExplanatory_1513" xlink:to="lab_huge_ScheduleOfNetLossAndComprehensiveLossFromDiscontinuedOperationsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ScheduleOfNetLossAndComprehensiveLossFromDiscontinuedOperationsExplanatory_1514" xlink:to="lab_huge_ScheduleOfNetLossAndComprehensiveLossFromDiscontinuedOperationsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ScheduleOfNonCapitalLossCarryforwardsTableTextBlock_1515" xlink:to="lab_huge_ScheduleOfNonCapitalLossCarryforwardsTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ScheduleOfNonCapitalLossCarryforwardsTableTextBlock_1516" xlink:to="lab_huge_ScheduleOfNonCapitalLossCarryforwardsTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ScheduleOfNonCapitalLossCarryforwardsTableTextBlock_1517" xlink:to="lab_huge_ScheduleOfNonCapitalLossCarryforwardsTableTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ScheduleOfStockClassLineItems_1518" xlink:to="lab_huge_ScheduleOfStockClassLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ScheduleOfStockClassLineItems_1519" xlink:to="lab_huge_ScheduleOfStockClassLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ScheduleOfStockClassTable_1520" xlink:to="lab_huge_ScheduleOfStockClassTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ScheduleOfStockClassTable_1521" xlink:to="lab_huge_ScheduleOfStockClassTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ScheduleOfWarrantTable_1522" xlink:to="lab_huge_ScheduleOfWarrantTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ScheduleOfWarrantTable_1523" xlink:to="lab_huge_ScheduleOfWarrantTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory_1524" xlink:to="lab_huge_SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory_1525" xlink:to="lab_huge_SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory_1526" xlink:to="lab_huge_SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ScicannTherapeuticsIncMember_1527" xlink:to="lab_huge_ScicannTherapeuticsIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ScicannTherapeuticsIncMember_1528" xlink:to="lab_huge_ScicannTherapeuticsIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ScicannTherapeuticsIncMember_1529" xlink:to="lab_huge_ScicannTherapeuticsIncMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SecuritiesExchangeAgreementMember_1530" xlink:to="lab_huge_SecuritiesExchangeAgreementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SecuritiesExchangeAgreementMember_1531" xlink:to="lab_huge_SecuritiesExchangeAgreementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees_1532" xlink:to="lab_huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees_1533" xlink:to="lab_huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees_1534" xlink:to="lab_huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Sep102018Member_1535" xlink:to="lab_huge_Sep102018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Sep102018Member_1536" xlink:to="lab_huge_Sep102018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Sep102018Member_1537" xlink:to="lab_huge_Sep102018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Sep112018Member_1538" xlink:to="lab_huge_Sep112018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Sep112018Member_1539" xlink:to="lab_huge_Sep112018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Sep112018Member_1540" xlink:to="lab_huge_Sep112018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Sep142018Member_1541" xlink:to="lab_huge_Sep142018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Sep142018Member_1542" xlink:to="lab_huge_Sep142018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Sep152017Member_1543" xlink:to="lab_huge_Sep152017Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Sep152017Member_1544" xlink:to="lab_huge_Sep152017Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Sep152017Member_1545" xlink:to="lab_huge_Sep152017Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Sep152018Member_1546" xlink:to="lab_huge_Sep152018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Sep152018Member_1547" xlink:to="lab_huge_Sep152018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Sep152018Member_1548" xlink:to="lab_huge_Sep152018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Sep172017Member_1549" xlink:to="lab_huge_Sep172017Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Sep172017Member_1550" xlink:to="lab_huge_Sep172017Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Sep172017Member_1551" xlink:to="lab_huge_Sep172017Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Sep262018Member_1552" xlink:to="lab_huge_Sep262018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Sep262018Member_1553" xlink:to="lab_huge_Sep262018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Sep262018Member_1554" xlink:to="lab_huge_Sep262018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_September292018Member_1555" xlink:to="lab_huge_September292018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_September292018Member_1556" xlink:to="lab_huge_September292018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_September292018Member_1557" xlink:to="lab_huge_September292018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_September302017Member_1558" xlink:to="lab_huge_September302017Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_September302017Member_1559" xlink:to="lab_huge_September302017Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_September302017Member_1560" xlink:to="lab_huge_September302017Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShareBasedPaymentExpenses_1561" xlink:to="lab_huge_ShareBasedPaymentExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShareBasedPaymentExpenses_1562" xlink:to="lab_huge_ShareBasedPaymentExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShareBasedPaymentExpenses_1563" xlink:to="lab_huge_ShareBasedPaymentExpenses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShareExchangeAgreementMember_1564" xlink:to="lab_huge_ShareExchangeAgreementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShareExchangeAgreementMember_1565" xlink:to="lab_huge_ShareExchangeAgreementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShareExchangeAgreementMember_1566" xlink:to="lab_huge_ShareExchangeAgreementMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShareholderAndPublicCompanyCosts_1567" xlink:to="lab_huge_ShareholderAndPublicCompanyCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShareholderAndPublicCompanyCosts_1568" xlink:to="lab_huge_ShareholderAndPublicCompanyCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShareholderAndPublicCompanyCosts_1569" xlink:to="lab_huge_ShareholderAndPublicCompanyCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShareholdersAndPublicCompanyCosts_1570" xlink:to="lab_huge_ShareholdersAndPublicCompanyCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShareholdersAndPublicCompanyCosts_1571" xlink:to="lab_huge_ShareholdersAndPublicCompanyCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShareholdersAndPublicCompanyCosts_1572" xlink:to="lab_huge_ShareholdersAndPublicCompanyCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShareIssuanceCostBookedDirectlyToEquity_1573" xlink:to="lab_huge_ShareIssuanceCostBookedDirectlyToEquity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShareIssuanceCostBookedDirectlyToEquity_1574" xlink:to="lab_huge_ShareIssuanceCostBookedDirectlyToEquity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShareIssuanceCostBookedDirectlyToEquity_1575" xlink:to="lab_huge_ShareIssuanceCostBookedDirectlyToEquity_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShareIssueCostsMember_1576" xlink:to="lab_huge_ShareIssueCostsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShareIssueCostsMember_1577" xlink:to="lab_huge_ShareIssueCostsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShareIssueCostsMember_1578" xlink:to="lab_huge_ShareIssueCostsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShareIssuePricePerShare_1579" xlink:to="lab_huge_ShareIssuePricePerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShareIssuePricePerShare_1580" xlink:to="lab_huge_ShareIssuePricePerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShareOptionsAbstract_1581" xlink:to="lab_huge_ShareOptionsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SharePriceOfSharesAndWarrants_1582" xlink:to="lab_huge_SharePriceOfSharesAndWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SharePriceOfSharesAndWarrants_1583" xlink:to="lab_huge_SharePriceOfSharesAndWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SharePrices_1584" xlink:to="lab_huge_SharePrices_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SharePrices_1585" xlink:to="lab_huge_SharePrices_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SharePrices_1586" xlink:to="lab_huge_SharePrices_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SharePrices_1587" xlink:to="lab_huge_SharePrices_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SharePricesOfWarrantsLiability_1588" xlink:to="lab_huge_SharePricesOfWarrantsLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SharePricesOfWarrantsLiability_1589" xlink:to="lab_huge_SharePricesOfWarrantsLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SharePurchaseAndSaleAgreementsMember_1590" xlink:to="lab_huge_SharePurchaseAndSaleAgreementsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SharePurchaseAndSaleAgreementsMember_1591" xlink:to="lab_huge_SharePurchaseAndSaleAgreementsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SharePurchaseAndSaleAgreementsMember_1592" xlink:to="lab_huge_SharePurchaseAndSaleAgreementsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShareSplitRatio_1593" xlink:to="lab_huge_ShareSplitRatio_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShareSplitRatio_1594" xlink:to="lab_huge_ShareSplitRatio_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShareSplitRatio_1595" xlink:to="lab_huge_ShareSplitRatio_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShortTermNotes_1596" xlink:to="lab_huge_ShortTermNotes_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShortTermNotes_1597" xlink:to="lab_huge_ShortTermNotes_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShortTermNotes_1598" xlink:to="lab_huge_ShortTermNotes_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ShortTermNotes_1599" xlink:to="lab_huge_ShortTermNotes_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SolarvestBioEnergyIncMember_1600" xlink:to="lab_huge_SolarvestBioEnergyIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SolarvestBioEnergyIncMember_1601" xlink:to="lab_huge_SolarvestBioEnergyIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SolarvestBioEnergyIncMember_1602" xlink:to="lab_huge_SolarvestBioEnergyIncMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SpecialWarrantsMember_1603" xlink:to="lab_huge_SpecialWarrantsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SpecialWarrantsMember_1604" xlink:to="lab_huge_SpecialWarrantsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SpecialWarrantsMember_1605" xlink:to="lab_huge_SpecialWarrantsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_StockOptionsMember_1606" xlink:to="lab_huge_StockOptionsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_StockOptionsMember_1607" xlink:to="lab_huge_StockOptionsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_StockOptionsMember_1608" xlink:to="lab_huge_StockOptionsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_StockOptionsOfAcquirer_1609" xlink:to="lab_huge_StockOptionsOfAcquirer_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_StockOptionsOfAcquirer_1610" xlink:to="lab_huge_StockOptionsOfAcquirer_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_StockOptionsOfAcquirer_1611" xlink:to="lab_huge_StockOptionsOfAcquirer_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_StockPromotionExpense_1612" xlink:to="lab_huge_StockPromotionExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_StockPromotionExpense_1613" xlink:to="lab_huge_StockPromotionExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_StockPromotionExpense_1614" xlink:to="lab_huge_StockPromotionExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_StrategicInvestmentValue_1615" xlink:to="lab_huge_StrategicInvestmentValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_StrategicInvestmentValue_1616" xlink:to="lab_huge_StrategicInvestmentValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_StrategicInvestmentValue_1617" xlink:to="lab_huge_StrategicInvestmentValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SubscriptionPricePerShare_1618" xlink:to="lab_huge_SubscriptionPricePerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SubscriptionPricePerShare_1619" xlink:to="lab_huge_SubscriptionPricePerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SubscriptionPricePerShare_1620" xlink:to="lab_huge_SubscriptionPricePerShare_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SubsequentEventsMember_1621" xlink:to="lab_huge_SubsequentEventsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SubsequentEventsMember_1622" xlink:to="lab_huge_SubsequentEventsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SubsequentEventsMember_1623" xlink:to="lab_huge_SubsequentEventsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SubsidiariesOneMember_1624" xlink:to="lab_huge_SubsidiariesOneMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SubsidiariesOneMember_1625" xlink:to="lab_huge_SubsidiariesOneMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SubsidiariesTwoMember_1626" xlink:to="lab_huge_SubsidiariesTwoMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SubsidiariesTwoMember_1627" xlink:to="lab_huge_SubsidiariesTwoMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SubsidiariesTwoMember_1628" xlink:to="lab_huge_SubsidiariesTwoMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_1629" xlink:to="lab_huge_SummaryOfSignificantAccountingPoliciesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesTable_1630" xlink:to="lab_huge_SummaryOfSignificantAccountingPoliciesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesTable_1631" xlink:to="lab_huge_SummaryOfSignificantAccountingPoliciesTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SupplementalInformationAbstract_1632" xlink:to="lab_huge_SupplementalInformationAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SupplementalInformationAbstract_1633" xlink:to="lab_huge_SupplementalInformationAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SupplyAgreementMember_1634" xlink:to="lab_huge_SupplyAgreementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SupplyAgreementMember_1635" xlink:to="lab_huge_SupplyAgreementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SupplyAgreementMember_1636" xlink:to="lab_huge_SupplyAgreementMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SupplyAgreementOptionToPurchaseAmount_1637" xlink:to="lab_huge_SupplyAgreementOptionToPurchaseAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SupplyAgreementOptionToPurchaseAmount_1638" xlink:to="lab_huge_SupplyAgreementOptionToPurchaseAmount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SupplyAgreementOptionToPurchaseAmount_1639" xlink:to="lab_huge_SupplyAgreementOptionToPurchaseAmount_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SupplyAgreementOptionToPurchasePeriod_1640" xlink:to="lab_huge_SupplyAgreementOptionToPurchasePeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SupplyAgreementOptionToPurchasePeriod_1641" xlink:to="lab_huge_SupplyAgreementOptionToPurchasePeriod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SupplyAgreementOptionToPurchasePeriod_1642" xlink:to="lab_huge_SupplyAgreementOptionToPurchasePeriod_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SupplyAgreementOptionToPurchasePricePerKilogramPerPercentOfCannabidiolExtracted_1643" xlink:to="lab_huge_SupplyAgreementOptionToPurchasePricePerKilogramPerPercentOfCannabidiolExtracted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SupplyAgreementOptionToPurchasePricePerKilogramPerPercentOfCannabidiolExtracted_1644" xlink:to="lab_huge_SupplyAgreementOptionToPurchasePricePerKilogramPerPercentOfCannabidiolExtracted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_SupplyAgreementOptionToPurchasePricePerKilogramPerPercentOfCannabidiolExtracted_1645" xlink:to="lab_huge_SupplyAgreementOptionToPurchasePricePerKilogramPerPercentOfCannabidiolExtracted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_TaxEffectOfDeferredTaxAssetNotRecognized_1646" xlink:to="lab_huge_TaxEffectOfDeferredTaxAssetNotRecognized_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_TaxEffectOfDeferredTaxAssetNotRecognized_1647" xlink:to="lab_huge_TaxEffectOfDeferredTaxAssetNotRecognized_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_TaxEffectOfDeferredTaxAssetNotRecognized_1648" xlink:to="lab_huge_TaxEffectOfDeferredTaxAssetNotRecognized_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_TaxEffectOfTemporaryDifferences_1649" xlink:to="lab_huge_TaxEffectOfTemporaryDifferences_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_TaxEffectOfTemporaryDifferences_1650" xlink:to="lab_huge_TaxEffectOfTemporaryDifferences_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_TaxEffectOfTemporaryDifferences_1651" xlink:to="lab_huge_TaxEffectOfTemporaryDifferences_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_TemporaryDifferences_1652" xlink:to="lab_huge_TemporaryDifferences_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_TemporaryDifferences_1653" xlink:to="lab_huge_TemporaryDifferences_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_TemporaryDifferences_1654" xlink:to="lab_huge_TemporaryDifferences_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_TermsOfWarrantGranted_1655" xlink:to="lab_huge_TermsOfWarrantGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_TermsOfWarrantGranted_1656" xlink:to="lab_huge_TermsOfWarrantGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_TermsOfWarrantGranted_1657" xlink:to="lab_huge_TermsOfWarrantGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ThomasFairfullMember_1658" xlink:to="lab_huge_ThomasFairfullMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ThomasFairfullMember_1659" xlink:to="lab_huge_ThomasFairfullMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ThomasFairfullMember_1660" xlink:to="lab_huge_ThomasFairfullMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_TotalCashTransactionCosts_1661" xlink:to="lab_huge_TotalCashTransactionCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_TotalCashTransactionCosts_1662" xlink:to="lab_huge_TotalCashTransactionCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_TotalCashTransactionCosts_1663" xlink:to="lab_huge_TotalCashTransactionCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_TransactionCostsAllocatedToWarrants_1664" xlink:to="lab_huge_TransactionCostsAllocatedToWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_TransactionCostsAllocatedToWarrants_1665" xlink:to="lab_huge_TransactionCostsAllocatedToWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_TransactionCostsAllocatedToWarrants_1666" xlink:to="lab_huge_TransactionCostsAllocatedToWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_TypeOfArrangementsAxis_1667" xlink:to="lab_huge_TypeOfArrangementsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_TypeOfArrangementsDomain_1668" xlink:to="lab_huge_TypeOfArrangementsDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_TypeOfInventoriesAxis_1669" xlink:to="lab_huge_TypeOfInventoriesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_TypeOfInventoriesAxis_1670" xlink:to="lab_huge_TypeOfInventoriesAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_TypeOfInventoriesDomain_1671" xlink:to="lab_huge_TypeOfInventoriesDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_TypeOfInventoriesDomain_1672" xlink:to="lab_huge_TypeOfInventoriesDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_UndiscountedLeasePaymentsPayable_1673" xlink:to="lab_huge_UndiscountedLeasePaymentsPayable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_UndiscountedLeasePaymentsPayable_1674" xlink:to="lab_huge_UndiscountedLeasePaymentsPayable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_UndiscountedLeasePaymentsPayable_1675" xlink:to="lab_huge_UndiscountedLeasePaymentsPayable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_UnobservableInputUsedToEstimateFairValueOfBiologicalAssetsTableTextBlock_1676" xlink:to="lab_huge_UnobservableInputUsedToEstimateFairValueOfBiologicalAssetsTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_UnobservableInputUsedToEstimateFairValueOfBiologicalAssetsTableTextBlock_1677" xlink:to="lab_huge_UnobservableInputUsedToEstimateFairValueOfBiologicalAssetsTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_UnobservableInputUsedToEstimateFairValueOfBiologicalAssetsTableTextBlock_1678" xlink:to="lab_huge_UnobservableInputUsedToEstimateFairValueOfBiologicalAssetsTableTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_UnrealizedLoss_1679" xlink:to="lab_huge_UnrealizedLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_UnrealizedLoss_1680" xlink:to="lab_huge_UnrealizedLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_UnrealizedLoss_1681" xlink:to="lab_huge_UnrealizedLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_UnrealizedLoss_1682" xlink:to="lab_huge_UnrealizedLoss_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_UnrealizedLossOnChangesInFairValueOfBiologicalAssets_1683" xlink:to="lab_huge_UnrealizedLossOnChangesInFairValueOfBiologicalAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_UnrealizedLossOnChangesInFairValueOfBiologicalAssets_1684" xlink:to="lab_huge_UnrealizedLossOnChangesInFairValueOfBiologicalAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_UnrealizedLossOnChangesInFairValueOfBiologicalAssets_1685" xlink:to="lab_huge_UnrealizedLossOnChangesInFairValueOfBiologicalAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_UnrestrictedClassBSharesMember_1686" xlink:to="lab_huge_UnrestrictedClassBSharesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_UnrestrictedClassBSharesMember_1687" xlink:to="lab_huge_UnrestrictedClassBSharesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_UnrestrictedClassBSharesMember_1688" xlink:to="lab_huge_UnrestrictedClassBSharesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfBrokerWarrantsIssuedInPrivatePlacements_1689" xlink:to="lab_huge_ValueOfBrokerWarrantsIssuedInPrivatePlacements_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfBrokerWarrantsIssuedInPrivatePlacements_1690" xlink:to="lab_huge_ValueOfBrokerWarrantsIssuedInPrivatePlacements_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfBrokerWarrantsIssuedInPrivatePlacements_1691" xlink:to="lab_huge_ValueOfBrokerWarrantsIssuedInPrivatePlacements_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfBrokerWarrantsIssuedInPrivatePlacements_1692" xlink:to="lab_huge_ValueOfBrokerWarrantsIssuedInPrivatePlacements_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfCommonStockForNotesPayable_1693" xlink:to="lab_huge_ValueOfCommonStockForNotesPayable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfCommonStockForNotesPayable_1694" xlink:to="lab_huge_ValueOfCommonStockForNotesPayable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfCommonStockForNotesPayable_1695" xlink:to="lab_huge_ValueOfCommonStockForNotesPayable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfSharesAcquired_1696" xlink:to="lab_huge_ValueOfSharesAcquired_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfSharesAcquired_1697" xlink:to="lab_huge_ValueOfSharesAcquired_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfSharesAcquired_1698" xlink:to="lab_huge_ValueOfSharesAcquired_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfSharesIssued_1699" xlink:to="lab_huge_ValueOfSharesIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfSharesIssued_1700" xlink:to="lab_huge_ValueOfSharesIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfSharesIssued_1701" xlink:to="lab_huge_ValueOfSharesIssued_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_1702" xlink:to="lab_huge_ValueOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_1703" xlink:to="lab_huge_ValueOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_1704" xlink:to="lab_huge_ValueOfSharesIssuedForAcquisitionOfCenturyFinancialCapitalGroupInc_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfSharesIssuedForDebtSettlement_1705" xlink:to="lab_huge_ValueOfSharesIssuedForDebtSettlement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfSharesIssuedForDebtSettlement_1706" xlink:to="lab_huge_ValueOfSharesIssuedForDebtSettlement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfSharesIssuedForDebtSettlement_1707" xlink:to="lab_huge_ValueOfSharesIssuedForDebtSettlement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfSharesIssuedInPrivatePlacement_1708" xlink:to="lab_huge_ValueOfSharesIssuedInPrivatePlacement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfSharesIssuedInPrivatePlacement_1709" xlink:to="lab_huge_ValueOfSharesIssuedInPrivatePlacement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfSharesIssuedInPrivatePlacement_1710" xlink:to="lab_huge_ValueOfSharesIssuedInPrivatePlacement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfSharesIssuedInShareExchange_1711" xlink:to="lab_huge_ValueOfSharesIssuedInShareExchange_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfSharesIssuedInShareExchange_1712" xlink:to="lab_huge_ValueOfSharesIssuedInShareExchange_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfSharesIssuedInShareExchange_1713" xlink:to="lab_huge_ValueOfSharesIssuedInShareExchange_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfStockOptionsExercised_1714" xlink:to="lab_huge_ValueOfStockOptionsExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfStockOptionsExercised_1715" xlink:to="lab_huge_ValueOfStockOptionsExercised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfStockOptionsExercised_1716" xlink:to="lab_huge_ValueOfStockOptionsExercised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement_1717" xlink:to="lab_huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement_1718" xlink:to="lab_huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement_1719" xlink:to="lab_huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfTradeAndOtherPayableOfSharesBasedCompensation_1720" xlink:to="lab_huge_ValueOfTradeAndOtherPayableOfSharesBasedCompensation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfTradeAndOtherPayableOfSharesBasedCompensation_1721" xlink:to="lab_huge_ValueOfTradeAndOtherPayableOfSharesBasedCompensation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfTradeAndOtherPayableOfSharesBasedCompensation_1722" xlink:to="lab_huge_ValueOfTradeAndOtherPayableOfSharesBasedCompensation_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfWarrantsExercised_1723" xlink:to="lab_huge_ValueOfWarrantsExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfWarrantsExercised_1724" xlink:to="lab_huge_ValueOfWarrantsExercised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfWarrantsExercised_1725" xlink:to="lab_huge_ValueOfWarrantsExercised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfWarrantsOfResidualValue_1726" xlink:to="lab_huge_ValueOfWarrantsOfResidualValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfWarrantsOfResidualValue_1727" xlink:to="lab_huge_ValueOfWarrantsOfResidualValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ValueOfWarrantsOfResidualValue_1728" xlink:to="lab_huge_ValueOfWarrantsOfResidualValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantExercisePrice_1729" xlink:to="lab_huge_WarrantExercisePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantExercisePrice_1730" xlink:to="lab_huge_WarrantExercisePrice_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantExercisePrice_1731" xlink:to="lab_huge_WarrantExercisePrice_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantLiabilitiesAbstract_1732" xlink:to="lab_huge_WarrantLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantLiabilitiesAbstract_1733" xlink:to="lab_huge_WarrantLiabilitiesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantLiabilitiesLineItems_1734" xlink:to="lab_huge_WarrantLiabilitiesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantLiabilitiesLineItems_1735" xlink:to="lab_huge_WarrantLiabilitiesLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantLiabilitiesTable_1736" xlink:to="lab_huge_WarrantLiabilitiesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantLiabilitiesTable_1737" xlink:to="lab_huge_WarrantLiabilitiesTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantLineItems_1738" xlink:to="lab_huge_WarrantLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantLineItems_1739" xlink:to="lab_huge_WarrantLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Warrants_1740" xlink:to="lab_huge_Warrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Warrants_1741" xlink:to="lab_huge_Warrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Warrants_1742" xlink:to="lab_huge_Warrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_Warrants_1743" xlink:to="lab_huge_Warrants_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsAbstract_1744" xlink:to="lab_huge_WarrantsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtAugust1St2021Member_1745" xlink:to="lab_huge_WarrantsByExpiryDateAtAugust1St2021Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtAugust1St2021Member_1746" xlink:to="lab_huge_WarrantsByExpiryDateAtAugust1St2021Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtAugust1St2021Member_1747" xlink:to="lab_huge_WarrantsByExpiryDateAtAugust1St2021Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtAugust6Th2020Member_1748" xlink:to="lab_huge_WarrantsByExpiryDateAtAugust6Th2020Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtAugust6Th2020Member_1749" xlink:to="lab_huge_WarrantsByExpiryDateAtAugust6Th2020Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtAugust6Th2020Member_1750" xlink:to="lab_huge_WarrantsByExpiryDateAtAugust6Th2020Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtDecember12Th2019Member_1751" xlink:to="lab_huge_WarrantsByExpiryDateAtDecember12Th2019Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtDecember12Th2019Member_1752" xlink:to="lab_huge_WarrantsByExpiryDateAtDecember12Th2019Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtDecember12Th2019Member_1753" xlink:to="lab_huge_WarrantsByExpiryDateAtDecember12Th2019Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtDecember29Th2019Member_1754" xlink:to="lab_huge_WarrantsByExpiryDateAtDecember29Th2019Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtDecember29Th2019Member_1755" xlink:to="lab_huge_WarrantsByExpiryDateAtDecember29Th2019Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtDecember29Th2019Member_1756" xlink:to="lab_huge_WarrantsByExpiryDateAtDecember29Th2019Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtJanuary16Th2026Member_1757" xlink:to="lab_huge_WarrantsByExpiryDateAtJanuary16Th2026Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtJanuary16Th2026Member_1758" xlink:to="lab_huge_WarrantsByExpiryDateAtJanuary16Th2026Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtJanuary16Th2026Member_1759" xlink:to="lab_huge_WarrantsByExpiryDateAtJanuary16Th2026Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtJanuary20Th2026Member_1760" xlink:to="lab_huge_WarrantsByExpiryDateAtJanuary20Th2026Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtJanuary20Th2026Member_1761" xlink:to="lab_huge_WarrantsByExpiryDateAtJanuary20Th2026Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtJanuary20Th2026Member_1762" xlink:to="lab_huge_WarrantsByExpiryDateAtJanuary20Th2026Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtJanuary5Th2020Member_1763" xlink:to="lab_huge_WarrantsByExpiryDateAtJanuary5Th2020Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtJanuary5Th2020Member_1764" xlink:to="lab_huge_WarrantsByExpiryDateAtJanuary5Th2020Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtJanuary5Th2020Member_1765" xlink:to="lab_huge_WarrantsByExpiryDateAtJanuary5Th2020Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtJuly24Th2023Member_1766" xlink:to="lab_huge_WarrantsByExpiryDateAtJuly24Th2023Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtJuly24Th2023Member_1767" xlink:to="lab_huge_WarrantsByExpiryDateAtJuly24Th2023Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtJuly24Th2023Member_1768" xlink:to="lab_huge_WarrantsByExpiryDateAtJuly24Th2023Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtJune8Th2025Member_1769" xlink:to="lab_huge_WarrantsByExpiryDateAtJune8Th2025Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtJune8Th2025Member_1770" xlink:to="lab_huge_WarrantsByExpiryDateAtJune8Th2025Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtJune8Th2025Member_1771" xlink:to="lab_huge_WarrantsByExpiryDateAtJune8Th2025Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtMay10Th2025Member_1772" xlink:to="lab_huge_WarrantsByExpiryDateAtMay10Th2025Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtMay10Th2025Member_1773" xlink:to="lab_huge_WarrantsByExpiryDateAtMay10Th2025Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtMay10Th2025Member_1774" xlink:to="lab_huge_WarrantsByExpiryDateAtMay10Th2025Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtMay17Th2025Member_1775" xlink:to="lab_huge_WarrantsByExpiryDateAtMay17Th2025Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtMay17Th2025Member_1776" xlink:to="lab_huge_WarrantsByExpiryDateAtMay17Th2025Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtMay17Th2025Member_1777" xlink:to="lab_huge_WarrantsByExpiryDateAtMay17Th2025Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtMay20Th2023Member_1778" xlink:to="lab_huge_WarrantsByExpiryDateAtMay20Th2023Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtMay20Th2023Member_1779" xlink:to="lab_huge_WarrantsByExpiryDateAtMay20Th2023Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtMay20Th2023Member_1780" xlink:to="lab_huge_WarrantsByExpiryDateAtMay20Th2023Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtMay24Th2022Member_1781" xlink:to="lab_huge_WarrantsByExpiryDateAtMay24Th2022Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtMay24Th2022Member_1782" xlink:to="lab_huge_WarrantsByExpiryDateAtMay24Th2022Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtMay24Th2022Member_1783" xlink:to="lab_huge_WarrantsByExpiryDateAtMay24Th2022Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtMay31St2025Member_1784" xlink:to="lab_huge_WarrantsByExpiryDateAtMay31St2025Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtMay31St2025Member_1785" xlink:to="lab_huge_WarrantsByExpiryDateAtMay31St2025Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtMay31St2025Member_1786" xlink:to="lab_huge_WarrantsByExpiryDateAtMay31St2025Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtMay4Th2025Member_1787" xlink:to="lab_huge_WarrantsByExpiryDateAtMay4Th2025Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtMay4Th2025Member_1788" xlink:to="lab_huge_WarrantsByExpiryDateAtMay4Th2025Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtMay4Th2025Member_1789" xlink:to="lab_huge_WarrantsByExpiryDateAtMay4Th2025Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtNovember14Th2019Member_1790" xlink:to="lab_huge_WarrantsByExpiryDateAtNovember14Th2019Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtNovember14Th2019Member_1791" xlink:to="lab_huge_WarrantsByExpiryDateAtNovember14Th2019Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtNovember14Th2019Member_1792" xlink:to="lab_huge_WarrantsByExpiryDateAtNovember14Th2019Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtNovember1St2019Member_1793" xlink:to="lab_huge_WarrantsByExpiryDateAtNovember1St2019Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtNovember1St2019Member_1794" xlink:to="lab_huge_WarrantsByExpiryDateAtNovember1St2019Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtNovember1St2019Member_1795" xlink:to="lab_huge_WarrantsByExpiryDateAtNovember1St2019Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtNovember21St2019Member_1796" xlink:to="lab_huge_WarrantsByExpiryDateAtNovember21St2019Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtNovember21St2019Member_1797" xlink:to="lab_huge_WarrantsByExpiryDateAtNovember21St2019Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtNovember21St2019Member_1798" xlink:to="lab_huge_WarrantsByExpiryDateAtNovember21St2019Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtNovember30Th2020Member_1799" xlink:to="lab_huge_WarrantsByExpiryDateAtNovember30Th2020Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtNovember30Th2020Member_1800" xlink:to="lab_huge_WarrantsByExpiryDateAtNovember30Th2020Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtNovember30Th2020Member_1801" xlink:to="lab_huge_WarrantsByExpiryDateAtNovember30Th2020Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtOctober20Th2020Member_1802" xlink:to="lab_huge_WarrantsByExpiryDateAtOctober20Th2020Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtOctober20Th2020Member_1803" xlink:to="lab_huge_WarrantsByExpiryDateAtOctober20Th2020Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtOctober20Th2020Member_1804" xlink:to="lab_huge_WarrantsByExpiryDateAtOctober20Th2020Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtSeptember11Th2023Member_1805" xlink:to="lab_huge_WarrantsByExpiryDateAtSeptember11Th2023Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtSeptember11Th2023Member_1806" xlink:to="lab_huge_WarrantsByExpiryDateAtSeptember11Th2023Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtSeptember11Th2023Member_1807" xlink:to="lab_huge_WarrantsByExpiryDateAtSeptember11Th2023Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtSeptember15Th2022Member_1808" xlink:to="lab_huge_WarrantsByExpiryDateAtSeptember15Th2022Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtSeptember15Th2022Member_1809" xlink:to="lab_huge_WarrantsByExpiryDateAtSeptember15Th2022Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsByExpiryDateAtSeptember15Th2022Member_1810" xlink:to="lab_huge_WarrantsByExpiryDateAtSeptember15Th2022Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsIssueDateAxis_1811" xlink:to="lab_huge_WarrantsIssueDateAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsIssueDateAxis_1812" xlink:to="lab_huge_WarrantsIssueDateAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsIssueDateDomain_1813" xlink:to="lab_huge_WarrantsIssueDateDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsIssueDateDomain_1814" xlink:to="lab_huge_WarrantsIssueDateDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsIssuedForPrivatePlacement_1815" xlink:to="lab_huge_WarrantsIssuedForPrivatePlacement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsIssuedForPrivatePlacement_1816" xlink:to="lab_huge_WarrantsIssuedForPrivatePlacement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsIssuedForPrivatePlacement_1817" xlink:to="lab_huge_WarrantsIssuedForPrivatePlacement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsLiability_1818" xlink:to="lab_huge_WarrantsLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsLiability_1819" xlink:to="lab_huge_WarrantsLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsLiability_1820" xlink:to="lab_huge_WarrantsLiability_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsLiability_1821" xlink:to="lab_huge_WarrantsLiability_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsMember_1822" xlink:to="lab_huge_WarrantsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsMember_1823" xlink:to="lab_huge_WarrantsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsMember_1824" xlink:to="lab_huge_WarrantsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsMember_1825" xlink:to="lab_huge_WarrantsMember_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsOptionsOfAcquirer_1826" xlink:to="lab_huge_WarrantsOptionsOfAcquirer_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsOptionsOfAcquirer_1827" xlink:to="lab_huge_WarrantsOptionsOfAcquirer_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WarrantsOptionsOfAcquirer_1828" xlink:to="lab_huge_WarrantsOptionsOfAcquirer_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WeightedAverageExercisePriceForReplacementOfShareOptions_1829" xlink:to="lab_huge_WeightedAverageExercisePriceForReplacementOfShareOptions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WeightedAverageExercisePriceForReplacementOfShareOptions_1830" xlink:to="lab_huge_WeightedAverageExercisePriceForReplacementOfShareOptions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WeightedAverageExercisePriceForReplacementOfShareOptions_1831" xlink:to="lab_huge_WeightedAverageExercisePriceForReplacementOfShareOptions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WeightedAverageExercisePriceForReplacementOfShareOptions_1832" xlink:to="lab_huge_WeightedAverageExercisePriceForReplacementOfShareOptions_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WeightedAverageExercisePriceForReplacementOfShareOptions_1833" xlink:to="lab_huge_WeightedAverageExercisePriceForReplacementOfShareOptions_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WeightedAverageExercisePricesWarrantExercised_1834" xlink:to="lab_huge_WeightedAverageExercisePricesWarrantExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WeightedAverageExercisePricesWarrantExercised_1835" xlink:to="lab_huge_WeightedAverageExercisePricesWarrantExercised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WeightedAverageExercisePricesWarrantExercised_1836" xlink:to="lab_huge_WeightedAverageExercisePricesWarrantExercised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WeightedAverageExercisePricesWarrantExpired_1837" xlink:to="lab_huge_WeightedAverageExercisePricesWarrantExpired_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WeightedAverageExercisePricesWarrantExpired_1838" xlink:to="lab_huge_WeightedAverageExercisePricesWarrantExpired_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WeightedAverageExercisePricesWarrantExpired_1839" xlink:to="lab_huge_WeightedAverageExercisePricesWarrantExpired_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WeightedAverageExercisePricesWarrantIssued_1840" xlink:to="lab_huge_WeightedAverageExercisePricesWarrantIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WeightedAverageExercisePricesWarrantIssued_1841" xlink:to="lab_huge_WeightedAverageExercisePricesWarrantIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WeightedAverageExercisePricesWarrantIssued_1842" xlink:to="lab_huge_WeightedAverageExercisePricesWarrantIssued_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WeightedAverageExercisePriceWarrantsOutstanding_1843" xlink:to="lab_huge_WeightedAverageExercisePriceWarrantsOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WeightedAverageExercisePriceWarrantsOutstanding_1844" xlink:to="lab_huge_WeightedAverageExercisePriceWarrantsOutstanding_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WeightedAverageExercisePriceWarrantsOutstanding_1845" xlink:to="lab_huge_WeightedAverageExercisePriceWarrantsOutstanding_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WeightedAverageExercisePriceWarrantsOutstanding_1846" xlink:to="lab_huge_WeightedAverageExercisePriceWarrantsOutstanding_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WeightedAverageExercisePriceWarrantsOutstanding_1847" xlink:to="lab_huge_WeightedAverageExercisePriceWarrantsOutstanding_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WeightedAverageSharePriceOfWarrants_1848" xlink:to="lab_huge_WeightedAverageSharePriceOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WeightedAverageSharePriceOfWarrants_1849" xlink:to="lab_huge_WeightedAverageSharePriceOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WeightedAverageSharePriceOfWarrants_1850" xlink:to="lab_huge_WeightedAverageSharePriceOfWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WorkingCapitalSurplus_1851" xlink:to="lab_huge_WorkingCapitalSurplus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WorkingCapitalSurplus_1852" xlink:to="lab_huge_WorkingCapitalSurplus_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_WorkingCapitalSurplus_1853" xlink:to="lab_huge_WorkingCapitalSurplus_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ZeeshanSaeedMember_1854" xlink:to="lab_huge_ZeeshanSaeedMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ZeeshanSaeedMember_1855" xlink:to="lab_huge_ZeeshanSaeedMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_huge_ZeeshanSaeedMember_1856" xlink:to="lab_huge_ZeeshanSaeedMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccountingProfit_1857" xlink:to="lab_ifrs-full_AccountingProfit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccountingProfit_1858" xlink:to="lab_ifrs-full_AccountingProfit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_1859" xlink:to="lab_ifrs-full_AccumulatedDepreciationAndAmortisationMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_1860" xlink:to="lab_ifrs-full_AccumulatedDepreciationAndAmortisationMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_1861" xlink:to="lab_ifrs-full_AccumulatedDepreciationAndAmortisationMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_1862" xlink:to="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_1863" xlink:to="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_1864" xlink:to="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_1865" xlink:to="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_1866" xlink:to="lab_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_1867" xlink:to="lab_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_1868" xlink:to="lab_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_1869" xlink:to="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_1870" xlink:to="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsFromPurchasesBiologicalAssets_1871" xlink:to="lab_ifrs-full_AdditionsFromPurchasesBiologicalAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsFromPurchasesBiologicalAssets_1872" xlink:to="lab_ifrs-full_AdditionsFromPurchasesBiologicalAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_1873" xlink:to="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_1874" xlink:to="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_1875" xlink:to="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_1876" xlink:to="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustedWeightedAverageShares_1877" xlink:to="lab_ifrs-full_AdjustedWeightedAverageShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustedWeightedAverageShares_1878" xlink:to="lab_ifrs-full_AdjustedWeightedAverageShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustedWeightedAverageShares_1879" xlink:to="lab_ifrs-full_AdjustedWeightedAverageShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustedWeightedAverageShares_1880" xlink:to="lab_ifrs-full_AdjustedWeightedAverageShares_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_1881" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_1882" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_1883" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_1884" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_1885" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_1886" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_1887" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_1888" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_1889" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_1890" xlink:to="lab_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDepreciationExpense_1891" xlink:to="lab_ifrs-full_AdjustmentsForDepreciationExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDepreciationExpense_1892" xlink:to="lab_ifrs-full_AdjustmentsForDepreciationExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForFairValueGainsLosses_1893" xlink:to="lab_ifrs-full_AdjustmentsForFairValueGainsLosses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForFairValueGainsLosses_1894" xlink:to="lab_ifrs-full_AdjustmentsForFairValueGainsLosses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_1895" xlink:to="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_1896" xlink:to="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_1897" xlink:to="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_1898" xlink:to="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_1899" xlink:to="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_1900" xlink:to="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_1901" xlink:to="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_1902" xlink:to="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_1903" xlink:to="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_1904" xlink:to="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_1905" xlink:to="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_1906" xlink:to="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossInventories_1907" xlink:to="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossInventories_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossInventories_1908" xlink:to="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossInventories_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_1909" xlink:to="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_1910" xlink:to="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities_1911" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities_1912" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_1913" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_1914" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_1915" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_1916" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForInterestExpense_1917" xlink:to="lab_ifrs-full_AdjustmentsForInterestExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForInterestExpense_1918" xlink:to="lab_ifrs-full_AdjustmentsForInterestExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_1919" xlink:to="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_1920" xlink:to="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForSharebasedPayments_1921" xlink:to="lab_ifrs-full_AdjustmentsForSharebasedPayments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForSharebasedPayments_1922" xlink:to="lab_ifrs-full_AdjustmentsForSharebasedPayments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForSharebasedPayments_1923" xlink:to="lab_ifrs-full_AdjustmentsForSharebasedPayments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_1924" xlink:to="lab_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_1925" xlink:to="lab_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdvertisingExpense_1926" xlink:to="lab_ifrs-full_AdvertisingExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdvertisingExpense_1927" xlink:to="lab_ifrs-full_AdvertisingExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_1928" xlink:to="lab_ifrs-full_AggregatedMeasurementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1929" xlink:to="lab_ifrs-full_AggregatedTimeBandsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_1930" xlink:to="lab_ifrs-full_AllLevelsOfFairValueHierarchyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_1931" xlink:to="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_1932" xlink:to="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_1933" xlink:to="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmountsPayableRelatedPartyTransactions_1934" xlink:to="lab_ifrs-full_AmountsPayableRelatedPartyTransactions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmountsPayableRelatedPartyTransactions_1935" xlink:to="lab_ifrs-full_AmountsPayableRelatedPartyTransactions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ApplicableTaxRate_1936" xlink:to="lab_ifrs-full_ApplicableTaxRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ApplicableTaxRate_1937" xlink:to="lab_ifrs-full_ApplicableTaxRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Assets_1938" xlink:to="lab_ifrs-full_Assets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Assets_1939" xlink:to="lab_ifrs-full_Assets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AssetsAbstract_1940" xlink:to="lab_ifrs-full_AssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_1941" xlink:to="lab_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_1942" xlink:to="lab_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AtFairValueMember_1943" xlink:to="lab_ifrs-full_AtFairValueMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AtFairValueMember_1944" xlink:to="lab_ifrs-full_AtFairValueMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BasicAndDilutedEarningsLossPerShareFromContinuingOperations_1945" xlink:to="lab_ifrs-full_BasicAndDilutedEarningsLossPerShareFromContinuingOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BasicAndDilutedEarningsLossPerShareFromContinuingOperations_1946" xlink:to="lab_ifrs-full_BasicAndDilutedEarningsLossPerShareFromContinuingOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BasicAndDilutedEarningsLossPerShareFromDiscontinuedOperations_1947" xlink:to="lab_ifrs-full_BasicAndDilutedEarningsLossPerShareFromDiscontinuedOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BasicAndDilutedEarningsLossPerShareFromDiscontinuedOperations_1948" xlink:to="lab_ifrs-full_BasicAndDilutedEarningsLossPerShareFromDiscontinuedOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BasicEarningsLossPerShare_1949" xlink:to="lab_ifrs-full_BasicEarningsLossPerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BasicEarningsLossPerShare_1950" xlink:to="lab_ifrs-full_BasicEarningsLossPerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BiologicalAssets_1951" xlink:to="lab_ifrs-full_BiologicalAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BiologicalAssets_1952" xlink:to="lab_ifrs-full_BiologicalAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BiologicalAssets_1953" xlink:to="lab_ifrs-full_BiologicalAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BiologicalAssets_1954" xlink:to="lab_ifrs-full_BiologicalAssets_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BiologicalAssetsByGroupAxis_1955" xlink:to="lab_ifrs-full_BiologicalAssetsByGroupAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BiologicalAssetsGroupMember_1956" xlink:to="lab_ifrs-full_BiologicalAssetsGroupMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsAbstract_1957" xlink:to="lab_ifrs-full_BorrowingsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsInterestRate_1958" xlink:to="lab_ifrs-full_BorrowingsInterestRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsInterestRate_1959" xlink:to="lab_ifrs-full_BorrowingsInterestRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_1960" xlink:to="lab_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_1961" xlink:to="lab_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_1962" xlink:to="lab_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BottomOfRangeMember_1963" xlink:to="lab_ifrs-full_BottomOfRangeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BottomOfRangeMember_1964" xlink:to="lab_ifrs-full_BottomOfRangeMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_1965" xlink:to="lab_ifrs-full_BusinessCombinationsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BusinessCombinationsMember_1966" xlink:to="lab_ifrs-full_BusinessCombinationsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1967" xlink:to="lab_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CarryingAmountMember_1968" xlink:to="lab_ifrs-full_CarryingAmountMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Cash_1969" xlink:to="lab_ifrs-full_Cash_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Cash_1970" xlink:to="lab_ifrs-full_Cash_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Cash_1971" xlink:to="lab_ifrs-full_Cash_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAbstract_1972" xlink:to="lab_ifrs-full_CashAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalents_1973" xlink:to="lab_ifrs-full_CashAndCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalents_1974" xlink:to="lab_ifrs-full_CashAndCashEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalents_1975" xlink:to="lab_ifrs-full_CashAndCashEquivalents_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalents_1976" xlink:to="lab_ifrs-full_CashAndCashEquivalents_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalents_1977" xlink:to="lab_ifrs-full_CashAndCashEquivalents_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_1978" xlink:to="lab_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_1979" xlink:to="lab_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_1980" xlink:to="lab_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_1981" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_1982" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_1983" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_1984" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_1985" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_1986" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_1987" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations_1988" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations_1989" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations_1990" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_1991" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_1992" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_1993" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_1994" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_1995" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_1996" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_1997" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_1998" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_1999" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_2000" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_2001" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_2002" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_2003" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations_2004" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations_2005" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations_2006" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_2007" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_2008" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_2009" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_2010" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashOutflowForLeases_2011" xlink:to="lab_ifrs-full_CashOutflowForLeases_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashOutflowForLeases_2012" xlink:to="lab_ifrs-full_CashOutflowForLeases_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashOutflowForLeases_2013" xlink:to="lab_ifrs-full_CashOutflowForLeases_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashOutflowForLeases_2014" xlink:to="lab_ifrs-full_CashOutflowForLeases_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashOutflowForLeases_2015" xlink:to="lab_ifrs-full_CashOutflowForLeases_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties_2016" xlink:to="lab_ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties_2017" xlink:to="lab_ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashTransferred_2018" xlink:to="lab_ifrs-full_CashTransferred_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_2019" xlink:to="lab_ifrs-full_CategoriesOfFinancialAssetsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_2020" xlink:to="lab_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_2021" xlink:to="lab_ifrs-full_CategoriesOfRelatedPartiesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract_2022" xlink:to="lab_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_2023" xlink:to="lab_ifrs-full_ClassesOfContingentLiabilitiesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_2024" xlink:to="lab_ifrs-full_ClassesOfFinancialInstrumentsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_2025" xlink:to="lab_ifrs-full_ClassesOfFinancialInstrumentsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_2026" xlink:to="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_2027" xlink:to="lab_ifrs-full_ClassesOfInventoriesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfOrdinarySharesAxis_2028" xlink:to="lab_ifrs-full_ClassesOfOrdinarySharesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_2029" xlink:to="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_2030" xlink:to="lab_ifrs-full_ClassesOfShareCapitalAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_2031" xlink:to="lab_ifrs-full_ClassesOfShareCapitalMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClosingForeignExchangeRate_2032" xlink:to="lab_ifrs-full_ClosingForeignExchangeRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClosingForeignExchangeRate_2033" xlink:to="lab_ifrs-full_ClosingForeignExchangeRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CommercialPapersIssued_2034" xlink:to="lab_ifrs-full_CommercialPapersIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CommercialPapersIssued_2035" xlink:to="lab_ifrs-full_CommercialPapersIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_2036" xlink:to="lab_ifrs-full_ComponentsOfEquityAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_2037" xlink:to="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_2038" xlink:to="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncome_2039" xlink:to="lab_ifrs-full_ComprehensiveIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncome_2040" xlink:to="lab_ifrs-full_ComprehensiveIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncome_2041" xlink:to="lab_ifrs-full_ComprehensiveIncome_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncome_2042" xlink:to="lab_ifrs-full_ComprehensiveIncome_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComputerEquipmentMember_2043" xlink:to="lab_ifrs-full_ComputerEquipmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComputerEquipmentMember_2044" xlink:to="lab_ifrs-full_ComputerEquipmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComputerEquipmentMember_2045" xlink:to="lab_ifrs-full_ComputerEquipmentMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ConstructionInProgressMember_2046" xlink:to="lab_ifrs-full_ConstructionInProgressMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ConstructionInProgressMember_2047" xlink:to="lab_ifrs-full_ConstructionInProgressMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContingentLiabilitiesMember_2048" xlink:to="lab_ifrs-full_ContingentLiabilitiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContractualCapitalCommitments_2049" xlink:to="lab_ifrs-full_ContractualCapitalCommitments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContractualCapitalCommitments_2050" xlink:to="lab_ifrs-full_ContractualCapitalCommitments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContractualCapitalCommitments_2051" xlink:to="lab_ifrs-full_ContractualCapitalCommitments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_2052" xlink:to="lab_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_2053" xlink:to="lab_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CostOfSales_2054" xlink:to="lab_ifrs-full_CostOfSales_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CostOfSales_2055" xlink:to="lab_ifrs-full_CostOfSales_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CostOfSales_2056" xlink:to="lab_ifrs-full_CostOfSales_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CounterpartiesAxis_2057" xlink:to="lab_ifrs-full_CounterpartiesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CounterpartiesMember_2058" xlink:to="lab_ifrs-full_CounterpartiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CreditRiskMember_2059" xlink:to="lab_ifrs-full_CreditRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CreditRiskMember_2060" xlink:to="lab_ifrs-full_CreditRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssets_2061" xlink:to="lab_ifrs-full_CurrentAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssets_2062" xlink:to="lab_ifrs-full_CurrentAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssets_2063" xlink:to="lab_ifrs-full_CurrentAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_2064" xlink:to="lab_ifrs-full_CurrentAssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_2065" xlink:to="lab_ifrs-full_CurrentAssetsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_2066" xlink:to="lab_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_2067" xlink:to="lab_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_2068" xlink:to="lab_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate_2069" xlink:to="lab_ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate_2070" xlink:to="lab_ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate_2071" xlink:to="lab_ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentDebtInstrumentsIssued_2072" xlink:to="lab_ifrs-full_CurrentDebtInstrumentsIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentDebtInstrumentsIssued_2073" xlink:to="lab_ifrs-full_CurrentDebtInstrumentsIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_2074" xlink:to="lab_ifrs-full_CurrentDerivativeFinancialLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_2075" xlink:to="lab_ifrs-full_CurrentDerivativeFinancialLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLeaseLiabilities_2076" xlink:to="lab_ifrs-full_CurrentLeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLeaseLiabilities_2077" xlink:to="lab_ifrs-full_CurrentLeaseLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLeaseLiabilities_2078" xlink:to="lab_ifrs-full_CurrentLeaseLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilities_2079" xlink:to="lab_ifrs-full_CurrentLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilities_2080" xlink:to="lab_ifrs-full_CurrentLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilities_2081" xlink:to="lab_ifrs-full_CurrentLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_2082" xlink:to="lab_ifrs-full_CurrentLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_2083" xlink:to="lab_ifrs-full_CurrentLiabilitiesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_2084" xlink:to="lab_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_2085" xlink:to="lab_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_2086" xlink:to="lab_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentPrepaidExpenses_2087" xlink:to="lab_ifrs-full_CurrentPrepaidExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentPrepaidExpenses_2088" xlink:to="lab_ifrs-full_CurrentPrepaidExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentPrepaidExpenses_2089" xlink:to="lab_ifrs-full_CurrentPrepaidExpenses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DecreaseDueToHarvestBiologicalAssets_2090" xlink:to="lab_ifrs-full_DecreaseDueToHarvestBiologicalAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DecreaseDueToHarvestBiologicalAssets_2091" xlink:to="lab_ifrs-full_DecreaseDueToHarvestBiologicalAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DecreaseDueToHarvestBiologicalAssets_2092" xlink:to="lab_ifrs-full_DecreaseDueToHarvestBiologicalAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DecreaseDueToHarvestBiologicalAssets_2093" xlink:to="lab_ifrs-full_DecreaseDueToHarvestBiologicalAssets_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxAssets_2094" xlink:to="lab_ifrs-full_DeferredTaxAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxAssets_2095" xlink:to="lab_ifrs-full_DeferredTaxAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxExpenseIncome_2096" xlink:to="lab_ifrs-full_DeferredTaxExpenseIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxExpenseIncome_2097" xlink:to="lab_ifrs-full_DeferredTaxExpenseIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxExpenseIncome_2098" xlink:to="lab_ifrs-full_DeferredTaxExpenseIncome_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilities_2099" xlink:to="lab_ifrs-full_DeferredTaxLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilities_2100" xlink:to="lab_ifrs-full_DeferredTaxLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilityAsset_2101" xlink:to="lab_ifrs-full_DeferredTaxLiabilityAsset_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilityAsset_2102" xlink:to="lab_ifrs-full_DeferredTaxLiabilityAsset_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilityAsset_2103" xlink:to="lab_ifrs-full_DeferredTaxLiabilityAsset_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilityAsset_2104" xlink:to="lab_ifrs-full_DeferredTaxLiabilityAsset_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilityAsset_2105" xlink:to="lab_ifrs-full_DeferredTaxLiabilityAsset_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilityAsset_2106" xlink:to="lab_ifrs-full_DeferredTaxLiabilityAsset_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationAndAmortisationExpense_2107" xlink:to="lab_ifrs-full_DepreciationAndAmortisationExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationAndAmortisationExpense_2108" xlink:to="lab_ifrs-full_DepreciationAndAmortisationExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationAndAmortisationExpense_2109" xlink:to="lab_ifrs-full_DepreciationAndAmortisationExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationAndAmortisationExpense_2110" xlink:to="lab_ifrs-full_DepreciationAndAmortisationExpense_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationBiologicalAssets_2111" xlink:to="lab_ifrs-full_DepreciationBiologicalAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationBiologicalAssets_2112" xlink:to="lab_ifrs-full_DepreciationBiologicalAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationBiologicalAssets_2113" xlink:to="lab_ifrs-full_DepreciationBiologicalAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationExpense_2114" xlink:to="lab_ifrs-full_DepreciationExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationExpense_2115" xlink:to="lab_ifrs-full_DepreciationExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationMethodPropertyPlantAndEquipment_2116" xlink:to="lab_ifrs-full_DepreciationMethodPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationMethodPropertyPlantAndEquipment_2117" xlink:to="lab_ifrs-full_DepreciationMethodPropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_2118" xlink:to="lab_ifrs-full_DepreciationPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_2119" xlink:to="lab_ifrs-full_DepreciationPropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationRightofuseAssets_2120" xlink:to="lab_ifrs-full_DepreciationRightofuseAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationRightofuseAssets_2121" xlink:to="lab_ifrs-full_DepreciationRightofuseAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationRightofuseAssets_2122" xlink:to="lab_ifrs-full_DepreciationRightofuseAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationRightofuseAssets_2123" xlink:to="lab_ifrs-full_DepreciationRightofuseAssets_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DerivativeFinancialLiabilities_2124" xlink:to="lab_ifrs-full_DerivativeFinancialLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForDecommissioningRestorationAndRehabilitationProvisionsExplanatory_2125" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForDecommissioningRestorationAndRehabilitationProvisionsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory_2126" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory_2127" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory_2128" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_2129" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_2130" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_2131" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_2132" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_2133" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_2134" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_2135" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_2136" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory_2137" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_2138" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_2139" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_2140" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_2141" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_2142" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_2143" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_2144" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_2145" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_2146" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_2147" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_2148" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_2149" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_2150" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_2151" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_2152" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForReclassificationOfFinancialInstrumentsExplanatory_2153" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForReclassificationOfFinancialInstrumentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_2154" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_2155" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_2156" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_2157" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_2158" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_2159" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_2160" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_2161" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_2162" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_2163" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_2164" xlink:to="lab_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_2165" xlink:to="lab_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_2166" xlink:to="lab_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_2167" xlink:to="lab_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_2168" xlink:to="lab_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_2169" xlink:to="lab_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_2170" xlink:to="lab_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements_2171" xlink:to="lab_ifrs-full_DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_2172" xlink:to="lab_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_2173" xlink:to="lab_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_2174" xlink:to="lab_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill_2175" xlink:to="lab_ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill_2176" xlink:to="lab_ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_2177" xlink:to="lab_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_2178" xlink:to="lab_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutedEarningsLossPerShare_2179" xlink:to="lab_ifrs-full_DilutedEarningsLossPerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutedEarningsLossPerShare_2180" xlink:to="lab_ifrs-full_DilutedEarningsLossPerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutedEarningsLossPerShare_2181" xlink:to="lab_ifrs-full_DilutedEarningsLossPerShare_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_2182" xlink:to="lab_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_2183" xlink:to="lab_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_2184" xlink:to="lab_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DirectorsRemunerationExpense_2185" xlink:to="lab_ifrs-full_DirectorsRemunerationExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DirectorsRemunerationExpense_2186" xlink:to="lab_ifrs-full_DirectorsRemunerationExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_2187" xlink:to="lab_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_2188" xlink:to="lab_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_2189" xlink:to="lab_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_2190" xlink:to="lab_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBorrowingsExplanatory_2191" xlink:to="lab_ifrs-full_DisclosureOfBorrowingsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBorrowingsExplanatory_2192" xlink:to="lab_ifrs-full_DisclosureOfBorrowingsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_2193" xlink:to="lab_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_2194" xlink:to="lab_ifrs-full_DisclosureOfBusinessCombinationsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_2195" xlink:to="lab_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_2196" xlink:to="lab_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_2197" xlink:to="lab_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_2198" xlink:to="lab_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_2199" xlink:to="lab_ifrs-full_DisclosureOfBusinessCombinationsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_2200" xlink:to="lab_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_2201" xlink:to="lab_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_2202" xlink:to="lab_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_2203" xlink:to="lab_ifrs-full_DisclosureOfClassesOfShareCapitalTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_2204" xlink:to="lab_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_2205" xlink:to="lab_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCommitmentsExplanatory_2206" xlink:to="lab_ifrs-full_DisclosureOfCommitmentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCommitmentsExplanatory_2207" xlink:to="lab_ifrs-full_DisclosureOfCommitmentsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_2208" xlink:to="lab_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_2209" xlink:to="lab_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_2210" xlink:to="lab_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_2211" xlink:to="lab_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_2212" xlink:to="lab_ifrs-full_DisclosureOfContingentLiabilitiesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExplanatory_2213" xlink:to="lab_ifrs-full_DisclosureOfCreditRiskExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExplanatory_2214" xlink:to="lab_ifrs-full_DisclosureOfCreditRiskExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDeferredTaxesExplanatory_2215" xlink:to="lab_ifrs-full_DisclosureOfDeferredTaxesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDeferredTaxesExplanatory_2216" xlink:to="lab_ifrs-full_DisclosureOfDeferredTaxesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory_2217" xlink:to="lab_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory_2218" xlink:to="lab_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_2219" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory_2220" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory_2221" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems_2222" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsTable_2223" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_2224" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_2225" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_2226" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_2227" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_2228" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_2229" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_2230" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_2231" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_2232" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_2233" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_2234" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_2235" xlink:to="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_2236" xlink:to="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_2237" xlink:to="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_2238" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_2239" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_2240" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_2241" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_2242" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_2243" xlink:to="lab_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_2244" xlink:to="lab_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_2245" xlink:to="lab_ifrs-full_DisclosureOfFinancialLiabilitiesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_2246" xlink:to="lab_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_2247" xlink:to="lab_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_2248" xlink:to="lab_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_2249" xlink:to="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_2250" xlink:to="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_2251" xlink:to="lab_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_2252" xlink:to="lab_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_2253" xlink:to="lab_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_2254" xlink:to="lab_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_2255" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_2256" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_2257" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_2258" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInventoriesExplanatory_2259" xlink:to="lab_ifrs-full_DisclosureOfInventoriesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInventoriesExplanatory_2260" xlink:to="lab_ifrs-full_DisclosureOfInventoriesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_2261" xlink:to="lab_ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_2262" xlink:to="lab_ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfLeasesExplanatory_2263" xlink:to="lab_ifrs-full_DisclosureOfLeasesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfLeasesExplanatory_2264" xlink:to="lab_ifrs-full_DisclosureOfLeasesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfLiquidityRiskExplanatory_2265" xlink:to="lab_ifrs-full_DisclosureOfLiquidityRiskExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfLiquidityRiskExplanatory_2266" xlink:to="lab_ifrs-full_DisclosureOfLiquidityRiskExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_2267" xlink:to="lab_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_2268" xlink:to="lab_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_2269" xlink:to="lab_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_2270" xlink:to="lab_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_2271" xlink:to="lab_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_2272" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_2273" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_2274" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_2275" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_2276" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory_2277" xlink:to="lab_ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory_2278" xlink:to="lab_ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_2279" xlink:to="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_2280" xlink:to="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_2281" xlink:to="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_2282" xlink:to="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_2283" xlink:to="lab_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_2284" xlink:to="lab_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_2285" xlink:to="lab_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_2286" xlink:to="lab_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_2287" xlink:to="lab_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_2288" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_2289" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_2290" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_2291" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_2292" xlink:to="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_2293" xlink:to="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_2294" xlink:to="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory_2295" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_2296" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_2297" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_2298" xlink:to="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_2299" xlink:to="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfRepurchaseAndReverseRepurchaseAgreementsExplanatory_2300" xlink:to="lab_ifrs-full_DisclosureOfRepurchaseAndReverseRepurchaseAgreementsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfRepurchaseAndReverseRepurchaseAgreementsExplanatory_2301" xlink:to="lab_ifrs-full_DisclosureOfRepurchaseAndReverseRepurchaseAgreementsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfRepurchaseAndReverseRepurchaseAgreementsExplanatory_2302" xlink:to="lab_ifrs-full_DisclosureOfRepurchaseAndReverseRepurchaseAgreementsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReservesWithinEquityAbstract_2303" xlink:to="lab_ifrs-full_DisclosureOfReservesWithinEquityAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_2304" xlink:to="lab_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_2305" xlink:to="lab_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_2306" xlink:to="lab_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_2307" xlink:to="lab_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_2308" xlink:to="lab_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_2309" xlink:to="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_2310" xlink:to="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_2311" xlink:to="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_2312" xlink:to="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_2313" xlink:to="lab_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_2314" xlink:to="lab_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_2315" xlink:to="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_2316" xlink:to="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_2317" xlink:to="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_2318" xlink:to="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_2319" xlink:to="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_2320" xlink:to="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_2321" xlink:to="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_2322" xlink:to="lab_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_2323" xlink:to="lab_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_2324" xlink:to="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_2325" xlink:to="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_2326" xlink:to="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory_2327" xlink:to="lab_ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory_2328" xlink:to="lab_ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember_2329" xlink:to="lab_ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember_2330" xlink:to="lab_ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisposalsPropertyPlantAndEquipment_2331" xlink:to="lab_ifrs-full_DisposalsPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisposalsPropertyPlantAndEquipment_2332" xlink:to="lab_ifrs-full_DisposalsPropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisposalsPropertyPlantAndEquipment_2333" xlink:to="lab_ifrs-full_DisposalsPropertyPlantAndEquipment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DistributionCosts_2334" xlink:to="lab_ifrs-full_DistributionCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DistributionCosts_2335" xlink:to="lab_ifrs-full_DistributionCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_2336" xlink:to="lab_ifrs-full_EarningsPerShareAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_2337" xlink:to="lab_ifrs-full_EarningsPerShareAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EarningsPerShareExplanatory_2338" xlink:to="lab_ifrs-full_EarningsPerShareExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EarningsPerShareExplanatory_2339" xlink:to="lab_ifrs-full_EarningsPerShareExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EarningsPerShareExplanatory_2340" xlink:to="lab_ifrs-full_EarningsPerShareExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EarningsPerShareLineItems_2341" xlink:to="lab_ifrs-full_EarningsPerShareLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EarningsPerShareTable_2342" xlink:to="lab_ifrs-full_EarningsPerShareTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_2343" xlink:to="lab_ifrs-full_EntitysTotalForBusinessCombinationsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_2344" xlink:to="lab_ifrs-full_EntitysTotalForRelatedPartiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_2345" xlink:to="lab_ifrs-full_EntitysTotalForSubsidiariesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Equity_2346" xlink:to="lab_ifrs-full_Equity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Equity_2347" xlink:to="lab_ifrs-full_Equity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Equity_2348" xlink:to="lab_ifrs-full_Equity_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Equity_2349" xlink:to="lab_ifrs-full_Equity_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Equity_2350" xlink:to="lab_ifrs-full_Equity_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Equity_2351" xlink:to="lab_ifrs-full_Equity_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAbstract_2352" xlink:to="lab_ifrs-full_EquityAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAbstract_2353" xlink:to="lab_ifrs-full_EquityAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAndLiabilities_2354" xlink:to="lab_ifrs-full_EquityAndLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAndLiabilities_2355" xlink:to="lab_ifrs-full_EquityAndLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_2356" xlink:to="lab_ifrs-full_EquityAndLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_2357" xlink:to="lab_ifrs-full_EquityAndLiabilitiesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityInterestsOfAcquirer_2358" xlink:to="lab_ifrs-full_EquityInterestsOfAcquirer_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityInterestsOfAcquirer_2359" xlink:to="lab_ifrs-full_EquityInterestsOfAcquirer_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityInterestsOfAcquirer_2360" xlink:to="lab_ifrs-full_EquityInterestsOfAcquirer_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityInterestsOfAcquirer_2361" xlink:to="lab_ifrs-full_EquityInterestsOfAcquirer_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityInterestsOfAcquirer_2362" xlink:to="lab_ifrs-full_EquityInterestsOfAcquirer_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityMember_2363" xlink:to="lab_ifrs-full_EquityMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExercisePriceOfOutstandingShareOptions2019_2364" xlink:to="lab_ifrs-full_ExercisePriceOfOutstandingShareOptions2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_2365" xlink:to="lab_ifrs-full_ExercisePriceShareOptionsGranted2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_2366" xlink:to="lab_ifrs-full_ExercisePriceShareOptionsGranted2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_2367" xlink:to="lab_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_2368" xlink:to="lab_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_2369" xlink:to="lab_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseByNature_2370" xlink:to="lab_ifrs-full_ExpenseByNature_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseByNature_2371" xlink:to="lab_ifrs-full_ExpenseByNature_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_2372" xlink:to="lab_ifrs-full_ExpenseByNatureAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_2373" xlink:to="lab_ifrs-full_ExpenseByNatureAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_2374" xlink:to="lab_ifrs-full_ExpenseByNatureAbstract_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_2375" xlink:to="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_2376" xlink:to="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_2377" xlink:to="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExplanationOfDesignatedFinancialAssetsThatAreHeldOutsideLegalEntityThatIssuesContractsWithinScopeOfIFRS4_2378" xlink:to="lab_ifrs-full_ExplanationOfDesignatedFinancialAssetsThatAreHeldOutsideLegalEntityThatIssuesContractsWithinScopeOfIFRS4_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FairValueOfAcquiredReceivables_2379" xlink:to="lab_ifrs-full_FairValueOfAcquiredReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FairValueOfAcquiredReceivables_2380" xlink:to="lab_ifrs-full_FairValueOfAcquiredReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceCosts_2381" xlink:to="lab_ifrs-full_FinanceCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceCosts_2382" xlink:to="lab_ifrs-full_FinanceCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceCosts_2383" xlink:to="lab_ifrs-full_FinanceCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_2384" xlink:to="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_2385" xlink:to="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsCategoryMember_2386" xlink:to="lab_ifrs-full_FinancialAssetsCategoryMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_2387" xlink:to="lab_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_2388" xlink:to="lab_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialLiabilitiesCategoryMember_2389" xlink:to="lab_ifrs-full_FinancialLiabilitiesCategoryMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinishedGoods_2390" xlink:to="lab_ifrs-full_FinishedGoods_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinishedGoods_2391" xlink:to="lab_ifrs-full_FinishedGoods_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FixturesAndFittingsMember_2392" xlink:to="lab_ifrs-full_FixturesAndFittingsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FixturesAndFittingsMember_2393" xlink:to="lab_ifrs-full_FixturesAndFittingsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives_2394" xlink:to="lab_ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives_2395" xlink:to="lab_ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives_2396" xlink:to="lab_ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives_2397" xlink:to="lab_ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnDisposalsOfInvestments_2398" xlink:to="lab_ifrs-full_GainsLossesOnDisposalsOfInvestments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnDisposalsOfInvestments_2399" xlink:to="lab_ifrs-full_GainsLossesOnDisposalsOfInvestments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnDisposalsOfInvestments_2400" xlink:to="lab_ifrs-full_GainsLossesOnDisposalsOfInvestments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnDisposalsOfInvestments_2401" xlink:to="lab_ifrs-full_GainsLossesOnDisposalsOfInvestments_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_2402" xlink:to="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_2403" xlink:to="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_2404" xlink:to="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_2405" xlink:to="lab_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_2406" xlink:to="lab_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_2407" xlink:to="lab_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_2408" xlink:to="lab_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_2409" xlink:to="lab_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets_2410" xlink:to="lab_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets_2411" xlink:to="lab_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets_2412" xlink:to="lab_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_2413" xlink:to="lab_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_2414" xlink:to="lab_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_2415" xlink:to="lab_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_2416" xlink:to="lab_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossAttributableToChangeInUnrealisedGainsOrLossesForAssetsHeldAtEndOfPeriodFairValueMeasurement_2417" xlink:to="lab_ifrs-full_GainsLossesRecognisedInProfitOrLossAttributableToChangeInUnrealisedGainsOrLossesForAssetsHeldAtEndOfPeriodFairValueMeasurement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossAttributableToChangeInUnrealisedGainsOrLossesForAssetsHeldAtEndOfPeriodFairValueMeasurement_2418" xlink:to="lab_ifrs-full_GainsLossesRecognisedInProfitOrLossAttributableToChangeInUnrealisedGainsOrLossesForAssetsHeldAtEndOfPeriodFairValueMeasurement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossAttributableToChangeInUnrealisedGainsOrLossesForAssetsHeldAtEndOfPeriodFairValueMeasurement_2419" xlink:to="lab_ifrs-full_GainsLossesRecognisedInProfitOrLossAttributableToChangeInUnrealisedGainsOrLossesForAssetsHeldAtEndOfPeriodFairValueMeasurement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GeneralAndAdministrativeExpense_2420" xlink:to="lab_ifrs-full_GeneralAndAdministrativeExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GeneralAndAdministrativeExpense_2421" xlink:to="lab_ifrs-full_GeneralAndAdministrativeExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GeneralAndAdministrativeExpense_2422" xlink:to="lab_ifrs-full_GeneralAndAdministrativeExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GeneralAndAdministrativeExpense_2423" xlink:to="lab_ifrs-full_GeneralAndAdministrativeExpense_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossCarryingAmountMember_2424" xlink:to="lab_ifrs-full_GrossCarryingAmountMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossCarryingAmountMember_2425" xlink:to="lab_ifrs-full_GrossCarryingAmountMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossCarryingAmountMember_2426" xlink:to="lab_ifrs-full_GrossCarryingAmountMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossLeaseLiabilities_2427" xlink:to="lab_ifrs-full_GrossLeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossLoanCommitments_2428" xlink:to="lab_ifrs-full_GrossLoanCommitments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossLoanCommitments_2429" xlink:to="lab_ifrs-full_GrossLoanCommitments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossProfit_2430" xlink:to="lab_ifrs-full_GrossProfit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossProfit_2431" xlink:to="lab_ifrs-full_GrossProfit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossProfit_2432" xlink:to="lab_ifrs-full_GrossProfit_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossProfit_2433" xlink:to="lab_ifrs-full_GrossProfit_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_2434" xlink:to="lab_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_2435" xlink:to="lab_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_2436" xlink:to="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_2437" xlink:to="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_2438" xlink:to="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_2439" xlink:to="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_2440" xlink:to="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_2441" xlink:to="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossOnFinancialAssets_2442" xlink:to="lab_ifrs-full_ImpairmentLossOnFinancialAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossOnFinancialAssets_2443" xlink:to="lab_ifrs-full_ImpairmentLossOnFinancialAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_2444" xlink:to="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_2445" xlink:to="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_2446" xlink:to="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeStatementAbstract_2447" xlink:to="lab_ifrs-full_IncomeStatementAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_2448" xlink:to="lab_ifrs-full_IncomeTaxesPaidRefundAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember_2449" xlink:to="lab_ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember_2450" xlink:to="lab_ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_2451" xlink:to="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_2452" xlink:to="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_2453" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_2454" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_2455" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_2456" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_2457" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_2458" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_2459" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_2460" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesInvestmentProperty_2461" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesInvestmentProperty_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesInvestmentProperty_2462" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesInvestmentProperty_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_2463" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_2464" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_2465" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InsuranceExpense_2466" xlink:to="lab_ifrs-full_InsuranceExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InsuranceExpense_2467" xlink:to="lab_ifrs-full_InsuranceExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_2468" xlink:to="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_2469" xlink:to="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_2470" xlink:to="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_2471" xlink:to="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_2472" xlink:to="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_2473" xlink:to="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_2474" xlink:to="lab_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife_2475" xlink:to="lab_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife_2476" xlink:to="lab_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseOnBorrowings_2477" xlink:to="lab_ifrs-full_InterestExpenseOnBorrowings_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_2478" xlink:to="lab_ifrs-full_InterestExpenseOnLeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_2479" xlink:to="lab_ifrs-full_InterestExpenseOnLeaseLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_2480" xlink:to="lab_ifrs-full_InterestExpenseOnLeaseLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestReceivable_2481" xlink:to="lab_ifrs-full_InterestReceivable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestReceivable_2482" xlink:to="lab_ifrs-full_InterestReceivable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Inventories_2483" xlink:to="lab_ifrs-full_Inventories_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Inventories_2484" xlink:to="lab_ifrs-full_Inventories_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Inventories_2485" xlink:to="lab_ifrs-full_Inventories_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InventoryWritedown2011_2486" xlink:to="lab_ifrs-full_InventoryWritedown2011_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InventoryWritedown2011_2487" xlink:to="lab_ifrs-full_InventoryWritedown2011_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssuedCapital_2488" xlink:to="lab_ifrs-full_IssuedCapital_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssuedCapital_2489" xlink:to="lab_ifrs-full_IssuedCapital_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssuedCapital_2490" xlink:to="lab_ifrs-full_IssuedCapital_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssuedCapital_2491" xlink:to="lab_ifrs-full_IssuedCapital_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssueOfEquity_2492" xlink:to="lab_ifrs-full_IssueOfEquity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssueOfEquity_2493" xlink:to="lab_ifrs-full_IssueOfEquity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssueOfEquity_2494" xlink:to="lab_ifrs-full_IssueOfEquity_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation_2495" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation_2496" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation_2497" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensation_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_2498" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_2499" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_2500" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_2501" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_2502" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_2503" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_2504" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_2505" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LandMember_2506" xlink:to="lab_ifrs-full_LandMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LandMember_2507" xlink:to="lab_ifrs-full_LandMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanFiveYearsMember_2508" xlink:to="lab_ifrs-full_LaterThanFiveYearsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanFiveYearsMember_2509" xlink:to="lab_ifrs-full_LaterThanFiveYearsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanFiveYearsMember_2510" xlink:to="lab_ifrs-full_LaterThanFiveYearsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_2511" xlink:to="lab_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_2512" xlink:to="lab_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_2513" xlink:to="lab_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_2514" xlink:to="lab_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_2515" xlink:to="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_2516" xlink:to="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_2517" xlink:to="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanOneYearMember_2518" xlink:to="lab_ifrs-full_LaterThanOneYearMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanOneYearMember_2519" xlink:to="lab_ifrs-full_LaterThanOneYearMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanOneYearMember_2520" xlink:to="lab_ifrs-full_LaterThanOneYearMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_2521" xlink:to="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_2522" xlink:to="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_2523" xlink:to="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_2524" xlink:to="lab_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_2525" xlink:to="lab_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_2526" xlink:to="lab_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilities_2527" xlink:to="lab_ifrs-full_LeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilities_2528" xlink:to="lab_ifrs-full_LeaseLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilities_2529" xlink:to="lab_ifrs-full_LeaseLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilities_2530" xlink:to="lab_ifrs-full_LeaseLiabilities_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilities_2531" xlink:to="lab_ifrs-full_LeaseLiabilities_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilities_2532" xlink:to="lab_ifrs-full_LeaseLiabilities_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilities_2533" xlink:to="lab_ifrs-full_LeaseLiabilities_6"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilitiesAbstract_2534" xlink:to="lab_ifrs-full_LeaseLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LegalProceedingsContingentLiabilityMember_2535" xlink:to="lab_ifrs-full_LegalProceedingsContingentLiabilityMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LegalProceedingsContingentLiabilityMember_2536" xlink:to="lab_ifrs-full_LegalProceedingsContingentLiabilityMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Level1OfFairValueHierarchyMember_2537" xlink:to="lab_ifrs-full_Level1OfFairValueHierarchyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Level1OfFairValueHierarchyMember_2538" xlink:to="lab_ifrs-full_Level1OfFairValueHierarchyMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Level2OfFairValueHierarchyMember_2539" xlink:to="lab_ifrs-full_Level2OfFairValueHierarchyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Level2OfFairValueHierarchyMember_2540" xlink:to="lab_ifrs-full_Level2OfFairValueHierarchyMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Level3OfFairValueHierarchyMember_2541" xlink:to="lab_ifrs-full_Level3OfFairValueHierarchyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Level3OfFairValueHierarchyMember_2542" xlink:to="lab_ifrs-full_Level3OfFairValueHierarchyMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_2543" xlink:to="lab_ifrs-full_LevelsOfFairValueHierarchyAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Liabilities_2544" xlink:to="lab_ifrs-full_Liabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Liabilities_2545" xlink:to="lab_ifrs-full_Liabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Liabilities_2546" xlink:to="lab_ifrs-full_Liabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Liabilities_2547" xlink:to="lab_ifrs-full_Liabilities_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Liabilities_2548" xlink:to="lab_ifrs-full_Liabilities_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Liabilities_2549" xlink:to="lab_ifrs-full_Liabilities_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Liabilities_2550" xlink:to="lab_ifrs-full_Liabilities_6"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilitiesAbstract_2551" xlink:to="lab_ifrs-full_LiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilitiesAbstract_2552" xlink:to="lab_ifrs-full_LiabilitiesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_2553" xlink:to="lab_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_2554" xlink:to="lab_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiquidityRiskMember_2555" xlink:to="lab_ifrs-full_LiquidityRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiquidityRiskMember_2556" xlink:to="lab_ifrs-full_LiquidityRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LoansAndReceivablesCategoryMember_2557" xlink:to="lab_ifrs-full_LoansAndReceivablesCategoryMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LoansAndReceivablesCategoryMember_2558" xlink:to="lab_ifrs-full_LoansAndReceivablesCategoryMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LossesOnChangeInFairValueOfDerivatives_2559" xlink:to="lab_ifrs-full_LossesOnChangeInFairValueOfDerivatives_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LossesOnChangeInFairValueOfDerivatives_2560" xlink:to="lab_ifrs-full_LossesOnChangeInFairValueOfDerivatives_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LossesOnChangeInFairValueOfDerivatives_2561" xlink:to="lab_ifrs-full_LossesOnChangeInFairValueOfDerivatives_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MachineryMember_2562" xlink:to="lab_ifrs-full_MachineryMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MachineryMember_2563" xlink:to="lab_ifrs-full_MachineryMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MarketRiskMember_2564" xlink:to="lab_ifrs-full_MarketRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MarketRiskMember_2565" xlink:to="lab_ifrs-full_MarketRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MaturityAxis_2566" xlink:to="lab_ifrs-full_MaturityAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MeasurementAxis_2567" xlink:to="lab_ifrs-full_MeasurementAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MediaProductionExpense_2568" xlink:to="lab_ifrs-full_MediaProductionExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MediaProductionExpense_2569" xlink:to="lab_ifrs-full_MediaProductionExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetDeferredTaxAssets_2570" xlink:to="lab_ifrs-full_NetDeferredTaxAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetDeferredTaxAssets_2571" xlink:to="lab_ifrs-full_NetDeferredTaxAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetDeferredTaxAssets_2572" xlink:to="lab_ifrs-full_NetDeferredTaxAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetDeferredTaxAssets_2573" xlink:to="lab_ifrs-full_NetDeferredTaxAssets_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetForeignExchangeGain_2574" xlink:to="lab_ifrs-full_NetForeignExchangeGain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetForeignExchangeGain_2575" xlink:to="lab_ifrs-full_NetForeignExchangeGain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetForeignExchangeGain_2576" xlink:to="lab_ifrs-full_NetForeignExchangeGain_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetForeignExchangeLoss_2577" xlink:to="lab_ifrs-full_NetForeignExchangeLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetForeignExchangeLoss_2578" xlink:to="lab_ifrs-full_NetForeignExchangeLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetForeignExchangeLoss_2579" xlink:to="lab_ifrs-full_NetForeignExchangeLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetForeignExchangeLoss_2580" xlink:to="lab_ifrs-full_NetForeignExchangeLoss_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_2581" xlink:to="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NonadjustingEventsMember_2582" xlink:to="lab_ifrs-full_NonadjustingEventsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_2583" xlink:to="lab_ifrs-full_NoncurrentAssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_2584" xlink:to="lab_ifrs-full_NoncurrentAssetsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_2585" xlink:to="lab_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_2586" xlink:to="lab_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_2587" xlink:to="lab_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_2588" xlink:to="lab_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_2589" xlink:to="lab_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_2590" xlink:to="lab_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLeaseLiabilities_2591" xlink:to="lab_ifrs-full_NoncurrentLeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLeaseLiabilities_2592" xlink:to="lab_ifrs-full_NoncurrentLeaseLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLeaseLiabilities_2593" xlink:to="lab_ifrs-full_NoncurrentLeaseLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLiabilities_2594" xlink:to="lab_ifrs-full_NoncurrentLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLiabilities_2595" xlink:to="lab_ifrs-full_NoncurrentLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_2596" xlink:to="lab_ifrs-full_NoncurrentLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_2597" xlink:to="lab_ifrs-full_NoncurrentLiabilitiesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NotesAndDebenturesIssued_2598" xlink:to="lab_ifrs-full_NotesAndDebenturesIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NotesAndDebenturesIssued_2599" xlink:to="lab_ifrs-full_NotesAndDebenturesIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NotLaterThanOneYearMember_2600" xlink:to="lab_ifrs-full_NotLaterThanOneYearMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NotLaterThanOneYearMember_2601" xlink:to="lab_ifrs-full_NotLaterThanOneYearMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NotLaterThanOneYearMember_2602" xlink:to="lab_ifrs-full_NotLaterThanOneYearMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_2603" xlink:to="lab_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_2604" xlink:to="lab_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_2605" xlink:to="lab_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_2606" xlink:to="lab_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_2607" xlink:to="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_2608" xlink:to="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_2609" xlink:to="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_2610" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_2611" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_2612" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_2613" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_2614" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_2615" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_2616" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_2617" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_2618" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_2619" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOutstandingShareOptions_2620" xlink:to="lab_ifrs-full_NumberOfOutstandingShareOptions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOutstandingShareOptions_2621" xlink:to="lab_ifrs-full_NumberOfOutstandingShareOptions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOutstandingShareOptions_2622" xlink:to="lab_ifrs-full_NumberOfOutstandingShareOptions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOutstandingShareOptions_2623" xlink:to="lab_ifrs-full_NumberOfOutstandingShareOptions_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_2624" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_2625" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_2626" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_2627" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_2628" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_2629" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_2630" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_2631" xlink:to="lab_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_2632" xlink:to="lab_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_2633" xlink:to="lab_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_2634" xlink:to="lab_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_2635" xlink:to="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_2636" xlink:to="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_2637" xlink:to="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_2638" xlink:to="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_2639" xlink:to="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_2640" xlink:to="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesIssued_2641" xlink:to="lab_ifrs-full_NumberOfSharesIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesIssued_2642" xlink:to="lab_ifrs-full_NumberOfSharesIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesIssued_2643" xlink:to="lab_ifrs-full_NumberOfSharesIssued_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesIssued_2644" xlink:to="lab_ifrs-full_NumberOfSharesIssued_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesIssued_2645" xlink:to="lab_ifrs-full_NumberOfSharesIssued_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesIssued_2646" xlink:to="lab_ifrs-full_NumberOfSharesIssued_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesIssued_2647" xlink:to="lab_ifrs-full_NumberOfSharesIssued_6"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesOutstanding_2648" xlink:to="lab_ifrs-full_NumberOfSharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesOutstanding_2649" xlink:to="lab_ifrs-full_NumberOfSharesOutstanding_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesOutstanding_2650" xlink:to="lab_ifrs-full_NumberOfSharesOutstanding_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesOutstanding_2651" xlink:to="lab_ifrs-full_NumberOfSharesOutstanding_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesOutstanding_2652" xlink:to="lab_ifrs-full_NumberOfSharesOutstanding_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OccupancyExpense_2653" xlink:to="lab_ifrs-full_OccupancyExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OccupancyExpense_2654" xlink:to="lab_ifrs-full_OccupancyExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OperatingExpense_2655" xlink:to="lab_ifrs-full_OperatingExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OperatingExpense_2656" xlink:to="lab_ifrs-full_OperatingExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OptionPricingModelMember_2657" xlink:to="lab_ifrs-full_OptionPricingModelMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OptionPricingModelMember_2658" xlink:to="lab_ifrs-full_OptionPricingModelMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OrdinarySharesMember_2659" xlink:to="lab_ifrs-full_OrdinarySharesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OrdinarySharesMember_2660" xlink:to="lab_ifrs-full_OrdinarySharesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_2661" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_2662" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_2663" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_2664" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_2665" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_2666" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherIncome_2667" xlink:to="lab_ifrs-full_OtherIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherIncome_2668" xlink:to="lab_ifrs-full_OtherIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherIncome_2669" xlink:to="lab_ifrs-full_OtherIncome_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherIncome_2670" xlink:to="lab_ifrs-full_OtherIncome_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherReceivables_2671" xlink:to="lab_ifrs-full_OtherReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherReceivables_2672" xlink:to="lab_ifrs-full_OtherReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherTangibleOrIntangibleAssetsTransferred_2673" xlink:to="lab_ifrs-full_OtherTangibleOrIntangibleAssetsTransferred_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsForShareIssueCosts_2674" xlink:to="lab_ifrs-full_PaymentsForShareIssueCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsForShareIssueCosts_2675" xlink:to="lab_ifrs-full_PaymentsForShareIssueCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsForShareIssueCosts_2676" xlink:to="lab_ifrs-full_PaymentsForShareIssueCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsForShareIssueCosts_2677" xlink:to="lab_ifrs-full_PaymentsForShareIssueCosts_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_2678" xlink:to="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_2679" xlink:to="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_2680" xlink:to="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_2681" xlink:to="lab_ifrs-full_PercentageOfVotingEquityInterestsAcquired_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_2682" xlink:to="lab_ifrs-full_PercentageOfVotingEquityInterestsAcquired_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PlantsMember_2683" xlink:to="lab_ifrs-full_PlantsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PlantsMember_2684" xlink:to="lab_ifrs-full_PlantsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PreviouslyStatedMember_2685" xlink:to="lab_ifrs-full_PreviouslyStatedMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PreviouslyStatedMember_2686" xlink:to="lab_ifrs-full_PreviouslyStatedMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary_2687" xlink:to="lab_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary_2688" xlink:to="lab_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromExerciseOfOptions_2689" xlink:to="lab_ifrs-full_ProceedsFromExerciseOfOptions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromExerciseOfOptions_2690" xlink:to="lab_ifrs-full_ProceedsFromExerciseOfOptions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromExerciseOfOptions_2691" xlink:to="lab_ifrs-full_ProceedsFromExerciseOfOptions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_2692" xlink:to="lab_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_2693" xlink:to="lab_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_2694" xlink:to="lab_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssuingShares_2695" xlink:to="lab_ifrs-full_ProceedsFromIssuingShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssuingShares_2696" xlink:to="lab_ifrs-full_ProceedsFromIssuingShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssuingShares_2697" xlink:to="lab_ifrs-full_ProceedsFromIssuingShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssuingShares_2698" xlink:to="lab_ifrs-full_ProceedsFromIssuingShares_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_2699" xlink:to="lab_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_2700" xlink:to="lab_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_2701" xlink:to="lab_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_2702" xlink:to="lab_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_2703" xlink:to="lab_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProductionSupplies_2704" xlink:to="lab_ifrs-full_ProductionSupplies_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProductionSupplies_2705" xlink:to="lab_ifrs-full_ProductionSupplies_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfessionalFeesExpense_2706" xlink:to="lab_ifrs-full_ProfessionalFeesExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfessionalFeesExpense_2707" xlink:to="lab_ifrs-full_ProfessionalFeesExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLoss_2708" xlink:to="lab_ifrs-full_ProfitLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLoss_2709" xlink:to="lab_ifrs-full_ProfitLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLoss_2710" xlink:to="lab_ifrs-full_ProfitLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLoss_2711" xlink:to="lab_ifrs-full_ProfitLoss_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLoss_2712" xlink:to="lab_ifrs-full_ProfitLoss_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossAbstract_2713" xlink:to="lab_ifrs-full_ProfitLossAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossAbstract_2714" xlink:to="lab_ifrs-full_ProfitLossAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_2715" xlink:to="lab_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_2716" xlink:to="lab_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromContinuingOperations_2717" xlink:to="lab_ifrs-full_ProfitLossFromContinuingOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromContinuingOperations_2718" xlink:to="lab_ifrs-full_ProfitLossFromContinuingOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromContinuingOperations_2719" xlink:to="lab_ifrs-full_ProfitLossFromContinuingOperations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromContinuingOperations_2720" xlink:to="lab_ifrs-full_ProfitLossFromContinuingOperations_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_2721" xlink:to="lab_ifrs-full_ProfitLossFromDiscontinuedOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_2722" xlink:to="lab_ifrs-full_ProfitLossFromDiscontinuedOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_2723" xlink:to="lab_ifrs-full_ProfitLossFromDiscontinuedOperations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_2724" xlink:to="lab_ifrs-full_ProfitLossFromOperatingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_2725" xlink:to="lab_ifrs-full_ProfitLossFromOperatingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_2726" xlink:to="lab_ifrs-full_ProfitLossFromOperatingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_2727" xlink:to="lab_ifrs-full_ProfitLossFromOperatingActivities_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipment_2728" xlink:to="lab_ifrs-full_PropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipment_2729" xlink:to="lab_ifrs-full_PropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipment_2730" xlink:to="lab_ifrs-full_PropertyPlantAndEquipment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipment_2731" xlink:to="lab_ifrs-full_PropertyPlantAndEquipment_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipment_2732" xlink:to="lab_ifrs-full_PropertyPlantAndEquipment_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipment_2733" xlink:to="lab_ifrs-full_PropertyPlantAndEquipment_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_2734" xlink:to="lab_ifrs-full_PropertyPlantAndEquipmentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_2735" xlink:to="lab_ifrs-full_PropertyPlantAndEquipmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_2736" xlink:to="lab_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_2737" xlink:to="lab_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_2738" xlink:to="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_2739" xlink:to="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_2740" xlink:to="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_2741" xlink:to="lab_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_2742" xlink:to="lab_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_2743" xlink:to="lab_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_2744" xlink:to="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_2745" xlink:to="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_2746" xlink:to="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_2747" xlink:to="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RangeAxis_2748" xlink:to="lab_ifrs-full_RangeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RangesMember_2749" xlink:to="lab_ifrs-full_RangesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_2750" xlink:to="lab_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_2751" xlink:to="lab_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RawMaterials_2752" xlink:to="lab_ifrs-full_RawMaterials_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RawMaterials_2753" xlink:to="lab_ifrs-full_RawMaterials_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RentalIncome_2754" xlink:to="lab_ifrs-full_RentalIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RentalIncome_2755" xlink:to="lab_ifrs-full_RentalIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RepaymentsOfBondsNotesAndDebentures_2756" xlink:to="lab_ifrs-full_RepaymentsOfBondsNotesAndDebentures_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RepaymentsOfBondsNotesAndDebentures_2757" xlink:to="lab_ifrs-full_RepaymentsOfBondsNotesAndDebentures_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ResearchAndDevelopmentExpense_2758" xlink:to="lab_ifrs-full_ResearchAndDevelopmentExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ResearchAndDevelopmentExpense_2759" xlink:to="lab_ifrs-full_ResearchAndDevelopmentExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_2760" xlink:to="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_2761" xlink:to="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_2762" xlink:to="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_2763" xlink:to="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfSharebasedPaymentsMember_2764" xlink:to="lab_ifrs-full_ReserveOfSharebasedPaymentsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfSharebasedPaymentsMember_2765" xlink:to="lab_ifrs-full_ReserveOfSharebasedPaymentsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RestatedMember_2766" xlink:to="lab_ifrs-full_RestatedMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarnings_2767" xlink:to="lab_ifrs-full_RetainedEarnings_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarnings_2768" xlink:to="lab_ifrs-full_RetainedEarnings_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarnings_2769" xlink:to="lab_ifrs-full_RetainedEarnings_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarnings_2770" xlink:to="lab_ifrs-full_RetainedEarnings_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarnings_2771" xlink:to="lab_ifrs-full_RetainedEarnings_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarningsMember_2772" xlink:to="lab_ifrs-full_RetainedEarningsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarningsMember_2773" xlink:to="lab_ifrs-full_RetainedEarningsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_2774" xlink:to="lab_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Revenue_2775" xlink:to="lab_ifrs-full_Revenue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Revenue_2776" xlink:to="lab_ifrs-full_Revenue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RightofuseAssets_2777" xlink:to="lab_ifrs-full_RightofuseAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RightofuseAssets_2778" xlink:to="lab_ifrs-full_RightofuseAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RightofuseAssets_2779" xlink:to="lab_ifrs-full_RightofuseAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RightofuseAssets_2780" xlink:to="lab_ifrs-full_RightofuseAssets_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_2781" xlink:to="lab_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SeparateManagementEntitiesAxis_2782" xlink:to="lab_ifrs-full_SeparateManagementEntitiesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SeparateManagementEntitiesMember_2783" xlink:to="lab_ifrs-full_SeparateManagementEntitiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SettlementOfLiabilitiesByEntityOnBehalfOfRelatedPartyRelatedPartyTransactions_2784" xlink:to="lab_ifrs-full_SettlementOfLiabilitiesByEntityOnBehalfOfRelatedPartyRelatedPartyTransactions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SettlementOfLiabilitiesByEntityOnBehalfOfRelatedPartyRelatedPartyTransactions_2785" xlink:to="lab_ifrs-full_SettlementOfLiabilitiesByEntityOnBehalfOfRelatedPartyRelatedPartyTransactions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_2786" xlink:to="lab_ifrs-full_SharebasedPaymentArrangementsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShareIssueRelatedCost_2787" xlink:to="lab_ifrs-full_ShareIssueRelatedCost_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShareIssueRelatedCost_2788" xlink:to="lab_ifrs-full_ShareIssueRelatedCost_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShareIssueRelatedCost_2789" xlink:to="lab_ifrs-full_ShareIssueRelatedCost_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShareIssueRelatedCost_2790" xlink:to="lab_ifrs-full_ShareIssueRelatedCost_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShareIssueRelatedCost_2791" xlink:to="lab_ifrs-full_ShareIssueRelatedCost_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SharePremium_2792" xlink:to="lab_ifrs-full_SharePremium_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShorttermBorrowingsMember_2793" xlink:to="lab_ifrs-full_ShorttermBorrowingsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShorttermBorrowingsMember_2794" xlink:to="lab_ifrs-full_ShorttermBorrowingsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_2795" xlink:to="lab_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_2796" xlink:to="lab_ifrs-full_StatementOfCashFlowsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfChangesInEquityAbstract_2797" xlink:to="lab_ifrs-full_StatementOfChangesInEquityAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_2798" xlink:to="lab_ifrs-full_StatementOfChangesInEquityLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_2799" xlink:to="lab_ifrs-full_StatementOfChangesInEquityTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_2800" xlink:to="lab_ifrs-full_StatementOfFinancialPositionAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SubsidiariesMember_2801" xlink:to="lab_ifrs-full_SubsidiariesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SubsidiariesMember_2802" xlink:to="lab_ifrs-full_SubsidiariesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_2803" xlink:to="lab_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_2804" xlink:to="lab_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_2805" xlink:to="lab_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxEffectOfForeignTaxRates_2806" xlink:to="lab_ifrs-full_TaxEffectOfForeignTaxRates_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxEffectOfForeignTaxRates_2807" xlink:to="lab_ifrs-full_TaxEffectOfForeignTaxRates_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_2808" xlink:to="lab_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_2809" xlink:to="lab_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_2810" xlink:to="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_2811" xlink:to="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TopOfRangeMember_2812" xlink:to="lab_ifrs-full_TopOfRangeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TopOfRangeMember_2813" xlink:to="lab_ifrs-full_TopOfRangeMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayables_2814" xlink:to="lab_ifrs-full_TradeAndOtherCurrentPayables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayables_2815" xlink:to="lab_ifrs-full_TradeAndOtherCurrentPayables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayables_2816" xlink:to="lab_ifrs-full_TradeAndOtherCurrentPayables_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_2817" xlink:to="lab_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivables_2818" xlink:to="lab_ifrs-full_TradeAndOtherCurrentReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivables_2819" xlink:to="lab_ifrs-full_TradeAndOtherCurrentReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivables_2820" xlink:to="lab_ifrs-full_TradeAndOtherCurrentReceivables_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivables_2821" xlink:to="lab_ifrs-full_TradeAndOtherCurrentReceivables_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_2822" xlink:to="lab_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_2823" xlink:to="lab_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_2824" xlink:to="lab_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_2825" xlink:to="lab_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherReceivables_2826" xlink:to="lab_ifrs-full_TradeAndOtherReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherReceivables_2827" xlink:to="lab_ifrs-full_TradeAndOtherReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherReceivables_2828" xlink:to="lab_ifrs-full_TradeAndOtherReceivables_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_2829" xlink:to="lab_ifrs-full_TradeAndOtherReceivablesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_2830" xlink:to="lab_ifrs-full_TradeAndOtherReceivablesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TravelExpense_2831" xlink:to="lab_ifrs-full_TravelExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TravelExpense_2832" xlink:to="lab_ifrs-full_TravelExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfRisksAxis_2833" xlink:to="lab_ifrs-full_TypesOfRisksAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfRisksMember_2834" xlink:to="lab_ifrs-full_TypesOfRisksMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_2835" xlink:to="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived_2836" xlink:to="lab_ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived_2837" xlink:to="lab_ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_2838" xlink:to="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_2839" xlink:to="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_2840" xlink:to="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ValuationTechniquesMember_2841" xlink:to="lab_ifrs-full_ValuationTechniquesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ValueAtRisk_2842" xlink:to="lab_ifrs-full_ValueAtRisk_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ValueAtRisk_2843" xlink:to="lab_ifrs-full_ValueAtRisk_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WagesAndSalaries_2844" xlink:to="lab_ifrs-full_WagesAndSalaries_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WagesAndSalaries_2845" xlink:to="lab_ifrs-full_WagesAndSalaries_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_2846" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_2847" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_2848" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_2849" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_2850" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_2851" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_2852" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_2853" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_2854" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_2855" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_2856" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_2857" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_2858" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_2859" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_2860" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_2861" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_2862" xlink:to="lab_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_2863" xlink:to="lab_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_2864" xlink:to="lab_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_2865" xlink:to="lab_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_2866" xlink:to="lab_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_2867" xlink:to="lab_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_2868" xlink:to="lab_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_2869" xlink:to="lab_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageShares_2870" xlink:to="lab_ifrs-full_WeightedAverageShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageShares_2871" xlink:to="lab_ifrs-full_WeightedAverageShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_2872" xlink:to="lab_ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_2873" xlink:to="lab_ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_2874" xlink:to="lab_ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WorkInProgress_2875" xlink:to="lab_ifrs-full_WorkInProgress_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WorkInProgress_2876" xlink:to="lab_ifrs-full_WorkInProgress_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_PresidentMember_2877" xlink:to="lab_srt_PresidentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_PresidentMember_2878" xlink:to="lab_srt_PresidentMember_1"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>16
<FILENAME>huge-20201231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#AcquisitionOfPrismicPharmaceutical" roleURI="http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceutical"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#AcquisitionOfPrismicPharmaceuticalNarrativeDetails" roleURI="http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#AcquisitionOfPrismicPharmaceuticalScheduleOfBlackScholesOptionsPricingModelDetails" roleURI="http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalScheduleOfBlackScholesOptionsPricingModelDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#AcquisitionOfPrismicPharmaceuticalScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" roleURI="http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#AcquisitionOfPrismicPharmaceuticalTables" roleURI="http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalTables"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#BasisOfPresentation" roleURI="http://www.fsdpharma.com/role/BasisOfPresentation"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#CapitalManagement" roleURI="http://www.fsdpharma.com/role/CapitalManagement"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#CapitalManagementNarrativeDetails" roleURI="http://www.fsdpharma.com/role/CapitalManagementNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#CommitmentsAndContingencies" roleURI="http://www.fsdpharma.com/role/CommitmentsAndContingencies"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#CommitmentsAndContingenciesNarrativeDetails" roleURI="http://www.fsdpharma.com/role/CommitmentsAndContingenciesNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#CommitmentsAndContingenciesScheduleOfQuantitiesOfCannabisAvailableToSupplyByFiscalPeriodDetails" roleURI="http://www.fsdpharma.com/role/CommitmentsAndContingenciesScheduleOfQuantitiesOfCannabisAvailableToSupplyByFiscalPeriodDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#CommitmentsAndContingenciesTables" roleURI="http://www.fsdpharma.com/role/CommitmentsAndContingenciesTables"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" roleURI="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION" roleURI="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#CONSOLIDATEDSTATEMENTSOFLOSSANDCOMPREHENSIVELOSS" roleURI="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFLOSSANDCOMPREHENSIVELOSS"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#DocumentAndEntityInformation" roleURI="http://www.fsdpharma.com/role/DocumentAndEntityInformation"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#FinancialInstrumentsAndRiskManagement" roleURI="http://www.fsdpharma.com/role/FinancialInstrumentsAndRiskManagement"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#GeneralAndAdministrative" roleURI="http://www.fsdpharma.com/role/GeneralAndAdministrative"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#GeneralAndAdministrativeDetails" roleURI="http://www.fsdpharma.com/role/GeneralAndAdministrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#GeneralAndAdministrativeTables" roleURI="http://www.fsdpharma.com/role/GeneralAndAdministrativeTables"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#IncomeTaxes" roleURI="http://www.fsdpharma.com/role/IncomeTaxes"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#IncomeTaxesScheduleOfNoncapitalLossCarryforwardsDetails" roleURI="http://www.fsdpharma.com/role/IncomeTaxesScheduleOfNoncapitalLossCarryforwardsDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#IncomeTaxesScheduleOfProvisionForIncomeTaxesDetails" roleURI="http://www.fsdpharma.com/role/IncomeTaxesScheduleOfProvisionForIncomeTaxesDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#IncomeTaxesScheduleOfTemporaryDifferencesForWhichDeferredTaxAssetsNotRecognisedDetails" roleURI="http://www.fsdpharma.com/role/IncomeTaxesScheduleOfTemporaryDifferencesForWhichDeferredTaxAssetsNotRecognisedDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#IncometaxesTables" roleURI="http://www.fsdpharma.com/role/IncometaxesTables"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#IntangibleAssets" roleURI="http://www.fsdpharma.com/role/IntangibleAssets"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#IntangibleAssetsNarrativeDetails" roleURI="http://www.fsdpharma.com/role/IntangibleAssetsNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#IntangibleAssetsScheduleOfIntangibleAssetsDetails" roleURI="http://www.fsdpharma.com/role/IntangibleAssetsScheduleOfIntangibleAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#IntangibleAssetsTables" roleURI="http://www.fsdpharma.com/role/IntangibleAssetsTables"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#LeaseObligations" roleURI="http://www.fsdpharma.com/role/LeaseObligations"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#LeaseObligationsScheduleOfLeaseObligationsDetails" roleURI="http://www.fsdpharma.com/role/LeaseObligationsScheduleOfLeaseObligationsDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#LeaseObligationsScheduleOfMaturityAnalysisOfOperatingLeasePaymentsDetails" roleURI="http://www.fsdpharma.com/role/LeaseObligationsScheduleOfMaturityAnalysisOfOperatingLeasePaymentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#LeaseObligationsTables" roleURI="http://www.fsdpharma.com/role/LeaseObligationsTables"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#LossPerShare" roleURI="http://www.fsdpharma.com/role/LossPerShare"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#LossPerShareDetails" roleURI="http://www.fsdpharma.com/role/LossPerShareDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#LossPerShareTables" roleURI="http://www.fsdpharma.com/role/LossPerShareTables"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#NatureOfBusinessScheduleOfOwnershipPercentageInSubsidiariesDetails" roleURI="http://www.fsdpharma.com/role/NatureOfBusinessScheduleOfOwnershipPercentageInSubsidiariesDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#NatureOfBusinessTable" roleURI="http://www.fsdpharma.com/role/NatureOfBusinessTable"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#NotesPayable" roleURI="http://www.fsdpharma.com/role/NotesPayable"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#NotesPayableNarrativeDetails" roleURI="http://www.fsdpharma.com/role/NotesPayableNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#NotesPayableScheduleOfNotesPayableDetails" roleURI="http://www.fsdpharma.com/role/NotesPayableScheduleOfNotesPayableDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#NotesPayableTables" roleURI="http://www.fsdpharma.com/role/NotesPayableTables"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#OtherInvestments" roleURI="http://www.fsdpharma.com/role/OtherInvestments"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#OtherInvestmentsNarrativeDetails" roleURI="http://www.fsdpharma.com/role/OtherInvestmentsNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#OtherInvestmentsScheduleOfOtherInvestmentsDetails" roleURI="http://www.fsdpharma.com/role/OtherInvestmentsScheduleOfOtherInvestmentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#OtherinvestmentsTables" roleURI="http://www.fsdpharma.com/role/OtherinvestmentsTables"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#RelatedPartyTransactions" roleURI="http://www.fsdpharma.com/role/RelatedPartyTransactions"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#RelatedPartyTransactionsNarrativeDetails" roleURI="http://www.fsdpharma.com/role/RelatedPartyTransactionsNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#RelatedPartyTransactionsScheduleOfKeyManagementPersonnelCompensationDetails" roleURI="http://www.fsdpharma.com/role/RelatedPartyTransactionsScheduleOfKeyManagementPersonnelCompensationDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#RelatedPartyTransactionsTables" roleURI="http://www.fsdpharma.com/role/RelatedPartyTransactionsTables"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#RightofuseAsset" roleURI="http://www.fsdpharma.com/role/RightofuseAsset"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#RightofuseAssetScheduleOfRightofuseAssetDetails" roleURI="http://www.fsdpharma.com/role/RightofuseAssetScheduleOfRightofuseAssetDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#RightofuseAssetTables" roleURI="http://www.fsdpharma.com/role/RightofuseAssetTables"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#SegmentedInformation" roleURI="http://www.fsdpharma.com/role/SegmentedInformation"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#SharebasedCompensation" roleURI="http://www.fsdpharma.com/role/SharebasedCompensation"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#SharebasedCompensationNarrativeDetails" roleURI="http://www.fsdpharma.com/role/SharebasedCompensationNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#SharebasedCompensationScheduleOfChangesInNumberOfShareOptionsDetails" roleURI="http://www.fsdpharma.com/role/SharebasedCompensationScheduleOfChangesInNumberOfShareOptionsDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#SharebasedCompensationScheduleOfExercisePriceAndWeightedAverageContractualTermOfShareOptionsOutstandingAndExercisableDetails" roleURI="http://www.fsdpharma.com/role/SharebasedCompensationScheduleOfExercisePriceAndWeightedAverageContractualTermOfShareOptionsOutstandingAndExercisableDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#SharebasedCompensationScheduleOfFairValueAssumptionsOfShareOptionsGrantedDetails" roleURI="http://www.fsdpharma.com/role/SharebasedCompensationScheduleOfFairValueAssumptionsOfShareOptionsGrantedDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#SharebasedCompensationTables" roleURI="http://www.fsdpharma.com/role/SharebasedCompensationTables"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#ShareCapital" roleURI="http://www.fsdpharma.com/role/ShareCapital"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#ShareCapitalNarrativeDetails" roleURI="http://www.fsdpharma.com/role/ShareCapitalNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#ShareCapitalScheduleOfChangesInNumberOfWarrantsOutstandingDetails" roleURI="http://www.fsdpharma.com/role/ShareCapitalScheduleOfChangesInNumberOfWarrantsOutstandingDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#ShareCapitalScheduleOfFairValueAssumptionsOfWarrantsDetails" roleURI="http://www.fsdpharma.com/role/ShareCapitalScheduleOfFairValueAssumptionsOfWarrantsDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#ShareCapitalScheduleOfReconciliationOfTheShareCapitalDetails" roleURI="http://www.fsdpharma.com/role/ShareCapitalScheduleOfReconciliationOfTheShareCapitalDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#ShareCapitalScheduleOfWarrantsOutstandingAndExercisePriceDetails" roleURI="http://www.fsdpharma.com/role/ShareCapitalScheduleOfWarrantsOutstandingAndExercisePriceDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#ShareCapitalTables" roleURI="http://www.fsdpharma.com/role/ShareCapitalTables"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#SignificantAccountingPolicies" roleURI="http://www.fsdpharma.com/role/SignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#SignificantAccountingPoliciesPolicies" roleURI="http://www.fsdpharma.com/role/SignificantAccountingPoliciesPolicies"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#SignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfAssetsDetails" roleURI="http://www.fsdpharma.com/role/SignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#SignificantAccountingPoliciesTables" roleURI="http://www.fsdpharma.com/role/SignificantAccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#SubsequentEvents" roleURI="http://www.fsdpharma.com/role/SubsequentEvents"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#SubsequentEventsNarrativeDetails" roleURI="http://www.fsdpharma.com/role/SubsequentEventsNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#TradeAndOtherReceivables" roleURI="http://www.fsdpharma.com/role/TradeAndOtherReceivables"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails" roleURI="http://www.fsdpharma.com/role/TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#TradeAndOtherReceivablesTables" roleURI="http://www.fsdpharma.com/role/TradeAndOtherReceivablesTables"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#NatureOfBusiness" roleURI="http://www.fsdpharma.com/role/NatureOfBusiness"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#LeaseObligationsNarrativeDetails" roleURI="http://www.fsdpharma.com/role/LeaseObligationsNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#RightofuseAssetNarrativeDetails" roleURI="http://www.fsdpharma.com/role/RightofuseAssetNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#BasisOfPresentationScheduleOfRestatementOfPriorPeriodInformationDetails" roleURI="http://www.fsdpharma.com/role/BasisOfPresentationScheduleOfRestatementOfPriorPeriodInformationDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#BasisOfPresentationTables" roleURI="http://www.fsdpharma.com/role/BasisOfPresentationTables"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#AssetsHeldForSale" roleURI="http://www.fsdpharma.com/role/AssetsHeldForSale"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#AssetsHeldForSaleTables" roleURI="http://www.fsdpharma.com/role/AssetsHeldForSaleTables"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#AssetsHeldForSaleDetails" roleURI="http://www.fsdpharma.com/role/AssetsHeldForSaleDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#AssetsHeldForSaleDetails2" roleURI="http://www.fsdpharma.com/role/AssetsHeldForSaleDetails2"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#AssetsHeldForSaleDetails1" roleURI="http://www.fsdpharma.com/role/AssetsHeldForSaleDetails1"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#AssetsHeldForSaleDetailTextuals" roleURI="http://www.fsdpharma.com/role/AssetsHeldForSaleDetailTextuals"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#WarrantsLiabilityDetailTextuals" roleURI="http://www.fsdpharma.com/role/WarrantsLiabilityDetailTextuals"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#WarrantsLiability" roleURI="http://www.fsdpharma.com/role/WarrantsLiability"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#IncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails" roleURI="http://www.fsdpharma.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="huge-20201231.xsd#IncomeTaxesNarrativeDetails" roleURI="http://www.fsdpharma.com/role/IncomeTaxesNarrativeDetails"/>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceutical">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LegalEntitiesAxis" xlink:label="loc_huge_LegalEntitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LegalEntitiesDomain" xlink:label="loc_huge_LegalEntitiesDomain_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PrismicPharmaceuticalMember" xlink:label="loc_huge_PrismicPharmaceuticalMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_4"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassBVotingSharesMember" xlink:label="loc_huge_ClassBVotingSharesMember_4"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_StockOptionsMember" xlink:label="loc_huge_StockOptionsMember_5"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsMember" xlink:label="loc_huge_WarrantsMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityInterestsOfAcquirer" xlink:label="loc_ifrs-full_EquityInterestsOfAcquirer_9"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares" xlink:label="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_10"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShareIssuePricePerShare" xlink:label="loc_huge_ShareIssuePricePerShare_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable" xlink:label="loc_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_12"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_huge_LegalEntitiesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_LegalEntitiesAxis_1" xlink:to="loc_huge_LegalEntitiesDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_LegalEntitiesDomain_1" xlink:to="loc_huge_PrismicPharmaceuticalMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_4" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_4" xlink:to="loc_huge_ClassBVotingSharesMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_4" xlink:to="loc_huge_StockOptionsMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_4" xlink:to="loc_huge_WarrantsMember_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_9" xlink:to="loc_ifrs-full_EquityInterestsOfAcquirer_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_9" xlink:to="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_9" xlink:to="loc_huge_ShareIssuePricePerShare_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_9" xlink:to="loc_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_12" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalScheduleOfBlackScholesOptionsPricingModelDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LegalEntitiesAxis" xlink:label="loc_huge_LegalEntitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LegalEntitiesDomain" xlink:label="loc_huge_LegalEntitiesDomain_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PrismicPharmaceuticalMember" xlink:label="loc_huge_PrismicPharmaceuticalMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_8"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShareOptionsAbstract" xlink:label="loc_huge_ShareOptionsAbstract_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_13"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsAbstract" xlink:label="loc_huge_WarrantsAbstract_15"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WeightedAverageSharePriceOfWarrants" xlink:label="loc_huge_WeightedAverageSharePriceOfWarrants_15"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceOfWarrantsGranted" xlink:label="loc_huge_ExercisePriceOfWarrantsGranted_16"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedDividendYieldOfWarrantsGranted" xlink:label="loc_huge_ExpectedDividendYieldOfWarrantsGranted_17"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_RiskFreeInterestRateOfWarrantsGranted" xlink:label="loc_huge_RiskFreeInterestRateOfWarrantsGranted_18"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedLifeOfWarrants" xlink:label="loc_huge_ExpectedLifeOfWarrants_19"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedVolatilityOfWarrantsGranted" xlink:label="loc_huge_ExpectedVolatilityOfWarrantsGranted_20"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_huge_LegalEntitiesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_LegalEntitiesAxis_1" xlink:to="loc_huge_LegalEntitiesDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_LegalEntitiesDomain_1" xlink:to="loc_huge_PrismicPharmaceuticalMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_RangeAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_4" xlink:to="loc_ifrs-full_RangesMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_4" xlink:to="loc_ifrs-full_BottomOfRangeMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_4" xlink:to="loc_ifrs-full_TopOfRangeMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_8" xlink:to="loc_huge_ShareOptionsAbstract_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ShareOptionsAbstract_8" xlink:to="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ShareOptionsAbstract_8" xlink:to="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ShareOptionsAbstract_8" xlink:to="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ShareOptionsAbstract_8" xlink:to="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_11" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ShareOptionsAbstract_8" xlink:to="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_12" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ShareOptionsAbstract_8" xlink:to="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_13" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_8" xlink:to="loc_huge_WarrantsAbstract_15" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_WarrantsAbstract_15" xlink:to="loc_huge_WeightedAverageSharePriceOfWarrants_15" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_WarrantsAbstract_15" xlink:to="loc_huge_ExercisePriceOfWarrantsGranted_16" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_WarrantsAbstract_15" xlink:to="loc_huge_ExpectedDividendYieldOfWarrantsGranted_17" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_WarrantsAbstract_15" xlink:to="loc_huge_RiskFreeInterestRateOfWarrantsGranted_18" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_WarrantsAbstract_15" xlink:to="loc_huge_ExpectedLifeOfWarrants_19" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_WarrantsAbstract_15" xlink:to="loc_huge_ExpectedVolatilityOfWarrantsGranted_20" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LegalEntitiesAxis" xlink:label="loc_huge_LegalEntitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LegalEntitiesDomain" xlink:label="loc_huge_LegalEntitiesDomain_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PrismicPharmaceuticalMember" xlink:label="loc_huge_PrismicPharmaceuticalMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_9"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_huge_LegalEntitiesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_LegalEntitiesAxis_1" xlink:to="loc_huge_LegalEntitiesDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_LegalEntitiesDomain_1" xlink:to="loc_huge_PrismicPharmaceuticalMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_4" xlink:to="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_4" xlink:to="loc_ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_4" xlink:to="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_4" xlink:to="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_4" xlink:to="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_4" xlink:to="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0" xlink:to="loc_huge_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/BasisOfPresentation">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BasisOfPresentationAbstract" xlink:label="loc_huge_BasisOfPresentationAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_BasisOfPresentationAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/CapitalManagement">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfCapitalManagementAbstract" xlink:label="loc_huge_DisclosureOfCapitalManagementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory" xlink:label="loc_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfCapitalManagementAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/CapitalManagementNarrativeDetails">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfCapitalManagementAbstract" xlink:label="loc_huge_DisclosureOfCapitalManagementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfCapitalManagementAbstract_0" xlink:to="loc_ifrs-full_IssuedCapital_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/CommitmentsAndContingencies">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfCommitmentsAndContingentLiabilitiesAbstract" xlink:label="loc_huge_DisclosureOfCommitmentsAndContingentLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfCommitmentsAndContingentLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/CommitmentsAndContingenciesNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesTable" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TypeOfArrangementsAxis" xlink:label="loc_huge_TypeOfArrangementsAxis_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TypeOfArrangementsDomain" xlink:label="loc_huge_TypeOfArrangementsDomain_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SupplyAgreementMember" xlink:label="loc_huge_SupplyAgreementMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_EpitechLicenseAgreementMember" xlink:label="loc_huge_EpitechLicenseAgreementMember_2"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_HeritageBuildingRestorationCommitmentMember" xlink:label="loc_huge_HeritageBuildingRestorationCommitmentMember_3"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DefinitiveStrategicAllianceAndStreamingAgreementMember" xlink:label="loc_huge_DefinitiveStrategicAllianceAndStreamingAgreementMember_4"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DefinitiveSettlementAgreementMember" xlink:label="loc_huge_DefinitiveSettlementAgreementMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:label="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContingentLiabilitiesMember" xlink:label="loc_ifrs-full_ContingentLiabilitiesMember_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LegalProceedingsContingentLiabilityMember" xlink:label="loc_ifrs-full_LegalProceedingsContingentLiabilityMember_8"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember" xlink:label="loc_huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CounterpartiesAxis" xlink:label="loc_ifrs-full_CounterpartiesAxis_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CounterpartiesMember" xlink:label="loc_ifrs-full_CounterpartiesMember_12"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AuxlyCannabisGroupIncMember" xlink:label="loc_huge_AuxlyCannabisGroupIncMember_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_15"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CanntabTherapeuticsLtdWorldClassExtractionsIncMember" xlink:label="loc_huge_CanntabTherapeuticsLtdWorldClassExtractionsIncMember_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_18"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonRefundableSumDueAndPayableUponFirstNotificationOfFda" xlink:label="loc_huge_NonRefundableSumDueAndPayableUponFirstNotificationOfFda_18"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFda" xlink:label="loc_huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFda_19"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights" xlink:label="loc_huge_PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights_20"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights" xlink:label="loc_huge_PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights_21"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition" xlink:label="loc_huge_PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition_22"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition" xlink:label="loc_huge_PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition_23"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition" xlink:label="loc_huge_PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition_24"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_EstimatedCostOfRestorationInCommitment" xlink:label="loc_huge_EstimatedCostOfRestorationInCommitment_25"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PartialPaymentOfSettlementAmount" xlink:label="loc_huge_PartialPaymentOfSettlementAmount_26"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClaimSettlementAmountCoveredByInsurance" xlink:label="loc_huge_ClaimSettlementAmountCoveredByInsurance_27"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClaimIssuedByContractorForVariousPurportedDamages" xlink:label="loc_huge_ClaimIssuedByContractorForVariousPurportedDamages_28"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClaimForLienComponent" xlink:label="loc_huge_ClaimForLienComponent_29"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees" xlink:label="loc_huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees_30"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FundsPaidForSettlementAgreement" xlink:label="loc_huge_FundsPaidForSettlementAgreement_31"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProvisionForEmployeeRelatedLiability" xlink:label="loc_huge_ProvisionForEmployeeRelatedLiability_32"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PaymentMadeToBeUnpaidWagesAndUnpaidHoliday" xlink:label="loc_huge_PaymentMadeToBeUnpaidWagesAndUnpaidHoliday_33"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_InsuredAmountForClaimSettlemnt" xlink:label="loc_huge_InsuredAmountForClaimSettlemnt_34"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement" xlink:label="loc_huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement_35"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement" xlink:label="loc_huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement_36"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_huge_TypeOfArrangementsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_TypeOfArrangementsAxis_1" xlink:to="loc_huge_TypeOfArrangementsDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_TypeOfArrangementsDomain_1" xlink:to="loc_huge_SupplyAgreementMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_TypeOfArrangementsDomain_1" xlink:to="loc_huge_EpitechLicenseAgreementMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_TypeOfArrangementsDomain_1" xlink:to="loc_huge_HeritageBuildingRestorationCommitmentMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_TypeOfArrangementsDomain_1" xlink:to="loc_huge_DefinitiveStrategicAllianceAndStreamingAgreementMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_TypeOfArrangementsDomain_1" xlink:to="loc_huge_DefinitiveSettlementAgreementMember_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_8" xlink:to="loc_ifrs-full_ContingentLiabilitiesMember_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ContingentLiabilitiesMember_8" xlink:to="loc_ifrs-full_LegalProceedingsContingentLiabilityMember_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ContingentLiabilitiesMember_8" xlink:to="loc_huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_ifrs-full_CounterpartiesAxis_12" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesAxis_12" xlink:to="loc_ifrs-full_CounterpartiesMember_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesMember_12" xlink:to="loc_huge_AuxlyCannabisGroupIncMember_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_dei_LegalEntityAxis_15" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_15" xlink:to="loc_dei_EntityDomain_15" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_15" xlink:to="loc_huge_CanntabTherapeuticsLtdWorldClassExtractionsIncMember_15" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_18" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_18" xlink:to="loc_huge_NonRefundableSumDueAndPayableUponFirstNotificationOfFda_18" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_18" xlink:to="loc_huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFda_19" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_18" xlink:to="loc_huge_PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights_20" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_18" xlink:to="loc_huge_PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights_21" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_18" xlink:to="loc_huge_PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition_22" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_18" xlink:to="loc_huge_PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition_23" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_18" xlink:to="loc_huge_PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition_24" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_18" xlink:to="loc_huge_EstimatedCostOfRestorationInCommitment_25" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_18" xlink:to="loc_huge_PartialPaymentOfSettlementAmount_26" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_18" xlink:to="loc_huge_ClaimSettlementAmountCoveredByInsurance_27" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_18" xlink:to="loc_huge_ClaimIssuedByContractorForVariousPurportedDamages_28" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_18" xlink:to="loc_huge_ClaimForLienComponent_29" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_18" xlink:to="loc_huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees_30" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_18" xlink:to="loc_huge_FundsPaidForSettlementAgreement_31" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_18" xlink:to="loc_huge_ProvisionForEmployeeRelatedLiability_32" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_18" xlink:to="loc_huge_PaymentMadeToBeUnpaidWagesAndUnpaidHoliday_33" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_18" xlink:to="loc_huge_InsuredAmountForClaimSettlemnt_34" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_18" xlink:to="loc_huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement_35" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_18" xlink:to="loc_huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement_36" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/CommitmentsAndContingenciesScheduleOfQuantitiesOfCannabisAvailableToSupplyByFiscalPeriodDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesTable" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CounterpartiesAxis" xlink:label="loc_ifrs-full_CounterpartiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CounterpartiesMember" xlink:label="loc_ifrs-full_CounterpartiesMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PharmadrugProductionGMBHMember" xlink:label="loc_huge_PharmadrugProductionGMBHMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TypeOfArrangementsAxis" xlink:label="loc_huge_TypeOfArrangementsAxis_4"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TypeOfArrangementsDomain" xlink:label="loc_huge_TypeOfArrangementsDomain_4"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SupplyAgreementMember" xlink:label="loc_huge_SupplyAgreementMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_7"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FvPharmaIncMember" xlink:label="loc_huge_FvPharmaIncMember_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_10"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_QuantitiesAvailableToSupplyInNextFiscalYear" xlink:label="loc_huge_QuantitiesAvailableToSupplyInNextFiscalYear_10"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_QuantitiesAvailableToSupplyInSecondFiscalYear" xlink:label="loc_huge_QuantitiesAvailableToSupplyInSecondFiscalYear_11"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_QuantitiesAvailableToSupplyInThirdFiscalYear" xlink:label="loc_huge_QuantitiesAvailableToSupplyInThirdFiscalYear_12"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_QuantitiesAvailableToSupplyInFifthFiscalYear" xlink:label="loc_huge_QuantitiesAvailableToSupplyInFifthFiscalYear_13"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_QuantitiesAvailableToSupplyInFourthFiscalYear" xlink:label="loc_huge_QuantitiesAvailableToSupplyInFourthFiscalYear_14"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_ifrs-full_CounterpartiesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesAxis_1" xlink:to="loc_ifrs-full_CounterpartiesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesMember_1" xlink:to="loc_huge_PharmadrugProductionGMBHMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_huge_TypeOfArrangementsAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_TypeOfArrangementsAxis_4" xlink:to="loc_huge_TypeOfArrangementsDomain_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_TypeOfArrangementsDomain_4" xlink:to="loc_huge_SupplyAgreementMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_dei_LegalEntityAxis_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_7" xlink:to="loc_dei_EntityDomain_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_7" xlink:to="loc_huge_FvPharmaIncMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_1" xlink:to="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_10" xlink:to="loc_huge_QuantitiesAvailableToSupplyInNextFiscalYear_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_10" xlink:to="loc_huge_QuantitiesAvailableToSupplyInSecondFiscalYear_11" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_10" xlink:to="loc_huge_QuantitiesAvailableToSupplyInThirdFiscalYear_12" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_10" xlink:to="loc_huge_QuantitiesAvailableToSupplyInFifthFiscalYear_13" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_10" xlink:to="loc_huge_QuantitiesAvailableToSupplyInFourthFiscalYear_14" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/CommitmentsAndContingenciesTables">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfCommitmentsAndContingentLiabilitiesAbstract" xlink:label="loc_huge_DisclosureOfCommitmentsAndContingentLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfQuantitiesAvailableToSupplyByFiscalPeriodUnderCommitmentExplanatory" xlink:label="loc_huge_DisclosureOfQuantitiesAvailableToSupplyByFiscalPeriodUnderCommitmentExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfCommitmentsAndContingentLiabilitiesAbstract_0" xlink:to="loc_huge_DisclosureOfQuantitiesAvailableToSupplyByFiscalPeriodUnderCommitmentExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfCashFlowsAbstract" xlink:label="loc_ifrs-full_StatementOfCashFlowsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromContinuingOperations" xlink:label="loc_ifrs-full_ProfitLossFromContinuingOperations_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:label="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForInterestExpense" xlink:label="loc_ifrs-full_AdjustmentsForInterestExpense_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForFairValueGainsLosses" xlink:label="loc_ifrs-full_AdjustmentsForFairValueGainsLosses_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives" xlink:label="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:label="loc_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_8"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold" xlink:label="loc_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets" xlink:label="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_10"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GainOnSettlementOfFinancialLiability" xlink:label="loc_huge_GainOnSettlementOfFinancialLiability_11"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AllowanceForImpairment" xlink:label="loc_huge_AllowanceForImpairment_12"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ChangesInNonCashWorkingCapitalItemsAbstract" xlink:label="loc_huge_ChangesInNonCashWorkingCapitalItemsAbstract_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_14"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit" xlink:label="loc_huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_22"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_24"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CashAcquiredOnAcquisition" xlink:label="loc_huge_CashAcquiredOnAcquisition_24"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_25"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_26"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_27"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_28"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_29"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_31"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_31"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_32"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RepaymentsOfBondsNotesAndDebentures" xlink:label="loc_ifrs-full_RepaymentsOfBondsNotesAndDebentures_33"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsForShareIssueCosts" xlink:label="loc_ifrs-full_PaymentsForShareIssueCosts_34"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromExerciseOfOptions" xlink:label="loc_ifrs-full_ProceedsFromExerciseOfOptions_35"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProceedsFromExerciseOfWarrants" xlink:label="loc_huge_ProceedsFromExerciseOfWarrants_36"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_37"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations_38"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_39"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_41"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_42"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_43"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" xlink:to="loc_ifrs-full_ProfitLossFromContinuingOperations_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" xlink:to="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_3" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForInterestExpense_4" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForSharebasedPayments_5" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForFairValueGainsLosses_6" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_7" order="50" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_8" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold_9" order="70" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_10" order="80" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_huge_GainOnSettlementOfFinancialLiability_11" order="90" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_huge_AllowanceForImpairment_12" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" xlink:to="loc_huge_ChangesInNonCashWorkingCapitalItemsAbstract_14" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ChangesInNonCashWorkingCapitalItemsAbstract_14" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_14" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveVerboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ChangesInNonCashWorkingCapitalItemsAbstract_14" xlink:to="loc_huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit_15" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ChangesInNonCashWorkingCapitalItemsAbstract_14" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_16" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ChangesInNonCashWorkingCapitalItemsAbstract_14" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_17" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ChangesInNonCashWorkingCapitalItemsAbstract_14" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_18" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations_20" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_21" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_22" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_24" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_24" xlink:to="loc_huge_CashAcquiredOnAcquisition_24" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_24" xlink:to="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_25" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_24" xlink:to="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_26" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_24" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_27" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_24" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_28" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_24" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_29" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_31" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_31" xlink:to="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_31" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_31" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_32" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_31" xlink:to="loc_ifrs-full_RepaymentsOfBondsNotesAndDebentures_33" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_31" xlink:to="loc_ifrs-full_PaymentsForShareIssueCosts_34" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_31" xlink:to="loc_ifrs-full_ProceedsFromExerciseOfOptions_35" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_31" xlink:to="loc_huge_ProceedsFromExerciseOfWarrants_36" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_31" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_37" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_31" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations_38" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_31" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_39" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_41" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ifrs-full_CashAndCashEquivalents_42" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ifrs-full_CashAndCashEquivalents_43" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityAbstract" xlink:label="loc_ifrs-full_StatementOfChangesInEquityAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassACommonStockSharesMember" xlink:label="loc_huge_ClassACommonStockSharesMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassBCommonStockSharesMember" xlink:label="loc_huge_ClassBCommonStockSharesMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_5"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsMember" xlink:label="loc_huge_WarrantsMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:label="loc_ifrs-full_ReserveOfSharebasedPaymentsMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetainedEarningsMember" xlink:label="loc_ifrs-full_RetainedEarningsMember_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-full_IssueOfEquity_13"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfShares" xlink:label="loc_huge_IssuanceOfShares_14"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset" xlink:label="loc_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset_15"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares" xlink:label="loc_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_17"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughExerciseOfOptionShares" xlink:label="loc_huge_IncreaseDecreaseThroughExerciseOfOptionShares_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_19"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares" xlink:label="loc_huge_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_21"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughExerciseOfWarrantsShares" xlink:label="loc_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares_22"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfWarrantsExercised" xlink:label="loc_huge_ValueOfWarrantsExercised_23"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughExpiryOfWarrantsValue" xlink:label="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue_24"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughExpiryOfWarrantsShares" xlink:label="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares_25"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_26"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_27"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_28"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityAbstract_0" xlink:to="loc_ifrs-full_StatementOfChangesInEquityTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_huge_ClassACommonStockSharesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_huge_ClassBCommonStockSharesMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_1" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_5" xlink:to="loc_huge_WarrantsMember_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_5" xlink:to="loc_ifrs-full_ReserveOfSharebasedPaymentsMember_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_5" xlink:to="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_5" xlink:to="loc_ifrs-full_RetainedEarningsMember_8" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_5" xlink:to="loc_ifrs-full_EquityMember_9" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_1" xlink:to="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_ifrs-full_Equity_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_ifrs-full_NumberOfSharesOutstanding_12" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_ifrs-full_IssueOfEquity_13" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_huge_IssuanceOfShares_14" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset_15" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares_16" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_17" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_huge_IncreaseDecreaseThroughExerciseOfOptionShares_18" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_19" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_huge_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares_20" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_21" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares_22" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_huge_ValueOfWarrantsExercised_23" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue_24" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares_25" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_ifrs-full_ComprehensiveIncome_26" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_ifrs-full_Equity_27" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_ifrs-full_NumberOfSharesOutstanding_28" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfFinancialPositionAbstract" xlink:label="loc_ifrs-full_StatementOfFinancialPositionAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ScheduleOfStockClassTable" xlink:label="loc_huge_ScheduleOfStockClassTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassACommonStockSharesMember" xlink:label="loc_huge_ClassACommonStockSharesMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassBCommonStockSharesMember" xlink:label="loc_huge_ClassBCommonStockSharesMember_2"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ScheduleOfStockClassLineItems" xlink:label="loc_huge_ScheduleOfStockClassLineItems_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAbstract" xlink:label="loc_ifrs-full_AssetsAbstract_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="loc_ifrs-full_CurrentAssetsAbstract_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="loc_ifrs-full_CurrentPrepaidExpenses_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:label="loc_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:label="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="loc_ifrs-full_NoncurrentAssetsAbstract_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-full_Assets_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAndLiabilitiesAbstract" xlink:label="loc_ifrs-full_EquityAndLiabilitiesAbstract_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesAbstract" xlink:label="loc_ifrs-full_LiabilitiesAbstract_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_CurrentLiabilitiesAbstract_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:label="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_22"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CurrentWarrantsLiability" xlink:label="loc_huge_CurrentWarrantsLiability_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued" xlink:label="loc_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_24"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities_25"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_NoncurrentLiabilitiesAbstract_27"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_27"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-full_Liabilities_28"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAbstract" xlink:label="loc_ifrs-full_EquityAbstract_31"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital_31"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Warrants" xlink:label="loc_huge_Warrants_32"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharePremium" xlink:label="loc_ifrs-full_SharePremium_33"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_34"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-full_RetainedEarnings_35"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_36"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-full_EquityAndLiabilities_38"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_0" xlink:to="loc_huge_ScheduleOfStockClassTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ScheduleOfStockClassTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_1" xlink:to="loc_huge_ClassACommonStockSharesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_1" xlink:to="loc_huge_ClassBCommonStockSharesMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ScheduleOfStockClassTable_1" xlink:to="loc_huge_ScheduleOfStockClassLineItems_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ScheduleOfStockClassLineItems_5" xlink:to="loc_ifrs-full_AssetsAbstract_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_5" xlink:to="loc_ifrs-full_CurrentAssetsAbstract_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_5" xlink:to="loc_ifrs-full_CashAndCashEquivalents_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_5" xlink:to="loc_ifrs-full_TradeAndOtherCurrentReceivables_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_5" xlink:to="loc_ifrs-full_CurrentPrepaidExpenses_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_5" xlink:to="loc_ifrs-full_Inventories_8" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_5" xlink:to="loc_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_9" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_5" xlink:to="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_10" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_5" xlink:to="loc_ifrs-full_CurrentAssets_11" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_5" xlink:to="loc_ifrs-full_NoncurrentAssetsAbstract_13" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_13" xlink:to="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_13" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_13" xlink:to="loc_ifrs-full_RightofuseAssets_14" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_13" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_15" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_13" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_16" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_5" xlink:to="loc_ifrs-full_Assets_18" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ScheduleOfStockClassLineItems_5" xlink:to="loc_ifrs-full_EquityAndLiabilitiesAbstract_20" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_20" xlink:to="loc_ifrs-full_LiabilitiesAbstract_20" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesAbstract_20" xlink:to="loc_ifrs-full_CurrentLiabilitiesAbstract_20" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_20" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayables_20" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_20" xlink:to="loc_ifrs-full_CurrentLeaseLiabilities_21" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_20" xlink:to="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_22" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_20" xlink:to="loc_huge_CurrentWarrantsLiability_23" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_20" xlink:to="loc_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_24" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_20" xlink:to="loc_ifrs-full_CurrentLiabilities_25" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesAbstract_20" xlink:to="loc_ifrs-full_NoncurrentLiabilitiesAbstract_27" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_27" xlink:to="loc_ifrs-full_NoncurrentLeaseLiabilities_27" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_27" xlink:to="loc_ifrs-full_Liabilities_28" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_20" xlink:to="loc_ifrs-full_EquityAbstract_31" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_31" xlink:to="loc_ifrs-full_IssuedCapital_31" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_31" xlink:to="loc_huge_Warrants_32" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_31" xlink:to="loc_ifrs-full_SharePremium_33" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_31" xlink:to="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_34" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_31" xlink:to="loc_ifrs-full_RetainedEarnings_35" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_31" xlink:to="loc_ifrs-full_Equity_36" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_20" xlink:to="loc_ifrs-full_EquityAndLiabilities_38" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFLOSSANDCOMPREHENSIVELOSS">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeStatementAbstract" xlink:label="loc_ifrs-full_IncomeStatementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseByNatureAbstract" xlink:label="loc_ifrs-full_ExpenseByNatureAbstract_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_GeneralAndAdministrativeExpense_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationAndAmortisationExpense" xlink:label="loc_ifrs-full_DepreciationAndAmortisationExpense_4"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LegalProvision" xlink:label="loc_huge_LegalProvision_5"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ImpairmentLossOnRightOfUseAsset" xlink:label="loc_huge_ImpairmentLossOnRightOfUseAsset_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseByNature" xlink:label="loc_ifrs-full_ExpenseByNature_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherIncome" xlink:label="loc_ifrs-full_OtherIncome_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesRecognisedInProfitOrLossAttributableToChangeInUnrealisedGainsOrLossesForAssetsHeldAtEndOfPeriodFairValueMeasurement" xlink:label="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossAttributableToChangeInUnrealisedGainsOrLossesForAssetsHeldAtEndOfPeriodFairValueMeasurement_11"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GainLossOnSettlementOfFinancialLiability" xlink:label="loc_huge_GainLossOnSettlementOfFinancialLiability_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives" xlink:label="loc_ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives_13"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LossGainOnChangesInFairValueOfOtherInvestments" xlink:label="loc_huge_LossGainOnChangesInFairValueOfOtherInvestments_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromContinuingOperations" xlink:label="loc_ifrs-full_ProfitLossFromContinuingOperations_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeAbstract" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeAbstract_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:label="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BasicAndDilutedEarningsLossPerShareFromContinuingOperations" xlink:label="loc_ifrs-full_BasicAndDilutedEarningsLossPerShareFromContinuingOperations_22"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BasicAndDilutedEarningsLossPerShareFromDiscontinuedOperations" xlink:label="loc_ifrs-full_BasicAndDilutedEarningsLossPerShareFromDiscontinuedOperations_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="loc_ifrs-full_AdjustedWeightedAverageShares_24"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_ExpenseByNatureAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_1" xlink:to="loc_ifrs-full_GeneralAndAdministrativeExpense_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_1" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_1" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_1" xlink:to="loc_ifrs-full_DepreciationAndAmortisationExpense_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_1" xlink:to="loc_huge_LegalProvision_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_1" xlink:to="loc_huge_ImpairmentLossOnRightOfUseAsset_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_1" xlink:to="loc_ifrs-full_ExpenseByNature_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_1" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_1" xlink:to="loc_ifrs-full_OtherIncome_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_1" xlink:to="loc_ifrs-full_FinanceCosts_10" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_1" xlink:to="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossAttributableToChangeInUnrealisedGainsOrLossesForAssetsHeldAtEndOfPeriodFairValueMeasurement_11" order="100" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_1" xlink:to="loc_huge_GainLossOnSettlementOfFinancialLiability_12" order="110" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_1" xlink:to="loc_ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives_13" order="120" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_1" xlink:to="loc_huge_LossGainOnChangesInFairValueOfOtherInvestments_14" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_ProfitLossFromContinuingOperations_16" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_17" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_ProfitLoss_18" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeAbstract_19" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_19" xlink:to="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_19" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_19" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_19" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_19" xlink:to="loc_ifrs-full_ComprehensiveIncome_21" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_19" xlink:to="loc_ifrs-full_BasicAndDilutedEarningsLossPerShareFromContinuingOperations_22" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_19" xlink:to="loc_ifrs-full_BasicAndDilutedEarningsLossPerShareFromDiscontinuedOperations_23" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_19" xlink:to="loc_ifrs-full_AdjustedWeightedAverageShares_24" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DocumentAndEntityInformationAbstract" xlink:label="loc_huge_DocumentAndEntityInformationAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_16"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityRegistrantName_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityCentralIndexKey_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityCurrentReportingStatus_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_CurrentFiscalYearEndDate_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_DocumentType_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_DocumentPeriodEndDate_6" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_AmendmentFlag_8" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_DocumentFiscalYearFocus_9" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_DocumentFiscalPeriodFocus_10" order="90" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityEmergingGrowthCompany_11" order="100" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityExTransitionPeriod_12" order="110" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityInteractiveDataCurrent_13" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityVoluntaryFilers_14" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_15" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityFilerCategory_16" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/FinancialInstrumentsAndRiskManagement">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/GeneralAndAdministrative">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/GeneralAndAdministrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfessionalFeesExpense" xlink:label="loc_ifrs-full_ProfessionalFeesExpense_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GeneralOfficeInsuranceAndAdministrationExpenditures" xlink:label="loc_huge_GeneralOfficeInsuranceAndAdministrationExpenditures_2"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ConsultingFeesExpenses" xlink:label="loc_huge_ConsultingFeesExpenses_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WagesAndSalaries" xlink:label="loc_ifrs-full_WagesAndSalaries_4"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_InvestorRelationsExpenses" xlink:label="loc_huge_InvestorRelationsExpenses_5"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BuildingAndFacilityCosts" xlink:label="loc_huge_BuildingAndFacilityCosts_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NetForeignExchangeLoss" xlink:label="loc_ifrs-full_NetForeignExchangeLoss_7"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GeneralAndAdministrativeExpenseContinuedAndDiscontinuedOperations" xlink:label="loc_huge_GeneralAndAdministrativeExpenseContinuedAndDiscontinuedOperations_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseByNatureAbstract" xlink:label="loc_ifrs-full_ExpenseByNatureAbstract_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_GeneralAndAdministrativeExpense_9"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GeneralAndAdministrativeExpenseDiscontinuedOperations" xlink:label="loc_huge_GeneralAndAdministrativeExpenseDiscontinuedOperations_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_ifrs-full_ProfessionalFeesExpense_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_huge_GeneralOfficeInsuranceAndAdministrationExpenditures_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_huge_ConsultingFeesExpenses_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_ifrs-full_WagesAndSalaries_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_huge_InvestorRelationsExpenses_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_huge_BuildingAndFacilityCosts_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_ifrs-full_NetForeignExchangeLoss_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_huge_GeneralAndAdministrativeExpenseContinuedAndDiscontinuedOperations_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_ifrs-full_ExpenseByNatureAbstract_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_9" xlink:to="loc_ifrs-full_GeneralAndAdministrativeExpense_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_9" xlink:to="loc_huge_GeneralAndAdministrativeExpenseDiscontinuedOperations_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/GeneralAndAdministrativeTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_huge_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/IncomeTaxes">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundAbstract" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/IncomeTaxesScheduleOfNoncapitalLossCarryforwardsDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundAbstract" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyTwo" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyTwo_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyThree" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyThree_2"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFour" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFour_3"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFive" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFive_4"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySix" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySix_5"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySeven" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySeven_6"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight_7"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine_8"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandFourty" xlink:label="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandFourty_9"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NonCapitalLossCarryforwards" xlink:label="loc_huge_NonCapitalLossCarryforwards_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyTwo_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyThree_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFour_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFive_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySix_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySeven_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandFourty_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_NonCapitalLossCarryforwards_10" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/IncomeTaxesScheduleOfProvisionForIncomeTaxesDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundAbstract" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccountingProfit" xlink:label="loc_ifrs-full_AccountingProfit_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ApplicableTaxRate" xlink:label="loc_ifrs-full_ApplicableTaxRate_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:label="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:label="loc_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_4"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BookToFilingAdjustments" xlink:label="loc_huge_BookToFilingAdjustments_5"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShareIssuanceCostBookedDirectlyToEquity" xlink:label="loc_huge_ShareIssuanceCostBookedDirectlyToEquity_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxEffectOfForeignTaxRates" xlink:label="loc_ifrs-full_TaxEffectOfForeignTaxRates_7"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TaxEffectOfDeferredTaxAssetNotRecognized" xlink:label="loc_huge_TaxEffectOfDeferredTaxAssetNotRecognized_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxExpenseIncome" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncome_9"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_ifrs-full_AccountingProfit_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_ifrs-full_ApplicableTaxRate_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_BookToFilingAdjustments_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_ShareIssuanceCostBookedDirectlyToEquity_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_ifrs-full_TaxEffectOfForeignTaxRates_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_TaxEffectOfDeferredTaxAssetNotRecognized_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_ifrs-full_DeferredTaxExpenseIncome_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/IncomeTaxesScheduleOfTemporaryDifferencesForWhichDeferredTaxAssetsNotRecognisedDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundAbstract" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_2"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfForeignUnrealizedForeignExchangeLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfForeignUnrealizedForeignExchangeLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_3"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised_4"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_5"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised_6"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfIfrs16ForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfIfrs16ForWhichNoDeferredTaxAssetIsRecognised_7"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NetDeferredTaxAssets" xlink:label="loc_ifrs-full_NetDeferredTaxAssets_9"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_DeductibleTemporaryDifferencesOfForeignUnrealizedForeignExchangeLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_DeductibleTemporaryDifferencesOfIfrs16ForWhichNoDeferredTaxAssetIsRecognised_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_ifrs-full_NetDeferredTaxAssets_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/IncometaxesTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundAbstract" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfProvisionForIncomeTaxesExplanatory" xlink:label="loc_huge_DisclosureOfProvisionForIncomeTaxesExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDeferredTaxesExplanatory_2"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory" xlink:label="loc_huge_DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory_3"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ScheduleOfNonCapitalLossCarryforwardsTableTextBlock" xlink:label="loc_huge_ScheduleOfNonCapitalLossCarryforwardsTableTextBlock_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_DisclosureOfProvisionForIncomeTaxesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDeferredTaxesExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_ScheduleOfNonCapitalLossCarryforwardsTableTextBlock_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/IntangibleAssets">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract" xlink:label="loc_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/IntangibleAssetsNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract" xlink:label="loc_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract_0" xlink:to="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract_0" xlink:to="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/IntangibleAssetsScheduleOfIntangibleAssetsDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract" xlink:label="loc_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1" xlink:to="loc_ifrs-full_CarryingAmountMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_1" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_1" xlink:to="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_5" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_5" xlink:to="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_5" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_5" xlink:to="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_8" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_5" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_9" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_5" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_10" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/IntangibleAssetsTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract" xlink:label="loc_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/LeaseObligations">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilitiesAbstract" xlink:label="loc_ifrs-full_LeaseLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfLeasesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfLeasesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LeaseLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfLeasesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/LeaseObligationsScheduleOfLeaseObligationsDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilitiesAbstract" xlink:label="loc_ifrs-full_LeaseLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashOutflowForLeases" xlink:label="loc_ifrs-full_CashOutflowForLeases_3"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_EffectsOfForeignExchangeOnLeaseLiabilities" xlink:label="loc_huge_EffectsOfForeignExchangeOnLeaseLiabilities_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LeaseLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_LeaseLiabilities_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LeaseLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LeaseLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_CashOutflowForLeases_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LeaseLiabilitiesAbstract_0" xlink:to="loc_huge_EffectsOfForeignExchangeOnLeaseLiabilities_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LeaseLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_LeaseLiabilities_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LeaseLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_CurrentLeaseLiabilities_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LeaseLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_NoncurrentLeaseLiabilities_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/LeaseObligationsScheduleOfMaturityAnalysisOfOperatingLeasePaymentsDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilitiesAbstract" xlink:label="loc_ifrs-full_LeaseLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:label="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_8"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_UndiscountedLeasePaymentsPayable" xlink:label="loc_huge_UndiscountedLeasePaymentsPayable_8"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OperatingLeaseImpactOfPresentValue" xlink:label="loc_huge_OperatingLeaseImpactOfPresentValue_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LeaseLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" xlink:to="loc_ifrs-full_MaturityAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_1" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_8" xlink:to="loc_huge_UndiscountedLeasePaymentsPayable_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_8" xlink:to="loc_huge_OperatingLeaseImpactOfPresentValue_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_8" xlink:to="loc_ifrs-full_LeaseLiabilities_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/LeaseObligationsTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilitiesAbstract" xlink:label="loc_ifrs-full_LeaseLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfOperatingLeaseObligationsTableTextBlock" xlink:label="loc_huge_DisclosureOfOperatingLeaseObligationsTableTextBlock_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LeaseLiabilitiesAbstract_0" xlink:to="loc_huge_DisclosureOfOperatingLeaseObligationsTableTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LeaseLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/LossPerShare">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/LossPerShareDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareTable" xlink:label="loc_ifrs-full_EarningsPerShareTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfOrdinarySharesAxis" xlink:label="loc_ifrs-full_ClassesOfOrdinarySharesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-full_OrdinarySharesMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsMember" xlink:label="loc_huge_WarrantsMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_StockOptionsMember" xlink:label="loc_huge_StockOptionsMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareLineItems" xlink:label="loc_ifrs-full_EarningsPerShareLineItems_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares" xlink:label="loc_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:label="loc_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_0" xlink:to="loc_ifrs-full_EarningsPerShareTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareTable_1" xlink:to="loc_ifrs-full_ClassesOfOrdinarySharesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfOrdinarySharesAxis_1" xlink:to="loc_ifrs-full_OrdinarySharesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OrdinarySharesMember_1" xlink:to="loc_huge_WarrantsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OrdinarySharesMember_1" xlink:to="loc_huge_StockOptionsMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareTable_1" xlink:to="loc_ifrs-full_EarningsPerShareLineItems_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareLineItems_5" xlink:to="loc_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareLineItems_5" xlink:to="loc_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/LossPerShareTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareExplanatory" xlink:label="loc_ifrs-full_EarningsPerShareExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_0" xlink:to="loc_ifrs-full_EarningsPerShareExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/NatureOfBusinessScheduleOfOwnershipPercentageInSubsidiariesDetails">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfNatureOfBusinessAbstract" xlink:label="loc_huge_DisclosureOfNatureOfBusinessAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SubsidiariesMember" xlink:label="loc_ifrs-full_SubsidiariesMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SubsidiariesOneMember" xlink:label="loc_huge_SubsidiariesOneMember_2"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SubsidiariesTwoMember" xlink:label="loc_huge_SubsidiariesTwoMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary" xlink:label="loc_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfNatureOfBusinessAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_1" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_ifrs-full_SubsidiariesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_huge_SubsidiariesOneMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_huge_SubsidiariesTwoMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_1" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_6" xlink:to="loc_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_6" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/NatureOfBusinessTable">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfNatureOfBusinessAbstract" xlink:label="loc_huge_DisclosureOfNatureOfBusinessAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfNatureOfBusinessAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/NotesPayable">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBorrowingsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfBorrowingsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfBorrowingsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/NotesPayableNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LegalEntitiesAxis" xlink:label="loc_huge_LegalEntitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LegalEntitiesDomain" xlink:label="loc_huge_LegalEntitiesDomain_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PrismicPharmaceuticalMember" xlink:label="loc_huge_PrismicPharmaceuticalMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_4"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassBCommonStockSharesMember" xlink:label="loc_huge_ClassBCommonStockSharesMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_7"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ConvertibleNotesMember" xlink:label="loc_huge_ConvertibleNotesMember_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShorttermBorrowingsMember" xlink:label="loc_ifrs-full_ShorttermBorrowingsMember_8"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NotesPayableMember" xlink:label="loc_huge_NotesPayableMember_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsInterestRate" xlink:label="loc_ifrs-full_BorrowingsInterestRate_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestExpenseOnBorrowings" xlink:label="loc_ifrs-full_InterestExpenseOnBorrowings_13"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BorrowingsSettled" xlink:label="loc_huge_BorrowingsSettled_14"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BorrowingsSettledAccruedInterestSettled" xlink:label="loc_huge_BorrowingsSettledAccruedInterestSettled_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SettlementOfLiabilitiesByEntityOnBehalfOfRelatedPartyRelatedPartyTransactions" xlink:label="loc_ifrs-full_SettlementOfLiabilitiesByEntityOnBehalfOfRelatedPartyRelatedPartyTransactions_16"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfCommonStockForNotesPayable" xlink:label="loc_huge_IssuanceOfCommonStockForNotesPayable_17"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfCommonStockToSettleNotesPayable" xlink:label="loc_huge_FairValueOfCommonStockToSettleNotesPayable_18"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CashReceiptsFromSalesOfDebtInstruments" xlink:label="loc_huge_CashReceiptsFromSalesOfDebtInstruments_19"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GainLossOnSettlementOfFinancialLiability" xlink:label="loc_huge_GainLossOnSettlementOfFinancialLiability_20"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1" xlink:to="loc_huge_LegalEntitiesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_LegalEntitiesAxis_1" xlink:to="loc_huge_LegalEntitiesDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_LegalEntitiesDomain_1" xlink:to="loc_huge_PrismicPharmaceuticalMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_4" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_4" xlink:to="loc_huge_ClassBCommonStockSharesMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_7" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_7" xlink:to="loc_huge_ConvertibleNotesMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_7" xlink:to="loc_ifrs-full_ShorttermBorrowingsMember_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_7" xlink:to="loc_huge_NotesPayableMember_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_12" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_12" xlink:to="loc_ifrs-full_BorrowingsInterestRate_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_12" xlink:to="loc_ifrs-full_InterestExpenseOnBorrowings_13" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_12" xlink:to="loc_huge_BorrowingsSettled_14" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_12" xlink:to="loc_huge_BorrowingsSettledAccruedInterestSettled_15" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_12" xlink:to="loc_ifrs-full_SettlementOfLiabilitiesByEntityOnBehalfOfRelatedPartyRelatedPartyTransactions_16" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_12" xlink:to="loc_huge_IssuanceOfCommonStockForNotesPayable_17" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_12" xlink:to="loc_huge_FairValueOfCommonStockToSettleNotesPayable_18" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_12" xlink:to="loc_huge_CashReceiptsFromSalesOfDebtInstruments_19" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_12" xlink:to="loc_huge_GainLossOnSettlementOfFinancialLiability_20" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/NotesPayableScheduleOfNotesPayableDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShorttermBorrowingsMember" xlink:label="loc_ifrs-full_ShorttermBorrowingsMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ConvertibleNotesMember" xlink:label="loc_huge_ConvertibleNotesMember_2"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NotesPayableMember" xlink:label="loc_huge_NotesPayableMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued" xlink:label="loc_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1" xlink:to="loc_ifrs-full_ShorttermBorrowingsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1" xlink:to="loc_huge_ConvertibleNotesMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1" xlink:to="loc_huge_NotesPayableMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_6" xlink:to="loc_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/NotesPayableTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/OtherInvestments">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfInvestmentsAbstract" xlink:label="loc_huge_DisclosureOfInvestmentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/OtherInvestmentsNarrativeDetails">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfInvestmentsAbstract" xlink:label="loc_huge_DisclosureOfInvestmentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfInvestmentsTable" xlink:label="loc_huge_DisclosureOfInvestmentsTable_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OtherInvestmentsNameOfEntityAxis" xlink:label="loc_huge_OtherInvestmentsNameOfEntityAxis_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OtherInvestmentsNameOfEntityDomain" xlink:label="loc_huge_OtherInvestmentsNameOfEntityDomain_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PharmadrugIncMember" xlink:label="loc_huge_PharmadrugIncMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CannaraBiotechIncMember" xlink:label="loc_huge_CannaraBiotechIncMember_2"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CloverCannastripThinFilmTechnologiesCorpMember" xlink:label="loc_huge_CloverCannastripThinFilmTechnologiesCorpMember_3"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_HighTideIncMember" xlink:label="loc_huge_HighTideIncMember_4"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_HugeShopsMember" xlink:label="loc_huge_HugeShopsMember_5"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ScicannTherapeuticsIncMember" xlink:label="loc_huge_ScicannTherapeuticsIncMember_6"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SolarvestBioEnergyIncMember" xlink:label="loc_huge_SolarvestBioEnergyIncMember_7"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TypeOfArrangementsAxis" xlink:label="loc_huge_TypeOfArrangementsAxis_10"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TypeOfArrangementsDomain" xlink:label="loc_huge_TypeOfArrangementsDomain_10"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SecuritiesExchangeAgreementMember" xlink:label="loc_huge_SecuritiesExchangeAgreementMember_10"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SharePurchaseAndSaleAgreementsMember" xlink:label="loc_huge_SharePurchaseAndSaleAgreementsMember_11"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShareExchangeAgreementMember" xlink:label="loc_huge_ShareExchangeAgreementMember_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfOrdinarySharesAxis" xlink:label="loc_ifrs-full_ClassesOfOrdinarySharesAxis_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-full_OrdinarySharesMember_15"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_UnrestrictedClassBSharesMember" xlink:label="loc_huge_UnrestrictedClassBSharesMember_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AllLevelsOfFairValueHierarchyMember" xlink:label="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Level1OfFairValueHierarchyMember" xlink:label="loc_ifrs-full_Level1OfFairValueHierarchyMember_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_21"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SubsequentEventsMember" xlink:label="loc_huge_SubsequentEventsMember_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_24"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_24"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassBCommonStockSharesMember" xlink:label="loc_huge_ClassBCommonStockSharesMember_24"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfInvestmentsLineItems" xlink:label="loc_huge_DisclosureOfInvestmentsLineItems_27"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesAcquired" xlink:label="loc_huge_NumberOfSharesAcquired_27"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SharePrices" xlink:label="loc_huge_SharePrices_28"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfSharesAcquired" xlink:label="loc_huge_ValueOfSharesAcquired_29"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_30"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfInvestmentSharesSold" xlink:label="loc_huge_NumberOfInvestmentSharesSold_31"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_32"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnDisposalsOfInvestments" xlink:label="loc_ifrs-full_GainsLossesOnDisposalsOfInvestments_33"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesIssuedInShareExchange" xlink:label="loc_huge_NumberOfSharesIssuedInShareExchange_34"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShareIssuePricePerShare" xlink:label="loc_huge_ShareIssuePricePerShare_35"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfSharesIssuedInShareExchange" xlink:label="loc_huge_ValueOfSharesIssuedInShareExchange_36"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LossesOnChangeInFairValueOfDerivatives" xlink:label="loc_ifrs-full_LossesOnChangeInFairValueOfDerivatives_37"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement" xlink:label="loc_huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement_38"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesHeld" xlink:label="loc_huge_NumberOfSharesHeld_39"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfWarrantsHeld" xlink:label="loc_huge_NumberOfWarrantsHeld_40"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SharePriceOfSharesAndWarrants" xlink:label="loc_huge_SharePriceOfSharesAndWarrants_41"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DiscountOnProceedsOfSharesAndWarrantsSold" xlink:label="loc_huge_DiscountOnProceedsOfSharesAndWarrantsSold_42"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProceedsFromSaleOfSharesAndWarrants" xlink:label="loc_huge_ProceedsFromSaleOfSharesAndWarrants_43"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SubscriptionPricePerShare" xlink:label="loc_huge_SubscriptionPricePerShare_44"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PercentageOfDeclineInFairValueOfInvestment" xlink:label="loc_huge_PercentageOfDeclineInFairValueOfInvestment_45"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ChangeInFairValueOfInvestmentDueToTenPercentChangeInAssumptionsUsed" xlink:label="loc_huge_ChangeInFairValueOfInvestmentDueToTenPercentChangeInAssumptionsUsed_46"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfWarrantsAcquired" xlink:label="loc_huge_NumberOfWarrantsAcquired_47"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PrincipalAmountOfBorrowings" xlink:label="loc_huge_PrincipalAmountOfBorrowings_48"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfSharesAndWarrantsAcquired" xlink:label="loc_huge_FairValueOfSharesAndWarrantsAcquired_49"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceOfWarrants" xlink:label="loc_huge_ExercisePriceOfWarrants_50"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_QuotedMarketPriceOfInvestments" xlink:label="loc_huge_QuotedMarketPriceOfInvestments_51"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_52"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfShares" xlink:label="loc_huge_FairValueOfShares_53"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfWarrants" xlink:label="loc_huge_FairValueOfWarrants_54"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_MarketPriceOfShares" xlink:label="loc_huge_MarketPriceOfShares_55"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DerivativeFinancialLiabilities" xlink:label="loc_ifrs-full_DerivativeFinancialLiabilities_56"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GainOnSettlementOfDerivativeLiability" xlink:label="loc_huge_GainOnSettlementOfDerivativeLiability_57"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GuaranteedMinimumLiquidationValueOfShares" xlink:label="loc_huge_GuaranteedMinimumLiquidationValueOfShares_58"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_RiskFreeRateOfWarrants" xlink:label="loc_huge_RiskFreeRateOfWarrants_59"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedVolatilityOfWarrants" xlink:label="loc_huge_ExpectedVolatilityOfWarrants_60"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedTermOfWarrants" xlink:label="loc_huge_ExpectedTermOfWarrants_61"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedDividendYieldOfWarrants" xlink:label="loc_huge_ExpectedDividendYieldOfWarrants_62"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DebtConversionRatio" xlink:label="loc_huge_DebtConversionRatio_63"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability" xlink:label="loc_huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability_64"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:label="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_65"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsAbstract_0" xlink:to="loc_huge_DisclosureOfInvestmentsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsTable_1" xlink:to="loc_huge_OtherInvestmentsNameOfEntityAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OtherInvestmentsNameOfEntityAxis_1" xlink:to="loc_huge_OtherInvestmentsNameOfEntityDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_1" xlink:to="loc_huge_PharmadrugIncMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_1" xlink:to="loc_huge_CannaraBiotechIncMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_1" xlink:to="loc_huge_CloverCannastripThinFilmTechnologiesCorpMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_1" xlink:to="loc_huge_HighTideIncMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_1" xlink:to="loc_huge_HugeShopsMember_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_1" xlink:to="loc_huge_ScicannTherapeuticsIncMember_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_1" xlink:to="loc_huge_SolarvestBioEnergyIncMember_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsTable_1" xlink:to="loc_huge_TypeOfArrangementsAxis_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_TypeOfArrangementsAxis_10" xlink:to="loc_huge_TypeOfArrangementsDomain_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_TypeOfArrangementsDomain_10" xlink:to="loc_huge_SecuritiesExchangeAgreementMember_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_TypeOfArrangementsDomain_10" xlink:to="loc_huge_SharePurchaseAndSaleAgreementsMember_11" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_TypeOfArrangementsDomain_10" xlink:to="loc_huge_ShareExchangeAgreementMember_12" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsTable_1" xlink:to="loc_ifrs-full_ClassesOfOrdinarySharesAxis_15" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfOrdinarySharesAxis_15" xlink:to="loc_ifrs-full_OrdinarySharesMember_15" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OrdinarySharesMember_15" xlink:to="loc_huge_UnrestrictedClassBSharesMember_15" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsTable_1" xlink:to="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_18" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_18" xlink:to="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_18" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_18" xlink:to="loc_ifrs-full_Level1OfFairValueHierarchyMember_18" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsTable_1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_21" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_21" xlink:to="loc_ifrs-full_NonadjustingEventsMember_21" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsMember_21" xlink:to="loc_huge_SubsequentEventsMember_21" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_24" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_24" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_24" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_24" xlink:to="loc_huge_ClassBCommonStockSharesMember_24" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsTable_1" xlink:to="loc_huge_DisclosureOfInvestmentsLineItems_27" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_27" xlink:to="loc_huge_NumberOfSharesAcquired_27" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_27" xlink:to="loc_huge_SharePrices_28" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_27" xlink:to="loc_huge_ValueOfSharesAcquired_29" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_27" xlink:to="loc_ifrs-full_NumberOfSharesIssued_30" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_27" xlink:to="loc_huge_NumberOfInvestmentSharesSold_31" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_27" xlink:to="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_32" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_27" xlink:to="loc_ifrs-full_GainsLossesOnDisposalsOfInvestments_33" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_27" xlink:to="loc_huge_NumberOfSharesIssuedInShareExchange_34" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_27" xlink:to="loc_huge_ShareIssuePricePerShare_35" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_27" xlink:to="loc_huge_ValueOfSharesIssuedInShareExchange_36" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_27" xlink:to="loc_ifrs-full_LossesOnChangeInFairValueOfDerivatives_37" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_27" xlink:to="loc_huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement_38" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_27" xlink:to="loc_huge_NumberOfSharesHeld_39" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_27" xlink:to="loc_huge_NumberOfWarrantsHeld_40" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_27" xlink:to="loc_huge_SharePriceOfSharesAndWarrants_41" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_27" xlink:to="loc_huge_DiscountOnProceedsOfSharesAndWarrantsSold_42" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_27" xlink:to="loc_huge_ProceedsFromSaleOfSharesAndWarrants_43" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_27" xlink:to="loc_huge_SubscriptionPricePerShare_44" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_27" xlink:to="loc_huge_PercentageOfDeclineInFairValueOfInvestment_45" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_27" xlink:to="loc_huge_ChangeInFairValueOfInvestmentDueToTenPercentChangeInAssumptionsUsed_46" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_27" xlink:to="loc_huge_NumberOfWarrantsAcquired_47" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_27" xlink:to="loc_huge_PrincipalAmountOfBorrowings_48" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_27" xlink:to="loc_huge_FairValueOfSharesAndWarrantsAcquired_49" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_27" xlink:to="loc_huge_ExercisePriceOfWarrants_50" order="230" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_27" xlink:to="loc_huge_QuotedMarketPriceOfInvestments_51" order="240" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_27" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_52" order="250" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_27" xlink:to="loc_huge_FairValueOfShares_53" order="260" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_27" xlink:to="loc_huge_FairValueOfWarrants_54" order="270" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_27" xlink:to="loc_huge_MarketPriceOfShares_55" order="280" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_27" xlink:to="loc_ifrs-full_DerivativeFinancialLiabilities_56" order="290" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_27" xlink:to="loc_huge_GainOnSettlementOfDerivativeLiability_57" order="300" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_27" xlink:to="loc_huge_GuaranteedMinimumLiquidationValueOfShares_58" order="310" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_27" xlink:to="loc_huge_RiskFreeRateOfWarrants_59" order="320" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_27" xlink:to="loc_huge_ExpectedVolatilityOfWarrants_60" order="330" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_27" xlink:to="loc_huge_ExpectedTermOfWarrants_61" order="340" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_27" xlink:to="loc_huge_ExpectedDividendYieldOfWarrants_62" order="350" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_27" xlink:to="loc_huge_DebtConversionRatio_63" order="360" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_27" xlink:to="loc_huge_NumberOfAdditionalSharesIssuedToSettleDerivativeLiability_64" order="370" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_27" xlink:to="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_65" order="380" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/OtherInvestmentsScheduleOfOtherInvestmentsDetails">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfInvestmentsAbstract" xlink:label="loc_huge_DisclosureOfInvestmentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfInvestmentsTable" xlink:label="loc_huge_DisclosureOfInvestmentsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MeasurementAxis" xlink:label="loc_ifrs-full_MeasurementAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedMeasurementMember" xlink:label="loc_ifrs-full_AggregatedMeasurementMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AtFairValueMember" xlink:label="loc_ifrs-full_AtFairValueMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OtherInvestmentsNameOfEntityAxis" xlink:label="loc_huge_OtherInvestmentsNameOfEntityAxis_4"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OtherInvestmentsNameOfEntityDomain" xlink:label="loc_huge_OtherInvestmentsNameOfEntityDomain_4"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PharmadrugIncMember" xlink:label="loc_huge_PharmadrugIncMember_4"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CannaraBiotechIncMember" xlink:label="loc_huge_CannaraBiotechIncMember_5"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CloverCannastripThinFilmTechnologiesCorpMember" xlink:label="loc_huge_CloverCannastripThinFilmTechnologiesCorpMember_6"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_HugeShopsMember" xlink:label="loc_huge_HugeShopsMember_7"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_HighTideIncMember" xlink:label="loc_huge_HighTideIncMember_8"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ScicannTherapeuticsIncMember" xlink:label="loc_huge_ScicannTherapeuticsIncMember_9"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SolarvestBioEnergyIncMember" xlink:label="loc_huge_SolarvestBioEnergyIncMember_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-full_OrdinarySharesMember_13"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsMember" xlink:label="loc_huge_WarrantsMember_14"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ConvertibleDebentureMember" xlink:label="loc_huge_ConvertibleDebentureMember_15"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfInvestmentsLineItems" xlink:label="loc_huge_DisclosureOfInvestmentsLineItems_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_19"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NetForeignExchangeGain" xlink:label="loc_ifrs-full_NetForeignExchangeGain_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_22"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_23"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsAbstract_0" xlink:to="loc_huge_DisclosureOfInvestmentsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsTable_1" xlink:to="loc_ifrs-full_MeasurementAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MeasurementAxis_1" xlink:to="loc_ifrs-full_AggregatedMeasurementMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedMeasurementMember_1" xlink:to="loc_ifrs-full_AtFairValueMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsTable_1" xlink:to="loc_huge_OtherInvestmentsNameOfEntityAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OtherInvestmentsNameOfEntityAxis_4" xlink:to="loc_huge_OtherInvestmentsNameOfEntityDomain_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_4" xlink:to="loc_huge_PharmadrugIncMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_4" xlink:to="loc_huge_CannaraBiotechIncMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_4" xlink:to="loc_huge_CloverCannastripThinFilmTechnologiesCorpMember_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_4" xlink:to="loc_huge_HugeShopsMember_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_4" xlink:to="loc_huge_HighTideIncMember_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_4" xlink:to="loc_huge_ScicannTherapeuticsIncMember_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_4" xlink:to="loc_huge_SolarvestBioEnergyIncMember_10" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsTable_1" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_13" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_13" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_13" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_13" xlink:to="loc_ifrs-full_OrdinarySharesMember_13" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_13" xlink:to="loc_huge_WarrantsMember_14" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_13" xlink:to="loc_huge_ConvertibleDebentureMember_15" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsTable_1" xlink:to="loc_huge_DisclosureOfInvestmentsLineItems_18" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_18" xlink:to="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_18" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_18" xlink:to="loc_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_19" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_18" xlink:to="loc_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_20" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_18" xlink:to="loc_ifrs-full_NetForeignExchangeGain_21" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_18" xlink:to="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_22" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsLineItems_18" xlink:to="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_23" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/OtherinvestmentsTables">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfInvestmentsAbstract" xlink:label="loc_huge_DisclosureOfInvestmentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfDetailedInformationAboutInvestmentsExplanatory" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutInvestmentsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfInvestmentsAbstract_0" xlink:to="loc_huge_DisclosureOfDetailedInformationAboutInvestmentsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/RelatedPartyTransactions">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:label="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/RelatedPartyTransactionsNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FvPharmaIncMember" xlink:label="loc_huge_FvPharmaIncMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FSDBiosciencesMember" xlink:label="loc_huge_FSDBiosciencesMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_5"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PresidentAndChiefExecutiveOfficerMember" xlink:label="loc_huge_PresidentAndChiefExecutiveOfficerMember_5"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FormerChiefExecutiveOfficerMember" xlink:label="loc_huge_FormerChiefExecutiveOfficerMember_6"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ChiefExecutiveOfficersMember" xlink:label="loc_huge_ChiefExecutiveOfficersMember_7"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PresidentsMember" xlink:label="loc_huge_PresidentsMember_8"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PresidentOfFSDMember" xlink:label="loc_huge_PresidentOfFSDMember_9"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ChiefFinancialOfficersMember" xlink:label="loc_huge_ChiefFinancialOfficersMember_10"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ChiefOperatingConsultantMember" xlink:label="loc_huge_ChiefOperatingConsultantMember_11"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FormerChiefOperatingOfficerMember" xlink:label="loc_huge_FormerChiefOperatingOfficerMember_12"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IndependentDirectorMember" xlink:label="loc_huge_IndependentDirectorMember_13"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DirectorsAndOfficersMember" xlink:label="loc_huge_DirectorsAndOfficersMember_14"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_KeyManagementAndDirectorsMember" xlink:label="loc_huge_KeyManagementAndDirectorsMember_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_18"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassBCommonStockSharesMember" xlink:label="loc_huge_ClassBCommonStockSharesMember_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_21"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PaymentOfExpenses" xlink:label="loc_huge_PaymentOfExpenses_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:label="loc_ifrs-full_AmountsPayableRelatedPartyTransactions_22"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DirectorsRemunerationExpense" xlink:label="loc_ifrs-full_DirectorsRemunerationExpense_23"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesIssuedForCompensationBonus" xlink:label="loc_huge_NumberOfSharesIssuedForCompensationBonus_24"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_25"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdditionalRemuneration" xlink:label="loc_huge_AdditionalRemuneration_26"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_27"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_dei_LegalEntityAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1" xlink:to="loc_dei_EntityDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_1" xlink:to="loc_huge_FvPharmaIncMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_1" xlink:to="loc_huge_FSDBiosciencesMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_5" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_5" xlink:to="loc_huge_PresidentAndChiefExecutiveOfficerMember_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_5" xlink:to="loc_huge_FormerChiefExecutiveOfficerMember_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_5" xlink:to="loc_huge_ChiefExecutiveOfficersMember_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_5" xlink:to="loc_huge_PresidentsMember_8" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_5" xlink:to="loc_huge_PresidentOfFSDMember_9" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_5" xlink:to="loc_huge_ChiefFinancialOfficersMember_10" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_5" xlink:to="loc_huge_ChiefOperatingConsultantMember_11" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_5" xlink:to="loc_huge_FormerChiefOperatingOfficerMember_12" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_5" xlink:to="loc_huge_IndependentDirectorMember_13" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_5" xlink:to="loc_huge_DirectorsAndOfficersMember_14" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_5" xlink:to="loc_huge_KeyManagementAndDirectorsMember_15" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_18" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_18" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_18" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_18" xlink:to="loc_huge_ClassBCommonStockSharesMember_18" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_21" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_21" xlink:to="loc_huge_PaymentOfExpenses_21" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_21" xlink:to="loc_ifrs-full_AmountsPayableRelatedPartyTransactions_22" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_21" xlink:to="loc_ifrs-full_DirectorsRemunerationExpense_23" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_21" xlink:to="loc_huge_NumberOfSharesIssuedForCompensationBonus_24" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_21" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_25" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_21" xlink:to="loc_huge_AdditionalRemuneration_26" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_21" xlink:to="loc_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_27" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/RelatedPartyTransactionsScheduleOfKeyManagementPersonnelCompensationDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensation_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensation_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/RelatedPartyTransactionsTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/RightofuseAsset">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/RightofuseAssetScheduleOfRightofuseAssetDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="loc_ifrs-full_DepreciationRightofuseAssets_2"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ImpairmentLossOnRightOfUseAsset" xlink:label="loc_huge_ImpairmentLossOnRightOfUseAsset_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_0" xlink:to="loc_ifrs-full_RightofuseAssets_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_0" xlink:to="loc_ifrs-full_DepreciationRightofuseAssets_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_0" xlink:to="loc_huge_ImpairmentLossOnRightOfUseAsset_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_0" xlink:to="loc_ifrs-full_RightofuseAssets_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/RightofuseAssetTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfDetailedInformationAboutRightOfUseAssets" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutRightOfUseAssets_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_0" xlink:to="loc_huge_DisclosureOfDetailedInformationAboutRightOfUseAssets_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/SegmentedInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/SharebasedCompensation">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/SharebasedCompensationNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_StockOptionsMember" xlink:label="loc_huge_StockOptionsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_4"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfReplacementShareOptionsIssued" xlink:label="loc_huge_NumberOfReplacementShareOptionsIssued_5"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WeightedAverageExercisePriceForReplacementOfShareOptions" xlink:label="loc_huge_WeightedAverageExercisePriceForReplacementOfShareOptions_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" xlink:label="loc_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_12"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" xlink:to="loc_huge_StockOptionsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_huge_NumberOfReplacementShareOptionsIssued_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_huge_WeightedAverageExercisePriceForReplacementOfShareOptions_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveVerboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_10" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_11" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_12" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/SharebasedCompensationScheduleOfChangesInNumberOfShareOptionsDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_StockOptionsMember" xlink:label="loc_huge_StockOptionsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_17"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" xlink:to="loc_huge_StockOptionsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_10" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_11" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_12" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_13" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_14" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_15" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_16" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_17" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/SharebasedCompensationScheduleOfExercisePriceAndWeightedAverageContractualTermOfShareOptionsOutstandingAndExercisableDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_StockOptionsMember" xlink:label="loc_huge_StockOptionsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceTwoPointSixOneMember" xlink:label="loc_huge_ExercisePriceTwoPointSixOneMember_4"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceThreePointSevenFiveMember" xlink:label="loc_huge_ExercisePriceThreePointSevenFiveMember_5"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceThreePointEightSixMember" xlink:label="loc_huge_ExercisePriceThreePointEightSixMember_6"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFourPointFourTwoMember" xlink:label="loc_huge_ExercisePriceFourPointFourTwoMember_7"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFourPointSevenFiveMember" xlink:label="loc_huge_ExercisePriceFourPointSevenFiveMember_8"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFivePointZeroThreeMember" xlink:label="loc_huge_ExercisePriceFivePointZeroThreeMember_9"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFivePointFourThreeMember" xlink:label="loc_huge_ExercisePriceFivePointFourThreeMember_10"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSixPointSixteenMember" xlink:label="loc_huge_ExercisePriceSixPointSixteenMember_11"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSevenPointSeventeenMember" xlink:label="loc_huge_ExercisePriceSevenPointSeventeenMember_12"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSevenPointSixtyThreeMember" xlink:label="loc_huge_ExercisePriceSevenPointSixtyThreeMember_13"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceNinePointFiveFourMember" xlink:label="loc_huge_ExercisePriceNinePointFiveFourMember_14"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceTenPointSixFiveMember" xlink:label="loc_huge_ExercisePriceTenPointSixFiveMember_15"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceThirteenPointZeroSevenMember" xlink:label="loc_huge_ExercisePriceThirteenPointZeroSevenMember_16"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceThirteenPointFourSevenMember" xlink:label="loc_huge_ExercisePriceThirteenPointFourSevenMember_17"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSixteenPointZeroEightMember" xlink:label="loc_huge_ExercisePriceSixteenPointZeroEightMember_18"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSeventeenPointEightNineMember" xlink:label="loc_huge_ExercisePriceSeventeenPointEightNineMember_19"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceEighteenPointZeroNineMember" xlink:label="loc_huge_ExercisePriceEighteenPointZeroNineMember_20"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceTwentyPointOneZeroMember" xlink:label="loc_huge_ExercisePriceTwentyPointOneZeroMember_21"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceTwentyOnePointElevenMember" xlink:label="loc_huge_ExercisePriceTwentyOnePointElevenMember_22"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceTwentyFourPointTwelveMember" xlink:label="loc_huge_ExercisePriceTwentyFourPointTwelveMember_23"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceTwentySixPointThirteenMember" xlink:label="loc_huge_ExercisePriceTwentySixPointThirteenMember_24"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFortyPointTwentyMember" xlink:label="loc_huge_ExercisePriceFortyPointTwentyMember_25"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFortyFourPointTwentyTwoMember" xlink:label="loc_huge_ExercisePriceFortyFourPointTwentyTwoMember_26"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFortySevenPointTwentyFourMember" xlink:label="loc_huge_ExercisePriceFortySevenPointTwentyFourMember_27"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFiftyPointTwentyFiveMember" xlink:label="loc_huge_ExercisePriceFiftyPointTwentyFiveMember_28"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFiftyTwoPointTwentySixMember" xlink:label="loc_huge_ExercisePriceFiftyTwoPointTwentySixMember_29"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFiftyFivePointTwentyEightMember" xlink:label="loc_huge_ExercisePriceFiftyFivePointTwentyEightMember_30"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFiftyNinePointThirtyMember" xlink:label="loc_huge_ExercisePriceFiftyNinePointThirtyMember_31"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSeventyFivePointThirtyEightMember" xlink:label="loc_huge_ExercisePriceSeventyFivePointThirtyEightMember_32"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceEightySixPointFortyThreeMember" xlink:label="loc_huge_ExercisePriceEightySixPointFortyThreeMember_33"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceEightyEightPointFortyFourMember" xlink:label="loc_huge_ExercisePriceEightyEightPointFortyFourMember_34"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceOneHundredTwentyPointSixtyMember" xlink:label="loc_huge_ExercisePriceOneHundredTwentyPointSixtyMember_35"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember" xlink:label="loc_huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember_36"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceFiftySixPointTwentyEightMember" xlink:label="loc_huge_ExercisePriceFiftySixPointTwentyEightMember_37"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSevenPointZeroZeroMember" xlink:label="loc_huge_ExercisePriceSevenPointZeroZeroMember_38"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSevenPointFiftyMember" xlink:label="loc_huge_ExercisePriceSevenPointFiftyMember_39"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceTwentyOnePointNinetyOneMember" xlink:label="loc_huge_ExercisePriceTwentyOnePointNinetyOneMember_40"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceTwentyOnePointTwentyTwoMember" xlink:label="loc_huge_ExercisePriceTwentyOnePointTwentyTwoMember_41"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceOneHundredFortyEightPointSeventyFourMember" xlink:label="loc_huge_ExercisePriceOneHundredFortyEightPointSeventyFourMember_42"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSixtyEightPointZeroOneMember" xlink:label="loc_huge_ExercisePriceSixtyEightPointZeroOneMember_43"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceSeventyOnePointZeroSevenMember" xlink:label="loc_huge_ExercisePriceSeventyOnePointZeroSevenMember_44"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_47"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_47"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_48"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_49"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_50"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_51"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" xlink:to="loc_huge_StockOptionsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_4" xlink:to="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceTwoPointSixOneMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceThreePointSevenFiveMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceThreePointEightSixMember_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceFourPointFourTwoMember_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceFourPointSevenFiveMember_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceFivePointZeroThreeMember_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceFivePointFourThreeMember_10" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceSixPointSixteenMember_11" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceSevenPointSeventeenMember_12" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceSevenPointSixtyThreeMember_13" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceNinePointFiveFourMember_14" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceTenPointSixFiveMember_15" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceThirteenPointZeroSevenMember_16" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceThirteenPointFourSevenMember_17" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceSixteenPointZeroEightMember_18" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceSeventeenPointEightNineMember_19" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceEighteenPointZeroNineMember_20" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceTwentyPointOneZeroMember_21" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceTwentyOnePointElevenMember_22" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceTwentyFourPointTwelveMember_23" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceTwentySixPointThirteenMember_24" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceFortyPointTwentyMember_25" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceFortyFourPointTwentyTwoMember_26" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceFortySevenPointTwentyFourMember_27" order="230" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceFiftyPointTwentyFiveMember_28" order="240" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceFiftyTwoPointTwentySixMember_29" order="250" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceFiftyFivePointTwentyEightMember_30" order="260" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceFiftyNinePointThirtyMember_31" order="270" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceSeventyFivePointThirtyEightMember_32" order="280" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceEightySixPointFortyThreeMember_33" order="290" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceEightyEightPointFortyFourMember_34" order="300" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceOneHundredTwentyPointSixtyMember_35" order="310" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember_36" order="320" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceFiftySixPointTwentyEightMember_37" order="330" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceSevenPointZeroZeroMember_38" order="340" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceSevenPointFiftyMember_39" order="350" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceTwentyOnePointNinetyOneMember_40" order="360" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceTwentyOnePointTwentyTwoMember_41" order="370" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceOneHundredFortyEightPointSeventyFourMember_42" order="380" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceSixtyEightPointZeroOneMember_43" order="390" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_4" xlink:to="loc_huge_ExercisePriceSeventyOnePointZeroSevenMember_44" order="400" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_47" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_47" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_47" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_47" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_48" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_47" xlink:to="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_49" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_47" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_50" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_47" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_51" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/SharebasedCompensationScheduleOfFairValueAssumptionsOfShareOptionsGrantedDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_StockOptionsMember" xlink:label="loc_huge_StockOptionsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_13"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" xlink:to="loc_huge_StockOptionsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_RangeAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_4" xlink:to="loc_ifrs-full_RangesMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_4" xlink:to="loc_ifrs-full_BottomOfRangeMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_4" xlink:to="loc_ifrs-full_TopOfRangeMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8" xlink:to="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8" xlink:to="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8" xlink:to="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8" xlink:to="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_11" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8" xlink:to="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_12" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8" xlink:to="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_13" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/SharebasedCompensationTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/ShareCapital">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReservesWithinEquityAbstract" xlink:label="loc_ifrs-full_DisclosureOfReservesWithinEquityAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:label="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReservesWithinEquityAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/ShareCapitalNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReservesWithinEquityAbstract" xlink:label="loc_ifrs-full_DisclosureOfReservesWithinEquityAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassesOfWarrantsAxis" xlink:label="loc_huge_ClassesOfWarrantsAxis_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassesOfWarrantsDomain" xlink:label="loc_huge_ClassesOfWarrantsDomain_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtAugust6Th2020Member" xlink:label="loc_huge_WarrantsByExpiryDateAtAugust6Th2020Member_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtOctober20Th2020Member" xlink:label="loc_huge_WarrantsByExpiryDateAtOctober20Th2020Member_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_5"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassACommonStockSharesMember" xlink:label="loc_huge_ClassACommonStockSharesMember_5"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassBCommonStockSharesMember" xlink:label="loc_huge_ClassBCommonStockSharesMember_6"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TypeOfArrangementsAxis" xlink:label="loc_huge_TypeOfArrangementsAxis_9"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TypeOfArrangementsDomain" xlink:label="loc_huge_TypeOfArrangementsDomain_9"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SecuritiesExchangeAgreementMember" xlink:label="loc_huge_SecuritiesExchangeAgreementMember_9"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_EquityDistributionAgreementMember" xlink:label="loc_huge_EquityDistributionAgreementMember_10"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OtherInvestmentsNameOfEntityAxis" xlink:label="loc_huge_OtherInvestmentsNameOfEntityAxis_13"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OtherInvestmentsNameOfEntityDomain" xlink:label="loc_huge_OtherInvestmentsNameOfEntityDomain_13"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PharmadrugIncMember" xlink:label="loc_huge_PharmadrugIncMember_13"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SolarvestBioEnergyIncMember" xlink:label="loc_huge_SolarvestBioEnergyIncMember_14"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LegalEntitiesAxis" xlink:label="loc_huge_LegalEntitiesAxis_17"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LegalEntitiesDomain" xlink:label="loc_huge_LegalEntitiesDomain_17"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PrismicPharmaceuticalMember" xlink:label="loc_huge_PrismicPharmaceuticalMember_17"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AllianceGlobalPartnersMember" xlink:label="loc_huge_AllianceGlobalPartnersMember_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DescriptionOfVotingRights" xlink:label="loc_huge_DescriptionOfVotingRights_21"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesAcquired" xlink:label="loc_huge_NumberOfSharesAcquired_22"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SharePrices" xlink:label="loc_huge_SharePrices_23"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfSharesAcquired" xlink:label="loc_huge_ValueOfSharesAcquired_24"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_25"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesIssuedInShareExchange" xlink:label="loc_huge_NumberOfSharesIssuedInShareExchange_26"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesIssuedForDebtSettlement" xlink:label="loc_huge_NumberOfSharesIssuedForDebtSettlement_27"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfSharesIssuedForDebtSettlement" xlink:label="loc_huge_ValueOfSharesIssuedForDebtSettlement_28"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfSharesIssuedInShareExchange" xlink:label="loc_huge_ValueOfSharesIssuedInShareExchange_29"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShareSplitRatio" xlink:label="loc_huge_ShareSplitRatio_30"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesIssuedInPrivatePlacement" xlink:label="loc_huge_NumberOfSharesIssuedInPrivatePlacement_31"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShareIssuePricePerShare" xlink:label="loc_huge_ShareIssuePricePerShare_32"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfSharesIssued" xlink:label="loc_huge_ValueOfSharesIssued_33"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LossesOnChangeInFairValueOfDerivatives" xlink:label="loc_ifrs-full_LossesOnChangeInFairValueOfDerivatives_34"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:label="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_35"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares" xlink:label="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_36"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfCommonStockOfShareBasedCompensation" xlink:label="loc_huge_IssuanceOfCommonStockOfShareBasedCompensation_37"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ValueOfTradeAndOtherPayableOfSharesBasedCompensation" xlink:label="loc_huge_ValueOfTradeAndOtherPayableOfSharesBasedCompensation_38"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfCommonSharesOfShareBasedBonusToEmployeesForPerformance" xlink:label="loc_huge_IssuanceOfCommonSharesOfShareBasedBonusToEmployeesForPerformance_39"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfShareBasedCompensationBonus" xlink:label="loc_huge_FairValueOfShareBasedCompensationBonus_40"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShareBasedPaymentExpenses" xlink:label="loc_huge_ShareBasedPaymentExpenses_41"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfCommonStockOfBoardOfDirectorsInLieuOfCash" xlink:label="loc_huge_IssuanceOfCommonStockOfBoardOfDirectorsInLieuOfCash_42"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfCommonStockForNotesPayable" xlink:label="loc_huge_IssuanceOfCommonStockForNotesPayable_43"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NotesSettledThroughIssuanceOfShares" xlink:label="loc_huge_NotesSettledThroughIssuanceOfShares_44"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfCommonStockToSettleNotesPayable" xlink:label="loc_huge_FairValueOfCommonStockToSettleNotesPayable_45"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GainLossOnSettlementOfFinancialLiability" xlink:label="loc_huge_GainLossOnSettlementOfFinancialLiability_46"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CommonStockIssuedForPrivatePlacement" xlink:label="loc_huge_CommonStockIssuedForPrivatePlacement_47"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsIssuedForPrivatePlacement" xlink:label="loc_huge_WarrantsIssuedForPrivatePlacement_48"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesIssuedThroughEquityDistributionAgreement" xlink:label="loc_huge_NumberOfSharesIssuedThroughEquityDistributionAgreement_49"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_50"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CashProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_huge_CashProceedsFromIssuanceOfPrivatePlacement_51"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromIssuingOtherEquityInstruments" xlink:label="loc_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_52"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfWarrantsIssued" xlink:label="loc_huge_FairValueOfWarrantsIssued_53"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfCommonStockOfDirectOffering" xlink:label="loc_huge_IssuanceOfCommonStockOfDirectOffering_54"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceCostOfCommonSharesAndWarrants" xlink:label="loc_huge_IssuanceCostOfCommonSharesAndWarrants_55"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfWarrantsOfDirectOffering" xlink:label="loc_huge_IssuanceOfWarrantsOfDirectOffering_56"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfWarrantLiability" xlink:label="loc_huge_FairValueOfWarrantLiability_57"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfWarrantLiabilityOfResidualAmount" xlink:label="loc_huge_FairValueOfWarrantLiabilityOfResidualAmount_58"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TotalCashTransactionCosts" xlink:label="loc_huge_TotalCashTransactionCosts_59"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TransactionCostsAllocatedToWarrants" xlink:label="loc_huge_TransactionCostsAllocatedToWarrants_60"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfCommonSharesIssued" xlink:label="loc_huge_FairValueOfCommonSharesIssued_61"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsForShareIssueCosts" xlink:label="loc_ifrs-full_PaymentsForShareIssueCosts_62"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceOfWarrantsGranted" xlink:label="loc_huge_ExercisePriceOfWarrantsGranted_63"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceOfWarrantIssue" xlink:label="loc_huge_ExercisePriceOfWarrantIssue_64"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReservesWithinEquityAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_huge_ClassesOfWarrantsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsAxis_1" xlink:to="loc_huge_ClassesOfWarrantsDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtAugust6Th2020Member_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtOctober20Th2020Member_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_5" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_5" xlink:to="loc_huge_ClassACommonStockSharesMember_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_5" xlink:to="loc_huge_ClassBCommonStockSharesMember_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_huge_TypeOfArrangementsAxis_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_TypeOfArrangementsAxis_9" xlink:to="loc_huge_TypeOfArrangementsDomain_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_TypeOfArrangementsDomain_9" xlink:to="loc_huge_SecuritiesExchangeAgreementMember_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_TypeOfArrangementsDomain_9" xlink:to="loc_huge_EquityDistributionAgreementMember_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_huge_OtherInvestmentsNameOfEntityAxis_13" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OtherInvestmentsNameOfEntityAxis_13" xlink:to="loc_huge_OtherInvestmentsNameOfEntityDomain_13" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_13" xlink:to="loc_huge_PharmadrugIncMember_13" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OtherInvestmentsNameOfEntityDomain_13" xlink:to="loc_huge_SolarvestBioEnergyIncMember_14" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_huge_LegalEntitiesAxis_17" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_LegalEntitiesAxis_17" xlink:to="loc_huge_LegalEntitiesDomain_17" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_LegalEntitiesDomain_17" xlink:to="loc_huge_PrismicPharmaceuticalMember_17" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_LegalEntitiesDomain_17" xlink:to="loc_huge_AllianceGlobalPartnersMember_18" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_huge_DescriptionOfVotingRights_21" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_huge_NumberOfSharesAcquired_22" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_huge_SharePrices_23" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_huge_ValueOfSharesAcquired_24" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_ifrs-full_NumberOfSharesIssued_25" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_huge_NumberOfSharesIssuedInShareExchange_26" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_huge_NumberOfSharesIssuedForDebtSettlement_27" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_huge_ValueOfSharesIssuedForDebtSettlement_28" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_huge_ValueOfSharesIssuedInShareExchange_29" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_huge_ShareSplitRatio_30" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_huge_NumberOfSharesIssuedInPrivatePlacement_31" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_huge_ShareIssuePricePerShare_32" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_huge_ValueOfSharesIssued_33" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_ifrs-full_LossesOnChangeInFairValueOfDerivatives_34" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_ifrs-full_CurrentDerivativeFinancialLiabilities_35" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_36" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_huge_IssuanceOfCommonStockOfShareBasedCompensation_37" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_huge_ValueOfTradeAndOtherPayableOfSharesBasedCompensation_38" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_huge_IssuanceOfCommonSharesOfShareBasedBonusToEmployeesForPerformance_39" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_huge_FairValueOfShareBasedCompensationBonus_40" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_huge_ShareBasedPaymentExpenses_41" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_huge_IssuanceOfCommonStockOfBoardOfDirectorsInLieuOfCash_42" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_huge_IssuanceOfCommonStockForNotesPayable_43" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_huge_NotesSettledThroughIssuanceOfShares_44" order="230" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_huge_FairValueOfCommonStockToSettleNotesPayable_45" order="240" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_huge_GainLossOnSettlementOfFinancialLiability_46" order="250" use="optional" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_huge_CommonStockIssuedForPrivatePlacement_47" order="260" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_huge_WarrantsIssuedForPrivatePlacement_48" order="270" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_huge_NumberOfSharesIssuedThroughEquityDistributionAgreement_49" order="280" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_50" order="290" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_huge_CashProceedsFromIssuanceOfPrivatePlacement_51" order="300" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_52" order="310" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_huge_FairValueOfWarrantsIssued_53" order="320" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_huge_IssuanceOfCommonStockOfDirectOffering_54" order="330" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_huge_IssuanceCostOfCommonSharesAndWarrants_55" order="340" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_huge_IssuanceOfWarrantsOfDirectOffering_56" order="350" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_huge_FairValueOfWarrantLiability_57" order="360" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_huge_FairValueOfWarrantLiabilityOfResidualAmount_58" order="370" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_huge_TotalCashTransactionCosts_59" order="380" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_huge_TransactionCostsAllocatedToWarrants_60" order="390" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_huge_FairValueOfCommonSharesIssued_61" order="400" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_ifrs-full_PaymentsForShareIssueCosts_62" order="410" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_huge_ExercisePriceOfWarrantsGranted_63" order="420" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_21" xlink:to="loc_huge_ExercisePriceOfWarrantIssue_64" order="430" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/ShareCapitalScheduleOfChangesInNumberOfWarrantsOutstandingDetails">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract" xlink:label="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfWarrantsOutstanding" xlink:label="loc_huge_NumberOfWarrantsOutstanding_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfWarrantsIssued" xlink:label="loc_huge_NumberOfWarrantsIssued_2"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfWarrantsExercised" xlink:label="loc_huge_NumberOfWarrantsExercised_3"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfWarrantsExpired" xlink:label="loc_huge_NumberOfWarrantsExpired_4"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfWarrantsOutstanding" xlink:label="loc_huge_NumberOfWarrantsOutstanding_5"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WeightedAverageExercisePriceWarrantsOutstanding" xlink:label="loc_huge_WeightedAverageExercisePriceWarrantsOutstanding_6"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WeightedAverageExercisePricesWarrantIssued" xlink:label="loc_huge_WeightedAverageExercisePricesWarrantIssued_7"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WeightedAverageExercisePricesWarrantExercised" xlink:label="loc_huge_WeightedAverageExercisePricesWarrantExercised_8"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WeightedAverageExercisePricesWarrantExpired" xlink:label="loc_huge_WeightedAverageExercisePricesWarrantExpired_9"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WeightedAverageExercisePriceWarrantsOutstanding" xlink:label="loc_huge_WeightedAverageExercisePriceWarrantsOutstanding_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract_0" xlink:to="loc_huge_NumberOfWarrantsOutstanding_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract_0" xlink:to="loc_huge_NumberOfWarrantsIssued_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract_0" xlink:to="loc_huge_NumberOfWarrantsExercised_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract_0" xlink:to="loc_huge_NumberOfWarrantsExpired_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract_0" xlink:to="loc_huge_NumberOfWarrantsOutstanding_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract_0" xlink:to="loc_huge_WeightedAverageExercisePriceWarrantsOutstanding_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract_0" xlink:to="loc_huge_WeightedAverageExercisePricesWarrantIssued_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract_0" xlink:to="loc_huge_WeightedAverageExercisePricesWarrantExercised_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract_0" xlink:to="loc_huge_WeightedAverageExercisePricesWarrantExpired_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract_0" xlink:to="loc_huge_WeightedAverageExercisePriceWarrantsOutstanding_10" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/ShareCapitalScheduleOfFairValueAssumptionsOfWarrantsDetails">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract" xlink:label="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfWarrantsTable" xlink:label="loc_huge_DisclosureOfWarrantsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_2"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfWarrantsLineItems" xlink:label="loc_huge_DisclosureOfWarrantsLineItems_5"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WeightedAverageSharePriceOfWarrants" xlink:label="loc_huge_WeightedAverageSharePriceOfWarrants_5"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceOfWarrantsGranted" xlink:label="loc_huge_ExercisePriceOfWarrantsGranted_6"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedDividendYieldOfWarrantsGranted" xlink:label="loc_huge_ExpectedDividendYieldOfWarrantsGranted_7"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_RiskFreeInterestRateOfWarrantsGranted" xlink:label="loc_huge_RiskFreeInterestRateOfWarrantsGranted_8"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedLifeOfWarrants" xlink:label="loc_huge_ExpectedLifeOfWarrants_9"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedVolatilityOfWarrantsGranted" xlink:label="loc_huge_ExpectedVolatilityOfWarrantsGranted_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract_0" xlink:to="loc_huge_DisclosureOfWarrantsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfWarrantsTable_1" xlink:to="loc_ifrs-full_RangeAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_1" xlink:to="loc_ifrs-full_RangesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_1" xlink:to="loc_ifrs-full_BottomOfRangeMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_1" xlink:to="loc_ifrs-full_TopOfRangeMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfWarrantsTable_1" xlink:to="loc_huge_DisclosureOfWarrantsLineItems_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfWarrantsLineItems_5" xlink:to="loc_huge_WeightedAverageSharePriceOfWarrants_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfWarrantsLineItems_5" xlink:to="loc_huge_ExercisePriceOfWarrantsGranted_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfWarrantsLineItems_5" xlink:to="loc_huge_ExpectedDividendYieldOfWarrantsGranted_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfWarrantsLineItems_5" xlink:to="loc_huge_RiskFreeInterestRateOfWarrantsGranted_8" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfWarrantsLineItems_5" xlink:to="loc_huge_ExpectedLifeOfWarrants_9" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfWarrantsLineItems_5" xlink:to="loc_huge_ExpectedVolatilityOfWarrantsGranted_10" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/ShareCapitalScheduleOfReconciliationOfTheShareCapitalDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReservesWithinEquityAbstract" xlink:label="loc_ifrs-full_DisclosureOfReservesWithinEquityAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsMember" xlink:label="loc_huge_WarrantsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_4"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassACommonStockSharesMember" xlink:label="loc_huge_ClassACommonStockSharesMember_4"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassBCommonStockSharesMember" xlink:label="loc_huge_ClassBCommonStockSharesMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-full_IssueOfEquity_10"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfShares" xlink:label="loc_huge_IssuanceOfShares_11"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue" xlink:label="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue_12"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares" xlink:label="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_14"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughShareIssueRelatedCostShares" xlink:label="loc_huge_IncreaseDecreaseThroughShareIssueRelatedCostShares_15"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughReverseAcquisition" xlink:label="loc_huge_IncreaseDecreaseThroughReverseAcquisition_16"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughReverseAcquisitionShares" xlink:label="loc_huge_IncreaseDecreaseThroughReverseAcquisitionShares_17"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughWarrantValuations" xlink:label="loc_huge_IncreaseDecreaseThroughWarrantValuations_18"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughWarrantValuationsShares" xlink:label="loc_huge_IncreaseDecreaseThroughWarrantValuationsShares_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_20"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares" xlink:label="loc_huge_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_22"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughExerciseOfOptionShares" xlink:label="loc_huge_IncreaseDecreaseThroughExerciseOfOptionShares_23"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughStockOptionsCancelled" xlink:label="loc_huge_IncreaseDecreaseThroughStockOptionsCancelled_24"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_25"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughExerciseOfWarrantsShares" xlink:label="loc_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares_26"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughExpiryOfWarrantsValue" xlink:label="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue_27"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseThroughExpiryOfWarrantsShares" xlink:label="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares_28"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_29"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_30"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReservesWithinEquityAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_EquityMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityMember_1" xlink:to="loc_huge_WarrantsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_4" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_4" xlink:to="loc_huge_ClassACommonStockSharesMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_4" xlink:to="loc_huge_ClassBCommonStockSharesMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_ifrs-full_Equity_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_ifrs-full_NumberOfSharesOutstanding_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_ifrs-full_IssueOfEquity_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_huge_IssuanceOfShares_11" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue_12" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares_13" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_ifrs-full_ShareIssueRelatedCost_14" order="60" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_huge_IncreaseDecreaseThroughShareIssueRelatedCostShares_15" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_huge_IncreaseDecreaseThroughReverseAcquisition_16" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_huge_IncreaseDecreaseThroughReverseAcquisitionShares_17" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_huge_IncreaseDecreaseThroughWarrantValuations_18" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_huge_IncreaseDecreaseThroughWarrantValuationsShares_19" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_20" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_huge_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares_21" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_22" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_huge_IncreaseDecreaseThroughExerciseOfOptionShares_23" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_huge_IncreaseDecreaseThroughStockOptionsCancelled_24" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_25" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares_26" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue_27" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares_28" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_ifrs-full_Equity_29" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_8" xlink:to="loc_ifrs-full_NumberOfSharesOutstanding_30" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/ShareCapitalScheduleOfWarrantsOutstandingAndExercisePriceDetails">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract" xlink:label="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfWarrantsTable" xlink:label="loc_huge_DisclosureOfWarrantsTable_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassesOfWarrantsAxis" xlink:label="loc_huge_ClassesOfWarrantsAxis_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassesOfWarrantsDomain" xlink:label="loc_huge_ClassesOfWarrantsDomain_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtJanuary5Th2020Member" xlink:label="loc_huge_WarrantsByExpiryDateAtJanuary5Th2020Member_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtNovember30Th2020Member" xlink:label="loc_huge_WarrantsByExpiryDateAtNovember30Th2020Member_2"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtAugust1St2021Member" xlink:label="loc_huge_WarrantsByExpiryDateAtAugust1St2021Member_3"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtMay24Th2022Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay24Th2022Member_4"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtSeptember15Th2022Member" xlink:label="loc_huge_WarrantsByExpiryDateAtSeptember15Th2022Member_5"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtMay20Th2023Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay20Th2023Member_6"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtJuly24Th2023Member" xlink:label="loc_huge_WarrantsByExpiryDateAtJuly24Th2023Member_7"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtSeptember11Th2023Member" xlink:label="loc_huge_WarrantsByExpiryDateAtSeptember11Th2023Member_8"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtMay4Th2025Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay4Th2025Member_9"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtMay10Th2025Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay10Th2025Member_10"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtMay17Th2025Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay17Th2025Member_11"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtMay31St2025Member" xlink:label="loc_huge_WarrantsByExpiryDateAtMay31St2025Member_12"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtJune8Th2025Member" xlink:label="loc_huge_WarrantsByExpiryDateAtJune8Th2025Member_13"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtAugust6Th2020Member" xlink:label="loc_huge_WarrantsByExpiryDateAtAugust6Th2020Member_14"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtOctober20Th2020Member" xlink:label="loc_huge_WarrantsByExpiryDateAtOctober20Th2020Member_15"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtJanuary16Th2026Member" xlink:label="loc_huge_WarrantsByExpiryDateAtJanuary16Th2026Member_16"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtJanuary20Th2026Member" xlink:label="loc_huge_WarrantsByExpiryDateAtJanuary20Th2026Member_17"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtNovember1St2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtNovember1St2019Member_18"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtNovember14Th2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtNovember14Th2019Member_19"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtNovember21St2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtNovember21St2019Member_20"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtDecember12Th2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtDecember12Th2019Member_21"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsByExpiryDateAtDecember29Th2019Member" xlink:label="loc_huge_WarrantsByExpiryDateAtDecember29Th2019Member_22"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfWarrantsLineItems" xlink:label="loc_huge_DisclosureOfWarrantsLineItems_25"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WeightedAverageExercisePriceWarrantsOutstanding" xlink:label="loc_huge_WeightedAverageExercisePriceWarrantsOutstanding_25"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfWarrantsOutstanding" xlink:label="loc_huge_NumberOfWarrantsOutstanding_26"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract_0" xlink:to="loc_huge_DisclosureOfWarrantsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfWarrantsTable_1" xlink:to="loc_huge_ClassesOfWarrantsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsAxis_1" xlink:to="loc_huge_ClassesOfWarrantsDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtJanuary5Th2020Member_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtNovember30Th2020Member_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtAugust1St2021Member_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtMay24Th2022Member_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtSeptember15Th2022Member_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtMay20Th2023Member_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtJuly24Th2023Member_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtSeptember11Th2023Member_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtMay4Th2025Member_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtMay10Th2025Member_10" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtMay17Th2025Member_11" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtMay31St2025Member_12" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtJune8Th2025Member_13" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtAugust6Th2020Member_14" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtOctober20Th2020Member_15" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtJanuary16Th2026Member_16" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtJanuary20Th2026Member_17" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtNovember1St2019Member_18" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtNovember14Th2019Member_19" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtNovember21St2019Member_20" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtDecember12Th2019Member_21" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ClassesOfWarrantsDomain_1" xlink:to="loc_huge_WarrantsByExpiryDateAtDecember29Th2019Member_22" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfWarrantsTable_1" xlink:to="loc_huge_DisclosureOfWarrantsLineItems_25" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfWarrantsLineItems_25" xlink:to="loc_huge_WeightedAverageExercisePriceWarrantsOutstanding_25" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfWarrantsLineItems_25" xlink:to="loc_huge_NumberOfWarrantsOutstanding_26" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/ShareCapitalTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReservesWithinEquityAbstract" xlink:label="loc_ifrs-full_DisclosureOfReservesWithinEquityAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory" xlink:label="loc_huge_DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_2"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory" xlink:label="loc_huge_DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory_3"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory" xlink:label="loc_huge_DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReservesWithinEquityAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReservesWithinEquityAbstract_0" xlink:to="loc_huge_DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReservesWithinEquityAbstract_0" xlink:to="loc_huge_DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReservesWithinEquityAbstract_0" xlink:to="loc_huge_DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/SignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SummaryOfSignificantAccountingPoliciesAbstract" xlink:label="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/SignificantAccountingPoliciesPolicies">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SummaryOfSignificantAccountingPoliciesAbstract" xlink:label="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory_14"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory" xlink:label="loc_huge_DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory_15"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_10" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_11" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_12" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_13" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory_14" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_huge_DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory_15" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/SignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfAssetsDetails">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SummaryOfSignificantAccountingPoliciesAbstract" xlink:label="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SummaryOfSignificantAccountingPoliciesTable" xlink:label="loc_huge_SummaryOfSignificantAccountingPoliciesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" xlink:label="loc_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="loc_ifrs-full_ComputerEquipmentMember_4"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProductionEquipmentMember" xlink:label="loc_huge_ProductionEquipmentMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FixturesAndFittingsMember" xlink:label="loc_ifrs-full_FixturesAndFittingsMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ConstructionInProgressMember" xlink:label="loc_ifrs-full_ConstructionInProgressMember_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LandMember" xlink:label="loc_ifrs-full_LandMember_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationMethodPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DepreciationMethodPropertyPlantAndEquipment_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill_13"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_huge_SummaryOfSignificantAccountingPoliciesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesTable_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesTable_1" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_4" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_4" xlink:to="loc_ifrs-full_ComputerEquipmentMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_4" xlink:to="loc_huge_ProductionEquipmentMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_4" xlink:to="loc_ifrs-full_FixturesAndFittingsMember_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_4" xlink:to="loc_ifrs-full_ConstructionInProgressMember_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_4" xlink:to="loc_ifrs-full_LandMember_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesTable_1" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_11" xlink:to="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_11" xlink:to="loc_ifrs-full_DepreciationMethodPropertyPlantAndEquipment_12" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_11" xlink:to="loc_ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill_13" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/SignificantAccountingPoliciesTables">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SummaryOfSignificantAccountingPoliciesAbstract" xlink:label="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory" xlink:label="loc_huge_SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_SummaryOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_huge_SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/SubsequentEvents">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/SubsequentEventsNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SubsequentEventsMember" xlink:label="loc_huge_SubsequentEventsMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TypeOfArrangementsAxis" xlink:label="loc_huge_TypeOfArrangementsAxis_4"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TypeOfArrangementsDomain" xlink:label="loc_huge_TypeOfArrangementsDomain_4"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_EquityDistributionAgreementMember" xlink:label="loc_huge_EquityDistributionAgreementMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_7"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BoardMembersMember" xlink:label="loc_huge_BoardMembersMember_7"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AllianceGlobalPartnersMember" xlink:label="loc_huge_AllianceGlobalPartnersMember_8"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DirectorsAndOfficersMember" xlink:label="loc_huge_DirectorsAndOfficersMember_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfOrdinarySharesAxis" xlink:label="loc_ifrs-full_ClassesOfOrdinarySharesAxis_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-full_OrdinarySharesMember_12"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassBSubordinatedVotingSharesMember" xlink:label="loc_huge_ClassBSubordinatedVotingSharesMember_12"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassBCommonSharesMember" xlink:label="loc_huge_ClassBCommonSharesMember_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_16"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfStockOptionsApprovedForIssuance" xlink:label="loc_huge_NumberOfStockOptionsApprovedForIssuance_17"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_CertainShareholdersClaimingToHoldInExcessPercentageOfClassBSubordinatedVotingShares" xlink:label="loc_huge_CertainShareholdersClaimingToHoldInExcessPercentageOfClassBSubordinatedVotingShares_18"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NumberOfSharesIssuedThroughEquityDistributionAgreement" xlink:label="loc_huge_NumberOfSharesIssuedThroughEquityDistributionAgreement_19"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfShares" xlink:label="loc_huge_IssuanceOfShares_20"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ShareIssuePricePerShare" xlink:label="loc_huge_ShareIssuePricePerShare_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_22"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DerivativeLiabilitiesSettledThroughIssuanceOfShares" xlink:label="loc_huge_DerivativeLiabilitiesSettledThroughIssuanceOfShares_23"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfCommonSharesApprovedForIssuance" xlink:label="loc_huge_FairValueOfCommonSharesApprovedForIssuance_24"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_MaximumAggregateOfferingPrice" xlink:label="loc_huge_MaximumAggregateOfferingPrice_25"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1" xlink:to="loc_ifrs-full_NonadjustingEventsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsMember_1" xlink:to="loc_huge_SubsequentEventsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_huge_TypeOfArrangementsAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_TypeOfArrangementsAxis_4" xlink:to="loc_huge_TypeOfArrangementsDomain_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_TypeOfArrangementsDomain_4" xlink:to="loc_huge_EquityDistributionAgreementMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_7" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_7" xlink:to="loc_huge_BoardMembersMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_7" xlink:to="loc_huge_AllianceGlobalPartnersMember_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_7" xlink:to="loc_huge_DirectorsAndOfficersMember_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ifrs-full_ClassesOfOrdinarySharesAxis_12" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfOrdinarySharesAxis_12" xlink:to="loc_ifrs-full_OrdinarySharesMember_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OrdinarySharesMember_12" xlink:to="loc_huge_ClassBSubordinatedVotingSharesMember_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OrdinarySharesMember_12" xlink:to="loc_huge_ClassBCommonSharesMember_13" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_16" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_16" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_16" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_16" xlink:to="loc_huge_NumberOfStockOptionsApprovedForIssuance_17" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_16" xlink:to="loc_huge_CertainShareholdersClaimingToHoldInExcessPercentageOfClassBSubordinatedVotingShares_18" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_16" xlink:to="loc_huge_NumberOfSharesIssuedThroughEquityDistributionAgreement_19" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_16" xlink:to="loc_huge_IssuanceOfShares_20" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_16" xlink:to="loc_huge_ShareIssuePricePerShare_21" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_16" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_22" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_16" xlink:to="loc_huge_DerivativeLiabilitiesSettledThroughIssuanceOfShares_23" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_16" xlink:to="loc_huge_FairValueOfCommonSharesApprovedForIssuance_24" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_16" xlink:to="loc_huge_MaximumAggregateOfferingPrice_25" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/TradeAndOtherReceivables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherReceivablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherReceivablesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SalesTaxRecoverable" xlink:label="loc_huge_SalesTaxRecoverable_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_RentReceivable" xlink:label="loc_huge_RentReceivable_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherReceivables" xlink:label="loc_ifrs-full_OtherReceivables_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherReceivables" xlink:label="loc_ifrs-full_TradeAndOtherReceivables_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0" xlink:to="loc_huge_SalesTaxRecoverable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0" xlink:to="loc_huge_RentReceivable_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0" xlink:to="loc_ifrs-full_OtherReceivables_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0" xlink:to="loc_ifrs-full_TradeAndOtherReceivables_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/TradeAndOtherReceivablesTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory" xlink:label="loc_huge_DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0" xlink:to="loc_huge_DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/NatureOfBusiness">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfNatureOfBusinessAbstract" xlink:label="loc_huge_DisclosureOfNatureOfBusinessAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfNatureOfBusinessExplanatoryTextBlock" xlink:label="loc_huge_DisclosureOfNatureOfBusinessExplanatoryTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfNatureOfBusinessAbstract_0" xlink:to="loc_huge_DisclosureOfNatureOfBusinessExplanatoryTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/LeaseObligationsNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilitiesAbstract" xlink:label="loc_ifrs-full_LeaseLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LeaseLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/RightofuseAssetNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ImpairmentLossOnRightOfUseAsset" xlink:label="loc_huge_ImpairmentLossOnRightOfUseAsset_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="loc_ifrs-full_DepreciationRightofuseAssets_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_0" xlink:to="loc_huge_ImpairmentLossOnRightOfUseAsset_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_0" xlink:to="loc_ifrs-full_DepreciationRightofuseAssets_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/BasisOfPresentationScheduleOfRestatementOfPriorPeriodInformationDetails">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BasisOfPresentationAbstract" xlink:label="loc_huge_BasisOfPresentationAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_RetrospectiveApplicationAndRetrospectiveRestatementTable" xlink:label="loc_huge_RetrospectiveApplicationAndRetrospectiveRestatementTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassACommonStockSharesMember" xlink:label="loc_huge_ClassACommonStockSharesMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassBCommonStockSharesMember" xlink:label="loc_huge_ClassBCommonStockSharesMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:label="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RestatedMember" xlink:label="loc_ifrs-full_RestatedMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PreviouslyStatedMember" xlink:label="loc_ifrs-full_PreviouslyStatedMember_5"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember" xlink:label="loc_huge_IncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" xlink:label="loc_ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember_7"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_RetrospectiveApplicationAndRetrospectiveRestatementLineItems" xlink:label="loc_huge_RetrospectiveApplicationAndRetrospectiveRestatementLineItems_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAbstract" xlink:label="loc_ifrs-full_AssetsAbstract_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="loc_ifrs-full_CurrentAssetsAbstract_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="loc_ifrs-full_CurrentPrepaidExpenses_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="loc_ifrs-full_NoncurrentAssetsAbstract_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-full_Assets_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesAbstract" xlink:label="loc_ifrs-full_LiabilitiesAbstract_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_CurrentLiabilitiesAbstract_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_22"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_NoncurrentLiabilitiesAbstract_25"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_25"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-full_Liabilities_26"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAbstract" xlink:label="loc_ifrs-full_EquityAbstract_28"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital_28"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_Warrants" xlink:label="loc_huge_Warrants_29"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharePremium" xlink:label="loc_ifrs-full_SharePremium_30"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-full_RetainedEarnings_31"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_32"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-full_EquityAndLiabilities_34"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_BasisOfPresentationAbstract_0" xlink:to="loc_huge_RetrospectiveApplicationAndRetrospectiveRestatementTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_RetrospectiveApplicationAndRetrospectiveRestatementTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_1" xlink:to="loc_huge_ClassACommonStockSharesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_1" xlink:to="loc_huge_ClassBCommonStockSharesMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_RetrospectiveApplicationAndRetrospectiveRestatementTable_1" xlink:to="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_5" xlink:to="loc_ifrs-full_RestatedMember_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RestatedMember_5" xlink:to="loc_ifrs-full_PreviouslyStatedMember_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RestatedMember_5" xlink:to="loc_huge_IncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RestatedMember_5" xlink:to="loc_ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_RetrospectiveApplicationAndRetrospectiveRestatementTable_1" xlink:to="loc_huge_RetrospectiveApplicationAndRetrospectiveRestatementLineItems_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_RetrospectiveApplicationAndRetrospectiveRestatementLineItems_10" xlink:to="loc_ifrs-full_AssetsAbstract_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_10" xlink:to="loc_ifrs-full_CurrentAssetsAbstract_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_10" xlink:to="loc_ifrs-full_CashAndCashEquivalents_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_10" xlink:to="loc_ifrs-full_TradeAndOtherCurrentReceivables_11" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_10" xlink:to="loc_ifrs-full_CurrentPrepaidExpenses_12" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_10" xlink:to="loc_ifrs-full_CurrentAssets_13" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_10" xlink:to="loc_ifrs-full_NoncurrentAssetsAbstract_15" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_15" xlink:to="loc_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_15" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_15" xlink:to="loc_ifrs-full_RightofuseAssets_16" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_15" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_17" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_RetrospectiveApplicationAndRetrospectiveRestatementLineItems_10" xlink:to="loc_ifrs-full_Assets_20" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_RetrospectiveApplicationAndRetrospectiveRestatementLineItems_10" xlink:to="loc_ifrs-full_LiabilitiesAbstract_21" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesAbstract_21" xlink:to="loc_ifrs-full_CurrentLiabilitiesAbstract_21" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_21" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayables_21" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_21" xlink:to="loc_ifrs-full_CurrentLeaseLiabilities_22" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_21" xlink:to="loc_ifrs-full_CurrentLiabilities_23" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesAbstract_21" xlink:to="loc_ifrs-full_NoncurrentLiabilitiesAbstract_25" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_25" xlink:to="loc_ifrs-full_NoncurrentLeaseLiabilities_25" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_25" xlink:to="loc_ifrs-full_Liabilities_26" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesAbstract_21" xlink:to="loc_ifrs-full_EquityAbstract_28" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_28" xlink:to="loc_ifrs-full_IssuedCapital_28" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_28" xlink:to="loc_huge_Warrants_29" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_28" xlink:to="loc_ifrs-full_SharePremium_30" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_28" xlink:to="loc_ifrs-full_RetainedEarnings_31" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_28" xlink:to="loc_ifrs-full_Equity_32" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesAbstract_21" xlink:to="loc_ifrs-full_EquityAndLiabilities_34" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/BasisOfPresentationTables">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_BasisOfPresentationAbstract" xlink:label="loc_huge_BasisOfPresentationAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfDetailedInformationAboutRestatementOfPriorPeriodExplanatory" xlink:label="loc_huge_DisclosureOfDetailedInformationAboutRestatementOfPriorPeriodExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_BasisOfPresentationAbstract_0" xlink:to="loc_huge_DisclosureOfDetailedInformationAboutRestatementOfPriorPeriodExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/AssetsHeldForSale">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfAssetsHeldForSaleAbstract" xlink:label="loc_huge_DisclosureOfAssetsHeldForSaleAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/AssetsHeldForSaleTables">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfAssetsHeldForSaleAbstract" xlink:label="loc_huge_DisclosureOfAssetsHeldForSaleAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ScheduleOfComponentsOfAssetsHeldForSaleExplanatory" xlink:label="loc_huge_ScheduleOfComponentsOfAssetsHeldForSaleExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ScheduleOfNetLossAndComprehensiveLossFromDiscontinuedOperationsExplanatory" xlink:label="loc_huge_ScheduleOfNetLossAndComprehensiveLossFromDiscontinuedOperationsExplanatory_2"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ScheduleOfCashFlowsFromDiscontinuedOperationsExplanatory" xlink:label="loc_huge_ScheduleOfCashFlowsFromDiscontinuedOperationsExplanatory_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleAbstract_0" xlink:to="loc_huge_ScheduleOfComponentsOfAssetsHeldForSaleExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleAbstract_0" xlink:to="loc_huge_ScheduleOfNetLossAndComprehensiveLossFromDiscontinuedOperationsExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleAbstract_0" xlink:to="loc_huge_ScheduleOfCashFlowsFromDiscontinuedOperationsExplanatory_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/AssetsHeldForSaleDetails">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfAssetsHeldForSaleAbstract" xlink:label="loc_huge_DisclosureOfAssetsHeldForSaleAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfAssetsHeldForSaleTable" xlink:label="loc_huge_DisclosureOfAssetsHeldForSaleTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember" xlink:label="loc_ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfAssetsHeldForSaleLineItems" xlink:label="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleAbstract_0" xlink:to="loc_huge_DisclosureOfAssetsHeldForSaleTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleTable_1" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_1" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_1" xlink:to="loc_ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleTable_1" xlink:to="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_4" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/AssetsHeldForSaleDetails2">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfAssetsHeldForSaleAbstract" xlink:label="loc_huge_DisclosureOfAssetsHeldForSaleAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfAssetsHeldForSaleTable" xlink:label="loc_huge_DisclosureOfAssetsHeldForSaleTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember" xlink:label="loc_ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfAssetsHeldForSaleLineItems" xlink:label="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_4"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AddDeductItemsNotAffectingCashAbstract" xlink:label="loc_huge_AddDeductItemsNotAffectingCashAbstract_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDepreciationExpense" xlink:label="loc_ifrs-full_AdjustmentsForDepreciationExpense_5"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold" xlink:label="loc_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossInventories" xlink:label="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossInventories_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets" xlink:label="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_9"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentsForLossesGainsOnDisposalOfInventory" xlink:label="loc_huge_AdjustmentsForLossesGainsOnDisposalOfInventory_10"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentsForLossesGainsOnDisposalOfEquipment" xlink:label="loc_huge_AdjustmentsForLossesGainsOnDisposalOfEquipment_11"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ChangesInNoncashWorkingCapitalBalancesAbstract" xlink:label="loc_huge_ChangesInNoncashWorkingCapitalBalancesAbstract_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_13"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_AdjustmentsForIncreaseDecreaseInPrepaidExpensesAndDeposits" xlink:label="loc_huge_AdjustmentsForIncreaseDecreaseInPrepaidExpensesAndDeposits_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_22"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_23"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleAbstract_0" xlink:to="loc_huge_DisclosureOfAssetsHeldForSaleTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleTable_1" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_1" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_1" xlink:to="loc_ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleTable_1" xlink:to="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_4" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_4" xlink:to="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_4" xlink:to="loc_huge_AddDeductItemsNotAffectingCashAbstract_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_AddDeductItemsNotAffectingCashAbstract_5" xlink:to="loc_ifrs-full_AdjustmentsForDepreciationExpense_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_AddDeductItemsNotAffectingCashAbstract_5" xlink:to="loc_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_AddDeductItemsNotAffectingCashAbstract_5" xlink:to="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossInventories_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_AddDeductItemsNotAffectingCashAbstract_5" xlink:to="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_8" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_AddDeductItemsNotAffectingCashAbstract_5" xlink:to="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_9" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_AddDeductItemsNotAffectingCashAbstract_5" xlink:to="loc_huge_AdjustmentsForLossesGainsOnDisposalOfInventory_10" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_AddDeductItemsNotAffectingCashAbstract_5" xlink:to="loc_huge_AdjustmentsForLossesGainsOnDisposalOfEquipment_11" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_4" xlink:to="loc_huge_ChangesInNoncashWorkingCapitalBalancesAbstract_13" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ChangesInNoncashWorkingCapitalBalancesAbstract_13" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_13" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ChangesInNoncashWorkingCapitalBalancesAbstract_13" xlink:to="loc_huge_AdjustmentsForIncreaseDecreaseInPrepaidExpensesAndDeposits_14" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ChangesInNoncashWorkingCapitalBalancesAbstract_13" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_15" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ChangesInNoncashWorkingCapitalBalancesAbstract_13" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_16" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_ChangesInNoncashWorkingCapitalBalancesAbstract_13" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_17" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_4" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_19" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_4" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_21" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_21" xlink:to="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_21" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_21" xlink:to="loc_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_22" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_21" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_23" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/AssetsHeldForSaleDetails1">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfAssetsHeldForSaleTable" xlink:label="loc_huge_DisclosureOfAssetsHeldForSaleTable_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember" xlink:label="loc_ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfAssetsHeldForSaleLineItems" xlink:label="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-full_CostOfSales_5"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_GrossProfitLossBeforeFairValueAdjustments" xlink:label="loc_huge_GrossProfitLossBeforeFairValueAdjustments_6"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueAdjustmentsOnInventorySold" xlink:label="loc_huge_FairValueAdjustmentsOnInventorySold_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets" xlink:label="loc_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-full_GrossProfit_9"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_OperatingExpensesAbstract" xlink:label="loc_huge_OperatingExpensesAbstract_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_GeneralAndAdministrativeExpense_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationAndAmortisationExpense" xlink:label="loc_ifrs-full_DepreciationAndAmortisationExpense_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OperatingExpense" xlink:label="loc_ifrs-full_OperatingExpense_13"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProfitLossBeforeOtherIncomeAndGainLossOnSaleOfEquipmentFromDiscontinuedOperations" xlink:label="loc_huge_ProfitLossBeforeOtherIncomeAndGainLossOnSaleOfEquipmentFromDiscontinuedOperations_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherIncome" xlink:label="loc_ifrs-full_OtherIncome_16"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LossOnSaleOfEquipment" xlink:label="loc_huge_LossOnSaleOfEquipment_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_18"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleTable_0" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_1" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_1" xlink:to="loc_ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleTable_0" xlink:to="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_4" xlink:to="loc_ifrs-full_Revenue_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_4" xlink:to="loc_ifrs-full_CostOfSales_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_4" xlink:to="loc_huge_GrossProfitLossBeforeFairValueAdjustments_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_4" xlink:to="loc_huge_FairValueAdjustmentsOnInventorySold_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_4" xlink:to="loc_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_4" xlink:to="loc_ifrs-full_GrossProfit_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_4" xlink:to="loc_huge_OperatingExpensesAbstract_10" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OperatingExpensesAbstract_10" xlink:to="loc_ifrs-full_GeneralAndAdministrativeExpense_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OperatingExpensesAbstract_10" xlink:to="loc_ifrs-full_DepreciationAndAmortisationExpense_11" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OperatingExpensesAbstract_10" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_12" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_OperatingExpensesAbstract_10" xlink:to="loc_ifrs-full_OperatingExpense_13" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_4" xlink:to="loc_huge_ProfitLossBeforeOtherIncomeAndGainLossOnSaleOfEquipmentFromDiscontinuedOperations_15" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_4" xlink:to="loc_ifrs-full_OtherIncome_16" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_4" xlink:to="loc_huge_LossOnSaleOfEquipment_17" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_4" xlink:to="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_18" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/AssetsHeldForSaleDetailTextuals">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfAssetsHeldForSaleAbstract" xlink:label="loc_huge_DisclosureOfAssetsHeldForSaleAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfAssetsHeldForSaleTable" xlink:label="loc_huge_DisclosureOfAssetsHeldForSaleTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember" xlink:label="loc_ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfAssetsHeldForSaleLineItems" xlink:label="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_4"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LossOnSaleOfEquipment" xlink:label="loc_huge_LossOnSaleOfEquipment_5"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProceedsFromSalesOfInventory" xlink:label="loc_huge_ProceedsFromSalesOfInventory_6"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_LossOnSaleOfInventory" xlink:label="loc_huge_LossOnSaleOfInventory_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_8"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleAbstract_0" xlink:to="loc_huge_DisclosureOfAssetsHeldForSaleTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleTable_1" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_1" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_1" xlink:to="loc_ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleTable_1" xlink:to="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_4" xlink:to="loc_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_4" xlink:to="loc_huge_LossOnSaleOfEquipment_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_4" xlink:to="loc_huge_ProceedsFromSalesOfInventory_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_4" xlink:to="loc_huge_LossOnSaleOfInventory_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_DisclosureOfAssetsHeldForSaleLineItems_4" xlink:to="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/WarrantsLiabilityDetailTextuals">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantLiabilitiesAbstract" xlink:label="loc_huge_WarrantLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantLiabilitiesTable" xlink:label="loc_huge_WarrantLiabilitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ClassBCommonStockSharesMember" xlink:label="loc_huge_ClassBCommonStockSharesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AllLevelsOfFairValueHierarchyMember" xlink:label="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Level2OfFairValueHierarchyMember" xlink:label="loc_ifrs-full_Level2OfFairValueHierarchyMember_4"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantLineItems" xlink:label="loc_huge_WarrantLineItems_7"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfCommonStockOfDirectOffering" xlink:label="loc_huge_IssuanceOfCommonStockOfDirectOffering_7"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_IssuanceOfWarrantsOfDirectOffering" xlink:label="loc_huge_IssuanceOfWarrantsOfDirectOffering_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromIssuingOtherEquityInstruments" xlink:label="loc_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_9"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceOfWarrantIssue" xlink:label="loc_huge_ExercisePriceOfWarrantIssue_10"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedLifeOfWarrants" xlink:label="loc_huge_ExpectedLifeOfWarrants_11"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_TransactionCostsAllocatedToWarrants" xlink:label="loc_huge_TransactionCostsAllocatedToWarrants_12"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_FairValueOfWarrantLiability" xlink:label="loc_huge_FairValueOfWarrantLiability_13"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SharePrices" xlink:label="loc_huge_SharePrices_14"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_RiskFreeInterestRateOfWarrantsGranted" xlink:label="loc_huge_RiskFreeInterestRateOfWarrantsGranted_15"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantsLiability" xlink:label="loc_huge_WarrantsLiability_16"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ProfitLossOnChangeInFairValue" xlink:label="loc_huge_ProfitLossOnChangeInFairValue_17"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExercisePriceOfWarrantsLiability" xlink:label="loc_huge_ExercisePriceOfWarrantsLiability_18"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_SharePricesOfWarrantsLiability" xlink:label="loc_huge_SharePricesOfWarrantsLiability_19"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_RiskFreeInterestRateOfWarrantsLiability" xlink:label="loc_huge_RiskFreeInterestRateOfWarrantsLiability_20"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_ExpectedVolatilityOfWarrantsGranted" xlink:label="loc_huge_ExpectedVolatilityOfWarrantsGranted_21"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_WarrantLiabilitiesAbstract_0" xlink:to="loc_huge_WarrantLiabilitiesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_WarrantLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_1" xlink:to="loc_huge_ClassBCommonStockSharesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_WarrantLiabilitiesTable_1" xlink:to="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_4" xlink:to="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AllLevelsOfFairValueHierarchyMember_4" xlink:to="loc_ifrs-full_Level2OfFairValueHierarchyMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_WarrantLiabilitiesTable_1" xlink:to="loc_huge_WarrantLineItems_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_WarrantLineItems_7" xlink:to="loc_huge_IssuanceOfCommonStockOfDirectOffering_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_WarrantLineItems_7" xlink:to="loc_huge_IssuanceOfWarrantsOfDirectOffering_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_WarrantLineItems_7" xlink:to="loc_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_WarrantLineItems_7" xlink:to="loc_huge_ExercisePriceOfWarrantIssue_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_WarrantLineItems_7" xlink:to="loc_huge_ExpectedLifeOfWarrants_11" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_WarrantLineItems_7" xlink:to="loc_huge_TransactionCostsAllocatedToWarrants_12" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_WarrantLineItems_7" xlink:to="loc_huge_FairValueOfWarrantLiability_13" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_WarrantLineItems_7" xlink:to="loc_huge_SharePrices_14" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_WarrantLineItems_7" xlink:to="loc_huge_RiskFreeInterestRateOfWarrantsGranted_15" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_WarrantLineItems_7" xlink:to="loc_huge_WarrantsLiability_16" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_WarrantLineItems_7" xlink:to="loc_huge_ProfitLossOnChangeInFairValue_17" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_WarrantLineItems_7" xlink:to="loc_huge_ExercisePriceOfWarrantsLiability_18" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_WarrantLineItems_7" xlink:to="loc_huge_SharePricesOfWarrantsLiability_19" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_WarrantLineItems_7" xlink:to="loc_huge_RiskFreeInterestRateOfWarrantsLiability_20" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_WarrantLineItems_7" xlink:to="loc_huge_ExpectedVolatilityOfWarrantsGranted_21" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/WarrantsLiability">
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_WarrantLiabilitiesAbstract" xlink:label="loc_huge_WarrantLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DisclosureOfWarrantLiabilitiesExplanatory" xlink:label="loc_huge_DisclosureOfWarrantLiabilitiesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_huge_WarrantLiabilitiesAbstract_0" xlink:to="loc_huge_DisclosureOfWarrantLiabilitiesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundAbstract" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeferredTaxAssetsOtherInvestments" xlink:label="loc_huge_DeferredTaxAssetsOtherInvestments_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward" xlink:label="loc_huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward_2"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeferredTaxAssetLiabilityNotRecognized" xlink:label="loc_huge_DeferredTaxAssetLiabilityNotRecognized_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_DeferredTaxAssetsOtherInvestments_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_DeferredTaxAssetLiabilityNotRecognized_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.fsdpharma.com/role/IncomeTaxesNarrativeDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundAbstract" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised" xlink:label="loc_huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_1"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_PreacquisitionNetOperatingLossCarryforwards" xlink:label="loc_huge_PreacquisitionNetOperatingLossCarryforwards_2"/>
    <loc xlink:type="locator" xlink:href="huge-20201231.xsd#huge_NetOperatingLossCarryforwardsLimitationsInUse" xlink:label="loc_huge_NetOperatingLossCarryforwardsLimitationsInUse_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_PreacquisitionNetOperatingLossCarryforwards_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_0" xlink:to="loc_huge_NetOperatingLossCarryforwardsLimitationsInUse_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>exhibit99-1x001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit99-1x001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  0" P,# @0# P,$! 0$!0D&!04%
M!0L(" 8)#0L-#0T+# P.$!01#@\3#PP,$A@2$Q46%Q<7#A$9&QD6&A06%Q;_
MVP!# 00$! 4%!0H&!@H6#PP/%A86%A86%A86%A86%A86%A86%A86%A86%A86
M%A86%A86%A86%A86%A86%A86%A86%A;_P  1" !C ,$# 2(  A$! Q$!_\0
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M&001'R#3O^%%?&__ *(WX_\ _"7O?_C= '0_\-4?M#?]%8\0?]_$_P#B:/\
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M_P#MH?'KP+J=N]UXLD\4Z=& LMAKZ_:/-4#&?/XF#8Z'>1GE@W2OO_\ 8_\
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M5J,V^5;7_,=+*U@6^:GRR>^G]:+^M1***DM89KFYCM[>)Y9IG"1QQJ69V)P
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MB::YNKF41Q0QJ,LSLW"@#N:M5X5\?O%!\2_$NT^',7ASQ)K'AS16BO\ Q?\
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JINE6^GV[W#PVL2Q1M<W,EQ*0!@%Y9&9W;U9B2>Y-%% %C:/2BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>exhibit99-1xu001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit99-1xu001.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M110 4444 %%%% !1110 4444 %%%% !1110 A.*6BB@ HHHH **** "BBB@
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M'FO-?%/[ OP]\3^!M#\(?VEXBTO0]*U&75Q%87D0>YO9&):XF9X7+/R< 84
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M:],^%EZ_B#_@J!JEU?\ @R?PE(/"1N1IU^8'EBE_<()AY+NH)3(R#G!KZO\
MCW^S/H'[0\OAA_$&L:WIP\.WG]H6*Z/<11 7 QMD;?$Y)7''0<G(-8>H?L?>
M'=0^+VL?$IO%/BJ'Q/JFGOI4\L%[ D:VS1B,J@$.5QM# @Y#<^U 'R)JW[4]
MUIG[?>A^+Y];T^7P??SW?@I;2&=F-M;QW(C\Z09P/,G E#=T5?3 G_:6UOPM
M\-_VZO%.O:YX#'C;2!X$%S?Z?!:PR;F+%//E#X&T;4!<9*C![5]:^-?V-/ ?
MQ ^$?ACX<:S+JK:)X=DBDL;BVN4CO,QQO&F^41\X5SR "2 2<TZP_9 \(6GQ
M6M/B!=:QXBU;7X=-&CR+J-ZDL%S:!"GE2Q^6 ZG)8Y/).: /BGP[\'-6\:_\
M$]_ ^E7>O6^M:QK?B/S-#F@D\XV)>*8):[V!*%I(_G48P6(ZBN-^(7QD\1_&
MW]B3[!J4EY:R_#=K>'5Y9 1]LN6F6WM8Y,\DK"TK..,.$/'2OO7PE^Q!X&\"
M6EA8^'M8\2Z3I%GK\?B2'38M162!;N,$* )(V(3!(*@C/<YYK3\:?L<^ O&_
M@CQ3X5E.IZ1I/B?7CXBU0:7<K$]Q<G:2,LC83**VT#J.O8@'D?[17C^W\"_L
M5>!/!NEZOIGA/4_&FC6VE6]U=,(88(?L)GN6P.F]4\H''W[A/6N__P""?'QB
M7XN_LV:#'<2!M8\-XT*]4L"W[I%\IR.HW1%/Q#>E=OX2_9NT7PEX_P##7BR'
MQ'XBO[WP]H \-6=I?W,,MLMK\N25\H,)"8X]SJREO+7.1D&#X-_LK^%_@?\
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MNUB20#WJBD!R..:6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MM'I2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MT=\0?&OBGQ9HNF_"_3;F3POXA@T'4WB\4G*K($8W48>S4/&BN&9<A\!MJL0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KY_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ<MOBU&S*//$)T>-$EAD"KM!P68A?JVT^ WPUM?#9T"'P#X:70S<?:SIQTF
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M=M;Q*$CAA0(B*.@ ' 'M0!-1110 4444 %%%% !1110 4444 %%%% !1110
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M+@^S:G^R%X4\3^#/$NA>*=:\2>+[K7HXHY]<UG40]];B*3S8?LY1%CAV2?.
MB#)^]N&!6?XE_8L\+>*_">OZ3J'B?Q5/J>NWEA=W_B.6\@?4IA9D-;0[S"4$
M:,-X 0$MR230!XWXT_;!^-W@A_B5'?>$O!,B_#[5]+M=5FBN;H&\@U"2%;=;
M9#T=1*2SN<<C"<'-KQ;^V+\4-&UWXJW>G^&/#FH>$_ASK\&GZD_GSI>36LC
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M /A6.BZW-HEM8:QI.C2CQ#J]C=&'4Y)Y56>(7"R;(9DA((\S(=\GY00*]/\
MVG/C;\0/ASXZ^&/A+P!I_A^_U3QK<WMG%_;S3JL3P0B7>3'T4#.>_H*ETO\
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MDO/+U<K]I%XRM=*^%Y5V0''8DD8K5O/V.?AY?0>,+2==7DTWQ3I5EHU]I_\
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MKWCKQ#H=]XDM=*:/3;62VC=XY#"9P!-/(  7DQA#PV<CZ;U[]EKP7XD^)?\
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M\T.Z\6^'-%O7L9=$M&@LHD16%J!&Q/W$V9'3*X]SX[\5?B=K?[+'PX\*^'_
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M$_ _]JWQW^SO\$O"MAJ-OH^O:!_PK&;Q'HUG!;O#-;20W'DQK-*7/F*VX,^
MN,X&-OS?77[.'Q!^*_BCQ7J]KX_T_3HM N=-MM3T.]BFLUN9MW$P,-O<S@Q9
M*E'STZG)P-?0OV-?A1X?N-"E@T"ZN5T72;C0K.WOM5NKF 6$YD,MN\4DA21#
MYK<.#C"8^XN-OX*?LR?#C]GD:D? ?A[^QWU (MQ+)=S7+LB9V(&E=BJ LQVK
M@9.: /4J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+X4OX:F\>>/]4\&GP)X@\=:N=1ET&2Y2XDL8515",Z?+NDE\^X8+P#.%_AH
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M\@*.<S:!^P);:9X=\/>'[WQ]J%[HMCX9O?">H6\6FV\3ZA83S><J>8=QB*,
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M]\8/#^GV&J> ?%FC>#SXFM;K3M7C>[M8Q* (;CRP'M;H$ /"<E58C=FN_O\
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M#?M_VSKBR3Q7;>)/AUJGAS7M.32&TC1I=0MYY]7;4Y9(;.,%"5B<R1$."6V
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MT'XOZ'\77C\&:SXEN-$O]!U;PU!<S6%A:V\LRW$/D3^3(TC><A:1W0,Q<XR
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M8DA4&1R'8Y;) R6; )'=^'_VPOAIXI\.Z-JFE:C?W\VJWUWIEOI-OITTE_\
M:K6,R7,30*I96C0!SGC#*03N&?#O&W[''Q&\4R>.M0AF\&KJ4WQ!'C70+74V
MEOK&[B-J+5[6_B:W&T&-0V4+\L1Q@,?+_P!HOPOXH^$>H?!V.\U7P%\.?%T^
MJ:UJ::OI4<FB:#I"/9P6_P!CBNA Y+2J/,9I8RS,I **J"@#ZK3]N?X4W'A/
M3/$5I>ZQ?:?J%C=ZI&+?1K@R)96T@CN+EU*#;$CG;N[D$+G!J#P%\6M>\4?M
MA>)O#4>NKJ'@1_!.G>(-*M(X(@$::9D,F\+YA+!<X<\ C@5\UZ5\ _'7[1?P
MJ\.6_A32_"NC>"M)T;5O"]M9:IK%[=V-S*S8CUFU985:XSF4(TP&&+.H/&?H
M+X%? SXD>"?C)I/BOQ8_AAM/M?A[8^$)1H]W</*;BVN&E60))"HV%9&4G=G*
M@X .  >M_%;XX>&/@ZM@FNM?37NH0W5Q:V.G6;W$TL5L@DN' 48"QHP8EB..
MF3Q7 >(OVX?A5X<>U#ZCJVHBYT&'Q.C:7HEU<JNF2$C[4Y2,A$7!W;L;<$'G
MBJ'[5_P%\;?&O6O"+>';W0)=!L+?4(=2T?Q&]P+:>29(U@F\N$$3&,JQ"2'9
MG!P>WD/@#]D+XP^$-%U2PNIO!-Z9_A6?A_ \.HW<>V=9YVCF;-LV4V3G=CG<
MHP .: .Z_;0_:DC\(_ [QL/A]K6JQ>+].TVRU :EH^F_:8=.CN)%,)N'>-HX
MQ+'NP#\P!#?+P:^I=5U*'1-)O=0N?,-M:0O/*(8FE?:JECM1068X!PJ@D] "
M:^&=<_8U^-=I\/\ QKX7\/:_X+N+3QUX:TS3=:36I;QS:7MI9I:M);.L?S+*
ML:MEU!0]%.WYOM"YA\0R_#^6!UTZ\\4MII1E\Q[>RENS%@_-M=TB+YYVLP7L
M30!XA9_M_P#PFU/PLNN:=<:U?PS2)%9VR:7)%+?.8FD80^;L5@@1@S;@JM@9
M^9<[DW[9OPT/A;2M?TV[U+7K74-(NM>6'2]/DEFAL+9MEQ/*AQL5'^7!Y)SM
M! )KQJU_8Y^)=E\%?@G9VVH^#D^(7PS^U6T5MJ$<U]HFI6L^%=9=T2R*Q1(^
M57@[L$9!'DW[3-MK'@/XI^!]"\1^,?!_AS5'\':I%K.H7L=UHNEZA;7=X2UA
M:O;1L<1!1@,=Y#;B2S\ 'V#_ ,-A> GL-2O5AUT06/A1?&KF32Y(VDTHL5\]
M%;#'&UC@@'"DC(P3QGAK]HHV7QO^*>HZWXBNI?A[IWA'1/$6GV+VB[K6.X68
MN45%WNS;4.&W'+ #  %<#<? OXA_&OPQIGBGPI;>&O!EGXD^&EQ\/M0TC5#=
MN+&V$THAN+0^6K.KHV5$H0JK*3N.16G9?LC?%+3M'U2*T\3^'M(U*;X=:5X+
MAOM.-PKF>RE+&9OD! >-WCRIW+P0.P ._P#&_P"VKH&B^'H;O1O#^N:IJJ>*
MM/\ #%YI,ED4N+:6XD0G*YY8PEBB@G<^U3CG'5:Y^UK\/O#6K3VE_/J<5E::
MO%H%]K*Z=*VGV.H2*K+;33 85OG0,W*JS ,P/%>"6_[&GQ)T?0/$4FEW?@F#
M6I?$VB^*]'L8H[N&R@N[%X]R2OAG*,J-D[6+,Q)QGCH9?V1/'U_X6\=^!-0U
MWP]<>"O&OB>#Q/?W,2W"7ME(\T5Q?0VZ,'0J\L7[LL_R!FR&)X .RUS]O;X;
MZ!%XHFN=-\8&T\,SRVVK7B^'+D06DD<L<3*\C*%!S+&=N<[7!P :]F\,_$/3
M/%7B77-$L(KII]'CM7N+EHA]G8SQ^:BI("0S!-I8#H&0]&!/SVVA6WP'^%/Q
MB;XW3:?>^$?&?B:]NX8= M[J]G,=_B-;9T6$'?\ *JJP&,D9.<$^D_LC_#'4
MOA5\!_#.E:Y/>77B&>W2\U&34&!N%E9%"1/CC,,20P\<?N1B@#V2BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L#QA
M\0/"_P /;.&[\4^(])\.6L[^7%/JU[':I(_]U3(P!/L*WZ^=_P!LOP7J_CK2
M/AC9:7X5F\56MEXZTK5-6ACB200Z? [-.Q5R V0579R6!/I0!Z?;_'3X=7>K
M:)I</CCP_+J6MQ1SZ9:)J4)DO(Y%+1M$N[+!@"5QUQQ3;SX[_#G3_%C>&+KQ
MUX>M_$*&0/IDNIPK.AC0O(&0MD%5!8@] ,FODD? ?6/#OQH\5Z%JGP5G\:^&
M]5\66>O^']9L]=>PTC38EBCC'G6R2X1[=(W5&6)BP(7 7:*X_P"']KXM\)^(
M?V:OAUXT\"ZOX?U7P_XOU9+CQ!=M!+9:J\EM=R^9#(':1VD$FYBRA<@Y)/
M/N;Q!\7/#4/A:[O]'\6^%Y;N32;C5-.DO-6B6UFCC4CSV=6)\A7P'D7( SWK
M \#_ +0/AEO!'A&Y\:>-/!FF>)]9T^TNGM+#6HF@E><A5-ON?<\;.=JMR">Y
MKX[\,>$?B3H'A+X>^&YOA5XK%EX6\&^*?#FI2?9K9TGFN$0P&)5E_>(WEH,J
MHR7PH.UL=#\'_@MK&O\ C#X41>)?AS?6<&E_")/#+7VL:6CQZ;K4<JE),MDJ
MP6"5ED4<>8@R"] 'V0GQL^'\EWKEJOC7P^;C0D,NJ1G4X0;) VUFE^;Y &^4
MD]#P>>*JM^T#\,4M+VZ?XA>%DMK*X2TN96UFW"0S/]Q'._ +8. >N#Z&O@;0
M/@MXAA^"VL:!K_P.\:2>/O#W@S4]!;7KG7KB^L[AGB,<":?!YSK)YDNR0H(U
M2,*S Y %:&M? 26.U\3W&E_"*_AFE^!D>C6@7P]@G7#O#JJ[3B<B2,%OO?(W
M/J ??^M?%3P;X<UG3](U;Q7HNF:KJ&W['97>H1137&[.S8C,"VX@@8ZD$"JE
MO\:OA]>ZQ%I-MXZ\-W.JRR31)90ZM;O,SQ#,JA ^<H.6'4=Z^#-)^"VO7GC"
M\A\:_!7QAXQLO%5GX?O-):UUN?3[&PN;:Q@@DBU&,3*(O)DC=PVR1B"0H.ZM
M*'X-36&J)?6/PLUM-8_X7R/$;:BVA,DRZ1YY<S"0#_4 $@)Z?P@G- 'UQX5_
M:(^$/C;2)?%MOXL\-PVMK?SZ6NIWU[;1'S(FD!VNS?=94=UY^9/FQ@UZGI^I
M6VKZ?;7]C<17EE=1K-!<6\@DCEC8 JZL,AE((((X(-?F_=?#7Q5H?PTT+PT/
M!?CWPUXM\'^)?$%YIWB;0]%&HV6VXGG>.-K5<_:K:>*01MP-I(X92XKZH_9O
M^*NJ2VGAOX7^)/ NH^#_ !+H_A'3[^8QVR1Z9M$<<;00$.Q4QEE7:1C*N ?D
MY /6[GXF^%+3Q0GAJ;Q'I4?B&3[FE->QBY;Y=W$9.X_+ENG09JEX:^*?P_UO
M7Y-"T'Q7X<OM9D\RX;3=.U*WDN'P2))#&C%C@@Y..H.:^(_B1X.\=7?[0B:[
M'\.?%7V'1?B%:ZOY.B6$;65[9K$J/>-*[AYIG "[%PB*#D98D\UX0_9_\2:;
MK?PRUC0/AUK7A7Q /%/BJ;5-3.G&&2*"Z1X[-I9%.Y8]KQ*,9 VN1TRP!]B:
MK^TK8G]I#P3\-="N] UZSUNWU%K^XL=46:\TZ>U3<8Y(4!" G@%FR2KC V\]
M-\2_BW=>%?&W@_P7X?TA->\4>(97F,,EQY,-CI\)3[3=RM@G"[U5% R[N!D
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MX.0=OI3^!I? 7Q$_9T\4>%OA7JD&@6FF:G8:S::+I4-O/97%U#9QK+=1,R'
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M\:^%M-\:6_B:'6)-":]M?[#U'Q180V>M74*VR(RW:QD^8T06.(2N=S!#T
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MQ5^.5]X/3XQ_\(G\0-2USPS!J7A5I[Z/4WU)M'TBZB;[7-"5?>J%=N75@^9
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MO6Y10 A -  %+10 4$9HHH  ,4$9HHH  ,4444 %%%% !1110 4444 %%%%
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M^W3X0\&^(_$^EWOA+QI+;^&;ZPLM6U:WTV%K.U6\*"VG+&8,8W\Q>BE^?NT
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M]JW3]0\%6-_I=OXRTS0Q<^';N3Q'X:DLCM%^1)';OYLF<%"@<*K']ZG\+9H
M^N0<TM?#?Q@_:A\:Z_X9^*,NEZ;JOA7_ (5_XRTC3HCI,\,MSJ,4EQ!'+;RK
MDDF03%EV%1]U6;@A_ICX-_'*S^+]YXKTS^P=4\,:]X7OUT_5-*U8P/)$SH)(
MV#P22(P9".C<$$<C!(!Z92;AG%4=?U&;2=#U"]MK*;4[FVMY)HK&W($EPZJ2
M(U)X#,0 ,\9-?#FB?M.^/_'.K_L\_$*UTC7&M_%?]O03>"-&NK8Q:FD5NSV\
MH\UUVE&X9G<?ZHD+\P# 'WE17REJ?_!13P+!X3\-ZMIVA:WJE_K.C3Z[_9"K
M#%<6]O#/);NAWN \IEBD143);82=N1GZ0\"^+[3Q_P"#]&\1V,%W:V>J6D=Y
M#!?P-!/&KJ&"R1GE6&<$>W4]: -VBO%?VC/%P\+>(/A%%+>>)-/AU;QE::>L
MV@W,,4,LC1R,L%VKG<\#A6)" _<Z@XSQ_A[]N;2=;\4:5IUQX"\3:1I5[XGN
M_"#ZW?/9_9K?4;=9&:)@D[,1B-LNH*#!PS8H ^FJ*^-?$7[3U_KOQG^"WB[3
MQK6A?";5+7Q%<75W<W,2VNH6MK8O,ETT"%G4#RV90Y!P0=H((K<D_P""@&CP
M>']8UI_A_P"*6TZR\.1^*(+E8XO)N+5Y439YA8*DP619"A)^7."3@$ ^KJ*^
M9+[]NW0/#MYJ.G>)O!?B7POK2C3Y-*TZ_2!GU2*]E\J"1'BE=(P&^_O(* $8
M+#;3/^&X4>;0[&#X5^,KG6-8UV]\/VMDJ6T0EG@A\X21R32HKQ.N2''"['W8
M( (!]/45\XV?[6EM\1M T[2O"GA36[KQEK%IJSRZ&MU;6UUI:V,QMIWDE9F1
M6\\HD> VYF!. "1YE\$_VSI_#/P"\!P:WIOB'Q_XWD\-'7]3^RKYEP\374L2
M $\O*[1N%0 #$9R5XR ?;=%?,'B3]N.U\/:EJX/PT\7OHVBS:0NJ:K.+2W6U
MBU$)]F?RGF$CDM(BE N5.[=M(P>T^ ?QB\3?%#QQ\5].UK0X](L/#'B)M'LB
MLRNS(D$+9;'7>7,@.!@.%YVY(![71110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !117*?$GXG:!\*/#\.K^(;B:*&YO(
M=.M(+6VDN+B[NIFV0P111@L[NQP !ZDD $T =717BEU^U_\ #>W\#:7XHCU#
M4;VWU$W@@TZSTNXEU ?9"PNR]LJ;T$.T[V8!1\O/S+E-=_;%^%N@6>GWSZ]/
M?:9=65GJ4NHZ?I\]Q;6-K=OLMI;J1$(@$C9 #X/!R !0![917D%W^U;\-[+Q
M\GA*76;@7K:H-"&H+83MIW]IE=PL/M83ROM&/^6>[(/RG#<5+I7[4_PWUF#P
MW+:ZQ>E?$&H7NE6(DTB\1C=VBLUQ"X:(&-UV/P^-VUMN[!P >M5X[^T7\&?$
M7QD@\$)H7B'3M ;PWXBM/$9-_ISW8N);9MT4?RRQ[5R6W=2>,$8YR-$_;A^#
MWBBW271?$EYJ9FTZ\U.VCCT6]C-S%:JS7"QF2%5:1 I)CSNQ@XP<U3\)?MI^
M"]4^$WAKQGKT6H:+)K&ESZP^G1V%Q/):VD) FG?$8_<IN3,N-AW#!(H V/BC
M\"?$OCOXQ^&O&FF^*]/TFST?0M1TDZ?<Z2URTLEVFTR^8)DPJE(3LQSL89^;
M*^2>$/V&O'/PPT?P-+X$^+Z^&/$VB:,WA[4[X:!'<VVI60NIKB+]Q)*=DB-.
MXW;CG(^[C!]2\<?MN_!SX<W]Y9:YXID@GM(;6YF$&G7,X6&X&8I,I&1L((^;
MH-P&<G%5!^V7X.LO'_Q.\/ZK;:CIMCX$M]->ZU1[*9X[F6[)"1Q[4(YWVXC!
M.Z7S'**50L0#W/0].DTC1;"QEO)]0EMH(X7N[D@RSE5 +N1U9L9/N:\W^/WP
M&@^-.G>'KJTU5_#OB[PQJ*ZMH.N) )_LMPHQAXR1YD3<;DR,[1SQ75_#WXD:
M-\3M$GU31C=K#!=RV,\5]:R6TT,T3;71XW 92#ZBN"TC]L3X3ZV=0-IXEF>&
MSTFXUTW#:5>)%/8P2F*:>!S$!.BN",Q;LCD9'- &)XX_9Y\:_'/X?>(O"GQ/
M\<Z?+INJ:>]DEGX7T@VL"R[T>.ZD,TLKNZM&I"*R*,G.XX8<;XV_9#^(/Q3\
M/Z__ ,)=\0M$NO$][X>@\+VNI6>A21Q):+<)<SS2Q&X.Z>62*+HP1 AVKECC
MU'PQ^U_\(_%]KK5UIGC&$VNCZ6-;O)[NTN+6-;$\>>C2QJ)$S\I*;L-\IYXK
MG_@I^T#<_%G]H7XE>'K2ZGE\*Z/I6DWFGV]_HUQIEU#).)O-W+<(DDBML1@^
MT+A@!GDD Y;XJ?LA>,/B</C*\WC31;27XAZ%I6E%8]'E M)+-@Q?)N#N5]\X
MQC*[DY;:=U7QI^QYX\\=:+\7+34/B!HB7/Q"31A/-#H#JMK)8K&I< 7&7,@C
M7.3Q@8X&*N?M"_M87NA:=\9O#G@Z'4=%\4^!- AUE-9OM'EFM)F)D=XOF0(J
ME(@%D9@'+ML#>6<]Y\/OVO?AAXP\$ZKK*^+X"?#UG;3:SYUI/ \1E0;"D;QA
MI1(W">4&WD@+DD @'FOQ6_8X\:?$S5?C6R^--$TVR^)6GZ392N-(EDFLS9@
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M3#_:6E:E9RVEU;K,F^)S'(H.UEY!'3H<'B@#P;P9^PEXD^&NF^$Y_"/Q?N-
M\5:'9WFE3:S%H$4L=]83W3W0@DMY)64-'-)(PD!R0P!!Q7U9X8T>3P]X;TK2
MYM0NM6FLK2*V?4+UMT]RR(%,LA[NQ&XGU)KSKX_?'ZQ^!,/@_P"U:1J.L3>)
M-=MM%@CL+=Y2AD8;F(4$E@N[:@&6(] 2/)O@M^UQIUC\0/%?@#X@>)KV_P#$
M)\>7WA_1;R316AM1'A#:VC3Q1B+S3EP,G<>,]J /6_CM\%M1^,5Y\/Y['Q+'
MX?'A/Q';^(_+DT[[6+N6%75(S^\0HN)),D9ZCTKS&/\ 8QU81:9'+X\M9EM/
MB#>>/I,Z"1Y\EP'#VQ_TG 7$TOSCGYEX^4[NZ\)?M>_#;QM\3;'P-IFIW3ZM
MJ?VD:5<R6;K::F;<,9Q!+C#; C')P& RI8<UA_%3XF^-?$'[1>A?!KP1J5OX
M7#Z!)XEUOQ'):+=7,-MYQ@BBMHY,Q[VD'+.K  ],C! .(T+]@>^TZX\(:7J/
MQ0O]8\"^$VU&#2?#]QI,*RI97EO+;S6\ETK!G/E3,H?:,=ATQ@?%W]F#QQX$
M_9D\;Z!'\0O%7Q)L[?P\=%\.>%[?2XU,09XU3S/)!>X*JBJ&?A%WG'IZ_9^/
MO%WP+U#Q;)\4M;_X2;P]=:G8V?@R?3[&/^TM0DG1]UF8(0-TRLF=P4*5RV5
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MBE^TCXN\!^'O&&M:8_@SQ-9Z7XQT_0(8],NIII;&WF:*.9;T @+<K))@*I
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MO@%<?M'?$+Q3JNN?#N^^'?AK5?AO'X5O+34TBCDEU+[0LT,L4<3,&%L$PLK
M$Y4 8! ^Q/"'A'1? 7ANPT#P]I\.DZ+8)Y5K96XQ'"F2=JCL,D\5K[@: /SW
M^'G[)7Q>D\:>!/$/C![.ZC\2Z=!H_C[3W97BM[33S;/9[?F/FR3&T*R-R,7#
M@ #D9WP]^!'C#P]XMN-,\8?"+6_%E_X:UG6=9M/%5QXAEDTV[@N#)(3%9^80
M\\P=(BA7!ZOT:OT9W#UKG/&/BVZ\+R:"MIX>U3Q -3U2'3YFTQ4;[!&X8FZF
MW,N(D*@,5R?F& : /SSTS]F_Q9X)^"/P"U[2?A3JK:IX=EO(_&'AW1;H:5J]
M]+(C1077G1,#(8\R8)8G;,1P"V-[1O@OXP^%UU:SV/P5U"^\'Z]X%U'P]I_A
M:TU*/4+G0+B>ZDFQ<R7$@7$ZR1%V1B$*E<$("WW;/\1_#5I;S3SZU:1Q0ZI'
MHCN7X%[(Z1I /5RTB# Z$\XP<=+F@#RC]E30=6\-_LV?#G1/$&D7&BZQINA6
MUA=Z?>;#)&\48C.=K,,';N'.<,,@'('QW\/_ (8^./AK\2?"-[??!W5]3\,^
M#_$WBA;K[+#:R?:X-2F9[2ZM8=_SK$D6UL[2HF 7/('Z-%AG%8/CGQ)-X,\)
M:GK5MHFI>([BSB,B:5I$:O=7)R!LC5F4$\]R.AH \K_8W^&FJ_"KX++I6K6$
MFC?:=7U'4[/1IG5GTZTGNI)(+=MI*AEC92P4X#,1VS7R=/\ !7Q'XD_LZQU/
MX5ZK<Z?9_'F\\32)<Z=&4;0IR[[P"W,9)BW(!@[,$$BOT:TR].HZ9:W;6\UF
MT\2RFWN5"RQ;@#L< D!AG! )Y%8GQ#\67/@7P;J6NV?A_5/%5S:*K)I&BHKW
M=SEU4B-6902 Q8Y(X4T ?#]M\!_%>I_"3XA:EX?\#7GA[QQX2^(]YXT\$6EY
M:1VZW%JTL<@MT"DC9(B.#'Q\PCST%5_BK^SCXF^'@^'6MW'@?6?B3IMU::M_
MPF&D>%[^2WO'U34I5N)[@!2!(F08<LPRBH">E?>NG>+M)U/7+S1(;R,ZS96T
M%W=V&X>;;QS%Q$7 Z;C%)C_=/M6P3@9H _-;Q%\%/%7A_P 3^$K+P=\+/$6A
M:A#9Z'!+I%X%UG0;ZVBNS.(KB\<AK6>TW,?,1L,1M7@C.GXC^''BS0O"GB;1
M!\*->N[C2OC3%XKM+W3M/AECGTU[\W"O;8;<=L*E6  "F0+_ 'L?HKD,*X/X
MX?&#1?@%\+];\=Z_:W][I&DK&T\.F1+).V^18UVJS*OWG7.6&!0!^?>K:AI^
MI?%;QI)XE\)^*-0^&VD_%S_A)W\0Z;HB7T37$");F">X,J[;=92VY/*8JBA<
MDGC<\&_#[XAZ_P#&_P &ZEK_ ,*?$>FZ5#JOB;3=2@@M;>/3+>.^BDCCEC8O
MY\L;9WR32MC.%B4<*?LC3_V6_A))XLD\9Q>!].76KVY&IR2MO,;W!(;SF@W>
M5YF[#;MN=W.<\UZYPHH _,CP_P#"_P :Z7X#^&,7B/X,>--<T'3_  M?^"M:
MT32;Q;*\\YY8V:X4)*/,MYE'EEF*Y"9/ 7=]Z?##P]J'A#X$>'M%AT*/2M2T
M_0X[>+0Y+YKA+>18<);M<=6VD!2X]"1VK"N/VD+ ZYXWT73_  =XJUG6/".H
MZ?I]]96%I#)))]L.8IHOWO,2H1(S-MVJ<D<''KZGB@#\HO"'PF^*$^F:D+WX
M2>)[<:K\-M>\+&REL+:*TL;YI/.MEA02-*T7F!0LL[/(SLS@[5ROK?@+]FC2
M9?B,FF:S\/[SPA\/]8^$EKX<UB=[6*S@CU1;A96=F#<S#KYA!RP')K] R0*Y
MSX@?#[PU\5/"MYX:\6:1;ZYH5YL,]C= E'*.'4\$$$,H.0>U 'A'["?A;74^
M%\/BKQ=<VFJ^(+F"/0++4[8$B;2=/>2"U;<?O>8WG3[A]X3(>PKGOVE_A5!X
MU_:F^'^K7WP\O?%VBV_A/6[6]N_[,6ZM4E:/=:QDMPLF1,%SCF5,'DX^@]2\
M6Z%\//#>LZ1X>TN35;SPIHT-VOA;08E:Y%L5E6VBBCR!E_L\BHN?X/I75Z)J
M1UC1;"_>SN=.:ZMXYS9WJA)X"RAO+D4$@.N<$ D9!Y- 'YJ^'?A!XL^''@[X
M1Q:/\$[^[\3CP!XHTOQ$LED8TN;F9%^S0W,\+ G<8'"Y8';*@4J2"O,Q? [X
MI>)_"7Q5ANOAMXH1]9\':'-IT&IV=I"KSV-W&TEM'% P6,[/-6.-PTA098Y;
MYOU=# C-+U% 'YW?%GX3^/\ Q[KGQK'AGX9ZSH[_ !#T'PY>6#W?D6T4"V#R
M&ZLKB2.1O+EE0(@1<YW8;:!FL[7_ (1S>/\ 1_#>OC]G[Q38"[\=Z-J6N66N
MW'V^^NK>VAFCNF:.5\+  \**/E,H5MRX5<_<7PO^,>F?%35?&FG66E:MI-WX
M4UA]&O8]5A2/S)1&D@DBV.VZ-E=2"<'!' R*[\$8H R=)\.:;X:\,0:)HMA;
MZ7IMK;?9[6RM(Q'%"@7"JJC@ 5^=/A3]FC78OAS\.K.'X1W7A[6?!?A76['Q
M([VD!;6[BYM7@AMXMKL+G=,PFWN0J!1@C=BOTL# UY?X^_:$\->!+JS@:"_U
MSS/$MEX5O9-)6*1=,O;KR_)^T;Y%(0^=%DH&(W@$9H ^3? 7P1U?X4V'[-_B
MFS^$=Q=:7I.DW5AXO\/V=A!]NBU66VA@.HM%NQ,6,#C<3D(X/&\@4/"7P5^(
M'PIF^&_B&W^&^KZG9/!XLT]/#MA+;M=:+;ZA,DFGP3,\H01JJG<0Y"%VSSU_
M1'<%HR",]J /R@?PYX\TC3?!/@0> =?N=>?X3/X8\2:4FE6VIRV-M+?NL4\8
M%S$(V?RY2"SG[J90E21V_C'X8?\ "T=-\::UX1^%NKZSHEW\)]/T'PI=7NEV
MZNEY%.X**N_]U(ID0L5Q_JG(R N[[=^(?[.7PT^+'B.WUSQ9X0T_6M7@@^RK
M>3!ED:'+'RG*D;TR[?*V1\QXKK=1U'P_\,?!=Q>7+6?A_P ,Z'9&1RB"*WM+
M:).@51A555X '; % 'S;^SYX7\0>#_VC_%NL7O@'5[33?&OAW0I_[9FBA1+&
M>TM98IX9_G+>:S&/A00<9)XYW?VG/!FOW?QC^#/C#0_"]]XDCT>75=/NFTU(
M3-9F\MTC@N6,CH D;J6)!R.2.>OI_A7XT:;XI^,/C'X=QZ1JMCJOAFTL[V:\
MNXXQ;7<5R&*- RNS, 48'<J\@CM7H@((ZT ? OP.^"/C6W\1? ;2;SP!>^#M
M9^&UYJG]N^*?W/V75+>1&4>5(KEYC<.RLVY05PYXR,^]?MD>'M5USPQX N-&
M\)ZAXLO-'\;Z-K+Q:;&CS6\%M<"::0;F7JB,@QU+@<=1[#X]\3W'@SP?J^MV
MFB:AXENK&W::/2=*0/=73#I'&"0"QI-$\<Z9K5_;:87>RUV73HM4ETBY %S;
M0N<#S "0I#97&>JG&<4 ?$/B[X1>*+2?XF^')?A_XN\B\^)P\7:9XL\*26R2
M6T<UJHCFAC=B9S%(CK)&P52)3AMW%?37[(>@>*?"_P"SUX5TSQGI5MHVOP_:
M3-9VMK'; *US*\;M%&2D;NC*[*IP&8BO9:RQXHTEO$K>'A?P'6UM!?M8!OWJ
MVY<H)".RE@0#W(/H: /SF\(?"3XP:Q\1/#TFM?#+5-/L?*\6:5>Q1O91Z3;B
M_1C&T*;O-:)F(9Y969G9B%X7%;OA;X5_$O\ L?X*31_##5M(OK3P1J/P]U2:
M2>VCELI9(;=([^3;)D6X<3L,9DPI^7+*#^B!(%,,RJ 3GGB@#\PK#]GKQK??
M SQ3HNJ? SQ"OC/2O C>$TU:[\3?;UO94FA^SK8P/+L6$/&9SP @7:F2:Z3X
MF?L^>)=53XH6?@OX4:CH^DZAX+\-?8;,V]K!'=WEA>QW,UN563 E,6$SCED?
MKQN_1@3*3@9J2@#\]OC/\+/B=\5O%_QFO=#^&^I:/-XC\,^'IK6WU*6WCAO)
M;*Z$T]C)+'*1O>)_+QRI*,"P !:3XS_!+Q3\:_#_ ,2/$>A_";4](D\20>&;
M%/#6I"SBF:XL[TSW5WM,HC5%MV-N&SN?+C 4G/W9XNUR?PUX7U?5K32KS7;F
MRM9;B/3+ *;B[95)$4>X@;F(P,D<FK'A_59-9T+3M0N+"YTJ>ZMHYY+"\"^=
M;,RAC&^TD;E)P<$C(.": /EOX7Z/XL^"OQ?^+]WHGPDOT\,^)/$VBC3([.2U
MMK:.V-O';75R$C=BHC97E*[1N!'()X] _;=\'>(_B-^S'XT\*^$]#N/$&O:Q
M#%;6UI;RPQ8/G([.S2NBA0$/<GI@5Z];>+M'O?%%[X<@U"&77+&UBO+FQ1LR
M0PRLZQNP[!C%)C_=-:] 'Y]?$G]GSQ5X]UOXH:U)\([F[U+7/AA8Z/I\UR^G
MN5U@*1((R\VY"H>(>9Q_J'P3\F?K+6O#OB7Q=^S-J7A^RCFT#Q?J/A273X%O
MY$,EK>/:&-2[(SKPY!)4L._->IYI"0.] 'P%X5\#_$+4O$WA26]^ VI:-9Z1
M\,M2\$7Y%YIY2XGVQF-8U\\%H6>%E4G;S/D_*-U<CXI^#WQ(O? _PL7PY\.?
M%&D^/=(\"Z5X<N9KA;2XTR^%O<NDMA?P22;8XU*+<QW",6Q(. P7'Z5;QBC>
M* /BGX6>!_B%X'^(5WX:U[X/6OB6/3?%^I^*M-^()NH"KPW)=V(C+J_VME;R
M%#$*IV$_+&&/D_@C]GGXE^!O"'P;ET?X/[?$6D>&/%=CKZSO9(EU=72.ME'<
M$3@R(6"Y()(63M@X_2X2*S%0P)'7!Z4N: /RLN?@#\:/$/PI^(ND?\*GUM]0
M\2^#-!TNW_M&]TQ4CO;*ZPRI$LB+#&L)81C!8+&I9MSUW?[1^DW.@_&K2_"?
MPT\ BU.J_#2ZT_Q!H.E6-D?L%E=W0+,D)FBA69624E@SJQ"Y# !J_1C=7E/Q
M&^&'P@^+?C^STGQEX8T'Q)XMM=--W#'?V:RSI9B79DMC_5^8Q 4G!); ZT ?
M+<7@:?QU+H^I^"OAGKM_X*N_@YJ'@^WDN)K%&EN0R^3!.1,/FS"P\P87=("#
M@DCA_&7P@UGX9_#B74]<^'5[X?T6S^!,OA+5]0MI[&$#5_,B<!S',7<-)&<O
MM;)D&>K8_2;2+"PTC3;>PTRWM[.QM$$$-M:(J10HHP$55X4 8&!TJ'Q%X>TG
MQ=HMWHVN:=::OI-[&8KFPOX5FAG0]5=&!##V(H ^.?V+[_6H/C3K\GC_ ,,:
MKHWCO7_#5@;:X>WM!8OI^GJD!V-#/*PD=[A6;=M##;@ "O8OC7X>US4?C]\#
MM:TOP;>Z[I^B:CJ#ZEK%O+;JMA%<6;VZ[EDD5V&]U<[5.!&<9) /??#;X)?#
M_P"#L5TG@GPCI'AD79'VA]-M5C>7;T#,.2!S@$X&3ZU7\?\ QAM/A_X]^'_A
MBYTR[O)/&-]/8P7D#QB*U>.!IOW@9@YW*C8VJ?NG)'&0#XLMO@K\3-'^%7@K
MP8_PU\5V^M^$+[7AI7C#0=5TQIXO.F=XV%O+*(Y+6=)-CQRD-\IX]?MGX16?
MB#0_@MX4M/%6FVJ>)+/1+:*_T[2TC6$3)"H:*-00@Y&T $)Z$+BNZW"FF9%&
M2P ]2: /S@\+_LE>.O#7[,G@*73_ (8BV^('AOQ=-JVLZ+;ZK#IM]K5HSW&P
M)J%M,""B7*A=\@*[''( #U_&?[-WQ!CT&S;P3\%]0\ ZS>:9?"$Z1XCM=5BW
M7$J[[#6$O92EQ#)M,K.F[82N S9K])Q,A?9O&_&=N><>N*:UPFPE64\[1R.3
MZ?6@#\W-2^$>K_%CQ)^T/X!L? =O<Z]J^OZ$DOBJP>U@M=&F6TM9;B4%G6;Y
M"'=5C5MQ<@D9.>V'[.WQ#O[6R^'=SX0>W73OBA)XQM/B%#>6_D+9O</=,^SS
M//\ M)#F#88RN<'<0N3],_"R#2]%\&ZQXU7X96GP]\1ZNUQ=ZIIL*VJW5W)'
M)+L:::+Y9&?E@6)QYIR>M:WP:^,>E_%[X7^'O&L,#:-::S&S16M[*OF(RNR;
M20<$Y0]* /CWP[^SEX^TN;P->O\ "L07]G\2->UV^\N^L1LTZ[BD6+>RS?,I
M$R*0,L!"V!]W=RY_9Z^,=U\(/B'X8L/A_K5MH-]H.DV^E>']<U/3;F]L[N*^
M6:2VMKM9<O911HVP3,&S( J\L:_2Q7##(J/[5#LW^:FS.-VX8S0!\3?%W]GW
MQM\2/$'QVLXOAW:S0?$RTT5=-U_4+JT T@PVT4<PN%#F7=$R%U$(=68#Y@"2
M(/B3\%OB?JV@_'/2-*\%WEU)K'BGP_K.BW4VHV834(K-+-)W.904<FQ+D/C/
MFKW#5]PO<PQ+(SRHBQC<Y9@-H]3Z4-<Q*BN9$"MT;<,&@#X9^+OP.^(?CF^_
M:3;3O 4X?7[_ ,-ZKX>FGO+-$OFT]H//5<2DJ[+')M\P*#N )%8OQ9_9W^+O
MQ:\<?%O7K;P9_P (_<:U9^&=6TVWN=7A\JZNM..Z:R>:WF$B,2Y"R#:,QYW)
M\K5]R^-?$MUX;\*:UJ6DZ3)XDU6QM)+B#1[6=(Y;IU7(C#,<*2>,G]:MZ-J\
MM]H>FWM_;?V3=W5O'-+93RJS0.R@M&6'#%2<$C@XH ^$+_X ^.;WPI9:KIWP
M@UCP+XFO-:NM4BF\.^,TN]7TVY-K%&+BZN+N8Q7"3NKH\0/$>"<MD'Z&_9X\
M?^+;+7+3X4^,-"TJTU;P]X4TN[GU'1KN)H6F9!')";:- +<*RD(.C*I*@#%=
MKX"^,:>-OB5\1/!LNCSZ1=^#[FS@:XN)D9;U;F S1R1A>@V]CS]#D5T?A7QG
MX<\3Z[XGL=%NH+G4=%O4LM5\E,%+@P1RJK-C#$1R1]"<=.",4 =+10>M% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?,
M_P#P45\,6/B7]E;7VO-.&HG3]2TJ\3$32/"!?P1S2*%Y!\B2<$CG:S5],4FT
M&@#\E_C!J_AYO%WQV^(/AB\GCNM$U[P;/X4>WN)[9 OEPQSM' &7>1'%L8E2
MRJ"..:[[X<7":O\ M3W*>*O%/C#3_BC9^/9I[32;+1VE%]I+R?NA]K)*"P%O
MRRY&!DH"2*_1'QAXMT3P#X;OM?\ $6HP:3HUB@DN+NX.$0$@#W)+$  9))
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M?1<5N^"_ O@'X@?M'ZGH>L7A%W\0_A9I/]DWL F9VG6*1)I$=3C=&+:-CN(
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M_=A%9P5#2*2,5[?6/XK\)Z+XYT&\T/Q#I5IK6C7BA+BQOH5EAE ((W*P(."
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MP">O ]!5/PM\!O ?AOXOCQ?H-GING:II6A+X?ATS3+:"".SMV=9/F5%#9(1
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M>#_#=WHGF1>&[VYTBW\K2;F4DJT"?)M)DPQ5&0N1U!.:X_\ 9<_9G\&?L_\
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MI-VSH&DD5%4C./O7PIX)\/>!+"2Q\-Z%IOA^QDD,SVVEVD=M&TA !<J@ +$
M<]>!69=_"#P)?ZK=:I<^"_#UQJ5U/'=7%Y+I<#3331Y,<CN5RS+DX8G(R<4
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M^US^U=KO[/\ K!M=&@T2Z%MH,VMR6EW'-=W=T4E""-8H6!MHMHD8W4N8\@(
M37CO[5_QMUGX[? ?XC3:3I6C6G@?PSJ&A6]Y+J0DFU":YEELYW,(7"1+&+A(
M\D/O_>8V@#/TU\9_V2/!7QV\3SZ[X@O/$%E=W.C'0+R+1]5DM(KRS\QY5CF5
M?OA9'9@#P3PP8<5QVN?\$]OAOK=C>V)UKQE9:?J-I:6VJ6=KKL@BU)[4 07$
MX8-NE0*H!!"_*OR\4 9B?M5?$+5_'6OWGA_P%%J/PW\,^*+CPUK-R9$CN8X[
M<$7%ZDKSJI"OM @$3,P'#Y8 8\'[7?Q#U'6OA3=P:3X:MO#GQ-LM8OM(@D6>
M6[L8[6S>X@-Q(L@1V?\ =%T51L^==Q.&'I5O^Q)\-[/XB2>+8#KD;W-Q'>W^
MC'5YFTS4;I#N6XN8"2)9-X60ECRZ[B"2<^5WG[&LGPV_:"^#FH^!-)UW5O 6
MB7.K/J5OJ6OB:RTB*ZMVB6*UMI7RJ[G8ML!)&,EB* +.B_ME^,]1TKP-JSZ3
MX=^Q^(/AOJ'B^:":5[58;VU*CRS<O*4C@8R*,LI*X)+'/' Z_P#MH_$?Q=X6
M\8:7I4^C6.I:'JGAF,ZS;:9>6B7=MJ<FTB.*:3S%"MMQ+G$D9)4(64CV.'_@
MG3\+(=.M;![_ ,6W%C:Z?>Z3;6LVO3-%!97.2]NJ?=V*Q+KD$[MI8MM7&@O[
M GPW:#Q&)]5\87MWX@M[*&_OKSQ#//<2/:2K+;SAG)_>H455;&%4$*!N;(!C
MZ?\ M)_%3Q9X_P!1L_"/@?3M;\,>'?%R^$]>N9)DMI!L2/[3>1O)< QA7D&V
M'RI"ZX(?)Q7L?[1OQ'U;X0_ OQKXUT.TL[[5-"TV2_AM]0+B%]G+!MGS?=S@
M C)P,CK7#6G[#OPVL?B';>,(9/$(OA+:7-[9-K,[6FJ75L!Y-U>1DGSY@RJY
M9C\SC<P)9MW;_M)>%-5\>? +X@>&-#TN/6-8UO1;K3;2UEG6%#)-&8U<NW "
M%M_OLP.2* /F+Q?^V?\ &;X9VVL6WB7P3X0N=;DT32_$>CV^F7USY)M;J^2S
M>&9V7F9))H>0%0@L<G&*[.Y_:(^,D<GQ T4Z/X)C\4_#W08]<UN.*2ZGM;UI
MC<2P6UNQ9&C/V>!2TD@;YW ";>:V](_8PT'Q=\)M,TKQCJ?BD:W=Z5I%M?S2
M:I$]U:K9@2Q6D<J)L"1SDN609=E4EV %=EX__91\(_$+Q-)X@N]2\0:7JMYI
M(T/5I]'U)K7^V++_ )Y7048;@L-Z[6 8@,,+@ \>G_;CU]3>7">']-2S\0>#
M+?Q+X%BD:3S]2NY7BA^P3#./,6>:-3LQE6##OC,O/C3XL^'?CG]HN\TCX=Z#
MJ/C?P_%X9EU"]\/VMQ/+>1SPMYDLT1=6F^SQ[F6.-E)'5NI'TOKW[/\ X&\1
MZI\/+^[T.$2^ I?,\/I%\J6@\H1*FWNJA8V [-$A[<\;XC_8[\)^)?&7C+Q3
M)K_BBPUCQ3<:?=7LUAJ*P^5+8LK6CPXC^0Q[<#KD,V<YS0!X%I'[4+>+?$_P
M8\?Z]IG@OQ5:O;^+777="M[H75DEE:M,?L\<KYB:6*.,.D@+<\8!!/5WG[7?
MQ(T'1O!&NZGH7AFXTKX@>%]2UO0H+1IQ)IMS;V!OHX+N3>PG1XE(+QHF&!&,
M8)].T']BWP!X>USPWJUO<:U+>:+>ZGJ1\^\5TU"YU ;;R2Z39B0R( F % 48
M HTS]BKX>Z3IQT^"?7WTZWT^^TO2;2XU5YH]%@O%*7 LP^?+9E)4,VXJI*@A
M210!Y1H'[6_QAN-&6[OO!GAS4+[6_AP/'/AW3-%DN))Y9 \*FVD#,#(Q299-
MJ!3_   L?FKUO]DCX^WO[0/A'Q'JU]?:1>MI^KM8PG3+.>RD2+R(7VW-M-)(
M\4RR/*A&XJ=F5)')S+G]AWP1=#1$?Q#XN":/X='A:S5-5"[+$,&5,B/(8%8R
M&!!'EIZ5Z=\*_@UHGPD37'TRZU+4M1UR[6^U+4]7NS<7-U*L:Q*S-P!A$48
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MOCS)"P/!D 'W:?X3_8P\#>#+CP;/8:EXD:?PCIEWI&DR3:JQ:&VN-_F+P!R
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MOA2/4O"_BJ+3_$6G75SX9U>\6V>3Q!':0^8[!%E!BDE0;T60)NSV/%=IXZ^
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MN=1OV&=-MSK^AV/C36;;X=>(Y;.YUOPI)%%*+R: 1AF%P1OC$WDQ^: /F&X
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MJ.DZ0-?\4:[J]KX>T'39&*Q3W]PQ$8D8<A %=CCD[0HQG(]>KQ;]JWX-Z_\
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M0Z]H;:1HOBC5K*\TDF[AF,B0VJV\C,B,Q0L8U;D\@C@$8KP[X[_L]?&#Q?\
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MOV-?BGJ'@KXHZ+)I?AN*7QKHNE6F\:]<SR175I*C/(\DD)+%L,W& I"J!C-
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MXK\N?A5X2T+X=>*OA!JB:'KNGW\GQ%UK1VGOK2]$D6B*DJ6L(\P?N[<?:+?
M&!EW/7?6#\"_@OX2UNT^!$E[X6UF\:_\4:_8^(Y_L=^IDT\!WMH;K PL)>2U
M.UOD.]\YS(: /TY\3>+-5T/QEX2TJS\.2ZGI6L2W,5]JR7<<2:9Y<)DC+1M\
MTOF%2N%^[@D\5GV'QR\#:M%X:FL_$-I=0^)-3N=(TF2(EEN[FW,PF5#W53;R
M_/\ =/RX)W+GX9^!Z>#]0O/V<-/&CW]Q%I?BCQ?I!AO]+G<1Z9.EZMO%,'3B
M-TNK, -QAFSPK8ROA]X:\)>$?AG\(K35OAQ=W\_A3XB7\'BKR_"UQ()'E&H1
MPR<0_P"D*"MGR P&V)3C   /TP2_M9+F6V2>)[B,!I(5<%T!Z$CJ,T6]]:WK
M3+!/%.87,<@C8-L<=5..AYZ&ORW^&'PSUO4=<UWR]+^(5M^TEHD6OPR7D=I9
M6NF2S7$,YBNI=0%LDUQ$[&$1K+,[H6&S" Y]M_8(\(Z+IOC*XU/2]%\<:7K:
M>'8M-\2+KUC9Z;I\=Y'*NQ$BM[6$W,Q/VAO/<LX7AR6<8 /M:^U>QT^6"*ZN
M[>VDG;;$D\JH9#P,*">3R.GJ*\Y^ GQRB^-VC^(KI]&?P]>Z+X@O_#\UC/<B
M9V>U=5=P0H!!WKTR!GJ:^4_VV_#C:I^T#:W^C^'YO&.O0Z/I5M/X8U'1IIK?
M4(/[0E=&L;V(;K6XC;<TFYE5D(SD*P/$:/\ #BVTKQM'\0XO!WB"U\5/\>II
M'U6'1K\3G0W5BS$;"?L[%N3T.3GTH _1/QEXSM_"WA?Q'J=O"-7O-%L)KZ32
M[651/)LC,@3D_*6Q@$^M>(_#;]LBW^(GC'X2:'%X2NK%/B!X?N=<AO7O4:.T
M,.[?!C:#(WRCD8X8''7'Q?\ !ZUO].^+>C:[_P (EXGT&WOM+\66.JV\/A6\
M8V;S2O)%%<W@0O?RY82,Y^1-T:(,KSZA^SMH>I:9K_[&C7FB:[:3Z1X>UVRU
M(W.DW$<5F\B;8UE=D 1F9'P&QD8/1AD _0V:YAMR@DD6,N=J[B!N."<#U. ?
MRJK+KVFP6"7TE_:QV3XVW+S*(VSTPV<&OEC_ (*":5X:O8?@?-XITYM1TD^/
M[6SO(HH)9W>VEM+KS8_+B!=U8HFY #N Q@CBOE_5OA=K/A*\TFX?PIXU7]GV
M?QEKLMGHVA:,EW=6D$UO;Q6\[Z?=P2GR2RW@7=&'17W+M9EW 'ZE3:M8V\*3
M2W<$<3@,DCR*%8$@ @D\C+*/^!#UKQ3PA^TO=^/?B7JND^'_  M;ZEX(T?5[
MG1-4\4KKD*/9SP0+(\C6K+DP%V$0=9"=P)*@8)^7_ 'P \#:U\;?A%X;U[X<
M>*9O#-CX-O8[>;Q5:S2RK(-1\ZPBNYXD2-76!9&6)O\ 5ATC.6%8L7@;4-/T
M7XG:E'\/=4GT>#XVKJ^MV":%+%+J7AH$Y B9 ;J$2J',*AA\N2N#D@'Z/Q^(
M=)GLHKR/4;.2SE8)'<+.AC=NP#9P3QTIZZUIS>21>VQ\_9Y7[U?WF[.S;SSG
M:V,=<'TK\SOB'\,-%UF_O[VU\#:M_P *MUKXKZ1J&F:9!X>O4*6*6BQZO<K;
MK'YD,,DO RJ[MIVC&*I_M ?LZZ*OC?X_Z7X4^&^H7-SIOA#0QX5%CH]W*$N8
M6CB?[,X4JTBQM&"02V QR-LE 'ZA6M_:7S3+;7$-PT+F.41.&V..JMCH1Z&N
M0\0>-=8T'XC:1I7]C67_  B5QIMU>ZAK]QJD4#V3Q%=J^0WS.A!)+@X7'/O\
MW?LH>#],^''[2GCK3-"\,:IX=T34_"&@7):73+J"VN+U$D:=GDD4!I\7$>[)
M+%B^?F#XUOCKX3M_$G[:?PN270+J[L+SPKK.E:IJBZ9--;QI.F((Y950QGYA
M-A)#@;B2 64D ]X\/?'#P)XE\%:?XL@\3:;;>']0EDAM;V_N4MTF9'92%+D9
M)V$@=2.:ZC7?$6F>'/#M]KVHW<5MI%C:R7MS=MRD<"(7=SC/ 4$\5^5T?@V>
M[_9M^%-C%X.\4Z%XP\+V.NV<]C>>"IKS3M5N)$@,MK/&J&16GC9$CN@!M*.-
MP(!'Z!>,/AYJ7Q7_ &3;[P8]F/#>LZWX0^P?8O,;;8W+V@41,S;F*H^%.220
M#SGF@#@O^&O/%=]\.;;XE:9\(;VX^'5U/$(-0N-8CBU!K.238+XV@B;;  0_
M,F_!R5"Y8?1?_"2:.NN#1#J=D-9\KSQIWVA/M'EYQO\ +SNV^^,5\S_ 7XZW
M_@KX0>#?AYJ7PT\:Q_$'P_I=IH3Z0=%G^RS/ B0"X%_L^S+"P4.7+Y ) #$
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M;@@$0[=V=^&!V]>1QS52Q^*7@O5/&%QX3L_%V@W?BJV#&;0X=2A>^B"@%MT
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M3$%&W:>!@X /T6\+^(['Q?X;TK7=->233M3M8KRV::%X7:*10RED<!E."."
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M4@&*6B@ (R*0# I:* "BBB@!" 10!@4M% !BC%%% !2;03FEHH *3:,YI:*
M"BBB@!"H-*0,444 <%\3/@OH/Q7U3PC?ZW/J4<WA?5$UC3UL+QH$^TIC:S@?
M?P-PP>SL.YKO,<TM% "%0:6BB@ Q1110 A4$YI:** $VC.:6BB@ HQ110 F*
M  *6B@!"* ,4M% "$4 4M% !2%032T4 %%%% "!0*6BB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K'\4>#M!\;Z8=-\1:+IVOZ
M<7$AL]4M8[F'<.C;'!&1D\X[UL44 <?<?!OP#=O.\_@CPY,]Q9QZ?,TFDV[&
M2U39L@;*<QKY<>$/RC8N!P*1O@WX#?5]#U4^"] _M+0HA#I5V-,A$EA&#D+"
MVW,8!R0%Q@DXKL:* ,G1?"6B^&[G5;C2M+M-.GU6Z-]?R6L*QFZN"JH99,#Y
MG*HH)//%<QX:^ ?PU\&V^K0:%X"\.:/#JT#6VH1V6EPQ+=0MG='( OS(<G*G
MCFN]HH X:W^!7PXM-'O-*@\!>&H--O;5;&ZM8])@6.>!3E8G 3YE! (!X!&>
MM1W/P#^&UYX/L/"<W@3P[)X8L+C[7:Z0=,A^RP388>8D>W:'P[C<!GYCZUWM
M% '%6WP2^'UEK^E:Y;^"?#]OK&E6AL+"^BTV%);2W(<&*-@N43$D@VC ^=O4
MU0L_V<_A7IUO=06GPX\*VT-U;RVDZPZ-;IYD,I)DC;"<JQ/(Z&O1** /.I_V
M<OA7<V4%G-\./"LUM!9_V?%')H]NPCMMQ;R5RG"98G:.,DU?A^"/P\MM-U;3
MX/ WARVL=7A2WU"W@TJ"..\B3[B2A5 =1V!SBNVHH X2;X#?#>XAT"*;P'X<
MFB\/C;I"2:7"PL!NW8AROR#=S@8YYJ6T^"7P^L?%U[XJM_!6@P^);TR&YU9-
M.B%S*9%VR%I-NXEAP3GD<&NVHH S/#7AC2/!FA6>BZ#IMKH^D6:>7;6-E"L4
M,*Y)PJ*  ,DGCUK3HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$FI^%DAL=<06PN;1"_FQS20J7A=%9MS(A 4_*3@5HZ+^U;K/Q6\,^'M"T/P
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MCQ7/>'OV\/A/XL@EFTJZUVZC&DW>LP,V@W<0NX+5B+CR#(BB1HP,LJYP/<$
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MOVH+?PC\8/C-XE\3>*WN?A7IGAGP_KNBK&BLJQ7:2 >4 H9FE<+@,?XAR!T
M+MW_ ,$\?"5_/K-Q<_$#Q_<76M#3FU.>;5()'NIK(@VTS%X#M=-JXVX  P
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M.'2)+FWN]8U32_(L%N8)5CDMA+O.906SM X .<$8H ]@HHHH **** "BBB@
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MZEM+87EVD3-#;&01B5P"53<>%R<#)Z9KX"US]E/XL7_P?^'_ (6'@W2(M?\
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M<-A37K?[0/@/5_BC\$?&W@_0YK*WU37])GTN*?4&=88A,AC=VV*QX5F( ')
M' YI;/\ :$^&.H7!MK3XA^%[JY%O<71AAU>!W$,&[SY,!\[4V-N/0!23T-<_
MX-_:V^%?B[X?6_C,^,=)T70[B]NK".36+V&V<RP2%6!5GX)79( >0DB$@9H
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M?[37P\L-8T]_"VL7N@66N:YJ"R_;G2&V19FM553&[LT4J%F8;6Y(.,5[!/\
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MJ *ND7L^HZ19W=U8S:9<SP)++8W#(TENY4$QL49D+*202K%<C@D<U^='QC^
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M?!?X++J'PB^+*:##8?$WP;:P:GX7\!:9;W4<<-SIDLAGN8X[K=M)>=_(\W<
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M?,QNQ[9Q5>Q\&:#I>LW6KV>BZ=::M=9^T7\%I&D\V3D[Y -S<@=30!^<EO\
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M5_BUXO\ AAX?\=1Z1\5-6U*YO?A'I'B^.X\0:J+MX;^6Y=+C[+D8C+Q<*JC
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*^;/^"AGB35?#7[+/B673+^;2H[RZLM.O[^W!WP6<]S'%.01]W*,5S_M8ZD5
M])UF>)?#6E^,="OM%UJP@U/2;Z(P7-I<H&CE0]01_G'6@#R7QQ\&OAGX2\,>
M%?$L6CVVC6_P[W:GHQTKRX"0L+J8-Q'SK*&P1G+-M.<]?"H_VL?BOI&B_#?Q
M!=1^&==LOB;X<U74](L-/L9E.CWL%DUW;PROYQ-PA7$<F!&0RN<@8%?17A#]
MF#P#X+ETTVEIJM_:Z7N&F6&LZW>:A:6 92I$,,\KHORL5!P2 2 0"<YOA_\
M8_\ AGX722+3=-U*"V6RO-/L;=M8NGCTJ&[_ ./A;)6D(MB_ )CVG' (&10!
M\[:#^U'\=O$FCZ$8+CP+;W.O?#N3QW:S/IMTWV86XC$D#CS\.93(OS# 0%N'
MVC=+XC_:Y^,>IV\NH>'[?PAHUA:_"JR^)<T>IV5S/(X=7,ULI69< M&Z@D @
M8ZGFOH;2/V0_AMHFF6EE:V6K*+/P_/X7MIVUR\,D.FS/O>!3YN ,XP<;@%4
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M+70/#[6&IS:9':&&2[O'M6DNI0V72,AW +!1D#CDGZ,U?]E+X8Z_>^+[O4M
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M%OQ6\>?&KXD1ZUXOTBX\%>$O$-QHBZ5!HPAN9R;:&6-_.\PX">;C&,MEB3T
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M?+)N&:^H_P!E[PR?#OP)\"&?4)-7O9] TXO?3V\$4A06R>7%^Z1 40$A=V6
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/_"_P3X-UWQ-=^-M$O-/T:=;.[73]1@GE6Z8$I;[0_$K8;"L1PK$X"DCX?\
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M_9QN_BO^Q=/\)Q:6'@[4KC2+:*"QM)WGM;&>&2.:.#S&W,Z!HU0OR2,D#H*
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M96%88X;:,# (Q!%&3GG>\A/)- 'NE%%% !1110 4444 %%%% !1110 4444
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M !E\(_LP?"CQ&NM)>0:[!J^H:WXF71/[0ET]O/\ ]&,\0F!\CS'?S)D4A%V
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M.3X7:7X%\;'P9?>)_$Z:!<7']G07O[J6WF?S0DHSN0Q# ! ._G/% 'T4<&C
MK\]- ^.OQ<E\8:K!-\5?#RW7@WQC#X9O]'U>2&WFUJVC6.+?'91V;2F>[E;*
M,D^Q2VT)A<TWPW^U7XNM_@.OQ:A^+NF>(M=U#0M7N)O -S8P$6=]&7DB$*Q(
MLT<<"1N',[,' 7# NIH _0W:/2@@=Z^"_%OQ\^)GPC?6XM%\='XFV-Y\+)O&
M=EJ.KVEI#]BNHW13,/)CC!A='9EC<,Q90N3S6%XZ^,_Q5T'X3?$KXB>'?B?K
MMSX7L;CP];>'I=?TFQBFFDF:);[S(_LR/MW3* < $JX7( 8@'WAXY\?^'_AK
MH8UCQ)J,>E:8;B&U%Q(C,/-E<1QKA03\S,!T[UT&%K\_/%'QB^)O@^X^)?AJ
M\\?WNL77@WQYX5MHM5O=,LX7NK6_\LSP%%CVJ@+EE8?/\HY'.;_C;XK^+Y/V
MD/$MKX3^(6K77AOP/-+J7B>ZOIHXM.:YD8BQT*WC$?+%O+C9\EB2Y^\,$ ^]
M0 .E+Q7YN>"/CK\6_%/@6^\4V/QN\)1ZGK_AB>X@T"\NHYI-,U+S8U#[/LD8
MLXT9_)Q.\B;F4EGSNKZ8_8R\<:QXM\+^-].\17?B4>(=(UYK:ZT_Q,T4USIN
MZUMV$"7$0V7$>2\BOM4XDP5X!8 ]<\7?%KPEX%UKP[I.N:S#8ZCX@OO[-TR
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MKM/CG='3OVXOAV;WQ#<V.G7/@W5_)M)[M([<S!HQL167YFDRNX [CL7! !!
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M(X+$@$DD U)H?[%GP8\.>)M>URQ\#6276MPW,%Y;222R6FVXXN/+MV8Q1>8
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MZ_J^IZ;/Y^JF6*V2WLTNX9&6!I2CNC/F(L<;5.X!P: /?O$OPP\+^+/AO=^
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MEO+1E4DG(.:7Q)^QQ\)_%NKW.J:KX?O;K4;B.RB>Y_MW4$<"TVFVVE9QM*%
M0RX.2Q))9L^%_"_XMZS\=_B5^S/X\U-1H6H:@/%>GZEH]M/*;61K=62(JFYD
M# *6W$G[Y7<V%K[=;[O% 'D6G_LG?#'2];\,ZQ;Z%=#4_#LUU<V%U)J][(_G
M73,US),6F/VAY=Q#M+O++A22H %'PS^Q?\&O"'B"WUG2?!%M;WEN]TT*-=7$
MEO&+D%9T6!Y#$(V!(\L+M&3@#)KPJS_;G\9:AX@<6ND:%=>'+[2/$VHZ5J\4
M$WV2=M+)(\J8S![B,@;7?R(1N/[LR!2:C'[=OC/PEX+T_P 3>*M'\.75IK'@
M*W\865OIHGMVMY9;RUM?*F>1W#H#=+(2 I 4J-QY(![3H'["7P*\,^&]=T#3
M_ -M%I>N212:A#)>W4C3>6_F1KYC2EU17^;8I"Y .,@5K^._V/?A%\3=?GUK
MQ1X/BUG4Y],32)9[B\N<R6Z?<W 2 &1>TI'F# ^;@5P?P537[/\ ;/\ C!!K
M>JVNI>;X=T2ZC_L^*:"W&XW"Y$<DTNUODQE6 ( . 2<^J_M*?&%O@%\$O$WC
MQ-.759-)2'9:O)Y:,TL\<*EFP<*ID#'V4T <[KO[%GP:\1C4Q>^#4QJ<5G#>
M"WU"[@$T=JJ"!6$<J\*(HLC^(QH6W%01LW/[+GPRO?&+^*+GPR+C6I9+6:>6
M6]N&CNI;;'V>6>$R>7-(FT$/(K-GG.3FO(_BC^TK\0OA1K7B+1[Q/"^L/IFC
M:3K\6JVUE/##-!<ZB+*6 P_:796&?,67>01QL/)'/_'W]IGXBZ1JWC_P_P"%
MKG2M/E\,>+_#.E'4!8F5_L>HJC/O#38+JY"' &5/ 4G*@'N\_P"RG\+[C[>7
M\.2#[=K8\27&S4[M?,U(9Q=<2C$@W'D>WH,==\1/A=X7^*VC6^E^*=+35+.W
MNH[R >:\,D,Z'*21R1LKHPR1E2."1T)KYXG_ &GO&UM^T3_PK/7])TK1M&U7
M4;G3M%UTV4UQ9:D%M6*Q_:([C$=RLZD/ Z+\F1O#;2_'_!?XJ:AXS\#?#SX,
M>'=+T;PHNO\ @&^UVZNKTW=[;1Q-<O;?9X-UPLI<EWD+-*VQ0  >, 'TC#^S
M%\,X;+PS:1^&52W\-ZD^L:8HO+@&*]9][7+MYF992W5Y"QP2,X)![#X@_#WP
M[\5/!^H^%?%>EPZUX?U (MU8SE@DH1UD7)4@C#HK @]0*^"OV;_VBOB59_"G
MX8_#[P/I_ABZU@>"!X@:X\4WKKYX-[=1%5Q(A"1K!EF&\@./E %??W@S69?$
M7A#1-6F>S>6_L8+IVT^?SK8L\:L3%)@;TY^5L#(P: /*O^&*/@@N@ZOHJ?#K
M28M,U8VS7=O$)$#/ I6)U(8&-P"V70AFW,6+%CG;?]ESX5M9>$;0>"M.B@\)
M2R3Z(L(>,V4KD%Y%*L"7+!7W,2=ZAL[@#7CW[3?[7'BGX+>(?%,/A[3=&U^Q
M\/6^DSWT;QR;[3[7<F(BXE,J!6==IB6-)6/+.%7&=#2_VH/$>NV'BKQ3:S>&
M;;0/"_BB_P##]]X>NHY_[4F6#*1>5(KE?/EDVE4,6W:YRV5)H ]$'[(_PE7P
MMHGAU/"$,6E:)<S7>FI%=W"2V<LP(E,<PD$BA\G<H;:3R1FM*7]FCX9RO9LO
MA*SMS9Z*_AR 6KR0B/3F)+VX",!M8L2>Y)R37SSJ?[:?BKPS\!+'XJ7MQX+U
M*'6='2ZL?#=NT\-Y;WK7,431NWF.)(HDD)D;$;;EP  W&C\9_P!J;XB_!#5?
M%>D7D?AGQ!-I.EZ/KMOJEO87$$#V][JJV#021_:&VNNXR)('((C.5YR #Z'\
M&_ KP)\/O$%IK?AWP[;:5J=II(T*":!W_=6(F,P@52Q4*)&+#C(Z9P *D^*7
MP3\%_&F#28/&6BC68])NA>V*FYFA\B<# E4QNOS#L>V3C&:^>/B!^U=X[T'Q
MEXVT/1H/#,ZZ%XZT+PM!+=6L[^9!J,2,6?9.,21O)C(X.P_*#TJQ?M*?$K6/
M'6@>&I9=#L3#\4;KP9J%[9Z?*([NVATY;M&"O,QC9B64C<<X!! !# 'TMXE^
M#?@SQAXHC\1ZUX>L]1UN/3I](6]F4E_LDP(EAZX*L&8'/J:X_5?V/?@SKFE^
M&]-U'X>:/?V/AQ&BTN"YC:1;>,R>88^6^=-Y)VON W-@<G/B?A?]K_Q[XC^*
MVE:%%8:$_A[7YO$EKINJK;N8Q)IJL8WC_?B2>,E=KEDA!;/EG R<BW_;"^*-
M_P##73-:EMO#:7WB+X;ZSXRL$T_3[@O9W%FB%(SOG82AMY[+@X^]W /M?6-!
MTWQ!H]SI.J:?:ZCI=U$89[*[A66&6,C!1D8$$>Q&*X3P%^S?\-?ACJ1O_#7A
M*QTV[\J2!)/GE\F*0@R1Q!V81(Q RJ8!QTKYG\1_M2_$OX9>&/A9>W\^FZOX
M7OO#^C7&N>)[?3#>S6MS<.JNUY!'<JT$3KPLRJP,FX!3PM?<*]* /*M _9<^
M%'AI-:32/!>FV"ZO:SV%X+;>N;>8YFB3#?ND<@%E3:#@9Z"I+']F#X7:=':K
M#X.L<VNDRZ#!+(TDDD6GR!P]LKLQ81D2R#:#P&P,<5\H:;\1M>^ WQ3_ &A=
M>\+Q:))X<C\?Z):7VF7L$QF=KU+=)I(I5D58SOF=^4?)STP,]MX)_:\\:>-?
MCWH?A.Q70+CPOXAUG7M(T_54M'*J;"V>5'3_ $@23 ,H60M'&I)(C8XW4 >S
MZ)^Q[\'?#UM/;V/@:Q6"?3FTB6.:6:8/9E_,,!#N?D+G=CUJY/\ LI_":YF,
MLG@?32YTE="X#@"P7&VW #8"# X'H*^>I_VUOB%I_@OQM?7OAK28]?\ AO;Z
MB?%MHMO.EM+<"<0Z>ELYD+*DB;YV9@Q*Q@#;OW#V']GGXG^/?&WB&[C\6ZOX
M!U+2;[3(=5T<>%+R:6Z$;$!FE#C:8R67:WRG.00>H .T7]G'X8B\TF[?P1HT
MUSI.E/HEC+/:K*T%BRNC6ZEL_(5DD7'H[#H36?/^RA\'KK2O#^F3_#GP]/8:
M 6.FV\MBCI;[G+L #]X%R6(;())/>I/VHOBAK'P6^ WB[QOH,5A/J>BVRW,<
M.IQN\$@\Q%96V.A&0QP<\'UKY^^(O[4WQ4\!ZM\8].^T>$+F;X>:'8:\TC:/
M<JMX+E2WV8#[7\NW&/,Y)S]T4 ?3-]\"?A_J?Q"@\=77A+2I_%\)1DU=[<>>
M&12J-GH6 . QY  YX%:/C3X5>$OB+>Z)>>)=!L]:NM$N?MFFRW:;FM9LJ=Z>
MARJ\^U?+?C']KOQU#X4^,GC+1%\/6NG_  VU"UM'\/7UM+)<:E$RPO)+]H$J
MB+S!*ZQ@1OS'SNSQ5\:?M:_%'PQHOQ>\6I;^&AH7@76K;25T>ZTVY2YD%U':
M&-YIQ.0@@-R3)B([PAQLSP ?3]U\"_A[>_$.'QW/X-T27QE%C9K;V49N@0-H
M;?C.X#@-U XSBH=+^"OPU\$ZSK_B&Q\(>'M'U#6U,>J7Z6441NE8X99#C!#D
M_,/XB<G)KE?V>_B'XS\8:EXCLO&&K^!M4:WCM+S3_P#A#KZ6Z=+>828:=F4+
M\QC8H5QD9R. 3RW_  47M+:Y_8]\?27,:.;9;*XA+8!61;V J03T/;/O0!L?
M$#]CSP1J_P &_&W@?P/I&D^ 9O$UO'!/?V.GJPQ'*)%1D#*2F0PVAAC>Q&#7
M(_!C]A3PWX1U/6=0\9^'O NJ17]M':#0-"\.FWTLA)"ZW$L5Q-.9)^<!OE"@
ML #G-8-S^UOXLUKX%7'CWP_>:#;:TWBFQT&X\,ZGIDSRZ&9+P6TL%R5N$:23
MY@X<!%(! 4YW" _M:>.M/^*=G\-=1F\/IJ5UXYN/#!\3#3Y8K:.&/3H+J,?9
MVG.9I))6C&9<<#"DT ?0WB']FWX6>*WU*35_A]X<OY-3GCNKZ2738M]U+&K+
M&\C 9<J'8 G.-QJ2Y_9Z^%3^()O$5Q\.O"3ZT]W_ &C+JDNBVQN&N Q?SVD*
M;M^XEMY.<\YKYMU7]KCXB>$O"^M>*M8CT&[\+^"O'\OA3Q/?V%A,1<Z<S1*E
M]!B5O+>)IE22,^8"P.",8JIX%^/GQ#^.EIXV^&?C'1M(T[5]/TR]O]<CFTZ5
M8)M(N+*-K*/F4B.>0SDORZJ(9!C/0 ^EK#]GKX4/:Z_)8^!/#7V;Q/&/[4>W
ML(MFH1E@XWD##*6 ?'0GYNO-=-X:\'>$_A9H;V>A:7I7A;23*9'BLX8[:(R,
M0-QP "Q.!D\G@5\.?#G]I+QIH'A/X5?#;PSJO@CPI(OPRTO6[?5?&UQ+'#>3
M,IC>-&4;2(P@)4$,<DYPI%9'[17QSO\ ]H#]G_XG"ZU;PSI<7A35M#CM]/\
MLDAN;F1VM)?MD4DS*R1N9I!&/*W;$;=]X@ 'W'<_ 7X;7FN/K4_@#PQ-K#WR
MZFU^^CVYG:[4Y6X+[-QD!Y#YS[TDOP#^&DQ!D^'_ (8D(NGOAOT>W/\ I#XW
MS?<^^V!ENIQR:^=-?_::^)&M?'K7?AWX6_LJWO\ 3O%6G:8L4FD37ML-(GM4
MGFO9;E941)4^;;$2N=RJ QRRGP6_:J\;?%/QW;RW>M> M$T1O$M[X>N/"L\\
M[ZXC12.L01$!&\JN]F),9 .-F#0!],:7\'? FB7>C76G>#= L;G15D73)K;3
M(8WL1(29!"0N8PVYL[<9R<]:M^*OAIX2\=WFGW?B3PQH^OW6G"06<VIV$5R]
ML)%"R",NI*[@ #C&0!FM^YN([.VDFFD2*&-2[R2'"JH&22>P KX"\&?MO?$3
MQ!!K=P=0\,36UQX*UGQ9I$S66UMUE*J1@P+<EECD59,"1_,R"WR@;* /LC3?
M@/\ #?1;K3+FP\ ^&;*XTRWFM+&6WTBW1K6&4R&6.,A/D1_.EW*, ^8^?O'-
MSX>> / OPXBU#2/!.@:#X<3S%EO++1+2&VP[#Y6D2,#DCIGL.*^-]1_;@^(7
M@V.]AUP^&[Y[GPEX=\16VH6^F300:=_:-W';S-,OVAS)'$)5889-QP.,UZ7^
MR]+;1?M3?M#@:SI6LW5ZGAZ\-UI<*01S@VDNYPH=]V-R9;<>6'K0!]64444
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M0="64 ]$\0?L7_!CQ1JMUJ5_X'M3=W'V3>UM<W%NBFV1$MRB1R*L91(HU!0
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M:Z,UE>Z9X:L_$5CXVU;PG?3VMO<WRW"VEL)XGM+!)5GE:3S(U;#D1X+-@'@
M^D[SX ?#+4-'T?2;KX>>%;C2]&W_ -FV4NBVSPV6]MS^2A3$>X\G:!D\FG>*
M/@+\-?&^J2:GXB^'_A?7M2DA6W>[U+1K>XF:-<;4+NA)48&!G P*^:-&_:S^
M,'CJS\"R>%O#?A%#XC\ W7BV275'N0D$]M*B2(H5LLC&2(!>"/,W%CMPV?X]
M_;R\4:#X=T'Q%I&DZ'?6%QX6T3Q#=V,,5S>3;KV4),KRQL$LXXP<(TP)D8X4
M'#8 -7Q'_P $\(]>^(/B6_.M^&6\,>(-4.I3QW/A"WDUFQ0J%-O9W^_="@"J
M$95W)R5P>3]26GPI\&6'C.?Q?:^$]#M_%=P"LNN1:="M[(" "&F"[SD #D]!
M7S%XW_:Y\<0?$W6?"GAM/"EMJ5KXXT[PA::#K-M<R:A=03PI))J'[N5<1*&9
MAA"-D;,6Z Q^$?VI/C+\0/&<^I^'O FFW'PX75M3T5[N\DA@:UDMY'AAE,WV
MLO*7D7+1"V4@$!2Y^8@'V5M!7!Y'O7G5O^S=\)[-(D@^&7@^%(EE1%CT&U 4
M2C$H&(^ XX;U'6OF?P;^U;\</'<?PL73= \!QS?$C3M1O=,^TR7BK8&R*F0S
M[6)?<C !5VD,_)PI!J0?ML?%3XEV?A*P^&_@>SU#Q->^#X?%=Y;L(I(I6>ZE
MM_)7S;NW,4>Z%V,@,K#>@V]6(!]>P?"3P1:HZ0^#] B5[(Z:P33(%W6A&TVY
MPO,6.-GW<=J?X0^%G@SX?3/+X8\):'X<EDC$+2:3IL-JS(,84F-02.!Q["OE
MWQ5^UA\5-"D\8ZT= \)67AGPI;:!?ZA;7$\LUWY>H"/S8EFCE\DF(M(WFC*D
M*,*V<UZ)^S/XH\:^)OBC\<X_$NN6NIZ9I/BG^S;"UAMI(S;JMK P"DR, A5U
MRH7)?>V[YL  ^AZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH *Y'XM_#]?BO\,O%'@V349M)@U_3IM-FO+=%>2.*5"D
MFT,",E68>V<CFNNK@OCSXF;P=\&?&FMKK%YX>-CI4\_]KZ?8"^GLL(?WZP'B
M39][#<8!)( )H \CUC]BW^VK;Q%%-X]U(MK/@BV\#.386^([6'!\W  )<YE[
M@#S3_=7%V']C33]0OO%,GB3Q?JOB&R\2>%+;PG?V<EM;0+Y$"8CF1D0%9 S2
M/W&7Z$*H&[H/[3?AB#4M!\,R2ZUK^JR0Z3!>:M;Z9M@BFO8U:W:<*?W7F;E/
M *J7 S7K'BSQ38>"?#.JZ_JKRQZ9IEK)>73PPO,ZQ(I9B$0%FP 3@ T ?.NO
M_L.Q>-?"&J:/XH^(>M:W?76A1>%[?5GL[9)K73$E65HP I#22-''OE;D[!@#
MG/;>)?V;I?%'C+1O$USXRU%=5T_PK=>%VD6SML3BX3$ERPV8$FY8W"CY 4QC
M#&L&+]O#X6W>C/J-I)KMS'Y3W4,)T:>&6YMDCCDDN8EE";HE$R#=W8X4-D9V
M+']L?X=ZWJNBV.BRZIKHU.+2IC<Z?8M)#9IJ,OE69G)(*AGX. =O&[!(! ."
MU#]@BTUKPGX<\.W_ ,0]=;3-&\'7/@P1VUM;PF:UF96WEMI(8&*W&,D$0C/W
MGW)<?L"6MUHGC:RN/BAXJO)_%-CI5M<3W,%EB&;3IDEM)41(%"A!&$$8PI5G
M+;F(9>O\,?MQ?##Q9XJTS0K677;634-1GT>*^U'0[FTLUO8@Y>W>:1%59,(?
ME)STS@\5KZ3^UU\/]9O=-A@DU=8-8M+J]T2[DTFX$6M1VREIA:87=*P4;@NT
M%P04#"@#C/$?[#FG^-[KQM=^)_'.NZS?>);32X1>F*"&:RN-/'^C74910-^X
MR,PQM8R-P.,6?%G[%=EXXL?$<^M^.=<O?$^O7NF7-WKIAMU=(K!M]M;Q1*@C
MC02$R,0-S,QR<<5I>&_VZ/A/XFL[B]CU'5M/TV/09_$<=_J6C75M!=6<! G:
M!G0><T9(#!,]>,X.,[Q1^T]HGBSP]X?N](U?Q)X)\SQ7I&F/+-X?$YO!<A94
MA.XE5AF1U'G@\'@9/% 'H7PO^"LWPW\??$#Q1)XENM:F\8WL5]<VL]M%$EN\
M:")!&4 ) B6-.<YV9ZDUY;-^PGI[?$,^*8/B%XDM%C\92^-K;38;>Q\J&\F/
M[X;S;EW4C"KN8A5&,$DM7/?"7]LJ#P_XQ^(?A;XE7NL3OIOC^[\/V'B Z.4T
MZW@;R_LL,\\<:QHQ)< L23P2<%2>@^$/[2MWHFF?$N7XE:M+>W6G_$K4?">A
M6UK9H9KB*."*6")$B !.SS)"SG@9W,,4 :^@?L5:%:G1M.\0^)M6\6>$="NK
MZ^TGP[?QPI%;W%TTQ>1YHT664JMQ*%W-@;L\D*0[P'^QEI?A-?#EMJWC'7O%
M>E^%=,OM)\.V>H"%#IT-VGE2DR(@:5EB'E(6X121M/&/4O@]\9?"_P =?!J>
M)_"5X]WIIGDM)%FB,4L$\9P\;J>C#CU!!!!(->4_M%?%?Q'I/QD^'GPWT;4M
M5\+6GB*RU"^N/$.F6%O<M$]OY013Y^56%/,:28[=VT1A6&YB #GM-_8(B$,2
M:U\4/$VNK%X/O/!"036UDD*Z=,A5%"B'=NCQ&X;=DM$O(7*U[GX%^&=UX<^%
M,'@S7_$E]XND%D]C<:M>1102RQLI7 6-0JA5(4=3QDDG)KA?!O[6O@S59= T
MVYGUF5]6L)[C2]<DT2:&TUW[.F9GM -Q8L SJF,LI&W=E<]9\%_V@O"GQ]M+
M^]\(KJT^F6J0NFH7^E7%G;W2R;QF!Y57S0K1NK%<A6&.XH \I\(?L37'A)O"
MLB_%'Q!?2^&O#^H>'-.$]C9;(K:YC\M?E$628PD!&2<M$2>'855T;]@FQ\+V
MOAR7P]\3?&/AS6])TA?#\VJZ7+;PM?Z>CN\<4R>65+1[RJR##  =2 1T/[2?
MQLU?X*_%WX.&*YU&Z\,Z]>:C8ZIHFF:8+VXNW6T9[?R@J&3?YNT<$+@DM@ F
MNE\#?M9?#[XC3^';?0KK4;JZUZ"_EL[=]/ECDWV1 NH)%8 QRH63Y&P3O7&0
M: .L\9_!GPO\0/A//\.]=LFO_#4UE'8F&5RTBK&%\MPYR=ZE%8,<\J#S7'>!
M?V?==\-6NEZ7KWQ4\2^,?#NF!1!IFH16L+3;<;!<3Q1K),JX^Z6 ;^/<!BJ%
MS^VE\.#I^DW6FRZKKB:EI;:XL>FV#/+;V"W#6[7$J,5*()5=3P2NTE@ *R6_
M:7\.?#/4?B;K7BSQ9KFI:%IWB:UT..S;P[(!I4[PI^YC,2%YHV)#B1QSO 7.
MY=P O@G]C#3?!5KX:TU/&6MZEX?\)7MWJ/AG2;R*W:/3+B9&5'+[-TWD^9*8
MPQP"YR" H#/A]^QK'\/F^$WD>/=9OX_AR-073DN+:W'GK=H4D60A,G ) Y_.
MNAM?VQ?AQ<Z%?W[W.IV5Y9ZN=#;1=0TV6UU%[SRS*L8@D"GYHP9-S8 7EBM9
M,?[='PPO?"NG:YIDVL:R+VWOKL:=IVFO+=PQ69473.F0!LW*< DD'(! ) !Y
M+I_[,WB_X4_%?X0^&_"VO^('T32[/Q ]UXS33K:9X)+QTF6"96!0J9!,X;82
M&9!TKK-5_P""=/A*YB6UTOQGXIT73Y]!;0=02![66>_1KB2Y>62:2%F5WGDW
MOY>Q21@!0:]5T3]J'P9XF^)D'@C28]6O]1DG6TDO8].<6=O.UDUZD4LC8VLT
M"EAQ@G(!R"!Z#XY\9Z;\._!NL>)]8^T#2=)M7O+MK6W>>1(D&78(@+' !)P.
M ">@H ^?]8_8BBUS0_'VFW?Q$UV?_A,=*TG2KZYDM+02HFG@")E*1*,M\Y;C
M^,XQ@5/X;^'FK_$;]J#3O&7BOP'+HZ_#_3[K2M-\3WEQ TGB"64HJW"PQC]T
MB(+A@#T-SQC!J'3_ -JGP_\ %'QS\-$\-Z[XG\.:?J>I3Q"VOO##K;:V@LUF
M"^?(!Y: 2*RNF=QZ97YJQ/CO^US'K'[._P 0M>^&MWK&BZOI>C'5],UVYTU#
M;74272Q.8C)N5LG((90P# X&10![[\;/A5:?&OX8:YX,O;Z;3(M26(I?6Z(\
MEO+%*DT4BJX()5XT.#Z=NM>/>)?V)AXOTOXAVFK?$SQ+>R^.+#3;'5+EK>S1
MS]CV[)%"0J S8?. /]81V7'K_P ._BSIGQ%U#5;/1K:_N[72V$$VMF +87$X
M \R."7/[THVY6*C"LC*3D8J+XR_'+PQ\"-'TC5/%3WR6FJ:I#I%L;"QENW-Q
M*&*+LC!;G8W0$GH 20* /')_V#=,N_$EYK4GQ(\80SW&OV?B?R;4V<<8U&!%
M0SD& EB0IVJ3M3<<*:LVG[$-M FC))\0O$$@TSQO)XZCQ;VB[KR1M[H<19V%
MF<XS_&?08U-&_;J^&VL76FV[6_B;3I+K6(]!N#J.@W%NNFWLC;88;IF&(FD/
M0'/^UMK;T_\ :^^'NI>+U\/02ZF\TS:G':7:6+/#>R:>N;Q(0I,CE,,H.P!V
M1@I8B@#I/C/\$=.^,MGH;3:KJ7AW6M"O1J&EZUH[HMS:R[2IQO5E96!Y4@@X
M%>3:#^PQ;>$O$A\5:'\3_&%GXR-_?WC:W-]CF9TO GGPM$8/+92\:2#Y>'&0
M!T'1^!OVW/AM\0)[8:<-?M[2[TB\UJTO[[1IXK:\AM<?:5@DQB9X]W(3</0G
MC-N']L7P$/#'B36KZ/6-)&@QZ=)<Z?>67^F/]OQ]C6.)&8EI"0 IP03\V,'
M!T&B?LU>!=&^!K_"5],?4O!\]O+!=Q7TIDGNVD<R2322#!,K2$ON&,-C;C
MQ? ?[,]QX+M-%T>[^*'C7Q1X2T;R?L6@ZS)9&/,7^K$T\5M'/,BG:0C2;?E
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MV:R G=/(\J!$ Y!R2M "7G[#'@*3Q##J=AK/B[0X9=/@TW5M-TS6FCM]=AB
M"_;B5:25F4!68.I89!ZG/H_QO^"VG_'7P?;>'=2UO6-!MH-1MM36XT1X%F:6
M!_,B!,T4J[0X1\!<DH.<9!X\_M?>$[674]-U/1]?T?Q;8ZI9:-_PBEY;P?VA
M<7-XA>U$129H75U20[_-"J(WW%<5@^)OV]?ASX1\/V5_JMKK-CJ5Q<WMJVA7
MJ6UI>PO:DB;=YTZ1,-WRKLD;S&R$W$' !>\0_L9:#XB_X3<2>-/%]BOBSQ%9
M^)KL65Q9KY%S;$&)(MULW[L,L1(;<?W,?/WMSM$_8L\'^&/B1J?B[1O$/BS2
MHM0OFU>7PW;ZHO\ 8XU$@_Z:+9HR#*&.\!B4W!?DPH 9IO[;O@7Q#J7A^RT#
M2]?\0R:O9:=J'^@6T.ZT@O)FAC>6*299&5'0B1HDD5!@DX(I+']M_P !W6G:
M_K%Q8:YIWA?1H+V:7Q'<P0-8R-;7:6K0@QS,Z2O+(FR.5(RRG/ H A\$_L1>
M&/ +_#)]-\8>+FD^'<&HVVB/<3V3D)>@B42_Z*-^T'Y>F,#.:;X?_8B\/>$=
M)\%6V@^._&ND7_A&"_M-.U:WN+%KDV]X_F3PR![1HV7=RI"!U.,-P,5M"_;\
M^'7B'3=0FM;/6&O[/5;/1_[.#64AFGNH7F@,=RERUJ59(Y.3.,%<'!(!]U\!
M>,HO'_A#3/$$&G:CI$=\A<6.K0"&ZA(8J5D0$@'*GH2",$$@T >':E^P3\.9
M;_P[=:+J?BOP=)I.EKHL_P#PC>MR6AU6R#;S#=L 6<,Q9F92C$L>>F.@LOV2
M?#NES?$)K#Q+XGTZ+QI:6UG<0V5U!"NGI;QB*V-HR0AD:.-54%V?('S!B23@
M^/?V@M*^%/QB^(]YK%UXQOK/PQX1M=7N=!MK""2R^SF9@UU;-O5V?[ROOPH$
M3<\5:A_;@\"BP\1W-]I'B?2)-'LM/OXK34-,$5QJ<5])Y5K]ECWDLSR87:^P
M@GT!( -;PK^REHWA*_EU&V\9>,'UB[U^U\0:IJ(OH+>359+>'R8[>Y2"".-X
M"H!90BEV&YF)R:Z;XK_ K3?BWKW@_5[[7]=T:[\*WQU+3_['GAB7SRNW=)OB
M<M\I9<9 (=L@YKQ/XR?M%:[JC?#BX\/0>(O _D_%'3?"OB+2]7LXHYKJ&52Y
M164R*\;?(=\<F",@GM7H%G^UYX8NKK3[=M!\16PN_&L_@$RSV]OL@U.-=QWD
M3G,3!7PZ!ON-D#C(!V/QI^"&E?&[2]!MM0UC6_#]YH>J1ZOI^J>'[I;>Z@G1
M'CX9T==K)(ZD%>AZBO._!O[#O@SP#XI\):]H_B3Q>MUX9U*^U2RCNM42X1I;
MP*MTLGF1%F60(,X(.2QSN)-<'K7[3NJ^/OC[\!I/!L?B&R^'?B&^UBVEOIH[
M9+'7!!;R;3&NYI<!XV92XC##D CD:7PN_:S\/^%OAK\.K=++XE>/KSQ;<:K#
MILVH65M/J4L]K-,9H)0DBJI3RV"]0$52S  D '7>)_V)?!_B76-7OQXD\7Z6
MFI^(XO%<MAI^J(EJFHQE6$R1M&P!+(K'J<J.<#%5O$?["'@#Q9+XBN=1U?Q.
MVI:OKZ^)XM2M]02WNM+OQD&2TDCC4QY0JA#;N(T/WANJ^O[9/AG4?#G@[4-$
M\.>(=>U'Q19ZC?VFBVD5NEW%%8OLN_,\R94!1\J KL6/W<CFO3O@_P#%#3OC
M3\.-#\:Z197UAI6L1&>UAU)$2?R]S*K,J.Z@,%W#YNA&<'@ '!^'/V3/"?A;
MQMX1\56.L>(VU;PU;W,$$EWJ(N3>&Y8M<R7+R(SRO*V"26 !5=H7%;OP$^&>
MO_##1_$UEKVO76MIJ&OW6I:?'=ZA)?-8VLBQA(/.D1&/S*\F-N%,I7+8W'Q_
M]H+X]>*I/$7Q>^'NAV6H^&F\-^!9?$UOXHLY(#()D#2(0&?(B<Q/"<*7R&/R
MC:Q=\./VYO#UE\.6F\=:7XCT+6-#\*Z9KEY/JEG$G]K)<%8%FMBLA!$EP0HW
M[!EQT 8@ ZG1?V)?!^A:]I>IVOB3Q>(M+\3R^*[#3)-45[.UNI&D9XXXC'A8
MB9I<C[Q\PY8X&,VX_8!^'ES862_VSXLMM8L=8NM;L_$%EJHMM1M9[G!N5CFB
MC7;'(P#%<<'.W;DY]"^"'[1?A_XZWOB6QTBPU'3K[P]-%#>17OD21OYBED:&
M:"66*5?E8$JYP00:R_C_ .,H/"WCCX06=QJ/B?2X]7\3I91OH7DBTN9C$Y6V
MO=[!O+<!V 0'_5$G&!D ]"\+?#G0/"'@6W\'V%B'T"*W>V:VNW:X,ZN6,IE9
MR3(SEW9BQ)8L2>M>;>$?V1O"G@NVM-+L-?\ %K^$K2X^T0>%+C6G?34(;>J;
M<>8T8;YO+9RI/W@P)!\T\3_M,S>+?C?\&KSPS)KFG_#>[U/6[.^UR7R8]*U5
M+:RG9F W&7;'+ 2KLJ*VU\;AS6M8_P#!0OP#?KJL\&B>(+G3[31;K7[>[M8K
M>475K;Y,ORB;,,GEJ91'-L8J.@;"D [:R_9 \#:?XFN]3@N-;33+K7AXGE\-
M_P!H$Z4=3#;Q<>21G(?#[-VPLJDJ=HQ5TG]CGPAI7_"-JWB#Q1>+H'BB;Q?:
M+<W\9#7\IRYDVQ#<A)D^7C_6R<\\>=^.?^"@%OIWPX\8ZMH_@#Q%:Z[IGAFW
M\3Z=!KD<$,-U97#+''<Y65CL21AN3AV'0=2O06/QHO;GXEZQ?OIOBR#Q#9?#
M6+7?^$9GNK9=&N=TSL)(\.Q%QN!C+EL!, @D T 8'C/]DB_T7QC\/;/P3>>)
MTT2+Q?>^+-;UN/5K5+FSGG@:-S$)(_F61W+.@1AA6 P6KL-7_81^'&K"$I>^
M*-,=[.^L=1FTW7)H)=6BNYC/<"[=?FEW2DL>0#PI!4!:\A^ _CRY.M?![QEX
MR\7_ !&MK[QG87M^;.\U:UF\/7#0V+3RN8D8M$NV1O+B 4Y@RRC:<^W:5^UM
M;:CI-UJ\GPZ\:VVC/X>;Q+I=\NGQW"ZK;!E")$(I'*3.)$98I-K;6R<8H SK
M?]A;P-:Z!XAT@^(/&5S:Z[H=OX>OGNM;::5[2&0.BAV4D' *>FQV4  U;\+_
M  I\4W_QJT"?Q#H^GIX*^'NG26?A?5IKXW6IZE-+##$TT^%4(%1)000=S,K?
MP@UQ/BK]O.*7PK-=^%?"ES?ZQ9>+-+\-W]F]W:3K']J=2-CQ3E'9EWQC#?(_
M+<*0>EM/CYI7@/QK\4Y]4M_&4NIPZSI.DVWAR^FMYXY;NY@'D1Z<JOA%E'SO
MO< %6/&"* /=?'?@ZT^('@_5O#E_/=VMGJ=NUM+/83>3<1AOXHW'W6'4'L:R
MOA_\*-%^',^N7E@UW>ZMKEQ'<ZGJFH2^;<W3QQ+%'O8 #"1HJ@ #H2<DDGR/
M6_VV]!\-'5;'4_!GB>'Q+I.OZ?H%]H,4=M+<QR7N?LLR$3;)(Y,'&UBV1@J,
M@UZ;\&?C!!\8=(UNX&A:GX:U'1-6ET;4=*U81^?;W,<<<A&Z-W1E*31D,K$'
M/!H Y#_AD#P0UU'.U[XA;9XK7QH$.JOL_M1?^6N .A))*]#GTP*H7?[$7P[O
M-2N-0>[\417L^N7?B!KFUU^YMYA<W48BN0LD;*ZI)&JHRJP^50,@5[GK>J#1
M-&OM1:WN+M;2"2<V]I$99I0JEML:#EF., =R0*^;=/\ V^?!\WASQOJ=]HVH
MV,_A$::=0LUGMYRGVV18XU:1)"D;1LP$JN1Y9# YVT =!X8_8F\ >#9[&31]
M0\4VGV/1[O0H4;7)I56SN"6DB <M@;B& & &13C(S6*G_!//X2+X?ET=D\2/
M9S6%KITR)X@NH5GCMGW6QE2-E21HLX0NIVC&!D U#K?[=&E:)H&B73^$+Z75
M-;34GTNS&J6(@OQ:.B8M[DR^7,TOF QK&6+88 9&#HS?MLZ ?'C:!:>&-<U"
MSM]:@\/7FHVL2R&UO9$5F5H%)D\N(NJ.^  QP-PYH \AOOV6OB[IOQ/\;76B
M75_92ZWJD<^F^,;+QW=P):6L<,<4)O+!HF%W-&D2@[R1*7.YA]ZO?8/V-OA=
M9^-=4\4VFC75EJ.H7,M_);VVH31V<=Y(A1KM+<-Y8GP20^W*L2PP>:X>W_;Y
MT"YL?&6I)X5U&71_#=E?7<UY#>6\K!K:[CMC#/$K%[9W,@D7S!@QJS#.TU.?
MVXX!%X8BA^'6O:O?^(]4O-*TQ-%O+.\M[N2"VBG\R*=90CQN)3A^,>5+NVE=
MI .N\-_L?>"/"<G@I],O?$<#>#;*_L-$SJ\C"UBO%*S<'J<'Y2?N[5_NKC#D
M_8"^$4VB^&-/;3]85O#D$UII]]!K-Q#=I;2.7>W,T;*QBW,^$SA0[ 8#$57\
M"_MQ:)XTU#PMY_@OQ)X>T+76U. :_JJ0):6]S80RS7,;;9&8J$@E_>;=I*$#
MD-MQ[+_@H%H=[HVIZU!X&\1WFB0^'Y?$ME>V:1R)<6L;'<DA+*L,OECS1&S$
ME?\ :PI .^\0?L<_#CQ'I_BC3KBVU6#2O$<>G0W^GVNIS1V[16*JMK&B X14
M"+PO7:,UU_@WX'^&_ GQ \1>,=);4DU;7TC&H1RW\KVTDB)&AF$&=@E98H]S
MXR=O7DY^?_B'^W5JUA\*/B%J^B_#S4])\2:#HNG:S:VFO30@/:7S-''=,L;M
MQ&REC$2&(QG:20OUKI%Q<W>F6LUY:&PNWC5I;4R+)Y3$<KN7AL'N* +E%%%
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MGY$0],X;[H_X6CX8?QY:>#(]8M9/$=U8RZC'91R!F\B.18V)QT.YB .IV/\
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ME "RODD FO7_ !=\#?$FDZM\ [?PM:66M:;X'U26\U?4=4OG@NY_,MI()90
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MF('T/W#H'[2_PM\3ZU::5I7C72KV]O;C[+9K'*=EW+W2&0C9*1WV$XZ&O3L
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MXS@X7.UX3:UL+#2'U6]U^-O%OP9OKGQ$]W<7KM<:J&C$)8DD),HBF5%7!&,
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M_P#B!\&/#_Q*\6>#/$.KRZ@+[PE?'4=-CM;QHH?.("[I$'#\9'/9F'0FN\
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M)?>']/TJZT[6-$CM;?[='>PE!;6UM:QF9T1+AC=-RJ,%8YE./TN^%OPQ\/\
MP<\"Z9X/\+V\UIH&FJR6EO/<R7#1*SERN^1F8C+' )X' X%=7P#VH ^1M ^%
M7@[X4?M/?#F_\,?#*ZM_#.H>&+JUL[ZWT.60Z=>RW:7 :>213);_ "-,/GVE
M=Y7 S@;_ .TOX;>;XY_"?Q+XD\/7'BGX9Z;;ZI!J=G'ISZE':7DL2?9[B2U1
M79_E65 ^QMFX]-_/TUD'TI<YH _,;X<?LM6_BCQW\'](^(_PZUC4?"P@\0)%
M%<Z5=!+'3Y+@2:5!=S1*HB*A9F$3ME#*-P4D"OK7]M7PT/$WPKT/38EUJ&X'
MB&REM;S1M"_MH6<R;VCEN+/:WFVX("N "?F4X.,'Z#VB@@'K0!^6GA'P;X.M
MOB9\,;7XE_":X:&?P)K=O_8.F>'+RY>5EU1FAF6S"O)"'$TSH&"B,S)C9A M
M2V_9U\8:*EOH7Q7\%_$3QO'J/AK2(=";PA'$ZZ;- I/V&XN'5S:[96!,P=1@
M,6W "OTCG^$?AJY^*UI\1Y+6Y;Q9:Z:^D0W0O9A$MLS[V3R=_EG+8.2N<@'J
M!5RS^(%E>_$/4?!RV.J1ZA8V$6H/>2V+K921R.5"I.1M9P5.5'(_ X /BCP!
M\/\ 5=)^+^MV7CKX/^(?%'C0?$(^)M(\;HK"RATYE2-!+>I@OY, <"VPP=MJ
MD#)(\WL?AQKEU\,?!^E6/PN\6)#9^)/%RQ@>'IC/I\5R<VJI;7.R%1*DBJ+B
M17$060#:Q)'Z=ZOJUAH.F76I:G>6^GZ=:1-/<7=W*L44,:C+.[L0%4 $DDX
M%6@ZD @CGI0!\/?LNZ5XDL?BM\$I-7\'>*-$CTOX5S>'[V?4](GCB@O$NH"(
MWE*E%++;R,NX@D;> 74'J/VZO#&O>*_$/@"STGP5K'B:UGLM;LY[[1[!;Q[)
MYK:...,K*P@B$N64SR*Q0*VW!:OKK@T87VH _+W3?AMXRO=.^&D]M\//%#>(
M],\.>&]+U#0?$7A]WT_4OL=X^&%TN&L9865Y0S. \94$ -L<T;X)>)KVQ^*>
MA:'\/->N-%U?PEXDCM;7Q/X=DM;W2+Q[A)H;>*\("7ZS3(LL?WFC*\%<G?\
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M7@G7X]<\/_#_ ,-Z+K$>\QWUCI<,,J%_OE6505SWQUJ73_@3\.M(US4-9L?
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M\-:SHVB:?JVF)J3V[+>P:O<&[LEAN5NHH[65F)@42HK'9@L0-Q.!@ \1U_\
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M90^%NCMHIMO#+A-&TFXT*QBEU*[EBBL)_,\VW*/*59&\UAA@> H& B;>??\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MH=O&9=G^DR7%Q)&G4#<0I;!_A7=VS0![^?VPO"7_  CH\5KH?B5_ !NEM?\
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MN@W%Q:WFM:0+*.&66 'SEMTGN(Y+C8P*DHA!((4L17A_AGX0>*/@'^T?\-?
M6C6]UJOP=O\ Q!?^(M$N0&D30)O['U.*>S=@#MCD:ZC>/) .U\98N3D_!?XE
M:3\#_P!ECQ#\%O&6K7O@?XD>%;;4X;2*$R0W%]NDEN+>XLI%!64,9%&$)Y^4
MJ P! /I+6/VI-*M]0\(Z5H7A7Q%XMU[Q)H2^)(=)TI+5)K:P8+B68SSQH#N8
M+M5F)(.!@9KT#X6_$.R^*_@'1O%FGV=[I]GJ<1E2UU&-8[B+#%2LBJS ,"IX
M!-?%7BKP]X7\4^&_A1:_$/Q1K_PX^+-KX-AUW3OB'<WSQ207,K%KJSF9L(=K
M, L;'.UV5<<AOIC]CSQ#XK\4_L[^$M3\:V:6GB&:.?S6CMA;"XC$\@BG\H*N
MPR)L?&!][.!G% 'L]%%% !112'I0 M%,B=I%RZ[3GIG/%/H **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HI%W9;)&.V*6@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H(R***
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MBOBE_P!J3XU>*]8NSX5\.^%(XO"EOI4OB>&[U2V:R;[1:I=7,D=Z;E?+B1)
MJN(Y5+(Y+$ "OH/]H_XKW_P;^%UQK^E6MM<ZG-?6>F6S7N?(@>YN$A$T@4@L
MD>_>5!7(7&Y<Y !ZG17Q1\8_VI_BM\&M7\6>%77PQK6MZ//HEU:ZQ-82P6UU
M97]R;8PO$MPQ2=9 2"&(:-'.P8S7T?<ZOXU\&? O5-6\276B7GC;2])N[R:>
MPMY5T]YHT=TQ&SA]N H(+C//([ 'I%%?"_A7]I7XY^+_ /A$;:SO_!2R>+?
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M]^T_\:]4T/X4VM_J7A*'6?BE93ZGI%S;6A@2R2&V1A;$32[7EDDE1LY. K@
M[E"]/HOQY^+WCG6)O =MXD\"^'?B!HGA1M>N[N(F\TS4+M+Z>V>(RY/EPQB
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M&M<^T>*YK^RT..76+)/M=W9L1<1DEOW:(HR9&'4,%5L D ]$M_V%_@^-"O\
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M>'-:_L!_B=,C23?81-'I<0^9XHH]Z@JSO.XP5 \T#!V#/KG[/?CK4?BC\"_
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M[P1^SA<^#?BGHGC>7QMJ.O7NG>'IO#TG]JPK)-=QRW N9)7E!&&,R@@*H55
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M#!1QT45PEO\ $G7/"G[2O_"O]>G2_P!$\3Z5+K/ARZ$*QR6TEL8TN[)]OWU
MDCF1R ?G=23M6M?XO_M"^%/@C?\ AVQ\0QZO/?>()98-,MM*TN>\>YF1-WE+
MY:GYVX55ZDG/"AF !YS!\!=6TOQ-\8_!T+7<'P^^*"S:H=5L&C:?2KZ>$07T
M3))G*S*J.CA3@EU(&%)E@_9_U>\\>_"'1KUY+OP%\+;,7-KJ&H-#]IU;4/(-
MO;#9$!L2WCRQ8A=SE,!@K&KG@']N'X8?$?7O#VEZ3/K4+:Y)/:P7FH:1/:VL
M5W"C/):22R*%$P52=H)'3GD53TC]OGX/:KJ5_;MKDUC:VVESZS#J-S"/L][:
MQ2&-VAV,SEMP^5&56<$% U 'N?C+PK9>./!^N>&]2\S^S]8L9]/N?);:_E2Q
MM&^T\X.UC@UX=X5_8NTOPW/IUTWQ"\:7]]9>&+GPA'//<6@QI\V<* +?AHR(
MBAS@&%,@Y;=R/C/_ (*(^%++P5K%]X:T+5K[Q'INJZ9ID^D7D40,7VU@8I6>
M.9D92@< *Y8. K!>2/H?XF?$6/X9_"WQ!XVN=+O[^#1M-DU*;3[94^T%$3>P
MP6"Y4 D\\ '&>A /#S^P!X4L8O#?]A^./&WAN\TC1U\/2ZAI6H0V]SJ.G*^Y
M+>X9(0&"K\@8*&P 22PS7TMH^D6F@Z39:98PK;V-G"EO;PJ3B.-%"JHSZ  5
M\3VW[8'B/0OB#\//%OB&#Q'/X4\4?#>37[GPEI&DQW30W<<D+/<Q;,N(3&TC
M R./EQGEE4>I^./V_/A1X%M]$N)+R^U:VU+3+76I)=/2+-C97) AEF261'.<
MY,<2R2  DJ!@D ?=?L3:+J#WOVGQUXK,4_C9?'T<<7V%/)U-<X(/V8DI]T;3
MG[@]3E^H_L1>&+Z^O=5C\7^+;'Q%+XEG\56VMV=U;17-C=SQ+#.L6V +Y<D2
M1HR.K<(,8RV[VO7O'^@>&? U[XQU+4X+?PU9V+:E-J).Z,6X3?O&.6RO( R3
MD 9)KPKQU^W)X7\)^%/$UXOA[Q!#X@TSPVOB>ST34[5+>6^LW;8DR$R8V*Q!
M<9WJN3L)&* *1_8#\*VWA^*TL?&WC/3]:M-;O==L/$5MJ,<=_9RW6//C5UC
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M'AWX=>-OC)XFO[3Q_?P^'M&T;4+K29GMGL([>9'\N>QB\P%=Q.)68]4Z?*:
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MEH_!>DF>;XQMX\R-3BRNG;LX4[1^]P2 .GS'GFJ_P5_90\:?##Q/'IM_\/O
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M44 %>+?MF^'?&7BS]F3Q]I/@$7#^*+FR18(K1]LTT0F0W$2'(^9X1*@ Y.[
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "@G%%4]9TQ-:TB]T^2:XMH[N!X&FM93%-&&4J61QRK
M#.0PY!P: 'V6IVFI"4VES#<B*0Q2&&0/L<=5..A&1Q5FOEG]@CP=I'PYTGXT
M>%=#B>VTO2/B/J-M;02S-+(L8M+/:69B6;//)/-?4U !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 5G^(=!L?%6@ZEHNJ0?:=,U&VDL[J#>R>9%(I1UW*01E21D$$=C6A10!
MYG\)OV;?AQ\"[W4+SP-X9BT.[U! EU.+J>=Y@#D;C*['KWKTRBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BD-*.E !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
/ 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>exhibit99-1xu003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit99-1xu003.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***0G!H 6BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **JZCJ$>EVIN)4GE0,J[;:!YGRS #Y4!
M..>3C@9)X%6J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?O+GJ,^+?\$W/@%JO@SPI;>+=;L_$.A^);.SO]+N]"UVTGBC*R2Q2PR0+(
M"J.&V9R2,X(YX+PK\'O$&@_$OX7>-?ACX2\9> ?%]]K$"^-/#,NG7,.CPVN\
M/<RK(PV>6PSMCW,?F& K+B@#Z%N_V\]4MY_BL8?AI+?6OPVO#;ZPT&K+YDD(
MED1IXE,6&4",L06! SZ&O;M.^.=AXR^!3_$OP=;IK-G)I<FI6UM<S>1OV*2\
M3L VU@593C(R*^#M#/C'1=>_:M2S^''C/4;OX@7-Q;>'DDT"ZCAG$CSIO=W1
M51 L@?YB.*^G_A%\*=8^ '[#,WA/5+:?4O$%OHFH/-9:="]T_P!HN/-<0HJ
MEL-*%X'8GI0!R7PG_P""@]YX\UCX<V^L_#_^P]/^(+7<.@W\&J"X#36\K1.L
MJ&-2HW@#(R<'.#2^#OV[O$_BSX7_ !5\9?\ " :?:)X"G^S7%FVL.7N)%;$F
MT^1P O()ZGCBL;]@;]G3P[IOP?\ !/B3QAX3UR+Q]X5:^BA@UZ"Z06!>XED!
MMK>3"@LC*V4!^8GG->#>%OA+XFO?@Y^T?)JG@CQ_9>(-7U*2[\/V$%GJ$"7:
M22MMW0IB.4@D%@X;"\],T ?>_P +_P!H0^*/V<5^+GBK28?#>G'3Y]6:U@NC
M<%;:,,02Q5?F8*?EQW%4K7]IM?$O[*:_&?PUHBZDO]D-JDFCRW80HT9(N(3(
M%/S(4D .WDKVS7S7H/A[QMX[^ ?P*^#,.D>(?"=P8Q>:[?ZSX8NKC3T%LSM'
M9W:Y0%)) K$,P4A%!R&P>(^!OA[XD_!#X3_M!?!S7?"7B?5-"2UO3X;U.QT.
MY:&]E?,+"' 8E9-T+@9.!YASP: /HKPS^W7<B^^%LGB[P7'HN@_$<!=%U.PU
M(W1CD,B1JEQ&8DV$M(G0MU/H16Q\/OVTO^$E_:G\0_!77O#":#?V F^Q:BEZ
M9DO&38Z*%*+M+1,6ZG!1A7Q/X*^%_P 2/AEK'P(\>ZCX-\7?$3PMI5L+>X\,
M:EI]Q)<>'KI7&]H;? *KPLL;X()7:3P,>B_%[X9>./C;X@N?B%X"\,^(O#/C
M70/B&;2TO+W3I;.:?2YHX(Q=+YBC=&DJ,2.0$9B<9Q0!]._"7]L>'XP?M+>+
M_A;I/A]%L/#D$\TNMM=D^=Y4J1'9'LQ@O(,'=TYKMKK]I'P[;?M,V/P7W(VN
MW.A2:P9UF!$;JXVVQ0#(=HA)+R1A5''S U\F?!O0+SX(?MH?%+6[3P-XLN?"
MMGX2&FZ=<P:'<-_:,]LEL66.3:%9I#;R8).&8CGD5YE\4?A%\7FLOA]^T9H]
MAJNM_$>?Q(^J3>%K?P==PZA8(X.ZWN)<EI(8E@CMUW1H&20E20>0#]$_VC/B
MO?\ P0^#7B3QSI^D6^NOHD(N9+*YNVME>/< V'$;_, >!C!]17SKXF_X*(WW
M@+X<?"_QSXC^'\<6@^-(&N&^PZL9IK-%< L085##:RL.1R=O45Z?^U[/J/CO
M]CGQ='I'AS6[W5M?TB%;71(--EEOEDE*,(Y(54LC*,[L@;=IS7A/PVT*'6/#
MW[/7PS\8> O$CV=WX1U32=:AO-"N8K>R9P@42NT8",&MR021C=&P^\I(!]%I
M^TY91Z]K=[<V]A'\.=-\-6WB8>*8[XN98)]XC40B/KF*3HQ_@QDD@>;:K^V5
M\1_^%.3?%G0_@PNK^!QF:&&77O)U1[3<5^T^0L#J$[X#$[?FQ@&O&O"/[#WQ
M"TKP/\?OA7)J<TVC7]EIT7@_5+V4M$UO%<S7 MSC[A#':P P"^1P0*]@_9O^
M-&O^#_A!X)\ :I\+_&4?CC3(X]'EM&TF6.R C8)]H:\8>4L6SYMV>>0 21D
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MH!/RGBOE+QM=RW7[</[,\6BK''XD7PS;-K1MR2T=J(I25?MC:90 ?;VKI?\
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M#QBZAET>1\3,#'Y@(! #93GCWI=5^-G@;1OB!:>!KWQ+80>++L(8-(9B9WW
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M&_/5RTH9L="V.H- '?4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/A;X;A\/^%-*AT318'=XK&V+>7&6.6V@DXR23@<9)/<U\9_L8>.;SQE^T_\
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MW\8?M)^$_C,GBW4].UKP];K9PZ<EO!);O 1*)(^5W#>MQ,"<D@MD8P*]XHH
M^=/B/^R0_P 0?CK9_%'_ (3.>QU2RL6TVWTZ33(;BT%NRR*Z.K'+[O-<G)'\
M/ISS7Q!_89N/B7X6DTG7_B?K5W<S:]_PD%Q?_8H 7F6)(H(UCQM2.)5.%7KN
MYZ5]844 ?.GAO]CW2_!O[0;_ !9T3Q-J&F:G?0^5J^E6\4:V.H,5 D<IC*%F
M&\@'[W/K7T2AW+FG44 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%(<]NM "T4"B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MMCW,JDG@ D@9(YH VZ*XWX9?%#2_B7\-O#7C2&.71['7;..\@M]2*QRHKKD
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M (#UK5I_#WC;_A#K^&WGMMT84(9+XDR8\E0XRN=_/('. #W"BF[L=>M*6 H
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MQ-?UBW@;3[EYHU>&)Y8)I?(D<,=JRA,[3S0![G17.>$/%-]XDFUV.]\/:AH
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MZXS;3QQX?=-.=-9L9(]0O9=-M'CN%99[J/S?,A0@\NOD3 KU!C8'D&@#P/\
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M4;O3U-CX0CM/%7B>&ZN-4\,P06R27<8>UAD'FNK;I#NA4O.^25^9;WQ \;6
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M,JD@?=9NHR*^-_C;8>&-<\0_'?Q;X>AU2PO]&F\%W'A"2RAO;(Q!$CBE,=N
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M1HLWQH^"$+:ZEK!_PSY;Q37=G=H&MRC1[^F<.@CD..H,9X^4U]V^'5\)^+-
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M.W2"V6!EG^T(WG?:5D.-[.VU0I7] =2\!>%]4.JR:AX=TB[.IHBZ@]S91/\
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M;0UPI )V5Q]Y^T=XEC^&&DZ1)\8-074M'E\7JNH_;[>UDU$64H2REN;Q]V[
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MQ$-?;P]I3:\""-4-E&;H$+M!\W;NX4!>O3BMZ@ HHHH **** "BBB@ HHHH
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MA1\I$>,*"#LQQB@#YJU[]IWQ_H-EKY3Q%:7<^E_&6S\'Q^;:0(9=)G2!MK\
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M,0>#BM3X1?LV?#;X#RWTO@3PK;:#->JL<\RRRS2,BDD('E=BJY).T$ GDC-
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M$E+"3+;5X"L2HR< 9.;47[*7PLA2%%\*QE(=;/B1$:\N6']I'K=$&3F3_:-
M'R[8?M._';7/A1JGQ/@N_"EAX6NO"NJ:K:0W2PO+#>VZ33I%;HDQDE(CB*2"
M4*5*E\8!2L3XS?''XPR?"#XL:5K/BS3+>]?P!I?BZUN_#^F&U-DEW,T4UDC/
M([,"JX\XX;)) 7C'UM9_LA?![3KCQ#/:> M+M)=?MYK34F@#IY\,K!I8^&^5
M6(&0N 1QT.*GE_95^%<[7YG\*17/V[2$T"X6>[N) ]@H&RWPTA 1< C&"",C
MGF@#Q'7?CY\0_!'[1VA>$M<U98/!UWJNEZ-8ZM:Z7#<6FH3RP*T]M=.CM):7
M9>5#&N-I0!B #N/V17EFA?LO?##PUJ-E?:;X3M[6>SN;>]A5;B8Q"Y@B$4,[
M1ERC2H@P)&!;J<Y)->ICB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?!'[#&A> ?#VI:%IGQ"\>)I$EO<VNEVAU8;-%CG;+BV&SAMI*!FW$ G&"22
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MQ5_:^\#_  =U:_N;3P3#X:N/%FHZ?;3O -9F$QMX;>1XR&:-.93'D*V!NW8
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M>'OV(?"GA[6M7"^)O%%YX.U*6ZN)?!<^H?\ $K$MPC),P10&P0[G;NP"V<9
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M7C:(@(SLYSA4&^OI3P[I+Z%X?TW39+R;49+.VBMVO+@*))RBA3(P4!=S8R<
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MHUM9I;#0O#\$<MS)%#M\Z9C+)''&B[TY=UR6 7)XKYV^,'[3,OQ8U#X(Z3X
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M8N]!M_%,5I"=+>]MHR\\>[SO. 4JR>88@C.I"L<9KVT'-?-WPR_9N^('PO\
M'VH0Z;\1XO\ A6%WK]SXC_L5=."Z@)IW:1[4W&XKY'F'<?EW'D<9)KZ1 P*
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M\F\?_M0> _AKXHN-!UF[U'[39M9IJ%S::9/<6NGM=/LMEGE1"J-(>@)S@@D
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M%^OW^N7WVC3B8K2]-PB2$B<ELI<Q[@N2!;'@X0'[ZZ4 %%%% !1110 4444
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M $(O. <=5X+\(ZEJ\FE6<7P]\16>I7W[/,GABX:]\/3P+)JL(5$@ED9 N\B
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M)W5Z9^WY8^$9]9^!4GC:7[-X=;QC]EO9C/)"HADM)LJS(00C,D88YZ \@9H
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M'X?^*/&WP+\*SZQXD\0?#G6=5\117,^N//8?:8I+6,VZ0JFPI +IG1-P&6W
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M6;3_ (87_A+19IHM.::.V&O_ -JP[8X0!Q-]B$QD1?7+C/(C^+?@;P+X7?\
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M_BKPO\([/Q_XF\0Z#X"NOAU9Z?I.H:'HSZB(]1CE9;F+[C-%<%E0;DYVHH.
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MD)/VQ\,9'0*,*68 _3#-(0#UK\Q='E\2#X,>$_'*_&OQY%JNN_$J'PK=1GQ
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MQONV[6&$ SC[4 P* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;H7A_3%AM/ &E^)/$0U"]<O9M?V_VJ*"W58_G:..,N7<H,[!CDE=2T^*UO\
M"G7_ !?XBL?!&G7?B'PW\*]%U5M6DU:=&O;'YMT3Q["D9C,<K#:"7PH++G@
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MOBIX@\5_M"_ [XBR^'[2TT[4_"?B/4=,L[;4&:XNXH[>&1(I]RK&C?,A!!8
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MB@ HHHH ****  ]*X#0_@_8Z)\8O$WQ&76]9N]3UVPMM.DTZZFB:RM88,E!
MHC#IEFD8Y<@M(QQTQWYZ5\<_'WXG:YX<_:TM/"=_\5O$/@#P7=^"6UB%=%TN
MVNV-^EVT3#Y[29MGED,1ZKU&0* -J^_X)^>'Y]"\>:;;_$#QA _BG7HO%"7+
M3P%].U2.8RK<PE8E.>0N"?N@=PK"D_\ P3A\)VF@RVNE^/?&VFZTOB23Q19:
M^FH1M>6=U)$L<VUO+&X2!5+$_,2B\X!!;^SG^V-<Z[\!_!.K^,EN/%GC3Q%J
M5]IFE6?AJUC:YU@6S-OG$19$A"H,OO9 .#QN KKKK]NOX?1>&=/U>WT[Q%?R
M3G4!=Z;#8I'<Z7]AQ]L%UYDB1H8RR#:KLS%UV!LT 9GPX_85T_X8W_P\FTKX
MC^+)[7P9J>H:I;VMX]O(MT]V-LJ2'RQA2N\$+CF1V&TG->B_L[_L]6'[.V@Z
MOI&F^(M:UVROK^:]AAU6XWQ6*R2O(8H$&%1=TCL2!EF8DUS*_MK^ [CQ9I^A
M6FG>)KU;K3;/69-4MM(=[&SL+F(RI=3RY_=Q*!AF(PIR/X6QYY:?'WQ=\7OV
MG-*\+^$M1\1>#O"FL^!+K5]-N-8TBV6*>X6>+R+R%'!E:,J^&2382.@7(:@#
MU#XT?LNQ_$GX@Z+\0O"_C#4OAS\0-,MGL/[;TJ"*X6ZM&R3#/#("L@!.5)Z>
MAPNW.U_]CO3-3TWPI<V?C/Q'8>-_#VK3ZS%XS=X;B_N+B=!'<>:LD9C*/&D:
M! @54B10,#!['X"_&H?%;X5OXCU6VCTK5M)N;O2]=M(27CMKRTD:.?9W*$KO
M7/.U@#S7&)^W1\.4T/7M4O+3Q+IL6CZ3;:[/#=:-()GL9Y/+CG5%R0N2"=^T
MA6#$8YH I^'OV+[3POJ/P_O=-\=:Y!=>$;;5$29H;=I+ZZU#>;N[E<IN\QF9
M",' \M??/.:9^P%%HWA_X<Z=9_$G6H;CP-I6L:5IET+&W/R:@KI(Q4CJJ/@<
M_P *G(P<]-XC_;[^%GA;35O+]M>@/V>2]>UGTF2WN8[19-BW+0R['\N0Y*<;
MF"L0N :ZKX^_M$VGPG_9\NOB?H=A)XKL9;6WGT]K09AD6XVB&9R2I$1WH21S
M\P '- 'G7AG]AZ^\.WW@FX7XH:I*?#/A&]\&Q[-+MXVEM)ED$;[N2K1YA(SN
M!\A>FYLV/A]^Q'/X'UKP!/-\1+[5=*\*^&+OPHVG2:9%']NM+AW9MTFXE< P
M*,=H!_>:N5B_;)D^%?QW^*-K\1[CQ G@N"UT.]TNW&A;_P"P8KE9%F-V\*G8
MID\OEV8_, HR"*]<\1?ME_##PQ\2;?P3=ZM<OJLFKQZ"\]O:M);0W\BJ4@=Q
M_%\Z@E054G#%2#@ \Y\-?\$_8- TGX;:;-\3?$5_9^#9[Q/)>.-$OM/N! KZ
M>P!^2 I;A6 SN\R0\$C&=X:_X)J^']-\$^)_">O?$#Q-XKT*\TU]*T&VU&0%
M?#\+7"7!:!<E2YDAMR6 7(CQC#8'T?\ $KXQ:#\+IM#M-2CO]0UC7;A[;2](
MTBS>ZN[QT7?(41>BHOS,[$*H(R1D5YW?_MN?#6T_X1R.W_X2#5KW7UO!86&E
MZ%=7-P\]JQ6XMF1$)6:,@AD/088D*0U &+X*_8\U3P?X>$#_ !:\4:IXBEU?
M2[V[U^Y8B:>QL7+1:< '^6$[Y,\G)D)(/2O6OCG\,YOC-\*/$O@B'6I/#ZZ[
M:FRFOXK=9W2%B!(H1B!\R;ESGC=D=*\@U?\ :<;6/B1\%-7\+:K+>?#GQ=HN
MO:E=V<6FF2ZE-E C@*,&3>&9E\M!DLF.<UZ9X'_:/\$?$:+P1)X?O+N_C\8V
MUY>:2RV,JAH;5PD\DF5_=*&95!?&2R@<D"@#SS3?V/KW4+_X<1^-?B'>>*_#
MG@%8'TC0(M+AL[>2X@4)#/<$,[2LBJ !E1U_O.&Y_5/V(?$-_J&KWL7Q6DAF
MO?'T'C^%I-!64V]U%&46'F<;HP-@' P$QSGCUKXM_M->"_@Q?W%GKS:G=3V5
M@-5U$:3I\EW_ &=9F3RUN)]@^1"X8#JQV,<84D9_BK]KWX;>#M5N;2^U'4)+
M2RN+:UU#5[32KB;3].FN-AACN+A4*1LPDC.">-PW8H XKQS^Q1-XI^-FL>-M
M,^)6M^&]!\13V4_B/PI8Q8M]5-NJIM,@<% ZHH/RL>7Y(; @^'_[#A\ ?%V\
MUZ#XAZM=?#Z35;O7K;P&]NJVT%_.I4N9-QWHN]RJ[%P0F2V"6ZS7?VW?A/X;
MU;5K#4=6U6W;2-6_L74;HZ%>FVM+DD!5DF\K8 Q8;3GYAR,CFDOOVW/A9I7A
M&]\17U_J]C:6.MQ>'[VUN-$NDO+2[E3>BRVYC\Q 5Y!*\XP,MQ0!YO\ #W]@
M/5_A9IO@VX\._%F\C\4^$9]0ATG4[S18Y;9--NEYL9+995\Q5DS(',F=S-@#
MY=O6>!OV/M0^'GC[X8Z[I'CM3IG@[3+VQNM/NM&#RZM/>R&6\N7G$R['DD$;
M ;6"E.X)KI-/_;/^%VH:)-?#5;^VOHM2.D/H-SI=Q'JPN=ADV?8RGF_ZL%\[
M<!0<D$$53C_;G^$%SI^B7EGKNHZBNM6MQ=V,5CH=[/)*('"3)M2(D2(3ED/*
MKAB I4D I?!7]E+6?AO\3+'QAXG\?CQM/I.C7.AZ2K:1]DG@MYKH3_OI_/D,
MY0?(O"@ DX)QCZ*8?+7A[_MG_"M]/TJ]LM:O=7MM1TR+65DTS2KFY$%G).8$
MFFV1GRAYH93NP5*G.!S5E_VN?AVWBMO#=O<ZK>ZN]SJ5C:0VVD7#K?W5@A:[
MM[=]FV61-I&T'D\#- 'EGB+]A+5_&NA_$^RUWXF&:\\7>(;;Q/IVH:=HS6LN
MC7L V1E3]I;S5$810,H1M)#9/$6H?L(^*=2T/P_JK_&W68_BSI>J7&H-XZ_L
MU6:2.:&*%K86WFA1&$@A'WB"0Y(^? W/ /[5=O\ &#_A3>LV>K7W@JW\4ZEJ
M<(T*]T"6<:O'#&Y5%NB D.P;)"ZDAF5T!.QJ[[2?VNOAGK6J6%E:ZK?O'J9N
MTTJ__LB[^R:JUMGSDM)A'MN&&UL+&6+XPNXX! /*->_80U[7-(G\.R?%B>X\
M):K8:?:ZYI^HZ,;JXNYX+Q[N:[@G:Y MY9I)903L? ?G<0"/I3XI>!XOB7\,
MO%?A">86T6O:5=:8UQY8?RO.B:/?M/4KNSCVK@OAI^UY\,OB[XCT?1/#&L7M
MY=ZQ:SW>GRSZ3=6\%TL) F6.62-49X\C<H.5Z'GBH/B;^T$/#GQH\/\ PDTW
M3M13Q'XDTBZO;76EL'N;2Q=?DB=U7_6*')+\J% &6&Z@#AM-^!OC?XB^ _@G
MIVJ:M!X.UCX6:K:RW]O+IC7MOJ\UK ($EMY!-'B%XI)&!(+ R88*T;*:&A?L
M3^)+./PO'J/Q&TV^32/'-]XUNA'X:>/[:;H$2VP_TP^4,2W.'^8CS$X^0[I?
MV6/VX/#'Q#^&7AY/&_B**U\='1KO5]2+:?+;VLD-O)()GBDV>6_EH@+!&.,'
MT.-SQ[^WAX"\+?#;QCXETVTUO5=0\.V-O>OH\^DW-G,Z7*L;65O-C&V!R #+
M@A<CN5! .1^%G["7B3X;Q:OI'_"UKN_\)65EJ5IX.T6YT\21:+)=I(AN)?G4
MSNJS2#;E0?,?&W.!%JW[!GB%]$\%V&B_%671+G2O!,O@+5[^#1E+:CIQ)9-D
M;2D1.,X)R2020RFOI3Q=\6_#7@#X<7'CGQ'>3:-X>MX$FEEO+66.9=[*J)Y)
M42;V9E4)MW$D#%.^&OQ8\/\ Q8TS4KS0);L_V9?2:9?6M_92VEQ:W*!6:.2*
M5593M=&Z<AA0!\G7G_!.?Q-%X<N=-T7XT7&C-K'A&U\)>(@/#T<D>J0VR&*W
M8#S@8=L.R(X+,RACNRYKK_$'[$WB77['Q1:/\3K,QZ[X(L?!,LLWAK?*D5N!
MNGW+=*"SEICMP OF+R=N6U?AY\2_B?\ M*+XJ\3^"-?T?P3X0TS5+G2=$AU'
M1FOYM5: A7N9V\Y/+B9]RA$ <;22V>*Z>+]IK2_ACX2\/V/Q4N)++QW%H,&J
M>)+31=.GOHM-& DL\Q@6010^9NPS'! )&0#0!XC^T-^RCX\3P?X\UBS\2-XL
MNO$/AG1_"ESI.B>'A%<"*WN(3+=H7NVWG;]I;R0!D.JY^4L>X_8GT[XC^&FU
M#0=<B6Y\#V]G'+:7]YX.3PO=_;2^&B%JC8=!&H)D902=O+<X[OQ/^VI\'_".
MJWUAJ/BF0RV-I::A<S6NF7=Q!%:W(!AN#+'$4\HAD/F [1O49R<4X?MG?"0:
M%XMUF3Q%<0:=X6BMKC4I9M*NT*PW!Q;S1J8MTD4AQMD0%2"#G!!H N_M&?!'
M7_C9'X(71/%]KX3;PSXAMO$>ZYT<ZA]IGMR3"A'GQ;$RS[L9)R,%<<^<:3^Q
M3JFC_%S6M6B^)%Y_PJ_7-8E\0:GX 2R*Q3WI&Y3]H\TL$\T^8555!\N,$-M#
M#J=2_;M^#NEIK)GU[4=VD!);U%T&^8PV[@,ET<0\0,&4K+]U@RX)W+G'\?\
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MVEAN+6X@.)898742(XX.TJ#@@XY%>5V'[>/P6U46+6GB6]N(]029K"1-#O\
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M4\%[K<VKV+SZM!<!8TN'@9'2(F81*?F4!"?E7 Q7UU10!\;^*_V0_B/JMO\
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MRA$]QL[_ "Q9'WJHZM^R)X\\5+XZ@U76_#UM;^)/AW:>#$>S6=FAN($?$Q#
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MU#Q(\JVE]<7+V,Z-YMN%#A1Y48^1(T7>S%F).=WWC10!\N?L9?#W1DU#QO\
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M;HW>N0.@M],\J,-&)03N/FDE5V@X(YQ74;A0 M%,:5$!+' '<TGGIQ\W7VH
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MU+4Q;>)O$J7,FDV)@E;[2MNGF3$.%*+M7GYF&>V:ZR@ HHHH **** "BBB@
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M?Q'^(7BW5;AOC'H/P[N=$BT.YMM%U)E!U*WEM()Y9$MT@<W)G>9@%BDROR*
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M'KBJ&M>&/A!X,N]#TG5=.\%Z'=7=^]UI-C>16EN\UX<!Y+=&P6E/RY*#=TH
M^0OA;\:O'/Q#O_A+X(\4?$/5=#TWQ!/XH^U>);,6]K>:E<V=_+%;VJ2^5LC*
MQC>0BC.% XX-7P'\6?B;\3;[X6Z#JGQ8U;18-6TWQ1;76HZ1:V<+Z@FF7"I;
M7R-)$^TS*3N;[I\D[ I9R?M>+X$?#.U\-1^'E^'WA?\ L%+DWBZ8='MS;"<J
M%,OEE-N\J -V,D<9J#3O!GPH\:ZDTMCH'A'7+[0(FT,R06=K/)I\>TAK3(4F
M)=LC Q<##D8Y- &%^R!X]U?XG_LR?#KQ1K]\-3UO4=)CDO+O:JF64$JS$*
M3MYP!SFOE[PO\=_B-K.G^"_B"OC2[N/$-Y\3Y/!^L> ?+B%G#9M<R1&%8U3S
M%EBB1)O,9B<;B<@X/W;X8\(:%X+TE-+\/:-I^@Z8C,Z66F6J6T*LQRQ"(  2
M>2<5C:AX-\ ^&=>G\;7VB^'=)UE%;SO$5Q:P0W ! #;K@@-R  <MT% '@?['
M/AN!?B5^T#J#:Y>ZJT/Q O$6VN9(GB5S:VQ\\*J K)@O'D$#:"N.M=M^W/97
M]W^R/\4CIFHW6F75OHD]UYUI,8G9(QO>,L!G:R*RD#&02,X)KT3X>>'/A_I
MOK[P-IGANR6_*2W5SX>M[=!<GYBC2-$/G^\Q!.>IQU-=3J6FVFL:?<V-_;0W
MME<QM#/;7$8DCEC889&4Y#*02"#P0: /RKU_5]<T'Q!\3O%7@GXJ7NFW'@[X
M;Z%?+J%J;6X_M"6,NPMYGV#*JSM'MZ\(&SC!])T3]H;XC_$3XN7TX^+OASP9
M#H/BZVT\^&+IMTFI:>XB55BM%MVDG>9I&PZRY!_N@ U]L1? 3X900W<,?P[\
M*1Q7<"VMS&FB6P6:%61UC<;/F4-'&P4\ HI["KT'P@\"VOB*PU^'P;H$.N:?
M;I:6>HQZ9"MQ;0HNU(XW"[D55^4 $ #@<4 >6_MV:58:W^S/K>FZFJOIM[K&
M@6URCOM#1/K-DK@GM\I/-?.%C-X[^#7Q^^#WP5\2Q7/B+0=%UZ?5?!GB23YG
MNM.CTB_B-G,0?];$TD2CCE3V&W/W%\0-.\#^(;73_#OC:#0=1M]5N1'9:7KJ
MPR+=SHI<+%%+]]PH9L*"0 36]-HFG74MA+-8VTLE@_F6C21*QMWV%-T9(^0[
M&9<C'#$=#0!\"?#7XS^/M0TKX'>+8OB'JNLZY\1=2U'2_$.@7*0"#346.=_.
M@MRF8/L@C!).0X +\&N<^#WC#XI_$%?@M#JOQ]US3T^(WA;6+O5)%MK$&R:R
MD!4VQ\L;&*L=SMN;$;X(XV?H);_"OP7::WJ.LP>$="@U?44>.]U"/385N+I7
M^^LD@7<X;N&)SWJA:_ SX<61TTVW@'PQ =-1X[(Q:/;J;9'W;UCPGRAM[Y Z
M[CGJ: /C3PA\>O''BW1O@!JK^/;R&3Q/X)\1_P!HQI';J'OK& B.] VD%RQ+
M8;*_N@=HRP/->%_CQXS^'?@'PEXOUKXO:[J\OC+X9:KK,RW=I;7D.EZA;?9A
M;R00*J'($LJL'<[V7+$?P_=:? 7X8VUO;Q1_#OPJL5K#);PHNB6V(HI PD11
MLX5@[[@.#N;.<FA/@1\,=L 7X=^% MO ]M"!HEM^ZB8N6C7Y.%)DD)4<'>WJ
M: /S>U[XR^)/$_PM^,6BWWQ#DU:RT*Z\(ZE:PR:]!J,IBN[E8;Q))D3:ZJTD
M#E$)6)RHWMCYO3?BO\=O&'AR]_:''ACXI:A<6/AJS\(SZ#J*M9W*A;J0++MQ
M'LD5Q)DN!D[1SC.?MNT^"'PZL;6[MK;P%X8M[>\MA9W,,6CVZI- &#")P$PR
M!@#M/&0#BH[[X#_#74C=F[^'OA:Y-W&D5P9M%MF,R( $5R4^8*%7 /3:,=!0
M!\9>+?CAXS^#4OQF\-7'Q&U/6].\+^+/"T<NLZH]K_:BZ=J,<37B6Q6-8]X.
M[8-GR+O(Y&1]!_L8ZWXB\3>"O%&K:UXJO_$VCS>(;N+PXVHW%M//'I2$"!I7
MB4.9'^=CYK%MNSA<G-KXX?L@^$?BOI-NNC66B>#]9CU.WU*?48/#]I=)?B(.
M!!=Q.H$T1#YVDC#*A_AQ5[X2?!_P[^S-IGBSQ)K'B+2[;^T_L\VJ:@+&UT33
M+9(594*PQXCCR9&+.S%F+#)P   ?-O[1/[1/B+PO\?[YM"^(T]AI_A_Q-X?T
MJ[TF>>VM+*."Y(^TP^2Z/)=LP+NTV8EB50%+%6K-M_C1\1=&\4GQ-'\3-4\1
MV]I\8[KP1%X<DAL_LUUIK1,_(CB5VE!"A&#87' Y.?M_6/A%X \6ZA/J^J^#
M?#FL7U[&B37UWID$\L\:E60-(RDLH*J0"2/E'I5>S^!GPVTZV@MK3X?^%K6W
MM[H7L,4.C6R)'<  "90$P'   8<\=: /A3X._$-?B?\ '7]EGQUJOQ);Q)X@
MUH:^VL:%)?1>1I%VUC((X8;=0#  "8\.2S[4.2<D_I)7*:7\)_!&B:S)J^G>
M#] L-6DF:Y>_M=,@CG:5L[I#(JABQW-ELYY/K75@8% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 !Z&ODSX-BWU+]O7XZ3
M^*6A_P"$GL].TBV\-07+*7CTHPLT[6^>=K3%3)CHS 'TKZSKS[XF? +P!\8+
MS3;WQ9X=AU+4=.#+::A%/+:W4"L"&19H720*<G*[L'TH \1\1ZU;_#GXT>$O
MA/\ "_5K7PM;>-]8UO5]9U*#9>-9WL-K#-):P1.&CC:0R)*R,. 6( +"O,_#
M?[0'QT^*^L_#KPIH7BK1?#&KZG<>(](U/5I]#%Q%/-I4T0%U"A<8$BR;"O12
MKD9X"_6NI_L\?#O6/".D>&9O#-O#I&C3BZTY+*:6UFM9LDF6.>)UE5V))9@V
M6))8DFJMA^S-\-]*UWP?K%CX;%E?^$(&MM#>VO;F)+-&+&3$:R!'+EV+LX9G
MS\Q:@#YKM?C;\:?"]U#XKUSQ?I&N>'[?XEOX%F\-V>B)#)<0O=_9UG67>7\Q
M<Y$8'(&23S5GX>?M)?$OQ7X?^#GCUM=TNXT7XF:O>Z$WA^/3U(T>7%U]FECE
M#!Y/+^S8E#G#9.-G&/3O@=^RC8^$/%_B?QAXTT;1]1\57_BB^\16%S9W]U<P
M6IN",$0RA8TF11L\U4W$=QTKM](_9:^%^@:[J&L:?X62TO[TW;.T=[<A(6NE
MVW#P1^9L@=UPI:((<  $ "@#Y"A^/'[1+?"?X<^)[[QMHEQ=>.=4CM;32?#N
M@QOJB0QBX,OD+,3%([!(V8R;$C //-6O OQ]\;>/-3^ ?C74_%$OV:X\/Z[J
M&HZ9;V\21WLMF&!9E4?*\B<$#A#RHYKZAD_8Y^$$G@C0_"+>#HY/#^AWKZCI
MEG+?73BTG?[Y1C+N"MDDIG:222,G-5O#O[%OP>\)VVD0:3X+M;2+2=4FUFRC
M%S.RPW4H0.WS.<KB*,;#\HV#B@#SW]F#XS_%?XG>(O#6M>(O[#/@;Q+H\E[
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M*\F3:Q!("Y7C  5<#G%7_$_[%_PN\8>+-2\1:AH]XVHW^HQZM-Y.IW,48ND
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M7]2U7P[XOL/C!K^G_%+3$G@N/%DEE!/'=P3 !X/L1Q#'&"J%57H1D[F.Z@#
M^('_  4/T7P'?0PR>"=:F^QVVF3Z[:3GR+[36O55UA2 H?.EC5@73<F"R@9.
M=NQ'^W'977B[QYI]GX/NK[1_!8U8:K<P:A$;^,V$)D9OL6-PBF*[(I"V&/!V
MGBEG_8QU;2O%M[J_A/XP^*?#4.N6-K9>)HC%#<W&K&%!'YXG8!H)VCR/,094
MG*X  I-2_8SU75OB+=^,)_B3<)JL*:PFBW\.D(M_8+?12111RW)D+7,5L)6:
M-' (;'S!1MH A\+?MOS>*M(L6L? AU#6=;U*+3?#MII>MP7-MJ;-:_:I':Y*
MJ(1%'_K%92X/&T]:IWW[>DYM=$M=&^%6OZYXHO-;U/PU?:%;WENKV&IV</FM
M 9&.UPZX<.,#8&/)&TP:-_P3_CT/4[KQ/9^.CI_CPZY:Z]::IINBQ6UA!-#;
MM ZFR#E6$RR2&3:ZY)&W9C!Z32?V/[_0_$OA+7[3Q_+_ &KIOBF^\7:S)+I,
M;)JUY=Q""4!0X,""#,:*"V 026(H T/A1^UQ'\5_BY?^";3PL^G'3I[FTOVN
M]1C%]9SPHA/FV87<L+LQ5)@Q5BO8LH,W[2W[6EI^SC>PQ7GAV34K<:>^IS7=
MQ?QV43(LHC\BW+J?/N3DL(1M.U2<U3T#]D::W^/&F_$S7O&)U^\TB_U&\TU?
M[*2"[2*Z#J+6:Z#DS00K(1&I4$87D ;:A_:+_8W;X_\ CR3Q$/'E_P"&8;GP
MS+X7O+"VT^"Y$L#S--N1Y<F)B_E[BHRRQA0RYS0!F:K^W9::9XP\4:>/A]KU
MQX<\,6%KJVK^(DN+<16MG<6;7,4AC+[BS *@0<Y)SMP-W0_LW_M<VWQ_\4ZW
MX=D\+7OAS4M/L8-4C9[A;F":VE.%RZJNR0'@H0?9C6#X-_8D?2A\0+/Q5X[G
M\7:/XW\/V>@ZE;'3$M)4^RP""&:)T<JK!=W5#SM.>#N[[X"?!+Q9\*59?%7Q
M2U;XAI;V2:=IL%W9QV<5I K9)98R?.D("#S)"6 7 ^\V0#EOBO\ MFZ5\)/B
MU:>#=5\/RK:RZC8:8VHS7T<,LSW2@B6VMB"]Q#'N59'!&UC@!B#CFK3]OB,>
M)M3CU+X;ZUIG@_2?%TG@O4_%+7D$L-IJ <H@,2G>R%MFYAPOF)RQ.*C^+G[!
M]W\2_B#XO\3VOQ-OM"77]3TS6%LTT>VN3;W-DBI%F5_G:, .1&"JAF!.[!!X
M']G'X$>(_B%>?%NS\87.N:/X'N/BE>>)O[ U7PW)9S:RBR1SVTXGD"GRG>*-
MFC2/.80,J'((!Z%HO[?,<VJZ5)K_ ,-->\->%+SQ+/X0F\17%W;SQ6VII*\:
M1-%&Q<JVSF0?*K$@;@-QZ'PI^VA8^)M1\%FX\$:WI>@>.OM0\*ZO/+ 1J+PJ
MSJDD8?= TJKF/?UR,XYQY;^S5\#-<^+.DZS>>,Y=5T?P7!\1M5\367A#6/#<
MNG75PS3-):RR2S$.8\R"3:J [A@M@%:])^'?[&1\!MX%L+GQQ=:[X8\!7%W>
M>&=-NM/1)[>>8,J-<3JX\]8Q))M4(F=PR2% H X[X9?M6-X7^&_PJT+PA\//
M%_C.]\5Z;J=WI46J:S;M<M):SR^?!/<3%?G3!)XP 45 ^,"Q8_MQZEXD\<_#
M6_TWPX+/X<:_X0U#Q1J%S>7*"\A2V;$W[L Y\G8QPI)DW]MM=#X"_8WUKP)J
M/PQO4^(B7L_@6+5X[9Y=$ :Z.H.[R,Y\\X*EP1USCGKQE>'OV"IM"T;X?Z6W
MQ%NWL_#6D:CX=OEATF)#JNEWDBO+;,6=O)/##S$^;!&-I&2 5/"__!2'PWJ<
M&NW.M^#=:T6TM=%37=.EA=;K[=#),D,<#$!5AN&>:$;"Q4;_ +_'.I^SMXR\
M7^(/VNOC58^)[/4=!CMM)T::#0;C66U"WM]XF)DBYV)OX)5  "#UZFS:_L4:
MKJ/PRU3P#XI^+OB'Q)X7&FIINB6IM(+=M,6.:&:"1V09N)(VMXE5GQA=X &X
MUV/P;_9X\0?#OXK>(?'OB/XC77C;5M<TFUTNZ2?2H+-,V[,8Y%$9XX=_E'4N
MQ)/  !D?%+]L?3OA1\6(/"&K>'9DL9-2T[2QJ4M]%%--)=@$2V]J1OG@BW*)
M) 1M8[0&(-5O#?[9QUWQ98:7=?#3Q)HFFS>*YO!UQJ]]<69CMM01'<(4CF9F
M4A/OKE1D88GBL7XK_L,W?Q*^(WB;Q1!\2;O1XM8U+3=76P_L>WN#!<V818QY
MS$2-%A7(BRH#,"<@8-Z?]CO7[W2X+2Z^)27,D7C_ /X3[S)- 0!Y_P#GV*B8
M#R\Y.>O.* ..UKX[ZO\ %C]HS]GS5/#EIK&C?#G4]7UJVAU=M4VV^N"&SG W
MV:,1M\R)C&T@W8R0%S7T+\5_C-+X \0>&?"^B^'YO%7C#Q&MU+I^EI=1VD?E
M6R*\TDLSY"*-\:C 8DN.,9(\=\(_L,ZEX-USP3]C^+&LR>%/!6OOK.@^'I--
MMRMM$XD62U:8Y=U*2,@;C:&; R01Z;\;/@7>?$3Q-X3\8>'_ !A>^!_%?A@7
M4<&IV=A%?>;;3JHFA:&0%6)\M2IP2". <T <A\,/VQ/^%DO\/+<>"KW3+[QG
M!K1MH9+Z*06]QIDK1SPNP ^\0NUP,?-STKF_&?\ P4!TWP?\/?#OC"?P9>1:
M7J>F-JDIU'48+38%N6@-M 3G[1<C8S^4N,(,EN0*XS]FW]G7Q1XL^"_PSU/^
MW_$7PU\=>"M8\1(L^KZ$IGF@OKJ0R%H)U"DM&8G60!E!W<-T&IJO_!. ZGH-
MGI)^*FJI GAF7PQ=2/I%K))<0-=272D,V?*_>2*'V89U0#<.M %/QO\ $>:T
MUO\ :MU)KKQ5KOABW\):!JEMINFZP]O/9Q7%O=>?+:M(2MMA%$K;5Q\A.UB<
M'4^)4'B/XF_''PK\-)++Q'_P@O\ P@DNJQ3Z/XG:SO))P\*+.[X4R21G$861
MBK&?>PX..M?]C?5FTGXF69^(\KGQQX7L/"]S,^C1[H8K>)H3( ) &+1RSK@;
M<;P?F*Y/4V?[//B2R^*OA?QQ#X_5KC1/"S>&&LY]%5TN%8JS3[A*"K&2.)L<
MC"8[DT >&^#/VV?#'PH^!G@*T\-^'O$'B2]O-$O-=.G:WK!GOHK.*[EB+27!
M1_-EDD5Q'& !A& *[5!C_:J_:MU/XA?L_>/H?AMH?B&S_LS0;#4]3\0KJ9T>
MYT5[D)/!$%4^9))Y>"ZJ0NV0#+9(':>%?V%-8^'^@>#_ /A%?BO?>'O%GAVP
MN=''B"UT>)_M>GRW)N1!+;R.R$I(\A5N<;^F0#3O'?["%WXF7Q=:Z3\5==TG
M2?&&E6>G^(;2]M(M0>_EMHECCN?,<AD=@B[MN-W/(XP >C?M8?%KQ)\$_P!F
MCQ+XT\+V=M>ZU86<922]DPD&\JGG$8.\J6!"=SU.,USOBG]KZ^\.7&OP6WP\
MU'79/"&DVVL^+WL+Z$)I<$T32HL._'VE_+1W*C:  /FR:].^(_PBC^*7P/U?
MX=:OK%P1J>E#39]72)!*7"@>=LQMR67=M&!V&*\CU/\ 8RU:^N=>NX_B??0W
MWB[P]#X<\77#:1 W]JQ1H8UFA4$+;2^4SQY =<'.TMS0![%XB^,^@Z#\$KSX
MI0_:-6\-0Z+_ &]&;&/=+/;&+S5*J<<E2#S@#OC%>+:G^W-::/X0BU6?PQ#<
MWNHZQ_96AQV&L)/9ZDHM5N7G^U>4-BJI9&78S"1=N.I7VC5?A6L?P6/P\\+:
MM/X4AM])CTC3M1MXQ+)9QQQJD;!20'PJ@$'@\YZUX)#^P&MG'>ZO8>/[C0O'
M;ZY!KMEK>AZ3%:6EC(D)A=$LM[(1*CR;\M\Q8<8&T@%NW_;JOM9MOA]%H?P@
M\4ZGK'C*WOGM=.EGM[9HI;.14N4+2,,HJL'$F &#)@9+!>O@_:TM)-;US07\
M+7X\1:9XMM/"0TN.XB:69[B,RI= $C$/E*\F>N(W/12:=I_[,VM6_P 0_AIX
MOO?B+?:UJ7A%=3-TVI62R-J3WY7S\$.H@11'&J(BD($ YR:ZB?\ 9R\,3_M!
MV_Q>8W']OQ:;]@-IO_T9I &1+HKWE6*2:($Y&V0X ZD \X\"?MPZ9\0?C!I7
MA+2_"6IW'A_5[V^T^R\2POO42VN0S3P[ 88W9) C;V)PNY5W8'TX.E?/OPH_
M9:U7X2>,Y'TCXFZV_P .DU*YU:U\$R6\7EP3S;V9/M7^M:$/([B+@;MI.<'/
MT%0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !7B7Q+_:Z\%?"[6M?L;^SUO4[;PV+0^(=3TFS6>UT7[2V(?M#;PV2,.1&K
ME5() R,^VGH:^6/B5^RUXPU[4?C#IWAS6]&@\+?%&*V_M$ZDLIN=+F1%AFEA
M505FWQ*,!F3:P7L#N .E^)G[;?@+X7>)M=T2_P!-\2ZI-HEC;:KJ%WH^E&YM
MH+*?[MR90P'EC*Y/7YN VUMOT C!T5AR",U\??$[]E#Q]K%]\68/#$_ALZ-X
MK\%V'A'31JE[.D]N+?*&279 0<I++W)RB<@,0OU7X.MM4L?">C6NMO#+K$%G
M#%>R6TC21O,J .RLP#$%@2"0#SS0!XC\3/C]KUK\<]3^$VD:%J-D#X-N];/B
M6W6!VMI&81P31J[X\N-A(&W(Q+[ %V@D\?\ LJ_MJ^'O&'PO\-VOC+4-6MO$
MD'A)O$6HZWJ^GFWM;R&#"W4T3@#>$8D$JH7*G;FO0/B9\&?%FL_'>R\?^&9=
M $+>$;SPQ>PZKYJ3,))1-$8V13@;Q@Y^Z&8A6/%>,:/^Q-X\N=$\$>'M:UCP
MY#HVD_#[5? NH3V$L\D\@N@0D\2-&H^7RX"06&<OR.* /??@S^U-X*^.7B+4
M-!T+^T+35[.SCU+[+J,"H9K1SM2="C,-I) P2&&1E14G[5GQR/[.OP-\0^-8
M+./4M2MA%;:?9RMM26ZFD6.,,?[H+;B!@D*1D=:X;]E'X&_$+X5ZC/-XVM?A
MU816VG)I=LW@?2/L]QJ.UE/VF\E:-#O 0 1I\F78GD+7J/[0/P6TS]H'X3:[
MX'U69K2+48U,-XB!GM9T</%*H_V649&1D9&1F@#AK+X=_&W07\':@GQ3D\23
MG4;5_$VEZEI5C#;&U)/GK9M# KIMR !([DJOWL]7:/\ MI^ -7UVPL5MM>M]
M.U6._?1=<FTX_8M9-F,SI:%6,DC8W;!L'F;3LW<9M>"M%^.=_:6>A>.KGP7'
MID.V*^UG1IKJ:[U2$ AE\AXT2W9Q@,X=\9;: <%?)_"/[*'Q+TK0OAGX-U?4
M_#FH>%OAI>7FH:3J:7$RWNK/Y4T=C%/'Y.VV6,3D.R/+N"+A: .KLO\ @H?\
M+]3L[6XL=-\8WO\ :&GOJ.E10>'9V?540D2K:C_EH8\,7/"+M;+9&*O>(/V_
M/A7X?TSPW>EM?U-/$.@GQ%I\>EZ--<O);*Q5P0@(#IMD+@G""-BQ'RYX'X6_
MLU?%[P$WP -S;^#;K_A6^C:QI]T8]7N@;J6Z39"R9M?N@1Q[L_WGQG SF_!G
M]E;XN_#*/X>1WMGX*U)/#'@O5O#,JKK-THGEN9S-$^#9GY/DB5N_SN0#M 8
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M!4YYD8HPR0&(]<^'/[:_PR^*?BK1_#^A7&M/>:M>7>G6LUWHUS;P-=6R-)+
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M"[;9;ZK/J<"6LS<_*DI;:Q^5N >Q]*^%-/\ A7XH>;X5> M7^$?B.]T#PO\
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M5K.@DBGA<.DBD9#*1P00<YK(\1^/O#'@Z18]>\1Z3HDC1-,JZC?16Y,:D!G
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MAG\(]7\$Z=X+\KX5:WIS7?P?U71->%MH9!N=5+*52Y Y>1S!)M+YSYB8X;@
M^N?#O[4_@]+OPGX>\4Z_H>E>,-6\.'Q#=V]GJ<4]C:QHJ;\7&X*P)9RA&=RQ
M2-T&3U/@SX^^ _&_@#1O&-IXFTVUT35E'V>6\O(HB'QDQM\V X'5<Y'>OCWX
M*_"WQ7X?USX$MKG@#7Y[27X;7GA#4IXK-%DTJZ-RAWW'FE1&@C5B&&6;/RAL
MX/#Z-\,?%4_A+X;0>*/A%X^OO#5CX*?P=J6DZ:(;:[2\5D:2X$1D.891E0YV
ML2F2!QD _1S6/B'X6\/ZAI]AJ?B32=-OM094L[:[OHHI+EF.%$:LP+$G@ 9S
M6CK&OZ;X>L'OM5U"UTVR0A6N;R98HU). "S$ 9/%?G%XN^!&KZ5XFU;1O$?P
M:\6^,])U=M#?P[!INMEK'3C!;)#Y%Y<XWQ+$_F$R $$,>!G-?4_[=O@Z3Q]^
MS%XGT*U\+WOBW4+J6T%I8:?:^?.KK<1L9% &5VH'R1@X)&>: /8(/B=X0N7M
M%A\5:)*UW=-96ZIJ,),UPN-T*8;YG&1E1R,]*;=?%/P79>(IO#UUXOT&WUZ%
M#)+I4VIPK=1J$\PLT1;< $^?)'W>>E?GA\7O@1=P1?M&2^"O@[JL%[<ZCX9N
M/",UMX?VE(X#;B\%J>"@S'(6"[=P([=-*^\,?$"Z_:!B\0W'PH\8-H]C\2IM
M6:VL;"![2YLY;9X$NM\TGG/+)\N\%E@B10-H)H _0'2OB+X2UV#3)M,\4:+J
M,6IRR06$EIJ$,JW<B LZ1%6.]E )(7) !S72#I7R'^S!\%I/!?Q=\7>'5FL]
M0\!_#O5;EO"JHNZ6SN-2ACN+B!FP I@1RJ@9)6\8M_"!]>4 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 'I7,6?BV]N?'^
MH^'7\.:E!I]K8PW<>OR!/L=Q([LK0)\V[>H56/&,-UXYZ<U^>O[63(GC7]J&
M&WGOH[JX\!:1+;I;3SJ6NDFE0!-IZXE@!0<'S!D'<<@'Z$;E'<5S?Q%\97'@
M/PI<ZS9^'=5\53Q2P1+I6BQ+)=2^9*D9959E&$#EV)(PJL>U?!_ASX1Z5X]U
MGXZ_#'P;K&I6::CX2T'6=#=]4N=[ZIY,TCW!ED?<6=I+82$G[L@R.F&?$!]7
MUK]EKQ%\8?&-OJ?@_P 0ZWJ?AV&STE[F9#I\%E/!#/\ )O "R,+V4C'^K\LD
M$KF@#] M-\4:3K&KZKIEG>PW.H:4\<=]!&<M;LZ!T#>A*D''H16KA2.W(K\Q
MOC-J>E^$/B%\=8O#BZC:Q7GB;0-9U^XTNUDGD_X1U[6*2ZGC93L,3W#(64NN
MY?-R-JMCZJ_89MM!3X>>(I_"7B?Q!XM\*7>MS7-AJ6LV)M+9MZ(TBV,;?.(%
M<E>54!UD"C - 'O$WBC18/%%IX;DOK==<NK26^AL-W[U[>-T223'90TJ#)ZE
MN.AQK;8^.!QT]J^'/VC=*LO!?[:$7B+2[&0>,]=^&VJP^'&BMY)/M>N0R1_9
MU&P'<PCQD,0BJN3C.:YS]E'6]/U[XE? J\\!ZYJFI:E+X6O8_B?:SW=Q,(KQ
M(8PKW:RL?+N#>&7:" 2F2/E R ?5?[0/PQ\">(/#EQXJ\3_#E_B!J&A6[O:V
M6F6@FU"521NBA&Y=V>NW/.#7:>![KP[I-E8^%]'M;?0Y;+3H+I= C54DLK=R
MP0,BY"_,CKP2,JW)KS+]N;4(-*_9&^*5Y/>OIYAT=W@N([AH&6XW+Y 5U(.3
M+L &?F)Q@YP?DCQ_J'@6R^(_Q"OW\57'AC4_%WPNT?4-(\2Z;!//(I<317%P
MK(<,@C6'>V00I.WYA0!^EH(/2@8]J^4O^"?>OG6/"OQ MREC<-9^(O+?5=!U
M"2\T:_;[+ /,L6DR40A07BW,%=GQMSM7R3]L"[\+WW[1GQ%TS4_%U[IS6_P@
MO=26R@UZ>V1=2BN-]MB-9 N_:JOY>,-@,5.<D _0C</6LKQ5X6T7QQX>O]!\
M0:;:ZQHU_$8;FRO(Q)%*O7!!]P"#U! (Y%?EEI7C_P 1>%K)+GPAXKUR_P#$
MWBWX'+XAOF.JR7<]UJBWB>=)"KL=LT=N+K"QX*K'P 1DS>(?B5H6D_#ZY\0>
M"?B)K^K?#:_\1Z&?%,D&@W4>E:- T%P&B\MK@S.YD2V,RI)CF,9;>%(!^A'@
M?X1?"GX#>(+)/#NBZ7X=UO7MVG6C-(TES<A(VG:&-I&9MH2)G*J0/DR1P*ZW
MP#XU?QSIU]>2>']9\-FUU"XL!;:Y;""681.5$\8#'=$_WE;/(K\\?"FE^!?"
M7CC]G/Q+<>,=3\8^%SXM\06UIXIU"VN;2'RY;$M!;VJF1Y#"MR2BECDL)!RO
M)R?"/B3PGXQF\ Z!=?$F_CT6Z^+WB336FL_%D\,UQIS0R_9U=Q-O9)&^SJ)"
M<XFP&!DR0#]2MB'L*,)Z"OR4M/V@- \-_#SX8VVJ>*+SQ/X&MO%OBW2KG1#X
MAECFGM$7_07EG63YEB$B%0S<F9&7H*G^)/B)M'^$/P_MY/BU8_$6^TWP9=7N
MKZ9-XDN%^VM+=%6N-.O0_P U] 5,2Q2*V%3B,EF! /U5'AW2AKG]M#3K4:O]
MG^R?;_)7S_)W;O+WXSMW<[<XSS7/Z[\)?"?B3Q]H7C74=+\_Q/H<;Q:=J"W,
MR-;H^=ZA5<*0V3D$'/&>@K7MM:5?!\.KO:W<:BQ%TULR9N%'E[BA4_Q]L>M?
MD=X+^.NEBWUVYD^(MY:V6N_#77I41]=O#>2ZNLRR6YNIPZQ&\;!.V%$PA5#N
M##(!^Q6Y?449!K\S_ /@Y/'WB>_\ >%OBCK5OJ_BSX1Z9KZ7B^*KB60Z^)RQ
MD'[W*_(B!D4#$;'@9KZ9_8ON]=^)/AS_ (63XECU'2]0ET^#PU'I$M]+);*U
MB3%=7 C+LI>2Y65=_+;(4YY.0#Z7^44<5\H?MCFSO/C#^SYHMSXMU7P]%K6O
MW5A>66FZW+8"]M6M6RK!'4G,GE1AAAAYV 06%?*_PG\?2>']-^%_BVQ^(^IW
M^O'X@:KX2MX-3\0O/9OIBPR_9X6C9RA4NUL1(1N)E3DC9@ _5<[>IQ7#?%3X
M(>!?C?8Z?:>-?#T&N1Z=,T]G(TDD,UN[+M8QRQLKKD8R <' ST&/S2^'/C:W
MU?X>ZOXCU#XT^(K7Q['X3UM/$_AZWMKNUEM+M$ED66\GDN"L;+<^4D?E(I<N
ML07;O"Z&LW&A07>K+!\5_$EU%<?!4>,HQ_PF-SMEUR)66-EQ(.0!_J1Q\N"O
M&* /O3X5>(?A[X!^(NK?!3P?H5QHM]HVG1ZY< 0G[/*DSA0_G,Y>63( );/"
M@9XP/8L@=Z_+J\U;1O'?B'0O%7B[XA:CH6JZA\!=+U&'5K#6S9RWNK)/,74!
M&7[1(LB\P_-\S'Y<XQCS?$GQ9K/C5]/^*GQ.\2_#'QS;:7X<N] TRUTZ\FN]
M1D-K%YD4$8N4@:62Y:2-UF0DEB"P"D* ?J[D&@D5\>?L5:?IOBSXI?&KQ/%X
M[UWQ#<Z1XTU/2;73)]?>[LXK-U@>.3R2S#[XF1'SC",!R#72_M?^+#X?^(GP
M1T[Q#K=YX=^&&K:S>VWB+4+6_DL(_/%J38Q37$;*\<;2[\X8 E1N.!0![=\4
M/BAI'PF\-Q:OJD5S=M=7EOIMC86**]S?7<[B.&")695+,Q[L  "20 35KX;>
M.8OB1X-L-?CT?5M!^TF1'TW7+0VMW;NCLCI(AST93@@D$8()!!K\Z/%&HZ7K
MWPS\#'Q?XQN-3\-6?QS^Q>%M9O=;GC:Y\/I*-THG$@,JHP=5N225&"KJ&R?T
MUT^&*UL+>&W):".-4C+2&0E0,#+$DMQW))- '!_$WXZ^&_A?K.DZ#=Q:CK?B
MC5XY9M/\/:%:&ZOKB.-<R2! 0$0=-[LJYXSFE^$GQOT3XPS>(;73M-UG1M1\
M/W,=GJ6GZ[8FUG@E>,2*I4DY&U@<@D'.02"#7@?CGQ/I'P._;WC\:>/+B#1_
M"OBGP:FB:9XDOCLM+.ZAN?->VEF8;(0ZDN"6 )'O53]H_P",_A'Q,G@S4?#^
ML._PWO\ Q?::9XS\6>'YWAM+B P2B*)[^$C,*R-$KNK[5R$+9W* #[*(&:"0
M/2OS%T/76OOB1X0\*O\ $GQ"?A_=?$_6-(T&ZA\1W$/VS2A8J6@CF$NZ:*.Y
M*0))EB"Y"N"U4_@SXU@T34O@SKM]\2=;N;^Y^(^K>$94OO$T\\#:6L4JQ0F,
MRE/O26S!SELR1G=C9@ _4;*^U&X>M?E#\+O$^E^'_!'P^\6^'OB!XDUWXCPZ
MQK\7B71[?7Y;^YM-&B%\SL;:1V$>!'!(KR8R\Y.2=NWSD?&N?3? OQ#M;+XB
MS1_:_AQIU[:+IVO7AG;4TO$WB69W'F7?EF3S?+"(<E=IVY(!^T9VFO'X?V1/
M@_#X\N/&,?@>P77KB\.H32"27[/)<DJ3,UMO\DON4-NV9W?-U)-?&P\'CQCX
M]_:.^'GP^^)VN75W9:-HOB;PW<)XIGN9+J[$#S7#B43999_,57VGRQYR-@;4
MQ]=_LI:I?_$7P;>?%35(K[3KGQN\-Y!H]Q>/-#I]K#$L$2Q*6*KYFQYBR@;O
M.&<X% 'M_'2FN4!^;%?$'[6]QI%Y^TO;Z-JOC?5= LY/AMK&H26%CXEFT]9)
MX7#0-Y:R  X69^!\WD'=N5"*\"^'GQ'U/P3:^ O%(\7^*M7NO&'PLUN\UZ_7
M6I+N;[7;K(87A20E$FB\DQKC;T.3G=N /U;W1J>H]*=N0C.1CUK\DYOBY$WA
M;XDZ5;_$ZXT^VNM)\-:CI?V+7+F9_M)N0EX!-*0SR^60TNP!0W\(VFO1_&_Q
M&MOAMK/Q+\%P^,=:U7P]#XJ\/&TFU'6IVBB2>W,MU]HN!NE%L74EA'@[L#(&
M00#])!(A!(8<=?:E#*PX(K\G;+XXH?ACX$T[QAKUSXA\-Q>+/$%EJ6E+?36K
MR0>4S6;F21PRQQE]RAVX!7J15BZ\5BQ\'?"?PEXR^/$Z>$-5\-ZH]QXUCO;S
M4[8ZP;A3Y/G17$;++!;LBJ),H,G]WF3( /TJ\._"7PKX4\?>(O&>F6,UOXD\
M0I%'JETU]<2)<B,8CS$TAC!49 *J" 2!P<5V.5]J_*SXC>(+.72/BX\GQ>\;
MOJ7ASX;Z%JVGFXU^XL9IM196'GO:++E&8-9[HV^Z;G+#<RFI/&_Q0U#P%;_%
M'2_!7Q(UF_&H>$O#6N7]T^L3:E<6RSW0&IW=N/,RA\F:-F$17:LF5V *5 /U
M/!%4=2US3M'ELH[Z[AM9+VX%I;+(V#-,59@B^IVHQQZ*?2OS*O-;\.PZ%HXT
M7XZ>(=8\,ZQ\1=#MDO\ 3;Z\T33[**:*0WEO!)+/(\@"K&[@MB$R( 5)9:J#
M5/!5M)X2U7Q-XDGN?"O@GXTZYH2WLFKW,\EGI\EO<26JF1)#*P=XU(?)+'(+
M$$@@'Z4?$7X:^%OBSX6N/#GC#0[+Q#H=P5:2SO8]R;E.58=U8=F!!'K61\*?
M@7X&^"=G=V_@S0H](6[V?:)GN)KF:4+NV!I9G=RJ[FP"V!N.!R:F^,WB(>&_
M@WXRUE'U-!:Z+=SI+HJAKU"(6(: $8\P<%<C&0,U^2\?QCM=(^&GQ.LK'XAR
M6,MWX,T'4]-M],UJ]#M>BX6.Y#S.X$\^UB)<!4+$@)E#0!^S_%<-X!^,&B?$
M3Q;XW\.:9#>1:AX1OX]/U W42HC2/'YBF/#$LNTCD@=>*_/GQS\2++X4>,_B
MAX>\'^/M:U7P1+?^$;[7-0'B">_NK73;AY3J=S#(&:5"X-N':,C:+A<;<J*]
MV_85OO 7_"X_VA+7X?ZW:ZQH#ZIIEU:-;S23?NWL\L0\A)91(9$!W'[AQ@8H
M ^R&9%ZD"DWITR/\*^-O^"@>L7.ER>'Y;7Q#!;_9-+U*[G\.W=_/I_\ :46V
M-6>VN(B!]JCSE$?<#D\5\^_&7XTS^&/!WQTL6U;7M/U:X/A+6/"VB:EJ$Z7*
MI);6SW9C.1P&>;S,?+NR"!TH _4>XN%MK>68(\HC0MLB7<S8'0#N:Y#X-?%K
M1/CG\.M,\:^'HKR'2-1>XCA34(/)G!AGD@?<F3M^>)L G.,9P>*^(OAO\9O#
MGB[XS:S_ ,)7X\\5V'Q*TWXELFF^']*NI6M[W1F'E6RB MY'V3R7,\L@^;:K
M/D[DSY]^ROXE7PAXC_9TU/1O'VIFW\7>*/$^F:GH\FL.VGI"DDC00I;%_+4L
M\T<H(4,6G7U&0#]4RJGJ ?K61XJ\4:-X*\/7^MZ[?V^EZ38Q&:YN[EMJ1(.Y
M/UZ#J2<#FO)/VV_$7B?PG^R]X[U;PC)?P:Q:VT3M<:6<74-MY\?VF2(_PLL/
MFG<.1C/:O@C]HZST:Y\-?&%OAAX@O?&GPCMO">CZV\/]JSWUKIVL-?11H(Y9
M)&97-H9970GC<-P&%V@'Z3^"?C#HWCGQ]XQ\*6=EJ%GJGA9H$O'O8!'',)E=
MHWA.XED(5OF(%>@!XQSD"ORX^)GBCP=KNH?&;QM\/_'FHQ0:#HWAR?09=(U.
M>&.5PQC+2*2#*5#A</G&\^M=#I?C,^/OCI?_ /"6_$S5?#?BC2?&4<VC:386
M5P9M0TED00K$XF$/V=HV>1W\O*@LY;% 'Z4 @]*#MSSBOCG_ ()PZ)8Z[X U
M7QTGCC7_ !5J5SJ6HZ3+:ZAKDU]:VD,5Y(T 5)&;#F(QOOSDK+[DF#]LN7PH
M/VDO@MIWCOQI>^#_  9K&E:_!J+C7IM+M9VCB@,*R.LBJAS*_P V06(523P*
M /LW"GGBDW+ZBOR,D\6ZOJ]GX,\)?%;XI:UX(\$7/AFZ?PKX@U*RN)#>A-3G
M6&5VMYXV%Q]ECM-I?<-CD8R^7]4L(=)UKXA_&K4=8^*WC?3[_P #^#M*U>U:
M359TEBN7TEUNKR6P#_ZQ"8B\:X"O(5X)% 'Z0<&C('>ORE\-_$JXT'2WTO7=
M>DD\")XKT"Q\7>*?"NOSW&DZA83VDX203%O,MO,D6(W*[@<R#.-P!U%UFSOM
M0\%^'Y?'^M_\(+/\8[O1_#MT/$-Q!]JT7[+B:%)?-W2PI<,L"R$D_.0C#=0!
M^HVX>M!P:_)S5_&MM=_!G0]/T[X@:=?6'AK5_&AA\/:YKMQ%!J^GPR+Y*)?1
MN6%U%'()+?S-V[>3D #/Z9?![4DUCX1^";^*UO;.*ZT.QG2VU)]]U$&MT8)*
M<#,@SAC@<@\"@#KPZ \$>E.W \YK\A_#7Q9-EXYT_5I_'NL:"FKV/BB'4M1O
M9;RXU2R=RWV1;L$^6)%('EQP*NU4ZDD8^ROV%/$=S?CXAZ)>1P7%[H][9++J
MVE:E+?:3?[[5<26K299&VH#(F3AW/3.* /H:X\;BT\?-X:FT/5H[1=(;5F\1
M- HTQ=LHC-N9MV1-@[]I7&P$YX(K;TC4['7]+LM4L)X[NQO($N+>XC.5DB=0
MRL#Z$$&OB3]K![36?VA?&_AF;77C;4O@GJ[6VER:@P3[=%=I-"\< 8?O=L3O
M\HR5A)Z*U?0/['%YX<O?V8/ANWA:[-[I2:):QF1I6D(G6-1,A+,V"LF]2H)"
MD%1P* .M^)WQ;TCX32>$QJUE?W \2:[:^'[62QA5UBN;AML;2DL-J9ZD9/L:
M[D;0!T%?E_X^^*GA77?'&D2^+]>N1\3M"^.5K%/87-U.5L])@O"L7DPYV>0(
MO+.X*27<D\MDY7P]\7>(M9UK5]:L/B1XB;]H/3X?$<=YX'M](N_,FD$5R\ N
M6DE: 0Q[8#'LB7#&.,#." #]5LK4%]8VVIV5Q:7423VUQ&T4L3C*NC##*1Z$
M$BOR?USQ;H?_  SK\3O$_A3XT>(-1U)O#VE-?:?8)>:;%IM]]L@C!EDFN'9K
MF0"9&"\.J,Q_A)M_&;5=&\#O^T8=$^(_B/4E\%7'AK6_#EJWBFXN&\^Y>'[7
M<*QD/F[O,P=VX+YG&,B@#],OAI\+O"GP=\)6OAGP;HMMH&AV[,\=I;9(W,<L
MS,Q+,Q_O,2>!SP*ZNOSZ\/\ CK'[;.BWUKX@MO'>E:QXJNH+<VFI2KJFC-_9
MLJ?9Y;4DQRZ>%/F+(@&'7<S DJWZ"T %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4FT'L/RI3TKX"^*G[1'B+1_P!IZ./2
M?'D\FAV7CW1/#=Y:FYAM+"SMI8R+JW-N^Y[AR69WN#M5,(%)P0 #[[PN>@S]
M*7:/05^?.F?$[XK:?JD_B>#XEZGX@6P^,;>!8_#T]G:"VO=.DG4-NVQAA*JM
ME7! 58R=O)-9WPE^*OQ?N-!^''C#4OBG?ZU=>)/']UX-N/#]S:62Q)9&2<?:
M8O+B!,T00R[FRFW8NW:N& /T5PH/7\*>!CI7YT?"KXG?%#5/!7P;O_$WQ=UB
M;3_BIX@N=+N]0CL;6*32_LYO5CBMG$156N72!<LOR[#MQDXL#XP?%C5O$GA[
MP0OQ+U'2(H/BIJG@I_$B6EDTVH6*0"6,-YD)3[1&<Q!U4 LPRK,* /T-8K@Y
MQ7,^$/B5X8\=:MXCTW0M5BU&^\.7O]G:K"B.IM;C:&V'< #P1RN1[U\4Z#XJ
M^,WCCQ#X6\$V_P :)[!O^$K\2>&I/$=IH]I*^H06=LD\$Q5DV^:K&2)MF%^4
M_P 2EC9\0?%[QWX:M_B/HD_C^_DU.+XFV&@:==16EI#>7-L]G%.]K"YC$$+$
M!_WLP*JJL222,@'WA+<0PO&LDB(TK;(PQ +M@G ]3@$X] :<54U^;OP_^(_B
M?XSZS^S?>^(OB!JMM=IXM\3V%Y):7%JK1_9K6Z\EY<0^6THCS'OVX*.Q4 L6
MKO?V3_C/\5?B]XN\!^+]:\?^&5\.:^^IV^I^$AJD,MVDZI(\$$%JMG');O"(
M\N))Y2R?,2"0" ?<FY5902 3T&>M/X]J^-?VH];U+P3^U)X+\266M:H[:9X&
M\1:K;:'%+'Y%S/:K#(L(0KDF;(5L$,0B[2O.8_@C\5/'$'CGX!7>H_$"?QSH
M_P 5_#][?7]A=6]M''IMW#;+=,UMY42L$5G,!1V;&T9);H ?9VT ]!FH#86Y
M@D@\B/R) 0\6P;6!X((Z'-?)?QF^+OBO7/CYXS^'FC_$BV^$Y\/>%K;6--O;
MV&V>'49Y)6,TDWGH288T0)B,J069B3@ >9ZA^U!XXNOCAX3ET;QE=:OX6U+Q
M]8^%9YK2"T@TJ2*6PB,L4-O(K71E65VD,K-L&]%&[G !^@,5G;0Q0Q101)'
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MI0+.W 8"",!D$9&P<J,X7Z#)X]S4U% %.WT;3[2WC@@L;:&"/)2..%55<]<
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MP 'W@#@=@.,8K6\+_ CX?>"O'6K^,]"\(:3I?BC5RQO=4MK95FF+$,YSVW,
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MV8?A<_@O6_"<G@VPN-!UN>.ZU*WN"\KW<L>WRWDE9C(2NQ=OS< 8'!->HT4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBPR3@\ 'U;17A.L_MB^"M$\0M:3V.MMX?B\0#PK/XMCMHSI4&IG \AV\SS0
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M 'ON<T5Y)^S+\<[C]H'X;#Q5<>'+SPX'O[VVBBN2K+)'%=30H58,22%C ?(
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M$?$5W'XLUF_T>\AO+:*"ZTZ>UA9GA=&E \S<T+'DJ$W\[L+5/X*?M4OHT?\
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MB1CNQM#.CJ"V,E3Z4 >L45P47QY^'TQM=OBW3/\ 2M9;P[#NFQOU)<9M.?\
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MGR4!488&XN>23TBYX(KZ)D_: ^'$7B__ (19O&6CGQ#YSV_]G+<AI3*B;W3
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M1\#?&RLKH^!E77(!R!.WQ^^&Z>.[CP6WCG04\5VZNTVD-J$8GCV(9'!7/!5
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MS1  F5_FXC^8?/\ =.>#70?#_P")7A;XK:')K'A'7;+Q#I<<[VKW5C)O195
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M@[:W'A:W\;'Q%>ZFOA_Q/]GAEMK"XL4>28JSD."3 P5D4JVT$,1@U] @\=:
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M ?V@[/XB^-[C1=,\)>)5T7-VEIXLDM8SI=Y):SF"X5'61G3$@(4R(OF;6*Y
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MQBV6-'=OG\M44+@BQHVD>!_'/BV*R\#^#]4TS5]1^#FMQ:Q#>:=/!?7>JQF
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ME=1W^G:E9.$NM/NH\^7/"Q! 89(P058,RL"I(/5J,* 3DCN>] 'Q7^R=\?\
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M1T)_#U[=P#RKZ?3X&5[R)2/F42E627')&0<@U];20QRJ5=%=3U5AD&G(B1J
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M;6"_N(Q/ 4MVABL[93Y4NZ7S1)E6X.6Q@FOTD4 # IC6\3NKM&I=>C$<C\:
M/B[]CCP;I7B?XY?%[Q7?:YK=SXC\/^*+NSMM,EUB=[2W@GAC,I$!<HP,XG4'
MD#R0!]Q<8'_!1KQI]A\26>AQZO?Z%>_\(?JMY8W#W%VMK+<DH(T@BMMI>\'E
MMM:1PD:L6*MT/V]XI\3Z1X(\/W^NZ[?P:5H]A$9KJ]N7V1PH.K,>PJQHVK67
MB/2+#5;&5;FQO8$N;:< @21NH96&1GE2#^- 'Y/>*_B!X;\?^$/B3XI?XI>(
M6U[2/A?X?U:&"'Q%>0(FN &.1_+$@7>)/LXV8*EK@L.3FOH;QAH'BJ\^+/AB
MX\-:I?:GX8^./ARUL[N_@OI!_9$L213W-W ,[4$UIYFW:!B4*> <'[A^P6IW
M_P"CQ9< -\@^8#IGUQ7 >'?@;I'A[XN:[\1)=9UW6-7U&W%I:V>J:@TUEI$)
MV>9'9PX B$C1(S=3E>"!D4 =G>>&M.U'PW-H-W;_ &G2I[1K&:"9V;S(638R
MLV=QRI()SGWK\O/A?:GX?_LP_"_XA>%8=:UG6?AQXPO;/Q=H&FO<H;VWGOIH
M]GE,=KR*K6S*,G;O)8YR:_58US?@7X@>&/B/87][X5U:TUNRL[V2PGN;)M\0
MN$P70-T8C<,D$C/?@T ?GEX1\/?&O0M'^(_@6==5.O?#;3]0\1Z-J=I>S3>=
M/J%LGV2VC+DF80XOC\Q;+HGR[E%>B_LOZKHFJ?M >![GX3ZOJFH^&+KP5)-X
MWM9[R>XBM]0+QF"2X,K$"\=S,&QABJL<;3FONO8H).T9(QGUKFA\1?#$?Q 7
MP2NK6H\6263:F=*4_OOLX8(92 .!E@.>: /G/]KR/1=6^/\ ^S[H.O\ B#4-
M'T35[W6+34H+/69]/CN86L6\N.0QNO#R[(P<@GS"H/S5\@?"3Q8-!A^ GB7P
M9XJU+6?'&N+XOT)EO]<GO$4PPS+I5LT3,RA%8P,JA1N,F>>,?K>\,;LK,BLR
MG*DCD?2FI:PQA0D2*%R5"J!C/7% 'X^^&=4T!/@9\2/$.F_$+QC)XRB\&2IX
MHTPVMUIZ6.JI<0LDEW<O*=]P\YV((\,X\P, I9:Z?XF6?A6+4/C%;VWC76[O
M3M+^'6F^*])$GB2]E(UJ5%\NZYD.YSYD.%/R@3 A1V_5PVT6'!C3#_?&T?-]
M?6D%K""Q$2?,-I^4<CT^E 'Y@_%JY\/>/?&7Q8\1WGB+6=.\7ZOX*\-ZKX$C
MT74;BW?5]2%O,5,$49 N665HD/#>6)G/RY)$OAZ_E\0_M)BP^)?CGQ/H/QDT
MGQ/9266CV&FS2-?:8$BRL<T;K$EH4\YY<@# =_F)(K]&_&WCCPM\-=%76/%.
ML:=H&FHX@2YOYEB4NWW8TSU8X.%7DXZ5G> /BQX%^*L]^?"7B32?$-SIVU+Q
M+&=9);7<7"K(H^9"2CX# =#0!^;OA_P_H<?[,6D>,T^(-QI_B;7/&5SH-_-X
MIU&[N=&N(H[B^N+>RO ) 88)(_+?S1D[I%).'8C[:_8TUJYUG]E+PA=V>BS:
M-,MG<);V5W<-.K%9I0K)(V&,3D;D+<["N2?O'WF2".5=LB*Z^C#(IP"@8& *
M /S3^%.I6UUJ/PD>'7M4'Q>EU;4H?BKI]UJ4I*Z=Y<[7<E^A8+"J;8!"P"@!
MP$.0*^AO^"<R>#;GX #4/"EVE])-JVHPWLJW<LS#9>W!@#*[':WD21-P!N#
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M.@_&[Q3\-H]0\,^%Y8--N/%_QD\6VDVKSRP1&!89S(L,;3JT*R2L54%P>%8
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M;.!))\<?B#<^%(+36/%.GZQJOAKXV6?@Z^NI-%@1K^S,\(0A""D4G[PG<@W
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M)_>%-5TG3=-N_&'BV2RL/"B^#HHDFM4'V%95E7)%OG>'CB.<_P#+,9!YR/\
ML">'Y)M1G;X@^.GN=1N+"ZO)9;ZUD,\UFP,#L&MR 1M484 8&,4 >?>-/VA]
M<\:>';W2_B-\+](O;_PI\2='T2<66N7$=O!),Z-;WD3*BO(T9E3*$J#O!Z9
MVO%7[;?Q%\-^*/$L,7PNTK4=!T/QM#X,,T/B!ENKJ>=$\CRXS!CDR(6)(P)
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M::>"-?LP=D2:1[?RE\U8VP4=P&P#W-86K?MS?$C0OAGX0\5:]X!\/^%;7Q=
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MUG]D7XBV<_Q(TC0?'=A?^&OB-HUKIVO77B"WD>_@N4MA:7%W (\(S2P@DJV
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M_91^(4!\*:AINI^%Y-8B^(=U\0];6Z^T+;M<2(8DMK?"L=HB."[8.Y00.<
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M<^&,'@206Z32/#<Q;MMP"0N4S(_'!Z>G(!U6E_MU> 4AUNSUBRU_P_KND"R
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M>\8Q?"[5O#WAQ_%-SX4\9VFNW6G07-O;W$ELEO<QMY33LL9(>6)MK,N0IY!
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M.V%8C )KJ-1^-O@72?'-GX.N_%&G0>);MA'!I[R_.\A4,L>?N[RI#!"=Q!!
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MZ444 &*,444 %&*** #%%%% !BC%%% !BC%%% !BC%%% !BC%%% " 8I:**
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M[XQ\7_'?Q#\*/%4\?CE_!GA36;'4AIT$AU0?8&D*&WEC<(TJEB  "&*C@9R
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M'YP5@&"*%!'0'(KR7]JAM;'[8O[*P\.MIZZHS^*!'_:8D,&T:?$7#;"&R4#
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M_P#"OB?56\#ZW_;&KQ:?HEEIC:SIFE1>7#9W?D7,!,]MO#3.!MD"SH#(NW-
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M(553# 'W!17P;>?M!?%#0=,^&6OVGCI?$VG_ !*\%ZQK#PR:3:I%H%]:Z?\
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MU+\<=4^"GB/QC?W'BK3_ !*NO#6AH]FL-SX3$)*HH2$(KO/LA9C\X+L5(VT
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MA>K$&*7%N0 8W0DJRX4#!'3CH36%??L;_!/4],T;3[GX9>'I;+2-_P!BA-H
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M@+@$1KG/)/V#10!\M7_[!>F:CH/C72[CXE^,;E?%T&F6^IW%S]ADED2P'^C
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M&ATK4XHEB^UVY$8;>R+M;<2,'@ @$3ZQ^P]H>JQ>'[^/Q_XXL?&ND75U=?\
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M<$9&/?J* /GWXG?L>Z;\3_$GQ U:Z\;>(M-3QKHUOH.H6-FMH88K2%PP6+?
MS*3F4$EC_KF]%V^W^%]%?PWX<TS2GO[C5&L;:.V-[=!!+/L4+O<(JKN.,G:H
M'M6G10!Y!I?[-NE6/CCXI>(;GQ#K6IQ?$6U2TU?2KAH%MXT2#R$,)2)74K$2
MF2QR.3DC->:Z/_P3Y\-Z/9WD2_$/QU=377A-_!;S7-];-C3"-JPJOD84*O Q
M]3DYKZIHH ^9]8_8.\)ZG?:7>6WC#QAHEQ%H-OX:U5M(U%+8:W8PHL:)=!8\
M$[ 4W(%.#Z@&M[2_V1-$LOBWIGCJ^\4^(M:?2-2O=5TG1[Z2!K73IKI=DBQ.
ML0F\L+TC,A4'G!->]44 4-?T.Q\3Z'J&CZG;K=Z;J%O):75N^=LL3J5=3CG!
M4D<>M>$^'_V,]$\.V]G'#XT\4W+:/HUUH7AR2ZDM9&T&VG"B3[/^X^9]BK&'
MEWD*,"OH6B@#B/@M\*[7X*?#/0O!-AJM_K.GZ-#]FMKG4O*\[R@250^6B*0H
M. <9XY)-=O110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% "$5\:? W]EGQ+J7B+XL_\+!?6=(\*ZM\2;OQ78^'-]C)9:I'
MYL<MM-*R>9*,/&A:(L@/E1Y!^85]F44 ?.MK^QO:/\*+WP;J?CC6]2N?^$BD
M\5Z9KODV\-UI6I-,\YFA"(%/[R20X((Q(P&!C%+Q5^Q#I'BM+[6[CQEKMM\3
M+G5X]:3QQ9B*"ZMYH[=+98XXD58Q#Y*!-A!)ZLQ-?2]% 'S-J_[%4MS<Z%K>
MD_%KQMH?CFSL9--U#Q5%<QRW6K6[RM*$F1U* ([-LVJ-HP.<"L[Q_P#L!:1X
MPEU^UT[XC>,/#GA_Q';V<>NZ/!<172:C+:K&D5P\DZ.XE*PQ[V!RY7)[@_55
M% 'ROX\_82_X3?Q+XAU-/BIXHTJVUVYTW4[^RAM[-UGU"R6%(KIB8>N(5)10
MJ[CG& %K8A_8OL[GP5\2/#FL>-M8U2/QAKX\417\<$-M=:5J2LC+<0-&H&08
M8>" /D.,;C7TA10!\VZS^Q_JGB?PW!8>(/BMK_BFZ-VT]X^OV-I>6=Y%Y7E1
MPM9,GDJ$Y<.%W[R6+'C'?_!_X%K\'+70--TWQ5K=]H&C>'X=#AT>]D1X&D21
MG:\)V[O-8-LP"%"@ #@8]3HH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH #TKY<\9^$_B3H/[9MU\4-#^'\OB?P^G@9/"T7DZQ:6SRS&]%T9,2N"$
M )3D9)&>AS7U'10!\7:I^Q_XW\?> ?C/K&M7>BZ%\3/'^JZ?JUA!:S/+::8+
M!D:SAEF"!G;Y"'=5QDY4''/LVAR_$SXA^.?!]SXG\'V_@;1O#<TNHW,G]J0W
MTFHW36DULL42Q_<A7[1))O?#'8@VC+5[710!\_\ _"&^.!^V_P#\)JGAM?\
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MV-+*L2?*BLW+NHR!QG)XK \2_M%?#WPCI_C6]U/Q'%%!X,:W37S%;RRFQ,Y
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M9"@<]TW[ ?PT6T\++;W_ (OL[_PTCP:=JMOXENEO(K9@!]E$FXE( HVB--H
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M8O'OB[P[^T5X\T?2_&T&BV*_"FXUK3QJJQ+9:9?"\\H7#-LW;< $[]P'/&,
M 'UAG-<M\2_BAX8^#_A&Z\4>+]531="M61)KR2-Y%0LP51A%8\D@=.]>&_L5
M_$?6O&(^(6C^)M1UR7Q)H.IV\%YIFM3PW0LM]NK*;>YB $T,I#2J2H(#@988
M8_.W[;OQ/OO&_@S]I;1]2\:7?A\>#I=*T[2_"]O-!$M_!.+=Y)I5(,DN]I6
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MI$\D<_D+.QC8!3OA9V.Y=NY,EE /JF/X*> ;9IGC\':%$9;#^S)&73H@6M,
M>03MYC^4?+TX''%6?AGX1\&>$O#,47@+3]'T_0+AVF3^Q(XQ;RMT+Y3AC\N,
M^V.U?,/PU_:5^(/Q[T'PMX(AL_"EAXQUO2M<O-8U"^LIKK2Q#97[6 CBM?-5
MG\URNX/)A5W'#_=KT3_@GL5_X8R^%84C']F/C'_7>6@#U?X@_!SP-\6%L!XR
M\):/XF^P2>;:MJ=FDS0MD$[2PR <#(Z''(-1:U\$?A[XC\*Z;X9U3P1X?O\
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M7[5C^)O$5U;^$_ .M>*] T[5[+1-3U;3Y(S):7,Z)([>1]YHH5DC\Q\C!8@
MA2: +'A3]C7X?^#YO")L9-=DA\+17T.EVUSJLLD427F[[4"IZ[]YSZ8&,8JC
MX2_8?^'?A!_#>VZ\1ZS!H%E=Z=96NLZQ+=0+;7*".:$QM\NQHU1-H &(UXR"
M3YY\ ?V@M2\'VUCH&O+JWBAO$/Q(\0^&;#4[R_,SVGV>64P1N9,L4\N(C(/&
M"<&NDTG]K]?BYH":%X9\':G+XNU.TU>273!JB6;6%M9S?9GN&N1RI>5@L>Q2
M2>25 S0!OZ!^Q#\/-!T;4M+:\\2:K97&C3>';2/4]7DG_LO39B#+:VA/,:.
MJDG<Q50N['%=AX%_9T\+_#WQE8^*-,NM8EU6ST2+P[&UY?M*AL8CF*(J>#M)
M)!ZY)]37RG\#OC;>Z#X:^#NO:[:^+_%?B$_#;4]6^U/KR_9-0$$@>998I&)D
MG \O$CD  @#<1@>H^'OV^;&?3M5U/Q/\/]:\*Z7!X%3Q]8327=O<R7]B61&5
M41OW;&21 F\C<#N8)TH ]Q^,WP2\-?'?PYI^C^)EODBT[48=7L;K3;R2UN+2
M[B#".:.1""&7>V/KGJ :\\\*_L0?#KP7J.DW>DW/B6W.E:S-KUG$VNSR)%=R
MKLE?#$D[UW!LDEMQR36Y\*?VAY?B/\4_$?@2Z\)W6C:AH>F6>J3WR7D5U:/'
M=*&A577#;R _!4#Y#R>,T/B]^TI?_#'XD6/@^P\ :KXGN+C3&UF2^MKRWA@@
MLXYDCN)6WMN_=!PQ&,ME0N<DJ 8D?[!WPXMK#0K>QU#Q5IEQHU[>7EKJ-AKD
MT-V%NCNN8#*O/E2-\Q48(8L006.?6O@]\(O#_P #? 5AX/\ "XO$T2Q:1K>.
M]NGN&C#N7*J6/RJ"QPHP!Z9))^?+#_@HEX=U&QU#5;7P1XEO-!BT.\UVUU&U
MMRZS1P9(20$ 0LZ#>I)(P1DYR!N^&_VW;#Q9=^'=*TCPK+JNO^);ZXM=$@L-
M5MYK2]BM[5+FXG^T@[55%D5"I&_?E=HP2 #N_BG^S#X5^*OC2'Q9<:AKOAWQ
M"-,DT6XO_#VH&TDN[%V+-;RG:=RY)((PP)X(XK:N_P!GWP%>P_#^)_#UND7@
M.59?#R+G%GMC\L 9R6& IYSED5CR*\"?X_W'Q6^,WP%U'0)-<T'?KOB/0O$'
MA>YNVBC%Y::;,QAF5"8Y=LA5E?D<J>",#HD_;>BU'PKX)U;3? ]])+XOTW7K
MJPM[B^BC\JYTM9C-!,PR &\D[77=UY H Z_Q-^QU\/?%7Q6D\>SKJMGJ-U<6
M]WJ6FV-\T.GZI+ 5,374 &)=I1#@G!*C(.3F*V_8\\(V7A-M M];\40Q_P#"
M3'Q='?IJF+N+4F#;I5DV<AB[,58$$DYX)%>3?#K]IBZ\57OP*\5^-[76M%GU
MW0=>U3S--U,+I,MO!"DLDD]H@9I'1 NP'&W<Q!8G [A_VU8K&+P[-J'P_P!;
ML;3Q;H=UKOA>=[NU8:E'##]H,3XDQ!(T!60*Q(P2,[AMH O:E^QQH6@6&GZE
MX+U/5=/\5Z!9:O\ V+)=W^+:2]OTD,TUR!&2=\C(6* 8$:;1\H%>&_ ?]D3X
M@Z-9Z5X0U:+Q7X)\&/I-UI_B&)O',6I6M\LL#Q[+2U$&(29)/,WDKM52N&+9
MKWSX'?M9)\:/&.DZ%-X*U7PJNM^&%\6:1<ZA<P2_;++S(HV8I$S&/YYEVACE
ME&2%Z5V7Q,^-8\$^--!\%Z-X<OO%GB_6;2YU"#3[26*".*U@VB26660A5!9T
M11R2S <#F@#C(/V*? B7Z7-QJ7B._5?"$O@86]UJ(,?]E2*P:+ 0'/S9!SP5
M7TKU?X8?#VQ^%?@C2O"VFW^J:G9:;$(8KG6;U[NY91T#2-V X"C 4    8KY
M4\??M!W_ ,?-;^">@^&[+Q%I?ACQ?J&KVNM)IFJ?V9J<5S96L^^U$J.CQF*5
M5E+!@'$84Y!*GZY\$^&Y/!WA'2-$DU74-=DT^UCMCJ>K3"6[NMB@>9*X W.<
M9)QS0!Y=\2_V2?!GQ,\5^(=?N=0U[0KOQ+IT6E>((=$OQ;PZQ;1_<2X4JQ)"
MY3<I5MA*YP:V?A_^SSH7PX^)WB/QMI.KZR;K7;:"SGTN::+[!## H6W2*-8U
M*"-<JHW'ACG/6O#?&G[06J_$KXI? S5/"EEK5EX&O_%-_91:G%J*PQ:ZL5K<
MJRFV#@M&9(2R-+P=N<+D54\'?MD>'_AA\)/"DK:;XFOY]?U;7;>V/C'7;?S8
MY+2YD$D,M[(WE!B3MBCW$87&X[<D ^T:^?='_8G\%:!XITG7-/U[Q;;R:1K]
MSXBT^R_M<M:VL]P6\Z..-D(6)O,D!4<L';<36!??MT:7HWQ%\+^$]6\'ZGH]
MSKFL:?H2"]NX$N4N;NWCE5Q;9\QH%:58C-@+O# 9VFK7AS]MBU\5:UX1ATOP
M)K.H:1XNU'4],T34K>[MLSR6._SC+$\BF(,(G*Y))QR%S0!!%_P3U^'%IX;T
M?3+/6O&&G7ND:A=ZA8Z[8:R;?48&N=IGB$J(/W;,@;;CJS$'YCGZ&\'^$M*\
M!^&-,\/:':K9:3IMNEM;0*2=J*,#)/+$]2Q))))))-?*^B_\%$+36/"V@ZY)
M\-/$.FVOB1@F@/=W, 342AG^U$,&)181!R2N6+I@8()+_P#X*/\ A^+0M.>R
M\!>)KKQ--ILVJ77AV:(07%M#',8>&.1(7=6V;1A@IY!P" ?17B7X0>%_%GQ%
M\+^-]3T\7'B#PW#=P:=.3@(MPJI)N'\7RJ0,\#>W&3FN+7]D3X>VGPITSP!I
MUK?:/I6DZH=:TR]T^Y,=[8WGG-*)8I<'!!8J,@C;@'.*\M\2_P#!0ZQT&+Q+
M>CX5>,YM(\-6>EZEJ][*+2W-I:7R!X7,;S!R_./+QG*OG;MYZ"\_;IT+08_%
MMMXC\(ZWX<UW19]-@M=(NGAEEU$Z@'-H4>)W09$4C/\ ,=@4]2"* -ZZ_8O\
M'7*:1(-=\31:G8>(_P#A+)=66^C:[OM2"A$FN':(A@B9144*@5F&W!JG\1/V
M&? ?Q,\2>)M>UC6/%":GKNHV6J//9ZF(C9W%I&T<#6^$_=[4<CN>G.:YZU_;
MN:]CT&VM?A/XLN]:U?7KOP[!91O;)&]S##YJ.DTDB+)$ZG/F#A0KD]%#5=._
M;*\1^,?&7P;MM!\"S0:3XNFUF+4X+N[B:Z@DT\O'-&@4E3L8"3<,EQA5 .:
M/JS3K0V&GVUL9YKDPQK'Y]PVZ23 QN8X&6.,DXZUXQ=_LA>!;KQQ?Z^9M:2S
MU#6HO$=[X<COR-*NM2CP4N7AQDMN"N5#!69%+*<8J+]F_P#:IT_]I">]DTC0
MI;#3H+5;E;E[Z&9T8RO&8)XD.^"4;"=KCD'*E@,UYK\6OC!XH^$O[9&I?V1H
M?BKQ]ILOPZ74Y/#FF7R+;6SI?NKW(CE=45O+3;\H9V)P!R: /;_A'\ ])^#G
MB+QAK&EZYK^JS^*K[^T=0CUB[2=/M&,;TQ&K+\H5<9(PJC'%>H$9KY$U?_@I
M#X,C>VD\/>%_$/BNQ6STV\OWTZWW3VJWBB1$6( F5XXV5G"D ;A@GG#&_;?U
MWPE8?%7Q#XK\ W3^%_"GBR+P\ESIEW$QMXVCMQOGWE2!F7>6Q@>:B?PEJ .W
M\+_L/>!_!VO>&]3TO7O%\0\.ZM=ZQI=C)K3R6MM)<Y\V-8F4@1G?)P,$^:^6
M)-9 _P"">?PT3P]I&FQZKXM@N](O;J\L-;M]9:+4;<7#;YX5G50?*9]SX.3N
M=R#\QSJVO[9FC7OB_P"(/A:'P]=RZ]X2UVPT/[$EU$7OC=.RK-'S@(B(\C@\
MJJ-D9XKCM$_X*/\ @_4C/J%QX5\06WA;^S+W58-=B@\V)X[<,P20  1/*%^0
M,V"64$@G@ ^HO!_A+2_ ?A;2?#NBVWV32=+MH[2U@W%BD:*%7+$DL<#DDDDY
M).37EOQ)_90\)_%+Q3XJUW6-5\1+/XET-/#M];6FH^7;_8U</L1-IP2V[)Y_
MUC^M>67_ /P4'ATOP]XAU2X^%_B5AHTVG)*('0Q2K=RB)3'*P4,ZR-&AC&22
M^1PK$>U?!'XW3_%N[\9:7J?A>[\(>(/"NIKIM_IMU=176-\*3Q.)(B5.4D7(
M!.T@C)ZT >?^*OV"OA[XU?6GUC5?%%Y/JND6&D23R:F&DA6S*&WFC8IE9E*9
MW<@EWR/F-5H_^">GPO?2=<M;V[\3:I?ZS+:W5WK-_K,LM\;JWSY=RLIZ2X9Q
MNQT;&,<59^*W[9$GPO\ &GCS01\.->UR+P=I4&N:AJ-I=6RPBQD5B9<,^[(*
ML-F"Q",< #)?I_[9"WL'C 3_  [\166H:)H]AKMIIS36TDVH6=Y*T<$F4D*P
MX*[GWM\B[B?NF@#A?'7[(&J_\+G^$,?A;_A(=-\(^'[;5FU;Q9I^OI%JTES=
MA,-(\@9Y>8@&/HZ@8V8KNO%?[ 7PI\3S^'9H(=;\./HNG?V0K:#JLMJ]Y:%V
M=HKEQEI S.Y8Y#,7;)Z8Q-._;UL=7T#0KW3? >J:W>:IXKN/!RPZ1J%I<0?;
MHX%F7RYRZK)&ZM\K\#".3C W3:]^W/::'X'M->N_!6H:?/\ :=4L;^VU&^AM
MXK.XL6*R0^=R'D=AA%49;!["@#J-;_8F^'>N?\)/&\VO6=GXBNK&\O;*RU1X
M81)9@"U,:K_JQ&%C "G&(T_NBLR\_8&^&5]XMN->>Z\31--KD?B7^S;?6Y8K
M*/4T.3=I"N LK$DENHR=NVL3QM^W39^'O!=QXCT7PA>Z_;V'A?3/%NHP/?16
MCV]G?,1&%W!O,=0"6 P.F"2<4S5_V^M*TWQ+!HUIX)US6);>\L-/U=+']Y<6
M,]Q$LCJL80B40^8BR?,I!)P#C- &[I7[ /PJT2^U^2R37;>PU:.[C72$U:46
M.GFZ5DN'M8ND3NCNA;DA78# -:8_8C^&\DH:[.MZ@H\)MX)\N[U2213I)W'R
M#W.UF#*Q.59$(^[7$V'[>MY?ZIIMJGP<\4>5?^([OPA%*+^PR=7@\S=;X\[&
MW]V<RDA!AL%MO,^H?M]:-8>'=),WA'4H/&%[=ZI9R^')9@?LSZ?(8[C=/&K@
MY?8J87YBXS@#- 'T+\-/AYIWPK\":1X3TJYU"\T[3(?)BGU2[>ZN'&2<O(W)
MY/ & !@   "O*/&_[$7PW\>>*=8\07IUVSO]6OH-4N4T_6)[>$W<.!'<"-6V
MB0!<;L9Y.,'FO/K_ /X* WDEI='1?A#XAU"\M/"2>,KJWO+V"Q-O9!Y([CS/
M,^8,C1.% 4F3&0 I!KK?@S^TMXC^+/[1/B3PLF@0V7@^T\,Z5K5G<O.#<8NE
MDD5W&.KHT:[!D*8V.XYQ0!I:+^PS\*=#\0:MJ,6F7T]CJ/VDOH5S?RR:;"\\
M9CFDC@)VJ[*6&[J-QQBJ6A?L"_"G1O FK^%98=:UBVU#R%CO]3U.2:]L$@<O
M;I:2\&!8V/RA,9_BW5K?M*?M26O[.HMVN]!EU*&33[C4#</>):Q'RBH\B,L#
MYDS;B0@[*3VKS/Q_^W_>>$+?5=1TKX5:SX@T/1].TW7-2U'^U+>W2WTZ\0,L
MH4Y9W!./+ YP264#D ]&O_V*/A]J_@W5M#U6Z\0ZQJ.J:E;ZQ<>)[[5'DU@7
MENI2VE2XQ\AB0E4 4!03QDDU7\/_ +#/PX\+ZM;:CIUYXJBGM]='B5 _B&YD
M4W_EB-IFW,2S,NX.6)+AV#$C 'C/[8O[1VJ^//@[XKG^&L.H)I/A7Q!I=GJ7
MBFPUAK*2*=Y(&>)84&Z:,+.D;AF #/PK;"1]2_M$_$34_A/\$O&GC'2+."]O
MM%TV:\CBN)"D8V+DLV 20HRVT==N,C.: //Y/V&OAQ+I5II\EUXE>&VUV?Q"
MDO\ ;<PG^TSKMN1YH.\+,,[\$$[FP1N.<[3?^">WPIT>W@AL9O%5K%!IUWH\
M2)XCNRJ6-P,2VR@N0L7WCM&.6).2!CQ[1OVA?'/A_P :^#O&UWIVN>+TU7X4
M#Q!J&C6.IHEGF*1'>^$3;8T=X_X$4ME@H&,D>E>(?V]]$MH+.;PWX4USQ7OT
M;3];N8+)")88;Q0\2*H1M\@0[V7*C'0D] #M'_8N^'\KS>?<^(+N*;PJW@MX
M+G5I)$.ED8$6#W4_,&ZY_*HM,_8C^'-E<V#W4_B/68+6>SNGL]6UN>Y@NI[7
MF":9&.'=3^& %QM 6O7]=\6KH?@?4O$BZ?>Z@MEITNH#3[>+_2I@D9D\I$./
MWAQM"G')Q7S%X6_X*(:1K\>M63>$VD\16MSHVG6%AI6J)>07][J)D6*#[3Y:
MK'Y;1LLC$':5?:&*X(!]:ZCIMMJ^GW-C>PI<V=S$T$T$J[DD1@0RD=P02"*^
M:M'_ ."=WPHT/PYKF@0R^)IM%U.W:S2QN-<F>.PMGD622&VSS$DC(F_DE@H!
M)&<Z</[5/B-M:TWPE/\ "K4['XA7][J4$.C75^L5G-;6:QL]W%=M&-\3^;&J
M$1\L2#MP35;_ (;"O]0MK^#1_AEK=SXCT/P]#XC\0Z%J-PEC/IL4F_$"[P3+
M.5CD8+A5("Y92V  ;FO_ +&/@#Q1!XPBU&X\0S#Q9IMCI6KDZO*3<06@009S
M_$-G)[[WS]XUY7X7_8RN]>^/_P 4-3\9Q:M#\.]5M]'LM-T^UU\^5JT-E;+"
M5U"-?GER4# ,1P6#9W&NJOOV[M"B\(>/O$UIX9OKO2O"NAZ/XB#BYC5KVSU!
M2T948.QTVD,K=QP2,&JNO_MOZCH?B+Q99-\+-5?2O">IZ58ZQJKZI;*D$5^(
M3#*B#+.V)U)3C ZLIX !Z#KO[(7P]\21^.!?P:E+)XOOK75+R87SK):W=L-M
MO/:L/]0\:X4%>R@'(XKC/B3\ /$?AWP%JOA#X=:7!XEG\?S/9^,/%?C#5&GO
M8[=X5@\_&!YQ2+<$1=JH5&%.XUE:;^UGXMT-?BUJGB#P[IUSIOASQG%X9LE3
M4UMK>R0Q09FNKAXODB D,CR88@L$"D $GAS]NV]\9Z3\/9/#WPQO=9U3QG/K
M%E96EOK$"1+<6&_</-D"YC95#;RJX4\*Q&V@#U#XK_LH^ OB_P"%/"NAZE!?
MZ/\ \(J$&A:EH5VUG>:<JHJ;8I5S@%40$8/W0>" :Y/Q+^P'\)/$46E1BSUK
M28[+2VT:9=)UBXMCJ-JSO(R7;*VZ?,DKR$L<LQ.[(R*X/P9^V_X@^*/CKX1R
MZ'X56Q\*>*-(U;4+^UENA+>":RE,,\280 B,J64C'F[L?)CGU/\ 9F_:CA_:
M4.JW%AHUG8Z9:6MK<QW%KK"7DJM,90;>YAV(UO/&(QN4[E^8;78<D ];\">#
M-,^'7@W1_#&C+.FE:3:I9VJW,[SR+&@PH+N2QP!W/MTKSGQM^RIX(\>>-M6\
M2:HVKYUM;5=;TF#49(]/U=;;_4+<P]'51QM! 8$A@P)SSOQ(_:HUCP%\:[GP
M);?#34];TS3]-MM<U3Q'#J$,4-CISNZ37)C8;G\LQM\BG<^UL#@9X2T_X*$0
M2:-XDUF\^'>MPZ)IGAD>*+2_MG9XKB)F0);2L\4:PSD2QL5#2#!)#-@9 /3=
M ^&_BSQ7^T6WC;QIHF@Z=H_A*TO-,\)R:=,TUS=+=/'YEQ-D 1E8H5C5!GF6
M8Y(*U[EMX%?+4/[:=Y;+\0;35/ -Q#K7@RRTR\O[?3M6BNK8_;MAA G*1[55
M&9W<KA50GGC.1<?MY75_X3TG4/#/P]N?%.JZCXCN_#$%A9ZQ$D<EU$F^,I,Z
M+N20=&*C !Z\ @'HOCO]C#X=?$'Q;X@\1:BVO6M[KMS:7E[%I^LSV]N]Q;!1
M%-Y2L%WCRXOF(/,:D8.<UO$O[#OPK\72^*IM5LM5O+OQ%JL&M7-TVJS^;;WD
M08)+ V[,1VL4XZJ%'88\4^._[1GB?XG?#_19=%\-7_AFVT3QWH6BZ_>QZZ8I
M;743- ;JR\N)0+F%#/Y+,6"EQD(0NX=7'^TM;_">\^)VI67@77M6N1\28/#5
MS:2:\L[2SSPVZQ2VZR?+$C;UQ"" ">67HH!],?#3X;:)\)_"-MX=T".=;&&2
M69I;N=[BXGED=I))997):1V9B2S$FN<^+/[/'@_XR:AHVJZS%?Z=XAT9RVG:
M]H=]+8:A; _>19HB&V,,@J<CYCC!.:\OT_\ ;0EGT=;>_P#!)TOQC)XZ_P"$
M"31Y=55[5;WRDF#M=K$0$\MQT1B6X /)'IOP ^,L_P </"&H:U/X=F\-2V.J
MW6D26LURMP'FMW\N9D=5 9!('4''.TG Z4 8^J?LD_#G6_!%UX;U"SU.\-QJ
M$&KOK=UJUS/JWVZ$8AN1>.[2+(@R%P=J@L  "08;?]D'P!#!HP#ZX]WIVO\
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MS*3M61$(3C+,0 /0 YP_L1K_ &?JMFOQ!U9(=2\$6W@*;_0+8G[!#D*XRO\
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M%H.C7VC)KFL:EJD5W-%X>L=*EDU.);5_+N3+!C,>Q_E.3R>%W&F7?[9_P_\
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M_K$(<#<.I'&002 >?^"_V&_ ?@?Q]X"\663W<VH^%-#FT8>?M/V]Y"Y:[F(
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M>+?V@D\0ZMI-OX5^)UK91VQL!(]Y83V<*Q02,&4*X(4.RAL90 ?>8U]3GI7
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M7U-=!<_M,?"JS\7P^%9_B%X=3Q'-??V8FF?VA&9S=<#R=H/#Y95P?XB!UXH
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MWM7SC^SW>:_8_'?3]1AM=/UW69/&6IW2^#]3TC6+>_T)+VZ9;JYC8@6406W
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MPHU7XDSZ[K&F:I;>*O$<OB&VBT^VDB:U:2-(FB8N[;@$@AP1CG>>X ]BHHH
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M"BT&>&^G@MHHKY;H7%LKD13E@J[#(N&,?)7.,GK6]10 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 455U75;30]+O-2U"XCM+"SA>XN+B4X2*-%+,S'L  2?I7EOPF_:D\!_&
M;Q-=>'M"GU2TUJ*T&HQ66M:7/827=F6"BYA695+Q%B!N'KTH ]<HH/%>)ZO^
MV!\/M'\1PZ'+'XFGO[G4[O1[06OAF_FCO+NU9UN(X'6$K*4,;@E"1\AYXH ]
MLHKRSX5?M*>"OC+XDU'0_#4NIM?V%G'?3KJ&F3V>(VE>+@2JI)$D4B$8X9&!
MY%>IT %%%><>-?V@/"'@?Q=%X4N)=2U;Q0]K]N;1M!TNXU&YBM\D>=(L*-L7
M(P-V"3T!H ]'HKE/AG\4/#?Q?\+)XB\*W[:AI33S6WF2020.LL3E)$:.15=2
M&!&& -=7F@ HHS1F@ HKEM;^(^EZ!X[\->$KF#4'U/Q!'=2VDL%E));(+=59
MQ+,!MC)##;N(R1CJ0#K)XFTB1;1EU.S9;NY>SMR+A")ITW[XDY^9U\J7*CD>
M6^1\IP :=%(&!I<T %%%<AX]^*WAWX:WOA>UUVXGMY?$FJQ:+IWE6TDJR74F
M=B,R@A,X/+$#@T =?11FN+\1?%SPYX5^(/ASP7J%Q<IK_B""ZN-/@CLY725+
M=-\O[P*5!"_PYW'(XYH [2BN3^%/Q1\/?&CP+I_B_P *W,UWH=^TR033V[P.
M3%,\+@HX#+AXW'('2F^//BIX?^&VH>%[/79[BWE\2ZK'HNG-%:R2H]U(&*([
M*"$SM."Q'0^AP ==11FC- !11D49H **X;XK_&;PI\%_">K>(_%&H/!IVE11
M7%XMI ]S-%%))Y:2&*,%@A<$;B,9!YXKM+:YCN[>*>)MT<J!U.,9!&10!+11
MG-% !129 KD?#_Q5T#Q/\0_%7@JPDN6UWPS#:3ZBDML\<:+<B1HMCL 'R(V)
M*Y Z9SD  Z^BBB@ HHS5'5-;LM'$8NIU26;?Y$ .99V5&=EC0?,[;58[5!.
M: +U%<;\(?BKH?QL^'NE>-/#?VK^QM2\X0"]@,,P,4SPN&0\J0\;"NRS0 45
MR_C?XA:?X$F\/17UGJ=VVMZI%I-O_9MD]R(I9 Q#RE0?+C 4Y=N!Q6]8ZI9Z
MD]U':W<%R]K*8+A89 YADVABCX/RMM93@\X8'O0!:HHJOJ&HVNDVCW5[<Q6E
MLA :69PB@D@ 9/J2 /4D4 6**,\44 %%&1ZT9H **,TC-@$T +17+?#3X@6O
MQ.\'VGB*STS5=(M[F26-;36K,VMTOER-&2T9)(!*$@]P0>];5]KVG:9?:=97
M=[!;7>HRM#9P2R!7N)%C:1E0'EB$1V('92>U %^BBC- !129I: "BC-&: "B
MN/\ "GQ4T/QCXZ\9>$M/%V-6\)R6L6I"> QQ[KB(RQ^63]\;1G.,<C&:[#-
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M0<J&\N3!/78V.AJ_0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"1WH _./X+?&SQC-:_ KQ#K7Q9U_5;OX@^%?$]KJ-G=7<'V:TFL(F:UECC5
M$E^4YD?<SL!DG)%+\(]?\8_$#_A24.N?'CQCIZ_$+PIJUQK9CU2"$P-9L@@%
MN?+S QW,7D7]Z_EME_3]$?\ A5W@WR((1X3T,0P*ZQ1_V;#MC#_?"C;P&R<X
MZ]ZRM=\+_#7PNFF'6=*\*Z2DLPTZP-];6T(>64MB"+<!EG+-\B\MD\')H ^/
MOA#\:->^(.L?LI_;O'.HS1>+_#_B&RUB :@(5N[BUC\J*<["&,I8N0<DY0$
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M-$\/:5X9LS::/IMGI5JSF0P64"0H6( +;5 &>!S[5'K?AG1_$R0IK&DV6JI
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MREWAFO596LX76-@\ZY91T!SBO?-%T#3/#EBMGI.GVNEV:DLMO9P+#&">I"J
M,FEUG1--\0V366JV%KJ5FY!:WO(5EC)'3*L"* /S6^&G[1,XU#X,3:S\5VD\
M/)XM\4:%KMXOB*Y>V^Q[)&L%GN)7#-_>AFDVR%=N#E3B'X0>/M"\6>)?V8O%
M7BKX@7UY';W_ (PTV?5[_P 1W"$NEP#803.90?,>.6,!6^:1#&I#+M%?HQK/
MA_PCI6A7TVK:;HMGHL#MJ-W)>00I;QLHW-/(6&T$ 9+GICK67X(U3X=?%'0+
M?5/"DWASQ/HUO>/+%<Z9Y%S##=#EF!7(63YLD\-\V>] 'YQ_L^>/-7^&FF_
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M3]3^ VFSZK?3:?IEGXKT.:ZN(KV6U6.%KZ*.1G=& "JLA;+G"D!@0RJ:]?\
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M[4-8^+#:W\:O%NE>*M!\'>'M4\+Z<NIRZ:^HZI+8%W==/#%B[S! ;==P4W#
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MU?[H]!P.*GH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ KXJ^*'[3WQ&\-?M)G0-(N+6[\+0>+]!\-&VM;)'MHTO$!G%U=
M.0XN26RD<(*HJ@OG.#]JUXQXT_8Y^#_Q"\4ZGXCU_P &07^M:E-%<75U]KN(
MRTL>S9(JI(%1\1H"R@$@$$D$Y /#O#O[3_Q)O_ [_&AM3T"X\"*/$ O/!4Z"
MWOK4V<4S6<,4N"TL[BW,D@. J.64$"J^N_M+?%7X8?!]_B#J_B;P?XFT[Q)X
M?TS4=$1(?*DTZ\N;B&*<O&C#S+.#[3$#(7W;RBDC=7T)HO[)_P )/#GQ#OO&
M^G^";"#Q)>M.\]P7E>)FF0I,WD,YB#.I96(0$AF_O'-'PU^QG\%_"6A^)-'T
MKP%IT&G>(K=K34H7DEE\V!GWF)"[DQ)OPP6,J 54CE00 >#^/_VCOBO\(O$O
MB?P7J.NZ9K^H:'J7ARY@U_\ LE81>V&HW0MIH)8EDVQ2(^XJRYRHY'>CXG_M
M2_%#PQXZ\::%H>J>'YUTKXA:%X9L?M>F,PD@U" R&-V2?@QL=I8<D)T0D@?1
M4G[*_P ,;CP1X@\)7/ALW^C:^83J(U"_N;JXF,040G[1+(TJ^6%79AQMQQC)
MK%C_ &)?@S")A%X1EA,U];:E*\6L7Z-)=6X(AF9A/DNN2=Q.2QW'+<T ?-WC
M/XF_%;7M/\-Z#J'CZU@UK1?C1;>$+O4;+24AAU"$PI=6[R1;^-IZQJP#9 )^
M7)Z70?VF_B=J7Q]TSP];ZEI^H>&M;\3:WX;M;M-)!T^V^RV\C6SK+O26>4/'
MNF5?W7)19 WW?>-4_8_^$^M:3K6FWWAF6[M-8UB+7[U9]4O)&DOX\[;A7:8L
MCX8J2A&5.#P!C/7]B#X,Q:[_ &Q!X3EL[]=0?5(Y+35KV 0W#!MS1*DP$0)8
MDA  3CC@8 /GWX5?M&?&GQ9IWP\FU_Q/H/V3XAZ#XB-J^FZ-LN-)N=.5PMP"
MTA68L=IV$!1C&#R3Q/A+]H+XN?#K]DSX6:S;>()I]+O]'O\ 4+[Q0^D?VG+I
M\J2A8$NX_,+_ &8GS0UPJE@60!?EVM]I>'OV4OAEX4G\(3:5H%S:OX1-P=#'
M]KWKK9"=BTX56F(8.2=P8$$<$8XKG8_V%?@O9Z;!IUEX9O-+L8XY[=[>QUR_
MA2>"<()H)=L_SQ,(TS&?EXX H ]OT'4HM9T6POX+B*[@NK>.>.X@.8Y%90P9
M?8@Y'L:^&/BU^V-\3?A;KGQ2T.ZFTF;7_"GB"UN[/2[?3&EDO/#DD<DLLX_>
M<&./9OD/RJR[3RXQ]VZ;86VDV%M8V<*6]I;1+###&N%C11A5 [   5SVK?"[
MPKKOB2\U_4="L[W6+S27T*XNYX]S26#,6:W.>-A+$D8YS0!\6?$/QOXS^+WQ
MA^!_BSP==Z$LU_XJ\16?A#4[^Q=XDTY-->*6>4+*/.#-'<21X*@CR^H)%=9\
M-?VD_BE\7CX"\$VVJ^&O#/C?4-%UC5=3UEM.DNK6X>QU*6P2*"$RKC>T?F.Q
M8X&=JC(Q]$/^SMX!W> 6719+?_A!%5/#HMK^YA6Q 4)]U) ),JH5O,#;@6!R
M&8' _P"&/OA9'H.AZ39Z'>Z;#H=Q<W.F75CK5]%>6;W!S<".Y$WFA9,DLF[:
M22<9.: -/]F#XM:E\;/@GH'BO6K*#3]:F:YL[^"T8F'[1;W$EO*T>23L9HBP
M!)P#C)ZUX/\ MG_M4>/O@QXDUJV\%2Z?/!H'AR'6[JU_LI[YS))=&(?:I/,C
M2WAV+\NTM(S$_+M&:^LO!?@O1?AYX6TWPYX=T^+2M$TZ$06MG #MC0<]R222
M22222223DUYW\4/V2_A;\9?$=SKOB[PU_:>HW5@--N72]N($GA5MR!TCD569
M"258C*YX/ P >#?%7]J?XE> ]"^/ES;W>BR3^ ]6\/?V:6TUV$EIJ1AW12 2
MC+()UPXQG8>/FXYKX[_$;Q5\9!I>LI>Z58^#O#7QGTSPU'HOV R7TCVU['$]
MP]SYF$+2%B(UC'[LKELDY]_\0_L*_!KQ3>W-UJ7AJ[GEN;*TL;@+K-[&)X[8
M*(3(%F&]U50N]LL1GGDU-K?[#WP8\1Z]J>K:CX4DGNM2EBN+E%U6\CB>>/&V
M?8DP E^49D^\><DY.0#YQ\8>+/'NI:5XIM_#U_HG@J]C^.MIX>N[O0M#6-;V
M*1K-X+F[^?<[AWC+G</,PJ$A>#]^Z?'/%9P174ZW-PD:K+,J; [8Y8+D[03D
MXR<5Y#J'[(7PQU31/&.DW.CWTEGXMU2+6M5!UB\+27D;ATFC)ES$P(',>W(5
M0<A5 ];TG2;70]+M-.LH_)L[2%+>"+);9&BA5&223@ =3F@#\X]1E\?^+?#_
M (SU#5=?L?$?B+0/CYI^GZ+_ &I9%(K>:*XLXHBNV3*0LCQ@Q*0<;CN+,37?
M2?M<_%JUU#_A7#Z9I>I_$(^,K[PXNMZ1:1K;/;VUE%>;TM[F[A3SG$RHJ-.!
MA7/)4!O?]?\ V./A3XEUS5]6O= NQ>ZKJ\&O7;6VL7MNKWT7W)PD<RJK=R5
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M!\3+'PDVAKHJB;4[6Z>#_EL[,5V(^1LY;=(2V%45]+^)_P!C7X.>,+L7&I^
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M@CQ996OARTN?!]QJ5M)I"/'XB%Q8PQDK(V#"O+L=HW?.,D8KVC2?VE?&]_\
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MO#5YJFT7<UA $:4*20OLH)/RC ]N!7H- !1110 4444 %%%% !1110 4444
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M])\3? #P[XO^!][\+-5O=7N] O;3[+<7DEZ7OY3O$AD:9@<N7&X\;><;=O%
M'@W@+]N[5/%-MJ1;PMH^K'3/%&@:!=WFCZO-]F:'5&6-9X#);YE,<C8*_*KC
MYE?&,N^)'[5GCZ37XM&\/>']'TF;3?BAIW@J^EGU5Y?MD4R1SH4)M?W0D5BC
M_*Q09V[B05ZR7]A+PO<VOBE;KQIXQOKOQ#'IC7-W/>6^Z*YL&5K6YC58 @=/
M+1=I4IM!&WG-$G["_A^ZL]<^T>//&L^J:MXALO%+:J]Y;>?;ZE;)L6>(" *I
M8'!7:5&%"A0HH \U^&'QKU;X'>-_%^A'P;=:OX/U;XM/X?\ [>?6-TMI<WJP
M>6BPR(6DC1B,MO& X !(('9V_P"VIJT__"*^*#X*@3X9>*/$DOA32]4.IL=0
M^UB62&*>>W$16.&26&1,!V=0 Y'(6MZY_8HTRX6^0?$'Q8%N_&5OXY)<V3NE
M_" $ 9K<Y3Y8S@Y_U:^K9U-(_8W\*:)<6EO!KFO'PWI^O2>)M,\-22P-8V&H
M,782QDP^:51Y&=8WD9 W52.* /%M=_:4\1_&/X+6?B;Q1\*1IOA&3Q3IVFQR
M6GBYHY3<+JK6KM^ZC5V1)%C&T[=^6/RC%:?B7]L#XC_#:7XU>(+_ ,(:1XF\
M)>#_ !;;Z*HBUE[233[1X(/WSJ+.0R+NE1W.XL#*P *H"?0H/V*=-M?@E;_#
M*/Q]XG&DV^OCQ##?NEBUTDHN/M(CR;?:5^T9ER5W9)7.WY:C^*WP-\0^'CX_
MU;P-I;^/+WXBO#9:UX?\0:K'::7:)]D%N]ZJB(N[;880R;LXSMQTH ]8^&WQ
M&O?B%JWC!?['ALM&T;4_[,L=2BO?._M%EB1IW">6OEJDCF+[S99'Z8&?!=&_
M;=UG4OCW+\-G\$:>MU<W&L6=A;IK3F^CEL4D=&NT^S^7$EPJ;DV2.RJ0Q!!%
M?0OPB^&VF_"#X9^'/!NDY-EH]DEJ)6'S3.!F25O]IW+.?=C7A\'[!?A_3M<T
MG5-.\>^,K&?1]3U+5-+59K25+-[X,+A5\RW8N#N/S.6?'&X4 <]X/_;PUBXT
M?2?%/C7X=Q>$O!>L>%-3\3:?<V^MK?7<GV'RC-&T?E1A=XF4)SDG&<;B%=\(
M-=\9^(_VVCJWBW1;/PV-5^&HO[73K'59;Y$C-_"%\PO&BI,HPK",%>AW'-=+
M#^P;X4DTKP1HVI^*/$&M>'_"FB7^@6NE7GV41S6UY&8Y][)"K[BNP!E8%?+4
MCG.>E^%O[*=M\,?'VD>+&^(GC+Q1?:7HTF@6\&N7%M)$;$NKK$VR!&8JR@AB
MVXX&20,4 8GQ1_:G\4^ OC3J_@C3OAQ%KNF:/H<'B:_UO^WD@:+33*R7$H@,
M)+/'L<A Y+XXQD"N&TC_ (*":K?>%_$NO7'PCUR*PTSPW_PD5M/"+P0R N@%
MO-)-91*CA)!(S1&9-JMM9\<^TZG^S5H^M?&;Q%\0+_7-4NO[?T$^&[[076#[
M%)9%3E,B/S02Q9L[\Y;'W<"N2\)?L96_@GPS/H.F?%3XB+80VXM-'635HV_L
M>(312!8!Y6&&(5CQ)O'EEE  8T <)8?MT>+=5C\%1:/\/O#_ (JN/%>N7>BV
M%UHGBW-FYCLXKF-R[VH=/]:R.KHKH8'^0EE6MCP1^VCXC^)-]I_A'P_\.H!\
M3DN=4MM9T?4]:,%CIOV!XTE;[2D#F7>\T00+'_&26  +<7XX_8MU_P +_%/X
M97WP[N-:$<?BB\\0^)/%$,FFPR6\D\"VX:*U9%BQM!W*L)RI;JQ%>P_\,9>'
M-/U71?$6@^)_$/AWQQI]S>W<_BFT:V>[U%[OFX%S')"T+AF"D 1@+L7;@"@#
MS#_AO/QGXM7PO!X*^$R7]UK6@W^KR-J6O"!;":QG>"\@D7R26".@ 8$%O,3Y
M1SC<O?VY9IM;\!Z;I?A:S\WQ7H6G:W;C5]8-IYWVF39)!;N86CEEA'SE69"P
M("C)KKM&_8J\-^&=3\/W6B^)]?T^+1M!U#0H[8?9I%F%Z[RW-Q(6A+&9I763
M((7**,8R#3F_88\,7WA'1?"FH>*O$6H^&=+M;2UBTVY:W*_Z/,TD<BN(M\;G
M=L9HRNY0 <]: /G7XB^*;V714U#PKX0O+'7-)_:+@M9],_X29Y5U*=HTD+>8
MXVQ1SEHE\H K'NSS\V?3?$7[0-Q\2[WPCH?C3X83Z7XC\/\ Q,TK1]2MK7Q"
M_E:9<R1^=:W:R1(OVB-D8YC;:N2N=V0*]*D_8QT>6QU^$^-?$B7&I^,H?'4%
MTBV8>PU.+&UHP8"K)M2-2D@880=RQ-O6_P!D+2M7%M=1^,O$=GKI\2VWBO4-
M9C^R&?4KVWC6.#S5,!C$:*H"QHBCUR>: /G.'Q#)X;C^*$NIZ3?^)]&3X[V=
ME")/$-S;/:,YM0'4C<9$5I$S%E5(;GA0*[:]_:[^*'@&#XP>(M;\&Z)XD\+^
M$O&4>AO]BUJ2VETZT:&W_>E/L;&5%,JNS%@V9& 4*@)]&U?]BS3=4M/$]L/'
MOB>UAU[QC%XVE6-;)A#>QD%4CW6Y_=Y2'@Y)\E>>6W4OB+\ ]?\ !W_">WO@
M'3YO&[?$:Z,&M^']?U:*UTRR6:W6&:]51#OD;$4>4W]"VP#I0!Z_\./B%?\
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M+CD]O^U;\2O'/PZG^%$7@R/39$\0^-+'1;];Z9HG>-P\@C5@CA%81.'?!8#
M56W'&7#^PYX<@\=:KXFB\=^.H&UQ;?\ M_3K?5UBMM9>(* ]P%C#995VMY;)
MD%@,9.?3OC/\%M+^-NBZ'8:EJNJZ+-HNL6^MV-_HLZ17$-S$'52"R,,;9''3
MOGJ* /DOX&_&/7?@CX]\9^'4\+'5O ^L_&2Z\-1:S-K#&XL[BYCB,<:PM&Q:
M) @YW_Q@8&"3ZG\%/VPO$'QF^(.A6ME\-=8B\#:\U\MKXB6TO EDMN'V/<R/
M;K;D3>60HAE?:Q"L<]=^']B[PY%"Z'Q?XLD9O&J^/?,>XM2_]IA0H.?L_,>
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M?Z>^&_P;TCX7:QXLU#2=1UB=?$>HRZI/97U\TUM;3R.SRF"/@)O=V8]2>!G
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M***0'G!ZT +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>exhibit99-1xu004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit99-1xu004.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@!&SCCK2T44 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%(!BEH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBD)
MQ0 M)D9QGFOD&;]L7Q?<_$_XJ^$+71O"]DW@V\M+&TEU"]N-VJ3W4A2WB553
MY6)P"1D#.>F<5[K]LKQ=J7Q-UOP+8Z3X8\.>)M&T:SOSHWB6[FBFU:ZFMUF>
MVM77"@IN"<AB2> ,&@#[&# ]Z6OCGQE^U9\4=)^-7PR^'EAX7\/VFH^,M"@U
M5DU?[2KV4QCE::!RA_A:(J/E[\UZ9^S+^T^/CS>^,_#^JZ)_PC7C+P??FPU7
M3DG\^(D,Z"2)RJDH6C?&0#P/6@#WD,#T.:-P]:^'_C!^VG\2?AQ\7OB5X2M=
M"\)W=AX/TE=>6:\EGBDNK8^2?*R&(63]Z0.""5&!S4DG[>'B76?'7P-TW2=
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@&E7EMI.&KU?]D/]GCQ=\.?'/Q.^)'C@V]GXB\=WWVG^Q[283+8PK)(R(T@
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M(WEOAAQ\M 'I5%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MIH>G(T=M!/<R7#(I8MC?(S,1EC@$\# &  *ZB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME[\&/ 7A3P5K?PR\6>'!K_C#6+&S::PBCM[%'GEN8#)A_E1HVVJ54C,;X^4
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M/XB6/A;Q%\*O$.H03?"21M*\.1:?-K>IVD_V^Y6U\UXE;RIA$R('<B.)L+O
M536WK'PT^)_ANTU^'5O".K>,+V/X,:1X=FB>UD:*XO4N0\\(FC(\UHED=CAP
M9,$9H _0BW\?>&[O1+G68=>TV72+;<9[]+N-H(@O+%I =J@=\GBF6GQ$\+7W
MAV'Q!;^)-(FT&8E8]4COXFM78,5(64-M)RI& >H([5^;&G>!?'^FP^,7M?AS
MXKUGPT/%&A>(+[2-0T>&Q&K64<(6XB6VCQ&<2!6\H \*N[)!-:WCSP/JGAN_
M\%>(M+^"'C.+X0R:CJXF\'Z-#]JU*WFNXXLWWV-MXBW$7$:QC"(@R#&9<$ _
M2RUO(+ZUBN;::.XMYD$D<T3!D=2,A@1P01W%?/7B/]L[P[%K?@^+PO#:>)]$
MU?Q6_A34-5COUC%A*J,WFJ@5O,C.R3YB4&(V()&#7>?LU^&H?"'P-\*Z1:^'
M=2\)V=K;.+;1=8NOM-W:1&5VC65_[^TJ2O.S.W)VY/PY%\.-?U'Q(/!=Q\*M
M=BTRS^-USKFHW<V@!M-O-'>6<Q%) #O15D&0!M ?C/S  'Z,-XTT./28M3?5
M[!-.E.([LW48A<\]'W;3T/>M2&YCN8DDA=9(V 974Y# ]"#WK\O(?A=XETFY
MTJ75_AIXTO\ X;6>M>);5="T>S"3VL=U,LEM/'!(/]6T99 0!L^897(#?H'^
MSYX=_P"$3^#GAC2$TB_T""TM D.F:I=FZNK:/<Q1)).[!2N1T7[HZ4 7/ WQ
M!NM7TBZN_$T>BZ'*-3NK.T6RUA+N.XAC8['W[5VR%5):/DKM.3Z:VL^/]"TK
MPDWB+^V](&EO&3;WUSJ$<-I,_.U?/)*@$C&>>_!Q7YQV/P7O=4TGX>:%KGPL
MUDZ-:?&'5;V>S?PS=/$FB3_,CR!8\)"VZ)2O Q'@CY2!K?"SP=K/@Z[\*2:W
M\*/$^J_#?1O%GBR-_"X\-33FVCN_+.GRI;2H-\(C\^/>N0ID;.-QH ^T?@E^
MT!IGQ0^"7A?X@ZZ+'P>NMK*!9W>H(R1NDLD9196";_\ 5D]!Q]*]#O?%VAZ=
M=FUN]8L+:Y7R\PS72(X\PD1Y!.?F*L%]=IQTK\LO"OPQ\3:;X.^%UUXZ^#WQ
M'UCP.GA?4_"UUH.A:<6U33KJ349K@R_9V.1#-"T49D(0_N_O 8#V/%'PR\-/
M\6/B!X7UGX6ZMK7B"?X5:;;Z1I-G8S:O<V&HF+RX?,N5C(CD3$:?:)-J@1L-
MV." ?J1=>)]'L=5M]+N=5LK?4[@9ALI;A%FE'/*H3ENAZ#M4$'C;P]=:O'I4
M.NZ;+JDID"627D9F<QG$F$#;CM[\<=Z_.JV^"GB+1?BG-X?\>_##QQXRUZ^N
M-"OM#\4Z)=9TR":WL8+=S=WF-UNL,D<S9!+.&/RY*EI/"'@/4/!]OX9UK2?A
M3KMAXME^,M[=/>KX7O%>UT>0S*LCL(@RVP6:,C^'Y2<<&@#[$\6_M'V.@_M!
M_#SX8:<NDZS/XF;44OIH-63[5I3VULTZA[95)(?8RY++@@]:]'E^(/A>%=1:
M3Q'I*#3E+WI:^B'V4 X)E^;Y #QEL<U^<WA#P=XQCU_X)Z2OPA\5:%X[T"7Q
M%IWB#Q7%I'^CR7%[:3PQWIO>/-1I91*6W<8;&3M!YG1_@A=:K\$/%MC)\%?B
M/I/Q"TWP9<Z+J-_J$<DEG>7"2(T*6,2*3=^9,HD+;=L8!(8G:: /T7\?_M%?
M#SX;^"?$?BG5?%.FRZ;H "WJ65U'/,DS#,<&Q6)\U_X5.">O0$UWFE:O9ZYI
MEMJ-A<)=65S&LL,T1RKJ1D$&OS4\=? C5IM'^,'ACP5\*]4TFSUCX:>'Y;=8
MM%EMH+O4+67SIH\[=KW7EOC&=Y9"IRW7]#_!E\;GX>:7=V'AZXT)FL$D@T.[
MC6WE@.S*Q,H)"'H,=N^#D4 3Z)\1?"GB;4M0T[1_$VCZKJ&G9^VVEC?Q32VN
M#@^8BL2G((^8#D57TSXJ>#-;T74]8T[Q;H5_I.F9^W7]KJ4,D%K@9/FR*Q5,
M#GYB*_*S2/@M\3_$M@+'0?ASXT\,ZMJG@S6='D2[T@:=86LGVR*=;-)=QD9'
MB211-<NS2M, &P"$]Q\2>&_$?C+PB/%GA3]GC6O"BZ7KGA^_\0^'[O;;W/B*
M&Q$H>WAM0Y1XX@864E09"!P2E 'W(_Q0\'1^%(_%#^*]$3PS(<)K+:C"+-CN
M*X$V[8?F!'7J"*L'Q_X9$"S_ /"1:5Y+V9U%9/MT6UK4 DS@[L&, $[_ +O'
M6OBR7PW??\+#^&GQ!/P2UC2_A>-4UJ2]\+3::UYJ-I<7D$ 74IK!/,*LTR7"
M;$!"1X?"F0J.2\#_  K\=?#/Q%\-O$UQ\-]<U+PNW_"56?\ 8%M;I<7=IIU_
M('T^TFC=AY2A1RI;";B#@EA0!]ZS?%;P;;6,-[+XJT6.RGA%Q%<MJ$/ER1%@
MH=6W8*EB ".,FL2#]H+P)<_%'4/A_'X@LCXBT_2QJ]U&;B,)%"><$EOO!!YA
M&.$PQP"*_/'P)^S_ *O>Z!HUGXC^$FM//IGPHU+2HUO]),F-6\^9X=IY&\JX
M*GJN['!XKJKGPIX[MM,UVXM/@YK_ (CNO$'PALM $5W8^3&+VW:=)X[EO,24
M,5"[0F6D^3& 0: /OS3/BYX&UK2O[3T_QEX?O]-^U)9?;+;5()(?M#XV0[U<
MC><C"YR<CBN6\<?M1?#+P%H^BZG>^+M+O+36-:@T&S?3[R*=7NI)$1@65MJK
M$'#R$D;5'J5!_/O6/A5XINM(\:Z7?_"+Q[JUKJNN^%=3MY]0T.VC>>&U)2\4
MPVBF*'Y&F5549V$;VR0K=?X^^$?B"U\0>*5\,?"[6T\+Z+\7O#WBBUTBST9H
MH[O3H;5;>Z^RQD!&S(BDC@;2&)P#@ _0BU^)/A*^\4OX9MO%&C7'B-%+MH\6
MH0M=JH&XDPAMX&"#G'2NC/%? W@SPMXS\%_M.ZMXSTCP)XJG\,QWWB75=2T7
M6-.1WMIRK;)],O!@R_;&6,"WR0I/<*KC[E\+:S)XC\,Z3JLVGW6DRWUI#=/I
M]\FRXMBZ!C%(O9USM([$&@#S*3X[7]M^T9J_PWNM"L;'1-+\-Q^)KCQ)<:KM
MVV[R/$ 83%A2)(Y,DR8"KNSD[:]!\._$/PMXPO)[30?$FD:W=6\4<\T.G7\5
MP\<<@W1NRHQ(5@003P0>*^6_C+H&L:G^T3\4YW\$^(-8T+5OA:?#EO>6VFM+
M;SWHEN)O)5AW*W"8;IN##((KE_V3?AMJ'P]^+_PGGC^'6J>&;<?"P:1KNH?V
M)]EC;5A<0R,+AP!E\02G>V<[TY.[@ ^IO'/Q^\%_#_XB^%/ NK:W:6WBGQ,[
MK86,LR(0 DC*\A)&U7>/REP"6=@ #SCF_P!G']I/3/C7X2TN75KC1=!\9W<N
MH!O#5MJ:SSK';7DMN9%5@KLA\K.[8!R:Y3]H3P?KG_#4'[/7CK3O#.I>(](T
M6?5]/U,Z7;QR/:?:[>..&:0NZXC5@Q8\X . 6V@_,'@;X+>,;!O@E>:5\-=<
M\,^)XO%7B236=;;2UBFMX;OS1:S3R*=QC"SQCD\"-P.@R ?HGHWQ$\*^(M?O
MM"TKQ-H^IZU8Y-WIMG?Q2W%O@A3YD:L67!(!R!R:M:_XOT+PH;8:UK.GZ0;I
MF2#[==1P>:54LP3>1N(4$G'0#-?$G['/PMUGP_XV\$6OBGX0>(M \6^#=,NM
M/O/%NHZL[Z8\;;U(M$5]LK2LRN05*KER#G;7=?MVPZ*GB[X 7.N>&)/%MDGC
M(Q2:9;V(O)9D:UER!$?O@,L;E>_EC@D"@#Z(N?C)X"LM-L]1N/&WAV"PO4DE
MMKJ75K=8IT0D2,CE\,%P<D$XP<U9A^*'@ZX\36_AR+Q7HDOB&XB$T.DIJ,)N
MY(RN\.L0;<05^;('3GI7P=X9_9REO?B_X N=7^$-W)X!NO&'B;43I5WI<4D&
MFV%S;P6]JL\3'$:-+"TPC ^0-G&:T-#^!_BZRTG_ (0)_ -]%XSTWXI1^(K'
MQC!;"&SDTP7'F_:?M2'"XMRT'D?>&54+P=H!]QVGQ+\)7_BN[\,6WB?2+CQ)
M9H9;G2(KZ)KN%  2SQ!MR@;AR1W%4K3XS^ +_2-6U6T\;^'+O3-(4/J-Y;ZM
M!)%9@D@&5E<A,D$#=C.*^&_"?P>^(.M^ M;^&=[\)9M.^(&BVWB46GQ(N[GR
M[:Y6_$Q!@G4YEEF:6%#O VHKDD,NVJVG_">7Q!X/O;O5/@#XWT'5[72]-\/Z
MKJ5OK$SW[M%>6TD<NF1;V1XX# \N2JYQ&H8*7( /MN^_:*^%VF>&+'Q'=_$+
MPS:Z!?2RPVFI3:K L%P\9(D6-RV&*D$'&<=Z] MKF*\MXIX)$F@E4/')&P97
M4C(((Z@CO7YG^)?A=\5-5\%V-M?>&/$LOBRV;Q!%I'B#2]#@$&L6MQ+&WV?5
MM/<F.(7;!BSE@5VJS Y8C[6^#/Q;G\1>*]?^'>J>%[GP]KWA#3M,>ZDBP^GS
MB> G_1W!)"J\<BA7P2%!&>< #_B)^T5X?\(>-[CP#8W=E=>/I-$N=6LM.O+E
M8(':,?NH7DY(>0[B%56;;&S$ 8R[X$?M!^'_ (N^!/#UY<:WH<'BVX\/V6MZ
MOH5G?(\NG+-"DA+QEMZ*"X&6'&1D\C/F_P <=!\3Z/\ M.^'?&&C^!]4\6:9
M-X*U70YI])\G=;7#2Q2H9#(Z  JC <Y); !KYDL?V7OB!)\/_ FB:+\.+S0?
M$$OPNU;P]JUZWD6T::@\N^))G5^6<P/AL'_7Q[B,G: ?HWX0^(OA3X@QW,GA
M;Q/HWB1+4JL[:1J$5T(BV=H?RV.W.#C/H:X3XT?'>7X<>*_!?@OP_H7_  D_
MCGQ?<2QZ;I\MU]EMHH85#W%Q<3!7,<:(<C:C%CP!UQY5^QGX)DT_Q%J_B2X^
M$OB'X=ZE/I-MIU]J'BC79[^YOI8V.(X4DE?;#&%.&(4G>H48!K>_:1\"^+]*
M^,_PK^,'A+1KCQ5'X5^VZ?K6@6;(+J>RND"F:W#D!GC8;BF06X QSD [[P[\
M2_%]AXYU[1_'GAK2_#OA_3]*CU2'Q19ZD\MC-F1EDCD:6*,1.@4,02?E8'/I
MK6/[0/PSU/P['K]IX^\.7&B27J::FH)JD)A:Z8X6 /NP9#V7KP?2O!?VD4^)
M/[2'P?U.S\,?#[4M'TRPNK'4UT[Q(\5M>:ZT%RDKVRVX=@D6U<YE92S  )CY
MCY9\:/@[XD^)^K>.O%]I\*=4?P]KVM>%$'AZ]M(A>7(LYC)>79@+[4'DO]GR
M3E@7SA3F@#[-TG]H'X9:[/I<&F_$#PS?S:I=R6%C';ZM [7-PF-\48#?,XW+
ME1S\R^HI)_V@OAE;:VFCS?$#PU%JKWDFGK9/JT E-S&%:2+:6SO4.N5ZC<*^
M*_%O[.WB*QU'XP:CH7PCGCO+_P"(&A:GX?GM(+19/L<#Q/<21,'!B3]U(2,#
MF51R=V+'COX':YKMK\098?@QJ,MSJ7Q<L-=CD,5IF?284A620#S<LK&.Z)0@
M9%R,]3@ ^L?$?QTT;5?"OA[6O 7C/P1J=OJ>O6VDI<ZEJP%M=;I LMO;O$6W
M7)!^1,'GJ,5QFJ?M^_!_28_$\LWB%6AT'7[?P[*R;<SSR,JM)&"03%&?,W2'
M"XA<J6^7/A&H_"WQ?I:^,;?3/A9KBV=M\:--\6V$%G!:HDNGQ&+S985\T#G[
M/(<?+GS4]6 G^*?P;^)J:5\9=-T?P)J6L-=?$/3/&FFW5M=V\:7\"O;;X8E:
M3*RIY3EBV <>N 0#[,7XS> W\66GA=?&.AGQ)>(DEOI/]H1?:I5=/,0K'NW'
M*#<,#D<]*?X?^+_@;Q9XHO?#>B^+]$U;Q!9*[7&EV=_%+<1!&"N616)&UB ?
M0G!KXLT?X'^/;OXO:Y9>(OA)?7\6K^-4\9Z5XLE\3R"ST4R;&)EM8IMCW%NH
M>-2H(9E49* $ZG[('P3\7^$?&/@>Q\7_  @FT36/ MI=V,GC>[\32W=K<PNC
MQJME:B4A3(2KME=J@2'"NZ@ 'V;K_P 0O#/A;7=&T76->T_2]7UIVCTVRN[E
M(Y;QE*AEB4G+D%E&!_>'K7+77[0?P\F\(IKVG>/?"\EA=S2V5CJ$^J1+9RW:
M1ES$9 <9 &Y@.0H)Q7+?M=?"[7_B!\.M/UCP5907GQ$\(:I;Z_X=CN2H26XB
M<;X7)91LDC+J02.=O((!'C'PM_9/\5_#/Q7XWTW4[>7Q5X,32YM;TY8Y(A<W
M^OWMFMM>%#(ZHA BFV[@@ NQEB%X /2F_:.\56FN^#-#:T\+ZQ<^(_!.I>(X
MM7TB[F>Q:ZMA&4$>Y=S6[B5"&SNZ^V?3_P!G[XC7GQ=^"?@GQKJ%K!8WVO:5
M!?SV]MGRXW= 2%W$G&>F2?K7RWX"^%/Q*L;;X&W5S\/=3B_X1CX::KX=U*)[
MVQ5X[YH8DACP;@9$AMOE89 \U-^SYMOT3^R5X9U[P3^SA\/_  [XGT:?0==T
MC2HK&ZL9YH961XQMR&B=U(. 1SGGD \4 >N4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1P!DT5XK^V;XB\2^$_V9?'FK>$
M9+Z#7+>TC*W&F?\ 'U;P&>-;F:+_ &D@,K@CD;>,'!H L>(OVE]'T+6_B/HU
MOX9\3ZSJ_@>QM-0NK'3=/$LM_'<%PGV1=V9"-C9R%'!QG!KURVE%S;Q3;6CW
MJ&V.,,N1G!'8U^4WC+QA\,=-T_\ :9NOAMXPO1I.H>"-$O\ 3]175;SSY[E;
MF5'"S2N)22\D2NA/WI&4K]X5W7C?QO;2?M4^']:TSQ%)XZ-[?^'K?3-,TW6Y
M(+[2YWL%E1EMBQBNM/G659)I!@H=Q)^4;P#]$[[PWI.IZKIVIWFFVEUJ6F^9
M]BNYH5>6U\Q0LAC8C*;E !QC(XK2R*_*[PIXTT?QO\#/$NKZ/XX^(%Q\88O!
M&K-XOTF.2\18-0A9ITN9V.T0,DR[(UB/*L$V[5D%:OB']H/2/'NJ?$F#P]\7
M?[)2\\$^&574KS4;L:?%>_;HHKHR;6'EJX>&&66/E1*Q/(>@#].MHIP&!7Y'
M>*?':W_PPM%CU@:5:V=QXG:Z\(7/C&:**]B585-UHVH(=MQY+%Q#%+O5OWB@
M$J:_5+P!<B]\">'+@17UN)M-MI/*U/'VI,Q*=LV/^6@Z-[YH W\TA SFOAG_
M (**_$@^&-?\/:)'KTVAW-QX9UNYMGN-3N;&R>?;$L;(+<&2>Z4Y$<1VH/,+
M$GA3\YZC\3[GXE6/B;6+[XM^)K.XTOX+6'B%([#Q'+:H^NPIY3!D##YC+@,B
MXW-+DY+ T ?IQ\:?C%HGP)\ 7GC'Q%;W\^C6<L,=PVG0"9XA)(L8=@2 $!89
M)/ K1^(WP\T+XO\ @+5?"GB*&>YT'5X1%<Q6]S);NZ;@V-\9# $@9&<$9!R"
M17YC?M(_%W0/BS\-?B[!XV\9WUEKL>D^'KGPGI46INEK>VDL-O)/-! KK%<.
M[M.'+;RFT8^Y7ZKZ+?6NIZ/8WEE,MQ9W$$<L,R,"KHR@JP(Z@@@T </XK^ W
MA'QI\'HOAAJUM>S^$([2WL?LRZA.DK0P[?+5I0P=L;%SDG..<UVFAZ-;^'M%
MT_2K5I6M;&WCMHC<3-+(410J[G8EF; &6)))Y-?%_P"V5X^TO2_CWI?AKXD>
M,O$'P]^'=[X0N9-"UW1)KJ"--<,Q4R2/;X+M'"%*QME/G.0"PSY+\4_B5K?V
M7XFP:_XY\8^'O&OA[PUX>N_A[!=WLNG76H[X83/*;:-MES/+<YCE1A(4W%!C
M:30!^G&T5YW8?!_PKX(^)/BOXHV=OJ;^)=8L5@U$K>SSI/%$ 45+<L4#*$PN
MT _,P'WCG\]_B'\0[C3=:^,GC?5OBIXATSQ'X-\1^&VMO#EEXD=+)9)UM3?P
MF+>0RAOM2;,E4$3 C@UU-Y\11=_M(>(-WQ$FUK2=4O/$@M-;T#Q3/;KHR0V$
ML1@O[(N0D$&%DCNX@HW!7R=P  /O'0_B?9:U\*H_'C:3K6G6#:<^I/IE[8,F
MHQHJEBA@&3YGRG"C.>,=:N_#/X@:7\5? 6A>+]%$ZZ3K-JEY:BZ0))Y;#C<H
M)P?QK\Y/!7QGM_%'@KX3:3\4?'6L:3X0NOAI>W=OJ,.M36ZZKK:S21-%-/&^
M^2:.*/*Q,W+L 5)(4\AH'Q2?4?AS\,/#VM_%V;X4>$6^'44FB:M#;WK0R:DM
MS-#>$-;7$.Z>,1^6L<GF( 3A06&X _7 @&LW7/#.E>)%LAJNG6VHI974=[;K
M<Q"013IG9(H/1E))!Z@\CFOB;]F[1;OXA_M4^-9M6^+/B^^G\)VV@W\&@2:H
MUO#=2SZ:?M9N+)F<QJ)9>85($;L%)/%?=9Z=: /./BC\>_"GPFL(+O59;J^1
MM:L] G32H?M#6=U<[#%YX!'E+B2-LMCATP"6 /H^017Y9?%.X\*>'="_:$\/
M7/B*?1M=F^+&E3"*;4Y?/BLVEL7%RBRLRY!$S"3!.(SU5,!/$/Q8\2_#;7?B
M#X#M?B3K,7@+2_B39V%_XAU*_NM1NM+M);1W*23131SK US&$8I(A4JR[@6(
M8 _1%/@EX:3XQ2?$_&H'Q8^G#2C*=0F^S_90=WE^1NV8W?-T^\2>O-=]7@W[
M&5W-<_"B\7_A8]Q\5=.BUBYCL/$<]I+"LD/R$Q1R2S2O/'&Y=!*6/W2O.W)Y
M7]O;QY;^#_"?@&VNM8N]&M]2\3PQ2RIJ<NF64R+#*QCO+N',L4.=K_NP68QA
M> 20 ?4>:,U^4GP]_:"M?$_P\^%VE_$SXDZ_I7@8V7B/3KGQ'IE_=I(NJI<,
M+(3S)B5O+M621%?.3)&7![=3XN^)^GW.IW6A>/OBI\0_!EO9^$]%F\!>)8[6
MZ@N-5=6WW5T;>([9YYB($"2Y.UR#ABU 'Z9<4@ %?FCXO^+'B'7YOBOK@\6>
M(=)^.7A?QS9V7A3P6^H/ MWIYDA6WMQIRN$F6>.29Y'*MTW;@@I/B!\=&^'5
MWJ'AVZ^(FIZ1KVF_'>'%C?ZY<>>GA]UB+;Q)(2UH?F^]E.3CKR ?IAFJ>F:S
M8:U#-+I]Y!>Q0SR6TCP2!PDL;E)$..C*RE2.H(-?F7\-_&7]D:QX"\92_&+Q
M#K4M[\7M1\+2:?>^)7FLSI3"X125W_-]ZV82$X_>QX_AKA_ /Q%TGPE\$/AQ
MX<'C#4-(O[GQAKZZS8W.MW=G9^8AD:$7<L3-/&VV19$BB7]\Y&_G!H _7C(J
MG)K-A%J\&E-=P+J4\$EU':&0>:\2,BO(%ZE5:2,$] 77UK\H_ 'Q.E^.UM\/
MM.U+XQ^(M*%I\,-7EUEM,\126K&\LYV:-I!DGS?+596)PS)%R=H8'9\/>.['
M6-9\,>/M6\=W6D^*-6^ ER(?$IO;F8_VG [).VQ&(>2.-7=T )#*9-N\!J /
MT5^,7QC\._ SPA_PD_BDWL>C+<QVTL]E:/<>1O) DD"C*QC'+=!QZTS2/@GX
M8T3XNZW\2[:.^_X2O6+*/3[N:2_F> P)MV*L);8N-@(('5F/\1S\R?L1_8OB
MGH?Q'\(^+(#XCCTO4-+DN9X?$$VMZ'>O]F1U:TGE8N58QB62!R0IE 88)4?:
MX! YH 4$&C([U\<_MG6WB+X?_$OP3XXT2?Q'J&EZ_:WO@F]T/2=2N(HVO;JW
ME&G3B-& 0^<2AE&&7,9!R #\Z:YJ?CVS_9=^(EUXQ\6>*M \2?":QN/"4>IP
M:_<VRZSJ4E\)%EP'!F MC;*A<$L)V./E5@ ?I-J7CU-,^(FC>$CHFL3MJ5C<
M7HUB"T+:?;^4R#RI9L_)(^\E1CD(?:K]EXT\/ZDFE/:ZUI]RNK,ZZ>8KE&^U
ME S.(L'YRH5B<9QM.>E?%,>@:)X1^.?@/P6?B;XE\;^'_%W@/6[EX=3\1M=O
M?-.8V26#:5!9XS<>6R\[8SM/RUX7\'%\-:7I?[)GB?2;VZF\00Z?X@TTP3W]
MTT)U9+=#:6H4OM0M++&IC4JC;B&!YH _6;([T9':OR L_B3J4OP@\6>(8OCC
MXFG\91^#KQ/$7AJ&UU&WDT^^#C$MU<7%XR0R"<K"GV=(]X95$84L*^I/V/M>
M_L/X^W?A9?B+K'C*UU?X>Z/XC*:UK7V\_;97?SFBR?E&QHFVCHKKVVX /MOC
MO4<\\<$3R2.L<:@LSL<!0.I)["DNG\NWE;YN%)^49/3L/6OR@^!7QN\.7'C*
M)/$/Q%N(M"U[P3K2:NFJ:Y>"YFO%N5>(W+;EC@NBA<A(<;4^7<VX$@'VA%^W
M-X7NF@6T\%^-+QM4>+_A'#!IT3+XB1S+B2T;S=N L$KE93&P0 E?F%>G_ WX
MR+\;?"=SK8\(>)_!1@NWM#I_BO3_ +'<L556\Q4W'*'?@'/56':OS]\!VOP[
ME^&W[%JSZ^+9IM7F:_$>O3QM%-]D9'4[91Y7[[R$(&T N5XWMF/6O%6G:S9>
M,]'U3XL:WX=D_P"%\_V7;W=OXEE6X3375(W7+.V8E5#AF!5"GU! /U*(!I>
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M'QEJGAC1_&7Q1^(>C^*-4TU]*^(7AA---OJ5S#;+9M! D[-!D"0F.&=7+AF
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MG2?$;6_A_K.HZG\$]#U#PEKEGJ%K>W-W;66H"_BCOEMY,LSH+0R-,N6VL0"
M<"@#],L#.:S=;\3:5X;^P#4[^WL3?W4=C:K-(%,\[G"1H/XF.#P.P)Z U^7?
MQ#^)7A/Q?\3/%$%AXWUO0_#FK?%;P_)#<6>I7=@3836)%W-#N(PAFPV]1P'1
MAA64FSCPO9:-::==ZC?Z_P"%?!WQ_ET6-[BXN+^:RT>:VSY+,NZ0QM=Q *QR
M2RC!.<D _4T 9S3)[B*VADEFD6**-2[R.P"JHY))/0"OR6\*_%W1K+X\V>L:
MCXFUW1;?4-4\56FLQ7IOX]1C62"18!>S*$AB17$?E)"N8OO,X/W;7PKT_3'T
MOX5PMK.NZ_-XZ^&&NKKEE?:I=W?VVZBA'DPQHSE4=?+<(H X7C.10!^JNAZ[
MI_B;1K'5M*NXK_3+Z!+FVNH6W)-$ZAE93W!!!J\#FOR+U_5M'M_A'\)9$#:T
M=.\#6IOO!5VMW8W<UVUYMDNM,D"E6O5GBV%&0J4!V[AN _6VQN#=V4$[0R6[
M2HKF&8 /&2,[6P2,CH<$T 3%@#BD&&-?F=_P4?U<-\6-;^Q'5K'Q3I7ABRN=
M$NGMKVX!G6\>0OIWV<!()1@"2:9\;5"JA(W"IXJ\+P?$[Q5^TQXR^'E_XJN?
M%.FP6&J>%4M+N^@9HKG3T74'AAD*DOF6<!<;D8*%"X H _3ZJNJ7C:=IMU=)
M;2WCPQ/(MO  9)2 2%7/<XP/<U\E?L'P:+/JOC#5O"OB7Q+KN@W]M8O-;:GI
M$^G6%C=A&5H8DN'=VF"A3(R'8=RG<VX;?I?XIK9/\-_%2:A/);6#:7=+/-"&
M+QH8FW,H7DD#H!S0!-\/?%-UXT\$Z+KU_H5_X8N]0MDN)='U10MU:$C_ %<@
M'1AZ=?4 \5T0.17Y<Z'X3\.?$+3?V>M(\47>MBQ_X5CJJ:M;I?7=L#+%M:))
M@CKCYTN" 2-_EJ#D!17VS^Q7XGN_%G[+7PVO=1N[J\U1-(BM;R2^+&?SHLQO
MYF[YMV4ZGDC![T =Y\7_ (H:5\&?ASK7C+6HKFXT_2XE=K>S56FF=W6..- Q
M +.[HHR0,MR14?PK\?ZA\0]"O[O5O".L>"M0L=0GT^73M91=TGED8FB="5EB
M8,-KJ<$A@,XR?&/^"C7]GR_LN:O:W<9GO;C5-,6QB2)I)6D%["9=@4$Y\@3Y
M_P!G=7RO\;_%UOI7[4L/B#2=.U*WT[0?%WAD1/'IMY<RC25MHQ*UJ\2B*"R/
MFKNB^=Y'?^$?*0#]/I9XX(GEE=8XT4LSN<!0.I)["J'A3Q3I/C?PYIVOZ%?Q
M:GH^HP+<VEY <I-&PRK+[$5^=?PRTJT^(4'BC2/$7A;QC<_'6*#Q3;^(B;21
M;"\AN8IA;^;)(N)( $M8X(D(*LP(4KN:OJC]@J?3W_9.^'D%C:36<MIIZVUY
M%/9RVS"[0D3Y$BJ6._=EQD$YP30!] T444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !5/6=6L]!TF]U34)A;V-E ]S<3,"1'&B
MEF8@<\ $\5<KB?C;JNHZ#\(/&^J:1/);:G8Z)>W5K+$%+++' [H0&5AU Z@_
M2@#=\'^+-(\>^%M*\1Z#=KJ&BZI;1WEG=HK*)HG4,K , 1D$<$ UF_$/XB>%
M/A#X;O?$_BS5+30-'B9!<7UQD#<Q"H. 2Q.0  ":^%6^*_Q(\4Z'I<NF_%*_
MT."'X/#Q9(EC!:-&]]"7!RQC)"DIA@.>PQTKD?VA/CQ?_&WX ?%J'6_$30+H
MNC>'KBR\.1F& :K]H6VGEN6W(7<;Y,!4("^7TYS0!^GEJ+::,7%N(V650PDC
MQAU/(.1U')/XT26EO(K))#&ZM@E64$'!R,_CS]:^$O"7QP\:^,/B'J%O#\2-
M%\%P^'/$EGI,7AJY<327VGM'$JF. 0EYC,TI*RJ_R[1P ,GSR/\ :>^,G@OX
M6> OB*GC6?QWJ.K:UK6E3^#6L;5/.@M?M6)PT4?F9C\E9&QCY64=.H!^ETFF
MVDL]O.]K"\UOD0R-&"T>1@[3VR/2K.,"ORPO/VD/BSX:_9Y\1^.;3X[Z)XEO
MKSPQ#JUOI]@T=W?V5T;^TCF=D^S*ENBBY,1B?)SC:3M)'?>*_C]\2?A#XY\8
M>!M6^*4T]A)XD\*6(\7:II]H)-(AU&WO)[MPH41*N;5$7>NU!)G!/S$ ^Y?!
M_P 0_"?Q*NM<AT#4K36I="OI-+U#R?F^S7*$;XCD=0<9QQD>U;L^AZ9<L[3:
M?:RL\8A8O"I+(""%.1R,@''3@5^=.D?$?5/@[XQ\<:%H/BVTBMO$GQ0:VO\
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M?>Y]#_X)UZ-&W[-^B:U<ZI<ZW?WE_JDCR7IA<VSF_F$BQLB!E#E%=@Q/S'/
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M&!Z5X+^T7KBZ-\8/@''-X7TK6XK[Q)<6D6I7TLBW&FSFSD97A"D [E20'=N
MPO&<$>6?#S]LWXCWVL^$+KQGX;\*V/A36M=UO0)Y]'NKJ2[AET]+AVF"NH4H
M?(*XSN.,X&[:H!]$6'P$^$OAS5=+-KX&\*Z=J$;W3V*IIL$;AIDQ<>6-O.Y,
MA@/X?:EE_9J^%<VBZ5H[_#WPVVEZ27-A9G3(O+M2S;V*#;QELD^IYKY$U[XR
MZ_J7Q,^!7QV\4:%I=EHDGA3Q5KUIIND[GOULH]/6XCBFF=@KNT8# *JA69@<
MYS762_MB_&G2?A;KWCS5?A?I%GH$7A2+Q'IU[-?JD;2LT;&WVK*[S*(90PE5
M4&X8(7/ !]D:IX>L-;T:XTF_M8KS3+B(P36LR;HY(R,%2.XQ7$K^SC\,DM]/
M@'@70?)TZ"6ULX_L$96WAEW>;&@Q\JMO;('7<:^=O%G[:GQ&^%VL7WAGQEX$
MT4^+-2M-,N_#<.A7\L]L_P!MNC;".X:1$):-^3LP&Q@%<[A9U3]J'XY:)J7A
MG1=3^&^BZ-JVO>*&T"SGU6X>*"6%X#)!<%8I)6C.8YMRDG(3"G.X@ ]]TO\
M9K^%FB07<-C\/_#=I%=VC6-PD6EPJ)8"P8QMA>5) .#Z"H+[]G7X/^-5MKR[
M\!>%-;6&S73(9WTV"8);QM@1*=IP%*XP.F"*\3\$?M7^,OB;-X9\ #P]X<7Q
MUJFH:]INL3W#ROI4$.FOY4K)$2)7,IDB 0D85F8Y'%>1_LX?'KQM\.?@-\-/
MAKX \(6?B#Q@^E:[K<UNV?)6.+5[J%(8U,D9PTF1O+'8H!VMG@ ^V_#_ , ?
MAOX4.O\ ]C>!] TM=?B,&JI::?'&E[&=V4E4##+\S<$8Y-:WP_\ A=X1^%.D
M2Z7X.\-Z9X9T^:4SRV^EVJ0))(0!O8*!DX &3Z5\?^+/VV/B[ITOCH67@GPI
MIS>#?#6G^)-3M-2U*:>8+*A,T$;09C9@RN%;<  !D,20/6_@=\0?'/C']IOX
MOZ;JVL6=SX2TNPT2;3=.2V:-[47-O), #O(+<L'8C+%4P$ VT >G^*_@%\.?
M'.LW&K^(/!.@ZSJMQ&(9;R^T^.:5T'W5+,"2!56U_9N^&%E8+90>!- BM1>I
MJ(A2PC""Y0$)-C'WP"0&ZC-><_M5_M(^(_@AJFFV'AO3]+U*ZN-$U35S!=1S
MW5Q,UJL;)"D$!WHC!I"UQ)B)!'R<E5;EM*_:K^(GQ/OD_P"%>>'O#;+HWA_0
M-?U^PUZ[>*6=-1B\]TMI0ZI&L,.6,D@8$_+M'4@'N"?LW_"^/QE#XL7P#X='
MB6&Y^V1ZI_9L7GI/DD2AL9W G(/4$ ]0#70^/_AAX2^*FE6^F>,/#FF^)M/M
MYUNHK;5+99XTE4$!P&!P0&89]S7@F@?M'_$#Q5J>K>+M*TKPY+\*]'\17^@Z
MA#-*T>K0Q6OR&[60R^4V^4%5@V;B"A#'=QSOA[]KOX@WVB?#+7-3T7PS!I?Q
M+L[YM%6RDN)I--NHXGFMH[HY'FJR(%<H$*L3V7) /6?CK^RUX6^+OA?QHMAI
M^E^'O&GB33/[,D\5)IR2W0B^0;';(9D*HJ$;AQCT%<+\"OV.!X'\27^L^+=-
M\!K#/I,^BG0_!_AYK*QNH)GB>1KH2R2><V8@JK@*H+=<\<Q-^VIXR7P/X3U^
M/PWHZRZY\--1\;FVF>9?*N+3RV,8.>8W23@8!R/O$&L/Q7^U=\6KCX;>-DN;
M;PUX;UF?X:K\0-"O])^T7)MK9G"-#,)MF9MIRK ;4)Y#XY /J";]FWX57'A0
M^&7^'?AH^'S<)=MIW]EPB%IEC,:RLH7EPA*ACR!QFO0;2R@L+2"UM84M[:!%
MCBBB7:J*!@* .@  &*^,/'_[6OQ$^&BZ-I]O;Z%KTFGZ)H>HZJZ6-S<2W/VR
MY$4N]XYMMALC*LKSA_-9OD4@-LO:G^UG\4=*\8^*I9O#OA1? _A?Q_9^$=0N
MC<7/VR2WNI+=$E1?NAHQ<*SDY#;L*!M+$ ^DM-^"'P\T?6+_ %6Q\#>';/4[
M^*6"[N[?2X(Y)XY?]:KD+\P?C<#][OFM/P/\.?"WPRTJ73/"7AW3/#6FR2F=
M[32K1+>-I" "Y5  3@ 9]A7QIHW[3'Q6\-^!_C!XG:>U\2QZ/\5;SPW-.=&N
M+J/0=-@CC62Y^SPSB22%%5#Y:'<&D=V9AG'U1^SW\2)_B[\'/#?BRYO](U*Y
MU*!GDNM"25+.1ED9#Y:RGS$'R\J_S Y!P10 OBSX=_"CQ;XR*>)?#GA'6?%-
M_:" PZK96T]W<6RMO"E9 6= T>X<$ IGM4FK?";X76,5_P#VEX.\)6Z:V(;&
M[^TZ7:I]NP5$,,A*_O,%4VJ<X*K@<"OBO1-;\3^'_'OQ)^)FOZ?X2\47.B?%
MNW\/V][>6<\5[9I(MI9 V\AG(6)8;HGRL/\ /O8\$%>O_:!^(=Y\1/%O]B:Q
MIFGK)X#^,'A6RTR^MT;S&CN#%*2VXG#;9=AVX!P>!TH ^P_!&A^%O#6D/HOA
M"RTC2M-T^9H7T_1HHHHK>7 +*4CP%;D$@C//O6+?? ?X>:EKUQK=WX+T&XU>
M>X2[DOI-.B:9IE.5D+%<E@>]>1_LCZ#9^'/BE^TA:6$$=M;MXY^T>5$NU0TM
ME;R.<>[.Q^IKG?VF_P!K+QM\'?B#JNG>'+'1-4TG1K;2[F\MFL;F]N66YNO*
ME\Z:&94L J%3&94<R$DJ" < 'T!!\"OA[;:TVL1^"M 356NOMQO1IT7FF?G]
M[NVYW<GGKS5:T_9S^%-@9#;?#/P?;O*DL<CPZ#:HSK*A24$B/)#J2K>H)!XK
MQG2OVEO'WB+6]=\5:79>&6^%F@>++WPSJ=M=L\&K+';H$^TQS/,(F:2X*JD'
ME;B'0;LL2O)R?M>_$[PS\'IOC!KFF>$-2\":QX=&HZ'9:?-);7EOJ$MVD-M9
MSM+*1,/+E#R2(J!3&X   + 'U%I/P5^'^A)HJ:=X'\.62Z)+)/I?D:5 AL))
M#F1X"%_=LQY)7!/>O-_VN?V?-9_:+T+P1H]A<:+%IVB>);;7KZWUJ&26.\2%
M746^U>J.)7#9[8]Z\N\1?M(_M!> /#.M7?BGX>Z9!%;:C9>3K>G6JWIBTR2.
M0W%U)IEOJ,LK")HNHG4%6+8&QA65>?MM^-5C^'U\LOA6T\-^(;2UD_X2632+
M^;3+VXDOI(9H%F64&Q9(8]X^T*X+%@2H4F@#ZF7X$_#<6&CV3> /##VNC2--
MIL4ND6[BSD9E9Y(LH=CLRJQ88)*@DDBM*;X4^";GQDGBZ7P?H,GBQ""FO/ID
M!OEPFP8G*[Q\OR]>G'2O+?VZO''B?X;?LL^./$OA'5ET76+"WBVW8A\R14DF
M2)O+.X;'Q)P^&QC@9P1Y/XB_:Q^)^A^&OB)KVE6OA76M*^%\EG:^(()[:XM[
MO5V9$DN9+8_:&6V"(X"B03;V1CD<"@#ZPL/AIX1TOQ9=^*+/PMHMKXFNQBXU
MF#3X4O)A@##S!=[< #D]JYM?A3\)[>^U;0(?"/A"UOM<A%UJ.G0:=:QS7\22
M ^9+&JAI%61@=S @,PYR:VO&WB&[7X5ZYKNB70T^[72)KZTN9[83>4PA+JS1
M;E#8X^7</K7YV^"?&/Q+O_'7P:\6:-?Z#K'C_4OA)?W3ZMXAMYL-$DZR OLD
M+22Y7:&)5?WA.WC:0#]!I/@9\/I[&QLI?!>@26=B7:U@;3(2D)<@N5&W W87
M/K@9JCX-^"6E>#_BSXN\?Q7#RZGX@M;2Q^SK!'##;00*=JC8H,C,S$EW). J
MC 6OE;1?VV/C'\4[*U_X5SX!TC4M3TSPUI&MZW;7<T$<$LEY'YKJDLU] UO$
ML:N0_EW'S8#!0 S?;-YJ-XWA2:_M+=7O_L;3Q6X;S%,FPLJ97[PS@9'7M0!S
MVKZ1\-].\?V_B+4[/PO:^-D@9(-5NXK9-26((P8+*P\P+M9@0#C!/8U?T3X8
M^"M%U74M:TGPGH-AJ>K(RWU_9:=#'->(QW,)9%4&0$\G<3FOD[]EOX$_#O\
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MS7>E^'-:\1WWPOUF'P_X5GLK#Q==I?P2R:1>RI$T\4<:Y-PMOYT8=QLYS\N
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M:A/"Y!.X*%/LO@_PIIG@7PGI'AS1K<6FDZ59Q6-I #G9%&@1!GN< <]ZV**
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MQZ_9:_X79XPT_P 0P^-=5\+W5MH]YH<D5K;P7,;V]SCS2BS*PBD( 7S%&[
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MOD32_P!N7Q+XDT[X81Z'\*7O]=\;W&L::MG-KJ00V=]I[.)4,IA(DC(C=MX
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M\4/CK\+;?^U_"K^%-;\,:KJES!H?FS17)AODA659&;*MY9A8(P#(7F5QG&T
M^PZ*\=_:/^,.L?"/2_"[:+%I;7&L:L+&6;4@\[11>5(Y,%I$PGNY245!'#EA
MNW$;5-7_ -F#XO7_ ,>/@7X7\<ZIIL6D:CJB3K<V4);9%+%<20.!N^8#,1.#
MR,XH ]3HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MR-(\SLS#RI2\DI#C<5W#&-O/U'9:'!IGAZ#1['-M:V]JMI  2QC14V+R3DX
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M'-E=W?AS7-.U^UM+AK2XFTR[CN$BF4*6B9D) <!E)4\@,/6@#Y3\(?LF>/\
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MM+\+WFG.+N#PY);0I"UF\\SEHHXW"R^8,[O+W<GBM3XU_"KXCV6D?%GPG9>
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M7Q->_#G6O#$ME%IT'V:SOIG$L"Q .9'B#@GS9&9RS9 XKT[X7_LR:1-\1(]
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M?%_A/X]7&N:CX4.B^'9? .CZ+]I%W;-_IML29(S'&Y;@2E0V,?NC@X*Y\O\
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MYX<M/#MYH^FWVFPK_P )#:W%K'-<226AS+<RSEBH6%OW1V8W9);(\+_$[6O
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MQ0!\:? WXJ7OQ2^*7PY\5:S\2)-/U2]^$U] ;XWT'DG45OUAP(V^03$+%*R
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MH1CE0>@Z"N?^(OC?P3X*T>P7Q9-:1Z=>:G:Z/!#+;&X0W<Q AB**K;<Y!R0
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M$S%'".(U!(.S)5=H<@_HOX4\2:-XNTO2=?TX>6-8L8[RW^TP&"YDMR PW1N
MXV^:,@CY2_.,UIVG]GZI''J-M]FNDN(5,=W%M<2Q'YEPXZKSD<XYS0!^7_CW
MXM:O\*?BS\1O!,'Q*U^Z^&=KK_AR74]?U"_N]4GLK6ZL9YII#)!*DL<+SBW#
M>2T> 54$;L-]L_L:S)/\' UMX^O_ (F:5_:5S]@\17]I+#YT)()2-I9)))8T
MD,B+(S9^4KSMR?</(B.[]VO/7CK3D01C"@ =@!C% #J*** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KRW]J'XA3?"K]G_ ,=>
M*;753H=[I^FNUKJ"VHN3#.Q"1$1'ACO=1\WR\Y/ ->I5F^(O#6D>,-%NM'UW
M2[/6M)NUV7%AJ%ND\$RY!PZ."K#(!Y'84 ?G];_M0_$3PU-KOA?Q-XRFT6V;
MQ]HWAYO$%[+87EYH]C=61GFW30P+;%_,C*;FC*QEV&7VAJ[/4OBSXI3Q5X2^
M&LGQYLEMK]]>:3X@6=M9+(\\"Q-:63ET-NS1K<*TA0 OY84%#NS]+Q?LT_"6
M#3]2L(?AEX1M[+4HDAO+>'1+9$N$1MR!P$ .TX(]" 1T%:-_\"OAOJWA33_#
M%]X \+WGAO3Y#+9Z//H]N]I;.<DM'"4V(26;) '4^M 'Q]J'[0WCSQ;8?$I=
M*^*UG97/PZ\%6.N6=YIVG0K:^)KE8I'NKA_.C8B R1"$"(J,R!@3D"I_'/[3
MOCC0/A9\8_$9\6#1]5TK2O#6MZ/IUS%:[K.34( \UKAX\R)N+A=PWC;UX-?7
MGB+X(?#SQ=/83ZWX&\.ZO-80I;6KWNEP2F"%3E8D+*<(#R$' .#CBH?%_P !
MOAQ\0=:.K^)_ GASQ#JAMQ:&[U32X;B3R@<A-SJ3@9./3)QU- 'R'KWQE^+&
MF?$#Q/JX^(LK:#HOQ9TSPE%H)TNT\F6PNS;EQ)+LW_*DV%((.06).1C%\&_$
M#Q)X-T/Q[I>E?$?5KSQ1K'QFO]#BM6^PO?30Q*P*1RRQ>7 SK'%EY041(L1I
MDA6^O[S]EGX1:A;W]O<_#GPY-;W]]'J=U$VGH4FN4#*DC+C!(#N!VPQ]:GUK
M]F;X3>)+K5+G5?ASX9U"YU2\CU"^EN-+A9KBX0,%D<E>6 =_KO;.=QR ?&_P
MN^/?QE^*UW\#O"\OQ&&AWOBR+Q-8ZGJEGIEG=.SZ=*XBG0F,(69=H)4!#C<%
MR:;\+_BIXV^)/C#X,^.=7\<&SU&?X<^(+VX-RL,6F+<V]RD(FE39@!R(VDVX
M(\OY2H)%?8.D?LJ_!_P_K,6K:9\-O#6G:E$)A'<VFG1Q,GFAA)C:!C(8CV&
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M1H(=_F'_ $=P""&VC"M7UL:Y_P *?#[POX#%V/#7AS2/#RW;![@:58Q6PF8
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M4)]"M/B/8:+-XMUJX475C97&GFZ>)[A(R(@9D\O?L^0%\;?X?K#]DS4=4O\
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M  K_ &>/!7P9U?6-5\-6VI+JFL1PQZA>ZEJ]W?2W/E+MC+F>1_F XR.<8 P
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MU9-+]J6WM@S*S"1<@I*=HQA7 9@X 4?+_P"RU^T=XB^!_P /OASHLND:1=>
M-4U7Q3:I%:B;^T8&M);F[9EY\O9@B-8PN?ESNYP/N_X@_!KPK\4-7\,:IK]E
M<3:CX;NVO--N;6]FM9(G90'4M$ZED;"[D)*MM ((R#Q^A_L>?";P[#X;ALO#
M5RL7AS4;G5M,2;6K^98+FX"B=B'G.]7"#*/N0[G^7YWW '!_L\?M"_%;XJ^(
M?">I:_X.TFP^'WBS2Y;^QU&UN8XY[27EXH2&N7:YS&/F98HB&SE0 :\Y^.'P
MUT[Q7^VOXNMX?A3H/Q'N[[X8VMQ+9ZG-#;$SF^N(5E621&PY2.--X*L%0<\5
M]"_"?]D7X7?!+Q;=^(_"'AYM-U&9)(XU>\FFAM$D;?(L$3L5B#'KM&<< @<5
M)XK_ &5_!7B_X@:CXUN;SQ58>(]0MDLKFZTGQ3J-D&MT.5A"Q3*%CR2VQ0%W
M,S8R22 ?+O[)W[0_B*T^#?P8^%7AZ^M[WQ]J%SK&F7VH>*()9K?2_L&99(-L
M;HTQ"2PHF)   <GC;6W??MU>/)O#-E;V_A_1-.\7Z=JNO:%K]O\ 9;G4UDO=
M-2,_Z';PR)(89#(Q:9VV1"-MQ/&?H5OV2/A?!X7\.Z%IGA]]"M_#M\^I:5=Z
M7>S0WMK<O_K9!<A_,8N,!MS-N &<X&,S5_V)_A)K>EZ%8W6@W8CTA;M4FM]5
MNH)[H73;KG[3+'(KS^:_S-O)R>.G% 'DFF_M=_%'Q/XB\)#1]!\(P:%>^ K#
MX@ZN^H2W0GMK)GV7<4.S(>0;7,>0!TW9JCX,\5^*OB7^TO\ LX_$#Q#;:%96
MGB?PIK-_I]KI44GVB"!XK>6..XE9R)2$E0C:J!6>48[GW?X<_LB_#KX6Z[::
MMHEKJKW-KHO_  CT4>H:Q<W4/V'>7\@Q2.59,L<*00,\ 8%9O@;]B/X5?#OQ
M3X?U[1-/UB"Z\/3W$VCV\NO7LEK8>=_K$BA:4HJ'NN,'C=G P <O\7OBQXZ\
M(?M:^%M#T_5=-_X1(>#]6UN;2)E,)N7A"\2SM)M3YE7;(5P@,F0V<CP+XH?M
M,>*/C7^SY\6?#OB73=-\EOA]9^*[2YL-/NK)5>2Z*^6OGR-]HC5HU*W";%?!
M(4@@U]J?$[]G;P'\8=?TS6?%>D2:A>Z?97>G1F.\F@62VN4V30R"-U\Q".S9
MP>1@UYS!_P $_/@Y:Z9-9II>M,LVD'0I)9->O'=K/>&$7,A&U<;5 & IP!WH
M X/0_P!L/5]&_9DU#XBZ=I6F:AH.FI8^']&@N;AX[Z?4-T5M*]XIPL,8D9F5
M20S(%)*;QCVGX"^/OB7XGUGQ?I'Q(\,66@S:5);OIM[9LL?]H6\OF_.UN+B<
MQ%3%CF0@Y./NFJI_8X^%TL'B:UFT6ZGTSQ-IEOI>KZ;-J,[VUXL"QK#,T9?
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M!\^V7[9GQ<^)8O;WX>>#O"ATNU\%6?C)X]<N[C[05D$GF6R^6 &<M#($8[5
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M^)='U;7M<^+%SX0TB[U+39EM-,CBTZ&9F$:W'*;$54A#*3([,SMN./=/V?\
MXTZ_XU@^(>B>-;.RA\2^!-8DTN^N]&1Q:WT?E+-%/&C,S(S1N-T99L'OS@7M
M>_9'^%/B6^\17E_X9E:ZU_4H-9OI8-5O(&^W0_ZNYA\N9?(E]7AV%OXB:[GX
M??#/PY\+='N-,\-V#65O=74E[<RSW,MS<75P^-\TT\S/)+(< %G8G  S@"@#
MXY\-?M@_'+Q1X3D^(&G^!]%/@#4]$U;4K"]U"2&(6D]K#/-!""EZTMWN%NR.
M/)A96#$ *I-:OA[]J_XS2:=J,%UX=\,:[X@U/X>V7CGP_8:.DZ%&N)T@%M+Y
MD@\YOGW@*4)/R G(:O9]._8G^"^BW>O7&G^#!8OKD%S;7B6VIWD<0CN.)UAC
M$P6#>,J3$$.TE1\I(*:C^Q3\(-8-LUYX>U&<VVC0^'XMWB+4_ET^)Q)%;_\
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M;/XTUW2/%1&LZO9/,$A6*"1A(@E5IG&V3&&4 R$A0 <_H%\.?A3X5^$OA/\
MX1GPGI*:1H(DDE6P6626-&?E]HD9MH)Y*CC))QDG/*>%_P!E/X3>"[G2KG1/
M!&G:?<:5)/+8RQ%]ULTR[92A+'&Y0%/L .@% 'ROX3_;/^+?QF\/_#[2_!ND
M:;:>--9\(7'B2<-'"8;F:*]DM411/<1;8F\EG?87=1(,8VDGVOXI?'WQ9H'P
M3^%_B"P?2+/Q+XJU'3[*[M=-_P")L7\V)VE33U1MD[[E 4LX0*69FXYZ[6_V
M-O@OXC\'Z-X6U#X?:5-H6CR/+86BB2/[.78,X5U8-M9@"RDX8]0:ZOQW\"O
MGQ+\+Z/X<\1^&[6_T31Y8IM/LU+PK:M$NV/RS&RE0%XP#C':@#Y6^'G[5WQ%
M^+UA\/\ PG;:KHW@_P :ZY9Z[=3:I>60EAGDL;F2WBMTCWLJNQ DD8%@%C?9
MU&+\?[27Q-\8ZAX@T;1?&7P\T;6/ VB:5J6L7ER[S:5J\DLKB]9+C[T4$:QE
M00I;>ZC(%>WWW[&GP3U+0(M$N?AQHLNEQ7TFI1V_E,/+G< .RD-E0P5<H#M.
M!QQ6QXB_9A^%'BS5] U/5O &@WEWH$,=OIA:S54M8HSNCC5!A=BGE5(('84
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\$$ WYO^"@7A"?2K*\TCP9XTUPWGAAO%T<5I8VXV:>DC1RN[-. I0HV1D@X
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M7M<L-4\.:I?26NW4$MHX%DB#QR&2+SC"YRP4?OOF(.ZL^^^"'B77O#UWJZ?
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MDDC#9610,2*1DX.<4 >ZW/[2'PLM?#-IXBD^(/APZ)=R/#!?)J43QR2(H:1
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MIVL,='N#%,8()&(M[Y@('*2)M98RY!ZD8P?,?!'[(_Q$\&?%G5[K4/"'PO\
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M&7PO\ :[I_CB'2(-8U#Q)J.LJNC74EQ"([F;SL%GC0@AF<8P> ISDD#VX]:
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M5YK_ (D\>ZE+KUQ\*]<@^W6^MFWD?5(KF.-84V,,321LI* !W4H2.E 'Z*^
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M3)YYM>//C)XH^%$/QRT:+XHZOK]MI5MX3U)+B_U2$:A%%=S8OUMG 58V92A
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MA7KG@$< 'V]17Q^G[?$^MVGC>QT[P.^F>(M(\,ZAXDL;#5-2C^T>1:R!'%[
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MHH **** "BBB@ HHHH ***Y3XJ_$G2/A!\.]>\9:\TRZ3HUJUU/]GB:60@8
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M=1W'K0!\1?"OX$_'/X;6O@G4V\#:-K,]MX7U3PAJ.A7.LPQBTCFOI+J"XBD
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MA!EV*Y PRYWQ^TO\,V\,P:_'XLM9]-FGGM@8(I9)EEA&Z='A5#(AC!!?<HV
M@M@$4 ?/7@[]DGXEP?$OP+XOUJ7PCH^MZ(VG17_B#POJ%]#/?6-O;)')8S6K
M1^7.&9!B9F4A3]W@ ?27Q[^$]M\;OA!XG\%7,HM7U6T*6UT1G[-<J0\$O'/R
M2*C<<\5UWAOQ+I?C#P_I^N:)?P:GI&H0+<6MY;/NCFC895E/TKYT^/O[7^AZ
M7\*_B!=?#+Q1IE]XT\,Z;/JJPWFG7$UK-#;W"0W&Q_W:2 .WEED=@K9!!((
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M\<^-KGXYV6G_  ]U>PEU[X8:38VTU[;1QI<:E;Q,[VX=7(>4"01[E)7=&1N
M"D_9-M\8M.N/CG=_"\Z9J,.KV^@IXA%_(D?V26W:?R=J$.6W!\YRH'!YKO\
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MKHV1B"BW96#":64OYA0( OWC^O6P4;!0!^:OQV\4Z=XEB_:QN].:YN8-5NO
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MF=!//-%<PSO!.T4<8$B*K*P.T@%Z_4$*!2T ?F_I_AF^L?C3\/\ [/HGB?Q
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MZ=\0_&/CKPY;:=?Z=?\ A"_BL+S[:L865I(Q*CQ[';*LA5AG!PPR <@=[N%
M"T5R?B;QK>^'_&?A+1+?PUJ>KVNN2W,=SJUF@-MI8BBWJTY/02'Y%QWKJPP-
M "T5YWK/QGT_1/C9X=^&LVDZD=1UO3+G4[?4PB?8]D!4/'NW;BXW*<;< ,O/
M->AA@10 M%)D4;A0 M%4]8U#^RM+O+P02W1MH7F\B#'F2;5)VKD@9.,#) SW
MKD?@A\6;#XY?"OP_XZTNSN=/L-:A>:&VO-OFQA9&3#;21G*$\$]: .ZHI"P%
M8FC>-]"\0Z_KFB:;J<%[JNAO%'J5M"V6M6E3?&K]@2O..N,9ZT ;E%-WBE#
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MQCXEOO!OPYUH:G+?ZA9ZG-IR7EY''&MM:S7,+(T,>)9).74.R(,_*0?F_P"
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MYINOZ'>PZGH^HP)<VEY <I-&PRK#ZBM:@ HHHH **** "BBB@ HHHH ****
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MM!E\,%3XAOF_XETDAD>WR93A2Q)Q^'2F:Q^PO\&]?U+PY?WGAB5Y]"LK;38
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M;W]FKPEJGQ0N?'%[-JUY>SZE:ZRVES7S'3EOK:W6W@N1!T$B1JN#GJ%)R57
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M/QSJE_HG@S7]1TJ*"XU.SL)[BUANI1%$\J1LR*[D@*I8 %B< 9-<)\.?V8?
M'PH\6V_B3PUIU[9:K!HT>@(\NIW,Z?8T8,D9221@<,,@D<9..M>@^*O#6G^,
MO#.K^']6B-QI>K6<UC=PARA>&5"CKN&",JQ&1S0!^=VO?M"_$CX@?#V\L-5\
M93:)XFT_Q5X7M]3\/7?A\Z=?67VB["R1LI8AX#((W1U<ET4*^W<=WH6O?M3?
M$C0?VBM.\/0ZG9:QX5N/&MOX*G%IHQ6UMS);JQ<WC2 F[#EV:%$=%55#$$\^
MYM^QI\++CPSJNAWVEZEJMOJ1L?/NM1UF\GNPMF<VJI<-*9(UC); 5A]XYS5&
MX_83^"]WK[ZTWABY6_;48M5#QZQ>J$N8Q@2*!-@$_P 1'7O0!\V?"[]H/XH>
M'?#/A?0--U>#QAXA\:^,O$5LFH75M")$CL9'+B(2W$,1>5C$%0LH10X53QCK
MU^.'[0U_J.A^&;[4O!GA?Q%)X1UC6-5DAL/MZ6MQ8W:QX!CN67<RO&K+\WEL
M9#AR @]IUO\ 89^"WB'2-8TZ]\'AH=4U5M;EDCOKE)8KMB6:2%Q)NB!+,2J$
M*=W3IB_IG['7PMT2^TNZT[1K_3WTW2+C0H$M-:O8D^R3EFF5@LPRSL[,SGYB
MV&SE00 ?->D_MH?%#POX?TGQCXD;0-9TOQ#\.[SQ;::-9V;VWV*YMI(8U0S%
MV,B/YP=L@8.0N ,EWQ+_ &E/VA_AQ\.M;\2W\G@^UM#!I-YHT\ZQ//>K-<Q0
MSA8(;F3$1^T(1(3P%QU<,/I;2?V0?A?HUQX:EAT.YF3P]I%UH-E;WFI7-Q!]
M@N"YEMY(Y)&61#YC8W X 0=$0#"T[]@CX):7X1U7PW;^$YUTS4YH)KH?VM>>
M:WDN7A02>;N6-&.X("%R <$J" #YY^,7Q&^*VI6GBGP1K?CBV_M/PC\1/"EH
MVK:/I8M4U""^\BX6%XB[%5BD=2,/EPF&)!->BZ/\??B'9?M=Z?X%\3:Y!HWA
MRZU2[MM.BFTM'LM;M8K/Y1;WL>2MXMP"TD,FT!?E!R ']:U/]CKX6ZQ-XSEO
M]'U"\?Q?-:W.K&XUJ]D,DMLP:"1"TQ,;H5 #(00/E&%XJG!^QC\+-*U+4-4T
M_09FNK@W5Q%97FJWDMA#<SPF&29(#+L1V0[=Z , 3M(- 'NL;K(H96# CJ#F
MO _VEO%^J^%/B/\  R&QM].O++6?%?\ 9=S%=:<EQ.FZWD=9H9&/[K9Y9+%1
MN([C&#WWP$^$]M\#?A'X<\#6EVU]!H\#1"<A@"6D>1@H9G8("Y"@LQ"@#)QF
MK'Q#^"WA+XJZIX<U'Q+875[>>';O[=I<D&I75J+:XXQ*%AE0,PQ@%@< L!PQ
MR ?&_P /_P!IKXTV6K>"]=\5^(O#^L>&=3\1>(/#UUI5AHIMYF&GQW4@G$QE
M;:Q, 4(!@*!DLQ)J_'\1_B'\8?V?=8\0:WXR\*WWA+X@?#_79+?0E@\F]T_4
M1!,Z0VX4%IXXH@P=G.[=&6XR!7T%I'[&7PJT+^PQ8Z/J<":)K$VNV"'7]0=8
MKN4*)7(:<A@^WY@V0=SY^^V8O#'[$OP4\&7/BN?1? ]MITOB>UEL=3:"ZN%+
M6\I)EAB(DS C9P5BV@@ = !0!X!X#^+7C;P-\%=/TW3/$,$-KIOP&TOQ;I-N
MUG#YEM=06Z(X+.<2(^Q<ANF_@CBO/_VD_C+XQ^/?[.GQ5T^;6]-TFP\->#O#
M.J:CI4=@DLFJW%_'!=2/O=B8HTR%0(N=V26Z5]B>(/V+O@[XKT[P_8:IX2-Y
M9:#I;Z)81-J=X-EDS!O(9A*&D12,J'+;>V,#%/6OV$_@;X@@M(;WP) ZVNF+
MHT;1W]W&QM%.4C<K*#)M.,,^YAA<'Y1@ \)^/OQ]\??"SQ'^T[J>@WFCV=SX
M8TOPY?Z5>OHD9E>&>1D=7ESF;[S %RP7:=JCFKWB7]HWXL?#'PW\:[#6]>TK
M7M5\+)X>O[?7;71Q EC9ZE(5N&-MYA\SR%5RF7)/!?(R*]TU+]BOX.ZNVN&[
M\*32KK=E;:=J,8UB_6.YM[<(((F03A=J")-N!QCW.>.^/?[%6B>.O"^MCP9!
M;6?B+6Y=+BUDZ[JFH2VVKV-E)$Z6LQ$K,F1!&OFH/, WX.78D H?"3Q9\5/B
M9X%^)LEO\1[6#3X-7ALO"'C;4-"@1;FV5HVEG9/DCF5BSP@JBC()!)Z?5<8;
MRE#-N8#E@,9-?*WP._8PA\->&_&FC>-++2K;PQXF@LX7\'Z#JFHW5E;O [2>
M?Y]S+YGFLQC!V*@ A3[W)KZKX QG- 'Q1/\ $V^TZ\_:L^*<M[I>D^(_"%R/
M#.B7?B&-C;Z;;0P1LI 16?$TTQDVJI\QO+&#@ 9^D>(O%?[0?PE_:$\'_$&>
M9'\.Z?:ZCH=]JUC;V>H6,LEDUU#/*MNY6-DDC211Q(JG#8)P/<O$O[,>FZ]\
M2_%^H3VVGZIX'^(%A#9^+O#UZKJ99[=6%O=P.AR'QM1A\OW5<,&7!Q]<_8M\
M(:!X<U/1_AGHVG^"Y/$EJNAZ_JRRSRW/]DE")D@#LRF9PJ)O;! )<EF500#T
MG]G/QGJ'Q%^ GP]\3:KEM3U70+*[NW(QOF:%2[X'0,V6Q[U\L_M(0:[/^UEX
M[L1XNO(M 3X+ZCJ3Z)+#%) P,LD+1IE<H-R)*7R7)4+G;@#[:\->'[#PCX<T
MS0]*MUL]+TRTBLK2W4DB*&- B*"><!5 Y]*X#XH_LS?#/XS^(+37?&7A>WUG
M6+6QETV&\,\T,BVT@</'F-UR/WCXSG:6)&#S0!\3V7[4'Q0^!OPXT>VEUK3-
M<L;GX9Z/KNE1R::L"Z4\UQ;6JAV#9D1(Y<DL1EE'09%?6G[-_B7XBZKKGB_3
M_'NLZ-JUO ME=Z1]AN(9;M+>82@FX\E$CP6B^0@<X;T%;MC^RM\*[".)$\(6
MD\<>C?\ "/(EW++<*-/W;OL^)';* \C/(XP>!6W\(_@3X%^!.E7NF^!?#\'A
M^SO9Q<7"0O)(9'"A02SLQP .!G R< 9H XW]M#QYXK^&'[._B+Q3X*U6/2?$
M.G369@DFMHYXY!)=10LC*X( (ESD#(QQ7SYXQ^)O[0NB>/\ Q)\-M*^(/AW4
M/$'A?08M:FUW5;2UTB*\%Q/(YD>)UD!M[>)!&3&R')#.S?=K[*^(WPR\,_%O
MPT_A_P 7:3%K>C/*DSV<[,$9T.4)VD$X/-<I\0_V8OA7\69])G\7^#-/UZYT
MJ)+>UGNRYD6-,[49@P,BC).'+#))ZF@#Y+U/XKZSX7\9_M.:WI'B?3O#?B>X
MLO!@AU>WM?M\*7,UJH98(2")2XD81[OERREN,UB>)?BO\2O&_@/2;#Q#XNU+
M3-3TCXKZ?X?ED$-DL\L#*DB"X$"F(LC#.$^4DX;.WC[+UO\ 99^%OB*[\5W>
MH^$;.ZG\4B'^V'DDEQ=^408BP#X!3:N"N, 8'!-4+3]CWX-V.CZMI%OX"TF'
M3M5FM[B]MU1MLTL&[R7^]PR[FY&,[FSG)H ^<M)_:+^+WBKXAZQK.G>*?#NF
M^$O#/CJ7PYJVBZC<6RM-91S+ @2/R//^TRM\RL)1&2X4( IS3^'GB[Q)\7/B
M_P#LG_$S6_%PU>+Q)+XCN!H5O;VR6NDDZ?+MAC=$$K,J@(YE=\N"0$SMKZTM
M_P!FSX7VWQ&@\>0^"=(B\7P,'CU5(<2*PC\O<!G;NV<;L9X'/%9VC_LE?!_P
M_P"+(/$VF_#_ $>SUN"^_M&"ZBB(\BXP!OC7.U.@.U0!D XR,T >MD9&*\"\
M-?L;^&?!_C31?$>F^*O&,3Z/JVHZK9Z<=7 M(UO?+:>SV! ?LWF0I((\_>R2
M2"17OU5M2TZWU?3[FQND\VUN8VAE3)&Y&!!&1@C@GI0!^5_P$\9^(/V>;S_A
M#/#L,QT_XQZ'9W_A:[&]XK37&*6MYU7&5)>9N0 L48Z,*Z+X,>(;_P""?PX\
M?^%/"'B*;2+^7XUWN@6:PQ17%_J,*0Q+Y4+3@Q)(PC4F67Y  V2":_0'PY\%
M_ WA*RT&TT?PQIMC%H+S2:5L@#-8M*I24PL<E-RD@X(R*YF]_9,^$>HZ==V%
MQX!T.6SN[]=4N(6M1MENE# 3-SR^'89]SVXH ^6/ 7QV^,7Q+E^#'AV/QZFA
MZAXENO$VGZIJ4.FVEU(?[/E98I%^7RRY&T94!3C=@YQ7#7?[8_Q.\6_ _P '
MZ_IOC&ZM?%47@75O$6H6FDV=G'^\MKZ2V2\NWN(F0PMY#(L,"B1I&ZA<$?<N
MC?LJ_";P[J%K?:7X"T33[NUEFF@EMK81F-Y5V2$ ''S+\I]JRX_V+/@@EG96
MC?#309[>RCEAMXY[<RB-)"Q=1N)XW,S 'HQ+#!YH ^;_ (L?M ?%;6O$VH:+
MX2\47FE^+6\,Z!JWA+2-&TV"[MM7FNBPO3=L\3B)5 ."SQJBIOR:L7'QX^,&
MN_%KQ=ING>/O#?ANQ\&^*+'1[G3M=N8(WO[+9&&E^RBQ:9Y+AV.QHKA "P58
M^-YV?B#_ ,$\XM;^).JZCH=AX&;PQ=VEE9Z?:Z[IEW-<: D$7ED6@AN(U8$_
MO/G(.X]>I/T!IG[+/PTMM:\+^(+_ ,+V>M>+?#]E;6=KXBU%/,O7\B(1QRR/
MGYY,*#O()SC!X% 'R1X:^)GQQUO4_!<C?%ZY5-;^(6L>")XO[!L@B6T!N&6Y
M4%,B;$&%S\HRN0<-OJZ?^T_\8[[_ (1?P)%XPTN/6)O$?B?1&\7:A-;::+W^
MSF1+<%GL[B%2WF;B!%E]JJ&4DEOLG2_V7_A9HD.DQ6'@K3;1-)U<Z]8")7'V
M:^.W,R?-P3L3CI\HXJK<?LE?!^[\-W>@3_#_ $:71KF];4I+-H246Y8!6E3G
M,;$  [,9 YH ^3->^)7QSO\ PWXI:3XRZ:FI>&?AK-XIDO?"VFV]Q97U[:WE
MY&3&\L*,4D2T4.0I7<24PN WH'P;@F^)O[2'Q%.L^(]3,'B+X>Z%.]@\D)2-
M;N&Y\R.)6C)54)9PHXW.Q;<#BO>]8_9_^$F;R>^\(:#;B31UT>=S&L073U*[
M8>" L8*KC&,%1W%;OAWX*^ O#&MZ9KFC>%-)L-5T[3QIEE?6]LHE@M<DB)&Z
MA?F/YGM0!\M?M->)]=_9XO?"VB>%?$VI^&OACX9\-6T5W;^'E@O+W2A]H$,-
M[=PRJTLUKLC:/*,#N#DG(4-]JV5W%?6D%S"_F0S()$<?Q*1D'\JX_P 9?!#P
M#\0]?M]<\3>$=)UW5H(%M8[N^MEE<0K)YBQG/50_SA3D9YZUVP&* %HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *X;XZB5?@MX[E
M@NKNQN8-#O+B&ZL+J2VGBD2%G1DDC964AE!X(].A-=S7-_$CPE-X]\!>(/#4
M&I/H[:O92V+7T<*RM"DBE'(5N"=I(&?7- 'PUJ=YXO\ AO\ L-^"/CSX>\>>
M*I/%^G:9INIZI::SKMUJ5CK"321I-%)!<22)&6\W(:,*5QQC@CT.S_:9TKX;
M>*?COK[^&=;6\T[7=#LKR/4-:,ECFYB6.*X7*$6< CVO(<-R<8S@5U5E^Q8]
M[X#\'> ?$_Q"U37_ (?>&C;F/P]'8P6J7P@P8DN9%R\B @$J",GD]!C4\0?L
MK:S>>)OB%KVC_$.;2[[QCJ&GWEQ;W.D175HL5I&8EM9(BR^;"\1V,I(S@&@#
MGA^VOK.J:'9_\([\*]1\2>*9-+OM<FT*PU2.0"PM[K[,LT$R1L+CSFR8A&IW
M*,@X(SK^-?VPKGP1X5^*.M77@&]/_"#)I=S):37Z1375O>J&5\%/W3IG#1MD
MY4C/3/->'/\ @GY:^";GP]JGA+XE>(?!WB.PAO;6]O\ 1((4AN[:YN6N7@2W
MD#I#&DCMY8^;;P<DC-:?Q2_8??Q[!XJT[2_B1K7AWP_XDT;3=*U'3C:0WC3M
M8\03-/+^\SMP&"E2Q&2W.* -2X_;%C'QI\0^ [7PE+>IH-S+;WMQ#J*?;45+
M$W9G%D4W&!B%B60-@NRY R,^5>,/VP;;XM? Z\\1ZAX*U"+PM%JF@-#?>&_%
M05I&N+@G;))'$&B:&2.)9(2"Q$JG@$,?1O$?[&NK>,_','B37OB3<7=YI\DT
M^DW]MH\5OJ=C))9M;[1=J^6A#.\PB"+AR,$ 8.(?V!9+WPYXKM+[Q^8]5\3S
M:4^J7FD:#!907(L)#-&[6X=E,SS;7>4$$[<  ,<@'3>,_P!M"V\(W/B?4H_!
MM_J/@'PIX@A\.:_XI^V11"RN&,:RNL!^>2*)IHE9L@Y;@$ FLZR_;BEN?'+:
M-<?#/6;/18?'"^ [C7VU"V>%+Z0IY!6-6+L&#AF. JJ5^9B=HM>)?V*HO$=[
MXUTQO&=S#X \;:M;ZYX@\-&P5WGNT>-Y##<;P8DE:*/>I1N 0I7C%75?V,-7
MO(-6%K\1%L9[SX@V_P 0H9!H2.L%U$B(("IF^9/W49SP?E[Y- 'O?Q/\<GX:
M?#OQ!XJ&D7^OG2;*2[&F:9$9+BY*KD(BCN?7L,GM7SI#_P %!-+_ .$4U[5'
M\'RZI=Z-X@TW0+BV\-:M!J4,CWD>Z-XIP$60A@8RH'W\ D#)7WSXV?#%?C-\
M)?%'@B74Y]%77+)[,W]LN]X,X.[;D;AQ@C(R"1D9KYNOOV _$NH7]W=7'QCG
MN!=WVC:E-;/X9M4@%QIJA8#&D3IY: *%"+P%SG>3N !V.C_MI'5+232G\ W]
MO\0CXKG\)0>%#J,#-)<16PN9)C<<((5A.XL V,J #FG_ +!OB37_ !+\.O'L
MOB274O[2M?'>LVGV75;]KZ:S1)5 M_./W@A)7( '&0!FLO7/V(]0U#QIK7BW
M3OB/<:-XAD\5'Q7H]Y;Z1&W]GS/!]GGAD5I,3QR0K&A'R8V?[1SZA^SQ\$+_
M .!NC^)[._\ %DWBVXU[7+K7YKF6PCM-D]P0TN%0G(+#/MV H \X_;M^-6L?
M#GP/;:+X/\2:?X<\87,%QKJ3W\ZQ VE@%FDC3<RAGFD,$(3^)9).#@UT?BW]
MK2Q\/?!_X9^/=-\+ZEXFM_'-WI]A:66ES1"2&>Z0E8R7906# IS@9!R5KLK#
MX*6TGQ,\7>+?$%Y#XGBUVUM+*#2]1L(GBTZ"#S"(XR<DAFE=VR.6QV %>-^&
M/V)M>\-^!/#OA(?$Q+G2/#_C"W\7:9$V@X%L8I#)]E0?:3B(NS$>FXX'3 !I
M']M=8? <FLWO@JXTG5K3Q!?^'-2M-1U.&&RT^XM$\R0RWN"@#*5"<?.QVCG&
M?-H_VA=8^(_QO^"WCSPA9:Y/8>(/ FM:D_@]M5,4-W/;G$<6S/EF3S"ZB0KD
M@H3@#CK=0_86UVY\4G7;3XKSZ;=)XPO_ !=;B+0(9E@EO(UCE4)+(Z&1%0>7
M*5RA+'!SP[P9^R1>?L^1>"?%L7B[5?&*?#?1=6@M]$L]&C^TZC!.#)]GBQ(/
MG##Y=VXLQZ@8  .E\$_MHVGC;PGH7B"R\(7LUK<>'-7\1:M;6MVDMSI2V,GE
MFW:/:"\LD@**OR\JW8$UYUXE_:KL_B[X&\-:GJ/A?5K#1'\8Z%9VNH^&/%"F
M&>6X)90\T2 LJ-\LL!PP; .W@UV/[-?P4NCX*^+?BVQTS4/AAKGQ0O+F]T^*
MY3-]HL,D)$,CQ$X24323W!C#<&102",#'M/V Y;.TUA[?QS::9J6KZ]I.O7K
MZ3X<CM;1I-/W-$([83%8V>1S)(P.&/ 510!Z+X(_:G3Q]\;-5\!:5X7=[72M
M1O-,O]1;48Q<VCV\882RV>-ZPRME8Y<D-CG!(![7XQ?&*'X5+X<LK?2+GQ%X
MD\2Z@-+T;1[:18OM$WEM(Y>5_ECC1$9F8Y.!P">*\YT/]DJZ@_: TSXH:YXQ
M36KS2;S4;C3XXM'2VN_)NE=%M+BZ$C&>&%9&\L% 0<<[0%'<?'?X&K\9+7PM
M=6>N2^&O$OA?5XM:TC58[<7"1S)D,DD19=\;J2I 93[XR" ?/?Q=_:3\1_%?
MP%IVA>'O"UYHFO1_$&P\(^*='FUK[)<0?O4D,4=S",F.= 5\U"" 6P#G-?5'
MPL\!0_#7P-IWA^"^U2^BM@Q5]7U![^=-S%O+\Y_F94SM7/\ "HKQ@_L@:B+:
M*[3QZ4\2W/C.+QMJ^J?V,A2]N8@%@MTB,G[J!%4+C>S'D[@3FOI3&!@<T ?G
MA8:Y;:O\7?C%X+OO%?Q>^US>,(="\/:SI6LZLUGHC7$<?^L<3"W"I*[%4ER6
M4  <BO4O$'[4.G_"/Q7\<=>'@WQ-JM]H>OZ'I.I61U>.2-DN(A';SVL+';$&
M#)\@Y=I%+%0&*>O_  5^!-]\)?&?Q&UZZ\4?V^OC'5?[6:U.GBW^R/MV[582
M-N&,=ATSW->=_$#]C#5_&^H_$^X3XCO90^.=6TK5Y(9-$CE^Q26!3R50B5=P
MQ%"#D _(3U8T /MOVUKB/P[XQDU?X>WF@>(_"VN66C:CIM]JUO\ 9;5;I0\=
MS/>KF..)4^9SAMN5');AGAS]M\>,]"\ W/AWP%?:[J7C&;5+2RLK35+<()[%
MF$@\Y]JM'P&\S PN2 Q 4YOC/]A?5?%WB[Q7XB'Q+-E?:WXBTOQ)&O\ 8,<\
M=O/90R0QHT<DI25"L@.&7AD4\\BK7P__ &*?$'@#QQX5UY/BM=:S;^'-9U?5
MK2TU'0X2[?VBI%PKRQNF6+,S;L8R>%4<4 7;7]M.\\4>%="G\'?#;4_$GBR_
MT&[\177AMKU;>2SM;>X>V9=^QO,E>:-TCC5<L5YV50;XW6>C?%KQIXI?P+XQ
M/B.T^'5CKRZ*U\S-+;.[,L L>D-P)?,1R<D>4W R=^3X4_X)^:AX*AT"_P!"
M^+NM:%XNT:/4+&/7],TR!&N+"ZN7NFMYH)#)&Q6>21@X"_>'R_*I&_XZ_8<7
MQI<^)"/B%K-G;:QX/@\'8:$33K!#*)EEDF9MTKM)YA?.-RRLOR]: /-?C5^T
MV_QM_9[^(,^CO<^&=:\%Z_X>5[KP[X@%S:W0N;RW0J+B$()%"R2HZ$8#H.I'
M'V)\5_&$OPZ^&'B[Q3!;"\GT32+O4H[8YQ*T4+2!3CG!*X)':OFFW_8$U231
M?&NFZE\6;^]A\5_V.]ZL6@VENB2:<T30F-$P$4>3&H1< *"#N/S#ZQN-)BU;
M0Y=,U98M2@N;8VUVDD8$=PK+M<%.1A@3QSP<4 ?)?@GX$^)/CO\ LRZ/XMN?
MB=XPT[XF^*=)CUA-8LO$%Y;V-O).HECMQ91R" 0*&5"!'NX)R372>,/VU7\.
M:GKNJ:?X&N-9^&?AKQ%'X7U_Q;'J21R6=X9$CE,=GY9:6*)Y8E9RZ9+':& S
M6OX)_96\0_#K0)/!N@?%SQ#9?#L92WTK[+ VHVD3-EH8;_&Y$Z@83>@)VN#@
MC,U3]B.TO=4\7Z?;>,]0M/AUXOUR'Q%K7A(VRR>;=I+'+)Y5SN#Q)*\2%UP3
MQPRT 4;;]M^^?QR-(N/AEJ5IH</CM/ -WKDFJ6[+#>RA/)98E!9\EOG&0$!0
MAG+%5X7Q[\=-?^+?Q>^ FNZ%HU]HOP_F\;W>E6FM)KF!K CCGC<26<8V^67@
M<HSN3B-OE7?SW=Q^Q1JLL>KF/XE2I->_$*/XBQL^B1.D5X@3;"R^8"T>8UZ%
M3P/?,.A_L'OX9UOPR-+^*.OVOA/POXC;Q'HOAPV5K)'9R.7\V/S60NRD2R 9
M^[O8X).0 <%X5^.FO>#/ O@)O 'A1[*W\4_%"_T#5+?Q!X@EO9UG6:4NB2O$
MP5)/(EY_Y9A1@.7++N^"?VG=+\%:K\1;&P\):A#XHU/XFS>&;+3+S76N4U#4
M&BB+2AW7%K % ;8H8#(QDG [&W_8I,/A#2]*/C_4%U72?&$OC/3=9ATRV62V
MNI?-,T?EE2C(S3.W(X(7L,54NOV%HM2USQ+K5[X^U*76;_Q5#XPTN\BL(8SI
M5^B[#A>5E1HUB0JPZ1YSDDT 5M0_;@O]->WTF?X=WTWBU?%P\'7>D6NHQ;4N
M7A,T,D<KA=\<B D,0N I)[9]D^ ?Q?G^,W@[4-4O-$E\.ZKINJW>C7VFO.L_
MDW%O(4;#@ ,#P0<5P-U^QU;:AKFC:_=>+;V3Q!;>+(O%]]>BSC O;F.'R(X@
MG2.)8R5 &3R3G-=M\"/@?<?!0>-4E\33^(H/$FO3Z_LGM5A-K+,%\U%*DY4E
M01P,<]<DT <'\6/VNC\+/BU9^$;KP\KV<U]IU@+N:_$=S</>,5$EM!L/F11'
M:LCEEP64 $FN:T']NJYOO$6E#5_ 5SH7A:\\72^#'UNXU*)U6^ 8QA44992(
MVR> #P":WOBK^Q+9?$WXB:_XLC\>:[H4VL7>EZA):6D-O)''<6 40,K.A8*-
MI.S.W<=Q!QBJ<O[#<,WAK3M'E\=7]Q#9>,_^$V5KC3H&WW>&!0@8PA+N>"#\
MW&,"@#A++XR>)/C+^T_^S9XI30)?#G@;6CXA?2I1KCS/JD"V$GE27-F(U2(D
M#S$^:0@.02AXKU#_ (*$B2T_99\1:I:ZAJ>EWFFWVF3PW&DW<UO,-]]!"ZYB
M(9@8YI!M[D@]0*R? '[#*_#[Q-X O;+XH>)[G1/ E_=7.@:+<P6KK;6]PC)+
M;-*8][H5;;DG(7(7:<$>P_'GX.0?'GX:WO@R\UF]T*RO+BWGFN;!(FE80S+,
MB_O%8 ;XT)P,_+CH30!\M?!KXP6WACX@?&CXA:->^*+7X&^$-%-K=:-XDOIY
MKI=9A*RRF"WN7,T"F,[-KXW2$XZ87=M?^"@&N6WA7Q/K6M?">_T^WTRSTV_M
MKX3W@TYX[J>*)Q/.]BKQF$2AW,<4H8*^W( )]/\ &O['NB>-/&>J^()_$>K6
M@\2Z2FC>+=.@6'[+K\*Q[%DD0I^ZF QB2/!  "[><X/AS]C76?#?@VYT-?C-
MXPU&>-+:VTNZU#RI8].M(9%<VX@(V2K($6-_,SE!MP 2" .^'?[67B;QIK&E
M:=<>!M&3^U]$UG5M-O=*\4B^MKIK"X2-45UMA^ZE2:!Q-U&Y@8P5Q7DEI\=-
M=\;?%+1OBIX<TN'3]3U+X,ZIK4>B:AJDLUC'+#J$&W<50!B%W_,J*6X!('(]
M3TK]A33?#>F:$GA[QWKWAG5-/N]6N)[[2;:TB2>+4FB:YMT@:)HX8QY$(C"C
MY O&>,6_A_\ L1:5X&3PI&_C/7-3@T3PO>^$9+>6*WC2\L;F1Y&5ML>Y65FC
MP0W_ "R7.<L2 >=Z=^VGXZ\(?#OX.PZQX7T'5/$WBGPM;:R9]2\0/I\>JLPC
M58K:5K3ROM;AQ*T3%57<%1I,@U]4?&#XH:9\%_A;XE\<:S'-/IVAV4EY+#!C
MS)<?=1<D#+,0HR>IKP#4_P!@R36_ >D>"M3^*?B'4_"]EI$&B/8WEC:2?N(9
M2T#0'RP()8T_=B4 N1]XMP!]$^/_ (;Z'\2_AYJ_@K7[=KO0M4LFL;B(/ARA
M& 0W9@0"#V(!H ^?U_:?^(<=QXA\+^(?!.D>&/%]UX0G\5^&W@UI[JTEB0 2
MPS2?9PRS0[T) 0J_."!S4O[ WPLM-&^#GAKX@WFG+9>+O%6BVT^I7EMJ]U=I
MJBLHE2ZGCEPJ7#;SNVAL9(#D' V] _9 CLHYKC6O'VN^(-=B\--X2TO5;B"V
M1],L' $AC01E6F? !E<,2%48X.?5?@U\,8?@U\,_#_@JUUB_URRT2V6RM;O4
MA$)_)3B-#Y:(IVKA0<9P!DDT >$?';6M0^(7[7/PX^#M[?WMCX)NM"O/$&JV
MVG7TEH^INC-''!(\;*YB4KN**PW9^;(%>?\ Q"^+5Y^Q=\;?&WA_PO93:[X0
MD\"-XRM_#=]J4FRTO(KHQ2^1*_F-%$T89S'C;N4!=N37T_\ %7X$:1\3O$OA
MCQ0NHZAX<\8>&GD;2]>TEH_/B25=LL3I(CQR1N.JLIQV(R<^-?'K]FM].^$G
MQAUZQ;7OB5\3?%N@-H<5U=K"9DA/$=O!'$D<<408[VXY*Y)/2@#)D_;S\1>&
MCJ,/C;X37?AB_N=$L]<\.VUKJJZA_:$=Q/';K'(8XQY;B29"5 8@$\$@;EU;
M]LOXC:-86T4OP?NAJ]UXEB\/V:7=U-8V]_YL;-%+ UQ CD9C(;<J[>.N:U_!
M_P"QQIOQ#^%>F/\ $/5O$-]XAO/"VG:+']K6"TGT-("LH2$0H )!*J%G8N6,
M:]!Q730_L<VL]OX?DU;XB>+M;UC1]8@UE-5OYX9999(%988RK1E510[\* 26
M))/& #@S^W+KVE?&71?A]K/@_2M/U.?5-,T6^T\ZP\E[#+=P*[7*!(FC\B.2
M2./+.&<[MHXKC++XP^+_ !CX9@C^*OA?1O$R0_&NT\,6YTS6[BV&GSI<*BM&
MBPH98XG *^9)^\\P[PH4 ^H_$+]@?1O&GCC5O$^G_$#Q9X6N]0U^T\2/!I,D
M B%Y H57.Z,EL ':"2%))P>E:'B#]B+3-<CUF"+Q]XGTZQU#QBGCB.UMEM"+
M345+.61F@+%6D8,021\B 8^;< 8FJ_MMZG87J>(8/!MK/\+D\9GP1-K)U1OM
MXN0YB-V+81%?(\WY0!(7(PV!G%4_AS^V[XK\;>+O"%M??#BTT?P[KWB34O"W
M]H1:W]IE^UVJ2.6C01*&CQ$R[LC)!P ,9[I/V+_"JZ_J4QUW6Y/#5_XH'C*7
MPK(T#V/]J?>,N3%YI0OAS$7V94<8&*S/#7[#FC^%K#PE:V?CSQ0%\->);GQ1
M9L4LANGG&)8WQ;C*'=+P,$>:W/"[0!/V4OVLM3_:/US5[:YT72=$BLK4SRV$
M.H.^I:?-Y[1_9KRWDCC9'VJ&W*"AS@-G("^*/V-;;Q-XYU#Q$=?N;%YO&6F^
M*[5+::X!MC;)^^"@RE=\Q9T) "!-I"[@2>?\0_L07FA^%]?U#PU\0/%^I?$:
MXT*#P]IOB"YU&"RNK>V2X24;[B*W#2?=4,[AY#&FQ2,U]5Z-:3V&DV5M=7+7
MMS# D<MRXP9G"@,Y'8DC/XT >1_M=_$S5_A7\"]8U+P],EMXCU"XM=&TRXD&
M5M[BZG2!9<=#L#EP#P2HS7SSXBTKQC\ ?VL9K/X6>#AXUD'PQBGN&UK69(3+
M)'J<K7$S.4<R7$NY/E^3+,6YP0?J?]H;X1#XX_"'7_",=\=+O[I(Y]/OQG_1
MKR&19K>0XYP)(TSCG&<<UP]Y\$-8^,$^C>-M>U?Q#\,?&CZ)+X>U?3-%NK.X
M@FMS*6D4,\4@PS#>DBE7"L,A6R* /._!WQ;^V_%SX+_$/PP;NU\-?&JSGAUC
M0KN1YEM[VWL_,AN(AT5PL30N5 5E16(R,CV?]I+XQ^(/@IX6\/ZOH'ABV\4R
MZAKUEH\MI<:A]C*"XD\M&1BC G>47G &[/(!KFM*^!EW-\6O  @TM/#GP\^%
M=F]KX>@\Y9IM3GFM!!YAP28XH8BR#>=[NS$@!06[WXV?!BV^-F@:3I=WX@U?
MP\NFZK:ZQ#/H[0AVGMY!)%N\V-P5# ' QR!G(XH ^;[C]M[XC:)=:FVN?#71
M;/3?#_C2W\(:U=6NO/,S23M&(WMD,"[L+(C'>1PZC&=VWJI/VM]=?XU'P*FE
M:3$EWJ&I:5:R&YDGFMY+>S:XBFN?+'EJLFP_N@_F!?FP.172^(_V+/#7B6/Q
MA%<^+O%<-MXG\2V_BJZ@MI[15AO(0-GEDVY(3Y(CAB?]2G/WMT6F_L2^%=+\
M<6OB6#Q5XL#6FO7'B"WTTZ@AM(IYU99U"^7DHZL5())QP" 30!\X_!O]I'XR
M:Q;_ +-EUJ?B+1=4T#QAJ&OW5]J 283726JW;-%+A<*B G8B*<F"/) '/H>C
M_MM?$WQ-H$_BS1OA2EWX,O-!U+6;+4KB2YMX[$VR2R1I=3&(I(98XN!#PKL$
M+?Q5Z)H7["G@GPYI/A#3=/\ $'BBWMO"FJW6I:2%O(0;9+A'6>T7$("PN)&W
M  .<GYO2OX?_ &!O!OARRUK3+7Q9XT;P]=0WL&F:'+J_F66AK=1R13FTC="
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MXFMKS8L<<2*@4."6Y)"J$QAL\=A>?L">#-3TW7;74?&7CO5GUO2+;0[ZZO\
M6$FEDM()5EB3YH2O!7&<="W=B3K>)_V*/#'C#2_&]CJWBSQ;=0>,;33K/52;
MNV#NMD4^SNK"WR&&SD\@[FXR00 <1\5_VNO''AWXA^(/#_A'1O#6HR:1XITG
MPJNDZG<S)?W<E[#'(+E2O"1*9=O"N<1NQP!BOKU?NU^?_B3]E'XN+\:?&WB/
M1Y_$-OKVKW,*:3XRT[Q1:6]I!;Q6T<$+WMJUN99)%$99TC 23=L&P?,/T '
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MS'\;+SXG:Y\3)+'PK#XA/BO3O%%IHAUB>>TG6.QDLYK<R& %'6-@4DVXW'H
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M=6QN)]7\MB--EC=O,0QMC> 1QP F,$MFD^)'[*OQ:\8?%+X@^.-,M]%T^_\
M^$G\/^+_  [:7.HF:"ZN-.M&MF@F C4QA]P?>.?E"\9W* >T7W[2GAWQYKGP
MU_X0KX@6^FVNL>(;C3+BRO- NI)K][>,F>R)=%-I*O#9E .,$9'75\-?MH?!
MKQGXNL/"VC>.K6YUW4)WM+6%[2XC1KA>#"7>-4$F2,(6#'(P#D5Y[K'PC^+W
MB/6?A5XAU71_"<>I:7XPD\1ZOI^E71MH+.%[9K8QH_E%KF4B1YFD;&6^0<8(
M\@_9U\$>(_C9X4TS1+31](C\(^'/BSJ'B2Z\0)J227$I@NIIHX1 %)5W=XUW
MEO\ 58(!R* /8_V>?VO8[[X,6>M_%'5%D\1W&NZOID$6AZ1<7$MU':2OOD2V
MMTDD"1Q@;GP0HV[FRW/HU]^V#\)[*VTFY3Q0^H6NIVMO>PW&F:9=WD44$\Q@
MA>=XHF$ :4-&/-*?,I'4&OEK0/V+OBUX:T[PEJ\>B^ ]<US0-<UMI= U^9KO
M3KVQU&6*3S Y@!26-E;^$DJHQUV'HO&_['WQ+UC6O#E[HVG^#_#>N:=96T5K
MXC\+W<VDQZ;F_EN;FT-E'"8[JU"R@(K[69E+,?G:@#[#^(?Q*\/_  K\.KK7
MB6]DL[)[F&RB6"VEN9I[B9PD444,2M)([,0 J*3^5<//^UA\-8/#5KK8U>_G
MMKB]N]/6TMM#OYKY)[4%KI'M$A,\?E!27+( O&<9%5OVK?AMXR^*OP[TO2/!
M<VG)>0:[8W][;ZE=26B7=I"Y=X4N(D:2!V8)B6,!EP<$&OF72_V-?B=9>![C
MPUJ'A7PC=VX\2ZKXCTZ[T?Q1>V5]I4UP$-N;>Y^S[EV$,K!@V]<9((&0#[7F
M^*'AR'X8_P#"P3?2/X3_ ++&L_;H[65V^R&,2^9Y04R?<.[&W([BN-'[5WPP
M\V"/_A(V5I_#C>+(2VGW0$NEK&TC7"$Q8;"HQ*#+#&,9(%=/\,/!FHZ#\'O#
M7A7Q7<PZ[JEIHT&G:I.?GCNI!"$E/(&Y6.[J,D'FOD?2_P#@GMXCT^P\+0W?
MB][]]%UZ33(U$[+&/![F3?8$8YDD5_F//W@ <*#0!]#K^U_\+9-8TC31KUVL
MNJW=MI\%P^C7JVT=Y/&LD5K-,80D,Y1U8Q2,K*#\P6O#_!'[0WQ*O'\ )JGB
M*QOGO/BKJO@K5&M].C1+JU@6<QF/O'@P'U)#\MQSH6G[*7COP]\</%>I6&D?
M#;6?"7B'Q/'XD37=>TO[1K6DDF,S10*T91O]650EQM+E^O%5?#_[,?Q4TEO"
M#-9^%%.E_%._\<70BU2<)]CN/,'EQK]G_P!8!/)P3C]VO/S< 'U/\1OB;H/P
MJT.WU3Q!/<1PW5Y#I]K!9VDMU/<W,IVQ0QQ1*S,S'H /<X%<4W[6'PS'AK3-
M<CUJ\NK349[RVMK>TT:]GO&>TR;H-:I"9D$0&6+( ,KS\PS3_:J^&?C3XI>#
M?#UCX)FTS[78:];:C?6>J7<UI'>VL:2!X!<0JTD19F3)0 E0PS@D'YA'[#OQ
M-A^%D/A"?0_ UW]EUK6-5T^YTW6K[3Y],EN1&UM+;3B%W3RV#J8R"&3;D[AF
M@#[H3QKIFH?#]/%UG<2OHT^F#589TM9)',#1>:K"%1O8[2#L W'IC-?/_A/]
MLSP'X$^&?@<^+O'6I>-/$&NZ1)JUK?67ABXBGU2!97#.MM#&RQE0I!3.0$+'
MCFO8/A_X7\4^%?@9HGA_7+ZU\4^,+'1([2YN9W,<%[=+#M.Y]A(4L,%RA)')
M4GBOE[X9_LM_%SP*?@_'/9>%+J+P5X1UG0[AEU>;,]Q<[C"RG[+D+E(0Q.<!
MY, [1O /6IOVV/!9^*7A/PU;1W<WA[7O#4GB:/Q0UM*MFD PR$G;E5"B4R.^
MT1D*I.XD"$?M_?!NW_M8:GK>I:-)IMK#J$L=]HMVK/:2R)'%<IMC8-$S2( P
M/\0R!7C&B_L1_$2/3/!MA?7OA^**/X=W_P /-;>.XEF$$,DKM'=6P,:YE*L
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MHU0 YLC=;?+\WC&,XS\N<@@8?AS]MSX6^+?%%KH&EWFM3WMU?7.EPR-H%['
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MV>9.#)&Q*E?8BNO\3?M@^#?"GB)-+N=,\0W=O)XE7P?'JEG8"6VDU8HK?9E
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MA2W? ).!^)H ?1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MU6 7%I<A2N]"2.5/(((((/(((KRC]J7QB;Z'PU\*M'GTRX\4>-[P0G3-0O\
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MPK\+?$E]XLU+5_,O9M/A@U-]0N)[>&[N4*,JJ'FVJ64,PR=VW@ _2 '(K/\
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M** "FL 3S3JX;XX^)_$/@WX2>+-:\)Z>FJ^)K+3I9=-LI.1-/C"*%R-QR1A
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MG=7.^#_VK/C/KW@S3;GQ!>^';7_A*OAUJOBK2[O2M.E5[*6UVX#%W*NS*X)
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M?B/\ O@M\.KYO$,?B?P[J/PXUW6;/P]-I\4,=A-8-&T)$R_O) 1(=P9L8SM
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M  TUOQ'\2[KQ!I_C6V\70+92:5:11Z>VFQW!@E,JKEW+Q _-QCY<'&: /TG
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MHZYI,2:M!HWBV6!=0BEO4=+Q1R+>0,XCP@.$#+C;7LGC']M^^\$^/?&?A_\
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M5W\?;3X%^)[.WDT.73/B_#X<U)--U-Y[&ZVQLX>-P$\Z)U\ME9XP1\V  <D
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MKX9.]A-XRNM>\,6ND:9I6DZ1=6<:-8_98/*DE:8'=*TQ"L<@!2.,YKP+PO\
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MNXY  .LTW]B"VLP1=?$KQ5J+GP/-X",D\=EG[#(Q;M!U4D!>^%4$GDG-L_\
M@GKX<TBZTR72OB#XUT:/^QK+0M<@TV_2W37;6UB$,2W 1!M(A'E93:=O(.XL
MQK:Q^V]XDTOQ-XEC_P"%9QCPQX8\4V/AS5]4EUQ5G1;N2)(94@\GEAYR%T+
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M!V$$9'IQ7:?LU_&"Z^-OPZE\174^BW#KJ5S9I+H4SO"\<;X1F63]Y$Y&"8W
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MA\6>,K8R^*SXR@TVTU*..TM]0?\ US*GE$D2< Y)95&%9<MGZ8HH ^;/!/[
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M#@.&)(# $+P,>^T4 >#>#OV./"/@>]\#W.G:]XH9O!U_?:CIB7&H(Z>;>?\
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M)?V"?C!X@\&:;HLVI^!+R73_  _X?TNQEO[B^D&FS:9)ES;A8@ +@ %Y"I8
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M$X [G )QZ"@">BC.*,YH **,8HH ***CGN([:&2::18HHU+N[G"JH&22>PH
MDHJM'J5I-8)?1W,,ED\8F6X5P8S'C.\-TVXYSTQ4T$\=U"DT+K+$ZAT=#E6!
MY!![B@!]%%% !129%+F@ HHHH **3(I: "BB@G% !1110 456U#4K32K5KF]
MN8;2W4@&6>0(@).!DGCDD"K(.1F@ HJI;:O8WE_=V-O>V\][9[#<VT<JM)!O
M!*;U!RNX D9ZX.*MT %%5+[5K'3)+6.\O(+62ZE$-NDTJH9I""0B GYFP"<#
MG@U;H **IW.LV%GJ%I83WMO!?7F_[-;22JLD^T9?8I.6P.3CH*MY% "T444
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MY\>;K6O!'A>7P'X3\/\ BK7K+69;B+6+N?9 ]EY;K)LB+,J/%-%A&._)).T
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M;]B/X2/9:?8/H^J'3;2PBTLV']OW_P!GN;6*=IXH;A/.Q.B.[;5DW  [1\H
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M/:KOAW]COQQX*UNXN_#7QFNM%LM<M=/A\36L.BHS7LMM!';M/:R-*6M'DBC
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M!W=B6=ARV,B@#ZZ^'E_<:C\/_#=Y=RM/<SZ7;332N<L[F)2S'W))-?,7B_\
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M^R%JOC'Q_P"&_%GB?Q^FMWVAZGIVKV\X\/P07JRVL2*\,=PKY2VFD5Y&AVD
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M\:]#\1_\%#_"VDV>D3Z5X2\0>(C<Z'I^OWEO8I'Y]K!>#=$BH6_>RA0[%5P
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M_-QNQDUWWB3]C"V\2:M/=W'CW7F%SX,N?!EPTHCDN)HIW>66X:8C/F&5@V
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M7EU!1X\\;Z?I^HZG;:[>Z;97ULEM/J<)0_;"AMSM=V0,P4A"V"%&U<?3BC%
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M)7^B_#C^T;<:G'K<\4FI0SP,D;"$VY\IAN .6;)S]T<G*^#'[+GQ2^&OA_\
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M'?V>OC(D?A0ZFO@>SFL/B9=^.+UK'4+J4"VF28&",-;+N?\ TF49.T85#W.
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M7=7Z6VLVH:/X1AFU!7U35;6R#W"62C=<S+'EQ&#M&68' X'(Z4 ><^(?VD]
M\.?M&>&/A#/;7+ZMKFG3WJWRJ?(AD3YHX&.,;G1)6ZY&U.#O!'HUWXPT*PEO
MX[G6].MY-/57O$ENXU-LK8VF0$_(#D8SC.17Q'\5?@E\0/$?P7D^*UE:^*+/
MXLQ^)H?%UMX06"SF:&Z25+9(=ZQM(T:VB 8\T@XSMYVU:^,VA^./$OCSQ1XE
MTWX.Z[J,?Q"^$[:";)%M5:QU/S)W,=Z7E4+A)(P&!8G:J@$C  /H+]I_]HW3
M_P!G[X0:MXMM;G1=2U:"&*XLM*OM36W:^C:10QBQEG.PLP"CG;U%2>*?VA[#
MX<W?Q U7Q=<Z+I_@_P ,:?9W:3VNI)/J3RRJY,,MJ.8V8A5C&?G)X[X^)==^
M$7Q-L?AC\0/">L?!K6O$6H^+?!>A6.C:G;M:RG2FL;.**2UF/FGR]LJ23*$+
M%R_3).WN_BE\'?&OCZ7]I*YT[X=:W92^-/!>D?88[]K<>=?01J9HB8W;,R[U
M4=0S1/AL%<@'UK9_&*&;QE>-<7_AJU\ PZ!#JZZU)K<0N [R8.^+HD.PH1*6
MP2<<]NOTWX@>&=8AU6:P\1:3?1:4YCU"2VOHI%LV )*S$,?+( /#8Z5\)?&S
MX;^-/B!J'C?5+7X2:]%_PD/PGAT-+62*VD,>J?:1+'&<2<%$*$L/NLC#J!GE
M?C!\.KOP3X3^+)@^'=_X0\(Z_P" ?#VG6YMK2VM ^LK<Q^7"^UR&;?<*LA()
M.QAG@9 /T5\*_$+POXZCDD\-^)-(\01QYWMI5]%<A<'!R48XYKQSXH_M)Z]H
MGQWL_A/X)T'1-7\3?V*->F7Q!K+:>MQ"9&06]L%BD,DQV,Q)PJ@9YYQPG['%
MX@^+_P 29O%7A?4?#?Q2U^"TU.^CFT:*RLOL42BWC%N4GF))<,SEF7<S95<*
M<6/VL/AC%\5_'%WI/B7X2:OXHT*+08GT/QGX5-NFJ:9J+27'FQ;GGC8IM6!A
MP4!)W9W# !Z3X"_:N\+^(M3\ ^&?$07PEX_\5Z2VJ+X9O)U,UI@J!$Y.T[G)
M;8-H+A&('%=[I_QD\!:O8ZG>V/C?PY>66EX-_<6^K6\D=IDX'FL'(3)X^;%?
M(%S\,/C19?\ "GM<\0>#/^$Z\76_@?7M!UCS+V$K%=SB-K1+J4N"RE4\MG1F
M^8L=W.X^+-\"OBQ?>"/%FD-\'_$;'6/AM:Z'&;R33EC@OH+L2)%!%'("D"<A
M/,+3?*&;);<0#].-,^(/A?6X-4GT[Q+I%_#I3,FH26M]%(MFPSD3%6/ED8.0
MV.AKR;X5?M5:)X]\1_%==1U3PUIOA/P;J-I:6WB&#68Y;6ZBGB#K(\QQ&IW'
M9@$C=E<DC)^5?$O[/OCJS\0>-+?P3\)I['P[<6O@_4SH3"TM+/5UL#OO+)MK
M[/,8RKG<N&\F3D_*'L^)_AM\5]6\8_%?Q5I?P<U6QTWQ%XH\,:O9VLLVG#4;
M6"T@=)YK>/SFB^T!]I DWH!*25R#0!]UR?&'P)%I%GJK^-?#J:7>+(]M?-JL
M @G6,$R%'W[6"A6W$'C!STKB?BW^TAHWP^\0>!-$TO4=!UK5O$7B#3]*FT[^
MUHUNX;6Z)"W4<(RT@'RGL"#G-?&?P[_9O^(.J7_PZ\.^-?A%?2^&M/\ 'NK:
MKJ)UF;3KY7T^ZC&Q)F28[]KMN?"[6VG;D@ ]?+\+OB+X-\3W'AV/X+76M10?
M%6#QE8^)])N; 0OI@N 8XOWDB/&\<0$00C 4=0O4 ^W?B1K^L>%? FNZSH6F
MVVLZKI]H]U#87EV;6.?8-S+YH1]I*AL?*1G . 21XCX>_;$C\??L[77Q#\):
M+8ZCXBTZ6WMM4\+WNJ&!K*:25(V5I5B<X <.I*#< 1@$$#V[XE+?2?#SQ0FF
M:=+J^HOIERMM80.B27$AB8+&K.RJ"Q(&6('/)KX[\7?LC>,;GP-\/_&?A"S;
MPS\0Y=)T?2?''AT20B'5H83!YC,0YC\Z)HR5<-DH,9R I /KZY^*GA+3/$]E
MX6U/Q5H-CXLN@@CT1]3B%T[,,@)$Q#MGG'R\CM75CGK7P+XP_9_^(FN6_P 8
MOA_+X.EDU#Q;X]@\4^'_ !_#- \%A;FYADWO(7$T<EO% 45%4DE]J_(<U]I^
M"_$>NZ]>>(X=:\,2^'(M/U.2SL)9+M)QJ-L%4I=*%'R!MQ&PY(VG- ''>#OC
M/JOB+]H+QW\.;_P['I=IX?TVQU*SU,7@E>^CG,BEC&%'E@-&P ))XR>HQSWP
MH_:2NOCG\3-9L/"5GHZ^!M$N9;*?5[W4,W^HRQC#M:VJC*PJY \YVPP/RK47
MA7PGXI'[7WQ"\17GA6^L/"FI>&;#3+36Y;JU:*XF@EE9PL:2F501/@;D',;9
MQE<^!_ []F7Q=X0\8?!W0)_AS'X;O/ASJVI7.H_$"VN;;R=9L98YEABC"N9I
M'E,B;Q(JB,1''W@* /M/Q[\4O!_PML[:[\8>*-(\,6]RYC@DU:]CMQ*P&2%W
MD;L#DXZ5CZ]^T%\,?"]T+;6/B#X8TRX,,-P(KO5[>-C'-_JG +\AP<J>XY'%
M>&_MJ_#+X@?$;Q7X0C\*^$'\2:0NDZS87-U8ZC:V%U;37,*(J//,"R6[A#O\
MD!SM )P=K>%^&?V=/B;?^#M>@U3X)R6^M+\(%\$VMU=:MIKM<:G%,R;EQ.=H
M*,CB0XXAQGE<@'T]^U[^UAIO[.7P[FU/2=0\/:EXKWVLD&@WU\!//;2RA&EC
MB4[WP"6'085SGY2*^ASP.O-?FEXJ_9Z^.%U\*OB/X+'PK77;CQ;I?ARYM-5?
M6;%)-/GLH+>*6SDW3?,4,#E&0E/WA.?F('Z&^*=9UO2O!.HZGI'A]]:\00V3
M36VAI=11&>XV96'S7(1<MP6)QWH \YT7]I72]8_:<UOX0?8Y(9['24OH-4DR
M(KJY4JUQ;1G&&:..:W8X.1N<$#;4O@OXM>*/$7[1_C[X?W>F:5!X?\-Z=97T
M6HPS2&ZG-UN\M60KM&WRI<D'^YCJ<?.OC/\ 9V^*7A/PG\*/B)X/M/$7BGXK
MZ'J[:E?^'-3U33H[:'[:LDFJKYF4W+)(=J_OG*@H ,+QZS-I'C_X=?M'>(O'
MMAX#U'Q=X<\8^'].MI[32KRQCO=)O;3S<1R"XN(HW1EF;+HYPRXP1@D ]&^"
M/Q#\0_$%/&)U^TTJT;1-?N=$A&F22.)!#MW.^\#!.X<#T]Z\J^*/[3GC*P^-
MGBCX=>!K#PM+K'A[1X=533_$=W-%=:Z\B,_DV008!4!02V[+-C  )'J?[/\
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MIU2^^+>G>+-/NH[S3HYYM,B='<[C-\I'E$;6(),Y//S8^^%8M$"5*D_PGJ*
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M5(&7!;"CG(4UR^H?LX_$[2O&DWQ2T'PWI1U27QZOB4>!)M02-#:_86LWD>8
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M1)'N851T+JQD #*,98'TY'/O7Y=OI=UHG@?3+%/"OB^;X4>&_B3XB6ZTK3-
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M:>0: .[U#QAH6E:Q:Z3>ZWIUGJMT 8+&>[C2>8$X&Q"=S9/' ZUXL_[1NO\
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M\<OB]XK\/?"B^U_XE)J5G\3?#/B-Y(=/TJVLVTB>RAW1S0S*I8R9R&W#:#G
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M7B&D_$;XA>(M*\%:-;_$W6K"34OBQKOA*[O[46KW$EA&L_ED;XF5601+M*J
M#)G!PN #]!L ]J  .U?F1J_[2GC&Z^'&BZ#%\3+N3Q%IS>+K>:ZFU&WTS[1%
M9SB*SN;J\*'+QKR(8DW3%E+%5!9GO\=/B)X_\(:YK=M\7-6TJ31OA#I_C%[?
M2WLPLFJH)$E5R8B0F^+]Y&.2T@7*@!2 ?IIP:YCP7\1-#\?7'B&'2))Y'T'5
M)='O?/MI(0MS&%+A=X&]<.,,N0>QKXGTW]H67XB>/=?U36_C%>_#6_T>X\/S
MZ!X;\I)$UFSFM(IY@MF"K7<EQ),Z?NRWE@18SU-%_CWXKLK7QQI-UX]OI+I/
MC#=Z!I\\]Y#:YL4MQ)]G:Z(Q;Q*V2656/RE0O/ !]OZ]\5O#'ACX@>%O!-_J
M!A\2^)EN7TNS$$C"=;>,R3$N%VKM49^8C/;-=:'4_P!:_/7X(?%2^^)WC3]E
M74M?\0VOB#6X=8\76-S>I<)(6*6;K'D@#)*%,$@$@J<<UZ7^W3\0O%G@F2PG
M\/>(KFQTVUTB]N]2T[1]2BL]2104"7L8D&V=(B"&BR"=U 'UM!J=C<WES:0W
M4$MU;;?/@20&2+<,KN7JN0"1GK3[F_M;-H1/<10&:00Q"1POF.02%7/4X!X'
MH:_-F?XG67@GQA^T1JFG^,=0T75-=U_PPEF9+F.*ZFBN+>!SDRD>0NURAE.1
M$IX!P!52#QY<_$K3_ +^*/B(#/X<^+UQI[:A8Z[O6&T^RW$D0,^$W!C&\:2,
MH+*7 X)% 'Z<9!HP .E?FAX+^,_C#QHD^O7?QZ30?$>SQ%;:KX-CWM=PLD-P
M]NZV[C9;) D",)MI4YPS;F(,>B>-?'^KOX"BG^-?BN.+Q/\ "N;Q??R+=6RF
M*[MXBRK&?*'EH#]_!#-Y9W/RU 'Z9C HVC'2OS)7]I'QG\2+7PU:ZY\9=/\
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MY:>)?%6KZAX,\=^%M1^(^M>*M/UCX)V?B^X^WZM)<J-3$JM)Y 5E94*!MT>
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MW!]FN530K4":'<&\M_W?S+N53M/&0#VKOZ* .7M?A9X,LK[1;V#PEH4-YHD
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M.N:["]Y8)JNNL+:]3SHT6VAG2$QBYVNS%)&0<( <N*^O@<B@!:*** "BBB@
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M^0C!?F[#M5V;XO\ @6UUG4=)F\9^'XM5TV)I[VRDU2!9K6-<;GE0ME%&1DL
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MX4!?G6,Y 7:?8K+]I3X8ZAKFJ:1!XQT[[9IL-S<7+.62$);C-PRS,HCD\O\
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M]<\0ZS_PM.T\86?B/2_(N89M-2XB=(O.DD23S(X5\H!ACJ2P^8U^C0&** /
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M ,;?AAK$?@O7/"_A'P'//KMW<:Y%%!=7UVT!2&VMXQ(V=I)WLV%]&Z9^I**
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M_ -[X#\,6\%M#KL.F?%&[U>2XO/+NXKA8C%:J<QSEYHR\A*C:C<,VW/Z(44
M?(_P(\"_%VP^+'PWU3Q?X!TK0=/\.^"KCPI?ZA::O%,'=9(&BEAC3YMCB 85
MON[VS@@!KWQ7^%?Q#L/C=X^\1^'/#-MXW\/>./!RZ ]O<W\4 TZ[3S$7S5D(
MW6S+(6;8&?.["GO]548Q0!\K? ']GWQ5\*?C!HESJFEV>H:%IGP\TSPM_;B7
M2%Y+NVE:5V6$C<B$OM!Z_(I(])OVU/A!XN^+$_A0^%?#MW?W>FVNHM:Z[I&M
M)IFH:1>R+"L+*SN%D@D D66/:25 (((VM]1T4 ?G[\4/V;OCA=V/Q#T32_#V
MA^)&\;:/X6^V:\VK)9)#=Z8L2SQB#R^?,="RD!45,_Q86LJX\(^)/CQXQ_:9
M^&NE^&-.$^O^(]%.J:^VI0O%I02W@>4;2HEF,9A81[5 +.V?+P<_HOUK%T;P
M3X>\.:EJ.HZ3H>FZ9J&I.)+VZL[2.*6Z89(,C* 7/)Y;/4^M 'PAX&\*:[\;
M]4^.'@O1-%T^333\74O[WQ3)>(&M$MY;>5]D(!9Y=L&Q3C:3*V3P<R^(/V3/
MB>6UC7D\(Z!XFO+7XF:UXMM?#6JWR?9-3L-0B6+8SXPLT83<&8<%AC)%?=^C
M>%-$\.W5]<Z5I%AIEQ?N)+N6SMDB>X<# :0J 7(!/)S6K0!\7>$?V=OB!X?\
M7>!-:B\#>$M MM/T#Q#!=:5X=N5M[>SN+XHT$"_)^\(\A \O0M*V!A1GFX?V
M4/B5X@^%/PT\!:GH>FZ-%IO@77/#&J:E:ZBDBP7-T\)AD"!070FU5FQS^^;N
MO/WK10!^?%S^RG\5-3^!_B/P^?AM\/- \0S66G:6DVARK%/J8@N[>XDGGG*?
M*N+; B Y:4DXV*#U/Q(_9X^+'BKQ9\8];TW0=(BDUOQ%X8\1Z%#<:F"D[::D
M,<L,S!<Q[A'N! /0CT-?;U% 'Q;X>_9A\?:+\6=4N;CPC\/[[2=?\1MXFF\6
M7, N=5T8RNLL]O;%T!+AE*1RC&W<'QGY15^&/P%^-W@WQ)\#]*O-"\)S^'OA
MA<ZA:IK*ZK(LVHV=Q;M D@A\DF-U1B2NXAV R5'-?;E% '-_#B[\4WW@G2I_
M&UAI^E^*7C)OK32YFEMHWW' 1VY(V[3SW)KI*** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#YAD<<UU] !112$X&: %HK&\(>,]"\?Z!!K?AO5[+7=(G9TBOM/G6:%RCE'
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M0%^C-5_9&^%FKQ>*$U/1;Z^3Q0;,:P+O7M0D^V&UQ]FW;I_X,#&,=!G-&O\
M[(_PJ\6W'B^35-"N[Z7Q7!9VNN;]<O\ %Y':A/LZN!/@;!&N",$\YSN.0#YP
M^+'CGQ_8:]^U3<)XPFMM-T7P!I5WI=C;0 +9^;!<.WE'.%;<LV7P6(=/F'EK
M6CJ_QZ^,L6J:EX-\"C3]7U3P9X;TG5+RZU-K.W34?M \R1IC-<(88HX1MWHK
M?-DLRY4'Z0U?]E[X:>(-5OM2U+PY]OOK_0O^$;NY[B^N7:XL?+,823,GSN%)
M E.9!DG=FN=U3]B+X(ZROAZ.]\$0W$FAVHL[*1]0NO--N'9O*F?S=T\>Z1LK
M*7!W8(QQ0!Y'H?[3'Q@\=^/M8U'P[I_A^'P;X>\8V_AK5;6^O;58%MB1'+.M
MT9A*9&DD3RU\G:PVA=Y)%>I?M=_$_P <?"[P_P"';_PG'+#I+W,SZ]JECIRZ
ME=Z?:I"669+4LN^,2;?,8<JO3!((ZN?]F'X5W'Q/C\?/X/L?^$O66.Y%XKR*
MK2QX$<K0AO+9UP,.5)!Y!SS6]\1O@QX3^+%QI$_B6PN;FYTGS_L5Q9ZC<V4L
M(F3RYEWP2(Q5U&TJ201VH ^!_%?QM\=^#];\9?$SP9K_ (9N-1/PV\,>(];O
M8],=X-;E$]S!B/<R&%6$I)++O'EHOR\U[#XY_:7^(.D?M#6FD:5J%C=^$H_&
M^E>%KJVMM/22"".YA0R1S7+.K_:PS,P2)6157YVS@-[5<_L??"*ZM=1M6\&P
M1VNHZ9;:/=V\-Y<Q136=N4,,+(L@7:IC0CC/7.=S9H7_ .Q#\$]4U">]N_ U
MO<7,\L%Q([WMT<RQ*%27'FX$F%&Y_O/SN+9.0#Y<T*&U=]+D1(3Y7[3=U'$Z
M#A5\J8;5]!A5&/\ 9'I7TU^U;XY^(?@Z;X96'P^UC2-(NO$WB1-!N9M5L#="
M,2P2R+*H\Q?N>2WRX^8E>5 .=Y/V2OA7'#%"GA@QQ1:Z/$Z1IJ5V%&J#_E[P
M)?\ 6>]=;X]^$7A7XG7>@W7B73#J%SH5U]NTV5;J:!K6?C$BF-U^88X)SCG'
M4T ?)O@K]H+XY>)_$FM)#?\ A>?2_!/B>'PMXADOO*LX[@(J17%T,OO1Y9G)
MA50$^ZN&(:M?P+\>OBEK?C9OA)>ZWIQ^)>G^-;B+4+IM+58AX;BMEF2[$(;C
MS?,A0'=P\A&<"O>=5_9;^%6M_$V+XA7W@?2KGQC',EP-39&W-*@PDC(#L9UX
MPS*2"%.<@8[*U^'GAVR\8:IXJATBWB\1ZG:16-WJ2 B:6",DHA.> "QZ8S@9
MSM& #X?^''[1_P 4=1\#_"OP;X<M_#UOXQ\1OXEGGN+:U@M+8FQOY(DC@A8J
M@W9+MP6(0GJ6:MWQC^TI\6_A_KN@V'B#6="6?Q5X0O8M$CTFUBN('\56TR0_
M9%E+X82,<8. K2%<_(37O=[^QE\&=2\'6GA6[\"65WH5G>2W]K;7$\\C6\TH
M E:.0R%T#[5+*K!6(R03S7;M\'?!CV?A*U/AO3S;^$Y5GT./RN+"14*!H_?:
MQZYYP>H!H \5_8]^/'B_]H>VAU_4;BS@TG2]$ATS6]/CM-DJ>(A-(;D;B3M5
M(5@.SGFX'3:0>-U?]HOXB-^T@FC:5JZ7_@]_&*^$W-KID1TZTW6+R%7G<B:6
M\6899(_W2HJ@L&;%?6?A;P1H7@FWU&'0=+MM*CU&]EU*[2V3:)KF4@R2M_M,
M0,_2O,_$O[&WP;\8>);_ ,0:OX$L+S5[Z[^W7%R99DWW&5)EVJX4,2JDD ;L
M<YH ^8OAM^U#\8=+A^'7BSQ?XFTSQ%H/B&/Q7;76A6VD):LCZ3%=RI,)P2=S
MFVV;<!0A&0S98[_PTUWQ-XU_:2_9Q\:^(O$=IKDOBGP+JFI?9[&RC@AL7=+:
M1HHRI+,@\U4_>,QS&QXW$5]#:7^R1\*-%C\.QV?A*..+P]>37^EQ-?73I:SS
M%3,RJTI!W[%W*<AN<@[CF7P9^R?\)?A]XET[7_#_ ('TW3=6TUI7LKE-[&U,
M@(<1!F(1<$@*H &3@#)H \C_ &FOB%K_ (OU_P"+7PWL-?M?#6CZ'\.9];N,
MVD5Q<:A),MPI3][D+$B1 ':N[,H.Y<#/GGP[^(/C[PU9Z3I7AR\T<)%^S_IV
MLZ&;ZS@A>&^58XD$MP^"4W?-M9@@+<CC)^MOB+^SY\//BSK%GJWBWPI8:SJE
MI ]K#>RJR3"%L[HBZ$%D^9CM;(!8D#)-8]M^R=\*+**>&W\'6MO!/HK^'9(8
MIYUC;3V)+0;0^,$DG.-V23G- 'RYX0_:E\<>)/%.A?#R\\;ZCX7UK6?$KZ=?
MWWB71;.WU30DBTY;C[.$$:V\IGERL<I3[K?=)Q7;>'_C%\0+7XBZ=X3UKXEZ
M3J2-X"UJ\O-6T:UM_LR:E97JPBX1GC^^(S^\C.8PZ/@ #CW*;]E7X47GA"Z\
M+WG@G3K[1;JZCO;B*\WSRS3QKLCD:9V,C%4^09;A?E'R\59UO]F3X5>(='\.
MZ3J'@+0KK3?#T1ATNV>T79:QG&Y% ZJQ +*<ACR030!\?Q?M/_%6[TSX2^)M
M9\1WFF>$-6T31KK4M8T/3;2[ABO9KW9*NHP[#+!'/&NR.2/:N[< &(.WTOX$
M?&GQWK/[4&H>&/&NO:@EM>VNK3:9816=K)HFH0PW42P36%U$OF%HXMZRI*Y^
M9AT/ ]HL?V2_A!ILFFM:_#_1K=-.CBBMX8HBL02.5IHPT8.UP)6:3YP?F.[K
MS70^$O@9X!\">(&UW0?"FG:;JS"95NX8OGC$S^9-LR3LWO\ ,VW&X@9S@4 ?
M/G[3WQ?^)?PP^+$WAW0-;NO*\8>'7'@ZTM[*UD9-<BN;='@)DB.Y&B?>2[8"
MM*?EVJR^>7'[2/C_ .)?P4L?B-IFNR66DVM[X:T&[TRYT6W*W.IO<1#4I098
MRP53-&JE<!6C<CI7W=J7AW3-7U#2[^]L+>ZO=+F>>QN)8PSVTC1O$S(>JDI(
MZG'4,17*ZY\"/A]XE\'_ /"*ZGX1TN[\.?;GU/\ LQH (/M3R/(TNT8^8O([
M9]6H ^%_C9+KMYX&_:?BNO%-YJEQ:>/M M;"#45A:.!3<Z:Z, B*VU/,"8!
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MZ-Q&V^-_+*+#;J&+MD[5*U]JV'[)7P;TB]6\L/AMX;LKE?,Q+;V"1L-ZE7'
MZ%6*X_N\= !5?_ACKX(_8[6V;X6^%Y8K6&2W@673HW,<;EBRJ2"0,NQ'H22,
M'F@#YI^+7[1_Q+U7XC^)_"W@_P 1WFD^*19^'+GPKINEZ=;WEE>I>$"]DNI&
MCD,00ER"[( J @-N&;4'QP^*'BCXY:U:1?$?0/">C>$_&MIX<O-'U.:+S]2L
MCY<09+46C2/<7$DNZ.1)U1<*IC !8[7Q'_X)XQ^*?&WBB[TF3P1'X;UR&SMK
M>VUKPS)=7>A106R6P2Q>.YB10%3>NY<!FY!Y)^CM/_9Y^'=KKND^(+CPCI&H
M^)M,LXK*#7+VSCEO-D:>6I,A&2VW(W=>: /B[P-\4/C=X@LO@G=3_&&8)X[U
MO6O#UX6T:Q_T>.VFN DT6$QYY%NP4D,@WQY5L'=0^'W[6/Q3^(_A#P'X:'BB
MS\/ZSJ<^O6O_  DFMR0V37LEI($MT)-O)'N"R990@+&/&1SG[<LOV:?A1IUC
MI-G;?#GPS#;:3>OJ-A&NEPXM;EF1FEC^7Y6)CCY'9%'11B5_V</A5-X>&@R?
M#KPN^B"Y:]&GOI,!@$[##2A"N Q &3UXH ^+]:^+'QAU"X\56H^+4$4OAKX=
M#Q-+=:%8P/;WMY#)*I\LR1YV.8QNP.<_+@&O0OV6?%6J>.OVI_&WB34_%=XD
M6I>#?#%Y;Z#<21JCFXM)9F14*[AY3><V$(P9F+9[?3%W\!/AO?37<MQX%\.R
MRW=DNFW#MID.9;50H6!CMYC 50%/ P*NZ1\(? _A_6--U?3/"&AV&K:99C3K
M+4(-/B2XMK4 @0QR!=RI@GY0<<GUH ^./VH?C]XR\+?''Q&/#?C:X@TKPA/X
M>CO-/AFMK6SLS=S_ +U+A9%:2[DDC(8",HD2#);.0:NK_%GXD0>-];\00_%.
MY3P_I/QAT[PI%I#6EL]N]A<F#S3*X0,4"2X3! &USDN0R_8WBGX$_#?QSJ\^
MJ^)/ /AG7]4N(E@FOM3TBWN)I(UQM5G="2!@8!/&*I-^S9\)CIUS8'X9>$&L
M;FY2\GMCH=MY<LZ!E25EV8+@2. QY =O4T ?%.J_%"_^+5Q\%O&WB#QK+'JX
M^+W]G'P=LMX8=+B26YA164)YQD$2H2[L0?/. O!'OW[7%M*GQ3_9]N6\2ZCH
M%A_PE4T4YMIXHX!_H4[+(XD1E+#85!/02/CDYKV+4/@)\,]5\0SZ_>_#WPM=
MZ[/.EU+J<^C6[W+S+]V0R%-Q8=FSFNA\4^"/#_CJQ@L_$FAZ=K]G;SK=0V^I
MVJ7$<<R@A9%5P0& 9@".<,?6@#\]_A_XV\7_  JUZX\2Z)XDO;_2M6^,?BC1
M9?"*10_9;E6%U,"&"&0RF2%-IW8&< <G/HG[(OQ=\;_$;Q;X2\1ZU\4='UBR
M\2VUU'?>$XKGS[B&ZC$KCRX%M8S:(BJ 2[N'ROS,64M]4VGP.^'5@]N]MX#\
M-6[V]\=3A:+2+=3'=D@FX7"<2Y .\?-QUK2T3X:>$?#7B"]UW2/"^C:5K=\&
M6ZU*RL(H;B<,V]@\BJ&;+?,<GD\]: /G[XZ^-_$6A?'_ %#1K#Q?J>C:3+\,
MM8U9;> P>7;74$T82X0-&3O 9OO$C X ZUX%I_[0WQ.^&OA^+7I/'&H>,;O6
M?@PGC&+3]1MX"EKJ'GVL0EC2- 2L<<LKN"3NV,6Z<?>GB3X0^!?&&N?VUKO@
MW0-:UC[,UE_:&H:9#//Y#!E:+>RD["'<%<XPQ]35'2_@+\-=$U#3KZP^'_A>
MRO=-MI+.RN;;1[>.2V@D\SS(HV"91&\Z;*C /F/G[QR ?!OQ&^+-U\'?B1\4
MO$G@OQ_)X[U>;X;Z1<VVNZA<17!B634S#-+&D2!1M67S@FTA2W(V@+6YXE^)
M?Q%T3P=J;>'/CUIVO)_PEGADQ7&D21ZE)IME>-+#+%-<21!) [JDH3 91'AO
MEDP?N'1O@YX#\.332Z5X*\.Z;)-#);R/9Z5!$SQ.27C8J@RK$DD'@]Z\R^-?
M[)>B>/\ X<Z;X-\&VWAOP)I$.N6NM7MG%X>2:UOC"<B.2*.2($$[=V<[@NWC
M.0 ?-GB[XU?$CX?^.-3^&FH_$AI?#$'C*#3/^$_U=DM757T[[4;&6>*+9&1,
M8U9@H.UR,H,[;&A:_P"/?'7B#P5X#E_:"N[J&Z\/:X][XF\*F 1W$MM<IY9C
MF>+YV42[&E3J(#MVDNQ^WH/A1X*@\)CPNGA#0D\,J_F#1AIL(LPV<[O)V[,Y
MYSCK2R_"CP3/)9/)X/T%WL;<V=JS:9"3;P$,#%&=ORH1(XVC ^=N.30!^>VG
M_M&ZK\<?AC<>'/B#XZ;PMI\WPEEU59+>Z@M&UV]?SX96=F4E@JQA3&N S/(2
M#A=M31OC-XFC\&>#_"EC\7]&^%%OX8^'?AN\T]]0FXU!O(5KIDC /VEP8O(\
MD$G[VU2V<?H5#\$_AY;V-C91>!/#4=G8LS6MNND6XCMRQRQC79A22 3C&:O3
M?##P=<?V1YOA/0Y/['V_V;NTZ$_8MIROD_+^[P>1MQ0!\(:QX^\9Z/XP\5>-
M9/BUKZ:=X;^+>G:$OAZ6YBCLI;&Z:V%Q&\;*&;"3'8A8",1.WWB[5[K^Q,ME
M8ZW\>=/34;NYO[;XBZC&\&H7IFF\E8X!%*58DX(^4.>6$:Y.5P/;KGX+_#^[
M2]6;P-X;F6]N!=W0DTFW83S ,!*^4^9QO?YCS\S>IKH=/\.Z7I6H7]_9Z;9V
ME_?E&O+J"!4EN2HVH9& R^!P,YP* -&BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N-^,GCNX^
M&/PJ\5^++6RAU&XT;39[Z.UN+E;:.5D0L%:1N%''4UV5<A\7/A=H_P :?AQK
MO@G7WN8]'UF#[/</92".90&#!D8@@$%0>01Z@T ?,>D?MW:K=6%]ILFA:;>>
M);CQ/I'A?1+J W5OI]Y+?P>:LS^=&LBQ1A),E0=^U=N P-=A>?M#_%"SUWP]
MX!G\$:':?$O5I=6EC6?52=-DLK-04N$*@R S&2(+&P!4%F; &*;??L >"]:?
MQ%+K'C/QYK-WK4EI=M=WNLQF:TOK8 07UNRPC9.J@H#RH4X"CC%S5_V$?!.J
M:-H4<?BCQOI_BG2+V?4(_&]KKA_MZ>6:)(9?-N71@P:.*),;1A8U QSD P-8
M_:N^(A37-/TKP#ID/BCP;X6M_$GBS2=1U-F:.20.QL[5H58.^R*1MY. 2BX)
M)(KI^VQJ]]X0^*WB?3O#FGW>F>%/#NA^*=-BENI(9+NTOX9)FCF.U@DB+&<%
M0021TKJ]9_8<\'WEVMSH_B+Q1X5FN-#?P]J\NE7D+2ZW:O(9)3=R3PR,\KL\
MA:92KY<G<*9X[_81\">-Y]6C@USQ3X4TC5M#L] OM(\/:@D%K<V]JK+;;P\;
ML2BG  8*<?,K9.0#AO$?[9WQ"T7Q1XQ>/P-X?D\(^%-<T;3=0NWUB47;PZBL
M!C:-/)"EU%PA;) &"!NZT:5^TQ\2M"LOB]J>I6VA:C%I'Q#A\+V#3S/;V^GP
MNEJID?\ BD15DW;4!D>20A5Q@#L=2_8/\-:MH7C32KKQ]XXEMO%MQIUSJ3&Z
ML2Y:R14MPI-IP-J1;LY+>4I)SG,_B;]A;PEXF\1:]K8\8>-='U'5M8M/$!DT
MC4XK=;;48(O*^U1H(2OF.I.[<&')VA: .$T#]M+Q]XUTWP#:^'O!F@S:_P")
M/$FL^&Y5U*_N;.&*2QC9Q*$:$RJK*I+*X#J5VD ME8_!/[3?Q,^*/Q"_9_-M
M!H>BZ/XJ'B ZSIJF61WETV9K>4)(<?*0RN@('S?>) %=MX._8,\,^!?$WA_6
M]-^('CZ6?1-:NM?M;>]U&TN(FNKE-EP7WVI9@ZEP3NW'>QW9P1=\/?L0>&?#
MT/@L0^-/&C7'A'5-0U+2[L7\$,P2^9'N[61HX%\R&1T+G(WC>P#@8  *_P"S
M!^U'K?QT\::]HNL:;H^A7.F6AFN=$6:5-6TV?SBGDW,,H&X;-C"6/*$MC@\5
MZK\>/B3<_"'X4Z_XMM+2TO9].2(K'?WB6ENN^5(R\DC$ *@<L0/F;;M7+$5X
MCX@_8>DT?P)X@A\)_$+QI?>-KO1;?0--U_5];BM;FPM8[A90HN+:T#N,JN[>
M'9E01AXP<CV?XK?!'2?C1\*/^$&\37^H- RVSMJ=C(L=VL\+*ZS*SJZAMR9Y
M4]3]: /GI_VYO$%O\,M<\13^';.$Z-XT/A>_U>6VO4L;.U, E2_FA*?:$1BT
M:8*\&0$G'!]NM?C'JQ_9DE^)1T_2-2UJ+09=5^Q:?JL8L))41FVK=.0HCR.6
M8C'.1D8KC=&_8BT;P[<ZA=Z5\2_B)87]_JZ:Y<W?]J6LS37/V9[>0NDMLZ.L
MJ/EU92"53&T*!78V_P"RWX*MOV=7^"T8U%?![VCVK2"ZVW;%Y3,TOF!0-YE)
M?[NW)QMQQ0!X#??M[>*=&\ _$#6W\*Z3K=WX7NM$1/LLEW907<-^2N]/.BW,
M%D78'P$;)8' &Z_XH_;4^)'P^O?$GA[Q%\-]';QEI&I:+%%9V&M.;6\M=1D>
M*(QRM$"'65!&2P4?,S8PH#<S^TS^Q%?>'OA+XME^'VH^/?'GB[Q,^D65Y;7^
ML02B1+2=)!<D.L:K(L<6P$9 R $ +&ND_:7_ &;-='PLGN?#3>,?'GC?Q!XC
MT2ZU'5KB:P34[.TLW,B"/8D,""+Y]H"$F27)W D@ YCXX?%;Q1\09-+\*^,O
M"]AHWB[P5\4/"91],O7GM;F.[E+Q,C,JL#@,IR.O(P>!T]C\?5^&_C[XL0V7
M@K2+#QGK/Q"TOPG:70U&8V^IW5Q;*8)[C<"8_+MP"RQH Q&%R26KT[7/V./#
M7C+1KS^U_%/BRYUW4M<L/$-[X@DGM%OYI[-2MK&RK;B!8XP>$2)>><G)RSQ+
M^Q#X&\8VWQ#BUG5O$5]_PFFJP:W<2&[BC?3KR'(AFLV2)3&R(0@+;\JHW;CD
MD YSQU^TG\4/AQX>TB/Q'X/T+2O$%]XBO=(C9+N6]BNK:*W,MO-!;0!KAWG;
M"",*63!9@!7C6C_&7QY\3?CC\+?B=X!\(://XH\5_#"_6;2]8U26&WC\C4(V
M<*RH=Q+@!00O^LY;Y:^@;G]ASPC+IWAI$\7>.XM:T6[NKP^)!KI?5+]KB*.&
M=;B=T8E6BABC^0(55?E*Y.8O#O[#GAGP9IWA2W\-^-O&VA77ANQO-,L]0M[V
MTEG:TNG5Y8&\ZV= NY 5**K*>0<\T >&Z)^TI9ZI\4]$^.$^@S6<C_!W5M3O
M=+\\M^]M=3BC,:N00%WH_P P&=I!() %>Z^ OC+\9O%^G^*%D^'FGV]]%I%O
M?Z#=3RRVMG>W#@&2W<R?/A=P_>!0#MSCD8U%_8O^'T5_8&$:G#HMGX3N/!BZ
M DZ&RDL)WWRE\QF4RL^',@D!W &J/@G]B;POX&\&:]X>M?&?CR^;4],71K?5
M]1USSK[2+-=I\FQ?RPL"ED5B IR57LH  /?=)>[ETRT>_2**_:)#<1P,6C63
M W!2>2 <X)[5;JKI.GC2=+M+)9IKE;:%(1-<OOEDVJ!N=N['&2>YJU0 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4=:*
M*  #%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $ Q2T44 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
24444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>exhibit99-1xu005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit99-1xu005.jpg
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBD9E098A1ZDT +14;7,*% TJ*7^Z"P^;Z4IGC'61!_P "
M% #Z* 0>G-(S!!EB /4F@!:*8TR(P4NH8]B>:$F1R0KJ2.P- #Z*0')IGVB+
M./-3/IN% $E%1M<1QLH>1$+<*"P&?I1+<10*&ED2,'H78"@"2BFAPRAE(92,
M@CH:7/% "T5!%?6\V[9/$^.NUP<5*9% !+  ]#GK0 ZBFM(JE06 +< $]:=0
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 'I7Y3?'W0= T_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ME3QM\(=&T?5=4\-6.N>*O$OB\ZSXH@M;U%@L+)H+F)85+G]Z5-U(Q"]=Q&2
M"0"I\7_V_P#5[+]F#P3X\\%6]FOB36=QU!)XO/BL/*;R9@4RIRTS*%R>0<\X
MJ/X__M7_ !4_9S\>^ 9]0O-'\4>#M0TNPNM:ABT[R+F%I'9)'3$A(5MK%<Y
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MG<ZK9WDUQJ-U<I*L<*6^1%#$#-M&1PX'\(KZ5H **** "BBB@ HHHH ****
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M87%A=P1SV\R@@/&RAE(!Y&016A0 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 $9IGDQ[]^Q=^,;L<XI]% $!LXBV[8N[K
MG'-'V.';CRT'3^$=NE3T4 1R6\<C*Q12R]&(Y%-%K&NX*BA6&"-HP:FHH C2
M!$X"@#T P*>4!&,4M% $1MHSGY%YZ\=:8+*,<;5V]=NT8S5BB@!D<8C&!TQC
M Z"GT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4=:** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/Z9\$O!/B+Q7XLA\8:QXADNX+27PKH=VSZF\$\JRFWLE1IMD2IAV*@#;DXW
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MOX/UV\TV[LVBM)(X[N+4#$S>?YK\(4=!'QRQ)KZZL?C#X#U1=>:S\;>';L:
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M 8@ _7'PTL]>T[P)HEIXFBT^'7;>U2&Z32YGEMPR\#8[JK-\H&25'.:I:O\
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M4 ?GU\#=6\9?LF>%/%WC'4_ /B;5O &E:!8+#'KEO;0:[I869C+8+,64W5M
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M+W(FR_F.FV*0*BM)SMVY_A ;Z_>58_O' ZDGH*C-Y$ 6+?*!NSVH _-?XQ?
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MV7^UKJ$MV_P?U:XT^_UOX7OKZR>)X+2)Y(6M9;=UMY+F%1N>!971V# J-HW
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M30!\;:A^T!XU^'_C'QY\.-0^(>I7VC1>/]#T27QG?FW2[TFQO+=YKD^8$\M
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M)! )Y.?O5?@+\-%L_L@^'GA06OEM"(!HEMLV,X=EV[,8+ ,1TR >M6HO@UX
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MP8#(/UG^R=XQ\3?&G]F'0M3\5ZFPUV\BO+"76],VQ-<K%/+ EW%\NT%U17!
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MFN\T'X<>$O"NJ2:GHOA?1M(U*6W2T>\L-/B@F:% H2(NJ@E%"( N< *N.@H
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M3JJ*"$Q'!<*2/+P0NUBN,<?<UEIEGIVG0Z?:6L-K8P1K#%;0QA(HXP,!%4#
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M'A&XT2]\,Z7=^&_L9T&ZMH[FQ?3U46\D,BAT>,+QM8,",>M &O1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% '@?[7GQ4\>?"O1OA_\
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M_8L@\7Z;>W'@:&-]5UGQ'9ZYXAM=>\0:C%#J:VZ.JJDJ-(;>09C =$R @'0
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MA@ !&*C+!2S>V:!^P3\&O#3;K#0M3C=;&\TR$MKU\WV:UN@PGAB!FQ&I#O\
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M3_%=YI'B70OB;\.-9URW;3-.-O\ V5<0V:3F,DR/YD6RX";CR753QDBOHO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MF?!^71?#6@?%KQ!J'A#QAXH\/#5#<:G/<2Z/I4\4^XI?M(7C^TM;%V.00N<
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M_"WX,OX(\;^-/&6KW]KJOB3Q)-#$)+2S^S0V6GVZE+:TC7<Q(4%F9LC<S'@
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M"2:BUK]FG1?AOHMSKOP8\/>&/"?Q!L]-33-,O]62=K&*U$BO)%(D;YVL YW
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M&DIK6E1W*7:VTDLD8$J A'RC*<C<<<]<'J!7':I^R3\)M;E\227_ (/@O/\
MA([R#4-66:[N&2[N(=XBD93)C*^8_0 <\]!CS_QQ^U7XQ\*_&SQ[X5@\"V-[
MX6\$Z-#XAU;5_P"TW6Y-BT3R,88/*Q))F-U"!L97EN<#B;G]L_XLZ1\)/$WC
MS4?A586VCP^'(O$.D7DM\\4#[Y8P;=]P\R1A'*'#HBJQ4@[<@T >VW'[&?P4
MO->GUJX^'>D7&K37XU1[R4.\AN@VXRY+<$MRV.&(&[.!4]I^R'\(;&#18(O!
M=K]GT::XN-/ADN9WCMWG_P!?M5I",/\ Q*1@]Q7BFK_MP^,_AYK>J^'?'7@;
M1['Q%=:9I>L: NG:I*]HT-_>K9HEW(\0:-HI&)<A>0C;5Z$Z'C;]L#Q]\,+/
MQYI6N>#=#U?Q=X6O]$C6/3-0EAL]0M=2D\J(HTB,T<BRAE(;Y<?-GL0#;^)/
M[ WPTN_ASX@TWX=^$?#WA'Q3>V+V-MJDT$DB+&[@RQOA]V)$#QEA\RA^.F*S
M_@+^QK#X1GU\>*/#G@W3/#NLZ3_9ESX8\+3WUS87Q:59#<3?:FP'7;A-B@J'
M;+'Y<9K?$WXR:W\8/$/@WQ-H7ATE?AS/K,WA2TOIF@EDDNKB!%^TA-Q=A"@)
M"@*)& &?FK"\)?M,^+_#O@+X9^'O '@;PW:Z?<_##_A+HH]2U2Z\NRCMA&'@
M'R,\@PR*N6R2V21MPP!]":-^R=\)/#NG:18:7X(L-/L])U4:W9Q6[R((KX!5
M$_#Y9P$4 MG R!U-,7]D_P"$EDEHR^$8(TLM7;Q!"3=W&(]0(&ZZYD^^=HR3
MZ5X3XS_;_P!3L/!7AC6=*\/:38WFI>"8_&36NM7CJ+UVG6 Z?9LH'F39+-ZX
M,?R'=QZE^U7KEVO['?BC6?$'@VRUR5-'AOM6\-W-_-!$%5HY)D$L8#G9@D8V
MYV]10!TEE^R/\']/UKQ#K%IX"TJVU/7X;BWU&ZA5D>:.?/GJ"&&P/DAMFW()
M'0D5:TW]ESX7Z3?6=Y;>$K?[19Z1)H%NTUQ-*(].<,&M0KN1Y1#L-N,<\=!7
MG/C#]J'Q'X3_ &D]'^'-QHFGZ)H%_=V-I8ZIK"7"KJWG1[I1:W"CR1+&S*@A
MD(9L$@G*JWF+_M\^.+70?B1?WGA/0K#5O".D2ZK-X7U*6>SU"()=QQC._B>)
MH7+K-$NTL%!"[EW 'U/9?L_?#NP^%DGPWA\(Z8G@:0-OT0Q;H&)D\PL<G);?
MAMV<@@8/ K,F_9;^%EQHL&E2^$+22S@U./65WRS&0WL:;(YVEW[W=4^52S':
M  , 5YE\1OVOM4\ >,/B5X;E\/V=U?Z%-H5KHC).RK=2:F9%0SY^ZL;1C(4D
MMG@#J,;Q%^U;\5?!7P_FU;Q/\-5T.2TUF2TO-7-O<7-I;Z?Y3-'>26T):=%9
MPJ-U"\G+<+0!]->.O /A[XF^%+_PUXITJWUO0KY56YL;H$I(%8.N<$'AE4@C
MN!7F_P#PQG\&?[)U32QX&M$TW5/LOVVS2YN%BN!;*4MPZB3!$:G"CH./05JO
M\8+JU_9K7XE-#I-UJ*^&EUA[>+48XK%KGR [1BY<[5C\S*[R>GO7SW:_MR>.
MY/ _CS4H/!>D:OJ7A;4=!@+>;<Z;!=V^I[51D2X3S 1(Z ,P"LC[P<## 'T5
M:_LS_"ZR^)<?Q B\%:6GC)&WKJ_EDRA]FS?@G&_;_%C=WSGFM3Q=\$_!/COQ
M1!XBUW1$U#6H+"XTN*[>>53';3HZ31@*X #+(P)QGISD#'@2?MA>,])UC6/!
M7B#PAHEO\0X?&&F^$[1;'4I)=,S?6ANXYI)&C60B.%6W*%!=@ -N<C7_ &(8
M-2M+OX[6VK):1ZE#\1+U9TL&<VX8VEH<Q[R6"G.<$\9(H ]%TC]EKX2Z=<:%
M-9^#K!FT&SGTO3UDDEECM[:4R>=!L9RI1O-D!5@1\V.PQ1\,?L9?!'P7=7-S
MHWPWT2RFN;*?3IV6)F\VWF4K+&P9B"&4D'/8D=*\6^$GQMN/A]8:%H^B>#]'
MT6RUCXNZSX/U*WAO+BX"RAYY6N8GD.<LT394@*,C"J.!J>$_VP_$7Q(U.S\#
MV&A:/_PF.J>*/$'AY)KEITTZ.VTQ%:29L9=F?S(U" C&YB2-HW %[XR?L1>'
M]0^$T7@KX3>&/#'ARRN_$-CJNL)>S3Q+=Q6S$F+S(U=\G[HY 4,Y&":]:?\
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MA^+OBCXJ:!XSM_&=EI-IXE\)^)KOPY>2:%YOV*X:%(G$L8E)901, 02>5]Z
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,-[ GDXP32ZA\ ?"NH_$[4O'[RZQ%XDU#2VT:>6'5KA(?LA4CRUB#;%P27!
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M0!1C A QD#/U#>?!"'QW\ +/X:?$+5;WQ&DVFV]EJ]_!=2037KQA2S&0'?\
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M6.YT+6-<U6QAN ]SI*V#F,P2(44M+)("BKP<AC@A2:YS1O\ @H%I6I^!M/\
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M/85V/C;Q%XI_9I@^$_AGPM;W-_/XZ\7B.^M_$GB"6_;3U>,.]G!/)$[>5\C
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M '67>#]SCS3]IG]H+QW\,OC=X[T:R^)FF^&M*TKP5%XHT?3=0TZVD^V7AE>
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MI?AS7I[2_P#$GA^UM8474[V +F5)_OVZRLH,B1\L"0& QC/^$/[8NGV?PO\
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MAI(O%.O>%/#GA Z1I^LZ/X*BUI;EWNY97MYX1<)M'EB!/WA*-\V0,DU]>_\
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M\*?M6Z-XTL)+O2?!GC&\1;O3+<+:Z?%<^9%?9,5VK0S.AMT4%I'W?)@@C<"
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M\">#?V'_ (P?"S7[+Q?X&\1>$-+\4VFMZQ=&TU W<^GW=G?&([),*) R-$O
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1PWK22@"WDD"&-']"PD3 ZG>OK0!MT4FX>M (- "T44FX>M "T4FX>M&X>M
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MWJ-AI4:S7445Q*T4+["R@!F1^21]QCVKOK'4(;ZS@N8G!BFC65">ZD @_D:
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M*#NW$$DD^N_M0WMOIW[-OQ5GN9(XHAX6U-=TC!1DVLBJ,GN20![FO1K2SM+
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M3M)+.35M-"Q7L092H=)<$AESE2<X(!Q0!\C_ +)6F^.IOB1>> ?%NNZ[J?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<;O>?$O['OPL\77GBB?4M#O7C\36=I8:K:6^LWMO;7$%JP-NGE1RJJA-JA0
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M.C_8K^#,/CK2_&">"H1X@TY;98;C[9<['-N%$#RQ>9LE=-B$/(K-E58DD9H
M\M^!_B[]H_XT^%_$6LS>*?!6A117UYH]FD&D3/)#<6NHK'+(RLY#*T*3H%SD
M'RR?XJ^P!T%>!>+OV,O ^J?!/Q3\-?#\,VB:7XAOO[2N);N\O+\Q7)D5WGCW
MW 99#MR,-LW8+(XW*WN>E6 TO3+2S$TMP+>)(1-.VZ1PJ@;F/=CC)/K0!;HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MAS;NQ/RS+A@%)&"<$ ]LO?VW/A!I]IHLMQXCN8I=7NKRQM[0Z7=&Y%S:D+-
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M*DY)C386^;Y/FP #NR2J@'L5%%% !1110 4444 %%%% !1110 4444 %%%%
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M4MKKVEWS7"VVH6LYM@&F\N=6\H$9!;!XXYYK\HO#5G=P6NJ&Y^'GB;3;#4O
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MYI!*(B[6R!H_LR^/I?V<Y?%/B6Z\&>*M=^'VG>&(;DZM<>%Y;+7].S>#-A=
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MX0ZIK>HV$7COX>_%#7;/Q%X,\/6&D0>'[58C;75E B2V=X9XBUI_I"M)YN0
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M)*H HZ.,[CR0#]$M"\)Z+X:N]6NM+L(+.YU>Z-[?31CY[F8J%WNQY)"JJCL
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 5=3TNSUJPGL=0M(+Z
MRN$,<UM<QB2.13U5E.01[&L-?AAX.6.:,>%-$$<Z)%*@TZ'$B+C8K#;R!M7
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M!1G    '744 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %)D>
MM-FD6*)W<[44%B?0"OA'PK^WAI_A;PY>^-/$9U/7=4\56<_B&R\.I>PV\6EZ
M-%>RVEK#"KLHDN9-DLC[<N^Q^=L<:T ?>-%?/'[,'Q/U'6_&?CKP->W=[JVF
M:-!INNZ%J6J%S>OINHPO+'!<ESO,D+)(FYOF*[=V2"3]#T %%%% !1FO&_VM
M_B[X@^!GP-UOQ?X:TNVU74K::VME6[F\M(1/.D(EQCYR&D7"\=<G@$'P&?\
M:7UCX)?M ?'+5/$'A[Q1KGAZUM/#%S=VD.IQW%MX=6:*1)=BRR@?/+(GR0*=
MVQF.,4 ?<5%?*OBK_@H3X-\,_&B/P(FDW>HV\?B"/PQ>ZE;S#S8+U@.5MMNY
MX5<A&D!&&#85L#/JGQA^.W_"MO$'A[PMHWAZX\7^,]>ANKJRT>WN4M_W%M'O
MED>1LX'*JH"DLS8 P"0 >K9HS7S+'^VG/>>-/"GA*R^$/C:Y\1:[HUMKK:?)
M';02V-M)<BWD:99)591&^0<@9P#PIW#SGX,_M$7\=M\#O#G@+2M=U/0_%>MZ
M['?W/B_6$N]3 M//>:+S#D$!F5PP;I'L&=Q:@#[@S17Q_P#"W]I[3-+TL:3X
M2\,>*_$7BSQ)XTUNR31?$>L1F2":U99+UO/):.*")74*B;ADX&223O\ C7]N
M.W\">#=(\1ZQ\/M>T>UN=,.IWL&L21V4MIBX,'V=5?\ ULQ*EPBXRF&SR* /
MJ#(SUI:^<?@KXKU#Q!^U7\9H_P"VM3O?#T>B^'=0L=-O;F1X+4W$-PS&&-CM
MBW"-2P Y/4\5:^(?[8>E_#3XGV7A35_#=[!:7>JVFCQ:E)<Q(TT]PN0\4!.^
M2)"0K2#@$XYQ0!]"45\\:?\ MC:==W4>IR>$M7C\ 3+JS1^+T*R6ZKI\;O.\
ML8^:)&\J18RWWRO Y%9T/[:G]E:-?:MXJ^&OB/PYIS:39:OI%R'CN8M36[G6
M&WMQ(I"17#,Z$Q,WRJ220!0!],45\Z:Y^V''X9U;6]%U;P)K%CKNAZAH]MJ-
MFUU RI:ZE+Y%O=Q2!L2HLQ6-U'(+=\&D\8?MCV_A'Q+XET)/ 6OZUJ&B>)+#
MPRR:=-;$33WD"S6S#?(N X95YZ,?F('- 'T90#FOD6^_;4UWQ1JO@?3_  GX
M,:TO[SQU<>#?$%CJUW'YUE/;0F::&,IN1R4.?,#;1M( .0PH>%_VE=,^%-CX
MFO-/\(>//$=QK7Q1N_"\MEJ&JVUU+;ZDZ(RQPAI=L4!/"("57!+,!B@#[)HK
MYU\/?MBV7B6VT.QM?!NK1>,]4\2:EX7'ARYN;=6@NK")Y;IGG#F/8J*,%22Q
M<  \FN[^ OQS@^/GPIB\;Z;X>U'2(I9KF"/3[Z2(RR/#(T;;65BN"Z,H)(Y!
M[8) /3Z*^0? O_!0_3_$%IX:UWQ#\.M=\(^!_$,6H&P\2W5S#/$TMG'++,C1
M(=ZC9#)AB/F92 " 6K2U_P#:R_X2WPTV@:AX7UWP->>,O!>H>(?"^IK>HS31
MQV[28+PMN@G6,QR@9( .-P8;2 ?5>X9ZTI.*^&?AS\>M-\!1_"C7O&47BB=[
M;X,IKTFM-JWF6=XD<5O)<!K8G,ER6*_O'()+*.<Y&Y\9_P!IC4-;^ GCJY\8
M?"_Q?X=T>WT?3M92^T#6TA,]K<2J0([U0HCE0A1)&N\X8@9!R0#[*ZT5\R>-
MOVXM#\&_%1/!=GX8U/78[75;31M2O+0DRVLTZ*X=80A,D:!TWMN4_-\H;%;G
M[/\ ^U=%^T!XNUC3M.\,G3])L8[EUU!M2CEG5XKD0B*>V"AH'<9D4,2" 1DE
M6  /?Z*^=/&O[8%OX'^,&F^"K_PS+%;7^NVOA^"^FU"..>>>= RS16V"SVX9
ME0RY W9 !VFLCPW^W7INH^)-#LM<\$ZMX7T?5==OO#<>M7]W;M"E]:F0.A5&
M+;?W9&_[H/&3@F@#ZAR,XI:^)%^/&N_%;]J[]F_6-+TO6/#_ ("\26FO3VDD
MFKDQ:M"EFQC>:S0[(V4X=2V6(D'0J0/7_C+^TUK/PT^)UIX&T#X<W_C;5KG0
MIM>5K748;91#%($D!W]",C'J64#KP >^45\J^'/V[X_'/B;0=(\*?#/Q#X@_
MM+0[?Q!)-!/ GV:T>=H)"RLP),<J2+CJVW(X(-4M#_X*&Z!*GBUM?\+W.C2:
M#HT>M?9[:^2\F97N5MTMY551Y,YDDB!0EL;^2,&@#ZV) [T!@>]?(/QL_:A^
M)_AGPS!%#X _X0S65\6:+HSWM]?)<VD\%VZLQ@D\O;(2 T+\?NRY()(%1^'O
MVB+3P)XP^*WD^$-:F\8W?C>P\+6FF:GX@\ZWO;N:WWP&)RI6T@\O?*0 QP>F
M2% !]AT5\H?$+]N:Z^&^B6MMK'PYU#3_ !S/>ZA;IX?O+F0136]H5#W<,\=N
M[/%(9$6)C$H=BV2JJ6JGI?\ P4!A\1>*?!>@:9X U"+4_$%C9WSV.LWJZ?<A
M9IFAE6VCDCQ<M"5W$!D++DJ#@@ 'UW03BO,/BW\:)/ASXD\%^%M(T!O$_BSQ
M9<7$6GZ?]L6TB6*"+S9YI965MJJ-HX4DE@ *^8/CC^TEKGQ@\+_##1]"T&[T
MAM5^(+>%?%.A3:P]E<+<6P8O8FXA7(BD)5S*A!PJ@K\S  'W;D8SVH#!NAS7
MRY\=_&7B?]D[X4_#7P[\/-,F\1I?^);'0!<:WJDEQ<1)-<;Q%O=&9PZAX0['
M,:E" Q''EGPK_:%G^"GQ0^+%K=Z+J_BCP]>_$.+3KS73J0E72Y[D+'% $E8O
M(%8!,K@*H4=,* #[WH)Q7R[H'[;\/BSXOZ-X5T7P/JNJ>'-1U6ZT=O$5J9'%
MK+"2GF21^5M$32*RAO,R I)':E^*VLZU\2/VQ_"OPAEUK4-&\%6_A"?Q7J<.
MDZA+8W&J2&Y-K' TT)6547.\JCKNYW9 Q0!]0Y!HKYMUEY/V5/$%U/IU]XC\
M;P>.-1TW1/#7A75-:GN$L+P+<O-MGN&?R8#&%8_>(,>T C:!AZK^W7-H]Y_8
MLGPSU:[\66_BZ/P=?:1::C;L(KN:%IK22.5MN^*9$8ABJ;0CEL84, ?5U%?(
MWA?]O:\U75["UUOX7:AX=LG\8_\ ""7E_)J]O,D&K$MB)% #2+M4$N  ,\;L
M9-G1?VX]6N=>LO[4^%>HZ;X5G\5R>#9-=CU6&?RK\3-$@\D*&*%@ 7S@$X!;
MJ0#ZPHKY*TG]O5;K4?$]A>^!I;;4='T&[U]=/@U>*:X\NWDVO#<+M"P2[2'V
M[FX."0:=;_MTZM-HVO7#?"C4H-1L?#%OXOL]/;587:]TZ1@'<%%;8Z@[MA&2
M!V/% 'UGFBOG/0/VJ-<^(2:^? /@&/Q<^F>&M/UF,1:Y' MQ>78WI8AFCVJ5
MBRYD)XRHV_,#7T5&28U+#:Q&2N<XH =1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% #7&1@@,#U!KX0^#?[(WCCP
M_J<=GIGC?6OAOXI\&6-QX8_MBWTJ.^L?$&B37D]Y:2Q>9A$F0RRHX&YT90>
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M;@L57:@^Z@&>X^PZ* /!?@I^SIKWPL^*?B#QAJ/C.+Q##K&@Z9HTME_9 MI
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MM0' 8,QR6R(_%/[$%_XW_LJS\1?$R^\1:3:/87+'5]+CN-0BNH)O.EGM+LR
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M?<1P.O05L44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MS1[_ ,1^-M<L[+P9JM]J,?@I#I>KVFA3:J9IQ>,[0P, 8[)D5?,>; D8;5!
M W<E\7_!MKK&G_M/7=I\-=1.K^*/#^B:[H5Y+X9DW.JPPF[/F^60DC3 LR$A
MF968@X)K]0,4N* /RE\:>#-+\;_&WQ!=ZOX.^)%C8:I)I%Y\/H?#/AV"U@-K
M''&(;<22VK2:?Y<P=GPR+ABQ7&"VBG@?P]X;U5/$5CX0U.WUZ#]H$W"7D6BW
M0F@T+S 9L?N]WV9D)W*,ABPR#V_4@J#2XH _,?P?X.TKPI96NFCX>:SI6OZ)
M\=TOUDL_#,ZHNG_:I?+82QQ[7B6'. I(&Y,##59T+P7J[ZIIFF3^%]:'Q]L?
MBR;R;Q,NFS%GTDW :2>6]*!39FU8H(@W.%4)R17Z7;1Z4N* /RE^#?@G1_!G
MBWX):]H?A75-)U]_B3K4.IWBZ+=12Q::[LD".WE@K 4FAP&X^=_[K8^FOVP?
M!UO<?M(_L_>*9O#LVHV]I_;=A-?6^BOJ'EW,MJBV E"1N0$F9Y5+#"E'88(-
M?8&*3 H _.O]FGPC=2:]\#)+?POJ^A?%S1-3U5/'VI:CID\4EW9F.97>ZNF4
M"Y,DAM3%\[\DD<*:Z3_@HII6K>)/%6GZ5IW@W4M7DN/!NL6]CJUEH4VL-]KD
M,>VUBC7Y+>1O+#FY8,R*#LVGFOO''M1B@#\AO%GA31_B+X4^+7B*\\ ZZWBA
M_A]X:_L^6]\/7J3+JT86"Y:+=&,RY\D"1>J%B#M+FO>;+X,)K'Q^T+2+33K2
M_P#!GQ?T+3O%'BJ"_M]MS#+I,D,CEHW4,$N9I[97#\EFE/48K[_(!KA/!?P1
M\(^ ?'/BOQAI&GR)XA\32K)?WEQ</,< D[(PQ(C0L2Q5< DY/1< 'FG[<VBW
M=_\  ^'5=,T:?6-4\/>(='UN!;*T^TW, @OH7EEB0 G<(O,SC^$L.A-?)7C"
MPM/'$WQ+N+G0O%_@JTU+XEZ;XATN_O/!TUS;H3I<@66[M3$WF0N\;!Q@LK3Q
M.PZBOT\Q1B@#\B=0^'6J:QIOAVT^)_PV\=:1H&K^$H=/T32O!&B17;6EQ'=W
M+/;XNX));0RDQ2C#(P#J&)"_)]J_M4^'?$__  S'X5BL=#U+5K?2+_1KKQ)X
M?BF-[=7FFPLAN[=BH'VD\ M@#>%8XP<5]0X%!Y&* /S*^-GP[N/$'PH_:5;X
M>>"-=E\&:Y=Z"WAG1[3P[<Q[]3BD7[?<6EH80\2;%VM)M56(8 D8K]$],T'0
M=<\%V=@=&MFT&YMHV&F7>G^5&$(#!7MY%&PYP2C*"#U (KHL44 ?'/\ P4%\
M+>"[6S^$.I:YX3AU.VG^(NFKJ36FF_:)IX&AF$B,D8,DNX1QC8 Q8(!@\"OG
MRU_9XT;5?'/P^?4?!FLW'PRUWXCZW=Z7HK:'=QQVFCSV<4:M*BIOMXGN$0HC
M[ $RY !;;^AWQ.^"WASXN7WA>Z\0?V@9?#>HKJNG?8KZ2V"7*\+(VPC<0,@9
MZ;F]:[O% 'YI:O\ "NY_XN!X&7X?ZE9_&!?']IJ/A'Q+9Z7.T<>CK/ +>5;\
M*4B@@M4EC,9=0/E4*7.*^F/^"A^C#Q%^R;XOTZ+0[OQ#J,\EF+&SL=-DO9O.
M%S&VY5C1BOR!QN.!SC/S 'Z4"@4N* /SG^*'@&*^G^.UE<?#+6-2MO%>A:4W
MPUNM)\-SO':%+<+#;*5BVZ>4NF61ED\O@N3T%8]M^S9I.N:G^TE?>-/ >K:Y
MXRM?#MF-%O'T>]DCNK[^QA!=S6GR;9W>\+Y8;LG#CCYJ_2_%+B@#\JH_V??#
MHL=4L8/A/KH_XL6BO"OAF](;Q-M<!MK1X:[&1M8_,.<'K6%\2?#_ (QU:VL+
MB/X7^.8]:TS0/!4L5Y'X7N+V\OFM8T:Z5[AU_P!%,3%U,<2J\DB[F.T$']<0
MH!/O2XH \S^%7QNT7XP:]XLTJUT/7-$U3PK>1VUS!K^G_9G;S8RT<T62<HP#
M -P2!G&""?2884@C5(T6-!T5!@#\*SM&\+:1X=N-2GTS3;:PFU*Y:]O9+>((
MUS.0%,DA'+-A5&3V ':M2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^N^%[S1;ZRL8]'@\2)<2R:'-!(CR_9D0%$,Y7YIOOA?E P2: .\_X;L^'_\
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MQ-\?>.-?U[3M6\/V6N36>M6EL#I[BV\RYD@:!06BE)W(A&54*,9)JU??MQ>
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MMYX=1U:;4X-,L/-^Q:6DBJ/L\!E=G*94MDD#+'"CN >Q4444 %%%% !1110
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M/^(_CSQ?:^&? NJZMI&H>#8;&VU+0VM4-U.ETTS0W4DS[Q&F-RQ0J&=RFXD
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MXJT[Q8=1329M5$NA0:_>6][J\=JL$<>+NX@RDA_=A4^9B$102    ?0E%%%
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MAR.>I8 _4/</6LGQ7XMTCP/X=O\ 7==OXM-TFPB,UQ=39VHH]ADDDX  !))
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MXU:*T%O\0!X/U?1?AC9>+5_L_3[9_P"U[Z1)"[S^;&X6%6B0%(@A_>MS@
M^L?C-\&(/B]I"Z1%XIU?PA%/.'U5O#\D<,VIVQC:-K>5RI.PAB,CD8XJ'XM_
M RP^*%AX'TU=9N/#FG^&=8M=6M;2QMX'29[<'RHR)4;"@9X';.0<#'SO^RSX
MW\0?%+]I:3Q9X@UG4+"YU?X=:+JO]@%HOLL9G>XW1Q@Q^8(\H9AAMV7^9F
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M/U+^R#>ZU+H'BFUU7XBV/Q&AM]4+6ES87,EXME&Z*XMS=. 9BH(/<J&&2<\
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MZ5#);6=N8SMBAD8N\77YHRS,2C97)/'->!_!/XWMK/P7^'G@'X;>!6DU+7]
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M@\6S^$=0T\>( D$4_P!DDNK2>.4P9:&6..1B65641L K$@5Z5\(?VG+3X@?
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MPGBTQ+%? .AM9BXENQ"]J'7S9 HD?G/+!%!]0!6[J_P2\!:_<_:-2\(:+?W
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M)#MY'RDDU^@E% 'R9+_P3ST2\TWQ#!=_$SQO?7.N>&X/#%Y<W4]I(6M87#(
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MAG0OAIJWAB\T?QWXP,/AR;4Y=/M+FXMI8XOMPQ.,F#<>1N!)SNR<G)KZ8HH
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M*\:\$_MB?!SXA7%Y!H?CJPNI+/2GUN=IHI;=%LD&9)@\B*K!!]\ DH00P!!
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MQE\2OB1\<-$B^(?B#78)/">M6TSQ>'IM#:TET^X%RWE^1<\"X@\D %CN)?\
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MHH **** "BBB@ HHHH **** "BBB@ HHHH ****  <CTHHHH **** "BBB@
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M:/V3-6^(OB?QO-H?BBWT30OB'8V.G>*[:YLVGG,=J2$DM&#A4=HF:([PP'#
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MO'Q+>:*NBQ->?:WD66:.*\9RT<,DBY*!20K,H8$EJ +G[57Q<\2>$/$'PM\
M^$-2BT/7O'VMM8'67@6=[&TB57N'BC<%#+AU"[\@9/RGM:NX?$_[/NO7_C#Q
M9\3]3\1?"?3] G:^M]=MK5KNTO5E@$4L;VUNCRAU\U=AZ,>,[@%V?VB_V>H_
MCK9>%[VPUR7PIXP\*:FNK:'KT-LMP;>4<,CQL1OC<!=RY&=J\\8/*^+OV=_'
MGQR^&OB/PO\ %7QUI\D6J6'V2&T\*:4;6UMYA(DB73F:222616C0JH9% +##
M$A@ 6O$7[:W@SP9:>)/^$CT+Q5H.J:#IUMJ]SH]YIB_:WLII1$MQ&$D92BN0
MKY8%3P1FLC5/V_\ P%HC^(8K_P ,>.[2X\/QQ7>IP3>')4:TLY #'=R9.%B.
M1C)#]?D^5L8OC#]C/Q?\4+;Q1?\ C#XCV5QXKU?PM;^$(=3TW0G@B@LUN1<3
M2M$;EB\TK#J&55[*:M^/OV/_ !/\0M1^*]S>^.-)LSX]\-V&@S-:Z#(#;O;[
M=TPS='<&)FPIY4.GS-L.X Z#QQ^W-\/_  #XI\5Z'?Z9XHNI/"T5I<ZM>6.D
M-+;6L%PH:.9GW#"?,O4 G/RA@"1A?$[]J[PQXI^$_P 5(K6Y\<>!+[PO:VD]
MU>PZ+Y6I16UP^8KNWAE/S1L$;);:5&<A6Q5/QK^QEXG\;:5\6(;OQ[IJ7?C[
M0]'T:62/075+7[#]Z0#[2=WF!I.#]W<O)"_,SQ[^QKXO\=6OQ%27X@:7;R>,
MO#>F>'9MNA2$6R6@0M(I^T_,79KG@] Z<G:=P _XF_MI:C\-)_BO;Q>!]5U2
MT\"Z!I]^NHR/;!9YKGS!')*!.&$38CX12WRRY"X6NA\4_MU> /AY#%!XJBU"
MPU6"PL;[5;.+[/(]@+K_ %>4$VZ7@;R(1(50@MC.*R?&G['?B'QG>>-I)?'E
MK:6WC7PC;>'M<MDT7S ]U;PR1P7,+--F- TI<QG<3@#>.HI67['_ ,0])\2?
MV]I_Q=@MM3U?3+;3/$CMX:@D2X%N"D,MHK.?L\BQ';DF0%@&(/W0 =D_[<?P
MO7XH67@>._N;F^O-:'AZ.]A$36XOB!B(KYGG ;B$\SR]F_C=P:['XV?M!>'_
M (%IX?CU:SU#5M2UZYDM=.TW3/($T[)&9'PT\L4?  PN_<Q8*JL3BO,_!?[)
M/B;X??$O4K_1/B3);> ]0\0'Q'/H3Z1%)?>>SB62%;XME87E&64)DJ2H(+%C
MU7[4/[/-_P#M#Z%IFC1ZKH]KI44=TEY8:UHYOXIFDC"Q31E98WAEA8%E=&!.
MY@>"00#R:Y_;%M_AM\6_&&K>(XO&6J>"]0\*:%XFM=/ATM)CX>BF%RL[3>7@
M1K\L.X,[MNW8RJG;ZMXI_:^\(>$/B/8>$]0TS7%@O-3LM%C\0"WB&GF\NH1-
M!$I:43295DR\<3HA=0S+FO-Y?V$M9DT'Q=HS?$IKFTUWP38>"EN;W1S+<PPV
M[[FF9_M $C,'F &!C>G)V'?D>,/V O%/BGQH^O\ _"S; 2Q:EI.L6CW?AH3S
MV]S911HL:2FXW+;DJ[B$' +#)8@D@'(W7QW^)&E^$/&-[)X\NYKK1/CO%X8A
M=K>WS<:89(5-D<1@ 8D8D@9RI&<5]??'+XY^'OV?/!D/B?Q/!J=QITM]#IZ)
MI5F;F8RRDA/D!'&1CZD 9) KP'6?V(?%NJ>&-?TC_A8FF?\ $S^)*_$-)9-!
MD(B<'<;;:+H?*75#G(_B]01[-^TU\&-5^/'PUB\,:3K=GX?N4U6RU+[;>V!O
M%_T>83*H021D$NB G=]W<.^0 <%XI_X*!_#/P9#G6[77M)O(%A?4=-U"VAM;
MW35EF\J,S6\LRR,3Q(1$LA6-E=@ 172']KSPL\OBZV@T/Q%<ZEX:UBPT2;3H
MK6'[1=S7DOEVSVZF4;HV'[S<Q7Y.<<$#FO'_ .RCXLUOXNZ[XW\(_$B/PB/%
M-C;6GB&SDT.*^,DD,?E+/:O(_P"X<1\ X;!&3GH._NOV=-$N/C_IWQ5%W=1Z
MC;Z5_9]Q8#_4WLJ9$%U+ZR1I).@..D@Y&WD \M\*_M6>$/AKX8\4ZCX@\4>(
M]?N[KQYJ.AV=AKPL;2XBGCV&2V@+2QQ);0*<[YG3OW9%.WX._;Q\!^/)_#4>
MAZ-XDOE\16&I7>GS?98$CDGL5=KBS+-, )]J C_EF0Z'?R<<AJG[#'B2^M;^
M^M?B1;:9XLB\<7_C/1M3M]"#PVAO%V7%M+#),PF1@!R2".>H.!VOC+]D(?$[
MX;>%?#WC+Q?>:KK&D:Z-:GU>TM5LQ-&V])[..)&Q#!)"[1X!/]XY).0#K?A9
M^TYX;^,-OX%N/#NEZQ+;^+=,O=5AEEBA L(K65(7%UB4E&:20*H7>"5;D;36
M9\9/VO/"7P/\22:3KVDZ[/' +(W6HVD$(MH/M4IBB ,LJ/,059F$*R%5!)Q6
MC\$/V;=#^!WB_P"(&MZ1<22)XIU!;F"R*[8=,MQN?[-"N<*GGS7,F%"C]X!C
MY<GRW]H;]AS5/CAXZ\6:_!\04TJWUZPLK1+2\T..^?3S;2)(@MYFD!BC>1-T
MB( 6/>@#JM2_;>\(:/X]NO#%WX8\8Q+9^(XO"]YK3:4O]GVMY+L\DO)YF=DG
MF+M(4G!!*@$$\-\9/VF+_7_B!\*(O W_  D]EX<F^(D'AK4-=B2T72-4VLRW
M%N,LUPVUHRH=42,XE&YB!C0\1?L:^,O$.B>,;67XF61O?$'C#3_%OVD^'B!%
M):K&OE;5N1G<(+<[AC!1QSO&VNG[$/BJQUCPY;6/Q7*^"]!\9CQI9:%<>'XW
MDCG,LLKPFX$RED+3/C<,C=WP* /??BC\7],^%\GA^QET_4M?\0>(;PV.D:%H
MR1-=WDBHTDA7S7CC5(XU9W=W55 Y.2 ?E/X'?&_6-=L?A\WB_P 1>.5O]1^)
M&M:1;+&EJ%D$0D,=GJ6"-H50QQ""-T; < $?1OQQ^!M[\4]:\$^)- \4R>#_
M !?X0N[BYTS4OL*7L)6>$PSQ20L5W!DP,A@1_+R?P[^Q7XJ\.S^%9#\3;;4?
M[%\;WGC>0W7AT*US/<Y#Q$I<*%&V6X.0/O.O "X(!MVO[??@"ZL->U,:5KZ:
M-IBW*Q:EMM'COKB&ZBM1:QHEPTL<\DDR&..=(BR9;A036_%^UQIMKJ6F:=K7
M@/QAX=OKWQ5;^$3%J-M; 0W<\(FBD+I<,KQ,N[YHBY!4Y RN?(M<_P""<7_"
M=7>MZAXI\=Q_VU?V<ML-6T'1%T^YGF^U0W%O=7>)C'-+&8%7*I&7#,2<\UVW
MB#]D_P =^+_!^G?V]\8;K5O'>F:]IVO6&MRZ/&MC;O9I(D<8LA(%^?SI&=PP
M+';V4"@#6\1_MN>%] LHD_X1K7IM<G\1WWA:#1IGLK:1[RUC#RYFEN5A52&0
M)F3<Y=0JG-6+3]L71]6^(^A>#=-\):]=ZE>VNF76H*[6T4VDK?*K0^=;M*)7
M"!AYK1HZQ\ GT\_G_8/UVXTGQ)I=W\1['7-.\1>(+_Q%J-IK?A>.XC>YN8HX
M_,39.C1O&8E9&1EV],$$YL)^P*TGB+P7=7OCIM3L_"TVEW%C>7>DAM9@-G'"
MIBCOA,,0S-$6:-HW WMMP26(![G\5OCAI/P?UWP18:UIFJSVWBO5DT6WU.TC
MB:UM+F0@1+<,TBE0^6P55ON-TXSPOA[]K_PW\0]'DCT7P[XIFU*7Q!J'A5M-
MMH[3[;#<VMNTT\H_T@IY848#;B2S(-O(-=U^T%\$M._:"^%>J>"]0O[C2/M3
M13VVJ68_?V5Q%(LD<T?(^8%?4<$\UP_P]_8]\.?"3XDZWXR\'WLFG7EUH$6C
MV-E<Q&>VL[A45'O"F]?,DD6&VW_=9O*;+_/P >??"K]I+4-7LO@=X1\/VOBO
MQ%H_CO1]1N#XOUR6R&JH('*-(R^;L#1,Z.QVN"A4(KMN @_8E_:RF\8^$?AY
MX*\8VGBJZ\6ZS;ZF]KXGU6UC^QZJ;6XD,@CE5]Q9(R@)**,J0">_0>"_V+M;
M\!:+\(+;2/B6]MJ'PZ6_M;>^&A1L+VTNY(GEB>-Y6"M^[*AP>C=,C=5OX6?L
M<:G\-+_X0RMX_.JVOP[_ +86"!M&6(WJ:@Q+J["8[=F>" <X&>X(!VGQ0^-.
ML^%OCK\._AO8>'+V\M/%EK?SSZO:SVZO;K J!BBR2+_JS*CL2"<8"*YW!?$_
MV4/VS;2+X0>&+'XCIXHCU0Z9K.I-XKU>V1[748["622Y\MD<R,T<)7K&H.P@
M$G&?>?BO\$=2\?\ Q/\ A[XXT3Q6_A?5O"7VV':VGI>1WEO="$31D,R[#B$
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M /*_!W[5&L^*M"NKG4O'$?AC?\6_^$7TRXN_#,V[4;(&,BP,.TO;2/N9?-E
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M%'[(?Q-A^(7_  DW_"*?#;XA/XCTB&SU*QUVW:"RT"XB9_*^R(J_/ J.JE0
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M"6C13V.N3V/G13W<L<K(%C;"E2!$T>YAYFYC@!>?(_&G[(OQ4U>R^*FEV?\
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MOM+A:&VO870203+&S.8V*'#)N8 C@G- 'I.F?#+PAHE_K5]IWA;1;"]UK/\
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MOC!HUQK<NFW>B6/AV_M]4M].%C-=0WTP290H<LL7\2,=KE#A@,F@#[X\&3>
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MN.G.<G.;<?L1_"IO"^G:0NDZEYNGZ@VJP:LFL7*ZD+@Q+$3]KW^8!Y:1K@,
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M:Y&S)"23L\:Q*A?$.XD[\( ?:E%>(?#S]H2V\3?%*U\/-JVEZWX?\4Z4VO\
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M%X?N+F:YT];.-)9/M#+F-,D@VZ#.6<N3T&%XU^&<WA;PQ>V$?@WQ!I.@Z?\
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M>./#WCVSN;WPWK=AKUG;7+V<UQIURD\:3)C?&64D;ER,CMF@#<HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@!&SCBOS_P#A-\;?$OBCQJEYX<72'^)7Q*U/
MQ"UGJGB6.2XATS2M+9H[33XXHI$(5G4LV'&"\DA$F5 _0 C-?*6G?L3Z5>Z_
MKVC>((9I/#,&NW?B;PIKNBZE+8ZGI$EZ<WEENC((CWC<I!(8-A@"@) *_P #
M?%FNZ+^U$/#]VFF6MGXT\%?\)1JFEZ/>_:;.RUNWNQ:WC0$$@+)O&_'5XR22
MVXGZVKPOX-_L\CP%\3]8\7W5K9Z?;VNE0^%O#6F6<[S?9-*BD,K/-(P!:::9
MB[=< *-S$L:]TH **** .'^-?CJ]^&GPN\2^)M/BL9[W3;)YX8]2N1;VY<=-
M[GH/8<GH.2*^7+#]M3X@7/@[Q9=6_AW1M1U;0?$6D:8'NH;K38[RVO@H#+%(
M6D1PYX)X*G.W(P?J[XJ?##1/C%X'U/PGXBCFETC445)EMY3'(-K!E*L.005'
M(KQUOV$_A^(]3VZGXL\_4Y;*YO;A]>FDDN)K4@PRN7)RX*@Y]L#CB@#RKQI^
MV/\ %KPMX6^);P^'_"][KGP[UZTMM>:"*ZE@&F7$>X7$:"16W(?O<XP"V !7
MT]\&OB!JGQ-M_$.O-_9C^%&U2:T\/7-@S.]W;0L8I)Y&)*D/,DFPIP4"MD[J
M\J^)7P#USPA9^-Y_AEHL/B;6OB5<BR\22>)M3"VUI T$D7VE4*'>$#@&,=1P
M :]W^&_@73OACX \.^$M)4KINAZ?!I\&?O,L:!0S>K'&2>Y)- 'C7Q>^-'Q&
M'Q5U7P!\+M*\/W>O:+X?B\17$?B)W U!9+AHA;PE)$$9 1F,KE@"47:-VX>>
M^+OVO_B!!IGQ(\=>'=%\.7/@+X<ZK'I6LZ5/+))J=_M6-KF:WG5Q%&BB9=@9
M&WA6.1]VO9_C)^RCX%^.'BW2O$NNC5[#6;&V>P:[T34I+%[NT8DM;3M&07B)
M). 0>3SBL_5OV,/AGJFMZI>"PU"QTS6&LWU7P]8W\D.EZBUJ%$!FMU.T[0B9
M P&V_,&R<@'COBO]K7XPZ#=^,]1MO"_@^;P]X>\667AN-9[BZCN+PWJ6[6^2
M 1&4%U"9#M;.\A5&W+,O/VO/BW97>I^'5\-^$;SQ3I/CVP\'7<\<ETEBZ7L0
M:"90277:V0VXD<K@$UZSJW[$_@;6AXN6YU;Q1M\4:Y;^(;X1:L4VWD!<PM'A
M<HJ[TPO(_<1?W>9=1_8K^'NJ:OJ.JSW'B+^T;_Q#;^)[BX36)E9KZ ,('&#A
M0@=@ ,<8R3@8 /)]-_:V^+=GKL<.N^&_!XTS3_B/:?#S4Y;">Z,]S+</'MN;
M=&X152:,[7+%CG[M;>F_M7^,KC3-&N9[;P[YK?%>X^&]_%%#/\R+*R1SQ_O2
M4?Y,E6##$@/&/F[RZ_8L\ 7MOJL,UYXCD&I>)T\83L-8D4_VFA8K*H& ,97C
M'_+-/[HJIJG["_PWU7Q7>Z\\_B2WFN?$@\6+9VFMS0VMOJ?.^XBB0@*[DY9O
MO<  @9! /*OA1^UY\5O%OB3X9RZYI/A%?#7B_7-6\.,FGQW2W<-Q:^=MGR\A
M7RR8PI7!)Y.5SM7F?@)^TKXLUSPS\,/ 7@#POX/\%ZKXCD\07MRZ6DSZ?;):
M7$H"PP^:K&263DLS$*,D*>B^_P"@?L0^ ?#-OX3BLM5\4K_PB^L7.N:8\FL.
MYBN9RIFZCE&*DE>F9)#_ !&LN[_X)]_"JY\+^'M$B&OVPT#4)]2TV_M]6D2\
MMWG(,R+*.0C,-V.H8D@C)R >??%/]L7XB?#>.S%UI/AN74;#3=/N=8TS3#+J
M7[Z6Y,,X::-E6UC3'REPQ9C@ @$UP/Q6^(GCW1/#O[0WB'Q+/X?\;^%-"\5:
M3!_PC?B/39V@A@+6OE&#RY\#:TJ$J5.]P7+?PGZ)\0_L%_"KQ%YR36&JVEO/
MI\&GSV]EJT\,<ZPDF)Y%5OWDBDD[FSDDD\G-:7B/]C#X?^)K77K:Y;74MM=C
MM(]1AAUB<)<&V\ORI&4L09,PQDN>3MZ\G(!YC\0?VM_B'HNE_%/Q[H.E>')?
M /PW\1KH&H:/?13_ -J:D$, N)HIPXCA -PNQ6C?<$8D\BH9_P!J+XOZ3XKU
M"YU'2_"!\(:=\2K?P-+'#%<B]N(;EH?*F1_-**R+/&6R"&)8 +@;O:-;_9'^
M'?B'Q3?ZY>V>HLVJ26L^K:9'J<R:?JLUOCR9;JV#".5AM7)(PV!N!K,U3]B[
MP#K$VL2W%]XF#ZKXFB\73^7K4R@:C&"(Y% . %^7 [;$_NK@ XSX$?M-^-_'
M7[0VN^ O&UEI?A1[:._DL]#GTVXAN[B.*>-8)[>[,S174;1,[-M2-E., J"U
M6?V]H-1&E?!>[\/V>GW/B:'XDZ2FFMJ2GREE9)\!V7Y@A(7=MY(%>C?#O]E_
MP3\,_$=EK6F#5KR\TX7:Z9'J>IS7,.FK=2>9<"WC8[4WMC/!.!@$<YZ_XF_"
MOP[\7=!MM)\1VTTL=G>0ZE9W%K</;W%G=Q$F*>*1"&1U).#[D$$$B@#Y(UC]
MLKXL>&O%@^%%[X8T;4_BJ==N+!+O0K8RV<]K%907OF1VUQ=P$R,ES&NTW P
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M&!$09@IPPS@\G)[XKO=9_8_^%GB.\\4W&K>'[G5'\3+;C5!>ZM>2K.T  @D
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M:V*W>H2+;6_F*\:RLD"0JW,K2,#MXCRQX]&^#W[-?PU^ DVI3> _"MMH$VH
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MQR ?*FG_ !U^/=U8Z#;2>,O#*7FO_#.7Q^+E/#Q/V(Q(O^C1KYV'+F:(L[Y
MVOA!Q7OWPUTVR^,G@SX5?'*_AL8O&D7A'[0KI&L-OYUU;1O(KR%3((D;S0%W
M;1YC$AB 1T-O^RK\*[2XCGA\)01/'HS^'HT6YG$::<Q8M;JGF;0A+MT&>>O
MKM/#/PZ\.>#O ]MX/T?2XK'PU;6S6<6G*S,B0MG*98DX^8]^] 'S?^QM\=/'
M'Q \9^)/#GQ*U.[M_%5MI=KJ,>A7&F00V_E/)(KW5G=096YM7S"%8L2"&Y;[
MU=;^TYXU^(GA_P"(WPC\/>!O$NG>'H?%FIW>E7DE]I0O2F+22995!=?F01L5
M7@%BN[*Y4^D?#/X#>!/@_*\OA+0(]+F:TBL/-:XFN'6VC),<*M*[%44L2%!
MYJ]XW^$?A/XBZ]X:UGQ#I9O]3\-W+7>E7 N9HC:RL &8"-U#$A0/F!XR.YR
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *,444 %%%% !1110!R/Q9^*.A?!?X>:WXS\2S20Z-I,(
MEF,$9DD<LZI'&BCJSNR*.@RPR0.:\"\<_M@ZQ9^"/BGI;^"=4\%?$;P]X.D\
M4V-AJ5Q;S++:E2OVA9$+(3#)PT;<DK@9KW/XV_"?2OCG\*O$O@36G>+3M;M3
M;M-$ 7A<,'CD4'@E'5& /=:\<U3]CW6O&&G>)Y_%OQ)FU?Q/K7A%/!0U>UTA
M+=(+ R>9<'R3(X>68]7+#&!M Q0!\\0_\+ A?]GF!=2^(-Y:_$RVCFUJS;QQ
M(&GDBTZ27S+>7=YEJ'W"X=4<*=BH%&"#ZQ\!/COI'PV\$3^&K1_'WC3QC>>.
M=2\+V>F>,];BO;^XN[2./[24N21&EM&J%NI^8L!N+5Z);?LLZQ#=? V9_B!(
M1\+H?)A5-(C7^T1Y/V9MYWGR\V_[LXSR=PP>*XFY_8(OU34-3TWXF7.D>,E\
M9WWC;2-=M-'C L+J\ %U$\+2$3Q.%088@@+C)!(H N>-_P#@H1X?\!^%-%O]
M5\$^(-/\07MA<ZG=>&]2:"SO+."&=H"2LCCS&DD1O+5 2Z@GCC/J/Q/_ &D]
M'^&?[/MO\7)="UK5-"GM+.]%C;0(EY'%<[/+,B.Z[2#(@8 D@GH:\\O?V-_$
MT?BG0?&FC?&;7=,^(=K8W.GZIX@FTVWN4U.&:8S%/LS8CA5';Y%4$* O!(R?
M0_C%^S_)\5/V>Y?A9'XHO-/CEM;2TDUN\B^W74BP/&^]]S+N=FB4EB>YXH \
M1\;?\%);#PCJ;Z-_PK#Q,/$EG#]NU/0]0D@MKNTM#(JQR*FYO-D=6#B)>0.I
M[UW]E^V98:[\1[SPGH?A+5-6DL@OVB030P3KNM/M*,+>1U?RSD1^8<*'.#@<
MTGCS]E?Q/XC^*$'CSPY\4;WP;KUWHT.CZ])8Z7#-'J2Q\K*J2$B%AN?&-V,C
M!X.[*\6?LG2CQ=;>-=4\4W6LVWANXEU/3+:'2C+JBHMJ(Q:FY5FDGC)4MLV$
MLQXH R?"W_!1OPQJ6C:%X@\2>#/$/@[PGKNFWU_IFN7_ ),L-T]I&TD\"K&Y
M8-A'"[@-Y7 ZU)I'_!1?PIJ=M<J_A/6XM1E%D-(M(I()5U22[F$,42S!_+CD
M#D;@S?* Q!.TUYW^RM^R'=_%+]FKP+I?Q8GUFTL='L-6L;3PI=Z0^EW&GRW3
M2Q//(TF6E=8W9HFV*J^83\V!CTBY_8:USQ+\/%\,^+_C/XC\2W&E?97\-:BU
MG# ^CS0/O28JI/VB3A5WR'<%! (W$T 7/%O[57CBS\1> ])M?ACJ.BWNK>,I
M_#=_!K%Q$GF1Q6AG$EL_W9$D!R)1P/*=<$D8R_"O[3MI\.M%\0W4?ACQ_P"*
M+O4_B?>>%O[/U+4K6[GM;YTC=882TJI%:]HT#$+\V6YS6]J_[(GBOQ%I&@7V
MJ?&+5;OXAZ5KR:ZGBEM'MO*4K:O;"".R_P!4B;'8YY)8L3G(Q5'[&&NK>3SC
MXD1E)/B$OQ%6$Z I"W@4J82?/R8\;,'@@KG// !I>&/VV--\5Z586]MX.U:#
MQK>>*[SP?_PC%S<VZ/#?6L)GG+SE_+\M8P.5))9@JJW6O1?@O\=;?XS?#&Y\
M:P>&M9T2V@GNK8Z??)%)<RO;L4E\M8I'#?O$=!R"2G3!!/QY^T/^RYXS\(2:
M)!I^J>)/$NC:MXZU/QMJ6I^&?#<5Y<Z3>RPK'$HMFFS)&2\AW#E=I)!.VOHW
M]G7P5XGU+]G/6/!?B2WF\,6LB76D:/-;Z7'I%Y%I[P*J3-;1RR+#*)'F(^;)
M"HS ,2* .*L_^"AFE76B^,;UO!-\+GPUX?@\37%C%J=K+*MF\HC=)0K?N;B/
M(9H&^8#CK@'O/%/[7^A>$?%7BS0KO0]0GN](CT8V*VKQLVJRZFS);11@D!&W
MH02Y  &<UYAH/_!.F;3M)N=,O_BIJ5_87/@R3P1+;1:-:VZ"SRS0E=N2"DC>
M8Q)+2-G+@$BK$_\ P3YU#7KK4]0\1_&'7=6UB]LM+C2_ATRUMFMKO3Y=]K<Q
MA0?NJ778<Y,CL6)V[0#SS7?B;K5KJG[04OC6#QY8:7IOBKPPBZ5I/B5/.T@3
MA"&CE9]HMY)6BW1Q DB500 "R]'\<?VB=6N?"G[1MCXWT77+#PAX-O\ 3+*.
M?P;J\5MJ4*2^1(KB8X.9#(I;&=JMLP>6KJ]6_88\2Z_I?Q#BU/XP7>H:CXWO
M=*OM2O)O#]NJJ]@ZO%L1'7',<0ZXVJ002VX7_BM^Q#J'Q//Q8M_^%C3:5I/Q
M'%A)J>GIHT4B17%L+8"6-RX?D6P&W.!YC9W$*0 3^/?VVY/ASX@\:Z?<?#37
MKS2/!-SIBZYK27EMY<%I>#]W<JA??*>GR*,]=Q3OH>//VU+/P?XJO],L?!6J
M:_96/BRR\%37EO=01.^I7,2RJL<3L-R*K %V*C<<#(RPS?B!^QIK_P 0M(^*
M>GW_ ,3FAB\?II,=V8M#3_1%L0H BS-TDV\@YQV/4GYTOOA1\8K+]I+QGXJM
M?#6N3^-9O$"W&E75QX6TZ[T&ZBCAC@@N'NWN!);9178A,N@; W-D$ ^Y/B]\
M:A\-=;\'>&M,T5_$GC#Q==36VD:4+E;6-U@B,UQ+),P(1(XQG@,Q)  /;QBZ
M_;UN&O/#^D:5\)/$NM^*-1OM5TBYT:TNK826FH:>J-<0;F8!U"R1OY@PI5AC
M+94>N_&WX#K\6M3\%^(+#79O"WC#PA?27NDZQ!;K<!/,C\N:%XF(#QR*%##(
M/RC!%<-X4_8[/A/QMX(\50>-[RXU?1-6U77-4FET^'_B<7FHHB73'!_<J515
M55SM"CDD9H [WXV?&R?X/>"-%UY_#XO)M1O8;*2&]OTL[>PWQ22-)<7!5@BK
MY93(5BSLB@$L*\LT7]N*3Q[X7T"\\"?#W4/$^OW_ (=N_$]WH37\<$MK:P7#
MVS(C!7\Z5YHW6-%4;@,DKD"O5?C?\#S\8I?"-W;>)]1\*:KX9U,ZI97NGQ0S
M'>87B(,<RLA.V0D,5)4]*\1\.?\ !/8^ Y?#U]X1^+OBOP_KNCPW.G)JD=O:
M2/+ITTYG-JRF,*<2M(X=@QS(>,!0H!V(_:XU76?$-U;^&?A;K^NZ3I5SI5EK
M<Q<0WVGW%ZB2F/[)M9G,$<L9E)90I)'.TFLV+]MV*:YT?65\%7*_#36?$4GA
M?3_&#ZC%B2\#O$CO;@%HX'FC=!(6R,9*@$9==_L-V4'C:]U30?B'XH\/^']9
MM;"U\1:!;R)(FL"UC6)&DF8;T9XT"R,F&;+'(R:MZ+^Q-I.D7D6G-XKU6Z\
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M $@0,'0XXY/HGAO]COP[X;U[QB(]7O9O!WB;PW:^%KCPHT<:P16=O T,028
M2@A99SG=DF4DG@4 >>1_M^:G:^"/$_B35/A5K5E::;I=MJMG<B.\%I+'-/%#
MLFEEM(RCIYRN_E+,-BN5+8&5O/V^KIO#>EC1O!5IXF\67\%_J,5AH>J7&H6,
MEC;3")98[BWLY'+2LZA4>) IW"1D( ;I_#O[%,WA7PI-HUC\7?'4\L$=M;:/
M>ZA=QSG2K:&XBF\F./8$</Y$:-O4Y5=N "0<F/\ X)Z^'])73=3\.>.O$OA+
MQE;7E]=S>(M!6VLVN!=E#-"8$B$2Q#RUVJJC:<GDT 87C+_@H!XA\,C5;A/@
MUJ:V6E^'-/\ %-X-2U5+*YALIY#%,&A>+<)8Y59%7^,*S94;<R7W[:/B7PEX
MN^,&IZUX=MKWP?X;30K71;&PN7:]N;G4(Q);@KY/)<3Q^9\Q\OR\1K,22W0Z
MW^P)H>N-XLBE\=^)Q9>(O#MCX9G1FMY9UMK>5)2YF>)F>21ED+,W>9\=%QJ^
M*/V&?"_C*77%U3Q7XGDL=:TG3=.O+2&>WB5I[$(+:^4K""LZA.V$.X@KC  !
MSWA/]M_7=?U73_"]]\+[W2?&NKZX=)T:VO)[FUT_4(%MVGENTGN+6*4)&J$,
MOD%LM&!G=Q)_P3X;4M?^"WCNQ\0F[6X7QIK5E+;3:C+<O;+N0&%;AB'(4E@'
MX)^]P36U>?L-:)J4>C:A>?$3QW=>-='OEO+'QE-J,+ZG @C:,6X+0F/R2KME
M2AW%CDG)%>C? 3X!Z=\ /#VMZ3INO:SX@CU?5KC6;BXUN2)Y?/F(,A!CC0<D
M G(/.>G2@#Y,_97_ &E_'O@?X/?#K0=0\ S:S8:_<:MI?A[Q)?>(=[ZCJ$<]
MU+'!.IC=X4;RWC$A+$;,E<5[S\ /VJK_ ./"^!TM?"MKI]WJECJ=]XBM?[4:
M27P_]FNOLT$3J85+R32"3@[-HAD(W8&8O#/[)VF_!S1+&\TB^U_QW#X+&H:I
MX2\(ZE<6L-O;WDRRN565859G9I71'F9Q&)"?>M?]E7X57OA*V\:^.=?\+V_@
M[Q9X_P!7_MG4-#M[D7/V% @6*%I% 5WSYDKD#[\[#M0!Y3^T[\2_'>H?$7XL
M^ (H[2U\':?\)]2UT2P7\L%R9B)%CG#K']]9(=@CWJNQF8LQ^0<M\%_VY[SX
M7?!K1-*^('@R[M6T7X9Z7XHT_4(-46\FUFW+062,Z[08GDFD0@%G(4DMSQ7T
M;\6_V6M&^+GCBZ\3W7BCQ)H=Q>^&;GPI>V>D7,*6]W93"7/F*\3DLK3,RG.,
MJN0><\9=_L >!-6CLX-5UWQ)J5C;>"H? :VDT]NJMI\,PFA8LD"MYJ2*C!@0
M,HN01D$ ZC]G']H?Q%\:=:\5:;K_ ,.]3\&'1OL[6^H3Q78M-0$BDL(S<VMN
M^Z-EVD;,'(()%</IG[:7B+Q9\2KC1O"GPMU+7O#$&J7^C/K*B[CV3VX=1,[&
MU-ND#2QM'D3,Z@AF08VGUKX*? *T^#,=W(?%GBCQKJ,\$5HNH^*M0%U-#;QE
MBD*;550NYV)."Q)&20J@<C8?L8^&-&^(&O>)=,\4^+=-L]7O9]5;PW;:FHTJ
M#4)4*M>1P%#^\#,74,60-M.W"J  <#\./V[=5\3ZGX(EU_X??V'H?C/PYJ6N
MZ3+::H+RY)L4+S))'Y: !U'R8)/3/WB%L>'?VX=<UNYD'_"!Z9-;-\/G^($4
MMCXD60QPY(CM)]\""*9FV DMM7+'+;#2ZO\ L+1>%/!/AS_A#O&'B+4/$'@?
MPYJVD>&;75;BU2WD:\BE4B=TMP^/WB*"I7 C7H<D^0_L^?L:^,(]'N_!NM:/
MXI\#>#M;T:73_%=OJFHZ/<K>-Y12 V36D/F;TD._S)C]T%2K;\T >H^#/V\+
MS4O!'CG4]5\-:9/J?AZ_T:PMGTG4I#I]VVI;1"[3RPJ8XXV8[I0K(0,H6!&5
MF_;MUN"+7[&3X?PRZ];>+V\&Z8NF:A<:A;WMQ'"T]Q/^YM3+Y<<80[41W)?!
M"X+#F_CY^PQJ=CX#UF?P7K7C/QUJFNW6DIXBTS4-=MHGU&TLVW!XS)"(A,-D
M2J&&P $ <X-_X:_L@:QX^\!WWASQTWBCP=X?TV^M=0\)Q-?::FMZ/>()?/N(
M[C3XQ"$?S$4(P=OD+$J2  #9TW]L+XJ:CJ'@+0A\$_L7B?Q0^J0I9:QJ\NG!
M7LE1V<"6VW^4\<B,K,H.<KMXS2?#[]O74?$^F>%O$.N_#AO#WA+Q'H6KZQ8W
MB:PEQ=2-IL0DN(_(\M1A@)-C%\L$R54&O2O#W[(OA_P[KGA;78?%?BVZ\0>'
MQ?O'JM]?Q7,]W/>1K%//.9(B'?8D2+@!56) !P<Y7AC]AOP1X:T?P)I3ZWXD
MU;3O!UKJ%EI]K?W4!CDAOD:.ZCEV0J6#J[#@@J#P1@4 >6ZC^WE\1-'^'7BK
MQC=_!^==)L- M]?LKZ;[;:V962>.-K5YI[9 \JQS+(#$"C[6VMCFF_%#]K[X
MG:;H7Q,\/OX5T?PGXS\,ZAH<>Z/4GO(C9ZE*L<9#B( 3(S*&X*X+%<[1GT!O
MV /!<GP[U[P7+XO\<7FC:G:#3X5O=9%P=,M/.BF>WM0\96-':&(-E2<( ".<
M[_BK]C/PKXTU/QQJ&L>)/%%S<>,+73H-2,=Y##B2Q>-[:>(I""DBM'GKM.]L
MKTP >D>$-;\=7GC/7K#Q'X;T[3/#MK;69TW5;._\]KV=H\W2F,J&1$?Y5) +
M 9P,\=O7C?PQ^#_B3P/\7/$NNW7B_7-7\+W.EV-A9Z?J^KO>F2>)%62Z*&-5
MA8A0"%+;V9W.W*J/9* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@!,<YI:** "BBB@ _"BBB@ HHHH *
M*** "C%%% !1110 4444 %%%% !1110 4444 &**** "BBB@ HHHH ,4444
M%%%% !1110 4444 %%%% !1110 4444 %&*** "C%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 44'I2#..>M "T444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !117EG[3
MWQC;X!_ OQ9XXBLFU&\TRV M+8*2KW$CK'%OQT0.ZECZ T >IYHKX,_X)J^-
MK*^\=?&3P^OCN]\=7J3:9J+7U[YG[V9[8"]>,,JA4%R715P&VJN<XS7WF>30
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %-=%D4JP# C!!Z&G44 <KX8^&/AWP?XM\6>)=*
ML!:ZQXIG@N-5G#L1.\,0BC(7.%PHYP!DDDY)KJJ** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H/0T44  Z444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
(4 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>exhibit99-1xu006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit99-1xu006.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1OB3HW@Q_""S7M[X8NO$=S-'JB[;8P,B20 %!O\ WDT*A\CAV.!MY\1\,?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<8J?PQ^TM\+?&.I:5IVC^--+NKS503I\1<QF]QU\DN ),?[.:^?C:&P^%'Q
MF^(3V<7Q?U7PQKRRM;LY@DTJ">4PLD>2HB'GIL9AO(8C.,BOD3X>^)[W4M3_
M &6/#GQ(-EX6^'6FF34-)UZU9B;N02$K%,[<1XDCC5@ <!P3UR #]B5 (R,4
M[ ]*;&=R D8IU ";%]!2"-1T4?E3J* #&**** "BBB@ HHHH **** "BBB@
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M9 1\I)))QUS7HE% $=M EM;QPQH(XXU"J@Z*!T%2444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MA+_A*8_$VCOX8P3_ &TM_$;+ <H3YV[9PX*]>H(ZT ='163X<\6Z'XQLWN]
MUG3]<M$?RVGTVZCN(U; .TLA(!P1Q[UK4 %%%% !1575-5LM$L)K[4;RWL+*
M$;I+FZE6.-!G&69B .3WJ"T\0Z7J&JW>F6NI6=SJ-I'%-<6<,Z/-#')GRW=
M<JK;6VDC!VG'2@#1HHHH **** "BBB@ HHHR/6@ HHS6;<>)M'M->M-#GU:Q
MAUJ[B>>WTV2Y1;F:-?OND9.YE'<@8% &E111D&@ HHHH **** "BBB@ HHHH
M **** "BC-% !11FC- !111F@ HK-N/$VCVFNVFB3ZK8PZU=Q//;Z=)<HMQ-
M&OWW2,G<RCN0,"K.HZE::187-]?74-E96T;337-Q((XXD499F8D!0 "23P*
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MO[;'C^TT^%]#7P_H^MR>"]#\4Z5H=]83W4WB.YO6Q-;6Q69"%CR%PH9R<G.
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M)-;QSK=%2J[GQ, 0VU<!0Q->S_L\>(O&.M?M*_M 6&OZ_)?Z1I%YID6GZ?)
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MBC.* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BC.:*
M"BBB@ HHHH **** "BBC.: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHSFB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MLD< D G) ,?[</PIU[XR?LV^)M \+PQ77B")[;4;.TF *W+V\Z2F+!XRP0@
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M<>AP:!)HY\-+XZDTC61^T!-;W!;67DU"UMP]U'')&LSLT;N-R^:RY;&3N*\
M'ZAY/>@D"OS#MOCOKFBKIOA35_BI?VG@BW^(OB70KKQ1JNH3F:.&VA@;3X9[
MRWD210S23,#O ;8,_*I%?;?[).JWVK? ?P])J'C4_$6>)KBW'B8VLD OECG=
M%9=_,@ 7:)?XPN[)SD@%SQ+^TIX+\.^,M0\,1KK6OZMI<0FU5/#VCW.HIIBE
M2R_:&A1@C%02$Y8XZ<C/:?#WQ]H?Q2\%Z1XK\-7@U#0M5@%S:7.QDWH<CE6
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M3,9,SS2R E7VHB9PQZ@'U5:2:/H,EEHEJUEI[^43:Z="4B/EKUV1C'RC(Z#
MS7+>//A3!\1O%?A#4-6U&9M$\.W9U-=#2,>5=WJ@"WFF;J1"=SJ@P"Y5B3M
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M%_-O;FRM(X9+E\D[I&4 N<DG+9ZFKNLZ)I_B+3IM/U6QMM2L)@!+:W<*RQ2
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M242X659XPS.%PRJB[05W$ ^R/$^O:)X:T*ZO_$6H6.F:.@"7%SJ4R16ZAR$
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %><?'GX*:=\>?
M;>'+_4K_ $2XANHM0T_5M,DV7-C=1$F.5#ZC+#Z,<$'!'H]>3?M+^/$^'WP[
MMK]_$NH^$1<:O860U73=(&I.ADG4>6R$;463'EF1N 7 &6*@@'"2?L606MMX
M7U32OB-XHL_B%H-Y>7J^,[MH;RZO'N8DBE6XCE0QNGEPPHJX&T1+SU--TK]B
MFT\+ZMX6O/#OC?5M)&@>'-3T*-/LEO(UQ-?,\D]Y(VT9D,K))M&%S$H& 6SO
MZQ^VG\,O#_C;4/"M]<ZW#J.FZM!HM].="N_LMI<3%5A\V?R]B)(S@*Q(#=1E
M>:T?^&I/ VJ^/H/ UEJ.H0:QJ5]>:-I^J?V9*UA-?6\6^>*.?;Y;-'D@C.-R
M,N<@B@#S*T_8&33?!7A_0]/^)6N:=<Z5X7U#PE)>6UI %O+*YD9]LD9S]S><
M8/)"MD%>>PUG]D^YN="^&<FC>/\ 4]"\:^!+)M,LO%$5C!(]Q:/&(WAEMR/*
M8$)'@D9!7/4DUD_LO_M-S>+?@_X.G\=7-WJ'C'5-+UC5GN;/2V2"YAL;Z2%P
MFP;?,"^5^[')R#SGFU\3OVOO"R?!F^U[P?J6HW&LW_A.Z\4:8+;2GFDM[2,$
M+=3HPVQQ^8 OS]?F(!"G !6F_8=T>TMO"MOHGC/7]%B\/^'M6T*%HA"\L[ZB
MK_:;N20H&\YI&63Y2 &C& N3GL?@9^SE_P *C\2Z_P"*-7\57GC/Q7K5E9:=
M=:K=6L5L6@M498]RQCYY&WDO(Y+-A>@'/)Z%^VCX'\&_#/P'=>/=?F.O7_AW
M2-3UFYM-/DEALFNX8RLMRT2;(0[LQ"\<<X"X-?16H:A'IVF7-\Z2SQ01-,4M
MXS+(X4$X15Y8G' ')- 'FGQC^!2?$_Q%X.\4Z7K]SX3\8^$[B:73=7MH$G'E
M3($G@EB?B2-U [@@@$$<YYR__8_\':Q^ST_PEU.:ZO\ 3;FZ&HWNJ2[1=W-X
M;D7$UP2  K2/O!VXPKE1P*V?"W[5?P\\977P^M],U"]D;QXMXV@M)I\T:7!M
M=_GJS,H",OEMPV#T]17AMI^WOH.A?%;Q1J.NZGK%Q\-;CP_I>L:/';^')VEL
MXY)I89[F9DCW+"2L;AY" 0Z[ <C(!Z;\9_V0[/XF^/=!\9^'?&>N_#?Q'IVF
MMHD][X>* W>GDDB!@V0"I9BK8."0<$JN-OX0?LX)\(OBCXM\5V7B6ZO--US3
MM.TN/0Y+6-8[2&RB\JVQ(,NY5"X)/7>2>@P[Q5^UU\+_  =XLM/#^H>(6^TS
MR6L+W5M:336=L]R ;=9IT4QQEU96&XCAE)P"#7BOC']MG5KVRTCQ#HEA?^'M
M"TOXG0^#M;M]0TF266[M#O20Q@*6\Y7C;]W&"XR@(R<$ ^J?B=X2NO'OP^\0
M^&[/56T.XU>QEL1J*VZSF 2*59A&Q 8[2>M>0:)^RQK.BVOPLA3XB7#_ /"
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M^QO<?%/X):6GQ2\4:GJ^I77@ZTT'3H7T@Z5<:#&KPW!RC,S/<+-;V^YVVY$
M 4!FSO>*?V+O$7C;PYX@77/BG+?^,M<32[*[\1'08E5=/L9FGCMXX!+\C/,?
M,>3><L.%4<5[S\2OBSX>^%<&D-K;WCW&L7JZ?I]EI]G+=W%U.5+;$CC4DX56
M8GH I->9WO[<GP@L],T:]&NZA=KJ^DR:U9166B7L\DMM'(T<IPD1PT;I('4\
MIL8M@8) '^/?V;=?\8?$1/&&G_$:ZT#4)_!\_A34X(=+CEAO]PE:*<@N#'Y<
MLS2;4(8X"AU!;/$^'_V)?$7AZ+PJD7Q.@E_L#P/>^"$$GAP8EAG+$3'%SD%,
M6_RY.?)/(WG'I&F_M??#/6M5N;"QU2^NFA\,GQB)H],N/*ETH(KFX1BGS?>"
M[1\V\%<;@17J_AO7K;Q1X>TW6;)9EL]0MH[N$7,+0R!'4,NY& 93@C((R* /
MSH^(W[.GBKP5\2O .D7=UXHU2P\$^$;72] \0Z-X"BUVVGN1=3.[O"[NMM*B
M+:J"Q.X*QW*.#]H_!OPS\1C_ &)XC\>^)9?MTOARVL=0\,Q00BW34%D9I;O>
MF<.RE5*(=@PV"W!KG_%_[4O@VZTGQ;IFCZ]JFDZA9:;JKP^(4\.W5Y:6TMG^
M[N)4'E[;CR)&7<@)!P>W-6(/VF_!O@CX?^&K_P 1^)+O6YI_#-IX@O-5L]%F
M_P"/-U0?;IH8E;[.CL2=IY'S  [30!Z#\7? EU\3_AGXC\)6FM2^'9-:LWL6
MU*"!9I(8Y!MDVJQ R4++GMNR.0*\L\7_ +,.O>(/V?O!/PTT_P"(<FE3>&;C
M3I5ULZ/'*]Q'8N'MD\H2*$*M' =P;DQ<@AB*FUW]N+X1>'WG2XUO59Y(=+M]
M;D2V\/ZA(4L)D#I='$'$04J6<X"E@"0W%5?%_P"T+!X2U_XNZA8Z[J'B-?"'
MAFTU3_A$X=!D46[R)*Z3+<[09DD"KD E8PCDD88* <?XR_8&;QS<>-=2U'XC
MZE#K^K^)H/%.BZG8V"0MH=Q"&154;SYR^640Y*_ZM6&"3GWGX,?#*Y^%/@XZ
M5J/B;4?&.L7%S)>ZAKFJ8$UW.^ 3M'"*JJB*HSA5 S7SW\#/C'XDNO&?@>^\
M;?%R^GLO%7AF76H?">I^#4T]4:.)'GE6\"+^Z3+,JG)*;26;(+>GK^V5\,CH
MNLZI]OU5+?3;"WU18Y=&NHY;ZUN)_(MY;5&C!G667:BE,Y++V.: )F_9PFO/
MCMXV\>ZEXH:^T/Q5X>C\.W7A@V"HB0H&PWGA]Q/[R7C:/]8><!<9?[/7[*=S
M\"=11[KXC^(_&>EZ?9S:;HFDZKL6WTZUDD1V7"\RO^ZC4,<  $!0#5YOVSOA
M=#I$%]=ZEJUE))K3^'GT^;0[TWD&H+'YAMY(5B+JQ7E>/FYVY(;&-J?[:7AF
M\O\ X9P^%M,U378_&&OSZ)(TMC-:O8- K>>LD<B!A*C!1Y9 XW$D;>0")/V*
M= \._LW>+/@_X.U=_#.G>(M0N;VXU%K-+F1!+.'V!"R@[8DCA#$YVH#UZ4=:
M_8JGU7XFR^+8/B1K.E0:Y;6,7C'2;& )!XADMD6/>?G(@5U7:RH"<$@,,G/T
MEK&L67A_2+W5-2N8[+3K*![FYN9FVI%$BEG=CV  )/TKY6A_;'LH_P!I"ZM;
MW6+G2_A9'\/I/%33:OI$EELVW<<:W",Z"61'1^ !R2 %W4 =_P#$#]D+PA\0
M_&OQ#\47C2PZGXS\*CPO=%%&(E!)^T#D9?BW&#QB!?4UZI\._!5C\-_ ?AWP
MIIA8Z?H>GP:=;L^-S)%&$!..,D+D^YKYR^-G[=7AO1?@_P#$;5/ ,UU?^+_#
M/V6VEL[S2YXS9/=$""XD215S%@E@>F=JG&X9T_ GQ??X?^.?'<'C_P"+.HZW
MI^D:-:ZQ_9>L^%%TR73H)7VJS3QQJ+B1V(C"(N=P*@%@0 #H/BM^RC'X]^(&
MO>+M \87_@S4O$F@GPYKRVEK%<)?6AR P#_ZN95.T2#. !QUS:^&_P"S(OPP
M^+K>+](\2RKHZ^'K3PS;^'C91B*&TME'DXE!R6#;V)QSYA&.AK*\;?M1>%[^
MWCT[3O$FN>#M9M/$FEZ1?1W'AJ62>)KE@T44L<J8BCG7*B8]#G&2,5MZG^V#
M\+](\9)X8FUFZEU&349=(CEMM.N)K>6^C5B]JDBH0\N49=BY);Y1D\4 =+^T
M)\'S\>OA1K'@=M:ET"#5##YU[!;K,ZK'*LN K$#DHO->1>,OV*=0\;'XI&_^
M)5X3\08-*BU';I$ \MK$($=,,.6V'(X W>U=5X*_;;^$OCTP2:=KEY;V4^G7
MNJ1:AJ.EW-K:R0VF/M6R61 KM$&!8*3@5S?Q5_:Z\(WWPJ\:7&B^)?$?@K4]
M)TZRU1M4;PI/-<6UK<2?N9TMYT5720(R98@+NYP: (?&W[!^D^/[CQU+JGC7
M6U3Q3+9ZG]GM52**PU>WCCC_ +0AQ\P=A%C:6V@2.!_#MO:%^QK=Z+XE\">(
MYOB9KNL>(?#VMW.NWVI:G!'+)JLTT$5LZ'! BC%O%Y05<X#9ZBNT\2?M5_#?
MP9XX_P"$1U;6YXM2BO+?3;FZ%E*]I;74RAHHIIU7RT9@R'D@#>N<5J_#_P#:
M)\(?$[Q2=#\/MJ5TYANYHK]]/ECLYA;7"V\ZI,P"EED=1MZD'(XYH \K\3?L
M4W?B-O$S?\+(U&S;7/&=MXS<Q:9 QAGMSF*)=Q/RJ$@&?^F(SG<V<GP=^P /
M!OC72?$%K\5_%131[_4[K3=-$-L+>UCOBS3QJ"A)+,5+,3R%P O6OH+XG_%?
M1_A19:3-JD&H7]UJ]^NFZ=IVE6K7%S=7!1Y-BJ,  1Q2.68@ (<FO-8/VXOA
M=J&G>&;G3)]>UN?Q+8W-]I-AI6@W=S<78@D:*:-52,CS$=&#*3\H&XD*02 >
M@? CX16WP(^%FA^!K+5;O6+#2$DC@N[]4$Q1I&<*VP ?+OP..@%><_'7]D.+
MXP?$JQ\<:/X\\0> -:.E-H6IR:$4']H6#2;S$2?N-DM\W./E.,J*;\1?VL?"
MM_\ "RZO_!&K:GJ6MZEX6N/$>FOHVE&[FM;90RK<RQNNU5$HV;7Y)5@!\I(]
M&_9[\7:EX]^!'P]\3:S.MSJVKZ!8WUY,B*@DFD@1W8*H &6).  !0!Y5X@_8
M=T#5=5UZSL/$>H:/X \2365SKW@ZWMX6M[V2UV>64E*[X5;RH]X7[VWJ,UGZ
M[^Q%>:K)K;VWQ+U'3CJ/CR#Q]&(]+MV%M=PC$<8!/*C;#S_TR&0=QKH?$/[=
MOPJ\+>+=8T'4Y]>MWT;5AHNIZ@-"NGLK.Y8?NUDF5" '(*KU+$9 VX)TT_;$
M\#S:1+<Q:?XE?4X]>3PX= ?1I8=2^V-"TZCR)-I"&%&EWD@!!DXH XFY_88D
MB\7?VOI7Q3\2:98#QH_C>/2!#!);PWCM(Q5,@':3-*&W;MRE1CY<G9\;?L5Z
M1XO\9^*;Z'Q5JND^$_&-Y9ZAXI\*P0PR0:G/;.KHRRNI>$.402*GWP".,\0V
MG[:VA^)O%WPMMO#FD:A>>%_&5GJ&HRZW<P")+6"T8Q2Y#."ICEP9&(VA.5W9
MR+"?M\_"5[+7[O[=JJP:1I8UHD:9(YN[+>J>?"JY)7YT;#A2$;>0%!( (]5_
M8]N4\3^*/$GASXDZUX=US6_$]MXH%PMG;3I;310S0>4J%1OC:*?:0Y/W!W))
M]5^!WPCL?@;\,M)\&Z?>SZE#8M/,]W<JJ/-+-/)/*VU0 H+RMA1T&!SC->16
M'[3/A[QM\7?"+Z?XA\6Z!I+Z?JUP^B:GX8>UM=5CMXD<W'FS1K* BNKJ$^]N
M&0O0X/Q1_;*LO%OP8^)Q\ 2:YX7\<Z#X47Q/:#5M,1)?LC?,DRH^]<%01AP&
M 8''0T >A?%C]E2R^)'CG4O%FE>,=>\%:KK.C'P]K9T?R'34;$DG:1+&WERC
M<0LJ$,!70:W^S3X(UR?X4O)IOE1?#2=9=!A0@K&JV_DI&V<DJI6&0'@[H4.>
MH/H/AFXEN?#6E7%Q(9IY;2)Y)" "S% 23@ <GTKQC7?VTO 7ANV\0SZA9Z[;
MQZ!XDC\+:CNLE'D7<@S&QR_^J;C$G3D>M &7KO[$V@:G\8]1\<V'BOQ'H5CK
M%[;:GK7A?3[H)IVJW4#!D>="/F4L%+)T;YN<,17??L\? ]O@%X*N_#Q\2WOB
M@W6I7.J27=[;PP$2SMOE"K&H 4N7;G.-V!P *Y3Q]^VK\._ASJ%_8:N-72^M
M;^YL$@CLQFZ:WC62X>$LX#(F]%))&6.U0Q! @\5_MR?#7PGX<TKQ#)_;.I>'
M;VSL[^75K&QS;V<-U*883*793N+JX*1AV7:Q( &: .N^._P''QQ;P:7\5:KX
M:'AC6H=>MQID<#>==0_ZEG,B,<+EQM& V\[@<#'"?$3]BZP^(=W\0YYO'?B'
M3SXVU/3-3ODMX[4K$]@%%ND8,1^4;(R=V2?+7.><U_ W[05WX:^*?Q(\%Z_>
MZSXVU6'Q<;31-.TVPA>YM;%]/M+EC((PBK!&]P4$LAR<J"6-=#HW[9O@#6O$
MVGZ)';>([:6]\07'A<7MWHLT-K%J40<FWDE885B$8@=0.6V\T <OXM_8:T_Q
M7XLU_P 23?$+Q3::KJNN66OQW%G]FB:RN;:%H%,16+@&(A3D'[JGKG,'@;]A
M:W^'7BKPWK&A_$WQ=LT.\O;VWM-3:UNUW76//&XP@_,022<Y)R,5N6G[>_PA
MN=;OK :W.(;?3KW58M06$26UU;VJEIFB*,S9"@D!E4L!QG(SL+^UUX1.D6-[
M)I6O03:CJ<.E:?936T227TTMM]I4PN9?*9/*R2V\<C;][B@#S:T_X)R^'].L
M?!IT[XD>-=%UWPS%=V4&O:3<P6UU-97$SS/;-B+;M#RS%2%S^\.=P"A>@\8?
ML)^'?%^H>(-WB[Q%IVB:GX>TWPY!H]G)$(K&WL'CDM3&Y0N621&?+,2?-<9Q
MC&CXQ_;O^%O@.UT^?6;G4[-9[*SO[N*2T"S:;%<D"'[1$6#AL')1%=E') !&
M>Y\(?M$^&?'7C_4O"FB6NJ7\VFZA<Z3=ZE' GV2"Z@C#RQ.=^]3\V 60*Q#;
M2<$T >2_\.^] N(-<BOOB=\0[XZSJ6GZO>33ZE;222W=IS'(Q>W8'D1G&./+
M0#@8KZJ(RN*\I_:<\91^ _A1<:M/K6M^'(%OK.)]5T&UAN)X-UP@ 99OEV.V
M(V/7]YQ7.^)?VR?!GA7QGXD\-76C>*9[KPU?V5AK-Y;:27M+$W7E_9Y9)=P&
MQO-3&W+8.=N 2 #,3]B3PU?_  U^(7@KQ#XFU_Q%IWC+6I/$$T]R;:.:PO7<
M.9K=DB&ULJOWMRX7  !;=Y5\3?V2_%'AO6?@]IOA+Q%X[\0WT/BMM7USQU=:
MC;W%]8QBV6W4_O\ Y2@4A1&(W!02!@<@'[6U2\EL--NKJ&TGU"6&)Y$M+8H)
M9V )")O95W-C W,HR1D@<U\/:9^VCXI\6:C\$?&L/AOQ*NB^)KOQ/93>$]'@
M@N)-16T#BVEC7<7W+M*OO>,;E<[=H4D ]EO_ -BKPO':>'KO0/$6O^'/&6B7
M]]JD/C"VDMY-0N;F]/\ I;W >(Q2"3/W BJN!M  P;O@K]CWPU\.?B!X*\3>
M'-?U[3H?"^D7&D1:5YL,L%Z)Y6FGFN'>,R/))(P=F##+(F, $'"U?_@H-\*-
M)\!>'_$XN+^Y&LZ=<ZK#I(^S07L5M;R&*9G6:>--RNK*(U=G<JVQ6VG'O7@?
MQKI/Q'\&:+XIT*=KK1M8LXKZSF>-HV>*10RDJP!!P>AH \)TO]AWP_HW]G16
M7CCQC;:?IGC#_A,]/T]+R!H+6XW.WDHKPL1%F:;(SEO,.XM@89I?[$NFZ!9>
M'H[;QYXLNAX>\5S^,;"UGELQ$U[+DM'(?LQ;RR7EX!!_?.>NW&)XY_:/O?%G
MQ>^"D?@J37[/PEJ?BJ^TF]U1H(%TW5UA@G62-2Q,V4EB.UMJ*P#D%L#&OH7_
M  40^$'B+5M6M+2_O6M[#2;W6A>HL,J3V]J&,V(XY6EB?"DA9XXRPP1D$9 /
M&/V5_P!G7XJ>!/'6@7]VWQ!\*7J7TU[XHAU37-/N?#5X'DD9TM+6)FE+.6R&
M8+MW%B<X!^U/BI\.;'XN_#W6?".IWE]I]CJD0BDN],D2.YBPZN&C9E8*P*C!
M*G%>'^+OVC=*\=>%/"VH)#XZ\$VUSXOTC3(KG3WTX_:VN6'EJ\J3RQO:OOVR
M&-BZD8P"I%=3K/[7?AC0_%(T?_A'O$M]:GQ.O@\:U:6L#69U5D#?9\&82\9Q
MO\O;D$9H R;/]B;PU:>+]%\52>,O&5YX@T_73XCGO9[RUSJ-WY*0+]H1;<+M
M6%#&!&(^)'R22".=7_@G?X"_LC3["3Q3XX;[*-126ZCUE8)KR*]</<13-%$H
M:-F7=M  ))SFNE\+_MO>#O%?BW2M#A\->+K1-0\03>%UU6[TZ)+*+4HT9S;N
MXF+;B%.-JD>N*]>^)WQ)T7X1^!]2\5>())DTVR" I;1F2::1W5(HHT'WG=V5
M%'<L.0.: /)-*_8L\':3H=]IBZYXJN!>^%_^$/EN;C5=\PT[<6V*2FT$;F (
M& &(  KV7P%X/M?A_P"#=&\-V5S=7=GI5I%9PS7L@DF:-%"KN8 9. !T'2O&
MO''[:GA/X<:=KLOB+PUXKT[5-$FL4OM$%E!->1PW?$%ROESM&\1?,1*.2'^4
MKDC/L?P_\7-X[\)6&NOH6L>&FNPY.EZ_;+;WL&UV3]Y&K,%SMW#YCE6![XH
MZ&BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MFN]LOCIHNK_&*V2T\>Z<WA0^!V\3?V4VFRJ9(#,A&HB]8!/*$;;3$/F!;<:
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MJUO%%%&AQC"9 /W6^RKOQUX<L+"YOKK7]+MK&U=8Y[F:]C6.%F 95=BV%)#
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M61U 9E4JQR0""0.0"#2_\)WX;-BEZ?$&EBR?S-MS]MC\MO+4M)AMV#M4$GT
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M@^S^!OVIO =]X,CNO%'C[P1:>(+"S6?6[?2=<BN+:U<R"([7)!*^80@..6(
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M?"'AS4-.^$.L>%KWP[\-=8T7Q?%-HGDR>(-0EMT2"".(<W;^:'E$H!'"#=D
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MT >$? KX=ZG\+/VCOBU96_@<Z3X,UF/2[O1]8LO)2S2.WLH;;[*(P0ZL&1R
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M*[BL+GR]0C;$(0F?&YDC(#8X$P'&6*_H/N'K1E: /A?X8?"CXEVNN?"&VO\
MPCJ^D):?"J\\'ZCJSSVY_LN^=H_+=MLN]@!; C9G'F)WW 9>C_ _Q]JGA[X3
M:9J'PMGTR?X;>%-;T35'6>S:'7/-L#:P16NV7,GFR 3MYPC4')SDU]]E@>]>
M=VOQKL)_CY=?"EM'U*#58- 'B)-2E1!:3P>>D+*A#%BP=P#E1T;V) /E#PE^
MSK>:5X;_ &8UE^":1:IHM\#XOE,-@"NVU>W\VXVR_O\ ,LB3*<L0L9XR=IY[
MPC\"?&>A_P#"!/H_P8NM U&S^)NJ>(+NX+V""+39A((%D=)MY7;/&FP9 %NV
M00%S^BI93296@#\V?!/[/GQFO-0$6L_#V[TZ&\\%ZQX:F;^U+)+.VEE9I(1#
M#&P,<.<*,AF))9NYK=D^#GQ<^(.I>%=,D\!7_@MH?A7JO@Z?5+B^MY($O)(S
M% 9&BD+A"8 ^55\><GN1^A6X>M9&@>+]&\4W6M6^E:A#?RZ-?'3;\0G(@N1%
M'*8B>A8)-&3C."V#R"  ? _C?X(?$WXE^![.6#X77GA75M"^%UYX1N+-KRS;
M^T[Q_)2"&#9,<PIY<DH>0IC<  3FO8_@;X"\3>&_VC[+6C\.;KPAX6N?AMIN
ME3NC6:PPZE%.\LD3)#(22%EV;PO5#VP:^J^/6O._!OQHLO&7Q=\>^ (=&U*R
MOO!\5C+=7UUY7D7 ND=X_*VN6QMC/W@#UX&.0#RS]L/P7\0O%GB'X<2^"O#E
MSKEA;2:G%JDVFWMM9WML)K81P[)ISB.-B7$A0>9M "D9.?G'P+\$/B@_A8:7
MX@^"MY'<6?PCO?!D,L]SIMSYNHB7,,BGS\JK*S=<$$#KQ7Z3;AZT;AZT ?G#
M<? +XU#X4^/_  @_PT&OOXY\*:+:Q7USJMI#+I%S8VD5N;:4&7YU$D;31E&(
MS)\PR6Q^@D4^JZIX/CGDTY=,UJXLA(VG7$JRK;SLF3$SIE6"L=I9>#C(K:W#
MUHW#UH _-*#X _&]M$UB"Z^%EPTNI>![SPN437+ 06\S3>;&8H%=5BAX  &6
M/WF)/)Z=OV<[72/'_B*_^(^EV?@#X3ZK\-+/PQ=75_?6<%O;7ZF)P5/F_P"L
M1D+*VWEESGH3^@VX5\S'XUV_[0-]H&E1?!6Y\>?"[6M1>*/Q+?O:S649MIWB
M>>2V<,RA987*YY88/!.* .B_8R\-:[8?!C3O$7BR_.K^*?$JQ7]W?LC(984A
M2"U.UB2N8(HI"#CYY9"0"33/CYX/\5^(?C/\$-9T/PO/KFC^&]8NK[5;N*[M
MHA;QRVKVZD)+(K.09-YV@\(<<X%>[P1Q6T,<,2)%%&H5$0855'  '8"GAUSU
M!H ^"A^SQX^T'X6ZX- ^&=O#XQD^(SZ])>^;IL>HSZ7)<M<$VMR[2+%,GR(I
M;E<$KSTS/A9\#/C'\+-5\%:[#\-C>+X;\9:]J']E-XBMY)[BTU*#RUD\YVY,
M1'S%SN?.<=Q^@Y()SFN9^('BO5O"NF:=<:+X:N/%$]SJ5M9S6UK<1PM!#(X6
M2X+2$ A <[<Y/3CK0!\#_"/]GSX\?":TT^\N/AGI_BF2Y\,:SX5O--DU^UB-
MN;C4IKQ;L.<H4=;@QM&HW'R@3CA:^S?V6O"6O> ?V=_A_P"&?$^GKI6O:/I$
M-C=VB7"3A'C&W[Z94Y !X)QG&3C->F75P\%G-+'"US*B,RP1D!I"!PH)( )Z
M<D"N"_9^^,5M\??A)H?CNTTJYT2WU5KA5L+QE::'R;B6 ABO&28B<#IG% 'H
ME%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %?,__!1C6X?#W[)7B^_.N7>@W\4MF;">QOWM)I)_M,9$:LI&[<F_*G(P
M"<?*"/IBHKBUANDV31),F<[9%##/T- 'YD?&CQ_I&D^._P!H;Q2/B1K7VSPO
MXB\+WWARPA\53):LDWV=[A8HO,VN"K7 *X*JO0#!KV"7P3KVE?M$:W\-M,OM
M8U/P=X^NK#QU:ZZ-2GD2QL[6;S+RS27?PLDWV1%"Y CNSUP*^T3I5C(26L[=
MB<9S$O..G:K.Q1C"@8&!@=!0!^;'PE^(^MW.L_"W4/\ A*M7/QLD\;ZA8?$'
M0;[4'D6#25:9YVDM681PP11+;&.544 G"G)Q57X9ZC_9?[*GPR^-/A>_U371
M\/O%.KG6]"T:^EVWMA<:G<DJ858*TB+/!,-P&48[N,8_2W[%;B=IA!&)F&&D
M"#<1Z$_A2)!;V4.R..*"(G&U5"@D\=* /S]\2Z=-\+?''PXT+Q/X_P!0T+Q7
MKO@?Q3?:PLOB&>."RNI@+B,Q9E_=>4SSHCK@E;?J=O'F?PM^(-WX!\)^#-9T
M_P")FJOK?BKX/Z[?W=QK6NS7T2:C;*/(98V9A&8O(G V*#^ZD')W9_2;PCX[
M\(_$S4/$$>B75OJUWX<U&71-2)MF5K:Z0*TD.74;L!UY7*G/7@TOQ'^%^@?$
M[P)K?A35[=H]-U:REL)I+,B*:..165O+?!VG#-V(.3D$$@@'QG_P3]\>Z'\3
MOB5<Z[I'B_4K2TA\)6-F?!>I^)9;N:6_0A;W4#:F5@%.V!!(0&)9B0-V3#^U
MS?:/K?[37BC0M2^(NM:!96'PHOM7&GZ9K\UFD=_#/YD1*1L/F,8\PKCYA$I(
M(KZ=^&G[-&G?#_QA:>)[_P 6>(/&>KV%D^GZ=+KHM%^Q0N5WA/L]O%N+;%&9
M-Q !QC<V?6YM/M;AR\MO%(Y&TLR DCTSZ4 ?E7X?^+UYX+32]8F\=^*]5?Q?
M\&&UK6'BUU[F<:FLR()( Y(A=%$H.T955<XR#G/;XQ7(T3Q7H>E?$;4],L5\
M8^'9-,DTG6[M?+M)U*70CFE;<Z=V)^4N-P6OU=?0=.=U<V-MN5#&&\E<A3U4
M<=#GI2-H.GO&$:SMV4;0 85P,=.,=NU 'YS:Q\5-*\,:IXH\#7WCC6+[0K/X
MC"RBGU'7[AX8(&L&?RKJX5C-Y/G*^(U(+.NW(Y-><:Y\>_MWP+^$]OXD\9ZM
MJEY<:+XDTV)+;6[C3YK36HIL6-S=R^:AV1HR+^\8[0V<'FOU@_X1_3OFS96Q
MW-O;]ROS-S\QXY//6O,?B7^SG9^/O%-OXDT_Q3K7A'6HK"333/I(MW1X'?>W
M[N:)U#;L'< #P!T H _/WQCX_P!2L=0\/>%/''QOO]!L;?P7IUSH'BO3$U'6
M&U+4][&]>VGM[J/S9C*%C!F$BA5VJ(^=TGQ4URZF@^/?B _%7Q9::]X;UOPX
M-.;^VWLS:2W,-LM\S6J2;49&\]#'R$,14=#G]*?AC\)M!^%'@C1_"^DK/=V6
MF>8T=QJ+B:XDDDD:621WP/F:1F8X  S@   #IY]'L;E9!+9P2"0Y<-$IWGWX
MYH _,_7/'>I_"*]^*_@WPYXWU^Z\*:3XGT*ZU/6KJ\GU&[M;*YMMUU*S(ZRE
M3,J!RC*<,0,=Q_$AU#Q?\#_"D7QI\6:WX,\2ZYKEM=:[:ZK<Z5'- MO$Z0Q-
M+*7EB660QAW)(.54]*_2_P#L6RW2M]FA!E4+)B-?G Z \<CZT+HUBJ0H+.#9
M"<Q+Y:XC_P!WCC\* /S$^"GBSPUJ'C7]E;Q+XF\4W&N7D>I>*_#CZQ<:E/</
M)+#<C^S(9"KD;V65"H(^=77.Y<5]?_MQ^*=7\(?"70[VQU'5-&T)_$^F0^)=
M3T=WCN+32&E/VB02(0\8X0%E((#'UKW]=*LT"!;6!1&_F)B-1M;&-PXX..,U
M/-!'<0O%+&LL3@JR. 58'J"#U% 'Y=?$CQD-.U?Q%H7AWXGZYI?PI3XF>&;/
M1O$5EXCE$,:743MJL,=T9#YL,.$DPS%8V].<_:GQCT/Q#\)?V0O%6F?#[5-;
MU;7]&\/S)I>H74YO-1; )W[\9=U0G:<9^5<9(KVM],M'@6%K6$PJ<K&8QM!]
MABK&* /RK^+RZ#XW^'OQ(M?AYXUU3QAX&F^&%OX@U9+S5KB\%MK$%Y%Y3RLT
MA,<TT*W)>$X!,89EZ54^,VN> ]8USXS:_P"%O'VHZ<-!^'FBZAH4VD:]<0M<
MW"R2*I<E]\FUIHE"R%B/M&1U%?JQ'I]K#')'';0QI(,.J( &^OK3#I-B00;.
M Y 7F)>@Z#ITX% 'Y=)\7=4\??&22?Q/\6M6\+>(UU32;OPC9:)I=]>2ZS83
M6\15+81W26ACE8R%S+"6)8[FVKL7Z*_83TNR\7Z]\0?&Z_$GQ-XON[+Q'K&A
M0V%]XA>^LH[$7*M;2>2V<,40%7R,JS8XQCZ^&G6JRQ2BVA$L2[(W$8W(OH#V
M'M3K:RM[,,(((X0W)$:!<_E0!^=O[1WCC56_:9\;:!XD^*.O?#F6UDTF\\%V
MVFZ1J%]+?1K$AE6S6"YB@DDDG,L3K-%)D';N 7CA/%>N0?VMXYUR#XN>(K&>
MP^--KH5K=V_BF>..WTVY*"Y14:3;A5\T;R",6_'R@U^I[VT,DJ2/$C2)]UV4
M$K]#VJ$Z59$,#9P$,VX_NEY/KTZ\F@#\O_&7CVS\(6UUX1L_B3KUKX=\._&Z
MQT275/\ A)9UEM-(NK-FG1Y"^=L<UO<%7?."CD?Q9U7UZT\+)X9LF\9/K7P[
MM?CII;^%]7U?4OM'F6J6[_:O+G=B7ABE?9OR1G)SS7W!\;?V>=&^-\/A-+[5
M=1T)O#>OVWB2V?24MP9KJ#<(_-\V)]R@2/QQG=SFO33I]J8HXS;1&.,Y12@P
MOT':@#\W/#_BO5?$FK>"[I/%&OK\<+GXFW6C^(O#5QJ$Z>9HSRR&9/LF[;';
M1VBQ,LJJ-IWE6W8([/X:^!_'O@SQ3\1? >EWFK:QJ?PPAU77M!U&YOIYFU:;
M4;0?V7#,'DQ(8O+N$96^4E8R ,L3]WSZ=;SB4^6(Y9$*&>/Y9 ",<,.0?\*X
M;X,_!;3/@OHE_:6NKZUXFU/4KG[7J&O>([S[7J%XX54022X&51%5%4   >I)
M(!^9GA'XE^(O^%0^*?$?@7XH^*O$?C?_ (1>%/$VA6NCWROICK?0"[NIYI[N
M0&YV27 4V_E90.P$>SCHK?QE:6OPVDC\)?'.X\2:'J7BRQDMO^$BL[[1M!DG
M%K</-IC7DMR]Q&&$:2,=WEK)Y0R-Y*_J=':0Q,[1Q)&SG<Y50"Q]3ZU&VF6C
MP+"UK"85.5C,8V@^H&* /"_V:A#\6OV//#%K/'K6D0ZQH<U@[WFHO->H"9(C
M*MR,,V[&]'X.UD-?&&@^(/BOX)MO!^KW&F:W>ZAX/N+SX6ZA'/?3LNK:G<FZ
M6SNU7S=OEQM):!I#AC]H;!.Q<?J4L:HH50%4#  X %(88V'**>0W([CH?K0!
M^;/QF\(Z'X>F_:$^%NF>(=3\1W6F_"[2KR2PU769[N5[RV>9Y90LDAVGROLL
MC1C@[P<?-7'_ !AU#X=>*M:^(^J^&_$UW9V6A?"K3;_1)=,U2YM,7D=]*R$C
M<IDP\T(4/D#SU*X)4C]4_L5OYS3>1'YSC#2;!N(]":1K"V<8:WB(V[,%!]WT
M^G XH ^8OV@_B&DW["4?BBYNM4N4U+2M(:>YTF[6VG<SRVZONFVOY:$N1(RJ
MS!2V 37)_P#!.WQH-5U/XQ^'(M734-*T[Q"MWI%O;07$5I%:31YS;+.6=869
M25!8@X+ 8-?9[(KKM90R^A% 4*H & .@% 'YJWOCFRD^//Q,L+_Q9=^*K#4?
M^$OMS=VFL7-C=^&S;QX:WO(%;9Y"F%5MIE*D^8<Y)VKPGC;XVVFG?#OX+:9J
M.O7E_'K?PD;3;5H]4FMXM%U@D11ZC<LK#.V2)XR<%E\N3@Y(/ZQ16T4+.T<:
M(SG+E5 +'U/K7E/Q#_9RTKQYXU_X2NW\5>*_"6LR:?'I<\GAS45@2XMXY'D1
M71XW7Y6ED.0!]XYS0!\(_%9M'N[KQ;:VWQ1UKQ!'HGP8LM0T[4;#Q5=B'4-:
MB,JK,N)?WCMB&39T)<$J2:VX?'/ACQC=_%G_ (2/Q%_:D&K_  6TF]O[:XU*
M6=#J'D.) @W':^3;[E3!);)&2U?H?X%\%:3\.O">F^'=$@>#3+",QQ+)(TCG
M)+,S,Q)9F9F8D]236TMO$A8K&H+#!P!S_G)H _,G3KR7PW;?LLI\-M3NK35-
M3^&VNPW-IIUZYA?5$T=3"'B+&/S?M6\<C)9 /X0!1^&WC#P%;_L^ZSK>A7?Q
M"N_&K^$TMO&BVL]Q"GVW[7%YT]Q+(CDSL[R+N0L?*#@@$"OU&V+M*@ #&.*A
M6QA1741H _WOE'S?7UH _*&QUNR\1:;J7A>?Q%J]EI0^*&C3::^E37NGI;V$
MT6)9+<R-O5!L9@Q/!&\!<UI2Z;X7TG1-(LM4M+K4/#W@GX\&RMIKJ6?4Y;?1
MIK:0[!C>YB:2-1CDEAW).?U+.GV[')B1CQU4<8J2&UB@W&-%0L<L5 &: /E7
M_@H'+I#^!OAL=5\3:IX5L[CQGIL-S=:=?7%H_P!C<M]H+B-A@*GS;F&4(XQD
MY^<_B_X?LO EQ\5O!IU;Q!;^./#RZ)+\)V:ZN)KB2 (@1+0CB3=/YHE)SZMQ
M&,?IUBEQ0!^8?Q:\:^*IOB-^TA-HTM_'':ZUX/'B&;P_&TEQ_9EO:R#4&C4,
MI<++B-U5AE=P) R:^H/V#H-$MOAYXG_X1CQ#XA\3>&9]=ENK*[UK3'L+>(R1
MHTD-G'(Q?R$;(Y^7=O"YY)^FR : H% 'Y7>*_%FD7?AC6-,M/$^IQ0Q_M"HK
MR66K74<J:3,@7S%E5]QC_<N58$[2F5(KZF_83U#3=.U#XX^#M&DF;1?#WCFY
MCTZ*:[DN/*MGAB4(C2%FVB2*;DD@DMZ5]68I,4 ?EU\<+SP_I]W\98M/\1ZM
M9/#\7-%D\RVU&YCDMHG@0W+QL&'RK*+S '"&(8QA:SM9LO!MEXDU2TEBN-5\
M%^"_C3:.8Y9+G438Z7<V4D<^/O.T374*#@'YEQDDY/ZKXHQ0!^5'A'4$E^+V
MNW'CKQ/XYTSXD6%YK;:KH=IILRVSZ8\,S!Y+Q7 %FD(AV@ ,A"^6O(:I_AY\
M/O <_P +_P!EW5=0UCQ)<ZWXQUN.TU^\_P"$@O5:2**VN(6M642#RT622"+Y
M0IV,1G#5^IY4&@ "@#\<-;U^UUOP;J'@U8]8U'3])U3QE:>%KJ]%YJMN OD/
M:)!;1KO-SL8^5+)($B#.Y#'@?3'[*GQ'7QE^TM\+/-O+F]N8_@7:VMU<WD<R
MRO?B^B\]'\P#+?N2V[^('<"P(-??&*3% 'PQ^U_JGAN+X_-IOQ=M?$O_  K;
M4_!YM=#O]$@N)EM=5-PYF,:PJW^D&,1[693@)Z$UY5\5I+[S/C%:>)HO$-G\
M7+K^P[[X;-<-++?-"$B6&*V"'9YJS+*+@*,%BS-D &OT]Q2%0: /RI\9Z;'9
MWOQ=\6:SJ.LQ>)= ^(V@+:SV^HWRPP.QMSJ#0Q"0@J2EP,X/RHH7 "@0_$6T
M\#^#-"^*OAB[L]0\-7MQ\9+"]6XLK6ZM%_LB7R<.EQ&H!3R_M;@;CC[P&=IK
M]7 H%* !0!^:OQ4\(:+\/==^,/@J_BUJQOH=!T^?X37:3W=W.S1JS_9[-V+/
MYQNW ?YMVUAT5!3?%VOO_P )3^T%IGBK6M6\/>([KP_X(M[[5[2Q-TL5PIC2
MZWJA59(1+<1B5$)RC28SC;7Z68'I1QZ4 ?.?[#-Q>'X3ZW:7V@VFB/9>([^W
M232_/&G7P#*?M%FLV72!BQ 7)4%6V\8 ^5OA9X4OO$NJ_"K3KK3]<F^-UMXP
MU6P^(M[/%/$;C2)#.]SY\V-C0-&;18@#CD!.<&OTUQ1QZ4 ?GII/P'\>^&O#
M_CGP!X<TB]MH/A39ZW?>"-<P?.U*\U&%GM1$Q'S2P1RW*$C_ ):R1'*E:\0;
MPKX:_P"&=O'6H^&U^(YU6]T?38]4TZYTMK&RAU7[9 &PL,2&YN?+%UNEPPV
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M:^CL44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MY8>#$EAN;E DMJ7"S$&$D*5D)XYRHX /&;XD_8H^,(\!^.?!GAWQ)X-D\/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MAK6;-;"WEE@9IPPDF5I 1$R].I;:0JMNP0#Z]^'7QNL?^%.>'?%WQ&\2>#-
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M*S9 /T<^('CC2?AGX+UGQ5KCW$>CZ1;M=W<EM;27#I$OWFV1J6( Y)Q@ $G
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M;XDA\=>+/B5XETKQEJ>L^$KR>Q_L+0=7\4KJ]WIL1M4:=ID$\S0EYBVU9'W
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M=22)=D8N8H)467:N%^8'@ '(KU6QL[?3+.&TM88[:U@18HH8E"I&BC"JH'
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M?%K>(9]-@\%W$UQ!I,=G#+!=&6/RI Y<9'[LE1CIG(YP1\>>(_VK?C)/\$?
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M]-N-3U+75MM,M-6AG7SY9;BU6WDD"[)4A'D3)M,8.':0%0#]!EC15"JH"@8
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MK9^(9?'WAG2_#J>,-0\/:AX2O-347/E)*\4,$=C]A$JSX19?,-RV=[%E5%*
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M&M^+YM.T3X=ZWK6AF^U+3;76+.0$2SV<<A8NA0+%$\D3QK(S]1E@!7-^'_\
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M175K#=L1%%#&L<AN)<+(Q4;1M7.22!74:%^UA=>,O&UU9>%_ >IZ_P"$-/\
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MUXE\/Z[>G1([*YN;=)[5\ ,6N [1_OE(&X$-N)+?*J@'UG_PSO\ #-H9HO\
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MA8RI\V4OYLC?(@&X* ?6<'PQ^'%VOB#2HO"GA>=;UX?[9LDTVV87#*-T/VE
MOS$ AEW@X!R*ZK1=#TWPUI=MIFD:?:Z5IMLGEP6=E"L,,2_W510 H]@*^0/B
M?\;/%_P<U;]H'7M$\/>$#K&D:KX;6.ZEMYU>_M[L);H;IUDRSQ[E52H  !X.
M:]?^ 'Q<\6>-?'7Q1\&>-(M"&M^"]1L[?S] $J0S0W-HDZ$I*[,""67=D!MI
MP!B@#VZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM^?# ?%%? \']K7U]+=76GV][9PQ2P7%Y;AO,MU19?.#;E*JS1*C'&UB.:/
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M!\W>(OV!_ GB33H+.7Q!XLLH1X:@\*7?V#4(H?[0L(,_9UN (<.T>0 0!D*
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M%+HY@;:Q4CD#) !ZY9_LE^&X_%MCX@U'Q'XG\036>M1>(8[35;R*2#[?';K
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M P/EPN< 8^A]?\):/XI\,7OAW5M-M]0T.\MFM+BPFC!BDA(VE"/3'Y=J\/\
M&/[8^F>"!X@%_P"%-59]#\86?A"Z$<L7^LNHTD@N%)."A66,E?O#<.*9:_M@
MZ1JGQJTOX97WAS5-&EUZ]U/2M/OY[J&.=WM V^9K8/YT4,A1Q%*1\Q7HHYH
MV_!?[)GA?P5_8EK'XA\7:QH&B3QW&F>'M8UJ2YT^U>,YAQ&0"XC8*R+(S!&1
M2H!48J^&/V,O GA'7;6^TR\U^'2].O+C4M'\/'4,Z;H]W.CI)/:Q;<JW[R0J
M&9E4NQ4"O#/A5X@\8P:!^R[J-[XUUO6IY?$'B32=3AGU21EUDI'J/V<S,Q_>
M;6MT52QP-R\=,>W?"K]K.U^+,/AD:?X0U:RO]6UO4-&NM.NI81-I9LU#3RW
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MCH2#R?A']N&T\7:3:0P^!]6M_%EWXD_X1BWTF29?LLUQY+S&1;S;L:,1QMG
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M8-5-._:4\ ZAX]\=>%&U^SL;SP9;PSZM/>SI!%$'#,_+D<1@)O;[H,BC.<@
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M?M":#I,?C6_UOQY/XIAC\93^'K"PA\.RV=Q97(12--CCQONF7#-YV,,">PH
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MBL^)]<\17MI';1:;:QW,5S<QO)'CS)[B1555QCEVPH0Y]N_:X\=ZU\+?V?\
MQ/XMT#5AHNH:2;6<W;6R7 $/VF)9AL96!)C9\<$@XK$@_;E^$,FD7]^^MZE;
M"QU&VTRXMKG0[V*YCEN0QMB8FB#A)0A*N0%.0"02!0![ZH^6OF#XX_L577Q=
MUSXCWEA\1K_PQ8^.K73(=2T^+3(;A/-L74Q2AV(<?*N-H(Y8DD\ ?0'AOQWH
M_BS5_$.F:9-//=Z!=K8ZAOM)8XXYFC64(LCJ$D(1T)V%L;@#@UX)\?OVF=1T
M+5OB;X$\+07VB^*O#G@R;Q/!KUUIYEM ZJ[HHW*4*$1.F]N-YV@$J10!G>./
MV(-4^(VM>)]6UOXHZC'J6HW6DZGIEUI>FI:RZ7?V$+Q17 82,9-RRRY3Y?O\
M$8%>Z?"7X<WWPXT.^M]6\5ZKXTUC4+LWMYJVJ[$9WV)&JQQ1@)$@2- %4#G)
M.237FOP\_;.^'6O>";K4-5UN\T^ZT72=/O\ 4I-1TFXM3.MRH6*2W0Q@S"63
M*H(P2Q("@Y%>@_"'XZ^%/C=;ZV_AJ>[^T:+>?8=0L[^T>VGMY=H8 JX&05.0
MPR#0!Z#1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MR[@$_,QR2<U-^V9X-U[XB?LR>/\ PQX7T>;7=>U:P%I:6,$D4;.[2)R6E=%
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M%SP]\0_A?'XNT;Q'X+BD\,ZW\7=.\26OCB+48/+:WEOK;RH7A)\W>@4)D@*
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M(R)\S@.P)\QQD9.?L#P7X$\)?#/26TOPGH&D>%],DG,K6>D6D5I"TQ !8I&
M"Q"J,XS\H]*K^-_&&K^'+OP[#HWABX\3)J.JQ6%]);744/\ 9L#!BURX<@NJ
MX&57YCGB@#XFT+]F7XN_";QWI_Q*T+P3H_BM]7U;Q'<ZMX"FU2*%;"SU.2)D
MACG?,1*B%?,"@KEG"Y5LC-\2_LC_ !0B\;ZI>3_"_P #>.-'\6Z+I]I<Z:-4
MET[3_#EQ;1B*-%A4KYUO&-K;57+%<@H>OZ)_:8E+AI$#(,N-P^4>_I0MW"[
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MY*8F=>!E=K#AA7HWPW\8W7Q!^&>EZMXQ\/VOA>^U6U9[O0IKZ*^CAC8D!&E
M"R I@GC'S$'I2?&'XGV?P9^$GB+QBEE%J%OH>G/>I8K<I;+,B+G8CD%02.@
M.> !DB@#Y0^*7[.7Q>\6_&Z7Q);Z%HM[I^G>-[+Q'I]V=7-J);.*-8S";=8R
MOFX7+3.2QVA0<8%4-(^!OQ0\./\ #M]3\(:=::1X9^(>I^+-6U$ZS @CLI-Y
M20>N%F<L",D1#INR/LKX<_$[3O'?P]\%^*)FAT@^*-+M=2MK&XN%W@SPI*(@
M3C>5#XX';I70W>MZ3'(MG=7UFLD\GV8032IF1R ?+VD\D@@[>N#0!\K?L>^
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M;\2IO"_Q;^(^D^+?[.N/A[\01X?'@F6Q@^RW6G)-% /,)0SF6;SC('611\F
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M_P#":66LB:U%QI6J[0C26X6W52CHJ1M'('4JHQ@Y:@#SD?MR^.9/$NA^"8/
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M>W?[2=]\2A\,KGQA\/="O-9T;XP/X*N'CU*<Q6&HQ*52\M@%'F *\@Q)T(!
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MIXGO4%G%=%C/%"OF;8T;>^0H&[<=VZNDU#]C3X?ZGX0T#PU-<^(TTO1='N=
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M+^R)\'_&'AC1_#^K^!--O]+TBYGO+*.4R>9'-,2TSF4.'<R,<MN8[B%)R5&
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M*02,#@9.,4 ?+W@?QMXQU?Q?X3\66GC*+2=3?X%R:U;:5JGV2VTN&]9X44R
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M<NK>,-$NX[6#3)YI8V6 GS%EF)C?YUC&%WKN/45Z'K'[<?@O0?B+:>#F@O\
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M =AOR<D"O<?AUX-D\ ?#[0/"YU2?5CI%A#8)J%S&J22K&@1695 7. ,XZXH
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MA#R[%0!(H42-!A<DA<LS,23P  >H&BBB@ HHHH **** "BBB@ HHHH ****
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M\4W?A^Z\5LNHV>H1:;=;--NWAMY90/*:258BBQN655D)VL3P2,D?,MO^R/\
M&2VD\+:Y<^!?A1XLU)_"=CX;U'2/%\1OH=.DLPT<-S"YB.2R%6=!QD$ M\I&
MQXL_90^*]WH_QQTRPT?0+K_A+=5\.W>EW/\ :(M(S'I[1&0^4L1$6X0 !!PH
MDP"=O(!]1_"7X]:?\6O&?Q"T"QTO4;(^$M4&F-<7EI-$MPWE([,"R!5(9R N
M2Q4*^,,*E\3_ +2/@'P=XF\3Z!JVJW5MJOAG2/[>U6%=*NW%O890&X#K$5D0
M;QGRRV-KYQL;',? SX=>-_ 7Q9^*M_JUAI<?A7Q5J<>O6D\5ZTMVEPUM;Q/
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M7BE_%!U>]T<7'B*U\R83RVD4C1^6%9P4$A)959F7:V-ON7[3_P /=?\ BS\
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M7K?P"^$WBCX:>*_BEJOB*^TF]A\6^(#K=JNG"0/ #$L7ER;P <)%%R.Y;VH
M]DHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ JCKFMZ?X:T>]U;5;N'3]-LH7N+FZN'"1Q1J"69B>@ !-7J\ _;W\,Q
M>*?V0/BC;26C7DD&D27D*(I9EDB(D5@!Z;<Y[#- '8_#_P"/FB_$7XI>./ ]
MCIVH6][X4AL)YKZX6/[/=QW<;21/"5<L1M7DL%ZUZ6LJ,2 >1UK\BO$$'PZU
M[3/B9K_A._U*$Z!X.\.2>'9K7[7:L;I&VF1D^4R/EE^^#Q(2.#7JGPNU^[\8
M?M#QS^*?%OC"U\<1>+1>:9I6G:5(T%_HTFT0LT^?*6T\DDN" 002/F:@#]&=
M3O9+'3;JZALY]0D@A>5;2VVB68@$A$WLJ[CC W,!DC) YKYZ^&G[=?@?XDR>
M!Y/[ \3^&],\;37-KX?U76K6W%M>SP.R2Q9AGE:)@RL )%3=CY217T%JFL6>
M@:3>ZGJ-Q'9Z?90/<W-S*=J11HI9W)[ *":_.S]CK]FO3_CK^R1X!UJ[\3:P
MVM>&$\00Z/HQ:&&QT^^N)IPDKA81,[8>*4;I"!N& !D$ ^DM2_;;T.+PGK7C
M71O 7C+Q1\.=):59_%^DVUJ;241';))#')<)-+$K9!E6/9\K'.%)KT_XN_&S
MPM\$/#.F:]XINS:6&H:G::5 PVY,L\@4$Y(&U%W2,>H6-B 2,5\T_LL?'[P9
M\,/V?="^%/C>SN=(^(/AVUFTB]\%2V$DMWJ#AWQY$9!6=9E8,"#M^<Y(49JM
M\6- /[9OQ5\:^"]*N=%M=%\"^'Y-'GM-:@D=X-4OER]S$(G"AK9;=(PWS#=)
M,!TR0#ZF^+'QC\/?!G0[/4->>>6?4+N/3]-TRPB\Z\U"ZD.$A@CR-S'KU  !
M)(%<GH7[15OJ/B74O"^I^#_$'ACQ?;Z>=3M-#U;[)OU2( [OLTL4[Q.5P P+
M*1N';)KXT\,?&6^^*_P\_9W^)VH)=:Y+\*-<DL?',,.]Y+>&2$V\>J,H&^1
MJ"8LH/60$$!L>M?$#QKHOQK_ &I/AAXP\"ZJFK^$/ASI>M7GB;Q+:@OI\*W5
MLB16Z2CB67*$LBYV Y/((H ]$\(?MM>%_$>F^#]6U3PSXA\+>'_%]Z--T;6-
M3BA:WN;HR-&L;>5([QEF5@"Z@':>U?2)P1T%?DGX9BM+KX"? T^'O%6M^+_'
M.D>)+6^A^'<\7G6J-]KDW%XQ&&B5%9F#.^!FOUI;!C.XX&,$@X_6@!_R^@_*
MFDH@YP!]*_)DZ(Q^!WC[X@>$/$GB;6;ZQ\?W>DZ]);ZE<ZB]MX5-\93LMWE
M=6")(6R"ZO*&;#,0[Q5XZ\(_#3X7>#-37Q%XI^)_@&?QW<SQ:'JVGR:1::CO
MLF+?9%(WK!!/,K;6 0N6"J=I- 'ZE^+_  EHGCOPYJ&@>(+"'5-&U&,P75E.
M"4F0]5..HXI?!_A70_ 7AO3_  _X>L(=*T73XA#:V5NI$<*#H%]J_+N^O],L
M?@5\,O#T^LS>(9[C2M?D?4K:2[U2PL[UE!AM%A \QKF-&1(R2BH=S8.:Z'X?
M>';/XW>/O!^H#6]>O?&NB?"K2]2TZSEO;F".;Q#:LV/,R0"043<O1A(6[YH
M^]?$7QNTSPS\;_"/PSNM+O3J'B>PN[^QU)/+-M_HXS+&PW;PP4J<[=IW  YS
MCH/AIXNO/'?@?2M=U/PUJ'A"^O$9I=%U8*+FU(=EP^TD<A0P]F'3I7YK?!+Q
M)\/M4^*/[/=]>-JZ>(8_#FOZ5X\O-3M;V*=;TVF9/.N"!E]QG(96W*NS)&%
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M4VKILEC4LKE@A4K)C0^+7P\T[5M+^++ZGIWBJ\U_3? 7AZXT=M=,QOUU!65
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *.M%>*?MB_%_6?@;\ =?\
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MT%+10 A4&C ]*6B@ Q2' I:",T &!28'I2T4 & :,444 &!Z48HHH 3 ]*7
M]*** # ]*,444 &*,444 &!1BBB@ P*,"BB@ HQ110 8'I28'I2T4 &****
M# ]**** #%&!110 8HQ110 8HQ110 8HQ110 8HQ110 8HQ110 8HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "@YP<=:**
M$&<#<<GVI:** "JFKZ18Z_IESIVIV<&H:?=1F*>UNHQ)%*AZJRD$$'T-6Z*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_#GQ@^NVWA)/&.HVMA#9O'!89(>;?]J*@#9(VTMNPN,%N* /I^BOFW5/V[_
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M0#(8*&PRJPW8(!H ]%HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJ4.M:IX:LM26+2M1OXRK&XFA"9R[1HSJK*K$8(VG;7'>(/\ @HYX \(0P_\
M"1>&_%/AR]3RVU'3-6M[:VO=-CDF:*)Y+=YQ))NV[\0K(0A#, ",]E:_MA^'
M[V+QVB^%?$BZIX2UZQ\/3Z0T5O\ :KR>[F6.WD@7SOFC8.'!8J=H) .#0!Y]
MIO\ P3-\ VMII=C>>,_&FK:3IVG7ND0:==W=H(5M+K)DCRELK#YR7#;MV0,D
M@8KT3X1?LD67PH^(MKXT?X@^,O%NK6VACP[&FOW=O)$+)7#QH1'"C$H02"6Y
M+$G/;@O!_P"UUX3^'V@^+KG6-0\5ZKJEW\0M4T.VTCQ-/86L]M/&D<LEO!))
M.D*6D*,NUI) 26QR64'8\(?M_P#@SQU<^&HM'\,>*)U\1:/J.JZ=+)!;1I+)
M9+(UQ:9:?'G 1C'\!$B'?@D@ 7QQ^P-X5\;>.-9\2MXX\::3+J>OV_B9K&PO
M;;[-%?PJ%255D@=C@#@,Q"Y.T"GC]@OPN?%8U?\ X33Q>MA#XHE\66NAQWD(
ML[>YFS]I0 PEF27<P8%N%)"[=S%L/QU^V7X7\>? N?6=&L?&MK8:OX4OO$,F
MI>&FLUU#2+:WG6"1B6FPDNXD@#=PC]U.+NN_MU^&/AI_:.C7/A+QSXA_X1O1
M=-U75-5M[6VE"65Q$I%U*WGKT)&\ 9R6*@JI( +7@K]@/PSX USPA?Z3\0/'
M:V_A"YN;C0--N=0MYK;3EG4K)$BM;DE/F/#$YZ$FKWAG]AGPUX8\,_#_ $F#
MQGXO:7P3K-YK&FZDE[##=,;O=]I@D=(AF.3?)DC#_.P# 8 T_B#^V-X<\#7F
MM>3H6M>(-,T2>QMM2U#2TA*6\MX ;=0CR*[9W+D@8&X5Z1\6?']Y\.OA1XD\
M76NF/J=SI6G27RV&]8R^Q"Q!8G P 2>>Q R: /%_C[\,O&_Q _:B^$VI>'T\
M0^'] T/3-6@O_%FB3:=F"2Z6,)'Y5SO9@/(.X^2<>9'M.0=N?XF_X)O_  ^\
M0::NFV_BCQEHFF2:*FB7=IINI1*E\B7$MRLLY:%B\GGS/(>0K,>5K@Y/VKO%
MOA3XM:3XAU;1?$FKZ/J?PVA\27?AO2S!)%8.)CYMR,OC;L7/5FY QU ]2\4_
MM[> _#NJ:3;6UO?ZU#=V^GW-S)9&+S+2.] :$F$L)'(4AF"!MH(S0!M^'_V/
M-%TF/XGP:EXT\5^)K3XAZ>-/UF'5IK4G"VXMTE1X[=&$BQ +DD@XRP8\UBS?
ML+:+<KJ/G_$;QQ<OJ/@]_!%U)<W5I,\NGO(TC#+VQP^7< C 4'  &*]Q^(?C
MJ+X>^!-5\32Z?>ZM'8P"866FQ>;<3DD *B^I+#KP!DG@5XSH'[:6AZ](8AH%
M[!-;>)[;PMJ&VZMY8[6XG7,4GF(Y61"?E.TY!ZB@#-@_X)_^#;2ZTB>V\8^-
M]/-MI%KH>IQZ=JZVD>NVELHC@2]2*-1)MA'D_*%RG7)R3ZA\&O@-9_!C6?&N
MH67B;7=<_P"$KU1M8N[;5GMVB@N6&UVB$4*%056-<$D8C7&.<\-J?[8%E!)J
M&DZ?X3U35O%T?B>?PK9:##-"CW=Q%&LKS>86VI"L;!BS<@=LU\]_ GXOZY?^
M'_!;>,M;\<RWUS\8]1T:*2SU>.2.!EB8Q:??EGS)#@N0J*5S$3\ORY /I7QE
M^QSX*\:^+/%.K3ZCKNGZ;XL-L_B/P]87BQZ?J\D#AHY)5*%U8A0K>4Z!U'S
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M)YYY-<0?^"?'P@%AH5K;VFOV)TBUET^*YL]?NH9YK.20R-:RR*X9H<LP"9
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MVCDEL%@-I!-^+X]> Y?'*^#T\3V9\0M/):"T&[F=(_,>$/MV>8J#<4W;@.U
M'C"?L0)HWA#XY:%X=\16^E+\1I'M[0W%BT\&BV$H9IH(81*@&9)[IU"E5!=,
M@[<5D^)/V(_%6KV/Q&CB^(.E"7QEX-TWPG,&T"0+"UJB(UP#]J/WU\_"8^4O
M'\S;"']CT/\ :Q^$OB&_UNSM/'&G"XT:TDU"]^TB2W1;5'*/.CR*JRQ!AMWQ
MEESCGD4RS_:W^$E]X;U+7(_&EHEEIUS#97,4\$T5TD\R[H8Q;.@F9I%R4"H=
MP!*YP: /BGQU\//'FD?'#Q9?BWU.^U>R32[73]-;P;>W6DZ_+:6L8BNB\4GD
MH3+OQYC,8PN<\"OT,\3>%CX]^'>J^'M3<6AUC3);*Y: 9\HRQ%7*YZX+'&?2
MN7T']I7X9^)UT9M.\4VT[ZOJ<VBVD3P31RM?1#=):NCH&CE4'.QPIQSBL:[_
M &R?@QIEK83W/CNPMQ?3W%I!%)#,LQGMP/.A:/9O61=RC8P#%B% )(% 'F^B
M_L;>,;.:>;4?B19W\LG@:7P0I70Q&$@8G9)_K>2H/XTGA+]BCQ1X#U?3KSPY
M\6;W0DN-*L=+\00V>FH?[0%J@BCEA9V8V\AB 4L,X.2,=!VY_;/^'E_XQ^'&
MCZ)J#ZWI_C6VNKRTUBVMIS;1PP95B6\O&1("K@E?* +/M&,VX_VUO@Q)HNHZ
MNWC1(--L+*+4IKFYTZ[A5K62;R8YX]\0\V-I/D#1[AGC- '8?&_X5R_&#X3Z
MYX,@URXT"74HDC&HP()&3:ZMAE)&Y6V[6&1D,17S]8?L'ZYI^C^+8Q\3 =5U
MG5--UVVN8-"AMXK2^LR-C>6K8,950NP8QU)-=OXZ_;M^%GASX>^*_$N@:S_P
MF$OA]X8)K/2[>=QYLY80%I!&0L+E2!-RAX ))4'K/VA_CNGP=_9\\0_$73[&
MXOYK?33<Z?;SV%R-TK)F+ST";X4SC<9 FWH2I- 'C\/["FO6VNS>)XOBO=KX
MR3Q$_B.RU4:/"$@FEA$5S&T0;#I(JH ,C:$'7)-4-%_8,\6^'I?#ZV'Q3LVM
M-/\ '<OCVYAN_#@?[3>NNS&4N$VC:TH(Z?,N!\O.U\)_V@-:TWQCJ,_C_P"*
MF@ZCX=C\,MX@321X5O-,U."!619+F4..(T82# !+ JW3FNUM_P!O3X"W<=L\
M/Q$LI!<RF"'%I<YDD$8DVJ/*R25(P.Y.T9;B@#H/@-\#-1^">I>.T_X2LZUH
M'B#7;K7;'2CIT=N=-DN)7DF3S58F4$LH&0,;.!S7G7QT_8MOOC)XQ\7:O'\0
M[K1++Q%:6$$MC_9D-R8'M)!)%Y<CG<B%P&9%QN/4UWG@[]L7X/>/M=T#1]"\
M9V]]J&NN\5A&+6X19)5W%H6=HPJ2@*3Y;D-C!Q\PSH_&GXA+X,\4_#33QXOC
M\,/K>O+:FSDTB2].KH(V+6JR*"(&)VD.>3M('>@#S";]B[5O$O@+XE>'O%GQ
M&EU6[\9:C;ZP-4L=+2TDL;V$1A)% D8,O[F+Y>. <$$Y'J/P%^%'B[X8Z-=K
MXV^).H?$O7+@0PB_NK1+*&&&(-L5($9@&)=RTA)9_E!/R"N0\"?MJ^!O%?AW
M5-9OH=7T2&WUZYT.SM)])NY;N]>$.S,D*0EB0L4K,BAC&JC?M)Q6SJ/[9'PD
MTK1-*U>X\4.-,U"SM;_[7'IUU)%:6]R2+>2[98B+4.5(7SBF2#Z4 )J?[/%[
MX@^+7C[Q+K/BE+_PKXP\.1^&KOPTNFB-X[=!+M9;D29W9N;@_<Z2 ?P@UPGA
M3]B2ZC@T2S\:^/9?&&F^&/#VI>&?#*II:6D]A;7L*P222R^8_G2K BQ*=JJ%
MSE23FN5^)?[6?CCX7^#/VE=5NULM4NO!.I6-IX<-M82>0(KR&.2*28@G<$$P
M+,2%)0 8W 'Z(^!NE^,],\/:@_B[Q@_C2*[NVNM*N[O1QIEY!:.JD0SQ*J L
MK;@#L4XQD>@!\U^(?^";VJ^)]$M-/OOC'J#F/PNGA":8^'K0LVGQ2%X(XSG,
M6 (U<J=T@4Y89XZKQ)^P1'XQNO$AUGXC:K+;>(-%TNQO8;.PAMV%_I__ !YW
MT4@RT>S+?NP>=QRQXQ]99S1B@#Y8O_V+_$VLP:1K.J_&[Q-J'Q%T74UO]*\4
MM96ZI:1B%XC +/\ U15UD?>>K\ D@8KTO]GCX&7WP,TGQ3:7WC"Z\83:_KES
MKTMQ<V,-J8Y[@AIL+'P=SY;L!P  !SZY1B@#Y*^(7[!=SXT^(VL>)['XH:EH
M4%[XFLO%L%A%I%K.;?4+956-_.D!=T #;8S\BELE6YS[!\"_@?+\#T\564'B
MB]US1-6U>XU:RTZ[MHHQIK3RO+,BN@#2;GD)RW0*H ')/JM&* /F#Q[^Q#;?
M$KQG\4]=UCQMJ,<?C4:7);P6-LL,ND7&GX-K+%+N.[:=Y*E1G>>A (HWW[#F
MM:]_PC>I:Y\;?%FJ^+M&O+BX37I+:V)$4ML+<Q10.K1Q$*"=X!8L[$DG:5^K
M:* /C5O^"<R77@33O FI?%/6]7\#V=BEA'H][IEHWD*ER\ZR02!08IOG*&0
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MV:-W555),93/;%7O@+KWC?\ 9,\'>+O%'B'P#XBU#P>+30M,TNWU.*QAUR%
MTJ"UDD20?:8[?S@J,RAV\Q5"J 0OZ#;%]!4-WI]KJ A%U;0W(AD6:/SHPVR1
M?NNN>C#L1R* /FW]L;PCXP\4:CX ?PQX4O/$,%K<W@O+G2I;>.]M1);-&HC,
M["-5<MM=R"57.W!.:^=/AQ\!?&<%II]KXH^#^H2W>F_"B]\,QR7 LK@/?BY=
MHPC^:<;HVPI.".W!K])"H/4 XI#&I["@#\U+SX._%:V^%WC+P]=?"K4O$EWX
MQ\":/I5E=?:+19-+N[.T$+P3>9*-J^8IE4J3DMZDX^L_VB_#'BOXD_L@>)_#
MFA^&KJX\6:UH"V46C&YMTDCE<*&5Y'D6/"Y.2'['&3Q7O'E)_=%+@9H ^(/'
MOP]^(VE>*;76]/\ A=J&NG6OA%)X*GLK2ZL8S9:@LA;]^3+L$14\&,N>,!<\
M5RGP%_9MUB_\4WD/C7X/M874/PST31++5=:M[*>*+5;.U,3NCI)(58YAVO@$
M"+!V[0*_0NC% 'YO>"/@SX^FA^"-AXH^#.KW-OX.\%:[H=]]M>PGBDN7@40%
M )L89HW1=X&/,0]R1@?#G]F_XDZ/X*\&6?C#X2:QXYTVZ\*KH%SH?_"0KI[Z
M;<07DSKYV)@K0.K(V1N("#C/RU^H%)M'I0!\A_LT?L^R^&?VAOBMXO\ $_@2
M"TEDOK%_#FK7$,,OD!+/R+@V\F]I0&+'YF"EAUY) R/B/\-?&NF?'OXM++\'
M;7XJ^%?B+%I,^GWL]W#';Z;/9P+$([OS&#")9%,P\O)Y. S,=OVGL7.<#-+0
M!^>5[^SQ\1[KPYK?PLNO!EP^K7'Q-7Q99?$:WFA6V2U>X$[W3'>)1<)&K0^6
M%Y+* <#-5O!GP>\<Z*?!]TGPGU2QO[7XU7OB>X=(;1&CTB5955]PEZ 3H-N>
M/+/H*_1; HQ0!^9FD_ 3XL-X#^(_A[3/AUX@F\.:IX,O-+TO0O$4^GO<Z7J-
MQ=Q[8+2\,R,]H K3_/MV84 %B<ZWQ6^%'QBU/PY\9M&@^$VH^(XOB/X?T=]-
MO1J%BDND26MM$CVEPK3=4D4LHC+ DDC)+%?T=Q1B@#\[I_@'\0=1^*FN1>)_
MA!J?BW3O$NM:?XBL+^?QB]II^B2"&))$O+>";9-);!"%9 Q<* K$8Q[G^Q9\
M('\%6WCG7=?^&<?@SQ'J'BO5[NQO+R*T:]?3KFX$D49EAD=@JA54H2%^0$9'
M-?3V!10!^>_Q'_90\3?$BU_::72OAU:Z7XAUGQ#9:GX?U'5(+79JL$/DM- D
MH<O&LSPR,0=JGS!N(RV(?C)^SI\0OCSJ?Q1\<Z'X)O?A[?ZIX2TK2+/0[R:U
M^UZC?6^H0W4LI\N4QA4CA$"LY4MP1A0,_H=F@C(YH _.KXB_"OXT>-_B3J.O
MCX57]M;CQ'HNNVUM8ZSI\,3Q6R1K()QYNZ:X&TH"6"*%^7/?>\6? [XC'0;[
M0-.^'UVZV7Q8@\96VHP7UB5NK+[2)FVAYD9"H &&P<]L<U]Z^6I&-HQ1L7^Z
M/RH _/\ '[-_Q.U3P;KWPSN_!2V[W/Q)_P"$NL?'JZC;F%;5KL7$DKH)?/6X
M" PA=A#;QR I:H_"7P'^)7AR?PC?0_"BYM+VV^,=]XLOG6\TP,-)N!(BN2ER
M2659E&P9QY1[;<_H*% Z"EQ0!\Y?&WP!XPM?VC?AW\3M!\*S>.]&TO2K_1=2
MT6UNK6&YMQ/M9;F$7,D<;D[=C*7!V^O->(?"[]G7XI_#3Q+^S[&_A&YGT?0=
M?UW7-9@L=2LS;Z/%J"O%;VRAYE:4PJY=S&I7YF";S7WY1B@#QO\ ;#^&^O?%
MK]FKQSX3\+VL=[X@U"TC%G;23+")72:.39O;"J2$(!) R1DCK7R_\:_@-\5_
MC#=_&G59OAR]K>>,?"NCZ=I%I<ZK8S-8W$$P>:+S1)VW%MPP"58 GY2?T$I-
MBYS@9H ^$=*_9X\=V7Q8UYM7^&5CXNT?Q!K=GXAM==U+Q&T,>CR+''NCEM48
M^<\13"%.#QSCI[S^U+X%\3>-_P#A5DWAK0'UR3PYXUL?$-ZJ7,$)2V@24.JF
M5UR[>:, <?*<D<9]UVCT%+0!^><WP#^*[V<,>G_#.\TJX;XUW?C.2ZAU'3!(
MNDSI.@D&+CF1!,/DZ_+Q5;PC^SE\;9=&^$'@;5/ASI6CZ9X#76M.G\2PZW;R
M1W<=]:3VZW$4*CS %,P=U8!F*C@=OT5HH _+GQ=\#O''P]_9A\;-XW^%_A_P
MU<^&/ $WA[_A+UU^74KK5%1XA"L$1?;;QGYV8,.I 54' ['XA_LM?$'X]6^G
M?$3P]X3T/PS+8^'=!@TWP_>:A%*NL-;77VIC)+;81(V0JB'<"<'(08-??_BG
MPCH7CC19]'\1Z+I_B#2)RIEL-4M8[FWD*L&4M&X*G# $9'! -6M'T;3_  [I
M5II>E6-MIFF6<2P6UG9PK%#!&HPJ(B@!5 &  ,"@#X9MOV>OB(GC'X9^)+3X
M->'/"=K8>,1K6IZ/HNLQW$\<*V[0F>XN)2@FE+2%T2-<*L?S-N;C.^%G[/7Q
MH^#7CC1O'.D^![+79+34_$%M)X>O]:MX)4M+^ZCN(KJ.50\:NNW8ZC!.W !#
M9'Z!T4 ?F?X4_8X^+_A?P[\/IM4^'?A?QO)8>&9_"6I>&]8UPQP0!;^:Y@O5
M=!AE99RKQ\G"#N?EZGX@?LO_ !7N/!WQXT70?!^F1ZCXLLO"]MHM[I][;PVL
M;V"0+<[$D??#%F$F-3DC"\ C-?H/1B@#P#X$>"O&W@SXP?%>^U;PW;6/A;Q9
M?P:_:Z@VJI+<1SFTMX7M6@1,?*T<A,F_'W0-V=P\!\5_LQ?%[Q+\8!K5UHFF
M2Z=;>+;W48-0BUOR$6PN+9X 5LUCV^:H?>\C$NY  XK[]P*3:/2@#\\==_9'
M^,WQ"^ ]M\.[_1_!WAW4/#FBKIMIXFMI!<W6N1P3QS6]MG8K6L+-$"^68%B#
MM'-=EXC^%GQQ^)DGASXB7OP]\&^%?&?AG7M-U@^&X;V.677&AAGAN9);Q4VH
MS)-&(58OY?EG+<BOMS H"@'.* /AK6?V8OB=!X@N/B9I/A_23XDNOB-:>,&\
M'R:L(T6TBL9+4HUSY;*)V,K2-MW(,\;B,&I\*_V9_BWX+^(OP\UG7?#6AW\.
ME>./$GB34)-.UCS$BAU&U\N,1B6)&.V1B<8S\BG ).W[QHH _/CX5?LN?&3X
M?Z=\++F/PKH4VJ>&Y_%%E=6^H:LAABAU.2-XKI=L;AU4!U,6,GO@,<<9=?L4
M?';4_!'B.VG\/>'TU+7? \'A:X\WQ/)(R30WJW F2/[.(HHRH");Q%4C5!SG
M(/Z=44 ?#'Q4_9H^*?Q!O/BQ!::#I-E#XI\*>';&SN)]6#!;S3YUFDB<"/.#
MND4/C'R*<?-A?>?VAO!?CGXN_LN^)?"UEI&E6_C/Q!I0LI[,ZDQM;9Y,"0K,
M8@7"\XRJYQ^?MV** /CWQ9\$/BEKOQ8B\71>'='6+_A5UQX.:W?6<;;Z4F3=
M_JCF,, F?0Y]JGTSX">/X_"_[+NG2^&=%CE^'EY$VNJ-4W )%:&T26(^5^\9
MMYFQQM*!<DG</KNCI0!\.^#OV:_BKH\/@LS>&?#M@VE_%2^\:74-KK+,BV5R
M)!L3]P,L@G88P,B%>!N^7W#]I;X>^,?'^L?"6;PMI6GZA#X:\7V_B'4&OM0-
MJ5CBAEB"(!&^XG[0S9XQY8&#NR/<J* /@OQ)^R;\3-2TOQ!X:O?"GAW7?#S^
M--7\2Z5J=IXCN-/U>V^UF1X9HI1$1$\;,@(/F!\-D#"DXVD_L5_&'1-=DU'5
M-)^%WQ'O_$.B:=9:I?\ BZVDN&TJ[MHC#YD*^5^]1H]A(^7>ZY(7DM^AM&*
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M917+S^/[6#XD6O@O^S-6>]N-,?51J*V3FP1%D$?EM/\ =$I)R$ZX&?3/3YH
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MQM_9,\)?%#X9ZWX8\/:7X>\#ZGJ=C%I?]O6>@0R7%O9HR'R(]IC(7;&J@;L
M <<"NY\*?!KPKX;\ 6?A23P[H4VGK!$MW!;:3#;VUU,B@&4P@$ EANP2V/4]
M: /SV\*_%?Q-XSO_ (9>&#\2M6TJWOOB3K'A^[;0_$;RM]@,*M#$+AOFE&=P
MCE<;OFRN& (U?"'Q%\6^"_A?X3^*;^+O&7BKPY\.O'.J^&?$VGMJTTS7^G&Y
M:.UF=%<"=XC+#][[P8 C:HQ^@$GPA\#3:A8W\G@SP^]]83BYM+EM+@,EO,
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M3$)AU";%+8#9%?5?A3X*>#O!'CKQ!XQT;2GM/$>OJBZG>&\GD%SM555C&[E
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MWP1I&OZUIH5;:[O(-Q55.55AG#J#T# @4 ?'VO\ [4WQMT&T\3>()O%/A/\
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M.,G)Z=CXJ_97^$'CC5XM4U[X;^&M5OHK9+-);C3HSMA081,8QA1P..!P..*
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M5XZ[<]30!U-%%% !1110 4444 %%%% !1110 @)+$8X]:6BB@ HHHH ****
M C-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %!&1110 4444 &,4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !55M5LE-VIO( UH UP#*N801D%^?E&.>>
MU6J^(F^#=W\4?B3^UYX&\-:U#X-DU?5?#[S7HLS<(ZO8137"M&'3(E)=6YY#
MMZT ?:.EZO8ZW:_:=/O;>_M]Q7S;:59$R.HRI(K+U#XA>%=(GE@OO$NCV4T+
M;9([B_BC9#Z$%A@_6O$_V(7ETKX<^(O#6H^'?#7AG6O#_B2^TJ\C\*VXMK*_
M>(1?Z4D0SM+*\:MR<%.WW1Q'[3WPU\+:#\9OV?'L/#VFPS:O\0);O4)3$@>[
ME:VG<O*[<N0QR 2<8"J!P* /JC2/'/ASQ!?+9:7X@TO4KQK?[6+>SO8Y9##N
MV^;M5B=F[C=TSQ6W7Y__ !LTW6/@-^T;XGN?A%#H'A2/1/A'?>(+B.YL#/&Z
MQZG-<O'&@D7:7?*Y.Y44D!1A<,_X;/\ C'\2KRYD\!Z;X;LCX?\ #6@^(-2L
MM6EMXXKE;VQBO+IWEFNHGA@B24*KHC_,#O(!% 'Z R2I$C.[JB*,EF. !ZUA
MZ)X_\+^)KR2TT?Q)I&JW4;,CP6-]%,ZL "P*JQ((!&1[U\[_ +>7B*\M?AIX
M"TZ6ZDT_P;XD\7Z7I/BJ\MYMFW2YF8RH9 1MC?"JS@_=)'1L'H/C?H?PZ^ '
M@YOBEI/A;2+#Q'X-T:^.B6NG01VOVM!:R,;8A%RT053(0/N!&;@;L@'T-17P
MGXK_ &G/C!\.='L1=:OX>\3OXG^'5[XSTO5(-+:./3KFTMUN9HG19#YD#1NJ
MHY(.]ESD<&/5OCE^T-##J4=OXG\%+M^'<?Q%CN9- FW1*N[?8*OVC!!"J3,W
M(R<)_= /O"J6M:S8>'=)O-4U2]M]-TVSA>XN;R[E6*&"-1EG=V("J "22< "
MOAWQ;^T[\;-2_P"$CU+PSJ/A/3-,T?X9:=\0Y+:[TN6:1V>%Y);56\X !C%+
M\Y!( 0 9+/3=5_:!^)NM:!\1?"WBF[\'7UY>?"=?B%81'19'LH8G+I-92I)*
M1,A50NYN[YVD#;0!]T:=J5IJ^GVM]8W4-[9742SP7-O('CEC8!E=6'#*0001
MP0:LU\$>)O%/Q*M/B)XHB\.>)Y/#NEZ3\%8=?T;2['3H/LD4NUE,:@D!#OA&
MTGE5R!@#G"\(_M'_ !@;P[\/OAYX+U/2+SQ':_#?2_$TNH>(9(8GOFGB5@C&
M60;HXHQ\\@.]B2QQ@Y /T4S17P58_M;_ !A\<^,M1N_#8\&6WA[PSJ>G6NMV
MMSJ,"Q&UEAA>>Z$[R!S&SR[8GC4@X7AR:]L_:_\ BQX[^%NG>&)O!T;-8SR7
M4NM3:?9QW^I6UK'$")X+1W7S8T=E,A&2HV]-U 'N=EXNT34O$%_H5IJ]A<ZU
MI\:2WFG0W*/<6R/G8TD8.Y0VTX) SBM:OS#U7XK^/[3Q#XU^+G@GQ)X>CU:#
MX4:#XAUFZ.DO)#JTZRS"1(U8H8@0L@RREOE0<<D>G^.OVM_B!I/QJLTT;4[.
M]\))XMT#P[=V-O9Q?9X%O8(S-'-/(RRM<AY&9! '153]Y@\$ ^O_ /A;O@?[
M.9_^$QT'R!J0T8R_VG#M%\=N+7.['G'<O[O[WS#CFNM!XK\S/$[:*G@;XHK#
M9I&$_:0M8K,"+'E3B2R$K+Z9 F&?]KWKZ\_:D^+>N_#J;X::!X?O(=%N_&OB
MBWT"37;BW6==/C=7=F1&^4RMM"('!7))(.,4 >N:]XZ\.>%]6T;2]8U[3=+U
M/696@TRSO+N.*:]D7&Y(48@R$;ER%!^\/6MO/'/'UK\Y?B9\1/'OC;Q#X:\%
M:QJ.GR>+_!/QGTS1M.\9RZ8OEW$5QI]W,C/ C*ID1=FY$95)\O.*T+'XK_%#
MQ5\7?AYX0\4^.PC:#\2-3T*[UK2K2&UMM6CM],:YC>2,@@.OFF-DR4!VG!9<
MT ?H+=W<-C;2W-Q*D,$*&2261@%10,DDGH *S_"?BS1_'7ARPU_P_J5OJ^BW
M\0FM;ZT</%,G3*D=>A_*OASX:_M,_$+XA?$W1M%'BVRO_#WC"Q\3+;:@^EVR
M:? ]FY6WEM%)%P\:Y"N;D;78.$R!FLCX9_&SXL>(M.^"?AKPUXBT7P?8^)?A
M]J&L3_8_#UN\-K<V\A*F")=B+QM79C:H+9#-@@ _0_('<4%U'5@/QKYQ\/?'
MK6+S]AK3?BKK.I6&D^(9?"ZZA)J$ULSV\=T4VJYA3D@OCY1W..!7SW%^TQ\7
MK\>+?#=MXMMM'UG3_$.@6=E>ZS86<\_D7X(<2I!^Z."5; ^8#*EL\T ?HEN!
M&1R/:L/P?XZ\/?$'2Y=2\-:S9:YI\5Q):/=6$PEB$L9PZ;AP2#QQ7PYX4_::
M^)6D>+[+X5^)O&D)U.7XBW?AR7QU)86L#FPALH[A46':8EFDD?RPS*P ;&&(
MS7K?[ UI,GPB\?V)UE-0U:'QWK\%SJB1QAI9Q<D><8U^52WROM Q@C'% 'U+
MFC(]:_-ZS_:2^-VE?"#P)XRUCXBZ1-9^-O$-QX:%Q<:;!IL.D_9[J[C\\W7E
M3(K2_9U0;X615))Y!>NLA^/?Q7^&_@CP9X]\9_$/0?%7A#1?%,^@^,W\*PQ7
MB"WE %K.\RP)AHGE19!$ #E,?,6  /M:_P#'GA_2_%VF>%KK5K6#Q#J<$MS9
MZ:[XFGBCQYCJ.X7(S]:W0ZGN/SKXBO\ XG_$SP)KGPTU/Q5-#J6O7_@GQ+KT
MND7VG6ZSV]Q D4\%N)(T#J1'(L;JIP3&<YKG/!7Q9^-GQ%\ ZYJ_AOXJ>'-0
MUB_\(/KND:9IJP7MZE_ \;R1>2;5!'&ZLT.R0LP9E(8X)H _0+(HK\]O#O[6
MOC[X@^)K33]&US6+;1?B1I5G:>"=2ETNV!M=3B:U3564>5ET@669\R90F"8*
M6&TU]!_M+?$O5? &L_"'PE%XM?PG8^*M:?3]3\52I 9XHX;5Y0BF1#"DDTBH
MFXH0,G"^@!Z18?'GP#JL.FS67B>SNX=1UI_#MI)#N99=11'=K<$#&X+&YR>.
M.O2N]W#U%?G-\&?%^N>#+3PQ:Z7XN.I+>?'S6-&U6[:*VD.IQ2)<-YS,$_=L
MYBW Q%01(PY&,4_$O[6_Q ^'7_"6W&HZ[=WNIW&F75UI,UM';W>BS6_V^*$7
M<!1!)$]O&S*T4H;+ $GLP!]_>/?B=X7^%^G65_XJUJVT6SO;R+3[:6Y)Q+<2
M$A(U !))P?H 2>!745^>W[1?Q&LM2^"WB.QE^),/Q(LV\0^&;[3+Q+2)?[.2
M2]B+))<1A8V=A%,VT .JL,C!S4WC7]I#XB+H7Q7\=:;XLN8O$/@+XAP^'[/X
M=);VRP:A8M<1011N"C3/+.LLCAUDQ^Z.U1M- 'Z!T5^=.J_'_P")5G\2/'$=
M]XUU&*.]T?Q9<>%KOP^;.\TB=K%-\4?EM&9;:>#RG#B7?O+  @'!I^-/VN/&
MDMCJ=SH7Q1MQY?P4M/%#);+8R-%KWGQ^8%!C.&9 P:(YP)"0%." #](B<=>*
M,U^<GQ(^*'Q8\->+?#_@?6/CQ9:/!K'A9_%%AXOU5;71K:XO)'519B5;>9&B
M@">9L^5G$V"_"U97]I'QW<?%[X?7&J>.GU3PM/>>&].N7\+JL*Q75S;J\JWM
MC,B3F*Z:0/',IVHH V[MRD _1+(HS7S1^U!K7BY_C%\%?"7AWXAW7@?3_%5U
MJMGJ*V,5LUQ*D=F94DC::-\,I!7IC,BGJ!7S7\(_VA_B+IJ_"KQ-XH^*U]K&
MEZM<^*]$U*WELK3R/*TZUGDMKA51%+3%XXR26.X,JCJ<@'Z5DX%<GX;^*?AG
MQ=XS\3^%-*U+[5K_ (9^S_VM9F"6,VWGAS#\S*%;<(W/RD]/<5^9.E?MP^/?
M"MAKZQ?$)=36Y\$Z5J4$]]<VE]>0W<U_%'<W0@C4I#(EN\LIM-T@C54+'[RC
M8\7?&V'X3_$OXZ:AX(^)AUZWU63P9'<>)I;U-0FM--87$=U<*T2L=L9EB!94
M)0SJ -Q7(!^H\TJP1/(V=J L< DX'L.M<W\./B5X<^+7A"S\4>%-1_M30KMY
MHX+KR9(M[12M%(-LBJPPZ,.1SCCBO'?V-/$^N>(_#'BY=7^)FE?%"WM=<D2Q
MU/22TT=K T:.+8W!11,R[LDC<5W8+'@#Y,^$^L>*](\%_#-/"/Q-ULWOBKXA
M:QX:U#PE;2VQ&G6,MS?/+>*@C\Q)8<+<%F)'[U0?EP" ?IYFN3^)'Q4\+_"3
MPKJGB/Q3J@T[2-+A2XO)DADG>&-GV*YCC5GVEN,XQU]*^<OV2O$/Q(\9>*CH
M/C75M<2_^&BWND>()9V7[/KVH3S;[>4';DI':A) !C_CXCZ@<^1?M,7>B^%?
MC!^TU::UXNNH+C5?A;YNEZ;J6HEDGD>.]4PPQ.3E58!@JC"LY/4YH _0[3[Z
M+4[&WNX"6AGC66,LI4E6&0<'D<'H:L9K\N_%_P =_'GP(D\4Z/H_Q4U'QG:7
M7A/PYK,U_=2179TE;BX\J]GMTB0;(UBV,%4?*)D;DX8_4W[$7BZZ\26/C6U/
MQ23XJ:5:7EO+8WT0FF6R66(L;<W4H#3.,*Q4Y,>\ GG  /3/''[3?PZ^'GB&
M_P!#UC6[AM3TV!+K48=-TN[OQI\3_=>Y:WB=8 >N9"O!!Z$5WGA3Q7I/CCPS
MI?B'0KV/4=&U2VCN[.[BR%EB=0RL 0",@C@@$=Q7R)^Q[XY\+_"5?C'X<^(V
MLZ=X7\;_ /"9:EJVI)K]Y'#+>VDFPPW*&0C?"4X!&0/;.*X7QS\2;#_A*_B!
MH5MX[UCX/^#_  ]X$MM5^'UG:[]'@N2!(TLYC;:UP0Z1((6!RDC84-S0!^A>
M1ZTFX>HK\O/%/Q>^(.NZ5\4=>UWXLZ[X0\1>&? &@>)D\.Z?>Q6T<6J26[>;
M"\14LJES'NA[M<)NZ(!-\6?CKXJ\$:%\9-+T?XJZ]JVHIX+T+QAI]\VHPN\%
MS/<QBX6'8H$<3)/$PC0;0K*>X) /T]R/6C(]:_,;XA?&7Q!\,]1\0V&E?&?Q
M%XT\&W]GH%U>:ZVH0E;#4[JZ?S+7[?$F+.WD@C>1C&I,2A=J_-AJ7@3X[:MX
MZ/P\\+W7QIU*SGG^)6KZ'=3:3KI>272FC;[+B:5?,D1F 6.5QN_>*>&VD 'Z
MC9'K7&^*_C#X2\#^-O"OA/7-4.GZYXH>6+2(7MI3'<O& 77S0AC5OF& S G(
M SFO@KP-\6?&]G\%_!WQBA\7^)/&NF> O%NIZ'XFT:WU1Y9-5T][EX[65U#[
M998C-"<D NK*3E4&?M3X8?".2Q\!>"$\;WE[XH\5Z,?[2DO-1O)9A%?RHWF%
M06VLL?F.D>X'8H&#G)H ]3R#WI:^"?V0OBGJ_B']I:XL]0\5WGC6SUC2=5O[
M35=-UJXFL7C%_'M6[TZ?/V&>'YH5\O:C*< -C<?O:@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBDW#UH 6BLWQ%K']@:#J.IBSN]2-E;2W/V+3XO-N;C8I;
MRXD)&YVQA1D9) S2^'=9_P"$@T#3=4-E>:8;VVCN39:C$(KFWWJ&\N5 3M=<
MX89."#S0!HT4FX>M<SX-\;OXNN_$$$GA[6M"&D:E)IRRZO;"%+X( ?M%N0QW
MPMGACC.#Q0!T]>-ZS^R+\+O$&J>*-1OM#OI;[Q+?0:EJ4Z:[?QM)<P[O)ECV
MSCR60,R@Q[<*=O3BO8]P]:X6_P#C%H^G?&?2_AG+::C_ &[J6CS:W!=" ?8S
M#%*(W3S-V?,!93M"GA@21D4 5O"'[/W@'P%XET_Q!H'A^/3M7L-,ET>"X2XF
M;%M+/]HE#*SD.[R_.TC N23ECFKGQ ^"O@[XHZQX=U7Q/I!U/4/#UP;O2IQ=
MS0FTFRI\Q/+=1NRB\G/3W-=Q2;AZT >9^,?V;OA[X^\9:CXJU[0Y;[7=0T:3
MP]=7/]HW48ET]\[[<QI*$V'))P,Y.>M8%_\ L7?!357\.OJ'P^TW47T"UCL=
M/:]>68QV\9)CB<NY\U%SA5DW #"C@8KVO</6C<",@T 9/BKPEHWCGPW?Z!X@
MTRVUC1K^(P75C=QAXI4/8@_@0>H(!'(K@? ?[+OPT^&Y)T;PV9<6TEE&-7O[
MG4Q#;NH62&(7,DGEQLH *)@$<$8KU3</6LSQ)XGTGP?HMSJ^M:A!IFF6P4RW
M5R^U$RP5<GW8@ =R10!YI9?LD?";3](U/3(/!\"V.HZ?_9,\;7=PQ%EO#FVC
M8R$Q0EE!,<953@9!%/G_ &4?A=<LYE\,LX?0?^$893J5WM.EX ^RX\W'E_*.
M/7GJ379Z5XWGU+X@:YX9?PYK%G;:;;07$>NW$*BPO#)G,<+[LLZ8^88&,CFN
MHW#UH \;M/V/OA'8I?I!X2"+?Z.N@7(_M&[(ET]0H6V.9?\ 5@(O'M[FI;K]
MDCX4WK3-/X5\UIM$3PV[-J-WN.F)MVVN?-R(QL7CV]S7KX8'I2D@4 >6I^R_
M\+EU'P]?R>#;"YO/#^EMHFFS7323&WLF5U,'SL=R[99 -V2 YP1FN=NOV'O@
M3?:-HVE3_#319+'1RYLXRKY3>VY@S;MTBD_PN6'M7N188ZU\V6G[<.B7MCI.
MJV_@7Q7-X>\0S_8_#>LI';?9]:NS=?9H[>/]]F)W8.X\X(#'&S9P* /0]8_9
M=^%/B#X@Z;XWU#P+I%QXHTXPFVU#R2I0Q8\DE%(1BFU=I925VKC&T8VOB3\%
M?!OQ<GTF;Q5I!U*?2O.^Q31W<]M)!YJA9=K1.IPR@ @GIQW-4_A#\5]2^*$>
MLMJ7P_\ $W@)].G6W5/$D4*&Z/S;FA,<CAE&!\W0[A@FO0]P]: /'+S]C[X/
M7\6L12^![(0ZOIMMI%[#%--''+9P-$T,(57 55,$1&T#[O.<G-&\_8@^!6H7
M+W%U\,M#NIGCMXB\T;N=L(58\9;@@(H)'+ 88D$U[CN'K2@YH \@O?V1_A)J
M-AJ-E<^"[26TU'65\07<)GFVS:@-^+@_/]X>8_MSTKO/'/P[\-_$S0'T3Q3H
MUIKNE/(DWV:\C#JLBG*NO=6!Z,,$5T6X>M&X>M 'FMU^S9\,KWP+_P (=-X,
MTQ_#WV[^TQ:["'%Y_P _0E!\P3<D>;NWX)&<5+-^SK\,KCPMH_AJ;P-HD^A:
M1>?VA8V,MFKQPW)))E /5R6;).<YYS4GQB^,-O\ ""+PE)=:-?ZLGB'Q%9>'
M8VL3'BVDN7V))(&8$J#_ '03G' ZUZ".E 'D-I^R%\%K'47U"#X8^&H;YY99
MC=)8()=T@(?YL9P03A>@R< 5=T[]E_X5:/\ V5]B\#:3;'2K.XT^Q,<1!M[>
M?S/.C0YX#^;)GUWFO4#(H(!8 DX&>]#.JCE@.W- '(Z/\(O!N@^ 3X(L/#FG
MP>$2DD1T;R0UL4=R[KL.1@LQ.*Y:/]DWX.0S12Q_#7PVDD00*RZ?&"-A)4].
M2"2<]:[+P+XIU3Q+8:C/K/ANY\+36VHSV<-O>7$4K7$2-A+@&,D*LG4*?FQU
M'(K>GU*TM;=+B:ZAB@?&V5Y JG/3!/'- '!:Y^SG\,O$NF:MI^J^!="O[+5K
MQ=1OH9[)&%Q<KG;,W'WP&8;NN&(Z$UN>"?A5X-^&NE7NF^$_"^D^&K&]D,MS
M!I5FENLSD8+.$ R<<9/:E?Q=J:?$V/PU_P (Y.=%;2#J/_"1?:HO*$XF$?V7
MR<^9NVD/OQMY SFNBAOK:XEEBBN(I98L>8B."4R,C('3(H \_P!*_9S^&.B>
M!+_P59^!="C\)7]R;RYT9K)'MI9B%'F%&!&[")SU^45TNG?#GPKI7@^+PG9^
M&])M?#$:"-=&BLHUM N[=CR@NW[W/3KSUKCOCK\>['X*^ +;Q;'I,_BG3GU6
MTTR<Z9<1@6WGRB)978G[H=D7 R<N.V2/4\\9H YO5_AMX6U[Q3IOB34M!L+[
M7]-1H[/4IX%::W5L[E1CR <GCW-1^$?A9X.\ W=]=>&O#&DZ#<WS;[F73K..
M%IC_ +14#/4_G7/?''XVZ?\ !70]&GFMXM0UC7=5M]%TG39;Q+47-S,^!ND8
M'8BC+,V&P!@ D@&'X,?%+Q5X[TW59?'/@-?AO?6EZMI!:2Z[;:D+H,H(8/#C
M:2> K#)X- '867P]\,Z:NA+::%IUJNA>9_98AMD066]"C^5@?)N5F!QUSS3O
M&?@+PS\1M'_LGQ7X>TOQ-I7F++]BU>SCNH=ZYVMLD!&1DX..]6;KQ3HUEI<V
MI7&KV-OIT+%9;R6Y184(."&<G (/')IDWB_0;>QAO9=:TZ.SF@:YBN'NHQ&\
M*@%I%;."H!!+#@9% '*Q_L]?"Z![9HOAQX3B:VO/[0@*:);#RKKY1YZX3B3Y
M$^8<_*.>*TM%^#_@7PXVH-I?@_0[!M01XKQK?3XD-PCDEU?"_,I))(/!S6S>
M>+M"TZVL+F[UK3[:WU JMG--=(B7)8941DG#Y'(QG-<YI?Q!NY/'7C#3-4LM
M.TSP[H=K:W$.LMJ\3O-YBR&;S8!\UNL93&YSAN2.AP -O?@1\-]1\-?\(Y=^
M /#5UX?^TB]_LN?28'MO/"E1+Y93;OVDC=C.#BM*;X5>"[CQ=;^*I?".AR>)
M[=52'6GTZ$WD:JI50LVW>, D#!X!Q7'?$_\ :$T_P$OP^N=*LH?%>E^+?$]I
MX9&H:??Q^3:/.6 E) ;?@H1M&.>XKUKMF@#CM ^#G@/PIKFIZQHG@KP_H^K:
MGO%]?V.EP0SW0=MS^8ZJ"^YN3DG)Y-9R?LZ_"N#2VTV+X;>$DT]EV-:KH=L(
MRN\28*[,8W@-CU&>M==K_BG1_"EHMWK>JV6CVC.(UGO[E($+$$A0SD#. >/8
MUY!\;OVI-,^%_BWP1X0T:+2==\5>+A<R6$%]K*6-JD4,!E#23;)"OFG;'%\N
M&9NHP: /2]8^%O@WQ!H^FZ5JGA+0]2TS3"&L;*[TZ&6&U(& 8D92$P/[H%.?
MX9>#Y?$J^(I/"FB/X@5E==5;3H3=!E4(I$NW=D* HYX  KY:T3]N7QKXWMQ=
M^%?A]X7NX;'4H]%UFWU#QW:6\]G>;8S(5^4I+#OD,<;JY+LC?*.*^K+OQ_X9
ML/$]MX;NO$.E6WB*Z0R6^D2WT2W<RCJR0EM[#W H EU;P/X<\0:O8:KJF@Z9
MJ.IV (M+V[LXY9K;)!/ENP)3) Z$=*R+#X-> =(%F+#P3X<LQ9RO/;?9]*@3
MR)&QN=,)\K':N2,$X'I5X?$CPFVJ:EI@\3Z,=3TR(S7UD-0B\ZTC&,O*F[**
M,CE@!S5GPWXU\/\ C)+E] US3=<2UD$5PVFW<=P(7*APKE"=I*LK8/8@]#0!
MG:9\)O!&BNKZ=X.T"PD6)X%>VTN",B-_OH"JCY6[CH>]3:7\-/".B6L]MI_A
M;1;"WN(?L\T-KI\,:219)\M@J@%<DG!XR36UJNK6.A:?/?ZE>6^GV,"[I;FZ
ME6**,=,LS$ #ZUR5S\=?AM9Z4^J7'Q!\+0:8ES]C:]DUJV6%9]H?RBY?:'VD
M-MSG!!QB@#J-#\/:7X8TR+3M'TVTTG3X<^7:6,"PQ)DY.$4 #DYX%8.O?#32
M;RT\0SZ);6GACQ/J]C-:?\))IME"+Z%G4@2;RN7*MM<!L@E1FF:]\8O OA:^
ML;/6O&7A[2+O4(1<65O?ZK!#)=1'H\:LP+KP>1D<5/<?%/PA::[:Z)/XHT:'
M6;O;]GT]]0B%Q-N!*;8RVX[@"1@<XXH S/@O\*_^%2>$'TNXUN\\3ZQ>74FH
M:IKNH(J3ZA=/@-(RKPN%1$51P%11VKIM;\'Z#XFW_P!L:)IVJ[XC WVZTCFW
M1[@Q0[@<KD XZ9 -<_'\;_AY/>7=G'X\\,M=V=N]W<P+K%N7@A1MKR.N_*HK
M<%CP#Q7BVE_M>7?BW2_B'<^'F\$NGA[Q5:Z#I>H:AXF6+3M4@E2*0NMQLV^;
ML=\1KN^92 6V\@'T#9?#[PMINH2W]IX;TBUOI;<6<EU!8Q)*\   B+!<E %4
M;>F%''%:>E:-I^A6@M=-L;;3[8,7\FUB6-,DY)PH R37,W'QG^']GK(T>X\<
M^&K?5S=_V>+"75[=9S<\?N/++[O,^9?DQGD<<T[5?C'X!T+Q,/#FI>./#FG^
M(25 TFZU:WBNR6&5_=,X?D<CCF@#7U?P;H&O:C9ZAJ6AZ=J-_9D_9KJ[M(Y9
M8,]=C,"5S[58U'P[I6LS6LVH:99WTUJQ>"2Y@61H6.,E"P.T\#IZ5H*<C-<O
MX[^*G@[X7P6<WB_Q1I/AF*\D,5N^JWB6XE8#+8+$< 8)/09&>M &G<^$="O)
MKJ:XT73YYKI0MQ)+:HS3 $$!R1\P!5>OH/2N ^._[/FB?&[X7^(/!AD3PVFM
MQ0V]SJ6GV<1N/*C='5 2.G[M1[ <5N^)OCG\._!>I:3I^O\ CCP]HU[JT2SV
M$-[J<,37,;'"NFYAE23@-T)Z9JKK7[0WPP\.:^^AZI\0?#6GZPER+-[&YU6%
M)DG(!$;*6R&P1P?6@#HM \%Z;HWA2QT*2TM+JVMX8XY ;2-(YG4#,AC V@EA
MNX'!-7IO#6D7-REQ+I=E+<)*)DE>W0LL@"@."1D-A5&>ORCTKC+7]HSX6WNC
MWFK0?$3PQ+IEG>+I]Q=KJT!CCN6SLB+;L;FVM@=]IQG!KSOXO_M;:5HGPI_X
M3;X9:EX;^(%G::W8:;JGV?5 XM(KF=8 V(\G?O=,*VW(+')Q@@'9^,?V>M(\
M8>,?#>J2:MJ>F:#HUPE[)X5TQTM],U"ZCD66&:XC507:-T1@,X)1<YQ@^K"O
M'] ^.MDGBWXFKX@\3^#8?#'AB[M;:&>PU/?=6C.A$L=\K?+')YH*HJ\D @C(
MK7O_ -I#X7Z5H=KK-]X^\.66E74DT4%W<:G%&DCQ#]XBDMRR\97J,CU% 'H5
MM8VUD&%O;Q0!B681(%R2<DG'<GFIZ\ZE_:)^&<'A'2?%,OCG08_#VK,ZV&HM
M?1B*Y* EPASR5VMN'\."#BIM:^/_ ,-_#EOHMQJ?CC0K*WUJ*.?3Y9;^,)<Q
M2$".13G&QB<!NA/&: ._HH!S7(^*/BUX1\%^*=$\-ZWKEMIVN:VDTFG64V[?
M<K$NZ4K@8^5>3S0!UU%>-ZS^U'\/KOX;GQ)X?\<Z L>HPWT6CW^I/(EG+=6T
M#RN)" &"($W/C!P#CG%<E=?M9VMOH6GZ!;:EH^K?$6]\$3>*H+BTM[D:1.RH
MACV%AYACD+.PYR%C.[!(H ^D:*\/_9F_:G\)?M >$M CM_$6C7'CN70[75=8
MT/3923:.Z)YH56))5)'"'DE20&.:]P)Q0 45\J_'/]MNQ\&Z-\06\%BSO=7\
M :GIEOKR:U;SI 8+FXCAD,3+M^9&E3ECCAB 0 3Z[H/[2WPR\5>$M1\3:/XR
MTS4-%TZZ6RN;F)V^2=@"L84C<S-N&T*"6SQF@#TVBO"K_P#:-TK6?&_PZ?PO
MXS\)2^#]6;4QJ@O))?MLQMX056V(^5&C?<91+@[<8YKL?AA^T-\./C1?WUEX
M(\7Z;XDNK&-9KF&RD):)&8J&(('&5/Z>HR >B4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^;7[2VG:!<?M'?':T\
M3>,==TF_M_"=EK/@[3K/Q)<PM)JRPRA&M[991YDP=%58P,8D8A?FW#]):\Q\
M,? RV\,_'/Q?\3E\1:K=WOB2QM["?29Q"+.%(,>44VQA]P_><EB#YC9!P, '
MP[X8T/2?%/B3]H76/'?CCQ#9^*O"&CV\BV<'B:YB@MYY=&5+ME17 ;%V\BX'
M"L$4  @'SW7]>T[Q5I5K!J'BW5'6#]G*'58K>+Q!<Q1/K\&4C#(L@#S*0I\O
M^\F2I.37ZX;!32D9<,5&\ @-W .,C]!^5 'YA>!_B?IGCGXAB]^).M>,YO$M
MYHGA74/ 4_AZ28S74B6ZF]MXG1#%F2[,D<[2 #&\%E"<0^//%F@7/A+QYI][
MXQU33M%L_P!H&VAU"ZM-;N8Y+?2IXHHY"9 ^[R_W5P%Y(4QDKC%?H=:_&SP%
M=Z'XJUF'Q5IK:5X6NYK#6KPS8CL;B+'F1R$_Q#<!@9R3@9->7ZO??#7]MZST
MRW\'_$J>7_A"];LM=E.@)"7CND+FV,HN(6XRDA  P2ISG&* /COQ-=V'AJ\F
M\-VM_K]Q\(K[Q?>_\(IJ=_=7^I:;L32HU==D>9KM#<RL+?$JIO1FW/@@]Y^R
MU\2+/Q#\5OV;8K[5Y[O5X/AYJNF7#WT4T<K7 GM]J$R#+';!(-P)!\LX]*_1
M# J&XGALX))YW6*&)2[R.<*J@9))] * )QT%?G-\7-<M[W]JCQ7H7Q U[QKH
MVOV^OZ7>^![7PYI<D\^HV@BC)AM9E_=QIY@D\S>5&68L25(7[[\"^.] ^)GA
M33_$WA?5(-:T&_5GM;ZV),<H5BC8R >&5A]0:W=HH _,[P_-I?A7]J87T]QX
MFN_@')XRG;2X\SR"U\210Q NR@><;/?(RJ.4+JA.57GFO ^N^(=8N]1EM?%/
MCZ+]IC2M.\0IJOAFPTJ189IFMYS;RW$S@1O"I%OY(!+ O$%7&"/U6P*S/$WB
M32O!OA_4-<UN^@TO2-/A:XNKRY?9'#&HRS,>P H _,[6?^$6\7_LP>.]2^&]
ME\0QXC;P+9S:U;7 O([2SU"WG@;S0)%#27;YF9I(W9=D3%@-WS4?C=XKTOXU
M>(?COK6@6VK>(?"UU9>$-9L"-*NDCD6"]B2\EB5D&YA'(P)7D@L!D*<?IA'\
M0_#,O@1/&HUNR3PF]B-3&L22A+?[,4WB4LV,+MYYK.LOC%X+U+Q!X:T2T\06
MESJGB333K&D01%F^VV84-YR,!M*X8'KR#0!\JVGA7P;\=/C#\</ ^B:CJ&GZ
M=XE\%>'[C3IDCN;=+.>)9RDL((7RS&LE@6C^4G)!'WA7E.N6WQ/US]FW5_B)
MJFC:[H/B'1_[(\#:G::=YLEV^CZ?<?\ $RN(H\_-Y\[$-D',=O@G:6K],]HS
M0<"@#YB_86@\,Q>&?%<W@K6_%?B/PI>:BMW:ZGK^GFQLWD=,2QV,+(CB-2H#
M':%W'"YPU>_?$*+6IO ?B./PVZQ^(WTVY73'<@*MT8F\DDGC&_;572?B=X6U
MWQ_KW@FPUB&Y\4Z#!;W.I::JL'MHYP3$22-IW 9P"2 1G&1GJL9H _,SX%Z+
M8WOC'X*W6@VFHPZ]%H^JV?QDTW5(;EUN8TMRKMJ22#]Y*TS,8U(8D.,#8M8E
MCX&^'EG^R+^S3INK^%H(KI_'5M<:S'<:/,L[6WFR?:Y)R8]^QHFMLEN&3R\9
M"C'ZFX%&!0!^8WQI2X\.^-?CII_AG2-;U/P2OC/PM=^(=%T>.X9KG1$MF&II
M$,C,9EVQNL;8 .#A*9\4;?PO-:>#&\-:=XTT_P#9XOO$6JSZI))H;W-M#=S6
M\'D^5I\L.];2)Q,J+Y>%?>4S@5^GF!1M&<XH _-'X5?!3P+X\^.GPF\/:VOC
MG5=!L?!%[-IL_B:6ZM+F6:+5/,LF?RRH0>2LDD<9VG9'#N!( K]+@ !Q1M'I
M2T ?FK_P46T[4?$GQ)\4PV?A#5YM0L?"U@=*U>#0KO5&FD%Y)+(+21!Y5B44
M%I)3\[A%48&=W-?$NST'Q'??M%^--*T;7K_7['Q)X=UWPTUQI>HP31*5@DGD
MCA**R$8G#G 8!>W%?J=@5S?CSXB>'?AEI-MJ?B74DTNQN;V#3X97C>3?<3.$
MB3" GYF(&<8'4D"@#\T_&>I(_B6[U'7?!OB*]^*FE_%RT\0Q:_\ \(]>79?P
M\+@&W:WG6%BMLL6P" GEAD*6X'ZGJP= PS@C/(Q0O(Z4[M0!\5_MF>%/ >L_
MM5?L^#QWIL^I:)J%CXAMKNWABN9EG\J*VD@5XX<L55Y';IC)&[@<>*_"'X!^
M'M>^,/PF\->.O#7B2333X>UMK>VO;>^B1+8:LT^E13N IC*PF1]KD;3Y:M@X
M%?9EAX=\ _M#?%71?B3HGBW5[[4?AU>WVA+9V,AM[2&[94^U1RH\0>0E3$#A
MMF%7'()KW$#B@#\N=/\ AUIFO1>#K6\\*ZT-(A^.>IS)8RZ)>H@T:X'RR,WE
MKMA)6!<' (;!X5A57PM;P^&]1T;2O%GPS\4:_P#!S2O%GBVS_L:VT*[N8K6.
MY:-M-N1;M&"RB/[2B%=VS>3E6;%?JA@5R_C+XF>&?A_J7AO3]>U(6%YXBOUT
MO2XS!))]HN6!(CRBD*2 3EB!QUH ^#=5\):;HWC364@\":WX:TJ3X&:OI6S4
MK*XGVLEQYMJES<F/:)OL\(;#ME#B/.X*#X_IWPWEM_@]X<\4_"WX>>(-5+?#
M26W\9PVUI>VJZM>3-;^2HD^1[A@6EE;R2P\M  0"M?J]XX\(V?C[P?K/AO49
M;F'3]6M)+*Y>TE\N7RI%*N%;G:2I(S[U5^&?P]TKX4> =%\(Z(UTVD:/;BUM
M/MDYFE6,$[5+GD@ X'H !VH _+J*P\4VGPT^+NCZ;X,\8S6&N^)?"VI69'@B
M?38)XH6MS<O!:PQ[(L/$,+RY106);)K]:D<2(K#.&&1N!!_(]*YGPM\2_#'C
M75->TS1M7AO=3T&X%KJ=B%9+BTD*[E#QL P#+RK8PPZ$U-X'\?Z%\1]%?5O#
MMZ;_ $Y+B6T:8P20XEC8I(F)%4Y5@5/'#*PZ@@ 'A7[:^@V?B!?A#'<>"]0\
M8BS\<:??7*6&A3:D+:R0L+AY#'&P1/FC)4_?V\!MIQ\Q?&7X<SS7/Q_A'PY\
M0OH-Y\0O#NIZ<+3PQ> 21Q*%U"ZA:./)3:EQET_YZ<$^:N?T6\8>-=(\#^'M
M9UK5;@I:Z383:E<QP*99A!$I9V6-<LW /0<GBI/!GBJP\=^$]'\1Z7YQTW5K
M2*]MOM$+12>7(H9=R, 5.",@]* /SA\1>#]1\*Z_X[TOP[\)O$J^%D^)UCJF
MGIIWA*Z>"PM5L)(GO+2S*I'.1(K@!E>('8Q5@4SB_!OX*)?^)/@)IWC[X3^*
M+G1_#G_"4VNL6^N>%)Y[98Y)9)[%7*1%)!^\;:%78&)VC/%?JC@4C_*N0.:
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M>* /RE\"?!#Q)!X%UC0_$OP0\=:C\0M"T'7]/O?$E[?-/IURUQ;3".2T3/\
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M'^TKR'3;26YMM,M3,Q_>332+%#$.Y9G95'USZT ?%GQ"^#_Q,E^)7QNUW0_
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M7X4@\+^*8;N]-VL<MO.TZR7<LT3F6%F# )*JX)R-IX Q7O\ O% .: %HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!#
MFODGQ+\:OB-XN^+?Q6T[PGXJ\-^$-)^&5QI;75IK\(:'4+62,SWDT\H#21*(
MP538!RIW'GY?K>O*/&O[*OPH^(GQ!A\;^(_!=EJOB>/RO]-EDE E\K'E^9&&
M"2;=JXWJW"@=A0!\U^&/VB_C7\1==G\3:)J'A[2/!!UW5M N(-3DM"EF\7F1
M6GECS!/)<%XU8QL,/YGR@+@UQ&G>-?CS\1O"/[._CGQ7\0K&ST3QAXNTJW@T
MG0],C@=<Q73F2=CN\S=Y"ML!"Y<Y0;5Q]@C]D+X/IX[U3QG'X'LH?$NI"<W-
M]#+-&2\R%)9%17"1R,K-^\0!_F8A@234DO[*'PKN/AOH_P /YO"HG\(:-?C4
M]/TV6_NG%K<#?AT<REP/WDGR[MOSMQS0!\A?$'7O%WCWX<?%33[[Q!IND'0O
MC3I^E1S0Z+;Q0S1&\L!%+.I7YRC.LA=MV\+@DKBNE\;?''Q!\ ?'_P =M*LG
M\-VTD%SX4M[;65TFWLW@?4/-CN+Z[V8^T-&5WX;Y02!\H)!^D]2_9$^%&K:7
MK^FW/AF8V.O:POB#48(]6O8UGOU)*S?+,-I!.0%PORIQ\BXO:W^R[\,?$NH>
M+;W5O#"ZG=>++2&QUJ2[O;B7[9#%M\H$-(0I3:I5EPPQP: / ?B;\4?BW\.)
MM(\(W'Q'TG6/$&K^)YH;!O#^EPSZS<:;]B,T"&!U6VCD\Q3OD<JBQL&W=*X_
MX/\ Q#^(7QP^*WP,\17GC*?2[O7?A_K%U)9P6T+6BW45U%"TGE%>=Y\MCSD;
M,*5!.?I _L0_! ^%=.\.'P!9'2=/OGU&WB-S<&19W54=FE\SS'!6-%*LQ7"*
M,8 JUI7[&OP:T+_A'_[/\#VEFWA^XN+O3'AN9U:UEG"^8RMYF3]Q,9)"%05V
MD4 ?/GP6^+GQ(^).@?"#P+IOBW3?!>KZOX2U77KW5++1K8M<3PWOV>*&& IY
M*1@L7;"[F5> IR:YCP[^U!\;/BW/X5T[3O%6D^"KZ_\  FK:Y>/#HB7H^VZ?
M?S6K-'YC !)3 &Y!"J[  G:R_6K_ +)GPI.@Z%H\7A1+.TT&:>?2I;*^N;:Y
ML6F),PBN(Y%E17+-N4/M.>E6O^&7_ABFJ:;J$/A:*TN--T:3P_:K:74\$46G
MR*RO;^4D@0JP=B25)W8;.X @ SOAY\9-4U?]DO1?BCJEHEWK#^$%\07-K:(R
MK-,+3SF1%&2-S @ 9/-?,EG\=_B9_8/PJO/$GB>U\:^'_C#X3U:>[TR+2HK5
M=#N8[%KD+;E!O>-58Q/YS.3Y>X$9Q7VWX"^'7A[X8^"].\)>&[#[!X>T^-H;
M6R>:2<1QEBQ7=(S,1EC@$G X' Q7(^"_V7_AA\/M0>\T+PG;6K^5<00Q2S37
M$-I'<,6GCMXI'9+=9"?F6)4##@C  H ^+?A3XK^(7@SX7?"WPKXK\36/B/X<
M>/\ X9:KY&E6^EI!-HZ6FGK(I63EIR\,BJP? W9QQU[CP'XW\5>#+3]F:'1#
M8:G%??!RYN(=)FLH3*UY:Z?:21YN2/-2.1I$4JK*,QY.>WTQX9_9=^%_@_3M
M2L-*\*0P6>H6,FES0RW,\P2SD),EM%YCMY,+$DF./:I/45C>*_V3? ]UX5-M
MX8TBW\.^(=.T&^T/P_JN^:4:7'<QRJP5"^"H:9CM/; & !@ ^9/AO^U!\4/$
MVA:EXR@\=17_ (/M/AO)XAU/4=4T*.'3],\0%65;%)8XE=D4_O-O[U\*!D[Q
M7*>.OB_\4/B+\-?C'H6I^+]<T]?#]]X.N[*2YM-/MKU[?4'1;A95A3:(2Q$J
M(V) -JR$@LA]3^!__!/=?"^KV?\ PENA^$=.T6+39]/U&S\+ZAJDHUX30&%Q
M<I/((XT&XR8123($8,NWGVW3?V'O@9I&FZI86?P[TZWMM4T]-+O0LLVZ>W60
M2*K-OW;MRJ=^=QVKDX P >"?%O\ :*\:? KQ1\>U&NVFLS:+IGA:/3-1OM*@
MC%E]K>2":YN&A13*%8B0*Q"@G"JJY!P_VA_V@OC-\ 9/BAX8L_'4?B&[T+3=
M"U[2M>O],LS<B*ZO%LY[>>.&)(L%RTBG9N"@<G<"/K>V_9<^%5HVIE/!&F.N
MIZ5'HEY',K2)/91JBQPLK$C:HC3'&05R#GFL^3]D/X1/X*U'PG-X.BN-%U)[
M=[M)[RYDGG\C'D*UPTAE*QX&Q-^U>P&: /GKQ1\9?C5X0/Q>\(6_B1_&GB+P
MSXBT)+6[TRQL;'4IK&\MOM-S;V4$B/%),B(X0.LC,-QP2!CZ!_9&^)-S\4_@
M)H?B#4/$5UXFOWN+Z&XU'4-/BL+GY+N54CG@B 2.1(Q&C!>"5)!.<FQK?[)/
MPH\2:SJVKZEX5%WJ>JS6ES>737]T))9;52MN^1*,,@8@$8]\UWO@+X>^'?A?
MX7M/#GA;2H=&T6U+M%:P9(#,Q9V+,2S,S,268DDGDT ?"G@;]J/XN:EXFFEB
M\2V^N:=JGA3Q1J=C=ZI!8V.B_:K*;%M-;2;$G6W1=J.]RP#$NPPH##VS]BWX
MM>+?'MWXZT+QWJ_B"7Q5H+6 N]$\3:99VMUI[20MO9)+6*..>"1T9HWVA@O!
M&,,_6M^PS\!6CE0_"_0?WAE+-Y3;OW@(<;MV0.3@ X!.0 :]!^''P;\&?"2&
M\C\(Z#;Z*+P1+</$SO)*L2E8E9W)8JBDA1G R<=30!\H_%WXS?%_P9\4OCO?
M:1XWM'\*_#C2+'7(/#]QHD,C7?VJUN-L#SC:ZHDL8D+ [BJA01DD\E)^TC\6
M/AYH<%]K'Q T76-!\9_V1!H^JM=V=]>:,+FX6.YORL%G!$8%5FVK*IVN$4E@
M&!^T]/\ @?X%TWQSXA\7P>';;_A(_$%O]DU6]E9Y/MD. OER(S%"N !C'3CI
M6!H_[)GP<T#PWKN@:?\ #G0+;1]<*G4;1;12MQM.4SGD;3RH!&T\C!H ^3_$
MOQR^)'PV\?\ Q>\.V_Q.U'6-)\*>+/!L%G?ZG;6$DGV74F/VR"5UMU4IAA@@
M*R^6,$?-G7^)'QG^(EBWQBCL?'T\EMX1^(F@6ECNL+*0FSNI8#+:$B'[J/-@
M.<R#R@"Q^;/I?PV_8@\/^$_'7QA@U/P]X8G^%WC6+2H+3PS:0N!;BRB*AG!4
M ,S.TA926W8.<DUZ-%^Q]\%HK"ZLX_AOH,=K=/"]Q$EMM$S1+MC+X/S8Z\_Q
M$L?F)- 'R[\8/CE\8O %G\?O&EA\1(KK2?AUK0TVST";0X"LB7T=LL+/.H#8
MM6N1(,JQ;RV#$AOEIQ?&_P"*_A2_TKPIKWQ6T,:7XK\3:196>N6&J6FJZCI5
MA<0W,DK-.+*W@_?- %B9HLH&; .T&OM70O@CX!\-3>*Y=.\*Z= _BMY)-<S%
MO&HE\[_-#9# [FR.G)K"T_\ 92^#^F>!+WP;:_#K0(_#-[.+FXT_[&I66500
MLC,?FW*"0&SD G&,T >5_L!Z>=%M/CMIDNMR>(KFU^)VJH^HW#QM/<?N+4!Y
M/+55WD@[MJ@;@V ,8K@OC[\9O&7@/3_VB(;'XB7ECJ'A?7/#UWHB.+4/#!>"
M'S;;#1?/%\TI'\7R#)Z[OK;X<?!?P)\((KV/P1X1T?PJM[Y?VK^RK-(#/LW;
M-Y4 MMWMC/\ >/J:S/&7[.?PP^(?B"ZUSQ-X$T+7=7NH$MYKR_LDEDDC0_*I
M)';IGKCCIQ0!\;>,OC#\7/#?BWXB^)+KXEWL6@>%?B;I>BVV@I86?D3:==/
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MIT7F7L4F/,21MN65\#<#P>^:ZCPAX/T+P#X?M-!\-Z39Z'HUH&%O86$*PPQ
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M?V/9;'3[+#L<*'7RUPP'0'CG% 'YK>+O'T.D:O\ %S3='\2ZE<>"$^)N@?\
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M<*V^.Z4^9]F)SN#$(0" W6?&_P"(]EHWA[XUZ'?Z;JWA_7_$.G>#_$F@Z/\
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M[F4$'"Y;=@Y9> ?H;XZ?!^R^//PNUKP+JNIWVE:7JZ+%=3Z=Y?G% P;:#(C
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MN2+8QM<QAB/.B"D @*>"Q /K.TG6ZM(9D=)$E0.KQL&5@1G((ZCWKXL\?_M
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MH&EWVI^"=1\6W,NJ7CK9S36<HBDL+9ASYK%7/S$[<J,,<UZEX4_8B\&^"5\
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M\)?LB> _!B6MC9S^(+KPS93BYL_"VH:U<7&DVTBMO4K;LQ#*K?,$<L@."%R
M:--_9#^'6D>)TU>UM-2AAAU>3Q!;:,NHR_V=:ZDZ%#=Q09VK( S$=E+94# P
M ?.OA?\ ; ^/GC&Z\ /8>%_ <$'C'6M4\.P0W4EZDEI=69E+RRG/"[8G^15)
M)C^\N\!=WPA^UY\4/B=I/PPB\-Z%X176/%ESK&GSRZA)=+;0S6)8-*H4[MC
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M 4@C!  (( IV@?LR?"GPIKVGZUHO@'0M(U33W:6TN;&S6$V[L269 N I;/)
MY  /   !\??"K]JGXM^.+&Z\=W/Q#\!:3I-_;Z_;1>#=8G"W&G7=K;W,MN2B
M6PDC5%MUDF>:=U*,[*$)1:]Q_8R^+/C+QSJ/CCPY\0=1UAO%_AX:?]LTG6;.
MQ1[,S0%R\5Q9JD5Q#(P+(=H90,'=]X^N/^SW\,Y-:U_5V\">'SJNOP36VJ7O
M]GQ>==QRJ4F5WQDAU8AO[V3G-:W@'X4>#?A9;W4'@_PQI7AJ*[*-<+IEJD/G
M%%VH7*C+8' STR: .KHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MN/"\%IX%T_Q'I6KRV>I7$C7$.I*41HE:V4$IA6*LRY*XR!0!ZKX?_;H\$O\
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MYYR!G:V..^/G[4$VL_!+Q?J_PK\03Z!XH\*:AI/]J0ZOHY2:&WNIXA@QW"8
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MVY:>(=;\(/)X*U+3_!_C74[O1O#'B6:ZC:.^NX69$66%<O DS1R!'.[.T$@
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MTM(H+G5)XUCDO)50*\S*ORJ7(+$#@9H U:*** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!",T;
M *6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *"<45Q7QMNM?LO@SX]N/"@N&\4Q:!
M?R:2+2/S)C>"WD,&Q<'<WF;<#!R<<4 =INI:^2OV*OB#/?:QJ'A?Q;XI^)%[
M\1_[%M-1U'0O'^GQ6L=N%/ERS60CB7,1E?;DLW 7N&KZUH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "LCQ?I>I:WX6U:PT;6'\/:M<VTD5IJT=NEPUG*5(241/\K[3@[6X
M.,5KT4 >(?"7]GO6_"'Q3U?XC^./'L_CWQ?=Z6FAVTL>F1Z;:65B)!*8TA1G
MW,T@W%RV>V *]OHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH ***,XH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *0G%+10
M #D4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %!&:** #I111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
G!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>exhibit99-1xu007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit99-1xu007.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHI#0 M% Z44 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]L*/X0Z%H=BWA^&WN)Y];N)G\R8PEDD\D#Y2!*K)SU*/STKM_''[5/A[P/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "LWQ)<7%IX?U*:TTZ;5[E+:1HK"V>-)+AMIQ&K2LJ L> 7(7GDX
MK2KD-:^*WAO0?B/X<\"7=^(_$VOV]S=6-F%)+QP &0L1]W@G&>NUL=#0!\B?
M\$^/V.M3^#NF0^)?'/A2Y\+>/M.DO;6*5+ZVN([ZSN%MV4/Y3OS&T+@#Y?\
M6'KG XCX@?LM>-OBOJ'A[69_AY=^$/BY:Z['+/XSTR]MH["YLUF)%Q.B/O\
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M*=1^$?[#2:U9^*YM,U6Q\-6?V77+^U2ZDCFE$21+Y4:!6.Z18U^7'*EB<$T
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ME;>**.V6R,HN),[UD-P58DC:JJ<>E?&W45T_]MWX"CQ!*8?#,FGZN--:5O\
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M? FBZ+'8>$I(9K<Z7'-(8Q'+GS%!+%E!W-T(ZG%=I10!Y7=_LM?"C4/AK9>
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MZ?\ &?B";PGX3U?6;?3+C69;"UDN5T^T9%FN-BEMB%R%R<<9(H VJ*^.H?\
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MU&#W8D!0"2>Q /8Z*^2Q_P % +>_3PU;:+\*_%VM:[K%WJ6FR:- ;9;BSO;
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MT9PVT'GH327_ ,0O"VDZ/::M?^)='LM*O'$=M?7%_%'!.QR0J.6"L>#P#V-
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M[#)H \U_:K\!>)/'&@^ )?#.D-KMQH'C;2=?N[&*>&&22UMY&:789G1"V",
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M?$FO>([?X;7^HW$'QG;QA:6)OK&(W>ERVDUKO5_.(1DPI(;!(D4\_-C-\5_
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MC7-XE\*WOAV#7?&MQK.FS7-Q;RK<VSP01*1Y4CD',!)# <.N,G('T!1D>M%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y!^UG
MHFM^(_V?_&&F^'?#R^*]7N;:..'2'; GS-'N/WEW%5W.%+ ,5P>":]?I"H)S
MZ4 ?FWH_PZ^*.B^(M9UUOAKXBUG1;;QK9^)+C1]36QBGU6U:Q^SDK'$WD^9'
M(-_EX  VY)()K?UWX?>(= \4Z%JMW^S[J&O?";5/#NH^'O\ A"-/FCGO])FN
MKL2M<.IEV1F8;5)C<>6HSN79@_H'Y:8/ IWRKZ#- 'YN^._@;XR^P_%3POJ'
MPLU"[U'Q=I6@0^#=5TQA>1:!)!!#%]E>[.7@2WECWF3/S@,W);)3XF?#WXA>
M$_$OQ,T./X<^*/%\VJ>+?#/BBVUC1[*-[.YBM$MOM1WEE(F:2.3Y>3DDG RQ
M_2/([<UQ7PB^+WA_XV^$Y/$?ALW1TU+VXL";R PR>9#(8W^4G(&0<9P?4"@#
M\_M.^"G_  C/B ^(++X1>(8M:MOCK_;<5Y#X<D-RF@XR=CJN/L^\M\JG;TZ\
M5J6'@+Q)X6M?"-BOPG\20W_AKXWR:O/J-CHH=9-)DEO&\V%H\LT*H\&> OW0
M,E>/TCQ2<"@#\T-#^#Y\,^)].UK2OA)XBTWQ##\<Y=3.JP>'IUF70"[_ #>8
MJ8%L?,&$&!@?=R"3A_LZZWX8U3XQ_#2^\4>&-8TVRT+Q1KATGQ1<^&I7AUR[
MU&[=+3S[T93<K,I5LM\X0 C:2?U*(##BO(? _P"R9\+OAUK,&I:#H$]LUM<F
M\M;.?5KRXLK6<Y_>0VLDK0QL-QPRH",\8H ]?(VJ/>OA'3O!>JVG[0?C&P\:
M_!S7_&GB*Z\?0>(_"WCVU7R[*QL@L2PQRW8;<D=O&DA,)W*[$KL!()^[\BO,
M/&O[1O@CP!XXM/"FJ7=Z^JS2V<$S6.GSW4-D]V[I:K<R1JRPF5HW"[\9QG@8
M- 'Q'\-?@MK)B^#^D7_P\UG2OB;X7\5:C<>-?$\FD3"WUC2W-R;IVNPA%Y]I
M7RD5,LQ)P J\UB?!S]G5-+T?X"S:7\+M?TS6I;7Q7I_BB?4=%GC8^;:RQV:W
MC.@4J7,6PGY =Q&.:_2GQ1XST?P?I]U>:K>QVT=K9S7\D8RTI@B ,DBQKEV"
M[ESM!^\!W%'@OQEH_P 0/"FE>)-#NOMFD:I;K=6L[(T9>-AD':P!'T(% 'YP
M_"OX0^'?'GB']FSPSXT^#OB&UT[3_"VH:7KT6I>&[F"!KY?),4D\D:[=C2)<
ME6D(Y.2 &!.OX)^%_B>"X^'>D'P;K>D_'#1_B1-J?B'QE'I<ZV^H:4;B62:9
M[W&R2"2%HHEA,A;*8V@$Y_2+<OM7GGC7X_>"/ 'B7_A'M4U&\N-=%N+N33='
MTF\U.X@@.[$LJ6L4AB0[6^9P!QUH _/GQ/X5N_$?A($Z%XKTW4[/QUXPU.T%
M_P""+S4M-GCN65HXKRV,/F!9XY,)*@)C(?@'E?T)_9ZFU&?X%^ &U;09/"^I
M#0K))]&E+EK-EA5?+.\EP1CHY+#HW(-=#X!\?:!\3_"5AXF\,:C'JVA7X=K:
M\B1E60*[(V P!&&5AR.U=#P* /E[]K'2/M7Q;^$5]XJ\)7GC;X50MJ4&LZ=;
M:7+JD-M>211BTN9[6-',BKB50VU@AD)X.,_*OASX!6OB[5O@!X>^(/@7Q+?>
M#_[;\2PV]K<:;?"2PT.<D:5#=S1J&A E 95D8%%;)VKFOU*.#Q1M'I0!!IUA
M!I5A;V=K&(;6WC6**->B(H 4#Z "OSY_X*.>&]0\6^.[ZU7P;K>IPQ>!)SIV
ML6?A^?6(OMIN6;R(=H\NSE B1GN&RWEMM4 \G]#LBDXH _*#XM07MWX4^,6E
M0_#CQ?=ZS\0?!GA>[TFU'AVZ>66\LRZ74TH"$Q2)M#?-AB "/O#.A\6(Y]5U
MOQ1?^)OASXKO_B>WQ$TWQ'HVJKX=N[YU\-K)$\$4,BQGR0D>]7@)4^83D%AA
M?U/XHP,]* /R[\7^'+)3\9+[4O!.IZEHFE_%[1_$<MC-X?F9I]+>5(KIXTDB
M_>H^V165>HZ\'E/C=X<TZZT;]HV+3O!GB#3K?4_%?A;6=&@A\/WL#OB.#[9)
M"%1?F4BZ#;6&"3@\J:^^[7]HSX=7_P 4Q\.K?Q"LWBYI9K=;-;2?RGFBC\V:
M%;CR_):1$^9HPY9>X%>E  =J /RU^,=[X<^&UI\7?#?AW0;M?!L7Q \*ZG;>
M'7L;L6>L(8HOMULRLA+1L\#%]JN6('RMQ7TI_P $\8_"<'AOXA?V#=VT6JWW
MB*75+S0+6WO+>/1+:?)M+1$N8HFV*J2898U4\@ !0![S\8O@OH/QMT'3],UR
MZU73WTV^34]/U#1-0DLKJSND1T66.1#]X+*XY!'/2IOAA\(]+^%T.H/;:GK7
MB#5=19#>:SXAU![R\G5"WEQES@*B;WVHBJHW,<98D@'-_M<P?:?V8?BI$L=U
M-</X;OA;1V:2-*]QY+>2%" L29-@]/7C-?G]H/P@\#75W;VE_HOB6UL]1^"T
M>M:FH.H!9_$,:_*[CH\\2JQ1"-H(7:O2OU7:Y5;I("KEW5G#"-BH"D Y;& ?
MF& 3D\XS@XEPOM0!^0OQ5U;4/$\=AK,_A_Q.?$&G>$_"$UIJ=[X?O=0N97BE
MB>]>SF"@6&QMRS.V]Y67:N 3NT_BMX*TC4-4^-JVWPXU.XE7QKH7B>.?_A'K
MB0'1V6(RD Q]<S2%HQ\^&ERH"M7ZSX6C"^U 'Y>:7X1M-<_:-N?^$HT[XC67
MBE?&EMJ_A2#1]"AAA_L=XXA;P27;Q;H8(H 5F@+!1Y9&TONK#\(?"#P7;?LT
MQ:U96VKZ9XEN/'KZ7-=ZOH]WJ=F]K'=7%Q:1WMG*0&LF3RW=XT)WL"02"!^K
M^!THVB@#P[]B;S#^S+X,$GA@>#RJW872$$JQQ+]KFP\:S 2+$XQ(BOR$=02<
M9/$?M]W<46@?#>&]T:\U72G\2K)=2)ID^J64&VVFV&ZL8!ON5+,-L>Y1O523
M@8/U/O4$#(]*#(@ZD4 ?E%\+- \.^+H/V=-"\8Z=XL_L_1M/\4:1XA@U"RU&
MQ0B-Q+8QRA !MVS/@*Q&1L).W%1>&-=FU'X2_#BV^*N@^(]?\-WG@'5-!T6R
MGTZZNFMO$*74NU9X44N9&@6W6%RIP,X_B(_536];T_P[HU]JNI7,=GIUC ]S
M<W$O"Q1(I9V/L ":Y'PO\<O OC34?#MAHNOP7UWXATV35]+C2*1?M5I&X1Y5
M+*  &8#!P3G@4 <7^P_#<6W[)?PNMKNTN[&ZM]&CMYH+ZVDMY4="RME' 8#(
MR#C!!!&00:Q/VN5$?B[]G^ZN0W]E0?$6R^T.P)B21[:Y2W+]AF9T"D_Q,/6O
MHW-8'CSP'H?Q+\*W_ASQ'8+J.D7H7S82[(0RL'1U=2&1U95964@@J"#Q0!\!
M_M1_#:PU[XY_')]2TGQ-_P )?J6@Z)+\/[K1OM:K/J*)-%E6B_=[EE,:DR?<
M1I", DU[_H?V^+]N?0K>:03ZE%\+0OB": 8B>;[?'Y!/ON%T5[X)[5]&Z-IC
M:1I%C8M>7.H-;0)";N\<-/.54#?(0 "QQDD #)/ KGO"/PKT+P9XH\3>)+2.
M:YU_Q%<+/?ZC>2^;,R(,10(?X(HUX5!P.2<DDD ZF^LX-1LY[6YB2>VGC:*6
M*095T88*D=P02*_+;X>^$?"5[X;^%7PYNO"VH6-S;?%;54\0VB:9=6B>1F\C
MA#S*J@IY<UM'@-C:^T\9K]4*:=H!Z4 ?DKIU['J/AKPC9^*AXPA^#UG=>)=)
MCEM--N+^;3YY+DR64K0R*SX%JW[J4*Q0EL$$-C])/V<[.6P^"'@ZVD'B "*P
M5(SXJ96U,Q GRS<8Z.4VG:>5R <$&NHT;QUH&O>*_$'AG3]1BN==T!;9]3LD
M#;K47"L\.XD8^948C!/3G%=!C% 'R7^V]J4.C^+_ (577B_2M9UKX0O-J5KX
MAMM'@EG\NZD@1;*:2.+]XRIFX(QG!(."P2O!-0T[0+:_73O'^G^,X?AFWPXD
MA\#7/B!;EKVWNHYI@Y?RQ\MXZ>4Z!@"(Q&N!R*_2[:/2N>U+Q]X=TCQCI'A2
M\U>UM_$>KQ2SV&FLW[ZXCB&9&4>BCN: /RU\0^'+B[T_XDWGQ$U#Q&?B#8_"
M72M2=EN[N!(M>2,I&'57VR701[$$8QF64D DFO1M2O/#7C/]H7Q_XP?33+=W
MWP46ZBOHK*<.-1D@8ML8+GSC"5']XA<#D$5^@%[\1/#6G>.M.\&7&KVT7BG4
M;22^M=+)/FRP(</(!C& <]?0^AKI=JGM0!^5>H:K!??"GPW8?$O1]?U#2-1^
M#T>F>#[9+6ZN85UR&.5+E7CC7*W)98=K,N%C7&<$DX-NDFL:)X=T_P")LWQ#
MTO3YO!/AZ/P9<Z!HTLMU#>VL>VZM87:-C;SO<1XWD+N3&7V;,_KEM'I2\4 ?
ME/XSMM(\(^*_B5XJ>\UZ?Q;H'Q:T>2QBN;^Z!^SRF%[D(BMY9WM'<!BBM\L0
M ^4+5;4;7PQ\.=!^,]E]@N]'U72_C78:C!+:V5RD<6F?:(VC =%V,@B-X=F3
MQSCE#7ZP8&<XHVB@#\O+_P 6?V7^U[H&N1IKFFNGQ+OH+WS=-U"YNI;-T>)'
M>[51$;5RBB&W1&VKN8OP2?>?V0/VB_ OA;X:^$O#%U=7,-]XE\8>(;#3%BL9
M/)\TZC)<(C$#$8:.[@*YX^8^AQ]E;!UQS7.>)/A]HGBW6- U+5H);F?0KDWM
MC']IE2!9RN!(\2L$D9>2I=6V$DK@G- '1]17Y<ZAXV@C_:VMM1F3Q!IUQ'\4
MI].OK>\LKZ6[%E-;/ &>\0"*.T=@ODVRJ[;2[&0 5^E/A+QUH'CI-6;0-6MM
M672=1FTF_-L^X6]W%CS86]&7<,CWK>Q0!^37P>\37'AK0?A!J_@O4-8D^(&L
M2>+]%+7E]<S+-BWF.G+(DI9 HG-JRJ>"TA8DDDUM^&K;0[_3/!,_A.\\0Z/K
M2>!=>A^*UO<->M<Q31V/RSW(8@^?]MR4VX9@V1\JD5^I6,TFT<<4 ?F=\%/A
MYX=\9Z_\/?"L.M>(([7QW\(7CUBXN-2NW<:HD\+12#>^$DB:.?8HP L6 ,=9
M]<T/Q+JG['_Q7\6^,Q>67B#POX<3X=:9)I-W<'[1)I]XR372^6?F$UQY4;$Y
M!%LV<*6%?H1\0/!R^/\ P;J_AYM7U70%U&$PG4M#N?LUY;\@[HI,':W'H>"1
MWJ/X:_#O1_A3X'TGPIH23+I>FQE(VN93+-(S,7DDD<\L[NS.Q[EC0!^7WQ%\
M*^$]-UCXOVVD^)/$[6.F?#K3O$^ELVNW[!]<D"!;LY?]Y,WFV^<\9F/ [=9\
M4/$*^(Y/BJWC*_U[_A-[OPWHFH_"N]L6NF,S&T1@++R^DSW8Q,3\S!O[JU^G
M>T>E<'XC^.GP_P#"5QXK@U?Q7IMC/X5M8;S6XI)<O812C,32 <C>",#J<C Y
M% 'P;\6O',_PKG^,^B:W#K!\;W^J^%?$NG6VG6-S)#&X6U^WR0R1ADC7>+E6
M;(W&7:-Q.*W?@=XAM;G]N.>YL(7\4C5-?\0J]Y<6US9:OH2JK$I=(^4ELV"1
M+ 3M9<XP&#)7WSXA\7Z+X5\*WWB35M0AL="L;5KVYOI#^[CA5=Q<X[ <U=TC
M5;/7=*L]2T^>.ZL+R%+BWN(SE98W4,K ^A!!_&@"VW2ORIU""/Q)XO\ C9I?
MA^"?QQ?:GHOBR2#48HKJ#7--NHF618+Q1F.:+SHX1;.K X&W'!4?JO1B@#\L
M_%WC.+XKGXA77A32O$VK_P!I_!".PN'.FWD:7^IQ3*)"I9,2.B+L+?Q&-E!:
MN?\ BCIVE:-\.OB/J7PVU;Q%%\/_ /A#]#:ZF@OK]T'B5K] 5C9V+%Q;&3S$
M^ZI9,@' 'ZU!5 P  !V%+M'I0!^3GQ9\'>'?#EG^T=<^$=8\5K+X/DT#5_!S
MC4]0N%6]N!%]JG0.Y\YI'"J[/N #9&*Z?XM^)-$U3QK^TYI]OXKN-$TK4M3\
M(7=G=26TU[8.^UFN?.BSDVS2,BRA<X#?=8#;7Z=C:1QC%+@4 ?CWXWDL+OX2
M^&(;G1+.)]-MM;AM_!LJ7CZ=KT,NH@_:-%N%4O!,7)$(=6R@498!L^M>./$9
M3Q?\<&L[;7$\'KX^\+77B?3[9IUE72Y+8#4 ?X_+%R&$@CQPK 86OTKQ2;0>
MU 'Y7>/TTMM02#0-5\06OPDN?BWH$'A]K2^NHH'MI+<_VQY#JZNENKLN'7A6
MR$QEB/J[]@6[A@\*_%/0;2^GNM+T;X@ZQ;:3%-+)(L&G%U-ND32?,8Q\^#DY
M(;DBOJ/ ':EQ0!X)^WCHNH>(?V1/B=8Z58W&I7\FF!H[:UC,DCA98W;:HY.%
M4GCTKYI3X"Z7\2&^)4'P;\1^(/\ A#(M!T[5;#4[W4KN6VE\10O,Y"O,VYO,
MMRB3 ?*IE7/S*%7]$2,UP?QE^$5G\:O""^'+[7_$'AZR-RD\\OAV_-G-<Q@,
M&@D< YB<,0R]\#D8H XW]D^74?&/@&X^)^MV9TW6?'\L6M-8><TJVEJ((XK:
M)2<<&.,2< <S-UKVZJ^FZ?;Z1I]K8V<2V]I;1+##$GW410 JCV  %6* "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KP_P#;8\7^
M)O ?[+_CO7/"%W/I^N6MO!LO+:$RRVT+W,27$JJ"#E(6E;(((VY!&*]PILD:
M31LDB*Z,"K*PR"#U!% 'YL>(_%Z:=X0G/@O]HO5/$FEZKXS\+VZ2:3>7*C2(
M[B62.:)+FZN+B1RZ(97A=B$*#*[3BET;Q-JW@[Q%J^IS?&CQ5-:>#/C%I_A&
MTL-5UL36\NFSRP"Y2Y+#,Y*//@N28Q;L5VG<:_0T^!O#9TTZ<?#^E'3S+YQM
M/L4?E&3&-^S;C=CC.,U#<_#SPM>&;S_#6CS^?*MQ+YEA$WF2KNVNV5Y8;WP3
MR-[>IH ^%M#UKQ/8^,-5U73OBWXGU+Q!H_QA3PQ'X2OM6\ZVN=,>>-7C,)PS
M%89)9=_0"$\?*365\//B#MG\%>%9?%%SX=\">)_B9XRMM9U+2+]K28SK+(]C
M;FYC<-$LC2,WRD%MB#(!.?K/X$?LV6_PE\1^-?$>LW>C^*/$OB/Q!=ZVFKQ:
M&EG<V23A0ULLADD<QC;Q\PZG())->A1_"?P1%HEUHR>#?#Z:/=S?:+C3UTN
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M21IG.U7=20N<_+G!R<CDT ?.^L>*[3Q9\?=#^%O@KQU-X'\"W?AC5/$%E?\
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M#W^N->_8[^$'BBZU6YU;P>FHW.J7T6I7<UQ?W3.]S&K(D@8RY4A79?EQQ@=
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M HHHH **,T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !7BW[1GBSQ;X.UKX4W'AW68=/TW4O&%
MCH^KV3VJR/>6\Y/"RG/E[=C9PN6W#YEQD^TUXU^TA\//'/Q"'@ >"QH2G0O$
M]GK]Z^M7LMN7CMV)\F,1P2Y,BNX+';MP",YX /G[PE^T1\4=;_;(N? KZG,Y
ML_$U]97_ (2:QA6VM_#Z6ZR6VHB?9YAE9Y%R/,QRHV<YK[3\21:I-X=U2+1)
MX+;67M95L9KI2T4<Y0^6S@<E0V"0.V:^--0_8V^).E?%2Z\8>'Y?!4NLV?BO
M5?%6E>)M3N;M;ZX6ZMF2+3+N*.'FW24H"ZSD^6F%122*^U=-^U#3[;[<83>^
M6OGFW!$9DQ\VW/.W.<9YQ0!\D)+\<IOC9XK^'.G?%M+R_P!+\)V.MV5Y>Z%9
M)!+=RSR1M',J0EEC/DG&TEE#Y^8BKW[.'[64-SK^M^ OB1XEDO\ QG%XTU7P
MYIUZNCR06MR+=R(XC-'&(1*51CM)#8*Y'(SZ'X;^'/CNQ_:O\6>/=0BT(>#=
M2T"UT6S6WOY6O5\B624/)$8 GS-/*,"3@!?O9X\B_P"&4/B5=Z=IL-T?"L4D
M?Q9O/B!=-;ZM=?-:3K,IA0FU!$H$[?[/R*=W)P >Y^"?VI?AS\0_'D'A#1-9
MFGUFZMI[RR\ZQGA@OX893%+);S.@290RMRC'(4D9 S53]ICXPZQ\,=!\,:5X
M5AM9O&?C#7+;0-(?4(S):VSR$F6XF4,I98XU<[0<EMHZ9KR[]EK]FKQU\%];
MT+2-:T7X<_\ "/\ AJ*XAM?%.DZ>W]N:I&V]8DE+1@0D*^YV5VW%549!8UZG
M^TK\&M7^+'A[PY>^%K^STSQIX4UJWU[1;C4@QM'FCR'AG"@MY;HS*2H)!P1T
MH H6L'Q/^&?CK3;_ ,2>-K/Q/\,UTF]N-<U'4K&VL9=,N(PKQR*T>T>25$@P
M0Q7:26.1BS8?M?\ PON[+7+F;6;W34T;24UVXCU+2+NUEDT]VVK=11R1!Y8B
M<#<@(&1G&:YCQ]X!^+G[17PX\2^#O%5EX>^'6DZEI,]F_P#9FI2ZK/=7#H1&
M=YBA$42MM9@ S/C;P,[O,/'/[-OQ<^+&AWVJZ]I'A[2/%=E\/+SP99P:?JK2
M1:E<78$<D\CF%?*BC0;UC^8EW(R ,D ]2O/^"A'P)L8KN2;QE(GV9(9BATF\
M#R0R D3QIY6YX@ =TB@JO&3R,[OCG]M/X._#G63I6N>+A#?"R@U+R[>PN;@?
M99@#',&CC92FTAB0>!UKQ?5OV<_BIKFHZ_-)X=\/6B7?P</P_@9-6)/VY@<O
M_J?]6"Q&>#A0>IP*=W^S)\5=1DUNYN?#_AO[1=?!J/X>0XUAW_TQ2Q9_]2/W
M;%_7_EFOK0![1>_M<?#'QOX2^(:^$?B';6^H>'-&EOI]6ATZ:Z2RC*LJ7B1[
M,7,<;X)V;EXP2 :P++]LC0O#4V@:'?QZWXQG;P%'XOF\1:5H-R(]1CV1XDC@
M2,[!)N9CDA8R50G<2!YY)^SA\67T2.Q30O#\:-\&9/A]*O\ :S B_9<>8N(B
M"G ZX.2>>!6EX+_9U^)^@ZS\.IGT[0DMK/X3-\/M7+ZFY:VG3:4FC B_>*QB
MC&.-N]N3M&X ]3TO]LKX?0?#'PMXO\47=[X:_MK1QK$EE)I-].]K$%C\V1PD
M!80JTJJ)V54?(*DYK?US]JOX5^'-2L+._P#%T$?VT6;1W<5M/+9H+L9M?-N4
MC,,)D7#*)'7*D-T.:^6KW]EGXKM>_#[Q!JWPV^'/CVYT7P=#X,NO#FOWQN+:
M-;9E:&]CDDM\!W^<,@4[1@;CDXG@_9&^)7@WQAJT=MX"^%/CG2?$*:6[:EK%
MD$70;B&SAMIO(M2A#6ZF'=%$I7 VKD<T ?<WB#7['POHFH:QJEU'9:9I]O)=
MW5S*<+%$BEG<^P )_"OE[XT?M@)I]AX/UKP+J:1:-;^,-)TSQ5_;.ES021:=
M=AF\V/S0IY49!56SD$=.?H;XIZ+>^)?AGXKTK3M.L=7O[[2KJU@T_4R1:W+O
M$RB*4@YV,2 V.Q-?&$/[)7Q8%MH%O':VL?AS2/&^A>(K/P]J>O?:7M;:T20W
M$"W'E$M"7<".)L[0.HSB@#ZET[]J#X;:MX4L?$5GXDCN]-O[Z33;86]M-)/)
M<QJ6DB$(3S-RJI8C;P!GI7'S?'?4/%?QN^$MEX.UG3[_ , ^,="U:_%PMHSL
M\UN(O*;S"1\O[WE %/RMD\C'DVI_LZ?%Z#7M0FL-%T6XT>[\=:EX@GM8M::S
MGGM9[40P@7"1;X<,"9%3!96*Y()!G^"W[.WQ,\!:A^SZ-4T'38K;P!;ZY;7Y
ML-5#(XNQB$JK("P&3D=L#D\T >Y?LA_$KQ-\6/@-HOB+QA);2^(Y+O4+6\>T
M@\F(M!>SPC:N3QB,<YYZU/XX_:X^$/PU\6WGACQ-X[TW2->LF@6YLIQ(7A\X
M QEBJD!<%26)PH9=Q&X9J?L@>"_%GP\^!VG:#XUTJ/1]<M[Z_F>"&_6\0I-=
MRSJ0XX  EV[>VWWKQ?X]_ ?XC>-?&W[0%UHW@[3M3L_&'A"PT'1;RYU*%=TT
M3DR,R,,QX\]F!];=3G+# ![]X>_:E^%/BO2O$^IZ3XYTJ]L/#(#:M<([!+96
M)"OD@;U8@A63<&/ )R*99?M3?"_4/#=[KD/BE!9V6IC1KB*6RN8[J.](R(#;
M-&)M^W+8V=%8]%)'RQ\2?V4OB=\0KOQ/]E\.Z9I0E\'>&[:R%UJ,;6]UJ&FW
M"7$EK*L?S!'W/&'X&8@<@$4W7_V5_'FOV6E>+K#X.^"O#6K:5KL-Y+X*AUEI
M3K$7V::&:6>_ 4!OWR^6FWY-C$E]VV@#Z5TW]K?X?^(O'?@7PWX?U&37O^$O
MM;NZLK^QM9W@40.$97(C^5MV\$-C9MRV-RY]/\:>-]!^'7AF]\0^)M5MM%T6
MR4/<7MV^R-,D*![DD@ #))( !)KY;\ _ GQSX+^)/PH\6:;X \,Z!86::O9:
MKX=TO4]L>D07D\#K*LI0_:90L3EMJJ&8X&T'</5OVM?AEXE^*/PIM[/PBEI<
M^(=)UO3==M;&_E\N"\:UN4E,+M@@;@IQGC(&<=0 78_VMOA%_8KZK<^-['2[
M./45TF7^U8Y;&6"Z9-ZQR13(CQY7YLLH& 3GBNQ^&7Q7\)_&/0)-;\':U#KF
MEQ7#VDD\*.ACF4*6C97 96 93@CN*^-OBG^S+\3OB7XU\2^/AX8M=.N-:\3^
M%[L^&CJ=N[_9--64SSR2X\LR,9-B*#G;G/7 ^B?V>_ OB;P7XU^,EUKVEIIV
MG^(/%;ZQI4D=Q'()H&MXHB2%.5;,.XA@/OCJ<X .K\8?'[X?> /%,'ASQ%XJ
ML-*UJ989!:SELHLTACB9V *QAW!4%B,D5V.OZ_8>%]#O]8U6ZCL=,L('N;JZ
MF.$BB12S.WL ":^)?VP_V=_BU\7/%GCY/#OAVUU/2=5LM&CTF]AUU-,\E[6<
MS3?:(U7==/EF$7FG9'O9@-W7[%\1#4M4^'FI*VD1W&KW.ER*VDK<*R-.T1!A
M\U@%(W';N( QS@=* //M$_;(^#'B/2;G4M,\?Z;>6MO/%;2&-9=YEDC:1$5-
MFYCLCD8A0=H1LXP:V]2_:4^&&D>'-*U^Z\::6-'U2T:_M+N*0RI);*P1YCM!
M*HK,JLS8"L0IP>*^4%_94\?Z?\(?V?V'@/1M>USP!;WVGZWX2O=62UBU)9T5
M%G2ZC#*&4QAAN&?WC#![^3_%7P_XF\!_$73/"-CH7A+P2E]\/+O3/$&@:7XA
MLM-M[:ROM0N7B@@>]&V:=54[I54 LS'Y!MR ?H./VDOAI)9ZA=Q>,-/FMK#2
M(]?N)8M[JFGR'"70(4[HR?XAD#!SC!KB(_VA[C0_C[X[TGQ/JFD:;\.='\):
M?XDM-29&CD1)I7C=I7+$'+(=JA0>5')//S_XK\ ^.OBGX8B\3?"OP$M[X6\8
M_"$>![:+5]8BM+C3"LEP4D?.X3H8W78T9PY*MD*VX3^/O@5\=/$,7B"[TWPC
MI::M??#[0?#^^_U"UNXGN[2[6:X"B4$;RLDFR1U(#19R#M- 'U!?_M9?"+2O
M#G]NWWCS2K+2_MQTPRW#-&RW03>8F1E#AMO/(Z5Z#H7B6R\;>$[/7/#E_!>6
M&IVBW-A?%&:*1'7,;E<J2O(.,@_2OA#PM^SU\5]$UE3=_#)K^QF^)&E^,"^H
M^*X-2GB@BMFBE,DTQ#R2A@&XXR^U?E7-?H':V\5G:Q001)#!$H1(HU"JBC@
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M:0R7$L,,,H0QI+Y+NDA4)(JR?(2C'!!'8U\M>'/@K\7=&U_X27=_H5[XBLM
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MC<RL W0[3SP:Z*?XY^ ;237H[CQ7IMO+H5[%INI132[)+>YE_P!5$5."6?\
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M0+H.I6.I>'[R=_#,\EQY'VY(%B:03;XG7[J;A'&5<@@%?CAX)N/&_A79\._
M_B;5](T_PKX?MO#FO:-X6N+F;4GM;@F8&1_^/!HY-Y>-%\UWW%GV\$ _1_Q9
M\9;:VT#Q=)X+L[?QUXE\-7,-G=:#;:C#:/YSF(E#-*=BE8Y0W/<%?O<5WLNI
M6EO/%!-<0Q3R_P"KB=P&?Z ]:_,KXX> ]3UCPM^U7IVD_!_Q#'KWB2^T76-!
MN(_#;N75S9&6-)8E+>:)%G=E4E597W'/7J_B_P" -:\47WQR2[\!^)M:\?\
MB6^TN^^'WB>#0[DFSA"0^1&MWY8&G^0ZNTBRM&?F8D,2<@'Z%G4K02^6;B$2
M;_*V%QG?C=MQZXYQZ58XQFOS)\:?!:Z\/ZY\5/$=O\/O$&H^*[;XA>'=2TO5
MM-\,WKS21IY,FH3V;+&<(TD5T69#ALQ@L=T>?OSXVS7TGP3\<R:1I5WK6H2:
M#>_9=,M&>*XN7,#[8T*C>KDD 8&X'&.: .MAUK3KF%Y8KVVEB1@C.DJE58G
M!(/!)(X]ZECO[:=)GBGBD6%BDA5P0C#J#Z$=P:_(75_A!X@U+PO\1; _"[Q=
M';ZGHGABZLK+3_!5UI\$=_;7B+<)#%&"VY+=YT$KG>P\PD_,N?6O$WP\U3PY
MX^^(.G^$?A9XD?X31>,_#6NWNAV&AW,*:MI\=D\=XL,$D:B?;<K;N\0RTF&)
M! ) !]P_!WXT6WQ?O?'-O:Z5/IR^%M?FT&266:.5+IXXXY/-0H3A2LJ\'G\<
M@>D5\N?L/:2VB77QDB@\$ZQX(T._\92ZII-IJFBR:8DEM+;PH#%&X7 #0MD
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MUI44 &!Z4A4&EHH *3%+10 F*-HI:*  C)HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "D9 W6EHH ;Y:\^_7WI54)T&*6B@
M!,"C I:* $P#VH  I:* $P*\)L/V//"EAXCU:]'B/Q?/H&J:G+K%UX1FUECI
M$ES))YKL8@H<J9/G*%RI/4$<5[O10 FT>E&!2T4 )M!H* C!&0:6B@"%+2&,
M$(@0$Y.WBE-M$3G8,^O>I:* &I&L>=HQDY-+M'I2T4 )@4;%W$X&3P32T4 )
M@5#;6%M9O*\%O%"\S;Y&C0*7;U..I]ZGHH CCMXHG=DC5&D.791@L?4^M/V#
MTI:* /++O]G_ $R]_:(@^+TVKW\FK0Z%_P (\FEND#68MO.\_(S'O#^;AMV_
MMCIQ7I,NEVD[EY+>.1RNTLR@DCT/M5JB@"&*S@@+F*)(V?EBB@;CZGUKSOX/
M_ ^S^$EUXDU!_$6N>+M;UVY66YU;Q#=">X6%-WDVR$ !8H]\A50.LC'N /2J
M* #&1BF>2GF!]HW@$!L<@'&1^@_*GT4 5WTZUEAEB>VB>*4YDC9 5<^X[]!^
M5%UIUK>P&&XMHIX2=QCE0,I/K@U8HH 38,8QQZ5431[".WE@2RMT@E.9(EB4
M*Y]2,8-7** *,^@Z;=;O.T^UFW$$[X5;) P.H[#CZ4^72+&<@R6<$A$?E M&
M"0G]WIT]NE6Z* *D&DV-M$D4-G!%$C^8J)&JJK?W@ .OO5NBB@ HHHH ****
M "CK110 8YS1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 49 [
MT5\V_MF^+-<\'W_P(FT76]1TE-4^)VBZ-?P6-P8DN[:8R,\<N.64F)05S@AF
M!!S0!])9HR*_-OP-^T[K=U\7/"UW+X^U"X\:ZK\4+KPMK/@:ZNL06^CD2)"\
M=B3^[$9$;>?@,6+*S,!BOOGXA^ 8_B+I=CIMQK6MZ):PWD=U.V@:E-I\]RJA
MAY+30LLBH2P)V,"=H&10!U61ZBER*_/_ ."?@C4?B/\ L]>/O%U[\0?'\.IZ
M+JWB6SVGQ=J,T4]M#'-'!$4DF8+Y9,;AQ\Y*88L&(KIO@Q^W G@KX0:3!\1?
M"FMZ2VC_  YL?%<&K37T5\^MVP\FV:0;6)222:6,@2')$F6VT ?;5&:\'_9W
M_:DC^/7B7Q+H;^%KW0;G1H;:Y6[\QI[2Y29<X24QQ_.A^5EQP0<$X-<-X?NK
MW]I?]IKXK^']=\0:M8^!OA^;'3;/P_HNIW&F-=W<T;2275S) Z2L%9-L:[PG
M&[!(S0!]8T5\V:-XKUO]GR_T[X8P76I_%7QEK]_J>K:1#JVKL);;2D8,JW%U
M/O8[-PC7ABQ],&L.R_;XMO$FG>!T\+_#7Q%XBU_Q5;ZB(M)BN;:!K.[L"HN[
M>=Y' 39N4[\<ATP"3M !]7T5\G?#_P#;XA^(%YX<-O\ #'Q+9:5XFTC4M0T/
M4;FXM0M]/8QE[FW"!\H 5**[8#'' '(AT']O6^\57_@*TTKX/^(G/CW3;F^\
M-&ZU*RA-ZUN"TRL/,/EH$ 8.>6#+A.: /K;(]:6OE"Q^/FD_%CQQ\"_$^E:#
MXF2^\1:5KMUI%H=8%I8M/;Q%9K>[A!(D;<H"R%=JY##/('$_#3]MWQSXXM_@
M+<3^'+2&W\<7WB"\U*87:+%%IMCY@)4[#M$1=3D_,WV8#_EKF@#[EHKY"TS_
M (*4^!;PWM]<>&M?@\-Q:/=:S;ZS$D4L<T<);]TRAQY4D@4%%<C)8 X->E_
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M+1I[G[)"8HMPE=1M4DD#"COSU[T >8P?L6:O'<7?A^3Q^LGPTE\8CQG'H?\
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M)=WM[8L+:5K#33,Q:*WBB:3S&@C)!P7#'+<C.:N>#/VO/@[\0O%>G>&O#OQ
MT?5=<U RK:V=O(Q,K1E@ZABH7=A20"<LN&7(()O:?^U!\+-4U74=.MO&FG/=
M6,%S<R;MZ))%;J6N'A=E"SB,*Q;RBVT#G% 'CL?[%WB2#]G_ .$_PU'C73)9
M/ 7B.TUU-1.D2*+Q+:222*$Q^>=I)DPSY/ X45+J7['_ (DUGXJ:IXRF\2Z)
MIUY=V^JVC7.F:/)#/>0W431P)=A90DOD[@0V S%5R>*]4\'_ +67PA\?:G/I
M_A_Q_H^IW4&FOJ\HBE(2.T09>1G("KL'WE)W+W KF_&/[47AK6-#LIO!OC?2
M-'NXM?TK3[MO$>EWD:R)=,62!$*(P>9%8H^"H )) Y !S?[,_P"R'K_[-/B6
MV;2/',=YX3N-/CBU;0/[-9([B]1-GVN%C*WDLP52Z@-N.?;;TWQ0_9]\2>,O
MCW:_$+2-<TNRMK?P9J'AE;*]M))7\ZX+,LVY7 V!O+R!S@.,_,,<KX _;3T>
MU^,_Q*\ ?$GQ)X=T"\TGQ$NF>'Q&DENUS \8=?.+NZA@6"[R45CG '04_B7^
MU'XE\'^"?%OB3PWK_A'Q7'I7Q M/#;0I976VQM9&BBD@D96&^Y5Y Q9-R@'&
M&/  .<L_V&O'NG^!O!>@6'Q$T_29] \%ZIX6;4+.QE$WF7<ZRB:([P5P(HE/
M.?OD8R ,"#]@#XD6WAGQEI%MXU\&6%KXEMM"CEL[#P_-!#;OIEP)H=F)B2&V
MG>S99RY.5Q@^L>+/VQ=%^%.K^,[CQ+KVG>(-,M?%-CX=L;'P[9W#SZ<TJ)YH
MO7VE=ZDR. F<A-H^8[1ZG9_M(?#6_P!,U_4(?%UBUIH%Q!::JYWJ;.::3RH8
MY%*@AV<A0N,Y(H ^??B-^Q9\0/&7C3QYX@M/'.A0P^)_$&C:[+HE]IDT^GSK
M96SP-:W,7FCS8WS"Y[,8@"!P1\^?'3X,>*O@#J/PUT75?&.EZ3I-MJGB;5[?
MQ3:>'M2CMH3>K$HL3]A<S1LZO<,$1U4JBCYMG/ZG'D5\G>-?VHM?U3X^>*?!
M/A;6_#OA.P\#16=YK-SXMTZ[,5]!(7:Z*S+L6W$4:KL9LB5G&#@&@#SSX3?L
M\?$/Q!9^#_B/X)F\,?#S6=-TJY\)#3;_ $"YDT_4=(CN7>UNH[>=Q<6[,27V
MN0S9!)P2&[KQ]^QYX[\8/\3XSXYTNYC\6^#K#PM%>7^G.;D/;L"\\VQU0E]]
MQP@ !>/C"G=Z[;?M:?".X\,>(/$/_";V$&E^'S$-4DNDE@DM?-;;$6B=!)AS
MD*0I!P<9KL_AI\5/"?QB\-?\)!X+UVU\0Z-]HDM?MEF24\V,X=>0#QQ[$$$9
M!!H ^8?&G[$/B[X@7NLR7_C/2])$WA#1="L)].L7,MO>Z=.ES'.P9MIC,OF9
M4#.TIW!SJ:_^R[\6?'L7@2[\7?$'0=3U7P[XPTOQ*\-EI+6EF8K)90$1%)8R
MRF9V=V./E0*JA>??OB#\:/!WPLEMHO%&MP:5)<1M-&CJ[MY:E0\A"*2J N@+
M' RP&:P)/VI_A3#XJB\-/XZT4:[)?C2Q8_:@9!='@1$=CDXR>,\4 >(2?L9^
M/!KT>N6OC/0K34[7XDW?CNU#Z9+- ([F(120NOF*Q90 5(8#).>Q&G^VOJ&I
M6WQ1_9QCT2^L['6_^$ODE@DU"*5[?;]F:-A)Y?(5C,D><CF0=LU[DOQ^^'3^
M-(_"2^,=);Q%)-+;)8"X&YI8U+2Q@_=+H =RYR,$$9KS[XB?M9^!)OAYX[NO
M!GQ%\,6^O:'IGVN.^U83/81;Y/)BF)C4F:(R_)NAW_-QR>* ..\*?LA^,/"W
MQ,\#^,$\6Z1<W-CXGUOQ3KT9L94%S/J48A>&WQ)\L<<2J!OR2RACUVBK+^Q3
MXE\C7?!R^-+&3X7ZMXS7QD]K+I[-JEN?.%P]G'+NV!&E53YF-P!88.XT?&3]
MJ;7[3QEHGP^\(>*/#F@>)Y/"K>)+K7=9TF[N-,F?:C)$K+CRHF3SY#*=^T(J
MXW$BO1?!G[3_ (4T'X(^#?%?Q!\>^'9KC6+5Y!J>D0SQVMYY;[9)8H74RB-<
MKO9E"J3D[010!YWX4_8U\;Z%X6U[X93?$> ?!N\_M,6NF6^FXU18[Q)0())V
M8J8XWF:3A=S,J\A?E"Z%^R_\8K'X4WG@[5O'_A'68(+&VTNQMI?#*"UO;=+B
M)Y/MZDDN3!$85\O;M$C-DMAA]8:5JMGKFEVFHZ?<Q7MA=Q)/;W,#AXY8V 97
M5AP00001ZUYUXO\ VF/A?X%\:IX.U[QQI&D^*9&BC33+F;]Z&E&8\@=,CGDC
M@C.,C(!\NW?_  3T\4O\,)_!":YX7N]#EO-5O;/3KZTN770)+GR?LQT^X#^<
MODF)V(9BK^80P/6N^\(?LC_$'X<>-K^;PW\0M*_X1O7)["^UF?4=%$^K&ZAA
MBCN)+>8L54S^4"=X;9O.!D9;M?#'[57A#PS\)_#/B#X@>/O#]U>:I#=7/]H>
M'[:Y>TGABN&C:9$VM(D29C1G?"[CUY%.\,_M(Q:-XJ^(NG^/M3TJPL](\46N
MAZ&UA:W'G7:W-G#=01M'\[/+ME.2H .UC@ 4 <I\"_V2O$GPS^.UU\1M5UO0
MDN;RPNK34X] LI;;^VI))@\4]S'O\E9(U7!:- 7)8GJ:ZSX\_LK6'QO^)?@W
MQ-<:C_9]I803Z9X@LHH1NUK3F9)DM7?J$6>)21W5Y!QGGN-._:!\ :O\1CX#
ML_$<%QXJ\R>$6,<4I5I(%#3QB79Y9>,$;E#97/(!KN]0U"VTJPN;Z\GCM;.V
MB:::>9@J1HH)9F)X  !)/M0!\72?L%>(_#O[/.E>!?#_ (FTW4O$-CXQM/$+
M:GK2RK'+:6C;;:W^0,05B2(8 QDOCKD]/XZ_9;^(OB'7?%,6G:]X8B\-:EX[
MTWQO:QW-O<?;%EMUMO,BD93L"G[*@&%)^8DD=*]4M_VN?@[<Z-?:L/B%HT.G
MV3P)<37,QA"&?=Y)PX!(<(Q# 8(4G/%:.E?M,?"W7O"FK>)-.\=:+=Z'I5VM
MC>7T5R"D4[$!(_4EBP"XSNSQF@#/^!?PDUSX7^)OBC?ZK?V%[:^+?$TOB"U2
MS5P]N'BCB,;[N"0L,9R.Y;T%>NUX=^RO\?[K]H.R^(>HN=/DTS1/%EUHNESV
M$$L1FM(XH71Y1(Q/F$R-GA>PV@@Y]QH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "O-OVCO@^/CW\$_%?@/^T#I4FL6RI#>B,.(
M98Y$EC8KW&^-<XP<9P0<&O2:I:UK>G^'-)O-4U6]M]-TRSB:>YO+N58H88U&
M6=W8@*H R2: /D+XE_L@?$;XW:?XVUKQ=KOAG3_&FJ^%++POIXTA)GL\0WT=
MZ\\[LBR9>6,*$4$(I."Q-1_$C]E;XM_$:U^-!NM0\'6][\0]#T+3M\,]VL=K
M-9',SX,1.UC)+MY)X3/4U](VWQ^^&5YHT&K0_$+PQ)I<]W]ABO%U>W\I[C ;
MR@V_!?!!V]<$&HF_:'^%J:-:ZLWQ&\*+I=TTJ07C:U;"*5HAF4*Q?!*#!8#I
MD9ZT ?/_ (-_91^(O@3XK:IJFFS> ;CPUK.N1^);FZU#3&N-9L;G;&9;>VG:
M,J8V:/8)& 95=F50]>O_ +*/PJ\3_!?X10>%/%<VDW6H6^HW]U'/H\TLD3QW
M%S)<X/F(A#*TSKC!&%4YR2!V5I\9/ =_;:7<VWC30)[?5+::\L)(]3A9;J"(
M,TLL1#?.B!6+,,A=ISC%0W'QN\ 6VE:7JDGC;P\FF:JC26%XVIPB*[56VL8F
MW8< \$@G!XH Y']J;X/>(OC!X"TB+P?JMGI'B_PYKMGXCT>;4D+6CW-N6VQS
M;06V$.W(&<XKSG5_@5\9[SQ9X$^*$^L>$=4^(OA^ZODN-#A6XLM(>PNH(HW@
MBFVRR[U>'S?,=#EI6! "J*M_$K]JCQ-X(\4?'+3+30M'NH_ 7A:T\2::9KJ0
M->K(LC2B7"G 7RV"A1S@98;OE]J\,?%OPQK6B"XG\0Z-;ZC:Z9%J>J60OXM^
MGQ-$LC/*N[,: ,#N8 8P: /G7P/^R%XT\$?$OX:>,8]1T*_GT2]\1:SK-HTT
MT$;WFJCF.VQ$W[J(A0&;!89.!TK*^%'['_Q+^%]A\"(8]1\,7DGP]7Q']O7[
M7<JEZ=2+&+8?()&PL"V<9V\=>/LVUU"VOK&&]MKB*XLYHQ-'<1.&C=",A@PX
M((YR.,5QUI\=OAOJ"7[VOC[PS<1V$2SW<D>KVY6"-I#&KN=^%4N"H)X)XZT
M?.?P<_9/^(GPOA^ 4,UQX6O(_AK:ZW!=>5=W"M>O>AMC(3!\H7(+ CKD@U'\
M)?V5?B9\/;OX )>3^%[JU^'MKKVGZG+!>W&^YBU!@4>%3 !N0(F0QP<D9'!K
MZ?L/BOX)U6YTRVL_&&@W=QJ88V$4&IP.]WABK>4 V7P58';GD$=JY^_^*1O?
MBCX1T+P]JWA?4]&OEU)=5!U1#?QRVZQ^6MO$K'S,.9!+D?)@9P>H!\W^#?V5
M/C#HFD? 2VOKSP=YGPY?4-*NA;7%T1=:7<VT=OYJEHO^/@ .VW 7.WG&:Y7P
M_P#L >._^%5ZM\,M3M/AEIFE1V-Q:6?C/2M')US4,.&MA<DQ@(,@&0J[%@ O
M/)/VBWQJ^'Z+J+-XY\-A=-8)?$ZO;XM6+^6!+\_R$N0OS8YXZU:G^*O@NV&H
M&7Q=H4?]GV:ZA>;M2A'V:V9599Y/F^6,JZ$.< AE.>10!\F2?LJ?$?Q!\/[S
M2M?\"_!^ SS6$5SHWAN"73([Z.)G:6Y-Y%;B6"<,8S&$4JI#9R&Q7T)^S!\.
MO%7PJ^#VG>&_&.J#5]8M[FZE$WVV2],<,D[R1QFXD1'E*JP!=E&3VQBO36U:
MS73#J1NX!IPA^T?:_,'E>5MW;]_3;CG/3'-?-'P@_:XO_BMK^I>)H9/!EE\&
M[>]N[!M9N-=$6H6;Q.4ADG1_DV7!7<@R"%8$Y[@'5?%SX5^.I?CMX)^*'@4:
M+J=QI.EWFB:CHNN7<EHD]O,RR+)%.D,I1UDC7(*<CC(YKRGP7^R+\0/A]IOP
M&L;.\T+4O^$.U_4/$&OW#W<L*O)=F4/#:Q^2VY46=L,[*24Z#=\OU+<_%3P9
M9:78:G<>+="@TV_226TO)-2A6&Y1!N=HW+8<* 22"< <UIZMXKTC0O#-UXAO
M]1MK;0[6U:]FU!Y1Y*0!=QDW=-NWG(H U@,"O#_B_P##/QGK7QW^%/COPM!I
M%[9^&K?5K/4+75+R2V;9=I %>(I$^XCR6R#CJOO6+I?[9?AGQ!XZ\!0Z;=Z/
M_P ('XHT*]U8^(;O45B>SEMS%F"5#\L9Q,F=SY!)! QS[A?>-O#VEV%I>WNO
M:9:65XGF6UQ/>1I',N =R,3AA@@Y'J* /BZR_8T^)FH> /A=X2U0^&;.#0-!
M\4:'JM[::C/(V-5BDB66%#;C?Y8<,59ER<C(ZUZA^RS\!O&7POU&Q?Q5X:^'
M>CR:5HRZ.-6\)VK&]U8*R['E=XD,2JJ<J"WF.Y8[=H!^F5D5U#*0RD9!!X-?
M&]A^WGXHC^'7B_XAZK\,-.@\&>$O$4WAW5Y;'Q.T]\KQO$AFB@:S1'0M,F 9
M%;KQTR ?1OQ\\(:Q\0?@CX[\*^'UM#K&O:)>:5;&_F:&!&GA:+>[*CD!0Y;
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MW[0_[,?Q(^)VO_':'0M%T2+3?&OA_1],TV[NM4:+9)97!D)9$C)!*N<<X!C
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M<*@#.>#Q7ZF @FJ.MWW]D:3>Z@+6XO3:P/-]EM%#33;5+;$!(!8XP 2,G'-
M'P7J'@/QX/$7QJU1?!'BA[CQ!\)+71+6Q:)&BFOA;F(Q+(K%2Z%\X![R=>,[
MGC+X4W'B+XM?!Y](>+2-3\7^&%\+^/= N\-<IID,4-TQD1&.Q_W9MBYR/])0
M=Z]S\!?M=^$_B!J?PJL['2-=MQ\2+"]U#1Y[J"(1QK:J6E28K*2KX&0%##D<
MCG'I.E?"OPEH?Q"UOQU8Z%:6_B[6H(K;4-7529YXHU540DG@ (G QG8N<X&
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M:_0CX8_M":'\6=<:QT31?$45C);2WEEK=]I;PZ??PQS>2S0S9/.[D(X1BOS
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M?M&:[8?"[5[[Q!?>*M&N/#]TFBS>;);@Q_;9+8[>C,LQ<CKE<]17Z?9HR.U
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M %64C@@@@@BLBW\!>&;*XU.>W\.Z5!/JC;[^2.QB5KMMQ;,I"Y<Y).6SR2:
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M\)Z';-J43PWK0Z;"ANHV.727"_.K'DAL@UU$4201)'$BQQH JH@P% Z #TH
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M(WQ-\<?#O0_VC=!T[XM>)-<&D^&/#^OZ;JEU?K]JMY[EX_.\ET5=D;B0'8H
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***,CUH **,T4 %%%%
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MQI_BRUU32O#FG2^(/!/_  CL]Y'KMQ=2/=QOO25@T.%5R NQ-JHO0&MKQ/\
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M+\:>#?AKX&^'&E^'_#_B*\\"3>*#Y&GV\%B7%W)!#;Q0M+&L<0\MF?8&89!
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M).<ET5PQR0/D'!)/T]\8?$&I^$OA3XPUW1IK:#5=+TBZOK:2\A,T0>*)G&]
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M0QM+$),"%@$\V/)9?F H ]9UC6M/\/:;/J.JWUMIFGP#=-=WDRQ11C.,L[$
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M .-'B[X/W_B+1H_#7CKP5\7F\):E96%VT]JY>SFD+QN0"R.(TQD9&&R.:W_
MWQ_O?A]\-YF\-^"_#_AV>\\<Z]IEW +VYN8!<022,[QQA3/.\LBD!8T 7KM4
M8  */Q6_8'UCQ-\7-=US1-(\(S:'?6-CI^D7$VKZGI5UX?AM[=8 D4-I\DX
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M77-0^*TVN:GK.N6GQ)6)-9T^[D@6&/RHQ' 8#'$KH8T50I+-]T%MS#->UT4
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M2TT[3WUPZG%!>O:V<RRI"TD,*;U?:%=G#,R@#<, CZ+' I:* "BBB@ HHHH
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M1L7C7Q%XNT+Q=#I7@S6],\1OHFF:7<:DAN+]!;6]PC*K[69RLX)55..!D]:
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M+G]EG7;V9;V[^$<D\M[\>I?$=QYME;&4>&F&=K$/S%DG]UG&<_+TS^F! -!
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MHN02:^L=6UFPT#3Y;[4KVWT^RBQYEQ=2K'&F2%&6) &20![D5<S0!\B?M8:
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MPIX5T"+0?A%?2ZE+\&;W0=2M9;80Q3ZD]TK/',\<B.795D8?,"=R =2!JQ^
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M0!\1:W^SOJD'PN\/>-/AG\+[OP=XO\(>,9-?T;PUK.IBYO+ZUEV17:RLTKI
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M;C34E:[UO4'U*_NKB3?)-,P51Z *J(B*H  "CJ22>GH **** "BBB@ HHHH
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MC*UZ7J'[-WA;PSHNFW?@+PYI6F^+/#-A<V_A6;4);EK33Y)=S%657SY;.WS
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M=E\UW?RDW,PRQ^]@5ZS%^PO\%H;:^@3PK=HE^8&NRNOZD#<-"P:)I"+C+,K
M$,>00.>!6WKW[(_PH\43^(Y]7\*_VC<>(-1@U;4)KC4+II&NX0XBFC;S<PLJ
MR,H\HI\I"]   #S3_@GM:7%AX*^+-K=78OKJ#XEZY%-=")8A,ZF$,^Q>%R03
MM' SBO,-"_:9^-7A[1=$\>:_KN@>(?"[^.;[P==^'K71C;7+HDTZ1W0G$C89
M?*SLVXV#)9B3C["^%_P6\&?!33M3L?!FC+HMKJ=ZVH7:"XFF,L[ !G)E=B.
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M4-1\/6NNZN\9LM.BBB9HKB]E$KX1B50[6+;U!Z%JZ#QU^S;>7GQ8G^)?P_\
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M(P<#-4;[_@H-!9^%O%FJ)X&N=6O/#FJ:=IEQ9Z)JT-VDK7@_=F.4* S!\(5
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M/F"KX9_8?O/ T7A%/#OQ(O=,;0?"]UX3F?\ LF&47]G+,9DWJS%5*N025&6
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M?:1X!\:Z)JLL^A#1)KFZ:ZMEB>.2W9$,DJN)PHPH7]V3GDX^C?A1\-]?\'?
M_3/!?B7Q&_B77+>QFLY]:F!9I=[/M)SRQ565=QY;;D\FO%_AI^REXX\&S?!H
M7^M>';NW^'FC:IHRBUAGC:[2ZAB1'YR%96BR?4,>XY /0-1_;4^$.E^'=*UR
M;Q-.^FZCHR^((Y;72;RY\JP,PA\^811-Y*^:=GS[?F!'8UH?#C]HW3?B?\9?
M'7@+3M*U.$>%H+*5]4EMF6"X,ZN_!(^52H4H3CS!N9<J 3\O7G_!/GXE2_"O
M2_ O_"7>&KS2[+PM+H$:7"WB1Q3O>23FZ"1D>8VQPH$I949=RKS7T=\%_@AX
MI^&WQ5\6>*=4UC2K^R\2:1H]I<6UK!(DEO<6-N8?W9)P8VWNWS?-T% 'GG[2
MO[6>N^$Y_BWX0\)Z??:%XD\'^%XO$=MKUYIS7%K.=Y9XP"I0(R*4$C,,OO !
M*UZ!X _;'^&_BSPAJVIRZ[<03Z!:6<^J)=:7<P2N+@ 1201-&'F61\JGEJVX
MXP/F7/+?'?\ 9?\ %WQ.\;?$;4=%UK1K+2O&7@J+PM*M^DQFMI4FF<2*$&TJ
M1,>ISE<8YR..^*_[#OBSXHZKKM_)XDT*S>]T30[."WGLWNH#=Z?(LN9HV WP
MN6F0KGH5)#<K0!]*?"GXY^#/C6FN?\(EJDM[<:'=FPU.TN[&XLKFSGQG9)#/
M&CKWY*XR".H->5>"_B5X_P#VA?B'\04\(Z_:>"/!G@O69?#:RRZ6M[=:IJ,'
M_'PSEW58X%+(H5?G?D[TZ5V7[//PFU?X96.L3:SHW@7P_>:D80VG> M(^Q6B
M^6&!D=R \KL7_B "A0!R6)Y3P1\$?B!\#/'?CV[\!W'A_7O"?C'69?$,NG^(
M;NXM+C3[Z8CS_+>*&59(VP"%*H1@#)ZT :=E^T2OPJ\*:3IWQ;F=O'Q@O+N^
ML_#.DW-Z!907#Q_;S% LK10&,(^YR.I &X;0WQ-^W/\ !3PC+:1ZCXR.Z[TB
M+7X/LFE7MR)+"3.VX!BA8;>#N_NX.[&#6+>? SXF6GQ<@^)L.J>%O$>O7WA>
M;PWK&CZDEQ::?M^TM/ T!59FVKOV.K#YP"?E+<>:^!_V#?%7P\%U!8>(-(U*
M _"RZ\ P2W331R+=3W$MPUQC8^V,-,4"@D[5'TH ]OTO]M+X.ZW%X@EL/%XN
MH=#THZY>2QZ==E6L0XC:XA/E8GC#G:6BW8/!Z&L23_@H+\!XK6YN&\;N$MX%
MNF7^QK\NT!S^^1?(R\0P<R*"JXY(KSP_L>>/AX=L-*34?#B?9_A!<_#5YA<W
M&3/+M'VD#R?N*(U.WJ2Q'&,G5U3]E?QUJMU+<R/X66:3X32_#P@7$Y_TEMN+
MC=Y'^JSNXQD#UH Z/XG?M1Z5\//$GBC7;7Q+/XCTG2_ T7B"'PAIVBRNTRO.
M=NI"]"$& JZ*P!(149ST(IWAS]M_PQJ?Q#O/#VJZ3K'AK2[#PI%XGN]:UG3+
MJTA168@KMDB4A %8"1L!W^1,G&>0?]DSX@WT-[!>:CX:CAO/@V?AM*8)KABM
MZ/,V7*@Q#]S\^",[ORP<CQI^Q7\1?B-97UMK/B/PU:#5O =CX3OI;6.XF:*X
MLKQKFWE0. )$<[%DW;3][ /% 'N$'[8?PJFL]8F.OWEO<Z1=VMC=Z7=:+?0Z
MB)[D%K>-+-X1/(9%#,-B-PK'H#7<?"WXM^%OC1X7/B'PAJ9U32UN9;-W>WEM
MY(IHVVR1O%*JNC ]F4=0>]?*?C#]B#Q3XW\):0LF@?"'P[K>D:O9:H--T;P_
M(NF:N88IXY%O/E5BK><-J!6V;6^8E_E^CO@A\,K[X=^!=1TB_P!.\+^'YKV[
MEN5L/!=A]CLK17C1 %X5I'^0L9& )R   H% 'D^M_M:1Z]^TK\*O"GA'4IW\
M(:I<ZY:ZU>76BS16ERUG9ROFVO9 J2+'+&0_E[AQ]['7OH?VQOA%)+JL<GBS
M["VFZ6-:E.HZ==6HFLBX19[<RQ*+A&8J%,._<67;G(SX9I?['7Q4_LGX9>%M
M3UGPC-X<\%)K&G+J=L]TE[>65_:2VI=H3&46=$E+?ZPJS8R1SG,E_8'\9:U\
M)9_!EZ/AKH=Y::7;V-KK^BZ&S7FK/;W$$L/VYI%^5"+<>8J;][/N/"[6 /=M
M0_;C^#.CV,]UJ?BN?2EMM3CT>YAU#1;^WGM[N2,R1QRQ/ 'CW(K%2P ;:V"=
MIP_0_P!M_P"#'B/6=&TJR\7DWVK:@-*MXY]+O(0MXS%4@E9X0L,C%2%60J6Q
MQFO+I_V3/'5_HOAL+H?PJ\-7>G^+M$U^[LO"VGRV-O<P6!D=@\@B+222-)A5
M90L8!Y8N<1R_LA^/U/BQX[KPS-+JWQ5M?B! TMY< I:PR*_V=C]G.'_=J 1E
M1O;T^8 ]Z\"?M(^"_B3XWG\+^'Y[^[NDCO)(KZ33IH;&Z^RSI!<K!.ZA)3')
M(JG82.X)'-+\2/VE/A_\)=:FTKQ1J]S8W5O:17UTT&EW=U#9V\DC11RW$L43
M)"C.K &1E'RGTKR;X*?LO>,?AG\;QXR6ZT7P_I%\NHR:_I6@ZA=36NKW,T@:
M"X6UFC"VK@#,A21@Q50%45C_ +6?[)7Q#^/WB7Q.VEZYX>'AW5=#M].M;757
MN87LKB.4NTNV%=LQ(+!3(6V;VVKR20#T_4OVV/@WH_CJZ\'WOBXVNOVNIIH]
MQ;R:7>*D-R[!45Y?)\M58D;7+;&YPQ -,L/VW/@SJ?BZT\,P^+S_ &S=:HVB
M1P2Z7>1K]M5MOD-(T(17+#"AB-W;-?-VF? _Q]\9/%_[0O@Z\TJW\-Z/XDU[
M1;FYU^]M;N(D6J1^>UAO@5;@>9 RJYD7 (< AN=;X7_"+QQ\65^(N@ZAHD/A
MSPZ?C%+XL_M35H+NUOIK2*>*:,VD3PA3YAA"^;YO"L_R],@'N.A?MU_!CQ'_
M &C]@\474C6 Q+&VB7RN[F<0"*-##NDE,C*!$@+G=G;@'%^^_;2^$ND:!'JV
MI^(KK2H3JQT*2VO='O$NK>_";S;RP^5O1L=,C#=B:\QTW]E#XAQ?"+3=)?5/
M#UGXKT+XA-XZTSR;BXFT^ZW7$DQMK@F%74#SW 95;E$;CH.)_:"^$?CGP[XQ
MT?QN-)CU?Q+XD^)_AW57TC18+N^L-.L["UE@\R>=+<LNXR9:0Q #*X#;22 >
MX:O^WK\%-'\):=XEF\4W$FE7]Y=Z?$\6CWID2YMHP\T,D?E;HG"LF%<*6W C
M(R11\'?M4^#TU;XA:_J7Q';6O#<.HZ5:Z;H\?AN[@NM.>[@7R8%40^;=M</F
M1=JL0#CI7,V/[+WQ M?B3I7C,W'A;S[CQ]+XPU/3UN)]D$7V'[#'#!)Y&9'V
M.\K,RQ@N%&,?,*?Q'_96^*&N>-_B=K7AO5O#>FVOB[7M$U/RY;NYBF>VL8&B
ME@:1(2T#RY4B6)MR@$#KF@#T#5OVU/!@UOP%8Z#9:UKZ^)]<NM#EDBTB\A>P
MEMD<SK+$\(<2JZH#$5#;2S\!>>O\/?M0?#?Q5X[L/"&F>(&GUO43<KI^ZPN8
M[:_-O_KQ;W+1B&8ISGRW;&#Z&OGGP%^QK\1O ]OX4^RW7@^ :!XXU'Q-%:VU
MQ=B$6MY;R0O"I:,L&B\P; 2=P7EA6O\ LU?L;>)?@7XC\.07EG\/-0TKP]<W
M;VOBJ#27_P"$CNK>59%2&21E"HV9?FD#L=J[ ,$D 'T+\3/CIX0^$=SIMIXB
MO;M;_48YI[:QTS3;G4+EXH0IFE\JWC=A&@92SD #/6N+U[]M;X0>'U\,/-XH
M>ZC\2VD5]I<EEI]S.EQ#),(0VY(R%*ONW*2&78V0",&3XA_"GQB/CWX?^*'@
MR;1;V:VT"Y\.ZCH^N3RVZ2P/,D\<D4L<4I5A(OS K@J,9%<+\"_V5/$_P<\7
M?#*<WVBZEH_AS1=7L]0E1Y(93<W]V+HFWA\HJ(XV01KEU)5V/&-K 'J7[1WC
M:3P-X+TN[C\:#P'+=:W86:ZH^C/J:.'F&Z!D52(Q(H*>8V I(Y!(-26?[2/@
MJ^^)\7@.UFU&YUB34)])%U'ITQL1>PV[7,ML;C;L\Q8E+$9]LYR*I_M2_"OQ
M'\9/A8/#7ABXTVUOFU2PO9'U262.(QV]REP5!1'.YFB4=.A)[8/G%C^S)XPL
M?VFX/B7IMSH_AFUFU::XU@:1J-SC6;(P.D27%FT/E&=69?WP<<9.TL<D ]2^
M-7[37P^_9\ETB+QQJUQI<NK"4V20Z=<W/G>4 7 ,4; $;EX)!Y%4(/VNOA5<
M>*=)\/CQ,\=]JURMC933:;=QVDURT:R"W%TT0A$P5US$7#@G:0&XI?C%\+O$
MWCCXI_"/Q'HQTH:=X0U6YU"^2^NI8I95EMGM]L06)P2!(S?,1DJ!QG(\+TK]
MB'Q-I/C_ ,4YM/AYJ/AW6_$TNOP^)]0TII_$FGQ22"5H(BT9CR&RJ/O&W.[&
M<* #W31/VM/AKXCU^VTC3]5U"YFOH+NYTZX31KTVVIQVH8W#6DWE;)PFP_ZL
MG=QMW9%7]+_:<^'.KP:%<0>(&CL]<T6?Q#87ES8W,%O-8PD":3S7C"*4W*2C
M$. RG;@C/R_X=^%GQ)^''Q=_9I\#^(K.SU+0/"VFZYIBZ_X<LKV:(1R67DV[
MW9,7EP,V$&W>P+ G(&*F7]B7XIZ[X&\$>!];UCPA9Z#X=\+:OX7;4-.ENI+J
M=;Q$V3^6\2K\K0PYCW?WR&Y  !] Q_MD_"B2/50?$%W;WVG+:M)I=YHU[;7T
MPN9%CM_)MI85DF$CLJ@QJPRPR1FL6V_;5\):Q\0O GA?2=(\07/_  D\^H0-
M>W&CW4"V36CM%,DJM'N5UD5=X8+Y2,'<J"N?,%_8\\87?@_4](U3P7\'YDOK
M:QL+NWTJSN;!M12*5#)<2721^9#*J1KL"!EW$L<X JYX8_9'^)FC3?#F34O%
M&G:Y_8%UXAMKI[Z_N)KB#3=22&-%CG:'=/-$D3<NJ LP[+0![+I?[7OPFU;4
M-0M(O%B0&RT^?5FN+VQN;:VGLX6VR7%O/)&L=Q&#_%$S@]LUR_P8_: U+XJ?
MM)^/O#T$MXGA#3=#TV_T^SU/0Y],NHI96D$A83JLDBML5E;:%PV #@D^':!_
MP3_\<VWP?U;P'.OPST>ZBTTV=EXKT72)%U/462>*2$7;E 44B,B0H6+9&<X.
M[WWX5_"_XF:;^T!KWQ!\9KX5BM=6\.V>C/;Z'>7,TBRV\CN) )($ 5_-?C)*
MX4?-R: -;7OVIO#OA;XVZ_X!UBRO]+M-"\/+XAO_ !#=6TBV4419N-^W;MVH
M?GS@O\B[F# =)\-/C[X/^+&LZEHVBW-_;:YIT,=U<Z5J^F7&GW2P2?ZJ81SH
MA:-Q@AER.0#@\5XQ^TC^R?XN^-'CKQE>Z1K>D:7HOB;PE:>'YI+DRFZMYK:[
MENXW557:R,[1JV6SMW\'BNW^'7PF\8S?';_A:/C9-!T_4X/":>%HK+09Y;A;
MC-R+B6XDDDBC*C<B*D8#;07)8Y& #/OOVB_#OP\^*/Q<E\6_$8/X=\,1:0LV
MA#P_<*=":X1L2-<)&?M"SL4((R$(P<9YWM'_ &P_A1KFC^(-2L_$LC6^AW%K
M:W<4FF7<=PTMSD6RPPM$))O-*ML\M6W;21D<UY+\:/V0O&WQ%\0?M"7.FWGA
MQ+3XD:9HUC8&^GG#VCV17>\JK"1S\Y4JQP57/4XI?%3]CWXB^/OB1XF\::;K
M7A_1=2?4_#.NZ+&UQ//&+O28KA#%<CR5S$YNG(922/+3CYCM .D^(/[6@U35
M?A+=_#[54?3-6\?IX,\1:;J6GR0W<$Q4F2%ED :)X]ISQSN7!P#GUGP[^TS\
M//%']BC3M9N'.KZS=>'K59M,NX6_M"W1GFMY \0,3JL;G]YM!VG&:\H\;? /
MXI?$6^^'&JZS)X.M;[P_XZA\67=EI<DT,"0Q0^6(TD,!>:5V+NSN%QD*,@9'
MGQ_8Q^*\TPT+^V/#$7AJ'XB7WC4:JMY=#498KJ.:)HO+\G:CJD[G.\AC@< '
M(!Z%J/[75MKG[1OPUT+PQJ\C^ =5LM:N-3U"[TF2"TN1:0EA+;W<H D175MQ
MC!7 !W$,*]:^&/[2?@#XOZZ^B^&-7N;C51IT>KI:WVEW=@\]E(VU+F(7$2>;
M$3@;TR.1SR*^9HOV.?B[JWAOX=>$M9U3P;%H7@[P_K?AA=2L9[K[5=6]_9FU
M2?R3"%1XUVDKO(8@_,N:]/\ V4OV=_$_P;O;=O$'A_X=Z0VGZ0=)74/!^G&.
M\U<[XB)[J1HD*$"')12P=I68XV** ,[7?VOM(^#_ .TA\1?"WQ'\3FR\-VFG
M:5>Z-%#I$TQM_-647+2201N0@*Q'?)@#?C->I2?M2?#:.X\90'7I3-X0@@NM
M81=.NB8HIL&%X\1?OUD!!4Q;]P(QG-<+\2?V?_&&L>/OBMJ_A_\ X1Z[L?B!
MX8M?#TKZQ<2I)IS1K<1O(L:PN)E*3AMA=,LF"0#D<ROP7M]>_:*\%VFAZ5K=
MCHGA#1XM(\4ZCJ5@T%KK<=H;>?2TCD8 3,DZ>86C&-J,C'!"D ]T^-GQ<3X1
M?!KQ'X\72;[6!I=@;N+3[>%A+*Y "*X(S&N2-Q(^4!CC(Q7SW9?MPZ?X(^+W
MB@?$#5[S3? ]UHVBZKHMN_AZY6?3OM)D2?[4RQ[E175/GD"CYUVY[_1/Q[^'
MM]\5O@KXU\&Z9=066H:YI5Q86]Q<[O*C=T(4MM!.,]< GV-?.'B']E+XI>--
M!^*4.K3^$;74/%OA'3O#-L;._NWB@-M+)^]?=;@X:.7H ?F0#@-E0#W?4_VH
M?AMI'C:R\*W?B!TU2\U&/1X)ET^Z>R:^==R6OVP1F 3$$?(9-W(&,FN"_:V^
M+WB3X5>*/A-!I/BNR\*:+XDUQM)U:]O[>&2.",Q[Q*'D("D;2.>/F'I@^??#
MW]CGQIX*^*&I:A-I/PRU72-3\21>)I/$&I:8UWKNGL9(Y9[6!WBVLI,95)"5
M*!RX&["CV+]HCX.^*/B;XP^%>L^'UT:6#PAK;ZQ=6^K74L!N/W>Q8T*0R 9W
M,2Q'&!P<\ '%? S]K6*]T[XKW/CCQ/HNL>%? U];Q0>.M(MS'9ZC#,ORKL1Y
M-TJOA#Y?#%UP,]?08?VNOAF^D:Q>W.JZCIT^D7UKIM[I-]HE[#J<=Q<G%L@L
MVA\]S+G*[4.<'T./%?$W[%'B_P 5WWQ2\0PZCX;\*ZUXENM(O=*T;3!--IL$
M]A.DR27#&.,NTA4ABD8QN)YSBG?$7]E_XM_$+Q1KGCZ*\\.^'?$^KSZ-:7/A
M^VU2Y>UETVSDD>93>K DJ2R,ZX:.,%40J&^<X /3/$/[>'P8\,:/HNIWWB6[
M2VU>:]M[55T6],OFVC!;F)XO)WQNA9<JX!P<XQS7)?&+]KRT/C?X;Z%\/M9N
MY3>^.K'P[K5P-#F:R=';$]J+N1!&LZ#;E%)<;NV#7&_ G]D?XI_"KQKX$NKZ
MV\$OHNB^)M<UNX33M0N]\45_;I L< >#DQ@,?G8[A@$@\C87]EWXK:>FE^&K
M2Z\)W/A70OB./'.GZG<W=S'?3Q-=2W#6TL2P,F\-,P\P/@X'RB@#[( I:X#X
M/Z_X[U^Q\1'QYH5AHES;:S<6^F'3I'9+NQ7;Y4Q#G<K$EU.0,[=P #"N_H *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O(OVL/'
M-M\./@/XE\07NJ>(]$L[,6[3:EX4B@DU"V4W$8+1K-\F#G:V<_*S8YKUVO+?
MVG?A'J'QW^!OBKP'IFHVVDW6M0) +R[B:1(P)4<\*0<_+C\: ."\?_MR^%/A
MOXU\4>&]2\'^-;E_#-U90:OJ=EI<<ME:170'DW#R^=Q&2P&,;R<X4X..C;]J
MSP_)\0V\+V?ASQ+J-DFOCPM-XFL[2*33(-3V!FMW;S?-&W.UG\K8&XW9KS;X
MF_LE^/?B#%\89/\ A)_#L%U\08=#C8?8IPEFVGE22/WA+!SNX[ CD\UK>#/V
M:OB;X#^+&M:EHOQ'LM/^'_B/Q"OBG6=$BT_==_;&"O<0PSL3M@EDC0,",^66
M P<D@$/[.7Q^U73M"T/PY\0KK5]:\4:YXO\ $.@:?J$B6Q5S8S3$))Y6P+^[
MA8 A,$J>@*U=US]L_0O$OP[2Z\&Z)XKU/Q#JVF:M=VFGZ;9VS7MA'92R6TMU
M,)I?)5%F3"@LQ<X 5CE:Y_P]^RC\2=%\.Z3<Q^*?#4?C+3/B#J/C6"ZDL9Y[
M-H[V.>.: IO1Q_Q\,PPV.!SWKDO!/["WQ2^&BZ;J.@_$G09=?6QU;0=1:\TB
M06EUIMW<272?NUDR)H[F:>0$$ AU7HIW@&A\"/VEYY_#/PSU/Q;KOB[6-:D^
M'E_XEO[:TLK5[+44@F =SC:_VA0N%5 %(8;CGKZ?X)_;A\!>-;;4[W^R_$F@
MZ99^&)/%\>H:SIH@BO-.B(6:2##LSE&9 1@ EAM+#FO,_!'[$'CCPA9^!;=O
M%F@W:>&O!>J^%>+*9#,UV92LF2QX4F+/0G#^H%8WQ3_9L\=> /@W87JSZ9XA
M3P9\+-6\''3M-M)Y+C4&G@"+*L>"#CR825[YD/I0!]#_  G_ &G]"^+/C>[\
M)6_AWQ'X?UJWTJ'6Q'K-K"(Y;*;'DRK)#+(OS[AA6(;A@0"I QO%/[9GA+P?
M\2_$'@R_\.>+VF\/JDVK:O;Z.9=/L;=X))EGEE5B5C(B902N68_*" Q'@O[
M,GB+1O'=QI\<&G>+-&GT*"WO_%RV.LVEY;?952.UM9#?KY;@AY3L@P 0Q( P
M#[5XG_9AUCQUXV^.-QK.LZ?'X8^(^@6FC1Q6D+B[L6MHY$BE))VOS/*Q'^R@
MZ9H S8?^"B'POET;Q%J)MM>VZ';VMY<P16L,\C07$JQ)(OE3.N [H&#,I4NH
M(SQ71VW[:7@26WU:*ZL/$>E:_I^IV6D+X:U/2VM]3NKB[W?95AA8C<) CD,2
M  C%MH%?.7Q\^&GQ.^%7[(WC"W\>^+M$U@V\&E:/HD'AW29(?.$=_;2&YNR
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M -CQM=LO$GA71H(M%\8:]>^%;[0[5[>XU!9/#UN5:;9<JT'E11^=Y<9.2X+
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M#%%%% !1110 4444 %- YZ4ZB@ HHHH **** "D  Z#%+10 4444 %%%% !1
M110 4444 %%%% !1110 4444 %(RAA@@$>AI:* "BBB@ HHHH *,444 &*:D
M2(2515)ZX&,TZB@ I"BD@E02.AQTI:* # HP/2BB@!GE*'+!%#'J0.33Z**
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MVJ)^T-HX\4WWQ#MOB5H_B'4EOHH-.8Z;?6#%FA>:\8[#;+&4"Q[B0Q 5><T
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M&HT]M'\2V?B:WFFU&U5569YK1)V0JP.7+#)^8*HR0,4 ?J/GBN%^)GQD\/\
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M<ZB-GAYGF9XEB;A(]C1,20"2>2.@ /TX:0+UI/.7&<]\5^:7[/6F21W?[/\
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MVAA0!]:9I#S7YG^./BIXY\ _"[P1J.A?&/4_B)J]MIFJVOB&\TLMY!T>.:2
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M:Y4,QB548[8XOG55!X./FH _034M(L=9M#;:A9P7ULQ#&&YB61"0<@X((R"
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MD4;?>16=20#D\#U-=A10!\[^%?V.?#.B_&SQ/XSO])\-:AHE]96-EI.B#1D
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHS10 5S'B;XH^#O!>NZ5HNO^*M&T36-6;9I
M]AJ%_%!/=MG $:,P+\\<#KQ73U\L?MF_#SPAXT\-ZWX1L/#NG:I\3_'EI';V
M]U,BF2RMK=E)OII2"8(+<-G<,;G95&6>@#Z3USQ3H_AG^S_[6U2STTZA=QV%
MF+N=8OM%P^=D,>XC<[8.%')P:T9)DAC:21@B("S,QP !U)-?G?\ M(?$N5OC
M1X*N]9\&^--0T#PWXJT&W\(ZK8Z>EQIVH+\LUQ/%*LH\Z><;8T 4@+"<,#(X
M'Z%175KJ N(4EBF:,^7-&K!BA(SM8=C@]#ZT <(W[1OPH1BK_$[P:C X(;7[
M0$?^1*Z7PMX^\->.)-33P[K^FZZVF7)L[X:==I/]FG')CDVD[6'H>:^9F\!:
M!I_[?&E>&K3P_IL?AE?A++:OIXMD\E8QJ04+LQT*D@^U>,R>)O&GP'^*'Q?U
M_P $:II>E^$+#XD:)I=YX:;3E=K];JVM8G_?D[H\!T(V*6R6)R." ?H]6=K_
M (CTKPKI<VIZWJ=GH^FP8\V\O[A((8\G W.Y '/J:^.OA9^T)\8/B9\1(?$*
MZAX4TSX<Q^+KGPW>Z9>7,:SQ*LQ@@1< RBY<@/M8E6W+@*#FNK^.4T.L_MK?
M!/PWXMACN/!4NF:E?Z7;785K:XUN, *74\,\<+$ID<-)QR: /H?PC\2?"7Q!
M%P?"WBC1O$@M]IG.DZA%=>5NSMW^6QVYP<9ZX/I725\T?M&:]HWP&N;GQ7X2
M?2]&\>^+KO1/#EU<S;6CMK5[QXQ?26X*[_+$\H#$X)" G"X/D'Q3_:4^+_PI
MU3Q_X(MO$6G:UK'AO6O#BV/B34M)1?M-KJ3,C0W,411 R. 0T8!*@\ \@ ^]
MJ*_/WQC\=/V@OAZ_Q*OKCQOX:UK2?AIXBTRRO8G\/^1/K4%\UN=A99"L/E"X
M505!+?,2W RGQ4_:3^.WAWQ7\8[[0?$/AK_A'_A_XGTO38=*N]'8RW\=])$B
M1/,)/D">:N6 W-\QRO H ^Z_%GC'0_ FC/J_B+5K/1-+22.)KR_G6&)7D<(B
MEF(&69E ]S6ON&,U\ _&3XT_%'PEX$^,V@>*KSPWXOO/!VO^'$AO9/#R&WG@
MOVC=D:W=W53$S(5<[CD=R05S/CQXL^(.DZU^U$UOX]O(-/T_6?"^D6MLUM$R
MV]O>BV+!"1\H47#*0/O@N6Y8,H!^B5%?%9^-WQLUWXK>+;'PYJ7AJ#PKX"UR
MSTG69->F@@>ZMA$CW%S)C#1M(9/W94*@V$88YQH? CX[?%[XP>,/#?C%;KPW
M;?"[5]8U+2[C3;B6-+JW,+S)!'#@^8TY\G>ZOC*LS!0N, 'V)63X=\6Z)XNA
MO)=#U>PUB*SN7LKE["Y2=89TQOB<J3M=<C*GD9%?+_[8/Q\\>_!SQEIW]EWR
M:'X&&EI+>Z[;:<NI&PO'G98_MT0)DAM7CC=5F1#^\W AL8KR3P;XZ\?_  D\
M:?$KQ!H&I:1#X-NOC?\ V)?:--I^Z>Z-VUK%+()P_P FP-&54+R6<DGA: /T
M,NKN&RMY;BXE2"WA0R22RL%1% R6)/  '.:YO2_BKX+UMM#73O%NB7[:[YO]
ME+;:A%(;\1;O-, #?O NQMQ7.-IS7R7\,/VI/&OC7]H7P9X;U"^L=>\$>+[O
MQ'8^9;Z5Y5@19 M&MK*Y$TVU0%E>2-8BS,(V;;QXY^S#9P_\(5^PE<M:P)=+
MK/BJ(2*V61";TE!SRI(4]_NCUY /U HKYB_:]^-7C#X=ZKIND>"-<M+75FT+
M5=9ETR*Q2ZO91;QJT<A\UDACME/F&1F<.2%6,,20/(M9_:7^-6L>$_%.OZ/X
MB\/Z5%H/PWT7QQ+;/HYF>6:XM6EE@5C+A59HY3N() V #JQ /OJBOSR^)7[6
M/QJTFR^*7C71O$'A>'PKX*'AN_CT@:0\\E];ZFEN_EM/YN4"B8DN%);' 0&O
M0_&'[1/Q"\':G\78KK5;66W\'>._#]A:>59QEI=,OWMC) ^<994N#AQ@Y49)
M% 'V-<7$5I!)//(D,,2EWDD8*J*!DDD] !WKGM'^)?A'Q"-'.E>)]'U+^V5E
M?3?LM_%)]M6//F&'#'S NULE<XP<U\I^ /VD/'?BC]H;POX=U&_LM9\#^*M:
M\0Z1&]IIJI8^590RO&L$[L)II!Y0$K&/RLN0C-CCSO\ 9H\-+%\./V4(])G3
M3M6@N_&=A87TD?G>1E=0VEER X#(C8)YV]1F@#]%:*^3?V8/CM\0_BSXGTGP
MOK][:PZ_X0&K1>/X$L-H^U"Z,.FPQ-]U5>-99MRYR(E_O5I_%+XN?$#7?C1X
MS\ ^ _$GA[PG>>%/#EIKRMK]OYL6HM+*_FB5\YB@CCC +(I;=*#G Q0!]/T5
M\1>,OVJ/B)#X0^)GQ+T75-&31/ GBFWT(^$?L8F;4;4O;QO/]H+JX>0W):+:
M "L:C:Q8BJ<?[27Q9TKQN=0U3Q)H<_A&'XO#X='3(-%9)Y8' Q*TOFG:5RH
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ML3,K,DF<E>H'?Z0H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHK@_C?\7=.^!OPWU/Q?J=I<ZC':M%!!8V8'FW-Q+(L4
M,2DX"[G=1N)P!D]J .\I"<5\D_%#]JKQA%\-OC7H7_"(_P#"&_$KP?X>75A&
M-52Z@-I-$Y%W;S")=[1%6W(4 W+@,:]4_9=^&J^ _AS8WYNM7-UK]K;:A=6&
MH:W-JD-M,8AO,+S ,OF$[W'3<3B@#V$8S3J^)D^/.I>$!K \#Z+=1ZEJWQH/
MA?54\1:OY\?G.L;,+<K&WDPR*H485C'ECAB1CU?X;_M4W/Q+^-^N>!M,\*V[
M:=HFH7VEZCJ2ZTC7=G+;<"2:R\L,L,K B.0.P..0I^6@#Z"KQWXM_LA?"/XZ
M>)5\0>./"":YK"VZVBW9O[J!Q"-V$_=2J-OSOQWW'-8OQ:_:=U+P3XOU[P_X
M0^'FJ_$:]\-V5I?Z['I-RBRVT=R[+%%#%M9YYBJ-(4PH"8.[D"O'O"/[1>J_
M"#XO_%6RU'1/$GB7PS<^/M.TTZC=ZHDD6B_;K: )&B2R%R!(Y_=H JAEP>0*
M /K<_#7PNVA>'=%;0[*32_#LEM+I%M)$'6Q>W7; \6?NLB\ ]<9I_A7X=^'?
M!.I^(=1T/2XM.O/$%[_:.IRQ%LW-QL">8P)(!VJ!Q@=^I->%2?MJP0_&&V\
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MC31(M;TV*=+J%'DDBD@F7.V2.6-E>-@"1N5@<$CO7A6B_MU07_C?4_#-_P"
M-5T?4(-*U75K:RNK^W6_>.R)R)[5F#VQE4%XRYPPY!(R1F^$_P#@H7I>I6 U
M7Q/X UOP=H5QX4N/%>G7]W=6TYU"*!XXY(HTC8E6+R@)OV[N#@;A0![';?LO
M?#"W\':[X7?PK%?:3KBHFI?VC=W%Y<W2H08PUS-(TWR$!E^?Y3RN#S44W[*?
MPPN_"%SX:NO#LM[I5W?PZG<F\U2\GN;FXA $+RW+S&:0(  JLY5<# &*\@^#
M_P 1O&_BO]N77[/Q+IVH^%=-D^'MMJ$'AN;6/MD".UX )]BX2.0KE& &04/)
M!R>Q\>?M<GP%\4_$OA.3X?:_>Z?X=M;?5-7\01SVXM;6P='=[K:7W%4\MAM
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M71? WCKXG^)?$%AXMT^;2O#6@7<NAWEU') SW)E$,-K;\%)VED\I]Y4ED'
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M&52""#Q72T4 >1W/[)OPHN['7;*;PA"]GK@M%U*W^UW CNA:J%M@R^9C]V
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M^(-;A^)]C:S:SI>D:9<6S^&!/;RI8MEEF1[HB6&8/.KQG'$B_-\GS>@_ /\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%/(QC'/0UGK^UWX"N?"MGK-D=7U*:\EOH(-&L]-D?47>SS]J'D=1Y>.2<#)
MSD@4 >VT5X-X9_;3^&GB^>2/2[K4IU3PO+XN$KV+1I)81XWE-Q!9P<J0!C*L
M,\5Z%K/QB\,^&/A4/B)KEQ<Z-X:^QPWKO>VDBSQK+M$:-"%+^86=5" $[B!0
M!V]%?+_QH_;.LO#7P:^)6J>&]&UBW\=^%;**2;0-8L?(N;(7 Q!=R(6VO""<
MDH6P1M8 \5Z7\!/#_C/P_P"%KJ[\6>--3\:IJ/EWEA%J^DV]C?6*-&-\$ODX
M1SNR1\JXZ<]: /5:*^'-8_;<UG7=(^'OC2TM-8\+>'Y/']UX7U715TI;VYU.
M(+/Y21*@DD:4-"BLL0^_(0"0N:]:3]I'PU\1M6^$E]X>\3:WH<&N:[>Z=)I<
MNB'=<3P6\OFV5X9!FU=&PPQ\Q*<97<0 ?1-%>3?"7]I7PM\9]>DT[P[9ZPUO
M]FGN[?5+FRV65W'#.()/*E#'YE=AE&"L <D5P]S\2O%OQH_:)\9?#CP;XD;P
M5H/@*ULWUS6+2UM[J]O;N[4R0P0B='CC1$CDW,58EL  8R0#Z1HKXS^(/Q=^
M*OP \??#>'QQXAN/$.A:CXGU2Q-OH6AQS7>LV7]G+)9@0Q*SK,+@LF$V@_>;
M"X(]23]MCX9W/@31_%EA/J^JZ7J5K>7:I8Z;))-;QVIQ<F9>-GEG@^N1C((-
M 'O5%?.7C+]N[X>^$]1@TZVTGQ;XFOY].M-7C@T#1'N2UI<(&BFW$JH0Y4%B
M0 QQU!QC:7_P4)\ VOP>\*>./$MGJ>DRZ_9W.H1:7!")94MX)-DDH8LJLH)4
M<'<Q/"X!P ?4U%>#Z+^V;\/_ !/\0]*\':##XAUW4-2M[&\AN]/T::2T6VNU
MW13R2X 2/&,LV,$XY(;&E\9_VK/!GP+U>YT[7[?6KR>RTM-:U!]*L#/'8V;S
M_9XYI6R  T@8 +N/R,2 .: /9J*\"U_]MGX<^'?&&L^';J/Q"TVBW]E8:GJ$
M.B3R6-D;K9Y$LUP!LCC8R* 6()SP#7&?M&?M0W-IJOAO1/A]>:M%=6OCW3/#
M^MZM%IR-IOS2+]HLVGE4CS-K*#Y?(.5+ \4 ?6%%<'\4/C)H?PF_L6'4[?4-
M1U+6IY+;3M,TJ 37-TZ1M(X12R@D*O3.22  2:X>Y_;$\$6OAOQ)K+Z?X@\G
M0/#^G^)[RW&GYG%A>1^9'($W]4 ?>IP5\MNH ) /=**^2)_VQ+/X5?&SXK:7
MXZOM=OO">F2Z3/8W-AH#W,&C6UQ:B262ZF@B^2/>Z &1F8_P@X..Q\2_MW_"
MCPEXBU;2-4NM=A&CZBNF:EJ2Z#=O96<CC,323+&5"2$,J$9W[20"N&(!]#45
M\N^/?VL/"OB?PEIMSI'B'Q5X(N;;QGI^A7ZR>&W%W%*[AUM[B*=1Y44R8_>=
M0&'&<K7HWP/^/(^,?B?XD:2/#]]HZ^$M=?1UFN0FV?;&A).UCA]YD.WIL,9S
MDD  ]<HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBN8^)7Q&T#X2>!]7\7^*+[^S= TJ'SKJY\MY"JE@H 5 6)+,H  ZD4
M =/17@-[^W#\+=(T^XGU.ZUK3;FUUS_A';G3Y]%N6N;>^*%TC=$1L;U!*')W
MX(7)! NZ!^V-\-O$L7A1K:ZU6%_$FM3^';2*YTJ>)XM0B*AX)P5_=-\P(#=L
M^AP >XYHKB_!_P 6/#WCKPOK/B'29;N;2-*O+RRGN&LIAYCVSLDQA7;F90RL
M T88,5(&2"*\I\&_M[_"+Q_I+7WA[4-:U4M<16MM:6^@WC7%[*Z2.4MX_+S*
M46&5G*Y"!"2>1D ^B3TKYO\ C]\+OC7XW^)NA:QX.O? =QX8T6+S['2_%(O?
MW6H\;;UEA&V5HAGRU8@*26^]M9=5_P!N3X/MX7TO7[;Q%=:AI]]83:LWV'2[
MJ>6SLXI/*FN+F-(RT*))E"7 R0=N[!K3\1?MA?"SPO>O%=Z_-<65NMD]]J]E
M83W&GZ<+L VIN;A$*0^8"I&XC 92V P) .;^)7P8^*_QDTZS\%>*]>\(/\/[
MB'39=9O+2PG&K3SV[1RSK"I;R8UEECRK]8U.-K'D>Q^&;;Q?#XL\5R:]>:5<
M>'99X#H$-E&ZW,,0A F%P6X9C)DKM[=?0>0:U^WU\%]!UG5--O=?U.-]+U.3
M1[VX70;YH+>[7_EDT@AQEB&5<9W;21Q@G3D_;4^%5CX.O?$NJZIJNA6%AK,>
M@7L&J:'>P75I>2()$CEA,6] 4(8,1M[9SQ0 _P 8_!WQ;K?[67@;XE6,VBCP
MQH>BW6E7-O<3S"]=IR2S(HC*8&V/&6&?F]J\Q^-G[+_Q2^)J_'ZRLKSPA!IW
MQ!CT>WTQKBYNEEMH[-AO,^V$@EUW8"D@''N:]"T']NKX->(M=TS1K+Q)=_VE
M?:DNC_9[C1KR$VUVS;8XKC?$/)9VX7?C)!_NG&U>_M=_#'3O&K^&+K6;N&\-
MU<Z?#>?V7=/97-W;Q[Y[:*X6,QO*@R"@.=P*#+_+0!Y-X0_9:^*/P\^+.O7_
M (=UKP4G@CQ3KD7B#6/[1L)+G5[&8A/M,-G(5\LHQCVJT@RH;.-PR?6_VDO@
M?J?QAT3PU>^&=:M_#OC;PGJ\6MZ)J%W!YT!E165H)E'S>5(K8;:<\*><8-/X
M=?MH_!_XI:I8:?X?\5/+<W]G/?VIO-,N[.*:* 9G*2S1+&YC&2P5B1@YZ&N/
MT7]KC2_$'[0[VEMKAM/A=;_#ZX\3S7FJ:1/8J\B7D"+=1S3HIDA,4C ;!M)!
M.6R, &I\1/@_\5?CY\.?$GA/QQJWAGPQI^HZ-+9+:>&FFO!<7;;"D\LL\2,D
M:,AQ$BDG=S(< 5YI\3/V2?BM\:;#7M8\4ZEX2MO&<G@<>#;#[!=7+6<S27"R
M7-Y.3;JT9(7Y(D5@"3EL8Q[?IW[7OPNU"#6S+KEYI=YHLEI%>:9J6D7EO?!K
MI@MJ([=HA),9<KM$:L3N' K&_97^-VL_&77?BZFHS/+IWA_Q7)IFEI<::UA<
MPVXAC;RI8V^;<C,PRP!.,D#.  >;:[^R[\5M?N_'TDUQX.@C\1?#.T\#P+'>
MW0,5Q&I#RMBW \O,UQC:,X6,;1EL'B']E[XM:XOQ- NO!L9\7_#^P\((QO+O
M]U<1(4FE(\CA"L]QMY)RL>1RV/8]:_:;\%:GK5[X-\/>(\>,+HWVFZ5,^EW,
MEE+J5O"7>!)RBPRR1Y4M&LF>"N0<@><_LJ_MO>%/B?\ ##PZ/%_B:"W\>'1;
MG6-3B.GSVT!A@=Q,\;E/+?8B@LL;,1SQP< '+>,?V1_B=XBO/%%Q#=>%(FUC
MX8VW@-=VHW2^7.I0RSG%L?DYEP.I 3(7)QN)^RU\19M=MIWU'PQ:6%_\+5^'
MNL*)+F>6.6-;GRY[<^6@92TL9;?@@!@ >#7I#_MJ_!^'PYK.O3^)KRTTK1XK
M"XOIKO0=1A,45Z";278]N&9) #AU!7IDC(K0TW]KOX2ZMX?\3:U;>+HS8^&Y
MH+?4Q)8W,<T4D_\ Q[JD+1"27S?^6?EJV_\ AS0!\_>&OV2/C3X%UKPYXDT7
M4/AM?ZVOA>U\,:S9:W:W<]GLLSLM+FW.W>9/+";@=J[@V <@KN>%?V4/BQ\.
M?B-K\GA[Q1X,O_"OB34K75-2UC6-&W:Y;S!(UNC;JJ>1B4QD@-\J;_E48^;V
M33_VNOA9J>GZQ=0>(+SS-(OH-+O+"71+^*_CO)F98K86C0"=Y6*-B-4+8!.,
M<UE:C^VY\)+/PM;:]:ZWJ.KVL_VX_9]-T2\ENH%LBHNVF@\H20K%YB;C(J\,
M",CF@!W[4GP5USXU:/I>EZ9I_AV_MH!/(6UJYN+6>TN"F(+BVF@1V1T;.1P&
M!Z\5XOXD_8_^*^O>#OB9H\OB#PWJVH>*_".C>'(]6U"YN5E>:U4+<7$V(6SO
MW2,,$DG;GJ<?0_QJ_:%T?X.?"BU\>-I]]KUA?36<%E!8POOE:Y95B+84E%PP
M/*DYPH!8@&+Q1^U7\,_!FHS66LZY=V,UL]E'>N^CWIAT]KO'V9;J40[+9G#*
M=LS(1D9 H ^:O%'[''QGUWQ_!XH74O 5QJ-KXFTOQ'9W>H37LDMI':PPH;&$
M"+;'#NC.2H#2#&XKVZ?5?V5OBE<^&/%5C!<>$'N]4^*T7Q @:2_NEC%JCQNM
MNV+<D29MX@2,J0[GC !]T_:%^/VF_L^>#M-U[4-+OM8&HZM::1;V]C&SG?/(
M%W,55C@+N( 4LQ 4#)R/)_A;^V)I^G_$[Q]X*^)/B*&#4;?Q>FC>'S#H]S$A
M@GBB:VBF=498Y&+L/WA4DJW8< '=?M0?"/QO\6;?P8GA34-'6UTC5?M^I:+K
MLT\5EJ:",JB2F%2SHK$DQG"OGYL@8/CGPJ_9/^+'P[O?AJ;NY\%:A;>#++Q)
M9(+6[N[<W":DXEC^7[.P39(,'!("GC)7YOH/3OVFOAQJ_CZP\&VVO3-KFH7=
MW860?3+M+2[N+7/VF*&[:(02/&58,%D)!&.O%>9?'/XY>*O G[2'A/P1#XS\
M->#_  OKNAW>HMJ>NV ?[+- 0,%VN(U8/N''!&#R<\ 'G_PT_8_^*7@34/ E
MS-/X/O&\,> M2\(?+J5V/-FFDD>"4#[+P@_=*V<G#.0"0 :FG_LC_&SPMX?\
M*6^@:CX)CU.#X=S?#S4Y;RXNI(H8C,SI=PXB4NQ4*"C !6.?G KT_P#9]_:_
MM?%OP3_X2_XA3V-C<IXDF\,6MSH%M<W46MS(X2*6SMT5Y7\PDD*H? 5CD ''
M?O\ M7?#&/1;74UUZ[N$N=2N='2RMM%OIK];RW0R7$+VB0&>-HT&YM\8V@@G
M (R ?)/B+]@SXT:_X=32KW6O NMK9Z9H5EI<^HSWQ;2CIRQ[Q:IY12/SV1M\
M@&[#L. Q [WQ]^RS\7_&EO\ %N19O!5MJ'C'Q%H&LVSM?W?E1+IZ0[]X%N2-
M[6\>%!. [Y;Y06]7U;]O#X(:/J&@V4OC037&NVT%YIPM].NI%N(99O)5U<1;
M>'#AAG*^6^0"I%8US^U9:^+/VD/A7X1\$ZF=1\,:Y_;46IW$NC7,4-P]I!N0
MVMY(BQ3*LBLK>27 QR1D4 <SX5T?PS\8_P!N#4O%/AF6Y$?A&P^Q^+HHXI8[
M.YUJ%I(+1"711.\,;W7S@8 $)'MZU^T3\-_&7Q$NOAO+X3.B*GAOQ1;>(+U=
M9N)8C-'"DB"*/9#(,L)7^8@;=HQR<CD?VG/C;K_@?XC?#/X=^%);O0M2\975
MTTVNP:$^I"!(H'952/ 61C($\SG*1!F.,AAL_#?]J?PAJ$&CZ#K7B8ZIX@=9
MK(ZY;:-=6VF:Q>VJ_P"E+8R,I24J5?Y8V;.TA=V* .(LOV:?B;X6^.'BW5]
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M/L=8\/:UX3^)5OIXU#Q!J+M;7VG7$=O'!=2I:QPF.4.L09$#QA"0,X%?;-%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%<9\9_&UY\-/A+XQ\7V%M
M;WEQX?TFYU86UT[)'*L$;2NI902,JC '!YQ0!V=%?-FE_M*>-?"^G>!M?^(?
MA'1=/\)>+9;2V@U+0-4FNGT^:Z53;BXCD@C.URP7*9VG&<YX[S6OVH_AKHVG
M>(KE?$]GJ,F@V-QJ%Y::>QFG\J!MDI1 /FVOA3C@$\XH ]7HKQ3P_P#MB_"C
M5_ GA?Q3?>+=/T"T\06BW4%OJ<PCEA^ZLBR=EV.P0OG9NX#'(KGOVDOVKM+^
M&$V@Z)X5\1^';_QA<^(=)L+S1[ES<2I:74P5B%C<;'*'>I<XV@G!R* /HRBN
M>\/^/?#_ (OU/7],T36+34-1T&Z%EJ=O ^YK2<H'"..QPP/YCJ#CQGX4?M/W
M_CCQQXV^'FN:/9:#X[T0W3:61<N]AK,,+M$TL3%0ZE)% DCP64,""PYH ^AZ
M*\<T7]IGPAI'@;P=JGC_ ,2Z#X2UOQ!H]OJYTV6^'[F.95(Y;!V N$WD %@<
M>E=/<?'CX?6FJ>)=.F\7Z3%?>&[/^T-8@>Y :QM]JMYLGHN&4Y_VA0!WE%>?
MO\?_ (=1^(=)T)O&>C+JVJ^2+*U-VH:=I4$D2KVW.A#*N<D$$#D9RH?VJ_@Y
M=7)MX?BAX3EF$,]P536(#B.'=YK?>Z*$8Y[A21D#- 'JM%?.7Q5_:RTKP=<?
M"?Q)HGB'PQJ/PQ\3ZO/IFK:_+<ADM@MO)(C1RB0(N&B8,'!QC& 37H^H_M%_
M#'2?"6E^)[KQYH*^'M3W_8M22^C>&XV?ZS:RDYV=&_NG@X- 'HU%>=-^T7\+
MQXET_P /#Q_X=DUR_:W6UL(]2B>68W"EX-H#'.]<%?7<O]Y<^&?M._MF^(/@
MM\2M4\+:'H6E7;:3X>M]?*:K-*)]8:6\%O\ 9+)8_P#EHH._<=Q/(V84M0!]
M<45A7NO7L/@N?6K;1[NZU!-/:\CT8E4N))1'O%ODG:')^3K@&OG'3OVM_%GP
MY\;Z]H/QI\+Z3X;CMO"DOC&VN/#E])?>5;12!)+68,BYG#, &3Y&/3KP ?5=
M%?-7CS]K#Q!X!\%>,;K5? <6G^*]%\.#Q7:Z1)J_FP76G;PCEIUB^2>,G#Q!
M2O*[9'!R.?\ B)^VEKWAZ_\ $]UX>\'V>L^'/ 6FZ5J?C&XFOVCN M\BR+'9
M*$VR&.%O-9G*@\* "<T ?6M%5]/O8=2L;>\MW$MO<1K+$ZG(96 ((^H-6* "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "O,OVF=$U?Q1^S[\2-"T+39]7U?5_#M_I
MEI9V[(KR2SP/"G+LJ@ ODDD< XR>*]-HQF@#Y'\2?#/Q]\9O@]\,?AY>>$I_
M"NGZ7_9%UKU]JMS Q!LUC?R(%AD9F+R1@;SM"C)Z\5Y;X-^!/QB;QI#>ZKX!
MFL$E\.>(-#F>+5K(6%I)>/YD)MH(V!6+(Y+;G+.2>!7Z%8HQB@#\Z)_@!\1+
M6\\':GJ_P5N/'&ES> ;'P=>>'D\4KI[65Q:2DJTY294EMI<ABN'(V\J.C6M=
M^ OQ7\&Z'XJ\"Z-\,(]=M;OQSIGC"PUW2-2M8+;[-$]LSV;">590T7D^6A(.
M4.2>/F_0VC&: .'\ :EJ-_XH\9)?^ ?^$2BBO(A;ZL;BWD.MIY8_?$1'<I3&
MS$G.,8[@>)_$']G;Q1XO\":MJNCK'X<^)GA_Q7JWB+PE?+(CB7S)7VPSD-@1
M7,>U77(P"A894@_4F,44 ?!U[\$OB1X#;QQII^'U]X\T?QE\-M*\-VR6>HVB
M'2KVUM&MVMY1+*@6,M(TOF1;@"#A236EXK_8U\8MK'PHMM/N+6_T^_\ "-GX
M'^(UW(^#/96I@F\V/+;F>7R9K?=AB%E7/ ROV^1FC'% 'P.O[._BJW^-?B?2
M]8^$%SXST*[\;Q^)]"\3R^+IK72=-C;RN7T])US) B,BD1DMPO" 5@>'/V=_
M&]P/A:E[\([NTCT_XJZGXAU43R:<1%ITTFZ%W G;< )(QL4$C[.W'"%OT7QB
MESQTH _.K1/V?/']C;^"M0NOA9?R:5X;^*FL^(9- \^PDGETVY#-;21HT_EG
M82H*LX(*@@&JD/[,'CGPSKK^+)?A5J7B+PEXBNM?\[X?:+XF&D76D07L\,D0
M=X9HXW1T@P\"N44R8YVC'Z/T4 ?'/[._P*NO"7QWN+C6O@Y!X=T2V\):18Z=
M>I<P7]G9WMO)--(L3R2-/N'GQ()"HRUNYS@J3SG[97P%^)GQ*^,$NOZ3HFJ:
MY#IFB6[>"+_1;ZWMQH>L+=(\LMRLLJ%E954[@K\*  ",U]TT4 >/_ /XW7WQ
M>^$E]XCD\-7UKK.DW%SIMSIOF1%KN[M@!)Y+AO+*M)E0=V 003P:^;M0\,?%
MSXWCXC6OB7X0:OX=\1>,M#N-.36-2U:R>PT2UA5Y+.RMUCD=Y3+-M,LAV99R
MV L:J/NJRL;;3;6.VM+>*UMX^$AA0(B]^ .!4] 'QA\=O OQ ^.'A_XC^(]*
M\"ZII^I7'P_?PE9Z+J,L$4]W>7%TLDY0^;L$42HN'9OG);:#M&[F/C3^RYK7
MQ,L]"M/"^B>+_"WB[QAH^DZ?XSNCJ<$>D16<*HD@NURYGN$6(HJPD9W@EMI(
M/WMC%&* *NE:;!HVF6MA:QB*UM8D@AC'1$50J@?0 5:HHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ /% .11UH P* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***0T +12"
MEH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
;"BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>exhibit99-2xu001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit99-2xu001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #__@ [0U)%051/4CH@9V0M:G!E9R!V,2XP
M("AU<VEN9R!)2D<@2E!%1R!V.3 I+"!Q=6%L:71Y(#T@.3 *_]L 0P # @(#
M @(# P,#! ,#! 4(!04$! 4*!P<&" P*# P+"@L+#0X2$ T.$0X+"Q 6$!$3
M%!45%0P/%Q@6%!@2%!44_]L 0P$#! 0%! 4)!04)% T+#104%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04_\  $0@
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MFMV]GXC^'W@RR'E6^D:9)<B-?X5D=8H__';=O^^J#S,'^[PM>O\ ]N_^!'Q
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M[MK[T_X)9>$A8?#?Q?XD= KZGJ<=FI_O+;Q[L_\ ?4S_ /?-,[<'_M69\_\
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CFU._U#4#'YMS<2!0SE8U5%X15PJ@?+17:T4CLC3C%61__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>exhibit99-2xu002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit99-2xu002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #__@ [0U)%051/4CH@9V0M:G!E9R!V,2XP
M("AU<VEN9R!)2D<@2E!%1R!V.3 I+"!Q=6%L:71Y(#T@.3 *_]L 0P # @(#
M @(# P,#! ,#! 4(!04$! 4*!P<&" P*# P+"@L+#0X2$ T.$0X+"Q 6$!$3
M%!45%0P/%Q@6%!@2%!44_]L 0P$#! 0%! 4)!04)% T+#104%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04_\  $0@
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M9))E6.QOY9OW;7#*S?+'M_U3<;?N_:%5[:UALHEBAB2&->BQKM6K% !1110
:4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>exhibit99-2xu003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit99-2xu003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #__@ [0U)%051/4CH@9V0M:G!E9R!V,2XP
M("AU<VEN9R!)2D<@2E!%1R!V.3 I+"!Q=6%L:71Y(#T@.3 *_]L 0P # @(#
M @(# P,#! ,#! 4(!04$! 4*!P<&" P*# P+"@L+#0X2$ T.$0X+"Q 6$!$3
M%!45%0P/%Q@6%!@2%!44_]L 0P$#! 0%! 4)!04)% T+#104%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04_\  $0@
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M'[POK/\ ]!FKG?\ @K[_ ,ASX<_]<+G_ -"6JC&/MR.:7U7F/K#]M'Q=XQ\
M?L_:MXH\&ZVNCZAIJQRS.]LLC/&QVMMW?=;YJ^8_@UKG[0?QW_9#O;WPMXCD
MM]6BNKJ0:A/(K7NK2>;_ *F-ONPQJO\ %_$W]U:^E?V[_P#DTGQQ_P!>4?\
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MOB!=3W'F175]:I"T";?N+M^]7IU%',/E"BBBI+"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BFEMO6G4 %%9]SJEGIT]M%<74,$]W
M)Y4$<DBJTS[=VU?[S;5J>TO;>_MDGM9H[B%Q\LD;;E;\: +-%1331P1[I9%C
M7^\S;:;#=0W'^JE23']UMU $]%%% !12;JHV^JV5W>7-I#=0S7-L5$\$<@9X
MMWW=R_PT 7Z*IM>P17D5L\L:W,BLZ0EOF95QN*K_ ,"7\ZN4 %%%% !1110
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6BBBI*"BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>exhibit99-2xu004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit99-2xu004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #__@ [0U)%051/4CH@9V0M:G!E9R!V,2XP
M("AU<VEN9R!)2D<@2E!%1R!V.3 I+"!Q=6%L:71Y(#T@.3 *_]L 0P # @(#
M @(# P,#! ,#! 4(!04$! 4*!P<&" P*# P+"@L+#0X2$ T.$0X+"Q 6$!$3
M%!45%0P/%Q@6%!@2%!44_]L 0P$#! 0%! 4)!04)% T+#104%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04_\  $0@
M20"B P$B  (1 0,1 ?_$ !\   $% 0$! 0$!           ! @,$!08'" D*
M"__$ +40  (! P,"! ,%!00$   !?0$" P $$042(3%!!A-180<B<10R@9&A
M""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U15
M5E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H
MJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V
M]_CY^O_$ !\!  ,! 0$! 0$! 0$        ! @,$!08'" D*"__$ +41  (!
M @0$ P0'!00$  $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P
M%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E
M9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V
MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P#
M 0 "$0,1 #\ _23QMX\MO MJ;N\LKZ>S2WDN+BYMH]T4$<;1JV[YOO?O?E5<
MLVUO[M-B^(EDQ'G030*UY'8QN'CEWR22%5^6-F95X_BVTSQ_X)O_ !F=/BM=
M>?2+6!_,FM_L<=PERVY67<&Z;=O_ (]7/:=\"M.TS4EU"/4)OMPFM7DG$$:M
M,L,[3(LFU?F;=)MW?>VU7ND>\=5<>-XQX@O=&LK"ZU.^L889KE+<1JL*RLPC
M.9'7=_JW^[_=_P!H5)<_$+PW:V[7$VN6,</[CYVF7_EM-Y,7?^*7]VO^U4,_
M@H1>)]2US3;^33KO4K>"WNU2-9%D\EF\MOF^ZVV1E_[Y_NUR#?L^Z7+9:1:M
MJ=TT>CO9?8'(7=%';ZC;WWEM_>W-:0KN_NK1[H>\=H/B%X9?3C?+KEC]C\MI
M?/\ .7;M7=N;_@/EO_WS4VI>-O#^D_\ 'YJ]K;?O/+S)(/O>4TVW_OVK-_NB
MN3U?X):?KKO]NU&Z9&^TJQ@586:.;S-T;,OWE_>?Q?W5JWIWPOF@U'3+^[U^
MXO[RSF6;S/L\<:R%;::W^ZO^S-_X[3]T/>-W3?'_ (;UE<V>MV5TOG+#^[F5
MOWC1^8J_[VT;JCM_B3X6E";-=L&+1K,NV=>59596_P"!+(K?\"KFYO@ZGG:=
M<1:W<0W>GW\.HV\QA5MLB6\ELWR_Q*T<S?[M7K[X6V>I:%J.CM<^5974T,BQ
MP6ZQK;^7#'&JQ[?N?ZM67;]VE[H>\2^,?BG8^#;S38#876H?;K&[U!'MFC55
MBM_*W9\QU^]YR[:UK;QUH5U!%*FIVZ&2-I-DK;67;&LC;A_#M5E9OK7/>-O@
M]8>/&TO^T+ZZ1=/L+FR0+MW,TC0LDV[^]&UNC+_X]5;4/@U_:NG26MQXCOA,
M[R3K<0HL;+-(JK(W^ZVUOE_VVH]T/>-3QI\5-&\)^%M2UF*XAU&6R@GG%I!,
MJO)Y,ODR+_P&1MO^]6KXQ\6V?@RS@O;_ '>5/<QVJ'<J@2/]W<S%55>/O,WM
MWK@;_P#9_P#MNCW>FQ>)[RVM;ZWGM+Q5MXV\Z.29IOXONLKR3_-_TT_V5KNK
M_P +7FKZ1)8:AJ:W<3W#22)+:1O'+"V[]S(C<,OS?^.BCW0]X;<^/M(T[1VO
MM0N8=.DC1?,M+F>-&CE:/S%B9MVW=M_VMM0Z'\3-"UB2[@^VK:W5K<16DL<[
M+S-):K=*JL#M;]TV[Y?[K5RFJ_ 6VU70X]&.NWD6E+:6\"P>4K-YD,;1K)N;
MYONM]W_9IX^!-M:ZG8ZA;ZW=Q7EGJ=OJD+-"C+YT>FMIS;E_B5H7;C^%OFI^
MZ'O'0>,?BKHO@S3K"^N'DNK;4(I+B"2UPZR11Q^:S(W\7R_=7[S?PUEWWQW\
M.:="MQ=QWL%E)<75E;7+0_+<W-O(T<L,:YW>9N23:&5=WEMMK0\8_"ZP\8:?
M86EQ*([2SMVMUM1;JT'S+M5EC_A9?X67[O\ #6)J/[/^D:K8V^GW&HWDEC9W
MMWJ=C$Y5FM[NXD:1IMW\15I)MN[_ )Z&E[H>\=SX9\4VOBFVNWMTEAFM+I[2
MXAF7YHY%^\OR_P ZZ"N?\*>%8?"T-]Y<IN+F]NI+N>9EV[Y&KH*DL**** "B
MBB@#S7XOB[MK#P_=V=W?V\QUS3;23[+=21JT$E[!YFY5;YOE7;G^Z[=F:L74
M?B#KNAWMQ:0VZ#['>74,]O=LTLL5C';R21WSMNW;6D1%_P"VE>B:_P"*[+PQ
M=:-#?B95U2]%C%.L9:..5E9D$C?P[F7:O^TRK7,ZA\9_#^D)KD\L>H/:Z1'<
M3WES#;&2%(X55Y&W+\OW7W8^\=K?W:H@YJ7XC^*[*W^]::E/<6EA>Z3Y5LT:
MZCYW^NA5=S?ZM5W;MW_+5?[OS8OCOXF^+3I'B*TT>^MY))/#>O:A8SZ;9MY\
M$UG-#'#MW,RMN\YOX?\ EG\M>RZ'XMT_7;GQ!!;LZOHE]]@NVE7:/,\B*;Y?
M]G;,OZUSNI?&G0-**^>MYN:RU&_4+$I_=631K/\ Q?>_?)M_O4 <]:_%>_AO
M[M[@PRZ9:7<OG,R[7;3%MUD74=R_P[MR_*OS?P_=KH/'&LR66J^%;B:\N;3P
MU)/(]]=6[,B[O*+0+(Z_,L9;_=W-Y:\AMIT+'XAZ1K6L0:,L-W]HN_/""YM6
MC658PF[AOFV_O%^;;M/S5V=(#Y[UGXD>*O!W@?7+R.ZMWET[3=5UC3XM3@::
MYO+>W96MMW[Q6_>?,O\ >^[6KKOQ$O?!NLZW VLW%\[:O-''%<6\<B6ZK8+<
M1P[EV[59OE_B9O\ >W-7M]%/F#E/"=?\=ZY?^'_[8MKJTO$M_$6E:?\ V7#!
M*K(TE_:*VZ19-WRQR2?+MV_=W+\K;NM^&GC?5O%=S:K>VT8C?2XKF\V+C[!>
MM_K+-O\ =_\ 9:](S1FE<!:***184444 %%%% !1110 4444 %%%% '(^.?!
MY\<Z4=)EOWL+"16\V2VBQ=I)UCD@FW;8I$8;MVUO^ URVI?"G7)3>Q:;XBTR
M*QNKS[7+;:EHK7*NVU=N[;<1[F5E+?W=S?=^6NU\4^,],\'?8/[2DD1KZ22&
MW6--S.T<,DS#\(XI&_X#65I_Q7\.:Q$&L+N2\E9E6.".)A))NA\Y656_A\OY
MMU41[I!IGPVMH[/QG;ZA-//!XDU1KZ=+>XDA:-?(AA54DCVLORVZM\I^\S"N
M*G_9EL+W^R_M/B#4)'L%U'RIO,FEF22ZN;:XCD22:21E:&2UC^]N5MS;E^:N
MXD^+WAT:A#;M+,D,JL3=RQ>7&I6-9&5MWS;MLB?+M_BHN?BQH5MJ,]C-]J%S
M#!<3S1-!CRO)CCF:-O\ IHT<RNJ_Q+N_NM1[PO=(=+^'-[_PEFF^(-;UQ=4U
M"PADBA:"Q6VW"0+N5OF;=&K+N5?O+_$S5Z!MK@+OXT>$[*2>*75$$\.P-&OS
M.&:98=NU?[LC*K5:TSXJZ'K5ZMA:23_V@TRVS0S0,GDSM9K>+')_=;R65J7O
M#]T[7%&*X3PY\4-.U:"&*X\R+4ML!FA6%@J^;(T:,N[^'>I6J6K_ !JT>U\/
MZC?V$5S>3VT>HLL0@;;NLYI+>3>W\*^;'MW4@YCTFBO-I?CAX;L-.66]N@+V
M.Q^VS6=N/,E^6'SI(U7[S,L>6_X#72-XXTM;:^G/FF&UN$M=WE[O/D9595C_
M +WWEH+.EHKBX_B;H+3VRO<R1F6:&V)>%E\F:9ML,,G]UF;^'_=;[K*:J0?&
MCPK-+ J7\CK-)"L<OD-M8S77V2/YO^NW[N@#OZ*** "BBB@ HHHH **** "B
MBB@#D_%O@2Q\9W.DSWT]S'_9LLTD*PLJAC+;RV[;MRG^"9_QKE8_@/I>F/%/
MIFLZQI6J6ZP+;:K;M;O/"L=NMML"R0M&RM&J[MRM\WS?+M7'9>(?%=OX?USP
MUIDEO-/+KEY)9Q-%]V+9;RSEF_V<0[?^!56^(GC:/P%X1UC5_(^V7%C8W-['
M:;]K2K#$TC?^@_\ CPH(]TXF/X)WFI>+=:U+5]1CDTK5+B9[G3(XX9%E7;$L
M)5S")HG7R86;$S*S1[MJ[MJ];:_##1XK@W-WY^I:B=0CU8ZA-)LE:Y6'[.K_
M +O:O^I_=[=NUEW;MVYJQ=<^-%CH6LW6D26DD=W'J1TZ,_-(K8M5N7EVHK-M
M6-ON_P"S6TOQ.T*]T6XO-+U6PUR=(E;[+972,[,R,ZKMSN7<JLWS?PJW]VJ]
MX7NF9+\&-,EM-4T\ZGJ7]D7UY'>IIZ?9UCM95N%N&\IO*\S#2+N8,S?>;;MJ
M^GPPL8O$=]K$5]?VUY=ZQ_;,@C,90S?8([';AHS\OEQJWKN_BQ\M><0_M9Z)
M;:78ZIJD,=C;36-O<R6GF?Z7NDLVN]RQ_P 4>U67=_>KT3PQ\3]'UVV5[O4+
M&ROWEC@6PDF\N7S)(UDCBQ)MWLRM_#PWX57O![I WPFLP6D76M4CN_LEI:)=
MJ8-T?D7#7",J^7MW;F^;*[<?PTZT^$&E6%AJ%E'>7XT^^M[^WDMS(C8^V7$E
MQ/)N92V[=(WWF9?]FL/2OC3J&LVWA^_M/#,LMMK-Q-:06RW2M.9(XY69S_"L
M:M#Y;-_>D6EN/C2=,T37[B^L$FU+2M0CLGMK9F^;<8_F^;E57S,;ONLR_+2]
MX?NFK9_"]?" U&YT.XGU!IK98XM'U&XCCLFF$:Q^9YBPM)&S*GS;?E.YFV;C
MNI\?PDLV\+:9H\6I:AIJ:;:PP6K6%Q\MK)&VY9(_,W?,OW?FW?+\K;J]$X]J
M./:ES2'RG GX4:9-J,5S=7EY>.9K6]OMQBC&HWEOY?DW4WEQK^\7RH_]7M5M
MJJR[551FI\!M#B@M[=-0U18;<VFQ=\?6WU#[=&W^K_YZ_+_N^_S5Z?@>M&!Z
MTN87*AU%%%(L**** "BBB@ HHHH **** ,#7O"=AXBN[&[NQ<"YLO,^SR6]U
M)"R;UVM]QE_AJKXD^'V@^,?#[Z'K=@-2L'M9+,_:I&>7RV78W[S.X,R_Q;MU
M=310!Q[_  U\/MJ,VHBSDCO)+I;TS0SR*R2+"L/R[6^7]VNW:M3'X<>&3H::
M.=%L5T^-=JPK"JA?E9=W^]M9OF_VFKIZ*">5'"CX/>$3I>D::^CQRV&E:>=,
MM;:61F18&C\HJP_B^7*[F^;YFK9T?P9I.C33RQ6QDFF:%FFN7:9LQQ+''AF.
M5VJO;^)F;[S-GH:*JX<J//K7X)>%[.:)K:+4H8HX)+;[,NK7/D-$[LS*T?F;
M65BS&I=3^#/@_6XK^*^T2*[6^6%9I9W=I&6%56-?,W;E5=OW?]IO[S5WE%+G
K8<HU(UBC54&U5&U5J6BBD4%%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>exhibit99-2xu005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit99-2xu005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #__@ [0U)%051/4CH@9V0M:G!E9R!V,2XP
M("AU<VEN9R!)2D<@2E!%1R!V.3 I+"!Q=6%L:71Y(#T@.3 *_]L 0P # @(#
M @(# P,#! ,#! 4(!04$! 4*!P<&" P*# P+"@L+#0X2$ T.$0X+"Q 6$!$3
M%!45%0P/%Q@6%!@2%!44_]L 0P$#! 0%! 4)!04)% T+#104%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04_\  $0@
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9H D\JE$?ONJ2B@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923859142520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DocumentAndEntityInformationAbstract', window );"><strong>Document And Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">FSD Pharma Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001771885<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">40-F<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">19,161,620<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923837964456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jan. 01, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssetsAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash</a></td>
<td class="nump">$ 17,524,822<span></span>
</td>
<td class="nump">$ 5,967,798<span></span>
</td>
<td class="nump">$ 15,899,808<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivables', window );">Other receivables</a></td>
<td class="nump">161,342<span></span>
</td>
<td class="nump">1,557,302<span></span>
</td>
<td class="nump">745,520<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentPrepaidExpenses', window );">Prepaid expenses and deposits</a></td>
<td class="nump">569,401<span></span>
</td>
<td class="nump">323,776<span></span>
</td>
<td class="nump">334,096<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventories</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">709,373<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners', window );">Current assets other than assets held for sale</a></td>
<td class="nump">18,255,565<span></span>
</td>
<td class="nump">8,558,249<span></span>
</td>
<td class="nump">16,979,424<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners', window );">Assets held for sale</a></td>
<td class="nump">8,610,504<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Total current assets</a></td>
<td class="nump">26,866,069<span></span>
</td>
<td class="nump">8,558,249<span></span>
</td>
<td class="nump">16,979,424<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Investments</a></td>
<td class="nump">1,676,745<span></span>
</td>
<td class="nump">8,862,744<span></span>
</td>
<td class="nump">13,589,954<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use asset, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">95,851<span></span>
</td>
<td class="nump">183,424<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,880,258<span></span>
</td>
<td class="nump">9,134,183<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">13,424,391<span></span>
</td>
<td class="nump">16,820,625<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="nump">41,967,205<span></span>
</td>
<td class="nump">43,217,727<span></span>
</td>
<td class="nump">39,886,985<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilitiesAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayables', window );">Trade and other payables</a></td>
<td class="nump">3,700,103<span></span>
</td>
<td class="nump">3,361,145<span></span>
</td>
<td class="nump">1,311,865<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Lease obligations</a></td>
<td class="nump">46,842<span></span>
</td>
<td class="nump">42,285<span></span>
</td>
<td class="nump">40,875<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentDerivativeFinancialLiabilities', window );">Derivative liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,990,788<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_CurrentWarrantsLiability', window );">Warrants liability</a></td>
<td class="nump">1,447,910<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued', window );">Notes payable</a></td>
<td class="nump">384,647<span></span>
</td>
<td class="nump">1,435,698<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Total current liabilities</a></td>
<td class="nump">5,579,502<span></span>
</td>
<td class="nump">6,829,916<span></span>
</td>
<td class="nump">1,352,740<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilitiesAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Lease obligations</a></td>
<td class="nump">79,120<span></span>
</td>
<td class="nump">110,334<span></span>
</td>
<td class="nump">142,549<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">Total liabilities</a></td>
<td class="nump">5,658,622<span></span>
</td>
<td class="nump">6,940,250<span></span>
</td>
<td class="nump">1,495,289<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>SHAREHOLDERS EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital</a></td>
<td class="nump">103,208,126<span></span>
</td>
<td class="nump">73,737,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_Warrants', window );">Warrant reserve</a></td>
<td class="nump">4,968,958<span></span>
</td>
<td class="nump">4,321,989<span></span>
</td>
<td class="nump">3,341,826<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SharePremium', window );">Contributed surplus</a></td>
<td class="nump">18,792,590<span></span>
</td>
<td class="nump">17,371,434<span></span>
</td>
<td class="nump">3,744,423<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReserveOfExchangeDifferencesOnTranslation', window );">Foreign exchange translation reserve</a></td>
<td class="nump">207,797<span></span>
</td>
<td class="num">(84,776)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RetainedEarnings', window );">Accumulated deficit</a></td>
<td class="num">(90,868,888)<span></span>
</td>
<td class="num">(59,069,095)<span></span>
</td>
<td class="num">(19,939,575)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total equity</a></td>
<td class="nump">36,308,583<span></span>
</td>
<td class="nump">36,277,477<span></span>
</td>
<td class="nump">38,391,696<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Equity and liabilities</a></td>
<td class="nump">41,967,205<span></span>
</td>
<td class="nump">43,217,727<span></span>
</td>
<td class="nump">39,886,985<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassACommonStockSharesMember', window );">Class A shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>SHAREHOLDERS EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital</a></td>
<td class="nump">151,588<span></span>
</td>
<td class="nump">151,588<span></span>
</td>
<td class="nump">151,588<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total equity</a></td>
<td class="nump">151,588<span></span>
</td>
<td class="nump">151,588<span></span>
</td>
<td class="nump">151,588<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember', window );">Class B shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>SHAREHOLDERS EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital</a></td>
<td class="nump">103,056,538<span></span>
</td>
<td class="nump">73,586,337<span></span>
</td>
<td class="nump">51,093,434<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total equity</a></td>
<td class="nump">$ 103,056,538<span></span>
</td>
<td class="nump">$ 73,586,337<span></span>
</td>
<td class="nump">$ 51,093,434<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_CurrentWarrantsLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of warrants liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_CurrentWarrantsLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_Warrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount related to warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_Warrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2020-01-01: The amount of resources: (a) controlled by the entity as a result of past events; and (b) from which future economic benefits are expected to flow to the entity.
Effective 2020-01-01: The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current assets other than non-current assets or disposal groups classified as held for sale or as held for distribution to owners. [Refer: Current assets; Disposal groups classified as held for sale [member]; Non-current assets or disposal groups classified as held for sale; Non-current assets or disposal groups classified as held for distribution to owners]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentDerivativeFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current derivative financial liabilities. [Refer: Derivative financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentDerivativeFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have an unconditional right to defer settlement for at least twelve months after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 69<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current notes and debentures issued and the current portion of non-current notes and debentures issued. [Refer: Notes and debentures issued]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Inventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 36<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_36_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_g&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 68<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Inventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2020-01-01: The amount of present obligations of the entity arising from past events, the settlement of which is expected to result in an outflow from the entity of resources embodying economic benefits.
Effective 2020-01-01: The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current assets or disposal groups classified as held for sale or as held for distribution to owners. [Refer: Non-current assets or disposal groups classified as held for distribution to owners; Non-current assets or disposal groups classified as held for sale]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph j<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_j&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current investments other than investments accounted for using the equity method. [Refer: Investments accounted for using equity method; Non-current assets; Investments other than investments accounted for using equity method]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReserveOfExchangeDifferencesOnTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing exchange differences on translation of financial statements of foreign operations recognised in other comprehensive income and accumulated in equity. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2019-01-01<br> -Paragraph 52<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_52_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReserveOfExchangeDifferencesOnTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing the entity's cumulative undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph IG6<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SharePremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount received or receivable from the issuance of the entity's shares in excess of nominal value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SharePremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph k<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_k&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_h&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassACommonStockSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=huge_ClassACommonStockSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923838067368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF LOSS AND COMPREHENSIVE LOSS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseByNatureAbstract', window );"><strong>Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">$ 10,058,083<span></span>
</td>
<td class="nump">$ 8,407,427<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">External research and development fees</a></td>
<td class="nump">7,832,847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Share-based payments</a></td>
<td class="nump">8,052,011<span></span>
</td>
<td class="nump">12,082,930<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAndAmortisationExpense', window );">Depreciation and amortization</a></td>
<td class="nump">3,900,458<span></span>
</td>
<td class="nump">1,943,048<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_LegalProvision', window );">Legal provision</a></td>
<td class="nump">757,829<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ImpairmentLossOnRightOfUseAsset', window );">Impairment of right-of-use asset</a></td>
<td class="nump">89,860<span></span>
</td>
<td class="nump">50,888<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseByNature', window );">Total operating expenses</a></td>
<td class="nump">30,691,088<span></span>
</td>
<td class="nump">22,484,293<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Loss from continuing operations</a></td>
<td class="num">(30,691,088)<span></span>
</td>
<td class="num">(22,484,293)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherIncome', window );">Other income</a></td>
<td class="num">(3,691)<span></span>
</td>
<td class="num">(40,454)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceCosts', window );">Finance expense</a></td>
<td class="nump">235,581<span></span>
</td>
<td class="nump">155,316<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_GainLossOnSettlementOfFinancialLiability', window );">Loss (gain) on settlement of financial liability</a></td>
<td class="num">(680,164)<span></span>
</td>
<td class="nump">18,665<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives', window );">Loss (gain) on change in fair value of warrants and derivative liability</a></td>
<td class="num">(2,561,456)<span></span>
</td>
<td class="nump">2,684,436<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_LossGainOnChangesInFairValueOfOtherInvestments', window );">Loss on changes in fair value of investments</a></td>
<td class="nump">770,874<span></span>
</td>
<td class="nump">8,778,707<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromContinuingOperations', window );">Net loss from continuing operations</a></td>
<td class="num">(28,452,232)<span></span>
</td>
<td class="num">(34,080,963)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromDiscontinuedOperations', window );">Net loss from discontinued operations</a></td>
<td class="num">(3,347,561)<span></span>
</td>
<td class="num">(5,048,557)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net loss for the period</a></td>
<td class="num">(31,799,793)<span></span>
</td>
<td class="num">(39,129,520)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract', window );"><strong>Items that may be subsequently reclassified to income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation', window );">Exchange gain (loss) on translation of foreign operations</a></td>
<td class="nump">292,573<span></span>
</td>
<td class="num">(84,776)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Comprehensive loss</a></td>
<td class="num">$ (31,507,220)<span></span>
</td>
<td class="num">$ (39,214,296)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BasicAndDilutedEarningsLossPerShareFromContinuingOperations', window );">Basic and diluted - continuing operations (in dollars per share)</a></td>
<td class="num">$ (2.36)<span></span>
</td>
<td class="num">$ (4.83)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BasicAndDilutedEarningsLossPerShareFromDiscontinuedOperations', window );">Basic and diluted - discontinued operations (in dollars per share)</a></td>
<td class="num">$ (0.28)<span></span>
</td>
<td class="num">$ (0.72)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustedWeightedAverageShares', window );">Weighted average number of shares outstanding - basic and diluted</a></td>
<td class="nump">12,043,961<span></span>
</td>
<td class="nump">7,056,245<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_GainLossOnSettlementOfFinancialLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of gain loss on settlement of financial liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_GainLossOnSettlementOfFinancialLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ImpairmentLossOnRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount related to impairment Loss of right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ImpairmentLossOnRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_LegalProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of legal provision.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_LegalProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_LossGainOnChangesInFairValueOfOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of Loss (gain) on changes in fair value of other investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_LossGainOnChangesInFairValueOfOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustedWeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2019-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustedWeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicAndDilutedEarningsLossPerShareFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Basic and diluted earnings (loss) per share from continuing operations. [Refer: Basic and diluted earnings (loss) per share]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicAndDilutedEarningsLossPerShareFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicAndDilutedEarningsLossPerShareFromDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Basic and diluted earnings (loss) per share from discontinued operations. [Refer: Basic and diluted earnings (loss) per share]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicAndDilutedEarningsLossPerShareFromDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationAndAmortisationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation and amortisation expense. Depreciation and amortisation are the systematic allocations of depreciable amounts of assets over their useful lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B13<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B13_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 104<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_104&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationAndAmortisationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseByNature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expenses aggregated according to their nature (for example, depreciation, purchases of materials, transport costs, employee benefits and advertising costs), and not reallocated among functions within the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseByNature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseByNatureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseByNatureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense from share-based payment transactions with employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of costs associated with financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 82<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_82_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) resulting from change in the fair value of derivatives recognised in profit or loss. [Refer: Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, related to exchange differences when financial statements of foreign operations are translated. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of operating income that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2019-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_35_b_iv&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2019-01-01<br> -Paragraph 39L<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2019-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2021-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2019-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing operations. [Refer: Continuing operations [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_vi&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from discontinued operations. [Refer: Discontinued operations [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_vii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 82<br> -Subparagraph ea<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_82_ea&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 98<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_98_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2019-01-01<br> -Paragraph IE33<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_IE33&amp;doctype=Illustrative%20Examples<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expenditure directly attributable to research or development activities, recognised in profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 126<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_126&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923859190008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDER'S EQUITY - USD ($)<br></strong></div></th>
<th class="th"><div>Class A shares</div></th>
<th class="th"><div>Class B shares</div></th>
<th class="th"><div>Warrants</div></th>
<th class="th"><div>Contributed surplus</div></th>
<th class="th"><div>exchange translation</div></th>
<th class="th"><div>Accumulated deficit</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Beginning balance at Jan. 01, 2019</a></td>
<td class="nump">$ 151,588<span></span>
</td>
<td class="nump">$ 51,093,434<span></span>
</td>
<td class="nump">$ 3,341,826<span></span>
</td>
<td class="nump">$ 3,744,423<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (19,939,575)<span></span>
</td>
<td class="nump">$ 38,391,696<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Beginning balance (shares) at Jan. 01, 2019</a></td>
<td class="nump">72<span></span>
</td>
<td class="nump">6,843,780<span></span>
</td>
<td class="nump">546,212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,681,103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,681,103<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IssuanceOfShares', window );">Shares issued (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">408,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset', window );">Issued on acquisition of net assets of Prismic Pharmaceuticals, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,361,657<span></span>
</td>
<td class="nump">$ 1,420,407<span></span>
</td>
<td class="nump">1,931,384<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,713,448<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares', window );">Issued on acquisition of net assets of Prismic Pharmaceuticals, Inc. (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">510,940<span></span>
</td>
<td class="nump">67,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Share options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,082,930<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,082,930<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share based payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,340,929<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(789,794)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">551,135<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares', window );">Share-based payments (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130,189<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity', window );">Warrants exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 109,214<span></span>
</td>
<td class="num">$ (37,753)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,461<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares', window );">Warrants exercised (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,167<span></span>
</td>
<td class="num">(12,167)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue', window );">Warrants expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (402,491)<span></span>
</td>
<td class="nump">402,491<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares', window );">Warrants expired (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(134,192)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Comprehensive loss for the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (84,776)<span></span>
</td>
<td class="num">(39,129,520)<span></span>
</td>
<td class="num">(39,214,296)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Ending balance at Dec. 31, 2019</a></td>
<td class="nump">$ 151,588<span></span>
</td>
<td class="nump">$ 73,586,337<span></span>
</td>
<td class="nump">$ 4,321,989<span></span>
</td>
<td class="nump">17,371,434<span></span>
</td>
<td class="num">(84,776)<span></span>
</td>
<td class="num">(59,069,095)<span></span>
</td>
<td class="nump">36,277,477<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Ending balance (shares) at Dec. 31, 2019</a></td>
<td class="nump">72<span></span>
</td>
<td class="nump">7,905,727<span></span>
</td>
<td class="nump">467,451<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,242,975<span></span>
</td>
<td class="nump">$ 1,110,904<span></span>
</td>
<td class="num">(1,302,076)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,051,803<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IssuanceOfShares', window );">Shares issued (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,925,942<span></span>
</td>
<td class="nump">6,335,758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Share options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 563,747<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(504,185)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,562<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughExerciseOfOptionShares', window );">Share options exercised (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share based payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,663,479<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,763,482<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,426,961<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares', window );">Share-based payments (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,307,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue', window );">Warrants expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (463,935)<span></span>
</td>
<td class="nump">463,935<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares', window );">Warrants expired (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(54,100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Comprehensive loss for the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">292,573<span></span>
</td>
<td class="num">(31,799,793)<span></span>
</td>
<td class="num">(31,507,220)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Ending balance at Dec. 31, 2020</a></td>
<td class="nump">$ 151,588<span></span>
</td>
<td class="nump">$ 103,056,538<span></span>
</td>
<td class="nump">$ 4,968,958<span></span>
</td>
<td class="nump">$ 18,792,590<span></span>
</td>
<td class="nump">$ 207,797<span></span>
</td>
<td class="num">$ (90,868,888)<span></span>
</td>
<td class="nump">$ 36,308,583<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Ending balance (shares) at Dec. 31, 2020</a></td>
<td class="nump">72<span></span>
</td>
<td class="nump">19,161,620<span></span>
</td>
<td class="nump">6,749,109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IncreaseDecreaseThroughExerciseOfOptionShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from exercise of option.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IncreaseDecreaseThroughExerciseOfOptionShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity shares resulting from warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IncreaseDecreaseThroughExerciseOfWarrantsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity shares resulting from warrants expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IncreaseDecreaseThroughExpiryOfWarrantsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from warrants expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IncreaseDecreaseThroughExpiryOfWarrantsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents Increase Decrease Through issued on acquisition of net assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents Increase Decrease Through issued on acquisition of net assets shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IncreaseDecreaseThroughIssuedOnAcquisitionOfNetAssetsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents increase decrease through share based payment transactions shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IssuanceOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IssuanceOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from the exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from the exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssueOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase in equity through the issue of equity instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssueOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_79_a_iv&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923837750072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromContinuingOperations', window );">Net loss from continuing operations</a></td>
<td class="num">$ (28,452,232)<span></span>
</td>
<td class="num">$ (34,080,963)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForReconcileProfitLossAbstract', window );"><strong>Add (deduct) items not affecting cash</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense', window );">Depreciation and amortization</a></td>
<td class="nump">3,900,458<span></span>
</td>
<td class="nump">1,943,048<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss', window );">Impairment of right-of-use asset</a></td>
<td class="nump">89,860<span></span>
</td>
<td class="nump">183,161<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForInterestExpense', window );">Interest expense</a></td>
<td class="nump">7,860<span></span>
</td>
<td class="nump">155,315<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Share-based payments</a></td>
<td class="nump">8,052,011<span></span>
</td>
<td class="nump">12,082,930<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForFairValueGainsLosses', window );">Change in fair value of investments</a></td>
<td class="nump">770,874<span></span>
</td>
<td class="nump">8,778,707<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives', window );">Change in fair value of derivative liability</a></td>
<td class="num">(2,561,456)<span></span>
</td>
<td class="nump">2,684,436<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains', window );">Unrealized foreign exchange loss (gain)</a></td>
<td class="num">(327,161)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_GainOnSettlementOfFinancialLiability', window );">Loss (gain) on settlement of financial liability</a></td>
<td class="num">(680,164)<span></span>
</td>
<td class="nump">18,665<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ChangesInNonCashWorkingCapitalItemsAbstract', window );"><strong>Changes in non-cash working capital balances</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables', window );">Other receivables</a></td>
<td class="nump">435,183<span></span>
</td>
<td class="num">(387,837)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit', window );">Prepaid expenses and deposits</a></td>
<td class="num">(526,738)<span></span>
</td>
<td class="num">(24,214)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables', window );">Other payables</a></td>
<td class="nump">898,691<span></span>
</td>
<td class="nump">1,516,025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations', window );">Cash used in continuing operating activities</a></td>
<td class="num">(18,392,814)<span></span>
</td>
<td class="num">(7,130,727)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations', window );">Cash used in discontinued operating activities</a></td>
<td class="num">(737,659)<span></span>
</td>
<td class="num">(6,581,998)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivities', window );">Cash used in operating activities</a></td>
<td class="num">(19,130,473)<span></span>
</td>
<td class="num">(13,712,725)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_CashAcquiredOnAcquisition', window );">Cash acquired from acquisition of Prismic Pharmaceuticals Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,752<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Proceeds from sale of investments</a></td>
<td class="nump">6,477,510<span></span>
</td>
<td class="nump">462,303<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities', window );">Additions to intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(293,126)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations', window );">Cash provided by continuing investing activities</a></td>
<td class="nump">6,477,510<span></span>
</td>
<td class="nump">170,929<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations', window );">Cash provided by (used in) discontinued investing activities</a></td>
<td class="nump">36,616<span></span>
</td>
<td class="num">(401,817)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivities', window );">Cash provided by (used in) investing activities</a></td>
<td class="nump">6,514,126<span></span>
</td>
<td class="num">(230,888)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities', window );">Repayment of lease obligation</a></td>
<td class="num">(39,993)<span></span>
</td>
<td class="num">(42,285)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Proceeds from issuance of shares, net of issuance costs</a></td>
<td class="nump">25,100,459<span></span>
</td>
<td class="nump">3,431,294<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RepaymentsOfBondsNotesAndDebentures', window );">Repayment of notes payable</a></td>
<td class="num">(946,643)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromExerciseOfOptions', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">59,548<span></span>
</td>
<td class="nump">551,133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ProceedsFromExerciseOfWarrants', window );">Proceeds from exercise of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,461<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations', window );">Cash provided by continuing financing activities</a></td>
<td class="nump">24,173,371<span></span>
</td>
<td class="nump">4,011,603<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations', window );">Cash provided by discontinued financing activities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivities', window );">Cash provided by financing activities</a></td>
<td class="nump">24,173,371<span></span>
</td>
<td class="nump">4,011,603<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents', window );">Net increase (decrease)</a></td>
<td class="nump">11,557,024<span></span>
</td>
<td class="num">(9,932,010)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash, beginning of the year</a></td>
<td class="nump">5,967,798<span></span>
</td>
<td class="nump">15,899,808<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash, end of the year</a></td>
<td class="nump">$ 17,524,822<span></span>
</td>
<td class="nump">$ 5,967,798<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in prepaid and deposits to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other assets; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_AdjustmentsForDecreaseIncreaseInPrepaidExpensesAndDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_CashAcquiredOnAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount related to cash inflow during acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_CashAcquiredOnAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ChangesInNonCashWorkingCapitalItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ChangesInNonCashWorkingCapitalItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_GainOnSettlementOfFinancialLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of gain on settlement of financial liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_GainOnSettlementOfFinancialLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ProceedsFromExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents proceeds from exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ProceedsFromExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in trade and other receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other receivables; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for depreciation and amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Depreciation and amortisation expense; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForFairValueGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for fair value losses (gains) to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForFairValueGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for gains (losses) on changes in the fair value of derivatives to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: At fair value [member]; Derivatives [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Impairment loss (reversal of impairment loss) recognised in profit or loss]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in trade and other payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other payables; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for interest expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Interest expense; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForReconcileProfitLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForReconcileProfitLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForSharebasedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForSharebasedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for unrealised foreign exchange losses (gains) to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) the entity's financing activities, related to continuing operations. [Refer: Continuing operations [member]; Cash flows from (used in) financing activities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) the entity's financing activities, related to discontinued operations. [Refer: Discontinued operations [member]; Cash flows from (used in) financing activities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) the entity's investing activities, related to continuing operations. [Refer: Continuing operations [member]; Cash flows from (used in) investing activities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) the entity's investing activities, related to discontinued operations. [Refer: Discontinued operations [member]; Cash flows from (used in) investing activities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) the entity's operating activities, related to continuing operations. [Refer: Continuing operations [member]; Cash flows from (used in) operating activities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) the entity's operating activities, related to discontinued operations. [Refer: Discontinued operations [member]; Cash flows from (used in) operating activities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cash and cash equivalents. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssuingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuing shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssuingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of investments other than investments accounted for using the equity method. [Refer: Investments accounted for using equity method; Investments other than investments accounted for using equity method]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing operations. [Refer: Continuing operations [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_vi&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RepaymentsOfBondsNotesAndDebentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for repayments of bonds, notes and debentures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RepaymentsOfBondsNotesAndDebentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923859011736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of business<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfNatureOfBusinessAbstract', window );"><strong>Disclosure of Nature of business [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfNatureOfBusinessExplanatoryTextBlock', window );">Nature of business</a></td>
<td class="text">
    <div>
      <div>
        <div>
          <div>
            <div>
              <p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>1.&#160; &#160; &#160; &#160;</strong><strong>Nature of business </strong></span></span></span></span></p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>FSD FSD Pharma Inc. (&#x201c;FSD&#x201d; or the &#x201c;Company&#x201d;), through its wholly owned subsidiary, FSD Biosciences Inc., is focused on Pharmaceutical research and development ("R&amp;D") of its lead compound, FSD 201, ultra-micronized Palmitoyl ethylamine (&#x201c;PEA&#x201d;). FSD 201 is known to stabilize mast cells of the human body and down-regulate the pro-inflammatory cytokines to effectuate an anti-inflammatory response.</span></span></span></span></p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>FV Pharma Inc. ("FV Pharma"), a wholly owned subsidiary of the Company, was a licensed producer of cannabis in Canada under the Cannabis Act (Canada) (together with the regulations promulgated thereunder (the "Cannabis Regulations"), the "Cannabis Act") and associated Cannabis Regulations. FV Pharma surrendered its cannabis license in September 2020. In March 2020, substantially all the assets of FV Pharma were classified as held for sale (refer to Note 5).</span></span></span></span></p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company's registered office is located at 1 Rossland Road West, Suite 202, Ajax, Ontario, L1Z 1Z2.</span></span></span></span></p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>On October 16, 2019, the Company completed a reverse share split of 201 to 1 Class B Shares. All share and per share amounts for all periods presented in these financial statements have been adjusted retrospectively to reflect the reverse share split.</span></span></span></span></p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Subsidiaries</strong></span></span></span></span></p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>These consolidated financial statements are comprised of the financial results of the Company and its subsidiaries, which are the entities over which FSD has control. An investor controls an investee when it is exposed, or has rights, to variable returns from its involvement with the investee and can affect those returns through its power over the investee.</span></span></span></span></p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company has the following subsidiaries:</span></span></span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-align:left">&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160;&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;</span></span></span></p>
              <div>
                <div>

                    <table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000">
                      <tbody>
                        <tr>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom">&#160;</td>
                          <td colspan="7" style="vertical-align:bottom;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Ownership percentage as at</strong></span></span></td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Entity Name</strong></span></span></td>
                          <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Country</strong></span></span></td>
                          <td style="text-align:right;vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>December&#160; 31, 2020</strong></span></span></td>
                          <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>December&#160; 31, 2019</strong></span></span></td>
                          <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>January 1, 2019</strong></span></span></td>
                          <td style="text-align:right;vertical-align:bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td style="border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>%</strong></span></span></td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>%</strong></span></span></td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>%</strong></span></span></td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(204, 238, 255)">
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">FSD Biosciences Inc.</span></span></td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">USA</span></span></td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100</span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(255, 255, 255)">
                          <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Prismic Pharmaceuticals Inc.</span></span></td>
                          <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">USA</span></span></td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100</span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100</span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100</span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(204, 238, 255)">
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">FV Pharma Inc.</span></span></td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Canada</span></span></td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100</span></span></td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100</span></span></td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100</span></span></td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                        </tr>
                      </tbody>
                    </table>

                </div>
              </div>
            </div>
          </div>
        </div>
      </div>
      <p><br/><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Impact of COVID-19</strong></span></span></span></span></p>
      <div>
        <div>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The outbreak of the novel strain of coronavirus, specifically identified as "COVID-19," has resulted in governments worldwide enacting emergency measures to combat the spread of the virus. These measures, which include the implementation of travel bans, self-imposed quarantine periods and social distancing, have caused material disruption to businesses globally resulting in an economic slowdown. Governments and central banks have reacted with significant monetary and fiscal interventions designed to stabilize economic conditions. The extent to which COVID-19 and any other pandemic or public health crisis impacts the Company's business, affairs, operations, financial condition, liquidity, availability of credit and results of operations will depend on future developments that are highly uncertain and cannot be predicted with any meaningful precision, including new information which may emerge concerning the severity of the COVID-19 virus and the actions required to contain the COVID-19 virus or remedy its impact, among others. The duration and impact of the COVID-19 outbreak is unknown at this time, as is the efficacy of the government and central bank interventions. It is not possible to reliably estimate the length and severity of these developments and the impact on the financial results and condition of the Company and its operating subsidiaries in future periods.</span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In order to mitigate the impact of COVID-19, the Company implemented a systematic and orderly scale back of FV Pharma's cultivation operations and a furlough policy for its workforce, except for certain personnel working staggered shifts to ensure continuity of operations and licensure effective March 23, 2020. In September 2020, FV Pharma surrendered its licenses and ceased all other operational activities. The Company&#x2019;s clinical trials for the use of FSD-201, its lead compound, to treat suspected or confirmed cases of COVID-19 continued to proceed throughout the year and as a result the impact of COVID-19 did not have a material impact on the continuing operations or financial results of the Company for the year ended December 31, 2020.</span></span></p>
        </div>
      </div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfNatureOfBusinessAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents Nature of business abstract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfNatureOfBusinessAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfNatureOfBusinessExplanatoryTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents nature of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfNatureOfBusinessExplanatoryTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923861623992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of presentation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_BasisOfPresentationAbstract', window );"><strong>Basis Of Presentation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory', window );">Basis of presentation</a></td>
<td class="text">
    <div>
      <p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2.</strong><span style="width:10.49pt;text-indent:0pt;display:inline-block">&#160;</span><strong>Basis of presentation </strong></span></span></p>
      <div>
        <div>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>[a] Statement of compliance </strong></span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These financial statements have been prepared by management in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board ("IASB"). The policies set out below have been consistently applied to all periods presented, unless otherwise noted.</span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These financial statements were approved and authorized for issuance by the Board of Directors of the Company on March 15, 2021.</span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>[b] Basis of measurement</strong></span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These financial statements have been prepared on a historical cost basis, except for certain financial instruments which are measured at fair value. Historical costs are generally based upon the fair value of the consideration given in exchange for goods and services received.</span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, regardless of whether that price is directly observable or estimated using another valuation technique. In estimating the fair value of an asset or a liability, the Company takes into account the characteristics of the asset or liability if market participants would take those characteristics into account when pricing the asset or liability at the measurement date. Fair value for measurement and/or disclosure purposes in these financial statements is determined on such a basis, except for share-based payment transactions that are within the scope of IFRS 2 <i>Share-based Payment</i> ("IFRS 2") and measurements that have some similarities to fair value, but are not fair value, such as value in use in IAS 36 <i>Impairment of Assets</i>.</span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>[c] Basis of presentation</strong></span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accompanying financial statements include the accounts of FSD and its subsidiaries, FV Pharma, FSD Biosciences and Prismic. The financial statements incorporate the assets and liabilities of the Company and its subsidiaries as at December 31, 2020 and 2019 and January 1, 2019 and the results of these subsidiaries for the years ended December 31, 2020 and 2019.</span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsidiaries are all those entities over which the Company has control. The Company controls an entity when it is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power over the entity. Subsidiaries are fully consolidated from the date on which control is transferred to the Company. All intra-entity assets and liabilities, revenue, expenses and cash flows relating to transactions between subsidiaries of the Company are eliminated in full on consolidation.</span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>[d] Functional currency and presentation currency </strong></span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The financial statements of each company within the consolidated group are measured using their functional currency which is the currency of the primary economic environment in which an entity operates. The Company changed its functional currency from the Canadian dollar (C$) to the United States dollar (US$) as of October 1, 2020. The change in functional currency was the result of a review of the primary economic environment in which the entity operates and the currency that mainly influences the underlying transactions entered into by the Company. The Company's functional currency is the United States dollar and the functional currencies of its subsidiaries are as follows:</span></span></p>
          <p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="width:31.5pt;display:inline-block">&#160;</span>FSD Biosciences <span style="display:inline-block;width:77.98pt">&#160;</span>United States Dollars</span></span></p>
          <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="width:31.5pt;display:inline-block">&#160;</span>Prismic<span style="display:inline-block;width:119pt">&#160;</span>United States Dollars</span></span></p>
          <p style="margin-top:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="width:31.5pt;display:inline-block">&#160;</span>FV Pharma<span style="display:inline-block;width:103.49pt">&#160;</span>Canadian Dollars</span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has elected to change its presentation currency from the Canadian dollar to the United States dollar effective October 1, 2020. The change in presentation currency is a voluntary change which is accounted for retrospectively. The change in presentation currency was made to better reflect the Company's business activities.&#160; For comparative reporting purposes, historical financial information has been translated to United States dollars using the exchange rate as at October 1, 2020, which is the date of the change in the functional and presentation currency.</span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following shows the restatement of prior period information:</span></span></p>

            <table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000">
              <tbody>
                <tr>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>December 31, 2018 </strong><br/><strong>as reported,</strong></span></span></td>
                  <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Foreign currency </strong><br/><strong>translation</strong></span></span></td>
                  <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>December 31, 2018 </strong><br/><strong>restated,</strong></span></span></td>
                  <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Adoption of<br/>IFRS 16</strong></span></span></td>
                  <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>January 1,<br/>2019</strong></span></span></td>
                  <td style="text-align:right;vertical-align:bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">C$</span></span></td>
                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$</span></span></td>
                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$</span></span></td>
                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$</span></span></td>
                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>ASSETS</strong></span></span></td>
                  <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Current assets</strong></span></span></td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash&#160;</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">21,134,930</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5,235,122</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,899,808</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,899,808</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade and other receivables&#160;</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">990,988</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(245,468</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">745,520</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">745,520</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Prepaid expenses and deposits</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">444,099</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(110,003</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">334,096</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">334,096</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22,570,017</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5,590,593</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16,979,424</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16,979,424</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Non-current assets</strong></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other investments&#160;</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18,064,541</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4,474,587</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,589,954</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,589,954</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Right-of-use asset, net&#160;</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">183,424</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">183,424</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property, plant and equipment, net&#160;</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,141,676</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,007,493</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,134,183</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,134,183</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">52,776,234</span></span></td>
                  <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(13,072,673</span></span></td>
                  <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">39,703,561</span></span></td>
                  <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">183,424</span></span></td>
                  <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">39,886,985</span></span></td>
                  <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>LIABILITIES</strong></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Current liabilities</strong></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade and other payables</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,743,806</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(431,941</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,311,865</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,311,865</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease obligations&#160;</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">40,875</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">40,875</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,743,806</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(431,941</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,311,865</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">40,875</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,352,740</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Non-current liabilities</strong></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease obligations&#160;</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">142,549</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">142,549</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,743,806</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(431,941</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,311,865</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">183,424</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,495,289</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>SHAREHOLDER'S EQUITY</strong></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Class A share capital&#160;</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">201,500</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(49,912</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">151,588</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">151,588</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Class B share capital&#160;</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">67,916,302</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(16,822,868</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">51,093,434</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">51,093,434</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Warrant reserve</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,442,145</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,100,319</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,341,826</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,341,826</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contributed surplus&#160;</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,977,300</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,232,877</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,744,423</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,744,423</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accumulated deficit</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(26,504,819</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,565,244</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(19,939,575</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(19,939,575</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">51,032,428</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,640,732</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">38,391,696</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">38,391,696</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff;border-bottom:1px solid #000000">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">52,776,234</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff;border-bottom:1px solid #000000">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff;border-bottom:1px solid #000000">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(13,072,673</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff;border-bottom:1px solid #000000">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">39,703,561</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff;border-bottom:1px solid #000000">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff;border-bottom:1px solid #000000">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">183,424</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff;border-bottom:1px solid #000000">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff;border-bottom:1px solid #000000">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">39,886,985</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff;border-bottom:1px solid #000000">&#160;</td>
                </tr>
              </tbody>
            </table>

          <p style="text-align:justify"><br/><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>[e] Use of estimates and judgments</strong></span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The preparation of these financial statements in conformity with IFRS requires management to make estimates, judgments and assumptions that affect the application of accounting policies and the reported amounts of assets and liabilities as at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates.</span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Estimates are based on management's best knowledge of current events and actions that the Company may undertake in the future. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.</span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following are the critical judgments, apart from those involving estimations, that management has made in the process of applying the Company's accounting policies and that have the most significant effect on the amounts recognized in the financial statements:</span></span></p>
          <p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[i]<span style="width:11pt;text-indent:0pt;display:inline-block">&#160;</span>Going concern</span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At each reporting period, management assesses the basis of preparation of the financial statements. These financial statements have been prepared on a going concern basis in accordance with IFRS. The going concern basis of presentation assumes that the Company will continue its operations for the foreseeable future and be able to realize its assets and discharge its liabilities and commitments in the normal course of business.</span></span></p>
          <p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[ii]<span style="width:9pt;text-indent:0pt;display:inline-block">&#160;</span>Estimated useful lives, residual values and depreciation of property, plant and equipment</span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation of property, plant and equipment is dependent upon estimates of useful lives and residual values, which are determined through the exercise of judgment. The assessment of any impairment of these assets' is dependent upon estimates of recoverable amounts that take into account factors such as economic and market conditions and the useful lives of assets.</span></span></p>
          <p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[iii]<span style="width:7pt;text-indent:0pt;display:inline-block">&#160;</span>Estimated useful life and amortization of intangible assets</span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company employs significant estimates to determine the estimated useful lives of intangible assets, considering the nature of the asset, contractual rights, expected use and review of asset useful lives. The Company reviews amortization methods and useful lives annually or when circumstances change and adjusts its amortization methods and assumptions prospectively.</span></span></p>
          <p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[iv]<span style="width:6.5pt;text-indent:0pt;display:inline-block">&#160;</span>Assets held for sale</span></span></p>
          <p style="text-indent:0.05pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The determination as to whether a disposal group meets the requirements to be classified as held for sale, and the assets and liabilities to be included within that disposal group, requires management to exercise judgment when making these determinations.&#160; Management must also exercise judgment when determining at which date all of the criteria are satisfied to be classified as held for sale. Management must also use estimates when determining the fair value less costs to sell of the disposal group to assess if the carrying value of the disposal group is greater than its recoverable amount.</span></span></p>
          <p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[v]<span style="width:8.5pt;text-indent:0pt;display:inline-block">&#160;</span>Valuation of share-based payments and warrants</span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Management measures the costs for share-based payments and warrants using market-based option valuation techniques. Assumptions are made and estimates are used in applying the valuation techniques. These include estimating the future volatility of the share price, expected dividend yield, expected term, expected risk-free interest rate and the rate of forfeiture. Such estimates and assumptions are inherently uncertain. Changes in these assumptions affect the fair value estimates of share-based payments and warrants.</span></span></p>
          <p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[vi]<span style="width:6.5pt;text-indent:0pt;display:inline-block">&#160;</span>Valuation of private company investments</span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The financial information of private companies may not always be available, or such information may be insufficient or unreliable for valuation purposes. In determining the fair value of shares held in private company investments, management is required to make certain estimates and assumptions regarding the fair value as of the reporting date. Assumptions are made and estimates are used in applying the valuation techniques to determine fair value. These include the most recently available financial statements of the investee, price for most recently completed financing, as well as closely comparable public companies and general market and economic conditions. Such investments are classified as Level 3 within the fair value hierarchy. The value at which the Company could ultimately realize upon disposition of these investments may differ from their carrying value and such differences could be material.</span></span></p>
          <p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[vii]<span style="width:4.5pt;text-indent:0pt;display:inline-block">&#160;</span>Asset acquisition</span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In the acquisition of Prismic on June 28, 2019 judgment was required to determine if the acquisition represented either a business combination or an asset purchase. Management concluded that Prismic did not represent a business as the assets acquired were not an integrated set of activities with inputs, processes and outputs. Since it was concluded that the acquisition represented the purchase of assets, there was no goodwill recognized on the transaction and acquisition costs were capitalized to the assets purchased rather than expensed. The fair values of the net assets acquired were determined using estimates and judgments. Refer to Note 4 for additional information on the Company's asset acquisition.</span></span></p>
          <p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[viii]<span style="width:2.5pt;text-indent:0pt;display:inline-block">&#160;</span>Functional currency</span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company and its subsidiaries are required to determine their functional currencies based on the primary economic environment in which each entity operates. In order to do that, management has to analyze several factors, including which currency mainly influences the cost of undertaking the business activities, in which currency the entity has received financing, and in which currency it keeps its receipts from operating activities. Management uses its judgment to determine which factors are most important when the above indicators are mixed and the functional currency is not obvious.</span></span></p>
        </div>
      </div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_BasisOfPresentationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_BasisOfPresentationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the basis used for the preparation of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923861617384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant accounting policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_SummaryOfSignificantAccountingPoliciesAbstract', window );"><strong>Summary Of Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory', window );">Significant accounting policies</a></td>
<td class="text">
    <div>
      <div>
        <div>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>3.<span style="width:10.49pt;text-indent:0pt;display:inline-block">&#160;</span>Significant accounting policies</strong></span></span></p>

            <div>
              <p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[a]<span style="width:7.99pt;text-indent:0pt;display:inline-block">&#160;</span>Cash</span></span></p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash consists of cash and cash held in trust accounts. There are no restrictions on cash held in trust.</span></span></p>
            </div>


            <div>
              <p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[b]<span style="width:7.99pt;text-indent:0pt;display:inline-block">&#160;</span>Property, Plant and Equipment</span></span></p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property, plant and equipment is measured at cost less accumulated depreciation and impairment losses, with the exception of land which is not depreciated.&#160; &#160; &#160; &#160; &#160; &#160; &#160;</span></span></p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">When parts of an item of property, plant and equipment have different useful lives, they are accounted for as separate items (major components) of property, plant and equipment.</span></span></p>
              <p style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The cost of replacing part of an item of property, plant and equipment is recognized in the carrying amount of the item if it is probable that the future economic benefits embodied within the part will flow to the Company and its cost can be measured reliably. The carrying amount of the replaced part is derecognized. The costs of the day-to-day servicing of property, plant and equipment are recognized in consolidated statements of loss and comprehensive loss.</span></span></p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsequent costs are included in the asset's carrying amount or recognized as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Company and the cost of the item can be measured reliably. All other repairs and maintenance are charged to the consolidated statements of loss and comprehensive loss.</span></span></p>
              <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">Gains and losses on disposal of an item of property, plant and equipment are determined by comparing the proceeds from disposal with the carrying amount and are recognized net within other income in the consolidated statements of loss and comprehensive loss.<br/>&#160;</p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation is based on the estimated useful lives of the assets provided as follows:</span></span></p>
              <div>

                  <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;margin-left:auto;margin-right:auto;width:75%">
                    <tbody>
                      <tr style="background-color:rgb(204, 238, 255)">
                        <td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;height:0px;background-color:rgb(204, 238, 255)">
                          <p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computer equipment</span></span></p>
                        </td>
                        <td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;height:0px;background-color:rgb(204, 238, 255)">
                          <p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">30% declining balance</span></span></p>
                        </td>
                      </tr>
                      <tr style="background-color:rgb(255, 255, 255)">
                        <td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Production equipment</span></span></td>
                        <td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20% declining balance</span></span></td>
                      </tr>
                      <tr style="background-color:rgb(204, 238, 255)">
                        <td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Furniture and fixtures</span></span></td>
                        <td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20% declining balance</span></span></td>
                      </tr>
                      <tr style="background-color:rgb(255, 255, 255)">
                        <td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)">
                          <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Facility and related</span></span><span style="font-size:10pt">&#160;</span></p>
                        </td>
                        <td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20 years under straight-line</span></span></td>
                      </tr>
                      <tr style="background-color:rgb(204, 238, 255)">
                        <td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)">
                          <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Land</span></span></span></p>
                        </td>
                        <td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)">
                          <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Not amortized</span></span></span></p>
                        </td>
                      </tr>
                    </tbody>
                  </table>

              </div>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">An item of property, plant and equipment and any significant part initially recognized are derecognized upon disposal or when no future economic benefits are expected from their use or disposal. Any gain or loss arising on derecognition of the asset (calculated as the difference between the net disposal proceeds and the carrying amount of the asset) is included in the consolidated statements of loss and comprehensive loss when the asset is derecognized. The assets' residual values, useful lives and methods of depreciation and the depreciation charge are adjusted prospectively, if appropriate.</span></span></p>
            </div>


            <div>
              <div>
                <p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[c]<span style="width:8.5pt;text-indent:0pt;display:inline-block">&#160;</span>Intangible Assets</span></span></p>
                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">intangible assets are recorded at cost less accumulated amortization and accumulated impairment losses. Amortization is recognized in profit or loss on a straight-line basis over the following terms:</span></span></p>
                <div>
                  <div>


                      <div>
                        <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;margin-left:auto;margin-right:auto;width:75%">
                          <tbody>
                            <tr style="background-color:rgb(204, 238, 255)">
                              <td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)">
                                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Intellectual Property</span></span></p>
                              </td>
                              <td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)">
                                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5 years</span></span></p>
                              </td>
                            </tr>
                          </tbody>
                        </table>
                      </div>


                  </div>
                </div>
              </div>
              <div>
                <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><br/>Expenditures on internally generated intangible assets during the development phase, which comprise deferred development costs, are initially capitalized and recognized in the consolidated balance sheet if they meet the recognition criteria. Subsequent to initial recognition, deferred development costs are accounted for at cost less accumulated amortization and are amortized on a straight-line basis over an estimated useful life beginning once the deferred development costs are used in commercial production. Expenditures on internally generated intangible assets during the research phase are expensed as incurred.</p>
              </div>
            </div>

          <div>

              <div>
                <p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[d]<span style="width:7.99pt;text-indent:0pt;display:inline-block">&#160;</span>Revenue Recognition</span></span></p>
                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company's accounting policy for revenue recognition under IFRS 15, Revenue from Contracts with Customers ("IFRS 15") is to follow a five step model to determine the amount and timing of revenue to be recognized i) identify the contract with a customer; ii) identify the performance obligations in the contract; iii) determine the transaction price; iv) allocate the transaction price to the performance obligations in the contract; and v) recognize revenue when (or as) the Company satisfies a performance obligation.</span></span></p>
                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue from the sale of cannabis is recognized when the Company transfers control of the good to the customer. This is generally considered to have occurred when products have been delivered to the location specified in the sales contract and accepted by the customer.</span></span></p>
                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company recognizes revenue in an amount that reflects the consideration the Company expects to receive taking into account any variation that may result from rights of return.</span></span></p>
                <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify">The Company was required to remit excise tax to the Canada Revenue Agency on the sale of medical cannabis in Canada. The Company became liable for these excise duties when cannabis products were delivered to the customer. In accordance with IFRS 15, revenue presented within discontinued operations (Note 5) represents revenue from the sale of goods less applicable excise tax.</p>
                <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Areas of judgment include identifying the customer per the definition within IFRS 15 and determining whether control has passed to the customer.</span></span></p>
              </div>

          </div>

            <div>
              <p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[e]<span style="width:7.99pt;text-indent:0pt;display:inline-block">&#160;</span>Foreign Currency Translation</span></span></p>
              <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">Foreign currency transactions are translated into United States dollars at exchange rates in effect on the date of the transactions. Monetary assets and liabilities denominated in foreign currencies at the statement of financial position date are translated to United States dollars at the foreign exchange rate applicable at that date. Realized and unrealized exchange gains and losses are recognized through profit or loss.</p>
              <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-monetary assets and liabilities that are measured in terms of historical cost in a foreign currency are translated using the exchange rate at the date of the transaction.</span></span></p>
              <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">The assets and liabilities of foreign operations with functional currencies other than United States dollars, are translated into United States dollars at year-end exchange rates. Income and expenses, and cash flows of such foreign operations are translated into United States dollars using average exchange rates for the period. Exchange differences resulting from translating foreign operations are recognized in other comprehensive loss and accumulated in equity.<br/>&#160;</p>
            </div>


            <div>
              <p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[f]<span style="width:10.5pt;text-indent:0pt;display:inline-block">&#160;</span>Financial Instruments</span></span></p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial assets and financial liabilities are recognized when the Company becomes a party to the contractual provisions of the instruments.</span></span></p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial assets and financial liabilities are initially measured at fair value. Transaction costs that are directly attributable to the acquisition or issue of financial assets and financial liabilities (other than financial assets and financial liabilities at fair value through profit or loss) are added to or deducted from the fair value of the financial assets or financial liabilities, as appropriate, on initial recognition. Transaction costs directly attributable to the acquisition of financial assets or financial liabilities at fair value through profit or loss are recognized immediately in profit or loss.</span></span></p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:32.85pt;display:inline-block">&#160;</span>Financial assets</span></span></p>
              <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On initial recognition, a financial asset is classified as measured at amortized cost, fair value through other comprehensive income (''FVOCI''), or fair value through profit and loss (''FVTPL''). The classification of financial assets is based on the business model in which a financial asset is managed and its contractual cash flow characteristics.</span></span></p>
              <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A financial asset is measured at amortized cost if it meets both of the following conditions and is not designated as at FVTPL:</span></span></p>
              <ul style="padding-left:0pt" type="disc">
                <li style="margin-left:45.14pt;text-align:justify;padding-left:8.86pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">It is held within a business model whose objective is to hold assets to collect contractual cash flows; and</span></span></li>
                <li style="margin-left:45.14pt;text-align:justify;padding-left:8.86pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Its contractual terms give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.</span></span></li>
              </ul>
              <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A financial asset (unless it is a trade receivable without a significant financing component that is initially measured at the transaction price) is initially measured at fair value plus, for an item not at FVTPL, transaction costs that are directly attributable to its acquisition.</span></span></p>
              <p style="text-indent:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following accounting policies apply to the subsequent measurement of financial assets.</span></span></p>
              <table cellpadding="0" cellspacing="0" style="margin-left:36.65pt;border:0.75pt solid #000000;border-collapse:collapse;font-size:10pt">
                <tbody>
                  <tr>
                    <td style="width:32%;padding-right:5.03pt;padding-left:5.03pt;vertical-align:top;border-right:0.75pt solid #000000;border-bottom:0.75pt solid #000000">
                      <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial assets at FVTPL</span></span></p>
                    </td>
                    <td style="width:67%;padding-right:5.03pt;padding-left:5.03pt;vertical-align:top;border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000">
                      <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsequently measured at fair value. Net gains and losses, including any interest or dividend income, are recognized in profit or loss.</span></span></p>
                    </td>
                  </tr>
                  <tr>
                    <td style="width:32%;padding-right:5.03pt;padding-left:5.03pt;vertical-align:top;border-top:0.75pt solid #000000;border-right:0.75pt solid #000000">
                      <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial assets at amortized cost</span></span></p>
                    </td>
                    <td style="width:67%;padding-right:5.03pt;padding-left:5.03pt;vertical-align:top;border-top:0.75pt solid #000000;border-left:0.75pt solid #000000">
                      <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsequently measured at amortized cost using the effective interest method, less any impairment losses. Interest income, foreign exchange gains and losses and impairment losses are recognized in profit or loss. Any gain or loss on derecognition is recognized in profit or loss.</span></span></p>
                    </td>
                  </tr>
                </tbody>
              </table>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:32.85pt;display:inline-block">&#160;</span>Financial liabilities</span></span></p>
              <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company initially recognizes financial liabilities at fair value on the date at which the Company becomes a party to the contractual provisions of the instrument.</span></span></p>
              <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company classifies its financial liabilities as either financial liabilities at FVTPL or amortized cost.</span></span></p>
              <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsequent to initial recognition, other liabilities are measured at amortized cost using the effective interest method. Financial liabilities at FVTPL are stated at fair value with changes being recognized in profit or loss.</span></span></p>
              <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company derecognizes a financial liability when its contractual obligations are discharged or cancelled or expire.</span></span></p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:32.85pt;display:inline-block">&#160;</span>Financial liabilities and equity instruments</span></span></p>
              <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:32.85pt;display:inline-block">&#160;</span>Classification as debt or equity</span></span></p>
              <p style="margin-left:72pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Debt and equity instruments issued by the Company are classified as either financial liabilities or as equity in accordance with the substance of the contractual arrangements and the definitions of a financial liability and an equity instrument.&#160;</span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company does not reclassify financial liabilities or equity after initial recognition due to a change in circumstance.</span></span></p>
              <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:32.85pt;display:inline-block">&#160;</span>Equity instruments</span></span></p>
              <p style="margin-left:72pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">An equity instrument is any contract that evidences a residual interest in the assets of an entity after deducting all of its liabilities. Equity instruments issued by a group entity are recognized at the proceeds received, net of direct issue costs.</span></span></p>
              <p style="margin-left:72pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Repurchase of the Company's own equity instruments is recognized and deducted directly in equity. No gain or loss is recognized in profit or loss on the purchase, sale, issue or cancellation of the Company's own equity instruments.</span></span></p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:32.85pt;display:inline-block">&#160;</span>Classification of financial instruments</span></span></p>
              <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company classifies its financial assets and liabilities depending on the purpose for which the financial instruments were acquired, their characteristics and management intent as outlined below:</span></span></p>
              <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Classification</strong></span></span></p>
              <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;margin-left:36pt;margin-right:auto;width:95%">
                <tbody>
                  <tr style="background-color:rgb(204, 238, 255)">
                    <td style="width:50%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash</span></span></td>
                    <td style="width:50%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortized cost</span></span></td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="width:50%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other receivables</span></span></td>
                    <td style="width:50%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortized cost</span></span></td>
                  </tr>
                  <tr style="background-color:rgb(204, 238, 255)">
                    <td style="width:50%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Investments</span></span></td>
                    <td style="width:50%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value through profit or loss</span></span></td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="width:50%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade and other payables</span></span></td>
                    <td style="width:50%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortized cost</span></span></td>
                  </tr>
                  <tr style="background-color:rgb(204, 238, 255)">
                    <td style="width:50%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivative liability</span></span></td>
                    <td style="width:50%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value through profit or loss</span></span></td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="width:50%;background-color:rgb(255, 255, 255)">
                      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Warrants liability</p>
                    </td>
                    <td style="width:50%;background-color:rgb(255, 255, 255)">
                      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Fair value through profit or loss</p>
                    </td>
                  </tr>
                  <tr style="background-color:rgb(204, 238, 255)">
                    <td style="width:50%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Notes payable</span></span></td>
                    <td style="width:50%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortized cost</span></span></td>
                  </tr>
                </tbody>
              </table>
              <p style="margin-top:0pt;margin-left:36pt;margin-bottom:0pt;text-align:justify">&#160;</p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:32.85pt;display:inline-block">&#160;</span>Impairment of financial assets</span></span></p>
              <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">An expected credit loss ("ECL") model applies to financial assets measured at amortized cost. The Company's financial assets measured at amortized cost and subject to the ECL model consist primarily of trade and other receivables. The Company applies the simplified approach to impairment for trade and other receivables by recognizing a loss allowance based on lifetime expected losses at each reporting date taking into considerations historical credit loss experience and financial factors specific to the debtors and general economic conditions. The Company has assessed the impairment of its trade and other receivables using the expected credit loss model, and no material difference was noted.&#160;</span></span></p>
            </div>


            <div>
              <p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>[g]<span style="width:7.99pt;text-indent:0pt;display:inline-block">&#160;</span></span></span>Inventory</span></span></p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventory of harvested work-in-process and finished goods are valued at the lower of cost and net realizable value. Inventory of harvested cannabis is transferred from biological assets at their fair value at harvest, which becomes the initial deemed cost. Any subsequent post-harvest costs are capitalized to inventory to the extent that cost is less than net realizable value. Net realizable value is determined as the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated costs necessary to make the sale. Inventory for supplies and consumables are valued at the lower of cost and net realizable value, with cost determined using the average cost basis.</span></span></p>
            </div>


            <div>
              <p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[h]<span style="width:11pt;text-indent:0pt;display:inline-block">&#160;</span>Impairment of long-lived assets</span></span></p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Long-lived assets, including property, plant and equipment and intangible assets are tested for impairment when there are indicators of impairment at each reporting date or whenever events or changes in circumstances indicate that the carrying amount of an asset exceeds its recoverable amount. Intangible assets with an indefinite useful life are tested for impairment at least annually in the fourth quarter and whenever there is an indication that the asset may be impaired.</span></span></p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the purpose of impairment testing, assets that cannot be tested individually are grouped together into the smallest group of assets that generates cash inflows from continuing use that are largely independent of the cash inflows of other assets or groups of assets (the cash-generating unit, or "CGU"). The recoverable amount of an asset or a CGU is the higher of its fair value, less costs to sell, and its value in use. If the carrying amount of an asset exceeds its recoverable amount, an impairment charge is recognized immediately in net&#160;loss&#160;equal to the amount by which the carrying amount exceeds the recoverable amount. Where an impairment loss subsequently reverses, the carrying amount of the asset is increased to the lesser of the revised estimate of recoverable amount, and the carrying amount that would have been recorded had no impairment loss been recognized previously.</span></span></p>
            </div>


            <div>
              <p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[i]<span style="width:11pt;text-indent:0pt;display:inline-block">&#160;</span>Income Taxes</span></span></p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income tax expense comprises of current and deferred tax. Current tax and deferred tax are recognized in net profit or loss except to the extent that it relates to a business combination or items recognized directly in equity or in other comprehensive loss.</span></span></p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current income taxes are recognized for the estimated income taxes payable or receivable on taxable income or loss for the current year and any adjustment to income taxes payable in respect of previous years. Current income taxes are determined using tax rates and tax laws that have been enacted or substantively enacted by the year-end date.</span></span></p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred tax assets and liabilities are recognized where the carrying amount of an asset or liability differs from its tax base, except for taxable temporary differences arising on the initial recognition of goodwill and temporary differences arising on the initial recognition of an asset or liability in a transaction which is not a business combination and at the time of the transaction affects neither accounting nor taxable profit or loss.</span></span></p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Recognition of deferred tax assets for unused tax losses, tax credits and deductible temporary differences is restricted to those instances where it is probable that future taxable profit will be available against which the deferred tax asset can be utilized. At the end of each reporting period, the Company reassesses unrecognized deferred tax assets. The Company recognizes a previously unrecognized deferred tax asset to the extent that it has become probable that future taxable profit will allow the deferred tax asset to be recovered.</span></span></p>
            </div>


            <div>
              <p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[j]<span style="width:8.5pt;text-indent:0pt;display:inline-block">&#160;</span>Share-based Compensation</span></span></p>
              <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify">Share options and warrants awarded to non-employees are accounted for using the fair value of the instrument awarded or service provided, whichever is considered more reliable. Share options and warrants awarded to employees are accounted for using the fair value method.&#160; The fair value of such share options and warrants granted is recognized as an expense on a proportionate basis consistent with the vesting features of each tranche of the grant. The fair value is calculated using the Black-Scholes option pricing model with assumptions applicable at the date of grant.</p>
            </div>


            <div>
              <p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[k]<span style="width:11pt;text-indent:0pt;display:inline-block">&#160;</span>Net Loss per Share</span></span></p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss per share is calculated based on the loss for the financial year and the weighted average number of common shares outstanding during the year. Diluted net loss per share is calculated using the loss for the financial year adjusted for the effect of any dilutive instruments and the weighted average diluted number of shares [ignoring any potential issue of common shares that would be anti-dilutive] during the year.</span></span></p>
            </div>

          <div>

              <div>
                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[l] Leases</span></span></p>
                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At inception of a contract, the Company assesses whether a contract is, or contains, a lease based on whether the contract conveys the right to control the use of identified asset for a period of time in exchange for consideration. The Company recognized a right-of-use asset and a lease liability at the lease commencement date. The right-of-use asset is initially measured based on the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date, plus any initial direct costs incurred and an estimate of the costs to dismantle and remove the underlying asset or to restore the underlying asset or the site on which it is located, less any lease incentives received. The right-of-use assets are depreciated to the earlier of the end of useful life of the right-of-use asset or the lease term using the straight-line method as this most closely reflects the expected pattern of the consumption of the future economic benefits. The lease term includes periods covered by an option to extend if the Company is reasonably certain to exercise that option. In addition, the right-of-use asset can be periodically reduced by impairment losses, if any, and adjusted for certain remeasurements of the lease liability. The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, and the Company's incremental borrowing rate.</span></span></p>
                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The lease liability is measured at amortized cost using the effective interest method. It is remeasured when there is a change in future lease payments arising from the change in an index or rate, if there is a change in the Company's estimate of the amount expected to be payable under a residual value guarantee, or if the Company changes its assessment of whether it will exercise a purchase, extension or termination option. When the lease liability is remeasured in this way, a corresponding adjustment is made to the carrying amount of the right-of-use asset, unless it has been reduced to zero.</span></span></span></span></p>
              </div>

            <div>
              <div>

                  <div>
                    <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[m] External research and development<span style="text-align:left">&#160; &#160;</span></span></span></p>
                    <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">External research and development costs are expensed in the periods in which they are incurred, with the exception of development costs for new products with proven technical feasibility and for which a defined future market exists. Such development costs are capitalized in accordance with the Company's policy for intangible assets. The Company's external research and development costs consist primarily of third-party services.</span></span><span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left">&#160; &#160;</span></p>
                  </div>


                  <div>
                    <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[n] Discontinued operations</span></span><span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left">&#160; &#160;</span></p>
                    <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Discontinued operations are reported when a component of the Company, representing a separate major line of business or area of operations with clearly distinguishable cash flows, has been disposed of or is held for sale. Classification as a discontinued operation occurs upon disposal or when the operation meets the criteria to be classified as held for sale, if earlier. Discontinued operations are reported as a separate element of net income or loss on the consolidated statement of net and comprehensive loss for both the current and comparative periods. When a disposal group is classified as held for sale, assets and liabilities are aggregated and presented as separate line items, respectively, on the consolidated statement of financial position. Comparative periods are not restated on the consolidated statement of financial position. Assets held for sale are not depreciated and are measured at the lower of carrying value and fair value less costs to sell.</span></span><span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left">&#160;</span><span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left">&#160; &#160; &#160;&#160;</span></p>
                  </div>

                </div></div></div></div></div></div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;&#160;&#160;</span></span>

                  <div>
                    <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>New standards, amendment and interpretation adopted by the Company</strong></span></span><span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left">&#160; &#160;</span></p>
                    <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">IFRS 3 - <i>Business combinations </i>("IFRS 3")</span></span><span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left">&#160; &#160;</span></p>
                    <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amendments to IFRS 3, issued in October 2018, provide clarification on the definition of a business. The amendments permit a simplified assessment to determine whether a transaction should be accounted for as a business combination or as an asset acquisition.</span></span><span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left">&#160; &#160;</span></p>
                    <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The amendments are effective for transactions for which the acquisition date is on or after the beginning of the first annual reporting period beginning on or after January 1, 2020. The amendment adoption did not have a significant impact on the Company's financial statements.</span></span><span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left">&#160; &#160;</span></p>
                    <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">IAS 1 -<i> Presentation of financial statements </i>("IAS 1")</span></span><span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left">&#160; &#160;</span></p>
                    <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amendments to IAS 1, issued in October 2018, provide clarification on the definition of material and how it should be applied. The amendments also align the definition of material across International Financial Reporting Standards and other publications.</span></span><span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left">&#160; &#160;</span></p>
                    <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The amendments are effective for annual periods beginning on or after January 1, 2020 and are required to be applied prospectively. The amendment adoption did not have a significant impact on the Company's financial statements.</span></span></p>
                  </div>







  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_SummaryOfSignificantAccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_SummaryOfSignificantAccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant accounting policies applied by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923861648120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisition of Prismic Pharmaceutical<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsAbstract', window );"><strong>Disclosure of detailed information about business combination [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsExplanatory', window );">Acquisition of Prismic Pharmaceutical</a></td>
<td class="text">
      <div>
        <div>
          <div>
            <p style="text-align:justify;margin-left:18pt;text-indent:-18pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>4.</strong><span style="width:10.49pt;text-indent:0pt;display:inline-block">&#160;</span><strong>Acquisition of Prismic Pharmaceutical</strong></span></span></p>
            <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On June 28, 2019, the Company closed the acquisition of Prismic by acquiring all of the issued and outstanding Prismic Shares from the holders thereof. Prismic is a U.S.-based specialty research and development pharmaceutical company that is developing non-addictive prescription drugs for the treatment of pain and inflammation. Prismic's goal is to address the opioid crisis based on formulations utilizing micro-PEA's complementary effect on certain drugs used to impact the body's endocannabinoid system.</span></span></p>
            <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">It was determined that the acquisition of Prismic did not qualify as a business combination in accordance with IFRS 3 <i>Business Combinations </i>["IFRS 3"] and therefore it was accounted for as an asset acquisition. The individual identifiable assets acquired and liabilities assumed were identified and the purchase consideration was allocated based on the relative fair values of the acquired assets and assumed liabilities.</span></span></p>
          </div>
        </div>
        <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The total consideration for the purchase of Prismic was<span><span> $15,713,448. </span></span>The purchase consideration consisted of<span><span> $12,361,657 </span></span>of Class B subordinate voting shares,<span><span> $1,931,384 </span></span>of share options and<span><span> $1,420,407 of warrants. </span></span>The fair value of the Class B subordinate voting shares was determined based on a total of 510,940 shares issued and a fair value of C$32.16 per share, which reflects the share price on the date of acquisition. The fair value of the 89,898 share options and 67,598 warrants issued as part of the consideration were determined using a Black-Scholes options pricing model with the following assumptions:</span></span></span></span></p>

          <div>
            <table border="0" cellpadding="0" cellspacing="0" style="border:0px;width:100%;border-collapse:collapse;margin:auto">
              <tbody>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">&#160;</td>
                  <td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Share Options</strong></span></span></span></span></td>
                  <td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Warrants</strong></span></span></span></span></td>
                </tr>
                <tr style="background-color:rgb(230, 239, 255)">
                  <td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(230, 239, 255)">
                    <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Grant date share price</p>
                  </td>
                  <td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>C$32.16</span></span></span></span></td>
                  <td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>C$32.16</span></span></span></span></td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(255, 255, 255)">
                    <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Exercise price</p>
                  </td>
                  <td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>C$2.61 - C$17.89</span></span></span></span></td>
                  <td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>C$2.61 - C$26.73</span></span></span></span></td>
                </tr>
                <tr style="background-color:rgb(230, 239, 255)">
                  <td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(230, 239, 255)">
                    <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Expected dividend yield</p>
                  </td>
                  <td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Risk free interest rate</span></span></span></span></td>
                  <td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1.39% - 1.66%</span></span></span></span></td>
                  <td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1.41% - 1.52%</span></span></span></span></td>
                </tr>
                <tr style="background-color:rgb(230, 239, 255)">
                  <td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Expected life (years)</span></span></span></span></td>
                  <td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>0.98&#x2014;16.21</span></span></span></span></td>
                  <td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1.39&#x2014;6.55</span></span></span></span></td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(255, 255, 255)">
                    <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Annualized volatility</p>
                  </td>
                  <td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></td>
                  <td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></td>
                </tr>
              </tbody>
            </table>
          </div>

        <p style="text-align:justify"><br/><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The allocation of the total purchase consideration to the identifiable assets acquired and liabilities assumed as at the date of acquisition was as follows:</span></span></span></span></p>
        <div style="margin-left:2.25pt">

            <div>
              <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;margin-left:auto;margin-right:auto;width:100%">
                <tbody>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><strong>Fair value</strong></span></span></span></span></span></span></td>
                    <td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);text-align:right">
                      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>recognized&#160;on</strong></span></span></p>
                    </td>
                    <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><strong>acquisition</strong></span></span></span></span></span></span></td>
                    <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><strong>$</strong></span></span></span></span></span></span></td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(230, 239, 255)">
                    <td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Cash</span></span></span></span></span></span></td>
                    <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)">&#160;</td>
                    <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>1,752</span></span></span></span></span></span></td>
                    <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(255, 255, 255)">
                      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Prepaid expenses and deposits</p>
                    </td>
                    <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>19,691</span></span></span></span></span></span></td>
                    <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(230, 239, 255)">
                    <td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(230, 239, 255)">
                      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Intangible assets</p>
                    </td>
                    <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)">&#160;</td>
                    <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>18,543,379</span></span></span></span></span></span></td>
                    <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Trade and other payables</span></span></span></span></span></span></td>
                    <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(1,404,732</span></span></span></span></span></span></td>
                    <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></td>
                  </tr>
                  <tr style="background-color:rgb(230, 239, 255)">
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(230, 239, 255)">
                      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Notes payable</span></span></p>
                    </td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)">&#160;</td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(1,446,642</span></span></span></span></span></span></td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;border-bottom:1pt solid black;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;border-bottom:1pt solid black;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;border-bottom:1pt solid black;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><strong>15,713,448</strong></span></span></span></span></span></span></td>
                    <td style="vertical-align:bottom;border-bottom:1pt solid black;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                  </tr>
                </tbody>
              </table>
            </div>

        </div>
      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBusinessCombinationsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Section Disclosures<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;doctype=Standard&amp;dita_xref=IFRS03_g59-63_TI<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBusinessCombinationsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923863171384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Assets held for sale<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfAssetsHeldForSaleAbstract', window );"><strong>Disclosure Of Assets Held For Sale [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory', window );">Assets held for sale</a></td>
<td class="text">
      <div>
        <p style="margin-top:0pt;margin-left:24px;margin-bottom:0pt;text-align:justify;text-indent:-18pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><strong>5.</strong><span style="width:10.49pt;text-indent:0pt;display:inline-block">&#160;</span><strong>Assets held for sale</strong></span></span></span></p>
        <p style="margin:0pt">&#160;</p>
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400">In March 2020, the Company decided to focus its efforts and resources on the pharmaceutical business and initiated the process to sell its Cobourg facility and exit the medical cannabis industry. The Company expects that the sale of the facility will be completed within the next twelve months and is actively marketing the facility for sale.</span></span></span></p>
        <p style="margin:0pt">&#160;</p>
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400">Assets held for sale consists of the Cobourg facility. It is anticipated that no liabilities of the Company will be transferred as part of any proposed transaction. Results of operations related to the Cobourg facility are reported as discontinued operations for the years ended December 31, 2020 and 2019.</span></span></span></p>
        <p style="margin:0pt">&#160;</p>
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400">In accordance with IFRS 5 -&#160;<i>Non-current Assets Held for Sale and Discontinued Operations</i>, the assets held for sale were assessed for impairment based on fair value less costs to sell. The fair value was measured using the price at which the Company expects to receive for the disposal of the Cobourg facility in its current state less estimates for the costs of disposal. The fair value less costs to sell was higher than the carrying value of the Cobourg Facility resulting in recognition of the resulting group at carrying value.</span></span></span></p>
        <p style="margin:0pt">&#160;</p>
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400">Assets held for sale as at December 31, 2020 consisted of the following:</span></span></span></p>

          <div>
            <p style="margin:0pt">&#160;</p>
            <table style="font-family:Times New Roman;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial;width:100%;border-collapse:collapse;font-size:13px;border:0px">
              <tbody>
                <tr>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                  <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
                  <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td>
                  <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property and plant</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,610,504</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
                </tr>
              </tbody>
            </table>
          </div>

        <p style="margin:0pt">&#160;</p>
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400">During the year ended December 31, 2020, the Company sold equipment for proceeds of $36,616 resulting in a loss on sale of $100,337. As part of the sale of equipment the Company also sold all remaining inventory for $1 and recognized a loss on sale of inventory of $197,436 during the year ended December 31, 2020. As FV Pharma surrendered its cannabis license in September 2020, the Company determined that the carrying value of the remaining equipment was not recoverable resulting in recognition of impairment loss of $387,474 for the year ended December 31, 2020.</span></span></span></p>
        <p style="margin:0pt">&#160;</p>
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400">Net loss and comprehensive loss from discontinued operations for the year ended December 31, 2020 and 2019 is comprised of the following:</span></span></span></p>
        <p style="margin:0pt">&#160;</p>
        </div>

          <table style="font-family:Times New Roman;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial;width:100%;border-collapse:collapse;font-size:13px;border:0px">
            <tbody>
              <tr>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom">&#160;</td>
                <td colspan="1" style="text-align:center;vertical-align:bottom">&#160;</td>
                <td colspan="4" style="text-align:center;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>For the year ended December 31,</strong></span></span></td>
                <td colspan="1" style="text-align:center;vertical-align:bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Notes</span></span></td>
                <td style="text-align:right;vertical-align:bottom">&#160;</td>
                <td style="text-align:right;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2020</strong></span></span></td>
                <td style="text-align:right;vertical-align:bottom">&#160;</td>
                <td style="text-align:right;vertical-align:bottom">&#160;</td>
                <td style="text-align:right;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2019</span></span></td>
                <td style="text-align:right;vertical-align:bottom">&#160;</td>
              </tr>
              <tr>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
                <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td>
                <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
                <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
                <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td>
                <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Revenue</strong></span></span></td>
                <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14,514</span></span></strong></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">193,416</span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right">&#160;</td>
                <td style="vertical-align:bottom;width:24px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right">&#160;</td>
                <td style="vertical-align:bottom;width:24px;text-align:left">&#160;</td>
              </tr>
              <tr>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost of revenue</span></span></td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,032,010</span></span></strong></td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,473,839</span></span></td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Gross loss before fair value adjustments</strong></span></span></td>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,017,496</span></span></strong></td>
                <td style="vertical-align:bottom;width:24px;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,280,423</span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value adjustments on inventory sold</span></span></td>
                <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(945</span></span></strong></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16,738</span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
              </tr>
              <tr>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unrealized loss on changes in fair value of biological assets&#160;</span></span></td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">166,886</span></span></strong></td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">513,625</span></span></td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left">&#160;</td>
              </tr>
              <tr>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Gross loss&#160;</span></span></td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,183,437</span></span></strong></td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,810,786</span></span></td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
              </tr>
              <tr>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right">&#160;</td>
                <td style="vertical-align:bottom;width:24px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right">&#160;</td>
                <td style="vertical-align:bottom;width:24px;text-align:left">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Expenses</strong></span></span></td>
                <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">General and administrative&#160;</span></span></td>
                <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16</span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,665,541</span></span></strong></td>
                <td style="vertical-align:bottom;width:24px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,735,286</span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation and amortization</span></span></td>
                <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">90,340</span></span></strong></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">424,199</span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
              </tr>
              <tr>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment of property, plant and equipment</span></span></td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">387,474</span></span></strong></td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">132,273</span></span></td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left">&#160;</td>
              </tr>
              <tr>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Total operating expenses</strong></span></span></td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,143,355</span></span></strong></td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,291,758</span></span></td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
              </tr>
              <tr>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left">&#160;</td>
              </tr>
              <tr>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Loss from discontinued operations</strong></span></span></td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,326,792</span></span></strong></td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5,102,544</span></span></td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
              </tr>
              <tr>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right">&#160;</td>
                <td style="vertical-align:bottom;width:24px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right">&#160;</td>
                <td style="vertical-align:bottom;width:24px;text-align:left">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other income</span></span></td>
                <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(79,568</span></span></strong></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(53,987</span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
              </tr>
              <tr>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss on sale of equipment</span></span></td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100,337</span></span></strong></td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left">&#160;</td>
              </tr>
              <tr>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Net loss from discontinued operations</strong></span></span></td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,347,561</span></span></strong></td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5,048,557</span></span></td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
              </tr>
            </tbody>
          </table>

        <p style="margin:0pt">&#160;</p>
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400">Cash flows from discontinued operations for the year ended December 31, 2020 and 2019 are comprised of the following:</span></span></span></p>
        <p style="margin:0pt">&#160;</p>

          <table style="font-family:Times New Roman;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial;width:100%;border-collapse:collapse;font-size:13px;border:0px">
            <tbody>
              <tr>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="text-align:right;vertical-align:bottom">&#160;</td>
                <td style="text-align:right;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2020</strong></span></span></td>
                <td style="text-align:right;vertical-align:bottom">&#160;</td>
                <td style="text-align:right;vertical-align:bottom">&#160;</td>
                <td style="text-align:right;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2019</span></span></td>
                <td style="text-align:right;vertical-align:bottom">&#160;</td>
              </tr>
              <tr>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
                <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td>
                <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
                <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
                <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td>
                <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Operating activities</strong></span></span></td>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss from discontinued operations</span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>(3,347,561</strong></span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>)</strong></span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5,048,557</span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
              </tr>
              <tr>
                <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Add (deduct) items not affecting cash</span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right">&#160;</td>
                <td style="vertical-align:bottom;width:24px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right">&#160;</td>
                <td style="vertical-align:bottom;width:24px;text-align:left">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160; Depreciation and amortization</span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>108,209</strong></span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">424,199</span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160; Change in fair value adjustments on inventory sold</span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>(945</strong></span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>)</strong></span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16,738</span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160; Impairment of inventory</span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>534,814</strong></span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160; Impairment of property, plant and equipment</span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>387,474</strong></span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160; Change in fair value of biological assets</span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>166,886</strong></span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">513,625</span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160; Loss on disposal of inventory</span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>197,436</strong></span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160; Loss on sale of equipment</span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>100,337</strong></span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes in non-cash working capital balances</span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right">&#160;</td>
                <td style="vertical-align:bottom;width:24px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right">&#160;</td>
                <td style="vertical-align:bottom;width:24px;text-align:left">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160; Trade and other receivables</span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>960,778</strong></span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(423,945</span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
              </tr>
              <tr>
                <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160; Prepaid expenses and deposits</span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>279,870</strong></span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">54,226</span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160; Inventories</span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>(21,932</strong></span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>)</strong></span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(709,373</span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
              </tr>
              <tr>
                <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160; Biological assets</span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>(166,886</strong></span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>)</strong></span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(513,625</span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
              </tr>
              <tr>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160; Trade and other payables</span></span></td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>63,861</strong></span></span></td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(895,286</span></span></td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
              </tr>
              <tr>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Cash used in operating activities</strong></span></span></td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:157px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>(737,659</strong></span></span></td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:24px;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>)</strong></span></span></td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:157px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(6,581,998</span></span></td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:24px;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Investing activities</strong></span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right">&#160;</td>
                <td style="vertical-align:bottom;width:24px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right">&#160;</td>
                <td style="vertical-align:bottom;width:24px;text-align:left">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Purchase of property, plant and equipment</span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>&#x2014;</strong></span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(401,817</span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
              </tr>
              <tr>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Proceeds from sale of equipment</span></span></td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>36,616</strong></span></span></td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Cash provided by (used in) investing activities</strong></span></span></td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>36,616</strong></span></span></td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(401,817</span></span></td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
              </tr>
            </tbody>
          </table>

      <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfAssetsHeldForSaleAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfAssetsHeldForSaleAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for non-current assets held for sale and discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Section Presentation and disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;doctype=Standard&amp;dita_xref=IFRS05_g30-42_TI<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923858985624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other receivables<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivablesAbstract', window );"><strong>Trade and other receivables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory', window );">Other receivables</a></td>
<td class="text">
    <div>
      <p style="text-align:justify;margin-left:2.25pt"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6. Other receivables</span></span></strong></p>
      <div>
        <div>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company's other receivables are comprised of the following:</span></span></p>

            <div>
              <table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000">
                <tbody>
                  <tr>
                    <td style="vertical-align:bottom">&#160;</td>
                    <td style="text-align:right;vertical-align:bottom">&#160;</td>
                    <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>December 31, 2020</strong></span></span></td>
                    <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2019</span></span></td>
                    <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">January 1, 2019</span></span></td>
                    <td style="text-align:right;vertical-align:bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                    <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
                    <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td>
                    <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
                    <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
                    <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td>
                    <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
                    <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
                    <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td>
                    <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Sales tax recoverable</span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">134,717</span></span></strong></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,529,828</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">739,257</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rent receivable</span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    <td style="vertical-align:bottom;width:12%;text-align:right"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></strong></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                    <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    <td style="vertical-align:bottom;width:12%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,772</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                    <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    <td style="vertical-align:bottom;width:12%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,263</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  </tr>
                  <tr>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26,625</span></span></strong></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17,702</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  </tr>
                  <tr>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom">&#160;</td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:12%;text-align:right"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">161,342</span></span></strong></td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:12%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,557,302</span></span></td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:12%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">745,520</span></span></td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  </tr>
                </tbody>
              </table>
            </div>

        </div>
      </div>
      <div style="margin-left:2.25pt">&#160;</div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of trade and other receivables. [Refer: Trade and other receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923858976600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfInvestmentsAbstract', window );"><strong>Disclosure Of Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory', window );">Investments</a></td>
<td class="text">
    <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span><span><span><span><span><span><span>7. Investments</span></span></span></span></span></span></span></span></strong></span></span></p>
    <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span>The following tables outline changes in investments during the periods:</span></span></span></span></span></span></span></span></span></span></p>
    <div>
      <div>

          <div>
            <table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000">
              <tbody>
                <tr>
                  <td style="vertical-align:bottom;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Entity</strong></span></span></span></span></td>
                  <td style="vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Instrument</strong></span></span></span></span></td>
                  <td style="vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Note</strong></span></span></span></span></td>
                  <td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Balance at<br/>January </strong><br/><strong>1,<br/>2019</strong></span></span></span></span></td>
                  <td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);white-space:nowrap;width:10px">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);white-space:nowrap;width:120px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Additions</strong></span></span></span></span></td>
                  <td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Change in fair<br/>value through<br/>profit or loss</strong></span></span></span></span></td>
                  <td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Proceeds<br/>from sale</strong></span></span></span></span></td>
                  <td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Balance at<br/>December 31,<br/>2019</strong></span></span></span></span></td>
                  <td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000">&#160;</td>
                </tr>
                <tr style="background-color:rgb(204, 238, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Pharmadrug Inc.</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Shares</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(i)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,256,900</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(2,001,825</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>255,075</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cannara Biotech Inc.</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Shares</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(ii)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>8,437,342</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(1,614,704</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>6,822,637</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(204, 238, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Clover Cannastrip</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Shares</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(iii)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,128,450</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(1,128,450</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>High Tide</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Shares</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(iv)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,352,665</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(890,362</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>462,303</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(204, 238, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>High Tide</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Warrants</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(iv)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>188,914</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(188,914</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>HUGE Shops</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Shares</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(v)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>977,990</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(405,589</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>572,401</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(204, 238, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>SciCann Therapeutics</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Shares</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(vi)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,504,593</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(968,769</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>535,824</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Solarvest BioEnergy Inc.&#160;</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Shares</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(vii)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>519,087</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(191,837</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>327,251</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(204, 238, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Solarvest BioEnergy Inc.&#160;</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Warrants</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(vii)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>290,225</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(202,470</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>87,756</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Solarvest BioEnergy Inc.&#160;</span></span></span></span></td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Convertible debenture</span></span></span></span></td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(vii)</span></span></span></span></td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,447,588</span></span></span></span></td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(1,185,787</span></span></span></span></td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>261,800</span></span></span></span></td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(204, 238, 255)">
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>13,589,954</span></span></span></span></td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:10px;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:120px;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4,513,800</span></span></span></span></td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(8,778,707</span></span></span></span></td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>462,303</span></span></span></span></td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>8,862,744</span></span></span></span></td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(204, 238, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:left;vertical-align:bottom;width:10px;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;width:120px;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Entity</strong></span></span></span></span></td>
                  <td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Instrument</strong></span></span></span></span></td>
                  <td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Note</strong></span></span></span></span></td>
                  <td style="text-align:left;vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;width:9%;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Balance at<br/>December 31,<br/>2019</strong></span></span></span></span></td>
                  <td style="text-align:left;vertical-align:bottom;width:2%;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:left;vertical-align:bottom;width:10px;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;width:120px;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Change in fair<br/>value through<br/>profit or loss</strong></span></span></span></span></td>
                  <td style="text-align:left;vertical-align:bottom;width:2%;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:left;vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;width:9%;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Foreign<br/>exchange<br/>gain</strong></span></span></span></span></td>
                  <td style="text-align:left;vertical-align:bottom;width:2%;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:left;vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;width:9%;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Proceeds<br/>from sale</strong></span></span></span></span></td>
                  <td style="text-align:left;vertical-align:bottom;width:2%;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:left;vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;width:9%;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Balance at<br/>December 31, 2020</strong></span></span></span></span></td>
                  <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(204, 238, 255)">
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="text-align:left"><strong>$</strong></span>&#160;</span></span></span></span></td>
                  <td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:10px;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:120px;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="text-align:left"><strong>$</strong></span>&#160;</span></span></span></span></td>
                  <td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="text-align:left"><strong>$</strong></span>&#160;</span></span></span></span></td>
                  <td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="text-align:left"><strong>$</strong></span>&#160;</span></span></span></span></td>
                  <td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="text-align:left"><strong>$</strong></span>&#160;</span></span></span></span></td>
                  <td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Pharmadrug Inc.</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Shares</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(i)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>255,075</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>397,006</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>652,081</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(204, 238, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cannara Biotech Inc.</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Shares</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(ii)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>6,822,637</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(997,208</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>5,825,429</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Clover Cannastrip</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Shares</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(iii)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(204, 238, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>HUGE Shops</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Shares</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(v)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>572,401</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>7,674</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>20,358</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>600,433</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>SciCann Therapeutics</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Shares</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(vi)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>535,824</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(354,910</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>14,765</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>195,679</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(204, 238, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Solarvest BioEnergy Inc.&#160;</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Shares</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(vii)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>327,251</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>106,380</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>14,047</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>447,678</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Solarvest BioEnergy Inc.&#160;</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Warrants</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(vii)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>87,756</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(14,920</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,977</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>74,813</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(204, 238, 255)">
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Solarvest BioEnergy Inc.&#160;</span></span></span></span></td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Convertible debenture</span></span></span></span></td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(vii)</span></span></span></span></td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>261,800</span></span></span></span></td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:10px;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:120px;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>85,104</span></span></span></span></td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>11,238</span></span></span></span></td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>358,142</span></span></span></span></td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>8,862,744</span></span></span></span></td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(770,874</span></span></span></span></td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>62,385</span></span></span></span></td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>6,477,510</span></span></span></span></td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,676,745</span></span></span></span></td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                </tr>
              </tbody>
            </table>
          </div>
        <span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#160;&#160;&#160;</span></span></span></span>
        <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(i) Pharmadrug Inc. (Formerly known as "Aura Health Inc.")</span></span></span></span></p>
      </div>
    </div>
    <div style="margin-left:0px">
      <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>On April 16, 2019, the Company entered into a share exchange agreement with Aura Health Inc. ("Aura"). Pursuant to the share exchange agreement, FSD acquired 13,562,387 common shares at C$0.2212 per share in the capital of Aura in exchange for the issuance of 65,577 Class B shares of the Company at C$45.75 for a total value of $2,256,900. The FSD shares issued to Aura were subject to a purchase price adjustment, such that FSD would be required to issue additional shares to Aura should the weighted average trading price of FSD's shares fall below the issue price. As the number of additional shares to be issued under the agreement were dependent on the FSD share price, it was determined that this created a derivative liability. As a result of the decline in the Company's share price, on September 20, 2019, 61,892 additional Class B shares of the Company were issued to Aura in settlement for the derivative liability. In 2019, Aura Health Inc. changed its name change to Pharmadrug Inc.</span></span></span></span></p>
      <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
      <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During the year ended December 31, 2020, the Company sold 13,562,387 common shares for gross proceeds of $652,081.</span></span></p>
      <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
      <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(ii) Cannara Biotech Inc. ("Cannara")</span></span></p>
      <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
      <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On February 5, 2020, the Company sold its investment of 85,003,750 Class B shares of Cannara for total cash proceeds of $5,825,429. The Company recognized a loss on sale of investment of $997,208.</span></span></p>
      <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
      <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(iii) Clover Cannastrip Thin Film Technologies Corp. ("Clover")</span></span></p>
      <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
      <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On September 6, 2018, the Company subscribed for $1,128,450 of equity units in a brokered private placement by Clover. The equity investment is measured at fair value through profit or loss. Clover is not a publicly traded company therefore, the fair value was classified as level 3 within the fair value hierarchy. As at December 31, 2019 and as at December 31, 2020, the fair value was determined to be $nil based on the financial position of Clover and the Company's ability to recover its investment.</span></span></p>
      <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
      <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(iv) High Tide</span></span></p>
      <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
      <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company's investment in High Tide included 4,551,999 shares and 2,000,000 warrants. On November 22, 2019 the Company sold the shares and warrants of High Tide Inc. for total cash proceeds of $462,303.</span></span></p>
      <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
      <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(v) HUGE Shops</span></span></p>
      <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
      <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company's investment in HUGE Shops includes 17,333,333 shares based on the December 2018 subscription price of C$0.075 per share. The equity investment is measured at fair value through profit or loss. Huge Shops is not a publicly traded company therefore, the fair value was classified as level 3 within the fair value hierarchy. As at December 31, 2020, the Company determined the best information to assess the fair value of the investment was based on movement of comparable public companies' share prices, resulting in a nominal change in the fair value of the investment of 0% from December 31, 2019. Comparable companies were determined in looking at product offering, relative size of operations, geographical market and other factors. A change in this assumption of plus or minus 10% would result in a corresponding change in fair value of the investment of approximately $285.</span></span></p>
      <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
      <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(vi) SciCann Therapeutics Inc.</span></span></p>
      <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
      <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The investment includes 117,648 shares based on the subscription price in May of 2018 and October of 2018 of C$17 per share. The equity investment is measured at fair value through profit or loss. SciCann Therapeutics Inc. is not a publicly traded company therefore, the fair value was classified as level 3 within the fair value hierarchy. As at December 31, 2020, the Company determined the best information to assess the fair value of the investment was based on movement of comparable public companies' share prices, resulting in decline in the fair value of investment of 65% from December 31, 2019. Comparable companies were determined in looking at product offering, relative size of operations, geographical market and other factors. A change in this assumption of plus or minus 10% would result in a corresponding change in fair value of the investment of approximately $36,372.</span></span></p>
      <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
      <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(vii) Solarvest BioEnergy Inc. ("Solarvest")</span></span></p>
      <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
      <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On May 7, 2019, the Company acquired 3,000,000 common shares, 3,000,000 warrants and a convertible debenture at a principal amount of $1,805,520 for a total fair value of $2,256,900 of Solarvest in exchange for 49,751 Class B common shares of the Company with a fair value of $1,880,750 based on a market price of C$50.25 and recognition of a derivative liability of $376,150. Under the terms of the agreement, the Company has guaranteed a minimum liquidation value of its shares to Solarvest of $2,256,900 resulting in recognition of the derivative liability. If the liquidation value of the Company's shares is below $2,256,900, the Company would be required to issue additional shares for the difference in actual value realized and the minimum guaranteed value.</span></span></p>
      <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
      </div>
      <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As at December 31, 2019, the fair value of the derivative liability was $1,990,788. The fair value was determined based on the additional common shares of the Company required to be issued to Solarvest to meet the minimum liquidation value of $2,256,900. On February 4, 2020, the Company issued 225,371 shares to Solarvest to settle the derivative liability. The fair value of the shares issued was $1,356,373 resulting in recognition of a gain of $634,415 on settlement of the derivative liability.</span></span></p>
      <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
      <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As at December 31, 2020, the fair value of the shares was determined based on the quoted market price of the shares at C$0.19 per share. The fair value of the associated warrants is based on the Black-Scholes model with the following assumptions: exercise price C$0.25, risk free rate 0.20%, expected volatility 112%, expected life 0.35 years and expected dividend yield of 0%. Fair value of the convertible debenture is calculated as the fair value of shares if converted at SVS share price as at December 31, 2020 of C$0.19. The shares have been classified as level 1 within the fair value hierarchy - quoted market price, and the warrants and convertible debenture have been classified as level 2 - valuation technique with observable market inputs.</span></span></p>

  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of investments other than investments accounted for using the equity method. [Refer: Investments other than investments accounted for using equity method]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923858991032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-use asset<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract', window );"><strong>Disclosure of quantitative information about right-of-use assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory', window );">Right-of-use asset</a></td>
<td class="text">
    <div>
      <div>
        <div>
          <p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>8.</strong><span style="width:10.49pt;text-indent:0pt;display:inline-block">&#160;</span><strong>Right-of-use asset</strong></span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The right-of-use asset as at December 31, 2020 is as follows:</span></span></p>

            <div>
              <table border="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;width:100%">
                <tbody>
                  <tr>
                    <td style="vertical-align:bottom">&#160;</td>
                    <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
                    <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td>
                    <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance &#x2013; January 1, 2019</span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">183,424</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation</span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    <td style="vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(36,685</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(50,888</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance &#x2013; December 31, 2019</span></span></td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">95,851</span></span></td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation</span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5,991</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(89,860</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance &#x2013; December 31, 2020</span></span></td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  </tr>
                </tbody>
              </table>
            </div>

          <p style="text-align:justify">&#160;</p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The right-of-use asset relates to an office lease. The right-of-use asset is carried at the lower of carrying value and present value of the expected future lease payments to be received from subleasing the premise over the remaining term of the lease. As of March 31, 2020, the Company did not occupy the leased premise and has been unsuccessful in subleasing the space. As a result, the Company recognized an impairment loss of $89,860 resulting in right-of-use asset balance of $nil. The Company recognized depreciation expense of $5,991 for the year ended December 31, 2020, respectively (2019 - $36,685).</span></span></p>
        </div>
      </div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of quantitative information about right-of-use assets. [Refer: Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923858998680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Changes in intangible assets other than goodwill [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsExplanatory', window );">Intangible assets</a></td>
<td class="text">
    <div>
      <div>
        <div>
          <p style="text-align:justify;margin-left:18pt;text-indent:-18pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>9.</strong><span style="width:10.49pt;text-indent:0pt;display:inline-block">&#160;</span><strong>Intangible assets</strong></span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Intangible assets as at December 31, 2020 are as follows:</span></span></p>

            <div>
              <table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:rgb(0, 0, 0)">
                <tbody>
                  <tr>
                    <td style="vertical-align:bottom">&#160;</td>
                    <td style="text-align:right;vertical-align:bottom">&#160;</td>
                    <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Intangible Assets</strong></span></span></td>
                    <td style="text-align:right;vertical-align:bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Cost</strong></span></span></td>
                    <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                    <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td>
                    <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As at January 1, 2019</span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Acquisition of Prismic Pharmaceuticals Inc.</span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    <td style="vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18,543,379</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions</span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">293,126</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  </tr>
                  <tr>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effects of foreign exchange</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(140,276</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  </tr>
                  <tr>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As at December 31, 2019</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18,696,229</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  </tr>
                  <tr>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effects of foreign exchange</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">505,264</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  </tr>
                  <tr>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>As at December 31, 2020</strong></span></span></td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>19,201,493</strong></span></span></td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom">&#160;</td>
                    <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    <td style="vertical-align:bottom;width:22%;text-align:right">&#160;</td>
                    <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  </tr>
                  <tr>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Accumulated amortization</strong></span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As at January 1, 2019</span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    <td style="vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortization</span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,906,363</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  </tr>
                  <tr>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effects of foreign exchange</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(30,759</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  </tr>
                  <tr>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As at December 31, 2019</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,875,604</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortization</span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    <td style="vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,894,467</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  </tr>
                  <tr>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effects of foreign exchange</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,031</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  </tr>
                  <tr>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>As at December 31, 2020</strong></span></span></td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>5,777,102</strong></span></span></td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  </tr>
                  <tr>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Net book value</strong></span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  </tr>
                  <tr>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As at January 1, 2019</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  </tr>
                  <tr>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As at December 31, 2019</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16,820,625</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  </tr>
                  <tr>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>As at December 31, 2020</strong></span></span></td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>13,424,391</strong></span></span></td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  </tr>
                </tbody>
              </table>
            </div>

          <p style="text-align:justify">&#160;</p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company acquired intellectual property as part of the acquisition of Prismic on June 28, 2019. Refer to Note 4 for additional details. The life of the intellectual property has been determined to be 5 years. Amortization of the intellectual property commenced on the date of acquisition. The Company recognized amortization expense of $3,894,467 for the year ended December 31, 2020 (2019 - $1,906,363).</span></span></p>
        </div>
      </div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;doctype=Standard&amp;dita_xref=IAS38_g118-128_TI<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923861640456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes payable<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract', window );"><strong>Disclosure of detailed information about borrowings [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBorrowingsExplanatory', window );">Notes payable</a></td>
<td class="text">
    <div>
      <p style="margin-top:0pt;margin-left:24px;margin-bottom:0pt;text-align:justify;text-indent:-18pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><strong>10.</strong><span style="width:5.49pt;text-indent:0pt;display:inline-block">&#160;</span><strong>Notes payable</strong></span></span></span></p>
      <p style="text-align:justify">&#160;</p>
      <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Notes payable consists of the following:</span></span></span></span></p>
      <div>
        <div>

            <div>
              <table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000">
                <tbody>
                  <tr>
                    <td style="vertical-align:bottom">&#160;</td>
                    <td style="text-align:right;vertical-align:bottom">&#160;</td>
                    <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>December 31, 2020</strong></span></span></td>
                    <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2019</span></span></td>
                    <td style="text-align:right;vertical-align:bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                    <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                    <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td>
                    <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                    <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                    <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td>
                    <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Short-term notes</span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>49,647</strong></span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">145,943</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  </tr>
                  <tr>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Notes payable</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>335,000</strong></span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,289,755</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  </tr>
                  <tr>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff">&#160;</td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>384,647</strong></span></span></td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,435,698</span></span></td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  </tr>
                </tbody>
              </table>
            </div>

        </div>
      </div>
      <p style="margin:0pt">&#160;</p>
      <div>
        <div>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><i>Short-term notes</i></span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The short-term notes represent notes outstanding that the Company assumed on acquisition of Prismic. The notes have matured, are due on demand and accrue interest at a rate of 10% per annum. The notes are held by former Directors and Shareholders of Prismic.</span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><i>Notes payable</i></span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The notes payable represent notes outstanding that the Company assumed on acquisition of Prismic. The notes have matured and are due on demand. The notes accrue interest at a rate of 20% per annum. The notes are held by former Directors and Shareholders of Prismic. The Company recognized accrued interest of $227,366 during the year ended December 31, 2020 (2019 - $142,907).</span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During the year ended December 31, 2020, the Company settled notes payable in the amount of $1,084,719, accrued interest of $795,367, and $438,599 of other Prismic related liabilities with 63,714 Class B Common Shares with a fair value of $185,976 and cash of $1,484,369. A gain of $680,164 was recognized on settlement as the value of the consideration was less than the carrying value of the notes payable, accrued interest and other related Prismic liabilities.</span></span></p>
        </div>
      </div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBorrowingsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBorrowingsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923861609128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Lease obligations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilitiesAbstract', window );"><strong>Lease liabilities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfLeasesExplanatory', window );">Lease obligations</a></td>
<td class="text">
      <div>
        <div>
          <div>
            <p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>11.</strong><span style="width:5.49pt;text-indent:0pt;display:inline-block">&#160;</span><strong>Lease obligations</strong></span></span></p>
            <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The lease obligations as at December 31, 2020 are as follows:</span></span></p>

              <div>
                <table border="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;width:90%">
                  <tbody>
                    <tr>
                      <td style="border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                      <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                      <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;<strong>$&#160;</strong></span></span></td>
                      <td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Balance as at January 1, 2019</strong></span></span></td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                      <td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">183,424</span></span></td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Add: Interest Expense</span></span></td>
                      <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                      <td style="vertical-align:bottom;width:12%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,480</span></span></td>
                      <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    </tr>
                    <tr>
                      <td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less: Lease Payments</span></span></td>
                      <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                      <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(42,285</span></span></td>
                      <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                    </tr>
                    <tr>
                      <td style="border-bottom:2px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Balance &#x2013; December 31, 2019</strong></span></span></td>
                      <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                      <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:12%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>152,619</strong></span></span></td>
                      <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Add: Interest Expense</span></span></td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                      <td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,367</span></span></td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less: Lease Payments</span></span></td>
                      <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                      <td style="vertical-align:bottom;width:12%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(39,993</span></span></td>
                      <td style="vertical-align:bottom;width:1%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                    </tr>
                    <tr>
                      <td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effects of foreign exchange</span></span></td>
                      <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                      <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff">
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2,969</span></p>
                      </td>
                    </tr>
                    <tr>
                      <td style="border-bottom:2px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Balance &#x2013; December 31, 2020</strong></span></span></td>
                      <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                      <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:12%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>125,962</strong></span></span></td>
                      <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                      <td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff">&#160;</td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current</span></span></td>
                      <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                      <td style="vertical-align:bottom;width:12%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">46,842</span></span></td>
                      <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    </tr>
                    <tr>
                      <td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-current&#160;</span></span></td>
                      <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                      <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">79,120</span></span></td>
                      <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                    </tr>
                    <tr>
                      <td style="border-bottom:2px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Balance &#x2013; December 31, 2020</strong></span></span></td>
                      <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                      <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:12%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>125,962</strong></span></span></td>
                      <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    </tr>
                  </tbody>
                </table>
              </div>

            <p style="margin:0pt">&#160;</p>
            <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease obligations are related to the Company's office lease. The Company recognized $10,367 interest expense for the year ended December 31, 2020 (2019 - $11,480).</span></span></p>
            <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2020, the Company did not occupy the leased premise. The Company has commenced plans to sublease the premise, however, if or when the Company will be able to sublease the premise is unknown.</span></span></p>
            <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table sets out a maturity analysis of the lease payments payable, showing the undiscounted lease payments to be paid on an annual basis, reconciled to the lease obligation.</span></span></p>
          </div>
        </div>
        <div style="margin-left:1.5pt">

            <div>
              <table border="0" cellpadding="0" cellspacing="0" style="width:90%;font-size:10pt;border-collapse:collapse;border-color:#000000">
                <tbody>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">&#160;</td>
                    <td style="vertical-align:bottom;text-align:right;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;text-align:right;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td>
                    <td style="vertical-align:bottom;text-align:right;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(230, 239, 255)">
                    <td style="vertical-align:bottom;text-align:left;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less than one year</span></span></td>
                    <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)">&#160;</td>
                    <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">46,842</span></span></td>
                    <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">One to two years</span></span></td>
                    <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">47,088</span></span></td>
                    <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(230, 239, 255)">
                    <td style="vertical-align:bottom;text-align:left;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Two to three years</span></span></td>
                    <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)">&#160;</td>
                    <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">47,088</span></span></td>
                    <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;text-align:left;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)">
                      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Thereafter</span></span></p>
                    </td>
                    <td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)">
                      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></p>
                    </td>
                    <td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(230, 239, 255)">
                    <td style="vertical-align:bottom;background-color:rgb(230, 239, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(230, 239, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total undiscounted lease payments payable</span></span></td>
                    <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">141,018</span></span></td>
                    <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(230, 239, 255)">
                    <td style="vertical-align:bottom;text-align:left;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less: impact of present value</span></span></td>
                    <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)">&#160;</td>
                    <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(15,056</span></span></td>
                    <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(230, 239, 255)">
                    <td style="vertical-align:bottom;text-align:left;border-top:1pt solid black;border-bottom:2pt solid black;background-color:rgb(230, 239, 255)">
                      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as at December 31, 2020&#160;&#160; &#160;</span></span></p>
                    </td>
                    <td style="vertical-align:bottom;text-align:left;width:1%;border-top:1pt solid black;border-bottom:2pt solid black;background-color:rgb(230, 239, 255)">&#160;</td>
                    <td style="vertical-align:bottom;text-align:right;width:17%;border-top:1pt solid black;border-bottom:2pt solid black;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">125,962</span></span></td>
                    <td style="vertical-align:bottom;text-align:left;width:2%;border-top:1pt solid black;border-bottom:2pt solid black;background-color:rgb(230, 239, 255)">&#160;</td>
                  </tr>
                </tbody>
              </table><br/>&#160;
            </div>

        </div>
      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfLeasesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Section Presentation<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;doctype=Standard&amp;dita_xref=IFRS16_g47-50_TI<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;doctype=Standard&amp;dita_xref=IFRS16_g51-60_TI<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfLeasesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923861660456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants Liability<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WarrantLiabilitiesAbstract', window );"><strong>Warrant Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantLiabilitiesExplanatory', window );">Warrants Liability</a></td>
<td class="text">
      <div>
        <p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>12.</strong><span style="width:5.49pt;text-indent:0pt;display:inline-block">&#160;</span><strong>Warrants Liability</strong></span></span><span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left">&#160; &#160;</span></p>
        <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In August 2020, the Company issued 2,762,430 Class B Common Shares and 1,381,215 warrants to purchase Class B Shares for total cash proceeds of $9,999,997. Each warrant is exercisable to purchase one Class B Common Share of the Company at an exercise price of $4.26 per share and expire five years from the date of issuance.<span style="text-align:left">&#160; &#160; &#160;</span></span></span></p>
        </div>
        <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On initial recognition the Company determined that these warrants did not meet the IFRS definition of equity due to the exercise price being denominated in United States dollars, which was not the functional currency of the Company at the time resulting in variability in exercise price. The change in functional currency was determined to be a change in circumstance and, as such, the Company has made an accounting policy choice to continue to recognize the warrants as a financial liability classified at fair value through profit or loss. The classification of any new warrants issued from October 1, 2020 forward are assessed based on the new functional currency which is the United States dollar.<span style="text-align:left">&#160; &#160;</span></span></span></p>
        <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Transaction costs allocated to the warrants of $284,049 were expensed immediately. The fair value of these warrants is classified as Level 2 in the fair value hierarchy. As at the date of issuance the fair value of the warrants was determined to be $3,289,069 using the Black-Scholes option pricing model and the following assumptions: exercise price of $4.26, the underlying share price of $3.01 on date of issuance, risk free interest rate of 0.32% and annualized volatility of 121%.<span style="text-align:left">&#160; &#160;</span></span></span></p>
        <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The fair value of the warrants liability as at December 31, 2020 was $1,447,910 resulting in a gain on change in fair value of $1,927,041 for the year ended December 31, 2020. The fair value was determined using the Black-Scholes option pricing model and the following assumptions: exercise price of $4.26, the underlying share price of $1.56, risk free interest rate of 0.33% and annualized volatility of 117%.</span></span></p>
      <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfWarrantLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of warrant liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfWarrantLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_WarrantLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrant Liabilities [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_WarrantLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923858998680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share capital<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfReservesWithinEquityAbstract', window );"><strong>Disclosure of reserves within equity [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory', window );">Share capital</a></td>
<td class="text">
            <div>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><strong>13.</strong><span style="width:5.49pt;text-indent:0pt;display:inline-block">&#160;</span><strong>Share capital</strong></span></span></span></span></span></span></p>
              <p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><strong>[a]</strong><span style="width:7pt;text-indent:0pt;display:inline-block">&#160;</span><strong>Authorized</strong></span></span></span></span></span></span></p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>The Company is authorized to issue an unlimited number of Class A multiple voting shares ("Class A shares") and an unlimited number of Class B subordinate voting shares ("Class B shares"), all without par value. All shares are ranked equally with regards to the Company's residual assets.</span></span></span></span></span></span></p>
              <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span>The holders of Class A shares are entitled to 276,660 votes per Class A share held.</span></span></span></span></span></span>&#160;</span></span>Class A shares are held by certain Directors of the Company.&#160;</span></span></p>
              <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p>
              <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong style="color:#000000;font-family:Times New Roman;font-size:13.3333px;font-style:normal;font-variant-ligatures:normal;font-variant-caps:normal;letter-spacing:normal;orphans:2;text-align:justify;text-indent:-24px;text-transform:none;white-space:normal;widows:2;word-spacing:0px;-webkit-text-stroke-width:0px;text-decoration-style:initial;text-decoration-color:initial">[b]</strong><span style="color:#000000;font-family:Times New Roman;font-size:13.3333px;font-style:normal;font-variant-ligatures:normal;font-variant-caps:normal;font-weight:400;letter-spacing:normal;orphans:2;text-align:justify;text-transform:none;white-space:normal;widows:2;word-spacing:0px;-webkit-text-stroke-width:0px;text-decoration-style:initial;text-decoration-color:initial;width:6.51pt;text-indent:0pt;display:inline-block"> </span><strong style="color:#000000;font-family:Times New Roman;font-size:13.3333px;font-style:normal;font-variant-ligatures:normal;font-variant-caps:normal;letter-spacing:normal;orphans:2;text-align:justify;text-indent:-24px;text-transform:none;white-space:normal;widows:2;word-spacing:0px;-webkit-text-stroke-width:0px;text-decoration-style:initial;text-decoration-color:initial">Issued and outstanding</strong></span></span></span></span><br/>&#160;</p>
              <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Reconciliation of the Company's share capital is as follows:</span></span><span>&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;</span></span></span></span></span></p>
              <div>
                <div>

                    <table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000">
                      <tbody>
                        <tr>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td colspan="4" style="border-bottom:1px solid #000000;vertical-align:bottom;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Class A shares</strong></span></span></span></span></td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td colspan="4" style="border-bottom:1px solid #000000;vertical-align:bottom;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Class B shares</strong></span></span></span></span></td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td colspan="4" style="border-bottom:1px solid #000000;vertical-align:bottom;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Warrants</strong></span></span></span></span></td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>#</strong></span></span></span></span></td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>$</strong></span></span></span></span></td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>#</strong></span></span></span></span></td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>$</strong></span></span></span></span></td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>#</strong></span></span></span></span></td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>$</strong></span></span></span></span></td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td style="vertical-align:bottom">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(204, 238, 255)">
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Balance, January 1, 2019</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>72</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>151,588</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>6,843,780</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>51,093,434</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>546,212</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3,341,826</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(255, 255, 255)">
                          <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Shares issued [a] [b] [c] [d]</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>408,651</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>8,681,103</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(204, 238, 255)">
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Issued on acquisition of net assets of Prismic Pharmaceuticals, Inc. [e]</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>510,940</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>12,361,657</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>67,598</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,420,407</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(255, 255, 255)">
                          <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Stock options exercised</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(204, 238, 255)">
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Share-based payments</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>130,189</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,340,929</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(255, 255, 255)">
                          <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Warrants exercised</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>12,167</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>109,214</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(12,167</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(37,753</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                        </tr>
                        <tr style="background-color:rgb(204, 238, 255)">
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Warrants expired</span></span></span></span></td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(134,192</span></span></span></span></td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(402,491</span></span></span></span></td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                        </tr>
                        <tr style="background-color:rgb(255, 255, 255)">
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Balance, December 31, 2019</strong></span></span></span></span></td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>72</strong></span></span></span></span></td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>151,588</strong></span></span></span></span></td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>7,905,727</strong></span></span></span></span></td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>73,586,337</strong></span></span></span></span></td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>467,451</strong></span></span></span></span></td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>4,321,989</strong></span></span></span></span></td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(204, 238, 255)">
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Shares issued [g] [j] [k] [l] [n] [o]</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>8,925,942</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>22,242,975</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>6,335,758</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,110,904</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(255, 255, 255)">
                          <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Share-based payments [f] [h] [i] [m]</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,307,569</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>6,663,479</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(204, 238, 255)">
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Share options exercised</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>22,382</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>563,747</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(255, 255, 255)">
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Warrants expired&#160;</span></span></span></span></td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(54,100</span></span></span></span></td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(463,935</span></span></span></span></td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                        </tr>
                        <tr style="background-color:rgb(204, 238, 255)">
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Balance, December 31, 2020</strong></span></span></span></span></td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>72</strong></span></span></span></span></td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>151,588</strong></span></span></span></span></td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>19,161,620</strong></span></span></span></span></td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>103,056,538</strong></span></span></span></span></td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>6,749,109</strong></span></span></span></span></td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>4,968,958</strong></span></span></span></span></td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                        </tr>
                      </tbody>
                    </table>

                  <p>&#160;</p>
                  <div>
                    <div>
                      <p style="margin-top:0pt;margin-left:20pt;margin-bottom:0pt;text-align:justify;text-indent:-18pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400">[a]<span style="width:7.99pt;text-indent:0pt;display:inline-block">&#160;</span>On April 24, 2019, the Company entered into a share exchange agreement with Aura. Pursuant to the share exchange agreement, FSD acquired 13,562,386 common shares at C$0.2212 per share in the capital of Aura in exchange for the issuance of 65,577 Class B shares of the Company at C$45.75 for a total value of $2,256,900.</span></span></span></p>
                      <p style="margin-top:0pt;margin-left:48px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
                    </div>
                  </div>
                </div>
              </div>
              <div style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:start;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-left:24px;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>On September 20, 2019, the Company issued an additional<span><span><span><span><span><span> 61,892 </span></span></span></span></span></span>Class B shares as part of the adjustment of purchase price related to the share exchange agreement with Aura to settle the related derivative liability. As part of the settlement, the Company recognized a loss on change in the fair value of derivative liability of $1,069,798.</span></span></span></span><br/>&#160;</p>
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span>[b]<span style="width:7.75pt;display:inline-block"> </span></span></span></span></span></span></span>On May 7, 2019, the Company entered into an agreement with Solarvest. Per the agreement the Company issued 49,751 </span></span>Class B Shares to Solarvest in exchange for the investment in Solarvest for a total fair value of $1,880,750. Refer to Note 7 for details regarding the investment in Solarvest.</span></span></p>
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt">&#160;</p>
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span>[c]<span style="width:7.75pt;display:inline-block"> </span></span></span></span></span></span></span>On October 4, 2019, the Company issued 3,735 Class B shares in settlement for trade payables of $18,808.</span></span></span></span><br/>&#160;</p>
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span>[d]<span style="width:7.75pt;display:inline-block"> </span>On November 4, 2019, the Company completed a private placement </span></span></span></span></span></span>through<span><span><span><span><span><span> the issuance of 228,670 Class B shares at a price of C$20.10 per share for total gross proceeds of $3,455,898.</span></span></span></span></span></span></span></span></span></span></p>
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt">&#160;</p>
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400">[e]<span style="width:7.99pt;text-indent:0pt;display:inline-block">&#160;</span>On June 29, 2019, the Company acquired all outstanding common and preferred shares of Prismic through the issuance of an aggregate of 510,940 Class B Shares. The Class B Shares issued to the Prismic shareholders were deposited into escrow upon closing of the transaction and were subject to an 18-month staggered escrow release.</span></span></span></p>
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt">&#160;</p>
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400">[f]<span style="width:8.5pt;text-indent:0pt;display:inline-block">&#160;</span>On January 2, 2020, the Company issued 27,580 Class B Common Shares as share-based compensation to certain members of the Board of Directors for services performed as directors for the fiscal year 2019 for the amount payable of $74,117, which was recorded as trade and other payables as at December 31, 2019.&#160;</span></span></span></p>
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt">&#160;</p>
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400">[g]<span style="width:6.99pt;text-indent:0pt;display:inline-block">&#160;</span>On February 4, 2020, the Company issued 225,371 Class B Common Shares to Solarvest as settlement under the Share Exchange Agreement to settle the derivative liability of $1,990,788.</span></span></span></p>
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt">&#160;</p>
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400">[h]<span style="width:6.99pt;text-indent:0pt;display:inline-block">&#160;</span>On March 16, 2020, the Company issued 405,926 Class B Common Shares as part of a share-based bonus to employees for performance related to fiscal year 2019 resulting in movement of $1,302,076 from contributed surplus to share capital and the recognition of an additional share-based compensation expense of $93,502 as a result of the increase in value of the shares issued.&#160;</span></span></span></p>
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt">&#160;</p>
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400">[i]<span style="width:9.5pt;text-indent:0pt;display:inline-block">&#160;</span>On March 16, 2020, the Company issued 69,069 Class B Common Shares to members of the Board of Directors as share-based compensation, in lieu of cash, for their annual compensation for the year ended December 31, 2020.</span></span></span></p>
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt">&#160;</p>
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400">[j]<span style="width:9pt;text-indent:0pt;display:inline-block">&#160;</span>On April 15, 2020, the Company issued 63,714 Class B Common Shares to settle Prismic notes payable of $226,385. The fair value of the Class B Common Shares was $185,976 resulting in a gain on settlement of liability of $40,409.</span></span></span></p>
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt">&#160;</p>
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;text-indent:-18pt;margin-left:24px;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400">[k]<span style="width:6.5pt;text-indent:0pt;display:inline-block">&#160;</span>On June 8, 2020, the Company issued 1,500,000 Class B Common Shares and 1,500,000 warrants as part of a private placement financing for total cash proceeds of C$10,125,000 ($7,617,038). The more reliably measured component, Class B Common Shares, were measured first, with the residual amount being allocated to the warrants. The fair value of the Class B Common Shares was $7,515,477 and the residual value allocated to the warrants was $101,561. The Company incurred issuance costs of $707,043, which has been allocated pro-rata to the common shares and warrants.&#160;</span></span></span></p>
                <p style="margin-top:0pt;margin-left:20pt;margin-bottom:0pt;text-align:justify;text-indent:-18pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
                </div></div>
                <div style="text-align:start">
                  <table style="width:100%;border-collapse:collapse;font-size:13px;border:0px">
                    <tbody>
                      <tr>
                        <td style="width:1333px">
                          <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400">[l]<span style="width:8.5pt;text-indent:0pt;display:inline-block">&#160;</span>On August 6, 2020, the Company issued 2,762,430 Class B Common Shares and 1,381,215 warrants as part of a direct offering for total cash proceeds of $9,999,997. Total cash proceeds were allocated to the warrants liability first with the residual amount allocated to the Class B Common Shares (Note 12). The fair value of the warrants liability was determined to be $3,289,069 and the residual amount of $6,710,928 was allocated to the Class B Common Shares. The Company incurred total cash transaction costs of $913,349. Transaction costs allocated to the warrants of $284,049 were expensed immediately and the transaction costs allocated to common shares were deducted from equity.</span></span></span></p>
                          <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
                          <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400">[m]<span style="width:3.5pt;text-indent:0pt;display:inline-block">&#160;</span>In August 2020, the Company approved the issuance of 1,804,994 Class B Common Shares to members of the Board of Directors and certain officers and employees of the company in the form of a compensation bonus for past services provided. Total fair value of the share-based compensation bonus was $4,956,324.</span></span></span></p>
                          <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
                          <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400">[n]<span style="width:5.99pt;text-indent:0pt;display:inline-block">&#160;</span>During the year ended December 31, 2020, the Company issued 56,248 Class B Common Shares through the Equity Distribution Agreement with A.G.P/Alliance Global Partners for net proceeds of $199,785.</span></span></span></p>
                          <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
                          <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400">[o]<span style="width:5.99pt;text-indent:0pt;display:inline-block">&#160;</span>In October 2020, the Company issued 4,318,179 Class B Common Shares and 3,454,543 warrants as part of a direct offering for total proceeds of $9,499,994. The more reliably measured component, Class B Common Shares, were measured first, with the residual amount being allocated to the warrants. The fair value of the Class B Common Shares was $8,377,267 and the residual value allocated to the warrants was $1,122,727. The Company incurred issuance costs of $879,621, which has been allocated pro-rata to the common shares and warrants.&#160;</span></span></span><br/>&#160;</p>
                        </td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The changes in the number of warrants outstanding during the year ended December 31, 2020 and 2019 were as follows:<span>&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160;</span></span></span></p>
                <div>
                  <div>

                      <table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000">
                        <tbody>
                          <tr>
                            <td style="vertical-align:bottom">&#160;</td>
                            <td style="text-align:right;vertical-align:bottom">&#160;</td>
                            <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>&#160;Number of warrants&#160;</strong></span></span></span></span></td>
                            <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>&#160;Weighted average<br/>exercise price&#160;</strong></span></span></span></span></td>
                            <td style="text-align:right;vertical-align:bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom">&#160;</td>
                            <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                            <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>&#160;#&#160;</strong></span></span></span></span></td>
                            <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                            <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                            <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>&#160;C$&#160;</strong></span></span></span></span></td>
                            <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          </tr>
                          <tr style="background-color:rgb(204, 238, 255)">
                            <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Outstanding as at December 31, 2018</span></span></span></span></td>
                            <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                            <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>546,212</span></span></span></span></td>
                            <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                            <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                            <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>9.47</span></span></span></span></td>
                            <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          </tr>
                          <tr style="background-color:rgb(255, 255, 255)">
                            <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Issued</span></span></span></span></td>
                            <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                            <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>67,598</span></span></span></span></td>
                            <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                            <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                            <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>10.45</span></span></span></span></td>
                            <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          </tr>
                          <tr style="background-color:rgb(204, 238, 255)">
                            <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Exercised</span></span></span></span></td>
                            <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                            <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(12,167</span></span></span></span></td>
                            <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                            <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                            <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>7.81</span></span></span></span></td>
                            <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          </tr>
                          <tr style="background-color:rgb(255, 255, 255)">
                            <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Expired</span></span></span></span></td>
                            <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                            <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(134,192</span></span></span></span></td>
                            <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                            <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                            <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>7.64</span></span></span></span></td>
                            <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          </tr>
                          <tr style="background-color:rgb(204, 238, 255)">
                            <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Outstanding as at December 31, 2019</span></span></span></span></td>
                            <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                            <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>467,451</span></span></span></span></td>
                            <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                            <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                            <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>10.20</span></span></span></span></td>
                            <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          </tr>
                          <tr style="background-color:rgb(255, 255, 255)">
                            <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Issued</span></span></span></span></td>
                            <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                            <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>6,335,758</span></span></span></span></td>
                            <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                            <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                            <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>5.27</span></span></span></span></td>
                            <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          </tr>
                          <tr style="background-color:rgb(204, 238, 255)">
                            <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Expired</span></span></span></span></td>
                            <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                            <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(54,100</span></span></span></span></td>
                            <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                            <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                            <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.97</span></span></span></span></td>
                            <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          </tr>
                          <tr style="background-color:rgb(255, 255, 255)">
                            <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Outstanding as at December 31, 2020</strong></span></span></span></span></td>
                            <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                            <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>6,749,109</strong></span></span></span></span></td>
                            <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                            <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                            <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>5.62</strong></span></span></span></span></td>
                            <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          </tr>
                        </tbody>
                      </table>

                  </div>
                </div>
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt">&#160;</p>
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Measurement of fair values</strong></span></span><br/>&#160;</p>
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The fair value of warrants&#160;during the year&#160;ended December 31, 2020&#160;and 2019&#160;were estimated at the date of grant using the Black-Scholes option pricing model with the following inputs:&#160;</span></span></p>
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt">&#160;</p>
                <div>
                  <div>

                      <table border="0" style="width:100%;border-collapse:collapse;font-size:10pt">
                        <tbody>
                          <tr>
                            <td>&#160;</td>
                            <td style="text-align:right;border-bottom:1px solid #000000;width:25%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2020</strong></span></span></td>
                            <td style="text-align:right;border-bottom:1px solid #000000;width:25%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2019</strong></span></span></td>
                          </tr>
                          <tr style="background-color:rgb(204, 238, 255)">
                            <td style="background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Grant date share price</span></span></td>
                            <td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">C$2.58 - C$4.00</span></span></td>
                            <td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">C$32.16</span></span></td>
                          </tr>
                          <tr style="background-color:rgb(255, 255, 255)">
                            <td style="background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise price</span></span></td>
                            <td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">C$3.46 - C$5.80</span></span></td>
                            <td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">C$2.61 - C$26.73</span></span></td>
                          </tr>
                          <tr style="background-color:rgb(204, 238, 255)">
                            <td style="background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expected dividend yield</span></span></td>
                            <td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#x2014;</span></span></td>
                            <td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#x2014;</span></span></td>
                          </tr>
                          <tr style="background-color:rgb(255, 255, 255)">
                            <td style="background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Risk free interest rate</span></span></td>
                            <td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.32% 0.36%</span></span></td>
                            <td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.41% - 1.52%</span></span></td>
                          </tr>
                          <tr style="background-color:rgb(204, 238, 255)">
                            <td style="background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expected life</span></span></td>
                            <td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5 years</span></span></td>
                            <td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.39 - 6.55</span></span></td>
                          </tr>
                          <tr style="background-color:rgb(255, 255, 255)">
                            <td style="background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expected volatility</span></span></td>
                            <td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">118% - 121%</span></span></td>
                            <td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></td>
                          </tr>
                        </tbody>
                      </table>

                  </div>
                </div>
                <p>&#160;</p>
                <div>
                  <div>

                      <div>
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table is a summary of the Company's warrants outstanding as at December 31, 2019:<span style="text-align:start">&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;</span></span></span></p>
                        <div>
                          <div>
                            <table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000">
                              <tbody>
                                <tr>
                                  <td colspan="6" style="text-align:center;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Warrants Outstanding</strong></span></span></td>
                                  <td colspan="1" style="text-align:center;vertical-align:bottom">&#160;</td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom">&#160;</td>
                                  <td style="text-align:right;vertical-align:bottom">&#160;</td>
                                  <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Exercise price</strong></span></span></td>
                                  <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                                  <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                                  <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Number outstanding</strong></span></span></td>
                                  <td style="text-align:right;vertical-align:bottom">&#160;</td>
                                </tr>
                                <tr>
                                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Expiry Date</strong></span></span></td>
                                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>C$</strong></span></span></td>
                                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>#</strong></span></span></td>
                                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(204, 238, 255)">
                                  <td style="vertical-align:bottom;text-align:center;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">August 1, 2021</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.43</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,476</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(255, 255, 255)">
                                  <td style="vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">May 24, 2022</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18.09</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">163,535</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(204, 238, 255)">
                                  <td style="vertical-align:bottom;text-align:center;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">September 15, 2022</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.42</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">199,005</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(255, 255, 255)">
                                  <td style="vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">May 20, 2023</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16.08</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,311</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(204, 238, 255)">
                                  <td style="vertical-align:bottom;text-align:center;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">July 24, 2023</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13.07</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,357</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(255, 255, 255)">
                                  <td style="vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">September 11, 2023</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.43</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22,382</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(204, 238, 255)">
                                  <td style="vertical-align:bottom;text-align:center;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">May 4, 2025</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26.73</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,730</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(255, 255, 255)">
                                  <td style="vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">May 10, 2025</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26.73</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,865</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(204, 238, 255)">
                                  <td style="vertical-align:bottom;text-align:center;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">May 17, 2025</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26.73</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,730</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(255, 255, 255)">
                                  <td style="vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">May 31, 2025</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26.73</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,865</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(204, 238, 255)">
                                  <td style="vertical-align:bottom;text-align:center;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">June 8, 2025</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9.65</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,500,000</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(255, 255, 255)">
                                  <td style="vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">August 6, 2020 (i)</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.42</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,381,215</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(204, 238, 255)">
                                  <td style="vertical-align:bottom;text-align:center;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">October 20, 2020 (ii)</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.31</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,454,543</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(255, 255, 255)">
                                  <td style="vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">January 16, 2026</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26.73</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,722</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(204, 238, 255)">
                                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">January 20, 2026</span></span></td>
                                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26.73</span></span></td>
                                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">373</span></span></td>
                                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(255, 255, 255)">
                                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.62</span></span></td>
                                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,749,109</span></span></td>
                                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                </tr>
                              </tbody>
                            </table><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;&#160;&#160;</span></span>
                            <p style="margin-left:108pt;margin-bottom:0pt;text-indent:-36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(i)<span style="width:28.89pt;text-indent:0pt;display:inline-block">&#160;</span>Warrants were issued in US$ with exercise price of $4.26</span></span></p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;&#160;&#160;</span></span>
                            <p style="margin-top:0pt;margin-left:108pt;text-indent:-36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(ii)<span style="width:26.12pt;text-indent:0pt;display:inline-block">&#160;</span>Warrants were issued in US$ with exercise price of $2.60<span style="text-align:start;text-indent:0px">&#160; &#160;</span></span></span></p>
                            <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table is a summary of the Company's warrants outstanding as at December 31, 2019:<span style="text-align:start">&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160;&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160;</span></span></span></p>
                            <table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000">
                              <tbody>
                                <tr>
                                  <td colspan="6" style="text-align:center;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Warrants Outstanding</strong></span></span></td>
                                  <td colspan="1" style="text-align:center;vertical-align:bottom">&#160;</td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom">&#160;</td>
                                  <td style="text-align:right;vertical-align:bottom">&#160;</td>
                                  <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Exercise price</strong></span></span></td>
                                  <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                                  <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                                  <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Number outstanding</strong></span></span></td>
                                  <td style="text-align:right;vertical-align:bottom">&#160;</td>
                                </tr>
                                <tr>
                                  <td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Expiry Date</strong></span></span></td>
                                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>C$</strong></span></span></td>
                                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>#</strong></span></span></td>
                                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(204, 238, 255)">
                                  <td style="text-align:center;vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">January 5, 2020</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6.03</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">37,313</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(255, 255, 255)">
                                  <td style="text-align:center;vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">November 30, 2020</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.61</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16,787</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(204, 238, 255)">
                                  <td style="text-align:center;vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">August 1, 2021</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.43</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,476</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(255, 255, 255)">
                                  <td style="text-align:center;vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">May 24, 2022</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18.09</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">163,535</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(204, 238, 255)">
                                  <td style="text-align:center;vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">September 15, 2022</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.42</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">199,005</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(255, 255, 255)">
                                  <td style="text-align:center;vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">May 20, 2023</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16.08</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,311</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(204, 238, 255)">
                                  <td style="text-align:center;vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">July 24, 2023</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13.07</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,357</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(255, 255, 255)">
                                  <td style="text-align:center;vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">September 11, 2023</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.43</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22,382</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(204, 238, 255)">
                                  <td style="text-align:center;vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">May 4, 2025</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26.73</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,730</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(255, 255, 255)">
                                  <td style="text-align:center;vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">May 10, 2025</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26.73</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,865</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(204, 238, 255)">
                                  <td style="text-align:center;vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">May 17, 2025</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26.73</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,730</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(255, 255, 255)">
                                  <td style="text-align:center;vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">May 31, 2025</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26.73</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,865</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(204, 238, 255)">
                                  <td style="text-align:center;vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">January 16, 2026</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26.73</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,722</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(255, 255, 255)">
                                  <td style="border-bottom:1px solid rgb(0, 0, 0);text-align:center;vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">January 20, 2026</span></span></td>
                                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26.73</span></span></td>
                                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">373</span></span></td>
                                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(204, 238, 255)">
                                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10.20</span></span></td>
                                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">467,451</span></span></td>
                                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                </tr>
                              </tbody>
                            </table>
                          </div>
                        </div>
                      </div>

                  </div>
                </div>
              <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReservesWithinEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReservesWithinEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share capital, reserves and other equity interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 79<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923861643944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory', window );">Share-based compensation</a></td>
<td class="text">
      <div>
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:-18pt;font-style:normal;font-weight:400;margin-left:24px;margin-top:0pt;margin-bottom:0pt"><strong>14.<span style="width:5.49pt;text-indent:0pt;display:inline-block"> </span>Share-based compensation</strong><br/>&#160;</p>
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt">The Company has established a share option plan (the "Option Plan") for directors, officers, employees and consultants of the Company. The Company's Board of Directors determines, among other things, the eligibility of individuals to participate in the Option Plan, the term and vesting periods, and the exercise price of options granted to individuals under the Option Plan.</p>
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt">&#160;</p>
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt">Each share option converts into one common share of the Company on exercise. No amounts are paid or payable by the individual on receipt of the option. The options carry neither rights to dividends nor voting rights. Options may be exercised at any time from the date of vesting to the date of their expiry.</p>
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-left:3px;margin-top:0pt;margin-bottom:0pt">&#160;</p>
        <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left">Share-based payment arrangements</strong></span></span></span></span></p>
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">The changes in the number of share options during the year ended December 31, 2020 and 2019 were as follows:</p>
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160;</span></span></span></p>
        <div>
          <div>

              <table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000">
                <tbody>
                  <tr>
                    <td style="vertical-align:bottom">&#160;</td>
                    <td style="text-align:right;vertical-align:bottom">&#160;</td>
                    <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>&#160;Number of<br/>options&#160;</strong></span></span></td>
                    <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>&#160;Weighted average<br/>exercise price&#160;</strong></span></span></td>
                    <td style="text-align:right;vertical-align:bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom">&#160;</td>
                    <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                    <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>&#160;#&#160;</strong></span></span></td>
                    <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                    <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                    <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>&#160;C$&#160;</strong></span></span></td>
                    <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(204, 238, 255)">
                    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding as at December 31, 2018</span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">485,159</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">74.53</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Granted</span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,363,322</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20.68</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(204, 238, 255)">
                    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercised</span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(82,094</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10.02</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Forfeited</span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,438</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">56.28</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(204, 238, 255)">
                    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cancelled</span></span></td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(299,006</span></span></td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">115.80</span></span></td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding as at December 31, 2019</span></span></td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,454,943</span></span></td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">21.96</span></span></td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(204, 238, 255)">
                    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Granted</span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,082,639</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.14</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercised</span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(22,382</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.61</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(204, 238, 255)">
                    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cancelled</span></span></td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(822,137</span></span></td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">31.65</span></span></td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Outstanding as at December 31, 2020</strong></span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>1,693,063</strong></span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>6.11</strong></span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(204, 238, 255)">
                    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Exercisable as at December 31, 2020</strong></span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>1,528,186</strong></span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>6.13</strong></span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  </tr>
                </tbody>
              </table>

          </div>
        </div>
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p>
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Measurement of fair values</strong></span></span></span></span></div>
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p>
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">The fair value of share options granted during the year ended December 31, 2020 and 2019 were estimated at the date of grant using the Black-Scholes option pricing model with the following inputs:</p>
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p>
        <div>
          <div>

              <div>
                <table border="0" style="width:100%;border-collapse:collapse;font-size:10pt">
                  <tbody>
                    <tr>
                      <td>&#160;</td>
                      <td style="text-align:right;border-bottom:1px solid #000000;width:25%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>&#160;2020&#160;</strong></span></span></td>
                      <td style="text-align:right;border-bottom:1px solid #000000;width:25%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>&#160;2019&#160;</strong></span></span></td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Grant date share price</span></span></td>
                      <td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>&#160;C$3.75 &#x2014; C$9.54&#160;</strong></span></span></td>
                      <td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;C$6.45 &#x2014; C$75.38&#160;</span></span></td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise price</span></span></td>
                      <td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>&#160;C$3.68 &#x2014; C$9.80&#160;</strong></span></span></td>
                      <td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;C$7.17 &#x2014; C$75.38&#160;</span></span></td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expected dividend yield</span></span></td>
                      <td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>&#x2014;</strong></span></span></td>
                      <td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Risk free interest rate</span></span></td>
                      <td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>0.27% &#x2014;&#160; 1.55%</strong></span></span></td>
                      <td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.24% &#x2014;&#160; 1.90%</span></span></td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expected life</span></span></td>
                      <td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>&#160;4 &#x2014; 9 years&#160;</strong></span></span></td>
                      <td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;5 years&#160;</span></span></td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expected volatility</span></span></td>
                      <td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>120%</strong></span></span></td>
                      <td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></td>
                    </tr>
                  </tbody>
                </table>
              </div>

          </div>
        </div>
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">Expected volatility was estimated by using the annualized historical volatility of the Company. The expected option life represents the period of time that options granted are expected to be outstanding. The risk-free interest rate is based on Canadian government bonds with a remaining term equal to the expected life of the options.</p>
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>

          <div>
            <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">The following table is a summary of the Company's share options outstanding as at December 31, 2020:</p>
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span>&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;</span></p>
            <div>
              <div>
                <table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000">
                  <tbody>
                    <tr>
                      <td style="vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td colspan="7" style="text-align:center;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Options outstanding</strong></span></span></td>
                      <td colspan="1" style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td colspan="4" style="text-align:center;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Options exercisable</strong></span></span></td>
                      <td colspan="1" style="text-align:center;vertical-align:bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise price</span></span></td>
                      <td style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number outstanding</span></span></td>
                      <td style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted average remaining contractual life [years]</span></span></td>
                      <td style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise price</span></span></td>
                      <td style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number exercisable</span></span></td>
                      <td style="text-align:center;vertical-align:bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">C$</span></span></td>
                      <td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">#</span></span></td>
                      <td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">#</span></span></td>
                      <td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">C$</span></span></td>
                      <td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">#</span></span></td>
                      <td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.61</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,683</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.49</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.61</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,683</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.75</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,500</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6.47</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.75</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">500</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.86</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">872,139</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.08</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.86</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">864,139</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.42</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">99,502</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.71</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.42</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">99,502</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.75</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">110,000</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.29</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.75</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">77,500</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.03</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">60,000</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.70</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.03</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,498</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.43</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16,264</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.49</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.43</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16,264</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6.16</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20,000</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.18</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6.16</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20,000</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.17</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">199,005</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.83</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.17</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">199,005</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.63</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">203,750</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.34</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.63</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">138,750</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9.54</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,000</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.06</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9.54</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,125</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10.65</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,730</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.49</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10.65</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,730</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13.07</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,855</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.49</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13.07</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,855</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13.47</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,418</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.49</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13.47</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,418</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16.08</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18,409</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.49</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16.08</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18,409</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17.89</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,178</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.49</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17.89</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,178</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18.09</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17,413</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.21</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18.09</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17,413</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20.10</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,289</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.27</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20.10</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,289</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">47.24</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,493</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.37</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">47.24</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,493</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">50.25</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,224</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.31</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">50.25</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,224</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">52.26</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">498</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.21</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">52.26</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">498</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">55.28</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">498</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.12</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">55.28</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">498</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">59.30</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">498</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.96</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">59.30</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">498</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">75.38</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">498</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.04</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">75.38</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">498</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">86.43</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,244</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.87</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">86.43</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,244</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">142.71</span></span></td>
                      <td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,975</span></span></td>
                      <td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.74</span></span></td>
                      <td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">142.71</span></span></td>
                      <td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,975</span></span></td>
                      <td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6.11</span></span></strong></td>
                      <td style="text-align:left;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="border-bottom:2px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="border-bottom:2px solid rgb(0, 0, 0);text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,693,063</span></span></strong></td>
                      <td style="border-bottom:2px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="border-bottom:2px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="border-bottom:2px solid rgb(0, 0, 0);text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.88</span></span></strong></td>
                      <td style="border-bottom:2px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="border-bottom:2px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="border-bottom:2px solid rgb(0, 0, 0);text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6.13</span></span></strong></td>
                      <td style="border-bottom:2px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="border-bottom:2px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="border-bottom:2px solid rgb(0, 0, 0);text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,528,186</span></span></strong></td>
                      <td style="border-bottom:2px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                  </tbody>
                </table>
                <div>
                  <p style="text-align:center">&#160;</p>
                </div>
                <div style="text-align:left"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="text-align:justify">The following table is a summary of the Company's share options outstanding as at December 31, 2019:</span></span></span></div>
                <div style="text-align:left">&#160;</div>
                <table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000">
                  <tbody>
                    <tr>
                      <td colspan="1" style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td colspan="7" style="text-align:center;vertical-align:bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><strong>Options outstanding</strong></span></span></td>
                      <td colspan="1" style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td colspan="4" style="text-align:center;vertical-align:bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><strong>Options exercisable</strong></span></span></td>
                      <td style="text-align:center;vertical-align:bottom;width:2%">&#160;</td>
                    </tr>
                    <tr>
                      <td style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Exercise price</span></span></td>
                      <td style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Number outstanding</span></span></td>
                      <td style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Weighted average remaining contractual life [years]</span></span></td>
                      <td style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Exercise price</span></span></td>
                      <td style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Number exercisable</span></span></td>
                      <td style="text-align:center;vertical-align:bottom;width:2%">&#160;</td>
                    </tr>
                    <tr>
                      <td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">C$</span></span></td>
                      <td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">#</span></span></td>
                      <td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">#</span></span></td>
                      <td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">C$</span></span></td>
                      <td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">#</span></span></td>
                      <td style="text-align:center;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2.61</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">35,065</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">3.49</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2.61</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">35,065</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4.42</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">99,502</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2.71</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4.42</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">99,502</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">5.43</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">16,264</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">3.49</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">5.43</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">16,264</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">10.65</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">3,730</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">3.49</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">10.65</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">3,730</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">13.07</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">10,855</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">3.49</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">13.07</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">10,855</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">13.47</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,418</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">3.49</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">13.47</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,418</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">16.08</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">18,409</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">3.49</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">16.08</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">18,409</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">17.89</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4,178</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">3.49</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">17.89</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4,178</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">18.09</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">37,313</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">3.34</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">18.09</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">37,313</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">20.10</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">493,363</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4.72</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">20.10</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">493,363</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">21.11</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">12,438</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4.67</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">21.11</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">12,438</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">24.12</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">9,950</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4.59</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">24.12</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">6,219</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">26.13</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">14,925</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">3.62</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">26.13</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">14,925</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">40.20</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">29,851</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4.45</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">40.20</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">22,388</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">44.22</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2,488</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">3.41</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">44.22</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2,488</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">47.24</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,493</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4.37</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">47.24</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,493</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">50.25</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">227,861</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">5.09</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">50.25</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">129,353</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">52.26</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">498</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4.21</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">52.26</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">498</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">55.28</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">498</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4.12</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">55.28</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">498</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">59.30</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">498</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">3.96</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">59.30</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">498</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">7.17</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">199,005</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4.83</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">7.17</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">199,005</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">75.38</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">498</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4.04</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">75.38</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">498</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">7.63</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">203,750</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">5.34</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">7.63</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">58,750</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">86.43</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,244</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">3.88</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">86.43</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,244</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">88.44</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">14,925</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">3.87</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">88.44</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">14,925</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">120.60</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">9,950</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">3.71</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">120.60</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">9,950</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">142.71</span></span></td>
                      <td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4,974</span></span></td>
                      <td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">3.74</span></span></td>
                      <td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">142.71</span></span></td>
                      <td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4,975</span></span></td>
                      <td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;border-bottom:1.5pt solid black;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;border-bottom:1.5pt solid black;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">21.96</span></span></td>
                      <td style="text-align:left;border-bottom:1.5pt solid black;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;border-bottom:1.5pt solid black;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;border-bottom:1.5pt solid black;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,454,943</span></span></td>
                      <td style="text-align:left;border-bottom:1.5pt solid black;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;border-bottom:1.5pt solid black;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;border-bottom:1.5pt solid black;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4.59</span></span></td>
                      <td style="text-align:left;border-bottom:1.5pt solid black;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;border-bottom:1.5pt solid black;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;border-bottom:1.5pt solid black;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">21.24</span></span></td>
                      <td style="text-align:left;border-bottom:1.5pt solid black;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;border-bottom:1.5pt solid black;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;border-bottom:1.5pt solid black;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,200,242</span></span></td>
                      <td style="text-align:right;border-bottom:1.5pt solid black;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                  </tbody>
                </table>
              </div>
            </div>
          </div>

      </div>
      <p style="margin:0pt">&#160;</p>
      <p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During the year ended December 31, 2020, the Company cancelled 822,137 share options outstanding and issued 822,137 replacement share options at an exercise price of C$3.86 resulting in incremental grant date fair value of $661,811 which was expensed immediately as all the replacement share options vested on date of replacement. The fair value was determined using the Black-Scholes option pricing model and the following assumptions: exercise price of C$3.86, the underlying share price of C$3.86, risk free interest rate of 0.72% and annualized volatility of 120%.</span></span></p>
      <div>
        <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company recognized $8,052,011 of share-based compensation expenses during the year ended December 31, 2020 (2019 - $12,082,930).</span></span></p>
      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 44<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_44&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923861427000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss per share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EarningsPerShareAbstract', window );"><strong>Earnings per share [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfEarningsPerShareExplanatory', window );">Loss per share</a></td>
<td class="text">
    <div>
      <p style="text-align:justify"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15.&#160; Loss per share</span></span></strong></p>
      <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss per common share represents net loss attributable to common shareholders divided by the weighted average number of common shares outstanding during the year.</span></span></p>
      <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For all the periods presented, diluted loss per share equals basic loss per share due to the anti-dilutive effect of warrants and share options. The outstanding number and type of securities that could potentially dilute basic net loss per share in the future but would have decreased the loss per share (anti-dilutive) for the period ended December 31, 2020 and 2019 presented are as follows:</span></span></p>

        <div>
          <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;margin-left:auto;margin-right:auto;width:100%">
            <tbody>
              <tr>
                <td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                <td colspan="4" rowspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><strong>Year ended December 31,</strong></p>
                </td>
                <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
              </tr>
              <tr style="background-color:rgb(255, 255, 255)">
                <td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2020</strong></span></span></td>
                <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2019</span></span></td>
                <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
              </tr>
              <tr style="background-color:rgb(255, 255, 255)">
                <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>#</strong></span></span></td>
                <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">#</span></span></td>
                <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
              </tr>
              <tr style="background-color:rgb(230, 239, 255)">
                <td style="vertical-align:bottom;text-align:left;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Warrants</span></span></td>
                <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>6,749,109</strong></span></span></td>
                <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">467,451</span></span></td>
                <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)">&#160;</td>
              </tr>
              <tr style="background-color:rgb(255, 255, 255)">
                <td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share Options</span></span></td>
                <td style="border:1pt none;vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="border:1pt none;vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>1,693,063</strong></span></span></td>
                <td style="border:1pt none;vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="border:1pt none;vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="border:1pt none;vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,454,943</span></span></td>
                <td style="border:1pt none;vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
              </tr>
              <tr style="background-color:rgb(230, 239, 255)">
                <td style="vertical-align:bottom;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>8,442,172</strong></span></span></td>
                <td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,922,394</span></span></td>
                <td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)">&#160;</td>
              </tr>
            </tbody>
          </table>
        </div>

    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2019-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2019-en-r&amp;doctype=Standard&amp;dita_xref=IAS33_g70-73A_TI<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923858985064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General and administrative<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract', window );"><strong>Selling, general and administrative expense [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory', window );">General and administrative</a></td>
<td class="text">
    <div>
      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-left:3px;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>16.<span style="width:5.25pt;display:inline-block"> </span>General and administrative</strong></span></span></span></span></p>
      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-left:3px;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Components of general and administrative expenses for the year ended December 31, 2020 and 2019 were as follows:&#160;</span></span></p>
      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-left:3px;margin-top:0pt;margin-bottom:0pt">&#160;</p>

        <div>
          <div>
            <table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000">
              <tbody>
                <tr>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom">&#160;</td>
                  <td colspan="4" style="text-align:center;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Year ended December 31,</strong></span></span></td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2020</strong></span></span></td>
                  <td style="text-align:right;vertical-align:bottom">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2019</span></span></td>
                  <td style="text-align:right;vertical-align:bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
                  <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td>
                  <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
                  <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
                  <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td>
                  <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
                </tr>
                <tr style="background-color:rgb(204, 238, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Professional fees</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2,734,123</strong></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,101,136</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">General office, insurance and administration expenditures</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>3,616,159</strong></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,742,550</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(204, 238, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Consulting fees</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>1,775,269</strong></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,675,258</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Salaries, wages and benefits</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2,656,162</strong></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,705,696</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(204, 238, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Investor relations</span></span></p>
                  </td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>541,944</strong></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,241,275</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Building and facility costs</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>586,926</strong></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">676,798</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(204, 238, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign exchange loss</span></span></td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>(186,959</strong></span></span></td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>)</strong></span></span></td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>11,723,624</strong></span></span></td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,142,713</span></span></td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(204, 238, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Allocated to:</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(204, 238, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Continuing operations</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>10,058,083</strong></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,407,427</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Discontinued operations</span></span></td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>1,665,541</strong></span></span></td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,735,286</span></span></td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                </tr>
              </tbody>
            </table>
          </div>
        </div>

    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of general and administrative expenses. [Refer: Administrative expenses]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923861662296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxesPaidRefundAbstract', window );"><strong>Income taxes paid (refund) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIncomeTaxExplanatory', window );">Income taxes</a></td>
<td class="text">
    <div>
      <p style="text-align:justify;margin-top:0pt;margin-left:5.25pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong><span>17.<span style="width:5.25pt;display:inline-block">&#160;</span>Income taxes</span></strong></span></p>
      <p style="text-align:justify;margin-left:2.25pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">The reconciliation of income tax expense for the years ended December 31, 2020 and 2019 consists of the following:</span></p>

        <div>
          <div style="margin-left:39pt">&#160;</div>
          <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;margin-right:auto;width:90%">
            <tbody>
              <tr style="background-color:rgb(255, 255, 255)">
                <td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>2020</strong></span></td>
                <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>2019</strong></span></td>
                <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
              </tr>
              <tr style="background-color:rgb(255, 255, 255)">
                <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>$</strong></span></td>
                <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>$</strong></span></td>
                <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
              </tr>
              <tr style="background-color:rgb(230, 239, 255)">
                <td style="vertical-align:bottom;text-align:left;border-top:1pt solid black;background-color:rgb(230, 239, 255)">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Loss from continuing operations before income taxes</p>
                </td>
                <td style="vertical-align:bottom;text-align:left;width:1%;border-top:1pt solid black;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;width:17%;border-top:1pt solid black;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>(28,452,232</strong></span></td>
                <td style="vertical-align:bottom;text-align:left;width:2%;border-top:1pt solid black;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>)</strong></span></td>
                <td style="vertical-align:bottom;text-align:left;width:1%;border-top:1pt solid black;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;width:17%;border-top:1pt solid black;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(34,080,963</span></td>
                <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span></td>
              </tr>
              <tr style="background-color:rgb(255, 255, 255)">
                <td style="vertical-align:bottom;text-align:left;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Statutory federal and provincial tax rate</span></p>
                </td>
                <td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>26.50%</strong></span></td>
                <td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">26.50%</span></td>
                <td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
              </tr>
              <tr style="background-color:rgb(230, 239, 255)">
                <td style="vertical-align:bottom;text-align:left;background-color:rgb(230, 239, 255)">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Income tax recovery at the statutory tax rate</span></p>
                </td>
                <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>(7,539,841</strong></span></td>
                <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>)</strong></span></td>
                <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(9,031,455</span></td>
                <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span></td>
              </tr>
              <tr style="background-color:rgb(255, 255, 255)">
                <td style="vertical-align:bottom;padding-left:0pt;background-color:rgb(255, 255, 255)">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><span>Permanent&#160;</span><span>differences</span></span></p>
                </td>
                <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>2,235,657</strong></span></td>
                <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">5,866,153</span></p>
                </td>
                <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
              </tr>
              <tr style="background-color:rgb(230, 239, 255)">
                <td style="vertical-align:bottom;padding-left:0pt;background-color:rgb(230, 239, 255)">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Book to filing adjustments</p>
                </td>
                <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong>(1,545,244</strong></p>
                </td>
                <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)">)</td>
                <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">4,765,959</p>
                </td>
                <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)">&#160;</td>
              </tr>
              <tr style="background-color:rgb(255, 255, 255)">
                <td style="vertical-align:bottom;padding-left:0pt;background-color:rgb(255, 255, 255)">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Share issuance cost booked directly to equity</p>
                </td>
                <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong>(584,538</strong></p>
                </td>
                <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">)</td>
                <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)">&#x2014;</td>
                <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
              </tr>
              <tr style="background-color:rgb(230, 239, 255)">
                <td style="vertical-align:bottom;padding-left:0pt;background-color:rgb(230, 239, 255)">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Foreign exchange</p>
                </td>
                <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong>(370,457</strong></p>
                </td>
                <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)">)</td>
                <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)">&#x2014;</td>
                <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)">&#160;</td>
              </tr>
              <tr style="background-color:rgb(255, 255, 255)">
                <td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Change in tax benefits not recognized</span></p>
                </td>
                <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>7,804,423</strong></span></td>
                <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(1,600,657</span></p>
                </td>
                <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span></td>
              </tr>
              <tr style="background-color:rgb(230, 239, 255)">
                <td style="vertical-align:bottom;text-align:left;padding-left:7.5pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:left;width:1%;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;width:17%;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>&#x2014;</strong></span></td>
                <td style="vertical-align:bottom;text-align:left;width:2%;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:left;width:1%;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;width:17%;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>&#x2014;</strong></span></p>
                </td>
                <td style="vertical-align:bottom;text-align:left;width:2%;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)">&#160;</td>
              </tr>
            </tbody>
          </table>
        </div>

      <div>
        <p><br/><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Deferred taxes reflect the tax effects of temporary differences that arise due to the differences between the income tax values and the carrying amount of assets and liabilities. Deferred tax liabilities as at December 31, 2020 and 2019 are comprised of the following:&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;</span></p>
        <div>
          <div>

              <table cellspacing="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;width:90%">
                <tbody>
                  <tr>
                    <td style="vertical-align:bottom">&#160;</td>
                    <td style="vertical-align:bottom">&#160;</td>
                    <td style="vertical-align:bottom;text-align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>2020</strong></span></td>
                    <td style="vertical-align:bottom;text-align:right">&#160;</td>
                    <td style="vertical-align:bottom;text-align:right">&#160;</td>
                    <td style="vertical-align:bottom;text-align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2019</span></td>
                    <td style="vertical-align:bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;border-bottom:1px solid #000000">&#160;</td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1px solid #000000">&#160;</td>
                    <td style="vertical-align:bottom;width:12%;text-align:right;border-bottom:1px solid #000000"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>$</strong></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1px solid #000000">&#160;</td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1px solid #000000">&#160;</td>
                    <td style="vertical-align:bottom;width:12%;text-align:right;border-bottom:1px solid #000000"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$</span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1px solid #000000">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Other investments</span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>&#x2014;</strong></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(126,461</span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">)</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;border-bottom:1px solid #000000"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Capital losses carried forward</span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1px solid #000000">&#160;</td>
                    <td style="vertical-align:bottom;width:12%;text-align:right;border-bottom:1px solid #000000"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>&#x2014;</strong></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1px solid #000000">&#160;</td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1px solid #000000">&#160;</td>
                    <td style="vertical-align:bottom;width:12%;text-align:right;border-bottom:1px solid #000000"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">126,461</span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1px solid #000000">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e6efff"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>Total</strong></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1px solid #000000;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:12%;text-align:right;border-bottom:1px solid #000000;background-color:#e6efff"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>&#x2014;</strong></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1px solid #000000;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1px solid #000000;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:12%;text-align:right;border-bottom:1px solid #000000;background-color:#e6efff"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#x2014;</span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1px solid #000000;background-color:#e6efff">&#160;</td>
                  </tr>
                </tbody>
              </table>
            <span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#160;&#160;&#160;</span>
            <p><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Deferred tax assets have not been recognized in respect of the following temporary differences as at December 31, 2020 and 2019:</span></p>
          </div>
        </div>
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
        <div>
          <div>

              <div>
                <table border="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;width:90%">
                  <tbody>
                    <tr>
                      <td style="vertical-align:bottom">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>2020</strong></span></td>
                      <td style="text-align:right;vertical-align:bottom">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2019</span></td>
                      <td style="text-align:right;vertical-align:bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                      <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                      <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>$</strong></span></td>
                      <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                      <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                      <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$</span></td>
                      <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(230, 239, 255)">
                      <td style="vertical-align:bottom;background-color:rgb(230, 239, 255)">
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Non-capital losses - Canada</span></p>
                      </td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>44,897,393</strong></span></td>
                      <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">20,703,137</span></td>
                      <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Net-operating loss - US</span></p>
                      </td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(255, 255, 255)">
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>5,032,915</strong></span></p>
                      </td>
                      <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(255, 255, 255)">
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">206,480</span></p>
                      </td>
                      <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(230, 239, 255)">
                      <td style="vertical-align:bottom;background-color:rgb(230, 239, 255)">
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Unrealized foreign exchange loss</span></p>
                      </td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>94,733</strong></span></td>
                      <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#x2014;</span></td>
                      <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Share-issuance costs</span></td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>3,419,003</strong></span></td>
                      <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">879,959</span></td>
                      <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(230, 239, 255)">
                      <td style="vertical-align:bottom;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Capital losses carried forward</span></td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>&#x2014;</strong></span></td>
                      <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">263,666</span></td>
                      <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Other investments</span></td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>4,449,544</strong></span></td>
                      <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">968,811</span></td>
                      <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(230, 239, 255)">
                      <td style="vertical-align:bottom;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">IFRS 16</span></td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>125,962</strong></span></td>
                      <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#x2014;</span></td>
                      <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Property, plant and equipment</span></td>
                      <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:15%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>88,248</strong></span></td>
                      <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:15%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">30,290</span></td>
                      <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(230, 239, 255)">
                      <td style="vertical-align:bottom;border-bottom:1pt solid black;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong><span>Total</span></strong></span></td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1pt solid black;background-color:rgb(230, 239, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:15%;text-align:right;border-bottom:1pt solid black;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>58,107,798</strong></span></td>
                      <td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1pt solid black;background-color:rgb(230, 239, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1pt solid black;background-color:rgb(230, 239, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:15%;text-align:right;border-bottom:1pt solid black;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">23,052,343</span></td>
                      <td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1pt solid black;background-color:rgb(230, 239, 255)">&#160;</td>
                    </tr>
                  </tbody>
                </table>
              </div>

          </div>
        </div>
        <p style="margin:0pt">&#160;</p>
        <div>
          <div>
            <p><span style="font-size:10pt;font-family:Times New Roman, Times, serif">The Company's Canadian non-capital income tax losses expire as follows:&#160;&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160;</span></p>
          </div>
        </div>
        <div>
          <div>

              <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;width:90%;float:left" width="90%">
                <tbody>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:left">&#160;</td>
                    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%">&#160;</td>
                    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:center;border-bottom:1px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$</span></td>
                    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(230, 239, 255)">
                    <td style="vertical-align:bottom;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(230, 239, 255);width:89%"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2032</span></td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%">&#160;</td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(230, 239, 255);width:8%"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">26,982</span></td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2033</span></td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">114,405</span></td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(230, 239, 255)">
                    <td style="vertical-align:bottom;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2034</span></td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%">&#160;</td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">144,411</span></td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2035</span></td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">65,782</span></td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(230, 239, 255)">
                    <td style="vertical-align:bottom;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2036</span></td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%">&#160;</td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">689,676</span></td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2037</span></td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2,677,789</span></td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(230, 239, 255)">
                    <td style="vertical-align:bottom;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2038</span></td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%">&#160;</td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">6,092,686</span></td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2039</span></td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">11,415,413</span></td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(230, 239, 255)">
                    <td style="vertical-align:bottom;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2040</span></td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%">&#160;</td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:1px solid rgb(0, 0, 0);font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">23,670,249</span></td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:1px solid rgb(0, 0, 0);font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)">44,897,393</td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
                  </tr>
                </tbody>
              </table>

          </div>
        </div>
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p>
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">The company has cumulative United States federal net operating loss carryforwards of approximately $5.03M which will start to expire in 2032. Utilization of net operating loss carryforwards may be subject to limitations in the event of a change in ownership pursuant to IRC &#xa7; 382, and similar state provisions. As a result of the acquisition of Prismic on June 28, 2019, the preacquisition net operating loss carryforwards of approximately $4.93M could be subject to IRC &#xa7; 382 limitation as the acquisition could constitute a change of ownership.</p>
      </div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIncomeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;doctype=Standard&amp;dita_xref=IAS12_g79-88_TI<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIncomeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxesPaidRefundAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxesPaidRefundAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923861632744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfCommitmentsAndContingentLiabilitiesAbstract', window );"><strong>Disclosure Of Commitments And Contingent Liabilities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory', window );">Commitments and contingencies</a></td>
<td class="text">
      <div>
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-left:3px;margin-top:0pt;margin-bottom:0pt"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18. Commitments and contingencies</span></span></strong></p>
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-left:3px;margin-top:0pt;margin-bottom:0pt">&#160;</p>
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-left:3px;margin-top:0pt;margin-bottom:0pt"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Commitments</span></span></strong></p>
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-left:3px;margin-top:0pt;margin-bottom:0pt">&#160;</p>
        <div>
          <div>
            <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><i>Epitech License Agreement</i></span></span></p>
            <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Under the terms of the Company's License Agreement with Epitech Group SPA ("Epitech"), the Company has payments due to Epitech pending the achievement of specified milestones. Upon first notification by the Food and Drug Administration ("FDA") of approval of a New Drug Application, the non-refundable sum of $700,000 will be due and payable to Epitech. Within ten business days of the first notification of approval of a Supplemental New Drug Application by the FDA, the Company will pay the non-refundable sum of $1,000,000 to Epitech.</span></span></p>
            <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For non-prescription drug rights, any one-off lump sum payments received by the Company as consideration for granting a sub-license to a Commercial Partner with respect to a Licensed Product, shall require the Company to pay to Epitech 25% of the lump sum payment received by the Company. For prescription drug rights the Company shall pay 5% of any one-off lump sum payments to Epitech as consideration for granting a sub-license to a Commercial Partner with respect to a Licensed Product. The Company will pay the amounts payable on a quarterly basis within 60 days of the end of each calendar quarter.</span></span></p>
            <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company shall pay either a) 7% of Net Sales of the Licensed Product in a Product Regulatory Category other than prescription drugs place on the market by the Company; or b) 25% of Net Receipts received by the Company from Commercial Partners where Licensed Products in a Product Regulatory Category other than prescription drugs are placed on the market by such Commercial Partners; or c) 5% of Net Sales or Net receipts of the Licensed Products in the Product Regulatory Category of prescription drugs. The Company will pay the amounts payable on a quarterly basis within 60 days of the end of each calendar quarter.&#160;</span></span></p>
            <div>
              <div>
                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><i>Heritage Building Restoration Commitment</i></span></span></p>
                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has a commitment to restore the designated heritage building on the Company's premises. The estimated commitment of remaining restoration work to be completed is $266,349.</span></span></p>
                <p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Contingencies</strong></span></span></p>
                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><i>Legal matters</i></span></span></p>
                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">From time to time, the Company is named as a party to claims or involved in proceedings, including legal, regulatory and tax related, in the ordinary course of its business. While the outcome of these matters may not be estimable at the reporting date, the Company makes provisions, where possible, for the estimated outcome of such claims or proceedings. Should a loss result from the resolution of any claims or proceedings that differs from these estimates, the difference will be accounted for as a charge to profit or loss in that period.</span></span></p>
                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><i>Environmental </i></span></span></p>
                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Management believes that there are no probable environmental related liabilities that will have a material adverse effect on the financial position or operating results of the Company.</span></span></p>
                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><i>Claims from suppliers </i></span></span></p>
                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A dismissed contractor commenced a lien action combined with a breach of contract action in the Cobourg Superior Court of Justice in early 2019 claiming approximately C$1,700,000 in various purported damages, with the claim for lien component of C$188,309 being registered on November 26, 2018. The Company has paid C$235,387 to the Cobourg Superior Court to vacate the lien from title for which the funds stand both as security for the lien claim as well as its costs with the Cobourg Superior Court of Justice.</span></span></p>
                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On October 7, 2020, FSD signed a settlement agreement of C$198,000. On December 16, 2020, the settlement was paid from funds paid into court and the remaining balance was remitted to the Company in accordance with the settlement agreement.</span></span></p>
                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><i>Former employee </i></span></span></p>
                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">FSD hired an individual by way of employment agreement. The individual's employment was subsequently terminated in the probationary period due to non-performance/cause in February 2019. The individual retained legal counsel in or around February 15, 2019 demanding that he be provided (i) unpaid wages; (ii) unpaid holiday pay, (iii) payment for wrongful dismissal (one week) and (iv) breach of contract.</span></span></p>
                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has a provision of $81,562 (&#xa3;59,748) in relation to the claimed amounts for unpaid wages and unpaid holiday pay.</span></span></p>
                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On July 29, 2020, a judgment was issued ordering the Company to pay unpaid wages and unpaid holiday pay in the amount of &#xa3;59,748. On August 6, 2020, the Company filed an application for reconsideration for that decision which was refused by the Tribunal on October 24, 2020.</span></span></p>
              </div>
            </div>
            <div>
              <div>
                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On August 25, 2020, the Claimant filed a separate cost order against the Company. To date, the Tribunal has not responded to this matter. The ultimate outcome of the matter cannot be reliably determined at this time and no additional provision has been recorded for this matter as at December 31, 2020.</span></span></p>
                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><i>Class Action </i></span></span></p>
                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On February 22, 2019, a shareholder in FSD commenced a proposed class action proceeding against the Company by issuing a statement of claim in the Ontario Superior Court. Amongst other causes of action, the individual seeks leave to bring a claim pursuant to s.138 of the Ontario Securities Act, alleging the Company made statements containing misrepresentations related to the build-out of the Company's Cobourg facility.</span></span></p>
                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has settled the class action by entering into a definitive settlement agreement in the amount of C$5.5M. In entering into the Settlement Agreement, the Company made no admissions of liability whatsoever. The Settlement Agreement provides for a full and final release of the Company, its officers, directors and various other related parties from any and all claims that arose or could have arisen from the claim issued by the plaintiff within the Settled Action.</span></span></p>
                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During November 2020, the Company paid C$928,541 as part of the settlement with the remaining amount of C$4,571,459 covered by the Company's insurance policy. The Settlement Agreement was approved in the Superior Court of Justice of Ontario on February 4, 2021.</span></span></p>
                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><i>Auxly Cannabis Group Inc. </i></span></span></p>
                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On March 3, 2018, FSD entered into a Definitive Strategic Alliance and Streaming Agreement (the "Agreement") with Auxly Cannabis Group Inc. ("Auxly"). On February 6, 2019, the Company delivered to Auxly a Notice of Default, thereby terminating the Agreement effective immediately. Subsequent to the issuance of the Notice of Default, Auxly sent a Notice of Default to the Company on February 6, 2019 in response. To date, neither party has taken further legal action against the counter party.</span></span></p>
                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">To fund the development, Auxly purchased 37,313 Class B shares for the aggregate of $5,642,250 from the Company's treasury by way of private placement, which funds were placed in trust to be spent on construction and development costs. The funds were placed in a trust account to be administered by Auxly. Due to the termination and subsequent negotiations, it is indeterminable at this point as to the amount, if any, of these funds will be released to the Company. Should any funds be released to the Company, those amounts will be recognized in future periods.</span></span></p>
              </div>
            </div>
          </div>
        </div>
      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfCommitmentsAndContingentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfCommitmentsAndContingentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of commitments and contingent liabilities. [Refer: Contingent liabilities [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923861606968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related party transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract', window );"><strong>Disclosure of transactions between related parties [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfRelatedPartyExplanatory', window );">Related party transactions</a></td>
<td class="text">
    <p style="text-align:justify"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>19.<span style="width:5.25pt;display:inline-block"> </span>Related party transactions</span></span></span></span></strong></p>
    <div style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:start;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt">
      <div>
        <div>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Key management personnel are those persons having the authority and responsibility for planning, directing and controlling activities of the entity, directly or indirectly.</span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Transactions with key management and directors comprised the following:</span></span></p>
          <p style="margin-left:36pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:14pt;text-indent:0pt;display:inline-block">&#160;</span>The Company paid expenses of $1,445,043 (2019 - $567,468) to a company owned by the CEO for the year ended December 31, 2020, included in the consolidated statement of loss and comprehensive loss under various expense line categories. As at December 31, 2020, the CEO has repaid a related party loan of $355,778 for withholding taxes paid by the Company on behalf of the CEO in relation to the Class B common shares issued during the year ended December 31, 2020.</span></span></p>
          <p style="margin-left:36pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:14pt;text-indent:0pt;display:inline-block">&#160;</span>As at December 31, 2020, the President of FSD BioSciences Division has repaid a related party loan of $21,876 for withholding taxes paid by the Company on behalf of the President of FSD BioSciences Division in relation to the Class B common shares issued during the year ended December 31, 2020.</span></span></p>
          <p style="margin-left:36pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:14pt;text-indent:0pt;display:inline-block">&#160;</span>The Company pays independent directors C$40,000 per annum, with the Chairman of each respective committee receiving an additional C$10,000 per annum. Directors compensation for the year ended December 31, 2020 was $246,226 (2019 - $153,109) which included $238,703 recognized as share-based compensation. As of December 31, 2020, directors have received their compensation for the 2020 fiscal year in advance, through the issuance of Class B shares.&#160;</span></span></p>
          <p style="margin-left:36pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:14pt;text-indent:0pt;display:inline-block">&#160;</span>The Company issued 1,676,066 shares to key management and directors in the form of a compensation bonus for past services provided during the year ended December 31, 2020. The fair value of shares issued to key management and directors is $4,602,301 and is included in share-based payments and bonuses below.&#160;</span></span></p>
        </div>
      </div>
    </div>
    <div style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:start;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt">
      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Key management personnel compensation during the year ended December 31, 2020 and 2019 is comprised of:</span></span></span></span></p>
      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt">&#160;</p>

        <div>
          <p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt">&#160;</p>
          <table border="0" cellpadding="0" cellspacing="0" style="width:80%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-right:auto">
            <tbody>
              <tr style="background-color:rgb(255, 255, 255)">
                <td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2020</strong></span></span></td>
                <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2019</strong></span></span></td>
                <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
              </tr>
              <tr style="background-color:rgb(255, 255, 255)">
                <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td>
                <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td>
                <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
              </tr>
              <tr style="background-color:rgb(230, 239, 255)">
                <td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Salaries, benefits, bonuses and consulting fees</span></span></td>
                <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,936,816</span></span></strong></td>
                <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,638,267</span></span></td>
                <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)">&#160;</td>
              </tr>
              <tr style="background-color:rgb(255, 255, 255)">
                <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;padding-left:1.5pt;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based payments</span></span></td>
                <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:17%;background-color:rgb(255, 255, 255)"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,045,994</span></span></strong></td>
                <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,385,984</span></span></td>
                <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
              </tr>
              <tr style="background-color:rgb(230, 239, 255)">
                <td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;padding-left:1.5pt;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong>Total</strong></p>
                </td>
                <td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong>9,982,810</strong></p>
                </td>
                <td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">13,024,251</p>
                </td>
                <td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)">&#160;</td>
              </tr>
            </tbody>
          </table>
        </div>

    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRelatedPartyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2019-01-01<br> -Section Disclosures<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2019-en-r&amp;doctype=Standard&amp;dita_xref=IAS24_g13-24_TI<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRelatedPartyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923863148200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Management<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfCapitalManagementAbstract', window );"><strong>Disclosure Of Capital Management [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory', window );">Capital Management</a></td>
<td class="text">
    <p style="text-align:justify"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20.<span style="width:5.25pt;display:inline-block"> </span>Capital Management</span></span></strong></p>
    <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify">The Company's capital management objectives are to maintain financial flexibility in order to complete the pharmaceutical research and development program centered on the lead asset, micro-PEA. The Company defines capital as the aggregate of its capital stock and borrowings.</p>
    <p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt">&#160;</p>
    <p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt">As at December 31, 2020, the Company's Share Capital was<span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"> $103,208,126 (2019&#160;- $73,737,925)&#160;</span></span>The Company does not have any long-term debt. Outstanding Notes payable were assumed on acquisition of Prismic and are due on demand.</p>
    <p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt">&#160;</p>
    <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify">The Company manages its capital structure in accordance with changes in economic conditions. In order to maintain or adjust its capital structure, the Company may elect to issue or repay financial liabilities, issue shares, repurchase shares or undertake any other activities as deemed appropriate under the specific circumstances. The Company is not subject to any externally imposed capital requirements.</p>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfCapitalManagementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfCapitalManagementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of information that enables users of financial statements to evaluate the entity's objectives, policies and processes for managing capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 134<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_134&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923863187608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Risk Management<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsAbstract', window );"><strong>Disclosure of detailed information about financial instruments [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory', window );">Financial Instruments and Risk Management</a></td>
<td class="text">
    <div>
      <div>
        <div>
          <p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>21.</strong><span style="width:5.49pt;text-indent:0pt;display:inline-block">&#160;</span><strong>Financial Instruments and Risk Management</strong></span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><i>Credit risk</i></span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Credit risk is the risk of financial loss to the Company if a customer or counterparty to a financial instrument fails to meet its contractual obligations, and arises principally from deposits with banks and outstanding receivables. The Company trades only with recognized, creditworthy third parties. The Company does not currently have any material outstanding trade receivables with customers.</span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company does not hold any collateral as security but mitigates this risk by dealing only with what management believes to be financially sound counterparties and, accordingly, does not anticipate significant loss for non-performance.</span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><i>Liquidity risk</i></span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Liquidity risk is the risk the Company will not be able to meet its financial obligations as they come due. The Company's exposure to liquidity risk is dependent on the Company's ability to raise additional financing to meet its commitments and sustain operations. The Company mitigates liquidity risk by management of working capital, cash flows, the issuance of share capital and if desired, the issuance of debt. The Company's trade and other payables and notes payables are all due within twelve months from the date of these financial statements.</span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">If unanticipated events occur that impact the Company's ability to carrying the planned clinical trials, the Company may need to take additional measures to increase its liquidity and capital resources, including issuing debt or additional equity financing or strategically altering the business forecast and plan. In this case, there is no guarantee that the Company will obtain satisfactory financing terms or adequate financing. Failure to obtain adequate financing on satisfactory terms could have a material adverse effect on the Company's results of operations or financial condition.</span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><i>Market risk</i></span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Market risk is the risk the fair value or future cash flows of a financial instrument will fluctuate because of changes in market prices. Market risk comprises three types of risk: foreign currency risk, interest rate risk and other price risk.</span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:32.85pt;display:inline-block">&#160;</span>Foreign currency risk</span></span></p>
          <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency risk arises on financial instruments that are denominated in a currency other than the functional currency in which they are measured. The Company's primary exposure with respect to foreign currencies is from Canadian dollar denominated cash and other payables. A 1% change in the foreign exchange rates would not result in any significant impact to the financial statements.</span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:32.85pt;display:inline-block">&#160;</span>Interest rate risk</span></span></p>
          <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest rate risk is the risk the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company is not exposed to interest rate risk as at December 31, 2020 as there are no material long-term borrowings outstanding.</span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:32.85pt;display:inline-block">&#160;</span>Other price risk</span></span></p>
          <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other price risk is the risk the fair value or future cash flows of a financial instrument will fluctuate because of changes in market prices (other than those arising from interest rate risk or currency risk), whether those changes are caused by factors specific to the individual financial instrument or its issuer, or factors affecting all similar financial instruments traded in the market. The Company is not exposed to other price risk as at December 31, 2020.</span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><i>Fair values</i></span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The carrying values of cash, other receivables, trade and other payables and notes payable approximate fair values due to the short-term nature of these items or they are being carried at fair value or, for notes payable, interest payables are close to the current market rates. The risk of material change in fair value is not considered to be significant. The Company does not use derivative financial instruments to manage this risk.</span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial instruments recorded at fair value on the consolidated statement of financial position are classified using a fair value hierarchy that reflects the significance of the inputs used in making the measurements. The Company categorizes its fair value measurements according to a three-level hierarchy. The hierarchy prioritizes the inputs used by the Company's valuation techniques. A level is assigned to each fair value measurement based on the lowest-level input significant to the fair value measurement in its entirety. The three levels of the fair value hierarchy are defined as follows:</span></span></p>
          <p style="margin-left:72pt;text-indent:-36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:32.85pt;text-indent:0pt;display:inline-block">&#160;</span>Level 1 - Unadjusted quoted prices as at the measurement date for identical assets or liabilities in active markets.</span></span></p>
          <p style="margin-left:72pt;text-indent:-36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:32.85pt;text-indent:0pt;display:inline-block">&#160;</span>Level 2 - Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.</span></span></p>
          <p style="margin-left:72pt;text-indent:-36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:32.85pt;text-indent:0pt;display:inline-block">&#160;</span>Level 3 - Significant unobservable inputs that are supported by little or no market activity. The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.</span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The fair value hierarchy requires the use of observable market inputs whenever such inputs exist. A financial instrument is classified to the lowest level of the hierarchy for which a significant input has been considered in measuring fair value.</span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Private company investments measured at fair value are classified as Level 3 financial instruments. The valuation method and significant assumptions used to determine the fair value of private company investments have been disclosed in the Investments note. During the year, there were no transfers of amounts between levels.</span></span></p>
        </div>
      </div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Section Scope<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;doctype=Standard&amp;dita_xref=IFRS07_g3-5A_TI<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923895847640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segmented information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract', window );"><strong>Disclosure of operating segments [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsExplanatory', window );">Segmented information</a></td>
<td class="text">
    <div>
      <div>
        <div>
          <p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>22.</strong><span style="width:5.49pt;text-indent:0pt;display:inline-block">&#160;</span><strong>Segmented information</strong></span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company reports segment information based on internal reports used by the chief operating decision maker ("CODM") to make operating and resource decisions and to assess performance. The CODM is the Chief Executive Officer of the Company. The CODM makes decisions and assesses performance of the Company on a consolidated basis such that the Company is a single reportable operating segment.</span></span></p>
        </div>
      </div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of operating segments. [Refer: Operating segments [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923864352104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract', window );"><strong>Disclosure of non-adjusting events after reporting period [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory', window );">Subsequent events</a></td>
<td class="text">
        <div>
          <p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>23.</strong><span style="width:5.49pt;text-indent:0pt;display:inline-block"> </span><strong>Subsequent events</strong></span></span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>On January 21, 2021, the Company approved the grant of 75,000 share options to certain board members.</span></span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>January 22, 2021, the Corporation announced that it will hold its annual meeting of shareholders on June 29, 2021, at which, in addition to normal course matters, it will address matters contained in a requisition for a special meeting submitted to the Corporation by certain shareholders of the Corporation claiming to hold in excess of 5.1% of the Corporation's class B subordinated voting shares, including two directors of the Corporation. These shareholders are seeking to reduce the size of the Corporation's board of directors to five, and to replace six of the incumbent directors with three directors selected by such shareholders.</span></span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The annual meeting date of June 29, 2021 was contested by certain shareholders and, pursuant to a decision by the Superior Court of Justice, province of Ontario, issued on March 5, 2021, the annual meeting of shareholders and special meeting of the shareholders&#160;has been set for May 14, 2021. Furthermore, the annual meeting of shareholders shall be conducted by an independent chair and Class B Common Shares issued on February 17, 2021, to certain directors and officers of the Company will not be allowed to vote at the meeting.</span></span></span></span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>From February 1, 2021 to February 10, 2021, the Company issued 7,356,326 Class B Common Shares through the Equity Distribution Agreement with A.G.P/Alliance Global Partners for gross proceeds of $19,770,762.</span></span></span></p>
          <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>On February 11, 2021, the Company entered into an Equity Distribution Agreement (the "Equity Distribution Agreement") with A.G.P./Alliance Global Partners. Under the Sales Agreement the Company may, at its discretion and from time-to-time during the term of the Sales Agreement, sell, through the Sales Agent, Class B Subordinate Voting Shares of the Company, with an aggregate offering price of up to $20,000,000.</span></span></span></p>
          </div>
          <div>
            <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify">From February 11, 2021 to March 12, 2021, the Company issued 7,247,288 Class B Common Shares through the Equity Distribution Agreement with A.G.P/Alliance Global Partners for gross proceeds of $18,167,511.</p>
            <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
            <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify">On February 17, 2021, the Company issued 1,349,764 Class B Common Shares to certain directors and officers of the Company. The fair value of the shares based on the February 17, 2021 closing share price of $2.65 per Class B Common Share was $3,576,875.</p>
            <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify">&#160;</p>
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Effective March 1, 2021, Randell Mack was appointed as President of FSD Biosciences and Dr. Ed Brennan was name Chief Medical Officer of the Company.&#160;</span></span></p>
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify">&#160;</p>
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">In March 2021, the Corporation entered into a license agreement ("Innovet License Agreement") with Innovet Italia S.R.L. ("Innovet"), under which Innovet granted the Company a license to use ultra-micro PEA to develop FDA approved veterinary drugs for the treatment of gastro-intestinal diseases in canines and felines. Under the Innovet License Agreement, the Corporation is required to make payments to Innovet upon the achievement of certain milestones.</span></span></p>
          </div>
        <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of non-adjusting events after the reporting period. [Refer: Non-adjusting events after reporting period [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 10<br> -IssueDate 2019-01-01<br> -Paragraph 21<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=10&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_21&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923859690856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant accounting policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_SummaryOfSignificantAccountingPoliciesAbstract', window );"><strong>Summary Of Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents', window );">Cash</a></td>
<td class="text">
            <div>
              <p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[a]<span style="width:7.99pt;text-indent:0pt;display:inline-block">&#160;</span>Cash</span></span></p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash consists of cash and cash held in trust accounts. There are no restrictions on cash held in trust.</span></span></p>
            </div>
          <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory', window );">Property, Plant and Equipment</a></td>
<td class="text">
            <div>
              <p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[b]<span style="width:7.99pt;text-indent:0pt;display:inline-block">&#160;</span>Property, Plant and Equipment</span></span></p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property, plant and equipment is measured at cost less accumulated depreciation and impairment losses, with the exception of land which is not depreciated.&#160; &#160; &#160; &#160; &#160; &#160; &#160;</span></span></p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">When parts of an item of property, plant and equipment have different useful lives, they are accounted for as separate items (major components) of property, plant and equipment.</span></span></p>
              <p style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The cost of replacing part of an item of property, plant and equipment is recognized in the carrying amount of the item if it is probable that the future economic benefits embodied within the part will flow to the Company and its cost can be measured reliably. The carrying amount of the replaced part is derecognized. The costs of the day-to-day servicing of property, plant and equipment are recognized in consolidated statements of loss and comprehensive loss.</span></span></p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsequent costs are included in the asset's carrying amount or recognized as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Company and the cost of the item can be measured reliably. All other repairs and maintenance are charged to the consolidated statements of loss and comprehensive loss.</span></span></p>
              <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">Gains and losses on disposal of an item of property, plant and equipment are determined by comparing the proceeds from disposal with the carrying amount and are recognized net within other income in the consolidated statements of loss and comprehensive loss.<br/>&#160;</p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation is based on the estimated useful lives of the assets provided as follows:</span></span></p>
              <div>

                  <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;margin-left:auto;margin-right:auto;width:75%">
                    <tbody>
                      <tr style="background-color:rgb(204, 238, 255)">
                        <td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;height:0px;background-color:rgb(204, 238, 255)">
                          <p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computer equipment</span></span></p>
                        </td>
                        <td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;height:0px;background-color:rgb(204, 238, 255)">
                          <p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">30% declining balance</span></span></p>
                        </td>
                      </tr>
                      <tr style="background-color:rgb(255, 255, 255)">
                        <td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Production equipment</span></span></td>
                        <td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20% declining balance</span></span></td>
                      </tr>
                      <tr style="background-color:rgb(204, 238, 255)">
                        <td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Furniture and fixtures</span></span></td>
                        <td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20% declining balance</span></span></td>
                      </tr>
                      <tr style="background-color:rgb(255, 255, 255)">
                        <td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)">
                          <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Facility and related</span></span><span style="font-size:10pt">&#160;</span></p>
                        </td>
                        <td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20 years under straight-line</span></span></td>
                      </tr>
                      <tr style="background-color:rgb(204, 238, 255)">
                        <td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)">
                          <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Land</span></span></span></p>
                        </td>
                        <td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)">
                          <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Not amortized</span></span></span></p>
                        </td>
                      </tr>
                    </tbody>
                  </table>

              </div>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">An item of property, plant and equipment and any significant part initially recognized are derecognized upon disposal or when no future economic benefits are expected from their use or disposal. Any gain or loss arising on derecognition of the asset (calculated as the difference between the net disposal proceeds and the carrying amount of the asset) is included in the consolidated statements of loss and comprehensive loss when the asset is derecognized. The assets' residual values, useful lives and methods of depreciation and the depreciation charge are adjusted prospectively, if appropriate.</span></span></p>
            </div>
          <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory', window );">Intangible Assets</a></td>
<td class="text">
            <div>
              <div>
                <p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[c]<span style="width:8.5pt;text-indent:0pt;display:inline-block">&#160;</span>Intangible Assets</span></span></p>
                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">intangible assets are recorded at cost less accumulated amortization and accumulated impairment losses. Amortization is recognized in profit or loss on a straight-line basis over the following terms:</span></span></p>
                <div>
                  <div>


                      <div>
                        <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;margin-left:auto;margin-right:auto;width:75%">
                          <tbody>
                            <tr style="background-color:rgb(204, 238, 255)">
                              <td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)">
                                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Intellectual Property</span></span></p>
                              </td>
                              <td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)">
                                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5 years</span></span></p>
                              </td>
                            </tr>
                          </tbody>
                        </table>
                      </div>


                  </div>
                </div>
              </div>
              <div>
                <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><br/>Expenditures on internally generated intangible assets during the development phase, which comprise deferred development costs, are initially capitalized and recognized in the consolidated balance sheet if they meet the recognition criteria. Subsequent to initial recognition, deferred development costs are accounted for at cost less accumulated amortization and are amortized on a straight-line basis over an estimated useful life beginning once the deferred development costs are used in commercial production. Expenditures on internally generated intangible assets during the research phase are expensed as incurred.</p>
              </div>
            </div>
          <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue', window );">Revenue Recognition</a></td>
<td class="text">
              <div>
                <p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[d]<span style="width:7.99pt;text-indent:0pt;display:inline-block">&#160;</span>Revenue Recognition</span></span></p>
                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company's accounting policy for revenue recognition under IFRS 15, Revenue from Contracts with Customers ("IFRS 15") is to follow a five step model to determine the amount and timing of revenue to be recognized i) identify the contract with a customer; ii) identify the performance obligations in the contract; iii) determine the transaction price; iv) allocate the transaction price to the performance obligations in the contract; and v) recognize revenue when (or as) the Company satisfies a performance obligation.</span></span></p>
                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue from the sale of cannabis is recognized when the Company transfers control of the good to the customer. This is generally considered to have occurred when products have been delivered to the location specified in the sales contract and accepted by the customer.</span></span></p>
                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company recognizes revenue in an amount that reflects the consideration the Company expects to receive taking into account any variation that may result from rights of return.</span></span></p>
                <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify">The Company was required to remit excise tax to the Canada Revenue Agency on the sale of medical cannabis in Canada. The Company became liable for these excise duties when cannabis products were delivered to the customer. In accordance with IFRS 15, revenue presented within discontinued operations (Note 5) represents revenue from the sale of goods less applicable excise tax.</p>
                <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Areas of judgment include identifying the customer per the definition within IFRS 15 and determining whether control has passed to the customer.</span></span></p>
              </div>
            <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory', window );">Foreign Currency Translation</a></td>
<td class="text">
            <div>
              <p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[e]<span style="width:7.99pt;text-indent:0pt;display:inline-block">&#160;</span>Foreign Currency Translation</span></span></p>
              <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">Foreign currency transactions are translated into United States dollars at exchange rates in effect on the date of the transactions. Monetary assets and liabilities denominated in foreign currencies at the statement of financial position date are translated to United States dollars at the foreign exchange rate applicable at that date. Realized and unrealized exchange gains and losses are recognized through profit or loss.</p>
              <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-monetary assets and liabilities that are measured in terms of historical cost in a foreign currency are translated using the exchange rate at the date of the transaction.</span></span></p>
              <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">The assets and liabilities of foreign operations with functional currencies other than United States dollars, are translated into United States dollars at year-end exchange rates. Income and expenses, and cash flows of such foreign operations are translated into United States dollars using average exchange rates for the period. Exchange differences resulting from translating foreign operations are recognized in other comprehensive loss and accumulated in equity.<br/>&#160;</p>
            </div>
          <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory', window );">Financial Instruments</a></td>
<td class="text">
            <div>
              <p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[f]<span style="width:10.5pt;text-indent:0pt;display:inline-block">&#160;</span>Financial Instruments</span></span></p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial assets and financial liabilities are recognized when the Company becomes a party to the contractual provisions of the instruments.</span></span></p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial assets and financial liabilities are initially measured at fair value. Transaction costs that are directly attributable to the acquisition or issue of financial assets and financial liabilities (other than financial assets and financial liabilities at fair value through profit or loss) are added to or deducted from the fair value of the financial assets or financial liabilities, as appropriate, on initial recognition. Transaction costs directly attributable to the acquisition of financial assets or financial liabilities at fair value through profit or loss are recognized immediately in profit or loss.</span></span></p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:32.85pt;display:inline-block">&#160;</span>Financial assets</span></span></p>
              <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On initial recognition, a financial asset is classified as measured at amortized cost, fair value through other comprehensive income (''FVOCI''), or fair value through profit and loss (''FVTPL''). The classification of financial assets is based on the business model in which a financial asset is managed and its contractual cash flow characteristics.</span></span></p>
              <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A financial asset is measured at amortized cost if it meets both of the following conditions and is not designated as at FVTPL:</span></span></p>
              <ul style="padding-left:0pt" type="disc">
                <li style="margin-left:45.14pt;text-align:justify;padding-left:8.86pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">It is held within a business model whose objective is to hold assets to collect contractual cash flows; and</span></span></li>
                <li style="margin-left:45.14pt;text-align:justify;padding-left:8.86pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Its contractual terms give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.</span></span></li>
              </ul>
              <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A financial asset (unless it is a trade receivable without a significant financing component that is initially measured at the transaction price) is initially measured at fair value plus, for an item not at FVTPL, transaction costs that are directly attributable to its acquisition.</span></span></p>
              <p style="text-indent:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following accounting policies apply to the subsequent measurement of financial assets.</span></span></p>
              <table cellpadding="0" cellspacing="0" style="margin-left:36.65pt;border:0.75pt solid #000000;border-collapse:collapse;font-size:10pt">
                <tbody>
                  <tr>
                    <td style="width:32%;padding-right:5.03pt;padding-left:5.03pt;vertical-align:top;border-right:0.75pt solid #000000;border-bottom:0.75pt solid #000000">
                      <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial assets at FVTPL</span></span></p>
                    </td>
                    <td style="width:67%;padding-right:5.03pt;padding-left:5.03pt;vertical-align:top;border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000">
                      <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsequently measured at fair value. Net gains and losses, including any interest or dividend income, are recognized in profit or loss.</span></span></p>
                    </td>
                  </tr>
                  <tr>
                    <td style="width:32%;padding-right:5.03pt;padding-left:5.03pt;vertical-align:top;border-top:0.75pt solid #000000;border-right:0.75pt solid #000000">
                      <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial assets at amortized cost</span></span></p>
                    </td>
                    <td style="width:67%;padding-right:5.03pt;padding-left:5.03pt;vertical-align:top;border-top:0.75pt solid #000000;border-left:0.75pt solid #000000">
                      <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsequently measured at amortized cost using the effective interest method, less any impairment losses. Interest income, foreign exchange gains and losses and impairment losses are recognized in profit or loss. Any gain or loss on derecognition is recognized in profit or loss.</span></span></p>
                    </td>
                  </tr>
                </tbody>
              </table>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:32.85pt;display:inline-block">&#160;</span>Financial liabilities</span></span></p>
              <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company initially recognizes financial liabilities at fair value on the date at which the Company becomes a party to the contractual provisions of the instrument.</span></span></p>
              <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company classifies its financial liabilities as either financial liabilities at FVTPL or amortized cost.</span></span></p>
              <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsequent to initial recognition, other liabilities are measured at amortized cost using the effective interest method. Financial liabilities at FVTPL are stated at fair value with changes being recognized in profit or loss.</span></span></p>
              <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company derecognizes a financial liability when its contractual obligations are discharged or cancelled or expire.</span></span></p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:32.85pt;display:inline-block">&#160;</span>Financial liabilities and equity instruments</span></span></p>
              <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:32.85pt;display:inline-block">&#160;</span>Classification as debt or equity</span></span></p>
              <p style="margin-left:72pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Debt and equity instruments issued by the Company are classified as either financial liabilities or as equity in accordance with the substance of the contractual arrangements and the definitions of a financial liability and an equity instrument.&#160;</span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company does not reclassify financial liabilities or equity after initial recognition due to a change in circumstance.</span></span></p>
              <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:32.85pt;display:inline-block">&#160;</span>Equity instruments</span></span></p>
              <p style="margin-left:72pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">An equity instrument is any contract that evidences a residual interest in the assets of an entity after deducting all of its liabilities. Equity instruments issued by a group entity are recognized at the proceeds received, net of direct issue costs.</span></span></p>
              <p style="margin-left:72pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Repurchase of the Company's own equity instruments is recognized and deducted directly in equity. No gain or loss is recognized in profit or loss on the purchase, sale, issue or cancellation of the Company's own equity instruments.</span></span></p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:32.85pt;display:inline-block">&#160;</span>Classification of financial instruments</span></span></p>
              <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company classifies its financial assets and liabilities depending on the purpose for which the financial instruments were acquired, their characteristics and management intent as outlined below:</span></span></p>
              <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Classification</strong></span></span></p>
              <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;margin-left:36pt;margin-right:auto;width:95%">
                <tbody>
                  <tr style="background-color:rgb(204, 238, 255)">
                    <td style="width:50%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash</span></span></td>
                    <td style="width:50%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortized cost</span></span></td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="width:50%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other receivables</span></span></td>
                    <td style="width:50%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortized cost</span></span></td>
                  </tr>
                  <tr style="background-color:rgb(204, 238, 255)">
                    <td style="width:50%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Investments</span></span></td>
                    <td style="width:50%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value through profit or loss</span></span></td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="width:50%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade and other payables</span></span></td>
                    <td style="width:50%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortized cost</span></span></td>
                  </tr>
                  <tr style="background-color:rgb(204, 238, 255)">
                    <td style="width:50%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivative liability</span></span></td>
                    <td style="width:50%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value through profit or loss</span></span></td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="width:50%;background-color:rgb(255, 255, 255)">
                      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Warrants liability</p>
                    </td>
                    <td style="width:50%;background-color:rgb(255, 255, 255)">
                      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Fair value through profit or loss</p>
                    </td>
                  </tr>
                  <tr style="background-color:rgb(204, 238, 255)">
                    <td style="width:50%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Notes payable</span></span></td>
                    <td style="width:50%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortized cost</span></span></td>
                  </tr>
                </tbody>
              </table>
              <p style="margin-top:0pt;margin-left:36pt;margin-bottom:0pt;text-align:justify">&#160;</p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2022;<span style="width:32.85pt;display:inline-block">&#160;</span>Impairment of financial assets</span></span></p>
              <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">An expected credit loss ("ECL") model applies to financial assets measured at amortized cost. The Company's financial assets measured at amortized cost and subject to the ECL model consist primarily of trade and other receivables. The Company applies the simplified approach to impairment for trade and other receivables by recognizing a loss allowance based on lifetime expected losses at each reporting date taking into considerations historical credit loss experience and financial factors specific to the debtors and general economic conditions. The Company has assessed the impairment of its trade and other receivables using the expected credit loss model, and no material difference was noted.&#160;</span></span></p>
            </div>
          <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories', window );">Inventories</a></td>
<td class="text">
            <div>
              <p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>[g]<span style="width:7.99pt;text-indent:0pt;display:inline-block">&#160;</span></span></span>Inventory</span></span></p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventory of harvested work-in-process and finished goods are valued at the lower of cost and net realizable value. Inventory of harvested cannabis is transferred from biological assets at their fair value at harvest, which becomes the initial deemed cost. Any subsequent post-harvest costs are capitalized to inventory to the extent that cost is less than net realizable value. Net realizable value is determined as the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated costs necessary to make the sale. Inventory for supplies and consumables are valued at the lower of cost and net realizable value, with cost determined using the average cost basis.</span></span></p>
            </div>
          <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory', window );">Impairment of long-lived assets</a></td>
<td class="text">
            <div>
              <p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[h]<span style="width:11pt;text-indent:0pt;display:inline-block">&#160;</span>Impairment of long-lived assets</span></span></p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Long-lived assets, including property, plant and equipment and intangible assets are tested for impairment when there are indicators of impairment at each reporting date or whenever events or changes in circumstances indicate that the carrying amount of an asset exceeds its recoverable amount. Intangible assets with an indefinite useful life are tested for impairment at least annually in the fourth quarter and whenever there is an indication that the asset may be impaired.</span></span></p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the purpose of impairment testing, assets that cannot be tested individually are grouped together into the smallest group of assets that generates cash inflows from continuing use that are largely independent of the cash inflows of other assets or groups of assets (the cash-generating unit, or "CGU"). The recoverable amount of an asset or a CGU is the higher of its fair value, less costs to sell, and its value in use. If the carrying amount of an asset exceeds its recoverable amount, an impairment charge is recognized immediately in net&#160;loss&#160;equal to the amount by which the carrying amount exceeds the recoverable amount. Where an impairment loss subsequently reverses, the carrying amount of the asset is increased to the lesser of the revised estimate of recoverable amount, and the carrying amount that would have been recorded had no impairment loss been recognized previously.</span></span></p>
            </div>
          <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory', window );">Income Taxes</a></td>
<td class="text">
            <div>
              <p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[i]<span style="width:11pt;text-indent:0pt;display:inline-block">&#160;</span>Income Taxes</span></span></p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income tax expense comprises of current and deferred tax. Current tax and deferred tax are recognized in net profit or loss except to the extent that it relates to a business combination or items recognized directly in equity or in other comprehensive loss.</span></span></p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current income taxes are recognized for the estimated income taxes payable or receivable on taxable income or loss for the current year and any adjustment to income taxes payable in respect of previous years. Current income taxes are determined using tax rates and tax laws that have been enacted or substantively enacted by the year-end date.</span></span></p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred tax assets and liabilities are recognized where the carrying amount of an asset or liability differs from its tax base, except for taxable temporary differences arising on the initial recognition of goodwill and temporary differences arising on the initial recognition of an asset or liability in a transaction which is not a business combination and at the time of the transaction affects neither accounting nor taxable profit or loss.</span></span></p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Recognition of deferred tax assets for unused tax losses, tax credits and deductible temporary differences is restricted to those instances where it is probable that future taxable profit will be available against which the deferred tax asset can be utilized. At the end of each reporting period, the Company reassesses unrecognized deferred tax assets. The Company recognizes a previously unrecognized deferred tax asset to the extent that it has become probable that future taxable profit will allow the deferred tax asset to be recovered.</span></span></p>
            </div>
          <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory', window );">Share-based Compensation</a></td>
<td class="text">
            <div>
              <p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[j]<span style="width:8.5pt;text-indent:0pt;display:inline-block">&#160;</span>Share-based Compensation</span></span></p>
              <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify">Share options and warrants awarded to non-employees are accounted for using the fair value of the instrument awarded or service provided, whichever is considered more reliable. Share options and warrants awarded to employees are accounted for using the fair value method.&#160; The fair value of such share options and warrants granted is recognized as an expense on a proportionate basis consistent with the vesting features of each tranche of the grant. The fair value is calculated using the Black-Scholes option pricing model with assumptions applicable at the date of grant.</p>
            </div>
          <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory', window );">Net Loss per Share</a></td>
<td class="text">
            <div>
              <p style="margin-left:18pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[k]<span style="width:11pt;text-indent:0pt;display:inline-block">&#160;</span>Net Loss per Share</span></span></p>
              <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss per share is calculated based on the loss for the financial year and the weighted average number of common shares outstanding during the year. Diluted net loss per share is calculated using the loss for the financial year adjusted for the effect of any dilutive instruments and the weighted average diluted number of shares [ignoring any potential issue of common shares that would be anti-dilutive] during the year.</span></span></p>
            </div>
          <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory', window );">Leases</a></td>
<td class="text">
              <div>
                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[l] Leases</span></span></p>
                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At inception of a contract, the Company assesses whether a contract is, or contains, a lease based on whether the contract conveys the right to control the use of identified asset for a period of time in exchange for consideration. The Company recognized a right-of-use asset and a lease liability at the lease commencement date. The right-of-use asset is initially measured based on the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date, plus any initial direct costs incurred and an estimate of the costs to dismantle and remove the underlying asset or to restore the underlying asset or the site on which it is located, less any lease incentives received. The right-of-use assets are depreciated to the earlier of the end of useful life of the right-of-use asset or the lease term using the straight-line method as this most closely reflects the expected pattern of the consumption of the future economic benefits. The lease term includes periods covered by an option to extend if the Company is reasonably certain to exercise that option. In addition, the right-of-use asset can be periodically reduced by impairment losses, if any, and adjusted for certain remeasurements of the lease liability. The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, and the Company's incremental borrowing rate.</span></span></p>
                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The lease liability is measured at amortized cost using the effective interest method. It is remeasured when there is a change in future lease payments arising from the change in an index or rate, if there is a change in the Company's estimate of the amount expected to be payable under a residual value guarantee, or if the Company changes its assessment of whether it will exercise a purchase, extension or termination option. When the lease liability is remeasured in this way, a corresponding adjustment is made to the carrying amount of the right-of-use asset, unless it has been reduced to zero.</span></span></span></span></p>
              </div>
            <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory', window );">External research and development</a></td>
<td class="text">
                  <div>
                    <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[m] External research and development<span style="text-align:left">&#160; &#160;</span></span></span></p>
                    <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">External research and development costs are expensed in the periods in which they are incurred, with the exception of development costs for new products with proven technical feasibility and for which a defined future market exists. Such development costs are capitalized in accordance with the Company's policy for intangible assets. The Company's external research and development costs consist primarily of third-party services.</span></span><span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left">&#160; &#160;</span></p>
                  </div>
                <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory', window );">Discontinued operations</a></td>
<td class="text">
                  <div>
                    <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">[n] Discontinued operations</span></span><span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left">&#160; &#160;</span></p>
                    <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Discontinued operations are reported when a component of the Company, representing a separate major line of business or area of operations with clearly distinguishable cash flows, has been disposed of or is held for sale. Classification as a discontinued operation occurs upon disposal or when the operation meets the criteria to be classified as held for sale, if earlier. Discontinued operations are reported as a separate element of net income or loss on the consolidated statement of net and comprehensive loss for both the current and comparative periods. When a disposal group is classified as held for sale, assets and liabilities are aggregated and presented as separate line items, respectively, on the consolidated statement of financial position. Comparative periods are not restated on the consolidated statement of financial position. Assets held for sale are not depreciated and are measured at the lower of carrying value and fair value less costs to sell.</span></span><span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left">&#160;</span><span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left">&#160; &#160; &#160;&#160;</span></p>
                  </div>
                <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory', window );">New standards, amendments and interpretations adopted by the Company</a></td>
<td class="text">
                  <div>
                    <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>New standards, amendment and interpretation adopted by the Company</strong></span></span><span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left">&#160; &#160;</span></p>
                    <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">IFRS 3 - <i>Business combinations </i>("IFRS 3")</span></span><span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left">&#160; &#160;</span></p>
                    <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amendments to IFRS 3, issued in October 2018, provide clarification on the definition of a business. The amendments permit a simplified assessment to determine whether a transaction should be accounted for as a business combination or as an asset acquisition.</span></span><span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left">&#160; &#160;</span></p>
                    <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The amendments are effective for transactions for which the acquisition date is on or after the beginning of the first annual reporting period beginning on or after January 1, 2020. The amendment adoption did not have a significant impact on the Company's financial statements.</span></span><span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left">&#160; &#160;</span></p>
                    <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">IAS 1 -<i> Presentation of financial statements </i>("IAS 1")</span></span><span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left">&#160; &#160;</span></p>
                    <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amendments to IAS 1, issued in October 2018, provide clarification on the definition of material and how it should be applied. The amendments also align the definition of material across International Financial Reporting Standards and other publications.</span></span><span style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left">&#160; &#160;</span></p>
                    <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The amendments are effective for annual periods beginning on or after January 1, 2020 and are required to be applied prospectively. The amendment adoption did not have a significant impact on the Company's financial statements.</span></span></p>
                  </div>
                <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents description of recent accounting pronouncements adopted policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DescriptionOfRecentAccountingPronouncementsAdoptedExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_SummaryOfSignificantAccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_SummaryOfSignificantAccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for discontinued operations. [Refer: Discontinued operations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for financial instruments. [Refer: Financial instruments, class [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for foreign currency translation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for the impairment of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for income tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for measuring inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 36<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_36_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for recognising revenue. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for research and development expense. [Refer: Research and development expense]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Share-based payment arrangements [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 46<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_46&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923859657336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of business (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfNatureOfBusinessAbstract', window );"><strong>Disclosure of Nature of business [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory', window );">Schedule of ownership percentage in subsidiaries</a></td>
<td class="text">
                    <table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000">
                      <tbody>
                        <tr>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom">&#160;</td>
                          <td colspan="7" style="vertical-align:bottom;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Ownership percentage as at</strong></span></span></td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Entity Name</strong></span></span></td>
                          <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Country</strong></span></span></td>
                          <td style="text-align:right;vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>December&#160; 31, 2020</strong></span></span></td>
                          <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>December&#160; 31, 2019</strong></span></span></td>
                          <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>January 1, 2019</strong></span></span></td>
                          <td style="text-align:right;vertical-align:bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td style="border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>%</strong></span></span></td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>%</strong></span></span></td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>%</strong></span></span></td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(204, 238, 255)">
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">FSD Biosciences Inc.</span></span></td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">USA</span></span></td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100</span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(255, 255, 255)">
                          <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Prismic Pharmaceuticals Inc.</span></span></td>
                          <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">USA</span></span></td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100</span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100</span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100</span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(204, 238, 255)">
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">FV Pharma Inc.</span></span></td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Canada</span></span></td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100</span></span></td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100</span></span></td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100</span></span></td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                        </tr>
                      </tbody>
                    </table>
                  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfNatureOfBusinessAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents Nature of business abstract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfNatureOfBusinessAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of subsidiaries. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B4<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B4_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923838064088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of presentation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_BasisOfPresentationAbstract', window );"><strong>Basis Of Presentation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfDetailedInformationAboutRestatementOfPriorPeriodExplanatory', window );">Schedule of restatement of prior period information</a></td>
<td class="text">
            <table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000">
              <tbody>
                <tr>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>December 31, 2018 </strong><br/><strong>as reported,</strong></span></span></td>
                  <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Foreign currency </strong><br/><strong>translation</strong></span></span></td>
                  <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>December 31, 2018 </strong><br/><strong>restated,</strong></span></span></td>
                  <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Adoption of<br/>IFRS 16</strong></span></span></td>
                  <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>January 1,<br/>2019</strong></span></span></td>
                  <td style="text-align:right;vertical-align:bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">C$</span></span></td>
                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$</span></span></td>
                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$</span></span></td>
                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$</span></span></td>
                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>ASSETS</strong></span></span></td>
                  <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Current assets</strong></span></span></td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash&#160;</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">21,134,930</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5,235,122</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,899,808</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,899,808</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade and other receivables&#160;</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">990,988</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(245,468</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">745,520</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">745,520</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Prepaid expenses and deposits</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">444,099</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(110,003</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">334,096</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">334,096</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22,570,017</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5,590,593</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16,979,424</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16,979,424</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Non-current assets</strong></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other investments&#160;</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18,064,541</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4,474,587</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,589,954</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,589,954</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Right-of-use asset, net&#160;</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">183,424</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">183,424</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property, plant and equipment, net&#160;</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,141,676</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,007,493</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,134,183</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,134,183</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">52,776,234</span></span></td>
                  <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(13,072,673</span></span></td>
                  <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">39,703,561</span></span></td>
                  <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">183,424</span></span></td>
                  <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">39,886,985</span></span></td>
                  <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>LIABILITIES</strong></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Current liabilities</strong></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade and other payables</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,743,806</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(431,941</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,311,865</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,311,865</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease obligations&#160;</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">40,875</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">40,875</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,743,806</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(431,941</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,311,865</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">40,875</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,352,740</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Non-current liabilities</strong></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease obligations&#160;</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">142,549</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">142,549</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,743,806</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(431,941</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,311,865</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">183,424</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,495,289</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>SHAREHOLDER'S EQUITY</strong></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Class A share capital&#160;</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">201,500</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(49,912</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">151,588</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">151,588</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Class B share capital&#160;</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">67,916,302</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(16,822,868</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">51,093,434</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">51,093,434</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Warrant reserve</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,442,145</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,100,319</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,341,826</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,341,826</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contributed surplus&#160;</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,977,300</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,232,877</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,744,423</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,744,423</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accumulated deficit</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(26,504,819</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,565,244</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(19,939,575</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(19,939,575</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">51,032,428</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,640,732</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">38,391,696</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">38,391,696</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff;border-bottom:1px solid #000000">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">52,776,234</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff;border-bottom:1px solid #000000">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff;border-bottom:1px solid #000000">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(13,072,673</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff;border-bottom:1px solid #000000">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">39,703,561</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff;border-bottom:1px solid #000000">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff;border-bottom:1px solid #000000">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">183,424</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff;border-bottom:1px solid #000000">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff;border-bottom:1px solid #000000">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;text-align:right;background-color:#e6efff;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">39,886,985</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff;border-bottom:1px solid #000000">&#160;</td>
                </tr>
              </tbody>
            </table>
          <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_BasisOfPresentationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_BasisOfPresentationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfDetailedInformationAboutRestatementOfPriorPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about restatement of prior period information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfDetailedInformationAboutRestatementOfPriorPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923837994168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant accounting policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_SummaryOfSignificantAccountingPoliciesAbstract', window );"><strong>Summary Of Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory', window );">Schedule of estimated useful lives of assets</a></td>
<td class="text">
                  <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;margin-left:auto;margin-right:auto;width:75%">
                    <tbody>
                      <tr style="background-color:rgb(204, 238, 255)">
                        <td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;height:0px;background-color:rgb(204, 238, 255)">
                          <p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computer equipment</span></span></p>
                        </td>
                        <td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;height:0px;background-color:rgb(204, 238, 255)">
                          <p style="margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">30% declining balance</span></span></p>
                        </td>
                      </tr>
                      <tr style="background-color:rgb(255, 255, 255)">
                        <td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Production equipment</span></span></td>
                        <td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20% declining balance</span></span></td>
                      </tr>
                      <tr style="background-color:rgb(204, 238, 255)">
                        <td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Furniture and fixtures</span></span></td>
                        <td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20% declining balance</span></span></td>
                      </tr>
                      <tr style="background-color:rgb(255, 255, 255)">
                        <td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)">
                          <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Facility and related</span></span><span style="font-size:10pt">&#160;</span></p>
                        </td>
                        <td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20 years under straight-line</span></span></td>
                      </tr>
                      <tr style="background-color:rgb(204, 238, 255)">
                        <td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)">
                          <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Land</span></span></span></p>
                        </td>
                        <td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(204, 238, 255)">
                          <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Not amortized</span></span></span></p>
                        </td>
                      </tr>
                    </tbody>
                  </table>


                      <div>
                        <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;margin-left:auto;margin-right:auto;width:75%">
                          <tbody>
                            <tr style="background-color:rgb(204, 238, 255)">
                              <td style="width:38%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)">
                                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Intellectual Property</span></span></p>
                              </td>
                              <td style="width:61%;padding-right:5.4pt;padding-left:5.4pt;vertical-align:top;background-color:rgb(255, 255, 255)">
                                <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5 years</span></span></p>
                              </td>
                            </tr>
                          </tbody>
                        </table>
                      </div>

              <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents information related to estimated useful lives of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_SchedulesOfEstimatedUsefulLivesOfAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_SummaryOfSignificantAccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_SummaryOfSignificantAccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923858973096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisition of Prismic Pharmaceutical (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsAbstract', window );"><strong>Disclosure of detailed information about business combination [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory', window );">Schedule of share options and warrants</a></td>
<td class="text">
          <div>
            <table border="0" cellpadding="0" cellspacing="0" style="border:0px;width:100%;border-collapse:collapse;margin:auto">
              <tbody>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">&#160;</td>
                  <td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Share Options</strong></span></span></span></span></td>
                  <td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255);border-bottom:1pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Warrants</strong></span></span></span></span></td>
                </tr>
                <tr style="background-color:rgb(230, 239, 255)">
                  <td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(230, 239, 255)">
                    <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Grant date share price</p>
                  </td>
                  <td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>C$32.16</span></span></span></span></td>
                  <td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>C$32.16</span></span></span></span></td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(255, 255, 255)">
                    <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Exercise price</p>
                  </td>
                  <td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>C$2.61 - C$17.89</span></span></span></span></td>
                  <td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>C$2.61 - C$26.73</span></span></span></span></td>
                </tr>
                <tr style="background-color:rgb(230, 239, 255)">
                  <td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(230, 239, 255)">
                    <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Expected dividend yield</p>
                  </td>
                  <td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Risk free interest rate</span></span></span></span></td>
                  <td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1.39% - 1.66%</span></span></span></span></td>
                  <td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1.41% - 1.52%</span></span></span></span></td>
                </tr>
                <tr style="background-color:rgb(230, 239, 255)">
                  <td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Expected life (years)</span></span></span></span></td>
                  <td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>0.98&#x2014;16.21</span></span></span></span></td>
                  <td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1.39&#x2014;6.55</span></span></span></span></td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:46%;background-color:rgb(255, 255, 255)">
                    <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Annualized volatility</p>
                  </td>
                  <td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></td>
                  <td style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;width:27%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></td>
                </tr>
              </tbody>
            </table>
          </div>
        <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory', window );">Schedule of identifiable assets acquired and liabilities assumed</a></td>
<td class="text">
            <div>
              <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;margin-left:auto;margin-right:auto;width:100%">
                <tbody>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><strong>Fair value</strong></span></span></span></span></span></span></td>
                    <td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);text-align:right">
                      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>recognized&#160;on</strong></span></span></p>
                    </td>
                    <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><strong>acquisition</strong></span></span></span></span></span></span></td>
                    <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255);text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><strong>$</strong></span></span></span></span></span></span></td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(230, 239, 255)">
                    <td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Cash</span></span></span></span></span></span></td>
                    <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)">&#160;</td>
                    <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>1,752</span></span></span></span></span></span></td>
                    <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(255, 255, 255)">
                      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Prepaid expenses and deposits</p>
                    </td>
                    <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>19,691</span></span></span></span></span></span></td>
                    <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(230, 239, 255)">
                    <td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(230, 239, 255)">
                      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Intangible assets</p>
                    </td>
                    <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)">&#160;</td>
                    <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>18,543,379</span></span></span></span></span></span></td>
                    <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Trade and other payables</span></span></span></span></span></span></td>
                    <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(1,404,732</span></span></span></span></span></span></td>
                    <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></td>
                  </tr>
                  <tr style="background-color:rgb(230, 239, 255)">
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(230, 239, 255)">
                      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Notes payable</span></span></p>
                    </td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)">&#160;</td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(1,446,642</span></span></span></span></span></span></td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;border-bottom:1pt solid black;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;border-bottom:1pt solid black;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;border-bottom:1pt solid black;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><strong>15,713,448</strong></span></span></span></span></span></span></td>
                    <td style="vertical-align:bottom;border-bottom:1pt solid black;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                  </tr>
                </tbody>
              </table>
            </div>
          <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about Share Options and Warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about business combinations. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Section Disclosures application of paragraphs 59 and 61<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;doctype=Appendix&amp;subtype=B&amp;dita_xref=IFRS03_gB64-B67_TI<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923863170136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Assets held for sale (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfAssetsHeldForSaleAbstract', window );"><strong>Disclosure Of Assets Held For Sale [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ScheduleOfComponentsOfAssetsHeldForSaleExplanatory', window );">Schedule of components of assets held for sale</a></td>
<td class="text">
          <div>
            <p style="margin:0pt">&#160;</p>
            <table style="font-family:Times New Roman;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial;width:100%;border-collapse:collapse;font-size:13px;border:0px">
              <tbody>
                <tr>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                  <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
                  <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td>
                  <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property and plant</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,610,504</span></span></td>
                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
                </tr>
              </tbody>
            </table>
          </div>
        <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ScheduleOfNetLossAndComprehensiveLossFromDiscontinuedOperationsExplanatory', window );">Schedule of net loss and comprehensive loss from discontinued operations</a></td>
<td class="text">
          <table style="font-family:Times New Roman;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial;width:100%;border-collapse:collapse;font-size:13px;border:0px">
            <tbody>
              <tr>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom">&#160;</td>
                <td colspan="1" style="text-align:center;vertical-align:bottom">&#160;</td>
                <td colspan="4" style="text-align:center;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>For the year ended December 31,</strong></span></span></td>
                <td colspan="1" style="text-align:center;vertical-align:bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Notes</span></span></td>
                <td style="text-align:right;vertical-align:bottom">&#160;</td>
                <td style="text-align:right;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2020</strong></span></span></td>
                <td style="text-align:right;vertical-align:bottom">&#160;</td>
                <td style="text-align:right;vertical-align:bottom">&#160;</td>
                <td style="text-align:right;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2019</span></span></td>
                <td style="text-align:right;vertical-align:bottom">&#160;</td>
              </tr>
              <tr>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
                <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td>
                <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
                <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
                <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td>
                <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Revenue</strong></span></span></td>
                <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14,514</span></span></strong></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">193,416</span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right">&#160;</td>
                <td style="vertical-align:bottom;width:24px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right">&#160;</td>
                <td style="vertical-align:bottom;width:24px;text-align:left">&#160;</td>
              </tr>
              <tr>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost of revenue</span></span></td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,032,010</span></span></strong></td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,473,839</span></span></td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Gross loss before fair value adjustments</strong></span></span></td>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,017,496</span></span></strong></td>
                <td style="vertical-align:bottom;width:24px;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,280,423</span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value adjustments on inventory sold</span></span></td>
                <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(945</span></span></strong></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16,738</span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
              </tr>
              <tr>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unrealized loss on changes in fair value of biological assets&#160;</span></span></td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">166,886</span></span></strong></td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">513,625</span></span></td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left">&#160;</td>
              </tr>
              <tr>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Gross loss&#160;</span></span></td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,183,437</span></span></strong></td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,810,786</span></span></td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
              </tr>
              <tr>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right">&#160;</td>
                <td style="vertical-align:bottom;width:24px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right">&#160;</td>
                <td style="vertical-align:bottom;width:24px;text-align:left">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Expenses</strong></span></span></td>
                <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">General and administrative&#160;</span></span></td>
                <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16</span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,665,541</span></span></strong></td>
                <td style="vertical-align:bottom;width:24px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,735,286</span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation and amortization</span></span></td>
                <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">90,340</span></span></strong></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">424,199</span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
              </tr>
              <tr>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment of property, plant and equipment</span></span></td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">387,474</span></span></strong></td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">132,273</span></span></td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left">&#160;</td>
              </tr>
              <tr>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Total operating expenses</strong></span></span></td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,143,355</span></span></strong></td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,291,758</span></span></td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
              </tr>
              <tr>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left">&#160;</td>
              </tr>
              <tr>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Loss from discontinued operations</strong></span></span></td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,326,792</span></span></strong></td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5,102,544</span></span></td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
              </tr>
              <tr>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right">&#160;</td>
                <td style="vertical-align:bottom;width:24px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right">&#160;</td>
                <td style="vertical-align:bottom;width:24px;text-align:left">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other income</span></span></td>
                <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(79,568</span></span></strong></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(53,987</span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
              </tr>
              <tr>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss on sale of equipment</span></span></td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100,337</span></span></strong></td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left">&#160;</td>
              </tr>
              <tr>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Net loss from discontinued operations</strong></span></span></td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,347,561</span></span></strong></td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5,048,557</span></span></td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
              </tr>
            </tbody>
          </table>
        <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ScheduleOfCashFlowsFromDiscontinuedOperationsExplanatory', window );">Schedule of cash flows from discontinued operations</a></td>
<td class="text">
          <table style="font-family:Times New Roman;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial;width:100%;border-collapse:collapse;font-size:13px;border:0px">
            <tbody>
              <tr>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="text-align:right;vertical-align:bottom">&#160;</td>
                <td style="text-align:right;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2020</strong></span></span></td>
                <td style="text-align:right;vertical-align:bottom">&#160;</td>
                <td style="text-align:right;vertical-align:bottom">&#160;</td>
                <td style="text-align:right;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2019</span></span></td>
                <td style="text-align:right;vertical-align:bottom">&#160;</td>
              </tr>
              <tr>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
                <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td>
                <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
                <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
                <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td>
                <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Operating activities</strong></span></span></td>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss from discontinued operations</span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>(3,347,561</strong></span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>)</strong></span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5,048,557</span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
              </tr>
              <tr>
                <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Add (deduct) items not affecting cash</span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right">&#160;</td>
                <td style="vertical-align:bottom;width:24px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right">&#160;</td>
                <td style="vertical-align:bottom;width:24px;text-align:left">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160; Depreciation and amortization</span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>108,209</strong></span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">424,199</span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160; Change in fair value adjustments on inventory sold</span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>(945</strong></span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>)</strong></span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16,738</span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160; Impairment of inventory</span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>534,814</strong></span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160; Impairment of property, plant and equipment</span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>387,474</strong></span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160; Change in fair value of biological assets</span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>166,886</strong></span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">513,625</span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160; Loss on disposal of inventory</span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>197,436</strong></span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160; Loss on sale of equipment</span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>100,337</strong></span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes in non-cash working capital balances</span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right">&#160;</td>
                <td style="vertical-align:bottom;width:24px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right">&#160;</td>
                <td style="vertical-align:bottom;width:24px;text-align:left">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160; Trade and other receivables</span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>960,778</strong></span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(423,945</span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
              </tr>
              <tr>
                <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160; Prepaid expenses and deposits</span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>279,870</strong></span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">54,226</span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160; Inventories</span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>(21,932</strong></span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>)</strong></span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(709,373</span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
              </tr>
              <tr>
                <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160; Biological assets</span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>(166,886</strong></span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>)</strong></span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(513,625</span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
              </tr>
              <tr>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160; Trade and other payables</span></span></td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>63,861</strong></span></span></td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(895,286</span></span></td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
              </tr>
              <tr>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Cash used in operating activities</strong></span></span></td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:157px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>(737,659</strong></span></span></td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:24px;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>)</strong></span></span></td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:157px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(6,581,998</span></span></td>
                <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:24px;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Investing activities</strong></span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right">&#160;</td>
                <td style="vertical-align:bottom;width:24px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right">&#160;</td>
                <td style="vertical-align:bottom;width:24px;text-align:left">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Purchase of property, plant and equipment</span></span></td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>&#x2014;</strong></span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(401,817</span></span></td>
                <td style="vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
              </tr>
              <tr>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Proceeds from sale of equipment</span></span></td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>36,616</strong></span></span></td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Cash provided by (used in) investing activities</strong></span></span></td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>36,616</strong></span></span></td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:11px;text-align:left;background-color:#e6efff">&#160;</td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:157px;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(401,817</span></span></td>
                <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:24px;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
              </tr>
            </tbody>
          </table>
        <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfAssetsHeldForSaleAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfAssetsHeldForSaleAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ScheduleOfCashFlowsFromDiscontinuedOperationsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about the cash flows from discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ScheduleOfCashFlowsFromDiscontinuedOperationsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ScheduleOfComponentsOfAssetsHeldForSaleExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about the assets held for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ScheduleOfComponentsOfAssetsHeldForSaleExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ScheduleOfNetLossAndComprehensiveLossFromDiscontinuedOperationsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about the net loss and comprehensive loss from discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ScheduleOfNetLossAndComprehensiveLossFromDiscontinuedOperationsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923895796664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other receivables (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesAbstract', window );"><strong>Trade and other current payables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory', window );">Schedule of other receivables</a></td>
<td class="text">
            <div>
              <table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000">
                <tbody>
                  <tr>
                    <td style="vertical-align:bottom">&#160;</td>
                    <td style="text-align:right;vertical-align:bottom">&#160;</td>
                    <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>December 31, 2020</strong></span></span></td>
                    <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2019</span></span></td>
                    <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">January 1, 2019</span></span></td>
                    <td style="text-align:right;vertical-align:bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                    <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
                    <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td>
                    <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
                    <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
                    <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td>
                    <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
                    <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
                    <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td>
                    <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Sales tax recoverable</span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">134,717</span></span></strong></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,529,828</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">739,257</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rent receivable</span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    <td style="vertical-align:bottom;width:12%;text-align:right"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></strong></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                    <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    <td style="vertical-align:bottom;width:12%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,772</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                    <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    <td style="vertical-align:bottom;width:12%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,263</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  </tr>
                  <tr>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26,625</span></span></strong></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17,702</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  </tr>
                  <tr>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom">&#160;</td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:12%;text-align:right"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">161,342</span></span></strong></td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:12%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,557,302</span></span></td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:12%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">745,520</span></span></td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  </tr>
                </tbody>
              </table>
            </div>
          <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for trade and other receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfDetailInformationAboutTradeAndOtherReceivablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923883209736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfInvestmentsAbstract', window );"><strong>Disclosure Of Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfDetailedInformationAboutInvestmentsExplanatory', window );">Schedule of investments</a></td>
<td class="text">
          <div>
            <table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000">
              <tbody>
                <tr>
                  <td style="vertical-align:bottom;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Entity</strong></span></span></span></span></td>
                  <td style="vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Instrument</strong></span></span></span></span></td>
                  <td style="vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Note</strong></span></span></span></span></td>
                  <td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Balance at<br/>January </strong><br/><strong>1,<br/>2019</strong></span></span></span></span></td>
                  <td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);white-space:nowrap;width:10px">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;border-bottom:1px solid rgb(0, 0, 0);white-space:nowrap;width:120px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Additions</strong></span></span></span></span></td>
                  <td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Change in fair<br/>value through<br/>profit or loss</strong></span></span></span></span></td>
                  <td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Proceeds<br/>from sale</strong></span></span></span></span></td>
                  <td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Balance at<br/>December 31,<br/>2019</strong></span></span></span></span></td>
                  <td style="text-align:right;vertical-align:bottom;border-bottom:1px solid #000000">&#160;</td>
                </tr>
                <tr style="background-color:rgb(204, 238, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Pharmadrug Inc.</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Shares</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(i)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,256,900</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(2,001,825</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>255,075</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cannara Biotech Inc.</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Shares</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(ii)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>8,437,342</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(1,614,704</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>6,822,637</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(204, 238, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Clover Cannastrip</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Shares</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(iii)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,128,450</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(1,128,450</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>High Tide</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Shares</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(iv)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,352,665</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(890,362</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>462,303</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(204, 238, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>High Tide</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Warrants</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(iv)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>188,914</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(188,914</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>HUGE Shops</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Shares</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(v)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>977,990</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(405,589</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>572,401</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(204, 238, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>SciCann Therapeutics</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Shares</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(vi)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,504,593</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(968,769</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>535,824</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Solarvest BioEnergy Inc.&#160;</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Shares</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(vii)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>519,087</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(191,837</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>327,251</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(204, 238, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Solarvest BioEnergy Inc.&#160;</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Warrants</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(vii)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>290,225</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(202,470</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>87,756</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Solarvest BioEnergy Inc.&#160;</span></span></span></span></td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Convertible debenture</span></span></span></span></td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(vii)</span></span></span></span></td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,447,588</span></span></span></span></td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(1,185,787</span></span></span></span></td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>261,800</span></span></span></span></td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(204, 238, 255)">
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>13,589,954</span></span></span></span></td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:10px;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:120px;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4,513,800</span></span></span></span></td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(8,778,707</span></span></span></span></td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>462,303</span></span></span></span></td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>8,862,744</span></span></span></span></td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(204, 238, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:left;vertical-align:bottom;width:10px;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;width:120px;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Entity</strong></span></span></span></span></td>
                  <td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Instrument</strong></span></span></span></span></td>
                  <td style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Note</strong></span></span></span></span></td>
                  <td style="text-align:left;vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;width:9%;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Balance at<br/>December 31,<br/>2019</strong></span></span></span></span></td>
                  <td style="text-align:left;vertical-align:bottom;width:2%;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:left;vertical-align:bottom;width:10px;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;width:120px;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Change in fair<br/>value through<br/>profit or loss</strong></span></span></span></span></td>
                  <td style="text-align:left;vertical-align:bottom;width:2%;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:left;vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;width:9%;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Foreign<br/>exchange<br/>gain</strong></span></span></span></span></td>
                  <td style="text-align:left;vertical-align:bottom;width:2%;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:left;vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;width:9%;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Proceeds<br/>from sale</strong></span></span></span></span></td>
                  <td style="text-align:left;vertical-align:bottom;width:2%;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:left;vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom;width:9%;white-space:nowrap;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Balance at<br/>December 31, 2020</strong></span></span></span></span></td>
                  <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(204, 238, 255)">
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="text-align:left"><strong>$</strong></span>&#160;</span></span></span></span></td>
                  <td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:10px;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:120px;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="text-align:left"><strong>$</strong></span>&#160;</span></span></span></span></td>
                  <td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="text-align:left"><strong>$</strong></span>&#160;</span></span></span></span></td>
                  <td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="text-align:left"><strong>$</strong></span>&#160;</span></span></span></span></td>
                  <td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="text-align:left"><strong>$</strong></span>&#160;</span></span></span></span></td>
                  <td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Pharmadrug Inc.</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Shares</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(i)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>255,075</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>397,006</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>652,081</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(204, 238, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cannara Biotech Inc.</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Shares</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(ii)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>6,822,637</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(997,208</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>5,825,429</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Clover Cannastrip</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Shares</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(iii)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(204, 238, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>HUGE Shops</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Shares</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(v)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>572,401</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>7,674</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>20,358</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>600,433</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>SciCann Therapeutics</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Shares</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(vi)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>535,824</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(354,910</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>14,765</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>195,679</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(204, 238, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Solarvest BioEnergy Inc.&#160;</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Shares</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(vii)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>327,251</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>106,380</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>14,047</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>447,678</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Solarvest BioEnergy Inc.&#160;</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Warrants</span></span></span></span></td>
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(vii)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>87,756</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(14,920</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,977</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>74,813</span></span></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(204, 238, 255)">
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Solarvest BioEnergy Inc.&#160;</span></span></span></span></td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Convertible debenture</span></span></span></span></td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(vii)</span></span></span></span></td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>261,800</span></span></span></span></td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:10px;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:120px;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>85,104</span></span></span></span></td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>11,238</span></span></span></span></td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>358,142</span></span></span></span></td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>8,862,744</span></span></span></span></td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:10px;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:120px;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(770,874</span></span></span></span></td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>62,385</span></span></span></span></td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>6,477,510</span></span></span></span></td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,676,745</span></span></span></span></td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                </tr>
              </tbody>
            </table>
          </div>
        <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfDetailedInformationAboutInvestmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the tabular disclosure of other investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfDetailedInformationAboutInvestmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923894730232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-use asset (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract', window );"><strong>Disclosure of quantitative information about right-of-use assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfDetailedInformationAboutRightOfUseAssets', window );">Schedule of Right-of-use asset</a></td>
<td class="text">
            <div>
              <table border="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;width:100%">
                <tbody>
                  <tr>
                    <td style="vertical-align:bottom">&#160;</td>
                    <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
                    <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td>
                    <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance &#x2013; January 1, 2019</span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">183,424</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation</span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    <td style="vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(36,685</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(50,888</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance &#x2013; December 31, 2019</span></span></td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">95,851</span></span></td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation</span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5,991</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(89,860</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance &#x2013; December 31, 2020</span></span></td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  </tr>
                </tbody>
              </table>
            </div>
          <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfDetailedInformationAboutRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents information on right of use assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfDetailedInformationAboutRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923895742776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Changes in intangible assets other than goodwill [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory', window );">Schedule of intangible assets</a></td>
<td class="text">
            <div>
              <table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:rgb(0, 0, 0)">
                <tbody>
                  <tr>
                    <td style="vertical-align:bottom">&#160;</td>
                    <td style="text-align:right;vertical-align:bottom">&#160;</td>
                    <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Intangible Assets</strong></span></span></td>
                    <td style="text-align:right;vertical-align:bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Cost</strong></span></span></td>
                    <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                    <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td>
                    <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As at January 1, 2019</span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Acquisition of Prismic Pharmaceuticals Inc.</span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    <td style="vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18,543,379</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions</span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">293,126</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  </tr>
                  <tr>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effects of foreign exchange</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(140,276</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  </tr>
                  <tr>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As at December 31, 2019</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18,696,229</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  </tr>
                  <tr>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effects of foreign exchange</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">505,264</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  </tr>
                  <tr>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>As at December 31, 2020</strong></span></span></td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>19,201,493</strong></span></span></td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom">&#160;</td>
                    <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    <td style="vertical-align:bottom;width:22%;text-align:right">&#160;</td>
                    <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  </tr>
                  <tr>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Accumulated amortization</strong></span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As at January 1, 2019</span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    <td style="vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortization</span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,906,363</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  </tr>
                  <tr>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effects of foreign exchange</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(30,759</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  </tr>
                  <tr>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As at December 31, 2019</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,875,604</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortization</span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    <td style="vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,894,467</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  </tr>
                  <tr>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effects of foreign exchange</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,031</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  </tr>
                  <tr>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>As at December 31, 2020</strong></span></span></td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>5,777,102</strong></span></span></td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  </tr>
                  <tr>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Net book value</strong></span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  </tr>
                  <tr>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As at January 1, 2019</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  </tr>
                  <tr>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As at December 31, 2019</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:22%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16,820,625</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  </tr>
                  <tr>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>As at December 31, 2020</strong></span></span></td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:22%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>13,424,391</strong></span></span></td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  </tr>
                </tbody>
              </table>
            </div>
          <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923861369592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes Payable (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract', window );"><strong>Disclosure of detailed information about borrowings [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory', window );">Schedule of notes payable</a></td>
<td class="text">
            <div>
              <table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000">
                <tbody>
                  <tr>
                    <td style="vertical-align:bottom">&#160;</td>
                    <td style="text-align:right;vertical-align:bottom">&#160;</td>
                    <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>December 31, 2020</strong></span></span></td>
                    <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2019</span></span></td>
                    <td style="text-align:right;vertical-align:bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                    <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                    <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td>
                    <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                    <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                    <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td>
                    <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Short-term notes</span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>49,647</strong></span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">145,943</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  </tr>
                  <tr>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Notes payable</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>335,000</strong></span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,289,755</span></span></td>
                    <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:2%;text-align:left">&#160;</td>
                  </tr>
                  <tr>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;background-color:#e6efff">&#160;</td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>384,647</strong></span></span></td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,435,698</span></span></td>
                    <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                  </tr>
                </tbody>
              </table>
            </div>
          <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923861413208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Lease obligations (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilitiesAbstract', window );"><strong>Lease liabilities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfOperatingLeaseObligationsTableTextBlock', window );">Schedule of lease obligations</a></td>
<td class="text">
              <div>
                <table border="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;width:90%">
                  <tbody>
                    <tr>
                      <td style="border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                      <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                      <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;<strong>$&#160;</strong></span></span></td>
                      <td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Balance as at January 1, 2019</strong></span></span></td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                      <td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">183,424</span></span></td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Add: Interest Expense</span></span></td>
                      <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                      <td style="vertical-align:bottom;width:12%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,480</span></span></td>
                      <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    </tr>
                    <tr>
                      <td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less: Lease Payments</span></span></td>
                      <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                      <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(42,285</span></span></td>
                      <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                    </tr>
                    <tr>
                      <td style="border-bottom:2px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Balance &#x2013; December 31, 2019</strong></span></span></td>
                      <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                      <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:12%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>152,619</strong></span></span></td>
                      <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Add: Interest Expense</span></span></td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                      <td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,367</span></span></td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less: Lease Payments</span></span></td>
                      <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                      <td style="vertical-align:bottom;width:12%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(39,993</span></span></td>
                      <td style="vertical-align:bottom;width:1%;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                    </tr>
                    <tr>
                      <td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effects of foreign exchange</span></span></td>
                      <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                      <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff">
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2,969</span></p>
                      </td>
                    </tr>
                    <tr>
                      <td style="border-bottom:2px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Balance &#x2013; December 31, 2020</strong></span></span></td>
                      <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                      <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:12%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>125,962</strong></span></span></td>
                      <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;background-color:#e6efff">&#160;</td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                      <td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff">&#160;</td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current</span></span></td>
                      <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                      <td style="vertical-align:bottom;width:12%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">46,842</span></span></td>
                      <td style="vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    </tr>
                    <tr>
                      <td style="border-bottom:1px solid #000000;vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-current&#160;</span></span></td>
                      <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                      <td style="border-bottom:1px solid #000000;vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">79,120</span></span></td>
                      <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                    </tr>
                    <tr>
                      <td style="border-bottom:2px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Balance &#x2013; December 31, 2020</strong></span></span></td>
                      <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                      <td style="border-bottom:2px solid #000000;vertical-align:bottom;width:12%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>125,962</strong></span></span></td>
                      <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left">&#160;</td>
                    </tr>
                  </tbody>
                </table>
              </div>
            <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory', window );">Schedule of maturity analysis of operating lease payments</a></td>
<td class="text">
            <div>
              <table border="0" cellpadding="0" cellspacing="0" style="width:90%;font-size:10pt;border-collapse:collapse;border-color:#000000">
                <tbody>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255);border-bottom:1pt solid black">&#160;</td>
                    <td style="vertical-align:bottom;text-align:right;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;text-align:right;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td>
                    <td style="vertical-align:bottom;text-align:right;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(230, 239, 255)">
                    <td style="vertical-align:bottom;text-align:left;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less than one year</span></span></td>
                    <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)">&#160;</td>
                    <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">46,842</span></span></td>
                    <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">One to two years</span></span></td>
                    <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">47,088</span></span></td>
                    <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(230, 239, 255)">
                    <td style="vertical-align:bottom;text-align:left;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Two to three years</span></span></td>
                    <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)">&#160;</td>
                    <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">47,088</span></span></td>
                    <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;text-align:left;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)">
                      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Thereafter</span></span></p>
                    </td>
                    <td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)">
                      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></p>
                    </td>
                    <td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(230, 239, 255)">
                    <td style="vertical-align:bottom;background-color:rgb(230, 239, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(230, 239, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total undiscounted lease payments payable</span></span></td>
                    <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">141,018</span></span></td>
                    <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(230, 239, 255)">
                    <td style="vertical-align:bottom;text-align:left;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less: impact of present value</span></span></td>
                    <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)">&#160;</td>
                    <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(15,056</span></span></td>
                    <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(230, 239, 255)">
                    <td style="vertical-align:bottom;text-align:left;border-top:1pt solid black;border-bottom:2pt solid black;background-color:rgb(230, 239, 255)">
                      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as at December 31, 2020&#160;&#160; &#160;</span></span></p>
                    </td>
                    <td style="vertical-align:bottom;text-align:left;width:1%;border-top:1pt solid black;border-bottom:2pt solid black;background-color:rgb(230, 239, 255)">&#160;</td>
                    <td style="vertical-align:bottom;text-align:right;width:17%;border-top:1pt solid black;border-bottom:2pt solid black;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">125,962</span></span></td>
                    <td style="vertical-align:bottom;text-align:left;width:2%;border-top:1pt solid black;border-bottom:2pt solid black;background-color:rgb(230, 239, 255)">&#160;</td>
                  </tr>
                </tbody>
              </table><br/>&#160;
            </div>
          <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfOperatingLeaseObligationsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of operating lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfOperatingLeaseObligationsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of a maturity analysis of operating lease payments. Operating lease is a lease that does not transfer substantially all the risks and rewards incidental to ownership of an underlying asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 97<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_97&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923883245000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share capital (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfReservesWithinEquityAbstract', window );"><strong>Disclosure of reserves within equity [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory', window );">Schedule of changes in share capital</a></td>
<td class="text">
                    <table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000">
                      <tbody>
                        <tr>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td colspan="4" style="border-bottom:1px solid #000000;vertical-align:bottom;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Class A shares</strong></span></span></span></span></td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td colspan="4" style="border-bottom:1px solid #000000;vertical-align:bottom;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Class B shares</strong></span></span></span></span></td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td colspan="4" style="border-bottom:1px solid #000000;vertical-align:bottom;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Warrants</strong></span></span></span></span></td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>#</strong></span></span></span></span></td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>$</strong></span></span></span></span></td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>#</strong></span></span></span></span></td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>$</strong></span></span></span></span></td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>#</strong></span></span></span></span></td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>$</strong></span></span></span></span></td>
                          <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td style="vertical-align:bottom">&#160;</td>
                          <td style="vertical-align:bottom">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(204, 238, 255)">
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Balance, January 1, 2019</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>72</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>151,588</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>6,843,780</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>51,093,434</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>546,212</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3,341,826</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(255, 255, 255)">
                          <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Shares issued [a] [b] [c] [d]</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>408,651</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>8,681,103</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(204, 238, 255)">
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Issued on acquisition of net assets of Prismic Pharmaceuticals, Inc. [e]</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>510,940</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>12,361,657</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>67,598</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,420,407</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(255, 255, 255)">
                          <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Stock options exercised</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(204, 238, 255)">
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Share-based payments</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>130,189</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,340,929</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(255, 255, 255)">
                          <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Warrants exercised</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>12,167</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>109,214</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(12,167</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(37,753</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                        </tr>
                        <tr style="background-color:rgb(204, 238, 255)">
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Warrants expired</span></span></span></span></td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(134,192</span></span></span></span></td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(402,491</span></span></span></span></td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                        </tr>
                        <tr style="background-color:rgb(255, 255, 255)">
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Balance, December 31, 2019</strong></span></span></span></span></td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>72</strong></span></span></span></span></td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>151,588</strong></span></span></span></span></td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>7,905,727</strong></span></span></span></span></td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>73,586,337</strong></span></span></span></span></td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>467,451</strong></span></span></span></span></td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>4,321,989</strong></span></span></span></span></td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(204, 238, 255)">
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Shares issued [g] [j] [k] [l] [n] [o]</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>8,925,942</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>22,242,975</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>6,335,758</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,110,904</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(255, 255, 255)">
                          <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Share-based payments [f] [h] [i] [m]</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,307,569</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>6,663,479</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(204, 238, 255)">
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Share options exercised</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>22,382</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>563,747</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(255, 255, 255)">
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Warrants expired&#160;</span></span></span></span></td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#x2014;</span></span></span></span></td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(54,100</span></span></span></span></td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(463,935</span></span></span></span></td>
                          <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                        </tr>
                        <tr style="background-color:rgb(204, 238, 255)">
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Balance, December 31, 2020</strong></span></span></span></span></td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>72</strong></span></span></span></span></td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>151,588</strong></span></span></span></span></td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>19,161,620</strong></span></span></span></span></td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>103,056,538</strong></span></span></span></span></td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>6,749,109</strong></span></span></span></span></td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>4,968,958</strong></span></span></span></span></td>
                          <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                        </tr>
                      </tbody>
                    </table>
                  <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory', window );">Schedule of changes in warrants outstanding and weighted average exercise price</a></td>
<td class="text">
                      <table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000">
                        <tbody>
                          <tr>
                            <td style="vertical-align:bottom">&#160;</td>
                            <td style="text-align:right;vertical-align:bottom">&#160;</td>
                            <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>&#160;Number of warrants&#160;</strong></span></span></span></span></td>
                            <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                            <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>&#160;Weighted average<br/>exercise price&#160;</strong></span></span></span></span></td>
                            <td style="text-align:right;vertical-align:bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom">&#160;</td>
                            <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                            <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>&#160;#&#160;</strong></span></span></span></span></td>
                            <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                            <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                            <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>&#160;C$&#160;</strong></span></span></span></span></td>
                            <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                          </tr>
                          <tr style="background-color:rgb(204, 238, 255)">
                            <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Outstanding as at December 31, 2018</span></span></span></span></td>
                            <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                            <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>546,212</span></span></span></span></td>
                            <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                            <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                            <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>9.47</span></span></span></span></td>
                            <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          </tr>
                          <tr style="background-color:rgb(255, 255, 255)">
                            <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Issued</span></span></span></span></td>
                            <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                            <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>67,598</span></span></span></span></td>
                            <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                            <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                            <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>10.45</span></span></span></span></td>
                            <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          </tr>
                          <tr style="background-color:rgb(204, 238, 255)">
                            <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Exercised</span></span></span></span></td>
                            <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                            <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(12,167</span></span></span></span></td>
                            <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                            <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                            <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>7.81</span></span></span></span></td>
                            <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          </tr>
                          <tr style="background-color:rgb(255, 255, 255)">
                            <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Expired</span></span></span></span></td>
                            <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                            <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(134,192</span></span></span></span></td>
                            <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                            <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                            <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>7.64</span></span></span></span></td>
                            <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          </tr>
                          <tr style="background-color:rgb(204, 238, 255)">
                            <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Outstanding as at December 31, 2019</span></span></span></span></td>
                            <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                            <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>467,451</span></span></span></span></td>
                            <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                            <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                            <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>10.20</span></span></span></span></td>
                            <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          </tr>
                          <tr style="background-color:rgb(255, 255, 255)">
                            <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Issued</span></span></span></span></td>
                            <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                            <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>6,335,758</span></span></span></span></td>
                            <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                            <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                            <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>5.27</span></span></span></span></td>
                            <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          </tr>
                          <tr style="background-color:rgb(204, 238, 255)">
                            <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Expired</span></span></span></span></td>
                            <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                            <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(54,100</span></span></span></span></td>
                            <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
                            <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                            <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4.97</span></span></span></span></td>
                            <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                          </tr>
                          <tr style="background-color:rgb(255, 255, 255)">
                            <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Outstanding as at December 31, 2020</strong></span></span></span></span></td>
                            <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                            <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>6,749,109</strong></span></span></span></span></td>
                            <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                            <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                            <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>5.62</strong></span></span></span></span></td>
                            <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                          </tr>
                        </tbody>
                      </table>
                    <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory', window );">Schedule of fair value assumptions of warrants outstanding</a></td>
<td class="text">
                      <table border="0" style="width:100%;border-collapse:collapse;font-size:10pt">
                        <tbody>
                          <tr>
                            <td>&#160;</td>
                            <td style="text-align:right;border-bottom:1px solid #000000;width:25%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2020</strong></span></span></td>
                            <td style="text-align:right;border-bottom:1px solid #000000;width:25%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2019</strong></span></span></td>
                          </tr>
                          <tr style="background-color:rgb(204, 238, 255)">
                            <td style="background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Grant date share price</span></span></td>
                            <td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">C$2.58 - C$4.00</span></span></td>
                            <td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">C$32.16</span></span></td>
                          </tr>
                          <tr style="background-color:rgb(255, 255, 255)">
                            <td style="background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise price</span></span></td>
                            <td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">C$3.46 - C$5.80</span></span></td>
                            <td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">C$2.61 - C$26.73</span></span></td>
                          </tr>
                          <tr style="background-color:rgb(204, 238, 255)">
                            <td style="background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expected dividend yield</span></span></td>
                            <td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#x2014;</span></span></td>
                            <td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#x2014;</span></span></td>
                          </tr>
                          <tr style="background-color:rgb(255, 255, 255)">
                            <td style="background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Risk free interest rate</span></span></td>
                            <td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.32% 0.36%</span></span></td>
                            <td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.41% - 1.52%</span></span></td>
                          </tr>
                          <tr style="background-color:rgb(204, 238, 255)">
                            <td style="background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expected life</span></span></td>
                            <td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5 years</span></span></td>
                            <td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.39 - 6.55</span></span></td>
                          </tr>
                          <tr style="background-color:rgb(255, 255, 255)">
                            <td style="background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expected volatility</span></span></td>
                            <td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">118% - 121%</span></span></td>
                            <td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></td>
                          </tr>
                        </tbody>
                      </table>
                    <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory', window );">Schedule of number of warrants outstanding and exercise price</a></td>
<td class="text">
                      <div>
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table is a summary of the Company's warrants outstanding as at December 31, 2019:<span style="text-align:start">&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;</span></span></span></p>
                        <div>
                          <div>
                            <table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000">
                              <tbody>
                                <tr>
                                  <td colspan="6" style="text-align:center;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Warrants Outstanding</strong></span></span></td>
                                  <td colspan="1" style="text-align:center;vertical-align:bottom">&#160;</td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom">&#160;</td>
                                  <td style="text-align:right;vertical-align:bottom">&#160;</td>
                                  <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Exercise price</strong></span></span></td>
                                  <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                                  <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                                  <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Number outstanding</strong></span></span></td>
                                  <td style="text-align:right;vertical-align:bottom">&#160;</td>
                                </tr>
                                <tr>
                                  <td style="border-bottom:1px solid #000000;vertical-align:bottom;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Expiry Date</strong></span></span></td>
                                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>C$</strong></span></span></td>
                                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>#</strong></span></span></td>
                                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(204, 238, 255)">
                                  <td style="vertical-align:bottom;text-align:center;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">August 1, 2021</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.43</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,476</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(255, 255, 255)">
                                  <td style="vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">May 24, 2022</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18.09</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">163,535</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(204, 238, 255)">
                                  <td style="vertical-align:bottom;text-align:center;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">September 15, 2022</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.42</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">199,005</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(255, 255, 255)">
                                  <td style="vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">May 20, 2023</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16.08</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,311</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(204, 238, 255)">
                                  <td style="vertical-align:bottom;text-align:center;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">July 24, 2023</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13.07</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,357</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(255, 255, 255)">
                                  <td style="vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">September 11, 2023</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.43</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22,382</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(204, 238, 255)">
                                  <td style="vertical-align:bottom;text-align:center;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">May 4, 2025</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26.73</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,730</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(255, 255, 255)">
                                  <td style="vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">May 10, 2025</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26.73</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,865</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(204, 238, 255)">
                                  <td style="vertical-align:bottom;text-align:center;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">May 17, 2025</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26.73</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,730</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(255, 255, 255)">
                                  <td style="vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">May 31, 2025</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26.73</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,865</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(204, 238, 255)">
                                  <td style="vertical-align:bottom;text-align:center;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">June 8, 2025</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9.65</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,500,000</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(255, 255, 255)">
                                  <td style="vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">August 6, 2020 (i)</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.42</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,381,215</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(204, 238, 255)">
                                  <td style="vertical-align:bottom;text-align:center;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">October 20, 2020 (ii)</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.31</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,454,543</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(255, 255, 255)">
                                  <td style="vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">January 16, 2026</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26.73</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,722</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(204, 238, 255)">
                                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:center;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">January 20, 2026</span></span></td>
                                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26.73</span></span></td>
                                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">373</span></span></td>
                                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(255, 255, 255)">
                                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.62</span></span></td>
                                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,749,109</span></span></td>
                                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                </tr>
                              </tbody>
                            </table><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;&#160;&#160;</span></span>
                            <p style="margin-left:108pt;margin-bottom:0pt;text-indent:-36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(i)<span style="width:28.89pt;text-indent:0pt;display:inline-block">&#160;</span>Warrants were issued in US$ with exercise price of $4.26</span></span></p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;&#160;&#160;</span></span>
                            <p style="margin-top:0pt;margin-left:108pt;text-indent:-36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(ii)<span style="width:26.12pt;text-indent:0pt;display:inline-block">&#160;</span>Warrants were issued in US$ with exercise price of $2.60<span style="text-align:start;text-indent:0px">&#160; &#160;</span></span></span></p>
                            <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table is a summary of the Company's warrants outstanding as at December 31, 2019:<span style="text-align:start">&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160;&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160;</span></span></span></p>
                            <table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000">
                              <tbody>
                                <tr>
                                  <td colspan="6" style="text-align:center;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Warrants Outstanding</strong></span></span></td>
                                  <td colspan="1" style="text-align:center;vertical-align:bottom">&#160;</td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom">&#160;</td>
                                  <td style="text-align:right;vertical-align:bottom">&#160;</td>
                                  <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Exercise price</strong></span></span></td>
                                  <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                                  <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                                  <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Number outstanding</strong></span></span></td>
                                  <td style="text-align:right;vertical-align:bottom">&#160;</td>
                                </tr>
                                <tr>
                                  <td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Expiry Date</strong></span></span></td>
                                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>C$</strong></span></span></td>
                                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>#</strong></span></span></td>
                                  <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(204, 238, 255)">
                                  <td style="text-align:center;vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">January 5, 2020</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6.03</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">37,313</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(255, 255, 255)">
                                  <td style="text-align:center;vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">November 30, 2020</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.61</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16,787</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(204, 238, 255)">
                                  <td style="text-align:center;vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">August 1, 2021</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.43</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,476</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(255, 255, 255)">
                                  <td style="text-align:center;vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">May 24, 2022</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18.09</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">163,535</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(204, 238, 255)">
                                  <td style="text-align:center;vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">September 15, 2022</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.42</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">199,005</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(255, 255, 255)">
                                  <td style="text-align:center;vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">May 20, 2023</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16.08</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,311</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(204, 238, 255)">
                                  <td style="text-align:center;vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">July 24, 2023</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13.07</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,357</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(255, 255, 255)">
                                  <td style="text-align:center;vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">September 11, 2023</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.43</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22,382</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(204, 238, 255)">
                                  <td style="text-align:center;vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">May 4, 2025</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26.73</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,730</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(255, 255, 255)">
                                  <td style="text-align:center;vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">May 10, 2025</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26.73</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,865</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(204, 238, 255)">
                                  <td style="text-align:center;vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">May 17, 2025</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26.73</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,730</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(255, 255, 255)">
                                  <td style="text-align:center;vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">May 31, 2025</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26.73</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,865</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(204, 238, 255)">
                                  <td style="text-align:center;vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">January 16, 2026</span></span></td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26.73</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,722</span></span></td>
                                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(255, 255, 255)">
                                  <td style="border-bottom:1px solid rgb(0, 0, 0);text-align:center;vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">January 20, 2026</span></span></td>
                                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26.73</span></span></td>
                                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">373</span></span></td>
                                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                                </tr>
                                <tr style="background-color:rgb(204, 238, 255)">
                                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10.20</span></span></td>
                                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:12%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">467,451</span></span></td>
                                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                                </tr>
                              </tbody>
                            </table>
                          </div>
                        </div>
                      </div>
                    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the tabular disclosure of changes in warrants outstanding and weighted average exercise price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfChangesInWarrantsOutstandingAndWeightedAverageExercisePriceExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the tabular disclosure of fair value assumption of warrants outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfFairValueAssumptionsOfWarrantsOutstandingExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the tabular disclosure of number of warrants outstanding and exercise price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfNumberOfWarrantsOutstandingAndExercisePriceExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of classes of share capital. [Refer: Share capital [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_79_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReservesWithinEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReservesWithinEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923858989336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory', window );">Schedule of stock options granted</a></td>
<td class="text">
              <table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000">
                <tbody>
                  <tr>
                    <td style="vertical-align:bottom">&#160;</td>
                    <td style="text-align:right;vertical-align:bottom">&#160;</td>
                    <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>&#160;Number of<br/>options&#160;</strong></span></span></td>
                    <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td style="text-align:right;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td style="text-align:right;vertical-align:bottom;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>&#160;Weighted average<br/>exercise price&#160;</strong></span></span></td>
                    <td style="text-align:right;vertical-align:bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom">&#160;</td>
                    <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                    <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>&#160;#&#160;</strong></span></span></td>
                    <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                    <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                    <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>&#160;C$&#160;</strong></span></span></td>
                    <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(204, 238, 255)">
                    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding as at December 31, 2018</span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">485,159</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">74.53</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Granted</span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,363,322</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20.68</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(204, 238, 255)">
                    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercised</span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(82,094</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10.02</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Forfeited</span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,438</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">56.28</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(204, 238, 255)">
                    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cancelled</span></span></td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(299,006</span></span></td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">115.80</span></span></td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding as at December 31, 2019</span></span></td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,454,943</span></span></td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">21.96</span></span></td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(204, 238, 255)">
                    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Granted</span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,082,639</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.14</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercised</span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(22,382</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.61</span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(204, 238, 255)">
                    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cancelled</span></span></td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(822,137</span></span></td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">31.65</span></span></td>
                    <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Outstanding as at December 31, 2020</strong></span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>1,693,063</strong></span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>6.11</strong></span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(204, 238, 255)">
                    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Exercisable as at December 31, 2020</strong></span></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>1,528,186</strong></span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                    <td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>6.13</strong></span></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  </tr>
                </tbody>
              </table>
            <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory', window );">Schedule of fair values of options granted using the Black-Scholes option pricing model</a></td>
<td class="text">
              <div>
                <table border="0" style="width:100%;border-collapse:collapse;font-size:10pt">
                  <tbody>
                    <tr>
                      <td>&#160;</td>
                      <td style="text-align:right;border-bottom:1px solid #000000;width:25%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>&#160;2020&#160;</strong></span></span></td>
                      <td style="text-align:right;border-bottom:1px solid #000000;width:25%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>&#160;2019&#160;</strong></span></span></td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Grant date share price</span></span></td>
                      <td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>&#160;C$3.75 &#x2014; C$9.54&#160;</strong></span></span></td>
                      <td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;C$6.45 &#x2014; C$75.38&#160;</span></span></td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise price</span></span></td>
                      <td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>&#160;C$3.68 &#x2014; C$9.80&#160;</strong></span></span></td>
                      <td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;C$7.17 &#x2014; C$75.38&#160;</span></span></td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expected dividend yield</span></span></td>
                      <td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>&#x2014;</strong></span></span></td>
                      <td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Risk free interest rate</span></span></td>
                      <td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>0.27% &#x2014;&#160; 1.55%</strong></span></span></td>
                      <td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.24% &#x2014;&#160; 1.90%</span></span></td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expected life</span></span></td>
                      <td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>&#160;4 &#x2014; 9 years&#160;</strong></span></span></td>
                      <td style="text-align:right;width:25%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;5 years&#160;</span></span></td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expected volatility</span></span></td>
                      <td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>120%</strong></span></span></td>
                      <td style="text-align:right;width:25%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></td>
                    </tr>
                  </tbody>
                </table>
              </div>
            <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory', window );">Schedule of number and weighted average remaining contractual life of outstanding and exercisable share options</a></td>
<td class="text">
          <div>
            <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">The following table is a summary of the Company's share options outstanding as at December 31, 2020:</p>
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span>&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;</span></p>
            <div>
              <div>
                <table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000">
                  <tbody>
                    <tr>
                      <td style="vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td colspan="1" style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td colspan="7" style="text-align:center;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Options outstanding</strong></span></span></td>
                      <td colspan="1" style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td colspan="4" style="text-align:center;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Options exercisable</strong></span></span></td>
                      <td colspan="1" style="text-align:center;vertical-align:bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise price</span></span></td>
                      <td style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number outstanding</span></span></td>
                      <td style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted average remaining contractual life [years]</span></span></td>
                      <td style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise price</span></span></td>
                      <td style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number exercisable</span></span></td>
                      <td style="text-align:center;vertical-align:bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">C$</span></span></td>
                      <td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">#</span></span></td>
                      <td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">#</span></span></td>
                      <td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">C$</span></span></td>
                      <td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">#</span></span></td>
                      <td style="text-align:center;vertical-align:bottom;border-bottom:1px solid #000000">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.61</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,683</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.49</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.61</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,683</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.75</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,500</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6.47</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.75</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">500</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.86</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">872,139</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.08</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.86</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">864,139</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.42</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">99,502</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.71</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.42</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">99,502</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.75</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">110,000</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.29</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.75</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">77,500</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.03</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">60,000</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.70</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.03</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,498</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.43</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16,264</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.49</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.43</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16,264</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6.16</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20,000</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.18</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6.16</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20,000</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.17</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">199,005</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.83</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.17</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">199,005</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.63</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">203,750</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.34</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.63</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">138,750</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9.54</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,000</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.06</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9.54</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,125</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10.65</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,730</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.49</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10.65</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,730</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13.07</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,855</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.49</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13.07</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,855</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13.47</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,418</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.49</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13.47</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,418</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16.08</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18,409</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.49</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16.08</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18,409</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17.89</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,178</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.49</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17.89</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,178</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18.09</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17,413</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.21</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18.09</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17,413</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20.10</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,289</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.27</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20.10</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,289</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">47.24</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,493</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.37</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">47.24</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,493</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">50.25</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,224</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.31</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">50.25</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,224</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">52.26</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">498</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.21</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">52.26</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">498</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">55.28</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">498</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.12</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">55.28</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">498</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">59.30</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">498</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.96</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">59.30</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">498</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">75.38</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">498</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.04</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">75.38</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">498</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">86.43</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,244</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.87</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">86.43</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,244</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">142.71</span></span></td>
                      <td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,975</span></span></td>
                      <td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.74</span></span></td>
                      <td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">142.71</span></span></td>
                      <td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="border-bottom:1px solid rgb(0, 0, 0);text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,975</span></span></td>
                      <td style="border-bottom:1px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6.11</span></span></strong></td>
                      <td style="text-align:left;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="border-bottom:2px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="border-bottom:2px solid rgb(0, 0, 0);text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,693,063</span></span></strong></td>
                      <td style="border-bottom:2px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="border-bottom:2px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="border-bottom:2px solid rgb(0, 0, 0);text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.88</span></span></strong></td>
                      <td style="border-bottom:2px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="border-bottom:2px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="border-bottom:2px solid rgb(0, 0, 0);text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6.13</span></span></strong></td>
                      <td style="border-bottom:2px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="border-bottom:2px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="border-bottom:2px solid rgb(0, 0, 0);text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,528,186</span></span></strong></td>
                      <td style="border-bottom:2px solid rgb(0, 0, 0);text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                  </tbody>
                </table>
                <div>
                  <p style="text-align:center">&#160;</p>
                </div>
                <div style="text-align:left"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="text-align:justify">The following table is a summary of the Company's share options outstanding as at December 31, 2019:</span></span></span></div>
                <div style="text-align:left">&#160;</div>
                <table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000">
                  <tbody>
                    <tr>
                      <td colspan="1" style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td colspan="7" style="text-align:center;vertical-align:bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><strong>Options outstanding</strong></span></span></td>
                      <td colspan="1" style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td colspan="4" style="text-align:center;vertical-align:bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><strong>Options exercisable</strong></span></span></td>
                      <td style="text-align:center;vertical-align:bottom;width:2%">&#160;</td>
                    </tr>
                    <tr>
                      <td style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Exercise price</span></span></td>
                      <td style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Number outstanding</span></span></td>
                      <td style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Weighted average remaining contractual life [years]</span></span></td>
                      <td style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Exercise price</span></span></td>
                      <td style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;vertical-align:bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Number exercisable</span></span></td>
                      <td style="text-align:center;vertical-align:bottom;width:2%">&#160;</td>
                    </tr>
                    <tr>
                      <td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">C$</span></span></td>
                      <td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">#</span></span></td>
                      <td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">#</span></span></td>
                      <td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">C$</span></span></td>
                      <td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                      <td style="text-align:center;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">#</span></span></td>
                      <td style="text-align:center;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2.61</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">35,065</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">3.49</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2.61</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">35,065</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4.42</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">99,502</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2.71</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4.42</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">99,502</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">5.43</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">16,264</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">3.49</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">5.43</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">16,264</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">10.65</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">3,730</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">3.49</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">10.65</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">3,730</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">13.07</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">10,855</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">3.49</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">13.07</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">10,855</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">13.47</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,418</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">3.49</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">13.47</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,418</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">16.08</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">18,409</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">3.49</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">16.08</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">18,409</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">17.89</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4,178</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">3.49</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">17.89</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4,178</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">18.09</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">37,313</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">3.34</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">18.09</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">37,313</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">20.10</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">493,363</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4.72</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">20.10</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">493,363</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">21.11</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">12,438</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4.67</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">21.11</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">12,438</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">24.12</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">9,950</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4.59</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">24.12</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">6,219</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">26.13</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">14,925</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">3.62</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">26.13</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">14,925</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">40.20</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">29,851</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4.45</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">40.20</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">22,388</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">44.22</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2,488</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">3.41</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">44.22</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2,488</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">47.24</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,493</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4.37</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">47.24</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,493</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">50.25</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">227,861</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">5.09</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">50.25</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">129,353</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">52.26</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">498</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4.21</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">52.26</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">498</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">55.28</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">498</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4.12</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">55.28</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">498</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">59.30</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">498</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">3.96</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">59.30</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">498</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">7.17</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">199,005</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4.83</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">7.17</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">199,005</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">75.38</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">498</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4.04</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">75.38</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">498</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">7.63</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">203,750</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">5.34</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">7.63</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">58,750</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">86.43</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,244</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">3.88</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">86.43</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,244</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">88.44</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">14,925</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">3.87</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">88.44</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">14,925</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">120.60</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">9,950</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">3.71</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">120.60</span></span></td>
                      <td style="text-align:left;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">9,950</span></span></td>
                      <td style="text-align:right;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(204, 238, 255)">
                      <td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">142.71</span></span></td>
                      <td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4,974</span></span></td>
                      <td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">3.74</span></span></td>
                      <td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">142.71</span></span></td>
                      <td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:left;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
                      <td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:8%;background-color:rgb(204, 238, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4,975</span></span></td>
                      <td style="text-align:right;border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;background-color:rgb(204, 238, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="text-align:left;border-bottom:1.5pt solid black;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;border-bottom:1.5pt solid black;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">21.96</span></span></td>
                      <td style="text-align:left;border-bottom:1.5pt solid black;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;border-bottom:1.5pt solid black;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;border-bottom:1.5pt solid black;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,454,943</span></span></td>
                      <td style="text-align:left;border-bottom:1.5pt solid black;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;border-bottom:1.5pt solid black;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;border-bottom:1.5pt solid black;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4.59</span></span></td>
                      <td style="text-align:left;border-bottom:1.5pt solid black;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;border-bottom:1.5pt solid black;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;border-bottom:1.5pt solid black;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">21.24</span></span></td>
                      <td style="text-align:left;border-bottom:1.5pt solid black;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:left;border-bottom:1.5pt solid black;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="text-align:right;border-bottom:1.5pt solid black;vertical-align:bottom;width:8%;background-color:rgb(255, 255, 255)"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,200,242</span></span></td>
                      <td style="text-align:right;border-bottom:1.5pt solid black;vertical-align:bottom;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                  </tbody>
                </table>
              </div>
            </div>
          </div>
        <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's share options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the number and weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923861355032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss per share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EarningsPerShareAbstract', window );"><strong>Earnings per share [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EarningsPerShareExplanatory', window );">Schedule of loss per share</a></td>
<td class="text">
        <div>
          <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;margin-left:auto;margin-right:auto;width:100%">
            <tbody>
              <tr>
                <td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                <td colspan="4" rowspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><strong>Year ended December 31,</strong></p>
                </td>
                <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
              </tr>
              <tr style="background-color:rgb(255, 255, 255)">
                <td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2020</strong></span></span></td>
                <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2019</span></span></td>
                <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
              </tr>
              <tr style="background-color:rgb(255, 255, 255)">
                <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>#</strong></span></span></td>
                <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">#</span></span></td>
                <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
              </tr>
              <tr style="background-color:rgb(230, 239, 255)">
                <td style="vertical-align:bottom;text-align:left;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Warrants</span></span></td>
                <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;width:17%;text-align:right;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>6,749,109</strong></span></span></td>
                <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">467,451</span></span></td>
                <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)">&#160;</td>
              </tr>
              <tr style="background-color:rgb(255, 255, 255)">
                <td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share Options</span></span></td>
                <td style="border:1pt none;vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="border:1pt none;vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>1,693,063</strong></span></span></td>
                <td style="border:1pt none;vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="border:1pt none;vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="border:1pt none;vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,454,943</span></span></td>
                <td style="border:1pt none;vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
              </tr>
              <tr style="background-color:rgb(230, 239, 255)">
                <td style="vertical-align:bottom;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>8,442,172</strong></span></span></td>
                <td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,922,394</span></span></td>
                <td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)">&#160;</td>
              </tr>
            </tbody>
          </table>
        </div>
      <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2019-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923837981864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General and administrative (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract', window );"><strong>Selling, general and administrative expense [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory', window );">Schedule of general and administrative expense</a></td>
<td class="text">
        <div>
          <div>
            <table border="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000">
              <tbody>
                <tr>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom">&#160;</td>
                  <td colspan="4" style="text-align:center;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Year ended December 31,</strong></span></span></td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2020</strong></span></span></td>
                  <td style="text-align:right;vertical-align:bottom">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom">&#160;</td>
                  <td style="text-align:right;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2019</span></span></td>
                  <td style="text-align:right;vertical-align:bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom">&#160;</td>
                  <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
                  <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td>
                  <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
                  <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
                  <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td>
                  <td style="border-bottom:1px solid #000000;text-align:right;vertical-align:bottom">&#160;</td>
                </tr>
                <tr style="background-color:rgb(204, 238, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Professional fees</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2,734,123</strong></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,101,136</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">General office, insurance and administration expenditures</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>3,616,159</strong></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,742,550</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(204, 238, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Consulting fees</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>1,775,269</strong></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,675,258</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Salaries, wages and benefits</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2,656,162</strong></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,705,696</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(204, 238, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Investor relations</span></span></p>
                  </td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>541,944</strong></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,241,275</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Building and facility costs</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>586,926</strong></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">676,798</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(204, 238, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign exchange loss</span></span></td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>(186,959</strong></span></span></td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>)</strong></span></span></td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#x2014;</span></span></td>
                  <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>11,723,624</strong></span></span></td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,142,713</span></span></td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(204, 238, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Allocated to:</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(204, 238, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Continuing operations</span></span></td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>10,058,083</strong></span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                  <td style="vertical-align:bottom;width:22%;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,407,427</span></span></td>
                  <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(204, 238, 255)">&#160;</td>
                </tr>
                <tr style="background-color:rgb(255, 255, 255)">
                  <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Discontinued operations</span></span></td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>1,665,541</strong></span></span></td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:22%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,735,286</span></span></td>
                  <td style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                </tr>
              </tbody>
            </table>
          </div>
        </div>
      <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of General and administrative expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923858949560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxesPaidRefundAbstract', window );"><strong>Income taxes paid (refund) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfProvisionForIncomeTaxesExplanatory', window );">Schedule of provision for income taxes</a></td>
<td class="text">
        <div>
          <div style="margin-left:39pt">&#160;</div>
          <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;margin-right:auto;width:90%">
            <tbody>
              <tr style="background-color:rgb(255, 255, 255)">
                <td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>2020</strong></span></td>
                <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>2019</strong></span></td>
                <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
              </tr>
              <tr style="background-color:rgb(255, 255, 255)">
                <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>$</strong></span></td>
                <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>$</strong></span></td>
                <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
              </tr>
              <tr style="background-color:rgb(230, 239, 255)">
                <td style="vertical-align:bottom;text-align:left;border-top:1pt solid black;background-color:rgb(230, 239, 255)">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Loss from continuing operations before income taxes</p>
                </td>
                <td style="vertical-align:bottom;text-align:left;width:1%;border-top:1pt solid black;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;width:17%;border-top:1pt solid black;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>(28,452,232</strong></span></td>
                <td style="vertical-align:bottom;text-align:left;width:2%;border-top:1pt solid black;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>)</strong></span></td>
                <td style="vertical-align:bottom;text-align:left;width:1%;border-top:1pt solid black;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;width:17%;border-top:1pt solid black;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(34,080,963</span></td>
                <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span></td>
              </tr>
              <tr style="background-color:rgb(255, 255, 255)">
                <td style="vertical-align:bottom;text-align:left;border-bottom:1pt solid black;background-color:rgb(255, 255, 255)">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Statutory federal and provincial tax rate</span></p>
                </td>
                <td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>26.50%</strong></span></td>
                <td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">26.50%</span></td>
                <td style="border-bottom:1pt solid black;vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
              </tr>
              <tr style="background-color:rgb(230, 239, 255)">
                <td style="vertical-align:bottom;text-align:left;background-color:rgb(230, 239, 255)">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Income tax recovery at the statutory tax rate</span></p>
                </td>
                <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>(7,539,841</strong></span></td>
                <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>)</strong></span></td>
                <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(9,031,455</span></td>
                <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span></td>
              </tr>
              <tr style="background-color:rgb(255, 255, 255)">
                <td style="vertical-align:bottom;padding-left:0pt;background-color:rgb(255, 255, 255)">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><span>Permanent&#160;</span><span>differences</span></span></p>
                </td>
                <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>2,235,657</strong></span></td>
                <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">5,866,153</span></p>
                </td>
                <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
              </tr>
              <tr style="background-color:rgb(230, 239, 255)">
                <td style="vertical-align:bottom;padding-left:0pt;background-color:rgb(230, 239, 255)">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Book to filing adjustments</p>
                </td>
                <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong>(1,545,244</strong></p>
                </td>
                <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)">)</td>
                <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">4,765,959</p>
                </td>
                <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)">&#160;</td>
              </tr>
              <tr style="background-color:rgb(255, 255, 255)">
                <td style="vertical-align:bottom;padding-left:0pt;background-color:rgb(255, 255, 255)">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Share issuance cost booked directly to equity</p>
                </td>
                <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong>(584,538</strong></p>
                </td>
                <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">)</td>
                <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)">&#x2014;</td>
                <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
              </tr>
              <tr style="background-color:rgb(230, 239, 255)">
                <td style="vertical-align:bottom;padding-left:0pt;background-color:rgb(230, 239, 255)">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Foreign exchange</p>
                </td>
                <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong>(370,457</strong></p>
                </td>
                <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)">)</td>
                <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)">&#x2014;</td>
                <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)">&#160;</td>
              </tr>
              <tr style="background-color:rgb(255, 255, 255)">
                <td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Change in tax benefits not recognized</span></p>
                </td>
                <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>7,804,423</strong></span></td>
                <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(255, 255, 255)">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(1,600,657</span></p>
                </td>
                <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span></td>
              </tr>
              <tr style="background-color:rgb(230, 239, 255)">
                <td style="vertical-align:bottom;text-align:left;padding-left:7.5pt;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:left;width:1%;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;width:17%;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>&#x2014;</strong></span></td>
                <td style="vertical-align:bottom;text-align:left;width:2%;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:left;width:1%;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;width:17%;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>&#x2014;</strong></span></p>
                </td>
                <td style="vertical-align:bottom;text-align:left;width:2%;border-top:1pt solid black;border-right:none;border-bottom:2pt solid black;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)">&#160;</td>
              </tr>
            </tbody>
          </table>
        </div>
      <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDeferredTaxesExplanatory', window );">Schedule of deferred tax assets (liabilities)</a></td>
<td class="text">
              <table cellspacing="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;width:90%">
                <tbody>
                  <tr>
                    <td style="vertical-align:bottom">&#160;</td>
                    <td style="vertical-align:bottom">&#160;</td>
                    <td style="vertical-align:bottom;text-align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>2020</strong></span></td>
                    <td style="vertical-align:bottom;text-align:right">&#160;</td>
                    <td style="vertical-align:bottom;text-align:right">&#160;</td>
                    <td style="vertical-align:bottom;text-align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2019</span></td>
                    <td style="vertical-align:bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;border-bottom:1px solid #000000">&#160;</td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1px solid #000000">&#160;</td>
                    <td style="vertical-align:bottom;width:12%;text-align:right;border-bottom:1px solid #000000"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>$</strong></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1px solid #000000">&#160;</td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1px solid #000000">&#160;</td>
                    <td style="vertical-align:bottom;width:12%;text-align:right;border-bottom:1px solid #000000"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$</span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1px solid #000000">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;background-color:#e6efff"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Other investments</span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>&#x2014;</strong></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:12%;text-align:right;background-color:#e6efff"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(126,461</span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff">)</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;border-bottom:1px solid #000000"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Capital losses carried forward</span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1px solid #000000">&#160;</td>
                    <td style="vertical-align:bottom;width:12%;text-align:right;border-bottom:1px solid #000000"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>&#x2014;</strong></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1px solid #000000">&#160;</td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1px solid #000000">&#160;</td>
                    <td style="vertical-align:bottom;width:12%;text-align:right;border-bottom:1px solid #000000"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">126,461</span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1px solid #000000">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#e6efff"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>Total</strong></span></td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1px solid #000000;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:12%;text-align:right;border-bottom:1px solid #000000;background-color:#e6efff"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>&#x2014;</strong></span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1px solid #000000;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1px solid #000000;background-color:#e6efff">&#160;</td>
                    <td style="vertical-align:bottom;width:12%;text-align:right;border-bottom:1px solid #000000;background-color:#e6efff"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#x2014;</span></td>
                    <td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1px solid #000000;background-color:#e6efff">&#160;</td>
                  </tr>
                </tbody>
              </table>
            <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory', window );">Schedule of temporary differences for which no deferred tax asset is recognised</a></td>
<td class="text">
              <div>
                <table border="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;width:90%">
                  <tbody>
                    <tr>
                      <td style="vertical-align:bottom">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>2020</strong></span></td>
                      <td style="text-align:right;vertical-align:bottom">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom">&#160;</td>
                      <td style="text-align:right;vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2019</span></td>
                      <td style="text-align:right;vertical-align:bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                      <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                      <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>$</strong></span></td>
                      <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                      <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                      <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$</span></td>
                      <td style="text-align:right;border-bottom:1px solid #000000;vertical-align:bottom">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(230, 239, 255)">
                      <td style="vertical-align:bottom;background-color:rgb(230, 239, 255)">
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Non-capital losses - Canada</span></p>
                      </td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>44,897,393</strong></span></td>
                      <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">20,703,137</span></td>
                      <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)">
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Net-operating loss - US</span></p>
                      </td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(255, 255, 255)">
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>5,032,915</strong></span></p>
                      </td>
                      <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(255, 255, 255)">
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">206,480</span></p>
                      </td>
                      <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(230, 239, 255)">
                      <td style="vertical-align:bottom;background-color:rgb(230, 239, 255)">
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Unrealized foreign exchange loss</span></p>
                      </td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>94,733</strong></span></td>
                      <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#x2014;</span></td>
                      <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Share-issuance costs</span></td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>3,419,003</strong></span></td>
                      <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">879,959</span></td>
                      <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(230, 239, 255)">
                      <td style="vertical-align:bottom;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Capital losses carried forward</span></td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>&#x2014;</strong></span></td>
                      <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">263,666</span></td>
                      <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Other investments</span></td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>4,449,544</strong></span></td>
                      <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">968,811</span></td>
                      <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(230, 239, 255)">
                      <td style="vertical-align:bottom;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">IFRS 16</span></td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>125,962</strong></span></td>
                      <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:15%;text-align:right;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#x2014;</span></td>
                      <td style="vertical-align:bottom;width:2%;text-align:left;background-color:rgb(230, 239, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(255, 255, 255)">
                      <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Property, plant and equipment</span></td>
                      <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:15%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>88,248</strong></span></td>
                      <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:1%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                      <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:15%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">30,290</span></td>
                      <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;width:2%;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                    </tr>
                    <tr style="background-color:rgb(230, 239, 255)">
                      <td style="vertical-align:bottom;border-bottom:1pt solid black;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong><span>Total</span></strong></span></td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1pt solid black;background-color:rgb(230, 239, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:15%;text-align:right;border-bottom:1pt solid black;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>58,107,798</strong></span></td>
                      <td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1pt solid black;background-color:rgb(230, 239, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:1%;text-align:left;border-bottom:1pt solid black;background-color:rgb(230, 239, 255)">&#160;</td>
                      <td style="vertical-align:bottom;width:15%;text-align:right;border-bottom:1pt solid black;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">23,052,343</span></td>
                      <td style="vertical-align:bottom;width:2%;text-align:left;border-bottom:1pt solid black;background-color:rgb(230, 239, 255)">&#160;</td>
                    </tr>
                  </tbody>
                </table>
              </div>
            <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ScheduleOfNonCapitalLossCarryforwardsTableTextBlock', window );">Schedule of non-capital loss carryforwards</a></td>
<td class="text">
              <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-color:#000000;font-size:10pt;width:90%;float:left" width="90%">
                <tbody>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:left">&#160;</td>
                    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%">&#160;</td>
                    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:center;border-bottom:1px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$</span></td>
                    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(230, 239, 255)">
                    <td style="vertical-align:bottom;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(230, 239, 255);width:89%"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2032</span></td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%">&#160;</td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(230, 239, 255);width:8%"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">26,982</span></td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2033</span></td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">114,405</span></td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(230, 239, 255)">
                    <td style="vertical-align:bottom;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2034</span></td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%">&#160;</td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">144,411</span></td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2035</span></td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">65,782</span></td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(230, 239, 255)">
                    <td style="vertical-align:bottom;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2036</span></td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%">&#160;</td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">689,676</span></td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2037</span></td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2,677,789</span></td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(230, 239, 255)">
                    <td style="vertical-align:bottom;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2038</span></td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%">&#160;</td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">6,092,686</span></td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2039</span></td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">11,415,413</span></td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(230, 239, 255)">
                    <td style="vertical-align:bottom;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">2040</span></td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%">&#160;</td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:1px solid rgb(0, 0, 0);font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(230, 239, 255)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">23,670,249</span></td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(230, 239, 255);width:1%">&#160;</td>
                  </tr>
                  <tr style="background-color:rgb(255, 255, 255)">
                    <td style="vertical-align:bottom;font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)">&#160;</td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:1px solid rgb(0, 0, 0);font-size:10pt;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)">44,897,393</td>
                    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
                  </tr>
                </tbody>
              </table>
            <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfProvisionForIncomeTaxesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the tabular disclosure of provision for income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfProvisionForIncomeTaxesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the tabular disclosure of temporary differences for which no deferred tax asset is recognised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognisedExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ScheduleOfNonCapitalLossCarryforwardsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of non-capital loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ScheduleOfNonCapitalLossCarryforwardsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDeferredTaxesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of deferred taxes. [Refer: Deferred tax liabilities; Deferred tax assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDeferredTaxesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxesPaidRefundAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxesPaidRefundAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923894730232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related party transactions (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract', window );"><strong>Disclosure of transactions between related parties [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory', window );">Schedule of key management personnel compensation</a></td>
<td class="text">
        <div>
          <p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-top:0pt;margin-bottom:0pt">&#160;</p>
          <table border="0" cellpadding="0" cellspacing="0" style="width:80%;font-size:10pt;border-collapse:collapse;border-color:#000000;margin-right:auto">
            <tbody>
              <tr style="background-color:rgb(255, 255, 255)">
                <td style="vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2020</strong></span></span></td>
                <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2019</strong></span></span></td>
                <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
              </tr>
              <tr style="background-color:rgb(255, 255, 255)">
                <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:left;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td>
                <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>$</strong></span></span></td>
                <td style="border-bottom:1px solid rgb(0, 0, 0);vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
              </tr>
              <tr style="background-color:rgb(230, 239, 255)">
                <td style="vertical-align:bottom;text-align:left;padding-left:1.5pt;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Salaries, benefits, bonuses and consulting fees</span></span></td>
                <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,936,816</span></span></strong></td>
                <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;text-align:right;width:17%;background-color:rgb(230, 239, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,638,267</span></span></td>
                <td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255)">&#160;</td>
              </tr>
              <tr style="background-color:rgb(255, 255, 255)">
                <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;padding-left:1.5pt;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based payments</span></span></td>
                <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:17%;background-color:rgb(255, 255, 255)"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,045,994</span></span></strong></td>
                <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
                <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:right;width:17%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,385,984</span></span></td>
                <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(255, 255, 255)">&#160;</td>
              </tr>
              <tr style="background-color:rgb(230, 239, 255)">
                <td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;padding-left:1.5pt;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong>Total</strong></p>
                </td>
                <td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong>9,982,810</strong></p>
                </td>
                <td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:1%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)">&#160;</td>
                <td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:right;width:17%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">13,024,251</p>
                </td>
                <td style="vertical-align:bottom;border-bottom:2pt solid black;text-align:left;width:2%;border-top:1pt solid black;border-right:none;border-left:none;border-image:initial;background-color:rgb(230, 239, 255)">&#160;</td>
              </tr>
            </tbody>
          </table>
        </div>
      <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of information about key management personnel. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923837697656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of business - Schedule of ownership percentage in subsidiaries (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">FSD Biosciences Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Country</a></td>
<td class="text">USA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Ownership percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=huge_SubsidiariesOneMember', window );">Prismic Pharmaceuticals Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Country</a></td>
<td class="text">USA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Ownership percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=huge_SubsidiariesTwoMember', window );">FV Pharma Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Country</a></td>
<td class="text">Canada<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Ownership percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The principal place of business of a subsidiary. [Refer: Principal place of business; Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16_b_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_b_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 12<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_12_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 19B<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_19B_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_b_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16_b_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 19B<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_19B_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestInSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=huge_SubsidiariesOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=huge_SubsidiariesOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=huge_SubsidiariesTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=huge_SubsidiariesTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923834097576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of presentation - Schedule of restatement of prior period information (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 01, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssetsAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash</a></td>
<td class="nump">$ 17,524,822<span></span>
</td>
<td class="nump">$ 5,967,798<span></span>
</td>
<td class="nump">$ 15,899,808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,899,808<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivables', window );">Trade and other receivables</a></td>
<td class="nump">161,342<span></span>
</td>
<td class="nump">1,557,302<span></span>
</td>
<td class="nump">745,520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">745,520<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentPrepaidExpenses', window );">Prepaid expenses and deposits</a></td>
<td class="nump">569,401<span></span>
</td>
<td class="nump">323,776<span></span>
</td>
<td class="nump">334,096<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">334,096<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Total current assets</a></td>
<td class="nump">26,866,069<span></span>
</td>
<td class="nump">8,558,249<span></span>
</td>
<td class="nump">16,979,424<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,979,424<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Investments</a></td>
<td class="nump">1,676,745<span></span>
</td>
<td class="nump">8,862,744<span></span>
</td>
<td class="nump">13,589,954<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,589,954<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use asset, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">95,851<span></span>
</td>
<td class="nump">183,424<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,880,258<span></span>
</td>
<td class="nump">9,134,183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,134,183<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Assets', window );">Assets</a></td>
<td class="nump">41,967,205<span></span>
</td>
<td class="nump">43,217,727<span></span>
</td>
<td class="nump">39,886,985<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,703,561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilitiesAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayables', window );">Trade and other payables</a></td>
<td class="nump">3,700,103<span></span>
</td>
<td class="nump">3,361,145<span></span>
</td>
<td class="nump">1,311,865<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,311,865<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Lease obligations</a></td>
<td class="nump">46,842<span></span>
</td>
<td class="nump">42,285<span></span>
</td>
<td class="nump">40,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Total current liabilities</a></td>
<td class="nump">5,579,502<span></span>
</td>
<td class="nump">6,829,916<span></span>
</td>
<td class="nump">1,352,740<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,311,865<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilitiesAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Lease obligations</a></td>
<td class="nump">79,120<span></span>
</td>
<td class="nump">110,334<span></span>
</td>
<td class="nump">142,549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">5,658,622<span></span>
</td>
<td class="nump">6,940,250<span></span>
</td>
<td class="nump">1,495,289<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,311,865<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>SHAREHOLDER'S EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital</a></td>
<td class="nump">103,208,126<span></span>
</td>
<td class="nump">73,737,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_Warrants', window );">Warrant reserve</a></td>
<td class="nump">4,968,958<span></span>
</td>
<td class="nump">4,321,989<span></span>
</td>
<td class="nump">3,341,826<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,341,826<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SharePremium', window );">Contributed surplus</a></td>
<td class="nump">18,792,590<span></span>
</td>
<td class="nump">17,371,434<span></span>
</td>
<td class="nump">3,744,423<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,744,423<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RetainedEarnings', window );">Accumulated deficit</a></td>
<td class="num">(90,868,888)<span></span>
</td>
<td class="num">(59,069,095)<span></span>
</td>
<td class="num">(19,939,575)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,939,575)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total equity</a></td>
<td class="nump">36,308,583<span></span>
</td>
<td class="nump">36,277,477<span></span>
</td>
<td class="nump">38,391,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,391,696<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Equity and liabilities</a></td>
<td class="nump">41,967,205<span></span>
</td>
<td class="nump">43,217,727<span></span>
</td>
<td class="nump">39,886,985<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,703,561<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ifrs-full_PreviouslyStatedMember', window );">December 31, 2018 as reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssetsAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,134,930<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivables', window );">Trade and other receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">990,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentPrepaidExpenses', window );">Prepaid expenses and deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">444,099<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Total current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,570,017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,064,541<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use asset, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,141,676<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Assets', window );">Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,776,234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilitiesAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayables', window );">Trade and other payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,743,806<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Lease obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Total current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,743,806<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilitiesAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Lease obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">Total Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,743,806<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>SHAREHOLDER'S EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_Warrants', window );">Warrant reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,442,145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SharePremium', window );">Contributed surplus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,977,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RetainedEarnings', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,504,819)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,032,428<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Equity and liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,776,234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=huge_IncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember', window );">Foreign currency translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssetsAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,235,122)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivables', window );">Trade and other receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(245,468)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentPrepaidExpenses', window );">Prepaid expenses and deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(110,003)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Total current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,590,593)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,474,587)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use asset, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,007,493)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Assets', window );">Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,072,673)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilitiesAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayables', window );">Trade and other payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(431,941)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Lease obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Total current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(431,941)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilitiesAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Lease obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">Total Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(431,941)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>SHAREHOLDER'S EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_Warrants', window );">Warrant reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,100,319)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SharePremium', window );">Contributed surplus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,232,877)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RetainedEarnings', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,565,244<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,640,732)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Equity and liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,072,673)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember', window );">Adoption of IFRS 16</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssetsAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivables', window );">Trade and other receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentPrepaidExpenses', window );">Prepaid expenses and deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Total current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use asset, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">183,424<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Assets', window );">Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">183,424<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilitiesAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayables', window );">Trade and other payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Lease obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Total current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilitiesAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Lease obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142,549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">Total Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">183,424<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>SHAREHOLDER'S EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_Warrants', window );">Warrant reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SharePremium', window );">Contributed surplus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RetainedEarnings', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Equity and liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">183,424<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassACommonStockSharesMember', window );">Class A shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>SHAREHOLDER'S EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital</a></td>
<td class="nump">151,588<span></span>
</td>
<td class="nump">151,588<span></span>
</td>
<td class="nump">151,588<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151,588<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total equity</a></td>
<td class="nump">151,588<span></span>
</td>
<td class="nump">151,588<span></span>
</td>
<td class="nump">151,588<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassACommonStockSharesMember', window );">Class A shares | December 31, 2018 as reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>SHAREHOLDER'S EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">201,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassACommonStockSharesMember', window );">Class A shares | Foreign currency translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>SHAREHOLDER'S EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(49,912)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassACommonStockSharesMember', window );">Class A shares | Adoption of IFRS 16</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>SHAREHOLDER'S EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember', window );">Class B shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>SHAREHOLDER'S EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital</a></td>
<td class="nump">103,056,538<span></span>
</td>
<td class="nump">73,586,337<span></span>
</td>
<td class="nump">51,093,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,093,434<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total equity</a></td>
<td class="nump">$ 103,056,538<span></span>
</td>
<td class="nump">$ 73,586,337<span></span>
</td>
<td class="nump">51,093,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember', window );">Class B shares | December 31, 2018 as reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>SHAREHOLDER'S EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67,916,302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember', window );">Class B shares | Foreign currency translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>SHAREHOLDER'S EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (16,822,868)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember', window );">Class B shares | Adoption of IFRS 16</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>SHAREHOLDER'S EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_Warrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount related to warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_Warrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2020-01-01: The amount of resources: (a) controlled by the entity as a result of past events; and (b) from which future economic benefits are expected to flow to the entity.
Effective 2020-01-01: The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have an unconditional right to defer settlement for at least twelve months after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 69<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2020-01-01: The amount of present obligations of the entity arising from past events, the settlement of which is expected to result in an outflow from the entity of resources embodying economic benefits.
Effective 2020-01-01: The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current investments other than investments accounted for using the equity method. [Refer: Investments accounted for using equity method; Non-current assets; Investments other than investments accounted for using equity method]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing the entity's cumulative undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph IG6<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SharePremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount received or receivable from the issuance of the entity's shares in excess of nominal value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SharePremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph k<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_k&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_h&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ifrs-full_PreviouslyStatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ifrs-full_PreviouslyStatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=huge_IncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=huge_IncreaseDecreaseDueToChangesInForeignCurrencyTranslationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassACommonStockSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=huge_ClassACommonStockSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923834069832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant accounting policies - Schedule of estimated useful lives of assets (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember', window );">Computer equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment', window );">Estimated useful lives</a></td>
<td class="text">30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationMethodPropertyPlantAndEquipment', window );">Method of amortized</a></td>
<td class="text">declining balance<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=huge_ProductionEquipmentMember', window );">Production equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment', window );">Estimated useful lives</a></td>
<td class="text">20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationMethodPropertyPlantAndEquipment', window );">Method of amortized</a></td>
<td class="text">declining balance<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment', window );">Estimated useful lives</a></td>
<td class="text">20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationMethodPropertyPlantAndEquipment', window );">Method of amortized</a></td>
<td class="text">declining balance<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember', window );">Facility and related</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment', window );">Estimated useful lives</a></td>
<td class="text">20 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationMethodPropertyPlantAndEquipment', window );">Method of amortized</a></td>
<td class="text">straight-line<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationMethodPropertyPlantAndEquipment', window );">Method of amortized</a></td>
<td class="text">Not amortized<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember', window );">Intellectual Property</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill', window );">Estimated useful lives for intangible assets</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationMethodPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The depreciation method used for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationMethodPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of useful life used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of useful life used for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=huge_ProductionEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=huge_ProductionEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923837697352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisition of Prismic Pharmaceutical (Narrative) (Details) - Prismic Pharmaceuticals Inc. ("Prismic")<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 28, 2019 </div>
<div>USD ($) </div>
<div>Share </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Consideration transferred, acquisition-date fair value</a></td>
<td class="nump">$ 15,713,448<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_LegalEntitiesAxis=huge_PrismicPharmaceuticalMember', window );">Class B subordinate voting shares</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Consideration transferred, acquisition-date fair value</a></td>
<td class="nump">$ 12,361,657<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares', window );">Issued on acquisition of net assets of Prismic Pharmaceuticals, Inc (shares) | shares</a></td>
<td class="nump">510,940<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ShareIssuePricePerShare', window );">Share issue price per share | $ / shares</a></td>
<td class="nump">$ 32.16<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_LegalEntitiesAxis=huge_PrismicPharmaceuticalMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Consideration transferred, acquisition-date fair value</a></td>
<td class="nump">$ 1,931,384<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable', window );">Number of instruments or interests issued or issuable | Share</a></td>
<td class="nump">89,898<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_LegalEntitiesAxis=huge_PrismicPharmaceuticalMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Consideration transferred, acquisition-date fair value</a></td>
<td class="nump">$ 1,420,407<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable', window );">Number of instruments or interests issued or issuable | Share</a></td>
<td class="nump">67,598<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity shares resulting from acquisition of net assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ShareIssuePricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the price per share of shares issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ShareIssuePricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBusinessCombinationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityInterestsOfAcquirer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value, at the acquisition date, of equity interests of the acquirer transferred as consideration in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B64_f_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityInterestsOfAcquirer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of instruments or interests issued or issuable at acquisition date for equity interests of the acquirer transferred as consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B64_f_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_LegalEntitiesAxis=huge_PrismicPharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_LegalEntitiesAxis=huge_PrismicPharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=huge_ClassBVotingSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=huge_ClassBVotingSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=huge_StockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=huge_StockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=huge_WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=huge_WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923859425912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisition of Prismic Pharmaceutical - Schedule of black scholes options pricing model (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 28, 2019 </div>
<div>Year </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WarrantsAbstract', window );"><strong>Warrants [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageSharePriceOfWarrants', window );">Grant date share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32.16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedDividendYieldOfWarrantsGranted', window );">Expected dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedLifeOfWarrants', window );">Expected life (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedVolatilityOfWarrantsGranted', window );">Annualized volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WarrantsAbstract', window );"><strong>Warrants [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageSharePriceOfWarrants', window );">Grant date share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExercisePriceOfWarrantsGranted', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.46<span></span>
</td>
<td class="nump">$ 2.61<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_RiskFreeInterestRateOfWarrantsGranted', window );">Risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.32%<span></span>
</td>
<td class="nump">1.41%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedLifeOfWarrants', window );">Expected life (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 4 months 20 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedVolatilityOfWarrantsGranted', window );">Annualized volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">118.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WarrantsAbstract', window );"><strong>Warrants [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageSharePriceOfWarrants', window );">Grant date share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExercisePriceOfWarrantsGranted', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.80<span></span>
</td>
<td class="nump">$ 26.73<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_RiskFreeInterestRateOfWarrantsGranted', window );">Risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.36%<span></span>
</td>
<td class="nump">1.52%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedLifeOfWarrants', window );">Expected life (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 6 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedVolatilityOfWarrantsGranted', window );">Annualized volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">121.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_LegalEntitiesAxis=huge_PrismicPharmaceuticalMember', window );">Prismic Pharmaceuticals Inc. ("Prismic")</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ShareOptionsAbstract', window );"><strong>Share Options [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Grant date share price</a></td>
<td class="nump">$ 32.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Annualized volatility</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WarrantsAbstract', window );"><strong>Warrants [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageSharePriceOfWarrants', window );">Grant date share price</a></td>
<td class="nump">$ 32.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedDividendYieldOfWarrantsGranted', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedVolatilityOfWarrantsGranted', window );">Annualized volatility</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_LegalEntitiesAxis=huge_PrismicPharmaceuticalMember', window );">Prismic Pharmaceuticals Inc. ("Prismic") | Bottom of range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ShareOptionsAbstract', window );"><strong>Share Options [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price</a></td>
<td class="nump">$ 2.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk free interest rate</a></td>
<td class="nump">1.39%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Expected life (years) | Year</a></td>
<td class="nump">0.98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WarrantsAbstract', window );"><strong>Warrants [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExercisePriceOfWarrantsGranted', window );">Exercise price</a></td>
<td class="nump">$ 2.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_RiskFreeInterestRateOfWarrantsGranted', window );">Risk free interest rate</a></td>
<td class="nump">1.41%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedLifeOfWarrants', window );">Expected life (years)</a></td>
<td class="text">1 year 4 months 20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_LegalEntitiesAxis=huge_PrismicPharmaceuticalMember', window );">Prismic Pharmaceuticals Inc. ("Prismic") | Top of range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ShareOptionsAbstract', window );"><strong>Share Options [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price</a></td>
<td class="nump">$ 17.89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk free interest rate</a></td>
<td class="nump">1.66%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Expected life (years) | Year</a></td>
<td class="nump">16.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WarrantsAbstract', window );"><strong>Warrants [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExercisePriceOfWarrantsGranted', window );">Exercise price</a></td>
<td class="nump">$ 26.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_RiskFreeInterestRateOfWarrantsGranted', window );">Risk free interest rate</a></td>
<td class="nump">1.52%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedLifeOfWarrants', window );">Expected life (years)</a></td>
<td class="text">6 years 6 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ExercisePriceOfWarrantsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the exercise price of warrants granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ExercisePriceOfWarrantsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ExpectedDividendYieldOfWarrantsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents expected dividend yield of warrants granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ExpectedDividendYieldOfWarrantsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ExpectedLifeOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents expected life of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ExpectedLifeOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ExpectedVolatilityOfWarrantsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents expected volatility of warrants granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ExpectedVolatilityOfWarrantsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_RiskFreeInterestRateOfWarrantsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents risk free interest rate of warrants granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_RiskFreeInterestRateOfWarrantsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ShareOptionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ShareOptionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_WarrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_WarrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_WeightedAverageSharePriceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the weighted average share price of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_WeightedAverageSharePriceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The option life of share options granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfOptionLifeShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExercisePriceShareOptionsGranted2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exercise price of share options granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExercisePriceShareOptionsGranted2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of an expected dividend used to calculate the fair value of share options granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_LegalEntitiesAxis=huge_PrismicPharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_LegalEntitiesAxis=huge_PrismicPharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923959138040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisition of Prismic Pharmaceutical - Schedule of identifiable assets acquired and liabilities assumed (Details) - Prismic Pharmaceuticals Inc. ("Prismic")<br></strong></div></th>
<th class="th">
<div>Jun. 28, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate', window );">Cash</a></td>
<td class="nump">$ 1,752<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate', window );">Prepaid expenses and deposits</a></td>
<td class="nump">19,691<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Intangible assets</a></td>
<td class="nump">18,543,379<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate', window );">Trade and other payables</a></td>
<td class="num">(1,404,732)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate', window );">Notes payable</a></td>
<td class="num">(1,446,642)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total consideration transferred, acquisition-date fair value</a></td>
<td class="nump">$ 15,713,448<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B64_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for borrowings assumed in a business combination. [Refer: Borrowings; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for cash and cash equivalents acquired in a business combination. [Refer: Cash and cash equivalents; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for current assets acquired in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBusinessCombinationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for identifiable intangible assets acquired in a business combination. [Refer: Intangible assets other than goodwill; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for trade and other payables assumed in a business combination. [Refer: Trade and other payables; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_LegalEntitiesAxis=huge_PrismicPharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_LegalEntitiesAxis=huge_PrismicPharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923883288824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Assets held for sale (Narrative) (Details) - Cobourg facility - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfAssetsHeldForSaleLineItems', window );"><strong>Disclosure Of Assets Held For Sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Proceeds from sale of equipment</a></td>
<td class="nump">$ 36,616<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_LossOnSaleOfEquipment', window );">Loss on sale of equipment</a></td>
<td class="nump">100,337<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ProceedsFromSalesOfInventory', window );">Proceeds from sales of inventories</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_LossOnSaleOfInventory', window );">Loss on disposal of inventory</a></td>
<td class="nump">197,436<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment', window );">Impairment of property, plant and equipment</a></td>
<td class="nump">$ 387,474<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfAssetsHeldForSaleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfAssetsHeldForSaleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_LossOnSaleOfEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of Loss on sale of equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_LossOnSaleOfEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_LossOnSaleOfInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of Loss on sale of inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_LossOnSaleOfInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ProceedsFromSalesOfInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ProceedsFromSalesOfInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for impairment loss (reversal of impairment loss) on property, plant and equipment recognised in profit or loss to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis=ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis=ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923838039352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Assets held for sale - Schedule of components of assets held for sale (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jan. 01, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfAssetsHeldForSaleLineItems', window );"><strong>Disclosure Of Assets Held For Sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property and plant</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 8,880,258<span></span>
</td>
<td class="nump">$ 9,134,183<span></span>
</td>
<td class="nump">$ 9,134,183<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis=ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember', window );">Cobourg facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfAssetsHeldForSaleLineItems', window );"><strong>Disclosure Of Assets Held For Sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property and plant</a></td>
<td class="nump">$ 8,610,504<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfAssetsHeldForSaleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfAssetsHeldForSaleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis=ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis=ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923833987800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Assets held for sale - Schedule of net loss and comprehensive loss from discontinued operations (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OperatingExpensesAbstract', window );"><strong>Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">$ 10,058,083<span></span>
</td>
<td class="nump">$ 8,407,427<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAndAmortisationExpense', window );">Depreciation and amortization</a></td>
<td class="nump">3,900,458<span></span>
</td>
<td class="nump">1,943,048<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherIncome', window );">Other income</a></td>
<td class="nump">3,691<span></span>
</td>
<td class="nump">40,454<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromDiscontinuedOperations', window );">Net loss from discontinued operations</a></td>
<td class="num">(3,347,561)<span></span>
</td>
<td class="num">(5,048,557)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis=ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember', window );">Cobourg facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfAssetsHeldForSaleLineItems', window );"><strong>Disclosure Of Assets Held For Sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenue</a></td>
<td class="nump">14,514<span></span>
</td>
<td class="nump">193,416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of revenue</a></td>
<td class="nump">1,032,010<span></span>
</td>
<td class="nump">1,473,839<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_GrossProfitLossBeforeFairValueAdjustments', window );">Gross loss before fair value adjustments</a></td>
<td class="num">(1,017,496)<span></span>
</td>
<td class="num">(1,280,423)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_FairValueAdjustmentsOnInventorySold', window );">Fair value adjustments on inventory sold</a></td>
<td class="num">(945)<span></span>
</td>
<td class="nump">16,738<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets', window );">Unrealized loss on changes in fair value of biological assets</a></td>
<td class="nump">166,886<span></span>
</td>
<td class="nump">513,625<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross loss</a></td>
<td class="num">(1,183,437)<span></span>
</td>
<td class="num">(1,810,786)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OperatingExpensesAbstract', window );"><strong>Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">1,665,541<span></span>
</td>
<td class="nump">2,735,286<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAndAmortisationExpense', window );">Depreciation and amortization</a></td>
<td class="nump">90,340<span></span>
</td>
<td class="nump">424,199<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment', window );">Impairment of property, plant and equipment</a></td>
<td class="nump">387,474<span></span>
</td>
<td class="nump">132,273<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OperatingExpense', window );">Total operating expenses</a></td>
<td class="nump">2,143,355<span></span>
</td>
<td class="nump">3,291,758<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ProfitLossBeforeOtherIncomeAndGainLossOnSaleOfEquipmentFromDiscontinuedOperations', window );">Loss from discontinued operations</a></td>
<td class="num">(3,326,792)<span></span>
</td>
<td class="num">(5,102,544)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherIncome', window );">Other income</a></td>
<td class="num">(79,568)<span></span>
</td>
<td class="num">(53,987)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_LossOnSaleOfEquipment', window );">Loss on sale of equipment</a></td>
<td class="nump">100,337<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromDiscontinuedOperations', window );">Net loss from discontinued operations</a></td>
<td class="num">$ (3,347,561)<span></span>
</td>
<td class="num">$ (5,048,557)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfAssetsHeldForSaleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfAssetsHeldForSaleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_FairValueAdjustmentsOnInventorySold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of Fair value adjustments on inventory sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_FairValueAdjustmentsOnInventorySold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_GrossProfitLossBeforeFairValueAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of gross profit (loss) before fair value adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_GrossProfitLossBeforeFairValueAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_LossOnSaleOfEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of Loss on sale of equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_LossOnSaleOfEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ProfitLossBeforeOtherIncomeAndGainLossOnSaleOfEquipmentFromDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the profit (loss) before other income and gain (loss) on sale of equipment from discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ProfitLossBeforeOtherIncomeAndGainLossOnSaleOfEquipmentFromDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of costs relating to expenses directly or indirectly attributed to the goods or services sold, which may include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, unallocated production overheads and abnormal amounts of production costs of inventories.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationAndAmortisationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation and amortisation expense. Depreciation and amortisation are the systematic allocations of depreciable amounts of assets over their useful lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B13<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B13_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 104<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_104&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationAndAmortisationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) arising from changes in fair value less costs to sell of biological assets due to price changes in the market. [Refer: Biological assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2019-01-01<br> -Paragraph 51<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_51&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2019-01-01<br> -Section Example 1 XYZ Dairy Ltd<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2019-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS41_IE_ex1_TI<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognised in profit or loss for property, plant and equipment. [Refer: Impairment loss recognised in profit or loss; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause v<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_e_v&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 98<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_98_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of all operating expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of operating income that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2019-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_35_b_iv&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from discontinued operations. [Refer: Discontinued operations [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_vii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 82<br> -Subparagraph ea<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_82_ea&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 98<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_98_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2020-01-01: The income arising in the course of an entity's ordinary activities. Income is increases in economic benefits during the accounting period in the form of inflows or enhancements of assets or decreases of liabilities that result in an increase in equity, other than those relating to contributions from equity participants.
Effective 2020-01-01: The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 32<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 34<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis=ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis=ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923859311688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Assets held for sale - Schedule of cash flows from discontinued operations (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromDiscontinuedOperations', window );">Net loss from discontinued operations</a></td>
<td class="num">$ (3,347,561)<span></span>
</td>
<td class="num">$ (5,048,557)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ChangesInNoncashWorkingCapitalBalancesAbstract', window );"><strong>Changes in non-cash working capital balances</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables', window );">Trade and other receivables</a></td>
<td class="nump">435,183<span></span>
</td>
<td class="num">(387,837)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables', window );">Trade and other payables</a></td>
<td class="nump">898,691<span></span>
</td>
<td class="nump">1,516,025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations', window );">Cash used in operating activities</a></td>
<td class="num">(737,659)<span></span>
</td>
<td class="num">(6,581,998)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations', window );">Cash provided by (used in) discontinued investing activities</a></td>
<td class="nump">36,616<span></span>
</td>
<td class="num">(401,817)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis=ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember', window );">Cobourg facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromDiscontinuedOperations', window );">Net loss from discontinued operations</a></td>
<td class="num">(3,347,561)<span></span>
</td>
<td class="num">(5,048,557)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_AddDeductItemsNotAffectingCashAbstract', window );"><strong>Add (deduct) items not affecting cash</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDepreciationExpense', window );">Depreciation and amortization</a></td>
<td class="nump">108,209<span></span>
</td>
<td class="nump">424,199<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold', window );">Change in fair value adjustments on inventory sold</a></td>
<td class="num">(945)<span></span>
</td>
<td class="nump">16,738<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossInventories', window );">Impairment of inventory</a></td>
<td class="nump">534,814<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment', window );">Impairment of property, plant and equipment</a></td>
<td class="nump">387,474<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets', window );">Change in fair value of biological assets</a></td>
<td class="nump">166,886<span></span>
</td>
<td class="nump">513,625<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_AdjustmentsForLossesGainsOnDisposalOfInventory', window );">Loss on disposal of inventory</a></td>
<td class="nump">197,436<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_AdjustmentsForLossesGainsOnDisposalOfEquipment', window );">Loss on sale of equipment</a></td>
<td class="nump">100,337<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ChangesInNoncashWorkingCapitalBalancesAbstract', window );"><strong>Changes in non-cash working capital balances</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables', window );">Trade and other receivables</a></td>
<td class="nump">960,778<span></span>
</td>
<td class="num">(423,945)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_AdjustmentsForIncreaseDecreaseInPrepaidExpensesAndDeposits', window );">Prepaid expenses and deposits</a></td>
<td class="nump">279,870<span></span>
</td>
<td class="nump">54,226<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories', window );">Inventories</a></td>
<td class="num">(21,932)<span></span>
</td>
<td class="num">(709,373)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets', window );">Biological assets</a></td>
<td class="num">(166,886)<span></span>
</td>
<td class="num">(513,625)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables', window );">Trade and other payables</a></td>
<td class="nump">63,861<span></span>
</td>
<td class="num">(895,286)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations', window );">Cash used in operating activities</a></td>
<td class="num">(737,659)<span></span>
</td>
<td class="num">(6,581,998)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Purchase of property, plant and equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(401,817)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Proceeds from sale of equipment</a></td>
<td class="nump">36,616<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations', window );">Cash provided by (used in) discontinued investing activities</a></td>
<td class="nump">$ 36,616<span></span>
</td>
<td class="num">$ (401,817)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_AddDeductItemsNotAffectingCashAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_AddDeductItemsNotAffectingCashAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for gains losses on changes in the fair value of inventory sold to reconcile profit (loss) to net cash flow from used in operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_AdjustmentsForGainsLossesOnChangeInFairValueOfInventorySold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_AdjustmentsForIncreaseDecreaseInPrepaidExpensesAndDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in prepaid expenses and deposits to reconcile profit (loss) to net cash flow from (used in) operating activities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_AdjustmentsForIncreaseDecreaseInPrepaidExpensesAndDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_AdjustmentsForLossesGainsOnDisposalOfEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for losses (gains) on disposal of equipment to reconcile profit (loss) to net cash flow from (used in) operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_AdjustmentsForLossesGainsOnDisposalOfEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_AdjustmentsForLossesGainsOnDisposalOfInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for losses (gains) on disposal of inventory to reconcile profit (loss) to net cash flow from (used in) operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_AdjustmentsForLossesGainsOnDisposalOfInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ChangesInNoncashWorkingCapitalBalancesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ChangesInNoncashWorkingCapitalBalancesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in biological assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Biological assets; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in inventories to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in trade and other receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other receivables; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDepreciationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for depreciation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDepreciationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for gains (losses) on changes in the fair value less costs to sell of biological assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Biological assets; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for impairment loss (reversal of impairment loss) on inventories recognised in profit or loss to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Impairment loss; Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss; Impairment loss (reversal of impairment loss) recognised in profit or loss]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for impairment loss (reversal of impairment loss) on property, plant and equipment recognised in profit or loss to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in trade and other payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other payables; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) the entity's investing activities, related to discontinued operations. [Refer: Discontinued operations [member]; Cash flows from (used in) investing activities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) the entity's operating activities, related to discontinued operations. [Refer: Discontinued operations [member]; Cash flows from (used in) operating activities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from discontinued operations. [Refer: Discontinued operations [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_vii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 82<br> -Subparagraph ea<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_82_ea&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 98<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_98_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis=ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis=ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923891896824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other receivables - Schedule of other receivables (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jan. 01, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesAbstract', window );"><strong>Trade and other current payables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_SalesTaxRecoverable', window );">Sales tax recoverable</a></td>
<td class="nump">$ 134,717<span></span>
</td>
<td class="nump">$ 1,529,828<span></span>
</td>
<td class="nump">$ 739,257<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_RentReceivable', window );">Rent receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,772<span></span>
</td>
<td class="nump">6,263<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherReceivables', window );">Other</a></td>
<td class="nump">26,625<span></span>
</td>
<td class="nump">17,702<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivables', window );">Total trade and other receivables</a></td>
<td class="nump">$ 161,342<span></span>
</td>
<td class="nump">$ 1,557,302<span></span>
</td>
<td class="nump">$ 745,520<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_RentReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of rent receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_RentReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_SalesTaxRecoverable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount for sales taxes recoverable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_SalesTaxRecoverable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount receivable by the entity that it does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of trade receivables and other receivables. [Refer: Trade receivables; Other receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_h&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923829524120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="7">1 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 05, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 04, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 04, 2019 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Nov. 04, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 07, 2019 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>May 07, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 06, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 04, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 22, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 20, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 24, 2019 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Apr. 24, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 16, 2019 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Apr. 16, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>CAD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>CAD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Feb. 04, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 01, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Oct. 31, 2018 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>May 31, 2018 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfInvestmentsLineItems', window );"><strong>Disclosure Of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Proceeds from sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,477,510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 462,303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Proceeds from issuing shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,100,459<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,431,294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentDerivativeFinancialLiabilities', window );">Derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,990,788<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember', window );">Class B shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfInvestmentsLineItems', window );"><strong>Disclosure Of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ShareIssuePricePerShare', window );">Share issue price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Proceeds from issuing shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,455,898<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_PharmadrugIncMember', window );">Pharmadrug Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfInvestmentsLineItems', window );"><strong>Disclosure Of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfInvestmentSharesSold', window );">Number of investment shares sold | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,562,387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Proceeds from sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 652,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_PharmadrugIncMember', window );">Pharmadrug Inc. | Share Exchange Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfInvestmentsLineItems', window );"><strong>Disclosure Of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfSharesAcquired', window );">Number of shares acquired | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,562,386<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,562,387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_SharePrices', window );">Share price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.2212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.2212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_PharmadrugIncMember', window );">Pharmadrug Inc. | Share Exchange Agreement | Class B shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfInvestmentsLineItems', window );"><strong>Disclosure Of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfSharesIssuedInShareExchange', window );">Number of shares issued in share exchange | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ShareIssuePricePerShare', window );">Share issue price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ValueOfSharesIssuedInShareExchange', window );">Value of shares issued in share exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,256,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,256,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LossesOnChangeInFairValueOfDerivatives', window );">Loss on change in fair value of derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,069,798<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_CannaraBiotechIncMember', window );">Cannara Biotech Inc. | Class B shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfInvestmentsLineItems', window );"><strong>Disclosure Of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfInvestmentSharesSold', window );">Number of investment shares sold | shares</a></td>
<td class="nump">85,003,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Proceeds from sale</a></td>
<td class="nump">$ 5,825,429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GainsLossesOnDisposalsOfInvestments', window );">Gain (loss) on sale of investment</a></td>
<td class="num">$ (997,208)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_CloverCannastripThinFilmTechnologiesCorpMember', window );">Clover Cannastrip Thin Film Technologies Corp.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfInvestmentsLineItems', window );"><strong>Disclosure Of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement', window );">Value of subscribed equity units in brokered private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,128,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_HighTideIncMember', window );">High Tide Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfInvestmentsLineItems', window );"><strong>Disclosure Of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfSharesHeld', window );">Number of shares held | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,551,999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsHeld', window );">Number of warrants held | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ProceedsFromSaleOfSharesAndWarrants', window );">Proceeds from sale of shares and warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 462,303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_HugeShopsMember', window );">HUGE Shops</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfInvestmentsLineItems', window );"><strong>Disclosure Of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfSharesHeld', window );">Number of shares held | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,333,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_SubscriptionPricePerShare', window );">Subscription price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_PercentageOfDeclineInFairValueOfInvestment', window );">Percentage of decline in fair value of investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ChangeInFairValueOfInvestmentDueToTenPercentChangeInAssumptionsUsed', window );">Change in fair value of investment due to ten percent change in assumptions used</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_ScicannTherapeuticsIncMember', window );">SciCann Therapeutics Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfInvestmentsLineItems', window );"><strong>Disclosure Of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfSharesHeld', window );">Number of shares held | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117,648<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_SubscriptionPricePerShare', window );">Subscription price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_PercentageOfDeclineInFairValueOfInvestment', window );">Percentage of decline in fair value of investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ChangeInFairValueOfInvestmentDueToTenPercentChangeInAssumptionsUsed', window );">Change in fair value of investment due to ten percent change in assumptions used</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_SolarvestBioEnergyIncMember', window );">Solarvest BioEnergy Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfInvestmentsLineItems', window );"><strong>Disclosure Of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_SharePrices', window );">Share price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfSharesHeld', window );">Number of shares held | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsHeld', window );">Number of warrants held | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_PrincipalAmountOfBorrowings', window );">Principal amount of convertible debenture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,805,520<span></span>
</td>
<td class="nump">$ 1,805,520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_FairValueOfSharesAndWarrantsAcquired', window );">Fair value of shares and warrants acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,256,900<span></span>
</td>
<td class="nump">2,256,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExercisePriceOfWarrants', window );">Exercise price of warrants | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_QuotedMarketPriceOfInvestments', window );">Quoted market price of investments | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_RiskFreeRateOfWarrants', window );">Risk free rate of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedVolatilityOfWarrants', window );">Expected volatility of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedTermOfWarrants', window );">Expected term of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedDividendYieldOfWarrants', window );">Expected dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_SolarvestBioEnergyIncMember', window );">Solarvest BioEnergy Inc. | Share Exchange Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfInvestmentsLineItems', window );"><strong>Disclosure Of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilities', window );">Derivative financial liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">376,150<span></span>
</td>
<td class="nump">376,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_GuaranteedMinimumLiquidationValueOfShares', window );">Guaranteed minimum liquidation value of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,256,900<span></span>
</td>
<td class="nump">$ 2,256,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,256,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,256,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_SolarvestBioEnergyIncMember', window );">Solarvest BioEnergy Inc. | Share Exchange Agreement | Class B shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfInvestmentsLineItems', window );"><strong>Disclosure Of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfSharesIssuedInShareExchange', window );">Number of shares issued in share exchange | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225,371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ShareIssuePricePerShare', window );">Share issue price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ValueOfSharesIssuedInShareExchange', window );">Value of shares issued in share exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,880,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentDerivativeFinancialLiabilities', window );">Derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,990,788<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_SolarvestBioEnergyIncMember', window );">Solarvest BioEnergy Inc. | Share exchange agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfInvestmentsLineItems', window );"><strong>Disclosure Of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ValueOfSharesIssuedInShareExchange', window );">Value of shares issued in share exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,356,373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LossesOnChangeInFairValueOfDerivatives', window );">Loss on change in fair value of derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 225,371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_GainOnSettlementOfDerivativeLiability', window );">Gain on settlement of derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">634,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 634,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentDerivativeFinancialLiabilities', window );">Derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,990,788<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,990,788<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ChangeInFairValueOfInvestmentDueToTenPercentChangeInAssumptionsUsed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in fair value of investment due to ten percent change in assumptions used.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ChangeInFairValueOfInvestmentDueToTenPercentChangeInAssumptionsUsed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ExercisePriceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the price per share of excercise price of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ExercisePriceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ExpectedDividendYieldOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected dividend yield of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ExpectedDividendYieldOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ExpectedTermOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the expected term of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ExpectedTermOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ExpectedVolatilityOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents expected volatility of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ExpectedVolatilityOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_FairValueOfSharesAndWarrantsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the fair value of shares and warrants acquired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_FairValueOfSharesAndWarrantsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_GainOnSettlementOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain on settlement of derivative liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_GainOnSettlementOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_GuaranteedMinimumLiquidationValueOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents guaranteed minimum liquidation value of shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_GuaranteedMinimumLiquidationValueOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NumberOfInvestmentSharesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of investment shares sold</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NumberOfInvestmentSharesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NumberOfSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares acquired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NumberOfSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NumberOfSharesHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of shares held.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NumberOfSharesHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NumberOfSharesIssuedInShareExchange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of shares issued in share exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NumberOfSharesIssuedInShareExchange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NumberOfWarrantsHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of warrants held.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NumberOfWarrantsHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_PercentageOfDeclineInFairValueOfInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of decline in fair value of investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_PercentageOfDeclineInFairValueOfInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_PrincipalAmountOfBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount related to principal amount of borrowings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_PrincipalAmountOfBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ProceedsFromSaleOfSharesAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount related to proceeds from sale of shares and warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ProceedsFromSaleOfSharesAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_QuotedMarketPriceOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the price per share related to quoted market price of investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_QuotedMarketPriceOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_RiskFreeRateOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the risk free rate of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_RiskFreeRateOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ShareIssuePricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the price per share of shares issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ShareIssuePricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_SharePrices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents Share price per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_SharePrices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_SubscriptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the subscription price per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_SubscriptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ValueOfSharesIssuedInShareExchange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount related to shares issued in share exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ValueOfSharesIssuedInShareExchange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the value of subscribed equity units in brokered private placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentDerivativeFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current derivative financial liabilities. [Refer: Derivative financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentDerivativeFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DerivativeFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of financial liabilities classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DerivativeFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnDisposalsOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) on disposals of investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 98<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_98_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnDisposalsOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LossesOnChangeInFairValueOfDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The losses resulting from changes in the fair value of derivatives recognised in profit or loss. [Refer: Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LossesOnChangeInFairValueOfDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssuingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuing shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssuingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of investments other than investments accounted for using the equity method. [Refer: Investments accounted for using equity method; Investments other than investments accounted for using equity method]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_OtherInvestmentsNameOfEntityAxis=huge_PharmadrugIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_OtherInvestmentsNameOfEntityAxis=huge_PharmadrugIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_TypeOfArrangementsAxis=huge_SecuritiesExchangeAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_TypeOfArrangementsAxis=huge_SecuritiesExchangeAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_OtherInvestmentsNameOfEntityAxis=huge_CannaraBiotechIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_OtherInvestmentsNameOfEntityAxis=huge_CannaraBiotechIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_OtherInvestmentsNameOfEntityAxis=huge_CloverCannastripThinFilmTechnologiesCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_OtherInvestmentsNameOfEntityAxis=huge_CloverCannastripThinFilmTechnologiesCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_OtherInvestmentsNameOfEntityAxis=huge_HighTideIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_OtherInvestmentsNameOfEntityAxis=huge_HighTideIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_OtherInvestmentsNameOfEntityAxis=huge_HugeShopsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_OtherInvestmentsNameOfEntityAxis=huge_HugeShopsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_OtherInvestmentsNameOfEntityAxis=huge_ScicannTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_OtherInvestmentsNameOfEntityAxis=huge_ScicannTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_OtherInvestmentsNameOfEntityAxis=huge_SolarvestBioEnergyIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_OtherInvestmentsNameOfEntityAxis=huge_SolarvestBioEnergyIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_TypeOfArrangementsAxis=huge_ShareExchangeAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_TypeOfArrangementsAxis=huge_ShareExchangeAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923836362312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Schedule of investments (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfInvestmentsLineItems', window );"><strong>Disclosure Of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Beginning balance</a></td>
<td class="nump">$ 8,862,744<span></span>
</td>
<td class="nump">$ 13,589,954<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,513,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Change in fair value through profit or loss</a></td>
<td class="num">(770,874)<span></span>
</td>
<td class="num">(8,778,707)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NetForeignExchangeGain', window );">Foreign exchange gain</a></td>
<td class="nump">62,385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Proceeds from sale</a></td>
<td class="nump">6,477,510<span></span>
</td>
<td class="nump">462,303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Ending balance</a></td>
<td class="nump">1,676,745<span></span>
</td>
<td class="nump">8,862,744<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_PharmadrugIncMember', window );">Pharmadrug Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfInvestmentsLineItems', window );"><strong>Disclosure Of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Proceeds from sale</a></td>
<td class="nump">652,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_PharmadrugIncMember', window );">Pharmadrug Inc. | Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfInvestmentsLineItems', window );"><strong>Disclosure Of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Beginning balance</a></td>
<td class="nump">255,075<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,256,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Change in fair value through profit or loss</a></td>
<td class="nump">397,006<span></span>
</td>
<td class="num">(2,001,825)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NetForeignExchangeGain', window );">Foreign exchange gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Proceeds from sale</a></td>
<td class="nump">652,081<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Ending balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">255,075<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_CannaraBiotechIncMember', window );">Cannara Biotech Inc. | Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfInvestmentsLineItems', window );"><strong>Disclosure Of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Beginning balance</a></td>
<td class="nump">6,822,637<span></span>
</td>
<td class="nump">8,437,342<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Change in fair value through profit or loss</a></td>
<td class="num">(997,208)<span></span>
</td>
<td class="num">(1,614,704)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NetForeignExchangeGain', window );">Foreign exchange gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Proceeds from sale</a></td>
<td class="nump">5,825,429<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Ending balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,822,637<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_CloverCannastripThinFilmTechnologiesCorpMember', window );">Clover Cannastrip | Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfInvestmentsLineItems', window );"><strong>Disclosure Of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Beginning balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,128,450<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Change in fair value through profit or loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,128,450)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NetForeignExchangeGain', window );">Foreign exchange gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Proceeds from sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Ending balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_HugeShopsMember', window );">HUGE Shops | Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfInvestmentsLineItems', window );"><strong>Disclosure Of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Beginning balance</a></td>
<td class="nump">572,401<span></span>
</td>
<td class="nump">977,990<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Change in fair value through profit or loss</a></td>
<td class="nump">7,674<span></span>
</td>
<td class="num">(405,589)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NetForeignExchangeGain', window );">Foreign exchange gain</a></td>
<td class="nump">20,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Proceeds from sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Ending balance</a></td>
<td class="nump">600,433<span></span>
</td>
<td class="nump">572,401<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_HighTideIncMember', window );">High Tide Inc. | Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfInvestmentsLineItems', window );"><strong>Disclosure Of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Beginning balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,352,665<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Change in fair value through profit or loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(890,362)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Proceeds from sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">462,303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_HighTideIncMember', window );">High Tide Inc. | Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfInvestmentsLineItems', window );"><strong>Disclosure Of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Beginning balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">188,914<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Change in fair value through profit or loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(188,914)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Proceeds from sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_ScicannTherapeuticsIncMember', window );">SciCann Therapeutics Inc. | Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfInvestmentsLineItems', window );"><strong>Disclosure Of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Beginning balance</a></td>
<td class="nump">535,824<span></span>
</td>
<td class="nump">1,504,593<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Change in fair value through profit or loss</a></td>
<td class="num">(354,910)<span></span>
</td>
<td class="num">(968,769)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NetForeignExchangeGain', window );">Foreign exchange gain</a></td>
<td class="nump">14,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Proceeds from sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Ending balance</a></td>
<td class="nump">195,679<span></span>
</td>
<td class="nump">535,824<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_SolarvestBioEnergyIncMember', window );">Solarvest BioEnergy Inc. | Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfInvestmentsLineItems', window );"><strong>Disclosure Of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Beginning balance</a></td>
<td class="nump">327,251<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">519,087<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Change in fair value through profit or loss</a></td>
<td class="nump">106,380<span></span>
</td>
<td class="num">(191,837)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NetForeignExchangeGain', window );">Foreign exchange gain</a></td>
<td class="nump">14,047<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Proceeds from sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Ending balance</a></td>
<td class="nump">447,678<span></span>
</td>
<td class="nump">327,251<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_SolarvestBioEnergyIncMember', window );">Solarvest BioEnergy Inc. | Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfInvestmentsLineItems', window );"><strong>Disclosure Of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Beginning balance</a></td>
<td class="nump">87,756<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">290,225<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Change in fair value through profit or loss</a></td>
<td class="num">(14,920)<span></span>
</td>
<td class="num">(202,470)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NetForeignExchangeGain', window );">Foreign exchange gain</a></td>
<td class="nump">1,977<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Proceeds from sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Ending balance</a></td>
<td class="nump">74,813<span></span>
</td>
<td class="nump">87,756<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_SolarvestBioEnergyIncMember', window );">Solarvest BioEnergy Inc. | Convertible debenture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfInvestmentsLineItems', window );"><strong>Disclosure Of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Beginning balance</a></td>
<td class="nump">261,800<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,447,588<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Change in fair value through profit or loss</a></td>
<td class="nump">85,104<span></span>
</td>
<td class="num">(1,185,787)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NetForeignExchangeGain', window );">Foreign exchange gain</a></td>
<td class="nump">11,238<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Proceeds from sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Ending balance</a></td>
<td class="nump">$ 358,142<span></span>
</td>
<td class="nump">$ 261,800<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount related to change in fair value through profit or loss of investments other than investments accounted for using equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ChangeInFairValueThroughProfitOrLossOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetForeignExchangeGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net gain arising from foreign exchange differences. [Refer: Foreign exchange gain (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2019-01-01<br> -Paragraph 52<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_52_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetForeignExchangeGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current investments other than investments accounted for using the equity method. [Refer: Investments accounted for using equity method; Non-current assets; Investments other than investments accounted for using equity method]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of investments other than investments accounted for using the equity method. [Refer: Investments accounted for using equity method; Investments other than investments accounted for using equity method]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchase of investments other than investments accounted for using equity method. [Refer: Investments accounted for using equity method; Investments other than investments accounted for using equity method]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_OtherInvestmentsNameOfEntityAxis=huge_PharmadrugIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_OtherInvestmentsNameOfEntityAxis=huge_PharmadrugIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_OrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_OrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_OtherInvestmentsNameOfEntityAxis=huge_CannaraBiotechIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_OtherInvestmentsNameOfEntityAxis=huge_CannaraBiotechIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_OtherInvestmentsNameOfEntityAxis=huge_CloverCannastripThinFilmTechnologiesCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_OtherInvestmentsNameOfEntityAxis=huge_CloverCannastripThinFilmTechnologiesCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_OtherInvestmentsNameOfEntityAxis=huge_HugeShopsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_OtherInvestmentsNameOfEntityAxis=huge_HugeShopsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_OtherInvestmentsNameOfEntityAxis=huge_HighTideIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_OtherInvestmentsNameOfEntityAxis=huge_HighTideIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=huge_WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=huge_WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_OtherInvestmentsNameOfEntityAxis=huge_ScicannTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_OtherInvestmentsNameOfEntityAxis=huge_ScicannTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_OtherInvestmentsNameOfEntityAxis=huge_SolarvestBioEnergyIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_OtherInvestmentsNameOfEntityAxis=huge_SolarvestBioEnergyIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=huge_ConvertibleDebentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=huge_ConvertibleDebentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923863171944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-use asset (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract', window );"><strong>Disclosure of quantitative information about right-of-use assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ImpairmentLossOnRightOfUseAsset', window );">Impairment loss on right of use asset</a></td>
<td class="nump">$ 89,860<span></span>
</td>
<td class="nump">$ 50,888<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation on right of use assets</a></td>
<td class="nump">$ 5,991<span></span>
</td>
<td class="nump">$ 36,685<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ImpairmentLossOnRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount related to impairment Loss of right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ImpairmentLossOnRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923861375912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-use asset - Schedule of right-of-use asset (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract', window );"><strong>Disclosure of quantitative information about right-of-use assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Beginning balance</a></td>
<td class="nump">$ 95,851<span></span>
</td>
<td class="nump">$ 183,424<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation</a></td>
<td class="num">(5,991)<span></span>
</td>
<td class="num">(36,685)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ImpairmentLossOnRightOfUseAsset', window );">Impairment</a></td>
<td class="num">(89,860)<span></span>
</td>
<td class="num">(50,888)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Ending balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 95,851<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ImpairmentLossOnRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount related to impairment Loss of right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ImpairmentLossOnRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923861648680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>Changes in intangible assets other than goodwill [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Useful life of intellectual property</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortisation, intangible assets other than goodwill</a></td>
<td class="nump">$ 3,894,467<span></span>
</td>
<td class="nump">$ 1,906,363<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_e_vi&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The useful life, measured as period of time, used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923833970280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets - Schedule of intangible assets (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Beginning balance</a></td>
<td class="nump">$ 16,820,625<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization</a></td>
<td class="nump">3,894,467<span></span>
</td>
<td class="nump">1,906,363<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Ending balance</a></td>
<td class="nump">13,424,391<span></span>
</td>
<td class="nump">16,820,625<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Beginning balance</a></td>
<td class="nump">18,696,229<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Acquisition of Prismic Pharmaceuticals Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,543,379<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">293,126<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Effects of foreign exchange</a></td>
<td class="nump">505,264<span></span>
</td>
<td class="num">(140,276)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Ending balance</a></td>
<td class="nump">19,201,493<span></span>
</td>
<td class="nump">18,696,229<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Beginning balance</a></td>
<td class="nump">1,875,604<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization</a></td>
<td class="nump">3,894,467<span></span>
</td>
<td class="nump">1,906,363<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Effects of foreign exchange</a></td>
<td class="nump">7,031<span></span>
</td>
<td class="num">(30,759)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Ending balance</a></td>
<td class="nump">$ 5,777,102<span></span>
</td>
<td class="nump">$ 1,875,604<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase in intangible assets other than goodwill resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_e_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_e_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_e_vi&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in intangible assets other than goodwill resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_e_vii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923859496504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes Payable (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 15, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems', window );"><strong>Disclosure of reconciliation of liabilities arising from financing activities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_CashReceiptsFromSalesOfDebtInstruments', window );">Cash receipts from sales of debt instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,484,369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_GainLossOnSettlementOfFinancialLiability', window );">Gain on settlement of financial liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 680,164<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (18,665)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_ShorttermBorrowingsMember', window );">Short-term notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems', window );"><strong>Disclosure of reconciliation of liabilities arising from financing activities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Notes payable, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=huge_NotesPayableMember', window );">Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems', window );"><strong>Disclosure of reconciliation of liabilities arising from financing activities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Notes payable, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnBorrowings', window );">Interest expense on borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 227,366<span></span>
</td>
<td class="nump">$ 142,907<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_BorrowingsSettled', window );">Settlement of notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,084,719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_BorrowingsSettledAccruedInterestSettled', window );">Accrued interest settled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">795,367<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_LegalEntitiesAxis=huge_PrismicPharmaceuticalMember', window );">Prismic Pharmaceuticals Inc. ("Prismic")</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems', window );"><strong>Disclosure of reconciliation of liabilities arising from financing activities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_BorrowingsSettled', window );">Settlement of notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 438,599<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_LegalEntitiesAxis=huge_PrismicPharmaceuticalMember', window );">Prismic Pharmaceuticals Inc. ("Prismic") | Class B shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems', window );"><strong>Disclosure of reconciliation of liabilities arising from financing activities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IssuanceOfCommonStockForNotesPayable', window );">Issuance of common stock for notes payable</a></td>
<td class="nump">63,714<span></span>
</td>
<td class="nump">63,714<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_FairValueOfCommonStockToSettleNotesPayable', window );">Fair value of common stock to settle notes payable</a></td>
<td class="nump">$ 185,976<span></span>
</td>
<td class="nump">$ 185,976<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_GainLossOnSettlementOfFinancialLiability', window );">Gain on settlement of financial liability</a></td>
<td class="nump">$ 40,409<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_BorrowingsSettled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of borrowings settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_BorrowingsSettled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_BorrowingsSettledAccruedInterestSettled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of borrowings settled accrued interest settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_BorrowingsSettledAccruedInterestSettled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_CashReceiptsFromSalesOfDebtInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of cash receipt from sale of debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_CashReceiptsFromSalesOfDebtInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_FairValueOfCommonStockToSettleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of fair value of common stock to settle notes payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_FairValueOfCommonStockToSettleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_GainLossOnSettlementOfFinancialLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of gain loss on settlement of financial liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_GainLossOnSettlementOfFinancialLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IssuanceOfCommonStockForNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents issuance of common stock for notes payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IssuanceOfCommonStockForNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The interest rate on borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of interest expense on borrowings. [Refer: Interest expense; Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_ShorttermBorrowingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_ShorttermBorrowingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=huge_NotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=huge_NotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_LegalEntitiesAxis=huge_PrismicPharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_LegalEntitiesAxis=huge_PrismicPharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923863634760">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Notes Payable - Schedule of notes payable (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jan. 01, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems', window );"><strong>Disclosure of reconciliation of liabilities arising from financing activities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued', window );">Notes payable</a></td>
<td class="nump">$ 384,647<span></span>
</td>
<td class="nump">$ 1,435,698<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_ShorttermBorrowingsMember', window );">Short-term notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems', window );"><strong>Disclosure of reconciliation of liabilities arising from financing activities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued', window );">Notes payable</a></td>
<td class="nump">49,647<span></span>
</td>
<td class="nump">145,943<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=huge_NotesPayableMember', window );">Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems', window );"><strong>Disclosure of reconciliation of liabilities arising from financing activities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued', window );">Notes payable</a></td>
<td class="nump">$ 335,000<span></span>
</td>
<td class="nump">$ 1,289,755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current notes and debentures issued and the current portion of non-current notes and debentures issued. [Refer: Notes and debentures issued]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentNotesAndDebenturesIssuedAndCurrentPortionOfNoncurrentNotesAndDebenturesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_ShorttermBorrowingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_ShorttermBorrowingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=huge_NotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=huge_NotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923914163640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Lease obligations - (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilitiesAbstract', window );"><strong>Lease liabilities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnLeaseLiabilities', window );">Interest expense on lease liabilities</a></td>
<td class="nump">$ 10,367<span></span>
</td>
<td class="nump">$ 11,480<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of interest expense on lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923829507928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Lease obligations - Schedule of lease obligations (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jan. 01, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilitiesAbstract', window );"><strong>Lease liabilities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Balance</a></td>
<td class="nump">$ 152,619<span></span>
</td>
<td class="nump">$ 183,424<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnLeaseLiabilities', window );">Add: Interest Expense</a></td>
<td class="nump">10,367<span></span>
</td>
<td class="nump">11,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashOutflowForLeases', window );">Less: Lease Payments</a></td>
<td class="num">(39,993)<span></span>
</td>
<td class="num">(42,285)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_EffectsOfForeignExchangeOnLeaseLiabilities', window );">Effects of foreign exchange</a></td>
<td class="nump">2,969<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Balance</a></td>
<td class="nump">125,962<span></span>
</td>
<td class="nump">152,619<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Current</a></td>
<td class="nump">46,842<span></span>
</td>
<td class="nump">42,285<span></span>
</td>
<td class="nump">$ 40,875<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Non-current</a></td>
<td class="nump">$ 79,120<span></span>
</td>
<td class="nump">$ 110,334<span></span>
</td>
<td class="nump">$ 142,549<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_EffectsOfForeignExchangeOnLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the effect of foreign exchange on lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_EffectsOfForeignExchangeOnLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashOutflowForLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53_g&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashOutflowForLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of interest expense on lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923860216360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Lease obligations - Schedule of maturity analysis of operating lease payments (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jan. 01, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_UndiscountedLeasePaymentsPayable', window );">Total undiscounted lease payments payable</a></td>
<td class="nump">$ 141,018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OperatingLeaseImpactOfPresentValue', window );">Less: impact of present value</a></td>
<td class="num">(15,056)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Balance as at December 31, 2020</a></td>
<td class="nump">125,962<span></span>
</td>
<td class="nump">$ 152,619<span></span>
</td>
<td class="nump">$ 183,424<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Less than one year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_UndiscountedLeasePaymentsPayable', window );">Total undiscounted lease payments payable</a></td>
<td class="nump">46,842<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember', window );">One to two years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_UndiscountedLeasePaymentsPayable', window );">Total undiscounted lease payments payable</a></td>
<td class="nump">47,088<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember', window );">Two to three years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_UndiscountedLeasePaymentsPayable', window );">Total undiscounted lease payments payable</a></td>
<td class="nump">47,088<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">Therafter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_UndiscountedLeasePaymentsPayable', window );">Total undiscounted lease payments payable</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_OperatingLeaseImpactOfPresentValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents operating lease impact of present value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_OperatingLeaseImpactOfPresentValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_UndiscountedLeasePaymentsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount related to undiscounted lease payments payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_UndiscountedLeasePaymentsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923837416104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants Liability (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Aug. 06, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 08, 2020 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Jun. 08, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WarrantLineItems', window );"><strong>Warrant [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedLifeOfWarrants', window );">Expected life (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WarrantsLiability', window );">Warrant liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,447,910<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ProfitLossOnChangeInFairValue', window );">Gain on change in fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,927,041<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExercisePriceOfWarrantsLiability', window );">Exercise Price Of Warrants Liability | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_SharePricesOfWarrantsLiability', window );">Share Prices Of Warrants Liability | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_RiskFreeInterestRateOfWarrantsLiability', window );">Risk Free Interest Rate Of Warrants Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedVolatilityOfWarrantsGranted', window );">Annualized volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WarrantLineItems', window );"><strong>Warrant [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExercisePriceOfWarrantIssue', window );">Exercise price of warrant issue | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_TransactionCostsAllocatedToWarrants', window );">Transaction costs allocated to warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 284,049<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_FairValueOfWarrantLiability', window );">Fair value of warrant liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,289,069<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_SharePrices', window );">Share price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_RiskFreeInterestRateOfWarrantsGranted', window );">Risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.32%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedVolatilityOfWarrantsGranted', window );">Annualized volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">121.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember', window );">Class B shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WarrantLineItems', window );"><strong>Warrant [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IssuanceOfCommonStockOfDirectOffering', window );">Issuance of common stock of direct offering | shares</a></td>
<td class="nump">2,762,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,318,179<span></span>
</td>
<td class="nump">2,762,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IssuanceOfWarrantsOfDirectOffering', window );">Issuance of warrants of direct offering | shares</a></td>
<td class="nump">1,381,215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,454,543<span></span>
</td>
<td class="nump">1,381,215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingOtherEquityInstruments', window );">Proceeds from direct offering</a></td>
<td class="nump">$ 9,999,997<span></span>
</td>
<td class="nump">$ 10,125,000<span></span>
</td>
<td class="nump">$ 7,617,038<span></span>
</td>
<td class="nump">$ 9,499,994<span></span>
</td>
<td class="nump">$ 9,999,997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExercisePriceOfWarrantIssue', window );">Exercise price of warrant issue | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedLifeOfWarrants', window );">Expected life (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_TransactionCostsAllocatedToWarrants', window );">Transaction costs allocated to warrants</a></td>
<td class="nump">284,049<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_FairValueOfWarrantLiability', window );">Fair value of warrant liability</a></td>
<td class="nump">$ 3,289,069<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ExercisePriceOfWarrantIssue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents exercise price of warrant issue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ExercisePriceOfWarrantIssue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ExercisePriceOfWarrantsLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents exercise price of warrants liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ExercisePriceOfWarrantsLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ExpectedLifeOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents expected life of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ExpectedLifeOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ExpectedVolatilityOfWarrantsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents expected volatility of warrants granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ExpectedVolatilityOfWarrantsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_FairValueOfWarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_FairValueOfWarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IssuanceOfCommonStockOfDirectOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents Issuance of common stock of direct offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IssuanceOfCommonStockOfDirectOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IssuanceOfWarrantsOfDirectOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents Issuance of warrants of direct offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IssuanceOfWarrantsOfDirectOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ProfitLossOnChangeInFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents profit loss on change in fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ProfitLossOnChangeInFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_RiskFreeInterestRateOfWarrantsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents risk free interest rate of warrants granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_RiskFreeInterestRateOfWarrantsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_RiskFreeInterestRateOfWarrantsLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents risk free interest rate of warrants liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_RiskFreeInterestRateOfWarrantsLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_SharePrices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents Share price per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_SharePrices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_SharePricesOfWarrantsLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents share price of warrants liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_SharePricesOfWarrantsLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_TransactionCostsAllocatedToWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents transaction costs allocated to warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_TransactionCostsAllocatedToWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_WarrantLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents information of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_WarrantLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_WarrantsLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the value of warrants liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_WarrantsLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssuingOtherEquityInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuing equity instruments that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssuingOtherEquityInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923829790648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share capital (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="11">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Aug. 06, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 08, 2020 </div>
<div>CAD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 08, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 02, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 04, 2019 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Nov. 04, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 04, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>May 07, 2019 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>May 07, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 15, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 16, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 04, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 20, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 29, 2019 </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 24, 2019 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Apr. 24, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 16, 2019 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Apr. 16, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 04, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 01, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentDerivativeFinancialLiabilities', window );">Derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,990,788<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_GainLossOnSettlementOfFinancialLiability', window );">Gain (loss) on settlement of financial liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">680,164<span></span>
</td>
<td class="num">$ (18,665)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Proceeds from issuance of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,100,459<span></span>
</td>
<td class="nump">$ 3,431,294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_OtherInvestmentsNameOfEntityAxis=huge_SolarvestBioEnergyIncMember', window );">Solarvest BioEnergy Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_SharePrices', window );">Share price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_TypeOfArrangementsAxis=huge_SecuritiesExchangeAgreementMember', window );">Share Exchange Agreement | Pharmadrug Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfSharesAcquired', window );">Number of shares acquired | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,562,386<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,562,387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_SharePrices', window );">Share price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.2212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.2212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassACommonStockSharesMember', window );">Class A shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DescriptionOfVotingRights', window );">Description of voting rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The holders of Class A shares are entitled to 276,660 votes per Class A share held.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember', window );">Class B shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfSharesIssuedForDebtSettlement', window );">Number of shares issued for debt settlement | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,735<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ValueOfSharesIssuedForDebtSettlement', window );">Value of shares issued for debt settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfSharesIssuedInPrivatePlacement', window );">Number of shares issued in private placement | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">228,670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ShareIssuePricePerShare', window );">Share issue price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares', window );">Issued on acquisition of net assets of Prismic Pharmaceuticals, Inc (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">510,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IssuanceOfCommonStockOfShareBasedCompensation', window );">Issuance of common stock of share based compensation | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,580<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ValueOfTradeAndOtherPayableOfSharesBasedCompensation', window );">Value of trade and other payable of shares based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74,117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IssuanceOfCommonSharesOfShareBasedBonusToEmployeesForPerformance', window );">Issuance of common shares of share based bonus to employees for performance | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,804,994<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">405,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_FairValueOfShareBasedCompensationBonus', window );">Fair value of share-based compensation bonus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,956,324<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,302,076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ShareBasedPaymentExpenses', window );">Share based payment expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 93,502<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IssuanceOfCommonStockOfBoardOfDirectorsInLieuOfCash', window );">Issuance of common stock of board of directors in lieu of cash | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,069<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_CommonStockIssuedForPrivatePlacement', window );">Common stock issued for private placement | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WarrantsIssuedForPrivatePlacement', window );">Warrants issued for private placement | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Proceeds from issuance of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,455,898<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingOtherEquityInstruments', window );">Proceeds from equity issuance</a></td>
<td class="nump">$ 9,999,997<span></span>
</td>
<td class="nump">$ 10,125,000<span></span>
</td>
<td class="nump">$ 7,617,038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,499,994<span></span>
</td>
<td class="nump">$ 9,999,997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_FairValueOfWarrantsIssued', window );">Fair value of warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,122,727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IssuanceOfCommonStockOfDirectOffering', window );">Issuance of common stock of direct offering | shares</a></td>
<td class="nump">2,762,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,318,179<span></span>
</td>
<td class="nump">2,762,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IssuanceCostOfCommonSharesAndWarrants', window );">Issuance cost of common shares and warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">707,043<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 879,621<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IssuanceOfWarrantsOfDirectOffering', window );">Issuance of warrants of direct offering | shares</a></td>
<td class="nump">1,381,215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,454,543<span></span>
</td>
<td class="nump">1,381,215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_FairValueOfWarrantLiability', window );">Fair value of warrant liability</a></td>
<td class="nump">$ 3,289,069<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_TransactionCostsAllocatedToWarrants', window );">Transaction costs allocated to warrants</a></td>
<td class="nump">284,049<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_FairValueOfCommonSharesIssued', window );">Fair value of common shares issued</a></td>
<td class="nump">6,710,928<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,515,477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,377,267<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PaymentsForShareIssueCosts', window );">Share issue costs</a></td>
<td class="nump">$ 913,349<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExercisePriceOfWarrantIssue', window );">Exercise price of warrant issue | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember', window );">Class B shares | Prismic Pharmaceuticals Inc. ("Prismic")</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares', window );">Issued on acquisition of net assets of Prismic Pharmaceuticals, Inc (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">510,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IssuanceOfCommonStockForNotesPayable', window );">Issuance of common stock for notes payable | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,714<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,714<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NotesSettledThroughIssuanceOfShares', window );">Notes settled through issuance of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 226,385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_FairValueOfCommonStockToSettleNotesPayable', window );">Fair value of common stock to settle notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">185,976<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 185,976<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_GainLossOnSettlementOfFinancialLiability', window );">Gain (loss) on settlement of financial liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,409<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember', window );">Class B shares | Share Exchange Agreement | Pharmadrug Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfSharesIssuedInShareExchange', window );">Number of shares issued in share exchange | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ValueOfSharesIssuedInShareExchange', window );">Value of shares issued in share exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,256,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,256,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ShareIssuePricePerShare', window );">Share issue price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LossesOnChangeInFairValueOfDerivatives', window );">Loss on change in fair value of derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,069,798<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember', window );">Class B shares | Share Exchange Agreement | Solarvest BioEnergy Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfSharesIssuedInShareExchange', window );">Number of shares issued in share exchange | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225,371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ValueOfSharesIssuedInShareExchange', window );">Value of shares issued in share exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,880,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ShareIssuePricePerShare', window );">Share issue price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentDerivativeFinancialLiabilities', window );">Derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,990,788<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember', window );">Class B shares | Equity distribution agreement | A.G.P/Alliance Global Partners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfSharesIssuedThroughEquityDistributionAgreement', window );">Number of shares issued through equity distribution agreement | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Proceeds from issuance of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 199,785<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtAugust6Th2020Member', window );">Warrants by expiry date at August 6, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExercisePriceOfWarrantIssue', window );">Exercise price of warrant issue | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtOctober20Th2020Member', window );">Warrants by expiry date at October 20, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExercisePriceOfWarrantIssue', window );">Exercise price of warrant issue | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_CommonStockIssuedForPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents common stock issued for private placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_CommonStockIssuedForPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DescriptionOfVotingRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of voting rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DescriptionOfVotingRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ExercisePriceOfWarrantIssue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents exercise price of warrant issue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ExercisePriceOfWarrantIssue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_FairValueOfCommonSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_FairValueOfCommonSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_FairValueOfCommonStockToSettleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of fair value of common stock to settle notes payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_FairValueOfCommonStockToSettleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_FairValueOfShareBasedCompensationBonus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of fair value of share based compensation bonus.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_FairValueOfShareBasedCompensationBonus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_FairValueOfWarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_FairValueOfWarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_FairValueOfWarrantsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of fair value of warrants issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_FairValueOfWarrantsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_GainLossOnSettlementOfFinancialLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of gain loss on settlement of financial liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_GainLossOnSettlementOfFinancialLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity shares resulting from acquisition of net assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IssuanceCostOfCommonSharesAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents issuance cost of common shares and warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IssuanceCostOfCommonSharesAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IssuanceOfCommonSharesOfShareBasedBonusToEmployeesForPerformance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents issuance of common shares of share based bonus to employees for performance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IssuanceOfCommonSharesOfShareBasedBonusToEmployeesForPerformance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IssuanceOfCommonStockForNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents issuance of common stock for notes payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IssuanceOfCommonStockForNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IssuanceOfCommonStockOfBoardOfDirectorsInLieuOfCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents issuance of common stock of board of directors in lieu of cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IssuanceOfCommonStockOfBoardOfDirectorsInLieuOfCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IssuanceOfCommonStockOfDirectOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents Issuance of common stock of direct offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IssuanceOfCommonStockOfDirectOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IssuanceOfCommonStockOfShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents issuance of common stock of share based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IssuanceOfCommonStockOfShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IssuanceOfWarrantsOfDirectOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents Issuance of warrants of direct offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IssuanceOfWarrantsOfDirectOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NotesSettledThroughIssuanceOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of notes settled through issuance of shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NotesSettledThroughIssuanceOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NumberOfSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares acquired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NumberOfSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NumberOfSharesIssuedForDebtSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of shares issued for debt settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NumberOfSharesIssuedForDebtSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NumberOfSharesIssuedInPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents number of shares issued in private placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NumberOfSharesIssuedInPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NumberOfSharesIssuedInShareExchange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of shares issued in share exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NumberOfSharesIssuedInShareExchange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NumberOfSharesIssuedThroughEquityDistributionAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents number of shares issued through equity distribution agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NumberOfSharesIssuedThroughEquityDistributionAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ShareBasedPaymentExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents share based payment expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ShareBasedPaymentExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ShareIssuePricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the price per share of shares issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ShareIssuePricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_SharePrices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents Share price per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_SharePrices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_TransactionCostsAllocatedToWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents transaction costs allocated to warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_TransactionCostsAllocatedToWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ValueOfSharesIssuedForDebtSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of shares issued for debt settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ValueOfSharesIssuedForDebtSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ValueOfSharesIssuedInShareExchange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount related to shares issued in share exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ValueOfSharesIssuedInShareExchange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ValueOfTradeAndOtherPayableOfSharesBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents value of trade and other payable of shares based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ValueOfTradeAndOtherPayableOfSharesBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_WarrantsIssuedForPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>it represents warrants issued for private placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_WarrantsIssuedForPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentDerivativeFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current derivative financial liabilities. [Refer: Derivative financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentDerivativeFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LossesOnChangeInFairValueOfDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The losses resulting from changes in the fair value of derivatives recognised in profit or loss. [Refer: Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LossesOnChangeInFairValueOfDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsForShareIssueCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for share issue costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsForShareIssueCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssuingOtherEquityInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuing equity instruments that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssuingOtherEquityInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssuingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuing shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssuingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_OtherInvestmentsNameOfEntityAxis=huge_SolarvestBioEnergyIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_OtherInvestmentsNameOfEntityAxis=huge_SolarvestBioEnergyIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_TypeOfArrangementsAxis=huge_SecuritiesExchangeAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_TypeOfArrangementsAxis=huge_SecuritiesExchangeAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_OtherInvestmentsNameOfEntityAxis=huge_PharmadrugIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_OtherInvestmentsNameOfEntityAxis=huge_PharmadrugIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassACommonStockSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=huge_ClassACommonStockSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_LegalEntitiesAxis=huge_PrismicPharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_LegalEntitiesAxis=huge_PrismicPharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_TypeOfArrangementsAxis=huge_EquityDistributionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_TypeOfArrangementsAxis=huge_EquityDistributionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_LegalEntitiesAxis=huge_AllianceGlobalPartnersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_LegalEntitiesAxis=huge_AllianceGlobalPartnersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtAugust6Th2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtAugust6Th2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtOctober20Th2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtOctober20Th2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923837434856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share capital - Schedule of reconciliation of the share capital (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Beginning balance</a></td>
<td class="nump">$ 36,277,477<span></span>
</td>
<td class="nump">$ 38,391,696<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Shares issued</a></td>
<td class="nump">22,051,803<span></span>
</td>
<td class="nump">8,681,103<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share based payments</a></td>
<td class="nump">9,426,961<span></span>
</td>
<td class="nump">551,135<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Share options exercised</a></td>
<td class="nump">59,562<span></span>
</td>
<td class="nump">12,082,930<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity', window );">Warrants exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,461<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Ending balance</a></td>
<td class="nump">36,308,583<span></span>
</td>
<td class="nump">36,277,477<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassACommonStockSharesMember', window );">Class A shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Beginning balance</a></td>
<td class="nump">$ 151,588<span></span>
</td>
<td class="nump">$ 151,588<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Beginning balance (shares)</a></td>
<td class="nump">72<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Ending balance</a></td>
<td class="nump">$ 151,588<span></span>
</td>
<td class="nump">$ 151,588<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Ending balance (shares)</a></td>
<td class="nump">72<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember', window );">Class B shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Beginning balance</a></td>
<td class="nump">$ 73,586,337<span></span>
</td>
<td class="nump">$ 51,093,434<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Beginning balance (shares)</a></td>
<td class="nump">7,905,727<span></span>
</td>
<td class="nump">6,843,780<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Shares issued</a></td>
<td class="nump">$ 22,242,975<span></span>
</td>
<td class="nump">$ 8,681,103<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IssuanceOfShares', window );">Shares issued (shares)</a></td>
<td class="nump">8,925,942<span></span>
</td>
<td class="nump">408,651<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue', window );">Issued on acquisition of net assets of Prismic Pharmaceuticals, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,361,657<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares', window );">Issued on acquisition of net assets of Prismic Pharmaceuticals, Inc (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">510,940<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share based payments</a></td>
<td class="nump">$ 6,663,479<span></span>
</td>
<td class="nump">$ 1,340,929<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares', window );">Share-based payments (shares)</a></td>
<td class="nump">2,307,569<span></span>
</td>
<td class="nump">130,189<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Share options exercised</a></td>
<td class="nump">$ 563,747<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughExerciseOfOptionShares', window );">Share options exercised (shares)</a></td>
<td class="nump">22,382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity', window );">Warrants exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 109,214<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares', window );">Warrants exercised (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,167<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Ending balance</a></td>
<td class="nump">$ 103,056,538<span></span>
</td>
<td class="nump">$ 73,586,337<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Ending balance (shares)</a></td>
<td class="nump">19,161,620<span></span>
</td>
<td class="nump">7,905,727<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=huge_WarrantsMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Beginning balance</a></td>
<td class="nump">$ 4,321,989<span></span>
</td>
<td class="nump">$ 3,341,826<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Beginning balance (shares)</a></td>
<td class="nump">467,451<span></span>
</td>
<td class="nump">546,212<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Shares issued</a></td>
<td class="nump">$ 1,110,904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IssuanceOfShares', window );">Shares issued (shares)</a></td>
<td class="nump">6,335,758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue', window );">Issued on acquisition of net assets of Prismic Pharmaceuticals, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,420,407<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares', window );">Issued on acquisition of net assets of Prismic Pharmaceuticals, Inc (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,598<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity', window );">Warrants exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (37,753)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares', window );">Warrants exercised (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,167)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue', window );">Warrants expired</a></td>
<td class="num">$ (463,935)<span></span>
</td>
<td class="num">$ (402,491)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares', window );">Warrants expired (shares)</a></td>
<td class="num">(54,100)<span></span>
</td>
<td class="num">(134,192)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Ending balance</a></td>
<td class="nump">$ 4,968,958<span></span>
</td>
<td class="nump">$ 4,321,989<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Ending balance (shares)</a></td>
<td class="nump">6,749,109<span></span>
</td>
<td class="nump">467,451<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity shares resulting from acquisition of net assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from acquisition of net assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IncreaseDecreaseThroughExerciseOfOptionShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from exercise of option.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IncreaseDecreaseThroughExerciseOfOptionShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IncreaseDecreaseThroughExerciseOfWarrantsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity shares resulting from warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IncreaseDecreaseThroughExerciseOfWarrantsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IncreaseDecreaseThroughExpiryOfWarrantsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity shares resulting from warrants expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IncreaseDecreaseThroughExpiryOfWarrantsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IncreaseDecreaseThroughExpiryOfWarrantsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from warrants expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IncreaseDecreaseThroughExpiryOfWarrantsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents increase decrease through share based payment transactions shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IssuanceOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IssuanceOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from the exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from the exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssueOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase in equity through the issue of equity instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssueOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_79_a_iv&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassACommonStockSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=huge_ClassACommonStockSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=huge_WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=huge_WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923837428696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share capital - Schedule of changes in number of warrants outstanding (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract', window );"><strong>Disclosure of Share based compensation and warrant reserve [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Warrants outstanding, Opening balance</a></td>
<td class="nump">467,451<span></span>
</td>
<td class="nump">546,212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsIssued', window );">Warrants, Issued</a></td>
<td class="nump">6,335,758<span></span>
</td>
<td class="nump">67,598<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsExercised', window );">Warrants, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,167)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsExpired', window );">Warrants, Expired</a></td>
<td class="num">(54,100)<span></span>
</td>
<td class="num">(134,192)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Warrants outstanding, Closing Balance</a></td>
<td class="nump">6,749,109<span></span>
</td>
<td class="nump">467,451<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Weighted average exercise price, Warrants outstanding opening balance</a></td>
<td class="nump">$ 10.20<span></span>
</td>
<td class="nump">$ 9.47<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePricesWarrantIssued', window );">Weighted average exercise price warrants issued</a></td>
<td class="nump">5.27<span></span>
</td>
<td class="nump">10.45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePricesWarrantExercised', window );">Weighted average exercise price warrants exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.81<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePricesWarrantExpired', window );">Weighted average exercise price warrants expired</a></td>
<td class="nump">4.97<span></span>
</td>
<td class="nump">7.64<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Weighted average exercise price, Warrants outstanding closing balance</a></td>
<td class="nump">$ 5.62<span></span>
</td>
<td class="nump">$ 10.20<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfShareBasedCompensationAndWarrantReserveAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NumberOfWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents number of number of warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NumberOfWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NumberOfWarrantsExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents number of warrants expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NumberOfWarrantsExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NumberOfWarrantsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents number of warrants issued during period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NumberOfWarrantsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NumberOfWarrantsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents number of warrants outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NumberOfWarrantsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_WeightedAverageExercisePriceWarrantsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents weighted average exercise Price warrants outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_WeightedAverageExercisePriceWarrantsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_WeightedAverageExercisePricesWarrantExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents weighted average exercise price warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_WeightedAverageExercisePricesWarrantExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_WeightedAverageExercisePricesWarrantExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents weighted average exercise price warrants expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_WeightedAverageExercisePricesWarrantExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_WeightedAverageExercisePricesWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents weighted average exercise price warrants issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_WeightedAverageExercisePricesWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923860188792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share capital - Schedule of fair value assumptions of warrants (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageSharePriceOfWarrants', window );">Weighted average share price of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32.16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedDividendYieldOfWarrantsGranted', window );">Expected dividend yield of warrants granted</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedLifeOfWarrants', window );">Expected life of warrants</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedVolatilityOfWarrantsGranted', window );">Expected volatility of warrants granted</a></td>
<td class="nump">117.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageSharePriceOfWarrants', window );">Weighted average share price of warrants</a></td>
<td class="nump">$ 2.58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExercisePriceOfWarrantsGranted', window );">Exercise price of warrants granted</a></td>
<td class="nump">$ 3.46<span></span>
</td>
<td class="nump">$ 2.61<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_RiskFreeInterestRateOfWarrantsGranted', window );">Risk free interest rate of warrants granted</a></td>
<td class="nump">0.32%<span></span>
</td>
<td class="nump">1.41%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedLifeOfWarrants', window );">Expected life of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 4 months 20 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedVolatilityOfWarrantsGranted', window );">Expected volatility of warrants granted</a></td>
<td class="nump">118.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageSharePriceOfWarrants', window );">Weighted average share price of warrants</a></td>
<td class="nump">$ 4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExercisePriceOfWarrantsGranted', window );">Exercise price of warrants granted</a></td>
<td class="nump">$ 5.80<span></span>
</td>
<td class="nump">$ 26.73<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_RiskFreeInterestRateOfWarrantsGranted', window );">Risk free interest rate of warrants granted</a></td>
<td class="nump">0.36%<span></span>
</td>
<td class="nump">1.52%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedLifeOfWarrants', window );">Expected life of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 6 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ExpectedVolatilityOfWarrantsGranted', window );">Expected volatility of warrants granted</a></td>
<td class="nump">121.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfWarrantsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of warrants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfWarrantsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ExercisePriceOfWarrantsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the exercise price of warrants granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ExercisePriceOfWarrantsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ExpectedDividendYieldOfWarrantsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents expected dividend yield of warrants granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ExpectedDividendYieldOfWarrantsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ExpectedLifeOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents expected life of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ExpectedLifeOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ExpectedVolatilityOfWarrantsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents expected volatility of warrants granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ExpectedVolatilityOfWarrantsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_RiskFreeInterestRateOfWarrantsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents risk free interest rate of warrants granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_RiskFreeInterestRateOfWarrantsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_WeightedAverageSharePriceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the weighted average share price of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_WeightedAverageSharePriceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923837199288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Share capital - Schedule of warrants outstanding and exercise price (Details) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jan. 01, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Exercise price of warrants outstanding</a></td>
<td class="nump">$ 5.62<span></span>
</td>
<td class="nump">$ 10.20<span></span>
</td>
<td class="nump">$ 9.47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Number of warrants outstanding</a></td>
<td class="nump">6,749,109<span></span>
</td>
<td class="nump">467,451<span></span>
</td>
<td class="nump">546,212<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtJanuary5Th2020Member', window );">Warrants by expiry date at January 5, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Exercise price of warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Number of warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtNovember30Th2020Member', window );">Warrants by expiry date at November 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Exercise price of warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Number of warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtAugust1St2021Member', window );">Warrants by expiry date at August 1, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Exercise price of warrants outstanding</a></td>
<td class="nump">$ 5.43<span></span>
</td>
<td class="nump">$ 5.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Number of warrants outstanding</a></td>
<td class="nump">4,476<span></span>
</td>
<td class="nump">4,476<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtMay24Th2022Member', window );">Warrants by expiry date at May 24, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Exercise price of warrants outstanding</a></td>
<td class="nump">$ 18.09<span></span>
</td>
<td class="nump">$ 18.09<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Number of warrants outstanding</a></td>
<td class="nump">163,535<span></span>
</td>
<td class="nump">163,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtSeptember15Th2022Member', window );">Warrants by expiry date at September 15, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Exercise price of warrants outstanding</a></td>
<td class="nump">$ 4.42<span></span>
</td>
<td class="nump">$ 4.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Number of warrants outstanding</a></td>
<td class="nump">199,005<span></span>
</td>
<td class="nump">199,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtMay20Th2023Member', window );">Warrants by expiry date at May 20, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Exercise price of warrants outstanding</a></td>
<td class="nump">$ 16.08<span></span>
</td>
<td class="nump">$ 16.08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Number of warrants outstanding</a></td>
<td class="nump">7,311<span></span>
</td>
<td class="nump">7,311<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtJuly24Th2023Member', window );">Warrants by expiry date at July 24, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Exercise price of warrants outstanding</a></td>
<td class="nump">$ 13.07<span></span>
</td>
<td class="nump">$ 13.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Number of warrants outstanding</a></td>
<td class="nump">3,357<span></span>
</td>
<td class="nump">3,357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtSeptember11Th2023Member', window );">Warrants by expiry date at September 11, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Exercise price of warrants outstanding</a></td>
<td class="nump">$ 5.43<span></span>
</td>
<td class="nump">$ 5.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Number of warrants outstanding</a></td>
<td class="nump">22,382<span></span>
</td>
<td class="nump">22,382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtMay4Th2025Member', window );">Warrants by expiry date at May 4, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Exercise price of warrants outstanding</a></td>
<td class="nump">$ 26.73<span></span>
</td>
<td class="nump">$ 26.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Number of warrants outstanding</a></td>
<td class="nump">3,730<span></span>
</td>
<td class="nump">3,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtMay10Th2025Member', window );">Warrants by expiry date at May 10, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Exercise price of warrants outstanding</a></td>
<td class="nump">$ 26.73<span></span>
</td>
<td class="nump">$ 26.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Number of warrants outstanding</a></td>
<td class="nump">1,865<span></span>
</td>
<td class="nump">1,865<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtMay17Th2025Member', window );">Warrants by expiry date at May 17, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Exercise price of warrants outstanding</a></td>
<td class="nump">$ 26.73<span></span>
</td>
<td class="nump">$ 26.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Number of warrants outstanding</a></td>
<td class="nump">3,730<span></span>
</td>
<td class="nump">3,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtMay31St2025Member', window );">Warrants by expiry date at May 31, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Exercise price of warrants outstanding</a></td>
<td class="nump">$ 26.73<span></span>
</td>
<td class="nump">$ 26.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Number of warrants outstanding</a></td>
<td class="nump">1,865<span></span>
</td>
<td class="nump">1,865<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtJune8Th2025Member', window );">Warrants by expiry date at June 8, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Exercise price of warrants outstanding</a></td>
<td class="nump">$ 9.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Number of warrants outstanding</a></td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtAugust6Th2020Member', window );">Warrants by expiry date at August 6, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Exercise price of warrants outstanding</a></td>
<td class="nump">$ 5.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Number of warrants outstanding</a></td>
<td class="nump">1,381,215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtOctober20Th2020Member', window );">Warrants by expiry date at October 20, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Exercise price of warrants outstanding</a></td>
<td class="nump">$ 3.31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Number of warrants outstanding</a></td>
<td class="nump">3,454,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtJanuary16Th2026Member', window );">Warrants by expiry date at January 16, 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Exercise price of warrants outstanding</a></td>
<td class="nump">$ 26.73<span></span>
</td>
<td class="nump">$ 26.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Number of warrants outstanding</a></td>
<td class="nump">1,722<span></span>
</td>
<td class="nump">1,722<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtJanuary20Th2026Member', window );">Warrants by expiry date at January 20, 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfWarrantsLineItems', window );"><strong>Disclosure of warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceWarrantsOutstanding', window );">Exercise price of warrants outstanding</a></td>
<td class="nump">$ 26.73<span></span>
</td>
<td class="nump">$ 26.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfWarrantsOutstanding', window );">Number of warrants outstanding</a></td>
<td class="nump">373<span></span>
</td>
<td class="nump">373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfWarrantsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of warrants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfWarrantsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NumberOfWarrantsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents number of warrants outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NumberOfWarrantsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_WeightedAverageExercisePriceWarrantsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents weighted average exercise Price warrants outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_WeightedAverageExercisePriceWarrantsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtJanuary5Th2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtJanuary5Th2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtNovember30Th2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtNovember30Th2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtAugust1St2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtAugust1St2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtMay24Th2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtMay24Th2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtSeptember15Th2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtSeptember15Th2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtMay20Th2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtMay20Th2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtJuly24Th2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtJuly24Th2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtSeptember11Th2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtSeptember11Th2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtMay4Th2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtMay4Th2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtMay10Th2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtMay10Th2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtMay17Th2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtMay17Th2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtMay31St2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtMay31St2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtJune8Th2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtJune8Th2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtAugust6Th2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtAugust6Th2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtOctober20Th2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtOctober20Th2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtJanuary16Th2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtJanuary16Th2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtJanuary20Th2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClassesOfWarrantsAxis=huge_WarrantsByExpiryDateAtJanuary20Th2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923829489896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based compensation (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>Share </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>Share</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Share-based compensation expenses | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,052,011<span></span>
</td>
<td class="nump">$ 12,082,930<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement', window );">Number of share options cancelled | Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">822,137<span></span>
</td>
<td class="nump">299,006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfReplacementShareOptionsIssued', window );">Number of replacement share options issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">822,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_WeightedAverageExercisePriceForReplacementOfShareOptions', window );">Share option exercise price</a></td>
<td class="nump">$ 3.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted', window );">Incremental grant date fair value of share options | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 661,811<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price</a></td>
<td class="nump">3.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Underlying share price</a></td>
<td class="nump">$ 3.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.72%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Expected volatility, share options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NumberOfReplacementShareOptionsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents number of replacement share options issued</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NumberOfReplacementShareOptionsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_WeightedAverageExercisePriceForReplacementOfShareOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Exercise Price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_WeightedAverageExercisePriceForReplacementOfShareOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExercisePriceShareOptionsGranted2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exercise price of share options granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExercisePriceShareOptionsGranted2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense from share-based payment transactions with employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options expired in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause v<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_v&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value of share options granted during the period at the measurement date. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923836214408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based compensation - Schedule of changes in number of share options (Details) - Stock options<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>Share </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>Share </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Opening Balance | Share</a></td>
<td class="nump">1,454,943<span></span>
</td>
<td class="nump">485,159<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Granted | Share</a></td>
<td class="nump">1,082,639<span></span>
</td>
<td class="nump">1,363,322<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Exercised | Share</a></td>
<td class="num">(22,382)<span></span>
</td>
<td class="num">(82,094)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">Forfeited | Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,438)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement', window );">Cancelled | Share</a></td>
<td class="num">(822,137)<span></span>
</td>
<td class="num">(299,006)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Closing Balance | Share</a></td>
<td class="nump">1,693,063<span></span>
</td>
<td class="nump">1,454,943<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Exercisable | Share</a></td>
<td class="nump">1,528,186<span></span>
</td>
<td class="nump">1,200,242<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of share options outstanding in share-based payment arrangement at beginning of period | $ / shares</a></td>
<td class="nump">$ 21.96<span></span>
</td>
<td class="nump">$ 74.53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price, Granted | $ / shares</a></td>
<td class="nump">4.14<span></span>
</td>
<td class="nump">20.68<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price, Exercised | $ / shares</a></td>
<td class="nump">2.61<span></span>
</td>
<td class="nump">10.02<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price, Forfeited | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56.28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019', window );">Weighted average exercise price, Cancelled | $ / shares</a></td>
<td class="nump">31.65<span></span>
</td>
<td class="nump">115.80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of share options outstanding in share-based payment arrangement at end of period | $ / shares</a></td>
<td class="nump">6.11<span></span>
</td>
<td class="nump">21.96<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Weighted average exercise price, Exercisable | $ / shares</a></td>
<td class="nump">$ 6.13<span></span>
</td>
<td class="nump">$ 21.24<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOutstandingShareOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOutstandingShareOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercisable in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_vii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercised in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options expired in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause v<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_v&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options forfeited in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_vii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options expired in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause v<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_v&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923859701000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based compensation - Schedule of fair value assumptions of share options granted (Details) - Stock options<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>Year </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>Year </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Grant date share price</a></td>
<td class="nump">$ 3.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price</a></td>
<td class="nump">$ 3.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk free interest rate</a></td>
<td class="nump">0.72%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Expected life (years) | Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Expected volatility</a></td>
<td class="nump">120.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">Bottom of range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Grant date share price</a></td>
<td class="nump">$ 3.75<span></span>
</td>
<td class="nump">$ 6.45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price</a></td>
<td class="nump">$ 3.68<span></span>
</td>
<td class="nump">$ 7.17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk free interest rate</a></td>
<td class="nump">0.27%<span></span>
</td>
<td class="nump">1.24%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Expected life (years) | Year</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">Top of range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Grant date share price</a></td>
<td class="nump">$ 9.54<span></span>
</td>
<td class="nump">$ 75.38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price</a></td>
<td class="nump">$ 9.80<span></span>
</td>
<td class="nump">$ 75.38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk free interest rate</a></td>
<td class="nump">1.55%<span></span>
</td>
<td class="nump">1.90%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Expected life (years) | Year</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The option life of share options granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfOptionLifeShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExercisePriceShareOptionsGranted2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exercise price of share options granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExercisePriceShareOptionsGranted2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of an expected dividend used to calculate the fair value of share options granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923832080232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based compensation - Schedule of exercise price and weighted average contractual term of share options outstanding  and exercisable (Details) - Stock options<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>Share </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>Share </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jan. 01, 2019 </div>
<div>Share </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 6.11<span></span>
</td>
<td class="nump">$ 21.96<span></span>
</td>
<td class="nump">$ 74.53<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">1,693,063<span></span>
</td>
<td class="nump">1,454,943<span></span>
</td>
<td class="nump">485,159<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">3 years 10 months 17 days<span></span>
</td>
<td class="text">4 years 7 months 2 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 6.13<span></span>
</td>
<td class="nump">$ 21.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">1,528,186<span></span>
</td>
<td class="nump">1,200,242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">2.61</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 2.61<span></span>
</td>
<td class="nump">$ 2.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">12,683<span></span>
</td>
<td class="nump">35,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">2 years 5 months 26 days<span></span>
</td>
<td class="text">3 years 5 months 26 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 2.61<span></span>
</td>
<td class="nump">$ 2.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">12,683<span></span>
</td>
<td class="nump">35,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">3.75</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 3.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">5,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">6 years 5 months 19 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 3.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">3.86</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 3.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">872,139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">4 years 29 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 3.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">864,139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">4.42</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 4.42<span></span>
</td>
<td class="nump">$ 4.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">99,502<span></span>
</td>
<td class="nump">99,502<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">1 year 8 months 15 days<span></span>
</td>
<td class="text">2 years 8 months 15 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 4.42<span></span>
</td>
<td class="nump">$ 4.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">99,502<span></span>
</td>
<td class="nump">99,502<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">4.75</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 4.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">110,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">4 years 3 months 14 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 4.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">77,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">5.03</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 5.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">4 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 5.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">7,498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">5.43</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 5.43<span></span>
</td>
<td class="nump">$ 5.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">16,264<span></span>
</td>
<td class="nump">16,264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">2 years 5 months 26 days<span></span>
</td>
<td class="text">3 years 5 months 26 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 5.43<span></span>
</td>
<td class="nump">$ 5.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">16,264<span></span>
</td>
<td class="nump">16,264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">6.16</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 6.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">3 years 2 months 4 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 6.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">7.17</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 7.17<span></span>
</td>
<td class="nump">$ 7.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">199,005<span></span>
</td>
<td class="nump">199,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">3 years 9 months 29 days<span></span>
</td>
<td class="text">4 years 9 months 29 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 7.17<span></span>
</td>
<td class="nump">$ 7.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">199,005<span></span>
</td>
<td class="nump">199,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">7.63</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 7.63<span></span>
</td>
<td class="nump">$ 7.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">203,750<span></span>
</td>
<td class="nump">203,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">4 years 4 months 2 days<span></span>
</td>
<td class="text">5 years 4 months 2 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 7.63<span></span>
</td>
<td class="nump">$ 7.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">138,750<span></span>
</td>
<td class="nump">58,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">9.54</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 9.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">4 years 21 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 9.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">13,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">10.65</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 10.65<span></span>
</td>
<td class="nump">$ 10.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">3,730<span></span>
</td>
<td class="nump">3,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">2 years 5 months 26 days<span></span>
</td>
<td class="text">3 years 5 months 26 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 10.65<span></span>
</td>
<td class="nump">$ 10.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">3,730<span></span>
</td>
<td class="nump">3,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">13.07</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 13.07<span></span>
</td>
<td class="nump">$ 13.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">10,855<span></span>
</td>
<td class="nump">10,855<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">2 years 5 months 26 days<span></span>
</td>
<td class="text">3 years 5 months 26 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 13.07<span></span>
</td>
<td class="nump">$ 13.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">10,855<span></span>
</td>
<td class="nump">10,855<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">13.47</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 13.47<span></span>
</td>
<td class="nump">$ 13.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">1,418<span></span>
</td>
<td class="nump">1,418<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">2 years 5 months 26 days<span></span>
</td>
<td class="text">3 years 5 months 26 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 13.47<span></span>
</td>
<td class="nump">$ 13.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">1,418<span></span>
</td>
<td class="nump">1,418<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">16.08</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 16.08<span></span>
</td>
<td class="nump">$ 16.08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">18,409<span></span>
</td>
<td class="nump">18,409<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">2 years 5 months 26 days<span></span>
</td>
<td class="text">3 years 5 months 26 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 16.08<span></span>
</td>
<td class="nump">$ 16.08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">18,409<span></span>
</td>
<td class="nump">18,409<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">17.89</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 17.89<span></span>
</td>
<td class="nump">$ 17.89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">4,178<span></span>
</td>
<td class="nump">4,178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">2 years 5 months 26 days<span></span>
</td>
<td class="text">3 years 5 months 26 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 17.89<span></span>
</td>
<td class="nump">$ 17.89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">4,178<span></span>
</td>
<td class="nump">4,178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">18.09</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 18.09<span></span>
</td>
<td class="nump">$ 18.09<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">17,413<span></span>
</td>
<td class="nump">37,313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">2 years 2 months 15 days<span></span>
</td>
<td class="text">3 years 4 months 2 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 18.09<span></span>
</td>
<td class="nump">$ 18.09<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">17,413<span></span>
</td>
<td class="nump">37,313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">20.10</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 20.10<span></span>
</td>
<td class="nump">$ 20.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">8,289<span></span>
</td>
<td class="nump">493,363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">2 years 3 months 7 days<span></span>
</td>
<td class="text">4 years 8 months 19 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 20.10<span></span>
</td>
<td class="nump">$ 20.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">8,289<span></span>
</td>
<td class="nump">493,363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">21.11</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 8 months 1 day<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">24.12</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 7 months 2 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">26.13</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 7 months 13 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">40.20</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,851<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 5 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,388<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">44.22</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 4 months 28 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">47.24</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 47.24<span></span>
</td>
<td class="nump">$ 47.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">1,493<span></span>
</td>
<td class="nump">1,493<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">3 years 4 months 13 days<span></span>
</td>
<td class="text">4 years 4 months 13 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 47.24<span></span>
</td>
<td class="nump">$ 47.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">1,493<span></span>
</td>
<td class="nump">1,493<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">50.25</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 50.25<span></span>
</td>
<td class="nump">$ 50.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">5,224<span></span>
</td>
<td class="nump">227,861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">3 years 3 months 21 days<span></span>
</td>
<td class="text">5 years 1 month 2 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 50.25<span></span>
</td>
<td class="nump">$ 50.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">5,224<span></span>
</td>
<td class="nump">129,353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">52.26</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 52.26<span></span>
</td>
<td class="nump">$ 52.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">498<span></span>
</td>
<td class="nump">498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">3 years 2 months 15 days<span></span>
</td>
<td class="text">4 years 2 months 15 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 52.26<span></span>
</td>
<td class="nump">$ 52.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">498<span></span>
</td>
<td class="nump">498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">55.28</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 55.28<span></span>
</td>
<td class="nump">$ 55.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">498<span></span>
</td>
<td class="nump">498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">3 years 1 month 13 days<span></span>
</td>
<td class="text">4 years 1 month 13 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 55.28<span></span>
</td>
<td class="nump">$ 55.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">498<span></span>
</td>
<td class="nump">498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">59.30</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 59.30<span></span>
</td>
<td class="nump">$ 59.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">498<span></span>
</td>
<td class="nump">498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">2 years 11 months 15 days<span></span>
</td>
<td class="text">3 years 11 months 15 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 59.30<span></span>
</td>
<td class="nump">$ 59.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">498<span></span>
</td>
<td class="nump">498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">75.38</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 75.38<span></span>
</td>
<td class="nump">$ 75.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">498<span></span>
</td>
<td class="nump">498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">3 years 14 days<span></span>
</td>
<td class="text">4 years 14 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 75.38<span></span>
</td>
<td class="nump">$ 75.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">498<span></span>
</td>
<td class="nump">498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">86.43</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 86.43<span></span>
</td>
<td class="nump">$ 86.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">1,244<span></span>
</td>
<td class="nump">1,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">2 years 10 months 13 days<span></span>
</td>
<td class="text">3 years 10 months 17 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 86.43<span></span>
</td>
<td class="nump">$ 86.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">1,244<span></span>
</td>
<td class="nump">1,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">88.44</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 88.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 10 months 13 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 88.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">120.60</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 120.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 8 months 15 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 120.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember', window );">142.71</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Exercise price of options outstanding | $ / shares</a></td>
<td class="nump">$ 142.71<span></span>
</td>
<td class="nump">$ 142.71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement | Share</a></td>
<td class="nump">4,975<span></span>
</td>
<td class="nump">4,974<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">2 years 8 months 26 days<span></span>
</td>
<td class="text">3 years 8 months 26 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of exercisable Share options | $ / shares</a></td>
<td class="nump">$ 142.71<span></span>
</td>
<td class="nump">$ 142.71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable in share-based payment arrangement | Share</a></td>
<td class="nump">4,975<span></span>
</td>
<td class="nump">4,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOutstandingShareOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOutstandingShareOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercisable in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_vii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_vii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=huge_StockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceTwoPointSixOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceTwoPointSixOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceThreePointSevenFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceThreePointSevenFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceThreePointEightSixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceThreePointEightSixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFourPointFourTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFourPointFourTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFourPointSevenFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFourPointSevenFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFivePointZeroThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFivePointZeroThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFivePointFourThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFivePointFourThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceSixPointSixteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceSixPointSixteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceSevenPointSeventeenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceSevenPointSeventeenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceSevenPointSixtyThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceSevenPointSixtyThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceNinePointFiveFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceNinePointFiveFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceTenPointSixFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceTenPointSixFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceThirteenPointZeroSevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceThirteenPointZeroSevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceThirteenPointFourSevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceThirteenPointFourSevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceSixteenPointZeroEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceSixteenPointZeroEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceSeventeenPointEightNineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceSeventeenPointEightNineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceEighteenPointZeroNineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceEighteenPointZeroNineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceTwentyPointOneZeroMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceTwentyPointOneZeroMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceTwentyOnePointElevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceTwentyOnePointElevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceTwentyFourPointTwelveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceTwentyFourPointTwelveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceTwentySixPointThirteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceTwentySixPointThirteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFortyPointTwentyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFortyPointTwentyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFortyFourPointTwentyTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFortyFourPointTwentyTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFortySevenPointTwentyFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFortySevenPointTwentyFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFiftyPointTwentyFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFiftyPointTwentyFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFiftyTwoPointTwentySixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFiftyTwoPointTwentySixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFiftyFivePointTwentyEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFiftyFivePointTwentyEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFiftyNinePointThirtyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceFiftyNinePointThirtyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceSeventyFivePointThirtyEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceSeventyFivePointThirtyEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceEightySixPointFortyThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceEightySixPointFortyThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceEightyEightPointFortyFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceEightyEightPointFortyFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceOneHundredTwentyPointSixtyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceOneHundredTwentyPointSixtyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=huge_ExercisePriceOneHundredFortyTwoPointSeventyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923863659400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss per share - Schedule of loss per share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EarningsPerShareLineItems', window );"><strong>Earnings per share [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares', window );">Dilutive effect of convertible instruments on number of ordinary shares</a></td>
<td class="nump">8,442,172<span></span>
</td>
<td class="nump">1,922,394<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfOrdinarySharesAxis=huge_WarrantsMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EarningsPerShareLineItems', window );"><strong>Earnings per share [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares', window );">Dilutive effect of convertible instruments on number of ordinary shares</a></td>
<td class="nump">6,749,109<span></span>
</td>
<td class="nump">467,451<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfOrdinarySharesAxis=huge_StockOptionsMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EarningsPerShareLineItems', window );"><strong>Earnings per share [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares', window );">Dilutive effect of share options on number of ordinary shares</a></td>
<td class="nump">1,693,063<span></span>
</td>
<td class="nump">1,454,943<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of dilutive potential ordinary shares that relate to the assumed conversion of the entity's convertible instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2019-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of dilutive potential ordinary shares that relate to the assumed exercise of the entity's share options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2019-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfOrdinarySharesAxis=huge_WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfOrdinarySharesAxis=huge_WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfOrdinarySharesAxis=huge_StockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfOrdinarySharesAxis=huge_StockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923829481016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General and administrative - Schedule of general and administrative expense (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract', window );"><strong>Selling, general and administrative expense [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfessionalFeesExpense', window );">Professional fees</a></td>
<td class="nump">$ 2,734,123<span></span>
</td>
<td class="nump">$ 3,101,136<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_GeneralOfficeInsuranceAndAdministrationExpenditures', window );">General office, insurance and administration expenditures</a></td>
<td class="nump">3,616,159<span></span>
</td>
<td class="nump">1,742,550<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ConsultingFeesExpenses', window );">Consulting fees</a></td>
<td class="nump">1,775,269<span></span>
</td>
<td class="nump">1,675,258<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WagesAndSalaries', window );">Salaries, wages and benefits</a></td>
<td class="nump">2,656,162<span></span>
</td>
<td class="nump">1,705,696<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_InvestorRelationsExpenses', window );">Investor relations</a></td>
<td class="nump">541,944<span></span>
</td>
<td class="nump">2,241,275<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_BuildingAndFacilityCosts', window );">Building and facility costs</a></td>
<td class="nump">586,926<span></span>
</td>
<td class="nump">676,798<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NetForeignExchangeLoss', window );">Foreign exchange loss</a></td>
<td class="num">(186,959)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_GeneralAndAdministrativeExpenseContinuedAndDiscontinuedOperations', window );">General and administrative</a></td>
<td class="nump">11,723,624<span></span>
</td>
<td class="nump">11,142,713<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseByNatureAbstract', window );"><strong>Allocated to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeneralAndAdministrativeExpense', window );">Continuing operations</a></td>
<td class="nump">10,058,083<span></span>
</td>
<td class="nump">8,407,427<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_GeneralAndAdministrativeExpenseDiscontinuedOperations', window );">Discontinued operations</a></td>
<td class="nump">$ 1,665,541<span></span>
</td>
<td class="nump">$ 2,735,286<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_BuildingAndFacilityCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expenses arising from building and facility costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_BuildingAndFacilityCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ConsultingFeesExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses of consulting fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ConsultingFeesExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_GeneralAndAdministrativeExpenseContinuedAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of general and administrative expense continued and discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_GeneralAndAdministrativeExpenseContinuedAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_GeneralAndAdministrativeExpenseDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of general and administrative expense discontinued operations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_GeneralAndAdministrativeExpenseDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_GeneralOfficeInsuranceAndAdministrationExpenditures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from general office, insurance and administration expenditures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_GeneralOfficeInsuranceAndAdministrationExpenditures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_InvestorRelationsExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Information about investor relations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_InvestorRelationsExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseByNatureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseByNatureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetForeignExchangeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net loss arising from foreign exchange differences. [Refer: Foreign exchange gain (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2019-01-01<br> -Paragraph 52<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_52_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetForeignExchangeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfessionalFeesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of fees paid or payable for professional services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfessionalFeesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WagesAndSalaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A class of employee benefits expense that represents wages and salaries. [Refer: Employee benefits expense]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2019-01-01<br> -Paragraph 9<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_9&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WagesAndSalaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923861657736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxesPaidRefundAbstract', window );"><strong>Income taxes paid (refund) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised', window );">Net operating losses carried forward - US</a></td>
<td class="nump">$ 5,032,915<span></span>
</td>
<td class="nump">$ 206,480<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_PreacquisitionNetOperatingLossCarryforwards', window );">Preacquisition net operating loss carryforwards</a></td>
<td class="nump">$ 4,930,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NetOperatingLossCarryforwardsLimitationsInUse', window );">Description for limitations of utilization of net operating loss carryforwards</a></td>
<td class="text">Utilization of net operating loss carryforwards may be subject to limitations in the event of a change in ownership pursuant to IRC &#xa7; 382, and similar state provisions. As a result of the acquisition of Prismic on June 28, 2019, the preacquisition net operating loss carryforwards of approximately $4.93M could be subject to IRC &#xa7; 382 limitation as the acquisition could constitute a change of ownership.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deductible temporary differences of domestic non-capital losses carried forward for which no deferred tax asset is recognised in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NetOperatingLossCarryforwardsLimitationsInUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents limitations in utilization of net operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NetOperatingLossCarryforwardsLimitationsInUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_PreacquisitionNetOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents preacquisition net operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_PreacquisitionNetOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxesPaidRefundAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxesPaidRefundAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923883276504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of provision for income taxes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxesPaidRefundAbstract', window );"><strong>Income taxes paid (refund) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AccountingProfit', window );">Loss from continuing operations before income taxes</a></td>
<td class="num">$ (28,452,232)<span></span>
</td>
<td class="num">$ (34,080,963)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Statutory federal and provincial tax rate</a></td>
<td class="nump">26.50%<span></span>
</td>
<td class="nump">26.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate', window );">Income tax recovery at the statutory tax rate</a></td>
<td class="num">$ (7,539,841)<span></span>
</td>
<td class="num">$ (9,031,455)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss', window );">Permanent differences</a></td>
<td class="nump">2,235,657<span></span>
</td>
<td class="nump">5,866,153<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_BookToFilingAdjustments', window );">Book to filing adjustments</a></td>
<td class="num">(1,545,244)<span></span>
</td>
<td class="nump">4,765,959<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ShareIssuanceCostBookedDirectlyToEquity', window );">Share issuance cost booked directly to equity</a></td>
<td class="num">(584,538)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TaxEffectOfForeignTaxRates', window );">Foreign exchange</a></td>
<td class="num">(370,457)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_TaxEffectOfDeferredTaxAssetNotRecognized', window );">Change in tax benefits not recognized</a></td>
<td class="nump">7,804,423<span></span>
</td>
<td class="num">(1,600,657)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncome', window );">Total Income tax expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_BookToFilingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents book to filing adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_BookToFilingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ShareIssuanceCostBookedDirectlyToEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents share issuance cost booked directly to equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ShareIssuanceCostBookedDirectlyToEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_TaxEffectOfDeferredTaxAssetNotRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount related to tax effect of deferred tax asset not recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_TaxEffectOfDeferredTaxAssetNotRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AccountingProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) for a period before deducting tax expense. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AccountingProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ApplicableTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The applicable income tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ApplicableTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_g_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxesPaidRefundAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxesPaidRefundAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to expenses not deductible in determining taxable profit (tax loss). [Refer: Accounting profit]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxEffectOfForeignTaxRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to foreign tax rates. [Refer: Accounting profit]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxEffectOfForeignTaxRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The product of the accounting profit multiplied by the applicable tax rate(s). [Refer: Accounting profit; Applicable tax rate]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxExpenseIncomeAtApplicableTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923858969144">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Schedule of deferred tax assets (liabilities) (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxesPaidRefundAbstract', window );"><strong>Income taxes paid (refund) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DeferredTaxAssetsOtherInvestments', window );">Other investments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (126,461)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward', window );">Capital losses carried forward</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">126,461<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DeferredTaxAssetLiabilityNotRecognized', window );">Total</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DeferredTaxAssetLiabilityNotRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax (asset) / liability not recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DeferredTaxAssetLiabilityNotRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DeferredTaxAssetsOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DeferredTaxAssetsOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of capital losses carried forward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DeferredTaxLiabilitiesCapitalLossesCarriedForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxesPaidRefundAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxesPaidRefundAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923883285032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Schedule of temporary differences for which deferred tax assets not recognised (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxesPaidRefundAbstract', window );"><strong>Income taxes paid (refund) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised', window );">Non-capital losses - Canada</a></td>
<td class="nump">$ 44,897,393<span></span>
</td>
<td class="nump">$ 20,703,137<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised', window );">Net-operating loss - US</a></td>
<td class="nump">5,032,915<span></span>
</td>
<td class="nump">206,480<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DeductibleTemporaryDifferencesOfForeignUnrealizedForeignExchangeLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised', window );">Unrealized foreign exchange loss</a></td>
<td class="nump">94,733<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised', window );">Share-issuance costs</a></td>
<td class="nump">3,419,003<span></span>
</td>
<td class="nump">879,959<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised', window );">Capital losses carried forward</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">263,666<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised', window );">Other investments</a></td>
<td class="nump">4,449,544<span></span>
</td>
<td class="nump">968,811<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DeductibleTemporaryDifferencesOfIfrs16ForWhichNoDeferredTaxAssetIsRecognised', window );">IFRS 16</a></td>
<td class="nump">125,962<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised', window );">Property, plant and equipment</a></td>
<td class="nump">88,248<span></span>
</td>
<td class="nump">30,290<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Total</a></td>
<td class="nump">$ 58,107,798<span></span>
</td>
<td class="nump">$ 23,052,343<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deductible temporary differences of capital losses carried forward for which no deferred tax asset is recognised in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DeductibleTemporaryDifferencesOfCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deductible temporary differences of domestic non-capital losses carried forward for which no deferred tax asset is recognised in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DeductibleTemporaryDifferencesOfDomesticNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deductible temporary differences of foreign non-capital losses carried forward for which no deferred tax asset is recognised in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DeductibleTemporaryDifferencesOfForeignNonCapitalLossesCarriedForwardForWhichNoDeferredTaxAssetIsRecognised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DeductibleTemporaryDifferencesOfForeignUnrealizedForeignExchangeLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents deductible temporary differences of foreign unrealized foreign exchange loss carried forward for which no deferred tax asset is recognised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DeductibleTemporaryDifferencesOfForeignUnrealizedForeignExchangeLossCarriedForwardForWhichNoDeferredTaxAssetIsRecognised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DeductibleTemporaryDifferencesOfIfrs16ForWhichNoDeferredTaxAssetIsRecognised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deductible temporary differences of IFRS 16 for which no deferred tax asset is recognised in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DeductibleTemporaryDifferencesOfIfrs16ForWhichNoDeferredTaxAssetIsRecognised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deductible temporary differences of other Investments for which no deferred tax asset is recognised in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DeductibleTemporaryDifferencesOfOtherInvestmentsForWhichNoDeferredTaxAssetIsRecognised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deductible temporary differences of Property, plant and equipment for which no deferred tax asset is recognised in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DeductibleTemporaryDifferencesOfPropertyPlantAndEquipmentForWhichNoDeferredTaxAssetIsRecognised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deductible temporary differences of share issuance costs for which no deferred tax asset is recognised in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DeductibleTemporaryDifferencesOfShareIssuanceCostsForWhichNoDeferredTaxAssetIsRecognised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxesPaidRefundAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxesPaidRefundAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred tax assets net of deferred tax liabilities, when the absolute amount of deferred tax assets is greater than the absolute amount of deferred tax liabilities. [Refer: Deferred tax assets; Deferred tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923837260184">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Schedule of non-capital loss carryforwards (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxesPaidRefundAbstract', window );"><strong>Income taxes paid (refund) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyTwo', window );">2032</a></td>
<td class="nump">$ 26,982<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyThree', window );">2033</a></td>
<td class="nump">114,405<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFour', window );">2034</a></td>
<td class="nump">144,411<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFive', window );">2035</a></td>
<td class="nump">65,782<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySix', window );">2036</a></td>
<td class="nump">689,676<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySeven', window );">2037</a></td>
<td class="nump">2,677,789<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight', window );">2038</a></td>
<td class="nump">6,092,686<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine', window );">2039</a></td>
<td class="nump">11,415,413<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandFourty', window );">2040</a></td>
<td class="nump">23,670,249<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NonCapitalLossCarryforwards', window );">Non-capital income tax losses expire</a></td>
<td class="nump">$ 44,897,393<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandFourty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of Non capital income tax losses expire on 2040.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandFourty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of Non capital income tax losses expire on 2038.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyEight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of Non capital income tax losses expire on 2035.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of Non capital income tax losses expire on 2034.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of Non capital income tax losses expire on 2039.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyNine</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySeven">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of Non capital income tax losses expire on 2037.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySeven</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySix">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of Non capital income tax losses expire on 2036.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtySix</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of Non capital income tax losses expire on 2033.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of Non capital income tax losses expire on 2032.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NonCapitalIncomeTaxLossesExpireOnTwoThousandThirtyTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NonCapitalLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of non-capital loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NonCapitalLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxesPaidRefundAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxesPaidRefundAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923837540504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and contingencies (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jul. 29, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>CAD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesLineItems', window );"><strong>Disclosure of contingent liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ProvisionForEmployeeRelatedLiability', window );">Provision for employee related liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 59,748<span></span>
</td>
<td class="nump">$ 81,562<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_PaymentMadeToBeUnpaidWagesAndUnpaidHoliday', window );">Payment made to be unpaid wages and unpaid holiday | &#8364;</a></td>
<td class="nump">&#8364; 59,748<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=ifrs-full_LegalProceedingsContingentLiabilityMember', window );">Legal proceedings contingent liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesLineItems', window );"><strong>Disclosure of contingent liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClaimIssuedByContractorForVariousPurportedDamages', window );">Claim issued by contractor for various purported damages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClaimForLienComponent', window );">Claim for lien component</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">188,309<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees', window );">Security deposit in respect of amount claimed and estimated legal fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">235,387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_FundsPaidForSettlementAgreement', window );">Funds paid for settlement agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 198,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_TypeOfArrangementsAxis=huge_EpitechLicenseAgreementMember', window );">Epitech License Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesLineItems', window );"><strong>Disclosure of contingent liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NonRefundableSumDueAndPayableUponFirstNotificationOfFda', window );">Non refundable sum due and payable upon first notification of FDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFda', window );">Non refundable sum payable within ten business days of first notification FDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights', window );">Percentage of lump sum payment received to pay for non prescription drug rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights', window );">Percentage of one off lump sum payment to pay for prescription drug rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition', window );">Percentage of net sales of Licensed Product as first payment condition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition', window );">Percentage of net receipts from commercial partners as second payment condition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition', window );">Percentage of net sales or net receipts of licensed products as third payment condition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_TypeOfArrangementsAxis=huge_HeritageBuildingRestorationCommitmentMember', window );">Heritage Building Restoration Commitment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesLineItems', window );"><strong>Disclosure of contingent liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_EstimatedCostOfRestorationInCommitment', window );">Estimated cost of restoration in commitment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 266,349<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_TypeOfArrangementsAxis=huge_DefinitiveStrategicAllianceAndStreamingAgreementMember', window );">Definitive Strategic Alliance and Streaming Agreement | Contingent liability for construction and development costs | Auxly Cannabis Group Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesLineItems', window );"><strong>Disclosure of contingent liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement', window );">Number of Class B shares issued from treasury under private placement | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,313<span></span>
</td>
<td class="nump">37,313<span></span>
</td>
<td class="nump">37,313<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement', window );">Amount of Class B shares issued from treasury under private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,642,250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_TypeOfArrangementsAxis=huge_DefinitiveSettlementAgreementMember', window );">Definitive settlement agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesLineItems', window );"><strong>Disclosure of contingent liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_PartialPaymentOfSettlementAmount', window );">Partial payment for settlement amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 928,541<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ClaimSettlementAmountCoveredByInsurance', window );">Claim settlement amount covered by insurance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,571,459<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of shares issued from entitys treasury by way of private placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_AmountOfSharesIssuedFromTreasuryUnderPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClaimForLienComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents information about claim for lien component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClaimForLienComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClaimIssuedByContractorForVariousPurportedDamages">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents information about claim issued by contractor for various purported damages.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClaimIssuedByContractorForVariousPurportedDamages</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ClaimSettlementAmountCoveredByInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of claim settlement amount covered by insurance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ClaimSettlementAmountCoveredByInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_EstimatedCostOfRestorationInCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount related to estimated cost of restoration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_EstimatedCostOfRestorationInCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_FundsPaidForSettlementAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of fund paid for the Settlement Agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_FundsPaidForSettlementAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NonRefundableSumDueAndPayableUponFirstNotificationOfFda">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NonRefundableSumDueAndPayableUponFirstNotificationOfFda</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFda">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount related to non refundable sum payable within ten business days of first notification FDA.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NonRefundableSumPayableWithinTenBusinessDaysOfFirstNotificationFda</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of shares issued from entitys treasury by way of private placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NumberOfSharesIssuedFromTreasuryUnderPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_PartialPaymentOfSettlementAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of partial payment for settlement amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_PartialPaymentOfSettlementAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_PaymentMadeToBeUnpaidWagesAndUnpaidHoliday">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of payment made to be unpaid wages and unpaid holiday.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_PaymentMadeToBeUnpaidWagesAndUnpaidHoliday</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of lump sum payment received to pay for non prescription drug rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_PercentageOfLumpSumPaymentReceivedToPayForNonPrescriptionDrugRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of net receipts from commercial partners as second payment condition under the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_PercentageOfNetReceiptsFromCommercialPartnersAsSecondPaymentCondition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of net sale of licensed product as first payment condition under the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_PercentageOfNetSalesOfLicensedProductAsFirstPaymentCondition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of net sales of net receipts of licensed products as third payment condition under the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_PercentageOfNetSalesOrNetReceiptsOfLicensedProductsAsThirdPaymentCondition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of one off lump sum payment to pay for prescription drug rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_PercentageOfOneOffLumpSumPaymentToPayForPrescriptionDrugRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ProvisionForEmployeeRelatedLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents information about provision for employee related liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ProvisionForEmployeeRelatedLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of security deposit with the court in respect of amount claimed and estimated legal fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_SecurityDepositInRespectOfAmountClaimedAndEstimatedLegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfContingentLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfContingentLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=ifrs-full_LegalProceedingsContingentLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfContingentLiabilitiesAxis=ifrs-full_LegalProceedingsContingentLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_TypeOfArrangementsAxis=huge_EpitechLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_TypeOfArrangementsAxis=huge_EpitechLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_TypeOfArrangementsAxis=huge_HeritageBuildingRestorationCommitmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_TypeOfArrangementsAxis=huge_HeritageBuildingRestorationCommitmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_TypeOfArrangementsAxis=huge_DefinitiveStrategicAllianceAndStreamingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_TypeOfArrangementsAxis=huge_DefinitiveStrategicAllianceAndStreamingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfContingentLiabilitiesAxis=huge_ContingentLiabilityForConstructionAndDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=huge_AuxlyCannabisGroupIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=huge_AuxlyCannabisGroupIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_TypeOfArrangementsAxis=huge_DefinitiveSettlementAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_TypeOfArrangementsAxis=huge_DefinitiveSettlementAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923863495336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related party transactions (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>CAD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DirectorsRemunerationExpense', window );">Directors remuneration expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 246,226<span></span>
</td>
<td class="nump">$ 153,109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment', window );">Share-based payments expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,045,994<span></span>
</td>
<td class="nump">9,385,984<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=huge_ChiefExecutiveOfficersMember', window );">Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_PaymentOfExpenses', window );">Payment of expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,445,043<span></span>
</td>
<td class="nump">$ 567,468<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmountsPayableRelatedPartyTransactions', window );">Related party payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">355,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=huge_PresidentsMember', window );">President</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment', window );">Share-based payments expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 238,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=huge_IndependentDirectorMember', window );">Independent directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DirectorsRemunerationExpense', window );">Directors remuneration expense</a></td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_AdditionalRemuneration', window );">Additional remuneration as Chairman</a></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=huge_KeyManagementAndDirectorsMember', window );">Key management and directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfSharesIssuedForCompensationBonus', window );">Number of shares issued for compensation bonus | shares</a></td>
<td class="nump">1,676,066<span></span>
</td>
<td class="nump">1,676,066<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment', window );">Share-based payments expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,602,301<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=huge_FSDBiosciencesMember', window );">FSD Biosciences | President of FSD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmountsPayableRelatedPartyTransactions', window );">Related party payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,876<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_AdditionalRemuneration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of additional remuneration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_AdditionalRemuneration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NumberOfSharesIssuedForCompensationBonus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents number of number of shares issued for compensation bonus.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NumberOfSharesIssuedForCompensationBonus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_PaymentOfExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of payment of expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_PaymentOfExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmountsPayableRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amounts payable resulting from related party transactions. [Refer: Related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2019-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmountsPayableRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DirectorsRemunerationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of remuneration paid or payable to the entity's directors.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DirectorsRemunerationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=huge_ChiefExecutiveOfficersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=huge_ChiefExecutiveOfficersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=huge_PresidentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=huge_PresidentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=huge_IndependentDirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=huge_IndependentDirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=huge_KeyManagementAndDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=huge_KeyManagementAndDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=huge_FSDBiosciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=huge_FSDBiosciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=huge_PresidentOfFSDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=huge_PresidentOfFSDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923858981256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related party transactions - Schedule of key management personnel compensation (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract', window );"><strong>Disclosure of transactions between related parties [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits', window );">Salaries, benefits, bonuses and consulting fees</a></td>
<td class="nump">$ 2,936,816<span></span>
</td>
<td class="nump">$ 3,638,267<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment', window );">Share-based payments</a></td>
<td class="nump">7,045,994<span></span>
</td>
<td class="nump">9,385,984<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensation', window );">Total</a></td>
<td class="nump">$ 9,982,810<span></span>
</td>
<td class="nump">$ 13,024,251<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of short-term employee benefits. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923883296904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Capital management (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_DisclosureOfCapitalManagementAbstract', window );"><strong>Disclosure Of Capital Management [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital</a></td>
<td class="nump">$ 103,208,126<span></span>
</td>
<td class="nump">$ 73,737,925<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_DisclosureOfCapitalManagementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_DisclosureOfCapitalManagementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139923837221192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent events (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 11, 2021</div></th>
<th class="th"><div>Feb. 10, 2021</div></th>
<th class="th"><div>Mar. 12, 2021</div></th>
<th class="th"><div>Jan. 22, 2021</div></th>
<th class="th"><div>Jan. 21, 2021</div></th>
<th class="th"><div>Feb. 17, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Proceeds from issuing shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,100,459<span></span>
</td>
<td class="nump">$ 3,431,294<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=huge_SubsequentEventsMember', window );">Subsequent events | Class B Subordinated Voting Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_CertainShareholdersClaimingToHoldInExcessPercentageOfClassBSubordinatedVotingShares', window );">Certain shareholders claiming to hold in excess percentage of class B subordinated voting shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=huge_SubsequentEventsMember', window );">Subsequent events | Board members</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfStockOptionsApprovedForIssuance', window );">Number of stock options approved for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=huge_SubsequentEventsMember', window );">Subsequent events | Directors and officers | Class B Common Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_IssuanceOfShares', window );">Number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,349,764<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_ShareIssuePricePerShare', window );">Share issue price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Proceeds from issuing shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,576,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=huge_SubsequentEventsMember', window );">Subsequent events | Equity distribution agreement | A.G.P/Alliance Global Partners | Class B Common Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_NumberOfSharesIssuedThroughEquityDistributionAgreement', window );">Number of shares issued through equity distribution agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,356,326<span></span>
</td>
<td class="nump">7,247,288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Proceeds from issuing shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,770,762<span></span>
</td>
<td class="nump">$ 18,167,511<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=huge_SubsequentEventsMember', window );">Subsequent events | Equity distribution agreement | Directors and officers | Class B Common Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_huge_MaximumAggregateOfferingPrice', window );">Maximum aggregate offering price</a></td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_CertainShareholdersClaimingToHoldInExcessPercentageOfClassBSubordinatedVotingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents information of Certain Shareholders claiming to hold in excess percentage of class B subordinated voting shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_CertainShareholdersClaimingToHoldInExcessPercentageOfClassBSubordinatedVotingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_IssuanceOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_IssuanceOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_MaximumAggregateOfferingPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of maximum offering price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_MaximumAggregateOfferingPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NumberOfSharesIssuedThroughEquityDistributionAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents number of shares issued through equity distribution agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NumberOfSharesIssuedThroughEquityDistributionAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_NumberOfStockOptionsApprovedForIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of number of stock options approved for issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_NumberOfStockOptionsApprovedForIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_ShareIssuePricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the price per share of shares issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_ShareIssuePricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>huge_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssuingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuing shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssuingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=huge_SubsequentEventsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=huge_SubsequentEventsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfOrdinarySharesAxis=huge_ClassBSubordinatedVotingSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfOrdinarySharesAxis=huge_ClassBSubordinatedVotingSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=huge_BoardMembersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=huge_BoardMembersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=huge_DirectorsAndOfficersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=huge_DirectorsAndOfficersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfOrdinarySharesAxis=huge_ClassBCommonSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfOrdinarySharesAxis=huge_ClassBCommonSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_huge_TypeOfArrangementsAxis=huge_EquityDistributionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">huge_TypeOfArrangementsAxis=huge_EquityDistributionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=huge_AllianceGlobalPartnersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=huge_AllianceGlobalPartnersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>119
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MG,W*2Z;&37GG=<O45D#N4KX!ES"X0*7*:Z3RP<A]<1.SE,;(K/BYXPSV'M8
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M1=]:2%:>4XT04T7B,$DB/*[V+(9A3&C@Z"K(H#?$WQ%!7]%F4B)5 UH%ZB.
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M;N%O8TTB1ZD:8/I,7)&+XE+<T3K@O@ F>2\9UD!']ZM&.:;(_A-N6#&^I&1
M:3O2!?1A!%15QDF'F%JJ,41#T[F57&NQT!KU4/Z!YH4#0:?@8Z.Y^R(<L >8
M4E/N4NX+R\> IZL!@U+[A=4II(FWIF1<G]1-YPF38)B=<NWL=L(#<$M\5%3L
M/Z59W%.)2EL9HK&0>0#B32)3_)JJA=>(;%9(%]@%_RP@=<!FC>@"NNYA)&+(
M#[7&.<""N" _]$/C861!1$U" HT.4 MLUK! +BP! _9''5:H0[80@KQ=L[.[
MBAVDDQ^*>(A9"6M0,,C8)_S&;X@RUATW] (.\IJ-8OA 3'YCW/( GS=''T%5
M(:Y,0QF"LDR8WZAX9#IZ3V!MT;QJ$H=L I&AG>=R[5OZXR>S[\6_I&N)]+K?
M1W\7^'?T5!<2O]Y=B-ETROUM-G_;?Q[=(/3H'(_:TJ-#W?^C1Z3<D>;>#O$!
M6"BNHZN/GSY<'\,HP@B3[0+C[WV?20Y84B(&3,!,Q1ZM2ZY-:!%12GQ0BV(F
M,B5E4D\THUYJ,<I)P F:2VQ)\7$YKS'5VA)#(>4AS; (!I(@+ '(5M1:TE3#
M#0G)OY"YJO* WEO(MHR[0NI/]$ENG+)MF1/=$*.05J9E/AXD>;>0CIS1MCK&
M'LI=\1G1(HY%-^Y9@G*0>=Z*TA #*QA;9%)0DH<&]$9LSAM"V[ :F-X/.'!D
M:?V"T<IXD+N&VJO0J"I/X8U(26K68_'C'DQ< /@6))M[WY$1<% $*E=,-$O'
MT4 )U=[I1 E'!RO,ASAG0'%A34&B#EAJVD_M;W^.&,S 9VFZ]D5YH1\2E28V
M9V#[\.8&B*+RW&Q17Z6F\ZC]IEV@JZ'E2 OK%-*7.CBG7=QG*?29'J&"*ER:
M@"^XF(7</XL]GAO,*M Q/[>HV8310:ZEL>Q"XKE"H6&!B\BT/6+<201>H/]2
MX^['DU[5\BRZ-]21@<@VXL@5Z L!:U&A(4F.%I.1\PG-@)I':79!("B0A Z1
MK5I+J\I$MC>G(D7<X3:'88JO790B&=%:;KO4)R^AC&3D?*<NTKG&N/78<^JS
M/3P"J.Q<T  FY,@25\O<U1X?0X0"]&$^9/[EN!34(Z&5@]E%OFPS:KF9#*QQ
M('%@#42X=7D^Y6+%[X1;;D&48'+4-0T24@W>[-C@BRP_3%E,0MQ?"'A4:334
M2+CA6FHJ0"]"5S_>6NV6*0_KC_"+CR+=X]?[YI[IK6Q=GW_/==HNR1[U%"KR
M+LDZ.N&QSH<RCU^X YAE;[GY@ID/1Z.!QW@XBELT.$HDQ3:P2&!!%8]A1:K[
M@YD0M::(=]8=!^Y*@NL81@;+S;3!.((8T:AD,DW?X[M")/6#PH#**WU%0$KT
MSH%*:1\[CYZYY+D1?;1*^4KA^(I**6E<V\7CD05Y#*9M^0*"J:H??D^*W3Q\
M."(77QFPN[FZ9U!)-$VS7Z:K03O"S&]0>!(ZF!:X_7[W%KCA$LL7P404GZ=(
M"@N8GR&^NS[F.]X3]S\XGU >"=;QK$@3',]1E0FH0+ )6;@7\!ZD7,2XK"C-
M%Q4>=%!LK'B+ZVAW_^ AF;+TF01"0RJY;KAKR%VC.LSY/C3$ +NXP-3_.6CV
M8+!-A'_YY5@T?NKEPV3OY0Z3WQ5?8A7-5OD]S_!T>$MVD5\.[;;G5VS(DZ5Q
M!'Z%H]/Q=Z]&>?;L?R3?\*NBA4_)U_P5S0FY0ANP7GG<@KH?I&!X=WC^%U!+
M P04    "  KJG!2% D+,DL1  #*+P  &    'AL+W=O<FMS:&5E=',O<VAE
M970W+GAM;*U::X_;N!7][E]!3!?=!%!F_!S;:1)@9I)@I\CNIIFD11'D RW1
M-AM9TI*2)^ZO[[F7I$QY[,EN6V"S8\ODY7V>^Z!>W)?FJUTK58MOF[RP+\_6
M=5T]O[BPZ5IMI#TO*U7@EV5I-K+&5[.ZL)51,N--F_QBV.]?7FRD+LY>O>!G
M[\VK%V53Y[I0[XVPS68CS>Y:Y>7]R[/!67CP0:_6-3VX>/6BDBMUI^I/U7N#
M;Q<ME4QO5&%U60BCEB_/K@;/K\>TGA?\7:M[&WT6),FB++_2E]OLY5F?&%*Y
M2FNB(/%GJVY4GA,AL/&;IWG6'DD;X\^!^EN6';(LI%4W9?X/G=7KEV>S,Y&I
MI6SR^D-Y_Y/R\DR(7EKFEO\O[MW:T>A,I(VMRXW?# XVNG!_Y3>OAVC#K']B
MP]!O&#+?[B#F\K6LY:L7IKP7AE:#&GU@47DWF-,%&>6N-OA58U_]ZEI:;46Y
M%#"I544M25<O+FJ0I@47J2=S[<@,3Y 9#,7/95&OK7A39"KK$K@ 3RUCP\#8
M]?!1BJ]5>BY&@T0,^\/^(_1&K: CIC=Z5-!?E^)])*CX?+6PM8%K?'GDB'%[
MQ)B/&/^ONGR<S/!<'*74^RR_B#M\5@B*FGY-RTV5:UFD2GQ<8Z%8Z@+?M,R%
M#>NL6,NM$@NE"J)62:,RL=C!APH$'5/2%!QI:3*F=*_KM;@M:F4*/A;$WK9D
M/ZBJ-+4N5L1(D4F36?'D[/;MA[NSIT):H:UM'/UZK0ZH7.&,ICC8?%WB#Y&X
MNKL^>WI.<HBJS'6JE146H 0@ ?/ CDB.M 0HV!J\YSLA*^@ 9]:ED'DN*F5T
M"<)><RI+1%/DRD*=8,G<:ZBI*/'\_#&=W2NCB+(IMR -9H5LZG5I]+_Q%5#(
M@K*ZO*A.#MCDM38 G-*P^>B7&QA)%CL!;_M9FG0M!A-VZL&Y^+SXLC?U1DG;
M&&>1/V9- C>QAD+ 7XK5:6EK@BIM$Z&^I:JJF>54F1HH'9'5!9R_\1*O-7@#
MO< (1,8^J8W8RKQ1Y^*G[@F6%Z]4H0STOF-LS$13@1L2>[\S*(*MEF$U1]X*
M8%R0ZX'#M2Q6BGE<E60[TK=59JM3. '4J; 6]GJ[)PF5$<D*["A\ J?W99/#
M\52[GAP"Z)^#&CR37<F(2FK^ 3%?V*4R4!P":*%S7>\X#@JL H^0AY=(ESL6
MJKXGE2-O?04AJ+V&A\*LI(6:68G-E\%:"1A9P2><ZRVA7T7^YYAU?$.(C+T%
MIY4+$E@N<D5L*EMK9!S2IZ5XD04[+POOU%>K=%WHW\@NMT583TL?ZCZ6/Q(W
MZ7AG+;]"U[J@*')QZFRVEH2.B"F<D+8^W=*+E+<\JAUG%J*.C:5]2+%S))14
ML'*")$<..J'OCGN0*\4+X% 7>)1IF^8E/1558RJP0^<3N5/11B928!:9UP6:
M;2A*CD27A5SJF0N"2N[XV,B%K#,\A0P!K#M5V!35%2F5$%0,Q5U$Y+TG<@L#
M:1,@_XH48L7G],OQ),$ 2NIDLY(:C\M5I'F3*:=CIWPF]?;N-4>?QE?;+!"O
M6AI <2+>_EV\!W<;F?"B:UU:8'1!$4H;WL.>&YTZ #]U9 F=(_S5WK1N<S N
M8?X!:AYCAA(-=(D*06T6B(I0)?#B87\PYP]_E46#,E/PC_X948:R4+&%@V#X
M#FDR):W:*0D(5U3,/'+0N;CK\$5) XCC/!U2>Y&VV.OP-19M#3& B;4I<Z>V
M\(-_2+IQ1'8N,'1-_JB^D>,2BB44&$3%4.EI^<D6G#"*&%4W!FZW-.6&-:B+
M;9EO73QPCB=>/'F2APBQ77R<45@NET G+TX@6*]-V:S63+,JD2B=?'MJ1Y2R
M;"A#4 ) :L\8V)@OVD1?*;*<@KSL#/ >HXW#\DAUY^(JI^R%%<^"!$>]B4 8
M::91%*KH8ZSWUE3:M5BBJ*#TDGO@++OQ&C"_XQZ'W@G95*Z!#BP3)5=(2M+L
M904Q9/KLBWC;%*DOA=(&4A6I4WPG?-M?3L816%"2->5XB."DH^ 5S%1U$[I+
M)E@)H%P>X<:9P.?6]JF7&;!,;9M0.*5$J,/:6VW*(I20OH!H71;(1K%N#WR;
M<[V+Z6,LM&YQ@_H46B]$5N:Y-.+)S0]/@QM\*C1)R+6P;1=\NON!:U#P^RLJ
M, I8'Z^.!5]FL)&.R.[=W\$#YTUR'NHK_Y "HJ@*&FBAISV,<P&US#E5'4ND
M+ 926M,47'ZPH6)WI%K6L(]!";[H;,,ATO"/Q_7JC7I4<X&]A_N\RS\$8 (Z
M LN<8NAYQ\*$(]QTN[ -6J_M"4<_:?''C*T8F5#F?<_4Q\^$-J0 '"+MD47]
M\M;]?4;TI3Z SY2V<N?EN]]W KG31E*&+0E)8#L:8>0.3F-C+2@HJ4;D^02C
M%DH9*M=I"17+6W+*T':%NB6)"_ZXHG=S&N*%#,&- OM1+KU!CNG3[J%A7X]S
MIG:I]D#)21<I'((O0\'H]7+@42>1SI<,[$K$@UT3+/M0C+M=Q!]5\-S?Q8(^
M[QTDZ,&,V'8ZH_X/VE1Z%1DG*(38>+C7'XN-5UE9\2*<OB\G>C<_"&!-^->[
MNKM[\_&N=\/4:Y^)>C>48H:#9# :)_-17SR9),/1)!D,A^(IM8"S^3R9]6?B
MSW^:#0?#OT2/>A\-.0XIS%7]KJ.AK&[%?-Y/YK.9>#(<3Y+QY0S$IO@T05$2
M*/GOO??4'Z+=Z62^#%JQ%(SC\3CIS^?BR6#03_K]$0B-1O3HLB7DO_>&PV0R
MQ:+!E*28@(/)G-8/+I/Y=)Z,A^.]%.VCWB]E\2SMZN17%@>%"#3LDME@EO0O
MQ\ED/!!/QLEXBH^S*9$>X<,\F4\BTNVC'H\.GY7+9XWU=60B"O0)8>GAW\%L
MQ%SZO] ,03.U0%4N77L@U&^-KH@I1VHP3 ;C07(YO11/1M#/-!FSS',V* BU
MQ-LGO<DPF4XO8>8QM(I-TR'VLV+GR;0/]B\'+2MX-)M!6;-)[]WMU?7MN]N/
MMV_V3A35, _< =V%\X5!,AV/X#%@<0SOG4.)T%PR&@R2V>5D+WUXTGN'0@"1
MNLCU2KJL<DICXWXRFT[\G]YW#O*+\8 T,.YW3!]+\OO/'XSA<^-Y^/L]#EH#
MPTJ(L]F\=_?3U8<W/_WZ[O6;#S_>B3=_^W3[\9^]FQS.(JY<KX8BL-(UD E!
MGTSZB- QO&O@PA-/9G%L\G>___I@_^44VRZ347\(LU\F,X3+C ,3N_IS,#;:
M._'^4>\?TAAR/L)$ XR'^X_)Z2:@D@SZ?0@W)]])1O##V3 *R_"D=T/%LEXT
MA.>H\*J\05PC *=@ID]DAB/P,ITRF2D"?CP<163\D]Y5FC:;QB6(3"W1?=?
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MUB+CK#7.,>G:#ZZ]Q>HC%[RN 48OS);)=VUARS69PUO='4C$C)&;'W3/8.(
MO/E5&1+)K73W2&EX%X;.17[*.3 1F;>^P4GAJ_NC_=T]=0Q_;> &PYF_,M^G
M1-EU\+W+^)024S2J??=* +-<9=%><\!JBU!^T LIX>44!"GJ'=O-C=2'N!*!
M:X/ :*8S1HSVI/B <(WM*X_4<\UO=#',%(RU*\-U)+]>LHPN7UQ#I(NJH1CW
M':?WL;*IZ3&<2%/KI)UB#IA\3!W<Q'I!]X4QOXE#+X: 6%'R.U#<247]I^],
MXW>2W-AC?XY+MBRFGTSR3G^+YM41#L\HLZQ#;O?SG<SW]*VOMV%,$_&C"HTZ
M&9? 3XS@:$A"C@QN?BD!J&-& IFYL#S,$L5A5\\>$@GK_/F@ESC^JHA1)SSW
MU#4X[6HG4;__WI>[_P=7W[?^?3(^NF0'20XG'%2?X?P=@,&J+8.8[[L2C[^D
M6/]Z1+C".GYYS&_^43/J)UX!^H]<,B9[UJ-KZ?;NFE\K"6_2Q<A<9$<V(A*^
M*E794"4J7=7^U1,_ : R.KK@C&*\X;>PL+Q%FXZ9W$FA$>6<1T*B_T5BE*%<
M=R^NH#@%<QG-5-O%^IM_@?/X#3??!1,LE(NM+AM[?NP]X(OH_>J-,BM^BYQA
MMJC=J];MT_9%]2OW?O9^N7O+_6=I5BA<4+TOL;5_/IV<N;XS?*G+BM_67I1U
M76[XXUHARQM:@-^7)>+'?Z$#VM?W7_T'4$L#!!0    ( "NJ<%*)7(M/]A@
M ,U1   8    >&PO=V]R:W-H965T<R]S:&5E=#@N>&ULM3S;<A1'EN_ZB@IM
M[ (1+0'"S#H\F @!9I8-#R:0/7X@])!=E=V=IJJRG5DET?/U>VYYJ5M+V-X'
MFU9WULF3YW[+>G%KW6>_T[HKOC1UZ[\_W77=_KO'CWVYTXWRYW:O6_AE8UVC
M.OC3;1_[O=.JHH>:^O'%DR=_>]PHTYZ^?$'??7 O7]B^JTVK/[C"]TVCW.&5
MKNWM]Z=/3\,7'\UVU^$7CU^^V*NMOM+=+_L/#OYZ'*%4IM&M-[8MG-Y\?WKY
M]+M7W^!Z6O OHV]]]KG DZRM_8Q_O*N^/WV"".E:EQU"4/#/C7ZMZQH! 1J_
M"\S3N"4^F'\.T-_2V>$L:^7U:UO_:JIN]_WIMZ=%I3>JK[N/]O9_M)SG.<(K
M;>WI_\4MKWW^S6E1]KZSC3P,&#2FY7_5%Z%#]L"W3Q8>N) '+@AOWHBP?*,Z
M]?*%L[>%P]4 #3_04>EI0,ZTR)2KSL&O!I[K7EZ9;6LVIE1M!Q0J;=]VIMT6
M>UN;TFC_XG$'F^#2QZ4 ?,4 +Q8 /KTH_FG;;N>+']I*5T, CP&[B.)%0/'5
MQ5&(;W1Y7CQ[NBHNGEP\.0+O63SR,X+W;.G(+'_%3YLB/_UE.OT'.7WQZ7+M
M.P>2<WUDWV_BOM_0OM_\=:0^#O#9^<DG=5V\5GY7E!;TQ'>^L)NBQ"]46_&'
MG:ZKPK1%YT":PL;^O/AYIYTN%/S76E O.*<A10$0[<R3L-?ZNOC@P!RX[K J
M]C6= W;1O_=F#WK:%<87C5:^=[HJ5 <XP8:U]AYW[9N^5AW\4&FP'J51K)3P
MO&GVRC@"4%OOM5^!#G2[HMOI0G\I]9Y6PKEJ7'V[,^4.=VIMEV#IZKSX=:?;
M8J\<$T&UA>ET@Q_W1Y'>J1M=5&:S 7+ G[W7F[XN:K 5@ C@<" :"=T ?S"$
MA?*%U[ 5;$R[^.)AHWZ#'TK;[&T+</RC.W<F%C"18*G3L*0D@8 C?-4)@!A
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M._E471/MQ2,\\),0]D"1D=,WNNVCP2-D64G?O?UX53Q]OBH^RA*2]M>0*V"
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M.@D-\KI*2/:FC!64&1F,Q#/[,;SFPRZ%ZX4X,T67;\'$:$I)LWL'L6J\5QU
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M;TDJR<Y?7A5?6NEDR)!9P])*5\L"EI6@D MLO2R$.A]Y<L4&HZ*'O>Y@TY_
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MO4 1,+B6PA0:WHL,L[\)/.JG;XH=FUJRLXQ7F XA#%Q@/O//\(7]D&'+%[[
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M_8Y9JHH"/61C]IWX>N[.?82-ZJV5!^Z2\)17LN4Y4VMC$FX/FM!$ZW=D0_:
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M,SFBU6!$Z'<T$ZGNY"Q:[ ;W7O=*8<RMJ%JAW4.BL^0@_B[]L;.G8:-=W ,
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M$" ?8D*0 %"RC/1X21 "1*?)+&2&D/EQD6,.^,Y37Z2QM=4A>$#1%/XWC%&
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MA7V8F09#NS,/NW?M,+2U^=PJ">_3 LROVW:8!J1@?NF__A=02P,$%     @
M*ZIP4I"#]>$_ P  "P<  !D   !X;"]W;W)K<VAE971S+W-H965T,C N>&UL
MG55-C]LV$+W[5PR42PNHUH=E[WIA&\@F*1H@:1;9M$$1Y$!+(XL(12KD:!W_
M^PPIV;&#[!YZD?@Q[_&]H6:TVAO[Q36(!-]:I=TZ:HBZFR1Q98.M<%/3H>:=
MVMA6$$_M+G&=15$%4*N2/$T722NDCC:KL'9G-RO3DY(:[RRXOFV%/=RB,OMU
ME$7'A?=RUY!?2#:K3NSP'NF?[L[R+#FQ5+)%[:318+%>1\^SF]O"QX> ?R7N
MW=D8O).M,5_\Y'6UCE(O"!66Y!D$OQ[P!2KEB5C&UY$S.AWI@>?C(_N?P3M[
MV0J'+XSZ*"MJUM%U!!76HE?TWNS_PM'/W/.51KGPA/T0.TLC*'M'IAW!K*"5
M>GB+;V,>S@#7CP'R$9 'W<-!0>5+06*SLF8/UD<SFQ\$JP'-XJ3VEW)/EG<E
MXVCSQC@''?(U-<+B*B'F]#M).>)O!WS^"#[+X:W1U#AXI2NL+@D2%G-2E!\5
MW>9/,K[$<@JS+(8\S=,G^&8GA[/ -WN$[Y6P6NK=F4OX)+:.+'\0GY_@+T[\
M1> O_G<&G\3[JKMQG2AQ'7%9.;0/&&VR^10NB>%OKE!U7"I-V_(W/>Q8#$!-
M#O0Q2!!9N>U);!4"F0M 8U2%UD$E'R3?&6P/0 W"/GS!/!</:+D@0??MEL\R
M]07: =>V(Z$KSBI4O?4OCS^@L%/@6@&A5%AAI=)4K'B0AU7,9ZK>GZ$NS>'7
M7BCGZTN6/^]5?7#@"84F^4>@X%(&K&NN;:]O+ZP5WC^K&E&F\U7OIO"!<>>*
M1U<^D@X=>KC#DFV09&_4"&*[O:J@,\2B)9LYC+)'??K\)H;3I [ZZIYZGG'>
MN1EYCH9SR4VBY'[IV+6/^0GYVX6GWX'[[%GN 'U5 =<$!M7'N@CR\S1;_L@M
M>#;AF$!QIW4WD__X/GZ!GP2\QTZ>P;/)QV/J%O%5L8RS= G%XBHNYMGD/@A\
M-R02LGBQG,7I8L:C8E[$RV(VN8Z+(H^SJYS7EGD>SY8%_*JDDK,&U:+=A3;L
M?)XU#;WJM'KJ],^'!O<C?/A-O!5V)UF.PIJAZ?1J'H$=6N\P(=.%=K<UQ,TS
M#!O^6Z'U ;Q?&[[7<>(/./W_-M\!4$L#!!0    ( "NJ<%)H+&T+30,  -H&
M   9    >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;*U5VV[C-A!]UU<,U$71
M!8A(I*YV;0-QTLL^+!!LT!9%T0=:&MG$2J1+TG'R]QU*MM=%-T$?^B+Q,N?,
MG*%XM#@:^]GM$#T\#[UVRWCG_7Z>)*[9X2#=C=FCIIW.V$%ZFMIMXO8693N"
MACX1:5HF@U0Z7BW&M0>[6IB#[Y7&!PON, S2OJRQ-\=ES./SPB>UW?FPD*P6
M>[G%1_2_[!\LS9(+2ZL&U$X9#1:[97S+Y^L\Q(\!ORH\NJLQ!"4;8SZ'R8=V
M&:>A(.RQ\8%!TNL)[[#O Q&5\=>),[ZD#,#K\9G]QU$[:=E(AW>F_TVU?K>,
MZQA:[.2A]Y_,\6<\Z2D"7V-Z-S[A.,4610S-P7DSG,!4P:#T]);/ISY< >KT
M%8 X <18]Y1HK/)>>KE:6',$&Z*)+0Q&J2.:BE,Z',JCM[2K".=7/Z%&*WN0
MN@794@+EO)6A4XO$$W^(2IH3UWKB$J]P<0$?C?8[!S_H%MM_$B14V*4Z<:YN
M+=YDO,?F!C+.0*0B?8,ONZC-1K[L%;Y'.GVEMPRVK\H&?*8/WB'\(3=AK?%_
MOI$XOR3.Q\3Y_]+F-[G"-9V[O6QP&=,]=&B?,%[Q\@;NS+ W&K5W8+K_(-$!
M76KP.X07E!8P'!I0RW'8H+VT?200*9_!$2V"#*B>[K*;1[]_'1:-L ")WL&[
MZ,&:#EVXQ51-AY16L"K+&1<99(RGG/&LC,X=,EVG&F2@M#M8J1O\EP"ZRZ.
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M,5+W:U<7<*$"QR1<")@.! 9$J>"*NNWL4.6H&*KOJ'*[7)*5:7?HU EBCZQ
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M3K=A!>VTHX46CC7]@Z#Q!G1?:>U.@@\P_B=M?P!02P,$%     @ *ZIP4J8
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MQX5@'Y8=4C\I(T4H4H'<;%S<EFO?D@J5BJ HSK4H51EB522[QOF0$7=:>.7
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M>7VIUK5:J5S4#5 HUVW=J'J=;76I<B5M]OB3^_3DY5$#^^%31[F#_89AGT[
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MR:>8V.:PRT)\&.RGY+RPKL4236-'3X*%\YO0P5;(9T)5E]ZXKK6.D9$C/%I
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M,5KSUB?=Y1#+B++!0IT/+S#7 GG%V!R%$]@%@6WM<$ 93G$F"\H%AA *XC[
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M(2G+<P'<]&]<7NV"&YKF.7>_X*/]7T>JI"A-O=2:K_N,12.J<</?EBLF(3(
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M/,[$P_?X9>LJ"SSBKWPIB2=OG!LE2Z#X6FP8R%@Q-K$./^$S"VQ^TJ4SO3K
MW1@^Q4;N"$GCUU7SZ&MD/<8@9-,Y:OWBC]$%-CY0U-%#'^UU\]/!_JG0XS%X
M01C%JJB03X'84N*,BJ-V#]$%C2]ER5R(;Z=R/0&D@6\$^49WDO8R0%=U*)2M
M0,I+Z6[<5OJ&MZ2K:R7'X#Y:;?A=%AZKT274XVED%B-8KBO3U:YT2(</CF)+
M^41L$$\QP2<QX240(?P1IE0QU7?Q6EIO\T6 (6,=RHP,ID>)\>I>9F3'RM5M
M'#*D]QR ?9-4JDBN-84VRU8T +&.-*^]1PICAQ,7A9D$"5+NHHQU^H+^EB\
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M47AOVA[P;1HL^'[4*A^%:JWI\[KNW8(H1U(S% VE";/(^R@-@(T*ZI:,1LS
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MMZSQ101E W"_DM)L#'O \,9F?P!02P,$%     @ *ZIP4JL):GD/ P  _@8
M !D   !X;"]W;W)K<VAE971S+W-H965T,S@N>&ULA57;CMLV$'WW5PS4HD@
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M131>@;ZOM7:'BW=P?&877P!02P,$%     @ *ZIP4A:>KT%E!@  ZA$  !D
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M965T-#(N>&ULU5A+<^,V$K[C5W1I,IN9*H;"DP1G;5?%SF-S2#(U,YL<4CG
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MKKU;^I8FH'S5-/U^0 ZF3S57_P%02P,$%     @ *ZIP4@MBOT)6 @  W 0
M !D   !X;"]W;W)K<VAE971S+W-H965T-#,N>&UL?91+;]LP#(#O^16">MD
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M#F=6,+?XD0#C'?"\T]H=%S[!Z;.S_ Y02P,$%     @ *ZIP4F+OI,+5!
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MG.L/B*@;NWJB>&%;G057NG&RPU0WPR#, ;V_Y%RM)R9 VUZ/_P%02P,$%
M  @ *ZIP4H5#/,/!"P  DD8  !D   !X;"]W;W)K<VAE971S+W-H965T-#@N
M>&ULK9S[;]NZ%<?_%2$8L#N@:?A^7*0!TLA".W1;U]SN8C\J-M,(U[9\)3EI
M@?WQHVS'E/@2G08%&C\.*9TCZG.^/")]^50W?[0/2G79]]5RW;X[>^BZS:\7
M%^W\0:W*]FV]46O]S7W=K,I.OVV^7;2;1I6+7:/5\@(!P"Y69;4^N[K<??:Y
MN;JLM]VR6JO/3=9N5ZNR^?%>+>NG=V?P[/F#+]6WAZ[_X.+J<E-^4[>J^[KY
MW.AW%\=>%M5*K=NJ7F>-NG]W=@U_+2#"?8N=R7\J]=0.7F>]+W=U_4?_YN/B
MW1GH3TDMU;SK^RCUGT=UHY;+OBM](G\>>CT['K1O.'S]W'NQ\UY[<U>VZJ9>
M_EXMNH=W9^(L6ZC[<KOLOM1/']3!(]KW-Z^7[>[_[.E@"\ZR^;;MZM6AL3Z#
M5;7>_RV_'R(Q:(!@H $Z-$"I#?"A 4YM0 X-2&H#>FA 4QNP0P.VB_T^6+M(
MYV577ETV]5/6]-:ZM_[%[G+M6NL 5^M^:-UVC?ZVTNVZJ_=E6[59?9_I@=FJ
M=5?NKO=Y=JO'\&*[5/U7^AO]N=(#JMM;5G63;93^L\BJ]7YX]ZU^R5575LOV
M;Y<7G3ZU_@ 7\\-IO-^?!@J<1J[F;S,,WV0((/#U-L]^^8NOEYOD7J ,]Y+'
M>_E[N7Z;@<E>9NGG(FZN0[T4)_3B/9<+?<&/5QT=KSK:=8L#W=YLFZ:_FF7;
MJJZ-=(B/'>)=AR348=D^^*[ZOA7;M>HI]W@%.45$('1Y\3B\L*XAE8QS*<9V
MN:=#*J04P#(L$@Q'GI*CIR3JZ6]-N5!9N5YD=?>@&GUSS%7U6-XM5>L+P+XS
M.CP-!C&QW?>84<HQL.QRUXX32A&PG)\T&[E.CZ[3J.N?&[4IJT6FONO$UJIV
M%X6%VM1M90^BO?/4.0W*) '0<MXUPPASSBS?/6:8 &F9%9-F(]_9T7<6O^QU
M5RXUD,/WS=YEYAP=,<$88-)RVC44E I$++O<M8-,<DD0L?Q.,!QYSH^>\R@K
M_EFOSV-^CSH5QTY%-)P?UX\ZJ?09Q1M%X?&%,SV&K2"Z=D(PQ(D5F]S3'^YI
M0.T@)AB._)5'?V74WYUD.Z_OS[>MVD?Q3;96G<]WZ9R"=7??N!:2"FK=5;EK
M!05VATWL<"-7(3"2 DQP0BO?IOOQ)MLLRW[4:$RH/[?5IK_>0;\/G<8<]Y@(
M(0"B=I;P&$I-71T R_L$PW$0!KH*1H-P'43$H>'PF 3J9(> /;Q]EAA!SA&W
M'78ML=3W@A34]MAGR0&F# 9<-J("IJF*957>5<NJJ^R4..[7: L8%Q=VRMV4
M/X+Y]M#5R#T.  38CJW'$#,(;<;D'D.((13,B>RTX3@ 1G+ N.;XI/3<*:OO
MEM6WG=+V>^XF?<*$HS1\9@C9PR3WF0'!'9]=LQ ^C,J <9DQ3K7!P73PVJ,Q
M*)?45DXW'D,FD)30EAD>0YT#=%*Q19;7,':]C=: +#GE)MY,)IM#_@ICB;L"
M4D);9MYXS*"^T["=?GUV!%%;ZQ0>N]!H,D(#QI7&?C1]FAA%;MZGC&HIX8PB
MU[!7M(@"VV6/DB"2(N'X[),<L5%D) >4T5%T^^'ZR^S#OS[ELR]_O<UF__[Z
M\;?_QN:.)K^C>'Z_?2@;E<W+3:5#ZPLG<K.J'A8("(BLN^W&8\JQ_B=1P']D
M,C"*9^#?RZ;IY4=?V&@>E?=$/0E6,B%M07'C,]296-J7,_<8XEY/V(X7"89C
MOP=S>Q2?B]?KKJGNMIU:9.VVV2RWWC%_Z&4L$/NX2_LV]UGJ2P2)<Z-[++%6
MXP39NBO!<.R]$0LH+A:NY_/M:KLL>^\7ZKZ:5UZUB=QD?2Z!8%I/.M?>8ZJ#
MQ"20=M;TF4(IL:1.YDPR'<? Z 4T4:/8,:^7W-T/K_-NUL8, T%M?7SCM42<
M$VXK4)^EP#J].A/T%,NQXT8ZH+ATF.U<WDG%"=V W.0=$.$^2[\(]U@&1+C7
M,B;"D=$.*%ZHR-5<K>ZT2GZN&NKIID;@IF[T'1'#OU$0*%X02"X>(I.D43Q)
M!\J'LT.S814/03T_DSB@"Y#)CB@^(S^MCC=#GDFW!H (5!.Q2:9X:K)\6E%M
MAMV,J<$)I R<B<F7.)XO$TM<,^QF+H1H/\GB@5,PJ0O'9Y GU9KPH#@=SPGQ
M:M,,>R9N C!"2>!NQ(;$.$[B]+K/#"=/I;#A(9ZJV+Z@$C/#GHD-@J0OP05.
MR- )Q^D4K(K,L%N_U),NSA .E-ZP 19. U;:5 H;:N&)J45Z76*&/3*?$ZR'
M6< [ S(<!UG*A&Z&D\M\Q)"+Q,EURCQ]1CQ3@IC_Q&"+P%>>+!/#(Q*7TDFQ
M):Z6#<76$(M,E+P29JTSXN%6-*:#9USD-:>.Q ")Q($T/2>;$8_>TA.#86%N
M?' #'Q*'3]K$:$9<$A').0:AJVI 1.*UE[2YR8RX99!SQ"@@ @:2/#',(BGE
MD.#48$8\E9!^[DY0Z+FI 16)@RI9G,^(2ZMX+J &6C0.K:)N5/5M?<#6_$?6
MZ?'8+G=W=V2$4X,C&L=1LCJFAD)T8D+O5\<%=<%S3A&F<%"V&A_2\(>>5G*/
MJ^.">B:S2.LG%A@TU)"(Q@74J?*XH*Z,.H<0 !"H+-#!T^]3ZM)!?5Q0%V#G
ME$I 9>@4#,%H>F%X>H 9+M$XE^+ZN* >'A'""14!P4\-CF@<1^GZN* NF4+K
M&0R2:!Q)+]+'!77Q=*ZS R>A"\P,GE@<3T%]7#!70)U###AB/'14PRR6QJPT
M^<0,N%@<7"<(Y()Y8$8PE*$Y&#,L8W&6I8BX@KD$"XPN9MC%4LIP:0*Y8!YN
M1?TWW&+TE04R&ZR*B4NJM-BZ@BH46X,L%D=6BD NF ]<L9@:;C'QF@*9&2*Q
M.)&F!7+!//CI,QP.J4-N\,/C^$E3R 7WL0AA)'@@(7"#(CZQ;"))(A?<K4$Q
MRB@BH<5.AEE\@EEQ@5QP#Z<@8@1P'%!=W)"*QTF5K) +[GMZ$,T&W&"+Q[%U
MO:@WN_6\]7WVL?ARF_6/R(-#FQL.\3B'DI4Q-_CA$S,ZOS+.>3)Q^& 9W 1Q
M3I+$.4]^ELT-=7A<+9TJAG.>K)FX(12?*)RGR>"<)Y><A.&3 *^G?X6!CHA#
M)ZY_<^'")N2)P8R(8R9=^.;"]Z 6!]=U"H,;$<?-B]1O+I*5DC#($1/("8XB
MX5D9'7/>T$BDT2A-$0F#)#&Q4#A=\^8B&5/"8$K\_/J>7+AP&J_N&A]\L*HW
MI;J4IGASX<(I=A(&4"*^[N5TO2L-@&1<("5%5WIJW>/E3N.C&T[)E"=T<=&;
M2Y=6L3M&&F3)^,.Y$S6O-!R2<0Y-:]Y<)D-'&NC(.'32Q&XNDY_+20,?&2\E
MI:G<7+J5I-"A#9]DRD:&H+[-93*3I&&2C#,I6=?FTK-2,#9X#9GDQ J#I4ZR
MV776]FO7HBP8+.E_U?5U>H9V[+E_'3O;R15VSQV, D4A=18OI1KFJ89%@J'E
M]V#-/$@!7'CATG/[!+?3#/,$0\N;P7)X,%&W'XVY['_92]?F0#!8*P_PZX[*
MP2IT$ ?FU*B</7<P6AH"( T].8-@L"@<Q)'I!/.%3W(@&"S#!O%R^\FQ'*S"
M!G$D3L6R>.Y@7+R2$@:J#! ,ED2#4V"H8WG:E!^"P1ID\+J0'.XRFMAF-!7"
M'$:W%%G''6[LB4-J'[WWTZD$#K?.3.R=.3E. R),;)^93B:^G2L  \HH=L#J
ML>68"H:QNR?)-:5ZO&!GW7"19&H%8,"MB>TSDUGET)XE^>_:!OUW:3CEU("'
M$[MDQJ/P9Y++<%_*Q,:4DT?I (@3^U*FD\NA@V'D&9>0#7=)6X<?('%BFX@3
MSI>FE^'^C-?=H $'.S3@3V[1*)X[&$;S'#*!D @]M(>#K1=P8N^%$\X3,\Q@
MMP-$KTO.P58".+&78#K#(/=G!NP,<S'X<8[^UUK^43;?JG6;+=6];@/>]E7S
M9O_[)_LW7;W9_5['7=UU]6KW\D&5"]7T!OK[^[KNGM_T/P%R_!F:J_\#4$L#
M!!0    ( "NJ<%)PH+Y"=P,  "$/   9    >&PO=V]R:W-H965T<R]S:&5E
M=#0Y+GAM;,U736_;.!#]*X2 !7:!-I)H)W$"VT"3--@"36$T:/=0]$!+(YLH
M1:KD:)WLK]\AY4AN$3,)D(,OMO@Q3X\SCP^:Z<;8'VX-@.RN5MK-DC5B<YZF
MKEA#+=R1:4#32F5L+9"&=I6ZQH(H0U"M4IYE)VDMI$[FTS"WL/.I:5%)#0O+
M7%O7PMY?@#*;69(G#Q.?Y6J-?B*=3QNQ@EO +\W"TBCM44I9@W;2:&:AFB7O
M\O,+/O8!8<=7"1NW\\S\49;&_/"##^4LR3PC4%"@AQ#T]R]<@E(>B7C\W((F
M_3M]X.[S _IU.#P=9BD<7!KUCRQQ/4LF"2NA$JW"SV;S-VP/=.SQ"J-<^&6;
M[=XL847KT-3;8&)02]W]B[MM(G8"\LF> +X-X(%W]Z+ \DJ@F$^MV3#K=Q.:
M?PA'#=%$3FI?E5NTM"HI#N>W<J5E)0NAD3)4F%:CU"O6&"4+"8Z]9;<DA+)5
MP$S%P*&D3$#)6@=5JYBBE#J_(IP#=.S/*T AE?MKFB*Q\^](BRV3BXX)W\,D
MY^S&:%P[]EZ74/X*D-*Q^K/QA[-=\"CB%11';)2_83SC601OU.=J%/#&>_ N
M3=VT");!SU8V)$V,@(Y[T'$ '>TC*5VAC&MM2' 9TD?YE;J[<4&Y2[I.K+%T
M%2W>OV&-"M72Y4"$??.X3"+4[GN$U7'/ZCAZU/>/%OJQHL9Q1MD?$38G/9N3
M*,H-X-J406:UL2C_^UT>'94X2 D%37EQ+P4EL( (L=.>V&D4<V%-V7;V\AQ-
M3'K8R0%IXJQG=?9*FHCC\*@F\FQPKNPU5/$$RDMDD>^X:AY%O6ZMEN@+Z$M2
MR3O_[&+0?(#F!R2.?##'/.Z.SY?'$T!/Z&,PUGS\*OJ(H[Q('X.]YG%?O!:%
M5!+O0U$L*)^W&/#@E/G)(:EC,,H\[I0O4$<<B&?L'H2-WJ7!9_/)JT@DCN+0
M"O_Q]]8OQ'@-3IO'+?(C52/V 31X),\.2 Y\\$<>]\=G)OX)E$\&]\7_RFLP
M5\ZCB!\T4H- '4,K%%ML<Q)#'NR1CPZI$H-+\KB_/7XQ&;$B;BCT2B[IV[_[
MO'^T1''XX_VW-=WI6FJPJ]";.19ZD*Z!Z6?[_N]=U_4,V[OF\4;8E=2.*:@H
M-#LZ)?>U73_6#= TH0=:&J2.*CRNJ8<%ZS?0>F4,/@S\"_JN>/X_4$L#!!0
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M@$7''@%8DQ";"3:4.N _,'SE@#7T,+HTAW!KA6\K*BUO_54M,*PRQQJ V S
MX>_SE44).GANG&B-1#P0B>WWLIK5XE-/IV.57- :&L^9]ZRIL*8@OF1]B37)
ML+F^'##7LS%SK5&'S:@;,]=F)=MJ"FOXX8'PL]1@*XO.^-44T3 D9HB- ,_
M10[1T"/PTM0A&FG$7,?9([$6:$<BG#G!O#L4B>8=,?-N1"A:E*#CGR\CWOK4
M^AYJ!MA8[-1R;>Q WT$]:4HT_LCTDI][-<^([4NE=;;],8M&HHE'S,0;,]N6
MCXN6Q1_1,"2V=?9 \%ATQBS^W-;&4$KS7;G!)D#$CYFLMC^:J\TFWDVY=75V
M?0VO-M56G):I=@:_A/F.*5(D=*LD/6>F8BVO-MNJ$\D/Y?;30UDBE8=[&L8T
M+QY0][><R]>3HH%FRW/Y/U!+ P04    "  KJG!2&17T#^("   "!P  &0
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MBL(XZ.<9YVJ[,0G:F3S\"U!+ P04    "  KJG!2J]L"O'4"   )!P  &0
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M+W=O<FMS:&5E=',O<VAE970U."YX;6R]6VMOVS@6_2M$, .TP&XL4J(H#=(
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M.*N<-(.-/80=Y"OZE_R.]/Q^144&OA!!R%X665D :$_2(!RO!^??OD]$[:*
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MI[T[E@9B\NFR*G""PJ!?^6@UYVZD#P'4^ET34$<2GZ,GOJFB,&O4#0OQ29Z
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MDSA+P*B\4A$N!SC)E2\?D8!)>8U"7)XOQ%&3KKC6)OZEA;ATJ4DB(55_Y7'
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M;FE05,ES:H*E>;90L)1 2*"!O_K&![(T<%1?X4"6'CB0)4G[6&KS)8S.>C4
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M!]1GD_K,J<_VJ#]H*#M.."N!R-(Z,#UAFJ2CG+3*M+O"E_<N[3#KG+P 5?J
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M^FIO/X_Z]46$$=#K>\[5R\ 8:-]SJ_\ 4$L#!!0    ( "NJ<%)(7H6[.00
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MNA=7#2.WY<5O(0U<(\O'#:-+INP >+^2D*JZ82=H_CLQ_A=02P,$%     @
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ML=,'93?@^X64YFEB6\/JO\/P#U!+ P04    "  KJG!2E1SG>-($  " %
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M?2+ZPNJ-_(;.[NND)_\'4$L#!!0    ( "NJ<%(D7V)]"08  (\=   9
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M%DF:I7&3<?-$[R12/8\7UU+'::9>&M^/M]?HQ6\O5TMM@-7AE\D1Q%4+@DZ
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M8U-KUPH%]0O%W'Z5NC(@A  61,-%,:(7P'!$HPFH5C#HC-[_H@_5OY!'-@.
M RX<S*XA 4S"*<A6/^B<W<"L/OL8J4>H DR/.('!"@[]7[V^/W-N/T\IA!-Z
M2JT(T>=HYZFK+6:M4S*A+-0J"_4KBSN\O^A<Q2"4B(DW E8OP*\7YYLS<&7
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M;H%SBV1X_%N##IH]K>'Q\P']=^>\<>:)*K@5_ O+]'HVF Q0!DNZX?I![/Z
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M YJ60CGE)XK=<:9DL&4R;,L#_7,C=^JXX&#N["+20EV?K$O 58DOVB4VI+*
MG>*N*\J4#?9,QN978A,GGL_#T.HA9YPI&9R>G,VFE0<=<84.517LF?A$4P*^
M2CS!Z26QZ11K/)V=5L,59@H'DR8C<^PEL4%6<RP^U>N(,N6"UY.S>??]/FT6
ML*'FH>#/U"?K4C!5ZHEU+ZG-NI@&873Z7VU7F"D<O)F.S,27U&9B2KFEUQ%E
MRFWM9YP-SJW%"[L["-R9^H1G"I9*?<$S?1$\NZ),V>#.=&QXIC86$T)GUMZ2
M*\P4##9/7X7/1_/A0R4%8Z8^Z9F"HU)?]$QM+"8BB*S><869^W;@SFQL>F8V
M%=.(AJ?[=HXH4RZ8/#N;G,O6P:&S=QCX,O/)S P,E?EB9F;3<%?O.,-,X:U-
MW]%W?3MH>"9.F=D59<H%>V>O(F8<N7L'/)GY)&8&5LI\$3.S4;BS=UQAIG P
M9C8V,;/.K5_+=QQ1IESP=W8V,9>]4]\3&^H=#I;,?0(S!R_EOH"9=VP.=_2.
M,\P4#L;,QP9FWK&);/N.*\J4"_[.SP;F]WM=TIF[=\"2N4]4YJT;8[Y0F=L0
M/ ]Z+S(8+A\;@KE-MYA7-T-[M( I\[/YMKZU()SWDC@X*?>)N!PLD/M"7&ZS
M*^_=M!/@DV)L=!4=&[ITA@GN:3\!7BK.YM(_5BHK=1+W#40!%BA\LJD [Q*^
MV%38T$D#VK-U)<#@Q-C,*6R:I(SKOSWKD  3%*]^/  ??^EBJ!BM!P1\0J4
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M78A1[**I6%\*(+17P)L0NSGV1JRC <0 NG'4#_90#,+(G6)R*9307BG_AY1
MU,/J/R2#>$ T=N'@[ VEKE/&=3@N51G:R_*]EZA)]C>HS 8)2U'IUZ41*44%
M]=\77J<#*0G?F<9,J!?KL9+U*[U=;9N_#Z;EZ:VO=%-H.IN+F;JC_(RY2MX"
M%&2K3/KN3)TY7C=I]42R@^ES-DRJKLD,]ZJQ)5P+J.];QN1YHAVTK?+R7U!+
M P04    "  KJG!2&H+W<.,#  "E#P  &0   'AL+W=O<FMS:&5E=',O<VAE
M970W-RYX;6S-5]^/XC80_E>LJ)6N4B^)'4+@!$C'[K77AY-6N_VAJNJ#-QG
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M.2 Q3'W**TBD:E",J/$&B;P,,O(R'=V@"H<@>QT_O63E#0U7"&.(H=_YTJQ
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M[W&"D9/MK-5NM-C9<64C- X_=EGB? K2".#W0@C]NC$.NHEW\2]02P,$%
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M^EXSUWZ=ZWUWKB\FYQ,,R,@&9#'O\Q1I,OFG$=CI+-@/AEX_>)P*NP>WK=C
MK.PUM[DG06O%#63UMKI*G]@+Y$?OI][;>7$A7JLI[N<_,[E"L#A-+U%E[W*(
MATD65][%%RTR>Z>[$%J+Q#ZN@6'$FP7X^U((O?]B#%1_>+CY#U!+ P04
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MRN#Z!LNEVBG9;HQLW*!92(-CRRTK_+" L@'XO)32;#<V0?^IFOP#4$L#!!0
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M/LCW=_/%W>WL^NKQP[58/,*?SQ_FCPMQ=R-N9O,K!!D0D,&+0=[>+18(<DI
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M<',O87!P+GAM;%!+ 0(4 Q0    ( "NJ<%*M@&U3[@   "L"   1
M      "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( "NJ<%*9
M7)PC$ 8  )PG   3              "  <P!  !X;"]T:&5M92]T:&5M93$N
M>&UL4$L! A0#%     @ *ZIP4A8&%KA* P  > L  !@              ("!
M#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( "NJ<%(E
M/P$^%P<  +8?   8              " @8T+  !X;"]W;W)K<VAE971S+W-H
M965T,BYX;6Q02P$"% ,4    "  KJG!2]&G@Z\8%  #8$P  &
M    @(':$@  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @
M*ZIP4D0+#6^$!@  WAL  !@              ("!UA@  'AL+W=O<FMS:&5E
M=',O<VAE970T+GAM;%!+ 0(4 Q0    ( "NJ<%*L'@XZ.P<  '(<   8
M          " @9 ?  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4
M    "  KJG!25A:W;?$(  !'%   &               @($!)P  >&PO=V]R
M:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ *ZIP4A0)"S)+$0  RB\
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M:&5E=#$Q+GAM;%!+ 0(4 Q0    ( "NJ<%(5:6'<?0L  +\B   9
M      " @2AJ  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%
M  @ *ZIP4I>58NM^ P  ^@<  !D              ("!W'4  'AL+W=O<FMS
M:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    "  KJG!22S-C.+$#  "Z"
M&0              @(&1>0  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+
M 0(4 Q0    ( "NJ<%(P'+?WY ,  'H)   9              " @7E]  !X
M;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ *ZIP4C ,B^H
M!   'PD  !D              ("!E($  'AL+W=O<FMS:&5E=',O<VAE970Q
M-BYX;6Q02P$"% ,4    "  KJG!2,"#3.> $  #@"P  &0
M@('+A0  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( "NJ
M<%(<FQFVDP<  )L3   9              " @>**  !X;"]W;W)K<VAE971S
M+W-H965T,3@N>&UL4$L! A0#%     @ *ZIP4E3@3 K^"   ]1<  !D
M         ("!K)(  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4
M    "  KJG!2D(/UX3\#   +!P  &0              @('AFP  >&PO=V]R
M:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( "NJ<%)H+&T+30,  -H&
M   9              " @5>?  !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL
M4$L! A0#%     @ *ZIP4J&L4&L6!@  &@T  !D              ("!VZ(
M 'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    "  KJG!2L6ML
M U@,  #1'P  &0              @($HJ0  >&PO=V]R:W-H965T<R]S:&5E
M=#(S+GAM;%!+ 0(4 Q0    ( "NJ<%) B]:F&P,  )\&   9
M  " @;>U  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @
M*ZIP4J8 Q8AO P  6@<  !D              ("!";D  'AL+W=O<FMS:&5E
M=',O<VAE970R-2YX;6Q02P$"% ,4    "  KJG!2>\E,U[4(  #8%P  &0
M            @(&OO   >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4
M Q0    ( "NJ<%+(?149E (  /L%   9              " @9O%  !X;"]W
M;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ *ZIP4JW]TRYU!@
M$1   !D              ("!9L@  'AL+W=O<FMS:&5E=',O<VAE970R."YX
M;6Q02P$"% ,4    "  KJG!2+*/@SD :  #$60  &0              @($2
MSP  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( "NJ<%)&
M1+)CA0(  '(%   9              " @8GI  !X;"]W;W)K<VAE971S+W-H
M965T,S N>&UL4$L! A0#%     @ *ZIP4B)OTCO=!   A0H  !D
M     ("!1>P  'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( "NJ<%*"/T)B:P0  ,\*   9              "
M@0T  0!X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @ *ZIP
M4@\*(H:  @  ;P4  !D              ("!KP0! 'AL+W=O<FMS:&5E=',O
M<VAE970S-RYX;6Q02P$"% ,4    "  KJG!2JPEJ>0\#  #^!@  &0
M        @(%F!P$ >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0
M   ( "NJ<%+$B&A+70(  /X$   9              " @:P* 0!X;"]W;W)K
M<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ *ZIP4JG#+&P] P  <@<
M !D              ("!0 T! 'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q0
M2P$"% ,4    "  KJG!2%IZO064&  #J$0  &0              @(&T$ $
M>&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( "NJ<%+P#1J_
MC 8  +81   9              " @5 7 0!X;"]W;W)K<VAE971S+W-H965T
M-#(N>&UL4$L! A0#%     @ *ZIP4@MBOT)6 @  W 0  !D
M ("!$QX! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4    "  K
MJG!23Z& #3D#  ""!@  &0              @(&@( $ >&PO=V]R:W-H965T
M<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( "NJ<%)B[Z3"U00  !T+   9
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M970T.2YX;6Q02P$"% ,4    "  KJG!2?9 :CI8#   U#   &0
M    @(&K/@$ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    (
M "NJ<%)'ZM(-8P4  /X<   9              " @7A" 0!X;"]W;W)K<VAE
M971S+W-H965T-3$N>&UL4$L! A0#%     @ *ZIP4AD5] _B @   @<  !D
M             ("!$D@! 'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6Q02P$"
M% ,4    "  KJG!2;R*ZM=<"  "?!P  &0              @($K2P$ >&PO
M=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    ( "NJ<%*KVP*\=0(
M  D'   9              " @3E. 0!X;"]W;W)K<VAE971S+W-H965T-30N
M>&UL4$L! A0#%     @ *ZIP4CA28O$,!0  &1(  !D              ("!
MY5 ! 'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q02P$"% ,4    "  KJG!2
M*JF,&HH%  "[%@  &0              @($H5@$ >&PO=V]R:W-H965T<R]S
M:&5E=#4V+GAM;%!+ 0(4 Q0    ( "NJ<%(?W'K%G (  &P'   9
M      " @>E; 0!X;"]W;W)K<VAE971S+W-H965T-3<N>&UL4$L! A0#%
M  @ *ZIP4IV(\AT/"@  ,CD  !D              ("!O%X! 'AL+W=O<FMS
M:&5E=',O<VAE970U."YX;6Q02P$"% ,4    "  KJG!2E;XU#$X(  !!,P
M&0              @($":0$ >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+
M 0(4 Q0    ( "NJ<%+: OZ1=0(  /<%   9              " @8=Q 0!X
M;"]W;W)K<VAE971S+W-H965T-C N>&UL4$L! A0#%     @ *ZIP4MG)&46K
M @  & <  !D              ("!,W0! 'AL+W=O<FMS:&5E=',O<VAE970V
M,2YX;6Q02P$"% ,4    "  KJG!2;YD2F'$"  #G!0  &0
M@($5=P$ >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0    ( "NJ
M<%+]7B\^PP,  -L-   9              " @;UY 0!X;"]W;W)K<VAE971S
M+W-H965T-C,N>&UL4$L! A0#%     @ *ZIP4DA>A;LY!   J1   !D
M         ("!MWT! 'AL+W=O<FMS:&5E=',O<VAE970V-"YX;6Q02P$"% ,4
M    "  KJG!2XDS:F)<"  !1"   &0              @($G@@$ >&PO=V]R
M:W-H965T<R]S:&5E=#8U+GAM;%!+ 0(4 Q0    ( "NJ<%+M5G_B.@(  !@%
M   9              " @?6$ 0!X;"]W;W)K<VAE971S+W-H965T-C8N>&UL
M4$L! A0#%     @ *ZIP4K29!/LW P  &PH  !D              ("!9H<!
M 'AL+W=O<FMS:&5E=',O<VAE970V-RYX;6Q02P$"% ,4    "  KJG!2U<>"
MK2T#  !'#   &0              @('4B@$ >&PO=V]R:W-H965T<R]S:&5E
M=#8X+GAM;%!+ 0(4 Q0    ( "NJ<%*5'.=XT@0  ( 4   9
M  " @3B. 0!X;"]W;W)K<VAE971S+W-H965T-CDN>&UL4$L! A0#%     @
M*ZIP4J0I$6KH"@  6CH  !D              ("!09,! 'AL+W=O<FMS:&5E
M=',O<VAE970W,"YX;6Q02P$"% ,4    "  KJG!2)%]B?0D&  "/'0  &0
M            @(%@G@$ >&PO=V]R:W-H965T<R]S:&5E=#<Q+GAM;%!+ 0(4
M Q0    ( "NJ<%(A@:N=A@,  +D+   9              " @:"D 0!X;"]W
M;W)K<VAE971S+W-H965T-S(N>&UL4$L! A0#%     @ *ZIP4G1-'?7, P
MPP\  !D              ("!7:@! 'AL+W=O<FMS:&5E=',O<VAE970W,RYX
M;6Q02P$"% ,4    "  KJG!2&!]L6R &  "U*@  &0              @(%@
MK $ >&PO=V]R:W-H965T<R]S:&5E=#<T+GAM;%!+ 0(4 Q0    ( "NJ<%(L
M0+KNJP,  #$,   9              " @;>R 0!X;"]W;W)K<VAE971S+W-H
M965T-S4N>&UL4$L! A0#%     @ *ZIP4E;U@#0F!   -@\  !D
M     ("!F;8! 'AL+W=O<FMS:&5E=',O<VAE970W-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( "NJ<%+(/73V.@,   P(   9              "
M@>G7 0!X;"]W;W)K<VAE971S+W-H965T.#$N>&UL4$L! A0#%     @ *ZIP
M4B[Z\Q## P  _0H  !D              ("!6ML! 'AL+W=O<FMS:&5E=',O
M<VAE970X,BYX;6Q02P$"% ,4    "  KJG!2T]Q?)% "  "Y!0  &0
M        @(%4WP$ >&PO=V]R:W-H965T<R]S:&5E=#@S+GAM;%!+ 0(4 Q0
M   ( "NJ<%(="6Q*; ,  -\)   9              " @=OA 0!X;"]W;W)K
M<VAE971S+W-H965T.#0N>&UL4$L! A0#%     @ *ZIP4GA1IR^K @  ZP<
M !D              ("!?N4! 'AL+W=O<FMS:&5E=',O<VAE970X-2YX;6Q0
M2P$"% ,4    "  KJG!29)N*!6$&  "$&   &0              @(%@Z $
M>&PO=V]R:W-H965T<R]S:&5E=#@V+GAM;%!+ 0(4 Q0    ( "NJ<%)"H!V.
M!@0  '$/   9              " @?CN 0!X;"]W;W)K<VAE971S+W-H965T
M.#<N>&UL4$L! A0#%     @ *ZIP4O=C4L3# @  M@8  !D
M ("!-?,! 'AL+W=O<FMS:&5E=',O<VAE970X."YX;6Q02P$"% ,4    "  K
MJG!2"Y7=A @"  !P!   &0              @($O]@$ >&PO=V]R:W-H965T
M<R]S:&5E=#@Y+GAM;%!+ 0(4 Q0    ( "NJ<%)\*L$1< 0  ,(1   9
M          " @6[X 0!X;"]W;W)K<VAE971S+W-H965T.3 N>&UL4$L! A0#
M%     @ *ZIP4DGEK]M< @  @@P   T              ( !%?T! 'AL+W-T
M>6QE<RYX;6Q02P$"% ,4    "  KJG!2EXJ[',     3 @  "P
M    @ &<_P$ 7W)E;',O+G)E;'-02P$"% ,4    "  KJG!2JM #*E\&  #X
M.@  #P              @ &%  ( >&PO=V]R:V)O;VLN>&UL4$L! A0#%
M  @ *ZIP4N;BI-"@ @  !34  !H              ( !$0<" 'AL+U]R96QS
M+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ *ZIP4L* #&LZ @  :#,
M !,              ( !Z0D" %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
/ &( 8@#E&@  5 P"

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>358</ContextCount>
  <ElementCount>484</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>120</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>9</UnitCount>
  <MyReports>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0002 - Statement - CONSOLIDATED STATEMENTS OF FINANCIAL POSITION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF FINANCIAL POSITION</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0003 - Statement - CONSOLIDATED STATEMENTS OF LOSS AND COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFLOSSANDCOMPREHENSIVELOSS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF LOSS AND COMPREHENSIVE LOSS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0004 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDER'S EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDER'S EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0006 - Disclosure - Nature of business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/NatureOfBusiness</Role>
      <ShortName>Nature of business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0007 - Disclosure - Basis of presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/BasisOfPresentation</Role>
      <ShortName>Basis of presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0008 - Disclosure - Significant accounting policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant accounting policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0009 - Disclosure - Acquisition of Prismic Pharmaceutical</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceutical</Role>
      <ShortName>Acquisition of Prismic Pharmaceutical</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0010 - Disclosure - Assets held for sale</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/AssetsHeldForSale</Role>
      <ShortName>Assets held for sale</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0011 - Disclosure - Other receivables</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/TradeAndOtherReceivables</Role>
      <ShortName>Other receivables</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0012 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/OtherInvestments</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0013 - Disclosure - Right-of-use asset</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/RightofuseAsset</Role>
      <ShortName>Right-of-use asset</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0014 - Disclosure - Intangible assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/IntangibleAssets</Role>
      <ShortName>Intangible assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0015 - Disclosure - Notes payable</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.fsdpharma.com/role/NotesPayable</Role>
      <ShortName>Notes payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0016 - Disclosure - Lease obligations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/LeaseObligations</Role>
      <ShortName>Lease obligations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0017 - Disclosure - Warrants Liability</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/WarrantsLiability</Role>
      <ShortName>Warrants Liability</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0018 - Disclosure - Share capital</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/ShareCapital</Role>
      <ShortName>Share capital</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0019 - Disclosure - Share-based compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/SharebasedCompensation</Role>
      <ShortName>Share-based compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0020 - Disclosure - Loss per share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/LossPerShare</Role>
      <ShortName>Loss per share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0021 - Disclosure - General and administrative</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/GeneralAndAdministrative</Role>
      <ShortName>General and administrative</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0022 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0023 - Disclosure - Commitments and contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0024 - Disclosure - Related party transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related party transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0025 - Disclosure - Capital Management</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/CapitalManagement</Role>
      <ShortName>Capital Management</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0026 - Disclosure - Financial Instruments and Risk Management</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/FinancialInstrumentsAndRiskManagement</Role>
      <ShortName>Financial Instruments and Risk Management</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0027 - Disclosure - Segmented information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/SegmentedInformation</Role>
      <ShortName>Segmented information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0028 - Disclosure - Subsequent events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0029 - Disclosure - Significant accounting policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant accounting policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0030 - Disclosure - Nature of business (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/NatureOfBusinessTable</Role>
      <ShortName>Nature of business (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/NatureOfBusiness</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0031 - Disclosure - Basis of presentation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/BasisOfPresentationTables</Role>
      <ShortName>Basis of presentation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/BasisOfPresentation</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0032 - Disclosure - Significant accounting policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/SignificantAccountingPoliciesTables</Role>
      <ShortName>Significant accounting policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0033 - Disclosure - Acquisition of Prismic Pharmaceutical (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalTables</Role>
      <ShortName>Acquisition of Prismic Pharmaceutical (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceutical</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0034 - Disclosure - Assets held for sale (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/AssetsHeldForSaleTables</Role>
      <ShortName>Assets held for sale (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/AssetsHeldForSale</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0035 - Disclosure - Other receivables (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/TradeAndOtherReceivablesTables</Role>
      <ShortName>Other receivables (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/TradeAndOtherReceivables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0036 - Disclosure - Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/OtherinvestmentsTables</Role>
      <ShortName>Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/OtherInvestments</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0037 - Disclosure - Right-of-use asset (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/RightofuseAssetTables</Role>
      <ShortName>Right-of-use asset (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/RightofuseAsset</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0038 - Disclosure - Intangible assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/IntangibleAssetsTables</Role>
      <ShortName>Intangible assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/IntangibleAssets</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0039 - Disclosure - Notes Payable (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.fsdpharma.com/role/NotesPayableTables</Role>
      <ShortName>Notes Payable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0040 - Disclosure - Lease obligations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/LeaseObligationsTables</Role>
      <ShortName>Lease obligations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/LeaseObligations</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0041 - Disclosure - Share capital (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/ShareCapitalTables</Role>
      <ShortName>Share capital (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/ShareCapital</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0042 - Disclosure - Share-based compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/SharebasedCompensationTables</Role>
      <ShortName>Share-based compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/SharebasedCompensation</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0043 - Disclosure - Loss per share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/LossPerShareTables</Role>
      <ShortName>Loss per share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/LossPerShare</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0044 - Disclosure - General and administrative (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/GeneralAndAdministrativeTables</Role>
      <ShortName>General and administrative (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/GeneralAndAdministrative</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0045 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/IncometaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/IncomeTaxes</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0047 - Disclosure - Related party transactions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/RelatedPartyTransactionsTables</Role>
      <ShortName>Related party transactions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/RelatedPartyTransactions</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0049 - Disclosure - Nature of business - Schedule of ownership percentage in subsidiaries (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/NatureOfBusinessScheduleOfOwnershipPercentageInSubsidiariesDetails</Role>
      <ShortName>Nature of business - Schedule of ownership percentage in subsidiaries (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0050 - Disclosure - Basis of presentation - Schedule of restatement of prior period information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/BasisOfPresentationScheduleOfRestatementOfPriorPeriodInformationDetails</Role>
      <ShortName>Basis of presentation - Schedule of restatement of prior period information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0051 - Disclosure - Significant accounting policies - Schedule of estimated useful lives of assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/SignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfAssetsDetails</Role>
      <ShortName>Significant accounting policies - Schedule of estimated useful lives of assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0052 - Disclosure - Acquisition of Prismic Pharmaceutical (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalNarrativeDetails</Role>
      <ShortName>Acquisition of Prismic Pharmaceutical (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0053 - Disclosure - Acquisition of Prismic Pharmaceutical - Schedule of black scholes options pricing model (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalScheduleOfBlackScholesOptionsPricingModelDetails</Role>
      <ShortName>Acquisition of Prismic Pharmaceutical - Schedule of black scholes options pricing model (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0054 - Disclosure - Acquisition of Prismic Pharmaceutical - Schedule of identifiable assets acquired and liabilities assumed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/AcquisitionOfPrismicPharmaceuticalScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails</Role>
      <ShortName>Acquisition of Prismic Pharmaceutical - Schedule of identifiable assets acquired and liabilities assumed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0055 - Disclosure - Assets held for sale (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/AssetsHeldForSaleDetailTextuals</Role>
      <ShortName>Assets held for sale (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/AssetsHeldForSaleTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0056 - Disclosure - Assets held for sale - Schedule of components of assets held for sale (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/AssetsHeldForSaleDetails</Role>
      <ShortName>Assets held for sale - Schedule of components of assets held for sale (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0057 - Disclosure - Assets held for sale - Schedule of net loss and comprehensive loss from discontinued operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/AssetsHeldForSaleDetails1</Role>
      <ShortName>Assets held for sale - Schedule of net loss and comprehensive loss from discontinued operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0058 - Disclosure - Assets held for sale - Schedule of cash flows from discontinued operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/AssetsHeldForSaleDetails2</Role>
      <ShortName>Assets held for sale - Schedule of cash flows from discontinued operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0059 - Disclosure - Other receivables - Schedule of other receivables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails</Role>
      <ShortName>Other receivables - Schedule of other receivables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0060 - Disclosure - Investments (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/OtherInvestmentsNarrativeDetails</Role>
      <ShortName>Investments (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/OtherinvestmentsTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0061 - Disclosure - Investments - Schedule of investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/OtherInvestmentsScheduleOfOtherInvestmentsDetails</Role>
      <ShortName>Investments - Schedule of investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0062 - Disclosure - Right-of-use asset (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/RightofuseAssetNarrativeDetails</Role>
      <ShortName>Right-of-use asset (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/RightofuseAssetTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0063 - Disclosure - Right-of-use asset - Schedule of right-of-use asset (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/RightofuseAssetScheduleOfRightofuseAssetDetails</Role>
      <ShortName>Right-of-use asset - Schedule of right-of-use asset (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0064 - Disclosure - Intangible assets (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/IntangibleAssetsNarrativeDetails</Role>
      <ShortName>Intangible assets (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/IntangibleAssetsTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0065 - Disclosure - Intangible assets - Schedule of intangible assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/IntangibleAssetsScheduleOfIntangibleAssetsDetails</Role>
      <ShortName>Intangible assets - Schedule of intangible assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0066 - Disclosure - Notes Payable (Narrative) (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.fsdpharma.com/role/NotesPayableNarrativeDetails</Role>
      <ShortName>Notes Payable (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/NotesPayableTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0067 - Disclosure - Notes Payable - Schedule of notes payable (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.fsdpharma.com/role/NotesPayableScheduleOfNotesPayableDetails</Role>
      <ShortName>Notes Payable - Schedule of notes payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0068 - Disclosure - Lease obligations - (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/LeaseObligationsNarrativeDetails</Role>
      <ShortName>Lease obligations - (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/LeaseObligationsTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0069 - Disclosure - Lease obligations - Schedule of lease obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/LeaseObligationsScheduleOfLeaseObligationsDetails</Role>
      <ShortName>Lease obligations - Schedule of lease obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0070 - Disclosure - Lease obligations - Schedule of maturity analysis of operating lease payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/LeaseObligationsScheduleOfMaturityAnalysisOfOperatingLeasePaymentsDetails</Role>
      <ShortName>Lease obligations - Schedule of maturity analysis of operating lease payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0071 - Disclosure - Warrants Liability (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/WarrantsLiabilityDetailTextuals</Role>
      <ShortName>Warrants Liability (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/WarrantsLiability</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0072 - Disclosure - Share capital (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/ShareCapitalNarrativeDetails</Role>
      <ShortName>Share capital (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/ShareCapitalTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0073 - Disclosure - Share capital - Schedule of reconciliation of the share capital (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/ShareCapitalScheduleOfReconciliationOfTheShareCapitalDetails</Role>
      <ShortName>Share capital - Schedule of reconciliation of the share capital (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0074 - Disclosure - Share capital - Schedule of changes in number of warrants outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/ShareCapitalScheduleOfChangesInNumberOfWarrantsOutstandingDetails</Role>
      <ShortName>Share capital - Schedule of changes in number of warrants outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0075 - Disclosure - Share capital - Schedule of fair value assumptions of warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/ShareCapitalScheduleOfFairValueAssumptionsOfWarrantsDetails</Role>
      <ShortName>Share capital - Schedule of fair value assumptions of warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0076 - Disclosure - Share capital - Schedule of warrants outstanding and exercise price (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/ShareCapitalScheduleOfWarrantsOutstandingAndExercisePriceDetails</Role>
      <ShortName>Share capital - Schedule of warrants outstanding and exercise price (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>0077 - Disclosure - Share-based compensation (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/SharebasedCompensationNarrativeDetails</Role>
      <ShortName>Share-based compensation (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/SharebasedCompensationTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>0078 - Disclosure - Share-based compensation - Schedule of changes in number of share options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/SharebasedCompensationScheduleOfChangesInNumberOfShareOptionsDetails</Role>
      <ShortName>Share-based compensation - Schedule of changes in number of share options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>0079 - Disclosure - Share-based compensation - Schedule of fair value assumptions of share options granted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/SharebasedCompensationScheduleOfFairValueAssumptionsOfShareOptionsGrantedDetails</Role>
      <ShortName>Share-based compensation - Schedule of fair value assumptions of share options granted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>0080 - Disclosure - Share-based compensation - Schedule of exercise price and weighted average contractual term of share options outstanding  and exercisable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/SharebasedCompensationScheduleOfExercisePriceAndWeightedAverageContractualTermOfShareOptionsOutstandingAndExercisableDetails</Role>
      <ShortName>Share-based compensation - Schedule of exercise price and weighted average contractual term of share options outstanding  and exercisable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>0081 - Disclosure - Loss per share - Schedule of loss per share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/LossPerShareDetails</Role>
      <ShortName>Loss per share - Schedule of loss per share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>0082 - Disclosure - General and administrative - Schedule of general and administrative expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/GeneralAndAdministrativeDetails</Role>
      <ShortName>General and administrative - Schedule of general and administrative expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>0083 - Disclosure - Income Taxes (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/IncometaxesTables</ParentRole>
      <Position>81</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>0084 - Disclosure - Income Taxes - Schedule of provision for income taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/IncomeTaxesScheduleOfProvisionForIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Schedule of provision for income taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>0085 - Disclosure - Income Taxes - Schedule of deferred tax assets (liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Schedule of deferred tax assets (liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>0086 - Disclosure - Income Taxes - Schedule of temporary differences for which deferred tax assets not recognised (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/IncomeTaxesScheduleOfTemporaryDifferencesForWhichDeferredTaxAssetsNotRecognisedDetails</Role>
      <ShortName>Income Taxes - Schedule of temporary differences for which deferred tax assets not recognised (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>0087 - Disclosure - Income Taxes - Schedule of non-capital loss carryforwards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/IncomeTaxesScheduleOfNoncapitalLossCarryforwardsDetails</Role>
      <ShortName>Income Taxes - Schedule of non-capital loss carryforwards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>0088 - Disclosure - Commitments and contingencies (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/CommitmentsAndContingenciesNarrativeDetails</Role>
      <ShortName>Commitments and contingencies (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>86</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>0090 - Disclosure - Related party transactions (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/RelatedPartyTransactionsNarrativeDetails</Role>
      <ShortName>Related party transactions (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/RelatedPartyTransactionsTables</ParentRole>
      <Position>87</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>0091 - Disclosure - Related party transactions - Schedule of key management personnel compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/RelatedPartyTransactionsScheduleOfKeyManagementPersonnelCompensationDetails</Role>
      <ShortName>Related party transactions - Schedule of key management personnel compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>0092 - Disclosure - Capital management (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/CapitalManagementNarrativeDetails</Role>
      <ShortName>Capital management (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="huge-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>0093 - Disclosure - Subsequent events (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.fsdpharma.com/role/SubsequentEventsNarrativeDetails</Role>
      <ShortName>Subsequent events (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.fsdpharma.com/role/SubsequentEvents</ParentRole>
      <Position>90</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>huge-20201231.xml</File>
    <File>huge-20201231.xsd</File>
    <File>huge-20201231_cal.xml</File>
    <File>huge-20201231_def.xml</File>
    <File>huge-20201231_lab.xml</File>
    <File>huge-20201231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.ifrs.org/taxonomy/2019-03-27/ifrs-full</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>124
<FILENAME>0001062993-21-002769-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001062993-21-002769-xbrl.zip
M4$L#!!0    ( "NJ<%)N=[+0,^\! -R9)@ 1    :'5G92TR,#(P,3(S,2YX
M;6SLO7N7FTB2-_S_? J]M;>><U0V]XO[\IQRV>ZI78^K7E?US#.[9X\/A5(2
MVPC4@*JL_?1/9 (2")!  @0H/#WEL@29D1&_N&1D9N1/_^?[PAZ]$,^W7.?G
M*_X-=S4BCNE.+&?V\]5O3Y^NM:O_\\N??OK_KJ_OOCQ]_/7N_XZ>UZ./_WO]
M?]]__7Q]_<N?1C]]?_;L$;3B^#]?S8-@^>[MV]?7US?TXS>N-WLK<)SXUG+\
MP'!,<A4^^6Y"K,W3[$F?F&]F[LM;^ +>X/5KCK\6^?CQ^6I&4JU/_<ER;G@+
MXXWI+N %>$78/FY-/?]ZNK+M=!_T8T928'QW'7>QCGH2KP7U[>:=32.^*PF\
MNF]0X1/Q"[;E_+[G:?KUL^%O6$"_G>QP(7I8>1M^N7DTT_2KR)[E=5U_R[Z]
M^N5/?QK!'_R!/_ '_L ?^ -_X _\@3_P!_[ '_@#?^ /_($_\ ?^P!_X W_@
M#_R!/_ '_L ?^ -_X _\@3_PQ\$?/]$]-^]\<TX6QE<R';$].._F'IG^?$4W
M*UW'6Y+>?/<G5]'7P7I)?K[RK<72)E>__/0VW<8OM%G3=0+R/1A9DY^O;K_1
M1CB>XP-WL\,IVN:SH27URT_$":Q@G7@F]77TD#6ACTTMXHU8Y^F=5?%&K-N[
M_[CZA8/N5977-/FGM]O7?F$M_O0V[HW]:TD\RYWLZWJ7#C\PO."#$9!?Z.CH
MAB^._^GM]M,_;08UV3[%"]<B3[N>;)_YZ6W<.?T]8F$!._O.1-HUVTL7I/@1
M?U:1'[P^*'[P^LG\H.HV)'Y$6G42/[[1O9%T:^2M;?@^\>^GCW/#([?&T@H,
M^^:[Y7^C-H]]>W/K+A:N\QBXYN_L*?^O9/%,O)-YVA"#J1TBLP6AO-GI(M-G
M]'RX-_,=^;ZT+=,*PO&-)A8T$NZBW6PE?5?(L*M?*,?>[6793V]S>]K0_79#
M>">00BT)(N42D'*:C0U],")E\$BI(3JIZGW>(U*J(J6(90/W/HB4OB*E;>^#
M2.DE4NKQ/@)-O?1_EKQ+1S+U$AE?87_J9:MX1Z9>>*WO3$P;(JWFX,9=+%T'
M* +5^OC'"NAB5BC^^BL)#,LADX^&YUC.[+)-4"ZKKG[9/I'/K9Y%--7@X1/O
MA416F9XRG3P8:SH81,H!I!Q@W !!0_WTWPW/,Q =N>A@<4R:0?U#02)PP6#W
M:(1T.-CM0DA7"#3T5G'/@_)6/<0<.KNN.;L>@@AG8;V9A?4:79%U__C=G!O.
MC'RPIE/B$<>$$,1Y @WU;2, ,2#L2CG)<FR\!#RBC4OTW'\;MSM=K&,/&!JI
MEG'3)2/5"4#A9+!?D\%S@ 9G<UV;S=6+@MWM[FA$&H%)=XS(OO"XM3,!U3"'
M-JAK-JC3(,(UE\M8<SD[T'!:W_-I?:_1A5F!P64%.H%'M'&)GOMOXT:U;M%%
M(W46W'3)2'4"4)AUZ%?6X1R@P;1!U](&=:.@('1^M&8.<->$-N^<%^('#.=W
MSN/JV;<FEN%9Q$^9E>07EXR4LHQ+6I8L[RXA2#X5>53WDA_>.P2!5P9XS&CE
M<F[XL"O<YH0&+]GS)1F\UHX2Q@8O/%2(R-O]@#U_4<C3RMB\[:'-L]D\=+5#
M<K6],7@(NT'!KAUK5__$XNG51=@=!;L-YW!B@; ;713L>NMD$7:]AEU+4XHT
MV+Z2P'/])3$#ZX7<+.F@V6+:C3-)??45^ F]T;&G9K0/'GFQW)5OKQ_I]Y-+
M!N"1O$Q.<O/9V>J>ZI,+#=4#,*JC=X[I$<,G'TCT]XH\N;=L$1CT^I/K$5#Y
MVY5'%X/7N*!^&@B943R-X_W":;IXS:F&<#_G;DS37<%HG=F#"RVOOY(_5I9'
M)N_7=Y^^/EYT+K &JUD#[_M5<4>KNN>[J#XOQ@$E$'TRQ)LLH8PA2J_U!\.<
M@@]8 Y>E8Q<7@=6FAL/0@2Y!OF-(J>U>&(SWT7+C5.2<4Y&BLY0X%>F,LAUY
MW!6G(KW6'YR*%'S &K@L'<.I"%91Z KD.X:4VBX)PZD(6FZ<BM0W%3E<$^?!
M<Z&Q8/U@0_/ 27H><)E1)WIB<!40;_/MD%3D:(W8R[LD[ K8-_Q]A(?Q=^<
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M-YC2\[O;&O/AL=V)MYI!U%]T:G>3S[YS_,!;A00F'<.]-X%'O'6UROL"O2-
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M)4R'+&<5 6B'@K"R"WTL+!UD@56.ZKF(XVV)EW35E_&>FC%1J9C8Y-.2>*P
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M[50UQ/A#GQ79#0M',6MOL5JBY'M8[S=PQ]3:LTK%=.^ SSYY 4J8:_1(L/+
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M 'GZ2JS=+)S?X,8T7"S# ,:)7V[\\NX,Z@ P[R),K-\B8,,<M6%]$8-U34D
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MKR]$#9TJVA8P'$-S-7B<Q ]X?.X]S/DQ1<$VF9 ATNI$M8.0CF0]*YPC3O$
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MP#:^;4N'KE=./-^PS3OZ1EJTN+M=/$0'.?O6H\J6E>-V@^;9>T11?1\IM.>
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MMF%,RGVF.\]'?S^EG0+=K3^C$H>=#6D?NBEVXCK\=!V<0Q2IKU#(OJ"VYK%
MF>**E[\P3&!$]B$\JL$*&[8+%_$"RUKC9V*YZ+3FDL\STQ][VFO/7^$@P:;Y
MY=QA[>1(FY95>-'/;D;*MHM?X_66\K3;Q@6YZ=RRA8D5_0LV+XS2FI_+$'DB
M)?.F34N* )!,KR@\P[.WZ43^78'()43 -:QF1Z;U,UJP#Q'Y3&!5?<L8C.V^
M.3%*K&H=LVH%E?W+_[?&0; 'EVC%"N[(D,26F2$@*\Q1U,@R?2SMWYH_"&1
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M#35'<ZY-W8IX/'PE;K:<!\>V!&Y]FMO<B]Q;7@-=F+<WN5&W18*B*;_D SB
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M+N9-P3YFC.)3*NW)-7)7][Z8N2+>4QX&@FVG*O-6W#K3="/&VU,(8XG %T3
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MQR(GFLZ?"HNGQZRZQ[8#QL <]B?FP!K6V#KWH^.&0Y.?C3][LW8HL'OZ[L:
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MH"N]*(VU+#V7A$MX+/E!_"D("Z\4X?O#.EAJ')A:%9IGWJSW@7:WC#Q?,X=
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MZQ+86EVQVN%5N7S*.R&J=V3EG1+;]I%A5L"L #4!$P(F!$P(F! P(6!"P(2
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MX'V8I/$T'Z"XP_S*C_& 7Q(_YY44\MM<:0/6]\=>D/QTA:XT?_#3U;MO]W'
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M 2" X/;>D,'$,4P$D(&(^&ZP."ZB%@&L0!3]T%7&<5P,>@DB[S7CRD"FZ;B
M*XC6MX\]UW)L"[ '$7YI$,D_<Z@-B(0- 2GAR:\P;/ T8?] 601C[)BV<Z$K
M[%[;#910VRK&#6S.-70A?!.1>(0%WSCGU-F&.&PKC;HV0A8(5/+=!LK7/8MN
M+M<'ROK:=6V"'!"VFKL*U#(LP[ *&*@#&A=BS1T/BLY">@8AKFD4S*,FP6!;
M]H6$>(_'@Q2A.&Y]<WB0 @HZP,PU-0T7PS*B0!2-&":R^3\%U$@#)HR$UP98
MDC7^)<(_E+@%+UQZ8%UCPR4 +"4B5\1P.$#<0@1(5>PY)KZ4C*Y-Z.V5/(DP
MIK0P86T;.6U;H\MDV@\LY5<Q_R%\^ZV?/?P?GA^>?:2H-&BZEF5<SIBVN:=<
M6$89QIYW"$05,9QIT*&4_011TY%/!!?LYY>*"1NV94HH)O"K]Q(>,NQS%=ZY
M.K+EDG3MLQ;DA3J.Y;+F7VA-,^[EJF%*C$)R@,5'N:]FR+RY#U,ASX_#?)6]
M[7,W+&:EZ0M&/D+Q"ENG.5?B_2_/$W[QK5@J'M@Z[CZS_C3V4V[>SL=\^Q"S
M[*(B_-Y_>%?*(8P=:MC86>%0DM'(94E-P:=Y!D4Y"TYD$3%D9Q$5!WBI2=8.
MM&ZPR-J31=G[GV*_SY)2OL@$&*,*+B9RB;G"B[O;-W]-^,,SXKAKTB,$SX_K
MK!"\+Q=J6\57B2'EJP.RL$6)LXT8[!Y/BESP+A-H!NX,WTT)E*_9#A?H7*/^
MRAY9(!3J/"KVWSYW5N+^Z'G-J,TN(V67[2M;BW(-ZM@;D<U5NF@/X6U4K4_F
M]TDR%25/L]_FW)9\_2_:,=GH[[R)GWK!2@"%?_KZ+AJ/H_!S&O6_5KD2U3K$
MQ8YKFB4+I&6:=KD"*67HR=QW%]QW";H0[A-$79<:9=SG8B$M<M]<<)_;J?68
MXJI(0=C%+O\ID8+AVB9N40H2F5?M<#_38J9!G#(KMM45:-5#$>GIES0'*!9_
M8T/X904I$&)2^ZA)D*E_T,*[/%VQ "'#*H:JY\7!]V3FJ8R_ !50$6K@[.=N
M(BY$1!P'V69+ LA6G=;7G]4A;7% *OB&;2IB6@6^<=>:VK0UX)ZQUBQCO-"9
M#K9L4F#\\2O&?%U?\BS_&L=6PR=6]K*3J6U:-B[S4BHB765T'$_MZL0T&\@;
M:,B[,"S*W8@R[\(Q$:++I6TGUY;15A%;340"#!]W^,9/)E'B!>O9,.IQL$(O
M&S9Q;%Q,%IJ?;SF(*\5%;GJ?]&/_G@WRS* _^$.2]^'K./K*8C;X%/N/7LH^
M!5X_6U^*"Y^S<)G%JP-,I</2+O9AE&MBOBZ5["BLU(HZCNPJH_Z_6:T+4Z$&
MSQY4FQ110JPRM]$TL>NZI3:S&'A;1*WG=>Q#DHF12TIW%&R:_>F:IFV)$OL0
M:%.ROO>U(!#;EN'40UXCQO1>2[[I4F0ANX0^BK(_!Q XW^668JJ)+=$R_4]*
MR5H=^H&$=2D[@QLR9426RZZ<R$]QU&=LD+R+H_%G+U@8@+?A8/Z%LJT;/*>9
M+]JD:6$23FBQR"RWX]!\?=F#BI5-C%RE3$0[LVPKX!.+L\M+=&9M*RBM6D&)
MZ6*T;4^&^Y3SS8NJ@1]'&S);74D-2DUC"Z78;H9,C-HGLQXJ^3M]/E#O(6O%
MUP_\<#7+?-5<;,<**-]_XQCFZYZS:LY]FF;0G4_.O<GHF/1]95_%!T=4*2%%
M/O0L\P16%(X7K%[V9LJ^1%]8.+OQ_-I;[KZ/,V@E?R0EJ1FM&HD6L@Q4#%<Z
ME=6D#R=05FZ=NIHXF*\GYB;KJ$7MRC*IIS"/KT-AWY]PGW@L#J-\'+Z.XCAZ
M\L.'TJ2')LR=RI KEP%UBR%7Q#7H8J&I'OZ2QA5&%6R$;:E,K1*++=LJ$+L>
MKMN'CHU@S!N6><O^(UMD.?[J>_=^D(4HFR2ZUO26*JYAP[:+T65J6]A<.T6Q
MG0U+I/QCZ@EN<KOR-S_TQ]/QKSYGZR!K@[O&>>4Y1[@7;^\(#^_-C7H86%^*
M;QL,I(;CKH5VN-5W&@.7<)W'"4M6^B622S'80(FX9C>(D$$PL6D)'[,MY4-Y
M4ALCSSC7:%,2B$O"R0(HEF44+ ^,+-=VG2-%D4\#SP\_AI]9F@896:N7S9?A
MY_(] 34V.1UBV"5YZ-0P\-SBW8L'2Y;]WVF4\E7#B[^R-',5M^^?M)U9:YK4
MW1K!6&36;B=D2?#;;]Q@]1,VNV9;(*I-2@W3,"R\C=)%AYP*"I8D_NXG7]]Q
M;/WNI=LI1,M06Q.TEB=_$VZ_6&1M+W#NRXJ).".RG(95,4Y8GPO\GWPH:8;I
M+BFMDJJ);6P4HQ>XMTB%WD9'D=HO+!ZW3V<Y:7P1Q];5SY_0_QJ_66\VR%D?
M:)&0-_ZC/V#AX']]%@RDE)QIH36?<#WNM(..3>?(3_I!E/ [?!S^WZDG!IJM
MQ^_#8<2UN+#2;N^C:?J[_S!*H^$T8=R-9BG7TY/ "[TTBDNUUL8QIH*NY1<8
MAL$-<'0E!J1I_R=(7PW\Q__SD+[*?B][I_R]_-V)EJ3/ ?OI:NS%#WYX';!A
M>H.=2?I*#.W:#SDKTIOKY3M>X#^$-_^>)JD_?+X2=Q2W229>.+_3D)-UG?C_
MC]U@-$FK+QEZ8S]XOOGBC[D9]8$]:;]'8R_4L]_UA&NXX?*[:1R%#^(WIR=^
M_V'YQN:MG_Q!.N)/[AGN!A%\,)P)">?_\XT?BF#:]7W ;9W\*=YX\NIOV$*O
M\OOS.Q8?G@GS.AI><W%JPIY*2P:S]MWU7R;;!- -=[^,F!87R.)_:UZJO6']
M;'9I%.N:0*#F)^*C810$T5-R<R"Y*R^K(#G_)/7N Z;=1_& Q9GM-",M?^>Z
MSP?@31)V,W_Q:OE!%-_\+=_1>K7.JU=S:*#OKDH>.WOP?31X+OUT]GE<\>'L
MX\%\I-G)S[X7S$1Z'Z5I-"Z#6CK8\XXS$O,[W>#)-RV) G^@S:E= 5 FT5=R
M#Z'-5>/%8?-49I'DGU:A\'2(OKKW^E\?XF@:#N:SB5EL.!RV(;77'E>.?:;E
MS/C&U1U]I?WBA5./J\ML#<)N7;(KIWZV1GRW*CJA$W>PY<CYM&T,A'Q7Q$^7
MPL$.U0UBM,%_TA#_&Y\\&Z-N0RQOV"3FMF]F<G8S-UJ= FVP]"6U=,LQNT%Z
M&P1^?RQI9ZU]WH\GGA\+_[,M^T &'73*&*7342]-I#N.(X/\#M9A%SKE.[,K
M-[S;^BS+==20$V=]C9/[L*%TI7U=4W=,+(,PJI2S+-9FE^M)]V8GN&1<W>FN
M6]M4 6VFAC:3W4Z5RAQM91HZKNY82 9I@#\ICXK<Q^HD#:'F5*NS#5_S='.T
M4_$NQ6HTM*%PJK7:?- T_ZQBSRS_4.SD%3[,/BIN_QVZ-[I.@3K;JS$+O)1_
M,8TT?M]H./3Y,A$P+V$]K>(K?J+UO3CVV4#LS*;\HB!ZXLM(-,S>?_;#!^U1
M)-+Q.PXT;ILGXK1+_@Z_1GR!S3(<M.%4E*+-'ZA-O.<\,8P/YIX_FJ]/_J.X
M*([&6C*]%U>)FXL[\-N.??X=<<([>X/_[OEA]C&+Q_,'S2BY3<0;OXGR?(O5
M3L\NN(NX"1,^:P,.[3!*M:C?GTZ>E]\=+)XDB!EY"1\9"[5IF$S[?9:(C$;-
M#S='QX74SQ_K\8$ETR!=?QHG+7H(N6P'@NO^PHKBG$RRH;[(]?CLR^*V_"$E
MLKB?+>SB*Z$?Y#(K><I@Q4?*N!\F^9<RLUT;1CD3GYD7:RP<\&\4M(,N!B/$
MQF42/&LO19Q"N]9>Y!'J[WL[%I[U*5$RZPIO;;RQE@E_>L[+,FUH]69O6.KY
M@2@@4G*CC\,_YC<Z-&,FKV=BBEXVE#JSC)E59D "@N2[W9" ()U(+L]DAP0$
M.0QN2$" ! 1(0( $A+/5/K('=B$! 1(0SF_*RQ(*A@0$2;0O)"#L.7,@ >'2
M73)(0+A$;2:[G2J5.0H)")<\'>6+9D(" B0@-,0@]1,09K4 CMF<+%1/6YJG
MFQNB.ZLO[6[28%)D(G>M/>>LV)^UWL!TVSA.&?+A/5<=/EYB&84AF]R"/';$
M*W)Z'Z9>^"":[=94:<' R# )LNNNM%#,1'FUN_A"^UN6;I>5%I;"S%,NDI*Q
MJ%5HH4!198T%49>XTR(+RS2%5Y7I#AN9#6O9#_'#_4ND:^+_[Y5,=&@AD6&_
M1[QZ&ODIN\X2FV["Z"GV)NTO!"O(O3UB+G;)]1JM^Z-\HO:%=1<E!Q:E.5X^
M)["DKEFCB%2:2O_I0"1G[3#?9BH9\GW.U[^5S7]5)>2;U0A/_"R3.1IJGV(_
M&?M]+:]9V\]JU7/73WL?]G>E)$,.T+[9;KII4)W:K2Q L-.X!?N#00;\!#1!
M1Q(@+M4QL4 )R.V*O!T.63_-CM(,HYCQAVML5AF[+M'!1N%I&X780#JQ:YM)
ML%/8V@26P#%J*6$-TE3;,"XMU]()D4*$H'-!YYZOSC61J1.KMF-+3:C<KN?3
MOGD&G4:CUB*ZI0IQGDO3\#%/2*UI6=C8U;FUHQLNE5"^"BC/^C>"I(\--O$P
M21=O%?R7C<6[WY^.IZ($RT#SQA$?[/];.4;0^B%]^5;OQKV;+D:I]#K9AGLO
MQ;[GV>WC=+^+*16<NPUC%19[V,QI/_:DN\C2J46[F0W2K?H06H+0TK';.13I
MMBEI#!=V<V3UAF WY\QV<W3'-G4+21ICED[C=N=G=6Y_GIU[177'-73#LB_+
MMU)/Z2AG38+BV2E36T>TH4(Y9Z=TCMKC@8U-J%2UM^A,W;9M'2,BH;#DT9S'
M:,96=BF5" VVLJ\I^=HM48AN?0'X('H31-'7O.U#*ZO &8;LI-B;5 KI$@2S
M&MJ[!(_B#,Y\7I1C(9%R4BK,+-44;"5H;.D.0;I%:BLS?XX:$#*3F^ 69";7
ME9F<=431Z;P&KU3R/8-Z@/^U?L5Y-"2<=ZKS1$V'F TT/TQ9$+!^.O4";1)'
M$R[49U&#;.+%Z;RIGU=> 8+_]LLT9!IQ<NW>TWYG0]$=,-(^1"G3C*S-G3<[
M0L_O/\CJ*29YT[S 'R[:$Y:/8M'\CW^/Q6,_Y./-.Q6:6>,\?J/57;7M-^M'
MXS$+^_P6_$IQV<!+L^>O$%?9S6\U4WBMF]]B"VJOCG[+'GZ+1*CNVOAM*9JX
MI=1B54G,&DLP9E4N^34NH89IU]*Z#\K:05D[*&NGBO.X+BPH:R>C5*"L7=GH
MY7,0)3K>H<0FEWHA3MG<,&42\J"L7=MA1RAK)XM6@+)V4-9.(B4@K=&K7.;J
MQ>UE05D[. AU]CO4D#T"9>VDF+*@<T'G0EF[/:B Y)$FN 7)(U#63@KE"67M
MSBM$IY[_LK%X0UF[CKT;*8Z.J+1.MN'>2['O>7;[.-WO8DH%9RAK=^F;.5#6
M#D)+$%J"LG:PFP.[.9?B[S2M4:&LG1I^5N?VY]FY5U#63A&EHYPU"8H'RMHU
M-F.AK%T#&YM2[5^V+SHH:]=45!+*VD%9.RE#=.L+ )2U@[)V72!=@F 6E+4[
M#X\"RMJU,V4AS"R_(FHX: QE[?:@ C*3F^ 69"9#63LERMI5E0,[HK#71IFP
ME8(*R9<19\G#Z/4T\4.6)'?1^-X/LYLFFS?\F(Y8_&7DA?^(HL&3'P2%>F'8
M11@142\,NZ)>V%_BF>*1=UX</_OAP^V8\S]=R8%]PR8QZ_LY%=D.59*_#@?O
MQQ//C\>,7Q\._A%'?'#K=_GF)XL'E'S^6[8(76D#?O^Q%R19F;%B_3+LFL1$
M-G6NM&GHY[3\\?G-U<_8,0U*;7=5#G5Q;E,@\U/^BPM!+*Y)Q2PGFV(A+L7$
M6A-*K=S;$,W[L!\S+V%<J67_SF[]@:5O9SM(;_SAD,6B8N$EB<:U'&-3--?8
M0,1>DTV][&M7-IO5#U61C>E8#MV4C8E,8AGG(IKNIDW5+</!ZEWWE!9'&*>#
M4JLPDRBR3?=<I-7=1*I=6M1QW<+<LA'%K<EJ=> 7.W'X,N=2EU@%47#Z+&K1
M-?/@$(;5RNQSPCVR;;3);#X9#,.RY63V'F1AA[HF+F!(*K(V)^Q^9!FF53"<
M:YX:?R2,__NK/V2_\36.>Z:#V^03B_UH\'$H @=U2+"4.A-SZIRKGS^9_[M*
MR\GCV5)+^U>QBI]2*9O[,6); =L$VX:SJ)0M//]-Q[_LO:IW\_<7U>K'7OS@
MA]<BVG&#G4F:AT#\<, 7C9OKY3MY4*3%@O8;@2/<*XD8K=X[C^&8/</=($+4
M^Q[X"9?#\XT?!MR[N[X/HO[7LAC.:M!I^:A,E%ITSUG@K136VS=XM=DM8$,"
MW?4+"#;I$JT!RH*QFA<S\=DP"H+H*;DYF."2P%9YG?=9/*^BTGME>?>U>N[S
M6-]&S?<<("[Z[FI;V'U+E?>=@?D:=[KV#AUO/K.3JM=-#J*-_=LYC:L5L#<6
MAAHBU4=S:;5!P8X=BB,V'JKWH0X&O.Q[3:\]KHS[;+;,E>9@-"#G;O:4#AJ%
M;+M&W!P5&T7RR$!,04+Y#"34Y7^9YO<2SK16DB0&@QN-V\4L9DFJO<V[Y70E
MIY:G1"O(Q[KA($486C.HU4OF^Y4ER8V6^P>?O&<1:3FAZK8:V7RUCE(VQ?/2
M(#IQ3D@QVI<[!]ATQVNG9GEU]&'VAA<.:<\JS<W/9=(H?565;]B '=KIX:5:
M!R/%\25L$MWJ0%PGK!P2VJQ==\J0QY@%QT],*J334\[&@]^GI*5[\6[?2PXO
MUSVAQ%@='+U,<U$%/[.18A3@;NY6=Q5#VMC"V]AIVB99+1>MELGVU6SW-8TF
MV3;E[-<9;5N!<\33LIL1W;5*CC05M^PV9Q\X<X<[<S4>8P%GKEEGCIA\8M17
MB0*<N=9<&%4=J<ZX 3[-; FXF\8Q]V/ C:F-HX:E.P91A*$7[U5\B,+K_FP.
M5.?!@3^A3OC,=G5,:MP][G3W2HZ)# Y(C5P"!P0<D/+/\T\KLV_SCTN/PE<>
MAM](.UZ+V.21EF6(99T**3.V"UGH659VS/*^4&FDI2.FW45C?OOGOXM0X=#O
MSW*\>]J7Y6?\*_WH(>3C&F@O\OT6S9_O@;%\#TQ$&;/[/3,OUE@XX-<6L\)?
MBNUJ[9K?)4M:^KZW ZY2LO4VBZH6B--7V:D-^$P)HU2+^OWIY#G[*&/L0)O$
M;.QO<GCD)5H_&H_%83U^"5^G$R&@9'J?I]R+[\^^J&NCZ(GQB:=K_E#C7'\:
ML7#MV=FYEWNF93GQ%7?1_$2;AE_#Z"E44@B">?GA C]\T/+T?W'@1HNFJ>9I
M8R^=QG[ZK'FA%SPG?B:RA1"TR6P_2KP07]6U9#2[$[^&&QI^TA?'W;@L-K[
MV7DO?N7BC4)^=_Y_./4XNSW^$#V;*6%?%,Z8SZ_-(Q.'<KMTJ:I\D[]7>DZG
M9\YXOG+G@DC+#UAD6F'S>$6?!<'$&PPXRQ:_<S+Z\]_7CMBXZ+O-HQ4'G<LH
MCZMGX]IR^"*WX1;:K-2&-,W,?%RQ(?>H&%.N\_8S6M<>6$C?3V<J]C[PRD\;
MG5B.=.?Y@;4![$."0H-LTS9[49M5IH!8=YMI<D_#9C&<C6)A$'<^G!P@L_'8
M$@QHA3^D_N&<CLUBF*%A;+:>E2L2=;BIPK\<A;G]WMIRM<_D.#7.4_OD:%U
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MVOVS:-XTYM>\\6/63Z,XR6[[><0O&44!G]7)ZNC4D]D"B$674F$4AFL[\>U
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M7;N ;Z<I]]!%>K($TE5#=*L' _Q$\Q8<%.U$?6Z(,(T/9,K%,?9%LG4XS7(
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M5H8VY0I@ [ !V!0#FX$<W3(QX QPUBC..,H<K&.TJR,0($VJ02F(-%"? #8
M6]-RK2MD<&G)!+-:.%&H>?W_3/W$GU=D"5DZJQDH?IOWI%^O]YOHVONPW]/^
M9&I%%R#H>)Z+"$2X 6P -@!;];8=1KIK0"8"X*SAW"JB4POKEFD#U !JS:97
MV;JYLZ$?P$RJ02D(,ZP;!.D&NJP%K:ZHPL4E(H@V.UHT$<&$1&/?6-SWDWD7
M"T6"!!!I/$^_#<+: #8 &X -P 9@ [ !V !L #8 &X -4A&Z#AJ(TPO7]U["
M!MK$>\[ZVLH ' @A7OB" /%J !N #<!6O3E"D8X=*0KP ,[.&6<Z-9#N$D :
M( W49^=R!; !V""]H / S'L7068!! XE6@X@2@U@ [ !V*K]-Z)C2ZT,2H"9
M@C!#KDZP6D40 6?JX>SE>:QGW3#O>QG8!C.AIIE ;=TVE:\E<V8SH:[PR@F)
M&%6MH<1]D:Z)_[^OZ!TM>=!N)08S\>/V(C G<+3CJ.W)(X?0;CM\[FRS ; -
MV 9L [8!VX!M148.V 9L [:EP?9+3 T=NZTU)ND4UV<6KH"9I_3,,Q#1#;>U
MRN4P\^0+%)Z0A[4N3G)ZH%":\&[V.HVC\$'\MFA>^X;UV?B>Q1I=:U^[N+";
M>700XSO>0SEYY INM*R#:=XE5SW0=+8O#G!7%^YK'7L!\X#Y"\"\K;O(U&UB
M ^H!]9>#>LH7>DNG%& /L+\<V!N6K1OSYF^ ><#\)6!>IP3KKJ-L_ /J*DD>
M-MWH"OWP+^W/?_.?K_PGX#\A_XF@?],9;44H>Z8-#N\#V !L +9*L#FZ2TS=
M-5K+;P"D72C2"-&)0737-@%J +5F.SCIE)JZ;4(3)T!:T_7CL&B B-0Z&@Y5
MECJ,&VS48];^'/Y+^W/$?WS^,U8K; "'F,_3DX/:$0 V !N K=J9TRFR==-2
MJVXN($T]I%FZ95'=L %I@#10H)W+%< &8(.<@ZYB!XHW@(9@XGFN"1"Y!K !
MV !LU>$"HE,'4@P 9LW"S+2H;AMJE<\%G*F',]"= #8 VP5D&=1>;%B:^%.A
MV/"Z:%K 6'O%F)H]8M5H,29I\'+>)?ZD0PA@&[ -V)9MY(!MP#9@&[ -V%9K
MY IB^Z5IZ!BABX!U-QP^PZK#,/'JJ#IL4=VEK1U2A)E7'V_KBAC6UIZLAJK#
M\L2A@W2/JL-DIK+4J[HC26WW1BLV20JF"Z@Z+!UH .Z=P?U2J@Y+AQS ?'>8
M=W5L8=U2USX V /L#X<]HCHR+=VDL-P#[B\']Y9N&WS%1^=?@U4Z[ #J.T.]
MH;N6H[LFK/6G1^KR*^ZCP7/E1?DEWGW *BXI>4M\9U(RWDG%+<2' _]QZQBV
M?3Y[XEQ"8R]^\,/K-)K<<%B^FOTJ&'U#5MZ825"\LR*/?T^3U!\^YV_YX8"%
MZ<TU=OA%ZVA_M0W96@YMK8CMAJ?._+M+%"T@F3]1?'P31O'8"_)WGIA8 FX,
MA+(;_>G]:_->.6KMGNO..35CB^#"P$\F@?=\XX>!'[+K^R#J?RV#ZGS&?0RU
MVTGL!QH1X$;<8]'2$=/NHC&_X%GCMV4Q&VA^F$::IR79>4SVK3_RP@>F>0\Q
M8Z*@D_;DIR/M=AI[/>W3-$ZF'G^/?T/<JNH[NO;N\QO-Z_]G*E(Q-4QUTQ(G
M9BRM'XW'49A_,=&\5+M[@7J$8*)-6#R[GQ]F-^][$S_U BT:9D\7;R^>-(SB
M[!I1L5J$;<5%EJF;MJW=!5Z2:*_GC^ ?K!*=/=$P>[:9W</CE(AG/'K!-+O)
M"Z(3;MZZ"/4.6=>J9MLA\\5P)M_VFR^GS8[]UHG9:E2]%&S]>,N'.S[BGY3/
MV_W)?%4R(U>XF*1>O#FYONV>LJ_*1;>45/F^RIKTCZ:H! 1K2ZVQA,[V\75D
M5O"EZ#.;I/G&"D%ER]&L^#Q_KC<8^.)4N!=LM5(.>*U96'=<HAUMMY3^LK'2
M>(DVX<B:KSC>0$@J6T'Y.Y-IS)>NA&E\0>;+5<P"+^74[EA'EVNON#)A:1JP
M[ OS[W/KR'_T4O^1:8'OW?N!GS[WM-OUD>3?R]?E58['K!\]A%SVG.M:$'%:
M^,H\&\)L#1YZ?KQ<',N>EBV:6$>6J]NN<]"BN?K+??S#WHM38U.J:(<H-<GJ
M>OWG?:5=8IO;[)":Y]>F,?.;]ZS9NRV9<'/^?(X"+WYD2<H-&);;#<LK2I8@
M[NC;)MY"S'SBS]IF\(<N'E%NI83BH^QQ_./EM:L6R/I,XS/*<1 ?!NIIO[.A
M&'6D?8A2IMG9MP8L]?P@X5/XP8L'?OBP[3F[)J6JLPS6"@G6BKZ<:\7'?AH)
M6Z/4\YG-<ZK;U-ST%_C$6>K+? ;'WH")\K;",4_RV>GH#@)E=Q8 'M0"8 ZY
M#]%C;M^68HX[OI. I9FM-<G,*(ZIP.OG.*L7_^DHCJ8/H]JLYTU/FQ!'MVRT
M.76X;^W-[%M^T=T+@GH8K?CUV63*E-U#+*S-21SU&1OD4XKJAFER(_WX657S
M+ZI.1UA4V@SAL<9#>+],0Z81MVQ-6038O"#0HFF:I%Z8&8.S*!O_C4\R83Z*
MBY8!L4^QGXS]OC9;)PKS.S.A'X1MF6:_FZ(E@+&<[[G=V].^B+&LV\(SU3KS
M:^</RAX]B@+N0";:$[?5N0$[B1(_G1OM+.G'T9,VG0@/E+NB@HB9]\K5;YAX
M?1$0R C*OIY,[__-^ED<D@\6.]><7&[I<P8\/&2NP.R&W$]FW.NN(98G_Y2!
MB=_FQ!]63'RG9]8T[[UPZL7/&LFSD$LM6&+KIK.<EW?YM/^\B$<E*_T9A '"
M^$S*)A*?-WT6<Q\RU,:9T;((E+^.N$,I?GG#5Q9N1/-/A-[F+'SDBCT1ZIS_
M/A:+3J(-UJ[) D9^TN<*_IEY<;9@+3[PQM&4&SHS,SI3^;:A8\P=^J>1WQ]I
M3UZ21:3B07[OW.P6,S[BWX^7!KB761H;:=K8[1U7\4'5>0*SO<W9_E QVZW:
MU/P[=A]G\]W8-M^)J5,;5TSXM3B4F/U+/W;*QY;/P[SLZMMYB.IV&0A;"S!O
M"?6Z+M)MYS [755\PBQK<Y:-&I]EOWDQ5S78VC+'#&3J+K&JE>I\:\5;4Z_W
M43C-IB#C?G[TS%BN$V?J,K.L5S9]"FJ2WWL:I,+L%2I91!)F&T=\PE%$=&1;
MVC".QER-AVGLWT_%C9)I/ GRI^8>]GS+7&C-?)LHV^')5/[,KE_LK54;!^R;
M>)WK:)?J)B*9SIV-<6XH^&$_%K:U&/ B;KW8S)I[ J"5%:1"E?7"KU@OW+IL
M\#V6"\L5>Y_5&GFW>;W%3M?%Y I\-A7?Z'O)2)_;TW[,9S-W$(+UJ3NWMK.%
MA87"E"Z<9P3%K0P5JDS$?U=-Q#JSV+"Y;1I2W<9&]32<F;;S@%08I<*777%&
M";%TZIAY4&M],S9="7.MWUCXK"^PPPT&KI[75+BG/0CG.EK;3>+W6C>F#:0;
MR(4)J0P5JDS(KY66=%W1*1&5=K9,2,SM1J0C5!F="E>O>9I7[URSKXO[9$,_
MY*:TF&/+S22A%]?VDNY>8*1C[BJ+.[]\8>L6MG5$G>_SR3V.XLP6YS,Q>.;Z
MV>-F]$SO1F&6)%4Z8CV//"^N'_IQPJ_-,DQR6SOQ!T(ASR)=]TP,TPLX,U=3
MO>:4'K'0V+K)UT##ME?L^]DS\UM4/FRV4"'.< O/XO9S<87]:;8]L-@ Z$=)
MFN_)V8CSS:#S"-V(W^2>L7#E.9SMU[&7>O,';J3WBG#]G-[&' $I4]#W7>[F
MF;"KKTLO7,F+W<QEK2KH(;Z6G2987P,P0M^]FIVLX"M,X$T2=C-_L4HVY<MB
M?IW(D*TN&Y(]9^O!AGF5DBT7;![]F(V54KKMT7O#H<F$:E640M#TEL7M]($S
M5-OF+A'=MHANT.UJ@3I8)]BL4 OYK@-_/>1,VJX*7KBZZXH?FZ]Z)9=D2WKU
MLKFTUK+5OGJQ+]RBG+J760H?)M]7K?XE3Q9+]X"E+!YS,63WOV<B78(XN>=9
MT 6S(0GJ+6X4(]TE3G:7_099H1Y6&+RZ([M4%BZF.C5<_O7"Q]4,SBQOQ^!:
MQLUE,8L]<74T'K.!S[_$=?2<Q.*#U^Z\KGQFV\R#:5]\G,7.V'^F(C_Z=/TC
MS=*S[UD.*0:KRCHYKE@G:2WKY/O%.EE<)+T)7YD>V:"0D8%U!QE\&=OBX>X1
M:.+3:+[KRQ=/O\]F;RY#UK,O]Q>S/]_4Y<S*E]ZU8%,>\LZBW!XG9[E%S&GP
M^<R;+[G%9:XR])S?,K-6.;DF=\F) ?,5YNO6^1I6S%>SGFVC-]-XGF"_+:Q:
M:NYP!!/#J9JT*^E7;S/5Q"=KDN_NB,EPNW$,J/>/WJ<?;@-N&HA5X1]!=,\G
MUR=N%H5LEH$1LG3=_,'<^+$=$Z803*&M4RAJ=@J]7R;D5^^[ZA0[.K:K]E*$
MHA))PH9N&O1@SV##*3 RI\!0/"#DZ-2V=6(='1#2,>$.&;'W#PDYMJM;!'<8
M$CKD\,3J*K"]@D-^176 (O]\2Y COZ"R=L/.^,[^BY3,*Y* 49Y9E,R-QW":
MJ4D.GJ77MY*J/-A/NV; R3(E<I==Z#L.N:?D9C[<=5!H\!)>EK^L.Q"]O43"
MMEHJVV*E6=PVC[[^=(6NC@SAB@5B>1TW#OZ&LC_;(ZK[!'07UVT/ZBXNV]Z*
M[ZAJ39MW+M1:ZOI1K[B23-DUQU%?F%]/L3?I_,C<LH;3@@4?"BOTYA1IH?!3
MS1SN5KZ KB4+_B=S-41./Z?">V K-AS[QN*^/R^*H0SHCBXMMZN4O_PK:E5S
MAYE::7/%/6$H<DV0O\D(_/,0M$1#D0MS=R\N&W2'K,:+8I2GMU;9KRVUY"5"
M/ZYX[^5G\9SV,"1)X=B#AD74*PMK&I9.,)%#KBV6,@:X=0(WMV?8%X>U^G12
ML3%:0SI)F@YL[[,])#D@TV)WPX;6 6G$:MFZZ4IB3;38YQ;0U@G:,.H9#;;)
ME!1LX H=CYBWLP"F:IH'+-"=77,QT;%U!D9H-^QKL!<U3(A.)&KW'"R'4,$E
M4\(E>_MM(FH3MH<9E=K2US]V!>WMEY@:.G9;C"I";WJIN0L3L&V=;AD*P0.<
M8B6<XMW[@VY7H).[^V3]8U?0SS L6S?,%ET-=7I, KJ51S=&O7G#>,!V<>3@
M:\/V9_<Q-VG$:NF4FKIMP@XH *Z=-*\>46W+ WP]"/(J:?$V&V.2!B$O34/'
MJ#.;M\DPDS0\/LL8+\R_>N(I/;=%E=[IY .'LZ-S13LCOO.81P>'C-H+D36]
M*=5LB$Q2:%FZ;;C<@'#5!5"';C. 7VGPFSV+ .YK4N7Y-7N4J=Y2Q4G\J:K]
MM*VXTWZ5GX[N>%!2]VU'B7,T^;:[-)QTG1VZI;.%%6$QS7_+B\K-NX8LJ\(E
M!ZT'[3>:/V<1%>OS%>OE;)0S6WY04==L><&\P-GRG;P@-N?8."NLQ\WJK#/C
MK"GS@WBR-DWFCWL=\,7U^G-_%(DFJ=$D*R$J"JN("\;1@ 7+TH1Y[;2\5<V$
M&^\W>]?$.E_L[#M')"_WM=W]S)Y5=V6O.JR]@VM!S&P,\[OV%^?#_=DS9P<^
MT#M394M&DM#>/[*5/EOW\S:?>;FLIB&W@)0L(<Z[%Z1G.MJU=O?"Z.W<4CA+
M!E#2PY8\L^NDP*<DKOC;]2)T78.J=?HYJ'J&E<TJL^=T/ZLZ8 #I63AC +%Z
M-I5G>IV#\GK[;<*R#CS<,O:YT3[0GGT6[,H8.,/%N[0 ,;RJ_=6LTO,W;I8:
MS=OE #-XI<RK6J<&6)&KT^YW/_FJ#6/&-#],6<R25(NYP];Y^M,Z(U"/DN\T
M_K?UW>41CWL&_HY;DKAGDI/)!SNRU(X,_&'WTZIU\LUL.R&Y/,)QC[I\1ED]
M<U=I+M!8QTVHQRCPTJS7;.?H:G_!QDZV7A-\B=H*H5:45'Z-C)D7&PY3T/[&
MW[:O+8:I^,YJLRC^LK:?G6^D^HGF:<ETS ?TO.BCEW>W^WM2WH>LHE+!S>;0
M5OC&OQMO;A[+T. *7L)+> DOX>4EO-QAP>V1O76(/;+O576G-1W1Q7!E&'MD
M/*U<O3OO:>5BT2<X$$S^Z<JZ*C$2^DS$ SON#+1(S/F?N>FS<F0GATF-J4SE
MW,''<6<=YWL^?3]/_WB1;SNZ=<*P=[J0<CRPR\:#"YB6I6TTA>%ZN".#A&08
M0YLHF;<V;6NU:VOBMK3 '=60[55A?>]B=9CXW/5_L]B":UO@;38M;'I ;0KN
M[@7(Z^P&U": _G89^#E< =2Z15S&DSV5@2P;B[?3AVF2:ODYK%WU1H^$B32%
M4 X>G,253LR><7*.[N$<:;7**V"I)2P9NF&??)Y" 3#5K2X.3(#8GS_[JHO6
M-\M_\YXU8F3*8E?#BBXG>!UU. X>G,2%-K#30[O*S7<YP3N1E]2#DQE,%M5-
M>G(>F@)P O?B5*Q\9I,T3R7!IO1: \S"#;.P9W0@+G QSA%+V'5UA&16&N!D
MR&)@9$X&RM1%!R$.L N/M@M[:%>/AG.P"@%,+8#)UBGN(!P-+H9R+L8OTV 1
MDY)978!%N*$N: _MJLE^#O8@@*D%,%&=FI< )G N:HQ(8>EU!EB%2FUZ@X>A
M$)8(T:DC<WP37 Q9K L1D,H=C X"F& 3'CO!ZRAC>#A+P,$X1S!1W:8U5 65
M'DS@8-2A+#"27EN .:B6M@#?0B$P8=VQ9-[K!M="%KLBTQ:V]-H"S$&UM 7X
M%@J!"7R+"C+ MRC1%K.>:3)K"S 'U=(6X%LH!";P+2K( -^BD!D5,LV17EN
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MUSKV N8!\Q> >5MWD:G;Q ;4 ^HO!_64+_263BG 'F!_.; W+%LWYLW? /.
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ML]%4O97O4.Y2E%D5)M<XSI9DHMW<K5\Z6(@EDPX6_]?(9HZKARCV!:=_9X%
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M=^?U$\W3DNEX+.)&G(<IO^8N&O,G//^=\WXNA)46BIK'OY)J;U@_+R>5G\O
M[LTNSE=S&EY*^;+LE0SCDO=EDXL'=-.&;MK03?MHUZK@4<KQ0"GZ)$,W;57'
MT"9*H)OV20M<R:ZQ&CUUH9MVC0-J4W#03?L,!]0F@*";=OG0F\].VM.LEV7?
M?IYXE/>ZZ^#09>=I&:IF7%@])',V*YR!4 A+5#0ON@0TU:TP:LC-.4UAM+Z/
M_B%ZG.T>(.E5!B2M;R28]BR9C\W! 0B%L(0MW79D;F!TQB<@%/,Q9D4Z\BJ
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MO8-1YO&[<;;A0(,DNOOP<,)U:D/3<8@3>#@!:#(C3.#!!-4.XN0:U0Y&F2_
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M)_!P8AHVUF-&F*#>0:  USL8:;X-HZD?O<CF_)(NOVAQ. ^FFGH'T37U[S<
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MU;*+A64ZRXK=-:Q4=U #+WO:^]F.];[[PUQ=.^JJNG:_JP>HWW]\7&[?55:
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M)2F]KYD?C-%GR!6<R7BQGRZ7+AAA.NZ>HMXZ[GP_%-^ 0&<OAYK/ARFSZK*
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M6\VZ?$-8R3IU#P8I(31UK69>OJVK9)XI2,&NMTJ?1-Z!RCV_FB3SWHAIYH/
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M1K5T[I +!RQZ9U#P]MLB\B4E_I-E0.U5MTJU[P@4[_69W?M*S^6Z;:)[!F=
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M ;,0F#J9+N,\&/TM\B?+ +?I<HVH:.SKST$IO;%N*WSMC4'&3G-L*7H)7<A
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M3<Z6OWDI*XIG]?8%V^'X^'25[6CT9>T@.C5]=>V:;LJ:7M(XVY=4B&4L\?,
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MA =';B_R:<83 "\&V1%D<H\G ,83 .,)@/$$P'@"8$RM'D\ ]"SO>B33\01
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M<:)TYY;F=(.L2+!1QY1$+)K#^GG V,DC#L\LR?W03B]54T)+EU8NK$N+W9+
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MC1E:.3+9=%2^1\'W[F6Y:HB&W$9N0-/A]]YLXKPV<FGX4.7!Z.(E4K?F;.4
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M8QM!JML(4C9_.MN#E/BVQ\ZN6^[MI8[#EUQE5;PZYLMM\UH-3=9453(J&ZY
M&D 9?(J5[^538:E#N)=8DT^Q@[.Y?8*& NZ^5$U$4$P@0#[!C;/()_N94\<-
MXCV#]EY@5-;-4K<4PRK/\D\PP_^DUOO)+TB%?++;9I'/E[Y+'XN;G:TI2]IJ
M<D=QML@.Z2F.C7/(Y_H5>.<26.>*<\Y78)S=)KV>)+1UTU<DH(K"]&^6.&OI
M#-,$^+QWG,]*_*K(C+^#G44C[2 P/N,V3WP^A;&^DD48X;4;D,>A]^+8BJ[8
MNFD92A9;J8^N#"J^4AON4-1V8BW"AA#+[7(2@UN%^1R$HG"_<XD;S(!>& )%
M8(./^M\.J":@0X5I7KGL.CD+/)9+F/Z\HX$(T%JF+DJ2Q!4B4[DTWN&2*$$[
M8!*B6S*G*CW>IMZ&!*\,6$H96!&P-_/A0-.#?^FF'CUX?(_^;";<XWD53,-@
ME@!UZ=&F &!2*.)]@!5:4/^]#(B@V.D'8!#JK8G4SO(\'D4(P46/YNC3A<L(
M;)>YDX"< 1\^_2(\"B(L3F]0.>-0VXG::Q$&#F(V&!IDCA O"/5ITZG%R\G<
M3PJ>3W&9DZ<,V>7Y3RN/@G/CSZFU%G(P8"S Q;G!T_J9_%/-6W_G3I'P$><1
M1AZ/73R$26:*X6(#=[;TZ."/H>#YX+6#4*V;!C4H 4ZEV2+YQH1\Y[.+B+?D
M_A.23_VT&&W#K?QK\"K&R41F:.(X('1<'.1'.@9,= G< .R3O_;H)_<8'@#3
M,;\8DQG\QD[!8R2C-.%C8J5UOZ/=O\(DJ1=8X@SJ$5#E&7-PU1(DC0HM@$66
M*+L .0ZU%6).Q(B;V^4"M7($B%Y&"?L0@ 2]35J3(&#V_C7P#SPFIB$9&. W
M=,8%O2@+MO W4L@JHW$2*3Z7^YP8NYH0 JLB"674WYPG0=;8)\^$2YCQ/3A%
M841V^C[\ ;)A0JUL('8..0=#E1Y9$*HYT8<#OPNG6A_PS@%P2281%8BRF0$A
M5P,Y5=-F#-,IP+3(G$S%4&F%\48,[J&#QB0.<#I)0QQ\-7N1_V 9 _?X"H#E
MU X0R:])=:J:8\4457!+5<58@[PT'HFO?F;!8S!@D\B?+*FX/K\#@4236:E\
M.C_[]>SFY_/9S*>QI5]GX03(Z\:)D@!QB11Y%X$/5=[$D&W1-"7<-SDFD75=
M)/A:<XE0QP%5'$J:8 N W^*K)QN?.7E70,/96CR<"7]@G(*),]P?+GRE.+^Y
M\T0M"I_N+L1N1+C1PB/,&,0_3<)3&LSWEE$:9,&X2\JW*^/C'N%L)I;H*GV$
MWL[VOG(]+OR;J7%.DF6!(+(58ZS^#CYRQX3_E-#)9-&7Y0)9XHTBH26*_UY,
M:)4]I'4^5;U7E80+ZG+P/WE)"+RRLGNZ^[;K&HI?$1 %"<'TD:QL% ^*!O\L
MZZ#BP1)EPQ1U63ZK14=7$*[;=C_47-9A^[I>RU8Q*XNJ!F+7T-9A=D_%O&;K
M@MO>Y7VFR@P%C(C4!4V5,T.G6\VU&]8TQJR*NFF(EJD?ECC6QD+VHI=G?WWK
MNO;1AWLJNPVZ]#-(8LPE(JFP22GR*Y 2* *X['ZG>'06BQ!#XG1/ZP9(QJ?&
M)1#!Y>TG[+48NSX!H<&(\%-T)GSVA(\1"0*8 -V#=D )7=S[9"K\1CS:EO&:
MD>HJI>Z\1=,[9+UJ6KI*/:CZ4$K9F!)F@'DL1N/D]M/)51"$#^ 8?>'W*G93
M^L!5 JMSA-NSKV=?SO(73]Z);(>'[XBGC]-(%X]Z9:&P; 8PG27\6,Z2R#F=
M^VX4"C>?S_&RAUNWX4*X_'2>A\X><-L*[!X0CUZTO(NS#; D(@Y-R49ZOG,P
MPGCJ4X?6Q]UZ,- P-SNFF0Y.X ><5:8$@YDEFV\M'*I0]6,6^XF8FS5WOA/L
MD$<SP_%".M1RP66[XP(+/I!TGJD. 2* B88XD2:,K6*VXXL"ZOGNPN\8<8FN
MI[=)Z'Z_9E'*<XX4/"R4[I=7(O!R%H&'GTJ>,WH!IN@=/;=Q/?U*9AB00DL'
M_J8IHOC1CQ@=8NF?,?N1O;W;2K*1\B@T>WCGG%*-YOX7-VJ8QC[YQ=3!3N9;
M'3L")X?F!</[;2&:<,$C>]_"?\&%J^ SC>K!.H ($^<.BWBADO]8L/P]9OES
MDV0+Y)4<\C.:WW(]O:;C1$]L@ Q8F[_3-B+4-8A0)4FOWW+2TTW(%J":H^PW
MYX<_7\[/4S?JFGM1=&>N#OA*!GQ%ENGBOSTMX+5SW "[HR(@ASGS#HK.029U
M5@"^ ]]\2BW2\\#C2GX5;;O1 #,GN\'[NJ1N19<4VZP<!F4U 5,&W(B<7_[V
MCY]QU%_^]O]02P,$%     @ *ZIP4ISD]FXO.@  '0$# !$   !H=6=E+3(P
M,C Q,C,Q+GAS9.U]6W?;.++N^_X5.GDYLQ_<B9VDN].K9_:2;XEF',MC*=TS
M^V4634(2)A2A!DC;FE]_4" I@L2%H.3$H \?IB<6JL#ZJ@KW0N'7_WE<QZ-[
M1!DFR9]?'?_PYM4()2&)<++\\ZLL71S]_.I__O)?O[)PA=;!B!,G[)=5MD1_
M?K5*T\TOKU\_/#S\L&#19A70=?!#2-:O3]Z<O#D^>7O\*B>O43Z\_8'0)2=Y
M<_SZ'Y^O9J+:@O"7&"=?:]2/=S0NZ=^^AN*[@*&2'$JC=,<@$[]_G1?N2&-+
MO?^XXA7+E6(+,4Y8&B1A)80B= 'Q^,.'#Z]%:4F:H&60HLA8^8?7E,3H=4%6
M<E&T,'+\^)J7EH01VE 4MGPAH*'XR"((TR/TN(F#)$@)W5[ROW=RDB3)UOI*
MHI2^3K<;+B5)CC@5HCC<\;4SU1E"DB4IW=8MR%#XPY+<ORX*N=C'/QV].3[:
M^=,O848I]U$37U$*C!_JC.@Q7.F9H$3#P'"HI^<%0'[<($\WU$#/2X#AYSI#
MA+">GA=HQ,G8$:BQ:E&+@-T)#9<E.@PT5>GYCWI2TP=V11HVO*#L:)'%<1T+
M_"QXT^"1)&1=6N3MT<E/KW<\.^<)<,CTRA!%-3]( [I$Z76P1FP3A&Y]$8K1
M&B7I):'K<[0(LIBKY8\LB/$"\\;VE_\:C7[]/T='H\GU_.+CY!^CN^WHXC]'
M_SB]O1H='8E2O-X0FHX2[5=-G43>;UX1WBY%!VMD@;^.2KXC^.GH^(2#_>&1
M1:]>=Q6@ZBJ["5#R=11 W_4Z?KID@&^^WP=NL]]T^6Y,:8T+/OX! !__>) (
MCK"ESZ<'?]K>I[N*(]=R455RB'1JO^\B3)/K:220AZMN4I#D>B]!6D<SG1C,
MQEC^<535TET0W?#H)HG,N?OKJ*JGLRS*J.LDQXY+_.N0[S='<8-?:'G@'T<5
M<_=O-V<$3MAW7.)?1Q5_Y^\W9QA.GR^9X!\=%6^?JM@T+W,N@V!3V#Y.V:ZN
M?65I3H.<Q"B9<A%@8K3_U_=5A2K#/GKH-$VSR66M ]C_!135OXY"0O]5D71V
M7G5&Z-)T*Z[\G_IN-$@2DHI:X$_X8;/!R8+D?_&_88[T"PR5<Z[R$?SCR^W$
M,@45H^HY"3.8?HZ3Z"))<;J=\"HY!7SGU0CS)9N5HOQX^?D(+7""A9!O^%)Z
M=#0JV>5_\JI&>5TCJ;)?7S>K:%2>,11-D[^(?_,E)>-5"498)A?,!8F%L:J^
M$UL8Q&$6VS]7_%B:X###G$VO9].KR?EX?G$^F_/_?KZXGL^FEY>3Z_'UV61\
M=3.=3>:3Z75N)7=RN\E.N)UF7*VHL)E<[ZBJ>#2]'.VJ'I5U#Q9TL>#5=#8;
M7Y^?33_?W%Y\NKB>37Z[@-_LAC1RV>WYUMV>4-N(?V)4^X;X>3"LBV'//HVO
M/U[,)M>S3V.NO^G5^<7M[.+O7R;S?]IM:V.TF_>=NWF+CXPFUR/I,_]W-LH_
M-)C8R<3CV2?>%']O::P5F=U\[SN8CU<Y$G4.EI(M=1VD&473Q6G&<((8RPVC
M_&JWPX\P.\$LC GC;/R/G']$%J.[HH9!Z[+63P.&V71Q(^',%:\KL.O^IZ;N
M116@>EF+@_IE]<_P,L$+' 9\6AZ*S1><+&](C$.,BA9@)[&;Y.>F2:3*1L&N
MMM&FJ&XPCFR<<?A'AID0%!H"9FL<W@B:$&4I5V*<6\B!SFZF#TTS235"^RGJ
M'-4K'8Q5,Q9C*&6?4!Q=$CH+8E381OG9:HKC-XHI1 6C%:]AQ%>X(\;K&#0O
M:WY.@PB-DVB:KA"]12'"]\%=7'9?QE*['8Z;=A#\(UI5,!A!-H)0SR2Y1RR%
M*6BA?.57N])/FDJ76 =UR^J^Q<M52A;\"Z)_R+7=_-&N[+=-90OV([(XXA6,
M JAAT+FL\PD'ERPQ;_MYGYPK7?G5KO5WJHN7_+G.!T>OK\I(BMA-L(4NMUB1
MR;_8E?U>68T![VB3,P^*EA5]A0*&IG<Q7HJ/%MZM_&I7N++\%?PC4E4P*%U6
M^N\!I7PIQ*YP<(=CG&YSK:L_V]6NK'S+"D:[&@:]UY:]_&]T%FQP6JZA:K_8
MM:TN:H%W%.;,@Z(514.\571&UAN4,&F'QU!F5[ZR5!6U'(EJ1J%4SV"'6N].
M&+M!5"BKZ-GE7ZPZ/U'6I, [VO#E$ /N0=.RIC^B!-$@YBO.<;3F$K.4\J_?
M%UHWEMHMH*Q&BWI&01*-@EI-@S7J<W;^3S0/'M%NNE[]8->Y9C$*K"/!.VBY
M=LA%UFN<+].Y9Y\1L:F+DFH/V49@MX*R2I6J$MX?RI4-9JEM$J 8(G]O IIN
MYWP^R()0FMH;2^T&41:P13U\5<4K&J5238,U:HTDGQ]^#I)@*8YIBZ:A_&S7
MO[*F+2H8534,>I?U?HF3@'<.03Q)^!B9E9W0+69?F[9P([7;1UD"[RH=2;6*
MK@OJ'<QF6CF@)2@%14H<H;;$;A1E@;RK8X2'N$&# ;([AO[(.,:+^VI'7_G5
MKGAUK;SC'Z'[85^_TWE\AW-YM_/Y$W4U;3^?'_VIK/B_![O9@H?FTGZUMLAJ
ME[?*BEL-(QK]250T&*(UGF@NG0:;B^T&41;@VMBBP2;=.S79.BZ$=CLIB_;6
M#FVPV%Z11[+9G*GMME.6^DY12(,%W<*1:@8S%-KMHZS\=:%)@SDZQ2C-'2*5
MG(RC; LH\4J#9<R!2[B*,Y(M8BBS6T+9 )""F 8;N$0SR2;0%]DMH*SVU<BF
MP1!.(4ZR)0QE=E,HZW\EW&FP1&O<DVP%S>]V"RA+_#P&JJABT+Y3,)1L 4.9
MU0KOU"/T9F#48(G62)W:4E']W6X!905?B]H9M-\A?$>Q@XG";A%UK6X(Y1F,
MTQK34^N@U-_MAE 6WO7XGD']G0)]9%.TT-C-HJRWS4$_@XDLT3\I!.S49[+-
MG^V&4-;6<B30H/JN(4&R*=K)[*91%MO6\*#!5IWBA&KK<#N-W4KJ@MP8,S28
MR![$@JL8$N[>%+.OZ'$CU%HS5P=ZN^F4!;QS.,M@2:>38D@0'64Q_V7ZP(=W
MML(;/GD+00=+-$D@7@)'.*"\^SKG8Q:.#8DI]JC';GEUXT ]@^9S]N*S\#,I
M/PQSQ^++(YR,F/3MT9^*KP]NT79N75GT%K$RMXLX8".4FQ83.0"JYAM/59G5
M0=XK>QKZ,_&ZC]#JZSDE_SZX"Q= #L4:W&2/H_3*QA<LQ6L88;\PM,CB*[Y$
MX/Z0[]O6/.4)Z[,[B[K]TG(P7W<;5 HPRH0$HQA$@))R%WGPE_T.\J_AJB"L
M(6M^L0>?W?[*9H_CX?[N,_\]F'A?$U?M^#0.PJ_\3\['IALQX>8<(6]XGTF$
MXHXNT+E>NXOL&?]1[RCN0!)(E@JBC$@N"PPS(,QH#=(,CG2X(TTBK@K>?0>[
MXT#!35'$E_'EI6/>C?,ROD*(]G:L/;]C=S0UD&4/1\.29.4@%!2RB>507$D'
MY2#>X'F.P4JYFN;H,<V"V!2TU""RVUS9P],'+PW#S9ZVLANIS3K*-I[6.O4&
M""=$)!&[#]4TL&'.P81=3'ALM^%QBQ&573X'(R8H'<5PVI3OU:ZY[E<H87"D
M(7Y>4+(>1;Q2L8V;\2Z4\,5B>6(^F+>+>4_LYCUI,:^R$^C21@.V&BUB\C!8
M<A]+FB)"J_F1B:+6*1]>C=TSE)U"-?:TL5&HQJ8.#N"254^_6&^ELIKO1V4?
MKQ:P.LR(NAI)VHEOE%BMULYF-Z.RPR:;L;%VD0T\&-4A)%G?\-J([ 93ML1T
M8<I#\^MH*>F@HUY@LUPKD]V2#JDTF\<@&E,/YG4)2=>WQ%8JNP';LW(.+;&[
MJ:1MO$:)U7;M;'9C:L*UFL9L#H>*L0<#MUU*T+=#*X7=;.K3&?6+"D/[ZV*>
MJA')OQIM92>W&T[9]ZD;KK'A(V?@'0SI=OU$W]9:J>QF4_9SU"LI1T.KZVZL
MJBDU2ZS6:V>SFU/9A-&94VZ)L7H#:3!P-P-_AH@XG&['21!O1<C5--_33):"
MB7>!ZKK_Z:JS.L1/#E?.Z@ZQ+CX_"HKOBZVZ4H+"7S:%#(.S.&;TUAUEMA'9
M#:ML]*C9OH=^N]O-0OT :Z6PVTA_MZVZ;3B8IXMYY.#5D"0A]_$@#Q^9KY!,
M:#1?YQKLYE4V?.KF;8:\RE^$7](5*J[6[1QB< )W)SA;\>4Z8I/D.EO?(3I=
ME!W@-$L97\I'?+AR\(0NU=C=0=D^LKE#F'\6 N,3\6'X\:'LPDGU[<$INCC%
M98#I;T&<(1$*EL?]529U< >W"NR.H&P]V1QAP3\XNH<OYO%A1:RB[ V#!W3P
M $WSA:?F'Q$-,9\\4QR:A_>]:K'[@K*?9?,%;?N'F!A4?%B$L X;)IWR%%AF
M=>VT=N.J"86-N0N&J=Y^UK,,U(*AB#-WL&W'FNR6U[_^H[.\P["?3P++*/7!
M/?9R#_W +5OV(_2MC2CT)Z_5[C;.[Q8Y3Q+JOK/,A1E\:#\?JHWO?+S_'<$!
M/8K&]X@&2P2)"6@0PN[,'-%UW0^T,P7EM.59);#ZYL_*3J&C;S;F)C!=>2BD
M'@6YV"+_0B'W*.6"JYXKSWCD*<]P0.26^J>^N:PIL!M?V4UL)/]I'!HT,@,-
MYNF2&JAFJC8BN]F4#49+<J"Z"9=F0O0(37TP:_MC8J8H)#.!W9S*AF(]Q="P
MANA@FVI,O:'D'C,NPR6A$H')9LZ,=EMJ@LDD6]8;XZ;\D+A!@7/"-#?Z8&AG
M0Y^C!:(41?SG/%),NAK:;FT7;KO)[1G"ZB:/BJ^!F7?Q9M)ET:&)=['\'*TW
MA 9T>XX77*\H"1'CC?;W%0Y7BEVO20K'/TL^Y#56@]^H;KO7:#*%&[TF+649
M194PHM-X '&T7I605!P^Y3(-;M7!K:Y)4FS4PG3XC ^_6Z[KAX!&#OV) [/=
M,93=18MC)"0Y*O>4Q>P\E+\W&+US>D+]U*X+@]VXR@9B2\K"8>YW@#&K1OGW
M+."_PP [79P%2<+'6S:^Y]H4F=3)+-MLXNWI]I);)HCSC%BN#O D'[$[C;)]
M:'>:>A?QQTZJ_$YN+M<H* 4;I63$A&BCN^UH(80K<W(-+M<I9:;AGI@KM=4)
M/BC[=+8TFD.WL:\-J^;\-[2M\EGRYLI(DJ!8WK]U,O,^%=H]0=FTLWA"O2_X
MBK:C=96C<U/*T#BT'#S&Z0EGPURAE<QN765OKWSB63+<T+X[/V!K" =HH[+;
M2HT$;#YP.YCJH#>Z+\ITQ7KS[<5I-ZFR?[?[Q@@W4AY#/N71+J'R8.FGL;1T
M"%]22_<E3@,AW7R%,#W/T#D?]UAGE]C_$W;?438"G7VG<>R_8Y/O:^0GLGQ\
M3D&R492A402R#<[VI,Y6)!I,HMTOINWD;_D!NZ,I>X<'.UJ9PY!S5#_*20P'
M)WL")SNC*,(I%![@2&HE=F=1]A/W=)90?#>G^?_$&^ _T.W>HL7H4?R2<IH_
MOV)XO8$7WO/?5A0MN)]D2W1T\N;DS?')V^-_<:@_/*[CD@2JK[G2XQV-?R!T
M^?KDS9NWN2LUM5-\N*PBH*%2R\-;4<?QAP\?7@LJ7@G<V8,6^[H4_M7KIP+%
MS= 55-UR_D&*@[NND#@+BOU$PQV^*YI&&WEJ3+^^#C8;2.T/?_(_DH3D'B[^
M1G&^GDV"-7))#<PF29AWF8#[7ZX,N?H //YE31+>=='M)$5K:/"O1L$=$T%J
M?WZUX R@7T&8;X'.!6N4Y;D*7XG7+%*<9O#71TJR35DOYO6]&B4X%INJ?W[%
M^]5=57=!S#M<J ?=X31731-[%)WSGC9,02XX3APO%BB$3=VS@*W&A8@R=D<&
M&3O_C9?KD,O2/@5P T1A*ACFR@QDD^3B,8^-AG24$%7&ZAC=. XV, R$09)^
M4_L64&[1.DM0J58-UCI!+WSWWUF14([;Y!SQB0+O 7C+*_[_AJ)-@*,RPZ28
M_]:0[\/^0O7"#E3,4S0&;S1SD4<DPESX'/%)*=[#;71UO&0-[>% VDI>@(X@
MO3$341,0FP,AZ7<P?7)6CX&_=YKY&/#A#8)1$)LF^26H2;*[X0*)UF"KFM#M
MC,2143\=:_%&2_FRU4%-I>$K1]BCD76KQ!LEN;K2%68PQ2S &+70).L?3N'G
MPN6GR3EFW&!!/%U<\/7&!FC,R%L97XHN=NV]JRXDQE[I8D[ G\,41;NXOU.4
MH 5.M<NS+FP^+=+:Y2X[_^+/Z4(3!OL?I!])GJ#6%^(TNZ$S!YZWBZ+Q=%2=
MO2IO].4T$IM10G?"^Q$NV+TX9=WEN^JH+4L]+T558E]DPACW",(ZNY/"[8U:
M#FMQLY2$7T^;EW"[*L=02<]T)-(!2F&D!BVH9+YLM=E:R")%]%- H0\$#YX3
M,%6,4KA9/4,QQ-Y^I,$:%GUT>QF3!T1E_'NQ]\'^G8#-*5[OK96<N0\Z62XI
M6@8I@A-2>(9VMZL\22Y82,F#K ,'XCYA_I*(_</\_5VF ]JDZ$/KCV,,1!]C
MPLDA'!?>)?^,(.N*#-%*EN-,2))DZU\BLN9KF&>;D<>\AP%)87=AS<U!FPM0
M T$?/'%-: JS>NA1E! 9U69.Y#[9SB"P%/#C#%+#XQ?2#)Z4KXZQBHX1II'1
M> F; *F4J41"4\>^?RW]\/<<'^]>Q>^701R?(MY^/^,$K[.U6,7I%-+"\&S8
M;2A/*?F*:)E2[Q85 2[<;I<(Y?>H^,22P05XG1-T8^^1]8O]WQL^LA:WPG"S
M![#1]0AIX:2B^<JM&BQ'DKQM?]E Y,D?&8Z4Y=@AM7BC)=M4I0!XD]%P%139
MG\#<8U::^XH$.I6T<G@#O]U)Y"[^DI+U' Y.,KK]DD2(WHA=&G03!R%JSGOV
MX_=&,S;'2-(52;;G&?T:A/]1IPC:8I]F [R;#O%&W(>K>6J<L3&X:2BNQ,+1
MJC+B=6;UQJ 65]_0GT_>'/^L6K)1X),--_2#2>8/_LJ,XV.CJIME/DF>+8_?
MZ>5NEG@F]7NCU._]E=K@(HT"KV2FP2<4Q.EJDH0:P36E7DG_&&_+E BB"CT*
M"Y5/:/+LEN4)P15>2)G#93QV.GG<*L5[MC7;:2">'+J1[B!H3K6M5/X<8I]B
M$I,EQ'^+G:$JF>_N9$/Q/7<61T?\/E8C 8URP=2-)%VA1ZWHE"09*R*$YN14
MK&(F276!.D^04L/CQM"#^> I(5_GY!+'D+.WBIFI@350] (=I>2!"\YF*$UC
M5#>B4N8-(LN"3!%['(:\"NY_*>*=8>H U,31"_BUK3@99:/ &S 6[ZR)G&\;
M0)1F?9_ #-+"41L!\UV)9QL9,AP7&<$O@U"$MS1#0<PD?;!BQG""&).N@)V+
MX:P&T$CCU2"NBLG&CYC9D10DWWC2%:6_1)C+RHJYZ=Z BN@9%V!UTKX!=/%"
MA=A'=[S"(<RTX*Q%@Z96VH/^0BPK:<"G^2D*M6MH(X5'<V:0,0WNYBN^L-R(
M*Z[L*HU^)]R/S^* \=FQ$ 9<S 2Q.[M7^$4JK/)T7 -06^Y3\VJ(R,S2]Z5A
ML97HVBAD59 ZN1HP(TU/$-Y0$B(4,3A?@@D@\(@KYZ;#J2Y,/='!+0H1WJ0"
MCK@:!R?4=ZF4LZ2!WX6A#]CY/S.ZA6GR?9Y=0.UWC"0^=9Z(IOSSXKAT1>((
M4<9[?;SF4ZHY^<1_$%?KD7A")H3M/;A)(,:%TUEV1RA?*\"IW&\$0C"4N_K?
MI/9">UQUFYSK^;IM_87'?%M&5H.=SJLX':NLYQF:DSE*"G.5M-)[:%]8;</C
M26KK0W?0Q#E?\=J7T-O#M25QZZUV T=<SI]S+NFW(J(619>$?F%P59*/B>GV
M,TI7Q*K4;_ Q;W1NV8"JGFZ$[/ILQ>>L7T6J$S%C.LUK8)H3BZZ,_AQBR)*?
M*9*#5&UX6[D\!"L_RRME488DC(VM W<6'[<07*17MA*Z,/DT\5AA!"\<AAE<
MMYLN%CA$-'^J,/_IC'!DF,^:$G5FU9W7=^3J29V=S#<\5<Y4*QXCF6]XIAN1
M;(EWDGP:DL5P/46/R$+H$R:8=8L<#"B!*UI\1*_/4/7EWLP"+#,OD#P_?CG=
MED^B$LJQ_!9P.3)VD]$-H? J;[#FZPO61-V-MW<:$=,G@6D<QVC)'95/ C;!
M%ABF"\TUK_W8^Z*7_(05?LTCA9O U?*^(CN#Y$1@PPGOERA4T895Q]$/](R-
MB[A_N(B=;Q2HW;6=SJ_>FK%3^2:#'HR6Q%<<;98QTWF'*!?O$Q+[5^**KP&2
MF="KTP?KAIL)6@NY?T:K!.X&[P!TW]%\#IAZ <2QM^A-9X%8E=P*(W:%$R0V
M7)J S'0>;<AH!)TW\B=::+[]ELMJ"T<"V1URWW(IQ2TCN9H;2OIR+W>/FJ*J
M6T4F"K]Z 9B&BL +T.QFOL+))8[7<Q2N$A&/C7CKIQM-O]"-T:>>@O#%59CO
M7)5I=>:DNNI&(*>W#-6-_N#)^[=/S"&E$<H/( PGQU:R6FOL'F*Y)\H6.-J>
M7EOL40=?R:?TZTJ1E]VYU!S$'D8Q.9#R(IBOEN_#[,WZN*6-%7.EXD(TL5VA
M=B,_L,T]K=>*G=<B!T294[>&2$_@C?$LFQOE([[I+B,A-P< XA6)\QV1._@>
MQ42DDA4Q8NK0>$@M7HV3^1YM%L3%05=]8 CBSYQB%8OA(8C5460?]EZ,HGRR
M35/,F<_1G8@[0CHG,!+Y9>-2S&N2-MMQHZA?MA%"V^Q2(_!J4D[@((2/ )-D
M0>@Z*+J,ZP"<:%H>@L$%!$WT07=>CV9$%(LW@XJ3#HB3X36NX8E%CN&O6;3,
MHVDTL+MR>@0ZHY3_);SQ)M@V9X*ZTCXTQ%SN<NVKRQ1L)ND!/@CTF"[X[ ;3
M;9$ 9YJ'T4D(;41N#OA=^AL("<[[1=@"N85Z91"Z4EGZ#>]9GE'V\/CDY,WQ
M3TI/KY1X-.R";/JL'4J)7U*?')MT72_Q3.JW1JG?>BSU!Z/4'_R56@AE%EU3
M[)7\L)<'D\,Y6L,\BF[/\6*!^#@5PE9NL9#)G]4XXP,7%@OVAX#"__V^PN'J
MFIPCSL!'CO+UA DKWDZH1VM_AV_U81QMT<(Y62/^Y5 $TWX_Y3_M9U^ '3A4
MA)?)-4IW,7B@D6]LAB?]Z@NRPO=M#$_ZU9=CA2\)1?E=T>*'\EG4[]<POH$(
M+\ ^DP5EQS\^N<Z[5?L"]"AN,DFWF)Y<H_M^X 7H]B9_L'M[PZM*X39%^3S=
MDROYX"^] &WOWE."FL1YRY.K>?]/O #]2N/0[NYITDCH!QNQNX<'GUS]WTR"
M7EBG#F"WDVIZ#-"5H8?872'W[T7#)@)CO\XLL&U,OEC;705,>GVD$4K83NIC
M5*%-:B7 T(78J[VUAKC-V9\-FDK;*V^5+&-90NL5X,K;"X7@!$,@99G#[(RL
M[R#L'PZIR_=U-+O&7=C\\OA"< @A#>Y(7G6>.0+FBY#ZT0%V!VXOT4M7WQS0
M6JC]1)="N 6?99;OV<%KC"F?C:X=S=NM J]TT'S E_=115;=(DM*E71+25>T
M%[<OG9QU1LI"BL4QOSC[%YGG?R,QAPI3[#+<X2/\MS%%[<98>(('J9EJDN<1
M#I!JWQ&JA4$V=X1"O,X3J#P_2$BLQCNH7;01[Y43_L\B#_$X(ALN/[<A=Y<
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M-[L;2+NQR@KP]@X&$Q>VIG ;-T0H*O._R(?M,Q)'346X\10MU(<K0204S[[
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M;I$.>\]\HO27"'.I6!'[YS8'*D4\%U,QG?!EB4\S-\H'Y)965H/B0MX+1^-
M8#)R0\D"IZ=H0?@Z07/\WP3OQN.-!FRC&=U! 5#N*G#CZ84*LD"$&Z'H,_?C
M=;:^PGP6'HG/FHZ3.O#T8"[W*:#P(CB*RNA$9>5II/!I@^H36F^X6T99F&H0
M: K]$IYBN$IWFN$8'I&5GFVH'FW0H.K Y15<O%S-<81TVQR:,H\&RT]<Q-F*
M;#0NUBSQ2.K)>A/ 8T0WO$_BOS9C@?3%/>BZ=((7[PM);PZW(-4Q] 0[IO"#
MV%"!5X>Y .E61)++VYS\W[>0OF.Z^,*0> >RH9"]:_%F?#=/\AKX$F=-J)2]
M0UL]]CEQQFWEZ94&E Y:+?)I2.3#'85NZ!P5_Y^A.<GWP]DD*=Y0.\LHO%:Z
MG<-3R;'^U/30BGP:MAI0+BE9PZZ8>+@+1;.,;N*,S8F8;!<'Q!9-N+%[X^2V
MOK^!K'9B,DU7B$+ NKIVZ\CGC2HL[5U!).\R2R%3AFC8/?F]T4P')YFO>.W+
ME0@%9!@^QU&A5/3M3%GC[L5=VY1[WC<K.\FO3(CW8.ZQ2Y0);'@?()XJ<'4&
M$Y__;E!)OGMHMS/F)F<?4,-ENWTPZ_GZA]BQH1O8>MS$\XC3::+MPMH5TL+^
M4A7CW$+<:O&_O=RB>T3Y>J^"T8Y=Q]-CAU#AN#J!F=-_PU?7?_@<%\C%RI"+
M!?MAK@IPJJ0GNA MNKC&#4\I=]*!B;D'V,55R/S!JC-H0G%<N\S0C:W'W4 Q
M],/(K^XB.[.\) 6XM@ CHV_>#W\'\2FAE#S Z1EOK7,BXHFR)!5G N7Z'ZNX
M.S(7NVH>Y/"9)!&"D"#^RSFF*$R)&L!OH?%J>Y!EW*WS2W"072<.\+K8ODGJ
MDUH[H3>MU+;/=2\.=\6@ HVJB+2I^Z61I@\(BTO8,%XVTD]4]UAEM&[T/4+>
MS,103:?$->PYN5AO8K)%B'$?OD%T0>BZD<#C\*I\ZJ1UU_*YO*:M7"=RW_%-
M%Z<DH)"/JNAXV22YPBCC1 %;M<%MX_8??2[X=+% $-/9CK=)[S]"?::%=J0F
M/B\1JY-%I<A+N<N!P\D1S<0>8?MKD.BO;S<+/)K9E:(5"C:*WBCW"4&6'!_K
MU=XL\4SJ$Z/4)YY*_3>T_1PDP1(5<4J[L4]!T4KI*RH^16-<*!2?!70<Q^2A
M,>]S(>[!3%BLFT4RR"2_US+;!#6<)@(9V[.G;+Y"RR"^2%*Q]&_<8M&4U<8*
M3VZRU,14;K-H2WT*IA("WE!RCUE]:M4LZ$.;P SR)Z@7<9H%?< "5X?$7= J
M(,TI<*DK8T]T8;L<[OO%<#=DN\2I!F12>0^0U28/9R1A60Q-4 05!KI[)ZX,
M'LT[*I$O46T%URSHA;WHB7X^JY1X90%Z\K-1ZI_]E3I<G?QHDKM9YIWD1HTW
MRWR3_(-9\ _^ROT5I>)=&<U6D;;TX-[FV]_(J<FM.;$PE->.!O/P@>^ JP6
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M-@PB-@]HKD_DW8,HT=+5%^*^3=%^>;.Y8E<1?J17!*^^LC5M@IPU(*S_T6+
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M=4K(?EF++E'[ A#S=!';0 V"%42<PTV SC2N[K;JNA;EJ-X!"MC><IEL[!]
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MYC6= U#!%(GK-:D#T+-TD^!KF@>@>4FRZVLR!Z!\J?/U:VH/6_O2S.&OJ1V
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M2Q&TH^):@LENJ!Y'.&.%:1O847&MK43> K.IZ#_(0AJ@R0<UCJ0U0=)FW47
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MNW=T=WD.L\>' [_IT%M^F/A2CZ_KA]@[.^1^'X8.WV&V^^CD_1URNP]S;_*
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M&7GT:E<M;R\Q#/>$0^'_)8\O<MV62(]F1+=Z1,L4,XT<X2@-S0,:#,<UCFX
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M'5XPJ<-%!!T;VNM-I;3J[SVRPB1(5(F\B&P](S^LDVV,/><$<!T)PR-3X:(
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M1FLHE3*MS=;^U+L XR$IXV[6)FVYS:GYI3D%?#-BU3=39!"L?N]=@'$B,!\
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M +9Q>Z-RL.<F_*+,;X[A%B_1O5K0QY&"TX?O6J4K?],'F!&WA:W\6#>9BXC
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M6>K/0*!1E;E7T*@:WBMH5+6/GN^5J_0B3D.F!U3RKMRG^":(8I.4/F"L-YK
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M8_B/WYZU^_PIO%0TP"AOXKR.Z+KX)KI7;C@+=$DO8.N!*46HNOT'3A%*6_[
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M7B*(UW]A!/&>01A!O-^X5+&C?>7MXG@*DWB[NW2ZKF+K/]<GP7GC@,\@XFY
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M* 82$FCW-A021A%V(FSD<3R]UH$3N-KQ&WSBRL<38(PV] @8HQ(] L9H2H^
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M)FH29KL\HIO@.C1*SX*+Q!@5N,N)<8+(K['?O-NL1 ZD-#+)@71*)CF0RAW
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M&Q]5)XW[_.;'6@CV+V0,J.K7 0-HIW,W#*A*R%/7^S3L7\@88/6P P983>R
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M6\>+58#U^K^Z;_D/KV=$6#5 (,*JP3K"9K%*74B; 8P)JP<83%A%@&!"]4*
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M:P+&<&*AV3"&\[[!C!C#B5TT36&ZQL,.<ZH29[R]4@![.+'+\;&'$_4<'WM
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M93?;VY+^O>6VO<9G72RLX575LREPJO%,GHV!!QAK ?)A&(]D<@(XZ;[O+5I
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M#SO0 ^!!.1 /CCLQ*MJ_-!#@\TY8'*8#'&./WC/3X47*]>$"#F2[%I%)<\Y
M.[\Y+D;6CM1$C>#680+]Q&9H!X(G667R\5^CL6RV"F+>.,D^0YYP'&?"XDGS
M(-8B.XW_WC+Q+B5>HUC2K]59FL=_33SVJ<GS&R2,1#L<&6NGO!J1<*)+$RKO
MR1"02U"POY2CTVTQQ'WMH2U\UX]L.(#[2%RW*EFB[@AR.O ?>&RY8F@5]9XG
M?!C>EH!@2DM=&48G4<^UUJ^=:L>Y1^7.,LPB6\_!:J^;^GT3: IZA^Y2 Y47
MRF"!23\:'UCPY Q]<&0PM7#SRYD)[]S4 \>@7);,AP\'S@)QW K9(,ZA&-C/
M(2_G=M0V^$=<7]$/=@1R/T=3Z>.(^\XM)!\#N^:L*6>_?FL)NSL#1V"GD':0
M#8\(K98*Z#ZQNMVBGGCI[49:8WVJ;[+43[NHVUY^V\8*:'CYRX!IWBML8X=I
M*S9CQLH=-$$23HLNG*=?V0ZTL#AGQ#3L(YI+<O7+4)HD[C;"FE@YH?;'S,FM
MYSP P\DJ@\N8>1R>C,LI!X8%4\ CEGT$=HLMCN1,QN/<0L:5W<OXGU7Z5+AU
M#=Y_&Z60CGNQ:M_AEY?VP3KZAOCX/6&P78;*F._K-_E<XT:C.B]]][H_;=1J
M[[)[=N'S6]MA !!6QM,HRLHJ]7JM"-$T$7G8X5:U9F6HKJG3.<,1V,K#$>P^
M>#IV?FX'0&WCHG]CP-$)9A:UX6Q;19I%0DTG,]$TD_>/1ELLB#VDB59R['?N
MQ@BX%QTH:U,S!NAWZ;O._8]GEK3I,*:;L],Q_KOGD+;I,)8TI[H<:;+GECE,
MIF_)[C[2J*2+VY3=B?PK#CN_NS%QKJ21%,21O)'G-XYUA3D<C-:2R,<NQ$!W
M>EVQ#PU,.TT:!(&OB_R!E;SP95Y<97&^IDO(NGF06[X;)1O//C*4SHM^];TE
MZX!YF,BU$,SH*<00E!/:9,@![A!W[2WIM2'_<\L'$9%F3CU#L\QOMIM-^G3V
M=,D+1JFXI/4E2VC1Y)<;%SLU7R'U9\@R)^)#Y.R)B$^IBW_X,2V;77!7/PYA
MMLEQT]^--9NW@ZJ<E,*:MT]D):PI[L6](%LT)[Y$*HK$M4)!1$^'L.9P[#32
M;%Z[I7Q%:QG]1>$1J"4/]4HX[@^'9YVWTZ40HJ0034PH^^MVH.,\3"_6T+R'
M&^@Q]R.;-],J98"JD1K E3 WR,9GJGI:-@3GY8;,^'BG=D0SQZOOY9K%Y/H^
MXNT:TVW%N#?RVCMQY?:,!]T)O)1(.3!T0?75O<^<B\6#\PL''*18\[X%D9C%
M1,G4K_+!)6\0&XJ/<K3"N"L=HPP1VIQ]@D4<HIW="U_UA4\W.P41S$RPC7'N
M &)^V,7MM2<LZ1H2Z!9/%PQ>N:)93$L^)?H#WIG_E%]0_KN")GQNA,=5KTIY
MLKL<?N"WW3DJ]1U.AOI#XB5+?-(^R^&]"_P8S*'DQ2<&Z9#4!X/K,X>QW>1)
MPP%,&D3W.HP9AV;K![!6$*3[DA7UY8K:<MPXFO$.LDZUU;ZC&0],HQG0[YK5
M2%L,KU_I DDM$5:PB"8SM+6LD688ZBEN+>^UX>7 .^+*3+N=58J!(]X3&=W1
M^S':THT8(RX55,U]_V<L<?LAFGA:;]2J.AY>>M\%,.H<8[W-%]PM@ETTPP>Y
MY\S5,KH97(]=-DT0T&'+-HCIARP5.#]#,SY/LZ5)\X2'_6J4M:64$/T%D]Y[
M8%X;<!3D@7:-UOD69[_U1>=$MT?SE$G?C;&9E@==O?LH>]@6^0V0_?"9-\<B
MNR[RF-*DE&L!>JJKFSQ-[$2&QL2''D3]>OFCG>B*E%R(7PX[P71P2KRU8OC@
M'97/38\S@E_B.AG!REC/;=U/94D$.$0(6V9/K>0M?6N]LJ(XZHQ56RF[YEW0
M=>+O>SXGB2O57/C62W*QA0?;Q1;C(NN<UE)'NT0%(VPA4VM"?,\E(0G*5>E)
M.?Z=LUG->2Y1\_C#\+[V,/5R:8^%7.4NQ:M""1%RU2;_(ML]3-\<LA0U?77P
M?:UBZO8-2V#[G;/!2!9PBT\T*CP1@3NRR[S@V++W7\4CD8L,3VUITZZ>/H"1
MEQ1 E 1H:7%4[6, >35&X'39LZ@;=2514X6:M[ XL#;W1'IX)W8$9CMS2Q-*
M?\VXWJ3Y$Z6?1?!;S_"-Y+S:R9M&9?4Z>/::[<0*QNA=E>JRM,?5C?<;5M'X
M_B.+(>/$Z5U!,3/W;_@FN=E-B!I$5B%U'?*GJ.4Q,N@%8VP)&QAOPU8O!&/7
M/B:$?B[]O>44OH#)'KO=8JCIPB>L1?1J07%J$)1Y:9:59(U_)WBV7VP]]6+U
M-A<:AFCDG<"2Z%@B?]Q3KS*>YV4%1WK**A?K"%=9<]S03,#Z0<>8UU5/%,C:
M\&)/<];2'PO=X#F$.[LK3K0/O[\+V^T[-ABJT^PZ9UGU_](B_\0RVN=4VC=F
M7K]]^>K=\3GIBL X,BD$6)NHZ@3K$Q! 0 +Y<SV?@W1R'JX@33YDMG:9R+ G
M_"]JS^/LZNF2?]B=96_?OGSS)@"6]:!P9=H3P<DQV2#;5B"%_W=;S#H>3Z-;
M#UH3Y69KI*F4NV%?&^67]WP '<&XGU^^^3$$QEE!N!..BY#.#840E!(BWZQ8
MC72;JX7&T^V2K7CO8 \4M5\^\LJB[[CS[:>?7IZ\]<NW(10.A$,1!&1(P@DI
M@HAA,6X(K8ERLS721,I!#"#4OV>\QXQ@V[N7/[X*@&UF ,Y$PS!-$@T%!$@Q
M,T0CN^9JE(GLTCH&]),1['KU\N2G -AE!N#,KI8'0Y\6'KO,$(WLFJM1)K)+
MC?731LN?PQ@M[2!Z6;;16-8$9X&/E7:L1KK-U4(3Z;9\S#7M.9819#MY>?)S
M &2S07!V:%Q FVK O?"(9L-II-E<;3.%9C*6A&GRR-GF3]XGFU;MG=A5Q_M0
M.\3YI16>D50!32REVK#B-YI3KT+A5%=[I\&QYA2NR(;,J2X\,Z?F:8T)G%)+
M>9J3Y2[7G5AOWKP\.?',K%X,+BX+%\+06[5&1!@BPR)9+U(3TV9KGHE4TQ0?
MP3$^6_&]0&%6WIE<+5Z%QZE=9$8RS=4.$\ET0Q_D'IB<]([:1GKSR\L3S]M(
M0RB<Z84R.FL4N(T4TJ[E$%HCY>9JI"F4DWX7H\918^3+-]Z'2*/N3ORJ1T41
MSH<W)AJA&<D43CM@-W!=2-UI"='=9U^%W*./=/$Y!/EO7OXRRY+D=$9U09@Y
M-8_6[IRJ]Q1 4]<A4%!*VS)!,EW.??1@/*-LZ!P(]>[E3[,,':,)9<-@XM-<
M2H^W_&)E>9G 9<C+5ZVG!&[\/I/AB,N!4WVX?,.2U^GP#HY+[]<2-F"=4&C7
MPF%JDRLX5UF?MJ0[+:3R,N!](7_'?7M0&0_Z]N,(K'7,7J![:Q61;.!PMN@H
MT'MB"TS_?J&&YN8(O.5HL*C] ?Y+S;>F[=J3.U$M-'XI-"Y7RP;!^;I-U@]M
MV N$0JW^2V/6<67F?#+[T*O_YICC"%/6E^&> CG O\CHK]LL*6B"JRW-F5V<
MRXQ=(GO]YNW+7SROD8U Y+"<P:41*4XNG8D3%MJ\NEX[FW$>--9UN-O >/Q_
MMF;<FZ!J>U\"68RZ;?+FY.4OKX-BIQ7.)&HV1S04,:%,4*MOKOC-M)RK_?:A
MI5B6%BC8US';5*]/7KW\V?,^U2".D424FPF2A2 G5/Y9\!J)-UM#C2=>LQ^"
MQYW<V?;+RY\\<\VLN@/!]-TJ<1@MJ'TJ,RX3D>9J@WUH)%POI=D8*KW^)10J
M==4?2:>Z>EANRH[/3*MYVF,O6H%/'7GH[)>7/WL^=-:CO\,:3XM8./8%>/"L
M!Z*96_.TR3[<@B-S\+\QS'H5S.#7T7ZDP\+SC/B?0%G5@6?FU#RM,9%3]<UX
MG">/S&#PR\NWGC,8]&-PI9>6Q$"L<(@L!L%QS K4&+C/U3I3F:;=&<4+?2-O
M+OWRT\L?/=]<&L;A,%"6<GEB!8<(1"Z#2ES!I.'=7QI&;/1Q<S759.HMLN;
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M;C6,R[0S%GY#+5;G^7J=9_AZ>7FZV13Y S[@!X]31UELOAV N+ ^A&M"@G@
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MX[I-K192/S7 ,QUL\ UO B?QI_=?XWM8_G';CFA B<T6*FL'YE':R$8=?Q@
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M>3=S5-YJ2BD &@U$-.<5FA7!(+KO %"'H+S==1.)FW?+E06WOVFB.^YA[CH
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MM\%DSFX<#?S=-NA8[R9**??.'UD,:S*)W!"#5W^*LII(JQ)DP@]**I%BQ:-
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M\4N]#IIAMJD* =&K@\'B_PRF]V?YQ>JR3,Y87L8,9[)]4X9:]<6*\%I$JQ;
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MW@I<;R;RE+<0G+U5+'WC+4MW@;IR5 *5#'WC&T-WX;GR4\(3['SC#3LS]IL
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M-62)3).7B79PMH&&C]-=:%3]LF$1Y'I*GB"C?7P.6U7J80*"1=-%LHT@5HW
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MO/YP>_=6Q_?ZXS* 6?WY3H(9=7>PXA\)P%$2][UR*420@A0!$V+((HD0I G
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MM"9@ P_W2+=9-8_P-ITB4G^7D,&NOEN_6)J>#-8U9+JZ^NZ\>$:YF6U_QMI
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MV#A.T$,.D0.T.W$Z*])O1'+7#^*Q"!]WMH6@4T !/3C-OH 97.^)^'P0K89
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MI!@ASJ-HN]ZF0K_Q?%+;$&(@+1Y5218*F"I%/%(.1,;V<XZD8.M18R R=L?
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M.PRU"'EGQ*)U)$RU*+%<='.N-S"T7@%>@919. +MY(]7(.43CD#K F@J^(
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M4';AF=YIQ/TFQQ74\=$L6(35;RMQUIQPX3D>LY4XATZX\#R/V4J<4:=S,#Z
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M+UF:&]B =)GLF6V&GJ%/ +$SV3/;W#Y#GP#R:+)GME4!CQSL!T!'C?(F=(Z
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MF"]I":_(EG_6;Q7S*UOJ.TG4R@(.DF]N+]+F,P0U2+D!7F8"-4BTN;U(F[<
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MLF&OG9AP@>S7;<=&ABS//YNE:9&>CC#$SOUZ!=0L#?3#1J9@N$ R#?0S&[A
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MFQ'Y3<*R\ %U-\[?C,C?P)^N\]K^9@=_NMYK^9L/^;_&:37WI^N^EK_YD/\
M_US2K_8W._CG$GZ5O_F0_U&]J-3B/Y?NJQW.A_Z'#@!J#XYV.+\..)?TJQW.
M: K$/RW\<TD_ZVY&]*_!GTOX5>[F!OY<LL^ZFP_MGYZULID/*+0XUN%\J'_L
M@',)O\;A_#K@7-*O=CBC*? CL_#/)?VLNQG1OP9_+MU7N9L9>*"*Y3AW_+0?
M;)JP$'VJ;FC$3V$G$)\^<QC)!.+36D,C0=2Z;6(Z;H,%"FGZ3071; C*IXE
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M(I>]>'AT/>2PET].NA9RV'-O;NB&5_WKYN?RV3X6LMCH.JAO+&O6#8#1-=#
M6#8PNO[I&TN::<W'C#?FYK?87\=YH>/OI;U_:.\.A"K%CO,GB; T^'0!1/$W
M-_A0F=AQ_F20?U$6>1&EJSC=]![57V5IO?O8WGY#!6+#?<D@/14V12?1?,T*
M-D4_D7S)('FS4P\J]CIL*X.DA[ IDDC$#LENV!3!(V(W9!-*^=VP-_Y>[=>
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M^D %SGY#MEDS#!A(\/V&G $?/^ ]E(J-3X?Z_0:4R?09LHX #@A(\CY#N8"
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M;X&2FCY#413K H+RML=0+B HF>.&?)2KM^[:77:'8X5.Q<0M'BC3HW9\A//
M 6IL^NS$PH$$ &HG@6Q?LT+E]]$^^IXH"P02 ("%!(+U(4"I'[(0 ,'N@G/L
MVK=HH/SO-Y8P-@@P2 \0C(4 R^OO;:JR;181) H0*RECU(<"R0',2B@42 @@
M5HP+<[/]PU;ZK^^PFN_Z+1)0 H!&C/1"@ "5-%$CF4# M \:":2678V!JIJH
ME4!R55# _(]8"84")G_8BI]@-W^5\:Y=PO(M4'\3-N&GE@,$F-XA$XD@P,0.
MF(BD$YC2 1.V<B Z6\>%W=]TJ=:95DVQR66VK8[RB>+4_FZ1UD+W&+75)-6W
MO6D1IZ5:-3NELK1:$T 5<.9+,<[!LW<:4/SS;[C4K]1IH+HY\Z48UY@&R2*]
M>H[23;N6@NT 4!0A9OS3!@ #RB+,3"H84!@A9HPT,UPO]O=)5&WZ.DZ)BSQ7
M]5G(MN1,5#V]@JJ(TGTP$C  )BBFR#YF 1.46U0?XDA[VGP U2SU68HC: L2
M**X\EG(A015*?9:,Q'N)<Z,+S RXV>Z2;*_4@TJB0JT.I_W8QWI015**-2,!
M2=! V4&P%@X-%"%^:RY"_E<9V=, 8I5?O$1Q8M\9/66/Y6Z7[(VZB-?%\ZV1
MM5'RWRJJYIM;F@1YX2)H*%2W5@GS,A.H;KT2Y$4F@;-2][&Z14N8&YD4=H!U
MBYA -W,!ZY8W86Y$TOBK^EETH )E74.<B*3P$*A;" 4YF0=0MRP*<2*2NG4!
MM2Y4MTP*<R.2OBZP(P33T,U<P(Z03 ,W(FE<E>CJ8AVAF?I>1)+8 76$9!IX
MF0G4$8*I[X6/P)FYI?PCTG^JXE['RT[!9/O* RBEZK'C(ZD'#E#^U&<G%@XD
M=5 [+K(]F&5[DU;5+A9KX)V$+>*MXY?JK.#V<Q*@#.EXEUP4G=0);A4TP>4<
M.\&MCL:[Y)L.A\+3S3YMH#YHKQT?<?OANM5,OYV8<-V*I->.CPRYT0'+9UL"
M0[VH)*O??FVT4IV=/D#13)HY'W6(X-QB@V@N'!Q0>)-FSD?+0F?Y3BWMDGEA
MM&N\C)IMEIU?&11%5%01?[$G<)B_6GT"E.R<Y)6/Q-.Z A(P4[S.IRN>FE48
M*"DZVN.,V'#L DC C/7(U@4O2N?J*?I39>9O3SI*\VA9UR%_"]0I16SX1A*#
M 6D<V$8D#$C[@#9L"<>6*E^LO^6JWOECV%\=G[?XGL2;XT9,H&8IQ9B-9C1@
M@ *B&(L&!E0UI1CS43'_\];(L+NT4-HLN@]FU>U\XPP4,/78\1'0!P=0*!X[
ML7  I8';R23;9_M?M;*H /% ,I=)O18X0#30S*6# Z0$R5PF+=N/Y8 2I50'
M,JG9 0AI#J(#9H##]1&2&L[VW./3#_\=4*X4:B\N?%P[",E*51V I^BG?;AN
M;A#JV\UW0$E25V,NV@"!NR6!L[&LP-U9W]58&%7<&=W5F.N3U,?ELUJ5]LN\
MJRA_ODVR'SG\9=[-SUT2I5%=2>,=4*!TM$>VV3*A"]QI?[S'&7:!6QB,]L@V
M@T\!9]M=9@\#RQ?KP0=8/?!N%3'"EP#RTV$#A5K'^)H5;+=J&>&+G^1?5?5=
MK#W5P@2MU;-*<[LOP/R,.O.!XK!GO ;_I#A'-P&RZXS7^"6Z"1!YY[N&@$F7
MI5?1+BZB9'#&4?4RZTG]+"Z-W9^V/P#M.,*9@&D4 MPG*P.<S0NX3TS2G?%3
M_;$P<5PE49Y_.;VP?P=4X<7-^.D+@/&)/Z>9(##-"_1W0/%=V$32B!Q!^,39
MP(0=1/. ZXC IZ<Z[?G'H!^^3^=TVS.';Q3Z35[$6_M-^;=<K<ODBQ$31]W>
MU29 T=T1OKA'+0PV+D%"?,T*-BY  GSQI>%X&:7IT[.1P;NJJ'V[%OX[H)HO
M:L5'7!P*)"@P*Z%0(#F!6+$13"U+77W==?-S67UG,-CQ^PZHZNLW9:,:!12@
M,ORFO*#VUVJ7Y7%QESZH:BNE6:ZJLWN,((JW:F4K_AP6M2]J$R6WRE:<?0?4
M 9[DE7E\1W<%H&\F>9UI5P!Z:(I7OJ5L]_K5FU>O/Y[F."![>@WY:#P(&! L
M_89R @8$2*\A)R5>=P,&9$:O(2<E>@$#8J+?4$S 0$7>?D-.2KSM!@PI@6Y#
M3DKT H92>:\A8\#O3!P?3@%#";?;D+.'>P%#:;'74$[ <*9K-^2<=.^Z'(8S
MW3LADZX7,)SIW@F:=*V X4SW3L@Z_*'+83C3?1"R2G0#!@JP#AK*"1C.=!]D
MK!)OWG<X#!1,[3=DI$0_8##3=1O*"1C,=)V&C)0HJ@C>?.J&#>8[1W-&>KB#
M!W.?J[FTX,$\Z&C.3IO?7G470# G.IJSTZ8?/)@?7<V%!0]4[70W9Z.-/9#R
M,LK5ZC[:VT>^IQ.[W@'5.&$3-OI@((!\"IM(! 'D6-"$E4[P&PB@/"9JQ4HJ
M! J0CE$KH5" Y(Q9L1+L.4M62E^DJ_OR>Q(O[9;**-U?97GU?190O])KR4HT
M#R0@B7LM!4,"4KO/4@#Q<@@34*+2;RJ >C H1 7@II)!(:H -66EWUV>EY%I
M:T.YS+(_U>HZUFI9)/NGS)YY8[]5?@=4FJ0Z8*4B#2 B(B@.Y -$I 7! 3M%
MJ^".AS:] XI-NINSTZ\?/"(FALVE!8_(AD%S?MI4]8[OE:Y^8L-')(+#@)\Z
M?0! W4C0@!/ 8E=]<W3Q/2]TM"QL]$CB[[=F[?NF3G;U=YNV6[4:@-*-N)E8
M,$AFA\W8P52A(SF[:<3?ZU6@2.X]-)(1*))5FT:L*_HI4"2#-HW8ZD><8G#6
M_7D'%"OTV E@,@ '2:B('2N<4B^?H]R>QFV_0S\^ACJ)'* \(<F:=Z3\T) ,
M[+46#@U+S!YKUG7M<6<FQ8/]0-NB0#)RJR$KS;H!(WFXW5!.P$@^;C7DHT2F
MBR>EMU^SHLIV0*G 7CL^0O3#A9)SMYV8<*%\W&DGAPQ0ONVT8U,_61)I>[30
M99S=I$IO]JTONMX#1?HP(S96XT" )(H9R00"I$S$B&TF[-0RCI*#ECQ! /*E
MLSD;G:#@@=SI;BXM>""/.INST<96.6@>+9TB!S+JL"T;89QA YG5T594V$"&
M';:50)+%^F+Y5QGK.G0@V[K;2R!+)WRH+AW07ESX0)IUMV<ES[WY668C:K9+
MV>B!W.ILSDH=5_! 5G4WEQ8\D%6=S?EHHZ-";>+EZ2S.ZE1"&S^06"$+/O+
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M&)"=*<:R@0&9FV#,1D7C?K&^L%%LZD]?+W[&%18@D;O;LQ%N$,ZU21MQ:@$
MV1RRX(5@MXVF16:W?QP& $CISN;2@@?JTP'-I01_Y Y0B0XR$-/[)P! /H<,
MF !\2U?V//(RK<ZXLH]QZ^JRN?FSV80"%)GS6G*-"062.['[+05#<J=TKR57
MVON69M]SI5]L$'?IKBR^Y38='PY<L[<=U?;]Q?HRSI)L$R^CI#ZXM'\>^7N@
MZ-S9KL!'Y/-UD5M+G.\*OT 7N=7*V:[ -]&TBA+[(N-+EE?*P"UK>NWX2-\+
M%RBLUV\G)ERW<.FU$T,&H&A>KQU7V8IN&(OTJJI/GM^ER+2SH"#%,L*;C'E
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M%1^M0JQ.8/X(E)=U-^>FY2!X7._TFDL)_G#V\D>@6"QD(*;W3P!P=3(PD #
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M3@+W-DZC=!E'26O3M^T_\JU%L'-)_!O1,>2;C'#GDCNF\R+K/MHW+\<^#8^
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MN+#;H7H<IDHOI[U\>%1QY;07,R];Q[8-%B&B6@)=B!E##"11&8$N!(WDX&P
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M3WX:?8G9=E)[YE'/@1I_C=EVTV&^4<^#&N=?3O?H:*4.-])U52H;8"^Y4<^
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MNXT%K KF?K[UZ-&&CZ5&EXF$WA^ P-*?RT3<2+0)Y<V#@*FXD6F#\N9,P%3
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M'Z>6S'W>"1E5$Z>6DGH9%06MEA)"WO]3FP2]RGZD;UZ]?FVC1[.\TT@$789
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MM!(H($Z,.O,N-G>?%5[90*9V@?71B1AP$[ZWD1/;19T 2<*B$AX.I@X0,<G
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M:GD'"]%R 4X JW_WA-(.X=G)<P NT_2I')6[_@LUADXIY#I@*'*NJ,$Z;=6
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MKS2;HNI;4Z1T.?,:Z4>D[X&O+O4O%%'H5&+#'LP>P\5+GLR+#"DLZ/;'^MD
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M9O8D.VP=O3K'M#WI#?&DST.*--F)DQ4B)VR\&.'-]RJ/[9.VMB<5(C7YE2*
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MV&3L,7E F7,'MNDFD\>EN5;!3(%C'EB*L6V.[3Q5KH5+3!(F-^Q'HP@[,.V
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M\9S2YQ<V:GB'VA3=\@7MJOV<P$3(( \+L<;0,5PDS'(Q8J@@3R632Z="+XU
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M+GAM;%!+ 0(4 Q0    ( "NJ<%*<Y/9N+SH  !T! P 1              "
M 6+O 0!H=6=E+3(P,C Q,C,Q+GAS9%!+ 0(4 Q0    ( "NJ<%*?TA1&[0T
M !#!   5              "  < I @!H=6=E+3(P,C Q,C,Q7V-A;"YX;6Q0
M2P$"% ,4    "  KJG!2@YLE'.A6   1*P8 %0              @ '@-P(
M:'5G92TR,#(P,3(S,5]D968N>&UL4$L! A0#%     @ *ZIP4M-8^0W[U0$
M8(P< !4              ( !^XX" &AU9V4M,C R,#$R,S%?;&%B+GAM;%!+
M 0(4 Q0    ( "NJ<%+#R)-D/78  )G("  5              "  2EE! !H
J=6=E+3(P,C Q,C,Q7W!R92YX;6Q02P4&      8 !@"* 0  F=L$

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
